PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Marjanovic, D; Witzmann, F				Marjanovic, David; Witzmann, Florian			An Extremely Peramorphic Newt (Urodela: Salamandridae: Pleurodelini) from the Latest Oligocene of Germany, and a New Phylogenetic Analysis of Extant and Extinct Salamandrids	PLOS ONE			English	Article							MIDDLE MIOCENE; NOTOPHTHALMUS-VIRIDESCENS; CAUDATA SALAMANDRIDAE; EVOLUTION; AMPHIBIANS; ONTOGENY; ORIGIN; SKULL; METAMORPHOSIS; BIOGEOGRAPHY	We describe an Oligocene newt specimen from western Germany that has gone practically unnoticed in the literature despite having been housed in the Museum fur Naturkunde (Berlin) for a century. It is referable to the coeval Chelotriton, but is unusually peramorphic; for many characters it is more peramorphic than all other caudates or even all other lissamphibians. Most noticeable are the position of the jaw joints far caudal to the occiput, the honeycombed sculpture on the maxilla, and the possible presence of a septomaxilla (which would be unique among salamandrids). Referral to a species would require a revision of the genus, but the specimen likely does not belong to the type species. A phylogenetic analysis of nonmolecular characters of Salamandridae, far larger than all predecessors, confirms the referral to Chelotriton. It further loosely associates the Oligocene Archaeotriton and the Miocene Carpathotriton with the extant Lissotriton, though the former may alternatively lie outside Pleurodelinae altogether. The Miocene? I. randeckensis may not belong to the extant Ichthyosaura. The Miocene "Triturus" roehrsi is found neither with the extant Ommatotriton nor with Lissotriton, but inside an Asian/aquatic clade or, when geographic distribution is included as a character, as the sister-group to all other European molgins. The main cause for discrepancies between the results and the molecular consensus is not heterochrony, but adaptations to a life in mountain streams; this is the most likely reason why the Paleocene Koalliella from western Europe forms the sister-group to some or all of the most aquatic extant newts in different analyses. We would like to urge neontologists working on salamandrids to pay renewed attention to the skeleton, not limited to the skull, as a source of diagnostic and phylogenetically informative characters.	[Marjanovic, David; Witzmann, Florian] Humboldt Univ, Leibniz Inst Evolutionary & Biodivers Res, Museum Nat Kunde, D-10099 Berlin, Germany; [Witzmann, Florian] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Brown University	Marjanovic, D (corresponding author), Humboldt Univ, Leibniz Inst Evolutionary & Biodivers Res, Museum Nat Kunde, D-10099 Berlin, Germany.	david.marjanovic@gmx.at		Marjanovic, David/0000-0001-9720-7726	Alexander von Humboldt Foundation; Directorate For Geosciences [1258878] Funding Source: National Science Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	DM was supported by an unnumbered postdoctoral fellowship of the Alexander von Humboldt Foundation (http://www.humboldtfoundation.de) until 31 January 2014. FW has been supported by an unnumbered research fellowship of the Alexander von Humboldt Foundation (http://www.humboldt-foundation.de) since 1 December 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akia Fahimeh, 2010, Russian Journal of Herpetology, V17, P179; AmphibiaTree, 2008, AMB GRAC NW SAL; Anderson J, 2008, EVOL BIOL, V35, P231, DOI 10.1007/s11692-008-9044-5; ARNTZEN JW, 1989, J ZOOL, V219, P645, DOI 10.1111/j.1469-7998.1989.tb02606.x; Bailon S., 1989, Palaeovertebrata (Montpellier), V19, P7; Boehme Madelaine, 2008, V260, P161; Bohme M, 2010, PALAEONTOL Z, V84, P3, DOI 10.1007/s12542-010-0050-4; Bohme Madelaine, 1998, Abhandlungen des Staatlichen Museums fuer Mineralogie und Geologie zu Dresden, V43-44, P265; Bolkay St.J., 1928, Z ANAT ENTWICKLUNGS, V86, P259; Bolt J.R., 1991, P194; BOLT JR, 1977, J PALEONTOL, V51, P235; Buckley David, 2012, Spanish Journal of Palaeontology, V27, P131; Carranza S, 2005, ZOOL J LINN SOC-LOND, V145, P555, DOI 10.1111/j.1096-3642.2005.00197.x; Desnitskiy AG, 2015, ZYGOTE, V23, P722, DOI 10.1017/S0967199414000379; DigiMorph Staff, 2008, AMB TIGR; DigiMorph Staff, 2008, TAR TOR; Duellman W. E., 1986, BIOL AMPHIBIANS; Estes R., 1976, B MUSEUM NATL DHISTO, V398, P297; Estes R., 1981, HDB PALAOHERPETOLOGI, V2; Francis ETB, 1934, ANATOMY SALAMANDER; Frost DR, AMPHIBIAN SPECIES WO; Gao KQ, 2012, P NATL ACAD SCI USA, V109, P5767, DOI 10.1073/pnas.1009828109; GIACOMA C, 1988, B ZOOL, V55, P337; Gonzalez-Fernandez JE., 2012, MORFOLOGIA COMP REL; Gosselin-Ildari A, 2007, PLEUR WALTL; Gu XM, 2012, ZOOTAXA, P41; Haller-Probst M., 1994, Courier Forschungsinstitut Senckenberg, V173, P23; Halliday T.R., 1990, Advances in the Study of Behavior, V19, P137, DOI 10.1016/S0065-3454(08)60202-8; HELLMUND M, 1987, Salamandra, V23, P142; Herre W., 1949, Zool Jahrb. Jena (Syst.), V78, P217; Herre W., 1935, Zoologica Stuttgart, V33, P1; Herre Wolf, 1941, ZOOL ANZ, V134, P1; Hilton William A., 1947, JOUR ENT AND ZOOL, V39, P37; Hou M, 2014, ZOOTAXA, V3895, P89, DOI 10.11646/zootaxa.3895.1.5; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; Ivachnenko M, 1978, PALEONTOL J, V1978, P362; Ivanov M, 2008, GEOBIOS-LYON, V41, P465, DOI 10.1016/j.geobios.2007.11.004; Ivanovic A, 2014, BIOL J LINN SOC, V113, P243, DOI 10.1111/bij.12314; Ivanovic Ana, 2012, Int J Evol Biol, V2012, P740605, DOI 10.1155/2012/740605; Jacisin J, 2014, J VERTEBRATE PALEONT, V2014, P153; Kalusa JW, 1976, THESIS CALIFORNIA ST; Klembara J, 2000, T ROY SOC EDIN-EARTH, V90, P287; Klembara J, 2007, ANN CARNEGIE MUS, V76, P53, DOI 10.2992/0097-4463(2007)76[53:FDOSOL]2.0.CO;2; Maddison WP, 2011, MESQUITE MODULAR SYS; Marjanovic D, 2007, SYST BIOL, V56, P369, DOI 10.1080/10635150701397635; Marjanovic D, 2014, HIST BIOL, V26, P535, DOI 10.1080/08912963.2013.797972; Marjanovic D, 2008, CONTRIB ZOOL, V77, P149, DOI 10.1163/18759866-07703002; Martin C., 2012, Graellsia, V68, P159, DOI 10.3989/graellsia.2012.v68.056; Meyer H., 1860, PALAEONTOGRAPHICA, V7, P47; Miklas Petra Maria, 2002, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V103A, P161; Milner Andrew R., 2000, Amphibian Biology, V4, P1412; NOBLE G. K., 1928, AMER MUS NOVITATES, V303, P1; NUSSBAUM RA, 1982, HERPETOLOGICA, V38, P320; OZETI N, 1969, COPEIA, P91; PANCHEN AL, 1967, EVOLUTION, V21, P24, DOI 10.1111/j.1558-5646.1967.tb00127.x; Pawley K, 2006, THESIS LATROBE U MEL; Pomel A., 1853, CATALOGUE METHODIQUE; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Rage JC, 2000, MEMOIR MUS NATL HIST, V183, P177; Ratnikov Viatcheslav Yu., 2009, Russian Journal of Herpetology, V16, P57; Ratnikovi Vyacheslav Yu., 2008, Russian Journal of Herpetology, V14, P177; REILLY SM, 1988, J MORPHOL, V195, P237, DOI 10.1002/jmor.1051950302; REILLY SM, 1990, J MORPHOL, V204, P121, DOI 10.1002/jmor.1052040202; Reilly SM, 1996, COPEIA, P29; REILLY SM, 1986, J MORPHOL, V188, P315, DOI 10.1002/jmor.1051880306; Rocek Z, 1996, PALAEONTOLOGY, V39, P477; Rocek Z, 1996, J MORPHOL, V230, P187, DOI 10.1002/(SICI)1097-4687(199611)230:2<187::AID-JMOR6>3.0.CO;2-E; Rocek Z, 2005, PALAEONTOGRAPHIA ITA, V90, P11; ROCEK Z, 1995, GEOLINES, V3, P55; Rocek Zbynek, 2000, Amphibian Biology, V4, P1274; Rocek Zbynek, 2010, Palaeobiodiversity Palaeoenvironments, V90, P321, DOI 10.1007/s12549-010-0042-0; Rocek Zbynek, 1994, Abhandlungen und Berichte fuer Naturkunde, V17, P51; Rose Christopher S., 2003, Amphibian Biology, V5, P1684; Sanchiz B., 1998, ANN NATURHIST MUS WI, V99, P13; Schoch RR, 2015, PALAEOBIO PALAEOENV, V95, P77, DOI 10.1007/s12549-014-0182-8; Schoch RR, 2013, J VERTEBR PALEONTOL, V33, P58, DOI 10.1080/02724634.2012.716113; SEVER DM, 1991, HERPETOLOGICA, V47, P165; SEVER DM, 1992, ANAT REC, V233, P229, DOI 10.1002/ar.1092330206; Skutschas PP, 2012, ACTA PALAEONTOL POL, V57, P135, DOI 10.4202/app.2010.0101; SMIRNOV SV, 1995, ZH OBSHCH BIOL, V56, P317; Sparreboom M, 2000, AMPHIBIA-REPTILIA, V21, P1, DOI 10.1163/156853800507219; Swofford DL, 2014, PAUP PHYLOGENETIC AN; TITUS TA, 1995, SYST BIOL, V44, P125, DOI 10.2307/2413703; Vasilyan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040665; VEITH M, 1992, ZOOL ANZ, V229, P63; Venczel M, 2008, J SYST PALAEONTOL, V6, P41, DOI 10.1017/S1477201907002283; Venczel M, 2013, PALAEONTOGR ABT A, V300, P117; Venczel M, 2008, GEODIVERSITAS, V30, P731; von Koenigswald W, 1992, DECHENIANA, V145, P312; Wake D, 2001, DIC ENS; WAKE DB, 1969, COPEIA, P124; Wang Y, 2006, ACTA PALAEONTOL POL, V51, P127; WESTPHAL F, 1980, Senckenbergiana Lethaea, V60, P475; Westphal F., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1978, P491; Westphal F., 1977, Bericht naturf Ges Freiburg i B, V67, P393; Whitmore SS, 2013, CONSERV GENET, V14, P771, DOI 10.1007/s10592-013-0472-0; Wiedersheim R., 1877, Morphologisches Jahrbuch, Viii, P352; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Witzmann F, 2003, J VERTEBR PALEONTOL, V23, P750, DOI 10.1671/3; Witzmann F, 2007, GEOBIOS-LYON, V40, P541, DOI 10.1016/j.geobios.2006.07.001; Witzmann F, 2013, EARTH ENV SCI T R SO, V104, P145, DOI 10.1017/S1755691013000480; Witzmann F, 2010, ZOOL J LINN SOC-LOND, V160, P302, DOI 10.1111/j.1096-3642.2009.00599.x; Wright AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109210; Wu YK, 2010, ZOOTAXA, P45; Wu YK, 2013, MOL PHYLOGENET EVOL, V66, P380, DOI 10.1016/j.ympev.2012.10.011; Wu YK, 2012, ASIAN HERPETOL RES, V3, P83, DOI 10.3724/SP.J.1245.2012.00083; YOUNG CHUNG-CHIEN, 1965, ACTA PALAEON TOLSINICA, V13, P455; Yu Pingjing, 2007, Sichuan Journal of Zoology, V26, P133; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020	109	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137068	10.1371/journal.pone.0137068	http://dx.doi.org/10.1371/journal.pone.0137068			72	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421432	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700008
J	Lundin, H; Torabi, F; Saaf, M; Strender, LE; Nyren, S; Johansson, SE; Salminen, H				Lundin, Hans; Torabi, Faramarz; Saaf, Maria; Strender, Lars-Erik; Nyren, Sven; Johansson, Sven-Erik; Salminen, Helena			Laser-Supported Dual Energy X-Ray Absorptiometry (DXL) Compared to Conventional Absorptiometry (DXA) and to FRAX as Tools for Fracture Risk Assessments	PLOS ONE			English	Article							HIP FRACTURE; BONE-DENSITY; OSTEOPOROSIS; CALCANEUS	Dual X-ray and Laser (DXL) adds a measure of the external thickness of the heel, measured by laser, to a conventional measurement of bone mineral density (BMD) of the calcaneus, using Dual energy X-ray Absorptiometry (DXA). The addition of heel thickness aims at a better separation of fatty tissue from bone than the standard method of DXA, which may mistake fatty tissue for bone and vice versa. The primary aim of this study was to evaluate whether DXL of the calcaneus can be used to assess the 10-year risk of fractures. Secondary aims were to compare the predictive ability of DXL with the two most established methods, Dual energy X-ray Absorptiometry (DXA) of the hip and spine and the WHO fracture risk assessment tool, FRAX. In 1999 a cohort of 388 elderly Swedish women (mean age 73.2 years) was examined with all three methods. Prospective fracture data was collected in 2010 from health care registers. One SD decrease in BMD of the heel resulted in an age-adjusted Hazard Ratio (HR) of 1.47 for a hip fracture (95% CI 1.09-1.98). Harrell's C is the Cox regression counterpart of the Area Under Curve (AUC) of the Receiver Operating Characteristic (ROC) as a measure of predictive accuracy. Harrell's C for BMD of the calcaneus was 0.65 for prediction of hip fractures. These results were not significantly different from those for BMD of the femoral neck or for FRAX. The HR for a hip fracture, for one SD decrease in BMD at the femoral neck, was 1.72 (95% CI 1.21-2.44. Harrell's C was 0.67 for BMD at the femoral neck and 0.59 for FRAX. We conclude that DXL of the calcaneus could be a useful tool for fracture risk assessments.	[Lundin, Hans; Torabi, Faramarz; Strender, Lars-Erik; Johansson, Sven-Erik; Salminen, Helena] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Saaf, Maria; Nyren, Sven] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Lundin, H (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	hans.lundin@ki.se		Nyren, Sven/0000-0003-3586-8785; Lundin, Hans/0000-0001-8840-3573	Stockholm City Council [SLL20080127]	Stockholm City Council	This work was supported by the Stockholm City Council, (https://forskningsstod.vmi.se/Ansokan/start.asp) Grant #SLL20080127. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin M, 2012, J BONE MINER RES, V27, P687, DOI 10.1002/jbmr.1472; Bates DW, 2002, JAMA-J AM MED ASSOC, V288, P1898, DOI 10.1001/jama.288.15.1898; Blake GM, 2008, J BONE MINER RES, V23, P457, DOI 10.1359/JBMR.071119; Brismar TB, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/875647; Cefalu CA, 2004, CURR MED RES OPIN, V20, P341, DOI 10.1185/030079903125003062; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kullenberg R, 2003, J CLIN DENSITOM, V6, P367, DOI 10.1385/JCD:6:4:367; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Muschitz C, 2013, OSTEOPOROSIS INT, V24, P2181, DOI 10.1007/s00198-013-2266-0; NICE NI for H and CE, 2012, OST ASS RISK FRAG FR; NOF NOA, 2013, NOFS CLIN GUID PREV; ORWOLL ES, 1991, J BONE MINER RES, V6, P191; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Salminen H, 2008, OSTEOPOROSIS INT, V19, P201, DOI 10.1007/s00198-007-0463-4; Salminen H, 2006, EUR J CLIN NUTR, V60, P486, DOI 10.1038/sj.ejcn.1602341; Salminen H, 2005, OSTEOPOROSIS INT, V16, P541, DOI 10.1007/s00198-004-1719-x; Small Ralph E, 2005, MedGenMed, V7, P3; Thorpe JA, 2006, BRIT J RADIOL, V79, P336, DOI 10.1259/bjr/22191429; WASNICH RD, 1987, CLIN ORTHOP RELAT R, P262; World Health Organization Collaborating Centre for Metabolic Bone Diseases University of Sheffield UK, FRAX WHO FRACT RISK	25	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137535	10.1371/journal.pone.0137535	http://dx.doi.org/10.1371/journal.pone.0137535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413715	Green Submitted, gold, Green Published			2022-12-27	WOS:000362170700008
J	Zhao, X; Zhang, LL; Zhao, ZT; Wang, WC; Leavitt, SD; Lumbsch, HT				Zhao, Xin; Zhang, Lu Lu; Zhao, Zun Tian; Wang, Wei Cheng; Leavitt, Steven D.; Lumbsch, Helge Thorsten			A Molecular Phylogeny of the Lichen Genus Lecidella Focusing on Species from Mainland China	PLOS ONE			English	Article							GRAPHIDACEAE ASCOMYCOTA; RIBOSOMAL DNA; CHARACTER EVOLUTION; PARALLEL EVOLUTION; PCR PRIMERS; SSU RDNA; LECANORACEAE; FUNGI; IDENTIFICATION; AMPLIFICATION	The phylogeny of Lecidella species is studied, based on a 7-locus data set using ML and Bayesian analyses. Phylogenetic relationships among 43 individuals representing 11 Lecidella species, mainly from mainland China, were included in the analyses and phenotypical characters studied and mapped onto the phylogeny. The Lecidella species fall into three major clades, which are proposed here as three informal groups-Lecidella stigmatea group, L. elaeochroma group and L. enteroleucella group, each of them strongly supported. Our phylogenetic analyses support traditional species delimitation based on morphological and chemical traits in most but not all cases. Individuals considered as belonging to the same species based on phenotypic characters were found to be paraphyletic, indicating that cryptic species might be hidden under these names (e.g. L. carpathica and L. effugiens). Potentially undescribed species were found within the phenotypically circumscribed species L. elaeochroma and L. stigmatea. Additional sampling across a broader taxonomic and geographic scale will be crucial to fully resolving the taxonomy in this cosmopolitan genus.	[Zhao, Xin; Zhang, Lu Lu; Zhao, Zun Tian; Wang, Wei Cheng] Shandong Normal Univ, Coll Life Sci, Jinan 250014, Peoples R China; [Leavitt, Steven D.; Lumbsch, Helge Thorsten] Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA; [Leavitt, Steven D.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA	Shandong Normal University; Field Museum of Natural History (Chicago); University of Chicago	Lumbsch, HT (corresponding author), Field Museum Nat Hist, Sci & Educ, Chicago, IL 60605 USA.	tlumbsch@fieldmuseum.org	Leavitt, Steven D./AAC-6462-2021	Leavitt, Steven D./0000-0002-5034-9724; Lumbsch, Thorsten/0000-0003-1512-835X	China Scholorship Council [201408370093]; National Natural Science Foundation of China [31170187, 31270059]	China Scholorship Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Scholorship Council (www.csc.edu.cn) 201408370093 to XZ, National Natural Science Foundation of China (www.nsfc.gov.cn) 31170187 to ZTZ and the National Natural Science Foundation of China (www.nsfc.gov.cn) 31270059 to LLZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Abdulla, 2001, Harvard Papers in Botany, V5, P359; de Paz GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039683; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DePriest PT, 2004, ANNU REV MICROBIOL, V58, P273, DOI 10.1146/annurev.micro.58.030603.123730; Divakar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083115; Doring H, 2000, LICHENOLOGIST, V32, P200, DOI 10.1006/lich.1999.0250; Ekman S, 2000, PLANT BIOLOGY, V2, P350, DOI 10.1055/s-2000-3703; ELIX JA, 1992, BRYOLOGIST, V95, P52, DOI 10.2307/3243785; Elix JA, 2009, SYST BIODIVERS, V7, P479, DOI 10.1017/S1477200009990223; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Grube M, 2004, MYCOL RES, V108, P1111, DOI 10.1017/S0953756204000826; Grube M, 2004, MYCOL RES, V108, P506, DOI 10.1017/S0953756204009888; Grube Martin, 2002, Mycologist, V16, P67, DOI 10.1017/S0269915X02002069; Gueidan C, 2007, MYCOL RES, V111, P1145, DOI 10.1016/j.mycres.2007.08.010; Hafellner J, 1984, MITT BOT TAG WIEN 19, P116; Hafellner J., 1984, NOVA HEDWIGIA S, V79, P241; Hertel H, 1984, NOVA HEDWIGIA S, V79, P399; Hertel H, 1967, NOVA HEDWIGIA S, V24, P1; INOUE M, 1991, Antarctic Record, V35, P271; Jaklitsch WM, 2015, SYLLABUS PLANT FAMIL, V1/2, P150; Kalb K, 2008, NOVA HEDWIGIA, V86, P23, DOI 10.1127/0029-5035/2008/0086-0023; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kirk PM, 2008, AINSWORTH BISBYS DIC; KNOPH J.-G., 1997, BIBLIOTHECA LICHENOL, V68, P129; Knoph J. G., 1990, BIBLIOTHECA LICHENOL, V36, P1; KNOPH JG, 1994, NOVA HEDWIGIA, V59, P455; Knoph Johannes-Guenther, 2000, Herzogia, V14, P1; Knoph Johannes-Guenther, 1995, Cryptogamic Botany, V5, P45; Koerber GW., 1855, SYSTEMA LICHENUM GER; Larena I, 1999, J BIOTECHNOL, V75, P187, DOI 10.1016/S0168-1656(99)00154-6; Leavitt SD, 2011, AM J BOT, V98, P175, DOI 10.3732/ajb.1000230; LEUCKERT C, 1992, Herzogia, V9, P1; LEUCKERT C, 1992, LICHENOLOGIST, V24, P383, DOI 10.1017/S0024282992000501; LEUCKERT C, 1990, Herzogia, V8, P265; LEUCKERT C., 1967, NOVA HEDWIGIA, V14, P291; Leuckert C, 1993, BIBLIOTHECA LICHENOL, V53, P161; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lucking R, 2014, P NATL ACAD SCI USA, V111, P11091, DOI 10.1073/pnas.1403517111; Lumbsch H.T., 2009, MYCONET, V14, P1, DOI DOI 10.3158/1557.1; LUMBSCH H. T., 2006, FUNGI MULTIFACETED M, P153; Lumbsch HT, 2014, SYST BIODIVERS, V12, P271, DOI 10.1080/14772000.2014.905506; Lumbsch H. Thorsten, 2002, P281; Lumbsch HT, 2000, NATURWISSENSCHAFTEN, V87, P335, DOI 10.1007/s001140050736; Mangold A, 2008, TAXON, V57, P476, DOI 10.2307/25066016; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Miadlikowska J, 2006, MYCOLOGIA, V98, P1088, DOI 10.3852/mycologia.98.6.1088; Miadlikowska J, 2014, MOL PHYLOGENET EVOL, V79, P132, DOI 10.1016/j.ympev.2014.04.003; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Orange A., 2001, MICROCHEMICAL METHOD; Otalora MAG, 2013, MOL PHYLOGENET EVOL, V68, P185, DOI 10.1016/j.ympev.2013.04.004; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Plata ER, 2011, MOL PHYLOGENET EVOL, V61, P45, DOI 10.1016/j.ympev.2011.04.025; Printzen C, PROGR BOT, V712010, P233; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruprecht U, 2012, NOVA HEDWIGIA, V94, P287, DOI 10.1127/0029-5035/2012/0017; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schmitt I, 2009, MOL PHYLOGENET EVOL, V52, P34, DOI 10.1016/j.ympev.2009.03.017; Schmull M, 2011, MYCOLOGIA, V103, P983, DOI 10.3852/10-234; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Tehler A, 2007, CLADISTICS, V23, P432, DOI 10.1111/j.1096-0031.2007.00156.x; VILGALYS R, 1990, Journal of Bacteriology, V172, P4238; Wedin M, 2009, MOL PHYLOGENET EVOL, V53, P862, DOI 10.1016/j.ympev.2009.08.013; Wei J.C., 1991, ENUMERATION LICHENS; Zhang LL, 2012, BRYOLOGIST, V115, P329, DOI 10.1639/0007-2745-115.2.329; Zhang LL, 2012, MYCOTAXON, V119, P445, DOI 10.5248/119.445; Zhao X, 2015, MYCOTAXON IN PRESS; Zhao X, 2015, FUNGAL DIVERSITY, Vxx; Zhou SG, 2001, MYCOL RES, V105, P1033, DOI 10.1016/S0953-7562(08)61965-6; Zoller S, 1999, LICHENOLOGIST, V31, P511	73	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139405	10.1371/journal.pone.0139405	http://dx.doi.org/10.1371/journal.pone.0139405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414323	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700056
J	Deng, K; Liu, RY; Rao, HY; Jiang, D; Wang, JH; Xie, XW; Wei, L				Deng, Kai; Liu, Ruyu; Rao, Huiying; Jiang, Dong; Wang, Jianghua; Xie, Xingwang; Wei, Lai			Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; E2 GLYCOPROTEIN; IMMUNE-RESPONSES; ENVELOPE; PARTICLES; IMMUNIZATION; CHIMPANZEES; PROTEIN; SERUM	Currently, there is no effective vaccine to prevent hepatitis C virus (HCV) infection, partly due to our insufficient understanding of the virus glycoprotein immunology. Most neutralizing antibodies (nAbs) were identified using glycoprotein immunogens, such as recombinant E1E2, HCV pseudoparticles or cell culture derived HCV. However, the fact that in the HCV acute infection phase, only a small proportion of patients are self-resolved accompanied with the emergence of nAbs, indicates the limited immunogenicity of glycoprotein itself to induce effective antibodies against a highly evolved virus. Secondly, in previous reports, the immunogen sequence was mostly the genotype of the 1a H77 strain. Rarely, other genotypes/subtypes have been studied, although theoretically one genotype/subtype immunogen is able to induce cross-genotype neutralizing antibodies. To overcome these drawbacks and find potential novel neutralizing epitopes, 57 overlapping peptides encompassing the full-length glycoprotein E1E2 of subtype 1b were synthesized to immunize BALB/c mice, and the neutralizing reactive of the induced antisera against HCVpp genotypes 1-6 was determined. We defined a domain comprising amino acids (aa) 192-221, 232-251, 262-281 and 292-331 of E1, and 421-543, 564-583, 594-618 and 634-673 of E2, as the neutralizing regions of HCV glycoprotein. Peptides PUHI26 (aa 444-463) and PUHI45 (aa 604-618)-induced antisera displayed the most potent broad neutralizing reactive. Two monoclonal antibodies recognizing the PUHI26 and PUHI45 epitopes efficiently precluded genotype 2 viral (HCVcc JFH and J6 strains) infection, but they did not neutralize other genotypes. Our study mapped a neutralizing epitope region of HCV glycoprotein using a novel immunization strategy, and identified two monoclonal antibodies effective in preventing genotype 2 virus infection.	[Deng, Kai; Rao, Huiying; Wang, Jianghua; Xie, Xingwang; Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China; [Liu, Ruyu] Capital Med Univ, Liver Dis Ctr, Beijing Ditan Hosp, Beijing, Peoples R China; [Jiang, Dong] Capital Med Univ, Inst Infect Dis, Beijing Ditan Hosp, Beijing Key Lab Emerging Infect Dis, Beijing, Peoples R China	Peking University; Capital Medical University; Capital Medical University	Wei, L (corresponding author), Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China.	weelai@163.com			National Science and Technology Major Project [2012ZX10002003]	National Science and Technology Major Project	The work was sponsored by National Science and Technology Major Project (2012ZX10002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2013, GASTROENTEROLOGY, V145, P447, DOI 10.1053/j.gastro.2013.05.007; Alexander J, 2014, J VIROL, V88, P14278, DOI 10.1128/JVI.01911-14; Carlsen THR, 2014, HEPATOLOGY, V60, P1551, DOI 10.1002/hep.27298; Cashman SB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00550; Claassen MAA, 2013, CURR OPIN VIROL, V3, P461, DOI 10.1016/j.coviro.2013.05.006; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062684; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Edwards VC, 2012, J GEN VIROL, V93, P1, DOI 10.1099/vir.0.035956-0; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Ishii K, 1998, HEPATOLOGY, V28, P1117, DOI 10.1002/hep.510280429; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck Z, 2013, J VIROL, V87, P37, DOI 10.1128/JVI.01941-12; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Liu RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066872; Mathiesen CK, 2014, VIROLOGY, V458, P190, DOI 10.1016/j.virol.2014.03.021; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Meyer K, 2008, J VIROL, V82, P2140, DOI 10.1128/JVI.01867-07; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Ndongo N, 2010, HEPATOLOGY, V52, P1531, DOI 10.1002/hep.23862; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Pedersen J, 2013, HEPATOLOGY, V58, P1587, DOI 10.1002/hep.26524; Puig M, 2004, VACCINE, V22, P991, DOI 10.1016/j.vaccine.2003.09.010; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Ruwona TB, 2014, J VIROL, V88, P10459, DOI 10.1128/JVI.01584-14; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tarr AW, 2007, J GEN VIROL, V88, P2991, DOI 10.1099/vir.0.83065-0; Torresi J, 2007, IMMUNOL CELL BIOL, V85, P169, DOI 10.1038/sj.icb.7100021; Walker CM, 2010, ADV VIRUS RES, V78, P43, DOI 10.1016/S0065-3527(10)78002-7	32	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138756	10.1371/journal.pone.0138756	http://dx.doi.org/10.1371/journal.pone.0138756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406225	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700088
J	Guy, F; Lazzari, V; Gilissen, E; Thiery, G				Guy, Franck; Lazzari, Vincent; Gilissen, Emmanuel; Thiery, Ghislain			To What Extent is Primate Second Molar Enamel Occlusal Morphology Shaped by the Enamel-Dentine Junction?	PLOS ONE			English	Article							BRIEF COMMUNICATION; THICKNESS; TOOTH; SURFACE; MODEL; EXPRESSION; DENTITIONS; EVOLUTION; MICROWEAR; PATTERNS	The form of two hard tissues of the mammalian tooth, dentine and enamel, is the result of a combination of the phylogenetic inheritance of dental traits and the adaptive selection of these traits during evolution. Recent decades have been significant in unveiling developmental processes controlling tooth morphogenesis, dental variation and the origination of dental novelties. The enamel-dentine junction constitutes a precursor for the morphology of the outer enamel surface through growth of the enamel cap which may go along with the addition of original features. The relative contribution of these two tooth components to morphological variation and their respective response to natural selection is a major issue in paleoanthropology. This study will determine how much enamel morphology relies on the form of the enamel-dentine junction. The outer occlusal enamel surface and the enamel-dentine junction surface of 76 primate second upper molars are represented by polygonal meshes and investigated using tridimensional topometrical analysis. Quantitative criteria (elevation, inclination, orientation, curvature and occlusal patch count) are introduced to show that the enamel-dentine junction significantly constrains the topographical properties of the outer enamel surface. Our results show a significant correlation for elevation, orientation, inclination, curvature and occlusal complexity between the outer enamel surface and the enamel dentine junction for all studied primate taxa with the exception of four modern humans for curvature (p<0.05). Moreover, we show that, for all selected topometrical parameters apart from occlusal patch count, the recorded correlations significantly decrease along with enamel thickening in our sample. While preserving tooth integrity by providing resistance to wear and fractures, the variation of enamel thickness may modify the curvature present at the occlusal enamel surface in relation to enamel-dentine junction, potentially modifying dental functionalities such as blunt versus sharp dental tools. In terms of natural selection, there is a balance between increasing tooth resistance and maintaining efficient dental tools. In this sense the enamel cap acts as a functional buffer for the molar occlusal pattern. In primates, results suggest a primary emergence of dental novelties on the enamel-dentine junction and a secondary transposition of these novelties with no or minor modifications of dental functionalities by the enamel cap. Whereas enamel crenations have been reported by previous studies, our analysis do not support the presence of enamel tubercles without dentine relief nuclei. As is, the enamel cap is, at most, a secondary source of morphological novelty.	[Guy, Franck; Lazzari, Vincent; Thiery, Ghislain] Univ Poitiers, Fac Sci, CNRS INEE UMR 7262, IPHEP, F-86073 Poitiers 9, France; [Gilissen, Emmanuel] Royal Museum Cent Afr, Dept African Zool, B-3080 Tervuren, Belgium; [Gilissen, Emmanuel] Univ Libre Bruxelles, Lab Histol & Neuropathol, B-1070 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Royal Museum for Central Africa; Universite Libre de Bruxelles	Guy, F (corresponding author), Univ Poitiers, Fac Sci, CNRS INEE UMR 7262, IPHEP, Bat B35-TSA 51106,6 rue Michel Brunet, F-86073 Poitiers 9, France.	franck.guy@univ-poitiers.fr	Thiery, Ghislain/ABI-7588-2020	Thiery, Ghislain/0000-0003-4789-7372; GUY, Franck/0000-0001-7032-7963; Lazzari, Vincent/0000-0002-8210-2646	Centre National de la Recherche Scientifique (CNRS, INEE); University of Poitiers; Region Poitou-Charentes [07/RPC-R-100, 12/RPC-013]	Centre National de la Recherche Scientifique (CNRS, INEE); University of Poitiers; Region Poitou-Charentes(Region Nouvelle-Aquitaine)	Funding: This work was supported by the Centre National de la Recherche Scientifique (CNRS, INEE); the University of Poitiers and the Region Poitou-Charentes (Conventions #07/RPC-R-100 & #12/RPC-013).	Adloff P., 1938, Z MORPHOL ANTHROPOL, P490; Anderson PSL, 2009, J EXP BIOL, V212, P3627, DOI 10.1242/jeb.033712; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Boyer DM, 2010, AM J PHYS ANTHROPOL, V142, P194, DOI 10.1002/ajpa.21211; BUTLER PM, 1956, BIOL REV, V31, P30, DOI 10.1111/j.1469-185X.1956.tb01551.x; Cuozzo FP, 2012, AM J PHYS ANTHROPOL, V148, P163, DOI 10.1002/ajpa.21656; Cuvier G., 1817, REGNE ANIMAL APRES S; Dean C, 2004, J HUM EVOL, V46, P633, DOI 10.1016/j.jhevol.2004.03.001; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Evans AR, 2005, ANN ZOOL FENN, V42, P603; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; Gregory WK, 1926, ANTHROPOL PAP AM MUS, V27, P3; Guy F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066142; Harjunmaa E, 2014, NATURE, V512, P44, DOI 10.1038/nature13613; Harjunmaa E, 2012, NATURE, V483, P324, DOI 10.1038/nature10876; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jones D, 2012, P ROY SOC B-BIOL SCI, V279, P2849, DOI 10.1098/rspb.2012.0147; Kato A, 2014, AM J PHYS ANTHROPOL, V155, P447, DOI 10.1002/ajpa.22593; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KAY RF, 1981, AM J PHYS ANTHROPOL, V55, P141, DOI 10.1002/ajpa.1330550202; Korenhof C.A.W., 1982, EVOLUTIONARY TRENDS, P350; Korenhof CAW, 1961, KONINKL NEDERL AKA B, V64, P639; Kraus BS, 1965, HUMAN DENTITION BIRT; LIEM KF, 1980, AM ZOOL, V20, P295; Lucas P.W., 2000, P282, DOI 10.1017/CBO9780511542626.020; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; MAAS MC, 1991, AM J PHYS ANTHROPOL, V85, P31, DOI 10.1002/ajpa.1330850106; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Morita W, 2014, J ANAT, V224, P669, DOI 10.1111/joa.12180; NAGER GOTTFRIED, 1960, ACTA ANAT, V42, P226; Norconk MA, 2011, ANAT REC, V294, P2092, DOI 10.1002/ar.21506; Olejniczak AJ, 2008, AM J PHYS ANTHROPOL, V135, P85, DOI 10.1002/ajpa.20711; Olejniczak AJ, 2004, ANN ANAT, V186, P479, DOI 10.1016/S0940-9602(04)80087-6; Ortiz A, 2012, J HUM EVOL, V63, P586, DOI 10.1016/j.jhevol.2012.06.003; Osborn JW, 2008, J THEOR BIOL, V255, P338, DOI 10.1016/j.jtbi.2008.09.008; OSBORN JW, 1993, J THEOR BIOL, V165, P429, DOI 10.1006/jtbi.1993.1199; Pampush JD, 2013, J HUM EVOL, V64, P216, DOI 10.1016/j.jhevol.2013.01.009; Schwartz GT, 2000, ARCH ORAL BIOL, V45, P401, DOI 10.1016/S0003-9969(00)00007-8; Schwartz GT, 1998, J HUM EVOL, V35, P523, DOI 10.1006/jhev.1998.0239; Shellis RP, 1998, J HUM EVOL, V35, P507, DOI 10.1006/jhev.1998.0238; Shimizu D, 2002, J HUM EVOL, V43, P605, DOI 10.1006/jhev.2002.0593; Skinner MM, 2008, J HUM EVOL, V54, P173, DOI 10.1016/j.jhevol.2007.09.012; Skinner MM, 2010, J ANAT, V217, P245, DOI 10.1111/j.1469-7580.2010.01265.x; Skinner MM, 2010, AM J PHYS ANTHROPOL, V142, P157, DOI 10.1002/ajpa.21248; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Skinner MM, 2009, J HUM EVOL, V56, P76, DOI 10.1016/j.jhevol.2008.08.021; Smith TM, 2008, AM J PHYS ANTHROPOL, V136, P237, DOI 10.1002/ajpa.20796; Suwa G, 2005, ANTHROPOL SCI, V113, P273, DOI 10.1537/ase.050118; Teaford MF, 1996, AM J PHYS ANTHROPOL, V101, P527; Tiphaine C, 2013, EVOLUTION, V67, P3323, DOI 10.1111/evo.12172; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; VONKOENIGSWALD W, 1994, ZOOL J LINN SOC-LOND, V110, P141, DOI 10.1006/zjls.1994.1008; Walkhoff O., 1925, Z STOMATOL, V23, P93; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Wright BW, 2012, AM J PHYS ANTHROPOL, V148, P262, DOI 10.1002/ajpa.22081	58	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138802	10.1371/journal.pone.0138802	http://dx.doi.org/10.1371/journal.pone.0138802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406597	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700101
J	Matt, P; Lindqvist, U; Kleinau, S				Matt, Peter; Lindqvist, Ulla; Kleinau, Sandra			Elevated Membrane and Soluble CD64: A Novel Marker Reflecting Altered Fc gamma R Function and Disease in Early Rheumatoid Arthritis That Can Be Regulated by Anti-Rheumatic Treatment	PLOS ONE			English	Article							C-REACTIVE PROTEIN; COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; RECEPTOR EXPRESSION; COMPLEMENT RECEPTORS; IMMUNE-COMPLEXES; DOWN-REGULATION; ALPHA-RI; MEDIATED PHAGOCYTOSIS; CLINICAL-RESPONSE	Objectives Fc receptors (FcR) interacting with immune complexes (ICs) is a central event in the immune pathogenesis of rheumatoid arthritis (RA). Here we asked if a specific FcR is linked to RA pathogenesis and if FcR activities relate to disease and treatment outcome in early RA. Material and Methods Twenty autoantibody-positive RA patients and 33 HC were included. The patients were evaluated before and after treatment with methotrexate and prednisolone. At follow-up, the EULAR response criteria were applied to determine the individual treatment outcomes. Serum immunoglobulin levels were measured and the expression of FcR for IgG (Fc gamma R) and IgA (Fc alpha R) on peripheral blood monocytes were determined by flow cytometry. The monocytic Fc gamma R function was evaluated by human IgG1 and IgG3 IC-binding and TNF alpha stimulated release. Plasma levels of soluble FcRs (sFcRs) were determined with ELISA. Results The IgG1 and IgG3 levels were elevated in the RA sera. The RA monocytes expressed more CD64 and cell surface-bound IgG than HC monocytes, and showed an impaired Fc gamma R function as reflected by changes in IC-binding and decreased IC-stimulated TNF alpha secretion. These findings correlated significantly with different disease activity markers. Furthermore, sFcRs were elevated in the patient plasma, and sCD64 was specific for RA (compared with a reference group of patients with active psoriatic arthritis). Following treatment, immunoglobulins and sFcR levels were reduced, whereas membrane CD64 was only decreased in patients with good response to treatment. Conclusions Early RA patients display increased membrane and soluble CD64 and an impaired Fc gamma R function correlating with joint disease activity. Beneficial responses of anti-rheumatic treatment in patients reduce CD64. These data suggest sCD64 as an important objective biomarker in RA.	[Matt, Peter; Lindqvist, Ulla] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Matt, Peter; Kleinau, Sandra] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden	Uppsala University; Uppsala University	Matt, P (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	johann.peter.matt@akademiska.se			Agnes and Mac Rudberg foundation; Gustaf Prim Rheumatic Foundation at Uppsala University	Agnes and Mac Rudberg foundation; Gustaf Prim Rheumatic Foundation at Uppsala University	This work was supported by the Agnes and Mac Rudberg foundation and by the Gustaf Prim Rheumatic Foundation at Uppsala University. PM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho K, 1997, ANN RHEUM DIS, V56, P351, DOI 10.1136/ard.56.6.351; Aletaha D, 2010, ARTHRITIS RHEUMATISM, V62; Amigorena S, 1999, IMMUNOL REV, V172, P279, DOI 10.1111/j.1600-065X.1999.tb01372.x; Barth E, 2001, CYTOKINE, V14, P299, DOI 10.1006/cyto.2001.0880; BLUESTONE R, 1970, ANN RHEUM DIS, V29, P47, DOI 10.1136/ard.29.1.47; Bobbio-Pallavicini F, 2007, ANN RHEUM DIS, V66, P302, DOI 10.1136/ard.2006.060608; Bodman-Smith KB, 2002, IMMUNOLOGY, V107, P252, DOI 10.1046/j.1365-2567.2002.01481.x; Boekhoudt GH, 2007, J LEUKOCYTE BIOL, V81, P1086, DOI 10.1189/jlb.0906543; BOLTZNITULESCU G, 1995, J LEUKOCYTE BIOL, V58, P256, DOI 10.1002/jlb.58.2.256; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Bucht A, 1996, CLIN EXP IMMUNOL, V103, P357; Bunescu A, 2004, J RHEUMATOL, V31, P2347; de Jong PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035070; Du Clos TW, 2003, ARTHRITIS RHEUM-US, V48, P1475, DOI 10.1002/art.11025; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72; Gillis C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00254; GITLIN JD, 1977, ARTHRITIS RHEUM, V20, P1491, DOI 10.1002/art.1780200808; Grossetete B, 1998, KIDNEY INT, V53, P1321, DOI 10.1046/j.1523-1755.1998.00885.x; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; Heijnen IAFM, 1996, J CLIN INVEST, V97, P331, DOI 10.1172/JCI118420; Hepburn AL, 2004, RHEUMATOLOGY, V43, P547, DOI 10.1093/rheumatology/keh112; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Jiang S, 2006, SCAND J RHEUMATOL, V35, P351, DOI 10.1080/03009740600757963; Jones NR, 2011, ARTHRITIS RHEUM-US, V63, P2641, DOI 10.1002/art.30444; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kramer PR, 2004, ARTHRITIS RHEUM, V50, P1967, DOI 10.1002/art.20309; KUMPEL BM, 1990, MOL IMMUNOL, V27, P247, DOI 10.1016/0161-5890(90)90137-O; Kylanpaa ML, 2005, PANCREAS, V31, P23, DOI 10.1097/01.mpa.0000164449.23524.94; Laurent L, 2001, ANN RHEUM DIS, P70; Lin GG, 2010, RHEUMATOL INT, V30, P837, DOI 10.1007/s00296-009-1330-8; Lu JH, 2011, P NATL ACAD SCI USA, V108, P4974, DOI 10.1073/pnas.1018369108; Magnusson SE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2206; Magnusson SE, 2014, IMMUNOL LETT, V162, P200, DOI 10.1016/j.imlet.2014.08.016; Matt P, 2015, SCAND J RHEUMATOL, P1; MCCONKEY B, 1972, Q J MED, V41, P115; MCMILLAN R, 1976, J IMMUNOL, V116, P1592; MELLBYE OJ, 1990, SCAND J RHEUMATOL, V19, P333, DOI 10.3109/03009749009096788; Nyugen J, 2010, J CLIN IMMUNOL, V30, P806, DOI 10.1007/s10875-010-9448-8; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; PATRY C, 1995, IMMUNOLOGY, V86, P1; Prokopec KE, 2010, CLIN IMMUNOL, V137, P322, DOI 10.1016/j.clim.2010.08.006; Reterink TJF, 1996, CLIN EXP IMMUNOL, V103, P161, DOI 10.1046/j.1365-2249.1996.00918.x; Romero IR, 1998, CLIN IMMUNOL IMMUNOP, V87, P155, DOI 10.1006/clin.1997.4516; Salinas-Carmona MC, 2009, AUTOIMMUNITY, V42, P537, DOI 10.1080/08916930903019119; SASSO EH, 1988, J IMMUNOL, V140, P3098; Schiff DE, 1997, BLOOD, V90, P3187, DOI 10.1182/blood.V90.8.3187; SHAKIB F, 1976, ANN RHEUM DIS, V35, P263, DOI 10.1136/ard.35.3.263; Shashidharamurthy R, 2009, J IMMUNOL, V183, P8216, DOI 10.4049/jimmunol.0902550; Stein MP, 2000, J IMMUNOL, V164, P1514, DOI 10.4049/jimmunol.164.3.1514; Steiner G, 2007, CLIN REV ALLERG IMMU, V32, P23, DOI 10.1007/BF02686079; Stohlawetz P, 1998, SCAND J IMMUNOL, V48, P324; Tanaka M, 2009, J IMMUNOL, V183, P2349, DOI 10.4049/jimmunol.0801683; ten Hove W, 2006, J IMMUNOL, V177, P6108, DOI 10.4049/jimmunol.177.9.6108; Torsteinsdottir I, 1999, CLIN EXP IMMUNOL, V115, P554; van de Stadt LA, 2011, ARTHRITIS RHEUM-US, V63, P3226, DOI 10.1002/art.30537; van der Heijden J, 2012, J IMMUNOL, V188, P1318, DOI 10.4049/jimmunol.1003945; van der Poel CE, 2010, BLOOD, V116, P5327, DOI 10.1182/blood-2010-04-280214; van Egmond M, 1999, BLOOD, V93, P4387, DOI 10.1182/blood.V93.12.4387.412k08_4387_4394; van Vugt MJ, 1999, BLOOD, V94, P808, DOI 10.1182/blood.V94.2.808.414k31_808_817; van Vuuren AJ, 2006, J IMMUNOL, V176, P5833, DOI 10.4049/jimmunol.176.10.5833; van Zandbergen G, 1999, J IMMUNOL, V163, P5806; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; VETVICKA V, 1985, IMMUNOLOGY, V56, P73; VEYS EM, 1968, ANN RHEUM DIS, V27, P431, DOI 10.1136/ard.27.5.431; Wijngaarden S, 2005, RHEUMATOLOGY, V44, P729, DOI 10.1093/rheumatology/keh583; Wijngaarden S, 2003, RHEUMATOLOGY, V42, P681, DOI 10.1093/rheumatology/keg174; Wolbink GJ, 2005, ANN RHEUM DIS, V64, P704, DOI 10.1136/ard.2004.030452; ZUBLER RH, 1976, J CLIN INVEST, V57, P1308, DOI 10.1172/JCI108399	71	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137474	10.1371/journal.pone.0137474	http://dx.doi.org/10.1371/journal.pone.0137474			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406605	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700021
J	Meijer, M; Cijsouw, T; Toonen, RF; Verhage, M				Meijer, Marieke; Cijsouw, Tony; Toonen, Ruud F.; Verhage, Matthijs			Synaptic Effects of Munc18-1 Alternative Splicing in Excitatory Hippocampal Neurons	PLOS ONE			English	Article							READILY RELEASABLE POOL; PROTEIN-PHOSPHORYLATION; NERVOUS-SYSTEM; CALYX; COMPLEX; EXPRESSION; PREDICTION; SNAP-25	The munc18-1 gene encodes two splice-variants that vary at the C-terminus of the protein and are expressed at different levels in different regions of the adult mammalian brain. Here, we investigated the expression pattern of these splice variants within the brainstem and tested whether they are functionally different. Munc18-1a is expressed in specific nuclei of the brainstem including the LRN, VII and SOC, while Munc18-1b expression is relatively low/absent in these regions. Furthermore, Munc18-1a is the major splice variant in the Calyx of Held. Synaptic transmission was analyzed in autaptic hippocampal munc18-1 KO neurons re-expressing either Munc18-1a or Munc18-1b. The two splice variants supported synaptic transmission to a similar extent, but Munc18-1b was slightly more potent in sustaining synchronous release during high frequency stimulation. Our data suggest that alternative splicing of Munc18-1 support synaptic transmission to a similar extent, but could modulate presynaptic short-term plasticity.	[Verhage, Matthijs] Vrije Univ Amsterdam, NCA, CNCR, Dept Funct Genom, Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Verhage, M (corresponding author), Vrije Univ Amsterdam, NCA, CNCR, Dept Funct Genom, Amsterdam, Netherlands.	m.verhage@vu.nl	Cijsouw, Anthony/B-8309-2008; Toonen, Rob/V-6230-2019	Cijsouw, Anthony/0000-0002-3670-7863; Toonen, Rob/0000-0001-6339-4340; verhage, matthijs/0000-0002-6085-7503; Toonen, Ruud/0000-0002-9900-4233	EU (EUROSPIN) [HEALTH-F2-2009-241498, HEALTH-F2-2009-242167]; Netherlands Organization for Scientific Research, NWO (ZonMW-TOP) [91208017]; NeuroBsik Mouse Phenomics Consortium [BSIK03053]	EU (EUROSPIN); Netherlands Organization for Scientific Research, NWO (ZonMW-TOP)(Netherlands Organization for Scientific Research (NWO)); NeuroBsik Mouse Phenomics Consortium	Funding: This work was supported by the EU (EUROSPIN project HEALTH-F2-2009-241498, and HEALTH-F2-2009-242167 SynSys project to MV), the Netherlands Organization for Scientific Research, NWO (ZonMW-TOP 91208017 to RFT) and the NeuroBsik Mouse Phenomics Consortium (BSIK03053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awatramani GB, 2005, J NEUROPHYSIOL, V93, P819, DOI 10.1152/jn.00798.2004; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Broeke JHP, 2010, BIOL CELL, V102, P479, DOI 10.1042/BC20100036; Chen ZX, 2013, J NEUROSCI, V33, P8336, DOI 10.1523/JNEUROSCI.5128-12.2013; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Cijsouw T, 2014, J CELL BIOL, V204, P759, DOI 10.1083/jcb.201308026; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Dondzillo A, 2010, J COMP NEUROL, V518, P1008, DOI 10.1002/cne.22260; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Goswami T, 2012, PROTEOMICS, V12, P2185, DOI 10.1002/pmic.201200003; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Han SH, 1999, NEUROSCIENCE, V94, P955, DOI 10.1016/S0306-4522(99)00372-3; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; KELLY PT, 1985, DEV BRAIN RES, V18, P211, DOI 10.1016/0165-3806(85)90265-2; Lee CJ, 2003, BIOL PSYCHIAT, V54, P771, DOI 10.1016/S0006-3223(03)00375-5; Lipstein N, 2013, NEURON, V79, P82, DOI 10.1016/j.neuron.2013.05.011; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schmitz SK, 2011, J NEUROSCI METH, V195, P185, DOI 10.1016/j.jneumeth.2010.12.011; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wierda KDB, 2014, J NEUROSCI, V34, P2100, DOI 10.1523/JNEUROSCI.3934-13.2014; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Xiao L, 2013, NAT NEUROSCI, V16, P856, DOI 10.1038/nn.3414; Xiao L, 2010, MOL CELL NEUROSCI, V44, P374, DOI 10.1016/j.mcn.2010.05.002	43	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138950	10.1371/journal.pone.0138950	http://dx.doi.org/10.1371/journal.pone.0138950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407320	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700126
J	Turner, LM; Croft, RJ; Churchyard, A; Looi, JCL; Apthorp, D; Georgiou-Karistianis, N				Turner, Lauren M.; Croft, Rodney J.; Churchyard, Andrew; Looi, Jeffrey C. L.; Apthorp, Deborah; Georgiou-Karistianis, Nellie			Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation	PLOS ONE			English	Article							MOVEMENT-RELATED POTENTIALS; CONTINGENT NEGATIVE-VARIATION; FUNCTIONAL COMPENSATION; WORKING-MEMORY; BASAL GANGLIA; CONNECTIVITY; ONSET; INHIBITION; PATHOLOGY; NETWORKS	Background Huntington's disease (HD) causes progressive motor dysfunction through characteristic atrophy. Changes to neural structure begin in premanifest stages yet individuals are able to maintain a high degree of function, suggesting involvement of supportive processing during motor performance. Electroencephalography (EEG) enables the investigation of subtle impairments at the neuronal level, and possible compensatory strategies, by examining differential activation patterns. We aimed to use EEG to investigate neural motor processing (via the Readiness Potential; RP), premotor processing and sensorimotor integration (Contingent Negative Variation; CNV) during simple motor performance in HD. Methods We assessed neural activity associated with motor preparation and processing in 20 premanifest (pre-HD), 14 symptomatic HD (symp-HD), and 17 healthy controls. Participants performed sequential tapping within two experimental paradigms (simple tapping; Go/NoGo). RP and CNV potentials were calculated separately for each group. Results Motor components and behavioural measures did not distinguish pre-HD from controls. Compared to controls and pre-HD, symp-HD demonstrated significantly reduced relative amplitude and latency of the RP, whereas controls and pre-HD did not differ. However, early CNV was found to significantly differ between control and pre-HD groups, due to enhanced early CNV in pre-HD. Conclusions For the first time, we provide evidence of atypical activation during preparatory processing in pre-HD. The increased activation during this early stage of the disease may reflect ancillary processing in the form of recruitment of additional neural resources for adequate motor preparation, despite atrophic disruption to structure and circuitry. We propose an early adaptive compensation mechanism in pre-HD during motor preparation.	[Turner, Lauren M.; Apthorp, Deborah] Australian Natl Univ, Res Sch Psychol, Coll Med Biol & Environm, Canberra, ACT, Australia; [Croft, Rodney J.; Apthorp, Deborah] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Croft, Rodney J.; Apthorp, Deborah] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Churchyard, Andrew; Georgiou-Karistianis, Nellie] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Churchyard, Andrew] Calvary Hlth Care Bethlehem Hosp, Caulfield, Vic, Australia; [Looi, Jeffrey C. L.] Australian Natl Univ, Sch Med, Canberra Hosp, Res Ctr Neurosci Ageing,Acad Unit Psychiat & Med, Canberra, ACT, Australia; [Looi, Jeffrey C. L.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia	Australian National University; University of Wollongong; University of Wollongong; Monash University; Australian National University; Canberra Hospital; University of Melbourne	Turner, LM (corresponding author), Australian Natl Univ, Res Sch Psychol, Coll Med Biol & Environm, Canberra, ACT, Australia.	lauren.turner@anu.edu.au	Georgiou-Karistianis, Nellie/ABC-5623-2020; Apthorp, Deborah/N-5623-2014	Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Apthorp, Deborah/0000-0001-5785-024X; Looi, Jeffrey/0000-0003-3351-6911; Croft, Rodney/0000-0002-5986-9136				Aylward EH, 2012, BIOL PSYCHIAT, V71, P822, DOI 10.1016/j.biopsych.2011.07.030; Bartenstein P, 1997, BRAIN, V120, P1553, DOI 10.1093/brain/120.9.1553; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beste C, 2008, NEUROPSYCHOLOGIA, V46, P1290, DOI 10.1016/j.neuropsychologia.2007.12.008; Beste C, 2007, NEUROPSYCHOLOGIA, V45, P2922, DOI 10.1016/j.neuropsychologia.2007.06.004; Beste C, 2011, NEUROPSYCHOLOGIA, V49, P3484, DOI 10.1016/j.neuropsychologia.2011.08.024; Beste C, 2009, EXP NEUROL, V216, P148, DOI 10.1016/j.expneurol.2008.11.018; Brandt J., 1992, CLIN NEUROPSYCHOL, V5, P125; Campodonico JR, 1996, J NEUROL NEUROSUR PS, V61, P621, DOI 10.1136/jnnp.61.6.621; Croft RJ, 2000, CLIN NEUROPHYSIOL, V111, P444, DOI 10.1016/S1388-2457(99)00296-5; Cunnington R, 1999, MOVEMENT DISORD, V14, P63; de Tommaso M, 2007, J NEUROL SCI, V254, P84, DOI 10.1016/j.jns.2007.01.011; Dominguez D JF, 2013, PLOS ONE, V8, P1; Farrow M, 2006, COGN BEHAV NEUROL, V19, P208, DOI 10.1097/01.wnn.0000213914.64772.b6; Feigin A, 2006, ANN NEUROL, V59, P53, DOI 10.1002/ana.20684; FEVE A, 1994, J NEUROL NEUROSUR PS, V57, P100, DOI 10.1136/jnnp.57.1.100; Gavazzi C, 2007, J COMPUT ASSIST TOMO, V31, P574, DOI 10.1097/01.rct.0000284390.53202.2e; Georgiou-Karistianis N, 2013, NEUROBIOL DIS, V51, P82, DOI 10.1016/j.nbd.2012.10.001; Georgiou-Karistianis N, 2014, HUM BRAIN MAPP, V35, P1847, DOI 10.1002/hbm.22296; Georgiou-Karistianis N, 2013, BRAIN COGNITION, V83, P80, DOI 10.1016/j.bandc.2013.07.004; GIORDANI B, 1995, ARCH NEUROL-CHICAGO, V52, P59, DOI 10.1001/archneur.1995.00540250063014; Gordon AM, 2000, EXP NEUROL, V163, P136, DOI 10.1006/exnr.2000.7348; Hinton SC, 2007, J INT NEUROPSYCH SOC, V13, P539, DOI 10.1017/S1355617707070671; Ikeda A, 1997, ELECTROEN CLIN NEURO, V102, P142, DOI 10.1016/S0921-884X(96)95067-5; Johnson KA, 2001, EXP BRAIN RES, V138, P492, DOI 10.1007/s002210100733; Johnson KA, 2002, MOVEMENT DISORD, V17, P998, DOI 10.1002/mds.10204; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kloppel S, 2009, BRAIN, V132, P1624, DOI 10.1093/brain/awp081; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Papoutsi M, 2014, MOVEMENT DISORD, V29, P673, DOI 10.1002/mds.25864; Poudel GR, 2015, BRAIN STRUCT FUNCT, V220, P501, DOI 10.1007/s00429-013-0670-z; Poudel GR, 2014, J PSYCHIATR NEUROSCI, V39, P87, DOI 10.1503/jpn.120226; Quinn L, 2001, MOVEMENT DISORD, V16, P469, DOI 10.1002/mds.1108; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Unschuld PG, 2012, NEUROSCI LETT, V514, P204, DOI 10.1016/j.neulet.2012.02.095; Weeks RA, 1997, BRAIN, V120, P1569, DOI 10.1093/brain/120.9.1569; Wolf RC, 2008, EXP NEUROL, V213, P137, DOI 10.1016/j.expneurol.2008.05.017	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138563	10.1371/journal.pone.0138563	http://dx.doi.org/10.1371/journal.pone.0138563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406226	Green Published, gold			2022-12-27	WOS:000361800700058
J	Visweswaran, GRR; Gholizadeh, S; Ruiters, MHJ; Molema, G; Kok, RJ; Kamps, JAAM				Visweswaran, Ganesh Ram R.; Gholizadeh, Shima; Ruiters, Marcel H. J.; Molema, Grietje; Kok, Robbert J.; Kamps, Jan. A. A. M.			Targeting Rapamycin to Podocytes Using a Vascular Cell Adhesion Molecule-1 (VCAM-1)-Harnessed SAINT-Based Lipid Carrier System	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VIVO; O-SOMES; EXPRESSION; DELIVERY; SIRNA; CYTOSKELETON; INFLAMMATION; ANTI-VCAM-1; INHIBITION	Together with mesangial cells, glomerular endothelial cells and the basement membrane, podocytes constitute the glomerular filtration barrier (GFB) of the kidney. Podocytes play a pivotal role in the progression of various kidney-related diseases such as glomerular sclerosis and glomerulonephritis that finally lead to chronic end-stage renal disease. During podocytopathies, the slit-diaphragm connecting the adjacent podocytes are detached leading to severe loss of proteins in the urine. The pathophysiology of podocytopathies makes podocytes a potential and challenging target for nanomedicine development, though there is a lack of known molecular targets for cell selective drug delivery. To identify VCAM-1 as a cell-surface receptor that is suitable for binding and internalization of nanomedicine carrier systems by podocytes, we investigated its expression in the immortalized podocyte cell lines AB8/13 and MPC-5, and in primary podocytes. Gene and protein expression analyses revealed that VCAM-1 expression is increased by podocytes upon TNF alpha-activation for up to 24 h. This was paralleled by anti-VCAM-1 antibody binding to the TNF alpha-activated cells, which can be employed as a ligand to facilitate the uptake of nanocarriers under inflammatory conditions. Hence, we next explored the possibilities of using VCAM-1 as a cell-surface receptor to deliver the potent immunosuppressant rapamycin to TNF alpha-activated podocytes using the lipid-based nanocarrier system Saint-O-Somes. Anti-VCAM-1-rapamycin-SAINT-O-Somes more effectively inhibited the cell migration of AB8/13 cells than free rapamycin and non-targeted rapamycin-SAINT-O-Somes indicating the potential of VCAM-1 targeted drug delivery to podocytes.	[Visweswaran, Ganesh Ram R.; Ruiters, Marcel H. J.; Molema, Grietje; Kamps, Jan. A. A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, Groningen, Netherlands; [Gholizadeh, Shima; Kok, Robbert J.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands	University of Groningen; Utrecht University	Kamps, JAAM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, Groningen, Netherlands.	j.a.a.m.kamps@umcg.nl	Kok, Robbert/I-9579-2016; Kok, Robbert/AAX-9863-2020	Kok, Robbert/0000-0003-4933-3968; Kok, Robbert/0000-0003-4933-3968; Molema, Grietje/0000-0002-4147-6676	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands;  [03D.07]	NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; 	Funding: This work is supported by NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners (Grant number: project 03D.07), http://www.nanonextnl.nl/.	Adrian JE, 2010, J CONTROL RELEASE, V144, P341, DOI 10.1016/j.jconrel.2010.03.003; Asgeirdottir SA, 2008, AM J PHYSIOL-RENAL, V294, pF554, DOI 10.1152/ajprenal.00391.2007; Asgeirsdottir SA, 2012, AM J PHYSIOL-RENAL, V302, pF1630, DOI 10.1152/ajprenal.00400.2011; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Chiang WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011837; Fogo AB, 2011, J CLIN INVEST, V121, P2142, DOI 10.1172/JCI57935; Gao HX, 2009, CYTOKINE, V46, P24, DOI 10.1016/j.cyto.2008.12.001; Haraldsson B, 2009, CURR OPIN NEPHROL HY, V18, P331, DOI 10.1097/MNH.0b013e32832c9dba; Hauser PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009463; Jin EJ, 2009, BLOOD, V114, P5557, DOI 10.1182/blood-2009-05-220434; Khattree N, 2013, J CELL SCI, V126, P4659, DOI 10.1242/jcs.126888; Kowalski PS, 2014, J CONTROL RELEASE, V176, P64, DOI 10.1016/j.jconrel.2013.12.029; Kowalski PS, 2013, MOL PHARMACEUT, V10, P3033, DOI 10.1021/mp4001124; Kuldo JM, 2013, J CONTROL RELEASE, V166, P57, DOI 10.1016/j.jconrel.2012.12.016; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Ricard I, 1998, EUR J IMMUNOL, V28, P1708, DOI 10.1002/(SICI)1521-4141(199805)28:05<1708::AID-IMMU1708>3.0.CO;2-Y; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sapra P, 2002, CANCER RES, V62, P7190; Siddiqi FS, 2013, DIABETES, V62, P3647, DOI 10.2337/db13-0795; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008	24	23	23	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138870	10.1371/journal.pone.0138870	http://dx.doi.org/10.1371/journal.pone.0138870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407295	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700106
J	Wu, PP; Zheng, J; Huang, TM; Li, DM; Hu, QQ; Cheng, AM; Jiang, ZY; Jiao, LY; Zhao, SQ; Zhang, K				Wu, Panpan; Zheng, Jie; Huang, Tianming; Li, Dianmeng; Hu, Qingqing; Cheng, Anming; Jiang, Zhengyun; Jiao, Luoying; Zhao, Suqing; Zhang, Kun			Synthesis and Evaluation of Novel Triterpene Analogues of Ursolic Acid as Potential Antidiabetic Agent	PLOS ONE			English	Article							IN-VITRO; CYTOTOXIC ACTIVITY; CONJUGATE APPROACH; DERIVATIVES; DESIGN; MECHANISM; APOPTOSIS; OBESITY	Ursolic acid (UA) is a naturally bioactive compound that possesses potential anti-diabetic activity. The relatively safe and effective molecule intrigued us to further explore and to improve its anti-diabetic activity. In the present study, a series of novel UA analogues was synthesized and their structures were characterized. Their bioactivities against the alpha-glucosidase from baker's yeast were determined in vitro. The results suggested that most of the analogues exhibited significant inhibitory activity, especially analogues 8b and 9b with the IC50 values of 1.27 +/- 0.27 mu M (8b) and 1.28 +/- 0.27 mu M (9b), which were lower than the other analogues and the positive control. The molecular docking and 2D-QSAR studies were carried out to prove that the C-3 hydroxyl could interact with the hydrophobic region of the active pocket and form hydrogen bonds to increase the binding affinity of ligand and the homology modelling protein. Thus, these results will be helpful for understanding the relationship between binding mode and bioactivity and for designing better inhibitors from UA analogues.	[Wu, Panpan; Zheng, Jie; Huang, Tianming; Hu, Qingqing; Cheng, Anming; Jiang, Zhengyun; Jiao, Luoying; Zhao, Suqing; Zhang, Kun] Guangdong Univ Technol, Fac Chem Engn & Light Ind, Dept Pharmaceut Engn, Guangzhou, Peoples R China; [Li, Dianmeng] Guangxi Zhuang Autonomous Reg, Guangxi Inst Bot, Guilin, Peoples R China; [Li, Dianmeng] Chinese Acad Sci, Guilin, Peoples R China	Guangdong University of Technology; Chinese Academy of Sciences	Wu, PP (corresponding author), Guangdong Univ Technol, Fac Chem Engn & Light Ind, Dept Pharmaceut Engn, Guangzhou, Peoples R China.	sqzhao@gdut.edu.cn; kzhang@gdut.edu.cn		Wu, Panpan/0000-0002-6515-0726	National Natural Science Foundation of China [21172046]; Guangdong Province; Ministry of Education [2011B090600033]; Guangzhou Science and Technology Plan [2013Y2-00081]; Guangdong Province Higher Education "Qianbaishi Engineering"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province; Ministry of Education; Guangzhou Science and Technology Plan; Guangdong Province Higher Education "Qianbaishi Engineering"	This study was supported by National Natural Science Foundation of China (Grant No. 21172046). The authors are also grateful to the combination research projects of Guangdong Province and Ministry of Education for financial support (Grant No. 2011B090600033), Guangdong Province Higher Education "Qianbaishi Engineering", and Guangzhou Science and Technology Plan (Grant No. 2013Y2-00081).	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Ali H, 2006, J ETHNOPHARMACOL, V107, P449, DOI 10.1016/j.jep.2006.04.004; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; Bai KK, 2012, BIOORG MED CHEM LETT, V22, P2488, DOI 10.1016/j.bmcl.2012.02.009; Buckley DA, 2002, MOL CELL BIOL, V22, P1998, DOI 10.1128/MCB.22.7.1998-2010.2002; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Dong HY, 2015, BIOCHEM PHARMACOL, V93, P151, DOI 10.1016/j.bcp.2014.11.014; Castro AJG, 2015, BBA-GEN SUBJECTS, V1850, P51, DOI 10.1016/j.bbagen.2014.10.001; Gu W, 2015, BIOORG MED CHEM LETT, V25, P554, DOI 10.1016/j.bmcl.2014.12.021; Hua SX, 2015, EUR J MED CHEM, V95, P435, DOI 10.1016/j.ejmech.2015.03.051; Huang TM, 2015, RSC ADV, V5, P44234, DOI 10.1039/c5ra05450h; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Ramirez-Espinosa JJ, 2011, EUR J MED CHEM, V46, P2243, DOI 10.1016/j.ejmech.2011.03.005; Kalani K, 2015, RSC ADV, V5, P32133, DOI 10.1039/c4ra13709d; Kashiwada Y, 2000, J NAT PROD, V63, P1619, DOI 10.1021/np990633v; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085827; Liu Y, 2011, CHEMMEDCHEM, V6, P1654, DOI 10.1002/cmdc.201100149; Ma CM, 2005, EUR J MED CHEM, V40, P582, DOI 10.1016/j.ejmech.2005.01.001; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meng YQ, 2009, BIOORGAN MED CHEM, V17, P848, DOI 10.1016/j.bmc.2008.11.036; Saravanan R, 2006, PHARMACOL REP, V58, P41; Schafer A, 2007, DIABETES RES CLIN PR, V77, P41, DOI 10.1016/j.diabres.2006.10.011; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Song GP, 2015, EUR J MED CHEM, V93, P431, DOI 10.1016/j.ejmech.2015.02.029; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05006; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Worawalai W, 2012, MEDCHEMCOMM, V3, P1466, DOI 10.1039/c2md20227a; Wu PP, 2014, EUR J MED CHEM, V80, P502, DOI 10.1016/j.ejmech.2014.04.073; Wu PP, 2014, MOLECULES, V19, P12559, DOI 10.3390/molecules190812559	33	16	16	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138767	10.1371/journal.pone.0138767	http://dx.doi.org/10.1371/journal.pone.0138767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406581	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700091
J	Qian, XY; Qin, J; Pan, SD; Li, X; Pan, YL; Ma, SL				Qian, Xinyu; Qin, Jing; Pan, Songdan; Li, Xin; Pan, Yuelong; Ma, Shenglin			Maintenance Therapy in Ovarian Cancer with Targeted Agents Improves PFS and OS: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PHASE-II TRIAL; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; DOUBLE-BLIND; CARBOPLATIN; PACLITAXEL; CHEMOTHERAPY; BEVACIZUMAB; COMBINATION; SORAFENIB	Background Maintenance therapy with targeted agents for prolonging remission for ovarian cancer patients remains controversial. As a result, a meta-analysis was conducted to assess the effectiveness and safety of using maintenance therapy with targeted agents for the treatment of ovarian cancer. Methods From inception to January 2015, we searched for randomized, controlled trials (RCTs) using the following databases: PubMed, ScienceDirect, the Cochrane Library, Clinicaltrials. gov and EBSCO. Eligible trials included RCTs that evaluated standard chemotherapy which was either followed or not followed by targeted maintenance in patients with ovarian cancer who had been previously receiving adjunctive treatments, such as cytoreductive surgery and standard chemotherapy. The outcome measures included progression-free survival (PFS), overall survival (OS) and incidence of adverse events. Results A total of 13 RCTs, which were published between 2006 and 2014, were found to be in accordance with our inclusion criteria. The primary meta-analysis indicated that both PFS and OS were statistically and significantly improved in the targeted maintenance therapy group as compared to the control group (PFS: HR = 0.84, 95%CI: 0.75 to 0.95, p = 0.001; OS: HR = 0.91, 95%CI: 0.84 to 0.98, p = 0.02). When taking safety into consideration, the use of targeted agents was significantly correlated with increased risks of fatigue, diarrhea, nausea, vomiting, and hypertension. However, no significant differences were found in incidence rates of abdominal pain, constipation or joint pain. Conclusions Our results indicate that targeted maintenance therapy clearly improves the survival of ovarian cancer patients but may also increase the incidence of adverse events. Additional randomized, double-blind, placebo-controlled, multicenter investigations will be required on a larger cohort of patients to verify our findings.	[Qian, Xinyu; Pan, Songdan; Li, Xin; Pan, Yuelong; Ma, Shenglin] Hangzhou Canc Hosp, Hangzhou Peoples Hosp 1, Dept Chemotherapy, Hangzhou, Zhejiang, Peoples R China; [Qin, Jing] Zhejiang Canc Hosp, Dept Chemotherapy, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital	Ma, SL (corresponding author), Hangzhou Canc Hosp, Hangzhou Peoples Hosp 1, Dept Chemotherapy, Hangzhou, Zhejiang, Peoples R China.	hzsyzlkp@sina.com; hzmasl@163.com			Projects of Hangzhou Science and Technology Development Program [20130633B07]; Science and Technology Department of Zhejiang Province [2014C33119]	Projects of Hangzhou Science and Technology Development Program; Science and Technology Department of Zhejiang Province	Projects of Hangzhou Science and Technology Development Program 20130633B07. Science and Technology Department of Zhejiang Province social welfare technology research development projects 2014C33119. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, GLOB CANC FACTS FIG; [Anonymous], 2012, REV MAN REVMAN COMP; Barakat R.R., 2009, PRINCIPLES PRACTICE, V5th ed.; Berek J, 2009, J CLIN ONCOL, V27, P418, DOI 10.1200/JCO.2008.17.8400; Bolis G, 2006, INT J GYNECOL CANCER, V16, P74, DOI 10.1111/j.1525-1438.2006.00313.x; Bookman MA, 2013, J GYNECOL ONCOL, V24, P105, DOI 10.3802/jgo.2013.24.2.105; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; du Bois A, 2014, J CLIN ONCOL, V32, P3374, DOI 10.1200/JCO.2014.55.7348; Gaitskell K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007930.pub2; Gonzalez-Martin A, 2014, DRUGS, V74, P879, DOI 10.1007/s40265-014-0221-9; Herzog TJ, 2013, GYNECOL ONCOL, V130, P25, DOI 10.1016/j.ygyno.2013.04.011; Higgins J., 2009, COCHRANE HDB SYSTEMA; Hirte H, 2006, GYNECOL ONCOL, V102, P300, DOI 10.1016/j.ygyno.2005.12.020; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Karlan BY, 2012, J CLIN ONCOL, V30, P362, DOI 10.1200/JCO.2010.34.3178; Kaye SB, 2012, CLIN CANCER RES, V18, P6509, DOI 10.1158/1078-0432.CCR-12-1796; Lambert HE, 1997, ANN ONCOL, V8, P327, DOI 10.1023/A:1008256431090; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Ledermann JA, 2011, J CLIN ONCOL, V29, P3798, DOI 10.1200/JCO.2010.33.5208; Meier W, 2012, GYNECOL ONCOL, V126, P236, DOI 10.1016/j.ygyno.2012.04.050; Ozols RF, 2006, SEMIN ONCOL, V33, pS3, DOI 10.1053/j.seminoncol.2006.03.011; Pecorelli S, 2009, J CLIN ONCOL, V27, P4642, DOI 10.1200/JCO.2009.21.9691; Pfisterer J, 2006, JNCI-J NATL CANCER I, V98, P1036, DOI 10.1093/jnci/djj296; Polcher M, 2010, CANCER CHEMOTH PHARM, V66, P203, DOI 10.1007/s00280-010-1276-2; Sabbatini P, 2013, J CLIN ONCOLOGY, V31; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Thigpen T, 2004, CANCER INVEST, V22, P21, DOI 10.1081/CNV-200030115; Vergote IB, 2014, J CLIN ONCOL, V32, P320, DOI 10.1200/JCO.2013.50.5669; Vergote IB, 2013, J CLIN ONCOL, V31, P3127, DOI 10.1200/JCO.2012.44.9116; Ye Q, 2013, ARCH GYNECOL OBSTET, V288, P655, DOI 10.1007/s00404-013-2820-1; Zhou MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081858	32	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139026	10.1371/journal.pone.0139026	http://dx.doi.org/10.1371/journal.pone.0139026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402447	Green Published, gold, Green Submitted			2022-12-27	WOS:000361798100052
J	Wittenbecher, C; di Giuseppe, R; Biemann, R; Menzel, J; Arregui, M; Hoffmann, J; Aleksandrova, K; Boeing, H; Isermann, B; Schulze, MB; Weikert, C				Wittenbecher, Clemens; di Giuseppe, Romina; Biemann, Ronald; Menzel, Juliane; Arregui, Maria; Hoffmann, Juliane; Aleksandrova, Krasimira; Boeing, Heiner; Isermann, Berend; Schulze, Matthias B.; Weikert, Cornelia			Reproducibility of Retinol Binding Protein 4 and Omentin-1 Measurements over a Four Months Period: A Reliability Study in a Cohort of 207 Apparently Healthy Participants	PLOS ONE			English	Article							ADIPOSE-TISSUE; RBP4; RETINOL-BINDING-PROTEIN-4; RISK; DISEASE; KIDNEY; ASSOCIATION; ADIPOKINE; OBESITY	The reliability of single time point measurements of the novel adipokines retinol-binding protein 4 and omentin-1 in the blood has not been evaluated in large samples yet. The present study aimed to assess the amount of biological variation of these two adipokines within individuals. The study sample comprised 207 participants (124 women and 83 men) from Potsdam (Germany) and surrounding areas, with an average age of 56.5 years (SD 4.2). Blood samples were collected from each participant twice, approximately four months apart. Using enzyme linked immunosorbent assays, the concentrations of retinol-binding protein 4 and omentin-1 were determined in EDTA plasma. As indicators of reliability, intraclass correlation coefficients (ICCs) were calculated from the repeated biomarker measurements. The ICCs for repeated retinol-binding protein 4 and omentin-1 measurements were 0.77 (95% CI 0.71, 0.82) and 0.83 (95% CI 0.78, 0.87), respectively, indicating for both adipokines excellent reliability. ICCs were stable across strata according to sex, age, BMI, and blood pressure. Thus, for epidemiological studies it seems reasonable to rely on concentrations of retinol-binding protein 4 and omentin-1 in samples from a single time point if repeated measurements are not available.	[Wittenbecher, Clemens; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Wittenbecher, Clemens; Schulze, Matthias B.] German Ctr Diabet Res DZD, Neuherberg, Germany; [di Giuseppe, Romina; Menzel, Juliane; Arregui, Maria; Weikert, Cornelia] German Inst Human Nutr Potsdam Rehbrucke, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany; [Biemann, Ronald; Hoffmann, Juliane; Isermann, Berend] Univ Magdeburg, Dept Clin Chem & Pathobiochem, D-39106 Magdeburg, Germany; [Aleksandrova, Krasimira; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Weikert, Cornelia] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Otto von Guericke University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Weikert, C (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Res Grp Cardiovasc Epidemiol, Nuthetal, Germany.	Weikert@dife.de	Schulze, Matthias B/AAH-6906-2021	Schulze, Matthias B/0000-0002-0830-5277; Menzel, Juliane/0000-0001-7938-4251; Aleksandrova, Krasimira/0000-0002-1275-1827; Wittenbecher, Clemens/0000-0001-7792-877X; di Giuseppe, Romina/0000-0002-5214-8897	German Federal Ministry of Education and Research (BMBF)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD, http://www.dzd-ev.de).	Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Chiba M, 2010, ENDOCR J, V57, P811, DOI 10.1507/endocrj.K10E-054; di Giuseppe R, 2012, ANN CLIN BIOCHEM, V49, P542, DOI 10.1258/acb.2012.011273; Frey SK, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-29; Gallo V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001117; Gavi S, 2008, OBESITY, V16, P893, DOI 10.1038/oby.2007.138; Graham TE, 2007, DIABETOLOGIA, V50, P814, DOI 10.1007/s00125-006-0557-0; Greulich S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059697; Henze A, 2010, BIOCHEM BIOPH RES CO, V393, P79, DOI 10.1016/j.bbrc.2010.01.082; Henze A, 2008, DIABETES, V57, P3323, DOI 10.2337/db08-0866; Hermsdorff HHM, 2011, INFLAMMATION, V34, P161, DOI 10.1007/s10753-010-9219-y; Kelly KR, 2010, OBESITY, V18, P663, DOI 10.1038/oby.2009.328; Lin CJ, 2013, CLIN PEDIATR, V52, P16, DOI 10.1177/0009922812459948; Luft Vivian C., 2013, Rev. bras. epidemiol., V16, P388, DOI 10.1590/S1415-790X2013000200014; Luque-Ramirez M, 2013, HUM REPROD, V28, P1908, DOI 10.1093/humrep/det097; Onur I, 2014, ANGIOLOGY, V65, P896, DOI 10.1177/0003319713511322; Pan HY, 2010, DIABETES RES CLIN PR, V88, P29, DOI 10.1016/j.diabres.2010.01.013; Rocha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078670; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Rosner B., 2010, CENGAGE LEARNING; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Sun L, 2014, J NUTR, V144, P722, DOI 10.3945/jn.113.189860; Sun Q, 2013, CIRCULATION, V127, P1938, DOI 10.1161/CIRCULATIONAHA.113.002073; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004	28	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138480	10.1371/journal.pone.0138480	http://dx.doi.org/10.1371/journal.pone.0138480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402656	Green Published, gold, Green Submitted			2022-12-27	WOS:000361798100025
J	Thies, S; Friess, M; Frischknecht, L; Korol, D; Felley-Bosco, E; Stahel, R; Vrugt, B; Weder, W; Opitz, I; Soltermann, A				Thies, Svenja; Friess, Martina; Frischknecht, Lukas; Korol, Dimitri; Felley-Bosco, Emanuela; Stahel, Rolf; Vrugt, Bart; Weder, Walter; Opitz, Isabelle; Soltermann, Alex			Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; GLUCOCORTICOID-RECEPTOR; CANCER; RECOMBINATION; MELANOMA; MARKERS; KIDNEY	Background The epithelioid and sarcomatoid histologic variants of malignant pleural mesothelioma (MPM) can be considered as E- and M-parts of the epithelial-mesenchymal transition (EMT) axis; the biphasic being an intermediate. EMT is associated with an increase of stem cell (SC) traits. We correlated the neural crest SC marker nestin and the EMT marker periostin with histology, type of neo-adjuvant chemotherapy (CT) and overall survival (OS) of MPM patients. Patients and Methods Tumor tissues of a historic cohort 1 (320 patients) and an intended induction chemotherapy followed by extrapleural pneumonectomy (EPP) cohort 2 (145 patients) were immunohistochemically H-scored (intensity of immunoreactivity multiplied by frequency of stained cells). Paired chemo-naive biopsies and - treated surgical specimens were available for 105/145 patients. CT included platinum/gemcitabine (Pla/Gem) or platinum/pemetrexed (Pla/Pem). Results Expression of any cytosolic nestin progressively increased from epithelioid to biphasic to sarcomatoid MPM in cohort 1, whereas the diagnostic markers calretinin and podoplanin decreased. In cohort 2, Pla/Pem CT increased the expression level of nestin in comparison to Pla/Gem, whereas the opposite was found for periostin. In Pla/Pem treated patients, nestin was higher in biphasic MPM compared to epithelioid. In addition to non-epithelioid histology, any expression of nestin in chemo-naive biopsies (median overall survival: 22 vs. 17 months) and chemo-treated surgical specimens (18 vs. 12 months) as well as high periostin in biopsies (23 vs. 15 months) were associated with poor prognosis. In the multivariate survival analysis, any nestin expression in chemo-naive biopsies proved to be an independent prognosticator against histology. In both pre- and post-CT situations, the combination of nestin or periostin expression with non-epithelioid histology was particularly/dismal (all pvalues < 0.05). Conclusions The SC marker nestin and the EMT marker periostin allow for further prognostic stratification among histologic variants of MPM. Their expression level is influenced by neo-adjuvant chemotherapy.	[Thies, Svenja; Frischknecht, Lukas; Vrugt, Bart; Soltermann, Alex] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Friess, Martina; Weder, Walter; Opitz, Isabelle] Univ Zurich Hosp, Div Thorac Surg, CH-8091 Zurich, Switzerland; [Korol, Dimitri] Univ Zurich Hosp, Canc Registry, CH-8091 Zurich, Switzerland; [Felley-Bosco, Emanuela; Stahel, Rolf] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Soltermann, A (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	alex.soltermann@usz.ch	Felley-Bosco, Emanuela/E-7484-2017; Soltermann, Alex/GRR-3265-2022; Soltermann, Alex/AAE-3012-2020	Felley-Bosco, Emanuela/0000-0002-3408-0294; Soltermann, Alex/0000-0001-9509-6938; Frischknecht, Lukas/0000-0001-5666-5747; Opitz, Isabelle/0000-0001-5900-9040	Center for Clinical Research, University Hospital and University of Zurich [DFL1225]; Cancer League of the Canton of Zurich [34080930]	Center for Clinical Research, University Hospital and University of Zurich; Cancer League of the Canton of Zurich	This work was funded by the Center for Clinical Research, University Hospital and University of Zurich, to AS, under ref. nr. DFL1225; and the Cancer League of the Canton of Zurich to I.O. under ref. nr. 34080930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; Byrne MJ, 2004, ANN ONCOL, V15, P257, DOI 10.1093/annonc/mdh059; Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; de Reynies A, 2014, CLIN CANCER RES, V20, P1323, DOI 10.1158/1078-0432.CCR-13-2429; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Frei C, 2011, CARCINOGENESIS, V32, P1324, DOI 10.1093/carcin/bgr127; Hinterberger M, 2007, MODERN PATHOL, V20, P248, DOI 10.1038/modpathol.3800736; Iwanami T, 2014, ONCOLOGY-BASEL, V86, P109, DOI 10.1159/000356874; Kobayashi M, 2013, ANN THORAC SURG, V95, P1181, DOI 10.1016/j.athoracsur.2013.01.012; Lai S, 2013, HISTOPATHOLOGY, V62, P487, DOI 10.1111/his.12018; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsui Yutaka, 2010, World J Biol Chem, V1, P69, DOI 10.4331/wjbc.v1.i5.69; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Petricevic J, 2012, ACTA HISTOCHEM, V114, P469, DOI 10.1016/j.acthis.2011.08.009; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qin Q, 2012, NEOPLASMA, V59, P310, DOI 10.4149/neo_2012_040; Reimer R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006084; Sakairi T, 2007, KIDNEY INT, V72, P307, DOI 10.1038/sj.ki.5002277; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Schramm A, 2010, EUR J CARDIO-THORAC, V37, P566, DOI 10.1016/j.ejcts.2009.08.027; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Sidi R, 2011, EUR J CANCER, V47, P326, DOI 10.1016/j.ejca.2010.09.044; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Soltermann A, 2011, RARE TUMORS, V3, P160, DOI 10.4081/rt.2011.e52; Soltermann Alex, 2011, J Clin Bioinforma, V1, P25, DOI 10.1186/2043-9113-1-25; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139312	10.1371/journal.pone.0139312	http://dx.doi.org/10.1371/journal.pone.0139312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421614	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000362175700093
J	Jiang, PS; Yu, CF; Yen, CY; Woo, CW; Lo, SH; Huang, YK; Hong, JH; Chiang, CS				Jiang, Pei-Shin; Yu, Ching-Fang; Yen, Chia-Yi; Woo, Christopher William; Lo, Shao-Hua; Huang, Yu-Kuan; Hong, Ji-Hong; Chiang, Chi-Shiun			Irradiation Enhances the Ability of Monocytes as Nanoparticle Carrier for Cancer Therapy	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ANTIRETROVIRAL DRUG; DELIVERY; HYPOXIA; TISSUES; EXPRESSION; RADIATION; MODEL	The tumor-homing ability of monocytes renders them a potential cellular delivery system for alternative cancer therapies, although their migratory ability can be impaired following reagent uptake. Approaches that enhance monocyte tumor homing and promote their migration will improve the clinical value of these cells as cellular carriers. Previous studies have shown that irradiation (IR) can promote macrophage aggregation in hypoxic regions. To investigate whether IR enhances the infiltration of bone marrow-derived monocytes (BMDMs) into tumors, the infiltration of BMDMs from GFP-transgenic mice in a murine prostate adenocarcinoma TRAMP-C1 model was examined by fluorescence microscopy. IR did not increase the number of BMDMs that infiltrated initially, but did increase monocyte retention within IR-treated tumors for up to 2 weeks. We also showed that BMDMs can take up various imaging and therapeutic agents, although the mobility of BMDMs decreased with increasing load. When BMDMs were differentiated in IR-treated tumor-conditioned medium (IR-CM) in vitro, the nanoparticle load-mediated inhibition of migration was attenuated. These IR-CM-differentiated BMDMs delivered polymer vesicles encapsulating doxorubicin to radiation therapy (RT)-induced hypoxic tumor regions, and enhanced the efficacy of RT. The prolonged retention of monocytes within irradiated tumor tissues and the ability of IRCM to enhance the migratory ability of cargo-laden BMDMs suggest that monocytes preconditioned by IR-CM can potentially act as cellular carriers for targeted therapy following conventional RT.	[Jiang, Pei-Shin; Yen, Chia-Yi; Woo, Christopher William; Lo, Shao-Hua; Huang, Yu-Kuan; Chiang, Chi-Shiun] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Yu, Ching-Fang; Hong, Ji-Hong] Chang Gung Mem Hosp Linkou, Dept Radiat Oncol, Taoyuan, Taiwan; [Yu, Ching-Fang; Hong, Ji-Hong] Chang Gung Univ, Inst Radiol Res, Radiat Biol Res Ctr, Chang Gung Mem Hosp, Taoyuan, Taiwan; [Hong, Ji-Hong] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan	National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Chiang, CS (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	cschiang@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008	Chiang, Chi-Shiun/0000-0002-2581-4129; HUANG, Yu-Kuan (Tony)/0000-0003-2262-7069	National Science Council, Taiwan [NSC 101-2627-N-007-001]; National Health Research Institute, Taiwan [NHRI-EX100-9827BI]; National Tsing Hua University, Taiwan [102N2767E1]; Chang-Gung Memorial Hospital [CIRPG3D0141, CMRPG3E1301]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Tsing Hua University, Taiwan; Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work is supported by NSC 101-2627-N-007-001, NHRI-EX100-9827BI, and 102N2767E1 from the National Science Council, National Health Research Institute, and National Tsing Hua University, respectively, Taiwan, to Chi-Shiun Chiang, and CIRPG3D0141 and CMRPG3E1301 from Chang-Gung Memorial Hospital to Ji-Hong Hong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh D, 2010, NANOMED-NANOTECHNOL, V6, P382, DOI 10.1016/j.nano.2009.10.001; Batrakova EV, 2011, EXPERT OPIN DRUG DEL, V8, P415, DOI 10.1517/17425247.2011.559457; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chen FH, 2011, INT J RADIAT ONCOL, V80, P1512, DOI 10.1016/j.ijrobp.2011.02.055; Chen FH, 2009, CLIN CANCER RES, V15, P1721, DOI 10.1158/1078-0432.CCR-08-1471; Chen JJ, 2012, MED PHYS, V39, P7490, DOI 10.1118/1.4762683; Chiang CS, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00089; Chiang WH, 2013, J CONTROL RELEASE, V168, P280, DOI 10.1016/j.jconrel.2013.03.029; Choi J, 2012, BIOMATERIALS, V33, P4195, DOI 10.1016/j.biomaterials.2012.02.022; Choi MR, 2007, NANO LETT, V7, P3759, DOI 10.1021/nl072209h; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dou HY, 2009, J IMMUNOL, V183, P661, DOI 10.4049/jimmunol.0900274; FIDLER IJ, 1974, CANCER RES, V34, P1074; GORDON S, 1992, CURR OPIN IMMUNOL, V4, P25, DOI 10.1016/0952-7915(92)90119-Y; Griffiths L, 2000, GENE THER, V7, P255, DOI 10.1038/sj.gt.3301058; Huang WC, 2011, J DRUG TARGET, V19, P944, DOI 10.3109/1061186X.2011.632012; Kang ST, 2011, LANGMUIR, V27, P13183, DOI 10.1021/la203212p; Leek RD, 2000, J PATHOL, V190, P430, DOI 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6; MANTOVANI A, 1986, BIOCHIM BIOPHYS ACTA, V865, P59, DOI 10.1016/0304-419X(86)90013-2; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; MEHTA K, 1982, J RETICULOENDOTH SOC, V32, P155; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Muthana M, 2013, CANCER RES, V73, P490, DOI 10.1158/0008-5472.CAN-12-3056; Muthana M, 2011, CANCER RES, V71, P1805, DOI 10.1158/0008-5472.CAN-10-2349; Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6; Wang SC, 2012, LAB INVEST, V92, P151, DOI 10.1038/labinvest.2011.128; YU CP, 1989, FUND APPL TOXICOL, V13, P452, DOI 10.1016/0272-0590(89)90282-0	29	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139043	10.1371/journal.pone.0139043	http://dx.doi.org/10.1371/journal.pone.0139043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418962	Green Published, gold			2022-12-27	WOS:000362171400037
J	Lambertini, L; Chen, J; Nomura, Y				Lambertini, Luca; Chen, Jia; Nomura, Yoko			Mitochondrial Gene Expression Profiles Are Associated with Maternal Psychosocial Stress in Pregnancy and Infant Temperament	PLOS ONE			English	Article							CHAIN COMPLEX-I; PARENTAL PSYCHOPATHOLOGY; ENDOPLASMIC-RETICULUM; UNCOUPLING PROTEINS; BRAIN-DEVELOPMENT; ANXIETY; DEPRESSION; BEHAVIOR; HEALTH; ROLES	Background Gene-environment interactions mediate through the placenta and shape the fetal brain development. Between the environmental determinants of the fetal brain, maternal psychosocial stress in pregnancy has been shown to negatively influence the infant temperament development. This in turn may have adverse consequences on the infant neurodevelopment extending throughout the entire life-span. However little is known about the underlying biological mechanisms of the effects of maternal psychosocial stress in pregnancy on infant temperament. Environmental stressors such as maternal psychosocial stress in pregnancy activate the stress response cascade that in turn drives the increase in the cellular energy demand of vital organs with high metabolic rates such as, in pregnancy, the placenta. Key players of the stress response cascade are the mitochondria. Results Here, we tested the expression of all 13 protein-coding genes encoded by the mitochondria in 108 placenta samples from the Stress in Pregnancy birth cohort, a study that aims at determining the influence of in utero exposure to maternal psychosocial stress in pregnancy on infant temperament. We showed that the expression of the protein-coding mitochondrial-encoded gene MT-ND2 was positively associated with indices of maternal psychosocial stress in pregnancy including Prenatal Perceived Stress (beta = 0.259; p-regression = 0.004; r(2)-regression = 0.120), State Anxiety (beta = 0.218; p-regression = 0.003; r(2)-regression = 0.153), Trait Anxiety (beta = 0.262; p-regression = 0.003; r(2)-regression = 0.129) and Pregnancy Anxiety Total (beta = 0.208; p-regression = 0.010; r(2)-regression = 0.103). In the meantime MT-ND2 was negatively associated with the infant temperament indices of Activity Level (beta = -0.257; p-regression = 0.008; r(2)-regression = 0.165) and Smile and Laughter (beta = -0.286; p-regression = 0.036; r(2)-regression = 0.082). Additionally, MT-ND6 was associated with the maternal psychosocial stress in pregnancy index of Prenatal Perceived Stress (beta = -0.231; p-regression = 0.004; r(2)-regression = 0.120), while MT-CO2 was associated with the maternal psychosocial stress in pregnancy indices of State Anxiety (beta = 0.206; p-regression = 0.003; r(2)-regression = 0.153) and Trait Anxiety (beta = 0.205; p-regression = 0.003; r(2)-regression = 0.129). Conclusions Our data support the role of mitochondria in responding to maternal psychosocial stress in pregnancy, as assessed in placenta, while also suggesting an important role for the mitochondria in the infant temperament development.	[Lambertini, Luca; Chen, Jia; Nomura, Yoko] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Lambertini, Luca] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Nomura, Yoko] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Nomura, Yoko] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai	Lambertini, L (corresponding author), Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA.	luca.lambertini@mssm.edu		Lambertini, Luca/0000-0003-3326-219X	Venture Capital Research Funding Program of the Mount Sinai Children's Environmental Health Center; Queens College; CUNY Research Enhancement Grant; NIMH [K01 MH080062]; ARRA [K01 MH080062S]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102729, K01MH080062] Funding Source: NIH RePORTER	Venture Capital Research Funding Program of the Mount Sinai Children's Environmental Health Center; Queens College; CUNY Research Enhancement Grant; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ARRA; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Venture Capital Research Funding Program of the Mount Sinai Children's Environmental Health Center, the Queens College, CUNY Research Enhancement Grant, and NIMH grants K01 MH080062 and ARRA supplement K01 MH080062S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton QA, 2012, ADV OVERWEIGHT RES T; Adzic M, 2009, INT J BIOCHEM CELL B, V41, P2181, DOI 10.1016/j.biocel.2009.04.001; ALDORETTA PW, 1995, CLIN PERINATOL, V22, P15; [Anonymous], 2014, J DEPRESS ANXIETY, DOI DOI 10.1186/2193-2697-3-13; Austin MP, 2005, EARLY HUM DEV, V81, P183, DOI 10.1016/j.earlhumdev.2004.07.001; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Badcock C, 2006, J EVOLUTION BIOL, V19, P1007, DOI 10.1111/j.1420-9101.2006.01091.x; Badcock C, 2008, NATURE, V454, P1054, DOI 10.1038/4541054a; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Belkacemi L, 2011, AM J PHYSIOL-REG I, V301, pR1599, DOI 10.1152/ajpregu.00100.2011; Berdanier CD, 2006, EXP BIOL MED, V231, P1593; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Brand SR, 2006, ANN NY ACAD SCI, V1071, P454, DOI 10.1196/annals.1364.041; Buss KA, 2011, DEV COGN NEUROS-NETH, V1, P131, DOI 10.1016/j.dcn.2010.12.003; Callahan Jennifer L, 2002, J Perinatol, V22, P448, DOI 10.1038/sj.jp.7210783; Choe DE, 2013, DEV PSYCHOL, V49, P2245, DOI 10.1037/a0032293; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; Dalwadi DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-413; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Davis EP, 2011, J CHILD PSYCHOL PSYC, V52, P119, DOI 10.1111/j.1469-7610.2010.02314.x; Del Giudice M, 2012, PSYCHONEUROENDOCRINO, V37, P1614, DOI 10.1016/j.psyneuen.2012.05.014; DeMier RL, 2000, J CLIN PSYCHOL, V56, P89, DOI 10.1002/(SICI)1097-4679(200001)56:1<89::AID-JCLP8>3.0.CO;2-6; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Ferguson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088606; First M. B., 2007, STRUCTURED CLIN INTE; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; GOLDSMITH HH, 1990, CHILD DEV, V61, P1944, DOI 10.2307/1130849; Gureje O, 2011, MOL PSYCHIATR, V16, P1221, DOI 10.1038/mp.2010.111; Hagekull Berit, 2003, Attach Hum Dev, V5, P2, DOI 10.1080/1461673031000078643; Heininger K, 2002, INT REV NEUROBIOL, V51, P103, DOI 10.1016/S0074-7742(02)51004-7; Hirshfeld-Becker DR, 2012, AM J PSYCHIAT, V169, P1175, DOI 10.1176/appi.ajp.2012.11101514; Holmboe K, 2010, DEV PSYCHOL, V46, P404, DOI 10.1037/a0018180; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; King JE, 2007, STANDARDIZED COEFFIC; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Kubera B, 2012, OBESITY FACTS, V5, P384, DOI 10.1159/000339958; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004; Martinez F, 2012, RECENT ADV RES HUMAN, P397; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; Mayeur S, 2012, AM J PHYSL ENDOCRINO; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Minamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086036; MOLINA RD, 1990, P SOC EXP BIOL MED, V195, P379, DOI 10.3181/00379727-195-43158AA; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nicholls TJ, 2013, INT J BIOCH CELL BIO; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Nomura Y, 2008, J CHILD PSYCHOL PSYC, V49, P1108, DOI 10.1111/j.1469-7610.2008.01939.x; Nomura Y, 2009, J PEDIATR PSYCHOL, V34, P406, DOI 10.1093/jpepsy/jsn092; Oliva K, 2012, J MOL ENDOCRINOL, V48, P139, DOI 10.1530/JME-11-0123; Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1; Peters A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00074; Petruzzella V, 2012, ADV EXP MED BIOL, V942, P371, DOI 10.1007/978-94-007-2869-1_17; Picard M, 2014, NAT REV ENDOCRINOL, V10, P303, DOI 10.1038/nrendo.2014.22; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Scatena R, 2012, ADV EXP MED BIOL, V942, P1, DOI 10.1007/978-94-007-2869-1; Sluse FE, 2012, ADV EXP MED BIOL, V942, P137, DOI 10.1007/978-94-007-2869-1_6; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Turlejski K, 1996, ACTA NEUROBIOL EXP, V56, P619; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Van Den Bergh BRH, 2006, PEDIATR RES, V59, P78, DOI 10.1203/01.pdr.0000191143.75673.52; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P259, DOI 10.1016/j.neubiorev.2004.10.010; Van Den Bergh BRH., 1990, PREPERINAT PSYCHOL J, V5, P119; Vera J, 2012, CHILD PSYCHIAT HUM D, V43, P376, DOI 10.1007/s10578-011-0272-z; Vidair HB, 2012, CHILD ADOL PSYCH CL, V21, P669, DOI 10.1016/j.chc.2012.05.007; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Weissman MM, 2000, ARCH GEN PSYCHIAT, V57, P675, DOI 10.1001/archpsyc.57.7.675; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wolpert L, 2010, PRINCIPLES DEV; Wright RJ, 2013, CURR OPIN PEDIATR, V25, P232, DOI 10.1097/MOP.0b013e32835e78cc; Zeltser LM, 2011, P NATL ACAD SCI USA, V108, P15667, DOI 10.1073/pnas.1112239108; Zhu P, 2014, DEV MED CHILD NEUROL, V56, P283, DOI 10.1111/dmcn.12378	91	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138929	10.1371/journal.pone.0138929	http://dx.doi.org/10.1371/journal.pone.0138929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418562	Green Published, gold			2022-12-27	WOS:000362171400027
J	Penna, A; Stutzin, A				Penna, Antonello; Stutzin, Andres			K(Ca)3.1-Dependent Hyperpolarization Enhances Intracellular Ca2+ Signaling Induced by fMLF in Differentiated U937 Cells	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNEL; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; METHIONYL-LEUCYL-PHENYLALANINE; HUMAN MACROPHAGES; CHEMOTACTIC FACTORS; MOLECULAR-CLONING; EXTRACELLULAR ATP; CALCIUM; CONDUCTANCE	Formylated peptides are chemotactic agents generated by pathogens. The most relevant peptide is fMLF (formyl-Met-Leu-Phe) which participates in several immune functions, such as chemotaxis, phagocytosis, cytokine release and generation of reactive oxygen species. In macrophages fMLF-dependent responses are dependent on both, an increase in intracellular calcium concentration and on a hyperpolarization of the membrane potential. However, the molecular entity underlying this hyperpolarization remains unknown and it is not clear whether changes in membrane potential are linked to the increase in intracellular Ca2+. In this study, differentiated U937 cells, as a macrophage-like cell model, was used to characterize the fMLF response using electrophysiological and Ca2+ imaging techniques. We demonstrate by means of pharmacological and molecular biology tools that fMLF induces a Ca2+-dependent hyperpolarization via activation of the K+ channel K(Ca)3.1 and thus, enhancing fMLF-induced intracellular Ca2+ increase through an amplification of the driving force for Ca2+ entry. Consequently, enhanced Ca2+ influx would in turn lengthen the hyperpolarization, operating as a positive feedback mechanism for fMLF-induced Ca2+ signaling.	[Penna, Antonello; Stutzin, Andres] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago 7, Chile	Universidad de Chile	Stutzin, A (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Independencia 838-0453, Santiago 7, Chile.	astutzin@bitmed.med.uchile.cl	Stutzin, Andrés/I-7605-2013; Penna, Antonello/O-6694-2019	Stutzin, Andrés/0000-0002-7264-066X; Penna, Antonello/0000-0002-8626-4415	Fondecyt-FONDAP (Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias) (Chile) [15010006]	Fondecyt-FONDAP (Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias) (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP)	This work was funded by Fondecyt-FONDAP (Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias) (Chile) Grant Number 15010006, http://www.conicyt.cl/fondap/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brechard S, 2008, J LEUKOCYTE BIOL, V84, P1223, DOI 10.1189/jlb.0807553; Bylund J, 2003, EXP CELL RES, V282, P70, DOI 10.1016/S0014-4827(02)00010-1; CASSATELLA MA, 1992, J IMMUNOL, V148, P3216; Desai R, 2000, J BIOL CHEM, V275, P39954, DOI 10.1074/jbc.M001562200; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Fay AJ, 2006, P NATL ACAD SCI USA, V103, P17548, DOI 10.1073/pnas.0607914103; Ferreira R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062345; GALLIN EK, 1977, J CELL BIOL, V75, P277, DOI 10.1083/jcb.75.1.277; Gao YD, 2010, CELL CALCIUM, V48, P19, DOI 10.1016/j.ceca.2010.06.002; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hill K, 2004, N-S ARCH PHARMACOL, V370, P227, DOI 10.1007/s00210-004-0981-y; INCE C, 1988, J CELL BIOL, V106, P1873, DOI 10.1083/jcb.106.6.1873; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; KAY GE, 1983, INFECT IMMUN, V41, P1166, DOI 10.1128/IAI.41.3.1166-1174.1983; LAZZARI KG, 1990, J BIOL CHEM, V265, P10959; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Schlichter LC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-4; Schmid-Antomarchi H, 1997, J IMMUNOL, V159, P6209; SELIGMANN BE, 1980, J MEMBRANE BIOL, V52, P257, DOI 10.1007/BF01869194; Shao ZF, 2011, AM J RESP CELL MOL, V45, P962, DOI 10.1165/rcmb.2010-0514OC; SHETH B, 1988, IMMUNOLOGY, V63, P483; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139243	10.1371/journal.pone.0139243	http://dx.doi.org/10.1371/journal.pone.0139243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418693	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400066
J	Zhang, WJ; Li, N; Wang, XY; Wang, SP				Zhang, Wenjia; Li, Nan; Wang, Xiaoyue; Wang, Suiping			Integration of Sentence-Level Semantic Information in Parafovea: Evidence from the RSVP-Flanker Paradigm	PLOS ONE			English	Article							EYE-MOVEMENT CONTROL; E-Z-READER; PREVIEW BENEFIT; SACCADE GENERATION; DYNAMICAL MODEL; WORD; COMPREHENSION; FIXATIONS; N400; POTENTIALS	During text reading, the parafoveal word was usually presented between 2 degrees and 5 degrees from the point of fixation. Whether semantic information of parafoveal words can be processed during sentence reading is a critical and long-standing issue. Recently, studies using the RSVP-flanker paradigm have shown that the incongruent parafoveal word, presented as right flanker, elicited a more negative N400 compared with the congruent parafoveal word. This suggests that the semantic information of parafoveal words can be extracted and integrated during sentence reading, because the N400 effect is a classical index of semantic integration. However, as most previous studies did not control the word-pair congruency of the parafoveal and the foveal words that were presented in the critical triad, it is still unclear whether such integration happened at the sentence level or just at the word-pair level. The present study addressed this question by manipulating verbs in Chinese sentences to yield either a semantically congruent or semantically incongruent context for the critical noun. In particular, the interval between the critical nouns and verbs was controlled to be 4 or 5 characters. Thus, to detect the incongruence of the parafoveal noun, participants had to integrate it with the global sentential context. The results revealed that the N400 time-locked to the critical triads was more negative in incongruent than in congruent sentences, suggesting that parafoveal semantic information can be integrated at the sentence level during Chinese reading.	[Zhang, Wenjia; Li, Nan; Wang, Xiaoyue; Wang, Suiping] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Zhang, Wenjia; Li, Nan; Wang, Xiaoyue; Wang, Suiping] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Zhang, Wenjia; Li, Nan; Wang, Xiaoyue; Wang, Suiping] S China Normal Univ, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University; South China Normal University	Wang, SP (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	suiping@scnu.edu.cn		Wang, Suiping/0000-0001-8726-169X; WANG, Xiaoyue/0000-0002-3809-1310	Natural Science Foundation of China [NSF 31271086]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	This work was funded by grants from the Natural Science Foundation of China (NSF 31271086) and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS 2011) to Suiping Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altarriba J, 2001, PERCEPT PSYCHOPHYS, V63, P875, DOI 10.3758/BF03194444; Baccino T, 2005, J PSYCHOPHYSIOL, V19, P204, DOI 10.1027/0269-8803.19.3.204; Barber HA, 2013, PSYCHOPHYSIOLOGY, V50, P48, DOI 10.1111/j.1469-8986.2012.01489.x; Barber HA, 2011, PSYCHOPHYSIOLOGY, V48, P523, DOI 10.1111/j.1469-8986.2010.01082.x; Barber HA, 2010, NEUROSCI LETT, V479, P152, DOI 10.1016/j.neulet.2010.05.053; Bemis DK, 2011, J NEUROSCI, V31, P2801, DOI 10.1523/JNEUROSCI.5003-10.2011; Chace KH, 2005, CAN J EXP PSYCHOL, V59, P209, DOI 10.1037/h0087476; Chwilla DJ, 2005, COGNITIVE BRAIN RES, V25, P589, DOI 10.1016/j.cogbrainres.2005.08.011; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Dimigen O, 2012, NEUROIMAGE, V62, P381, DOI 10.1016/j.neuroimage.2012.04.006; Drieghe D, 2008, Q J EXP PSYCHOL, V61, P1239, DOI 10.1080/17470210701467953; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Engbert R, 2002, VISION RES, V42, P621, DOI 10.1016/S0042-6989(01)00301-7; Hohenstein S, 2010, J EXP PSYCHOL LEARN, V36, P1150, DOI 10.1037/a0020233; Hyona J, 2005, SCAND J PSYCHOL, V46, P475, DOI 10.1111/j.1467-9450.2005.00479.x; Juhasz BJ, 2008, J EXP PSYCHOL HUMAN, V34, P1560, DOI 10.1037/a0012319; Miellet S, 2004, BRAIN LANG, V90, P299, DOI 10.1016/S0093-934X(03)00442-5; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Paterson KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088358; Rayner K, 2006, VISION RES, V46, P310, DOI 10.1016/j.visres.2005.06.018; RAYNER K, 1986, CAN J PSYCHOL, V40, P473, DOI 10.1037/h0080111; RAYNER K, 1992, J EXP PSYCHOL HUMAN, V18, P163, DOI 10.1037/0096-1523.18.1.163; Rayner K, 2007, COGNITIVE SCI, V31, P1021, DOI 10.1080/03640210701703824; Rayner K, 2007, J EXP PSYCHOL HUMAN, V33, P230, DOI 10.1037/0096-1523.33.1.230; Rayner K, 2009, J EYE MOVEMENT RES, V2; Reichle ED, 2006, COGN SYST RES, V7, P4, DOI 10.1016/j.cogsys.2005.07.002; Reichle ED, 2009, PSYCHON B REV, V16, P1, DOI 10.3758/PBR.16.1.1; Simola J, 2009, BRAIN LANG, V111, P101, DOI 10.1016/j.bandl.2009.08.004; Starr MS, 2004, EUR J COGN PSYCHOL, V16, P203, DOI 10.1080/09541440340000150; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; Wang SP, 2008, LANG COGNITIVE PROC, V23, P241, DOI 10.1080/01690960701437061; Yan M, 2012, J EXP PSYCHOL LEARN, V38, P1069, DOI 10.1037/a0026935; Yan M, 2009, PSYCHON B REV, V16, P561, DOI 10.3758/PBR.16.3.561; Yang JM, 2014, VIS COGN, V22, P193, DOI 10.1080/13506285.2014.890689; Yang JM, 2012, READ WRIT, V25, P1031, DOI 10.1007/s11145-010-9281-8; Zhou W, 2013, J RES READ, V36, pS51, DOI 10.1111/j.1467-9817.2013.01556.x; Zhou XL, 2010, NEUROPSYCHOLOGIA, V48, P1551, DOI 10.1016/j.neuropsychologia.2010.02.001	38	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139016	10.1371/journal.pone.0139016	http://dx.doi.org/10.1371/journal.pone.0139016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418230	Green Submitted, gold, Green Published			2022-12-27	WOS:000362171400033
J	Svirskis, G; Baranauskas, G; Svirskiene, N; Tkatch, T				Svirskis, Gytis; Baranauskas, Gytis; Svirskiene, Natasa; Tkatch, Tatiana			Visual Stimuli Evoked Action Potentials Trigger Rapidly Propagating Dendritic Calcium Transients in the Frog Optic Tectum Layer 6 Neurons	PLOS ONE			English	Article							RETINAL GANGLION-CELL; MAMMALIAN SUPERIOR COLLICULUS; IN-VITRO; SUPRATHRESHOLD EXCITATION; RANA-PIPIENS; MECHANISMS; DRIVEN; ACTIVATION; ATTENTION; NETWORK	The superior colliculus in mammals or the optic tectum in amphibians is a major visual information processing center responsible for generation of orientating responses such as saccades in monkeys or prey catching avoidance behavior in frogs. The conserved structure function of the superior colliculus the optic tectum across distant species such as frogs, birds monkeys permits to draw rather general conclusions after studying a single species. We chose the frog optic tectum because we are able to perform whole-cell voltage-clamp recordings fluorescence imaging of tectal neurons while they respond to a visual stimulus. In the optic tectum of amphibians most visual information is processed by pear-shaped neurons possessing long dendritic branches, which receive the majority of synapses originating from the retinal ganglion cells. Since the first step of the retinal input integration is performed on these dendrites, it is important to know whether this integration is enhanced by active dendritic properties. We demonstrate that rapid calcium transients coinciding with the visual stimulus evoked action potentials in the somatic recordings can be readily detected up to the fine branches of these dendrites. These transients were blocked by calcium channel blockers nifedipine CdCl2 indicating that calcium entered dendrites via voltage-activated L-type calcium channels. The high speed of calcium transient propagation, > 300 mu m in < 10 ms, is consistent with the notion that action potentials, actively propagating along dendrites, open voltage-gated L-type calcium channels causing rapid calcium concentration transients in the dendrites. We conclude that such activation by somatic action potentials of the dendritic voltage gated calcium channels in the close vicinity to the synapses formed by axons of the retinal ganglion cells may facilitate visual information processing in the principal neurons of the frog optic tectum.	[Svirskis, Gytis; Baranauskas, Gytis; Svirskiene, Natasa; Tkatch, Tatiana] Lithuanian Univ Hlth Sci, Neurosci Inst, Neurophysiol Lab, Kaunas, Lithuania	Lithuanian University of Health Sciences	Baranauskas, G (corresponding author), Lithuanian Univ Hlth Sci, Neurosci Inst, Neurophysiol Lab, Kaunas, Lithuania.	gytis11@yahoo.com		Tkatch, Tatiana/0000-0001-6626-7435	Lithuanian Research Council [VP1-3.1-SMM-07-K-02-059]	Lithuanian Research Council(Research Council of Lithuania (LMTLT))	This work was supported by the Lithuanian Research Council grant No. VP1-3.1-SMM-07-K-02-059 to TT that is a part of the Global Grant measure of the European Social Fund.	ANTAL M, 1986, J COMP NEUROL, V246, P238, DOI 10.1002/cne.902460208; Asadollahi A, 2010, NAT NEUROSCI, V13, P889, DOI 10.1038/nn.2573; BACKSTROM AC, 1975, J PHYSIOL-LONDON, V246, P79; Baginskas A, 2008, NEUROSCI RES, V60, P412, DOI 10.1016/j.neures.2007.12.010; Baranauskas G, 2012, NEUROSCI LETT, V528, P196, DOI 10.1016/j.neulet.2012.09.009; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; Cakir Y, 2005, PHARMACOL REP, V57, P467; COMER C, 1978, BRAIN RES, V153, P217, DOI 10.1016/0006-8993(78)91148-4; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; Delvendahl I, 2015, P NATL ACAD SCI USA, V112, pE3075, DOI 10.1073/pnas.1508419112; Dutta A, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00001; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Gutmaniene N, 2003, BRAIN RES, V981, P213, DOI 10.1016/S0006-8993(03)03038-5; Gutmaniene N, 2006, NEUROSCI LETT, V406, P142, DOI 10.1016/j.neulet.2006.07.035; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; JACKSON MB, 1992, BIOPHYS J, V61, P756, DOI 10.1016/S0006-3495(92)81880-5; Kuras A, 2006, NEUROSCI RES, V54, P328, DOI 10.1016/j.neures.2005.12.014; Kuras A, 2004, EXP BRAIN RES, V159, P509, DOI 10.1007/s00221-004-1976-0; Leopold DA, 2012, ANNU REV NEUROSCI, V35, P91, DOI 10.1146/annurev-neuro-062111-150356; Lettvin Jerome Y., 1968, MIND BIOL APPROACHES, P233; Luksch H, 2003, REV NEUROSCIENCE, V14, P85; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Maximino C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003582; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; Mysore SP, 2014, NEURON, V84, P214, DOI 10.1016/j.neuron.2014.08.019; Narayanan R, 2012, J NEUROPHYSIOL, V108, P2343, DOI 10.1152/jn.00530.2012; Nikolakopoulou AM, 2010, J COMP NEUROL, V518, P972, DOI 10.1002/cne.22258; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; POTTER HD, 1969, J COMP NEUROL, V136, P203, DOI 10.1002/cne.901360207; REH TA, 1984, J NEUROSCI, V4, P442; Safronov BV, 2007, J NEUROSCI METH, V164, P292, DOI 10.1016/j.jneumeth.2007.05.010; SPARKS DL, 1987, TRENDS NEUROSCI, V10, P312, DOI 10.1016/0166-2236(87)90085-3; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Svirskis G, 2009, J NEUROSCI METH, V180, P22, DOI 10.1016/j.jneumeth.2009.02.012; Szekely G, 1973, J Hirnforsch, V14, P189; Thier P, 2002, CURR BIOL, V12, pR158, DOI 10.1016/S0960-9822(02)00730-3; Wurtz Robert H., 1994, Current Opinion in Neurobiology, V4, P857, DOI 10.1016/0959-4388(94)90134-1; Wurtz RH, 2011, PHILOS T R SOC B, V366, P492, DOI 10.1098/rstb.2010.0186	45	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139472	10.1371/journal.pone.0139472	http://dx.doi.org/10.1371/journal.pone.0139472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414356	gold, Green Published, Green Submitted			2022-12-27	WOS:000362170700058
J	Huh, I; Kwon, MS; Park, T				Huh, Iksoo; Kwon, Min-Seok; Park, Taesung			An Efficient Stepwise Statistical Test to Identify Multiple Linked Human Genetic Variants Associated with Specific Phenotypic Traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BIPOLAR AFFECTIVE-DISORDER; CORONARY-ARTERY-DISEASE; VARIABLE SELECTION; RARE VARIANTS; RISK; IDENTIFICATION; REGRESSION	Recent advances in genotyping methodologies have allowed genome-wide association studies (GWAS) to accurately identify genetic variants that associate with common or pathological complex traits. Although most GWAS have focused on associations with single genetic variants, joint identification of multiple genetic variants, and how they interact, is essential for understanding the genetic architecture of complex phenotypic traits. Here, we propose an efficient stepwise method based on the Cochran-Mantel-Haenszel test (for stratified categorical data) to identify causal joint multiple genetic variants in GWAS. This method combines the CMH statistic with a stepwise procedure to detect multiple genetic variants associated with specific categorical traits, using a series of associated I x J contingency tables and a null hypothesis of no phenotype association. Through a new stratification scheme based on the sum of minor allele count criteria, we make the method more feasible for GWAS data having sample sizes of several thousands. We also examine the properties of the proposed stepwise method via simulation studies, and show that the stepwise CMH test performs better than other existing methods (e.g., logistic regression and detection of associations by Markov blanket) for identifying multiple genetic variants. Finally, we apply the proposed approach to two genomic sequencing datasets to detect linked genetic variants associated with bipolar disorder and obesity, respectively.	[Huh, Iksoo; Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Kwon, Min-Seok; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Park, T (corresponding author), Seoul Natl Univ, Dept Stat, Seoul, South Korea.	tspark@stats.snu.ac.kr			National Research Foundation (NRF) of the Korea government (MSIP) [2012R1A3A2026438]; Ministry of Science, ICT, and Future Planning [2013M3A9C4078158]; NRF	National Research Foundation (NRF) of the Korea government (MSIP); Ministry of Science, ICT, and Future Planning; NRF	This work was supported by a grant funded by the National Research Foundation (NRF) of the Korea government (MSIP) (2012R1A3A2026438), and by the Bio-Synergy Research Project (2013M3A9C4078158) of the Ministry of Science, ICT, and Future Planning, also through the NRF.	Alan A, INTRO CATEGORICAL DA; Ament SA, 2015, P NATL ACAD SCI USA, V112, P3576, DOI 10.1073/pnas.1424958112; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BIRCH MW, 1965, J ROY STAT SOC B, V27, P111; Bolbecker AR, 2009, BIPOLAR DISORD, V11, P19, DOI 10.1111/j.1399-5618.2008.00642.x; Bulik CM, 2004, J CLIN PSYCHIAT, V65, P1000; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho S, 2010, ANN HUM GENET, V74, P416, DOI 10.1111/j.1469-1809.2010.00597.x; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Craddock N, 2010, MOL PSYCHIATR, V15, P146, DOI 10.1038/mp.2008.66; Derkach A, 2014, STAT SCI, V29, P302, DOI 10.1214/13-STS456; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Han B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S5; Hasstedt SJ, 2013, J HUM GENET, V58, P378, DOI 10.1038/jhg.2013.21; He H, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-127; Huh IS, 2011, IEEE INT C BIO BIO W, P708, DOI 10.1109/BIBMW.2011.6112457; Juruena MF, 2009, J PSYCHOPHARMACOL, V23, P985, DOI 10.1177/0269881108092121; Karumbaiah L, 2014, CURR MED CHEM, V21, P4257, DOI 10.2174/0929867321666140815124447; Kim K, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S2-S9; Kwon MS, 2011, IEEE INT C BIO BIO W, P703, DOI 10.1109/BIBMW.2011.6112456; LANDIS JR, 1978, INT STAT REV, V46, P237, DOI 10.2307/1402373; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-44; Liu L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-132; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Morris AP, 2010, GENET EPIDEMIOL, V34, P335, DOI 10.1002/gepi.20486; Nolan DK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-12; Oh S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S9-S5; Ollila HM, 2009, MOL PSYCHIATR, V14, P351, DOI 10.1038/mp.2008.122; Park MY, 2008, BIOSTATISTICS; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Risher WC, 2012, MATRIX BIOL, V31, P170, DOI 10.1016/j.matbio.2012.01.004; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rosenstock J, 2005, DIABETES CARE, V28, P950, DOI 10.2337/diacare.28.4.950; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Song Y, 2013, DIS MODEL MECH, V6, P404, DOI 10.1242/dmm.009688; Tesli M, 2010, AM J MED GENET B, V153B, P1276, DOI 10.1002/ajmg.b.31098; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Topaloglu AK, 2014, J CLIN ENDOCR METAB, V99, pE2067, DOI 10.1210/jc.2014-1836; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhang Y, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003737; Zuo LJ, 2013, DRUG ALCOHOL DEPEN, V129, P254, DOI 10.1016/j.drugalcdep.2013.02.006	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138700	10.1371/journal.pone.0138700	http://dx.doi.org/10.1371/journal.pone.0138700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406920	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700072
J	Prehn-Kristensen, A; Lotzkat, K; Bauhofer, E; Wiesner, CD; Baving, L				Prehn-Kristensen, Alexander; Lotzkat, Kristin; Bauhofer, Eva; Wiesner, Christian D.; Baving, Lioba			Sleep Supports Memory of Odors in Adults but Not in Children	PLOS ONE			English	Article							SLOW-WAVE SLEEP; SMELL IDENTIFICATION TEST; RECOGNITION MEMORY; ENHANCES MEMORY; CONSOLIDATION; REM; CONSISTENCY; FAMILIARITY; INSTRUMENT; INTENSITY	Sleep supports the consolidation of declarative memory in children and adults. However, it is unclear whether sleep improves odor memory in children as well as adults. Thirty healthy children (mean age of 10.6, ranging from 8-12 yrs.) and 30 healthy adults (mean age of 25.4, ranging from 20-30 yrs.) participated in an incidental odor recognition paradigm. While learning of 10 target odorants took place in the evening and retrieval (10 target and 10 distractor odorants) the next morning in the sleep groups (adults: n = 15, children: n = 15), the time schedule was vice versa in the wake groups (n = 15 each). During encoding, adults rated odors as being more familiar. After the retention interval, adult participants of the sleep group recognized odors better than adults in the wake group. While children in the wake group showed memory performance comparable to the adult wake group, the children sleep group performed worse than adult and children wake groups. Correlations between memory performance and familiarity ratings during encoding indicate that pre-experiences might be critical in determining whether sleep improves or worsens memory consolidation.	[Prehn-Kristensen, Alexander; Bauhofer, Eva; Wiesner, Christian D.; Baving, Lioba] Univ Kiel, Sch Med, Ctr Integrat Psychiat, Dept Child & Adolescent Psychiat & Psychotherapy, Kiel, Germany; [Lotzkat, Kristin] Univ Kiel, Dept Psychol, Kiel, Germany	University of Kiel; University of Kiel	Prehn-Kristensen, A (corresponding author), Univ Kiel, Sch Med, Ctr Integrat Psychiat, Dept Child & Adolescent Psychiat & Psychotherapy, Kiel, Germany.	a.prehn@zip-kiel.de	Prehn-Kristensen, Alexander/A-3234-2019	Prehn-Kristensen, Alexander/0000-0002-3510-9888; Wiesner, Christian/0000-0003-1287-4955	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [Sonderforschungsbereich (SFB) 654]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This study was supported by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) Sonderforschungsbereich (SFB) 654 "Plasticity and Sleep" [http://www.sfb654.uni-luebeck.de/].	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; [Anonymous], 1991, MANUAL CHILD BEHAV C; Backhaus J, 2008, NEUROBIOL LEARN MEM, V89, P76, DOI 10.1016/j.nlm.2007.08.010; Barnes DC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00134; Barnes DC, 2014, J NEUROSCI, V34, P5134, DOI 10.1523/JNEUROSCI.5274-13.2014; Barnes DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018130; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cairney SA, 2011, EXP BRAIN RES, V214, P83, DOI 10.1007/s00221-011-2808-7; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Chalouhi C, 2005, PEDIATRICS, V116, pE81, DOI 10.1542/peds.2004-1970; Cleland TA, 2003, HDB OLFACTION GUSTAT, P165, DOI DOI 10.1201/9780203911457.CH8; Cox R, 2014, NEUROIMAGE, V99, P103, DOI 10.1016/j.neuroimage.2014.05.028; Crabtree VM, 2009, CHILD ADOL PSYCH CL, V18, P799, DOI 10.1016/j.chc.2009.04.013; Diekelmann S, 2012, NEUROBIOL LEARN MEM, V98, P103, DOI 10.1016/j.nlm.2012.07.002; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Distel H, 1999, CHEM SENSES, V24, P191, DOI 10.1093/chemse/24.2.191; Distel H, 2001, CHEM SENSES, V26, P247, DOI 10.1093/chemse/26.3.247; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 1986, ONTOGENY OLFACTION, P3; Durrant SJ, 2015, NEUROBIOL LEARN MEM, V122, P41, DOI 10.1016/j.nlm.2015.02.011; Falbe J, 2015, PEDIATRICS, V135, pE367, DOI 10.1542/peds.2014-2306; Fischer S, 2007, J COGNITIVE NEUROSCI, V19, P214, DOI 10.1162/jocn.2007.19.2.214; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Frank RA, 2011, CHEM SENSES, V36, P29, DOI 10.1093/chemse/bjq095; Franke G, 1995, QUAL LIFE RES, V9, P185; Gais S, 2011, J COGNITIVE NEUROSCI, V23, P2582, DOI 10.1162/jocn.2011.21622; German Sleep Society, AB MORG; Goel N, 2004, CHRONOBIOL INT, V21, P691, DOI 10.1081/CBI-200025989; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Herz RS, 2012, ADV CONSC RES, V85, P95; Herz RS, 1996, PSYCHON B REV, V3, P300, DOI 10.3758/BF03210754; Hugh SC, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0061-y; Jehl C, 1998, ANN NY ACAD SCI, V855, P632, DOI 10.1111/j.1749-6632.1998.tb10635.x; Larsson M, 1997, MEMORY, V5, P361; Larsson M, 2009, ANN NY ACAD SCI, V1170, P318, DOI 10.1111/j.1749-6632.2009.03934.x; Larsson M, 2009, EXP PSYCHOL, V56, P375, DOI 10.1027/1618-3169.56.6.375; Lehrner J, 2002, OLFACTION, TASTE, AND COGNITION, P278, DOI 10.1017/CBO9780511546389.024; LEHRNER JP, 1993, CHEM SENSES, V18, P17, DOI 10.1093/chemse/18.1.17; Lehrner JP, 1999, CHEM SENSES, V24, P337, DOI 10.1093/chemse/24.3.337; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Nordin S, 2003, PSYCHOPHYSIOLOGY, V40, P612, DOI 10.1111/1469-8986.00062; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Owens JA, 2000, J DEV BEHAV PEDIATR, V21, P27, DOI 10.1097/00004703-200002000-00005; Owens JA, 2000, SLEEP, V23, P1043; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Prehn-Kristensen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065098; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Price JL, 2004, HUMAN NERVOUS SYSTEM; RABIN MD, 1984, J EXP PSYCHOL LEARN, V10, P316, DOI 10.1037/0278-7393.10.2.316; Rasch B, 2012, PHYSIOL REV, DOI [10.1152/physrev.00007.2012, DOI 10.1152/PHYSREV.00007.2012]; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rihm JS, 2014, J COGNITIVE NEUROSCI, V26, P1806, DOI 10.1162/jocn_a_00579; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; SCHAAL B, 1988, CHEM SENSES, V13, P145, DOI 10.1093/chemse/13.2.145; Schaal B, 2015, PRENATAL POSTNATAL H; Scholle S, 2007, CLIN NEUROPHYSIOL, V118, P1525, DOI 10.1016/j.clinph.2007.03.007; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; van Dongen EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043426; Watzlawik M, 2009, DIAGNOSTICA, V55, P55, DOI 10.1026/0012-1924.55.1.55; Wilhelm I, 2012, NEUROSCI BIOBEHAV R, V36, P1718, DOI 10.1016/j.neubiorev.2012.03.002; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Wright KP, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00050; Zucco GM, 2007, CONV EVI LANG COMMUN, V8, P155	69	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139069	10.1371/journal.pone.0139069	http://dx.doi.org/10.1371/journal.pone.0139069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406604	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700161
J	Shcherbik, S; Pearce, N; Balish, A; Jones, J; Thor, S; Davis, CT; Pearce, M; Tumpey, T; Cureton, D; Chen, LM; Villanueva, J; Bousse, TL				Shcherbik, Svetlana; Pearce, Nicholas; Balish, Amanda; Jones, Joyce; Thor, Sharmi; Davis, Charles Todd; Pearce, Melissa; Tumpey, Terrence; Cureton, David; Chen, Li-Mei; Villanueva, Julie; Bousse, Tatiana L.			Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation	PLOS ONE			English	Article							H7N9; PROTECTION; TECHNOLOGY; STABILITY; INFECTION; YIELD; MICE	Background Avian influenza A (H7N9) virus has emerged recently and continues to cause severe disease with a high mortality rate in humans prompting the development of candidate vaccine viruses. Live attenuated influenza vaccines (LAIV) are 6: 2 reassortant viruses containing the HA and NA gene segments from wild type influenza viruses to induce protective immune responses and the six internal genes from Master Donor Viruses (MDV) to provide temperature sensitive, cold-adapted and attenuated phenotypes. Methodology/Principal Findings LAIV candidate A/Anhui/1/2013(H7N9)-CDC-LV7A (abbreviated as CDC-LV7A), based on the Russian MDV, A/Leningrad/134/17/57 (H2N2), was generated by classical reassortment in eggs and retained MDV temperature-sensitive and cold-adapted phenotypes. CDC-LV7A had two amino acid substitutions N123D and N149D (H7 numbering) in HA and one substitution T10I in NA. To evaluate the role of these mutations on the replication capacity of the reassortants in eggs, the recombinant viruses A(H7N9) RG-LV1 and A (H7N9) RG-LV2 were generated by reverse genetics. These changes did not alter virus antigenicity as ferret antiserum to CDC-LV7A vaccine candidate inhibited hemagglutination by homologous A(H7N9) virus efficiently. Safety studies in ferrets confirmed that CDC-LV7A was attenuated compared to wild-type A/Anhui/1/2013. In addition, the genetic stability of this vaccine candidate was examined in eggs and ferrets by monitoring sequence changes acquired during virus replication in the two host models. No changes in the viral genome were detected after five passages in eggs. However, after ten passages additional mutations were detected in the HA gene. The vaccine candidate was shown to be stable in the ferret model; post-vaccination sequence data analysis showed no changes in viruses collected in nasal washes present at day 5 or day 7. Conclusions/Significance Our data indicate that the A/Anhui/1/2013(H7N9)-CDC-LV7A reassortant virus is a safe and genetically stable candidate vaccine virus that is now available for distribution by WHO to vaccine manufacturers.	[Shcherbik, Svetlana; Pearce, Nicholas; Balish, Amanda; Jones, Joyce; Thor, Sharmi; Davis, Charles Todd; Pearce, Melissa; Tumpey, Terrence; Cureton, David; Chen, Li-Mei; Villanueva, Julie; Bousse, Tatiana L.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Shcherbik, Svetlana; Pearce, Nicholas] Battelle Mem Inst, Atlanta, GA USA; [Cureton, David] Atlanta Res & Educ Fdn, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Bousse, TL (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA.	tbousse@cdc.gov			WHO; BARDA	WHO(World Health Organization); BARDA	We thank the Chinese Center for Disease Control and Prevention, Beijing, China; Centre for Health Protection, Hong Kong, SAR; Centers for Disease Control, Taiwan; and the National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada for providing wild type A(H7N9) viruses used in this study. We thank IEM, St Petersburg, Russia and Bio-Diem (Australia) for providing MDV and serum to MDV. We thank WHO and BARDA for special contribution funds to support LAIV seed strains generation and quality control at CDC. We thank Nancy Cox for support of LAIV development at CDC and David Wentworth for constructive suggestions for the paper. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency.	ALEKSANDROVA GI, 1977, VOP VIRUSOL+, P387; [Anonymous], 2005, WHOCDSCSRGIP20056; [Anonymous], 2013, WHO REC ASS QUAL SAF; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Blanchfield K, 2014, INFLUENZA OTHER RESP, V8, P628, DOI 10.1111/irv.12285; Buonagurio DA, 2006, VACCINE, V24, P2151, DOI 10.1016/j.vaccine.2005.11.007; Chen ZY, 2014, J VIROL, V88, P7016, DOI 10.1128/JVI.00100-14; Chia MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120793; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Dong J, 2009, INFLUENZA OTHER RESP, V3, P287, DOI 10.1111/j.1750-2659.2009.00104.x; Duan YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099322; Friede M, 2011, VACCINE, V29, pA2, DOI 10.1016/j.vaccine.2011.02.079; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GHENDON YZ, 1984, INFECT IMMUN, V44, P730, DOI 10.1128/IAI.44.3.730-733.1984; Guo L, 2014, EMERG INFECT DIS, V20, P192, DOI 10.3201/eid2002.131094; Guo Wanshen, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P949; Halliley JL, 2015, J INFECT DIS, V212, P1270, DOI 10.1093/infdis/jiv210; Isakova-Sivak I, 2011, VIROLOGY, V412, P297, DOI 10.1016/j.virol.2011.01.004; Jernigan DB, 2015, ANNU REV MED, V66, P361, DOI 10.1146/annurev-med-010714-112311; Jin H, 2014, CURR OPIN VIROL, V6, P34, DOI 10.1016/j.coviro.2014.02.008; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Kendal AP, 1997, EUR J EPIDEMIOL, V13, P591, DOI 10.1023/A:1007327505862; KLIMOV AI, 1992, VIROLOGY, V186, P795, DOI 10.1016/0042-6822(92)90050-Y; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Krammer F, 2014, J VIROL, V88, P3976, DOI 10.1128/JVI.03095-13; Liu YV, 2015, VACCINE, V33, P2152, DOI 10.1016/j.vaccine.2015.03.009; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Neuzil KM, 2012, EXPERT REV VACCINES, V11, P939, DOI [10.1586/ERV.12.76, 10.1586/erv.12.76]; Reed L. J., 1938, AM J HYG, V27, P5; Ridenour C, 2015, INFLUENZA OTHER RESP, V9, P263, DOI 10.1111/irv.12322; Rudenko L, 2011, VACCINE, V29, pA40, DOI 10.1016/j.vaccine.2011.04.122; Rudenko LG, 1996, B WORLD HEALTH ORGAN, V74, P77; Shcherbik S, 2014, J VIROL METHODS, V195, P18, DOI 10.1016/j.jviromet.2013.09.003; Shcherbik SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092580; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Smith GE, 2013, VACCINE, V31, P4305, DOI 10.1016/j.vaccine.2013.07.043; SMORODINTSEN AA, 1965, IND MED SURG, V34, P53; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wareing MD, 2002, VACCINE, V20, P2082, DOI 10.1016/S0264-410X(02)00056-7; Wodal W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113963; Wong SS, 2015, J INFECT DIS, V212, P542, DOI 10.1093/infdis/jiv099; Wong SS, 2014, VACCINE, V32, P4571, DOI 10.1016/j.vaccine.2014.06.016; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Yang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123659	46	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138951	10.1371/journal.pone.0138951	http://dx.doi.org/10.1371/journal.pone.0138951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405798	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700127
J	Simpson, MJ; Sharp, JA; Morrow, LC; Baker, RE				Simpson, Matthew J.; Sharp, Jesse A.; Morrow, Liam C.; Baker, Ruth E.			Exact Solutions of Coupled Multispecies Linear Reaction-Diffusion Equations on a Uniformly Growing Domain	PLOS ONE			English	Article							NEURAL CREST CELLS; TRAVELING-WAVE MODEL; TRANSPORT PROBLEMS; MIGRATION; INVASION; GROWTH; ASSAY; SKIN	Embryonic development involves diffusion and proliferation of cells, as well as diffusion and reaction of molecules, within growing tissues. Mathematical models of these processes often involve reaction-diffusion equations on growing domains that have been primarily studied using approximate numerical solutions. Recently, we have shown how to obtain an exact solution to a single, uncoupled, linear reaction-diffusion equation on a growing domain, 0 < x < L(t), where L(t) is the domain length. The present work is an extension of our previous study, and we illustrate how to solve a system of coupled reaction-diffusion equations on a growing domain. This system of equations can be used to study the spatial and temporal distributions of different generations of cells within a population that diffuses and proliferates within a growing tissue. The exact solution is obtained by applying an uncoupling transformation, and the uncoupled equations are solved separately before applying the inverse uncoupling transformation to give the coupled solution. We present several example calculations to illustrate different types of behaviour. The first example calculation corresponds to a situation where the initially-confined population diffuses sufficiently slowly that it is unable to reach the moving boundary at x = L(t). In contrast, the second example calculation corresponds to a situation where the initially-confined population is able to overcome the domain growth and reach the moving boundary at x = L(t). In its basic format, the uncoupling transformation at first appears to be restricted to deal only with the case where each generation of cells has a distinct proliferation rate. However, we also demonstrate how the uncoupling transformation can be used when each generation has the same proliferation rate by evaluating the exact solutions as an appropriate limit.	[Simpson, Matthew J.; Sharp, Jesse A.; Morrow, Liam C.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Baker, Ruth E.] Univ Oxford, Inst Math, Radcliffe Observ Quarter, Oxford OX1 3LB, England	Queensland University of Technology (QUT); University of Oxford	Simpson, MJ (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	matthew.simpson@qut.edu.au		Baker, Ruth/0000-0002-6304-9333; Morrow, Liam/0000-0002-3413-6200	Australian Research Council [FT130100148]	Australian Research Council(Australian Research Council)	Funding: This work was supported by the Australian Research Council (http://www.arc.gov.au/) who provided a Future Fellowship (FT130100148) to support MJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RE, 2010, B MATH BIOL, V72, P719, DOI 10.1007/s11538-009-9467-x; Bear J., 1972, DYNAMICS FLUIDS PORO; Binder BJ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031912; Cheeseman BL, 2014, J THEOR BIOL, V363, P344, DOI 10.1016/j.jtbi.2014.08.016; Crampin EJ, 2002, B MATH BIOL, V64, P747, DOI 10.1006/bulm.2002.0295; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; Crowley S, 2012, J ENG MATH, V76, P33, DOI 10.1007/s10665-011-9529-6; Denman PK, 2007, B MATH BIOL, V69, P157, DOI 10.1007/s11538-006-9082-z; Denman PK, 2007, B MATH BIOL, V69, P495, DOI 10.1007/s11538-006-9138-0; Dziuk G, 2013, ACTA NUMER, V22, P289, DOI 10.1017/S0962492913000056; Gershon Michael D, 2004, Semin Pediatr Surg, V13, P224, DOI 10.1053/j.sempedsurg.2004.10.019; Haberman R, 2004, APPLIED PARTIAL DIFF; Haitjema H.M., 1995, ANAL ELEMENT MODELIN; Hou Z, 2013, INT J DIFF EQUATIONS, V2013; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; Koffman EB, 1993, FORTRAN ENG APPL; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Landman KA, 2003, B MATH BIOL, V65, P235, DOI 10.1016/S0092-8240(02)00098-8; Landman KA, 1997, AICHE J, V43, P3147, DOI 10.1002/aic.690431204; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; Madzvamuse A, 2010, J MATH BIOL, V61, P133, DOI 10.1007/s00285-009-0293-4; Maini PK, 2004, APPL MATH LETT, V17, P575, DOI 10.1016/S0893-9659(04)90128-0; Maini PK, 2004, TISSUE ENG, V10, P475, DOI 10.1089/107632704323061834; Newgreen DF, 1996, ACTA ANAT, V157, P105; NEWGREEN DF, 1986, INT REV CYTOL, V103, P89, DOI 10.1016/S0074-7696(08)60834-7; Newgreen DF, 2013, DEV BIOL, V382, P305, DOI 10.1016/j.ydbio.2013.06.029; Painter KJ, 1999, P NATL ACAD SCI USA, V96, P5549, DOI 10.1073/pnas.96.10.5549; Sengers BG, 2007, J R SOC INTERFACE, V4, P1107, DOI 10.1098/rsif.2007.0233; SHERRATT JA, 1990, P ROY SOC B-BIOL SCI, V241, P29, DOI 10.1098/rspb.1990.0061; Simpson MJ, 2006, J COMPUT APPL MATH, V192, P282, DOI 10.1016/j.cam.2005.05.003; Simpson MJ, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042701; Simpson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117949; Simpson MJ, 2013, J HYDROL, V501, P241, DOI 10.1016/j.jhydrol.2013.08.005; Srinivasan V, 2008, ADV WATER RESOUR, V31, P219, DOI 10.1016/j.advwatres.2007.08.001; Srinivasan V, 2008, ADV WATER RESOUR, V31, P203, DOI 10.1016/j.advwatres.2007.08.002; Sun Y, 1999, WATER RESOUR RES, V35, P185, DOI 10.1029/1998WR900003; Sun Y, 2008, TRANSPORT POROUS MED, V71, P217, DOI 10.1007/s11242-007-9121-8; Sun YW, 2012, COMPUT GEOSCI-UK, V39, P86, DOI 10.1016/j.cageo.2011.06.015; Sun YW, 2004, TRANSPORT POROUS MED, V55, P301, DOI 10.1023/B:TIPM.0000013327.32136.52; Sun YW, 1999, TRANSPORT POROUS MED, V37, P327, DOI 10.1023/A:1006507514019; Swanson KR, 2008, MATH COMPUT MODEL, V47, P638, DOI 10.1016/j.mcm.2007.02.024; Treloar KK, 2014, J THEOR BIOL, V356, P71, DOI 10.1016/j.jtbi.2014.04.026; Treloar KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067389; Trewenack AJ, 2009, B MATH BIOL, V71, P291, DOI 10.1007/s11538-008-9362-x; Venkataraman C, 2012, J MATH BIOL, V64, P41, DOI 10.1007/s00285-011-0404-x; Woolley TE, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046216; Yates CA, 2014, J THEOR BIOL, V350, P37, DOI 10.1016/j.jtbi.2014.01.041; Young HM, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-23	48	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138894	10.1371/journal.pone.0138894	http://dx.doi.org/10.1371/journal.pone.0138894			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407013	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700113
J	Hughes, J; Kabir, Z; Bennett, K; Hotchkiss, JW; Kee, F; Leyland, AH; Davies, C; Bandosz, P; Guzman-Castillo, M; O'Flaherty, M; Capewell, S; Critchley, J				Hughes, John; Kabir, Zubair; Bennett, Kathleen; Hotchkiss, Joel W.; Kee, Frank; Leyland, Alastair H.; Davies, Carolyn; Bandosz, Piotr; Guzman-Castillo, Maria; O'Flaherty, Martin; Capewell, Simon; Critchley, Julia			Modelling Future Coronary Heart Disease Mortality to 2030 in the British Isles	PLOS ONE			English	Article							RISK-FACTORS; IRELAND; DECLINE; TRENDS	Objective Despite rapid declines over the last two decades, coronary heart disease (CHD) mortality rates in the British Isles are still amongst the highest in Europe. This study uses a modelling approach to compare the potential impact of future risk factor scenarios relating to smoking and physical activity levels, dietary salt and saturated fat intakes on future CHD mortality in three countries: Northern Ireland (NI), Republic of Ireland (RoI) and Scotland. Methods CHD mortality models previously developed and validated in each country were extended to predict potential reductions in CHD mortality from 2010 (baseline year) to 2030. Risk factor trends data from recent surveys at baseline were used to model alternative future risk factor scenarios: Absolute decreases in (i) smoking prevalence and (ii) physical inactivity rates of up to 15% by 2030; relative decreases in (iii) dietary salt intake of up to 30% by 2030 and (iv) dietary saturated fat of up to 6% by 2030. Probabilistic sensitivity analyses were then conducted. Results Projected populations in 2030 were 1.3, 3.4 and 3.9 million in NI, RoI and Scotland respectively (adults aged 25-84). In 2030: assuming recent declining mortality trends continue: 15% absolute reductions in smoking could decrease CHD deaths by 5.8-7.2%. 15% absolute reductions in physical inactivity levels could decrease CHD deaths by 3.1-3.6%. Relative reductions in salt intake of 30% could decrease CHD deaths by 5.2-5.6% and a 6% reduction in saturated fat intake might decrease CHD deaths by some 7.8-9.0%. These projections remained stable under a wide range of sensitivity analyses. Conclusions Feasible reductions in four cardiovascular risk factors (already achieved elsewhere) could substantially reduce future coronary deaths. More aggressive polices are therefore needed in the British Isles to control tobacco, promote healthy food and increase physical activity.	[Hughes, John; Kee, Frank] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Kabir, Zubair] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Bennett, Kathleen] St James Hosp, Trinity Ctr Hlth Sci, Dept Pharmacol & Therapeut, Dublin 8, Ireland; [Hotchkiss, Joel W.] Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland; [Leyland, Alastair H.; Davies, Carolyn] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Bandosz, Piotr; Guzman-Castillo, Maria; O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Critchley, Julia] St Georges Univ London, Populat Hlth Res Inst, London, England	Queens University Belfast; University College Cork; Trinity College Dublin; University of Glasgow; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Liverpool; St Georges University London	Hughes, J (corresponding author), Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland.	john.hughes@qub.ac.uk	Bandosz, Piotr/E-4964-2017; Shao, Ruitai/AAU-7642-2021	Kabir, Zubair/0000-0003-1529-004X; Leyland, Alastair/0000-0003-3741-7099; Bennett, Kathleen/0000-0002-2861-7665; O'Flaherty, Martin/0000-0001-8944-4131; Critchley, Julia/0000-0002-5248-4188	Euroheart II project [2010 12 04]; Medical Research Council [MC_UU-12017/5]; Chief Scientist Office of the Scottish Government Health & Social Care Directorates [SPHSU2]; MRC [MR/K023241/1, G0900847, MC_UU_12017/5, MC_UU_12017/13] Funding Source: UKRI; Medical Research Council [MC_UU_12017/5, MC_CF023241, MC_UU_12017/13, MR/K023241/1, G0900847] Funding Source: researchfish; Chief Scientist Office [SPHSU13, SPHSU2] Funding Source: researchfish	Euroheart II project; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health & Social Care Directorates; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This study was supported by the Euroheart II project, grant number 2010 12 04. In addition to the Euroheart grant, The Social and Public Health Sciences Unit, University of Glasgow is funded by the Medical Research Council (MC_UU-12017/5) and the Chief Scientist Office of the Scottish Government Health & Social Care Directorates (SPHSU2).	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; [Anonymous], 2013, HLTH IR FRAM IMPR HL; [Anonymous], 2012, FIT WELL CHANG LIV 2; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Bull F.C., 2004, PHYS INACTIVITY, V1, P729; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-641; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Department for Environment Food and Rural Affairs, FAM FOOD 2010; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Hughes J, 2013, EUR J PREV CARDIOL, V20, P310, DOI 10.1177/2047487312441725; Ji C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005683; Kabir Z, 2013, INT J CARDIOL, V168, P2462, DOI 10.1016/j.ijcard.2013.03.007; Martin A, 2012, AM J PREV MED, V43, pE45, DOI 10.1016/j.amepre.2012.09.001; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; PUSKA P, 1985, ANNU REV PUBL HEALTH, V6, P147, DOI 10.1146/annurev.pu.06.050185.001051; Ruszkowska-Majzel Joanna, 2005, Przegl Lek, V62 Suppl 3, P23; Scarborough P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000263; Scottish Government, 2013, REV DIET GOALS SCOTL; SHIMAMOTO T, 1989, CIRCULATION, V79, P503, DOI 10.1161/01.CIR.79.3.503; Tunstall-Pedoe H, 2006, BRIT MED J, V332, P629, DOI 10.1136/bmj.38753.779005.BE; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wakefield MA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003175; Ward M, 2007, SLAN 2007 SURVEY LIF; Winstanley M., 2012, TOBACCO AUSTR FACTS	29	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138044	10.1371/journal.pone.0138044	http://dx.doi.org/10.1371/journal.pone.0138044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422012	Green Published, Green Accepted, gold			2022-12-27	WOS:000362175700027
J	Andrich, S; Haastert, B; Neuhaus, E; Neidert, K; Arend, W; Ohmann, C; Grebe, J; Vogt, A; Jungbluth, P; Rosler, G; Windolf, J; Icks, A				Andrich, Silke; Haastert, Burkhard; Neuhaus, Elke; Neidert, Kathrin; Arend, Werner; Ohmann, Christian; Grebe, Juergen; Vogt, Andreas; Jungbluth, Pascal; Roesler, Grit; Windolf, Joachim; Icks, Andrea			Epidemiology of Pelvic Fractures in Germany: Considerably High Incidence Rates among Older People	PLOS ONE			English	Article							HIP FRACTURE; RING FRACTURES; BURDEN; OSTEOPOROSIS; MORTALITY; FINLAND; OUTCOMES; TRENDS; COSTS; WALES	Epidemiological data about pelvic fractures are limited. Until today, most studies only analyzed inpatient data. The purpose of this study was to estimate incidence rates of pelvic fractures in the German population aged 60 years or older, based on outpatient and inpatient data. We conducted a retrospective population-based observational study based on routine data from a large health insurance company in Germany. Age and sex-specific incidence rates of first fractures between 2008 and 2011 were calculated. We also standardized incidence rates with respect to age and sex in the German population. Multiple Poisson regression models were used to evaluate the association between the risk of first pelvic fracture as outcome and sex, age, calendar year and region as independent variables. The total number of patients with a first pelvic fracture corresponded to 8,041 and during the study period 5,978 insured persons needed inpatient treatment. Overall, the standardized incidence rate of all first pelvic fractures was 22.4 [95% CI 22.0-22.9] per 10,000 person-years, and the standardized incidence rate of inpatient treated fractures 16.5 [16.1-16.9]. Our adjusted regression analysis confirmed a significant sex (RR 2.38 [2.23-2.55], p < 0.001, men as reference) and age effect (higher risk with increasing age, p < 0.001) on first fracture risk. We found a slight association between calendar year (higher risk in later years compared to 2008, p = 0.0162) and first fracture risk and a further significant association with region (RR 0.92 [0.87-0.98], p = 0.006, Westfalen-Lippe as reference). The observed incidences are considerably higher than incidences described in the international literature, even if only inpatient treated pelvic fractures are regarded. Besides which, non-inclusion of outpatient data means that a relevant proportion of pelvic fractures are not taken into account. Prevention of low energy trauma among older people remains an important issue.	[Andrich, Silke; Haastert, Burkhard; Arend, Werner; Roesler, Grit; Icks, Andrea] Univ Dusseldorf, Fac Med, Dept Publ Hlth, Dusseldorf, Germany; [Haastert, Burkhard] MediStatistica, Neuenrade, Germany; [Neuhaus, Elke; Neidert, Kathrin] AOK NORDWEST, Dortmund, Germany; [Ohmann, Christian; Grebe, Juergen; Vogt, Andreas] Univ Dusseldorf, Fac Med, Coordinat Ctr Clin Trials, Dusseldorf, Germany; [Jungbluth, Pascal; Windolf, Joachim] Univ Hosp, Dept Trauma & Hand Surg, Dusseldorf, Germany; [Roesler, Grit] Joint Practice Diagnost Radiol & Nucl Med, Cologne, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Andrich, S (corresponding author), Univ Dusseldorf, Fac Med, Dept Publ Hlth, Dusseldorf, Germany.	silke.andrich@ddz.uni-duesseldorf.de	Ohmann, Christian/AAV-8608-2020; Jungbluth, Pascal/L-6703-2017		German Federal Ministry of Education and Research [01GY1136]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The project was supported by a grant of the German Federal Ministry of Education and Research (http://www.bmbf.de/; 01GY1136; coordinating investigator: AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The AOK NORDWEST was responsible for the salary for Elke Neuhaus and Kathrin Neidert, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. mediStatistica was responsible for the salary for Burkhard Haastert, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balogh Z, 2007, J TRAUMA, V63, P1066, DOI 10.1097/TA.0b013e3181589fa4; Benzinger P, 2013, J AM MED DIR ASSOC, V14, P673, DOI 10.1016/j.jamda.2013.03.012; Bleibler F, 2013, OSTEOPOROSIS INT, V24, P835, DOI 10.1007/s00198-012-2020-z; Bohme J, 2012, Z ORTHOP UNFALLCHIR, V150, P477, DOI 10.1055/s-0032-1315270; Boufous S, 2005, INJURY, V36, P1323, DOI 10.1016/j.injury.2005.02.008; Boufous S, 2007, INJURY PREV, V13, P211, DOI 10.1136/ip.2006.014654; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Breuil V, 2008, JOINT BONE SPINE, V75, P585, DOI 10.1016/j.jbspin.2008.01.024; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Deakin DE, 2007, INJURY, V38, P312, DOI 10.1016/j.injury.2006.09.024; Grobe TG, 2011, SCHRIFTENREIHE GESUN; Henes FO, 2012, EUR J RADIOL, V81, P2337, DOI 10.1016/j.ejrad.2011.07.012; Hoffmann F, 2012, GESUNDHEITSWESEN, V74, P291, DOI 10.1055/s-0031-1275711; Hoffmann F, 2011, EXP CLIN ENDOCR DIAB, V119, P569, DOI 10.1055/s-0031-1275277; Icks A, 2008, OSTEOPOROSIS INT, V19, P1139, DOI 10.1007/s00198-007-0534-6; Icks A, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0140-5; Islam S, 2009, MENOPAUSE, V16, P77, DOI 10.1097/gme.0b013e31817b816e; Kannus P, 2000, OSTEOPOROSIS INT, V11, P443, DOI 10.1007/s001980070112; Kelsey JL, 2005, AM J EPIDEMIOL, V162, P879, DOI 10.1093/aje/kwi295; King AB, 2009, J BONE MINER RES, V24, P681, DOI 10.1359/JBMR.081226; Korhonen N, 2013, OSTEOPOROSIS INT, V24, P1599, DOI 10.1007/s00198-012-2190-8; Krappinger D, 2010, ARCH ORTHOP TRAUM SU, V130, P1167, DOI 10.1007/s00402-010-1108-1; Le CT, 2003, INTRO BIOSTATISTICS, DOI 10.1002/0471308889; Mann E, 2010, WIEN KLIN WOCHENSCHR, V122, P126, DOI 10.1007/s00508-010-1321-5; Morris RO, 2000, POSTGRAD MED J, V76, P646, DOI 10.1136/pmj.76.900.646; Nanninga GL, 2014, AGE AGEING, V43, P648, DOI 10.1093/ageing/aft212; Parkkari J, 1996, CALCIFIED TISSUE INT, V59, P79, DOI 10.1007/s002239900090; Pike C, 2010, PHARMACOECONOMICS, V28, P395, DOI 10.2165/11531040-000000000-00000; Prieto-Alhambra D, 2012, OSTEOPOROSIS INT, V23, P2797, DOI 10.1007/s00198-012-1907-z; RAGNARSSON B, 1992, ACTA ORTHOP SCAND, V63, P297, DOI 10.3109/17453679209154786; Soles GLS, 2012, CURR REV MUSCULOSKE, V5, P222, DOI 10.1007/s12178-012-9128-9; Sullivan MP, 2014, ORTHOPEDICS, V37, P151, DOI 10.3928/01477447-20140225-50; Swart E, 2015, GOOD PRACTICE SECOND; WHO, 2011, GLOBAL HLTH AGING	36	62	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139078	10.1371/journal.pone.0139078	http://dx.doi.org/10.1371/journal.pone.0139078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418971	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400038
J	Cardoso-Toset, F; Gomez-Laguna, J; Amarilla, SP; Vela, AI; Carrasco, L; Fernandez-Garayzabal, JF; Astorga, RJ; Luque, I				Cardoso-Toset, Fernando; Gomez-Laguna, Jaime; Amarilla, Shyrley P.; Vela, Ana I.; Carrasco, Librado; Fernandez-Garayzabal, Jose F.; Astorga, Rafael J.; Luque, Inmaculada			Multi-Etiological Nature of Tuberculosis-Like Lesions in Condemned Pigs at the Slaughterhouse	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; LYMPH-NODES; GRANULOMATOUS LESIONS; RED DEER; ARCANOBACTERIUM; STREPTOCOCCI; INFECTION; DIAGNOSIS; COMPLEX; AVIUM	Tuberculosis-like lesions (TBL) in pigs have been associated with microorganisms other than mycobacteria. In this work a histopathological and microbiological evaluation of TBL in pigs is shown. A total of 352 samples belonging to 171 pigs totally condemned at slaughterhouse due to generalized TBL were sampled and selected for analysis. Pyogranulomatous (56.2%) and granulomatous lesions (20.2%) were observed in all analysed organs. Most of the granulomas observed in both lymph nodes and lungs belonged to more advanced stages of development (stages III and IV) whereas in the liver and the spleen most of lesions belonged to intermediate stages (stages II and III). Different microorganisms were simultaneously detected from TBL in the 42.7% of the animals. Mycobacterium tuberculosis complex (MTC) (38%), coryneform bacteria (40.3%) and streptococci (28.1%) were the main groups of microorganisms detected after bacteriological analysis, with Trueperella pyogenes and Streptococcus suis as the most frequently isolated species. Mycobacteria belonging to MTC were the most frequently detected pathogens in granulomatous and pyogranulomatous lesions in submandibular lymph nodes (32.7%) and coryneform bacteria were the microorganisms more frequently isolated from lungs (25.9%) and spleen samples (37.2%). These results may provide new insights into the pathogenesis and diagnosis of this pathology. The importance of coryneform bacteria and streptococci in such processes must be evaluated in future studies.	[Cardoso-Toset, Fernando; Astorga, Rafael J.; Luque, Inmaculada] Int Excellence Agrifood Campus, Fac Vet Med, Dept Anim Hlth, CeiA3, Cordoba, Spain; [Cardoso-Toset, Fernando; Gomez-Laguna, Jaime] CICAP Food Res Ctr, Dept R&D, Cordoba, Spain; [Amarilla, Shyrley P.; Carrasco, Librado] Int Excellence Agrifood Campus, Fac Vet Med, Dept Anat & Comparat Pathol, CeiA3, Cordoba, Spain; [Vela, Ana I.; Fernandez-Garayzabal, Jose F.] Univ Complutense, Fac Vet Med, Dept Anim Hlth, E-28040 Madrid, Spain; [Vela, Ana I.; Fernandez-Garayzabal, Jose F.] Univ Complutense, Fac Vet Med, VISAVET Hlth Surveillance Ctr, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Cardoso-Toset, F (corresponding author), Int Excellence Agrifood Campus, Fac Vet Med, Dept Anim Hlth, CeiA3, Cordoba, Spain.	v52catof@uco.es	Luque, Inmaculada/R-9952-2019; studies, IT VISAVET Account for bibliometric/C-3115-2014; Gomez-Laguna, Jaime/AAP-6053-2020; Luque, Inmaculada/K-9464-2014; Vela, Ana I/K-8015-2014; Otero, Librado Carrasco/AAN-8170-2021; FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/K-9611-2014; Gomez-Laguna, Jaime/M-1411-2014	Luque, Inmaculada/0000-0003-1838-2636; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Luque, Inmaculada/0000-0003-1838-2636; Vela, Ana I/0000-0001-5004-3103; Otero, Librado Carrasco/0000-0002-4823-758X; FERNANDEZ-GARAYZABAL, JOSE FRANCISCO/0000-0003-1597-0643; Gomez-Laguna, Jaime/0000-0002-1787-5642; Amarilla, Shyrley Paola/0000-0001-5943-4901	Council of Economy, Science, Innovation and Employment of the Andalusian Government [AGR-2685-2012]; Centre for the Development of Industrial Technology (CDTI) of Spain [IDI-20111632/IDI-20111633]; Agrifood Campus of International Excellence Programme (ceiA3) from the Ministry of Education, Culture and Sport; Santander Universities Global Division	Council of Economy, Science, Innovation and Employment of the Andalusian Government; Centre for the Development of Industrial Technology (CDTI) of Spain; Agrifood Campus of International Excellence Programme (ceiA3) from the Ministry of Education, Culture and Sport; Santander Universities Global Division	This study was financially supported by the Council of Economy, Science, Innovation and Employment of the Andalusian Government (AGR-2685-2012) and by the Centre for the Development of Industrial Technology (CDTI) of Spain (project reference IDI-20111632/IDI-20111633). Cardoso-Toset F was funded by a grant of the Agrifood Campus of International Excellence Programme (ceiA3) from the Ministry of Education, Culture and Sport and by the Santander Universities Global Division.	Adderson EE, 2008, J CLIN MICROBIOL, V46, P921, DOI 10.1128/JCM.01849-07; Bailey SS, 2013, VET J, V198, P391, DOI 10.1016/j.tvjl.2013.08.035; Lara GHB, 2011, RES VET SCI, V90, P185, DOI 10.1016/j.rvsc.2010.06.009; Cardoso-Toset F, 2015, VET J; Co DO, 2004, CLIN IMMUNOL, V113, P130, DOI 10.1016/j.clim.2004.08.012; Contzen M, 2011, ZOONOSES PUBLIC HLTH, V58, P479, DOI 10.1111/j.1863-2378.2011.01396.x; Costa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081337; Di Marco V, 2012, J CLIN MICROBIOL, V50, P1209, DOI 10.1128/JCM.06544-11; Domingo M, 2014, RES VET SCI, V97, pS20, DOI 10.1016/j.rvsc.2014.03.017; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Garcia-Jimenez WL, 2013, VET IMMUNOL IMMUNOP, V156, P54, DOI 10.1016/j.vetimm.2013.09.008; Gomez-Laguna J, 2010, J VET DIAGN INVEST, V22, P123, DOI 10.5533/2177-8264-201022303; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Johansen TB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/189649; Katsumi M, 1998, J VET MED SCI, V60, P129, DOI 10.1292/jvms.60.129; Komijn RE, 2007, VET MICROBIOL, V120, P352, DOI 10.1016/j.vetmic.2006.10.031; Makrai L, 2008, VET MICROBIOL, V131, P318, DOI 10.1016/j.vetmic.2008.04.009; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Martinez J, 2007, VET J, V174, P160, DOI 10.1016/j.tvjl.2006.05.005; Miranda C, 2012, J COMP PATHOL, V147, P401, DOI 10.1016/j.jcpa.2012.05.005; Oliveira M, 2014, BMC VET RES, V218, P1; Parra A, 2003, VET MICROBIOL, V97, P123, DOI 10.1016/j.vetmic.2003.08.007; de Val BP, 2014, VET REC, V174, P96, DOI 10.1136/vr.101886; Radostits OM., 2007, VET MED TXB DIS CATT, V10. ed, P2156; Ribeiro MG, 2015, VET QUART, V35, P82, DOI 10.1080/01652176.2015.1022667; Rzewuska M, 2012, VET MICROBIOL, V160, P69, DOI 10.1016/j.vetmic.2012.05.004; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Smibert RM, 1994, METHODS GEN MOL BACT; Ulbegi-Mohyla H, 2009, RES VET SCI, V87, P186, DOI 10.1016/j.rvsc.2009.01.008; Vela AI, 2003, INT J SYST EVOL MICR, V53, P2027, DOI 10.1099/ijs.0.02645-0; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43	34	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139130	10.1371/journal.pone.0139130	http://dx.doi.org/10.1371/journal.pone.0139130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418681	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000362171400048
J	Chao, DHM; Kallemeijn, WW; Marques, ARA; Orre, M; Ottenhoff, R; van Roomen, C; Foppen, E; Renner, MC; Moeton, M; van Eijk, M; Boot, RG; Kamphuis, W; Hol, EM; Aten, J; Overkleeft, HS; Kalsbeek, A; Aerts, JMFG				Chao, Daniela Herrera Moro; Kallemeijn, Wouter W.; Marques, Andre R. A.; Orre, Marie; Ottenhoff, Roelof; van Roomen, Cindy; Foppen, Ewout; Renner, Maria C.; Moeton, Martina; van Eijk, Marco; Boot, Rolf G.; Kamphuis, Willem; Hol, Elly M.; Aten, Jan; Overkleeft, Hermen S.; Kalsbeek, Andries; Aerts, Johannes M. F. G.			Visualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based Probes	PLOS ONE			English	Article							GAUCHER-DISEASE; ALPHA-SYNUCLEIN; BETA-GLUCOCEREBROSIDASE; PARKINSONS-DISEASE; MOUSE MODEL; INHIBITORS; IDENTIFICATION; EXPRESSION; MUTATIONS; BETA-GLUCOSIDASE-2	Gaucher disease is characterized by lysosomal accumulation of glucosylceramide due to deficient activity of lysosomal glucocerebrosidase (GBA). In cells, glucosylceramide is also degraded outside lysosomes by the enzyme glucosylceramidase 2 (GBA2) of which inherited deficiency is associated with ataxias. The interest in GBA and glucosylceramide metabolism in the brain has grown following the notion that mutations in the GBA gene impose a risk factor for motor disorders such as alpha-synucleinopathies. We earlier developed a beta-glucopyranosylconfigured cyclophellitol-epoxide type activity based probe (ABP) allowing in vivo and in vitro visualization of activemolecules of GBA with high spatial resolution. Labeling occurs through covalent linkage of the ABP to the catalytic nucleophile residue in the enzyme pocket. Here, we describe a method to visualize active GBA molecules in rat brain slices using in vivo labeling. Brain areas related to motor control, like the basal ganglia and motor related structures in the brainstem, show a high content of active GBA. We also developed a beta-glucopyranosyl cyclophellitol-aziridine ABP allowing in situ labeling of GBA2. Labeled GBA2 in brain areas can be identified and quantified upon gel electrophoresis. The distribution of active GBA2 markedly differs from that of GBA, being highest in the cerebellar cortex. The histological findings with ABP labeling were confirmed by biochemical analysis of isolated brain areas. In conclusion, ABPs offer sensitive tools to visualize active GBA and to study the distribution of GBA2 in the brain and thus may find application to establish the role of these enzymes in neurodegenerative disease conditions such as alpha-synucleinopathies and cerebellar ataxia.	[Chao, Daniela Herrera Moro; Kallemeijn, Wouter W.; Marques, Andre R. A.; Ottenhoff, Roelof; van Roomen, Cindy] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Chao, Daniela Herrera Moro; Foppen, Ewout; Kalsbeek, Andries] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Orre, Marie; Renner, Maria C.; Moeton, Martina; Kamphuis, Willem; Hol, Elly M.; Kalsbeek, Andries] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Hol, Elly M.] Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Hol, Elly M.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Aten, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Overkleeft, Hermen S.] Leiden Univ, Leiden Inst Chem, Dept Bioorgan Synth, NL-2300 RA Leiden, Netherlands; [Kallemeijn, Wouter W.; van Eijk, Marco; Boot, Rolf G.; Aerts, Johannes M. F. G.] Leiden Insitute Chem, Dept Biochem, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC	Aerts, JMFG (corresponding author), Leiden Insitute Chem, Dept Biochem, Leiden, Netherlands.	j.m.f.g.aerts@lic.leidenuniv.nl	Marques, André R. A./Q-3892-2018; Kalsbeek, Andries/H-3076-2019; Hol, Elly M/F-1891-2013; Hol, Elly/J-2025-2019; Kallemeijn, Wouter W./F-6801-2014; Aerts, Johannes/A-1028-2009; Kallemeijn, W. W./P-2768-2019	Marques, André R. A./0000-0001-9674-3017; Kalsbeek, Andries/0000-0001-9606-8453; Hol, Elly M/0000-0001-5604-2603; Hol, Elly/0000-0001-5604-2603; Kallemeijn, Wouter W./0000-0002-3660-2930; Aerts, Johannes/0000-0001-8168-2565; Kallemeijn, W. W./0000-0002-3660-2930; Overkleeft, Herman/0000-0001-6976-7005; Boot, Rolf/0000-0002-7031-3390; Aten, Jan/0000-0002-0997-6777; van Eijk, Marco/0000-0001-7751-4112; Herrera Moro Chao, Daniela/0000-0001-8406-1377				AERTS JMFG, 1985, EUR J BIOCHEM, V150, P565, DOI 10.1111/j.1432-1033.1985.tb09058.x; Aerts JMFG, 2011, J INHERIT METAB DIS, V34, P605, DOI 10.1007/s10545-011-9308-6; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Farfel-Becker T, 2014, HUM MOL GENET, V23, P843, DOI 10.1093/hmg/ddt468; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Ghisaidoobe AT, 2014, J MED CHEM, V57, P9096, DOI 10.1021/jm501181z; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012; Jiang JB, 2015, CHEM SCI, V6, P2782, DOI 10.1039/c4sc03739a; Kallemeijn WW, 2014, J BIOL CHEM, V289, P35351, DOI 10.1074/jbc.M114.593376; Kallemeijn WW, 2014, ADV CARBOHYD CHEM BI, V71, P297, DOI 10.1016/B978-0-12-800128-8.00004-2; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; Karssen AM, 2004, ANN NY ACAD SCI, V1032, P308, DOI 10.1196/annals.1314.048; Li KY, 2014, ORG BIOMOL CHEM, V12, P7786, DOI 10.1039/c4ob01611d; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Nordstrom V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001506; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Poole RM, 2014, DRUGS, V74, P1829, DOI 10.1007/s40265-014-0296-3; Ramirez S, 2013, DIABETES, V62, P2329, DOI 10.2337/db12-1451; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Ron I, 2010, HUM MOL GENET, V19, P3771, DOI 10.1093/hmg/ddq292; Rothaug M, 2014, P NATL ACAD SCI USA, V111, P15573, DOI 10.1073/pnas.1405700111; Sardi SP, 2015, PROG NEUROBIOL, V125, P47, DOI 10.1016/j.pneurobio.2014.12.001; Sardi SP, 2012, NEURODEGENER DIS, V10, P195, DOI 10.1159/000335038; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Schapira AH, 2015, MOL CELL NEUROSCI; Sekiyama K, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/271732; Siebert M, 2014, BRAIN, V137, P1304, DOI 10.1093/brain/awu002; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Vitner EB, 2012, BRAIN, V135, P1724, DOI 10.1093/brain/aws095; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; Westbroek W, 2011, TRENDS MOL MED, V17, P485, DOI 10.1016/j.molmed.2011.05.003; Willems LI, 2014, CHEM-EUR J, V20, P10864, DOI 10.1002/chem.201404014; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	47	25	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138107	10.1371/journal.pone.0138107	http://dx.doi.org/10.1371/journal.pone.0138107			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418157	Green Submitted, gold, Green Published			2022-12-27	WOS:000362171400010
J	Dyer, L; Lockyer, P; Wu, YX; Saha, A; Cyr, C; Moser, M; Pi, XC; Patterson, C				Dyer, Laura; Lockyer, Pamela; Wu, Yaxu; Saha, Arnab; Cyr, Chelsea; Moser, Martin; Pi, Xinchun; Patterson, Cam			BMPER Promotes Epithelial-Mesenchymal Transition in the Developing Cardiac Cushions	PLOS ONE			English	Article							NEURAL CREST; HEART; PROTEIN; FIELD; CELLS; SOX9; ALK3	Formation of the cardiac valves is an essential component of cardiovascular development. Consistent with the role of the bone morphogenetic protein (BMP) signaling pathway in cardiac valve formation, embryos that are deficient for the BMP regulator BMPER (BMP-binding endothelial regulator) display the cardiac valve anomaly mitral valve prolapse. However, how BMPER deficiency leads to this defect is unknown. Based on its expression pattern in the developing cardiac cushions, we hypothesized that BMPER regulates BMP2-mediated signaling, leading to fine-tuned epithelial-mesenchymal transition (EMT) and extracellular matrix deposition. In the BMPER-/- embryo, EMT is dysregulated in the atrioventricular and outflow tract cushions compared with their wild-type counterparts, as indicated by a significant increase of Sox9-positive cells during cushion formation. However, proliferation is not impaired in the developing BMPER-/- valves. In vitro data show that BMPER directly binds BMP2. In cultured endothelial cells, BMPER blocks BMP2-induced Smad activation in a dose-dependent manner. In addition, BMP2 increases the Sox9 protein level, and this increase is inhibited by co-treatment with BMPER. Consistently, in the BMPER-/- embryos, semi-quantitative analysis of Smad activation shows that the canonical BMP pathway is significantly more active in the atrioventricular cushions during EMT. These results indicate that BMPER negatively regulates BMP-induced Smad and Sox9 activity during valve development. Together, these results identify BMPER as a regulator of BMP2-induced cardiac valve development and will contribute to our understanding of valvular defects.	[Dyer, Laura; Wu, Yaxu; Saha, Arnab; Cyr, Chelsea; Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Lockyer, Pamela] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Moser, Martin] Univ Freiburg, Ctr Heart, Cardiol & Angiol 1, D-79106 Freiburg, Germany; [Pi, Xinchun] Baylor Coll Med, Dept Med Athero & Lipo, Cardiovasc Res Inst, Houston, TX 77030 USA; [Patterson, Cam] New York Presbyterian Hosp, New York, NY 10065 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Baylor College of Medicine; NewYork-Presbyterian Hospital	Pi, XC (corresponding author), Baylor Coll Med, Dept Med Athero & Lipo, Cardiovasc Res Inst, Houston, TX 77030 USA.	xpi@bcm.edu		Dyer, Laura/0000-0002-3052-4601	National Institutes of Health [R01HL061656, R01HL112890]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112890, R01HL061656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (http://report.nih.gov; grants #R01HL061656 and #R01HL112890 for XP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Chakraborty S, 2010, PEDIATR CARDIOL, V31, P414, DOI 10.1007/s00246-009-9616-x; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Choi M, 2007, CIRC RES, V100, P220, DOI 10.1161/01.RES.0000257780.60484.6a; Dyer L, 2014, DEV BIOL, V386, P385, DOI 10.1016/j.ydbio.2013.12.019; Dyer LA, 2010, DEV BIOL, V348, P167, DOI 10.1016/j.ydbio.2010.09.021; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Lockhart MM, 2014, DEV BIOL, V396, P8, DOI 10.1016/j.ydbio.2014.09.031; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Moreno-Miralles I, 2011, ARTERIOSCL THROM VAS, V31, P2216, DOI 10.1161/ATVBAHA.111.230235; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; Park C, 2006, DEVELOPMENT, V133, P3473, DOI 10.1242/dev.02499; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; Sakai D, 2006, DEVELOPMENT, V133, P1323, DOI 10.1242/dev.02297; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Van den Berg G, 2007, ANAT REC, V290, P783, DOI 10.1002/ar.20559; Waldo KL, 1996, DEV DYNAM, V205, P281, DOI 10.1002/(SICI)1097-0177(199603)205:3<281::AID-AJA8>3.0.CO;2-E; Willis MS, 2013, CARDIOVASC PATHOL, V22, P228, DOI 10.1016/j.carpath.2012.10.005; Zakin L, 2008, DEV BIOL, V323, P6, DOI 10.1016/j.ydbio.2008.08.019; Zhang J, 2010, CIRC RES, V107, P1209, DOI 10.1161/CIRCRESAHA.110.225318	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139209	10.1371/journal.pone.0139209	http://dx.doi.org/10.1371/journal.pone.0139209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418455	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400064
J	Kawazoe, Y; Miyauchi, M; Nagasaki, A; Furusho, H; Yanagisawa, S; Chanbora, C; Inubushi, T; Hyogo, H; Nakamoto, T; Suzuki, K; Moriwaki, S; Tazuma, S; Niida, S; Takata, T				Kawazoe, Yusuke; Miyauchi, Mutsumi; Nagasaki, Atsuhiro; Furusho, Hisako; Yanagisawa, Syunryo; Chanbora, Chea; Inubushi, Toshihiro; Hyogo, Hideyuki; Nakamoto, Takashi; Suzuki, Keiko; Moriwaki, Sawako; Tazuma, Susumu; Niida, Shumpei; Takata, Takashi			Osteodystrophy in Cholestatic Liver Diseases Is Attenuated by Anti-gamma-Glutamyl Transpeptidase Antibody	PLOS ONE			English	Article							BILE-DUCT OBSTRUCTION; HEPATIC OSTEODYSTROPHY; EXPRESSION; OSTEOPOROSIS; ALPHA; RATS; HYPERBILIRUBINEMIA; OSTEOCLASTOGENESIS; TRANSFERASE; SERUM	Background Cholestatic liver diseases exhibit higher levels of serum gamma-glutamyl transpeptidase (GGT) and incidence of secondary osteoporosis. GGT has been identified as a novel bone-resorbing factor that stimulates osteoclast formation. The aim of this study was to elucidate the interaction of elevated GGT levels and cholestatic liver disease-induced bone loss. Methods Wistar rats were divided into three groups: sham-operated control (SO) rats, bile duct ligation (BDL) rats, and anti-GGT antibody-treated BDL rats (AGT). Serum GGT level was measured. Bone mineral density (BMD) was analyzed by dual-energy X-ray absorptiometry. Bone morphometric parameters and microarchitectural properties were determined by micro-computed tomography and histomorphometry of the distal metaphysis of femurs. Alterations of bone metabolism-related factors were evaluated by cytokine array. Effects of GGT on osteoblasts or stromal cells were evaluated by RT-PCR, enzyme activity, and mineralization ability. Results Serum levels of GGT were significantly elevated in the BDL-group. In the BDL group, BMD, bone mass percentage, and osteoblast number were significantly decreased, whereas osteoclast number was significantly increased. These alterations were markedly attenuated in the AGT group. The mRNA levels of vascular endothelial growth factor-A, LPS-induced CXC chemokine, monocyte chemoattractant protein-1, tumor necrosis factor-alpha interleukin-1 beta and receptor activator of nuclear factor-kappa B ligand were upregulated, and those of interferon-gamma and osteoprotegerin were downregulated in the GGT-treated stromal cells. Furthermore, GGT inhibited mineral nodule formation and expression of alkaline phosphatase and bone sialo-protein in osteoblastic cells. Conclusion Our results indicate that elevated GGT level is involved in hepatic osteodystrophy through secretion of bone resorbing factor from GGT-stimulated osteoblasts/bone marrow stromal cells. In addition, GGT also possesses suppressive effects on bone formation. Managing elevated GGT levels by anti-GGT antibody may become a novel therapeutic agent for hepatic osteodystrophy in chronic liver diseases.	[Kawazoe, Yusuke; Miyauchi, Mutsumi; Nagasaki, Atsuhiro; Furusho, Hisako; Yanagisawa, Syunryo; Chanbora, Chea; Inubushi, Toshihiro; Takata, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Hyogo, Hideyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Med & Mol Sci, Hiroshima, Japan; [Nakamoto, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Radiol, Hiroshima, Japan; [Suzuki, Keiko] Showa Univ, Sch Dent, Dept Pharmacol, Tokyo 142, Japan; [Moriwaki, Sawako; Niida, Shumpei] Natl Ctr Geriatr & Gerontol, Biobank Om Unit, Obu, Aichi, Japan; [Tazuma, Susumu] Hiroshima Univ Hosp, Dept Gen Internal Med, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Showa University; National Center for Geriatrics & Gerontology; Hiroshima University	Niida, S (corresponding author), Natl Ctr Geriatr & Gerontol, Biobank Om Unit, Obu, Aichi, Japan.	sniida@ncgg.go.jp; ttakata@hiroshima-u.ac.jp	Miyauchi, Mutsumi/G-5268-2019; Furusho, Hisako/H-2351-2019		Ministry of Education, Science and Culture [21592328, 20390469]	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for scientific research (C) from the Ministry of Education, Science and Culture (#21592328; https://kaken.nii.ac.jp/d/p/21592328.ja.html [MM] and #20390469 [SN]; https://kaken.nii.ac.jp/d/p/20390469.ja.html).	Ackerman Z, 2002, LIVER, V22, P166, DOI 10.1046/j.0106-9543.2002.01566.x; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; ATKINSON M, 1956, Q J MED, V25, P299; BESSEY OA, 1946, J BIOL CHEM, V164, P321; BULLE F, 1990, HEPATOLOGY, V11, P545, DOI 10.1002/hep.1840110404; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Collier J, 2007, HEPATOLOGY, V46, P1271, DOI 10.1002/hep.21852; Fernandez-Martinez E, 2006, EXP TOXICOL PATHOL, V58, P49, DOI 10.1016/j.etp.2006.03.002; Gasser RW, 2008, WIEN MED WOCHENSCHR, V158, P553, DOI 10.1007/s10354-008-0594-z; Gatta A, 2014, CLIN CASES MINER BON, V11, P185, DOI 10.11138/ccmbm/2014.11.3.185; Goral V, 2010, WORLD J GASTROENTERO, V16, P1639, DOI 10.3748/wjg.v16.i13.1639; Hiramatsu K, 2007, ENDOCRINOLOGY, V148, P2708, DOI 10.1210/en.2007-0215; IKEDA Y, 1995, P NATL ACAD SCI USA, V92, P126, DOI 10.1073/pnas.92.1.126; Ishizuka Y, 2007, J BONE MINER RES, V22, P1933, DOI 10.1359/JBMR.070726; JANES CH, 1995, J CLIN INVEST, V95, P2581, DOI 10.1172/JCI117959; Kitaura H, 2004, J IMMUNOL, V173, P4838, DOI 10.4049/jimmunol.173.8.4838; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; LIEBERMAN MW, 1995, AM J PATHOL, V147, P1175; Lopez-Larramona G, 2011, WORLD J HEPATOL, V3, P300, DOI 10.4254/wjh.v3.i12.300; Mansueto P, 2013, INTERN EMERG MED, V8, P377, DOI 10.1007/s11739-012-0753-5; MINKIN C, 1991, BONE MINER, V13, P191, DOI 10.1016/0169-6009(91)90068-B; Moon SS, 2012, ENDOCRINE, V42, P423, DOI 10.1007/s12020-012-9639-6; Nakchbandi IA, 2009, NAT REV GASTRO HEPAT, V6, P660, DOI 10.1038/nrgastro.2009.166; Niida S, 2004, J BIOL CHEM, V279, P5752, DOI 10.1074/jbc.M311905200; Nilsson M, 2008, J PERIODONTOL, V79, P1689, DOI 10.1902/jop.2008.070599 ; Pereira FA, 2009, CALCIFIED TISSUE INT, V85, P75, DOI 10.1007/s00223-009-9249-3; Ruiz-Gaspa S, 2011, HEPATOLOGY, V54, P2104, DOI 10.1002/hep.24605; Lacativa PGS, 2010, ARQ BRAS ENDOCRINOL, V54, P123, DOI 10.1590/S0004-27302010000200007; Smith DLH, 2006, J CLIN DENSITOM, V9, P105, DOI 10.1016/j.jocd.2005.10.001; Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031; Weinreb M, 2004, J HEPATOL, V40, P385, DOI 10.1016/j.jhep.2003.11.032	32	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139620	10.1371/journal.pone.0139620	http://dx.doi.org/10.1371/journal.pone.0139620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418133	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400096
J	Sothmann, P; Krumkamp, R; Kreuels, B; Sarpong, N; Frank, C; Ehlkes, L; Fobil, J; Gyau, K; Jaeger, A; Bosu, B; Marks, F; Owusu-Dabo, E; Salzberger, B; May, J				Sothmann, Peter; Krumkamp, Ralf; Kreuels, Benno; Sarpong, Nimako; Frank, Clemens; Ehlkes, Lutz; Fobil, Julius; Gyau, Kennedy; Jaeger, Anna; Bosu, Benedicta; Marks, Florian; Owusu-Dabo, Ellis; Salzberger, Bernd; May, Juergen			Urbanicity and Paediatric Bacteraemia in Ghana-A Case-Control Study within a Rural-Urban Transition Zone	PLOS ONE			English	Article							CHILDREN; MALARIA; HEALTH; URBANIZATION; AFRICA; FEVER; POOR; AREA	Background Systemic bacterial infections are a major cause of paediatric febrile illness in sub-Saharan Africa. Aim of this study was to assess the effects of social and geographical determinants on the risk of bacteraemia in a rural-urban transition zone in Ghana. Methods Children below 15 years of age with fever were recruited at an outpatient department in the suburban belt of Kumasi, Ghana's second largest city. Blood was taken for bacterial culture and malaria diagnostics. The socio-economic status of participants was calculated using Principle Component Analysis. A scale, based on key urban characteristics, was established to quantify urbanicity for all communities in the hospital catchment area. A case-control analysis was conducted, where children with and without bacteraemia were cases and controls, respectively. Results Bacteraemia was detected in 72 (3.1%) of 2,306 hospital visits. Non-typhoidal Salmonella (NTS; n = 24; 33.3%) and Salmonella typhi (n = 18; 25.0%) were the most common isolates. Logistic regression analysis showed that bacteraemia was negatively associated with urbanicity (odds ratio [OR] = 0.8; 95% confidence interval [CI]: 0.7-1.0) and socio-economic status (OR = 0.8; 95% CI: 0.6-0.9). Both associations were stronger if only NTS infections were used as cases (OR = 0.5; 95% CI: 0.3-0.8 and OR = 0.6; 95% CI: 0.4-1.0, respectively). Conclusions The results of this study highlight the importance of individual as well as community factors as independent risk factors for invasive bacterial infection (IBI) and especially NTS. Epidemiological data support physicians, public health experts and policy makers to identify disease prevention and treatment needs in order to secure public health in the transitional societies of developing countries.	[Sothmann, Peter; Krumkamp, Ralf; Kreuels, Benno; Frank, Clemens; Ehlkes, Lutz; Jaeger, Anna; May, Juergen] Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, D-20359 Hamburg, Germany; [Sothmann, Peter; Kreuels, Benno] Univ Med Ctr Hamburg Eppendorf UKE, Dept Med 1, Div Trop Med, Hamburg, Germany; [Krumkamp, Ralf; Kreuels, Benno; May, Juergen] Partner Site Hamburg Borstel Lubeck, German Ctr Infect Res DZIF, Hamburg, Germany; [Sarpong, Nimako; Gyau, Kennedy; Bosu, Benedicta; Owusu-Dabo, Ellis] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Frank, Clemens] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Fobil, Julius] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Marks, Florian] Int Vaccine Inst, Seoul, South Korea; [Salzberger, Bernd] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Center for Infection Research; Kumasi Center for Collaborative Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Ghana; International Vaccine Institute; University of Regensburg	Krumkamp, R (corresponding author), Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	krumkamp@bnitm.de		Marks, Florian/0000-0002-6043-7170; May, Jurgen/0000-0001-7831-8420; Ehlkes, Lutz/0000-0002-0143-7154	Bill & Melinda Gates Foundation [OPPGH5231]; German Centre for Infection Research (Deutsches Zentrum fur Infektionsforschung, DZIF) [80 00 201-3, TI 03.001, TI 07.001]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); German Centre for Infection Research (Deutsches Zentrum fur Infektionsforschung, DZIF)	This work was supported by the Bill & Melinda Gates Foundation (www.gatesfoundation.org/de, grant number: OPPGH5231), as well as by grants from the German Centre for Infection Research (Deutsches Zentrum fur Infektionsforschung, DZIF, www.dzif.de) to Ralf Krumkamp (grant number: 80 00 201-3, TI 03.001) and Benno Kreuels (grant number: TI 07.001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs HM, 2014, CLIN INFECT DIS, P1; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Cyril S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-513; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; DeVellis RF., 2003, APPL SOCIAL RES METH, V2nd; Filmer D, 2005, HEALTH POLICY PLANN, V20, P337, DOI 10.1093/heapol/czi043; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Ghana Statistical Service, 2013, 2010 POP HOUS CENS; Ghana Statistical Service, 2010, 2010 POP HOUS CENS; Hay SI, 2005, URBANIZATION MALARIA, V3, P1; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McMichael AJ, 2000, B WORLD HEALTH ORGAN, V78, P1117; Netemeyer R.G., 2003, SCALING PROCEDURES I; Novignon Jacob, 2012, BMC Res Notes, V5, P380, DOI 10.1186/1756-0500-5-380; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Razak F, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001684; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Riha J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001683; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Takem EN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-400; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; UN Inter-agency Group for Child Mortality Estimation, 2021, LEVELS TRENDS CHILD; UN-HABITAT, 2014, STAT AFR CIT 2014 RE, DOI [10.2174/97816080506351100101, DOI 10.2174/97816080506351100101]; UNICEF, STAT GLANC GHAN; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Westreich D, 2012, EPIDEMIOLOGY, V23, P159, DOI 10.1097/EDE.0b013e31823b6296; WHO, 2013, WORLD MALARIA REPORT 2013, P1	34	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139433	10.1371/journal.pone.0139433	http://dx.doi.org/10.1371/journal.pone.0139433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418004	gold, Green Published			2022-12-27	WOS:000362171400091
J	Toren-Haritan, G; Efrat, S				Toren-Haritan, Ginat; Efrat, Shimon			TGF beta Pathway Inhibition Redifferentiates Human Pancreatic Islet beta Cells Expanded In Vitro	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; INSULIN GENE-TRANSCRIPTION; PROTEIN-KINASE B; SIGNALING PATHWAY; MAFA; MECHANISMS; CANCER; PHOSPHORYLATION; DIFFERENTIATION	In-vitro expansion of insulin-producing cells from adult human pancreatic islets could provide an abundant cell source for diabetes therapy. However, proliferation of beta-cell-derived (BCD) cells is associated with loss of phenotype and epithelial-mesenchymal transition (EMT). Nevertheless, BCD cells maintain open chromatin structure at beta-cell genes, suggesting that they could be readily redifferentiated. The transforming growth factor beta (TGF beta) pathway has been implicated in EMT in a range of cell types. Here we show that human islet cell expansion in vitro involves upregulation of the TGF beta pathway. Blocking TGF beta pathway activation using short hairpin RNA (shRNA) against TGF Chi Receptor 1 (TGFBR1, ALK5) transcripts inhibits BCD cell proliferation and dedifferentiation. Treatment of expanded BCD cells with ALK5 shRNA results in their redifferentiation, as judged by expression of beta-cell genes and decreased cell proliferation. These effects, which are reproducible in cells from multiple human donors, are mediated, at least in part, by AKT-FOXO1 signaling. ALK5 inhibition synergizes with a soluble factor cocktail to promote BCD cell redifferentiation. The combined treatment may offer a therapeutically applicable way for generating an abundant source of functional insulin-producing cells following ex-vivo expansion.	[Toren-Haritan, Ginat; Efrat, Shimon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Efrat, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	sefrat@post.tau.ac.il		Efrat, Shimon/0000-0001-5987-232X	Israel Science Foundation [916/11]	Israel Science Foundation(Israel Science Foundation)	Support was provided by the Israel Science Foundation 916/11 [http://www.isf.org.il/english/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kelly RJ, 2010, J IMMUNOTOXICOL, V7, P15, DOI 10.3109/15476910903389920; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lenz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112914; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsumura H, 2007, BIOCHEM BIOPH RES CO, V364, P151, DOI 10.1016/j.bbrc.2007.09.110; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nathan G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122108; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sintov E, 2015, SCI REP-UK, V5, DOI 10.1038/srep13024; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; White MG, 2013, DIABETES CARE, V36, P3818, DOI 10.2337/dc13-0705; Wu YY, 2011, ONCOGENE, V30, P3682, DOI 10.1038/onc.2011.85; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu YF, 2009, J NEPHROL, V22, P403; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	48	23	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139168	10.1371/journal.pone.0139168	http://dx.doi.org/10.1371/journal.pone.0139168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418361	gold, Green Submitted, Green Published			2022-12-27	WOS:000362171400056
J	Wong, DY; Ranganath, T; Kasko, AM				Wong, Darice Y.; Ranganath, Thanmayi; Kasko, Andrea M.			Low-Dose, Long-Wave UV Light Does Not Affect Gene Expression of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; CULTURED HUMAN KERATINOCYTES; SINGLET OXYGEN; PHOTODEGRADABLE HYDROGELS; FAMILY-MEMBERS; DRUG-DELIVERY; KAPPA-B; ACTIVATION; P53; PHOTOPOLYMERIZATION	Light is a non-invasive tool that is widely used in a range of biomedical applications. Techniques such as photopolymerization, photodegradation, and photouncaging can be used to alter the chemical and physical properties of biomaterials in the presence of live cells. Long-wave UV light (315 nm-400 nm) is an easily accessible and commonly used energy source for triggering biomaterial changes. Although exposure to low doses of long-wave UV light is generally accepted as biocompatible, most studies employing this wavelength only establish cell viability, ignoring other possible (non-toxic) effects. Since light exposure of wavelengths longer than 315 nm may potentially induce changes in cell behavior, we examined changes in gene expression of human mesenchymal stem cells exposed to light under both 2D and 3D culture conditions, including two different hydrogel fabrication techniques, decoupling UV exposure and radical generation. While exposure to long-wave UV light did not induce significant changes in gene expression regardless of culture conditions, significant changes were observed due to scaffold fabrication chemistry and between cells plated in 2D versus encapsulated in 3D scaffolds. In order to facilitate others in searching for more specific changes between the many conditions, the full data set is available on Gene Expression Omnibus for querying.	[Wong, Darice Y.; Ranganath, Thanmayi; Kasko, Andrea M.] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn, Los Angeles, CA 90042 USA	University of California System; University of California Los Angeles	Kasko, AM (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn, Los Angeles, CA 90042 USA.	akasko@ucla.edu	Ranganath, Thanmayi/N-8616-2019	Ranganath, Thanmayi/0000-0001-9865-2119	National Institutes of Health through the NIH Director's New Innovator Award Program [1-DP2-OD008533]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008533] Funding Source: NIH RePORTER	National Institutes of Health through the NIH Director's New Innovator Award Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health through the NIH Director's New Innovator Award Program, 1-DP2-OD008533 awarded to AK. The website for this funding program is http://commonfund.nih.gov/newinnovator/index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASUMODAK S, 1993, CANCER RES, V53, P4505; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078; Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chang TY, ANN REV CELL DEV BIO, V222006, P129; Chaudhuri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7365; Chaudhuri O, 2012, NAT MATER, V11, P568, DOI 10.1038/nmat3366; Djavaheri-Mergny M, 2001, EXP DERMATOL, V10, P204, DOI 10.1034/j.1600-0625.2001.010003204.x; Djavaheri-Mergny M, 1999, BIOCHEM J, V338, P607, DOI 10.1042/0264-6021:3380607; DjavaheriMergny M, 1996, FEBS LETT, V384, P92, DOI 10.1016/0014-5793(96)00294-3; Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W; Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037; GretherBeck S, 1996, P NATL ACAD SCI USA, V93, P14586, DOI 10.1073/pnas.93.25.14586; Griffin DR, 2012, ACS MACRO LETT, V1, P1330, DOI 10.1021/mz300366s; Griffin DR, 2012, J AM CHEM SOC, V134, P13103, DOI 10.1021/ja305280w; Griffin DR, 2010, BIOTECHNOL BIOENG, V107, P1012, DOI 10.1002/bit.22882; Groves JT, 2007, ANNU REV PHYS CHEM, V58, P697, DOI 10.1146/annurev.physchem.56.092503.141216; Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; HARRIS MG, 1993, OPTOMETRY VISION SCI, V70, P839, DOI 10.1097/00006324-199310000-00011; Hensman C, 1998, SURG ENDOSC-ULTRAS, V12, P335, DOI 10.1007/s004649900665; HILLWEST JL, 1994, OBSTET GYNECOL, V83, P59; Hong GN, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0950; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Iwaguchi S, 2000, COLLOID SURFACE B, V18, P113, DOI 10.1016/S0927-7765(99)00144-7; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kawabata K, 2013, J TOXICOL SCI, V38, P215, DOI 10.2131/jts.38.215; Kersters I, 1998, INDIAN J ENG MATER S, V5, P211; Kirschner RD, 2010, CELL CYCLE, V9, P2177, DOI 10.4161/cc.9.11.11844; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lajoie P, INT REV CELL MOL BIO, V282, P135; Larson BL, 2008, STEM CELLS, V26, P193, DOI 10.1634/stemcells.2007-0524; Lippincott-Schwartz J, ANN REV BIOPHYSICS, V39, P559; Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319; Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236; Maziere C, 2000, FREE RADICAL BIO MED, V28, P1430, DOI 10.1016/S0891-5849(00)00264-1; Menicanin D, 2009, STEM CELL REV REP, V5, P36, DOI 10.1007/s12015-009-9056-2; Mironi-Harpaz I, 2012, ACTA BIOMATER, V8, P1838, DOI 10.1016/j.actbio.2011.12.034; Occhetta P, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035002; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Sen B, 2014, J BONE MINER RES, V29, P78, DOI 10.1002/jbmr.2031; Shamay Y, 2011, BIOMATERIALS, V32, P1377, DOI 10.1016/j.biomaterials.2010.10.029; Silvers AL, 2002, PHOTOCHEM PHOTOBIOL, V75, P302, DOI 10.1562/0031-8655(2002)075<0302:UIIAOA>2.0.CO;2; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Sun HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055693; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; VILE GF, 1995, PHOTOCHEM PHOTOBIOL, V62, P463, DOI 10.1111/j.1751-1097.1995.tb02369.x; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024; WLASCHEK M, 1995, J INVEST DERMATOL, V104, P194, DOI 10.1111/1523-1747.ep12612751; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200	65	46	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139307	10.1371/journal.pone.0139307	http://dx.doi.org/10.1371/journal.pone.0139307			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418040	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400073
J	Delhomme, N; Sundstrom, G; Zamani, N; Lantz, H; Lin, YC; Hvidsten, TR; Hoppner, MP; Jern, P; Van de Peer, Y; Lundeberg, J; Grabherr, MG; Street, NR				Delhomme, Nicolas; Sundstrom, Gorel; Zamani, Neda; Lantz, Henrik; Lin, Yao-Cheng; Hvidsten, Torgeir R.; Hoppner, Marc P.; Jern, Patric; Van de Peer, Yves; Lundeberg, Joakim; Grabherr, Manfred G.; Street, Nathaniel R.			Serendipitous Meta-Transcriptomics: The Fungal Community of Norway Spruce (Picea abies)	PLOS ONE			English	Article							RNA-SEQ DATA; SEQUENCE	After performing de novo transcript assembly of >1 billion RNA-Sequencing reads obtained from 22 samples of different Norway spruce (Picea abies) tissues that were not surface sterilized, we found that assembled sequences captured a mix of plant, lichen, and fungal transcripts. The latter were likely expressed by endophytic and epiphytic symbionts, indicating that these organisms were present, alive, and metabolically active. Here, we show that these serendipitously sequenced transcripts need not be considered merely as contamination, as is common, but that they provide insight into the plant's phyllosphere. Notably, we could classify these transcripts as originating predominantly from Dothideomycetes and Leotiomycetes species, with functional annotation of gene families indicating active growth and metabolism, with particular regards to glucose intake and processing, as well as gene regulation.	[Delhomme, Nicolas; Sundstrom, Gorel; Zamani, Neda; Hvidsten, Torgeir R.; Street, Nathaniel R.] Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, Umea, Sweden; [Sundstrom, Gorel; Zamani, Neda; Lantz, Henrik; Hoppner, Marc P.; Jern, Patric; Grabherr, Manfred G.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Lantz, Henrik; Hoppner, Marc P.; Grabherr, Manfred G.] BILS, Uppsala, Sweden; [Lin, Yao-Cheng; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9000 Ghent, Belgium; [Lin, Yao-Cheng; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Hvidsten, Torgeir R.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Van de Peer, Yves] Univ Pretoria, Genom Res Inst, ZA-0002 Pretoria, South Africa; [Lundeberg, Joakim] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Solna, Sweden	Umea University; Uppsala University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Norwegian University of Life Sciences; University of Pretoria; Royal Institute of Technology	Street, NR (corresponding author), Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, Umea, Sweden.	nathaniel.street@umu.se	LIN, Yao-Cheng/B-4394-2008; Van de Peer, Yves/D-4388-2009; Jern, Patric/AAR-2133-2021; Delhomme, Nicolas/B-9187-2015; Hvidsten, Torgeir R./A-3409-2009; Street, Nathaniel Robert/B-3920-2008; Van de Peer, Yves/AAE-7666-2019	LIN, Yao-Cheng/0000-0002-9390-795X; Van de Peer, Yves/0000-0003-4327-3730; Jern, Patric/0000-0003-3393-5825; Delhomme, Nicolas/0000-0002-3053-0796; Hvidsten, Torgeir R./0000-0001-6097-2539; Street, Nathaniel Robert/0000-0001-6031-005X; Van de Peer, Yves/0000-0003-4327-3730; Grabherr, Manfred/0000-0001-8792-6508; Lantz, Henrik/0000-0003-2419-0075	Knut and Alice Wallenberg Foundation; Swedish Research Council (VR); Swedish Governmental Agency for Innovation Systems (Vinnova); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Swedish foundation for Strategic Research (SSF); Trees and Crops for the Future project; Ghent University (Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks")	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council (VR)(Swedish Research Council); Swedish Governmental Agency for Innovation Systems (Vinnova)(Vinnova); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Trees and Crops for the Future project; Ghent University (Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks")(Ghent University)	The authors would like to acknowledge support from the Knut and Alice Wallenberg Foundation. Additional funding was provided by the Swedish Research Council (VR), the Swedish Governmental Agency for Innovation Systems (Vinnova), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), the Swedish foundation for Strategic Research (SSF), the Trees and Crops for the Future project, and Ghent University (Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks").	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grabherr MG, 2010, BIOINFORMATICS, V26, P1145, DOI 10.1093/bioinformatics/btq102; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Muller MM, 2000, MYCOL RES, V104, P1139, DOI 10.1017/S0953756200003105; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Rajala T, 2013, FUNGAL BIOL-UK, V117, P182, DOI 10.1016/j.funbio.2013.01.006; Street NR, 2006, PLANT J, V48, P321, DOI 10.1111/j.1365-313X.2006.02864.x; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	12	21	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139080	10.1371/journal.pone.0139080	http://dx.doi.org/10.1371/journal.pone.0139080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413905	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700039
J	Khan, HU; Daud, A; Malik, TA				Khan, Hikmat Ullah; Daud, Ali; Malik, Tahir Afzal			MIIB: A Metric to Identify Top Influential Bloggers in a Community	PLOS ONE			English	Article								Social networking has revolutionized the use of conventional web and has converted World Wide Web into the social web as users can generate their own content. This change has been possible due to social web platforms like forums, wikis, and blogs. Blogs are more commonly being used as a form of virtual communication to express an opinion about an event, product or experience and can reach a large audience. Users can influence others to buy a product, have certain political or social views, etc. Therefore, identifying the most influential bloggers has become very significant as this can help us in the fields of commerce, advertisement and product knowledge searching. Existing approaches consider some basic features, but lack to consider some other features like the importance of the blog on which the post has been created. This paper presents a new metric, MIIB (Metric for Identification of Influential Bloggers), based on various features of bloggers' productivity and popularity. Productivity refers to bloggers' blogging activity and popularity measures bloggers' influence in the blogging community. The novel module of BlogRank depicts the importance of blog sites where bloggers create their posts. The MIIB has been evaluated against the standard model and existing metrics for finding the influential bloggers using dataset from the real-world blogosphere. The obtained results confirm that the MIIB is able to find the most influential bloggers in a more effective manner.	[Khan, Hikmat Ullah; Daud, Ali] Int Islamic Univ, Dept Comp Sci & Software Engn, Islamabad, Pakistan; [Malik, Tahir Afzal] Ibn Rushd Coll Management Sci, Dept Management Informat Syst, Abha, Saudi Arabia	International Islamic University, Pakistan	Khan, HU (corresponding author), Int Islamic Univ, Dept Comp Sci & Software Engn, Islamabad, Pakistan.	hikmat.phdcs55@iiu.edu.pk	Daud, Ali/G-6568-2017; Khan, Hikmat Ullah/GZG-2251-2022; Daud, Adil/T-3079-2019; Daud, Ali/ABD-4485-2020	Daud, Ali/0000-0002-8284-6354; Daud, Adil/0000-0002-6617-8421; Khan, Hikmat/0000-0002-8178-6652				Agarwal N., 2008, ACM SIGKDD EXPLOR NE, V10, P18, DOI DOI 10.1145/1412734.1412737; Agarwal N., 2008, P INT C WEB SEARCH W, P207, DOI DOI 10.1145/1341531.1341559; Agarwal N, 2012, SOC NETW ANAL MIN, V2, P139, DOI 10.1007/s13278-011-0039-3; Akritidis L, 2014, WORLD WIDE WEB, V17, P777, DOI 10.1007/s11280-013-0237-1; Akritidis L, 2011, IEEE T SYST MAN CY C, V41, P759, DOI 10.1109/TSMCC.2010.2099216; Akritidis L, 2009, 2009 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCES ON WEB INTELLIGENCE (WI) AND INTELLIGENT AGENT TECHNOLOGIES (IAT), VOL 1, P76; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; [Anonymous], 1998, TECHNICAL REPORT; Bross J, 2012, SOC NETW ANAL MIN, V2, P53, DOI 10.1007/s13278-011-0027-7; Ding Y, 2011, J AM SOC INF SCI TEC, V62, P236, DOI 10.1002/asi.21452; Gill K. E., 2004, P ANN WORKSH WEBL EC, P1; Gruhl D., 2004, WWW 04 P 13 INT C WO, P491; Haveliwava T. H., 2002, P 11 INT C WORLD WID, P517, DOI [DOI 10.1145/511446.511513, 10.1145/511446.511513]; Java A, 2006, P 15 C WORLD WID WEB; Kayes I, 2012, LECT NOTES COMPUT SC, V7710, P29, DOI 10.1007/978-3-642-35386-4_3; Keller E, 2006, ONE AM 10 TELLS OTHE; Kritikopoulos A., 2006, P 2 INT WORKSH ADV A; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; Shafiq MZ, 2013, IEEE J SEL AREA COMM, V31, P618, DOI 10.1109/JSAC.2013.SUP.0513054; Teng-Sheng Moh, 2013, 2013 IEEE International Conference on Big Data, P18, DOI 10.1109/BigData.2013.6691792; Xu EL, 2015, LECT NOTES COMPUT SC, V9050, P452, DOI 10.1007/978-3-319-18123-3_27	21	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138359	10.1371/journal.pone.0138359	http://dx.doi.org/10.1371/journal.pone.0138359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414063	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700016
J	Hotaling, JM; Cohen, AL; Shiffrin, RM; Busemeyer, JR				Hotaling, Jared M.; Cohen, Andrew L.; Shiffrin, Richard M.; Busemeyer, Jerome R.			The Dilution Effect and Information Integration in Perceptual Decision Making	PLOS ONE			English	Article							VISUAL-PERCEPTION; RULES; CATEGORIZATION; HEURISTICS; SIMILARITY; EXEMPLARS; JUDGMENT; SYSTEMS; MODEL	In cognitive science there is a seeming paradox: On the one hand, studies of human judgment and decision making have repeatedly shown that people systematically violate optimal behavior when integrating information from multiple sources. On the other hand, optimal models, often Bayesian, have been successful at accounting for information integration in fields such as categorization, memory, and perception. This apparent conflict could be due, in part, to different materials and designs that lead to differences in the nature of processing. Stimuli that require controlled integration of information, such as the quantitative or linguistic information (commonly found in judgment studies), may lead to suboptimal performance. In contrast, perceptual stimuli may lend themselves to automatic processing, resulting in integration that is closer to optimal. We tested this hypothesis with an experiment in which participants categorized faces based on resemblance to a family patriarch. The amount of evidence contained in the top and bottom halves of each test face was independently manipulated. These data allow us to investigate a canonical example of sub-optimal information integration from the judgment and decision making literature, the dilution effect. Splitting the top and bottom halves of a face, a manipulation meant to encourage controlled integration of information, produced farther from optimal behavior and larger dilution effects. The Multi-component Information Accumulation model, a hybrid optimal/averaging model of information integration, successfully accounts for key accuracy, response time, and dilution effects.	[Hotaling, Jared M.] Univ Basel, Dept Psychol, Basel, Switzerland; [Cohen, Andrew L.] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Shiffrin, Richard M.; Busemeyer, Jerome R.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Basel; University of Massachusetts System; University of Massachusetts Amherst; Indiana University System; Indiana University Bloomington	Hotaling, JM (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	jaredhotaling@gmail.com	Hotaling, Jared/AAA-1025-2019; Busemeyer, Jerome R./H-9707-2017	Hotaling, Jared/0000-0001-7265-1310; Busemeyer, Jerome R./0000-0002-7594-1871	NSF GRF; NIMH [1 R01 MH12717, 1 R01 MH63993]; NIMH Cognition and Perception [MH068346]; NSF [0817965]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068346, R01MH063993, R01MH012717] Funding Source: NIH RePORTER	NSF GRF(National Science Foundation (NSF)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH Cognition and Perception; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	J. M. H. was supported by an NSF GRF. A. L. C. and R. M. S. were supported by NIMH Grants 1 R01 MH12717 and 1 R01 MH63993. J. R. B. was supported by NIMH Cognition and Perception MH068346 and NSF Grant 0817965. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SW, 1991, J EXP PSYCHOL GEN, V120, P3, DOI 10.1037/0096-3445.120.1.3; ANDERSON JR, 1991, PSYCHOL REV, V98, P409, DOI 10.1037/0033-295X.98.3.409; ASHBY FG, 1988, J EXP PSYCHOL LEARN, V14, P33, DOI 10.1037/0278-7393.14.1.33; ASHBY FG, 1992, J EXP PSYCHOL HUMAN, V18, P50, DOI 10.1037/0096-1523.18.1.50; ASHBY FG, 1990, J EXP PSYCHOL HUMAN, V16, P598, DOI 10.1037/0096-1523.16.3.598; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Auguie B, 2017, GRIDEXTRA MISCELLANE; BURGESS AE, 1981, SCIENCE, V214, P93, DOI 10.1126/science.7280685; Cohen AL, 2006, J EXP PSYCHOL HUMAN, V32, P574, DOI 10.1037/0096-1523.32.3.574; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Donovan S, 1997, J EXP SOC PSYCHOL, V33, P1, DOI 10.1006/jesp.1996.1309; Eaton JW, 2015, GNU OCTAVE 3 6 4; Erickson MA, 1998, J EXP PSYCHOL GEN, V127, P107, DOI 10.1037/0096-3445.127.2.107; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Feller, 2008, INTRO PROBABILITY TH; Geisler WS, 2003, COGNITIVE SCI, V27, P379, DOI 10.1016/S0364-0213(03)00009-0; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Hammond K. R., 2000, JUDGMENTS STRESS; HAMMOND KR, 1987, IEEE T SYST MAN CYB, V17, P753, DOI 10.1109/TSMC.1987.6499282; Hastie R, 2001, ANNU REV PSYCHOL, V52, P653, DOI 10.1146/annurev.psych.52.1.653; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; LaBella C, 2004, MEM COGNITION, V32, P1076, DOI 10.3758/BF03196883; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Macmillan N. A., 2004, DETECTION THEORY USE; MARTIN LL, 1990, J PERS SOC PSYCHOL, V59, P27, DOI 10.1037/0022-3514.59.1.27; Massaro D.W., 1998, PERCEIVING TALKING F; McKenzie CRM, 2002, J BEHAV DECIS MAKING, V15, P1, DOI 10.1002/bdm.400; Moran R, 2015, PSYCHON B REV, V22, P38, DOI 10.3758/s13423-014-0669-3; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NISBETT RE, 1981, COGNITIVE PSYCHOL, V13, P248, DOI 10.1016/0010-0285(81)90010-4; Nosofsky RM, 1997, PSYCHOL REV, V104, P266, DOI 10.1037/0033-295X.104.2.266; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; ODEN GC, 1978, PSYCHOL REV, V85, P172, DOI 10.1037/0033-295X.85.3.172; Payne J. W., 1993, ADAPTIVE DECISION MA; Peters E, 2000, PERS SOC PSYCHOL B, V26, P177, DOI 10.1177/0146167200264005; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Runeson S, 2000, PSYCHOL REV, V107, P525, DOI 10.1037/0033-295X.107.3.525; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHANTEAU J, 1975, ACTA PSYCHOL, V39, P83, DOI 10.1016/0001-6918(75)90023-2; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sides A, 2002, MEM COGNITION, V30, P191, DOI 10.3758/BF03195280; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Tenenbaum JB, 2000, ADV NEUR IN, V12, P59; Tenenbaum JB, 1999, ADV NEUR IN, V11, P59; Trueblood JS, 2014, PSYCHOL REV, V121, P179, DOI 10.1037/a0036137; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1994, PSYCHOL REV, V101, P547, DOI 10.1037/0033-295X.101.4.547; TVERSKY A, 1972, PSYCHOL REV, V79, P281, DOI 10.1037/h0032955; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	56	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138481	10.1371/journal.pone.0138481	http://dx.doi.org/10.1371/journal.pone.0138481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406323	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700049
J	Hrynets, Y; Ndagijimana, M; Betti, M				Hrynets, Yuliya; Ndagijimana, Maurice; Betti, Mirko			Rapid Myoglobin Aggregation through Glucosamine-Induced alpha-Dicarbonyl Formation	PLOS ONE			English	Article							MAILLARD REACTION-PRODUCTS; GLYCATION END-PRODUCTS; ANTIOXIDANT CAPACITY; PROTEIN MODIFICATION; CIRCULAR-DICHROISM; DIABETES-MELLITUS; MASS-SPECTROMETRY; IN-VITRO; METHYLGLYOXAL; GLYOXAL	The extent of glycation and conformational changes of horse myoglobin (Mb) upon glycation with N-acetyl-glucosamine (GlcNAc), glucose (Glc) and glucosamine (GlcN) were investigated. Among tested sugars, the rate of glycation with GlcN was the most rapid as shown by MALDI and ESI mass spectrometries. Protein oxidation, as evaluated by the amount of carbonyl groups present on Mb, was found to increase exponentially in Mb-Glc conjugates over time, whereas in Mb-GlcN mixtures the carbonyl groups decreased significantly after maximum at 3 days of the reaction. The reaction between GlcN and Mb resulted in a significantly higher amount of alpha-dicarbonyl compounds, mostly glucosone and 3-deoxyglucosone, ranging from and 27 to 332 mg/L and from 14 to 304 mg/L, respectively. Already at 0.5 days, tertiary structural changes of Mb-GlcN conjugate were observed by altered tryptophan fluorescence. A reduction of metmyoglobin to deoxy-and oxymyoglobin forms was observed on the first day of reaction, coinciding with the greatest amount of glucosone produced. In contrast to native alpha-helical myoglobin, 41% of the glycated protein sequence was transformed into a beta-sheet conformation, as determined by circular dichroism spectropolarimetry. Transmission electron microscopy demonstrated that Mb glycation with GlcN causes the formation of amorphous or fibrous aggregates, started already at 3 reaction days. These aggregates bind to an amyloid-specific dye thioflavin T. With the aid of alpha-dicarbonyl compounds and advanced products of reaction, this study suggests that the Mb glycation with GlcN induces the unfolding of an initially globular protein structure into amyloid fibrils comprised of a beta-sheet structure.	[Hrynets, Yuliya; Ndagijimana, Maurice; Betti, Mirko] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Alberta	Betti, M (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	Mirko.Betti@ales.ualberta.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Support was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) [http://www.nserc-crsng.gc.ca/].	Amoresano A, 2000, GLYCOBIOLOGY, V10, P451, DOI 10.1093/glycob/10.5.451; Bhattacherjee A, 2011, INT J BIOL MACROMOL, V48, P202, DOI 10.1016/j.ijbiomac.2010.11.003; Block JA, 2010, OSTEOARTHR CARTILAGE, V18, P5, DOI 10.1016/j.joca.2009.07.005; Bokiej M, 2011, BIOCHEM BIOPH RES CO, V407, P191, DOI 10.1016/j.bbrc.2011.02.138; Bouma B, 2003, J BIOL CHEM, V278, P41810, DOI 10.1074/jbc.M303925200; Capuano E, 2011, LWT-FOOD SCI TECHNOL, V44, P793, DOI 10.1016/j.lwt.2010.11.002; Chan JTY, 2011, FOOD CHEM, V127, P109, DOI 10.1016/j.foodchem.2010.12.095; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009052; Chen L, 2009, CELL MOL LIFE SCI, V66, P2559, DOI 10.1007/s00018-009-0058-7; Fogliano V, 2011, FOOD FUNCT, V2, P117, DOI 10.1039/c0fo00156b; Gensberger S, 2012, ANAL BIOANAL CHEM, V403, P2923, DOI 10.1007/s00216-012-5817-x; Gersten RA, 2010, CARBOHYD RES, V345, P2499, DOI 10.1016/j.carres.2010.09.013; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Hail Mark E., 2004, American Biotechnology Laboratory, V22, P12; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Hauser C, 2014, FOOD CHEM, V145, P608, DOI 10.1016/j.foodchem.2013.08.083; Hofmann T, 1999, J AGR FOOD CHEM, V47, P379, DOI 10.1021/jf980626x; Hoppener JWM, 1999, DIABETOLOGIA, V42, P427, DOI 10.1007/s001250051175; Hrynets Y, 2015, J AGR FOOD CHEM, V63, P6249, DOI 10.1021/acs.jafc.5b02664; Hrynets Y, 2013, FOOD CHEM, V139, P1062, DOI 10.1016/j.foodchem.2013.02.026; HUNT JV, 1988, BIOCHEM J, V250, P87, DOI 10.1042/bj2500087; HUNT JV, 1991, FREE RADICAL RES COM, V12-3, P115, DOI 10.3109/10715769109145775; HUNT JV, 1993, BIOCHEM J, V291, P529, DOI 10.1042/bj2910529; Iannuzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080768; Jin RX, 2013, CARBOHYD RES, V370, P72, DOI 10.1016/j.carres.2012.07.001; Kanzler C, 2014, J AGR FOOD CHEM, V62, P2837, DOI 10.1021/jf404322r; Kapurniotu A, 1998, EUR J BIOCHEM, V251, P208, DOI 10.1046/j.1432-1327.1998.2510208.x; Liggins J, 1997, BBA-MOL BASIS DIS, V1361, P123, DOI 10.1016/S0925-4439(97)00023-9; Liu JH, 2012, FOOD RES INT, V49, P170, DOI 10.1016/j.foodres.2012.07.034; Liu Q, 2014, FOOD SCI BIOTECHNOL, V23, P33, DOI 10.1007/s10068-014-0005-8; Ma G, 2014, J SPECTROSC, V2014, DOI 10.1155/2014/285806; Martin SR, 2008, METHOD CELL BIOL, V84, P263, DOI 10.1016/S009l-679X(07)84010-6; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Monacelli F, 2013, INT J MOL SCI, V14, P10694, DOI 10.3390/ijms140610694; Mossine VV, 1999, CHEM RES TOXICOL, V12, P230, DOI 10.1021/tx980209e; Nagy A, 2009, CZECH J FOOD SCI, V27, P320, DOI 10.17221/48/2008-CJFS; Niwa T, 2001, KIDNEY INT, V59, pS37, DOI 10.1046/j.1523-1755.2001.59780037.x; Niwa T, 2006, MASS SPECTROM REV, V25, P713, DOI 10.1002/mas.20089; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Papetti A, 2014, FOOD CHEM, V164, P259, DOI 10.1016/j.foodchem.2014.05.022; Picotti P, 2004, PROTEIN SCI, V13, P1572, DOI 10.1110/ps.04635304; Qu CJ, 2006, BBA-MOL BASIS DIS, V1762, P453, DOI 10.1016/j.bbadis.2006.01.005; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Raj DSC, 2000, AM J KIDNEY DIS, V35, P365, DOI 10.1016/S0272-6386(00)70189-2; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Roberts NB, 2001, CLIN CHEM, V47, P316; Roncone R, 2004, EUR J INORG CHEM, P2203, DOI 10.1002/ejic.200400126; Rondeau P, 2011, PROTEIN AGGREGATION, P139; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Sajithlal GB, 1998, FREE RADICAL BIO MED, V25, P265, DOI 10.1016/S0891-5849(98)00035-5; Schwarzenbolz U, 1997, Z LEBENSM UNTERS F A, V205, P121, DOI 10.1007/s002170050137; Shimamura T, 2003, BIOSCI BIOTECH BIOCH, V67, P295, DOI 10.1271/bbb.67.295; Sirangelo I, 2002, J BIOL CHEM, V277, P45887, DOI 10.1074/jbc.M207659200; Stepuro II, 1997, BIOCHEMISTRY-MOSCOW+, V62, P967; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Summa C, 2008, MOL NUTR FOOD RES, V52, P342, DOI 10.1002/mnfr.200700403; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; SWAMY MJ, 1989, BIOSCIENCE REP, V9, P189, DOI 10.1007/BF01115995; Tagliazucchi D, 2015, AMINO ACIDS, V47, P1077, DOI 10.1007/s00726-015-1951-z; Tang CH, 2011, J AGR FOOD CHEM, V59, P10114, DOI 10.1021/jf202517f; Tang J, 2004, J FOOD SCI, V69, pC717, DOI 10.1111/j.1365-2621.2004.tb09922.x; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Upmacis RK, 1997, J AM CHEM SOC, V119, P10424, DOI 10.1021/ja964249l; Uzzan M, 2007, J FOOD SCI, V72, pE109, DOI 10.1111/j.1750-3841.2007.00284.x; Villamena FA, 2013, MOLECULAR BASIS OF OXIDATIVE STRESS: CHEMISTRY, MECHANISMS, AND DISEASE PATHOGENESIS, P1, DOI 10.1002/9781118355886; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848; Zehl M, 2004, RAPID COMMUN MASS SP, V18, P1932, DOI 10.1002/rcm.1563; Zhang XF, 2004, ANAL BIOCHEM, V325, P255, DOI 10.1016/j.ab.2003.11.001	72	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139022	10.1371/journal.pone.0139022	http://dx.doi.org/10.1371/journal.pone.0139022			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406447	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700150
J	Kim, JK; Kim, YS; Song, YR; Kim, HJ; Kim, SG; Moon, SJ				Kim, Jwa-Kyung; Kim, Young-Su; Song, Young Rim; Kim, Hyung Jik; Kim, Sung Gyun; Moon, Sung Jin			Excessive Weight Gain during the First Year of Peritoneal Dialysis Is Associated with Inflammation, Diabetes Mellitus, and a Rapid Decrease in Residual Renal Function	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY; PROTEINURIA; MORTALITY; SURVIVAL; INCREASE; SIZE; FAT	Objectives Significant weight gain is a potential problem in most patients starting peritoneal dialysis (PD); however, few studies have explored the clinical effects of increased body weight (BW) in these patients. We evaluated the effect of excess weight gain during the first year after PD on residual renal function (RRF). Methods A total of 148 incident PD patients were analyzed in a longitudinal observational study. The mean duration of follow-up was 23.8 months. RRF was measured at baseline (within 1 month of starting PD) and thereafter at 6-month intervals for 2-3 years or until loss of RRF. BW was measured at the time of RRF measurement, and excess weight gain was defined as a BW increase over the median value (3.0%). Results The median 1-year increase in BW was 2.3kg (IQR, 1.01-4.58) or 3.0% (IQR, 1.13-5.31). The mean slope of RRF decline was -0.068 +/- 0.053 mL/min/month/1.73m(2), and RRF loss developed in 48 patients at a mean follow-up time of 19.4 +/- 6.8 months. Patients with BW increases > 3.0% showed significantly increased RRF decline rate compared to those without excess weight gain (p<0.001), and the BW increase (%/year) correlated significantly with higher hs-CRP levels and RRF decline rate. High systolic blood pressure, diabetes, large amount of proteinuria and excess BW gain significantly influenced the RRF decline rate. Also, it increased the risk of RRF loss by 4.17-fold (95% confidence intervals, 1.879.28; p<0.001). Conclusions Excess weight gain during the first year of PD was closely linked to systemic inflammation, diabetes and rapid decline in RRF.	[Kim, Jwa-Kyung; Kim, Young-Su; Song, Young Rim; Kim, Hyung Jik; Kim, Sung Gyun] Hallym Univ, Sacred Heart Hosp, Kidney Res Inst, Dept Internal Med, Anyang, South Korea; [Moon, Sung Jin] Catholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Internal Med, Inchon, South Korea	Hallym University; Catholic Kwandong University	Moon, SJ (corresponding author), Catholic Kwandong Univ, Coll Med, Int St Marys Hosp, Dept Internal Med, Inchon, South Korea.	moonsj75@hanmail.net						Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Abbott KC, 2007, SEMIN DIALYSIS, V20, P561, DOI 10.1111/j.1525-139X.2007.00347.x; Bergia R, 1993, Perit Dial Int, V13 Suppl 2, pS512; Cordeiro AC, 2009, CONTRIB NEPHROL, V163, P132, DOI 10.1159/000223791; Fernandes NMD, 2013, CLINICS, V68, P51, DOI 10.6061/clinics/2013(01)OA08; de Mutsert R, 2009, CONTRIB NEPHROL, V163, P124, DOI 10.1159/000223790; DIAZBUXO JA, 1992, ADV PERIT D, V8, P334; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fernstrom A, 1998, PERITON DIALYSIS INT, V18, P166; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Inal S, 2014, INT UROL NEPHROL, V46, P1851, DOI 10.1007/s11255-014-0709-y; Jackson CL, 2014, J GEN INTERN MED, V29, P25, DOI 10.1007/s11606-013-2553-7; Johnson DW, 2000, PERITON DIALYSIS INT, V20, P715; Jolly S, 2001, INT J ARTIF ORGANS, V24, P197, DOI 10.1177/039139880102400405; Kaysen GA, 2009, J RENAL NUTR, V19, P357, DOI 10.1053/j.jrn.2009.04.002; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Lu Q, 2008, J RENAL NUTR, V18, P495, DOI 10.1053/j.jrn.2008.05.006; Mehrotra R, 2013, CURR OPIN NEPHROL HY, V22, P663, DOI 10.1097/MNH.0b013e328365b3d1; Park J, 2014, PROG CARDIOVASC DIS, V56, P415, DOI 10.1016/j.pcad.2013.10.005; Pellicano R, 2011, CLIN J AM SOC NEPHRO, V6, P1668, DOI 10.2215/CJN.06790810; Praga M, 2000, KIDNEY INT, V58, P2111, DOI 10.1046/j.1523-1755.2000.00384.x; Praga M, 2006, CURR OPIN NEPHROL HY, V15, P481, DOI 10.1097/01.mnh.0000242172.06459.7c; Ramkumar N, 2005, PERITON DIALYSIS INT, V25, P461; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Trimarchi H, 2012, INT J NEPHROL RENOV, V5, P1, DOI 10.2147/IJNRD.S27675	25	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139033	10.1371/journal.pone.0139033	http://dx.doi.org/10.1371/journal.pone.0139033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406589	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700151
J	Meakin, PJ; Morrison, VL; Sneddon, CC; Savinko, T; Uotila, L; Jalicy, SM; Gabriel, JL; Kang, L; Ashford, MLJ; Fagerholm, SC				Meakin, Paul J.; Morrison, Vicky L.; Sneddon, Claire C.; Savinko, Terhi; Uotila, Liisa; Jalicy, Susan M.; Gabriel, Jennie L.; Kang, Li; Ashford, Michael L. J.; Fagerholm, Susanna C.			Mice Lacking beta2-Integrin Function Remain Glucose Tolerant in Spite of Insulin Resistance, Neutrophil Infiltration and Inflammation	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ADHESION RECEPTORS; ADIPOSE-TISSUE; IN-VIVO; CD18; SKIN; METABOLISM; EXPRESSION; ELASTASE; MUSCLE	Beta2-integrins are important in leukocyte trafficking and function, and are regulated through the binding of cytoplasmic proteins, such as kindlin-3, to their intracellular domain. Here, we investigate the involvement of beta2-integrins in the regulation of metabolic disease using mice where the kindlin-3 binding site in the beta2-integrin cytoplasmic tail has been mutated (TTT/AAA-beta2-integrin knock-in (KI) mice), leading to expressed but dysfunctional beta2-integrins and significant neutrophilia in vivo. Beta2-integrin KI mice fed on a high fat diet showed normal weight gain, and normal accumulation of macrophages and lymphocytes in white adipose tissue (WAT) and liver, but increased neutrophil numbers especially in WAT. In addition, beta2-integrin KI mice fed on a high fat diet showed significantly increased peripheral insulin resistance in response to high-fat feeding. However, this was associated with improved glucose disposal following glucose load. Interestingly, beta2-integrin KI neutrophils produced more elastase in vitro, in response to stimulation. Beta2-integrin KI mice displayed variability of tissue inflammatory status, with liver and WAT exhibiting little or no difference in inflammation compared to high fat fed controls, whereas skeletal muscle demonstrated a raised inflammatory profile in association with higher elastase levels and diminished signalling through the IRS1-PKB pathway. In conclusion, although expression of dysfunctional beta2-integrins increased neutrophil production and infiltration into tissue, skeletal muscle was the most affected tissue exhibiting evidence of higher neutrophil activity and insulin resistance. Thus, beta2-integrins modulate glucose homeostasis during high fat feeding predominantly through actions on skeletal muscle to affect metabolic phenotype in vivo.	[Meakin, Paul J.; Sneddon, Claire C.; Jalicy, Susan M.; Gabriel, Jennie L.; Kang, Li; Ashford, Michael L. J.] Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland; [Morrison, Vicky L.; Fagerholm, Susanna C.] Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Canc Res, Dundee DD1 9SY, Scotland; [Morrison, Vicky L.; Savinko, Terhi; Uotila, Liisa; Fagerholm, Susanna C.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Dundee; University of Dundee; University of Helsinki	Ashford, MLJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland.	m.l.j.ashford@dundee.ac.uk; susanna.fagerholm@helsinki.fi	Meakin, Paul/L-3003-2019	Meakin, Paul/0000-0002-8553-3863; Savinko, Terhi/0000-0003-4483-7235; Uotila, Liisa/0000-0003-4743-9013; Ashford, Michael/0000-0002-0861-7676; Morrison, Vicky/0000-0002-4351-8737; Kang, Li/0000-0002-6990-1996; Fagerholm, Susanna Carola/0000-0002-0354-8763	Biotechnology and Biological Sciences Research Council; Arthritis Research UK; Tenovus Scotland; Academy of Finland; Biocentrum Helsinki; Sigrid Juselius foundation; Diabetes UK; Biotechnology and Biological Sciences Research Council - CASE; AstraZeneca; MRC [MR/K003291/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1133987] Funding Source: researchfish; Diabetes UK [12/0004458] Funding Source: researchfish; Medical Research Council [MR/K003291/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Arthritis Research UK(Versus Arthritis); Tenovus Scotland; Academy of Finland(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius foundation(Sigrid Juselius Foundation); Diabetes UK(Diabetes UK); Biotechnology and Biological Sciences Research Council - CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This work was supported by Biotechnology and Biological Sciences Research Council, Arthritis Research UK, Tenovus Scotland, The Anonymous Trust, the Academy of Finland, Biocentrum Helsinki and the Sigrid Juselius foundation (all to S.C.F) and Diabetes UK and Biotechnology and Biological Sciences Research Council - CASE awards to MLJA. This work was supported in part by a grant from AstraZeneca. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babic AM, 2004, MOL MED, V10, P72, DOI 10.2119/2004-00038.Wagner; Bakele M, 2014, J BIOL CHEM, V289, P5320, DOI 10.1074/jbc.M113.505636; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Dong ZM, 1997, P NATL ACAD SCI USA, V94, P7526, DOI 10.1073/pnas.94.14.7526; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Feral CC, 2008, DIABETES, V57, P1842, DOI 10.2337/db07-1751; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Gomez JC, 2010, LAB INVEST, V90, P599, DOI 10.1038/labinvest.2010.4; Goulet B, 2008, MOL CANCER RES, V6, P644, DOI 10.1158/1541-7786.MCR-07-0268; Herishanu Y, 2006, EUR J HAEMATOL, V76, P516, DOI 10.1111/j.1600-0609.2006.00658.x; Horwitz BH, 2001, BLOOD, V97, P1578, DOI 10.1182/blood.V97.6.1578; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Morrison VL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6359; Morrison VL, 2013, BLOOD, V122, P1428, DOI 10.1182/blood-2013-02-484998; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Robker RL, 2004, OBES RES, V12, P936, DOI 10.1038/oby.2004.114; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Savinko TS, 2015, J INVEST DERMATOL, V135, P2249, DOI 10.1038/jid.2015.164; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schmidt S, 2013, MOL IMMUNOL, V55, P49, DOI 10.1016/j.molimm.2012.11.006; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Trellakis S, 2012, OBESITY FACTS, V5, P305, DOI 10.1159/000339452; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044	28	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138872	10.1371/journal.pone.0138872	http://dx.doi.org/10.1371/journal.pone.0138872			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405763	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000361800700107
J	Morrison, MC; Mulder, P; Stavro, PM; Saurez, M; Arola-Arnal, A; van Duyvenvoorde, W; Kooistra, T; Wielinga, PY; Kleemann, R				Morrison, Martine C.; Mulder, Petra; Stavro, P. Mark; Saurez, Manuel; Arola-Arnal, Anna; van Duyvenvoorde, Wim; Kooistra, Teake; Wielinga, Peter Y.; Kleemann, Robert			Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; KAPPA-B; CARDIOVASCULAR-DISEASE; HEPATIC STEATOSIS; VASCULAR-LESIONS; BILBERRY EXTRACT; INFLAMMATION; POLYPHENOLS; CHOLESTEROL; MICE	Background and Aims As dietary saturated fatty acids are associated with metabolic and cardiovascular disease, a potentially interesting strategy to reduce disease risk is modification of the quality of fat consumed. Vegetable oils represent an attractive target for intervention, as they largely determine the intake of dietary fats. Furthermore, besides potential health effects conferred by the type of fatty acids in a vegetable oil, other minor components (e.g. phytochemicals) may also have health benefits. Here, we investigated the potential long-term health effects of isocaloric substitution of dietary fat (i.e. partial replacement of saturated by unsaturated fats), as well as putative additional effects of phytochemicals present in unrefined (virgin) oil on development of non-alcoholic fatty liver disease (NAFLD) and associated atherosclerosis. For this, we used pumpkin seed oil, because it is high in unsaturated fatty acids and a rich source of phytochemicals. Methods ApoE*3Leiden mice were fed a Western-type diet (CON) containing cocoa butter (15% w/w) and cholesterol (1% w/w) for 20 weeks to induce risk factors and disease endpoints. In separate groups, cocoa butter was replaced by refined (REF) or virgin (VIR) pumpkin seed oil (comparable in fatty acid composition, but different in phytochemical content). Results Both oils improved dyslipidaemia, with decreased (V) LDL-cholesterol and triglyceride levels in comparison with CON, and additional cholesterol-lowering effects of VIR over REF. While REF did not affect plasma inflammatory markers, VIR reduced circulating serum amyloid A and soluble vascular adhesion molecule-1. NAFLD and atherosclerosis development was modestly reduced in REF, and VIR strongly decreased liver steatosis and inflammation as well as atherosclerotic lesion area and severity. Conclusions Overall, we show that an isocaloric switch from a diet rich in saturated fat to a diet rich in unsaturated fat can attenuate NAFLD and atherosclerosis development. Phytochemical-rich virgin pumpkin seed oil exerts additional anti-inflammatory effects resulting in more pronounced health effects.	[Morrison, Martine C.; Mulder, Petra; van Duyvenvoorde, Wim; Kooistra, Teake; Wielinga, Peter Y.; Kleemann, Robert] Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Morrison, Martine C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Stavro, P. Mark] Bunge Ltd, White Plains, NY USA; [Saurez, Manuel; Arola-Arnal, Anna] Rovira iVirgili Univ, Dept Biochem & Biotechnol, Tarragona, Spain; [Saurez, Manuel; Arola-Arnal, Anna] CEICS, TECNIO, CTNS, Reus, Spain; [Kleemann, Robert] Wageningen Univ, Dept Human & Anim Physiol, NL-6700 AP Wageningen, Netherlands	University of Groningen; Wageningen University & Research	Morrison, MC (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands.	martine.morrison@tno.nl	Arola-Arnal, Anna/C-2087-2015; Morrison, Martine C./C-3168-2014; Recio, Manuel Suarez/F-5039-2016	Arola-Arnal, Anna/0000-0001-6529-1345; Morrison, Martine C./0000-0003-4996-943X; Recio, Manuel Suarez/0000-0003-0122-8253; Mulder, Petra/0000-0002-0982-4466	Netherlands Organisation for Applied Scientific Research (TNO) research program Healthy Nutrition; Bunge Ltd.; TNO; Top Institute Food and Nutrition (TIFN); Bunge Ltd	Netherlands Organisation for Applied Scientific Research (TNO) research program Healthy Nutrition; Bunge Ltd.; TNO; Top Institute Food and Nutrition (TIFN); Bunge Ltd	The study was funded partly by the Netherlands Organisation for Applied Scientific Research (TNO) research program Healthy Nutrition and partly by Bunge Ltd. MCM received funding from TNO and Top Institute Food and Nutrition (TIFN), a public-private partnership on pre-competitive research in food and nutrition. Co-author P. Mark Stavro is employed by Bunge Ltd. Bunge Ltd provided support in the form of salary for author PMS and had a role in data collection (analyses of fatty acid composition of the oils). Bunge Ltd had no role in the data analysis, decision to publish, or preparation of the manuscript. The specific roles of PMS are articulated in the 'author contributions' section.	Aguirre L, 2014, WORLD J GASTROENTERO, V20, P7366, DOI 10.3748/wjg.v20.i23.7366; Allison GL, 2006, J NUTR, V136, p782S, DOI 10.1093/jn/136.3.782S; AlZuhair H, 1997, PHARMACOL RES, V35, P403, DOI 10.1006/phrs.1997.0148; Andjelkovic M, 2010, EUR J LIPID SCI TECH, V112, P208, DOI 10.1002/ejlt.200900021; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Biesalski HK, 2007, CURR OPIN CLIN NUTR, V10, P724, DOI 10.1097/MCO.0b013e3282f0cef2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chirala SS, 2004, LIPIDS, V39, P1045, DOI 10.1007/s11745-004-1329-9; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Farrell N, 2015, FOOD FUNCT, V6, P1278, DOI [10.1039/C4FO01036A, 10.1039/c4fo01036a]; Ferramosca A, 2014, WORLD J GASTROENTERO, V20, P1746, DOI 10.3748/wjg.v20.i7.1746; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Gossell-Williams M, 2008, PHYTOTHER RES, V22, P873, DOI 10.1002/ptr.2381; Gossell-Williams M, 2011, CLIMACTERIC, V14, P558, DOI 10.3109/13697137.2011.563882; Gylling H, 2014, ATHEROSCLEROSIS, V232, P346, DOI 10.1016/j.atherosclerosis.2013.11.043; Janega P, 2014, FOOD FUNCT, V5, P2202, DOI [10.1039/c4fo00097h, 10.1039/C4FO00097H]; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Khurana S, 2013, NUTRIENTS, V5, P3779, DOI 10.3390/nu5103779; Kim DY, 2013, NUTR RES PRACT, V7, P481, DOI 10.4162/nrp.2013.7.6.481; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleemann R, 2011, ATHEROSCLEROSIS, V218, P44, DOI 10.1016/j.atherosclerosis.2011.04.023; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922; Liang W, 2014, LAB INVEST, V94, P491, DOI 10.1038/labinvest.2014.11; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Michas G, 2014, ATHEROSCLEROSIS, V234, P320, DOI 10.1016/j.atherosclerosis.2014.03.013; Monteiro J, 2014, FOOD FUNCT, V5, P426, DOI 10.1039/c3fo60551e; Morrison M, 2014, ATHEROSCLEROSIS, V233, P149, DOI 10.1016/j.atherosclerosis.2013.12.027; Morrison MC, 2015, J HEPATOL, V62, P1180, DOI 10.1016/j.jhep.2014.12.011; Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rezig L, 2012, IND CROP PROD, V37, P82, DOI 10.1016/j.indcrop.2011.12.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Shimoda H, 2009, J AGR FOOD CHEM, V57, P1786, DOI 10.1021/jf803441c; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Tang CC, 2014, FOOD FUNCT, V5, P678, DOI 10.1039/c3fo60478k; van de Steeg E, 2013, J PHARMACOL EXP THER, V347, P635, DOI 10.1124/jpet.113.208595; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Verschuren L, 2011, J NUTR, V141, P863, DOI 10.3945/jn.110.133751; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wielinga PY, 2012, MOL NUTR FOOD RES, V56, P1081, DOI 10.1002/mnfr.201100762; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Xu L, 2015, BIOMOLECULES, V5, P1563, DOI 10.3390/biom5031563; Xu ZR, 2015, NUTRIENTS, V7, P7085, DOI 10.3390/nu7085324; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	55	26	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139196	10.1371/journal.pone.0139196	http://dx.doi.org/10.1371/journal.pone.0139196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405765	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700187
J	von Stumm, S; Plomin, R				von Stumm, Sophie; Plomin, Robert			Breastfeeding and IQ Growth from Toddlerhood through Adolescence	PLOS ONE			English	Article							COGNITIVE-ABILITIES; INTELLIGENCE; VALIDITY; SAMPLE	Objectives The benefits of breastfeeding for cognitive development continue to be hotly debated but are yet to be supported by conclusive empirical evidence. Methods We used here a latent growth curve modeling approach to test the association of breastfeeding with IQ growth trajectories, which allows differentiating the variance in the IQ starting point in early life from variance in IQ gains that occur later in childhood through adolescence. Breastfeeding (yes/no) was modeled as a direct predictor of three IQ latent growth factors (i.e. intercept, slope and quadratic term) and adjusted for the covariates socioeconomic status, mother's age at birth and gestational stage. Data came from the Twins Early Development Study (TEDS), a prospective cohort study of twins born between 1996 and 1994 in the United Kingdom, who were assessed 9 times on IQ between age 2 and 16 years (N = 11,582). Results Having been breastfed was associated with a small yet significant advantage in IQ at age 2 in girls (beta = .07, CI 95% from 0.64 to 3.01; N = 3,035) but not in boys (beta = .04, CI 95% from -0.14 to 2.41). Having been breastfeeding was neither associated with the other IQ growth factors in girls (slope: beta = .02, CI 95% from -0.25 to 0.43; quadratic: beta = .01, CI 95% from -0.02 to 0.02) nor in boys (slope: beta = .02, CI 95% from -0.30 to 0.47; quadratic: beta = -.01, CI 95% from -0.01 to 0.01). Conclusions Breastfeeding has little benefit for early life intelligence and cognitive growth from toddlerhood through adolescence.	[von Stumm, Sophie] Goldsmiths Univ London, Dept Psychol, London, England; [Plomin, Robert] Univ London, Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London SW3 6LX, England	University of London; Goldsmiths University London; University of London; King's College London	von Stumm, S (corresponding author), Goldsmiths Univ London, Dept Psychol, London, England.	s.vonstumm@gold.ac.uk		von Stumm, Sophie/0000-0002-0447-5471; Plomin, Robert/0000-0002-0756-3629	UK Medical Research Council [G0901245, G0500079]; US National Institutes of Health [HD044454, HD059215]; Medical Research Council [G19/2]; European Research Council [295366]; MRC [G19/2, G0901245, G0500079] Funding Source: UKRI; Medical Research Council [G0500079, G0901245] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059215, R01HD044454] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors gratefully acknowledge the ongoing contribution of the participants in the Twins Early Development Study (TEDS) and their families. TEDS is supported by the UK Medical Research Council [G0901245; and previously G0500079], with additional support from the US National Institutes of Health [HD044454; HD059215]. RP is supported by a Medical Research Council Research Professorship award [G19/2] and a European Research Council Advanced Investigator award [295366].	Arbuckle JL., 1996, ADV STRUCTURAL EQUAT, P243, DOI DOI 10.4324/9781315827414; Bartels M, 2002, BEHAV GENET, V32, P237, DOI 10.1023/A:1019772628912; Calvin C, 2009, INTELLIGENCE, V37, P243, DOI 10.1016/j.intell.2008.12.005; Davis OSP, 2008, INTELLIGENCE, V36, P68, DOI 10.1016/j.intell.2007.01.006; Deary IJ, 2010, INT J EPIDEMIOL, V39, P1362, DOI 10.1093/ije/dyq072; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Fenson L, 2000, APPL PSYCHOLINGUIST, V21, P95, DOI 10.1017/S0142716400001053; Ganjavi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019698; Haier RJ, 2005, NEUROIMAGE, V25, P320, DOI 10.1016/j.neuroimage.2004.11.019; Hanscombe KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030320; Haworth CMA, 2007, TWIN RES HUM GENET, V10, P554, DOI 10.1375/twin.10.4.554; Huang J, 2014, DEVELOPMENTAL SCI, V17, P452, DOI 10.1111/desc.12136; Johnson W, 2004, INTELLIGENCE, V32, P95, DOI 10.1016/S0160-2896(03)00062-X; Johnson W, 2008, INTELLIGENCE, V36, P81, DOI 10.1016/j.intell.2007.06.001; Kaplan E, 1998, WISC 3 PROCESS INSTR; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Lo A, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/591531; McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612; McCarthy D, 1972, MCCARTHY SCALES CHIL; Oliver B, 2002, EARLY CHILD DEV CARE, V172, P337, DOI DOI 10.1080/03004430212713; Petrill SA, 2002, INTELLIGENCE, V30, P353, DOI 10.1016/S0160-2896(02)00087-9; Raven J.C., 1984, LONDON H K LEWIS ITA; Raven JC, 1998, MANUAL RAVENS ADV PR; Saudino KJ, 1998, BRIT J DEV PSYCHOL, V16, P349, DOI 10.1111/j.2044-835X.1998.tb00757.x; Smith P., 2001, COGNITIVE ABILITIES; Walfisch A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003259; Wechsler D., 1992, WECHSLER INTELLIGENC	28	8	8	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138676	10.1371/journal.pone.0138676	http://dx.doi.org/10.1371/journal.pone.0138676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406251	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700068
J	Belkorchia, A; Gasc, C; Polonais, V; Parisot, N; Gallois, N; Ribiere, C; Lerat, E; Gaspin, C; Pombert, JF; Peyret, P; Peyretaillade, E				Belkorchia, Abdel; Gasc, Cyrielle; Polonais, Valerie; Parisot, Nicolas; Gallois, Nicolas; Ribiere, Celine; Lerat, Emmanuelle; Gaspin, Christine; Pombert, Jean-Francois; Peyret, Pierre; Peyretaillade, Eric			The Prediction and Validation of Small CDSs Expand the Gene Repertoire of the Smallest Known Eukaryotic Genomes	PLOS ONE			English	Article							PARASITE ENCEPHALITOZOON-CUNICULI; MULTIPLE SEQUENCE ALIGNMENT; MICROSPORIDIAN GENOME; PROTEINS; PERFORMANCE; ANNOTATION; COMPACTION; ACCURACY; INSIGHTS; REVEALS	The proper prediction of the gene catalogue of an organism is essential to obtain a representative snapshot of its overall lifestyle, especially when it is not amenable to culturing. Microsporidia are obligate intracellular, sometimes hard to culture, eukaryotic parasites known to infect members of every animal phylum. To date, sequencing and annotation of microsporidian genomes have revealed a poor gene complement with highly reduced gene sizes. In the present paper, we investigated whether such gene sizes may have induced biases for the methodologies used for genome annotation, with an emphasis on small coding sequence (CDS) gene prediction. Using better delineated intergenic regions from four Encephalitozoon genomes, we predicted de novo new small CDSs with sizes ranging from 78 to 255 bp (median 168) and corroborated these predictions by RACE-PCR experiments in Encephalitozoon cuniculi. Most of the newly found genes are present in other distantly related microsporidian species, suggesting their biological relevance. The present study provides a better framework for annotating microsporidian genomes and to train and evaluate new computational methods dedicated at detecting ultra-small genes in various organisms.	[Belkorchia, Abdel; Polonais, Valerie] Univ Auvergne, Clermont Univ, Lab Microorganismes Genome & Environm, F-63000 Clermont Ferrand, France; [Belkorchia, Abdel; Polonais, Valerie] CNRS, UMR 6023, LMGE, F-63171 Aubiere, France; [Gasc, Cyrielle; Gallois, Nicolas; Ribiere, Celine; Peyret, Pierre; Peyretaillade, Eric] Univ Auvergne, Clermont Univ, EA CIDAM 4678, F-63001 Clermont Ferrand, France; [Parisot, Nicolas] Univ Lyon, Biol Fonct Insectes & Interact, INRA, INSA Lyon,UMR203 BF21, Villeurbanne, France; [Lerat, Emmanuelle] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Gaspin, Christine] INRA, UBIA UR 875, F-31320 Castanet Tolosan, France; [Pombert, Jean-Francois] IIT, Dept Biol, Chicago, IL 60616 USA	Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; INRAE; Illinois Institute of Technology	Peyret, P (corresponding author), Univ Auvergne, Clermont Univ, EA CIDAM 4678, BP 10448, F-63001 Clermont Ferrand, France.	pierre.peyret@udamail.fr; eric.peyretaillade@udamail.fr	Polonais, Valérie/AAF-9474-2019; Parisot, Nicolas/C-8116-2012; Gallois, Nicolas/HGC-2974-2022; Polonais, Valérie/AAL-4400-2021	Parisot, Nicolas/0000-0001-5217-8415; Polonais, Valérie/0000-0002-2455-4425; Pombert, Jean-Francois/0000-0002-3449-8375; PEYRET, Pierre/0000-0003-3114-0586; LERAT, Emmanuelle/0000-0001-6757-8796; Gallois, Nicolas/0000-0003-4172-8359	Direction Generale de l'Armement (DGA)	Direction Generale de l'Armement (DGA)(General Electric)	N.P. and C.G. were funded by Direction Generale de l'Armement (DGA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000261; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhagwat Medha, 2007, V395, P177; Brent MR, 2008, NAT REV GENET, V9, P62, DOI 10.1038/nrg2220; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Catanzariti AM, 2007, FEMS MICROBIOL LETT, V269, P181, DOI 10.1111/j.1574-6968.2007.00684.x; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; Cheng HY, 2011, CURR PROTEIN PEPT SC, V12, P503, DOI 10.2174/138920311796957667; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1082; Corradi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r106; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Grisdale CJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-207; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heinz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002979; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keeling PJ, 2011, VIRULENCE, V2, P67, DOI 10.4161/viru.2.1.14606; Keeling PJ, 2010, GENOME BIOL EVOL, V2, P304, DOI 10.1093/gbe/evq022; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee Soo Chan, 2009, Commun Integr Biol, V2, P414; McDermott JE, 2011, INFECT IMMUN, V79, P23, DOI 10.1128/IAI.00537-10; McHardy Alice Carolyn, 2008, V452, P163, DOI 10.1007/978-1-60327-159-2_8; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Parisot N, 2014, GENOME BIOL EVOL, V6, P2289, DOI 10.1093/gbe/evu178; Parisot N, 2012, BIOINFORMATICS, V28, P3161, DOI 10.1093/bioinformatics/bts597; Pelin A, 2015, ENVIRON MICROBIOL, V17, P4443, DOI 10.1111/1462-2920.12883; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peyret P, 2001, GENOME RES, V11, P198, DOI 10.1101/gr.164301; Peyretaillade E, 2015, HEREDITY, V114, P441, DOI 10.1038/hdy.2014.78; Peyretaillade E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2156; Peyretaillade E, 2011, RES MICROBIOL, V162, P598, DOI 10.1016/j.resmic.2011.03.004; Peyretaillade E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-607; Polonais V, 2005, FUNGAL GENET BIOL, V42, P791, DOI 10.1016/j.fgb.2005.05.005; Pombert JF, 2015, MBIO, V6, DOI 10.1128/mBio.02400-14; Pombert JF, 2012, P NATL ACAD SCI USA, V109, P12638, DOI 10.1073/pnas.1205020109; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot3944; Selman Mohammed, 2011, Mob Genet Elements, V1, P251; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Texier C, 2010, CURR OPIN MICROBIOL, V13, P443, DOI 10.1016/j.mib.2010.05.005; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Vavra J, 2013, ADV PARASIT, V82, P253, DOI 10.1016/B978-0-12-407706-5.00004-6; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; Washietl S, 2012, WIRES RNA, V3, P759, DOI 10.1002/wrna.1134; Yang XH, 2011, GENOME RES, V21, P634, DOI 10.1101/gr.109280.110	57	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139075	10.1371/journal.pone.0139075	http://dx.doi.org/10.1371/journal.pone.0139075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421846	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700067
J	Cao, WL; Li, LN; Mii, S; Amoh, Y; Liu, F; Hoffman, RM				Cao, Wenluo; Li, Lingna; Mii, Sumiyuki; Amoh, Yasuyuki; Liu, Fang; Hoffman, Robert M.			Extensive Hair-Shaft Elongation by Isolated Mouse Whisker Follicles in Very Long-Term Gelfoam (R) Histoculture	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; GROWTH; REPAIR; CULTURE; SKIN	We have previously studied mouse whisker follicles in Gelfoam (R) histoculture to determine the role of nestin-expressing plutipotent stem cells, located within the follicle, in the growth of the follicular sensory nerve. Long-term Gelfoam (R) whisker histoculture enabled hair follicle nestin-expressing stem cells to promote the extensive elongation of the whisker sensory nerve, which contained axon fibers. Transgenic mice in which the nestin promoter drives green fluorescent protein (ND-GFP) were used as the source of the whiskers allowing imaging of the nestin-expressing stem cells as they formed the follicular sensory nerve. In the present report, we show that Gelfoam (R)-histocultured whisker follicles produced growing pigmented and unpigmented hair shafts. Hair-shaft length increased rapidly by day-4 and continued growing until at least day-12 after which the hair-shaft length was constant. By day-63 in histoculture, the number of ND-GFP hair follicle stem cells increased significantly and the follicles were intact. The present study shows that Gelfoam (R) histoculture can support extensive hair-shaft growth as well as hair follicle sensory-nerve growth from isolated hair follicles which were maintained over very long periods of time. Gelfoam (R) histoculture of hair follicles can provide a very long-term period for evaluating novel agents to promote hair growth.	[Cao, Wenluo; Li, Lingna; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Cao, Wenluo; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Cao, Wenluo; Liu, Fang] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China; [Amoh, Yasuyuki] Kitasato Univ, Dept Dermatol, Sagamihara, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Naval Medical University; Kitasato University	Liu, F (corresponding author), Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China.	liu_fang403@163.com; all@anticancer.com	Singh, Shree Ram/B-7614-2008	Singh, Shree Ram/0000-0001-6545-583X	National Institute of Neurological Disorders and Stroke [NS086217]; AntiCancer, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS086217] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AntiCancer, Inc.(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurological Disorders and Stroke, grant NS086217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. AntiCancer, Inc., provided support in the form of salaries for authors [LL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; Duong J, 2012, IN VITRO CELL DEV-AN, V48, P301, DOI 10.1007/s11626-012-9514-z; Jo SJ, 2013, J DERMATOL SCI, V72, P16, DOI 10.1016/j.jdermsci.2013.05.007; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; LI LN, 1992, IN VITRO CELL DEV-AN, V28A, P695; LI LN, 1992, P NATL ACAD SCI USA, V89, P8764, DOI 10.1073/pnas.89.18.8764; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; Mii S, 2013, J CELL BIOCHEM, V114, P1674, DOI 10.1002/jcb.24509; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Uchugonova A, 2013, J CELL BIOCHEM, V114, P99, DOI 10.1002/jcb.24305; Yashiro M, 2015, CELL CYCLE, V14, P2362, DOI 10.1080/15384101.2015.1042633	13	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138005	10.1371/journal.pone.0138005	http://dx.doi.org/10.1371/journal.pone.0138005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421923	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700026
J	Caetano-Anolles, K; Seo, M; Rodriguez-Zas, S; Oh, JD; Han, JY; Lee, K; Park, TS; Shin, S; Jiao, ZJ; Ghosh, M; Jeong, DK; Cho, S; Kim, H; Song, KD; Lee, HK				Caetano-Anolles, Kelsey; Seo, Minseok; Rodriguez-Zas, Sandra; Oh, Jae-Don; Han, Jae Yong; Lee, Kichoon; Park, Tae Sub; Shin, Sangsu; Jiao, Zhang Jiao; Ghosh, Mrinmoy; Jeong, Dong Kee; Cho, Seoae; Kim, Heebal; Song, Ki-Duk; Lee, Hak-Kyo			Comprehensive Identification of Sexual Dimorphism-Associated Differentially Expressed Genes in Two-Way Factorial Designed RNA-Seq Data on Japanese Quail (Coturnix coturnix japonica)	PLOS ONE			English	Article							Z-CHROMOSOME; GENERATION; ALIGNMENT; BRAIN; BIRDS; LPA	Japanese quail (Coturnix coturnix japonica) reach sexual maturity earlier, breed rapidly and successfully, and cost less and require less space than other birds raised commercially. Given the value of this species for food production and experimental use, more studies are necessary to determine chromosomal regions and genes associated with gender and breed-differentiation. This study employed Trinity and edgeR for transcriptome analysis of next-generation RNA-seq data, which included 4 tissues obtained from 3 different breeding lines of Japanese quail (random bred control, heavy weight, low weight). Differentially expressed genes shared between female and male tissue contrast groups were analyzed to identify genes related to sexual dimorphism as well as potential novel candidate genes for molecular sexing. Several of the genes identified in the present study as significant sex-related genes have been previously found in avian gene expression analyses (NIPBL, UBAP2), and other genes found differentially expressed in this study and not previously associated with sex-related differences may be considered potential candidates for molecular sexing (TERA, MYP0, PPR17, CASQ2). Additionally, other genes likely associated with neuronal and brain development (CHKA, NYAP), as well as body development and size differentiation (ANKRD26, GRP87) in quail were identified. Expression of homeobox protein regulating genes (HXC4, ISL1) shared between our two sex-related contrast groups (Female Brain vs. Male Brain and Ovary vs. Testis) indicates that these genes may regulate sex-specific anatomical development. Results reveal genetic features of the quail breed and could allow for more effective molecular sexing as well as selective breeding for traits important in commercial production.	[Caetano-Anolles, Kelsey; Rodriguez-Zas, Sandra] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Seo, Minseok; Kim, Heebal] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul 151741, South Korea; [Oh, Jae-Don; Song, Ki-Duk; Lee, Hak-Kyo] Chonbuk Natl Univ, Dept Anim Biotechnol, Jeonju 561756, South Korea; [Han, Jae Yong; Park, Tae Sub; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Han, Jae Yong; Park, Tae Sub; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Lee, Kichoon] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Shin, Sangsu] Kyungpook Natl Univ, Fac Anim Sci & Biotechnol, Sangju 37224, South Korea; [Jiao, Zhang Jiao; Ghosh, Mrinmoy; Jeong, Dong Kee] Jeju Natl Univ, Fac Biotechnol, Dept Anim Biotechnol, Jeju 690756, South Korea; [Cho, Seoae; Kim, Heebal] Seoul Natl Univ, CHO & KIM Genom, Seoul 151919, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; Seoul National University (SNU); Jeonbuk National University; Seoul National University (SNU); Seoul National University (SNU); University System of Ohio; Ohio State University; Kyungpook National University; Jeju National University; Seoul National University (SNU)	Song, KD (corresponding author), Chonbuk Natl Univ, Dept Anim Biotechnol, Jeonju 561756, South Korea.	kiduk.song@gmail.com; breedlee@empas.com	Ghosh, Mrinmoy/ABB-4479-2021; Lee, Kichoon/G-2234-2012; Zhang, Jiao Jiao/V-8705-2018; Kim, Heebal/A-8889-2016	Zhang, Jiao Jiao/0000-0002-2699-6729; Kim, Heebal/0000-0003-3064-1303; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Caetano-Anolles, Kelsey/0000-0001-6310-6679; Ghosh, Mrinmoy/0000-0001-6817-622X	Next-Generation BioGreen 21 Program [PJ01104401]; Rural Development Administration, Republic of Korea; Achievement Rewards for College Scientists (ARCS) Foundation; National Science Foundation (NSF) [IIA-1415113]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Achievement Rewards for College Scientists (ARCS) Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ01104401), Rural Development Administration, Republic of Korea, the Achievement Rewards for College Scientists (ARCS) Foundation to KC, and the National Science Foundation (NSF) under Grant No IIA-1415113 to KC.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bera TK, 2008, P NATL ACAD SCI USA, V105, P270, DOI 10.1073/pnas.0710978105; Blackburn J, 2012, BONE, V50, P756, DOI 10.1016/j.bone.2011.12.002; Blaise S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-19; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen Y., 2014, DIFFERENTIAL EXPRESS; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Cui HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-213; Dawson DA, 2001, MOL ECOL NOTES, V1, P201, DOI 10.1046/j.1471-8278.2001.00060.x; Delfino KR, 2010, NEUROPEPTIDES, V44, P31, DOI 10.1016/j.npep.2009.11.002; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Ellegren H, 2001, EMBO REP, V2, P192, DOI 10.1093/embo-reports/kve050; Gat-Viks I, 2003, BIOINFORMATICS, V19, P2381, DOI 10.1093/bioinformatics/btg330; GOZES I, 1989, J MOL NEUROSCI, V1, P55, DOI 10.1007/BF02896857; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hinshaw W, 1969, COTURNIX COTURNIX CO; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kawahara-Miki R, 2013, GENOMICS, V101, P345, DOI 10.1016/j.ygeno.2013.03.006; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; LAM KSL, 1990, BRAIN RES, V526, P135, DOI 10.1016/0006-8993(90)90259-E; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SI, 2009, POULTRY SCI, V88, P1003, DOI 10.3382/ps.2008-00197; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu XF, 2009, APOPTOSIS, V14, P1237, DOI 10.1007/s10495-009-0392-0; Lovmar L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-35; Maechler M, 2012, CLUSTER CLUSTER ANAL, V1; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mills A, 1994, P 9 EUR POULTR C GLA; Nadeau N, 2008, GENETICS, V178, P777, DOI 10.1534/genetics.107.077073; Nam K, 2008, GENETICS, V180, P1131, DOI 10.1534/genetics.108.090324; Paoletti L, 2011, IUBMB LIFE, V63, P714, DOI 10.1002/iub.521; Rawat A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S13; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Suh A, 2011, MOL BIOL EVOL, V28, P2993, DOI 10.1093/molbev/msr147; TOUART L, 2003, REVISED DRAFT DETAIL; Wahlberg P, 2007, CYTOGENET GENOME RES, V117, P22, DOI 10.1159/000103161; WILSON WO, 1961, POULTRY SCI, V40, P651, DOI 10.3382/ps.0400651; WILSON WO, 1971, CALIF AGR, V25, P5; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Yokoyama K, 2011, EMBO J, V30, P4739, DOI 10.1038/emboj.2011.348	43	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139324	10.1371/journal.pone.0139324	http://dx.doi.org/10.1371/journal.pone.0139324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418419	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400077
J	Fitterer, JL; Nelson, TA				Fitterer, Jessica L.; Nelson, Trisalyn A.			A Review of the Statistical and Quantitative Methods Used to Study Alcohol-Attributable Crime	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; EXTENDED DRINKING HOURS; LATER TRADING HOURS; TIME-SERIES ANALYSIS; OUTLET DENSITY; INTERPERSONAL VIOLENCE; LONGITUDINAL ANALYSIS; ASSAULTIVE VIOLENCE; MULTILEVEL ANALYSIS; LICENSED PREMISES	Modelling the relationship between alcohol consumption and crime generates new knowledge for crime prevention strategies. Advances in data, particularly data with spatial and temporal attributes, have led to a growing suite of applied methods for modelling. In support of alcohol and crime researchers we synthesized and critiqued existing methods of spatially and quantitatively modelling the effects of alcohol exposure on crime to aid method selection, and identify new opportunities for analysis strategies. We searched the alcohol-crime literature from 1950 to January 2014. Analyses that statistically evaluated or mapped the association between alcohol and crime were included. For modelling purposes, crime data were most often derived from generalized police reports, aggregated to large spatial units such as census tracts or postal codes, and standardized by residential population data. Sixty-eight of the 90 selected studies included geospatial data of which 48 used cross-sectional datasets. Regression was the prominent modelling choice (n = 78) though dependent on data many variations existed. There are opportunities to improve information for alcohol-attributable crime prevention by using alternative population data to standardize crime rates, sourcing crime information from non-traditional platforms (social media), increasing the number of panel studies, and conducting analysis at the local level (neighbourhood, block, or point). Due to the spatio-temporal advances in crime data, we expect a continued uptake of flexible Bayesian hierarchical modelling, a greater inclusion of spatial-temporal point pattern analysis, and shift toward prospective (forecast) modelling over small areas (e.g., blocks).	[Fitterer, Jessica L.; Nelson, Trisalyn A.] Univ Victoria, Dept Geog, Spatial Pattern Anal & Res Lab, Victoria, BC, Canada	University of Victoria	Fitterer, JL (corresponding author), Univ Victoria, Dept Geog, Spatial Pattern Anal & Res Lab, Victoria, BC, Canada.	jessyka@uvic.ca		Nelson, Trisalyn/0000-0003-2537-6971	Social Science and Humanities Research Council (SSHRC) doctoral fellowship [752-2014-1015]	Social Science and Humanities Research Council (SSHRC) doctoral fellowship	This work was funded in part by a Social Science and Humanities Research Council (SSHRC) doctoral fellowship (752-2014-1015) awarded to Jessica Fitterer.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 2009, SAGE HDB SPATIAL ANA, P255, DOI [DOI 10.4135/9780857020130.N14, 10.4135/9780857020130]; Anselin L, 1989, WHAT IS SPECIAL SPAT; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Biderman C, 2010, ECON J, V120, P157, DOI 10.1111/j.1468-0297.2009.02299.x; Bloomfield K, 2009, EUR ADDICT RES, V15, P224, DOI 10.1159/000239416; Borges G, 1998, ADDICTION, V93, P103, DOI 10.1046/j.1360-0443.1998.93110310.x; Braga A. A., 2005, J EXEPERIMENTAL CRIM, V1, P317, DOI [10.1007/s11292-005-8133-z, DOI 10.1007/S11292-005-8133-Z]; Breen C, 2011, ALCOHOL ALCOHOLISM, V46, P464, DOI 10.1093/alcalc/agr040; Briscoe S, 2003, AUST NZ J CRIMINOL, V36, P18; Britt HR, 2005, ENVIRON ECOL STAT, V12, P411, DOI 10.1007/s10651-005-1518-3; Brower AM, 2002, J AM COLL HEALTH, V55, P267; Burke JG, 2005, QUAL HEALTH RES, V15, P1392, DOI 10.1177/1049732305278876; Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028; Cargo M, 2008, ANNU REV PUBL HEALTH, V29, P325, DOI 10.1146/annurev.publhealth.29.091307.083824; Cheng T, 2014, GEOGR ANAL, V46, P75, DOI 10.1111/gean.12026; Chikritzhs T, 2002, J STUD ALCOHOL, V63, P591, DOI 10.15288/jsa.2002.63.591; Chikritzhs T, 2007, ADDICTION, V102, P1609, DOI 10.1111/j.1360-0443.2007.01981.x; Chikritzhs T, 2006, ADDICTION, V101, P1254, DOI 10.1111/j.1360-0443.2006.01487.x; Clark T. S., 2012, SHOULD I USE FIXED R, P1; Cliff A. D., 1981, SPATIAL PROCESSES MO; Connor JL, 2011, J EPIDEMIOL COMMUN H, V65, P841, DOI 10.1136/jech.2009.104935; Conrow L, 2015, APPL GEOGR, V58, P198, DOI 10.1016/j.apgeog.2015.02.006; Cook PJ, 2013, J HEALTH ECON, V32, P261, DOI 10.1016/j.jhealeco.2012.11.003; Costanza C. E., 2001, J CRIME JUSTICE, V24, P71, DOI DOI 10.1080/0735648X.2001.9721617; Cunradi CB, 2012, ALCOHOL CLIN EXP RES, V36, P847, DOI 10.1111/j.1530-0277.2011.01683.x; Cunradi CB, 2011, J URBAN HEALTH, V88, P191, DOI 10.1007/s11524-011-9549-6; Day P, 2012, AUST NZ J PUBL HEAL, V36, P48, DOI 10.1111/j.1753-6405.2012.00827.x; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Douglas M, 1998, AUST NZ J PUBL HEAL, V22, P714, DOI 10.1111/j.1467-842X.1998.tb01476.x; Duailibi S, 2007, AM J PUBLIC HEALTH, V97, P2276, DOI 10.2105/AJPH.2006.092684; El-Maaytah M, 2008, BRIT J ORAL MAX SURG, V46, P460, DOI 10.1016/j.bjoms.2008.01.018; Erickson DJ, 2013, PREV SCI; Felson RB, 2010, CRIM JUSTICE BEHAV, V37, P1343, DOI 10.1177/0093854810382003; Fotheringham AS, 2009, SAGE HDB SPATIAL ANA, P511; Franklin FA, 2010, WEST J EMERG MED, V11, P283; Freisthler B, 2004, J STUD ALCOHOL, V65, P586, DOI 10.15288/jsa.2004.65.586; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Garson, 2013, HIERARCHICAL LINEAR; GERSON LW, 1979, J STUD ALCOHOL, V40, P307, DOI 10.15288/jsa.1979.40.307; Getis A., 2010, HDB APPL SPATIAL ANA, P461, DOI [10.1007/978-3-642-03647-7_22, DOI 10.1007/978-3-642-03647-7_22]; Gorman DM, 2013, GEOJOURNAL, V78, P417, DOI 10.1007/s10708-011-9425-7; Gorman DM, 2005, DRUG ALCOHOL REV, V24, P507, DOI 10.1080/09595230500292946; Gorman DM, 1998, AM J DRUG ALCOHOL AB, V24, P661, DOI 10.3109/00952999809019615; Gorman DM, 1998, AM J PUBLIC HEALTH, V88, P97, DOI 10.2105/AJPH.88.1.97; Gorman DM, 2001, J STUD ALCOHOL, V62, P628, DOI 10.15288/jsa.2001.62.628; Graham CA, 1998, J ACCID EMERG MED, V15, P23; Grubesic TH, 2013, ALCOHOL ALCOHOLISM, V48, P613, DOI 10.1093/alcalc/agt055; Grubesic TH, 2012, SOC SCI RES, V41, P92, DOI 10.1016/j.ssresearch.2011.07.004; Grubesic TH, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-30; Gruenewald PJ, 2007, ADDICTION, V102, P870, DOI 10.1111/j.1360-0443.2007.01856.x; Gruenewald PJ, 2006, ALCOHOL CLIN EXP RES, V30, P1184, DOI 10.1111/j.1530-0277.2006.00141.x; Gruenewald PJ, 2006, ADDICTION, V101, P666, DOI 10.1111/j.1360-0443.2006.01405.x; Gruenewald PJ, 2002, J STUD ALCOHOL, V63, P460, DOI 10.15288/jsa.2002.63.460; Gruenewald PJ, 1996, ADDICTION, V91, P967, DOI 10.1111/j.1360-0443.1996.tb03594.x; Gustafsson NKJ, 2011, INT J EPIDEMIOL, V40, P432, DOI 10.1093/ije/dyq153; Gyimah-Brempong K, 2001, SOUTHERN ECON J, V68, P2, DOI 10.2307/1061508; Herttua K, 2008, J EPIDEMIOL COMMUN H, V62, P995, DOI 10.1136/jech.2007.069575; Iritani BJ, 2013, J FAM VIOLENCE, V28, P459, DOI 10.1007/s10896-013-9516-y; Jackson CK, 2011, J PUBLIC ECON, V95, P106, DOI 10.1016/j.jpubeco.2010.09.010; Jennings JM, 2013, J URBAN HLTH; Johnson SD, 2004, BRIT J CRIMINOL, V44, P55, DOI 10.1093/bjc/44.1.55; Kent J, 2006, COMPUT ENVIRON URBAN, V30, P181, DOI 10.1016/j.compenvurbsys.2004.10.002; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kypri K, 2008, ADDICTION, V103, P1131, DOI 10.1111/j.1360-0443.2008.02239.x; Kypri K, 2011, ADDICTION, V106, P303, DOI 10.1111/j.1360-0443.2010.03125.x; Liang WB, 2011, DRUG ALCOHOL REV, V30, P524, DOI 10.1111/j.1465-3362.2010.00281.x; Lipton R, 2002, J STUD ALCOHOL, V63, P187, DOI 10.15288/jsa.2002.63.187; Livingston M, 2008, ADDICTION, V103, P619, DOI 10.1111/j.1360-0443.2008.02136.x; Livingston M, 2007, DRUG ALCOHOL REV, V26, P557, DOI 10.1080/09595230701499191; Livingston M, 2011, DRUG ALCOHOL REV, V30, P515, DOI 10.1111/j.1465-3362.2010.00251.x; Livingston M, 2011, ADDICTION, V106, P919, DOI 10.1111/j.1360-0443.2010.03333.x; Livingston M, 2010, GEOSPATIAL HEALTH, V5, P139, DOI 10.4081/gh.2010.194; Lynch HJ, 2008, CAN J FOREST RES, V38, P3112, DOI 10.1139/X08-143; Macdonald S, 2005, ADDICT BEHAV, V30, P103, DOI 10.1016/j.addbeh.2004.04.016; Mair C, 2013, J STUD ALCOHOL DRUGS, V74, P50, DOI 10.15288/jsad.2013.74.50; Malleson N, 2015, CARTOGR GEOGR INF SC, V42, P112, DOI 10.1080/15230406.2014.905756; Markowitz S, 2000, SOUTHERN ECON J, V67, P279, DOI 10.2307/1061471; Markowitz S, 2005, INT REV LAW ECON, V25, P20, DOI 10.1016/j.irle.2005.05.003; Markowitz S, 2000, J HEALTH ECON, V19, P271, DOI 10.1016/S0167-6296(99)00025-9; Markowitz S, 2012, GER ECON REV, V13, P416, DOI [10.3386/w17918, 10.1111/j.1468-0475.2012.00574.x]; Matthews K, 2006, APPL ECON, V38, P661, DOI 10.1080/00036840500397341; Mazerolle L, 2012, LAW POLICY, V34, P55, DOI 10.1111/j.1467-9930.2011.00353.x; McKinney CM, 2009, ALCOHOL CLIN EXP RES, V33, P169, DOI 10.1111/j.1530-0277.2008.00825.x; McMillan GP, 2007, ACCIDENT ANAL PREV, V39, P252, DOI 10.1016/j.aap.2006.07.012; Miller P, 2012, DRUG ALCOHOL REV, V31, P370, DOI 10.1111/j.1465-3362.2011.00375.x; Mumola BCJ, 1999, 172871 BUR JUST STAT; Myrstol BA, 2012, POLICING, V35, P55, DOI 10.1108/13639511211215450; National Institute of Alcohol Abuse and Alcoholism, DRINK LEV DEF; Newton A, 2009, CRIME PREV COMMUNITY, V11, P171, DOI 10.1057/cpcs.2009.12; Nielsen AL, 2005, SOCIOL QUART, V46, P479, DOI 10.1111/j.1533-8525.2005.00023.x; Nielsen AL, 2006, JUSTICE Q, V20, P37, DOI DOI 10.1080/07418820300095581; Norstrom T, 2005, DRUG ALCOHOL REV, V24, P537, DOI 10.1080/09595230500293845; Norstrom T, 2003, J STUD ALCOHOL, V64, P393, DOI 10.15288/jsa.2003.64.393; Norstrom T, 2000, J STUD ALCOHOL, V61, P907, DOI 10.15288/jsa.2000.61.907; O'Leary M, 2011, CITYSCAPE, V13, P161; Parker RN, 2011, DRUG ALCOHOL REV, V30, P505, DOI 10.1111/j.1465-3362.2011.00336.x; Plant Moira, 2000, Subst Abus, V21, P265; Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Pridemore WA, 2012, BRIT J SOCIOL, V63, P680, DOI 10.1111/j.1468-4446.2012.01432.x; Pridemore WA, 2012, DRUG ALCOHOL REV, V31, P385, DOI 10.1111/j.1465-3362.2011.00329.x; Ratcliffe JH, 2008, SECUR J, V21, P58, DOI 10.1057/palgrave.sj.8350068; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Reid RJ, 2003, SUBST USE MISUSE, V38, P1971, DOI 10.1081/JA-120025122; Resko SM, 2010, AM J COMMUN PSYCHOL, V46, P253, DOI 10.1007/s10464-010-9353-6; Robertson C, 2010, SPAT SPATIO-TEMPORAL, V1, P105, DOI 10.1016/j.sste.2009.12.001; Rossow I, 2012, ADDICTION, V107, P530, DOI 10.1111/j.1360-0443.2011.03643.x; Sanchez AI, 2011, INT J EPIDEMIOL, V40, P1037, DOI 10.1093/ije/dyr051; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Schofield TP, 2013, ALCOHOL ALCOHOLISM, V48, P363, DOI 10.1093/alcalc/agt003; Scribner R, 1999, J STUD ALCOHOL, V60, P310, DOI 10.15288/jsa.1999.60.310; Scribner RA, 2010, J STUD ALCOHOL DRUGS, V71, P184, DOI 10.15288/jsad.2010.71.184; Sivarajasingam V, 2006, INJURY, V37, P388, DOI 10.1016/j.injury.2006.01.035; Son CH, 2011, EUR J HEALTH ECON, V12, P103, DOI 10.1007/s10198-010-0231-9; Speer PW, 1998, J PUBLIC HEALTH POL, V19, P303, DOI 10.2307/3343538; Spicer V, 2012, COMPUT ENVIRON URBAN, V36, P412, DOI 10.1016/j.compenvurbsys.2012.02.004; SRIDHARAN S., 2003, INTERVENTION TIME SE; Stevenson RJ, 1999, ADDICTION, V94, P397, DOI 10.1046/j.1360-0443.1999.9433979.x; Stockwell T, 2002, J STUD ALCOHOL, V63, P372, DOI 10.15288/jsa.2002.63.372; Stockwell T, 2009, CRIME PREV COMMUNITY, V11, P153, DOI 10.1057/cpcs.2009.11; Sun F., 2002, PROPORTIONS CRIMES A; Toomey TL, 2012, ALCOHOL CLIN EXP RES, V36, P1468, DOI 10.1111/j.1530-0277.2012.01753.x; Toomey TL, 2012, J STUD ALCOHOL DRUGS, V73, P21, DOI 10.15288/jsad.2012.73.21; Treno AJ, 2003, ALCOHOL CLIN EXP RES, V27, P835, DOI 10.1097/01.ALC.0000067979.85714.22; Treno AJ, 2007, ACCIDENT ANAL PREV, V39, P894, DOI 10.1016/j.aap.2006.12.011; Vingilis E, 2006, ACCIDENT ANAL PREV, V38, P63, DOI 10.1016/j.aap.2005.06.023; Vingilis E, 2005, ACCIDENT ANAL PREV, V37, P549, DOI 10.1016/j.aap.2004.05.006; Vingilis E, 2007, J STUD ALCOHOL DRUGS, V68, P905, DOI 10.15288/jsad.2007.68.905; Vingilis E, 2008, TRAFFIC INJ PREV, V9, P527, DOI 10.1080/15389580802344788; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Waller MW, 2012, J INTERPERS VIOLENCE, V27, P2062, DOI 10.1177/0886260511431435; Waller MW, 2013, VIOLENCE VICTIMS, V27, P1, DOI DOI 10.1891/0886-6708.27.4.527; Watt K, 2004, ADDICTION, V99, P1262, DOI 10.1111/j.1360-0443.2004.00823.x; Wechsler H, 2002, SOC SCI MED, V55, P425, DOI 10.1016/S0277-9536(01)00259-3; Wheeler DC, 2009, J GEOGR SYST, V11, P1, DOI 10.1007/s10109-008-0073-5; White GF, 2012, CRIME DELINQ; Wilkinson C, 2012, DRUG ALCOHOL REV, V31, P394, DOI 10.1111/j.1465-3362.2011.00346.x; World Health Organization, 2011, GLOB STAT REP ALC HL; Yu Q, 2010, GEOSPAT HLTH, V2, P161, DOI [10.4081/gh.2008.240, DOI 10.4081/GH.2008.240]; Yu QZ, 2009, STAT MED, V28, P1896, DOI 10.1002/sim.3600; Zhu L, 2004, ALCOHOL ALCOHOLISM, V39, P369, DOI 10.1093/alcalc/agh062	143	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139344	10.1371/journal.pone.0139344	http://dx.doi.org/10.1371/journal.pone.0139344			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418016	Green Published, gold			2022-12-27	WOS:000362171400081
J	Han, QJ; Witschey, WRT; Fang-Yen, CM; Arkles, JS; Barker, AJ; Forfia, PR; Han, YC				Han, Q. Joyce; Witschey, Walter R. T.; Fang-Yen, Christopher M.; Arkles, Jeffrey S.; Barker, Alex J.; Forfia, Paul R.; Han, Yuchi			Altered Right Ventricular Kinetic Energy Work Density and Viscous Energy Dissipation in Patients with Pulmonary Arterial Hypertension: A Pilot Study Using 4D Flow MRI	PLOS ONE			English	Article							WALL SHEAR-STRESS; BLOOD-FLOW; VALVE MOTION; QUANTIFICATION; REPRODUCIBILITY; MASS; PHYSIOLOGY; VORTICES; PATTERNS; VOLUMES	Introduction Right ventricular (RV) function has increasingly being recognized as an important predictor for morbidity and mortality in patients with pulmonary arterial hypertension (PAH). The increased RV after-load increase RV work in PAH. We used time-resolved 3D phase contrast MRI (4D flow MRI) to derive RV kinetic energy (KE) work density and energy loss in the pulmonary artery (PA) to better characterize RV work in PAH patients. Methods 4D flow and standard cardiac cine images were obtained in ten functional class I/II patients with PAH and nine healthy subjects. For each individual, we calculated the RV KE work density and the amount of viscous dissipation in the PA. Results PAH patients had alterations in flow patterns in both the RV and the PA compared to healthy subjects. PAH subjects had significantly higher RV KE work density than healthy subjects (94.7 +/- 33.7 mJ/mL vs. 61.7 +/- 14.8 mJ/mL, p = 0.007) as well as a much greater percent PA energy loss (21.1 +/- 6.4% vs. 2.2 +/- 1.3%, p = 0.0001) throughout the cardiac cycle. RV KE work density and percent PA energy loss had mild and moderate correlations with RV ejection fraction. Conclusion This study has quantified two kinetic energy metrics to assess RV function using 4D flow. RV KE work density and PA viscous energy loss not only distinguished healthy subjects from patients, but also provided distinction amongst PAH patients. These metrics hold promise as imaging markers for RV function.	[Han, Q. Joyce; Han, Yuchi] Univ Penn, Cardiovasc Div, Philadelphia, PA 19104 USA; [Witschey, Walter R. T.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Fang-Yen, Christopher M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Barker, Alex J.] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Arkles, Jeffrey S.; Forfia, Paul R.] Temple Univ, Cardiovasc Div, Philadelphia, PA 19122 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Han, YC (corresponding author), Univ Penn, Cardiovasc Div, Philadelphia, PA 19104 USA.	yuchi.han@uphs.upenn.edu	Han, Q. Joyce/GLR-1652-2022; Barker, Alex J/G-5884-2012; Fang-Yen, Christopher/AAY-9017-2020	Barker, Alex J/0000-0002-6283-9157; Han, Q. Joyce/0000-0001-7089-1767	FOCUS Junior Faculty Award for Research in Women's Cardiovascular Health by Edna G. Kynett Memorial Foundation; Cardiovascular Medical Research and Education Fund	FOCUS Junior Faculty Award for Research in Women's Cardiovascular Health by Edna G. Kynett Memorial Foundation; Cardiovascular Medical Research and Education Fund	The study is funded by FOCUS Junior Faculty Award for Research in Women's Cardiovascular Health funded by the Edna G. Kynett Memorial Foundation (to YH) and the Cardiovascular Medical Research and Education Fund (http://www.ipahresearch.org/)(to YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkles JS, 2011, AM J RESP CRIT CARE, V183, P268, DOI 10.1164/rccm.201004-0601OC; Barker AJ, 2015, MAGN RESON MED, V73, P1904, DOI 10.1002/mrm.25326; Barker AJ, 2014, MAGN RESON MED, V72, P620, DOI 10.1002/mrm.24962; Barker AJ, 2012, CIRC-CARDIOVASC IMAG, V5, P457, DOI 10.1161/CIRCIMAGING.112.973370; Bird R., 2006, WILEY INT EDITION; Bock J., 2007, P 15 ANN M ISMRM; Bolger AF, 2007, J CARDIOVASC MAGN R, V9, P741, DOI 10.1080/10976640701544530; Catalano O, 2007, J CARDIOVASC MED, V8, P807, DOI 10.2459/JCM.0b013e32801105ef; Charonko JJ, 2013, ANN BIOMED ENG, V41, P1049, DOI 10.1007/s10439-013-0755-0; Eriksson J, 2011, AM J PHYSIOL-HEART C, V300, pH2135, DOI 10.1152/ajpheart.00993.2010; Eriksson J, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-9; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Fredriksson AG, 2011, AM J PHYSIOL-HEART C, V301, pH2344, DOI 10.1152/ajpheart.00622.2011; Frydrychowicz A, 2011, INVEST RADIOL, V46, P317, DOI 10.1097/RLI.0b013e3182034fc2; Geiger J, 2011, EUR RADIOL, V21, P1651, DOI 10.1007/s00330-011-2108-4; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Haddad F, 2009, ANESTH ANALG, V108, P407, DOI 10.1213/ane.0b013e31818f8623; Hope MD, 2011, JACC-CARDIOVASC IMAG, V4, P781, DOI 10.1016/j.jcmg.2011.05.004; Kheradvar A, 2012, J AM SOC ECHOCARDIOG, V25, P220, DOI 10.1016/j.echo.2011.10.003; Lee N, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-93; Maceira AM, 2006, EUR HEART J, V27, P2879, DOI 10.1093/eurheartj/ehl336; Markl M, 2011, J MAGN RESON IMAGING, V33, P988, DOI 10.1002/jmri.22519; Nordmeyer S, 2010, J MAGN RESON IMAGING, V32, P677, DOI 10.1002/jmri.22280; Peacock AJ, 2014, CIRC-CARDIOVASC IMAG, V7, P107, DOI 10.1161/CIRCIMAGING.113.000629; Peacock AJ, 2013, EUR RESPIR REV, V22, P526, DOI 10.1183/09059180.00006313; Reiter G, 2015, RADIOLOGY, V275, P71, DOI 10.1148/radiol.14140849; Reiter G, 2008, CIRC-CARDIOVASC IMAG, V1, P23, DOI 10.1161/CIRCIMAGING.108.780247; Reiter U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082212; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Stewart J., 2008, CALCULUS EARLY TRANS, V6th ed.; TAHARA M, 1981, CIRCULATION, V64, P1249, DOI 10.1161/01.CIR.64.6.1249; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Venkatachari AK, 2007, MAGN RESON IMAGING, V25, P101, DOI 10.1016/j.mri.2006.09.027; Vonk-Noordegraaf A, 2013, J AM COLL CARDIOL, V62, pD22, DOI 10.1016/j.jacc.2013.10.027; WEYMAN AE, 1974, CIRCULATION, V50, P905, DOI 10.1161/01.CIR.50.5.905	36	28	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138365	10.1371/journal.pone.0138365	http://dx.doi.org/10.1371/journal.pone.0138365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418553	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400014
J	Nishikawa, S; Toshima, T; Kobayashi, M				Nishikawa, Saori; Toshima, Tamotsu; Kobayashi, Masao			Perceived Parenting Mediates Serotonin Transporter Gene (5-HTTLPR) and Neural System Function during Facial Recognition: A Pilot Study	PLOS ONE			English	Article							DIFFERENTIAL SUSCEPTIBILITY; PREFRONTAL CORTEX; LIFE EVENTS; POLYMORPHISM; AMYGDALA; ASSOCIATION; EMOTION; ACTIVATION; GENOTYPE; DISORDER	This study examined changes in prefrontal oxy-Hb levels measured by NIRS (Near-Infrared Spectroscopy) during a facial-emotion recognition task in healthy adults, testing a mediational/moderational model of these variables. Fifty-three healthy adults (male = 35, female = 18) aged between 22 to 37 years old (mean age = 24.05 years old) provided saliva samples, completed a EMBU questionnaire (Swedish acronym for Egna Minnen Betraffande Uppfostran [ My memories of upbringing]), and participated in a facial-emotion recognition task during NIRS recording. There was a main effect of maternal rejection on RoxH (right frontal activation during an ambiguous task), and a gene x environment (GxE) interaction on RoxH, suggesting that individuals who carry the SL or LL genotype and who endorse greater perceived maternal rejection show less right frontal activation than SL/LL carriers with lower perceived maternal rejection. Finally, perceived parenting style played a mediating role in right frontal activation via the 5-HTTLPR genotype. Early-perceived parenting might influence neural activity in an uncertain situation i.e. rating ambiguous faces among individuals with certain genotypes. This preliminary study makes a small contribution to the mapping of an influence of gene and behaviour on the neural system. More such attempts should be made in order to clarify the links.	[Nishikawa, Saori; Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima, Hiroshima, Japan; [Toshima, Tamotsu] Hiroshima Univ, Grad Sch Educ, Dept Psychol, Higashihiroshima, Hiroshima 724, Japan; [Kobayashi, Masao] Hiroshima Univ, Phoenix Leader Educ Program, Hiroshima, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Nishikawa, S (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima, Hiroshima, Japan.	saolingon@gmail.com; masak@hiroshima-u.ac.jp			Japanese Society for the Promotion of Science [40599213]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by Grant-in-Aid for Young Scientific Research from Japanese Society for the Promotion of Science (40599213); link: http://kaken.nii.ac.jp/d/r/40599213.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DSM 5; Antypa N, 2011, NEUROSCIENCE, V172, P303, DOI 10.1016/j.neuroscience.2010.10.042; Bakermans-Kranenburg MJ, 2008, DEV PSYCHOL, V44, P293, DOI 10.1037/0012-1649.44.1.293; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Briley DA, 2014, PSYCHOL BULL, V140, P1303, DOI 10.1037/a0037091; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Firk C, 2012, SOCIAL COGNITIVE AFF; Gyurak A, 2013, EMOTION, V13, P25, DOI 10.1037/a0029616; Haase CM, 2013, EMOTION, V13, P1068, DOI 10.1037/a0033761; Halliday DWR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094013; Hanson JL, 2013, CHILD DEV, V84, P1566, DOI 10.1111/cdev.12069; Holmes-Smith P, 2000, INTRO STRUCTURAL EQU; Hosokawa M, 2014, PSYCHIAT CLIN NEUROS; IBM Corp, 2013, IBM SPSS STAT WINDOW; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036513; Loggia ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027764; Long HX, 2013, NEUROSCI BULL, V29, P4, DOI 10.1007/s12264-013-1299-x; Ma Y, 2013, CEREB CORTEX; Maki Y, 2013, INT PSYCHOGERIATR, V25, P105, DOI 10.1017/S1041610212001482; Meyer A, 2015, J ABNORM CHILD PSYCH, V43, P821, DOI 10.1007/s10802-014-9918-1; Miu AC, 2012, GENES BRAIN BEHAV, V11, P398, DOI 10.1111/j.1601-183X.2012.00774.x; Moutsiana C, 2014, J CHILD PSYCHOL PSYC, V55, P999, DOI 10.1111/jcpp.12198; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Nakadoi Y, 2012, PSYCHIAT CLIN NEUROS, V66, P26, DOI 10.1111/j.1440-1819.2011.02290.x; Nardi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082192; Nishikawa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047608; Nishikawa S, 2010, J CHILD FAM STUD, V19, P57, DOI 10.1007/s10826-009-9281-y; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Nomura M, 2004, NEUROIMAGE, V21, P352, DOI 10.1016/j.neuroimage.2003.09.021; Olsson A, 2014, SOC COGN AFFECT NEUR; Owens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048482; PERRIS C, 1980, ACTA PSYCHIAT SCAND, V61, P265, DOI 10.1111/j.1600-0447.1980.tb00581.x; Pluess M, 2010, PROG NEURO-PSYCHOPH, V34, P1070, DOI 10.1016/j.pnpbp.2010.05.028; Schardt DM, 2010, NEUROIMAGE, V53, P943, DOI 10.1016/j.neuroimage.2009.11.078; Shibazaki M, 2014, WORLD C FAC EXPR EM; Someya T, 1997, SEISHIN IGAKU, V38, P1065; Szily E, 2008, J NEURAL TRANSM, V115, P819, DOI 10.1007/s00702-008-0029-4; van der Knaap NJF, 2014, J NEUROSCI, V34, P9516, DOI 10.1523/JNEUROSCI.0505-14.2014; van IJzendoorn MH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.73; Wendt J, INT J PSYCH IN PRESS; Williams JR, 2008, WORLD MED J, V54, P120, DOI DOI 10.2471/BLT.08.050955; Yoshida H, 2012, FUK U 68 C PSYCH CHU; Zhang KR, 2009, J AFFECT DISORDERS, V114, P224, DOI 10.1016/j.jad.2008.07.012; Zheng LL, 2011, PSYCHIAT CLIN NEUROS, V65, P648, DOI 10.1111/j.1440-1819.2011.02285.x	49	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0134685	10.1371/journal.pone.0134685	http://dx.doi.org/10.1371/journal.pone.0134685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418317	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400002
J	Hernandez, LMR; Fan, JF; Johnson, MH; de Mejia, EG				Hernandez, Luis M. Real; Fan, Junfeng; Johnson, Michelle H.; de Mejia, Elvira Gonzalez			Berry Phenolic Compounds Increase Expression of Hepatocyte Nuclear Factor-1 alpha (HNF-1 alpha) in Caco-2 and Normal Colon Cells Due to High Affinities with Transcription and Dimerization Domains of HNF-1 alpha	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE IV; GENE-EXPRESSION; IN-VITRO; INHIBIT; INFLAMMATION; MUTATIONS; ENZYMES; BINDING; MODY3	Hepatocyte nuclear factor-1 alpha (HNF-1 alpha) is found in the kidneys, spleen, thymus, testis, skin, and throughout the digestive organs. It has been found to promote the transcription of various proteins involved in the management of type II diabetes, including dipeptidyl peptidase-IV (DPP-IV). Phenolic compounds from berries and citrus fruits are known to inhibit DPP-IV, but have not been tested for their interactions with wild-type HNF-1 alpha. By studying the interactions of compounds from berries and citrus fruits have with HNF-1 alpha, pre-transcriptional mechanisms that inhibit the expression of proteins such as DPP-IV may be elucidated. In this study, the interactions of berry phenolic compounds and citrus flavonoids with the dimerization and transcriptional domains of HNF-1 alpha were characterized using the molecular docking program AutoDock Vina. The anthocyanin delphinidin-3-O-arabinoside had the highest binding affinity for the dimerization domain as a homodimer (-7.2 kcal/mol) and transcription domain (-8.3 kcal/mol) of HNF-1 alpha. Anthocyanins and anthocyanidins had relatively higher affinities than resveratrol and citrus flavonoids for both, the transcription domain and the dimerization domain as a homodimer. The flavonoid flavone had the highest affinity for a single unit of the dimerization domain (-6.5 kcal/mol). Nuclear expression of HNF-1 alpha was measured in Caco-2 and human normal colon cells treated with blueberry and blackberry anthocyanin extracts. All extracts tested increased significantly (P < 0.05) the nuclear expression of HNF-1 alpha in Caco-2 cells by 85.2 to 260% compared to a control. The extracts tested increased significantly (P < 0.02) the nuclear expression of HNF-1 alpha in normal colon cells by 48.6 to 243%. It was confirmed that delphinidin-3-O-glucoside increased by 3-fold nuclear HNF-1 alpha expression in Caco-2 cells (P < 0.05). Anthocyanins significantly increased nuclear HNF-1 alpha expression, suggesting that these compounds might regulate the genes HNF-1 alpha promotes.	[Hernandez, Luis M. Real; de Mejia, Elvira Gonzalez] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Hernandez, Luis M. Real] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Fan, Junfeng] Beijing Forestry Univ, Coll Biosci & Biotechnol, Beijing 100083, Peoples R China; [Johnson, Michelle H.; de Mejia, Elvira Gonzalez] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Beijing Forestry University; University of Illinois System; University of Illinois Urbana-Champaign	de Mejia, EG (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.	edemejia@illinois.edu		Real Hernandez, Luis/0000-0003-1613-6458				Alzaid F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078932; [Anonymous], 2014, R LANG ENV STAT COMP; Armendariz AD, 2009, CURR OPIN LIPIDOL, V20, P106, DOI 10.1097/MOL.0b013e3283295ee9; Bower AM, 2014, J AGR FOOD CHEM, V62, P6147, DOI 10.1021/jf500639f; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chi YI, 2002, MOL CELL, V10, P1129, DOI 10.1016/S1097-2765(02)00704-9; Fan JF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/479505; Galan M, 2011, MOL MED, V17, P256, DOI 10.2119/molmed.2010.00097; Gu N, 2008, CLIN EXP PHARMACOL P, V35, P1433, DOI 10.1111/j.1440-1681.2008.05015.x; Gu N, 2006, BIOCHEM BIOPH RES CO, V346, P1016, DOI 10.1016/j.bbrc.2006.06.010; HANSEN LP, 1993, CURR OPIN GENET DEV, V3, P246, DOI 10.1016/0959-437X(93)90030-S; Jadav P, 2012, BIOORG MED CHEM LETT, V22, P3516, DOI 10.1016/j.bmcl.2012.03.078; Johnson JL, 2011, J MED FOOD, V14, P325, DOI 10.1089/jmf.2010.0310; Johnson MH, 2013, MOL NUTR FOOD RES, V57, P1182, DOI 10.1002/mnfr.201200678; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Luni C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053130; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Brien VP, 2013, J PHARMACOL EXP THER, V347, P181, DOI 10.1124/jpet.113.206359; Parmar HS, 2012, DIABETES RES CLIN PR, V97, P105, DOI 10.1016/j.diabres.2012.02.011; Pedersen KB, 2013, BBA-GENE REGUL MECH, V1829, P1225, DOI 10.1016/j.bbagrm.2013.09.007; Pelletier L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-427; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rose RB, 2000, BIOCHEMISTRY-US, V39, P15062, DOI 10.1021/bi001996t; Rose RB, 2000, NAT STRUCT BIOL, V7, P744; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Sridhar Gumpeny Ramachandra, 2012, Advances in Bioinformatics, V2012, P705435, DOI 10.1155/2012/705435; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Yang YM, 2010, MOLECULES, V15, P6332, DOI 10.3390/molecules15096332	29	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138768	10.1371/journal.pone.0138768	http://dx.doi.org/10.1371/journal.pone.0138768			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413797	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700022
J	Anderson, J; Wysong, M; Estep, D; Besana, G; Kibwana, S; Varallo, J; Sun, K; Lu, E				Anderson, Jean; Wysong, Megan; Estep, Deb; Besana, Giulia; Kibwana, Sharon; Varallo, John; Sun, Kai; Lu, Enriquito			Evaluation of Cervical Cancer Screening Programs in Cote d'Ivoire, Guyana, and Tanzania: Effect of HIV Status	PLOS ONE			English	Article							VISUAL INSPECTION; ACETIC-ACID; HUMAN-PAPILLOMAVIRUS; INFECTED WOMEN; WESTERN KENYA; PREVENTION; LESIONS; ACCEPTABILITY; FEASIBILITY; PREVALENCE	Background HIV infection increases a woman's risk for cervical cancer, and cervical cancer incidence and mortality rates are higher in countries with high HIV prevalence and limited resources for screening. Visual inspection with acetic acid (VIA) allows screening and treatment of cervical lesions in a single-visit approach (SVA), but data on its performance in HIV-infected women are limited. This study's objective was to examine cervical cancer screening using VIA/SVA in programs serving HIV-infected women. Methods A VIA/SVA program with cryotherapy for VIA-positive lesions was implemented in Cote d'Ivoire, Guyana, and Tanzania from 2009 to 2012. The effect of HIV status on VIA positivity and on presence of cryotherapy-eligible lesions was examined using a cross-sectional study design, with Chi-square tests for comparisons and constructed multivariate logistic regression models. A P-value of <0.05 was significant. Findings VIA was performed on 34,921 women, 10% (3,580) were VIA positive; 2,508 (85%) eligible women received cryotherapy during the same visit; only 234 (52%) of those who postponed returned for treatment; 622 (17%) VIA-positive women had lesions too large to be treated with cryotherapy and were referred for excisional treatment. In multivariate analysis-controlling for HIV status, location of the screening clinic, facility location, facility type, and country-compared to HIV-uninfected/unknown women, HIV-infected women had higher odds of being VIA positive (OR 1.95, 95% CI 1.76, 2.16, P<0.0001) and of having large lesions requiring referral (OR 1.93, 95% CI 1.49, 2.51, P<0.0001). Minor treatment complications occurred in 19 of 3,032 (0.63%) women; none required further intervention. Conclusions This study found that compared to HIV-uninfected/unknown women, HIV-infected women had nearly twice the odds of being VIA-positive and to require referral for large lesions. SVA was safe and resulted in significant reductions in loss to follow-up. There is increased need for excisional treatment in countries with high HIV prevalence.	[Anderson, Jean] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Wysong, Megan; Estep, Deb; Kibwana, Sharon; Varallo, John; Lu, Enriquito] Jhpiego, Baltimore, MD USA; [Besana, Giulia] Jhpiego Tanzania, Dar Es Salaam, Tanzania	Johns Hopkins University; Johns Hopkins Medicine; Jhpiego; Jhpiego	Anderson, J (corresponding author), Johns Hopkins Med Inst, Baltimore, MD 21205 USA.	janders@jhmi.edu		Kibwana, Sharon/0000-0002-6344-2303	Cote D'Ivoire: the Centers for Disease Control and Prevention (CDC) [5U2GPS001463 (FOA PS09-904)]	Cote D'Ivoire: the Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding provided by Cote D'Ivoire: the Centers for Disease Control and Prevention (CDC) under the grant number 5U2GPS001463 (FOA PS09-904), "Technical Assistance in the Support of HIV Prevention, Care and Treatment Program in Cote d'Ivoire." Guyana: the generous support of the American people through the United States Agency for International Development (USAID) under the Associate Cooperative Agreement #621-A-00-08-00023-00 (Reference Leader Cooperative Agreement #GHS-A-00-04-00002-00). Tanzania: the generous support of the American people through the United States Agency for International Development (USAID) under Associate Cooperative Agreement #621-A-00-08-00023-00 (Reference Leader Cooperative Agreement #GHS-A-00-04-00002-00). The contents of this paper are the responsibility of Jhpiego and do not necessarily reflect the views of USAID, CDC, or the United States Government.	Adjorlolo-Johnson G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-242; Ahdieh L, 2001, J INFECT DIS, V184, P682, DOI 10.1086/323081; Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Ashraf H, 2003, LANCET, V361, P2209, DOI 10.1016/S0140-6736(03)13788-9; Atashili J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018527; Cervical Cancer Action (CCA), 2012, PROGR CERV CANC PREV; Cronje HS, 2004, INT J GYNECOL OBSTET, V84, P101, DOI 10.1016/j.ijgo.2003.09.009; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; Denny L, 2010, JNCI-J NATL CANCER I, V102, P1557, DOI 10.1093/jnci/djq342; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Ferlay J, 2012, IARC CANCERBASE; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Horo A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-237; Huchko MJ, 2011, INT J GYNECOL OBSTET, V114, P106, DOI 10.1016/j.ijgo.2011.02.009; International Agency for Research on Cancer (IARC) World Health Organization, CERV CANC EST INC MO; Joshi S, 2013, AIDS, V27, P607, DOI 10.1097/QAD.0b013e32835b1041; Kahesa C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-262; Khozaim K, 2014, INT J GYNECOL OBSTET, V124, P12, DOI 10.1016/j.ijgo.2013.06.035; Kupets R, 2011, GYNECOL ONCOL, V120, P63, DOI 10.1016/j.ygyno.2010.09.011; Melnikow J, 1998, OBSTET GYNECOL, V92, P727, DOI 10.1016/S0029-7844(98)00245-2; Moodley JR, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-135; Mwanahamuntu MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074607; Parkin DM, 2002, CA CANC J CLIN, V55; Phongsavan K, 2011, INT J GYNECOL OBSTET, V114, P268, DOI 10.1016/j.ijgo.2011.03.009; Plotkin M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-120; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Sanghvi H, 2008, REPROD HEALTH MATTER, V16, P67, DOI 10.1016/S0968-8080(08)32401-X; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Sherigar B, 2010, ASIAN PAC J CANCER P, V11, P619; UNAIDS, REG COUNTR; UNAIDS, UNAIDS REP GLOB AIDS; WHO, 2012, DEM PROJ 6 AFR COUNT; World Health Organization, 2011, GLOB HLTH SECT STRAT; Yanik EL, 2013, CLIN INFECT DIS, V57, P756, DOI 10.1093/cid/cit369	36	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139242	10.1371/journal.pone.0139242	http://dx.doi.org/10.1371/journal.pone.0139242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405784	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700197
J	Jonas, R; Klusch, A; Schmelz, M; Petersen, M; Carr, RW				Jonas, Robin; Klusch, Andreas; Schmelz, Martin; Petersen, Marlen; Carr, Richard W.			Assessment of TTX-s and TTX-r Action Potential Conduction along Neurites of NGF and GDNF Cultured Porcine DRG Somata	PLOS ONE			English	Article							ROOT GANGLION NEURONS; RESISTANT SODIUM-CHANNELS; INDUCED CALCIUM-RELEASE; RAT SENSORY NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; MEMBRANE-PROPERTIES; NERVE-TERMINALS; CA2+ RELEASE; NA+ CURRENT; C-FIBERS	Nine isoforms of voltage-gated sodium channels (NaV) have been characterized and in excitable tissues they are responsible for the initiation and conduction of action potentials. For primary afferent neurons residing in dorsal root ganglia (DRG), individual neurons may express multiple NaV isoforms extending the neuron's functional capabilities. Since expression of NaV isoforms can be differentially regulated by neurotrophic factors we have examined the functional consequences of exposure to either nerve growth factor (NGF) or glial cell line-derived neurotrophic factor (GDNF) on action potential conduction in outgrowing cultured porcine neurites of DRG neurons. Calcium signals were recorded using the exogenous intensity based calcium indicator Fluo-8 (R), AM. In 94 neurons, calcium signals were conducted along neurites in response to electrical stimulation of the soma. At an image acquisition rate of 25 Hz it was possible to discern calcium transients in response to individual electrical stimuli. The peak amplitude of electrically-evoked calcium signals was limited by the ability of the neuron to follow the stimulus frequency. The stimulus frequency required to evoke a half-maximal calcium response was approximately 3 Hz at room temperature. In 13 of 14 (93%) NGF-responsive neurites, TTX-r NaV isoforms alone were sufficient to support propagated signals. In contrast, calcium signals mediated by TTX-r NaVs were evident in only 4 of 11 (36%) neurites from somata cultured in GDNF. This establishes a basis for assessing action potential signaling using calcium imaging techniques in individual cultured neurites and suggests that, in the pig, afferent nociceptor classes relying on the functional properties of TTX-r NaV isoforms, such as cold-nociceptors, most probably derive from NGF-responsive DRG neurons.	[Jonas, Robin; Klusch, Andreas; Schmelz, Martin; Petersen, Marlen; Carr, Richard W.] Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Carr, RW (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Anesthesiol, Mannheim, Germany.	richard.carr@medma.uni-heidelberg.de	Carr, Richard/GSD-4859-2022; Schmelz, Martin/A-9327-2013; Carr, Richard/AAE-9188-2020	Schmelz, Martin/0000-0002-9736-7241; Carr, Richard/0000-0001-8617-9133; Jonas, Robin/0000-0002-7708-2898	Deutsche Forschungsgemeinschaft [IRTG 1874/1, FR 937/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from Deutsche Forschungsgemeinschaft (IRTG 1874/1, DIAMICOM) to MS and from the Deutsche Forschungsgemeinschaft to RC (FR 937/15-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-32; Benn SC, 2001, J NEUROSCI, V21, P6077, DOI 10.1523/JNEUROSCI.21-16-06077.2001; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Blair NT, 2002, J NEUROSCI, V22, P10277; Blair NT, 2003, J NEUROSCI, V23, P10338; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Campenot RB, 2009, NAT PROTOC, V4, P1869, DOI 10.1038/nprot.2009.210; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cox JJ, 2010, HUM MUTAT, V31, pE1670, DOI 10.1002/humu.21325; De Col R, 2008, J PHYSIOL-LONDON, V586, P1089, DOI 10.1113/jphysiol.2007.145383; Dib-Hajj SD, 1998, J NEUROPHYSIOL, V79, P2668, DOI 10.1152/jn.1998.79.5.2668; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Fang X, 2002, J NEUROSCI, V22, P7425; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Farrag KJ, 2002, BRIT J PHARMACOL, V135, P1449, DOI 10.1038/sj.bjp.0704607; Fjell J, 1999, MOL BRAIN RES, V67, P267, DOI 10.1016/S0169-328X(99)00070-4; Gold MS, 1998, J NEUROSCI, V18, P10345; Gover TD, 2003, J NEUROSCI, V23, P4793; Gover TD, 2007, J PHYSIOL-LONDON, V578, P481, DOI 10.1113/jphysiol.2006.119008; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; JEFTINIJA S, 1994, BRAIN RES, V639, P125, DOI 10.1016/0006-8993(94)91772-8; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Klusch A, 2013, J INVEST DERMATOL, V133, P1387, DOI 10.1038/jid.2012.471; Liu M, 2003, J BIOL CHEM, V278, P5462, DOI 10.1074/jbc.M209111200; Lu SG, 2006, J PHYSIOL-LONDON, V577, P169, DOI 10.1113/jphysiol.2006.116418; Molliver DC, 2005, PAIN, V113, P277, DOI 10.1016/j.pain.2004.10.025; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Muroi Y, 2011, J PHYSIOL-LONDON, V589, P5663, DOI 10.1113/jphysiol.2011.215384; Obreja O, 2008, EUR J PAIN, V12, P775, DOI 10.1016/j.ejpain.2007.11.010; Obreja O, 2012, ANESTH ANALG, V115, P560, DOI 10.1213/ANE.0b013e3182542843; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Persson AK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-84; Petersen M, 1996, NEUROSCIENCE, V75, P495, DOI 10.1016/0306-4522(96)00259-X; Pinto V, 2008, J NEUROPHYSIOL, V99, P617, DOI 10.1152/jn.00944.2007; Pristera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040079; QUASTHOFF S, 1995, NEUROSCIENCE, V69, P955, DOI 10.1016/0306-4522(95)00307-5; Ramirez JD, 2014, NEUROLOGY, V83, P1577, DOI 10.1212/WNL.0000000000000913; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Shmigol A, 1995, J PHYSIOL-LONDON, V489, P627, DOI 10.1113/jphysiol.1995.sp021078; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Solovyova N, 2002, EMBO J, V21, P622, DOI 10.1093/emboj/21.4.622; Steffens H, 2001, NEUROSCI RES, V39, P413, DOI 10.1016/S0168-0102(01)00198-5; Stucky CL, 1999, J NEUROSCI, V19, P6497; USACHEV Y, 1993, NEUROSCIENCE, V57, P845, DOI 10.1016/0306-4522(93)90029-F; Usachev YM, 1997, J NEUROSCI, V17, P7404; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Usoskin D, 2010, P NATL ACAD SCI USA, V107, P16336, DOI 10.1073/pnas.0914705107; Vasylyev DV, 2012, J NEUROPHYSIOL, V108, P729, DOI 10.1152/jn.00091.2012; Villiere V, 1996, J NEUROPHYSIOL, V76, P1924, DOI 10.1152/jn.1996.76.3.1924; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; Wu ZZ, 2004, BRAIN RES, V1029, P251, DOI 10.1016/j.brainres.2004.09.051; YOSHIDA S, 1979, J NEUROPHYSIOL, V42, P1134, DOI 10.1152/jn.1979.42.4.1134; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	62	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139107	10.1371/journal.pone.0139107	http://dx.doi.org/10.1371/journal.pone.0139107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407014	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700173
J	Lagergren, K; Ek, WE; Levine, D; Chow, WH; Bernstein, L; Casson, AG; Risch, HA; Shaheen, NJ; Bird, NC; Reid, BJ; Corley, DA; Hardie, LJ; Wu, AH; Fitzgerald, RC; Pharoah, P; Caldas, C; Romero, Y; Vaughan, TL; MacGregor, S; Whiteman, D; Westberg, L; Nyren, O; Lagergren, J				Lagergren, Katarina; Ek, Weronica E.; Levine, David; Chow, Wong-Ho; Bernstein, Leslie; Casson, Alan G.; Risch, Harvey A.; Shaheen, Nicholas J.; Bird, Nigel C.; Reid, Brian J.; Corley, Douglas A.; Hardie, Laura J.; Wu, Anna H.; Fitzgerald, Rebecca C.; Pharoah, Paul; Caldas, Carlos; Romero, Yvonne; Vaughan, Thomas L.; MacGregor, Stuart; Whiteman, David; Westberg, Lars; Nyren, Olof; Lagergren, Jesper			Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium	PLOS ONE			English	Article							RECEPTOR GENE; GASTROESOPHAGEAL-REFLUX; ESR1 GENE; ASSOCIATION; CANCER; CARCINOMA; PROLIFERATION; VARIABILITY; VARIANTS; BEHAVIOR	Background The strong male predominance in oesophageal adenocarcinoma (OAC) and Barrett's oesophagus (BO) continues to puzzle. Hormonal influence, e.g. oestrogen or oxytocin, might contribute. Methods This genetic-epidemiological study pooled 14 studies from three continents, Australia, Europe, and North America. Polymorphisms in 3 key genes coding for the oestrogen pathway (receptor alpha (ESR1), receptor beta (ESR2), and aromatase (CYP19A1)), and 3 key genes of the oxytocin pathway (the oxytocin receptor (OXTR), oxytocin protein (OXT), and cyclic ADP ribose hydrolase glycoprotein (CD38)), were analysed using a gene-based approach, versatile gene-based test association study (VEGAS). Results Among 1508 OAC patients, 2383 BO patients, and 2170 controls, genetic variants within ESR1 were associated with BO in males (p = 0.0058) and an increased risk of OAC and BO combined in males (p = 0.0023). Genetic variants within OXTR were associated with an increased risk of BO in both sexes combined (p = 0.0035) and in males (p = 0.0012). We followed up these suggestive findings in a further smaller data set, but found no replication. There were no significant associations between the other 4 genes studied and risk of OAC, BO, separately on in combination, in males and females combined or in males only. Conclusion Genetic variants in the oestrogen receptor alpha and the oxytocin receptor may be associated with an increased risk of BO or OAC, but replication in other large samples are needed.	[Lagergren, Katarina; Lagergren, Jesper] Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden; [Ek, Weronica E.; MacGregor, Stuart] QIMR Berghofer Med Res Inst, Stat Genet, Herston, Qld, Australia; [Ek, Weronica E.] Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Levine, David] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chow, Wong-Ho] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Bernstein, Leslie] Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Bernstein, Leslie] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Risch, Harvey A.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Shaheen, Nicholas J.] Univ N Carolina, UNC Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Bird, Nigel C.] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Corley, Douglas A.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Hardie, Laura J.] Univ Leeds, Div Epidemiol, Leeds, W Yorkshire, England; [Wu, Anna H.] Univ So Calif, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Fitzgerald, Rebecca C.] Univ Cambridge, Hutchison MRC Res Ctr, Canc Unit, Med Res Council MRC, Cambridge, England; [Pharoah, Paul] Univ Cambridge, Dept Publ Hlth, Cambridge, England; [Caldas, Carlos] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Romero, Yvonne] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Whiteman, David] Queensland Inst Med Res, Canc Control Grp, Herston, Qld 4006, Australia; [Westberg, Lars] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden; [Nyren, Olof] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Karolinska Institutet; QIMR Berghofer Medical Research Institute; University of Washington; University of Washington Seattle; University of Texas System; UTMD Anderson Cancer Center; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Saskatchewan; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Sheffield; Fred Hutchinson Cancer Center; Kaiser Permanente; University of Leeds; University of Southern California; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Mayo Clinic; Fred Hutchinson Cancer Center; QIMR Berghofer Medical Research Institute; University of Gothenburg; Karolinska Institutet; University of London; King's College London	Lagergren, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden.	jesper.lagergren@ki.se	Hardie, Laura/AAY-6724-2020; Pharoah, Paul/V-6658-2019; Macgregor, Stuart/C-6442-2009; Caldas, Carlos/U-7250-2019; Whiteman, David C/P-2728-2014	Hardie, Laura/0000-0001-5039-2100; Pharoah, Paul/0000-0001-8494-732X; Macgregor, Stuart/0000-0001-6731-8142; Caldas, Carlos/0000-0003-3547-1489; Whiteman, David C/0000-0003-2563-9559; Fitzgerald, Rebecca/0000-0002-3434-3568	NIH [R01CA136725, K05CA124911, NIDDK 02956]; Australian Research Council [FT0990987]; Australian NHMRC; Australian Research Council; Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program; California Tobacco Related Research Program [3RT-0122, 10RT-0251]; Cancer Research UK [C490/A10119, C490/A10124]; Swedish Cancer Society [4559-B01-01XAA, 4758-B02-01XAB]; U.S. National Institutes of Health [P01CA091955, R01CA072866, R01CA57947, R01CA59636, R01CA100264, P30CA016672, R01CA133996, P50CA093459, U01CA57949, U01CA57983, U01CA57923, R01DK63616]; Medical Research Council; Cambridge NIHR Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Wellcome Trust [076113, 090355]; American Digestive Health Foundation; American College of Gastroenterology; Glaxo Wellcome Inc. Institute for Digestive Health; Miles and Shirley Fiterman Center for Digestive Diseases at Mayo Clinic, Rochester, Minnesota; MRC [MC_U105365007] Funding Source: UKRI; Cancer Research UK [16942, 16561] Funding Source: researchfish; Medical Research Council [MC_U105365007] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016672, K05CA124911, R01CA100264, R01CA059636, U01CA057949, R01CA057947, P50CA093459, U01CA057923, R01CA072866, P01CA091955, U01CA057983, R01CA133996, R01CA136725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK100548, R01DK063616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program(Robert Wood Johnson Foundation (RWJF)); California Tobacco Related Research Program; Cancer Research UK(Cancer Research UK); Swedish Cancer Society(Swedish Cancer Society); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Wellcome Trust(Wellcome Trust); American Digestive Health Foundation; American College of Gastroenterology(General Electric); Glaxo Wellcome Inc. Institute for Digestive Health; Miles and Shirley Fiterman Center for Digestive Diseases at Mayo Clinic, Rochester, Minnesota; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Primary funding: This work was primarily funded by NIH grant R01CA136725. Personal support: TLV is supported by NIH Career Development Award K05CA124911. DCW is supported by a Future Fellowship (FT0990987) from the Australian Research Council. SM is supported by an Australian NHMRC Career Development Award and an Australian Research Council Fellowship. YR was supported in part by a grant from the NIH (NIDDK 02956) and the Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program. Funding of constituent studies: California Tobacco Related Research Program: 3RT-0122, 10RT-0251. Cancer Research UK: C490/A10119, C490/A10124. Swedish Cancer Society: 4559-B01-01XAA, 4758-B02-01XAB. U.S. National Institutes of Health: P01CA091955, R01CA072866, R01CA57947, R01CA59636, R01CA100264, P30CA016672, R01CA133996, P50CA093459, U01CA57949, U01CA57983, U01CA57923, and R01DK63616. Additional funding came from the Medical Research Council, the Cambridge NIHR Biomedical Research Centre and the Cambridge Experimental Cancer Medicine Centre. This study made use of data generated by the Wellcome Trust Case Control Consortium; Funding for the project was provided by the Wellcome Trust under award 076113 and 090355; a full list of the investigators who contributed to the generation of the data is available from the website (http://www.wtccc.org.uk). The Romero Registry Consortium is supported in part by the American Digestive Health Foundation "Endoscopic Research Award," the American College of Gastroenterology "Junior Faculty Development Award," the Glaxo Wellcome Inc. Institute for Digestive Health "Clinical Research Award," and the Miles and Shirley Fiterman Center for Digestive Diseases at Mayo Clinic, Rochester, Minnesota. The Romero Registry also has charitable gifts from five industry partners (Affymetrix, AstraZeneca, Santarus, Takeda and Wyeth.) None of the funding sources had any involvement in the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgun H, 2002, ANTICANCER RES, V22, P1459; Alexandropoulou K, 2013, EUR J GASTROEN HEPAT, V25, P15, DOI 10.1097/MEG.0b013e3283595086; Bodelon C, 2011, CANCER PREV RES, V4, P840, DOI 10.1158/1940-6207.CAPR-10-0389; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CASSONI P, 1994, VIRCHOWS ARCH, V425, P467; Cassoni P, 1998, INT J CANCER, V77, P695, DOI 10.1002/(SICI)1097-0215(19980831)77:5<695::AID-IJC6>3.0.CO;2-Q; Cassoni P, 2000, J PATHOL, V190, P470, DOI 10.1002/(SICI)1096-9896(200003)190:4<470::AID-PATH550>3.0.CO;2-G; Chandanos E, 2009, EUR J CANCER, V45, P3149, DOI 10.1016/j.ejca.2009.09.001; Cronin-Fenton DP, 2010, EUR J CANCER, V46, P2067, DOI 10.1016/j.ejca.2010.03.032; Dahlgren A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001807; Derakhshan MH, 2009, GUT, V58, P16, DOI 10.1136/gut.2008.161331; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Edgren G, 2013, GUT, V62, P1406, DOI 10.1136/gutjnl-2012-302412; Ek WE, 2013, JNCI-J NATL CANCER I, V105, P1711, DOI 10.1093/jnci/djt303; Gouin JP, 2010, PSYCHONEUROENDOCRINO, V35, P1082, DOI 10.1016/j.psyneuen.2010.01.009; Grover S, 2010, AM J MED GENET B, V153B, P1391, DOI 10.1002/ajmg.b.31119; Jansson C, 2005, CANCER EPIDEM BIOMAR, V14, P1754, DOI 10.1158/1055-9965.EPI-05-0140; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Johansson A, 2012, GENES BRAIN BEHAV, V11, P214, DOI 10.1111/j.1601-183X.2011.00744.x; Keene KL, 2008, HUM GENET, V123, P333, DOI 10.1007/s00439-008-0482-z; Kim J, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-77; Konda VJA, 2012, AM J GASTROENTEROL, V107, P827, DOI 10.1038/ajg.2012.70; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Levine DM, 2013, NAT GENET, V45, P1487, DOI 10.1038/ng.2796; Levran O, 2014, ANN HUM GENET, V78, P290, DOI 10.1111/ahg.12064; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Monstein HJ, 2004, REGUL PEPTIDES, V119, P39, DOI 10.1016/j.regpep.2003.12.017; Morita T, 2004, INT J CANCER, V109, P525, DOI 10.1002/ijc.20017; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Novak JF, 2000, CANCER RES, V60, P3470; Rubenstein JH, 2010, ALIMENT PHARM THER, V32, P1222, DOI 10.1111/j.1365-2036.2010.04471.x; Rutegard M, 2010, EUR J CANCER, V46, P1093, DOI 10.1016/j.ejca.2010.01.029; Schuit SCE, 2005, EUR J ENDOCRINOL, V153, P327, DOI 10.1530/eje.1.01973; Stankova T, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-17; Sukocheva OA, 2013, DIS ESOPHAGUS, V26, P628, DOI 10.1111/dote.12000; Taylor JB, 2010, AM J GASTROENTEROL, V105, P1730, DOI 10.1038/ajg.2010.194; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tobias JH, 2007, J CLIN ENDOCR METAB, V92, P2286, DOI 10.1210/jc.2006-2447; Velasco J, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-16; Viero C, 2010, CNS NEUROSCI THER, V16, pe138, DOI 10.1111/j.1755-5949.2010.00185.x; Walum H, 2012, BIOL PSYCHIAT, V71, P419, DOI 10.1016/j.biopsych.2011.09.002; Whittington K, 2007, PROSTATE, V67, P1132, DOI 10.1002/pros.20612	43	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138738	10.1371/journal.pone.0138738	http://dx.doi.org/10.1371/journal.pone.0138738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406593	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700081
J	Mallikarjuna, MG; Thirunavukkarasu, N; Hossain, F; Bhat, JS; Jha, SK; Rathore, A; Agrawal, PK; Pattanayak, A; Reddy, SS; Gularia, SK; Singh, AM; Manjaiah, KM; Gupta, HS				Mallikarjuna, Mallana Gowdra; Thirunavukkarasu, Nepolean; Hossain, Firoz; Bhat, Jayant S.; Jha, Shailendra K.; Rathore, Abhishek; Agrawal, Pawan Kumar; Pattanayak, Arunava; Reddy, Sokka S.; Gularia, Satish Kumar; Singh, Anju Mahendru; Manjaiah, Kanchikeri Math; Gupta, Hari Shanker			Stability Performance of Inductively Coupled Plasma Mass Spectrometry-Phenotyped Kernel Minerals Concentration and Grain Yield in Maize in Different Agro-Climatic Zones	PLOS ONE			English	Article							X ENVIRONMENT INTERACTION; STATISTICAL-ANALYSIS; AMMI ANALYSIS; IRON; ZINC; SELECTION; TRIALS; BIOAVAILABILITY; IMPROVEMENT; SOUTHERN	Deficiency of iron and zinc causes micronutrient malnutrition or hidden hunger, which severely affects similar to 25% of global population. Genetic biofortification of maize has emerged as cost effective and sustainable approach in addressing malnourishment of iron and zinc deficiency. Therefore, understanding the genetic variation and stability of kernel micronutrients and grain yield of the maize inbreds is a prerequisite in breeding micronutrient-rich high yielding hybrids to alleviate micronutrient malnutrition. We report here, the genetic variability and stability of the kernel micronutrients concentration and grain yield in a set of 50 maize inbred panel selected from the national and the international centres that were raised at six different maize growing regions of India. Phenotyping of kernels using inductively coupled plasma mass spectrometry (ICP-MS) revealed considerable variability for kernel minerals concentration (iron: 18.88 to 47.65 mg kg(-1); zinc: 5.41 to 30.85 mg kg(-1); manganese: 3.30 to 17.73 mg kg(-1); copper: 0.53 to 5.48 mg kg(-1)) and grain yield (826.6 to 5413 kg ha(-1)). Significant positive correlation was observed between kernel iron and zinc within (r = 0.37 to r = 0.52, p < 0.05) and across locations (r = 0.44, p < 0.01). Variance components of the additive main effects and multiplicative interactions (AMMI) model showed significant genotype and genotype x environment interaction for kernel minerals concentration and grain yield. Most of the variation was contributed by genotype main effect for kernel iron (39.6%), manganese (41.34%) and copper (41.12%), and environment main effects for both kernel zinc (40.5%) and grain yield (37.0%). Genotype main effect plus genotype-by-environment interaction (GGE) biplot identified several mega environments for kernel minerals and grain yield. Comparison of stability parameters revealed AMMI stability value (ASV) as the better representative of the AMMI stability parameters. Dynamic stability parameter GGE distance (GGED) showed strong and positive correlation with both mean kernel concentrations and grain yield. Inbreds (CM-501, SKV-775, HUZM-185) identified from the present investigation will be useful in developing micronutrient-rich as well as stable maize hybrids without compromising grain yield.	[Mallikarjuna, Mallana Gowdra; Thirunavukkarasu, Nepolean; Hossain, Firoz; Jha, Shailendra K.; Gupta, Hari Shanker] ICAR Indian Agr Res Inst, Div Genet, Maize Res Lab, New Delhi, India; [Bhat, Jayant S.] ICAR Indian Agr Res Inst, Reg Res Ctr, Dharwad, Karnataka, India; [Rathore, Abhishek] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Agrawal, Pawan Kumar] ICAR Vivekanand Parvatiya Krishi Anusandhan Sanst, Almora, India; [Pattanayak, Arunava] ICAR Res Complex North Eastern Hill Reg, Umiam, Meghalaya, India; [Reddy, Sokka S.] Prof Jayshankar Telangana State Agr Univ, Hyderabad, Andhra Pradesh, India; [Gularia, Satish Kumar] CSK Himachal Pradesh Krishi Viswavidyalaya, Bajaura, India; [Singh, Anju Mahendru] ICAR Indian Agr Res Inst, Div Genet, Grain Qual Lab, New Delhi, India; [Manjaiah, Kanchikeri Math] ICAR Indian Agr Res Inst, Div Soil Sci & Agr Chem, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Indian Council of Agricultural Research (ICAR); ICAR - Vivekananda Parvatiya Krishi Anusandhan Sansthan; Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region; Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Gupta, HS (corresponding author), Borlaug Inst South Asia, New Delhi, India.	h.s.gupta@cgiar.org	Gowdra, Mallikarjuna Mallana/AAF-3654-2019	/0000-0003-4565-9792	ICAR-NPTC on Functional Genomics [Maize component: 21-22]; DBT, GoI Project on Development of micronutrient enriched maize through molecular breeding -Phase II [102/IFD/SAN/4455/2011-12]; Department of Science & Technology, Government of India [DST/INSPIRE/2011/IF110504]	ICAR-NPTC on Functional Genomics; DBT, GoI Project on Development of micronutrient enriched maize through molecular breeding -Phase II; Department of Science & Technology, Government of India(Department of Science & Technology (India))	This work was supported by the ICAR-NPTC on Functional Genomics (Maize component: 21-22) and the DBT, GoI Project on Development of micronutrient enriched maize through molecular breeding -Phase II (102/IFD/SAN/4455/2011-12). MGM is thankful to the Department of Science & Technology, Government of India, for the INSPIRE Fellowship (DST/INSPIRE/2011/IF110504) to carry out the doctoral degree programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwala S, 2010, FIELD CROP RES, V119, P225, DOI 10.1016/j.fcr.2010.07.010; Annicchiarico P, 1997, THEOR APPL GENET, V94, P1072, DOI 10.1007/s001220050517; [Anonymous], 2003, MINERALS ANIMAL HUMA, DOI DOI 10.1016/B978-0-444-51367-0.50006-4; ARGILLIER O, 1994, AGRONOMIE, V14, P661, DOI 10.1051/agro:19941003; Badu-Apraku B, 2012, FIELD CROP RES, V129, P99, DOI 10.1016/j.fcr.2012.01.018; Banziger Marianne, 2000, Food and Nutrition Bulletin, V21, P397; Bashir EMA, 2014, FIELD CROP RES, V166, P82, DOI 10.1016/j.fcr.2014.06.007; Bashir EMA, 2014, PLANT GENET RESOUR-C, V12, P35, DOI 10.1017/S1479262113000233; BECKER HC, 1988, PLANT BREEDING, V101, P1, DOI 10.1111/j.1439-0523.1988.tb00261.x; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Cakmak I, 2004, SOIL SCI PLANT NUTR, V50, P1047, DOI 10.1080/00380768.2004.10408573; CASTLEBERRY RM, 1984, CROP SCI, V24, P33, DOI 10.2135/cropsci1984.0011183X002400010008x; Chakraborti M, 2011, J PLANT BIOCHEM BIOT, V20, P224, DOI 10.1007/s13562-011-0050-9; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; Fan LJ, 2001, PLANT BREEDING, V120, P139, DOI 10.1046/j.1439-0523.2001.00564.x; FINLAY KW, 1963, AUST J AGR RES, V14, P742, DOI 10.1071/AR9630742; FRANCIS TR, 1978, CAN J PLANT SCI, V58, P1029, DOI 10.4141/cjps78-157; Gauch H.G., 1992, STAT ANAL REGIONAL Y; GAUCH HG, 1988, BIOMETRICS, V44, P705, DOI 10.2307/2531585; Gauch HG, 1997, CROP SCI, V37, P311, DOI 10.2135/cropsci1997.0011183X003700020002x; Gauch HG, 1996, CROP SCI, V36, P838, DOI 10.2135/cropsci1996.0011183X003600040002x; Genstat, 2013, GENST WIND REL 16 1; Ghandilyan A, 2006, PHYSIOL PLANTARUM, V126, P407, DOI 10.1111/j.1399-3054.2006.00646.x; Goyal A, 2011, CAN J PLANT SCI, V91, P125, DOI 10.4141/CJPS10063; Gupta H.S., 2015, NUTR USE EFFICIENCY, P255, DOI [10.1007/978-81-322-2169-2_17, DOI 10.1007/978-81-322-2169-2-17]; Horton S, 2008, CHALLENGE HUNGER MAL, P3; House WA, 1999, FIELD CROP RES, V60, P115, DOI 10.1016/S0378-4290(98)00136-1; Khalid N, 2014, CRIT REV FOOD SCI, V54, P1222, DOI 10.1080/10408398.2011.630541; LIN CS, 1986, CROP SCI, V26, P894, DOI 10.2135/cropsci1986.0011183X002600050012x; LIN CS, 1988, CAN J PLANT SCI, V68, P193, DOI 10.4141/cjps88-018; Long JK, 2004, CROP SCI, V44, P2019, DOI 10.2135/cropsci2004.2019; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mason S. C., 2002, Journal of Crop Production, V5, P75, DOI 10.1300/J144v05n01_04; Menkir A, 2008, FOOD CHEM, V110, P454, DOI 10.1016/j.foodchem.2008.02.025; Milligan SB, 2003, CROP SCI, V43, P1729, DOI 10.2135/cropsci2003.1729; Mohammadi R, 2013, EUPHYTICA, V192, P227, DOI 10.1007/s10681-012-0839-1; Oikeh SO, 2003, J AGR FOOD CHEM, V51, P3688, DOI 10.1021/jf0261708; Piepho HP, 2007, GENETICS, V177, P1881, DOI 10.1534/genetics.107.074229; Pixley KV, 2011, FIELD CROP RES, V123, P153, DOI 10.1016/j.fcr.2011.05.011; Prasanna BM, 2011, INDIAN J AGR SCI, V81, P704; Purchase J. L., 2000, South African Journal of Plant and Soil, V17, P101; Roostaei M, 2014, CROP J, V2, P154, DOI 10.1016/j.cj.2014.02.002; Schaaf G, 2005, PLANT CELL PHYSIOL, V46, P762, DOI 10.1093/pcp/pci081; Shi RL, 2008, PLANT SOIL, V306, P95, DOI 10.1007/s11104-007-9483-2; SHUKLA GK, 1972, HEREDITY, V29, P237, DOI 10.1038/hdy.1972.87; Simic D, 2009, J CEREAL SCI, V50, P392, DOI 10.1016/j.jcs.2009.06.014; Velu G, 2011, EUPHYTICA, V180, P251, DOI 10.1007/s10681-011-0387-0; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; WRICKE G, 1962, Z PFLANZENZUCHT, V47, P92; Yan W., 2003, GGE BIPLOT ANAL GRAP; Yan WK, 2007, CROP SCI, V47, P643, DOI 10.2135/cropsci2006.06.0374; Yan WK, 2000, CROP SCI, V40, P597, DOI 10.2135/cropsci2000.403597x; Yan WK, 2001, AGRON J, V93, P1111, DOI 10.2134/agronj2001.9351111x; Yates F, 1938, J AGR SCI, V28, P556, DOI 10.1017/S0021859600050978; Zhang Ze, 1998, Acta Agronomica Sinica, V24, P304; Zobel R.W, 1994, INTSORMIL PUBLICATIO, P80; ZOBEL RW, 1988, AGRON J, V80, P388, DOI 10.2134/agronj1988.00021962008000030002x	58	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139067	10.1371/journal.pone.0139067	http://dx.doi.org/10.1371/journal.pone.0139067			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406470	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000361800700160
J	Shpigel, NY; Pasternak, Z; Factor, G; Gottlieb, Y				Shpigel, Nahum Y.; Pasternak, Zohar; Factor, Gilad; Gottlieb, Yuval			Diversity of Bacterial Biofilm Communities on Sprinklers from Dairy Farm Cooling Systems in Israel	PLOS ONE			English	Article							CORYNEBACTERIUM-PSEUDOTUBERCULOSIS INFECTION; MULTIPLE SEQUENCE ALIGNMENT; PYROSEQUENCING ANALYSIS; DRINKING-WATER; HEAT-STRESS; COWS; CATTLE; RESERVOIR; SURFACE; MUSCLE	On dairy farms in hot climates worldwide, cows suffer from heat stress, which is alleviated by the use of water cooling systems. Sprinklers and showerheads are known to support the development of microbial biofilms, which can be a source of infection by pathogenic microorganisms. The aim of this study was to investigate the presence of microbial biofilms in dairy cooling systems, and to analyze their population compositions using culture-independent technique, 16S rRNA gene sequencing. Biofilm samples were collected on eight dairy farms from 40 sprinklers and the microbial constituents were identified by deep sequencing of the 16S rRNA gene. A total of 9,374 operational taxonomic units (OTUs) was obtained from all samples. The mean richness of the samples was 465 +/- 268 OTUs which were classified into 26 different phyla; 76% of the reads belonged to only three phyla: Proteobacteria, Actinobacteria and Firmicutes. Although the most prevalent OTUs (Paracoccus, Methyloversatilis, Brevundimonas, Porphyrobacter, Gp4, Mycobacterium, Hyphomicrobium, Corynebacterium and Clostridium) were shared by all farms, each farm formed a unique microbial pattern. Some known potential human and livestock pathogens were found to be closely related to the OTUs found in this study. This work demonstrates the presence of biofilm in dairy cooling systems which may potentially serve as a live source for microbial pathogens.	[Shpigel, Nahum Y.; Gottlieb, Yuval] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Pasternak, Zohar] Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Factor, Gilad] Hachaklait, Mutual Soc Vet Serv, Caesarea, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shpigel, NY (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	nahum.shpigel@mail.huji.ac.il	Gottlieb, Yuval/H-6461-2013		Israeli Dairy Board [705-0048-11]	Israeli Dairy Board	This work was supported by the Israeli Dairy Board (project 705-0048-11). http://www.israeldairy.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor A, 2011, J CLIN MICROBIOL, V49, P449, DOI 10.1128/JCM.01117-10; Berman A, 2008, J DAIRY SCI, V91, P4571, DOI 10.3168/jds.2008-1175; Berman A, 2010, J DAIRY SCI, V93, P242, DOI 10.3168/jds.2009-2601; Berman A, 2009, J ANIM SCI, V87, P3413, DOI 10.2527/jas.2008-1104; Borderas TF, 2004, J DAIRY SCI, V87, P2085, DOI 10.3168/jds.S0022-0302(04)70026-0; Chen CL, 2004, APPL MICROBIOL BIOT, V63, P466, DOI 10.1007/s00253-003-1286-7; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esposito A, 2014, FEMS MICROBIOL LETT, V351, P145, DOI 10.1111/1574-6968.12375; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Flamenbaum I, 2010, J REPROD DEVELOP, V56, pS36, DOI 10.1262/jrd.1056S36; Gauly M, 2013, ANIMAL, V7, P843, DOI 10.1017/S1751731112002352; Golan L, 2009, J INFECT DIS, V199, P350, DOI 10.1086/596033; Henne K, 2013, WATER RES, V47, P5614, DOI 10.1016/j.watres.2013.06.034; HER E, 1988, J DAIRY SCI, V71, P1085, DOI 10.3168/jds.S0022-0302(88)79656-3; Hogan J, 2012, VET CLIN N AM-FOOD A, V28, P217, DOI 10.1016/j.cvfa.2012.03.009; Hong PY, 2010, APPL ENVIRON MICROB, V76, P5631, DOI 10.1128/AEM.00281-10; Honig H, 2012, J DAIRY SCI, V95, P3736, DOI 10.3168/jds.2011-5054; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kelly JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098542; Koerner RJ, 2009, FEMS IMMUNOL MED MIC, V55, P296, DOI 10.1111/j.1574-695X.2008.00513.x; Liu RY, 2012, SCI TOTAL ENVIRON, V435, P124, DOI 10.1016/j.scitotenv.2012.07.022; Luo JH, 2013, BIORESOURCE TECHNOL, V148, P189, DOI 10.1016/j.biortech.2013.08.109; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Mather P. M., 1976, COMPUTATIONAL METHOD; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Navarro-Noya YE, 2013, MICROB ECOL, V66, P19, DOI 10.1007/s00248-013-0222-3; Percival SL, 2012, INT WOUND J, V9, P14, DOI 10.1111/j.1742-481X.2011.00836.x; Rathnaiah G, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00144; Rosenblueth M, 2011, DNA CELL BIOL, V30, P633, DOI 10.1089/dna.2011.1231; Satoh H, 2006, BIOTECHNOL BIOENG, V94, P762, DOI 10.1002/bit.20894; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHPIGEL NY, 1993, VET REC, V133, P89, DOI 10.1136/vr.133.4.89; Sun HF, 2014, SCI TOTAL ENVIRON, V472, P99, DOI 10.1016/j.scitotenv.2013.11.017; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Williams MM, 2013, BIOFOULING, V29, P147, DOI 10.1080/08927014.2012.757308; Wingender J, 2011, INT J HYG ENVIR HEAL, V214, P417, DOI 10.1016/j.ijheh.2011.05.009; Yeruham I, 1997, VET REC, V140, P423, DOI 10.1136/vr.140.16.423; Yeruham I, 2000, VET REC, V146, P695, DOI 10.1136/vr.146.24.695; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	49	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139111	10.1371/journal.pone.0139111	http://dx.doi.org/10.1371/journal.pone.0139111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407190	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700175
J	Bauskar, A; Mack, WJ; Mauris, J; Argueso, P; Heur, M; Nagel, BA; Kolar, GR; Gleave, ME; Nakamura, T; Kinoshita, S; Moradian-Oldak, J; Panjwani, N; Pflugfelder, SC; Wilson, MR; Fini, ME; Jeong, SW				Bauskar, Aditi; Mack, Wendy J.; Mauris, Jerome; Argueeso, Pablo; Heur, Martin; Nagel, Barbara A.; Kolar, Grant R.; Gleave, Martin E.; Nakamura, Takahiro; Kinoshita, Shigeru; Moradian-Oldak, Janet; Panjwani, Noorjahan; Pflugfelder, Stephen C.; Wilson, Mark R.; Fini, M. Elizabeth; Jeong, Shinwu			Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye	PLOS ONE			English	Article							APOLIPOPROTEIN-J CLUSTERIN; EPITHELIAL-CELLS; CORNEAL EPITHELIUM; GENE-EXPRESSION; TEAR PROTEOME; IN-VITRO; MATRIX-METALLOPROTEINASE-9; GALECTIN-3; MECHANISMS; RECEPTOR	Dry eye is a common disorder caused by inadequate hydration of the ocular surface that results in disruption of barrier function. The homeostatic protein clusterin (CLU) is prominent at fluid-tissue interfaces throughout the body. CLU levels are reduced at the ocular surface in human inflammatory disorders that manifest as severe dry eye, as well as in a preclinical mouse model for desiccating stress that mimics dry eye. Using this mouse model, we show here that CLU prevents and ameliorates ocular surface barrier disruption by a remarkable sealing mechanism dependent on attainment of a critical all-or-none concentration. When the CLU level drops below the critical all-or-none threshold, the barrier becomes vulnerable to desiccating stress. CLU binds selectively to the ocular surface subjected to desiccating stress in vivo, and in vitro to the galectin LGALS3, a key barrier component. Positioned in this way, CLU not only physically seals the ocular surface barrier, but it also protects the barrier cells and prevents further damage to barrier structure. These findings define a fundamentally new mechanism for ocular surface protection and suggest CLU as a biotherapeutic for dry eye.	[Bauskar, Aditi; Fini, M. Elizabeth; Jeong, Shinwu] Univ So Calif, Keck Sch Med, USC Inst Genet Med, Los Angeles, CA 90033 USA; [Bauskar, Aditi] Univ So Calif, Keck Sch Med, Grad Program Med Biol, Los Angeles, CA 90033 USA; [Mack, Wendy J.] Univ So Calif, Keck Sch Med, Southern Calif Clin & Translat Sci Inst, Los Angeles, CA 90033 USA; [Mack, Wendy J.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Mauris, Jerome; Argueeso, Pablo] Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA USA; [Mauris, Jerome; Argueeso, Pablo] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Heur, Martin] Univ So Calif, Keck Sch Med, USC Eye Inst, Los Angeles, CA 90033 USA; [Nagel, Barbara A.] St Louis Univ, Sch Med, Dept Pathol, Res Microscopy & Histol Core, St Louis, MO 63104 USA; [Kolar, Grant R.] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Kolar, Grant R.] St Louis Univ, Sch Med, Dept Ophthalmol, St Louis, MO USA; [Gleave, Martin E.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Gleave, Martin E.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Nakamura, Takahiro; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kyoto, Japan; [Moradian-Oldak, Janet] Univ So Calif, Ctr Craniofacial Mol Biol, Div Biomed Sci, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Panjwani, Noorjahan] Tufts Univ, Sch Med, Dept Ophthalmol, New England Eye Ctr, Boston, MA 02111 USA; [Panjwani, Noorjahan] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Pflugfelder, Stephen C.] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Fini, M. Elizabeth] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Fini, M. Elizabeth; Jeong, Shinwu] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University of Southern California; Saint Louis University; Saint Louis University; Saint Louis University; University of British Columbia; University of British Columbia; Kyoto Prefectural University of Medicine; University of Southern California; Tufts University; Tufts University; Baylor College of Medicine; University of Wollongong; University of Southern California; University of Southern California	Jeong, SW (corresponding author), Univ So Calif, Keck Sch Med, USC Inst Genet Med, Los Angeles, CA 90033 USA.	shinwuje@usc.edu	Wilson, Mark R/B-3254-2018	Wilson, Mark R/0000-0002-9551-7445; Jeong, Shinwu/0000-0002-4847-813X; Gleave, Martin/0000-0003-4235-0167; Argueso, Pablo/0000-0001-7321-9503	James H. Zumberge Faculty Research & Innovation Fund; National Institutes of Health [R01-EY009828, R01-EY024031, R01-DE013414, UL1-TR000130]; Research to Prevent Blindness, New York, NY; Keck School of Medicine of USC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024031, R01EY009828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013414] Funding Source: NIH RePORTER	James H. Zumberge Faculty Research & Innovation Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Keck School of Medicine of USC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by an award from the James H. Zumberge Faculty Research & Innovation Fund (to SJ) (http://research.usc.edu/zumberge); National Institutes of Health grants R01-EY009828 (to MEF)(https://nei.nih.gov), R01-EY024031 (to PA) (https://nei.nih.gov), R01-DE013414 (to JM-O) (http://www.nidcr.nih.gov) and UL1-TR000130 (formerly UL1-RR031986; sub-award to WJM) (http://www.nih.gov/about/almanac/organization/NCRR.htm); an unrestricted grant from Research to Prevent Blindness, New York, NY (https://www.rpbusa.org/rpb/grants/grants) to the University of Southern California; and start-up funding from the Keck School of Medicine of USC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson MB, 2005, THE DYE NAMICS OF DR; Adisetiyo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069484; Argueso P, 2011, EXP EYE RES, V92, P2, DOI 10.1016/j.exer.2010.11.009; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; Bailey RW, 2001, BIOCHEMISTRY-US, V40, P11828, DOI 10.1021/bi010135x; Bandamwar KL, 2014, CONTACT LENS ANTERIO, V37, P213, DOI 10.1016/j.clae.2013.11.003; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Bron AJ, 2015, PROG RETIN EYE RES, V44, P36, DOI 10.1016/j.preteyeres.2014.10.001; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Chen W, 2009, EXP EYE RES, V89, P311, DOI 10.1016/j.exer.2009.03.015; Chieze L, 2011, J MOL BIOL, V410, P60, DOI 10.1016/j.jmb.2011.04.006; Chotikavanich S, 2009, INVEST OPHTH VIS SCI, V50, P3203, DOI 10.1167/iovs.08-2476; Clouzeau C, 2012, MOL VIS, V18, P851; COLLARD MW, 1987, BIOCHEMISTRY-US, V26, P3297, DOI 10.1021/bi00386a008; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dabbs RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086989; De Paiva CS, 2006, INVEST OPHTH VIS SCI, V47, P2847, DOI 10.1167/iovs.05-1281; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; DESILVA HV, 1990, J BIOL CHEM, V265, P14292; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Fini ME, 1998, BIOL EXTRAC, P299; Foulks GN, 2007, OCUL SURF, V5, P65, DOI 10.1016/S1542-0124(12)70076-9; Foulks GN, 2014, AM J OPHTHALMOL, V157, P1122, DOI 10.1016/j.ajo.2014.03.002; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2007, INVEST OPHTH VIS SCI, V48, P4391, DOI 10.1167/iovs.07-0770; Gipson IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100393; Handattu SP, 2007, J BIOL CHEM, V282, P1980, DOI 10.1074/jbc.M606231200; Hochgrebe T, 2000, BIOCHEMISTRY-US, V39, P1411, DOI 10.1021/bi991581b; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Jeong S, 2012, AM J PATHOL, V180, P2028, DOI 10.1016/j.ajpath.2012.01.025; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Karnati R, 2013, EXP EYE RES, V117, P39, DOI 10.1016/j.exer.2013.05.020; Kierzek AM, 2010, MOL BIOSYST, V6, P531, DOI 10.1039/b906951h; Kompella UB, 2010, THER DELIV, V1, P435, DOI 10.4155/TDE.10.40; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P13070, DOI 10.1074/jbc.270.22.13070; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271; Li DQ, 2005, OCUL SURF, V3, pS198; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Li N, 2005, J PROTEOME RES, V4, P2052, DOI 10.1021/pr0501970; Li ZR, 2013, INVEST OPHTH VIS SCI, V54, P155, DOI 10.1167/iovs.12-10648; Liang JF, 2014, INT J MOL SCI, V15, P11220, DOI 10.3390/ijms150711220; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; Mantelli F, 2013, J CELL PHYSIOL, V228, P2253, DOI 10.1002/jcp.24398; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; Matani P, 2007, FRONT BIOSCI-LANDMRK, V12, P3852, DOI 10.2741/2356; Matsumoto H, 2013, CANCER RES, V73, P5206, DOI 10.1158/0008-5472.CAN-13-0359; Matveev V, 2000, J NEUROSCI, V20, P1575; Mauris J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072304; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; Mokhtarzadeh M, 2011, INVEST OPHTH VIS SCI, V52, P2127, DOI 10.1167/iovs.10-6489; Nakamura T, 2002, INVEST OPHTH VIS SCI, V43, P1702; Navab M, 2007, J CLIN LIPIDOL, V1, P142, DOI 10.1016/j.jacl.2007.03.002; Nishida I, 1999, BRIT J OPHTHALMOL, V83, P1178, DOI 10.1136/bjo.83.10.1178; Nishida K, 1996, INVEST OPHTH VIS SCI, V37, P1800; Novack GD, 2014, OCUL SURF, V12, P227, DOI 10.1016/j.jtos.2014.05.001; Ochieng J, 1998, BBA-GEN SUBJECTS, V1379, P97, DOI 10.1016/S0304-4165(97)00086-X; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Radziwon-Balicka A, 2014, CARCINOGENESIS, V35, P324, DOI 10.1093/carcin/bgt332; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Savkovic V, 2007, BIOCHEM BIOPH RES CO, V356, P431, DOI 10.1016/j.bbrc.2007.02.148; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Shim YJ, 2011, J LEUKOCYTE BIOL, V90, P761, DOI 10.1189/jlb.0311110; Stewart EM, 2007, BIOCHEMISTRY-US, V46, P1412, DOI 10.1021/bi062082v; Sullivan DA, 2012, OCUL SURF, V10, P108, DOI 10.1016/j.jtos.2012.02.001; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Toren PJ, 2013, ASIAN J ANDROL, V15, P342, DOI 10.1038/aja.2013.38; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Tsianou M, 2014, LANGMUIR THE ACS JOU, DOI [10.1021/la5013999, DOI 10.1021/LA5013999]; Uchino Y, 2015, AM J OPHTHALMOL, V159, P1027, DOI 10.1016/j.ajo.2015.02.008; Ulmer TA, 2010, BBA-GEN SUBJECTS, V1800, P336, DOI 10.1016/j.bbagen.2009.07.030; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; Villareal Arturo L, 2006, Eye Contact Lens, V32, P272, DOI 10.1097/01.icl.0000224360.10319.b1; Wiechmann AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113810; Williamson JF, 2014, EYE CONTACT LENS, V40, P111, DOI 10.1097/ICL.0000000000000020; Wilson MR, 2000, TRENDS BIOCHEM SCI, V25, P95, DOI 10.1016/S0968-0004(99)01534-0; Xiao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115333; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhou L, 2012, J PROTEOMICS, V75, P3877, DOI 10.1016/j.jprot.2012.04.053	88	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138958	10.1371/journal.pone.0138958	http://dx.doi.org/10.1371/journal.pone.0138958			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402857	Green Published, Green Submitted, gold			2022-12-27	WOS:000361798100045
J	Sun, P; Du, JB; Zhu, X; Ren, CL; Xie, L; Dai, NB; Gu, YY; Yan, CW; Dai, JC; Ma, HX; Jiang, Y; Chen, JP; Hu, ZB; Shen, HB; Wu, HR; Jin, GF				Sun, Ping; Du, Jiangbo; Zhu, Xun; Ren, Chuanli; Xie, Lan; Dai, Ningbin; Gu, Yayun; Yan, Caiwang; Dai, Juncheng; Ma, Hongxia; Jiang, Yue; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing; Wu, Haorong; Jin, Guangfu			Genetic Variation in the 3 '-Untranslated Region of NBN Gene Is Associated with Gastric Cancer Risk in a Chinese Population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; BASAL-CELL CARCINOMA; DNA-REPAIR GENES; NBS1 POLYMORPHISM; BREAST-CANCER; LUNG-CANCER; SUSCEPTIBILITY; COMPLEX; DAMAGE; REPLICATION	NBN plays a crucial role in carcinogenesis as a core component for both homologous recombination (HR) and non-homologous end-joining (NHEJ) DNA double-strand breaks (DSBs) repair pathways. Genetic variants in the NBN gene have been associated with multiple cancers risk, suggesting pleiotropic effect on cancer. We hypothesized that genetic variants in the NBN gene may modify the risk of gastric cancer. To test this hypothesis, we evaluated the association between four potentially functional single nucleotide polymorphisms in NBN and gastric cancer risk in a case-control study of 1,140 gastric cancer cases and 1,547 controls in a Chinese population. We found that the A allele of rs10464867 (G>A) was significantly associated with a decreased risk of gastric cancer (odds ratio [OR] = 0.81, 95% confidence interval [95% CI] = 0.71-0.94; P = 4.71x10(-3)). Furthermore, the association between A allele of rs10464867 and decreased risk of gastric cancer was more significantly in elder individuals (per-allele OR = 0.72[0.59-0.88], P = 1.07x10(-3)), and male individuals (per-allele OR = 0.73[0.62-0.87], P = 3.68x10(-4)). We further conducted a haplotype analysis and identified that the NBN A(rs10464867)G(rs14448)G(rs1063053) haplotype conferred stronger protective effect on gastric cancer (OR = 0.76[0.65-0.89], P = 6.39x10(-4)). In summary, these findings indicate that genetic variants at NBN gene may contribute to gastric cancer susceptibility and may further advance our understanding of NBN gene in cancer development.	[Sun, Ping; Wu, Haorong] Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou 215004, Peoples R China; [Sun, Ping] Nanjing Med Univ, Affiliated Wuxi Hosp 2, Dept Pathol, Wuxi 214006, Peoples R China; [Du, Jiangbo; Zhu, Xun; Dai, Ningbin; Gu, Yayun; Yan, Caiwang; Dai, Juncheng; Ma, Hongxia; Jiang, Yue; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing; Jin, Guangfu] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China; [Du, Jiangbo; Dai, Ningbin; Gu, Yayun; Dai, Juncheng; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing; Jin, Guangfu] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China; [Ren, Chuanli] Northern Jiangsu Peoples Hosp, Med Lab, Yangzhou 225001, Peoples R China; [Xie, Lan] Tsinghua Univ, Sch Med, Med Syst Biol Res Ctr, Beijing 100084, Peoples R China	Soochow University - China; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Tsinghua University	Jin, GF (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing 211166, Jiangsu, Peoples R China.	wuhaorong666@126.com; guangfujin@njmu.edu.cn	Dai, Ningbin/AFS-0341-2022	Shen, Hongbing/0000-0002-2581-5906	National Natural Science Foundation of China [81230067, 81422042, 81373090]; Science and Technology Agency of Jiangsu Province, China [BK20130042]; Science and Technology committee of Nanjing, China [BL2012008]; Government of Jiangsu Province, China; Science Foundation for Distinguished Young Scholars in Jiangsu [BK20130042]; Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center) [BL2012008]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Agency of Jiangsu Province, China; Science and Technology committee of Nanjing, China; Government of Jiangsu Province, China; Science Foundation for Distinguished Young Scholars in Jiangsu(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center); Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	81230067, http://www.nsfc.gov.cn/, National Natural Science Foundation of China, HS; 81422042 and 81373090, http://www.nsfc.gov.cn/, National Natural Science Foundation of China, GJ; BK20130042, http://www.jstd.gov.cn/, Science and Technology Agency of Jiangsu Province, China, GJ; BL2012008, http://www.njkj.gov.cn/, Science and Technology committee of Nanjing, China, HS; http://www.jiangsu.gov.cn/, Government of Jiangsu Province, China, HS; Science Foundation for Distinguished Young Scholars in Jiangsu (BK20130042); Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center, BL2012008); and Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Berardinelli F, 2013, CURR GENOMICS, V14, P425, DOI 10.2174/13892029113146660012; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; di Masi A, 2008, CURR GENOMICS, V9, P275, DOI 10.2174/138920208784533610; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Dzikiewicz-Krawczyk A, 2008, MUTAT RES-REV MUTAT, V659, P262, DOI 10.1016/j.mrrev.2008.05.005; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gong YT, 2013, GENE, V519, P335, DOI 10.1016/j.gene.2013.01.059; Gu Daquan, 2011, INSTRUMENTATION TECH, V01, P1, DOI DOI 10.1371/J0URNAL.P0NE; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanada K, 2014, INFECT IMMUN, V82, P4182, DOI 10.1128/IAI.02368-14; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang MD, 2012, DNA CELL BIOL, V31, P678, DOI 10.1089/dna.2011.1421; Koppensteiner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100041; Lafrance-Vanasse J, 2015, PROG BIOPHYS MOL BIO, V117, P182, DOI 10.1016/j.pbiomolbio.2014.12.004; Li N, 2013, MOL BIOL REP, V40, P3749, DOI 10.1007/s11033-012-2451-9; Liu JW, 2013, ASIAN PAC J CANCER P, V14, P6103, DOI 10.7314/APJCP.2013.14.10.6103; Lu JC, 2006, CARCINOGENESIS, V27, P2209, DOI 10.1093/carcin/bgl077; Margulis V, 2008, CANCER EPIDEM BIOMAR, V17, P2366, DOI 10.1158/1055-9965.EPI-08-0259; MAYER PJ, 1991, ANN HUM BIOL, V18, P405, DOI 10.1080/03014469100001702; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Park SL, 2010, CARCINOGENESIS, V31, P1264, DOI 10.1093/carcin/bgq096; Ryk C, 2006, LUNG CANCER, V54, P285, DOI 10.1016/j.lungcan.2006.08.004; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Sanyal S, 2004, CARCINOGENESIS, V25, P729, DOI 10.1093/carcin/bgh058; Seemanov E, 2007, JNCI-J NATL CANCER I, V99, P1875, DOI 10.1093/jnci/djm251; Shen HB, 2013, J BIOMED RES, V27, P167, DOI 10.7555/JBR.27.20130040; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Silva J, 2012, DNA CELL BIOL, V31, P1182, DOI 10.1089/dna.2011.1562; Slyskova J, 2011, ENVIRON MOL MUTAGEN, V52, P511, DOI 10.1002/em.20650; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Thirumaran RK, 2006, CARCINOGENESIS, V27, P1676, DOI 10.1093/carcin/bgi381; Thrumurthy SG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6367; Wang LX, 2013, MOL BIOL REP, V40, P2711, DOI 10.1007/s11033-012-2358-5; WEI QY, 1993, P NATL ACAD SCI USA, V90, P1614, DOI 10.1073/pnas.90.4.1614; Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang MD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-174; Yuan T, 2011, CANCER EPIDEMIOL, V35, P170, DOI 10.1016/j.canep.2010.08.008; Zheng J, 2011, MOL CARCINOGEN, V50, P689, DOI 10.1002/mc.20803	46	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139059	10.1371/journal.pone.0139059	http://dx.doi.org/10.1371/journal.pone.0139059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402912	gold, Green Published, Green Submitted			2022-12-27	WOS:000361798100056
J	Chou, AC; Ju, YT; Pan, CY				Chou, Ai-Chuan; Ju, Yu-Ten; Pan, Chien-Yuan			Calmodulin Interacts with the Sodium/Calcium Exchanger NCX1 to Regulate Activity	PLOS ONE			English	Article							CARDIAC NA+-CA2+ EXCHANGER; NA+/CA2+ EXCHANGER; CA2+-BINDING DOMAIN; MUTATIONAL ANALYSIS; TARGET RECOGNITION; CA2+ REGULATION; BINDING MOTIF; CALCIUM; ISOFORMS; ACTIVATION	Changes in intracellular Ca2+ concentrations ([Ca2+](i)) are an important signal for various physiological activities. The Na+/Ca2+ exchangers (NCX) at the plasma membrane transport Ca2+ into or out of the cell according to the electrochemical gradients of Na+ and Ca2+ to modulate [Ca2+](i) homeostasis. Calmodulin (CaM) senses [Ca2+](i) changes and relays Ca2+ signals by binding to target proteins such as channels and transporters. However, it is not clear how calmodulin modulates NCX activity. Using CaM as a bait, we pulled down the intracellular loops subcloned from the NCX1 splice variants NCX1.1 and NCX1.3. This interaction requires both Ca2+ and a putative CaM-binding segment (CaMS). To determine whether CaM modulates NCX activity, we co-expressed NCX1 splice variants with CaM or CaM1234 (a Ca2+-binding deficient mutant) in HEK293T cells and measured the increase in [Ca2+](i) contributed by the influx of Ca2+ through NCX. Deleting the CaMS from NCX1.1 and NCX1.3 attenuated exchange activity and decreased membrane localization. Without the mutually exclusive exon, the exchange activity was decreased and could be partially rescued by CaM1234. Point-mutations at any of the 4 conserved a. a. residues in the CaMS had differential effects in NCX1.1 and NCX1.3. Mutating the first two conserved a. a. in NCX1.1 decreased exchange activity; mutating the 3rd or 4th conserved a. a. residues did not alter exchange activity, but CaM co-expression suppressed activity. Mutating the 2nd and 3rd conserved a. a. residues in NCX1.3 decreased exchange activity. Taken together, our results demonstrate that CaM senses changes in [Ca2+](i) and binds to the cytoplasmic loop of NCX1 to regulate exchange activity.	[Chou, Ai-Chuan; Pan, Chien-Yuan] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Ju, Yu-Ten] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10764, Taiwan; [Pan, Chien-Yuan] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Pan, CY (corresponding author), Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan.	cypan@ntu.edu.tw		PAN, CHIEN-YUAN/0000-0002-6654-9309	Ministry of Science and Technology, Taiwan [103-2320-B-002-060-MY3, 103-2627-M-002-010]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology, Taiwan (http://www.most.gov.tw/mp.aspx), Grants No. 103-2320-B-002-060-MY3 (CYP) and 103-2627-M-002-010 (CYP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Ander BP, 2007, CARDIOVASC RES, V73, P395, DOI 10.1016/j.cardiores.2006.09.013; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Franco-Echevarria E, 2014, BIOCHEM J, V463, P319, DOI 10.1042/BJ20140757; Giladi M, 2015, BIOCHEM J, V465, P489, DOI 10.1042/BJ20141036; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Ginsburg KS, 2013, J PHYSIOL-LONDON, V591, P2067, DOI 10.1113/jphysiol.2013.252080; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HUBBARD MJ, 1989, EUR J BIOCHEM, V185, P411, DOI 10.1111/j.1432-1033.1989.tb15130.x; IIDA S, 1986, J BIOCHEM-TOKYO, V99, P1765, DOI 10.1093/oxfordjournals.jbchem.a135654; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; John SA, 2013, P NATL ACAD SCI USA, V110, P7500, DOI 10.1073/pnas.1218751110; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kiedrowski L, 2004, J NEUROCHEM, V90, P117, DOI 10.1111/j.1471-4159.2004.02462.x; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lin TY, 2013, LAB CHIP, V13, P676, DOI [10.1039/c2lc40772h, 10.1039/c21c40772h]; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Matsuoka S, 1997, J GEN PHYSIOL, V109, P273, DOI 10.1085/jgp.109.2.273; Molnar E, 2011, SEMIN CELL DEV BIOL, V22, P506, DOI 10.1016/j.semcdb.2011.07.017; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Pan CY, 1998, BIOCHEM J, V336, P305, DOI 10.1042/bj3360305; Philipson KD, 2002, ANN NY ACAD SCI, V976, P1; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ritter M, 2003, CELL CALCIUM, V34, P11, DOI 10.1016/S0143-4160(03)00017-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma V, 2014, GENESIS, V52, P93, DOI 10.1002/dvg.22735; Sun Y, 2013, BIOCHEM J, V449, P39, DOI 10.1042/BJ20121034; Szerencsei RT, 2013, CHANNELS, V7, P109, DOI 10.4161/chan.23898; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wu MP, 2008, BRAIN RES, V1201, P41, DOI 10.1016/j.brainres.2008.01.042; Zhang BM, 2001, BIOCHEMISTRY-US, V40, P3189, DOI 10.1021/bi001675h	43	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138856	10.1371/journal.pone.0138856	http://dx.doi.org/10.1371/journal.pone.0138856			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421717	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700052
J	Kao, HY; Wu, WH; Liang, TY; Lee, KT; Hou, MF; Shi, HY				Kao, Hao-Yun; Wu, Wen-Hsiung; Liang, Tyng-Yeu; Lee, King-The; Hou, Ming-Feng; Shi, Hon-Yi			Cloud-Based Service Information System for Evaluating Quality of Life after Breast Cancer Surgery	PLOS ONE			English	Article							HEALTH-CARE; DIAGNOSIS; POPULATION	Objective Although recent studies have improved understanding of quality of life (QOL) outcomes of breast conserving surgery, few have used longitudinal data for more than two time points, and few have examined predictors of QOL over two years. Additionally, the longitudinal data analyses in such studies rarely apply the appropriate statistical methodology to control for censoring and inter-correlations arising from repeated measures obtained from the same patient pool. This study evaluated an internet-based system for measuring longitudinal changes in QOL and developed a cloud-based system for managing patients after breast conserving surgery. Methods This prospective study analyzed 657 breast cancer patients treated at three tertiary academic hospitals. Related hospital personnel such as surgeons and other healthcare professionals were also interviewed to determine the requirements for an effective cloud-based system for surveying QOL in breast cancer patients. All patients completed the SF-36, Quality of Life Questionnaire (QLQ-C30) and its supplementary breast cancer measure (QLQ-BR23) at baseline, 6 months, 1 year, and 2 years postoperatively. The 95% confidence intervals for differences in responsiveness estimates were derived by bootstrap estimation. Scores derived by these instruments were interpreted by generalized estimating equation before and after surgery. Results All breast cancer surgery patients had significantly improved QLQ-C30 and QLQ-BR23 subscale scores throughout the 2-year follow-up period (p<0.05). During the study period, QOL generally had a negative association with advanced age, high Charlson comorbidity index score, tumor stage III or IV, previous chemotherapy, and long post-operative LOS. Conversely, QOL was positively associated with previous radiotherapy and hormone therapy. Additionally, patients with high scores for preoperative QOL tended to have high scores for QLQ-C30, QLQ-BR23 and SF-36 subscales. Based on the results of usability testing, the five constructs were rated on a Likert scale from 1-7 as follows: system usefulness (5.6 +/- 1.8), ease of use (5.6 +/- 1.5), information quality (5.4 +/- 1.4), interface quality (5.5 +/- 1.4), and overall satisfaction (5.5 +/- 1.6). Conclusions The current trend in clinical medicine is applying therapies and interventions that improve QOL. Therefore, a potentially vast amount of internet-based QOL data is available for use in defining patient populations that may benefit from therapeutic intervention. Additionally, before undergoing breast conserving surgery, patients should be advised that their postoperative QOL depends not only on the success of the surgery, but also on their preoperative functional status.	[Kao, Hao-Yun; Wu, Wen-Hsiung; Lee, King-The; Shi, Hon-Yi] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Liang, Tyng-Yeu] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 80778, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung 807, Taiwan; [Hou, Ming-Feng] Natl Sun Yat Sen Univ Kaohsiung Med Univ Joint Re, Kaohsiung 80708, Taiwan	Kaohsiung Medical University; National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University	Shi, HY (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	hshi@kmu.edu.tw	Kao, Hao-Yun/AAZ-5597-2021; Hao-Yun, Kao/AGD-6394-2022	Kao, Hao-Yun/0000-0002-9390-9314; Hou, Ming-Feng/0000-0001-6030-9702	NSYSU-KMU JOINT RESEARCH PROJECT [NSYSUKMU 104-I005]; National Science Council, Taiwan [NSC 102-2314-B-037-043]	NSYSU-KMU JOINT RESEARCH PROJECT; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research is supported by the NSYSU-KMU JOINT RESEARCH PROJECT, (NSYSUKMU 104-I005) and funding from the National Science Council, Taiwan (NSC 102-2314-B-037-043).	Bates T, 2014, EJSO-EUR J SURG ONC, V40, P1230, DOI 10.1016/j.ejso.2014.06.001; Bhavani SR, 2015, JMIR MED INF, V3, DOI 10.2196/medinform.3709; Fabian B, 2015, INFORM SYST, V48, P132, DOI 10.1016/j.is.2014.05.004; Hamidou Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096848; Kaur PD, 2014, COMPUT METH PROG BIO, V113, P346, DOI 10.1016/j.cmpb.2013.09.013; Kemp A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084835; LEWIS JR, 1995, INT J HUM-COMPUT INT, V7, P57, DOI 10.1080/10447319509526110; Li GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094608; Montazeri A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-330; Shanahan HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102642; Shi HY, 2011, EJSO-EUR J SURG ONC, V37, P695, DOI 10.1016/j.ejso.2011.05.008; Shi HY, 2013, SURG ONCOL, V22, P178, DOI 10.1016/j.suronc.2013.05.004; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; Tsai JT, 2013, SUPPORT CARE CANCER, V21, P1341, DOI 10.1007/s00520-012-1672-8; Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858	15	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139252	10.1371/journal.pone.0139252	http://dx.doi.org/10.1371/journal.pone.0139252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422018	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700083
J	Duncan, MJ; Mota, J; Carvalho, J; Nevill, AM				Duncan, Michael J.; Mota, Jorge; Carvalho, Joana; Nevill, Alan M.			An Evaluation of Prediction Equations for the 6 Minute Walk Test in Healthy European Adults Aged 50-85 Years	PLOS ONE			English	Article							6-MINUTE WALK; ELDERLY SUBJECTS; DISTANCE; RELIABILITY; VALIDITY; INDIVIDUALS; CHILDREN	Objective This study compared actual 6 minute walk test (6MWT) performance with predicted 6MWT using previously validated equations and then determined whether allometric modelling offers a sounder alternative to estimating 6MWT in adults aged 50-80 years. Methods We compared actual 6MWT performance against predicted 6MWT in 125 adults aged 5085 years (62 male, 63 female). In a second sample of 246 adults aged 50-85 years (74 male, 172 female), a new prediction equation for 6MWT performance was developed using allometric modelling. This equation was then cross validated using the same sample that the other prediction equations were compared with. Results Significant relationships were evident between 6MWT actual and 6MWT predicted using all of the commonly available prediction equations (all P<0.05 or better) with the exception of the Alameri et al prediction equation (P>0.05). A series of paired t-tests indicated significant differences between 6MWT actual and 6MWT predicted for all available prediction equations (all P<0.05 or better) with the exception of the Iwama et al equation (P =.540). The Iwama et al equation also had similar bias (79.8m) and a coefficient of variation of over 15%. Using sample 2, a log-linear model significantly predicted 6MWT from the log of body mass and height and age (P = 0.001, adjusted R-2 =.526), predicting 52.6% of the variance in actual 6MWT. When this allometric equation was applied to the original sample, the relationship between 6MWT actual and 6MWT predicted was in excess of values reported for the other previously validated prediction equations (r =.706, P = 0.001). There was a significant difference between actual 6MWT and 6MWT predicted using this new equation (P = 0.001) but the bias, standard deviation of differences and coefficient of variation were all less than for the other equations. Conclusions Where actual assessment of the 6MWT is not possible, the allometrically derived equation presented in the current study, offers a viable alternative which has been cross validated and has the least SD of differences and smallest coefficient of variation compared to any of the previously validated equations for the 6MWT.	[Duncan, Michael J.] Coventry Univ, Ctr Appl Biol & Exercise Sci, Coventry, W Midlands, England; [Mota, Jorge; Carvalho, Joana] Univ Porto, Fac Sports, Res Ctr Phys Act Hlth & Leisure CIAFEL, P-4100 Oporto, Portugal; [Nevill, Alan M.] Wolverhampton Univ, Fac Hlth Educ & Wellbeing, Walsall, W Midlands, England	Coventry University; Universidade do Porto; University of Wolverhampton	Duncan, MJ (corresponding author), Coventry Univ, Ctr Appl Biol & Exercise Sci, Coventry, W Midlands, England.	Michael.duncan@coventry.ac.uk	Nevill, Alan/Q-1010-2019; mota, jorge/B-2980-2013	Nevill, Alan/0000-0003-0506-3652; mota, jorge/0000-0001-7571-9181; Carvalho, Maria Joana/0000-0001-6500-7543; Duncan, Michael/0000-0002-2016-6580				Alameri H, 2009, RESP MED, V103, P1041, DOI 10.1016/j.rmed.2009.01.012; Beriault K, 2009, INT J SPORTS MED, V30, P725, DOI 10.1055/s-0029-1231043; Camarri B, 2006, RESP MED, V100, P658, DOI 10.1016/j.rmed.2005.08.003; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Duncan MJ, 2013, PEDIATR EXERC SCI, V25, P385, DOI 10.1123/pes.25.3.385; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Gibbons W J, 2001, J Cardiopulm Rehabil, V21, P87, DOI 10.1097/00008483-200103000-00005; Iwama AM, 2009, BRAZ J MED BIOL RES, V42, P1080, DOI 10.1590/S0100-879X2009005000032; Jenkins Sue, 2009, Physiotherapy Theory and Practice, V25, P516, DOI [10.1080/09593980802664711, 10.3109/09593980802664711]; Kervio G, 2003, MED SCI SPORT EXER, V35, P169, DOI 10.1097/00005768-200301000-00025; King S, 1999, J RHEUMATOL, V26, P2233; Lin SJ, 2008, ARCH PHYS MED REHAB, V89, P2354, DOI 10.1016/j.apmr.2008.05.021; Maher CA, 2008, INT J REHABIL RES, V31, P185, DOI 10.1097/MRR.0b013e32830150f9; Masmoudi Kaouthar, 2008, Tunis Med, V86, P20; Nevill A, 1997, J SPORT SCI, V15, P457; Nevill AM, 2004, ANN HUM BIOL, V31, P436, DOI 10.1080/03014460410001723996; NEVILL AM, 1992, EUR J APPL PHYSIOL, V65, P110, DOI 10.1007/BF00705066; NEVILL AM, 1995, J APPL PHYSIOL, V79, P1027, DOI 10.1152/jappl.1995.79.3.1027; Poh H, 2006, RESPIROLOGY, V11, P211, DOI 10.1111/j.1440-1843.2006.00820.x; Ries JD, 2009, PHYS THER, V89, P569, DOI 10.2522/ptj.20080258; Rikli RE, 1998, J AGING PHYS ACTIV, V6, P363, DOI 10.1123/japa.6.4.363; Saad HB, 2009, RESP MED, V103, P74, DOI 10.1016/j.rmed.2008.07.023; Steffens D, 2013, PHYSIOTHERAPY, V99, P21, DOI 10.1016/j.physio.2011.11.004; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Vis JC, 2009, ARCH PHYS MED REHAB, V90, P1423, DOI 10.1016/j.apmr.2009.02.015	26	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139629	10.1371/journal.pone.0139629	http://dx.doi.org/10.1371/journal.pone.0139629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418238	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400097
J	Ishtikhar, M; Chandel, TI; Ahmad, A; Ali, MS; Al-lohadan, HA; Atta, AM; Khan, RH				Ishtikhar, Mohd; Chandel, Tajjali Ilm; Ahmad, Aamir; Ali, Mohd Sajid; Al-lohadan, Hamad A.; Atta, Ayman M.; Khan, Rizwan Hasan			Rosin Surfactant QRMAE Can Be Utilized as an Amorphous Aggregate Inducer: A Case Study of Mammalian Serum Albumin	PLOS ONE			English	Article							CIRCULAR-DICHROISM; CATIONIC SURFACTANTS; CORROSION-INHIBITOR; PROTEIN AGGREGATION; AMYLOID FIBRILS; BINDING-SITES; B ISOFORMS; NANOPARTICLES; THYMOQUINONE; FIBRILLATION	Quaternary amine of diethylaminoethyl rosin ester (QRMAE), chemically synthesized bio-compatible rosin based cationic surfactant, has various biological applications including its use as a food product additive. In this study, we examined the amorphous aggregation behavior of mammalian serum albumins at pH 7.5, i.e., two units above their isoelectric points (pI similar to 5.5), and the roles played by positive charge and hydrophobicity of exogenously added rosin surfactant QRMAE. The study was carried out on five mammalian serum albumins, using various spectroscopic methods, dye binding assay, circular dichroism and electron microscopy. The thermodynamics of the binding of mammalian serum albumins to cationic rosin modified surfactant were established using isothermal titration calorimetry (ITC). It was observed that a suitable molar ratio of protein to QRMAE surfactant enthusiastically induces amorphous aggregate formation at a pH above two units of pI. Rosin surfactant QRMAE-albumins interactions revealed a unique interplay between the initial electrostatic and the subsequent hydrophobic interactions that play an important role towards the formation of hydrophobic interactions-driven amorphous aggregate. Amorphous aggregation of proteins is associated with varying diseases, from the formation of protein wine haze to the expansion of the eye lenses in cataract, during the expression and purification of recombinant proteins. This study can be used for the design of novel biomolecules or drugs with the ability to neutralize factor(s) responsible for the aggregate formation, in addition to various other industrial applications.	[Ishtikhar, Mohd; Chandel, Tajjali Ilm; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Prot Biophys Lab, Aligarh 202002, Uttar Pradesh, India; [Ahmad, Aamir] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Ali, Mohd Sajid; Al-lohadan, Hamad A.; Atta, Ayman M.] King Saud Univ, Coll Sci, Dept Chem, Surfactant Res Chair, Riyadh 11541, Saudi Arabia	Aligarh Muslim University; Barbara Ann Karmanos Cancer Institute; Wayne State University; King Saud University	Khan, RH (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Prot Biophys Lab, Aligarh 202002, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Ali, Mohd Sajid/C-5334-2011; Khan, Rizwan Hasan/F-8276-2014; atta, ayman/ABK-3417-2022; Khan, Rizwan/GXZ-5789-2022; CHANDEL, TAJALLI ILM/AAU-5662-2020; Ishtikhar, Mohd/AAK-8918-2020; atta, ayman/E-9273-2017	Ali, Mohd Sajid/0000-0003-0191-9708; Khan, Rizwan Hasan/0000-0002-9965-8982; CHANDEL, TAJALLI ILM/0000-0002-6082-5544; atta, ayman/0000-0002-9613-3099; Ishtikhar, Mohd/0000-0001-5116-2470	Indian Council of Medical Research (ICMR), New Delhi, India [BIC/11(12)/2013]; Deanship of Scientific Research at King Saud University [RGP-148]	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Deanship of Scientific Research at King Saud University(King Saud University)	The financial assistance for the authors was provided by Indian Council of Medical Research (ICMR), New Delhi, India, [BIC/11(12)/2013] in the form of senior research fellowship (http://icmr.nic.in). The authors would also like to thank Deanship of Scientific Research at King Saud University for funding to the research group Project no. RGP-148. The funding agency has no role/no objection for study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Ahmad E, 2013, J BIOMOL STRUCT DYN, V31, P630, DOI 10.1080/07391102.2012.706081; Ahmad E, 2011, CELL BIOCHEM BIOPHYS, V61, P313, DOI 10.1007/s12013-011-9214-4; Atta AM, 2014, INT J MOL SCI, V15, P6974, DOI 10.3390/ijms15046974; Atta AM, 2013, INT J ELECTROCHEM SC, V8, P9629; Atta AM, 2011, J APPL POLYM SCI, V122, P183, DOI 10.1002/app.34052; Bai GY, 2001, LANGMUIR, V17, P3522, DOI 10.1021/la000768x; Belatik A, 2012, EUR J MED CHEM, V48, P114, DOI 10.1016/j.ejmech.2011.12.002; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Cordeiro Y, 2006, BIOPHYS J, V91, P957, DOI 10.1529/biophysj.106.085928; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; El-Mahdy GA, 2013, INT J ELECTROCHEM SC, V8, P5052; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Gull N, 2015, J COLLOID INTERF SCI, V439, P170, DOI 10.1016/j.jcis.2014.10.012; Hebia C, 2014, J PHOTOCH PHOTOBIO B, V130, P254, DOI 10.1016/j.jphotobiol.2013.11.025; Huang H, 2011, ANALYST, V136, P1747, DOI 10.1039/c0an00890g; Ishtikhar M., 2015, J BIOMOL STRUCT DYN, P1, DOI DOI 10.1080/07391102.2015.1054433; Ishtikhar M, 2015, J LUMIN, V167, P399, DOI 10.1016/j.jlumin.2015.06.012; Ishtikhar M, 2015, INT J BIOL MACROMOL, V78, P379, DOI 10.1016/j.ijbiomac.2015.03.069; Ishtikhar M, 2015, RSC ADV, V5, P18218, DOI 10.1039/c4ra09892g; Ishtikhar M, 2014, COLLOID SURFACE B, V123, P469, DOI 10.1016/j.colsurfb.2014.09.044; Ishtikhar M, 2014, MOL BIOSYST, V10, P2954, DOI 10.1039/c4mb00306c; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Kang J, 2004, BBA-GEN SUBJECTS, V1674, P205, DOI 10.1016/j.bbagen.2004.06.021; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; Khan JM, 2014, SOFT MATTER, V10, P2591, DOI 10.1039/c3sm52435c; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; Khan MV, 2015, INT J BIOL MACROMOL, V78, P417, DOI 10.1016/j.ijbiomac.2015.04.021; Kumar S, 2008, J FLUORESC, V18, P1199, DOI 10.1007/s10895-008-0378-2; Kundu B, 2002, BIOCHEM BIOPH RES CO, V293, P572, DOI 10.1016/S0006-291X(02)00257-7; Liu XQ, 2009, GREEN CHEM, V11, P1018, DOI 10.1039/b903955d; Liu Y, 2005, SPECTROCHIM ACTA A, V61, P2245, DOI 10.1016/j.saa.2004.09.004; Liu Y, 2003, SPECTROCHIM ACTA A, V59, P2747, DOI 10.1016/S1386-1425(03)00055-6; Liu Z, 2014, LANGMUIR, V30, P7968, DOI 10.1021/la501656s; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; MAITI S, 1989, PROG POLYM SCI, V14, P297, DOI 10.1016/0079-6700(89)90005-1; Nada T, 2003, BIOPHYS J, V85, P1876, DOI 10.1016/S0006-3495(03)74615-3; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Norvaisas P, 2012, J PHYS CHEM B, V116, P2138, DOI 10.1021/jp2095888; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Pandey NK, 2014, J BIOMOL STRUCT DYN, V32, P1366, DOI 10.1080/07391102.2013.819300; Qadeer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050633; Sedaghat R, 2014, IRAN J PHARM RES, V13, P227; Selkoe D.J., 2011, COLD SPRING HARB PER, V3; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stranks SD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051907; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Varshney A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017230; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Vetri V, 2007, BIOPHYS CHEM, V125, P184, DOI 10.1016/j.bpc.2006.07.012; Vonhoff S, 2010, J PHARMACEUT BIOMED, V51, P39, DOI 10.1016/j.jpba.2009.07.031; Wang SSS, 2011, BBA-MOL CELL BIOL L, V1811, P301, DOI 10.1016/j.bbalip.2011.02.003; Waters EJ, 2005, AUST J GRAPE WINE R, V11, P215, DOI 10.1111/j.1755-0238.2005.tb00289.x; Zheng Y, 2010, MACROMOLECULES, V43; Zsila F, 2013, J PHYS CHEM B, V117, P10798, DOI 10.1021/jp4067108	64	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139027	10.1371/journal.pone.0139027	http://dx.doi.org/10.1371/journal.pone.0139027			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418451	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400035
J	Martinelle, L; Poskin, A; Dal Pozzo, F; De Regge, N; Cay, B; Saegerman, C				Martinelle, Ludovic; Poskin, Antoine; Dal Pozzo, Fabiana; De Regge, Nick; Cay, Brigitte; Saegerman, Claude			Experimental Infection of Sheep at 45 and 60 Days of Gestation with Schmallenberg Virus Readily Led to Placental Colonization without Causing Congenital Malformations	PLOS ONE			English	Article							AKABANE VIRUS; CULICOIDES SPP.; NEWBORN LAMBS; CATTLE; ARTHROGRYPOSIS; ABNORMALITIES; CALVES; FETUSES; IMPACT	Background Main impact of Schmallenberg virus (SBV) on livestock consists in reproductive disorders, with teratogenic effects, abortions and stillbirths. SBV pathogenesis and viral placental crossing remain currently poorly understood. Therefore, we implemented an experimental infection of ewes, inoculated with SBV at 45 or 60 days of gestation (dg). Methodology "Mourerous" breed ewes were randomly separated in three groups: eight and nine ewes were subcutaneously inoculated with 1 ml of SBV infectious serum at 45 and 60 dg, respectively (G45 and G60). Six other ewes were inoculated subcutaneously with sterile phosphate buffer saline as control group. All SBV inoculated ewes showed RNAemia consistent with previously published studies, they seroconverted and no clinical sign was reported. Lambs were born at term via caesarian-section, and right after birth they were blood sampled and clinically examined. Then both lambs and ewes were euthanatized and necropsied. Principal Findings/Significance No lambs showed any malformation suggestive of SBV infection and none of them had RNAemia or anti-SBV antibodies prior to colostrum uptake. Positive SBV RNA detection in organs was rare in both G45 and G60 lambs (2/11 and 1/10, respectively). Nevertheless most of the lambs in G45 (9/11) and G60 (9/10) had at least one extraembryonic structure SBV positive by RTqPCR. The number of positive extraembryonic structures was significantly higher in G60 lambs. Time of inoculation (45 or 60 dg) had no impact on the placental colonization success rate but affected the frequency of detecting the virus in the offspring extraembryonic structures by the time of lambing. SBV readily colonized the placenta when ewes were infected at 45 or 60 dg but infection of the fetuses was limited and did not lead to congenital malformations.	[Martinelle, Ludovic; Poskin, Antoine; Dal Pozzo, Fabiana; Saegerman, Claude] Univ Liege, Fac Vet Med, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, FARAH, Liege, Belgium; [Poskin, Antoine; De Regge, Nick; Cay, Brigitte] Vet & Agrochem Res Ctr CODA CERVA, Operat Directorate Viral Dis, Brussels, Belgium	University of Liege	Martinelle, L (corresponding author), Univ Liege, Fac Vet Med, Res Unit Epidemiol & Risk Anal Appl Vet Sci UREAR, FARAH, Liege, Belgium.	lmartinelle@ulg.ac.be		Saegerman, Claude/0000-0001-9087-7436; Martinelle, Ludovic/0000-0002-7875-8722	Federal Public Service Public Health and Safety of the Food Chain and Environment [RF12/6270]; European Union as outlined in Council by the Union for studies on Schmallenberg virus [2012/349/EU]	Federal Public Service Public Health and Safety of the Food Chain and Environment; European Union as outlined in Council by the Union for studies on Schmallenberg virus	This study was financially supported by Federal Public Service Public Health and Safety of the Food Chain and Environment (RF12/6270), and the European Union as outlined in Council Decision 2012/349/EU concerning a financial contribution by the Union for studies on Schmallenberg virus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecia JA, 2011, VET CLIN N AM-FOOD A, V27, P67, DOI 10.1016/j.cvfa.2010.10.001; Afonso A, 2014, PREV VET MED, V116, P391, DOI 10.1016/j.prevetmed.2014.02.012; Balseiro A, 2013, 1 CONFIRMATION SCHMA; Barbato O, 2009, THERIOGENOLOGY, V72, P993, DOI 10.1016/j.theriogenology.2009.06.020; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; CLARKE GL, 1978, VET PATHOL, V15, P68, DOI 10.1177/030098587801500109; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; De Regge N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087005; De Regge N, 2013, VET MICROBIOL, V162, P595, DOI 10.1016/j.vetmic.2012.11.029; Dominguez M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0248-x; EDWARDS JF, 1989, VET PATHOL, V26, P33, DOI 10.1177/030098588902600106; Elliott RM, 2009, CLIN MICROBIOL INFEC, V15, P510, DOI 10.1111/j.1469-0691.2009.02849.x; EU consortium, 2014, SCHMALL VIR TECHN SC; EVANS CAN, 1974, J PHYSIOL-LONDON, V238, P371, DOI 10.1113/jphysiol.1974.sp010530; Gubbins S, 2014, PREV VET MED, V116, P404, DOI 10.1016/j.prevetmed.2014.02.004; HASHIGUCHI Y, 1979, NATL I ANIM HEALTH Q, V19, P1; Herder V, 2012, VET PATHOL, V49, P588, DOI 10.1177/0300985812447831; Herder V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062939; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Jackson P., 2002, CLIN EXAMINATION FAR, V1rd; KUROGI H, 1975, ARCH VIROL, V47, P71, DOI 10.1007/BF01315594; KUROGI H, 1976, ARCH VIROL, V51, P67, DOI 10.1007/BF01317835; KUROGI H, 1977, INFECT IMMUN, V17, P338, DOI 10.1128/IAI.17.2.338-343.1977; LAWN AM, 1969, J ANAT, V105, P557; Luttikholt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100135; Martinelle L, 2017, TRANSBOUND EMERG DIS, V64, P305, DOI 10.1111/tbed.12356; PARSONSON IM, 1988, J COMP PATHOL, V99, P215, DOI 10.1016/0021-9975(88)90073-4; PARSONSON IM, 1977, INFECT IMMUN, V15, P254, DOI 10.1128/IAI.15.1.254-262.1977; Peperkamp NH, 2014, VET PATHOLOGY; Poskin A, 2014, VET J, V201, P419, DOI 10.1016/j.tvjl.2014.05.031; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Scharpenberg LG, 1938, J ANAT, V72, P344; Sedda L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03361; Seehusen F, 2014, J COMP PATHOL, V151, P148, DOI 10.1016/j.jcpa.2014.04.006; SILVERSTEIN AM, 1963, J EXP MED, V117, P799, DOI 10.1084/jem.117.5.799; Stockhofe N, 2013, EP 7 ANN M 2013 1 4; Takken W, 2008, PREV VET MED, V87, P41, DOI 10.1016/j.prevetmed.2008.06.015; van Maanen C, 2012, VET REC, V171, P299, DOI 10.1136/vr.101061; Varela M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003133; Veldhuis AMB, 2014, VET MICROBIOL, V168, P281, DOI 10.1016/j.vetmic.2013.11.021; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Wemike K, 2013, DEV BIOLOGICALS, V135, P175, DOI 10.1159/000312546; Wernike K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098223; Wernike K, 2013, VET MICROBIOL, V166, P461, DOI 10.1016/j.vetmic.2013.06.030; Wernike K, 2013, VET MICROBIOL, V165, P155, DOI 10.1016/j.vetmic.2013.01.040; Wernike K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-84; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013	47	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139375	10.1371/journal.pone.0139375	http://dx.doi.org/10.1371/journal.pone.0139375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418420	Green Submitted, Green Published, gold			2022-12-27	WOS:000362171400085
J	Podesta, M; Bruschettini, M; Cossu, C; Sabatini, F; Dagnino, M; Romantsik, O; Spaggiari, GM; Ramenghi, LA; Frassoni, F				Podesta, Marina; Bruschettini, Matteo; Cossu, Claudia; Sabatini, Federica; Dagnino, Monica; Romantsik, Olga; Spaggiari, Grazia Maria; Ramenghi, Luca Antonio; Frassoni, Francesco			Preterm Cord Blood Contains a Higher Proportion of Immature Hematopoietic Progenitors Compared to Term Samples	PLOS ONE			English	Article							STEM; CELLS; ONTOGENY; INFANTS; MARROW; EMERGE	Background Cord blood contains high number of hematopoietic cells that after birth disappear. In this paper we have studied the functional properties of the umbilical cord blood progenitor cells collected from term and preterm neonates to establish whether quantitative and/or qualitative differences exist between the two groups. Methods and Results Our results indicate that the percentage of total CD34+ cells was significantly higher in preterm infants compared to full term: 0.61% (range 0.15-4.8) vs 0.3% (0.032-2.23) p = 0.0001 and in neonates <32 weeks of gestational age (GA) compared to those >= 32 wks GA: 0.95%(range 0.18-4.8) and 0.36% (0.15-3.2) respectively p = 0.0025. The majority of CD34+ cells co-expressed CD71 antigen (p<0.05 preterm vs term) and grew in vitro large BFU-E, mostly in the second generation. The subpopulations CD34+ CD38- and CD34 +CD45-resulted more represented in preterm samples compared to term, conversely, Side Population (SP) did not show any difference between the two group. The absolute number of preterm colonies (CFCs/10microL) resulted higher compared to term (p = 0.004) and these progenitors were able to grow until the third generation maintaining an higher proportion of CD34+ cells (p = 0.0017). The number of colony also inversely correlated with the gestational age (Pearson r = -0.3001 p<0.0168). Conclusions We found no differences in the isolation and expansion capacity of Endothelial Colony Forming Cells (ECFCs) from cord blood of term and preterm neonates: both groups grew in vitro large number of endothelial cells until the third generation and showed a transitional phenotype between mesenchymal stem cells and endothelial progenitors (CD73, CD31, CD34 and CD144) The presence, in the cord blood of preterm babies, of high number of immature hematopoietic progenitors and endothelial/ mesenchymal stem cells with high proliferative potential makes this tissue an important source of cells for developing new cells therapies.	[Podesta, Marina; Cossu, Claudia; Sabatini, Federica; Dagnino, Monica; Frassoni, Francesco] IRCCS Ist Giannina Gaslini, Lab Cellule Staminali Postnatali & Terapie Cellul, Genoa, Italy; [Bruschettini, Matteo; Romantsik, Olga] Lund Univ, Inst Clin Sci, Dept Pediat, Neonatal Intens Care Unit, Lund, Sweden; [Spaggiari, Grazia Maria] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy; [Ramenghi, Luca Antonio] IRCCS Ist Giannina Gaslini, Neonatal Intens Care Unit, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Lund University; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini	Podesta, M (corresponding author), IRCCS Ist Giannina Gaslini, Lab Cellule Staminali Postnatali & Terapie Cellul, Genoa, Italy.	marinapodesta@ospedale-gaslini.ge.it	matteo, bruschettini/J-6030-2019; Bruschettini, Matteo/G-2613-2010; Frassoni, Francesco/K-3971-2018; Sabatini, Federica/J-5984-2016; Ramenghi, Luca/AAB-4067-2020; Podestà, Marina/K-3875-2016	matteo, bruschettini/0000-0002-4775-872X; Bruschettini, Matteo/0000-0002-4775-872X; Frassoni, Francesco/0000-0003-1262-0648; Sabatini, Federica/0000-0003-2271-2597; Ramenghi, Luca/0000-0003-0065-762X; Podestà, Marina/0000-0002-6755-613X; SPAGGIARI, GRAZIA MARIA/0000-0002-0981-3265; Romantsik, Olga/0000-0003-1414-9386				[Anonymous], 2013, NETCORD FACT INT STA; Ballen KK, 2015, BONE MARROW TRANSPL, V50, P1271, DOI 10.1038/bmt.2015.124; Borghesi A, 2009, AM J RESP CRIT CARE, V180, P540, DOI 10.1164/rccm.200812-1949OC; Burger D, 2015, AM J PATHOL, V185, P2309, DOI 10.1016/j.ajpath.2015.04.010; Charbord P, 1996, BLOOD, V87, P4109, DOI 10.1182/blood.V87.10.4109.bloodjournal87104109; D'Alessio F, 2011, CYTOM PART A, V79A, P14, DOI 10.1002/cyto.a.20989; Dang D, 2015, J OBSTET GYNAECOL RE, V41, P890, DOI 10.1111/jog.12657; DELAGRANGE PB, 2013, STEM CELL RES, V11, P625, DOI DOI 10.1016/J.SCR.2013.04.003; Dong HY, 2011, AM J SURG PATHOL, V35, P723, DOI 10.1097/PAS.0b013e31821247a8; Frandberg S, 2015, TRANSFUSION, V55, P1283, DOI 10.1111/trf.13013; Fung ME, 2014, PEDIATR RES, V75, P2, DOI 10.1038/pr.2013.176; Golub R, 2013, BLOOD CELL MOL DIS, V51, P226, DOI 10.1016/j.bcmd.2013.08.004; Granados-Riveron Javier T., 2015, BioMolecular Concepts, V6, P157, DOI 10.1515/bmc-2015-0004; Hong SH, 2011, J CELL SCI, V124, P1445, DOI 10.1242/jcs.077511; Isern J, 2011, BLOOD, V117, P4924, DOI 10.1182/blood-2010-10-313676; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Jeanblanc C, 2014, BRIT J HAEMATOL, V166, P268, DOI 10.1111/bjh.12870; Jing L, 2015, J EXP MED, V212, P649, DOI 10.1084/jem.20141528; Ling F, 2014, CURR TOP DEV BIOL, V110, P189, DOI 10.1016/B978-0-12-405943-6.00005-1; Luzo ACM, 2007, VOX SANG, V93, P145, DOI 10.1111/j.1423-0410.2007.00936.x; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; Mizuochi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035763; Montemurro T, 2011, J CELL MOL MED, V15, P796, DOI 10.1111/j.1582-4934.2010.01047.x; Nakajima M, 2009, BIOCHEM BIOPH RES CO, V389, P290, DOI 10.1016/j.bbrc.2009.08.139; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; Podesta M, 1998, BLOOD, V91, P1959, DOI 10.1182/blood.V91.6.1959.1959_1959_1965; PRASAIN N, 2012, JOVE-J VIS EXP   APR, P26095, DOI DOI 10.3791/3872; Robin C, 2009, CELL STEM CELL, V5, P385, DOI 10.1016/j.stem.2009.08.020; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Serke S, 2001, BONE MARROW TRANSPL, V27, P463, DOI 10.1038/sj.bmt.1702813; Shah N, 2015, CYTOTHERAPY, V17, P693, DOI 10.1016/j.jcyt.2015.03.001; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Wisgrill L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106717; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yu WJ, 2014, CURR STEM CELL RES T, V9, P196, DOI 10.2174/1574888X09666140213154144; Zhu DD, 2014, CYTOTHERAPY, V16, P1614, DOI 10.1016/j.jcyt.2014.06.004	38	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138680	10.1371/journal.pone.0138680	http://dx.doi.org/10.1371/journal.pone.0138680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417990	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400019
J	Hail-Jares, K; Chang, RCF; Choi, S; Zheng, H; He, N; Huang, ZJ				Hail-Jares, Katie; Chang, Ruth C. F.; Choi, Sugy; Zheng, Huang; He, Na; Huang, Z. Jennifer			Intimate-Partner and Client-Initiated Violence among Female Street-Based Sex Workers in China: Does a Support Network Help?	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; SOCIAL SUPPORT; DOMESTIC VIOLENCE; RISK-FACTORS; SELF-ESTEEM; HIV RISK; SUBSTANCE-ABUSE; HOST-RESISTANCE; MENTAL-HEALTH; WOMEN	Background Globally, female street-based sex workers are vulnerable to gender-based violence. Previous research has shown having a peer social network can reduce sex workers' risks of victimization. However, mechanisms of how social network impacts violence among female street-based sex workers are still far from clear. Methods Our study was based on data abstracted from a paper-and-pencil survey administered among 218 female street-based sex workers in Shanghai, China. We focused on selfreported client-initiated violence and intimate-partner violence in emotional, physical, and sexual forms. Social networks were characterized by the size and sources of financial and psychosocial support (e.g. family, friends, and peers). Multi-variable logistic regression was used to estimate adjusted odds ratios (AOR) of each type of violence exposure by social network structure after the adjustment of age, education, and years in Shanghai. Results The street-based female sex workers in our study were primarily rural-to-urban migrants (95.7%) with an average age of 41 years old. 24.3% and 62.8% of the sex workers reported intimate-partner violence and client-initiated violence respectively. Lack of financial support, as defined by having only one individual or none in her peer support system to help financially, was significantly associated with self-reported intimate-partner violence (AOR: 2.5; 95% CI: 1.1-5.9). Respondents who reported client-initiated violence, by contrast, were more likely to report lacked psychosocial support from family (AOR: 2.2, 95% CI: 1.0-4.6) and peers (AOR: 5.1, 95% CI: 2.2-11). Conclusion This study is one of the first to systematically analyze the associations between social network and gender-based violence among street-based female sex worker. We reported a high prevalence of both types of gender-based violence and their complex associations with family, friends, and peer support network. Policies with goals to reduce violence against women may apply these findings to leverage social network in the interventions against gender-based violence.	[Hail-Jares, Katie; Choi, Sugy; Huang, Z. Jennifer] Georgetown Univ, Sch Nursing & Hlth Studies, Dept Int Hlth, Washington, DC 20057 USA; [Chang, Ruth C. F.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Zheng, Huang] Shanghai Piao Xue, Shanghai, Peoples R China; [He, Na] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China	Georgetown University; Columbia University; Fudan University	Huang, ZJ (corresponding author), Georgetown Univ, Sch Nursing & Hlth Studies, Dept Int Hlth, Washington, DC 20057 USA.	zh34@georgetown.edu		Hail-Jares, Katie/0000-0003-3732-1935; Choi, Sugy/0000-0002-5549-2861	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD-066362]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066362] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	ZJH received an R21 funding from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), with grant number as HD-066362. NICHD website: [http://www.nichd.nih.gov]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BD, 2005, J SEX RES, V42, P238, DOI 10.1080/00224490509552278; Argento E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102129; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Beeble ML, 2009, J CONSULT CLIN PSYCH, V77, P718, DOI 10.1037/a0016140; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; BROWNELL A, 1984, J SOC ISSUES, V40, P1, DOI 10.1111/j.1540-4560.1984.tb01104.x; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Carlson BE, 2002, VIOLENCE AGAINST WOM, V8, P720, DOI 10.1177/10778010222183251; Carlson CE, 2012, J INTERPERS VIOLENCE, V27, P1911, DOI 10.1177/0886260511431439; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; Chen JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118651; Chen R., 2014, PLOS ONE, V9; Choi SYP, 2008, SEX TRANSM DIS, V35, P141, DOI 10.1097/OLQ.0b013e31815407c3; Church S, 2001, BMJ-BRIT MED J, V322, P524, DOI 10.1136/bmj.322.7285.524; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Coker AL, 2007, TRAUMA VIOLENCE ABUS, V8, P149, DOI 10.1177/1524838007301162; Cutrona C. E., 1990, SOCIAL SUPPORT INTER, P319, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Das P, 2015, LANCET, V385, P3, DOI 10.1016/S0140-6736(14)61064-3; Decker MR, 2014, J ADOLESCENT HEALTH, V55, pS58, DOI 10.1016/j.jadohealth.2014.08.022; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Dowshen N, 2009, AIDS PATIENT CARE ST, V23, P371, DOI 10.1089/apc.2008.0256; Dutton MA, 2009, TRAUMA VIOLENCE ABUS, V10, P211, DOI 10.1177/1524838009334451; El-Bassel N, 2001, AIDS PATIENT CARE ST, V15, P41, DOI 10.1089/108729101460092; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Erausquin JT, 2011, J INFECT DIS, V204, pS1223, DOI 10.1093/infdis/jir539; Gielen A.C., 2002, AIDS BEHAV, V6, P107, DOI DOI 10.1023/A:1015494513192; Goldenberg SM, 2014, J URBAN HEALTH, V91, P736, DOI 10.1007/s11524-014-9888-1; Gonzaalez-Guarda RM, 2008, J ASSOC NURSE AIDS C, V19, P252, DOI 10.1016/j.jana.2008.04.001; Goodyear MDE, 2007, BMJ-BRIT MED J, V334, P52, DOI 10.1136/bmj.39087.642801.BE; Hao C, 2014, CULT HEALTH SEX, V16, P47, DOI 10.1080/13691058.2013.826820; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; HOBFOLL SE, 1993, J COMMUNITY PSYCHOL, V21, P128, DOI 10.1002/1520-6629(199304)21:2<128::AID-JCOP2290210206>3.0.CO;2-5; HONG Y, 2013, PLOS ONE, V8; Hong Y, 2008, AIDS BEHAV, V12, P623, DOI 10.1007/s10461-007-9287-7; Hong Y, 2010, J TRANSCULT NURS, V21, P29, DOI 10.1177/1043659609349063; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Huang ZJ, 2015, CULT HEALTH SEX, V17, P763, DOI 10.1080/13691058.2014.990518; Huang ZJ, 2012, AIDS BEHAV, V16, P858, DOI 10.1007/s10461-011-0119-4; Jenkins C, 2002, AIDS EDUC PREV, V14, P97, DOI 10.1521/aeap.14.4.97.23882; Kalra G, 2013, INDIAN J PSYCHIAT, V55, P244, DOI 10.4103/0019-5545.117139; Karandikar S, 2010, J INTERPERS VIOLENCE, V25, P257, DOI 10.1177/0886260509334393; Kerrigan D, 2015, LANCET, V385, P172, DOI 10.1016/S0140-6736(14)60973-9; Kim JY, 2011, J INTERPERS VIOLENCE, V26, P2991, DOI 10.1177/0886260510390946; Klot JF, 2013, AM J REPROD IMMUNOL, V69, P2, DOI 10.1111/aji.12037; Krantz G, 2002, J EPIDEMIOL COMMUN H, V56, P242, DOI 10.1136/jech.56.4.242; Krusi A, 2012, AM J PUBLIC HEALTH, V102, P1154, DOI 10.2105/AJPH.2011.300638; Kurtz SP, 2004, VIOLENCE AGAINST WOM, V10, P357, DOI 10.1177/1077801204263199; Lang DL, 2013, AIDS BEHAV, V17, P551, DOI 10.1007/s10461-012-0245-7; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Lowman J., 2000, VIOLENCE AGAINST WOM, V6, P987, DOI DOI 10.1177/10778010022182245; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; McDonnell KA, 2011, J URBAN HEALTH, V88, P240, DOI 10.1007/s11524-011-9546-9; Merrill GS, 2000, J HOMOSEXUAL, V39, P1, DOI 10.1300/J082v39n02_01; MITCHELL RE, 1983, AM J COMMUN PSYCHOL, V11, P629, DOI 10.1007/BF00896600; Moskowitz D, 2013, J URBAN HEALTH, V90, P175, DOI 10.1007/s11524-012-9757-8; Moskowitz DA, 2011, AIDS BEHAV, V15, P621, DOI 10.1007/s10461-010-9692-1; Odinokova V, 2014, INT J DRUG POLICY, V25, P96, DOI 10.1016/j.drugpo.2013.06.008; Panchanadeswaran S, 2008, INT J DRUG POLICY, V19, P106, DOI 10.1016/j.drugpo.2007.11.013; Parish WL, 2004, INT FAM PLAN PERSPEC, V30, P174, DOI 10.1363/3017404; Potterat JJ, 2004, AM J EPIDEMIOL, V159, P778, DOI 10.1093/aje/kwh110; Preston DB, 2007, AIDS EDUC PREV, V19, P218, DOI 10.1521/aeap.2007.19.3.218; Ramirez-Valles J, 2005, AIDS BEHAV, V9, P387, DOI 10.1007/s10461-005-9012-3; Ratinthorn A, 2009, HEALTH CARE WOMEN IN, V30, P249, DOI 10.1080/07399330902733281; RENZETTI CM, 1989, FAM RELAT, V38, P157, DOI 10.2307/583669; Rizo CF, 2011, AGGRESS VIOLENT BEH, V16, P250, DOI 10.1016/j.avb.2011.03.004; Sanders T, 2004, URBAN STUD, V41, P1703, DOI 10.1080/0042098042000243110; Scambler G, 2008, SOC SCI MED, V66, P1848, DOI 10.1016/j.socscimed.2008.01.002; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; Seib C, 2009, SEX HEALTH, V6, P45, DOI 10.1071/SH08038; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Stockman JK, 2012, AIDS BEHAV, V16, P1877, DOI 10.1007/s10461-012-0235-9; Stokes JP, 1998, AIDS EDUC PREV, V10, P278; Su SB, 2014, AIDS CARE, V26, P1019, DOI 10.1080/09540121.2013.878780; Suvak MK, 2013, J CONSULT CLIN PSYCH, V81, P455, DOI 10.1037/a0031787; Sylaska KM, 2014, TRAUMA VIOLENCE ABUS, V15, P3, DOI 10.1177/1524838013496335; Taylor SE, 2007, PSYCHOL SCI, V18, P831, DOI 10.1111/j.1467-9280.2007.01987.x; Teng P, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.26528; Thompson MP, 2000, AM J COMMUN PSYCHOL, V28, P127, DOI 10.1023/A:1005198514704; Thompson RS, 2000, AM J PREV MED, V19, P253, DOI 10.1016/S0749-3797(00)00231-2; Tucker JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024816; Turell SC, 2008, J LESBIAN STUD, V12, P211, DOI 10.1080/10894160802161372; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Walters ML, 2011, J GAY LESBIAN SOC SE, V23, P250, DOI 10.1080/10538720.2011.559148; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Weiss R., 1974, DOING OTHERS, P17; Wong E., 2013, NY TIMES; Wuest J, 2008, J PAIN, V9, P1049, DOI 10.1016/j.jpain.2008.06.009; Xia GM, 2005, AIDS EDUC PREV, V17, P143, DOI 10.1521/aeap.17.3.143.62904; Xiao S., 1993, CHINESE MENTAL HLT S, V7, P42; Xu J, 2014, PUBLIC HEALTH, V128, P430, DOI 10.1016/j.puhe.2014.03.002; Xu X, 2005, AM J PUBLIC HEALTH, V95, P78, DOI 10.2105/AJPH.2003.023978; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Yoshihama M, 2009, FACTS STATS DOMESTIC; Zhang C, 2012, AIDS BEHAV, V16, P1020, DOI 10.1007/s10461-011-9968-0; Zhang H, 2015, J HUAZHONG U SCI-MED, V35, P405, DOI 10.1007/s11596-015-1445-y; Zhang WJ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0053-0	100	16	17	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139161	10.1371/journal.pone.0139161	http://dx.doi.org/10.1371/journal.pone.0139161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EO	26413776	Green Published, gold			2022-12-27	WOS:000362170700048
J	Namjou, B; Marsolo, K; Lingren, T; Ritchie, MD; Verma, SS; Cobb, BL; Perry, C; Kitchner, TE; Brilliant, MH; Peissig, PL; Borthwick, KM; Williams, MS; Grafton, J; Jarvik, GP; Holm, IA; Harley, JB				Namjou, Bahram; Marsolo, Keith; Lingren, Todd; Ritchie, Marylyn D.; Verma, Shefali S.; Cobb, Beth L.; Perry, Cassandra; Kitchner, Terrie E.; Brilliant, Murray H.; Peissig, Peggy L.; Borthwick, Kenneth M.; Williams, Marc S.; Grafton, Jane; Jarvik, Gail P.; Holm, Ingrid A.; Harley, John B.			A GWAS Study on Liver Function Test Using eMERGE Network Participants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SERUM BILIRUBIN LEVELS; ALKALINE-PHOSPHATASE; ACTIVE METABOLITE; UGT1A1 GENE; POLYMORPHISMS; VARIANTS; LOCI; ABO; UGT1A1-ASTERISK-28	Introduction Liver enzyme levels and total serum bilirubin are under genetic control and in recent years genome-wide population-based association studies have identified different susceptibility loci for these traits. We conducted a genome-wide association study in European ancestry participants from the Electronic Medical Records and Genomics (eMERGE) Network dataset of patient medical records with available genotyping data in order to identify genetic contributors to variability in serum bilirubin levels and other liver function tests and to compare the effects between adult and pediatric populations. Methods The process of whole genome imputation of eMERGE samples with standard quality control measures have been described previously. After removing missing data and outliers based on principal components (PC) analyses, 3294 samples from European ancestry were used for the GWAS study. The association between each single nucleotide polymorphism (SNP) and total serum bilirubin and other liver function tests was tested using linear regression, adjusting for age, gender, site, platform and ancestry principal components (PC). Results Consistent with previous results, a strong association signal has been detected for UGT1A gene cluster (best SNP rs887829, beta = 0.15, p = 1.30x10(-118)) for total serum bilirubin level. Indeed, in this region more than 176 SNPs (or indels) had p<10(-8) spanning 150Kb on the long arm of chromosome 2q37.1. In addition, we found a similar level of magnitude in a pediatric group (p = 8.26x10(-47), beta = 0.17). Further imputation using sequencing data as a reference panel revealed association of other markers including known TA7 repeat indels (rs8175347) (p = 9.78x10(-117)) and rs111741722 (p = 5.41x10(-119)) which were in proxy (r2 = 0.99) with rs887829. Among rare variants, two Asian subjects homozygous for coding SNP rs4148323 (G71R) were identified. Additional known effects for total serum bilirubin were also confirmed including organic anion transporters SLCO1B1-SLCO1B3, TDRP and ZMYND8 at FDR<0.05 with no gene-gene interaction effects. Phenome-wide association studies (PheWAS) suggest a protective effect of TA7 repeat against cerebrovascular disease in an adult cohort (OR = 0.75, p = 0.0008). Among other liver function tests, we also confirmed the previous effect of the ABO blood group locus for variation in serum alkaline phosphatase (rs579459, p = 9.44x10(-15)). Conclusions Taken together, our data present interesting findings with strong confirmation of previous effects by simply using the eMERGE electronic health record phenotyping. In addition, our findings indicate that similar to the adult population, the UGT1A1 is the main locus responsible for normal variation of serum bilirubin in pediatric populations.	[Namjou, Bahram; Cobb, Beth L.; Harley, John B.] Cincinnati Childrens Hosp Med Ctr CCHMC, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Namjou, Bahram; Marsolo, Keith; Lingren, Todd; Harley, John B.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Marsolo, Keith; Lingren, Todd] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Ritchie, Marylyn D.; Verma, Shefali S.] Penn State Univ, Ctr Syst Genom, University Pk, PA 16802 USA; [Perry, Cassandra] Boston Childrens Hosp BCH, Div Genet & Genom, Boston, MA USA; [Kitchner, Terrie E.; Brilliant, Murray H.; Peissig, Peggy L.] Marshfield Clin Fdn Med Res & Educ, Ctr Human Genet, Marshfield, WI USA; [Borthwick, Kenneth M.; Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA USA; [Grafton, Jane] Grp Hlth Res Inst, Seattle, WA USA; [Jarvik, Gail P.] Univ Washington, Dept Med, Seattle, WA USA; [Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Holm, Ingrid A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [Holm, Ingrid A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Holm, Ingrid A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Harley, John B.] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Boston Children's Hospital; Marshfield Clinic; Geisinger Health System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Namjou, B (corresponding author), Cincinnati Childrens Hosp Med Ctr CCHMC, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA.	Bahram.namjou@cchmc.org		Holm, Ingrid/0000-0003-4712-8821	National Institutes of Health [U01HG006828, U01HG006389, U01HG006382, U01HG006375, U01HG006385, U01HG004438]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006389, U01HG006828, U01HG004438, U01HG006382, U01HG006385, U01HG006375, U01HG008657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024717, R01AI024717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (http://www.nih.gov/) grants: U01HG006828-NHGRI-Cincinnati Children's Hospital Medical Center/Boston Children's Hospital (to JBH, IAH, BN, BLC, KM, TL, CP); U01HG006389-NHGRI-Essentia Institute of Rural Health, Marshfield Clinic Research Foundation and Pennsylvania State University (to PLP, MHB, TEK, MDR, SSV); U01HG006382-NHGRI-Geisinger Clinic (to MSW, KMB); U01HG006375-NHGRI-Group Health Cooperative/University of Washington (to GPJ, JG); U01HG006385-NHGRI-Vanderbilt University Medical Center serving as the Coordinating Center and the PGRNSeq dataset (eMERGE PGx); U01HG004438-NHGRI- The Center for Inherited Disease Research (CIDR) serving as a Sequencing Center for eMERGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AONO S, 1993, BIOCHEM BIOPH RES CO, V197, P1239, DOI 10.1006/bbrc.1993.2610; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Bathum L, 2001, CLIN CHEM, V47, P81; BAYER PM, 1980, CLIN CHIM ACTA, V108, P81, DOI 10.1016/0009-8981(80)90295-8; Berk PD, 2011, CECIL MED; Bielinski SJ, 2011, MAYO CLIN PROC, V86, P606, DOI 10.4065/mcp.2011.0178; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chen GJ, 2012, EUR J HUM GENET, V20, P463, DOI 10.1038/ejhg.2011.206; Dai XY, 2013, GENET EPIDEMIOL, V37, P293, DOI 10.1002/gepi.21711; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; HIRANO K, 1987, CLIN CHIM ACTA, V166, P265, DOI 10.1016/0009-8981(87)90429-3; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Innocenti F, 2006, J CLIN ONCOL, V24, P2221, DOI 10.1200/JCO.2005.05.2464; Jinno H, 2003, DRUG METAB DISPOS, V31, P108, DOI 10.1124/dmd.31.1.108; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Kang TW, 2010, HUM MOL GENET, V19, P3672, DOI 10.1093/hmg/ddq281; Kim JY, 2014, YONSEI MED J, V55, P232, DOI 10.3349/ymj.2014.55.1.232; Lampe JW, 1999, PHARMACOGENETICS, V9, P341, DOI 10.1097/00008571-199906000-00009; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Namjou B, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00401; Nelson D, 2014, ANTIVIR THER, V19, P679, DOI 10.3851/IMP2747; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Pratt DS, 2010, SLEISENGER FORDTRANS; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Rahim F, 2013, GENET RES INT, V2013, DOI 10.1155/2013/546909; Rasmussen-Torvik LJ, 2014, CLIN PHARMACOL THER, V96, P482, DOI 10.1038/clpt.2014.137; Sampietro M, 1999, HAEMATOLOGICA, V84, P150; Sanna S, 2009, HUM MOL GENET, V18, P2711, DOI 10.1093/hmg/ddp203; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sneitz N, 2010, HUM MUTAT, V31, P52, DOI 10.1002/humu.21133; Sugatani J, 2002, BIOCHEM BIOPH RES CO, V292, P492, DOI 10.1006/bbrc.2002.6683; Verma SS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00370; Vitek L, 2001, AM J CARDIOL, V88, P1218, DOI 10.1016/S0002-9149(01)01962-2; Yamamoto K, 1998, BBA-MOL BASIS DIS, V1406, P267, DOI 10.1016/S0925-4439(98)00013-1; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zucker SD, 2001, P NATL ACAD SCI USA, V98, P12671, DOI 10.1073/pnas.231140698	43	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138677	10.1371/journal.pone.0138677	http://dx.doi.org/10.1371/journal.pone.0138677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413716	gold, Green Published, Green Submitted			2022-12-27	WOS:000362170700020
J	Deckx, S; Carai, P; Bateman, J; Heymans, S; Papageorgiou, AP				Deckx, Sophie; Carai, Paolo; Bateman, John; Heymans, Stephane; Papageorgiou, Anna-Pia			Breeding Strategy Determines Rupture Incidence in Post-Infarct Healing WARPing Cardiovascular Research	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; MATRIX PROTEIN WARP; MYOCARDIAL-INFARCTION; THERAPEUTIC ANGIOGENESIS; INCREASED EXPRESSION; CARDIAC-FUNCTION; MOUSE; PROLIFERATION; PERLECAN; SCAR	Background Von Willebrand A domain Related Protein (WARP), is a recently identified extracellular matrix protein. Based upon its involvement in matrix biology and its expression in the heart, we hypothesized that WARP regulates cardiac remodeling processes in the post-infarct healing process. Methods and results In the mouse model of myocardial infarction (MI), WARP expression increased in the infarcted area 3-days post-MI. In the healthy myocardium WARP localized with perlecan in the basement membrane, which was disrupted upon injury. In vitro studies showed high expression of WARP by cardiac fibroblasts, which further increases upon TGF beta stimulation. Furthermore, WARP expression correlated with aSMA and COL1 expression, markers of fibroblast to myofibroblast transition, in vivo and in vitro. Finally, WARP knockdown in vitro affected extra-and intracellular basic fibroblast growth factor production in myofibroblasts. To investigate the function for WARP in infarction healing, we performed an MI study in WARP knockout (KO) mice backcrossed more than 10 times on an Australian C57Bl/6-J background and bred in-house, and compared to wild type (WT) mice of the same C57Bl/6J strain but of commercial European origin. WARP KO mice showed no mortality after MI, whereas 40% of the WT mice died due to cardiac rupture. However, when WARP KO mice were backcrossed on the European C57Bl/6-J background and bred heterozygous inhouse, the previously seen protective effect in the WARP KO mice after MI was lost. Importantly, comparison of the cardiac response post-MI in WT mice bred heterozygous in-house versus commercially purchased WT mice revealed differences in cardiac rupture. Conclusion These data demonstrate a redundant role for WARP in the wound healing process after MI but demonstrate that the continental/breeding/housing origin of mice of the same C57Bl6-J strain is critical in determining the susceptibility to cardiac rupture and stress the importance of using the correct littermate controls.	[Deckx, Sophie; Carai, Paolo; Heymans, Stephane; Papageorgiou, Anna-Pia] Maastricht Univ, Dept Cardiol, Maastricht, Netherlands; [Deckx, Sophie; Carai, Paolo; Heymans, Stephane; Papageorgiou, Anna-Pia] KULeuven, Ctr Mol & Vasc Biol, Leuven, Belgium; [Bateman, John] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bateman, John] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia	Maastricht University; KU Leuven; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Deckx, S (corresponding author), Maastricht Univ, Dept Cardiol, Maastricht, Netherlands.	s.deckx@maastrichtuniversity.nl	Papageorgiou, Anna/J-9413-2015	Heymans, Stephane/0000-0001-9477-7803; Bateman, John/0000-0001-8542-0730; Carai, Paolo/0000-0003-0718-4773	ZonMW MKMD; Publiceren van negatieve of neutrale dierexperimentele data-Module Amendement 21; CARIM; European Commission [602904, 261409]; CVON	ZonMW MKMD; Publiceren van negatieve of neutrale dierexperimentele data-Module Amendement 21; CARIM; European Commission(European CommissionEuropean Commission Joint Research Centre); CVON	This research was funded by ZonMW MKMD, Publiceren van negatieve of neutrale dierexperimentele data-Module Amendement 21, http://www.zonmw.nl/nl/programmas/programma-detail/meer-kennis-met-minder-dieren/algemeen/, a CARIM-funded PhD grant, and by the European Commission's grants No 602904 (FIBROTARGETS), No 261409 (MEDIA), and the CVON 2011 (ARENA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JM, 2006, J BIOL CHEM, V281, P7341, DOI 10.1074/jbc.M513746200; Allen JM, 2008, MATRIX BIOL, V27, P295, DOI 10.1016/j.matbio.2008.01.005; Allen JM, 2009, J BIOL CHEM, V284, P12020, DOI 10.1074/jbc.M806968200; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Barnabei MS, 2010, PHYSIOL GENOMICS, V42A, P103, DOI 10.1152/physiolgenomics.00071.2010; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; DeWindt LJ, 1997, J MOL CELL CARDIOL, V29, P2095, DOI 10.1006/jmcc.1997.0444; Fedak PWM, 2012, CIRC-HEART FAIL, V5, P349, DOI 10.1161/CIRCHEARTFAILURE.111.965889; Fitzgerald J, 2002, FEBS LETT, V517, P61, DOI 10.1016/S0014-5793(02)02579-6; Fomovsky GM, 2010, AM J PHYSIOL-HEART C, V298, pH221, DOI 10.1152/ajpheart.00495.2009; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goldsmith EC, 2014, J MOL CELL CARDIOL, V70, P92, DOI 10.1016/j.yjmcc.2014.01.008; Gorog DA, 2003, J MOL CELL CARDIOL, V35, P705, DOI 10.1016/S0022-2828(03)00082-8; Hansen U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052793; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Khalil N, 2005, J BIOL CHEM, V280, P43000, DOI 10.1074/jbc.M510441200; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Liao S, 2009, DEV DYNAM, V238, P249, DOI 10.1002/dvdy.21677; Lindsey ML, 2003, ANN MED, V35, P316, DOI 10.1080/07853890310001285; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; Shah AP, 2010, CARDIOVASC RES, V87, P683, DOI 10.1093/cvr/cvq111; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Swinnen M, 2009, CIRCULATION, V120, P1585, DOI 10.1161/CIRCULATIONAHA.109.863266; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Van Aelst LNL, 2015, CIRC RES, V116, P425, DOI 10.1161/CIRCRESAHA.116.304599; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Vanhoutte D, 2007, CIRCULATION, V115, P475, DOI 10.1161/CIRCULATIONAHA.106.644609; Virag JAI, 2007, AM J PATHOL, V171, P1431, DOI 10.2353/ajpath.2007.070003; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Zachary I, 2011, HEART, V97, P181, DOI 10.1136/hrt.2009.180414; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zurita E, 2011, TRANSGENIC RES, V20, P481, DOI 10.1007/s11248-010-9403-8	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139199	10.1371/journal.pone.0139199	http://dx.doi.org/10.1371/journal.pone.0139199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406320	Green Published, gold			2022-12-27	WOS:000361800700189
J	Flaugnacco, E; Lopez, L; Terribili, C; Montico, M; Zoia, S; Schon, D				Flaugnacco, Elena; Lopez, Luisa; Terribili, Chiara; Montico, Marcella; Zoia, Stefania; Schoen, Daniele			Music Training Increases Phonological Awareness and Reading Skills in Developmental Dyslexia: A Randomized Control Trial	PLOS ONE			English	Article							SPEECH; LANGUAGE; CHILDREN; EXPERIENCE; CHILDHOOD; ABILITIES; LITERACY; RHYTHM; SOUND	There is some evidence for a role of music training in boosting phonological awareness, word segmentation, working memory, as well as reading abilities in children with typical development. Poor performance in tasks requiring temporal processing, rhythm perception and sensorimotor synchronization seems to be a crucial factor underlying dyslexia in children. Interestingly, children with dyslexia show deficits in temporal processing, both in language and in music. Within this framework, we test the hypothesis that music training, by improving temporal processing and rhythm abilities, improves phonological awareness and reading skills in children with dyslexia. The study is a prospective, multicenter, open randomized controlled trial, consisting of test, rehabilitation and re-test (ID NCT02316873). After rehabilitation, the music group (N = 24) performed better than the control group (N = 22) in tasks assessing rhythmic abilities, phonological awareness and reading skills. This is the first randomized control trial testing the effect of music training in enhancing phonological and reading abilities in children with dyslexia. The findings show that music training can modify reading and phonological abilities even when these skills are severely impaired. Through the enhancement of temporal processing and rhythmic skills, music might become an important tool in both remediation and early intervention programs.	[Flaugnacco, Elena; Zoia, Stefania] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Child Neurol & Psychiat Ward, Trieste, Italy; [Flaugnacco, Elena] Ctr Child Hlth Onlus, Trieste, Italy; [Lopez, Luisa; Terribili, Chiara] Villaggio Eugenio Litta, Rehabil Ctr Dev Disorders, Rome, Italy; [Montico, Marcella] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Epidemiol & Biostat Unit, Trieste, Italy; [Schoen, Daniele] Aix Marseille Univ, INS, Marseille, France; [Schoen, Daniele] INSERM, U1106, F-13258 Marseille, France	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Schon, D (corresponding author), Aix Marseille Univ, INS, Marseille, France.	daniele.schon@univ-amu.fr	Montico, Marcella/B-5290-2013; Schön, Daniele/B-2484-2013; ZOIA, STEFANIA/HCI-1235-2022	Montico, Marcella/0000-0003-0377-8232; Schön, Daniele/0000-0003-4472-4150; 	Mariani Foundation of Milan [R-11-85]	Mariani Foundation of Milan	The financial support was given by the Mariani Foundation of Milan (Grant R-11-85). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitay S, 2002, JARO-J ASSOC RES OTO, V3, P302, DOI 10.1007/s101620010093; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Bishop DVM, 2013, J CHILD PSYCHOL PSYC, V54, P247, DOI 10.1111/jcpp.12034; Bracken B. A., 2003, TMA TEST VALUTAZIONE; Burani C., 2011, LEXICAL SUBLEXICAL V; Carr KW, 2014, P NATL ACAD SCI USA, V111, P14559, DOI 10.1073/pnas.1406219111; Chobert J, 2011, J COGNITIVE NEUROSCI, V23, P3874, DOI 10.1162/jocn_a_00088; Cogo-Moreira H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059984; Cogo-Moreira H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009133.pub2; Cornoldi C., 2011, MT READING TEST; Corriveau KH, 2009, CORTEX, V45, P119, DOI 10.1016/j.cortex.2007.09.008; Dege F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00124; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; Elmer S, 2013, CORTEX, V49, P2812, DOI 10.1016/j.cortex.2013.03.007; Flaugnacco E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00392; Francois C, 2013, CEREB CORTEX, V23, P2038, DOI 10.1093/cercor/bhs180; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Fujii S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00777; Goswami U, 2013, CORTEX, V49, P1363, DOI 10.1016/j.cortex.2012.05.005; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Grassi M, 2009, BEHAV RES METHODS, V41, P20, DOI 10.3758/BRM.41.1.20; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Katz L., 1992, REPORT SPEECH RES SR, P147; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Leong V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00096; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P294, DOI 10.1162/jocn.2010.21413; Martin J, 2010, ANN DYSLEXIA, V60, P238, DOI 10.1007/s11881-010-0043-8; Marzocchi G. M., 2010, BIA ITALIAN BATTERY; Marzocchi GM, 2003, PSICHIATRIA INFANZIA, V70, P17; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Overy K, 2003, DYSLEXIA, V9, P18, DOI 10.1002/dys.233; Parbery-Clark A, 2012, NEUROSCIENCE, V219, P111, DOI 10.1016/j.neuroscience.2012.05.042; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Peelle JE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00320; Pernet CR, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00606; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; Reinke KS, 2003, COGNITIVE BRAIN RES, V17, P781, DOI 10.1016/S0926-6410(03)00202-7; Sartori G., 2007, DDE 2 BATTERY READIN; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Shaywitz SE, 2008, ANNU REV PSYCHOL, V59, P451, DOI 10.1146/annurev.psych.59.103006.093633; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Snowling MJ, 2012, J CHILD PSYCHOL PSYC, V53, P593, DOI 10.1111/j.1469-7610.2011.02495.x; Steinbrink C, 2014, CHILD DEV, V85, P1711, DOI 10.1111/cdev.12208; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; Tallal P, 2006, TRENDS NEUROSCI, V29, P382, DOI 10.1016/j.tins.2006.06.003; Tallal P, 2012, P NATL ACAD SCI USA, V109, P16406, DOI 10.1073/pnas.1214122109; Thomson JM, 2013, READ WRIT, V26, P139, DOI 10.1007/s11145-012-9359-6; Tierney A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00949; Vicari S., 2007, PROMEA MEMORY LEARNI; Vihman M, 2007, LINGUISTICS, V45, P683, DOI 10.1515/LING.2007.021; Wolff P.H., 2002, READ WRIT, V15, P179, DOI [10.1023/A:1013880723925, DOI 10.1023/A:1013880723925, 10.1023/a:1013880723925]; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Zuk J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080546	62	118	121	10	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138715	10.1371/journal.pone.0138715	http://dx.doi.org/10.1371/journal.pone.0138715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26407242	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700075
J	Leguillier, T; Lecso-Bornet, M; Lemus, C; Rousseau-Ralliard, D; Lebouvier, N; Hnawia, E; Nour, M; Aalbersberg, W; Ghazi, K; Raharivelomanana, P; Rat, P				Leguillier, Teddy; Lecso-Bornet, Marylin; Lemus, Christelle; Rousseau-Ralliard, Delphine; Lebouvier, Nicolas; Hnawia, Edouard; Nour, Mohammed; Aalbersberg, William; Ghazi, Kamelia; Raharivelomanana, Phila; Rat, Patrice			The Wound Healing and Antibacterial Activity of Five Ethnomedical Calophyllum inophyllum Oils: An Alternative Therapeutic Strategy to Treat Infected Wounds	PLOS ONE			English	Article							MEDICINAL-PLANTS; OXIDATIVE STRESS; EXTRACTS; BACTERIA; AGENTS	Background Calophyllum inophyllum L. (Calophyllaceae) is an evergreen tree ethno-medically used along the seashores and islands of the Indian and Pacific Oceans, especially in Polynesia. Oil extracted from the seeds is traditionally used topically to treat a wide range of skin injuries from burn, scar and infected wounds to skin diseases such as dermatosis, urticaria and eczema. However, very few scientific studies reported and quantified the therapeutic properties of Calophyllum inophyllum oil (CIO). In this work, five CIO from Indonesia (CIO1), Tahiti (CIO2, 3), Fiji islands (CIO4) and New Caledonia (CIO5) were studied and their cytotoxic, wound healing, and antibacterial properties were presented in order to provide a scientific support to their traditional use and verify their safety. Methods The safety of the five CIO was ascertained using the Alamar blue assay on human keratinocyte cells. CIO wound healing properties were determined using the scratch test assay on human keratinocyte cells. CIO-stimulated antibacterial innate immune response was evaluated using ELISA by measuring beta defensin-2 release in human derivative macrophage cells. CIO antibacterial activity was tested using oilogramme against twenty aerobic Gram-bacteria species, twenty aerobic Gram+ bacteria species, including a multi-drug resistant Staphylococcus aureus strain and two anaerobic Gram+ bacteria species e.g. Propionibacterium acnes and Propionibacterium granulosum. To detect polarity profile of the components responsible of the antibacterial activity, we performed bioautography against a Staphylococcus aureus strain. Results Based on Alamar Blue assay, we showed that CIO can be safely used on keratinocyte cells between 2.7% and 11.2% depending on CIO origin. Concerning the healing activity, all the CIO tested accelerated in vitro wound closure, the healing factor being 1.3 to 2.1 higher compared to control when keratinocytes were incubated after scratch with CIO at 0.1%. Furthermore, our results showed that CIO exhibit two distinct antibacterial effects: one against Gram + bacteria by direct inhibition of mitotic growth and another potent effect against Gram-bacteria due to increased release of beta-defensin 2 peptide by macrophages. Interestingly, the needed concentrations of CIO to inhibit bacteria growth and to promote wound healing are lower than concentrations exhibiting cytotoxic effects on keratinocyte cells. Finally, we performed bioautography assay against Staphylococcus aureus to determine polarity profile of the components responsible for CIO antibacterial activity. Our results showed for the five tested CIO that components responsible of the bacterial growth inhibition are the more polar one on the TLC chromatographic profile and are contained in the resinous fraction of the oil. Conclusions This study was conducted to evaluate cytotoxicity, wound healing and antibacterial properties of five CIO traditionally used to treat infected wounds. Using cell and bacteria cultures, we confirmed the pharmacological effects of CIO as wound healing and antimicrobial agent. Moreover, we showed that concentration of CIO needed to exhibit therapeutic effects are lower than concentrations exhibiting cytotoxic effects in vitro. For the first time, this study provides support for traditional uses of CIO. These wound healing and antibiotic properties make CIO a valuable candidate to treat infected wounds especially in tropical areas.	[Leguillier, Teddy; Rat, Patrice] Univ Paris 05, UMR CNRS COMETE 8638, Lab Chim Toxicol Analyt & Cellulaire, Sorbonne Paris Cite,Fac Pharm, Paris, France; Univ Paris 05, Sorbonne Paris Cite, Fac Pharm, Lab Ecosyst Intestinal Probiot Antibio EA 4065, Paris, France; [Lemus, Christelle] Univ Paris 05, UMR CNRS COMETE 8638, Lab Pharmacognosie, Sorbonne Paris Cite,Fac Pharm, Paris, France; [Rousseau-Ralliard, Delphine] INRA, Biol Dev & Reprod, UMR 1198, Jouy En Josas, France; [Lebouvier, Nicolas; Hnawia, Edouard; Nour, Mohammed] Univ Nouvelle Caledonie, Lab Insuiaire Vivant & Environm, EA 4243, Noumea, New Caledonia; [Aalbersberg, William] Univ S Pacific, Inst Appl Sci, Suva, Fiji; [Ghazi, Kamelia] Univ Technol Compiegne, CNRS UMR 7338, Ctr Rech BioMecan & Bioingenierie, Compiegne, France; [Raharivelomanana, Phila] Univ Polynesie Francaise, UMR EIO 241, Equipe Etude Integree Metabolites Secondaires, FAAA, Tahiti, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Nouvelle Caledonie; University of the South Pacific; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Picardie Universites; Universite de Technologie de Compiegne; Ifremer	Rat, P (corresponding author), Univ Paris 05, UMR CNRS COMETE 8638, Lab Chim Toxicol Analyt & Cellulaire, Sorbonne Paris Cite,Fac Pharm, Paris, France.	patrice.rat@parisdescartes.fr	Lebouvier, Nicolas/AAV-3456-2020; ROUSSEAU-RALLIARD, Delphine/AAA-4035-2020	Rousseau (Rousseau-Ralliard), Delphine/0000-0003-2684-1791	Laboratoire Chimie-Toxicologie Analytique et Cellulaire; Fonds Pacifique (project CALOPS)	Laboratoire Chimie-Toxicologie Analytique et Cellulaire; Fonds Pacifique (project CALOPS)	This work was supported by the Laboratoire Chimie-Toxicologie Analytique et Cellulaire and by the Fonds Pacifique (project CALOPS).	Bhatia A, 2014, INT J COSMETIC SCI, V36, P361; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bruneton J., 1993, PHARMACOGNOSY PHYTOC; Buonomo R, 2012, J CELL PHYSIOL, V227, P2106, DOI 10.1002/jcp.22944; Butaud J-F, 2008, GUIDE ARBRES POLYNES, P320; Cambie R, 1994, FIJIAN MED PLANTS, P365; Chah KF, 2006, J ETHNOPHARMACOL, V104, P164, DOI 10.1016/j.jep.2005.08.070; Chevalier J, 1951, STUDY NEW CICATRIZIN; Cho-Ngwa F, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-62; Cockerill F, 2012, CLIN LAB STANDARDS I, V32; Dawid-Pac R, 2013, POSTEP DERM ALERGOL, V30, P170, DOI 10.5114/pdia.2013.35620; Dreno B, 2001, EUR J DERMATOL, V11, P549; Dutot M, 2008, EUR J PHARM SCI, V33, P138, DOI 10.1016/j.ejps.2007.10.006; Dutot M, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-48; Dweck A C, 2002, Int J Cosmet Sci, V24, P341, DOI 10.1046/j.1467-2494.2002.00160.x; Dzoyem JP, 2014, J ETHNOPHARMACOL; Eldin HME, 2014, PARASITOL RES, V113, P1949, DOI 10.1007/s00436-014-3845-5; Freire-Moran L, 2011, DRUG RESIST UPDATE, V14, P118, DOI 10.1016/j.drup.2011.02.003; Girardi C, 2014, J ETHNOPHARMACOL PRE; Grepin F, 1984, TAHITIAN TRADITIONAL; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Kagan IA, 2014, JOVE-J VIS EXP, DOI 10.3791/51411; Kovac-Besovic Elvira E, 2003, Bosn J Basic Med Sci, V3, P19; Kuete V, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00123; Lahlou M, 2004, PHYTOTHER RES, V18, P435, DOI 10.1002/ptr.1465; Laure F, 2008, ANAL CHIM ACTA, V624, P147, DOI 10.1016/j.aca.2008.06.046; Leu T, 2009, MAGN RESON CHEM, V47, P989, DOI 10.1002/mrc.2482; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Mahboubi A, 2014, IRAN J PHARM RES, V13, P559; McLaws FB, 2011, ANTIMICROB AGENTS CH, V55, P1173, DOI 10.1128/AAC.00817-10; Morin C, 2012, J PHARMACOL EXP THER, V343, P115, DOI 10.1124/jpet.111.188599; Nakatsuji T, 2010, J INVEST DERMATOL, V130, P985, DOI 10.1038/jid.2009.384; PATIL AD, 1993, J MED CHEM, V36, P4131, DOI 10.1021/jm00078a001; Petard P., 1972, RAAU TAHITI USE POLY; Petard P, 1986, QUELQUES PLANTES UTI; Pidoux M., 2012, Phytotherapie (Paris), V10, P143, DOI 10.1007/s10298-012-0700-7; POCIDALO JJ, 1955, CR SOC BIOL, V149, P357; Prabakaran K, 2012, INT J NAT PROD  0526, P24; RALPH P, 1982, CELL IMMUNOL, V71, P215, DOI 10.1016/0008-8749(82)90257-X; Said T, 2007, EUR J PHARM SCI, V30, P203, DOI 10.1016/j.ejps.2006.11.001; Skrivanova E, 2005, LETT APPL MICROBIOL, V41, P77, DOI 10.1111/j.1472-765X.2005.01709.x; Sofowora A, 2013, AFR J TRADIT COMPLEM, V10, P210, DOI 10.4314/ajtcam.v10i5.2; STEVENS PF, 1980, J ARNOLD ARBORETUM, V61, P117, DOI 10.5962/bhl.part.8541; Suleiman MM, 2010, AFR J TRADIT COMPLEM, V7, P64; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tarrade A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083458; VLIETINCK AJ, 1995, J ETHNOPHARMACOL, V46, P31, DOI 10.1016/0378-8741(95)01226-4; Whistler WA, 1992, FLOWERS PACIFIC ISLA; Yimdjo MC, 2004, PHYTOCHEMISTRY, V65, P2789, DOI 10.1016/j.phytochem.2004.08.024	50	34	34	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138602	10.1371/journal.pone.0138602	http://dx.doi.org/10.1371/journal.pone.0138602			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406588	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700061
J	Nielsen, MJ; Kazankov, K; Leeming, DJ; Karsdal, MA; Krag, A; Barrera, F; McLeod, D; George, J; Gronbaek, H				Nielsen, Mette J.; Kazankov, Konstantin; Leeming, Diana J.; Karsdal, Morten A.; Krag, Aleksander; Barrera, Francisco; McLeod, Duncan; George, Jacob; Gronbaek, Henning			Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; LIVER FIBROSIS; BLOOD-TESTS; FIBROGENESIS; DEGRADATION; PREDICT; MATRIX-METALLOPROTEINASE-9; PROGRESSION; DIAGNOSIS; DISEASE	Background and Aim Detection of advanced fibrosis (Metavir F >= 3) is important to identify patients with a high urgency of antiviral treatments vs. those whose treatment could be deferred (F <= 2). The aim was to assess the diagnostic value of novel serological extracellular matrix protein fragments as potential biomarkers for clinically significant and advanced fibrosis. Methods Specific protein fragments of matrix metalloprotease degraded type I, III, IV and VI collagen (C1M, C3M, C4M, C6M) and type III and IV collagen formation (Pro-C3 and P4NP7S) were assessed in plasma from 403 chronic hepatitis C patients by specific ELISAs. Patients were stratified according to Metavir Fibrosis stage; F0 (n = 46), F1 (n = 161), F2 (n = 95), F3 (n = 44) and F4 (n = 33) based on liver biopsy. Results Pro-C3 was significantly elevated in patients with significant fibrosis (>= F2) compared to F0-F1 (p< 0.05), while the markers C3M, C4M, C6M and P4NP7S were significantly elevated in patients with advanced fibrosis (>= F3) compared to F0-F2 (p< 0.05). C1M showed no difference between fibrosis stages. Using Receiver Operating Characteristics analysis, the best marker for detecting >= F2 and >= F3 was Pro-C3 with AUC = 0.75 and AUC = 0.86. Combination of Pro-C3 and C4M with age, BMI and gender in a multiple ordered logistic regression model improved the diagnostic value for detecting >= F2 and >= F3 with AUC = 0.80 and AUC = 0.88. Conclusion The Pro-C3 protein fragment provided clinically relevant diagnostic accuracy as a single marker of liver fibrosis. A model combining Pro-C3 and C4M along with patient's age, body mass index and gender increased the diagnostic power for identifying clinically significant fibrosis.	[Nielsen, Mette J.; Leeming, Diana J.; Karsdal, Morten A.] Fibrosis Biol & Biomarkers, Nord Biosci A S, Herlev, Denmark; [Nielsen, Mette J.; Krag, Aleksander] Univ Southern Denmark, Odense Univ Hosp, Fac Hlth Sci, Dept Gastroenterol & Hepatol, Odense, Denmark; [Kazankov, Konstantin; Gronbaek, Henning] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, DK-8000 Aarhus, Denmark; [Barrera, Francisco; George, Jacob] Westmead Hosp, Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW, Australia; [Barrera, Francisco; George, Jacob] Univ Sydney, Sydney, NSW 2006, Australia; [McLeod, Duncan] Westmead Hosp, Inst Clin Pathol & Med Res, Dept Anat Pathol, Sydney, NSW, Australia	Nordic Bioscience; University of Southern Denmark; Odense University Hospital; Aarhus University; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Nielsen, MJ (corresponding author), Fibrosis Biol & Biomarkers, Nord Biosci A S, Herlev, Denmark.	mju@nordicbioscience.com	Nielsen, Mette Juul/AAP-1647-2020; Gronbaek, Henning/AAJ-3202-2020; Krag, Aleksander/ABH-9649-2020	Gronbaek, Henning/0000-0001-8998-7910; Krag, Aleksander/0000-0002-9598-4932; Karsdal, Morten/0000-0001-5026-8740; Barrera, Francisco/0000-0001-5334-1528	Danish Science Foundation; Danish Ministry of Science and Technology; NOVO Nordisk Foundation; National and Medical Research Council of Australia [1053206, 632630, 1049857, 1047417]; Robert W. Storr Bequest; Novo Nordisk Fonden [NNF10OC1013267] Funding Source: researchfish	Danish Science Foundation(Danmarks Grundforskningsfond); Danish Ministry of Science and Technology; NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Robert W. Storr Bequest; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was funded by the Danish Science Foundation, the Danish Ministry of Science and Technology, and the NOVO Nordisk Foundation. Grants were received from the National and Medical Research Council of Australia (Program Grant no. 1053206, project grants 632630, 1049857, and 1047417) and Robert W. Storr Bequest to the Sydney Medical Foundation of the University of Sydney. The funders provided support in the form of salaries for authors MJN, DJL, and MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Afdhal NH, 1997, J HEPATOL, V27, P993, DOI 10.1016/S0168-8278(97)80142-0; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fontana RJ, 2010, GUT, V59, P1401, DOI 10.1136/gut.2010.207423; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Guechot J, 1996, CLIN CHEM, V42, P558; Guha IN, 2011, HEPATOLOGY, V54, P1454, DOI 10.1002/hep.24515; Hsieh YY, 2012, WORLD J GASTROENTERO, V18, P746, DOI 10.3748/wjg.v18.i8.746; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Karsdal MA, 2011, CLIN BIOCHEM, V44, P1278, DOI 10.1016/j.clinbiochem.2011.08.1135; Kazankov K, 2014, HEPATOLOGY; Lackner C, 2005, HEPATOLOGY, V41, P1376, DOI 10.1002/hep.20717; Leeming DJ, 2013, ALIMENT PHARM THER, V38, P1086, DOI 10.1111/apt.12484; Leeming DJ, 2011, BIOMARKERS, V16, P616, DOI 10.3109/1354750X.2011.620628; Leeming DJ, 2012, HEPATOL RES, V42, P482, DOI 10.1111/j.1872-034X.2011.00946.x; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Li SM, 2014, WORLD J GASTROENTERO, V20, P9528, DOI 10.3748/wjg.v20.i28.9528; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Nielsen MJ, 2015, LIVER INT, V35, P429, DOI 10.1111/liv.12700; Nielsen MJ, 2013, AM J TRANSL RES, V5, P303; Pares A, 1996, HEPATOLOGY, V24, P1399, DOI 10.1053/jhep.1996.v24.pm0008938169; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Pinzani M, 2010, GUT, V59, P1165, DOI 10.1136/gut.2010.214932; Poordad FF, 2004, EXPERT REV MOL DIAGN, V4, P593, DOI 10.1586/14737159.4.5.593; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; RILEY DJ, 1988, EXP LUNG RES, V14, P549, DOI 10.3109/01902148809087827; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P476, DOI 10.3748/wjg.v11.i4.476; Sharma S, 2014, WORLD J GASTROENTERO, V20, P16820, DOI 10.3748/wjg.v20.i45.16820; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Vassiliadis E, 2011, BIOMARK INSIGHTS, V6, P49, DOI 10.4137/BMI.S6347; Veidal SS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-22; Veidal SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024753; Veidal SS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-5; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; World Health Organization, 2002, WHO TRADITIONAL MED, P1; Zarski JP, 2012, J HEPATOL, V56, P55, DOI 10.1016/j.jhep.2011.05.024	40	52	53	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137302	10.1371/journal.pone.0137302	http://dx.doi.org/10.1371/journal.pone.0137302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406331	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700019
J	Servan-Mori, E; Heredia-Pi, I; Montanez-Hernandez, J; Avila-Burgos, L; Wirtz, VJ				Servan-Mori, Edson; Heredia-Pi, Ileana; Montanez-Hernandez, Julio; Avila-Burgos, Leticia; Wirtz, Veronika J.			Access to Medicines by Seguro Popular Beneficiaries: Pending Tasks towards Universal Health Coverage	PLOS ONE			English	Article							INSTRUMENTAL VARIABLES; SOCIAL PROTECTION; INSURANCE; IDENTIFICATION; EXPENDITURE; PROGRAM; IMPACT	Objective In the context of aiming to achieve universal health coverage in Mexico, this study compares access to prescribed medicines (ATPM) between Seguro Popular (SP) and non-SP affiliated outpatient health service users. Materials and Methods ATPM by 6,123 users of outpatient services was analyzed using the National Health and Nutrition Survey 2012. Adjusted bi-probit models were performed incorporating instrumental variables. Results 17.3% of SP and 10.1% of the non-SP population lacked ATPM. Two-thirds of all outpatient SP and 18.5% of all outpatient non-SP received health services at Ministry of Health facilities, among whom, 64.6 and 53.6% of the SP and non-SP population respectively reported ATPM at these facilities. Lack of medicines in health units, chronic health problems (compared to acute conditions) and prescription >= 3 medicines were risk factors for non-ATPM. Adjusted models suggest that when using Ministry of Health services, the SP population has a higher probability of ATMP compared to the non-SP population. Conclusion Given the aspirations of achieving universal health coverage in Mexico, it is important to increase ATPM in Ministry of Health facilities thereby ensuring basic rights to health care are met.	[Servan-Mori, Edson; Heredia-Pi, Ileana; Montanez-Hernandez, Julio; Avila-Burgos, Leticia; Wirtz, Veronika J.] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Wirtz, Veronika J.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	Instituto Nacional de Salud Publica; Boston University	Wirtz, VJ (corresponding author), Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.	vwirtz@bu.edu	Heredia-Pi, Ileana Beatriz/L-4247-2019; Avila-Burgos, Leticia/AAR-1815-2021; Wirtz, Veornika/AAG-9712-2019	Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Servan-Mori, Edson/0000-0001-9820-8325; Wirtz, Veronika J./0000-0002-0863-8768				Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; Cameron A.C., 2009, MICROECONOMETRICS US; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Comision Nacional de Proteccion Social en Salud, 2012, LIBR BLANC SIST PROT; Comision Nacional de Proteccion Social en Salud, 2010, DAT ADM AF SEG POP N; Comision Nacional de Proteccion Social en Salud, 2013, CIFR SEG POP AF HIST; Comision Nacional para el Desarrollo de los Pueblos Indigenas (CDI), 2009, HOG POBL IND; CONAPO, 2010, GRAD MARG NIV LOC 20; de Salud Secretaria, 2006, EV PROC, V2006, P39; Galarraga O, 2010, EUR J HEALTH ECON, V11, P437, DOI 10.1007/s10198-009-0180-3; Garrido-Latorre F, 2008, SALUD PUBLICA MEXICO, V50, pS429, DOI 10.1590/S0036-36342008001000003; Gómez Dantés Octavio, 2004, Salud pública Méx, V46, P585, DOI 10.1590/S0036-36342004000600013; Greene H., 2003, ECONOMETRIC ANAL; Greenwood P. E., 1996, GUIDE CHI SQUARED TE, V280; Heckman J, 1997, J HUM RESOUR, V32, P441, DOI 10.2307/146178; Hernandez Avila M, 2012, DOCUMENTO ANALITICO; Instituto Nacional de Salud Publica, 2012, EV EXT SIST PROT SOC; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Lopez Moreno S, 2010, ABASTO MEDICAMENTOS; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; McDonald JH., 2008, HDB BIOL STAT; Organizacion Mundial de la Salud (OMS), MED ES; Organizacion Mundial de la Salud (OMS), MED ES 10 DAT MED ES; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; Secretaria de Salud de Mexico (SeSa), 2006, SIST PROT SOC SAL EV; Secretaria de Salud (SeSa)-Direccion General de Evaluacion del Desempeno (DGED), 2006, SINT EJ; Sistema de Proteccion Social en Salud, INF RES 2012; Sistema de Proteccion Social en Salud, INF RES 2011; Sistema de Proteccion Social en Salud, 2012, INF RES SPSS EN DIC; Sosa-Rubi SG, 2009, J HEALTH ECON, V28, P20, DOI 10.1016/j.jhealeco.2008.08.002; Stata Corp. LP, 2011, STAT SE 12 1 WIND XP; Teruel GL, 2005, DOCUMENTOS INVESTIGA; Wirtz VJ, 2013, SALUD PUBLICA MEXICO, V55, pS112; Wirtz VJ, 2012, VALUE HEALTH, V15, P593, DOI 10.1016/j.jval.2012.01.006; Wirtz VJ, 2010, SALUD PUBLICA MEXICO, V52, P32; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; World Health Organization (WHO), 2012, ANCDINF131 WHO	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136823	10.1371/journal.pone.0136823	http://dx.doi.org/10.1371/journal.pone.0136823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26407158	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700015
J	Tanaka, N; Dutrow, EV; Miyadera, K; Delemotte, L; MacDermaid, CM; Reinstein, SL; Crumley, WR; Dixon, CJ; Casal, ML; Klein, ML; Aguirre, GD; Tanaka, JC; Guziewicz, KE				Tanaka, Naoto; Dutrow, Emily V.; Miyadera, Keiko; Delemotte, Lucie; MacDermaid, Christopher M.; Reinstein, Shelby L.; Crumley, William R.; Dixon, Christopher J.; Casal, Margret L.; Klein, Michael L.; Aguirre, Gustavo D.; Tanaka, Jacqueline C.; Guziewicz, Karina E.			Canine CNGA3 Gene Mutations Provide Novel Insights into Human Achromatopsia-Associated Channelopathies and Treatment	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; MOLECULAR-DYNAMICS; CONE VISION; MOUSE MODEL; STRUCTURAL BASIS; RPE65 MUTATIONS; VOLTAGE-SENSORS; PROTEIN DESIGN; CHANNEL; THERAPY	Cyclic nucleotide-gated (CNG) ion channels are key mediators underlying signal transduction in retinal and olfactory receptors. Genetic defects in CNGA3 and CNGB3, encoding two structurally related subunits of cone CNG channels, lead to achromatopsia (ACHM). ACHM is a congenital, autosomal recessive retinal disorder that manifests by cone photoreceptor dysfunction, severely reduced visual acuity, impaired or complete color blindness and photophobia. Here, we report the first canine models for CNGA3-associated channelopathy caused by R424W or V644del mutations in the canine CNGA3 ortholog that accurately mimic the clinical and molecular features of human CNGA3-associated ACHM. These two spontaneous mutations exposed CNGA3 residues essential for the preservation of channel function and biogenesis. The CNGA3-R424W results in complete loss of cone function in vivo and channel activity confirmed by in vitro electrophysiology. Structural modeling and molecular dynamics (MD) simulations revealed R424-E306 salt bridge formation and its disruption with the R424Wmutant. Reversal of charges in a CNGA3R424E-E306R double mutant channel rescued cGMP-activated currents uncovering new insights into channel gating. The CNGA3-V644del affects the C-terminal leucine zipper (CLZ) domain destabilizing intersubunit interactions of the coiled-coil complex in the MD simulations; the in vitro experiments showed incompetent trimeric CNGA3 subunit assembly consistent with abnormal biogenesis of in vivo channels. These newly characterized large animal models not only provide a valuable system for studying cone-specific CNG channel function in health and disease, but also represent prime candidates for proof-of-concept studies of CNGA3 gene replacement therapy for ACHM patients.	[Tanaka, Naoto; Tanaka, Jacqueline C.] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Dutrow, Emily V.; Miyadera, Keiko; Reinstein, Shelby L.; Crumley, William R.; Casal, Margret L.; Aguirre, Gustavo D.; Guziewicz, Karina E.] Univ Penn, Sch Vet Med, Dept Clin Studies Philadelphia, Philadelphia, PA 19104 USA; [Delemotte, Lucie; MacDermaid, Christopher M.; Klein, Michael L.] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA; [Dixon, Christopher J.] Vet Vis, Penrith CA11 9FJ, Cumbria, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Tanaka, JC (corresponding author), Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA.	jtanaka@temple.edu; karinag@vet.upenn.edu	Miyadera, Keiko/AAQ-8196-2020	Aguirre, Gustavo/0000-0002-5228-256X; MacDermaid, Christopher/0000-0003-2376-8867; Delemotte, Lucie/0000-0002-0828-3899; Dutrow, Emily/0000-0002-9113-8528; Tanaka, Naoto/0000-0001-7312-0239	Foundation Fighting Blindness; National Eye Institute [EY06855, EY17549, P30 EY-001583]; National Science Foundation [CNS-09-58854, DMR-1120901]; XSEDE [TG-MCA93S020]; European Union [PIOF-GA-2012-329534]; Hope for Vision; Macula Vision Research Foundation; Van Sloun Fund for Canine Genetic Research; NATIONAL EYE INSTITUTE [P30EY001583, R01EY006855, R01EY017549] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); XSEDE; European Union(European Commission); Hope for Vision; Macula Vision Research Foundation; Van Sloun Fund for Canine Genetic Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This study was supported by Foundation Fighting Blindness; National Eye Institute EY06855, EY17549, and P30 EY-001583; National Science Foundation CNS-09-58854 and DMR-1120901 & XSEDE allocation TG-MCA93S020; European Union Seventh Framework Program PIOF-GA-2012-329534; Hope for Vision; Macula Vision Research Foundation; and the Van Sloun Fund for Canine Genetic Research. Simulations conducted on the CLZ domain were made possible by the Department of Energy's INCITE program through allocation CHM045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CJD is a co-owner of Veterinary Vision. This funder provided support in the form of salaries for author (CJD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; ACLAND GM, 1987, EXP EYE RES, V44, P491, DOI 10.1016/S0014-4835(87)80160-4; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Banin E, 2015, MOL THERAPY J A 0619; Beltran W. A., 2014, COLD SPRING HARB PER, V5; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Bright SR, 2007, MOL PHARMACOL, V71, P176, DOI 10.1124/mol.106.026401; BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cooper AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106610; Dai G, 2013, AM J PHYSIOL-CELL PH, V305, pC147, DOI 10.1152/ajpcell.00037.2013; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Ding XQ, 2012, ADV EXP MED BIOL, V723, P769, DOI 10.1007/978-1-4614-0631-0_98; Dixon CJ, 2016, VET OPHTHALMOL, V19, P68, DOI 10.1111/vop.12265; Du W, 2015, HUM MOL GENET, V24, P3699, DOI 10.1093/hmg/ddv114; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Ekesten B, 2013, DOC OPHTHALMOL, V127, P79, DOI 10.1007/s10633-013-9388-8; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P510, DOI 10.1038/nsb0696-510; Goto-Omoto S, 2006, VISUAL NEUROSCI, V23, P395, DOI 10.1017/S095252380623308X; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Guziewicz KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075666; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hawes NL, ARVO; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izaguirre JA, 1999, J CHEM PHYS, V110, P9853, DOI 10.1063/1.478995; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jobling AI, 2013, INVEST OPHTH VIS SCI, V54, P3350, DOI 10.1167/iovs.13-11831; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2015, NATURE GENETICS; Kohl S, 1993, GENEREVIEWS; Komaromy AM, 2013, MOL THER, V21, P1131, DOI 10.1038/mt.2013.50; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Kono H, 2007, METH MOL B, V352, P3; Kowal J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4106; Kullmann DM, 2010, ANNU REV NEUROSCI, V33, P151, DOI 10.1146/annurev-neuro-060909-153122; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Muraki-Oda S, 2007, BIOCHEM BIOPH RES CO, V362, P88, DOI 10.1016/j.bbrc.2007.07.152; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Pang JJ, 2010, ADV EXP MED BIOL, V664, P639, DOI 10.1007/978-1-4419-1399-9_73; PANG JX, 2012, PLOS NEGLECT TROP D, V6, P34567, DOI DOI 10.1371/JOURNAL.PONE.0035250; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Podda MV, 2014, PFLUG ARCH EUR J PHY, V466, P1241, DOI 10.1007/s00424-013-1373-2; Reicher S, 2010, GENOMICS, V95, P101, DOI 10.1016/j.ygeno.2009.10.003; Roosing S, 2014, PROG RETIN EYE RES, V42, P1, DOI 10.1016/j.preteyeres.2014.05.001; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; Schon C, 2013, MOL GENET GENOMICS, V288, P459, DOI 10.1007/s00438-013-0766-4; Shuart NG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1466; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Tanaka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088768; Thiadens AAHJ, 2010, OPHTHALMOLOGY, V117, P825, DOI 10.1016/j.ophtha.2009.09.008; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Vardanyan V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00145; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	75	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138943	10.1371/journal.pone.0138943	http://dx.doi.org/10.1371/journal.pone.0138943			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407004	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700123
J	Zhu, XM; Wang, YF; Zhao, XL; Jiang, CP; Zhang, QY; Jiang, WJ; Wang, Y; Chen, HX; Shou, XF; Zhao, Y; Li, YM; Li, SQ; Ye, HY				Zhu, Xiaoming; Wang, Yongfei; Zhao, Xuelan; Jiang, Cuiping; Zhang, Qiongyue; Jiang, Wenjuan; Wang, Yan; Chen, Haixia; Shou, Xuefei; Zhao, Yao; Li, Yiming; Li, Shiqi; Ye, Hongying			Incidence of Pituitary Apoplexy and Its Risk Factors in Chinese People: A Database Study of Patients with Pituitary Adenoma	PLOS ONE			English	Article							TRANSSPHENOIDAL SURGERY; PRECIPITATING FACTORS; CLINICAL-FEATURES; TUMOR APOPLEXY; MANAGEMENT; CLASSIFICATION; ENDOCRINE; INVASION; GROWTH; SERIES	Background There are few studies of the incidence and clinical characteristics of pituitary apoplexy (PA) in pituitary adenoma patients, and the findings have been inconsistent. Objective The aim of the study was to retrospectively assess the incidence, clinical presentation, surgical management and postoperative complications of PA in pituitary adenoma patients. Methods A database was specifically designed to collect clinical, therapeutic, prognostic and histological information about pituitary adenoma patients. Using multivariate logistic regression, odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to identify associated factors. Results A total of 2021 pituitary adenoma patients were recruited. 97 (4.8%) patients had PA. The incidence of PA was 10.11% in patients with pituitary macroadenoma, and 0.36% in patients with microadenoma. Variables for the logistic regression model independently associated with PA were sex (male vs. female, OR = 2.54, 95% CI: 1.59 similar to 4.07), tumor type (negative staining vs. positive staining, OR = 2.04, 95% CI: 1.29 similar to 3.23), and tumor size (macroadenoma vs. microadenoma, OR = 26.46, 95% CI = 9.66 similar to 72.46). Headache, visual deterioration, and vomiting were the most common symptoms in patients with pituitary adenoma. Patients with and without PA had similar frequency of visual deterioration, head trauma, acromegalic appearance, galactorrhoea, cold intolerance and Cushingoid appearance, but headache, vomiting, ptosis, diplopia, fever and blindness were significantly more common in patients with PA. Pearson Chi-Square tests revealed a significant difference in surgical approach between patients with and without PA (95.88% vs. 85.57%, P = 0.01). Conclusion Our findings suggest that PA is not a rare event. Male sex, non-functioning tumor, and macroadenoma are associated with an increased risk of PA. Compared with pituitary adenoma patients without PA, patients with PA have more severe symptoms.	[Zhu, Xiaoming; Zhao, Xuelan; Jiang, Cuiping; Zhang, Qiongyue; Jiang, Wenjuan; Li, Yiming; Ye, Hongying] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Jiang, Cuiping] Fudan Univ, Shanghai Med Coll, Huadong Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Jiang, Wenjuan] Fudan Univ, Shanghai Med Coll, Jinshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Wang, Yan; Chen, Haixia] Fudan Univ, Huashan Hosp, Dept Neuropathol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Yongfei; Shou, Xuefei; Zhao, Yao; Li, Shiqi] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Xiaoming; Wang, Yongfei; Wang, Yan; Shou, Xuefei; Zhao, Yao; Li, Yiming; Li, Shiqi; Ye, Hongying] Shanghai Pituitary Tumor Ctr, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Li, SQ (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai Med Coll, Shanghai 200433, Peoples R China.	liu888mm@sina.com; dryehongying@hotmail.com			985 Project (Fudan University) [985 III-YFX0302]; Key Clinical Discipline Programs of the Ministry of Health; Shanghai Committee of Science and Technology of China [11411951900, 11411951901]; National Natural Science Foundation of China [81270955]	985 Project (Fudan University); Key Clinical Discipline Programs of the Ministry of Health; Shanghai Committee of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work were supported by the 985 Project (985 III-YFX0302, Fudan University), the Key Clinical Discipline Programs of the Ministry of Health and by the Shanghai Committee of Science and Technology of China (No. 11411951900, 11411951901) and by National Natural Science Foundation of China(81270955).	Agrawal D, 2005, SURG NEUROL, V63, P42, DOI 10.1016/j.surneu.2004.03.014; Ahmed SK, 2008, ACTA NEUROCHIR, V150, P1193, DOI 10.1007/s00701-008-0130-3; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; BILLS DC, 1993, NEUROSURGERY, V33, P602, DOI 10.1227/00006123-199310000-00007; Biousse V, 2001, J NEUROL NEUROSUR PS, V71, P542, DOI 10.1136/jnnp.71.4.542; BONICKI W, 1993, ACTA NEUROCHIR, V120, P118, DOI 10.1007/BF02112028; Capatina C, 2015, EUR J ENDOCRINOL, V172, pR179, DOI 10.1530/EJE-14-0794; Cinar N, 2013, PITUITARY, V16, P483, DOI 10.1007/s11102-012-0444-2; Dubuisson AS, 2007, CLIN NEUROL NEUROSUR, V109, P63, DOI 10.1016/j.clineuro.2006.01.006; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Imboden PNE, 2005, MEDICINE, V84, P188, DOI [10.1097/01.md.0000164205.77287.9c, 10.1097/01.md.0000164205.77287.9e]; KNOSP E, 1993, NEUROSURGERY, V33, P610, DOI 10.1227/00006123-199310000-00008; Liu ZH, 2010, J CLIN NEUROSCI, V17, P694, DOI 10.1016/j.jocn.2009.11.012; McCabe CJ, 2002, J CLIN ENDOCR METAB, V87, P4238, DOI 10.1210/jc.2002-020309; Miyajima K, 2010, ACTA HISTOCHEM CYTOC, V43, P33, DOI 10.1267/ahc.09034; Moller-Goede DL, 2011, EUR J ENDOCRINOL, V164, P37, DOI 10.1530/EJE-10-0651; Mou CZ, 2009, J CLIN NEUROSCI, V16, P64, DOI 10.1016/j.jocn.2008.02.012; Nielsen EH, 2006, CLIN ENDOCRINOL, V64, P319, DOI 10.1111/j.1365-2265.2006.02463.x; Nomikos P, 2004, ACTA NEUROCHIR, V146, P27, DOI 10.1007/s00701-003-0174-3; Rajasekaran S, 2011, CLIN ENDOCRINOL, V74, P9, DOI 10.1111/j.1365-2265.2010.03913.x; Ranabir S, 2011, IND J ENDOCRINOL MET, V15, pS188, DOI [DOI 10.4103/2230-8210.84862S188-S196, DOI 10.4103/2230-8210.84862, 10.4103/2230-8210.84862]; Randall BR, 2010, ACTA NEUROCHIR, V152, P1737, DOI 10.1007/s00701-010-0706-6; Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x; Semple PL, 2007, NEUROSURGERY, V61, P956, DOI 10.1227/01.neu.0000303191.57178.2a; Seuk JW, 2011, J KOREAN NEUROSURG S, V49, P339, DOI 10.3340/jkns.2011.49.6.339; Shou XF, 2005, NEUROSURGERY, V56, P249, DOI 10.1227/01.neu.0000147976.06937.1D; Sibal Latika, 2004, Pituitary, V7, P157, DOI 10.1007/s11102-005-1050-3; WAKAI S, 1981, J NEUROSURG, V55, P187, DOI 10.3171/jns.1981.55.2.0187; Wang C, 2008, NEUROSURGERY, V62, P947, DOI 10.1227/01.neu.0000318181.80040.99	29	21	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139088	10.1371/journal.pone.0139088	http://dx.doi.org/10.1371/journal.pone.0139088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407083	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700164
J	Zhao, YL; Liu, F; Liu, Y; Zhou, D; Dai, Q; Liu, SQ				Zhao, Yinglan; Liu, Fang; Liu, Yao; Zhou, Dan; Dai, Qing; Liu, Songqing			Anti-Arthritic Effect of Chebulanin on Collagen-Induced Arthritis in Mice	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TERMINALIA-CHEBULA; TNF-ALPHA; ANIMAL-MODELS; THERAPY; EXTRACT; EPIDEMIOLOGY; PATHOGENESIS; INFLAMMATION; ETANERCEPT	Rheumatoid arthritis is a chronic degenerative autoimmune disease characterized by persistent inflammation of synovial membranes, which leads to cartilage destruction and bone erosion. To date, there are no effective therapies to slow the progress of this degenerative condition. Here, we evaluate the anti-arthritic effect of chebulanin, an abundant anti-inflammatory agent isolated from Terminalia chebula, in collagen induced arthritis in DBA/1 mice by intragastric administration. Arthritic severity was scored by performing histopathological evaluation of the joints and measuring the expression of inflammatory cytokines and relative enzymes by immunohistochemical staining. In parallel, bone destruction and erosion were confirmed by micro-CT. Our data revealed that chebulanin significantly improved the severity of arthritis. Specifically, the histopathological characteristics of the tissues were improved and expression of TNF-alpha, IL-6, MMP-3 and COX-2 in the paws and joints of the treated mice decreased in a dose-dependent manner compared with control mice. Furthermore, micro-CT analysis revealed that chebulanin induced a dose-dependent reduction in cartilage destruction and bone erosion. Taken together, our findings suggest that chebulanin suppresses the expression of inflammatory mediators and prevents cartilage destruction and bone erosion in mice. Therefore, chebulanin is a strong therapeutic alternative for the treatment of RA.	[Zhao, Yinglan; Liu, Fang; Liu, Yao; Dai, Qing; Liu, Songqing] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China; [Zhou, Dan] Tradit Chinese Med Hosp Dianjiang Cty, Chongqing, Peoples R China	Army Medical University	Liu, SQ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China.	songqingliu@hotmail.com	Liu, Songqing/AAM-7520-2020; Liu, Y/AAK-4063-2021		Application and Development Project from Chongqing Science and Technology Commission, China [cstc2014yykfA110023]	Application and Development Project from Chongqing Science and Technology Commission, China	This study was supported by Application and Development Project from Chongqing Science and Technology Commission, China, ( Grant Number: No.cstc2014yykfA110023), Website: http://www.clin.ac.cn/, Grant Recipient: SL.	Atzeni F, 2012, AUTOIMMUN REV, V12, P225, DOI 10.1016/j.autrev.2012.06.008; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Botsios C, 2007, REUMATISMO, V59, P32, DOI 10.4081/reumatismo.2007.32; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Das ND, 2011, PHYTOTHER RES, V25, P927, DOI 10.1002/ptr.3398; Machado MAD, 2013, REV BRAS REUMATOL, V53, P419, DOI 10.1590/S0482-50042013000500009; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008920; Edrees AF, 2005, CLIN EXP RHEUMATOL, V23, P469; Farkouh ME, 2007, ANN RHEUM DIS, V66, P764, DOI 10.1136/ard.2006.066001; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Ferraccioli G, 2010, MOL MED, V16, P552, DOI 10.2119/molmed.2010.00067; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Hashizume M, 2011, ARTHRITIS, DOI 10.1155/2011/765624; Hu YP, 2013, CLIN RHEUMATOL, V32, P161, DOI 10.1007/s10067-012-2041-1; Ito M, 1998, BONE, V23, P163, DOI 10.1016/S8756-3282(98)00083-0; Kannan P, 2009, AFR J MICROBIOL RES, V3, P180; Kozaci LD, 1997, ARTHRITIS RHEUM-US, V40, P164, DOI 10.1002/art.1780400121; Kunisch E, 2009, J IMMUNOL, V183, P1328, DOI 10.4049/jimmunol.0900801; Lee HS, 2005, BIOL PHARM BULL, V28, P1639, DOI 10.1248/bpb.28.1639; Lee WJ, 2014, J MICROBIOL BIOTECHN, V24, P1377, DOI 10.4014/jmb.1405.05030; Li QC, 2014, INT IMMUNOPHARMACOL, V21, P119, DOI 10.1016/j.intimp.2014.04.018; Liu M, 2009, FITOTERAPIA, V80, P369, DOI 10.1016/j.fitote.2009.05.006; Luo W, 2012, FOOD CHEM, V132, P1527, DOI 10.1016/j.foodchem.2011.11.146; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; Myers LK, 1997, LIFE SCI, V61, P1861, DOI 10.1016/S0024-3205(97)00480-3; Nishimoto N, 2009, ANN RHEUM DIS, V68, P1580, DOI 10.1136/ard.2008.092866; Pfundstein B, 2010, PHYTOCHEMISTRY, V71, P1132, DOI 10.1016/j.phytochem.2010.03.018; Pisetsky DS, 2001, JAMA-J AM MED ASSOC, V286, P2787, DOI 10.1001/jama.286.22.2787; Ribbens C, 2002, ANN RHEUM DIS, V61, P161, DOI 10.1136/ard.61.2.161; Rossini M, 2013, ANN RHEUM DIS, V72, P409; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Seetharaman R, 1999, J IMMUNOL, V163, P1577; Seo JB, 2012, BIOMOL THER, V20, P104, DOI 10.4062/biomolther.2012.20.1.104; Sireeratawong S, 2012, PLANTA MED, V78, P1169; Thiruppathi M, 2014, J AUTOIMMUN, V52, P64, DOI 10.1016/j.jaut.2013.12.014; Tikiz H, 2010, ANATOL J CARDIOL, V10, P98, DOI 10.5152/akd.2010.031; Wang HZ, 2014, J PHARMACOL EXP THER, V350, P435, DOI 10.1124/jpet.114.215145; Widdifield J, 2013, ANN RHEUM DIS, V72, P549; Zwerina J, 2005, ANN NY ACAD SCI, V1051, P716, DOI 10.1196/annals.1361.116	40	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139052	10.1371/journal.pone.0139052	http://dx.doi.org/10.1371/journal.pone.0139052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402786	Green Submitted, Green Published, gold			2022-12-27	WOS:000361798100054
J	Zhang, GH; Chen, ZG; Tian, LQ; Zhang, DW				Zhang, Guanghua; Chen, Zhenguo; Tian, Liqin; Zhang, Dongwen			Using Trust to Establish a Secure Routing Model in Cognitive Radio Network	PLOS ONE			English	Article							SPECTRUM ASSIGNMENT	Specific to the selective forwarding attack on routing in cognitive radio network, this paper proposes a trust-based secure routing model. Through monitoring nodes' forwarding behaviors, trusts of nodes are constructed to identify malicious nodes. In consideration of that routing selection-based model must be closely collaborative with spectrum allocation, a route request piggybacking available spectrum opportunities is sent to non-malicious nodes. In the routing decision phase, nodes' trusts are used to construct available path trusts and delay measurement is combined for making routing decisions. At the same time, according to the trust classification, different responses are made specific to their service requests. By adopting stricter punishment on malicious behaviors from non-trusted nodes, the cooperation of nodes in routing can be stimulated. Simulation results and analysis indicate that this model has good performance in network throughput and end-to-end delay under the selective forwarding attack.	[Zhang, Guanghua] Xidian Univ, State Key Lab Integrated Serv Networks, Xian, Shannxi, Peoples R China; [Zhang, Guanghua; Zhang, Dongwen] Hebei Univ Sci & Technol, Coll Informat Sci & Engn, Shijiazhuang, Hebei, Peoples R China; [Chen, Zhenguo] Northeastern Univ, Sch Informat Sci & Engn, Shenyang, Liaoning, Peoples R China; [Chen, Zhenguo; Tian, Liqin] North China Inst Sci & Technol, Coll Comp Sci & Technol, Beijing, Peoples R China	Xidian University; Hebei University of Science & Technology; Northeastern University - China; North China Institute Science & Technology	Chen, ZG (corresponding author), Northeastern Univ, Sch Informat Sci & Engn, Shenyang, Liaoning, Peoples R China.	czhenguo@gmail.com			National Natural Science Foundation of China [61472137, 61301091, 61300120, 61163050]; University Scientific Research Foundation of Hebei Province of China [YQ2014036, YQ2013032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Scientific Research Foundation of Hebei Province of China	The work was supported by the National Natural Science Foundation of China (61472137, 61301091, 61300120, 61163050), the University Scientific Research Foundation of Hebei Province of China (YQ2014036, YQ2013032).	Akyildiz IF, 2008, IEEE COMMUN MAG, V46, P40, DOI 10.1109/MCOM.2008.4481339; Akyildiz IF, 2006, COMPUT NETW, V50, P2127, DOI 10.1016/j.comnet.2006.05.001; [Anonymous], 2008, COMPUT COMMUN, V31, P3941; Cheng G, 2007, IEEE ICC, P6499, DOI 10.1109/ICC.2007.1075; Commerce B.E., 2002, P 15 BLED ELECT COMM, V5, P324; Cormio C, 2009, AD HOC NETW, V7, P1315, DOI 10.1016/j.adhoc.2009.01.002; Hoque M. A., 2012, 2012 International Conference on Computing, Networking and Communications (ICNC), P402, DOI 10.1109/ICCNC.2012.6167453; How KC, 2011, COMPUT NETW, V55, P330, DOI 10.1016/j.comnet.2010.09.008; Huisheng Ma, 2008, 3rd International Conference on Cognitive Radio Oriented Wireless Networks and Communications (CrownCom 2008), P1, DOI 10.1109/CROWNCOM.2008.4562509; Hung KS, 2007, IEEE WCNC, P3125; Josang A, 2007, DECIS SUPPORT SYST, V43, P618, DOI 10.1016/j.dss.2005.05.019; Karlof C., 2003, AD HOC NETW, V1, P293, DOI DOI 10.1016/S1570-8705(03)00008-8; Mitola J, 1999, IEEE PERS COMMUN, V6, P13, DOI 10.1109/98.788210; Pefkianakis I., 2008, P INT C IEEE DYSPAN, DOI DOI 10.1109/DYSPAN.2008.90; Perkins CE, 1999, WMCSA '99, SECOND IEEE WORKSHOP ON MOBILE COMPUTING SYSTEMS AND APPLICATIONS, PROCEEDINGS, P90, DOI 10.1109/MCSA.1999.749281; Qin T., 2009, ACM SIGMOBILE MOB CO, V13, P86, DOI DOI 10.1145/1621076.1621085; Sampath A, 2008, P 3 INT C COGN RAD O, P11; [田春岐 Tian Chunqi], 2007, [电子与信息学报, Journal of Electronics & Information Technology], V29, P1628; Wang X, 2011, IEEE T INSTRUM MEAS, V60, P2088, DOI 10.1109/TIM.2009.2036483; Xie LM, 2012, INT J COMMUN SYST, V25, P30, DOI 10.1002/dac.1285; Xiong L, 2004, IEEE T KNOWL DATA EN, V16, P843, DOI 10.1109/TKDE.2004.1318566; Yang ZK, 2008, MOBILE NETW APPL, V13, P67, DOI 10.1007/s11036-008-0025-9; Zeng K, 2010, IEEE COMMUN LETT, V14, P226, DOI 10.1109/LCOMM.2010.03.092240	23	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139326	10.1371/journal.pone.0139326	http://dx.doi.org/10.1371/journal.pone.0139326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421843	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700095
J	Ichida, Y; Utsunomiya, Y; Yasuda, T; Nakabayashi, K; Sato, T; Onodera, M				Ichida, Yu; Utsunomiya, Yuko; Yasuda, Toru; Nakabayashi, Kazuhiko; Sato, Toshinori; Onodera, Masafumi			Functional Domains of ZFP809 Essential for Nuclear Localization and Gene Silencing	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; EMBRYONIC STEM-CELLS; KRAB DOMAIN; RESTRICTION; SYSTEM; VIRUS; KAP1	Zinc finger protein 809 (ZFP809) is a member of the Kruppel-associated box-containing zinc finger protein (KRAB-ZFP) family, and is highly expressed in mouse immature cells. ZFP809 is known to inhibit the expression of transduced genes driven by Moloney murine leukemia virus (MoMLV)-typed retroviral vectors by binding to the primer binding site (PBS) located downstream of the MLV-long terminal repeat (LTR) of the vectors and recruiting protein complexes that introduce epigenetic silencing marks such as histone modifications and DNA methylation at the MLV-LTR. However, it remains undetermined what domains of ZFP809 among the KRAB domain at N-terminus and the seven zinc fingers are critical for gene silencing. In this study, we assessed subcellular localization, gene silencing ability, and binding ability to the PBS of a series of truncated and mutated ZFP809 proteins. We revealed the essential role of the KRAB A box for all functions assessed, together with the accessory roles of a subset of zinc fingers. Our data also suggest that interaction between KAP1 and the KRAB A box of ZFP809 is critical in KAP1-dependent control of gene silencing for ZFP809 targets.	[Ichida, Yu; Utsunomiya, Yuko; Yasuda, Toru; Onodera, Masafumi] Natl Ctr Child Hlth & Dev, Dept Human Genet, Setagaya Ku, Tokyo 1578535, Japan; [Nakabayashi, Kazuhiko] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo 1578535, Japan; [Sato, Toshinori] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 2238522, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Keio University	Ichida, Y (corresponding author), Natl Ctr Child Hlth & Dev, Dept Human Genet, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	ichida-y@ncchd.go.jp		Sato, Toshinori/0000-0002-4429-6101	Grants-in-Aid for Scientific Research [23241075] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Corsinotti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056721; de Sio FRS, 2014, NUCLEUS-PHILA, V5, P138, DOI 10.4161/nucl.28738; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; FRANZ T, 1986, P NATL ACAD SCI USA, V83, P3292, DOI 10.1073/pnas.83.10.3292; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hirasawa R, 2008, DEV CELL, V15, P487, DOI 10.1016/j.devcel.2008.09.006; Lupo A, 2013, CURR GENOMICS, V14, P268, DOI 10.2174/13892029113149990002; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Onodera M, 1998, J VIROL, V72, P1769, DOI 10.1128/JVI.72.3.1769-1774.1998; Quenneville S, 2012, CELL REP, V2, P766, DOI 10.1016/j.celrep.2012.08.043; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Suzuki A, 2002, J NEUROCHEM, V82, P953, DOI 10.1046/j.1471-4159.2002.01048.x; Tan XY, 2013, STEM CELL RES, V11, P1045, DOI 10.1016/j.scr.2013.07.006; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wang GZ, 2014, J VIROL, V88, P1825, DOI 10.1128/JVI.02578-13; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092155; Wang W, 2013, CELL MOL LIFE SCI, V70, P3947, DOI 10.1007/s00018-013-1359-4; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114	21	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139274	10.1371/journal.pone.0139274	http://dx.doi.org/10.1371/journal.pone.0139274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417948	Green Submitted, Green Published, gold			2022-12-27	WOS:000362171400069
J	Nguyen, HT; Jia, W; Beedle, AM; Kennedy, EJ; Murph, MM				Nguyen, Ha T.; Jia, Wei; Beedle, Aaron M.; Kennedy, Eileen J.; Murph, Mandi M.			Lysophosphatidic Acid Mediates Activating Transcription Factor 3 Expression Which Is a Target for Post-Transcriptional Silencing by miR-30c-2-3p	PLOS ONE			English	Article							NEGATIVE FEEDBACK LOOP; OVARIAN-CANCER CELLS; TUMOR-GROWTH; AUTOTAXIN; LYSOPHOSPHOLIPIDS; IDENTIFICATION; METASTASIS; CARCINOMA; INVASION	Although microRNAs (miRNAs) are small, non-protein-coding entities, they have important roles in post-transcriptional regulation of most of the human genome. These small entities generate fine-tuning adjustments in the expression of mRNA, which can mildly or massively affect the abundance of proteins. Previously, we found that the expression of miR-30c-2-3p is induced by lysophosphatidic acid and has an important role in the regulation of cell proliferation in ovarian cancer cells. The goal here is to confirm that ATF3 mRNA is a target of miR-30c-2-3p silencing, thereby further establishing the functional role of miR-30c-2-3p. Using a combination of bioinformatics, qRT-PCR, immunoblotting and luciferase assays, we uncovered a regulatory pathway between miR-30c-2-3p and the expression of the transcription factor, ATF3. Lysophosphatidic acids triggers the expression of both miR-30c-23p and ATF3, which peak at 1 h and are absent 8 h post stimulation in SKOV-3 and OVCAR-3 serous ovarian cancer cells. The 3'-untranslated region (3'-UTR) of ATF3 was a predicted, putative target for miR-30c-2-3p, which we confirmed as a bona-fide interaction using a luciferase reporter assay. Specific mutations introduced into the predicted site of interaction between miR-30c-2-3p and the 3'-UTR of ATF3 alleviated the suppression of the luciferase signal. Furthermore, the presence of anti-miR-30c-2-3p enhanced ATF3 mRNA and protein after lysophosphatidic acid stimulation. Thus, the data suggest that after the expression of ATF3 and miR-30c-2-3p are elicited by lysophosphatidic acid, subsequently miR-30c-2-3p negatively regulates the expression of ATF3 through post-transcriptional silencing, which prevents further ATF3-related outcomes as a consequence of lysophosphatidic acid signaling.	[Nguyen, Ha T.; Jia, Wei; Beedle, Aaron M.; Kennedy, Eileen J.; Murph, Mandi M.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Murph, MM (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, 240 W Green St, Athens, GA 30602 USA.	mmurph@uga.edu	Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Beedle, Aaron M/0000-0002-1019-3235; Kennedy, Eileen/0000-0001-5610-1677	National Institutes of Health [1R15CA176653-01A1]; American Cancer Society [120634-RSG-11-269-01-CDD]; Georgia Research Alliance; NATIONAL CANCER INSTITUTE [R15CA176653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Georgia Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from the National Institutes of Health (1R15CA176653-01A1), a Research Scholar Grant 120634-RSG-11-269-01-CDD from the American Cancer Society and the Georgia Research Alliance.	[Anonymous], 2011, ATF3; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Balch C, 2009, ENDOCRINOLOGY, V150, P4003, DOI 10.1210/en.2009-0404; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Byrd AE, 2012, J CELL BIOL, V196, P689, DOI 10.1083/jcb.201201077; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; Darlyuk-Saadon I, 2012, BBA-GENE REGUL MECH, V1819, P1142, DOI 10.1016/j.bbagrm.2012.09.005; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jia W, 2011, MOL CANCER RES, V9, P1732, DOI 10.1158/1541-7786.MCR-11-0245; Lan YF, 2012, J AM SOC NEPHROL, V23, P2012, DOI 10.1681/ASN.2012050438; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lutgendorf SK, 2009, BRAIN BEHAV IMMUN, V23, P176, DOI 10.1016/j.bbi.2008.04.155; Mathew LK, 2014, CANCER DISCOV, V4, P53, DOI 10.1158/2159-8290.CD-13-0291; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Murph M, 2006, CLIN CANCER RES, V12, P6598, DOI 10.1158/1078-0432.CCR-06-1721; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; Murph MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005583; Nguyen HT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00071; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Shukla K, 2015, MOL ONCOL, V9, P1106, DOI 10.1016/j.molonc.2015.01.008; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zhang J, 2015, HEPATOLOGY, V61, P561, DOI 10.1002/hep.27491	35	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139489	10.1371/journal.pone.0139489	http://dx.doi.org/10.1371/journal.pone.0139489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418018	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400093
J	Schmid, P; Bregenzer, A; Huber, M; Rauch, A; Jochum, W; Mullhaupt, B; Vernazza, P; Opravil, M; Weber, R				Schmid, Patrick; Bregenzer, Andrea; Huber, Milo; Rauch, Andri; Jochum, Wolfram; Muellhaupt, Beat; Vernazza, Pietro; Opravil, Milos; Weber, Rainer		Swiss HIV Cohort Study	Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CHRONIC VIRAL-HEPATITIS; TRANSIENT ELASTOGRAPHY; BIOCHEMICAL MARKERS; DIAGNOSTIC-ACCURACY; HYALURONIC-ACID; VIRUS-INFECTION; BLOOD-TESTS; HIV; BIOMARKERS	Objectives To evaluate the diagnostic performance of seven non-invasive tests (NITs) of liver fibrosis and to assess fibrosis progression over time in HIV/HCV co-infected patients. Methods Transient elastography (TE) and six blood tests were compared to histopathological fibrosis stage (METAVIR). Participants were followed over three years with NITs at yearly intervals. Results Area under the receiver operating characteristic curve (AUROC) for significant fibrosis (> = F2) in 105 participants was highest for TE (0.85), followed by FIB-4 (0.77), ELF-Test (0.77), APRI (0.76), Fibrotest (0.75), hyaluronic acid (0.70), and Hepascore (0.68). AUROC for cirrhosis (F4) was 0.97 for TE followed by FIB-4 (0.91), APRI (0.89), Fibrotest (0.84), Hepascore (0.82), ELF-Test (0.82), and hyaluronic acid (0.79). A three year follow-up was completed by 87 participants, all on antiretroviral therapy and in 20 patients who completed HCV treatment (9 with sustained virologic response). TE, APRI and Fibrotest did not significantly change during follow-up. There was weak evidence for an increase of FIB-4 (mean increase: 0.22, p = 0.07). 42 participants had a second liver biopsy: Among 38 participants with F0-F3 at baseline, 10 were progessors (1-stage increase in fibrosis, 8 participants; 2-stage, 1; 3-stage, 1). Among progressors, mean increase in TE was 3.35 kPa, in APRI 0.36, and in FIB-4 0.75. Fibrotest results did not change over 3 years. Conclusion TE was the best NIT for liver fibrosis staging in HIV/HCV co-infected patients. APRI-Score, FIB-4 Index, Fibrotest, and ELF-Test were less reliable. Routinely available APRI and FIB-4 performed as good as more expensive tests. NITs did not change significantly during a follow-up of three years, suggesting slow liver disease progression in a majority of HIV/HCV co-infected persons on antiretroviral therapy.	[Schmid, Patrick; Bregenzer, Andrea; Vernazza, Pietro] Cantonal Hosp St Gallen, Div Infect Dis & Hosp Epidemiol, St Gallen, Switzerland; [Huber, Milo; Opravil, Milos; Weber, Rainer] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Rauch, Andri] Univ Hosp Bern, Div Infect Dis & Hosp Epidemiol, CH-3010 Bern, Switzerland; [Jochum, Wolfram] Cantonal Hosp St Gallen, Inst Pathol, St Gallen, Switzerland; [Muellhaupt, Beat] Univ Zurich Hosp, Div Hepatol, CH-8091 Zurich, Switzerland	Kantonsspital St. Gallen; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; Kantonsspital St. Gallen; University of Zurich; University Zurich Hospital	Schmid, P (corresponding author), Cantonal Hosp St Gallen, Div Infect Dis & Hosp Epidemiol, St Gallen, Switzerland.	Patrick.Schmid@kssg.ch	Weber, Rainer/D-5175-2012; Rauch, Andri/E-9948-2017; Pantaleo, Giuseppe/K-6163-2016; Fellay, Jacques/A-6681-2009; Kouyos, Roger/G-6226-2014; Mullhaupt, Beat/O-3744-2016	Rauch, Andri/0000-0001-5297-6062; Fellay, Jacques/0000-0002-8240-939X; TARR, Philip/0000-0002-1488-5407; Kouyos, Roger/0000-0002-9220-8348; Egger, Matthias/0000-0001-7462-5132; Mullhaupt, Beat/0000-0002-9020-8192	Swiss HIV Cohort Study - Swiss National Science Foundation [148522]; SHCS project [474]; SHCS research foundation; Schering-Plough; Siemens	Swiss HIV Cohort Study - Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); SHCS project; SHCS research foundation; Schering-Plough(Merck & CompanySchering Plough Corporation); Siemens(Siemens AG)	This study has been financed within the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant #148522), by SHCS project #474 and by the SHCS research foundation. The data are gathered by the Five Swiss University Hospitals, two Cantonal Hospitals, 15 affiliated hospitals and 36 private physicians (listed in http://www.shcs.ch/180-healthcare-providers). The study was supported by an unrestricted grant from Schering-Plough. Biopredictive offered a 50% discount for Fibrotest calculations. ELF-test was financed by Siemens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Becker L, 2009, CLIN GASTROENTEROL H, V7, P696, DOI 10.1016/j.cgh.2009.01.010; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Cacoub P, 2008, J HEPATOL, V48, P765, DOI 10.1016/j.jhep.2008.01.025; Cales P, 2010, J HEPATOL, V53, P238, DOI 10.1016/j.jhep.2010.03.007; Castera L, 2014, HIV MED, V15, P30, DOI 10.1111/hiv.12082; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Halfon Philippe, 2005, Comp Hepatol, V4, P6, DOI 10.1186/1476-5926-4-6; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Konerman MA, 2014, HEPATOLOGY, V59, P767, DOI 10.1002/hep.26741; Lenth RV, 2007, J ANIM SCI, V85, pE24, DOI 10.2527/jas.2006-449; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Macias J, 2013, CLIN INFECT DIS, V57, P1401, DOI 10.1093/cid/cit537; McHutchison JG, 2000, J GASTROEN HEPATOL, V15, P945, DOI 10.1046/j.1440-1746.2000.02233.x; Myers RP, 2003, AIDS, V17, P721, DOI 10.1097/00002030-200303280-00010; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Patel K, 2003, J GASTROEN HEPATOL, V18, P253, DOI 10.1046/j.1440-1746.2003.02930.x; Rohrbach J, 2014, ANTIVIR THER, V19, P149, DOI 10.3851/IMP2686; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Sebastiani G, 2011, ALIMENT PHARM THER, V34, P1202, DOI 10.1111/j.1365-2036.2011.04861.x; Sebastiani G, 2009, HEPATOLOGY, V49, P1821, DOI 10.1002/hep.22859; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; Smith JO, 2009, ALIMENT PHARM THER, V30, P557, DOI 10.1111/j.1365-2036.2009.04062.x; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Vermehren J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-27; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	37	39	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138838	10.1371/journal.pone.0138838	http://dx.doi.org/10.1371/journal.pone.0138838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418061	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000362171400022
J	Bonanni, A; Bertelli, R; Rossi, R; Bruschi, M; Di Donato, A; Ravani, P; Ghiggeri, GM				Bonanni, Alice; Bertelli, Roberta; Rossi, Roberta; Bruschi, Maurizio; Di Donato, Armando; Ravani, Pietro; Ghiggeri, Gian Marco			A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome	PLOS ONE			English	Article							REGULATORY T-CELLS; PUROMYCIN AMINONUCLEOSIDE; INTERLEUKIN-2; RITUXIMAB; CHILDREN; DISEASE; VASCULITIS; INDUCTION; COMPLEXES; EXPANSION	Tregs infusion reverts proteinuria and reduces renal lesions in most animal models of nephrotic syndrome (i.e. Buffalo/Mna, Adriamycin, Promycin, LPS). IL2 up-regulates Tregs and may be an alternative to cell-therapy in this setting. To evaluate a potential role of IL2 as Tregs inducer and proteinuria lowering agent in human nephrotic syndrome we treated 5 nephrotic patients with 6 monthly cycles of low-dose IL2 (1x10(6) U/m(2) first month, 1.5x10(6) U/m(2) following months). The study cohort consisted of 5 children (all boys, 11-17 years) resistant to all the available treatments (i.e. steroids, calcineurin inhibitors, mycophenolate, Rituximab). Participants had Focal Segmental Glomerulosclerosis (3 cases) or Minimal Change Nephropathy (2 cases). IL2 was safe in all but one patient who had an acute asthma attack after the first IL2 dose and did not receive further doses. Circulating Tregs were stably increased (>10%) during the whole study period in 2 cases while were only partially modified in the other two children who started with very low levels and partially responded to single IL2 Proteinuria and renal function were not modified by IL2 at any phase of the study. We concluded that low-dose IL2 given in monthly pulses is safe and modifies the levels of circulating Tregs. This drug may not be able to lower proteinuria or affect renal function in children with idiopathic nephrotic syndrome. We were unable to reproduce in humans the effects of IL2 described in rats and mice reducing de facto the interest on this drug in nephrotic syndrome.	[Bonanni, Alice; Bertelli, Roberta; Rossi, Roberta; Bruschi, Maurizio; Di Donato, Armando; Ghiggeri, Gian Marco] Giannina Gaslini Children Hosp, Div Nephrol Dialysis Transplantat & Lab Physiopat, Genoa, Italy; [Ravani, Pietro] Univ Calgary, Div Nephrol, Calgary, AB T2N 2T9, Canada	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Calgary	Ghiggeri, GM (corresponding author), Giannina Gaslini Children Hosp, Div Nephrol Dialysis Transplantat & Lab Physiopat, Genoa, Italy.	GMarcoGhiggeri@ospedale-gaslini.ge.it	Bertelli, Roberta/AAA-7207-2020; Ravani, Pietro/J-3050-2015; Bruschi, Maurizio/E-7090-2016; Ghiggeri, Gian Marco/N-4712-2015; Coviello, Domenico/J-9477-2016; Bonanni, Alice/K-4453-2016	Ravani, Pietro/0000-0001-6973-8570; Bruschi, Maurizio/0000-0001-6036-1500; Ghiggeri, Gian Marco/0000-0003-3659-9062; Coviello, Domenico/0000-0001-8440-865X; Bonanni, Alice/0000-0002-4878-6271	Cinque per mille of IRPEF-Finanziamento della ricerca sanitaria; Italian Ministry of Health 'Ricerca Corrente contributo per la ricerca intramuraria'; Institute Giannina Gaslini; Renal Child Foundation; Fondazione La Nuova Speranza ('Progetto integrato per la definizione dei meccanismi implicati nella glomerulo sclerosi focale')	Cinque per mille of IRPEF-Finanziamento della ricerca sanitaria; Italian Ministry of Health 'Ricerca Corrente contributo per la ricerca intramuraria'; Institute Giannina Gaslini; Renal Child Foundation; Fondazione La Nuova Speranza ('Progetto integrato per la definizione dei meccanismi implicati nella glomerulo sclerosi focale')	This study was supported by funds deriving from 'Cinque per mille of IRPEF-Finanziamento della ricerca sanitaria' and from the Italian Ministry of Health 'Ricerca Corrente contributo per la ricerca intramuraria' to Istituto Giannina Gaslini. The Institute Giannina Gaslini provided financial and logistic support to the trial. This work was also supported by the Renal Child Foundation, and Fondazione La Nuova Speranza ('Progetto integrato per la definizione dei meccanismi implicati nella glomerulo sclerosi focale').	Alachkar N, 2014, NEW ENGL J MED, V370, P1263, DOI 10.1056/NEJMc1400502; Bertelli R, 2016, CLIN EXP IMMUNOL, V183, P166, DOI 10.1111/cei.12675; Bertelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111285; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Churlaud G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00171; Finger EB, 2002, NAT IMMUNOL, V3, P1056, DOI 10.1038/ni1102-1056; Garin EH, 2009, J AM SOC NEPHROL, V20, P260, DOI 10.1681/ASN.2007080836; GHIGGERI GM, 1991, KIDNEY INT, V40, P35, DOI 10.1038/ki.1991.176; GHIGGERI GM, 1992, EUR J PHARM-ENVIRON, V228, P77, DOI 10.1016/0926-6917(92)90015-5; GINEVRI F, 1990, CLIN SCI, V78, P283, DOI 10.1042/cs0780283; Kim MG, 2013, J AM SOC NEPHROL, V24, P1529, DOI 10.1681/ASN.2012080784; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Le Berre L, 2009, J AM SOC NEPHROL, V20, P57, DOI 10.1681/ASN.2007111244; Polhill T, 2012, J AM SOC NEPHROL, V23, P1303, DOI 10.1681/ASN.2011111130; Ravani P, 2013, KIDNEY INT, V84, P1025, DOI 10.1038/ki.2013.211; Ravani P, 2011, CLIN J AM SOC NEPHRO, V6, P1308, DOI 10.2215/CJN.09421010; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Saadoun D, 2008, BLOOD, V111, P5334, DOI 10.1182/blood-2007-11-122713; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Taylor PA, 2004, J IMMUNOL, V172, P34, DOI 10.4049/jimmunol.172.1.34; TROMPETER RS, 1985, LANCET, V1, P368; Vincenti F, 2005, AM J TRANSPLANT, V5, P1179, DOI 10.1111/j.1600-6143.2005.00968.x; Wang YM, 2012, J AM SOC NEPHROL, V23, P1058, DOI 10.1681/ASN.2011090914; Yu CC, 2013, NEW ENGL J MED, V369, P2416, DOI 10.1056/NEJMoa1304572	24	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138343	10.1371/journal.pone.0138343	http://dx.doi.org/10.1371/journal.pone.0138343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413873	Green Submitted, gold, Green Published			2022-12-27	WOS:000362170700014
J	Kesimer, M; Cullen, J; Cao, R; Radicioni, G; Mathews, KG; Seiler, G; Gookin, JL				Kesimer, Mehmet; Cullen, John; Cao, Rui; Radicioni, Giorgia; Mathews, Kyle G.; Seiler, Gabriela; Gookin, Jody L.			Excess Secretion of Gel-Forming Mucins and Associated Innate Defense Proteins with Defective Mucin Un-Packaging Underpin Gallbladder Mucocele Formation in Dogs	PLOS ONE			English	Article							GALL-BLADDER MUCOCELES; RESPIRATORY MUCIN; OLIGOMERIC MUCINS; EPITHELIAL-CELLS; GENE-EXPRESSION; CYSTIC-FIBROSIS; TREFOIL FACTORS; MUCUS; DISEASE; GLYCOPROTEIN	Mucosal protection of the gallbladder is vital yet we know very little about the mechanisms involved. In domestic dogs, an emergent syndrome referred to as gallbladder mucocele formation is characterized by excessive secretion of abnormal mucus that results in obstruction and rupture of the gallbladder. The cause of gallbladder mucocele formation is unknown. In these first mechanistic studies of this disease, we investigated normal and mucocele-forming dog gallbladders to determine the source, identity, biophysical properties, and protein associates of the culprit mucins with aim to identify causes for abnormal mucus behavior. We established that mucocele formation involves an adoptive excess secretion of gel forming mucins with abnormal properties by the gallbladder epithelium. The mucus is characterized by a disproportionally significant increase in Muc5ac relative to Muc5b, defective mucin un-packaging, and mucin-interacting innate defense proteins that are capable of dramatically altering the physical and functional properties of mucus. These findings provide an explanation for abnormal mucus behavior and based on similarity to mucus observed in the airways of people with cystic fibrosis, suggest that abnormal mechanisms for maintenance of gallbladder epithelial hydration may be an instigating factor for mucocele formation in dogs.	[Kesimer, Mehmet; Cao, Rui; Radicioni, Giorgia] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Kesimer, Mehmet; Cao, Rui; Radicioni, Giorgia] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Cullen, John] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Mathews, Kyle G.; Gookin, Jody L.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Coll Vet, Dept Clin Sci, Raleigh, NC 27695 USA; [Seiler, Gabriela] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Gookin, JL (corresponding author), N Carolina State Univ, Ctr Comparat Med & Translat Res, Coll Vet, Dept Clin Sci, Raleigh, NC 27695 USA.	Jody_Gookin@ncsu.edu	, Mehmet Kesimer/AHB-9223-2022; Cullen, John M/I-2051-2019	Gookin, Jody/0000-0002-2911-0874	Morris Animal Foundation [D12CA-044]; National Institutes of Health National Heart Lung and Blood Institute [HL103940]; Cystic Fibrosis Foundation [KESIME14XX0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103940] Funding Source: NIH RePORTER	Morris Animal Foundation; National Institutes of Health National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were funded by grant D12CA-044 from the Morris Animal Foundation (JLG), and partially supported by grant HL103940 (MK) from the National Institutes of Health National Heart Lung and Blood Institute and grant KESIME14XX0 (MK) from the Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AL, 2007, JAVMA-J AM VET MED A, V231, P79, DOI 10.2460/javma.231.1.79; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Barbhuiya MA, 2011, PROTEOMICS, V11, P4443, DOI 10.1002/pmic.201100197; BERNHOFT RA, 1983, GASTROENTEROLOGY, V85, P1166; Buisine MP, 2000, J HISTOCHEM CYTOCHEM, V48, P1667, DOI 10.1177/002215540004801210; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Cooper JL, 2013, AM J PHYSIOL-LUNG C, V304, pL184, DOI 10.1152/ajplung.00143.2012; Crews LJ, 2009, JAVMA-J AM VET MED A, V234, P359, DOI 10.2460/javma.234.3.359; CROWTHER RS, 1984, BIORHEOLOGY, V21, P253; Cullen JM, 2014, J VET DIAGN INVEST, V26, P434, DOI 10.1177/1040638714532099; Farid SG, 2011, PROTEOMICS, V11, P2134, DOI 10.1002/pmic.201000653; Farina A, 2011, J PROTEOME RES, V10, P2047, DOI 10.1021/pr200011b; Finzi L, 2006, AM J PATHOL, V169, P2031, DOI 10.2353/ajpath.2006.060146; GEIL RG, 1977, J TOXICOL ENV HEALTH, V3, P179, DOI 10.1080/15287397709529557; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Ho SB, 2000, DIGEST DIS SCI, V45, P1061, DOI 10.1023/A:1005573213100; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Jackowiak H., 2006, Folia Morphologica, V65, P105; Kesimer M, 2013, MUCOSAL IMMUNOL, V6, P379, DOI 10.1038/mi.2012.81; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; KINDON H, 1995, GASTROENTEROLOGY, V109, P516, DOI 10.1016/0016-5085(95)90340-2; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Kjellev S, 2006, BRIT J PHARMACOL, V149, P92, DOI 10.1038/sj.bjp.0706840; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; KOVATCH RM, 1965, PATHOL VET, V2, P574, DOI 10.1177/030098586500200605; Kutsunai M, 2014, VET J, V199, P76, DOI 10.1016/j.tvjl.2013.10.019; Kuver R, 2006, AM J PHYSIOL-GASTR L, V291, pG1148, DOI 10.1152/ajpgi.00547.2005; Malek S, 2013, VET SURG, V42, P418, DOI 10.1111/j.1532-950X.2012.01072.x; MAUDESLE.LE, 1967, VET REC, V80, P658, DOI 10.1136/vr.80.22.658; Mesich MLL, 2009, J SMALL ANIM PRACT, V50, P630, DOI 10.1111/j.1748-5827.2009.00811.x; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Mollenhauer J, 2000, CANCER RES, V60, P1704; NUNES DP, 1995, BIOCHEM J, V310, P41, DOI 10.1042/bj3100041; Palaniyar N, 2003, ANN NY ACAD SCI, V1010, P471, DOI 10.1196/annals.1299.085; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pike FS, 2004, JAVMA-J AM VET MED A, V224, P1615, DOI 10.2460/javma.2004.224.1615; Ridley C, 2014, J BIOL CHEM, V289, P16409, DOI 10.1074/jbc.M114.566679; RUNDEGREN J, 1987, INFECT IMMUN, V55, P288, DOI 10.1128/IAI.55.2.288-292.1987; Sasaki M, 2007, PROG HISTOCHEM CYTO, V42, P61, DOI 10.1016/j.proghi.2007.02.001; SCOTT AJ, 1978, GUT, V19, P558, DOI 10.1136/gut.19.6.558; SELMAN PJ, 1995, VET QUART, V17, P128, DOI 10.1080/01652176.1995.9694551; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Sun XS, 2014, AM J PATHOL, V184, P1309, DOI 10.1016/j.ajpath.2014.01.035; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; Thornton DJ, 2001, GLYCOBIOLOGY, V11, P969, DOI 10.1093/glycob/11.11.969; Tsukagoshi T, 2012, VET RADIOL ULTRASOUN, V53, P84, DOI 10.1111/j.1740-8261.2011.01868.x; Vandenhaute B, 1997, J HEPATOL, V27, P1057, DOI 10.1016/S0168-8278(97)80150-X; Wiede A, 1999, AM J RESP CRIT CARE, V159, P1330, DOI 10.1164/ajrccm.159.4.9804149; Worley DR, 2004, JAVMA-J AM VET MED A, V225, P1418, DOI 10.2460/javma.2004.225.1418; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020334; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	52	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138988	10.1371/journal.pone.0138988	http://dx.doi.org/10.1371/journal.pone.0138988			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414376	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700031
J	Pourzanjani, A; Herzog, ED; Petzold, LR				Pourzanjani, Arya; Herzog, Erik D.; Petzold, Linda R.			On the Inference of Functional Circadian Networks Using Granger Causality	PLOS ONE			English	Article							BRAIN NETWORKS; SYNCHRONIZATION; OSCILLATIONS; SIGNAL; MODEL	Being able to infer one way direct connections in an oscillatory network such as the supra-chiastmatic nucleus (SCN) of the mammalian brain using time series data is difficult but crucial to understanding network dynamics. Although techniques have been developed for inferring networks from time series data, there have been no attempts to adapt these techniques to infer directional connections in oscillatory time series, while accurately distinguishing between direct and indirect connections. In this paper an adaptation of Granger Causality is proposed that allows for inference of circadian networks and oscillatory networks in general called Adaptive Frequency Granger Causality (AFGC). Additionally, an extension of this method is proposed to infer networks with large numbers of cells called LASSO AFGC. The method was validated using simulated data from several different networks. For the smaller networks the method was able to identify all one way direct connections without identifying connections that were not present. For larger networks of up to twenty cells the method shows excellent performance in identifying true and false connections; this is quantified by an area-under-the-curve (AUC) 96.88%. We note that this method like other Granger Causality-based methods, is based on the detection of high frequency signals propagating between cell traces. Thus it requires a relatively high sampling rate and a network that can propagate high frequency signals.	[Pourzanjani, Arya; Petzold, Linda R.] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Herzog, Erik D.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Santa Barbara; Washington University (WUSTL)	Pourzanjani, A (corresponding author), Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA.	arya@umail.ucsb.edu			Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-0001]; National Institute of Health [1R01GM096873-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096873] Funding Source: NIH RePORTER	Institute for Collaborative Biotechnologies from the U.S. Army Research Office; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office: AAP, LRP and National Institute of Health Award number 1R01GM096873-01: AAP, LRP, EDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Brockwell P. J., 2002, INTRO TIME SERIES FO, V1; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Freeman GM, 2013, NEURON, V78, P799, DOI 10.1016/j.neuron.2013.04.003; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Hartemink A J, 2001, Pac Symp Biocomput, P422; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Levnajic Z, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.034101; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Liitkepohl H, 2007, NEW INTRO MULTIPLE T; Lozano AC, 2009, BIOINFORMATICS, V25, pI110, DOI 10.1093/bioinformatics/btp199; Meeker K, 2011, J BIOL RHYTHM, V26, P353, DOI 10.1177/0748730411409863; Nedungadi AG, 2009, J COMPUT NEUROSCI, V27, P55, DOI 10.1007/s10827-008-0126-2; Prignano L, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036112; Shandilya SG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013004; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timme M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.224101; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Vasalou C, 2009, J BIOL RHYTHM, V24, P243, DOI 10.1177/0748730409333220; Weaver D C, 1999, Pac Symp Biocomput, P112; Wilmer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044633; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yu DC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188701	33	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137540	10.1371/journal.pone.0137540	http://dx.doi.org/10.1371/journal.pone.0137540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413748	Green Published, gold			2022-12-27	WOS:000362170700009
J	Caillet, P; Payet, C; Polazzi, S; Carty, MJ; Lifante, JC; Duclos, A				Caillet, Pascal; Payet, Cecile; Polazzi, Stephanie; Carty, Matthew J.; Lifante, Jean-Christophe; Duclos, Antoine			Increased Mortality for Elective Surgery during Summer Vacation: A Longitudinal Analysis of Nationwide Data	PLOS ONE			English	Article							SURGICAL MORTALITY; PERFORMANCE; VOLUME	Surgical safety during vacation periods may be influenced by the interplay of several factors, including workers' leave, hospital activity, climate, and the variety of patient cases. This study aimed to highlight an annually recurring peak of surgical mortality during summer in France and explore its main predictors. We selected all elective of open surgical procedures performed in French hospitals between 2007 and 2012. Surgical mortality variation was analyzed over time in relation to workers leaving on vacation, the volume of procedures performed by hospitals, and temperature changes. We ran a multilevel logistic regression for exploring the determinants of surgical mortality, taking into account the clustering of patients within hospitals and adjusting for patient and hospital characteristics. A total of 609 French hospitals had 8,926,120 discharges related to open elective surgery. During 6 years, we found a recurring mortality peak of 1.15%(95% CI 1.09-1.20) in August compared with 0.81% (0.79-0.82, p<.001) in other months. The incidence of worker vacation was 43.0% (38.9-47.2) in August compared with 7.3% (4.6-10.1, p<.001) in other months. Hospital activity decreased substantially in August (78,126 inpatient stays, 75,298-80,954) in relation to other months (128,142, 125,697-130,586, p<.001). After adjusting for all covariates, we found an "August effect" reflecting a higher risk to patients undergoing operations at this time (OR 1.16, 95% CI 1.12-1.19, p<.001). The main study limitation was the absence of data linkage between surgical staffing and mortality at the hospital level. The observed, recurring mortality peak in August raises questions about how to maintain hospital activity and optimal staffing through better regulation of human activities.	[Caillet, Pascal; Payet, Cecile; Polazzi, Stephanie; Duclos, Antoine] Hosp Civils Lyon, Pole Informat Med Evaluat Rech, F-69003 Lyon, France; [Caillet, Pascal] INSERM, Res Unit 1033, F-69003 Lyon, France; [Caillet, Pascal; Payet, Cecile; Polazzi, Stephanie; Lifante, Jean-Christophe; Duclos, Antoine] Univ Lyon 1, Hlth Serv & Performance Res Lab, F-69003 Lyon, France; [Lifante, Jean-Christophe] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Chirurg Gen & Endocrinienne, F-69300 Pierre Benite, France; [Carty, Matthew J.; Duclos, Antoine] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Caillet, P (corresponding author), Hosp Civils Lyon, Pole Informat Med Evaluat Rech, F-69003 Lyon, France.	p.caillet@yahoo.fr	Caillet, Pascal/K-5299-2019; Duclos, Antoine/N-3756-2016; Lifante, Jean-Christophe/AAX-2606-2020	Caillet, Pascal/0000-0001-5667-7887; Duclos, Antoine/0000-0002-8915-4203; Polazzi, Stephanie/0000-0003-4622-7983	Hospices Civils de Lyon teaching hospital	Hospices Civils de Lyon teaching hospital	PC, CP, JCL, SP and AD received financial support from Hospices Civils de Lyon teaching hospital for independently conducting the submitted work. MJC received no specific funding for this work.	Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Biausque V, 2012, 2010 EMPLOYEES TOOK; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Couris CM, 2009, J CLIN EPIDEMIOL, V62, P660, DOI 10.1016/j.jclinepi.2008.07.013; Duclos A, 2009, BRIT J SURG, V96, P171, DOI 10.1002/bjs.6418; Duclos A, 2013, MED CARE, V51, P1085, DOI 10.1097/MLR.0b013e3182a97c54; Duclos A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8041; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; French Ministry of Health, 2006, WHIT PLAN CRIS MAN G; Haller G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3974; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Lilford R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2016; National Institute of Statistics and Economic Studies (INSEE), NAT CENS RES POP FRA; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ray R, 2013, NOVACATION NATION RE; Shahian DM, 2010, NEW ENGL J MED, V363, P2530, DOI 10.1056/NEJMsa1006396; Technical Agency for Hospital Information (ATIH), FRENCH HOSP EP STAT; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Xu R, 2013, ANN SURG, V258, P953, DOI 10.1097/SLA.0b013e3182864ffe; Zare MM, 2007, ANN SURG, V246, P866, DOI 10.1097/SLA.0b013e3180cc2e60	28	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137754	10.1371/journal.pone.0137754	http://dx.doi.org/10.1371/journal.pone.0137754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407191	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700025
J	da Silva, AP; Lopes, AD; Vieira, YR; de Almeida, AJ; Sion, FS; Grinsztejn, B; Wagner, S; de Paula, VS				da Silva, Amanda Perse; Lopes, Amanda de Oliveira; Vieira, Yasmine Rangel; de Almeida, Adilson Jose; Sion, Fernando Samuel; Grinsztejn, Beatriz; Wagner, Sandra; de Paula, Vanessa Salete			Genotypic Characterization of Herpes Simplex Virus Type 1 Isolates in Immunocompromised Patients in Rio de Janeiro, Brazil	PLOS ONE			English	Article							ACYCLOVIR-RESISTANT; THYMIDINE KINASE; DNA-REPLICATION; POLYMERASE; EVOLUTION; VIREMIA; SEROPREVALENCE; RECOMBINATION; EPIDEMIOLOGY; POLYMORPHISM	Herpes simplex virus type 1 (HSV-1) is a prevalent human pathogen that causes a variety of diseases, including an increased risk of developing more severe disease in HIV-infected individuals. In Brazil, there is no information about the molecular epidemiology of HSV-1 infection, especially in HIV-infected individuals. The aim of this study was to perform the genotypic characterization of HSV-1 among HIV-infected patients. A total of 214 serum samples from HIV-positive patients without HSV infection symptoms were enrolled in one of two reference hospitals for HIV infection managing in Rio de Janeiro. The gG and gI genes were analyzed by restriction fragment length polymorphism (RFLP) and full nucleotide sequencing of the US8 (1601 bp), UL44 (1996 bp), and UL23 (1244 bp) regions was performed. A total of 38.3%(82/214) and 32.7%(70/214) of the serum samples tested positive for gG and gI genes, respectively. RFLP analysis classified the HSV-1 as belonging to genotype A. Phylogenetic analysis of the Brazilian samples for the US8, UL44, and UL23 regions demonstrated that the nucleotide identity between Brazilian samples was higher than 97% for all genes. No acyclovir mutation was detected in the patients. The shedding of HSV in the serum samples from HIV-positive patients who were asymptomatic for HSV infection was detected in this work. This is the first report of molecular characterization of HSV-1 in Brazilian samples since there is no previous data available in the literature concerning the genotypic classification and stable distribution of Brazilian strains of HSV-1 in Rio de Janeiro, Brazil.	[da Silva, Amanda Perse; Lopes, Amanda de Oliveira; Vieira, Yasmine Rangel; de Paula, Vanessa Salete] Fiocruz MS, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil; [de Almeida, Adilson Jose; Sion, Fernando Samuel] Fed Univ State Rio De Janeiro UNIRIO, Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil; [Grinsztejn, Beatriz; Wagner, Sandra] Evandro Chagas Natl Inst Infectol INI, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro	da Silva, AP (corresponding author), Fiocruz MS, Oswaldo Cruz Fdn, BR-21045900 Rio De Janeiro, Brazil.	amandaps@ioc.fiocruz.br; vdepaula@ioc.fiocruz.br	de Paula, Vanessa S/I-8037-2016; da Silva, Amanda Perse/S-7036-2019; Lopes, Amanda/AAJ-6598-2020	de Paula, Vanessa S/0000-0002-6314-754X; Sion, Fernando Samuel/0000-0001-6315-139X	research and support foundation of the Rio de Janeiro-FAPERJ/PPSUS [E_35/2013]	research and support foundation of the Rio de Janeiro-FAPERJ/PPSUS	This work was supported by the research and support foundation of the Rio de Janeiro-FAPERJ/PPSUS E_35/2013.	Bacon TH, 2003, CLIN MICROBIOL REV, V16, P114, DOI 10.1128/CMR.16.1.114-128.2003; Berrington WR, 2009, CLIN INFECT DIS, V49, P1295, DOI 10.1086/606053; Bestman-Smith J, 2001, J VIROL, V75, P3105, DOI 10.1128/JVI.75.7.3105-3110.2001; Burrel S, 2010, ANTIMICROB AGENTS CH, V54, P4833, DOI 10.1128/AAC.00669-10; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chakraborty N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-147; Chayavichitsilp P, 2009, PEDIATR REV, V30, P119, DOI 10.1542/pir.30-4-119; Clemens SAC, 2010, REV SAUDE PUBL, V44, P726, DOI 10.1590/S0034-89102010000400017; DUTCH RE, 1995, J VIROL, V69, P3084, DOI 10.1128/JVI.69.5.3084-3089.1995; Gaudreau A, 1998, J INFECT DIS, V178, P297, DOI 10.1086/515626; Harel L, 2004, CLIN INFECT DIS, V39, P636, DOI 10.1086/422643; Harishankar A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-65; JOHNSON JR, 1992, CLIN INFECT DIS, V14, P38, DOI 10.1093/clinids/14.1.38; Johnston C, 2008, J INFECT DIS, V198, P31, DOI 10.1086/588676; Juhl D, 2010, TRANSFUSION MED, V20, P38, DOI 10.1111/j.1365-3148.2009.00951.x; Kolb AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076267; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P9061, DOI 10.1167/iovs.11-7812; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P4630, DOI 10.1167/iovs.10-7032; KUSNE S, 1991, J INFECT DIS, V163, P1001, DOI 10.1093/infdis/163.5.1001; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mertz GJ, 2003, SEX TRANSM DIS, V30, P801, DOI 10.1097/01.OLQ.0000093080.55201.D1; Morfin F, 2000, J INFECT DIS, V182, P290, DOI 10.1086/315696; Morfin F, 2003, J CLIN VIROL, V26, P29, DOI 10.1016/S1386-6532(02)00263-9; MULLER SA, 1972, AM J MED, V52, P102, DOI 10.1016/0002-9343(72)90012-5; Norberg P, 2004, J VIROL, V78, P10755, DOI 10.1128/JVI.78.19.10755-10764.2004; Norberg P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022527; Norberg P, 2006, J CLIN MICROBIOL, V44, P4511, DOI 10.1128/JCM.00421-06; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Roizman B., 2013, FIELDS VIROLOGY, P2456; Roizman B TB, 2007, STRATEGY HERPES SIMP; SAKAOKA H, 1994, J GEN VIROL, V75, P513, DOI 10.1099/0022-1317-75-3-513; Sauerbrei A, 2010, ANTIVIR RES, V86, P246, DOI 10.1016/j.antiviral.2010.03.002; Sauerbrei A, 2012, J MED VIROL, V84, P651, DOI 10.1002/jmv.23223; Schiffer Joshua T, 2009, Curr Infect Dis Rep, V11, P457, DOI 10.1007/s11908-009-0066-7; Schmidt-Chanasit J, 2009, J CLIN VIROL, V44, P235, DOI 10.1016/j.jcv.2008.12.016; Schomogyi M, 1998, INFECT DIS CLIN N AM, V12, P47, DOI 10.1016/S0891-5520(05)70408-6; Schubert A, 2014, ANTIVIR RES, V107, P16, DOI 10.1016/j.antiviral.2014.03.015; SHELDRICK P, 1974, COLD SPRING HARB SYM, V39, P667, DOI 10.1101/SQB.1974.039.01.080; Stanberry L, 1999, ANTIVIR RES, V42, P1, DOI 10.1016/S0166-3542(99)00004-2; STANBERRY LR, 1994, CLIN INFECT DIS, V18, P401, DOI 10.1093/clinids/18.3.401; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Umene K, 1999, ARCH VIROL, V144, P637, DOI 10.1007/s007050050533; van Velzen M, 2013, J MED VIROL, V85, P1669, DOI 10.1002/jmv.23634; WADSWORTH S, 1975, J VIROL, V15, P1487, DOI 10.1128/JVI.15.6.1487-1497.1975; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	48	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136825	10.1371/journal.pone.0136825	http://dx.doi.org/10.1371/journal.pone.0136825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407292	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700016
J	Flamar, AL; Contreras, V; Zurawski, S; Montes, M; Dereuddre-Bosquet, N; Martinon, F; Banchereau, J; Le Grand, R; Zurawski, G; Levy, Y				Flamar, Anne-Laure; Contreras, Vanessa; Zurawski, Sandra; Montes, Monica; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Banchereau, Jacques; Le Grand, Roger; Zurawski, Gerard; Levy, Yves			Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo	PLOS ONE			English	Article							T-CELL RESPONSES; DENDRITIC CELLS; ANTIGEN PRESENTATION; LANGERHANS CELLS; DEC-205 RECEPTOR; EX-VIVO; CD8(+); PROTEIN; CD4(+); PROGRESSION	Targeting dendritic cell-specific endocytic receptors using monoclonal antibodies fused to desired antigens is an approach widely used in vaccine development to enhance the poor immunogenicity of protein-based vaccines and to induce immune responses. Here, we engineered an anti-human DCIR recombinant antibody, which cross-reacts with the homologous cynomoigous macaque receptor and was fused via the heavy chain C-terminus to HIV Gagp24 protein (alpha DCIR.Gagp24). In vitro, alpha DCIR.Gagp24 expanded multifunctional antigen-specific memory CD4(+) T cells recognizing multiple Gagp24 peptides from HIV-infected patient peripheral blood mononuclear cells. In non human primates, priming with alpha DCIR.Gagp24 without adjuvant elicited a strong anti-Gagp24 antibody response after the second immunization, while in the non-targeted HIV Gagp24 protein control groups the titers were weak. The presence of the double-stranded RNA poly(I:C) adjuvant significantly enhanced the anti-Gagp24 antibody response in all the groups and reduced the discrimination between the different vaccine groups. The avidity of the anti-Gagp24 antibody responses was similar with either alpha DCIR.Gagp24 or Gagp24 immunization, but increased from medium to high avidity in both groups when poly(I: C) was co-administered. This data provides a comparative analysis of DC-targeted and non-targeted proteins for their capacity to induce antigen-specific antibody responses in vivo. This study supports the further development of DCIR-based DC-targeting vaccines for protective durable antibody induction, especially in the absence of adjuvant.	[Flamar, Anne-Laure; Zurawski, Sandra; Montes, Monica; Zurawski, Gerard] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Flamar, Anne-Laure; Contreras, Vanessa; Zurawski, Sandra; Montes, Monica; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Banchereau, Jacques; Le Grand, Roger; Zurawski, Gerard; Levy, Yves] Vaccine Res Inst, Creteil, France; [Flamar, Anne-Laure; Zurawski, Sandra; Montes, Monica; Banchereau, Jacques; Zurawski, Gerard; Levy, Yves] INSERM, UMR 955, Creteil, France; [Contreras, Vanessa; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Le Grand, Roger] Inst Emerging Dis & Innovat Therapies, CEA, Div Immuno Virol, IDMIT Ctr, Fontenay Aux Roses, France; [Contreras, Vanessa; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Le Grand, Roger] INSERM, UMR 1184, Fontenay Aux Roses, France; [Contreras, Vanessa; Dereuddre-Bosquet, Nathatlie; Martinon, Frederic; Le Grand, Roger] Univ Paris Sud 11, Orsay, France; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Banchereau, Jacques; Levy, Yves] Serv dimmunol Clin, Assistance Publ Hop Paris, Groupe Henri Mondor Albert Chenevier, Creteil, France; [Banchereau, Jacques; Levy, Yves] Univ Paris Est, Fac Med, Creteil, France	Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Jackson Laboratory; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Zurawski, G (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.	gerardz@baylorhealth.edu; yves.levy@hmn.aphp.fr	Martinon, Frédéric/Y-3684-2018	Martinon, Frédéric/0000-0001-9634-442X; Contreras, Vanessa/0000-0003-4072-9819	Agence Nationale de Recherche pour le Sida et hepatites virales through Vaccine Research Institute programme [CRA 2007-291]; National Institutes of Health [U-19 AI-57234]; Baylor Healthcare System through Baylor Research Institute; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	Agence Nationale de Recherche pour le Sida et hepatites virales through Vaccine Research Institute programme(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Healthcare System through Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by the Agence Nationale de Recherche pour le Sida et hepatites virales through the Vaccine Research Institute programme via a Collaborative Research Agreement (CRA 2007-291)-ALF, VC, SZ, NDB, FM, RL, JB, YL, GZ (www.anrs.fr). The parental anti-DCIR mAb was developed with support from grants from the National Institutes of Health (U-19 AI-57234) and the generosity of the Baylor Healthcare System through the auspices of the Baylor Research Institute -ALF, SZ, JB, GZ (www.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanzar G, 2013, J IMMUNOL METHODS, V387, P36, DOI 10.1016/j.jim.2012.09.008; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Cheong C, 2010, BLOOD, V116, P3828, DOI 10.1182/blood-2010-06-288068; Cobb A, 2011, J IMMUNOL METHODS, V365, P27, DOI 10.1016/j.jim.2010.11.002; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Epaulard O, 2014, J IMMUNOL, V193, P2416, DOI 10.4049/jimmunol.1303339; Flamar AL, 2013, AIDS, V27, P2041, DOI 10.1097/QAD.0b013e3283624305; Flamar AL, 2012, J IMMUNOL, V189, P2645, DOI 10.4049/jimmunol.1102390; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Franz B, 2011, BLOOD, V118, P348, DOI 10.1182/blood-2011-03-341917; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; HOGERVORST E, 1995, J INFECT DIS, V171, P811, DOI 10.1093/infdis/171.4.811; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Kneitz RH, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-33; Lahoud MH, 2011, J IMMUNOL, V187, P842, DOI 10.4049/jimmunol.1101176; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Park HY, 2013, J IMMUNOL, V191, P4919, DOI 10.4049/jimmunol.1301947; Ramduth D, 2005, J INFECT DIS, V192, P1588, DOI 10.1086/496894; Romain G, 2012, EUR J IMMUNOL, V42, P2019, DOI 10.1002/eji.201242478; STRATHDEE SA, 1995, J INFECT DIS, V172, P1375, DOI 10.1093/infdis/172.5.1375; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0135513	10.1371/journal.pone.0135513	http://dx.doi.org/10.1371/journal.pone.0135513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407317	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700006
J	Friend, K; Brooks, HA; Propson, NE; Thomson, JA; Kimble, J				Friend, Kyle; Brooks, Hunter A.; Propson, Nicholas E.; Thomson, James A.; Kimble, Judith			Embryonic Stem Cell Growth Factors Regulate eIF2 alpha Phosphorylation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DOUBLE-STRANDED-RNA; SELF-RENEWAL; MESSENGER-RNA; TRANSCRIPTION FACTOR; INITIATION FACTOR-2-ALPHA; DEPENDENT STIMULATION; TRANSLATIONAL CONTROL; MOUSE; GCN4	Growth factors and transcription factors are well known to regulate pluripotent stem cells, but less is known about translational control in stem cells. Here, we use embryonic stem cells (ESCs) to investigate a connection between ESC growth factors and eIF2 alpha-mediated translational control (eIF2 alpha phosphorylation promotes protein expression from mRNAs with upstream open-reading frames, or uORFs). We find abundant phosphorylated P-eIF2 alpha (P-eIF2 alpha) in both pluripotent mouse and human ESCs, but little P-eIF2 alpha in ESCs triggered to differentiate. We show that the growth factors LIF (leukemia inhibitory factor) and BMP4 (bone morphogenic protein 4) both maintain P-eIF2 alpha in mESCs, but use distinct mechanisms: LIF inhibits an eIF2 alpha phosphatase whereas BMP4 activates an eIF2 alpha kinase. The mRNAs encoding the pluripotency factors Nanog and c-Myc possess uORFs while Oct4 mRNA does not. We find that salubrinal, a chemical that increases eIF2 alpha phosphorylation, promotes Nanog and c-Myc expression, but not Oct4 expression. These experiments connect ESC growth factors to eIF2 alpha phosphorylation and suggest a chemical substitute for LIF to enhance Nanog and c-Myc expression.	[Friend, Kyle; Kimble, Judith] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Friend, Kyle; Brooks, Hunter A.] Washington & Lee Univ, Dept Chem & Biochem, Lexington, VA 24450 USA; [Propson, Nicholas E.; Thomson, James A.] Morgridge Inst Res, 309 North Orchard St, Madison, WI 53715 USA; [Thomson, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Washington & Lee University; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Friend, K (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	friendk@wlu.edu; jekimble@wisc.edu			American Cancer Society [PF-10-127-01-DDC]; National Institutes of Health [1U01 HL099773-01, GM069454]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069454] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.F. was supported by PF-10-127-01-DDC from the American Cancer Society. J.T. was supported by National Institutes of Health grant 1U01 HL099773-01. J.K. was supported by National Institutes of Health grant GM069454. J.K. is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Baltzis D, 2002, J BIOL CHEM, V277, P38364, DOI 10.1074/jbc.M203564200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dumoulin JCM, 1999, HUM REPROD, V14, P465, DOI 10.1093/humrep/14.2.465; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Goplen N, 2008, J IMMUNOL, V180, P4256, DOI 10.4049/jimmunol.180.6.4256; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HOWARD GA, 1970, BIOCHIM BIOPHYS ACTA, V213, P237, DOI 10.1016/0005-2787(70)90028-6; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; KOZAK M, 1978, J BIOL CHEM, V253, P6568; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; LEBLEU B, 1976, P NATL ACAD SCI USA, V73, P3107, DOI 10.1073/pnas.73.9.3107; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Malabanan KP, 2008, CIRC RES, V103, P378, DOI 10.1161/CIRCRESAHA.107.168682; MANZELLA JM, 1991, J BIOL CHEM, V266, P2383; MASTROIANNI L, 1965, J REPROD FERTIL, V9, P99; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Savatier P, 1996, ONCOGENE, V12, P309; Schnerch A, 2010, STEM CELLS, V28, P419, DOI 10.1002/stem.298; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; So JS, 2015, MOL CELL BIOL, V35, P2761, DOI 10.1128/MCB.00215-15; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Steinert S, 2009, CELL COMMUN SIGNA S1, V7, pA37, DOI [10.1186/1478-811X-7-S1-A37, DOI 10.1186/1478-811X-7-S1-A37]; THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Warmflash A, 2012, WIRES SYST BIOL MED, V4, P443, DOI 10.1002/wsbm.1182; Watanabe A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0292; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	60	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139076	10.1371/journal.pone.0139076	http://dx.doi.org/10.1371/journal.pone.0139076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406898	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700162
J	Jung, WM; Lim, J; Lee, IS; Park, HJ; Wallraven, C; Chae, Y				Jung, Won-Mo; Lim, Jinwoong; Lee, In-Seon; Park, Hi-Joon; Wallraven, Christian; Chae, Younbyoung			Sensorimotor Learning of Acupuncture Needle Manipulation Using Visual Feedback	PLOS ONE			English	Article							ERROR	Objective Humans can acquire a wide variety of motor skills using sensory feedback pertaining to discrepancies between intended and actual movements. Acupuncture needle manipulation involves sophisticated hand movements and represents a fundamental skill for acupuncturists. We investigated whether untrained students could improve their motor performance during acupuncture needle manipulation using visual feedback (VF). Methods Twenty-one untrained medical students were included, randomly divided into concurrent (n = 10) and post-trial (n = 11) VF groups. Both groups were trained in simple lift/thrusting techniques during session 1, and in complicated lift/thrusting techniques in session 2 (eight training trials per session). We compared the motion patterns and error magnitudes of pre- and post-training tests. Results During motion pattern analysis, both the concurrent and post-trial VF groups exhibited greater improvements in motion patterns during the complicated lifting/thrusting session. In the magnitude error analysis, both groups also exhibited reduced error magnitudes during the simple lifting/thrusting session. For the training period, the concurrent VF group exhibited reduced error magnitudes across all training trials, whereas the post-trial VF group was characterized by greater error magnitudes during initial trials, which gradually reduced during later trials. Conclusions Our findings suggest that novices can improve the sophisticated hand movements required for acupuncture needle manipulation using sensorimotor learning with VF. Use of two types of VF can be beneficial for untrained students in terms of learning how to manipulate acupuncture needles, using either automatic or cognitive processes.	[Jung, Won-Mo; Lim, Jinwoong; Lee, In-Seon; Park, Hi-Joon; Chae, Younbyoung] Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea; [Wallraven, Christian] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Kyung Hee University; Korea University	Chae, Y (corresponding author), Kyung Hee Univ, Coll Korean Med, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea.	ybchae@khu.ac.kr	Chae, Younbyoung/AAM-1243-2020; Park, Hi-Joon/AAG-1196-2021; Lee, In-Seon/AAM-1252-2020; Park, Hyun Jin/I-4942-2015	Lee, In-Seon/0000-0001-9275-3111; Chae, Younbyoung/0000-0001-6787-2215; Park, Hi-Joon/0000-0002-0538-2664; Wallraven, Christian/0000-0002-2604-9115; Lim, Jinwoong/0000-0003-2080-9432	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0009913]; Korea Institute of Oriental Medicine [K15070]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Institute of Oriental Medicine	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2011-0009913), and the Korea Institute of Oriental Medicine (no. K15070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; Davis RT, 2012, ACUPUNCT MED, V30, P113, DOI 10.1136/acupmed-2011-010111; Hinder MR, 2008, BRAIN RES, V1197, P123, DOI 10.1016/j.brainres.2007.12.067; Huang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051417; Ikegami T, 2012, J NEUROSCI, V32, P653, DOI 10.1523/JNEUROSCI.4230-11.2012; 임진웅, 2014, Journal of Acupuncture Research, V31, P11; Lee IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117992; Lee IS, 2014, J ALTERN COMPLEM MED, V20, P654, DOI 10.1089/acm.2013.0475; Li Jing, 2013, Zhen Ci Yan Jiu, V38, P415; Li J, 2013, ACUPUNCT MED, V31, P172, DOI 10.1136/acupmed-2012-010265; Liu Tang-yi, 2010, Zhen Ci Yan Jiu, V35, P61; Liu Tang-yi, 2009, Zhongguo Zhen Jiu, V29, P927; Liu Tang-Yi, 2008, Zhen Ci Yan Jiu, V33, P330; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Seo Y, 2014, ACUPUNCT MED, V32, P394, DOI 10.1136/acupmed-2014-010585; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112	17	5	6	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139340	10.1371/journal.pone.0139340	http://dx.doi.org/10.1371/journal.pone.0139340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406248	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700208
J	Kulp, AJ; Sun, B; Ai, T; Manning, AJ; Orench-Rivera, N; Schmid, AK; Kuehn, MJ				Kulp, Adam J.; Sun, Bo; Ai, Teresa; Manning, Andrew J.; Orench-Rivera, Nichole; Schmid, Amy K.; Kuehn, Meta J.			Genome-Wide Assessment of Outer Membrane Vesicle Production in Escherichia coli	PLOS ONE			English	Article							ENTEROBACTERIAL COMMON ANTIGEN; PSEUDOMONAS-AERUGINOSA PAO1; ENVELOPE STRESS; VIRULENCE GENES; LIPOPOLYSACCHARIDE; RELEASE; BIOGENESIS; PROTEINS; TOXIN; DNA	The production of outer membrane vesicles by Gram-negative bacteria has been well documented; however, the mechanism behind the biogenesis of these vesicles remains unclear. Here a high-throughput experimental method and systems-scale analysis was conducted to determine vesiculation values for the whole genome knockout library of Escherichia coli mutant strains (Keio collection). The resultant dataset quantitatively recapitulates previously observed phenotypes and implicates nearly 150 new genes in the process of vesiculation. Gene functional and biochemical pathway analyses suggest that mutations that truncate outer membrane structures such as lipopolysaccharide and enterobacterial common antigen lead to hypervesiculation, whereas mutants in oxidative stress response pathways result in lower levels. This study expands and refines the current knowledge regarding the cellular pathways required for outer membrane vesiculation in E. coli.	[Kulp, Adam J.; Kuehn, Meta J.] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA; [Sun, Bo; Ai, Teresa; Schmid, Amy K.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Manning, Andrew J.; Orench-Rivera, Nichole; Kuehn, Meta J.] Duke Univ, Dept Biochem, Med Ctr, Durham, NC 27710 USA; [Schmid, Amy K.] Duke Univ, Duke Ctr Syst Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Schmid, AK (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	amy.schmid@duke.edu	Kuehn, Meta/AAL-2950-2021	Kuehn, Meta/0000-0003-0519-3019; Sun, Bo/0000-0003-2473-6066	Duke Center for Systems Biology; Duke University Undergraduate Research Support; Duke University Trinity Research Forum; Duke School of Medicine; National Institutes of Health [R01AI079068, R01GM099471]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099471] Funding Source: NIH RePORTER	Duke Center for Systems Biology; Duke University Undergraduate Research Support; Duke University Trinity Research Forum; Duke School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a seed grant from the Duke Center for Systems Biology (http://www.genome.duke.edu/centers/systems-biology/) to AKS and MJK, Duke University Undergraduate Research Support (TA and BS), Duke University Trinity Research Forum (BS), Duke School of Medicine (MJK), and National Institutes of Health grants R01AI079068 (MJK) and R01GM099471 (MJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barr K, 1999, J BACTERIOL, V181, P6564, DOI 10.1128/JB.181.20.6564-6568.1999; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Button JE, 2007, J BACTERIOL, V189, P1523, DOI 10.1128/JB.01534-06; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Chutkan H, 2011, INFECT IMMUN, V79, P3760, DOI 10.1128/IAI.05336-11; Danese PN, 1998, J BACTERIOL, V180, P5875, DOI 10.1128/JB.180.22.5875-5884.1998; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gorby Y, 2008, GEOBIOLOGY, V6, P232, DOI 10.1111/j.1472-4669.2008.00158.x; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Hu JC, 2014, NUCLEIC ACIDS RES, V42, pD677, DOI 10.1093/nar/gkt1203; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karavolos MH, 2011, EMBO REP, V12, P252, DOI 10.1038/embor.2011.4; Karp Peter D, 2014, EcoSal Plus, V6, DOI 10.1128/ecosalplus.ESP-0009-2013; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Klein G, 2014, J BIOL CHEM, V289, P14829, DOI 10.1074/jbc.M113.539494; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; MacDonald IA, 2013, J BACTERIOL, V195, P2971, DOI 10.1128/JB.02267-12; Mahalakshmi S, 2014, MOL MICROBIOL, V91, P145, DOI 10.1111/mmi.12452; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Maredia R, 2012, SCI WORLD J, P1, DOI 10.1100/2012/402919; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; McMahon KJ, 2012, J BACTERIOL, V194, P3241, DOI 10.1128/JB.00016-12; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Meno Y, 2000, MICROBIOL IMMUNOL, V44, P271, DOI 10.1111/j.1348-0421.2000.tb02494.x; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Murphy K, 2014, J BACTERIOL, V196, P1306, DOI 10.1128/JB.01463-13; Nishida Kozo, 2014, F1000Res, V3, P144, DOI 10.12688/f1000research.4524.1; Rahman A, 2001, J BACTERIOL, V183, P6509, DOI 10.1128/JB.183.22.6509-6516.2001; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Sabra W, 2003, MICROBIOL-SGM, V149, P2789, DOI 10.1099/mic.0.26443-0; Schertzer JW, 2012, MBIO, V3, DOI 10.1128/mBio.00297-11; Schilling B, 2014, INNATE IMMUN-LONDON, V20, P269, DOI 10.1177/1753425913490534; Schooling SR, 2009, J BACTERIOL, V191, P4097, DOI 10.1128/JB.00717-08; Schwechheimer C, 2015, NATURE REV IN PRESS; Schwechheimer C, 2015, MICROBIOLOGYOPEN, V4, P375, DOI 10.1002/mbo3.244; Schwechheimer C, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0324-1; Schwechheimer C, 2013, J BACTERIOL, V195, P4161, DOI 10.1128/JB.02192-12; Schwechheimer C, 2013, BIOCHEMISTRY-US, V52, P3031, DOI 10.1021/bi400164t; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; SONNTAG I, 1978, J BACTERIOL, V136, P280, DOI 10.1128/JB.136.1.280-285.1978; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tashiro Y, 2009, J BACTERIOL, V191, P7509, DOI 10.1128/JB.00722-09; THOMPSON SS, 1985, APPL ENVIRON MICROB, V50, P1038, DOI 10.1128/AEM.50.4.1038-1042.1985; van de Waterbeemd B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054314; Vasilyeva NV, 2008, FEBS J, V275, P3827, DOI 10.1111/j.1742-4658.2008.06530.x; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; WENSINK J, 1981, EUR J BIOCHEM, V116, P331, DOI 10.1111/j.1432-1033.1981.tb05338.x; Wyckoff TJO, 1998, TRENDS MICROBIOL, V6, P154, DOI 10.1016/S0966-842X(98)01230-X; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yaron S, 2000, APPL ENVIRON MICROB, V66, P4414, DOI 10.1128/AEM.66.10.4414-4420.2000; Yonezawa H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-197; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	67	56	57	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139200	10.1371/journal.pone.0139200	http://dx.doi.org/10.1371/journal.pone.0139200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406465	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700190
J	Marston, S; Montgiraud, C; Munster, AB; Copeland, O; Choi, O; dos Remedios, C; Messer, AE; Ehler, E; Knoll, R				Marston, Steven; Montgiraud, Cecile; Munster, Alex B.; Copeland, O'Neal; Choi, Onjee; dos Remedios, Cristobal; Messer, Andrew E.; Ehler, Elisabeth; Knoll, Ralph			OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency	PLOS ONE			English	Article							OBSCURIN GENE; PHOSPHORYLATION; MUSCLE; TITIN	Background Studies of the functional consequences of DCM-causing mutations have been limited to a few cases where patients with known mutations had heart transplants. To increase the number of potential tissue samples for direct investigation we performed whole exon sequencing of explanted heart muscle samples from 30 patients that had a diagnosis of familial dilated cardiomyopathy and screened for potentially disease-causing mutations in 58 HCM or DCM-related genes. Results We identified 5 potentially disease-causing OBSCN mutations in 4 samples; one sample had two OBSCN mutations and one mutation was judged to be not disease-related. Also identified were 6 truncating mutations in TTN, 3 mutations in MYH7, 2 in DSP and one each in TNNC1, TNNI3, MYOM1, VCL, GLA, PLB, TCAP, PKP2 and LAMA4. The mean level of obscurin mRNA was significantly greater and more variable in healthy donor samples than the DCM samples but did not correlate with OBSCN mutations. A single obscurin protein band was observed in human heart myofibrils with apparent mass 960 +/- 60 kDa. The three samples with OBSCN mutations had significantly lower levels of obscurin immunoreactive material than DCM samples without OBSCN mutations (45 +/- 7, 48 +/- 3, and 72 +/- 6% of control level). Obscurin levels in DCM controls, donor heart and myectomy samples were the same. Conclusions OBSCN mutations may result in the development of a DCM phenotype via haploinsufficiency. Mutations in the obscurin gene should be considered as a significant causal factor of DCM, alone or in concert with other mutations.	[Marston, Steven; Montgiraud, Cecile; Munster, Alex B.; Copeland, O'Neal; Choi, Onjee; Messer, Andrew E.; Knoll, Ralph] Univ London Imperial Coll Sci Technol & Med, NHLI, London, England; [dos Remedios, Cristobal] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Ehler, Elisabeth] Kings Coll London, Randall Div, London WC2R 2LS, England	Imperial College London; University of Sydney; University of London; King's College London	Marston, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI, London, England.	s.marston@imperial.ac.uk	Knöll, Ralph/GOH-3587-2022; Ralph, Knoell/AAE-5990-2020	Ralph, Knoell/0000-0001-8871-112X; Munster, Alex/0000-0003-4266-0499; Marston, Steven/0000-0001-6054-6070; Ehler, Elisabeth/0000-0001-5646-5964	British Heart Foundation [RG/11/20/29266]; Medical Research Council [G0400153] Funding Source: researchfish; MRC [G0400153] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support was provided by British Heart Foundation programme grant RG/11/20/29266 [https://www.bhf.org.uk/research]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088162; Arimura T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/j.bbrc.2007.07.183; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Bayliss CR, 2013, CARDIOVASC RES, V97, P500, DOI 10.1093/cvr/cvs322; Borisov AB, 2003, BIOCHEM BIOPH RES CO, V310, P910, DOI 10.1016/j.bbrc.2003.09.035; den Haan AD, 2009, CIRC-CARDIOVASC GENE, V2, P428, DOI 10.1161/CIRCGENETICS.109.858217; Dyer EC, 2009, CIRC-HEART FAIL, V2, P456, DOI 10.1161/CIRCHEARTFAILURE.108.818237; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Fukuzawa A, 2005, J MUSCLE RES CELL M, V26, P427, DOI 10.1007/s10974-005-9025-6; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Marangoni S, 2011, CARDIOVASC RES, V91, P606, DOI 10.1093/cvr/cvr142; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Marston S, 2012, J MUSCLE RES CELL M, V33, P75, DOI 10.1007/s10974-011-9268-3; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; Memo M, 2013, CARDIOVASC RES, V99, P65, DOI 10.1093/cvr/cvt071; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Perry NA, 2013, IUBMB LIFE, V65, P479, DOI 10.1002/iub.1157; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Schlossarek S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0235-3	25	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138568	10.1371/journal.pone.0138568	http://dx.doi.org/10.1371/journal.pone.0138568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406308	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700059
J	Osiowy, C; Giles, E; Trubnikov, M; Choudhri, Y; Andonov, A				Osiowy, Carla; Giles, Elizabeth; Trubnikov, Max; Choudhri, Yogesh; Andonov, Anton			Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; CHRONIC INFECTION; UNITED-STATES; RISK-FACTORS; PREVALENCE; MUTATIONS; DIVERSITY; MUTANTS; ENGLAND; IMPACT	Objective The prevalence and distribution of hepatitis B virus (HBV) genotypes in Canada is not known. Genotypic analysis may contribute to a better understanding of HBV strain distribution and transmission risk. Methods HBV surface antigen (HBsAg) positive samples of acute (n = 152) and chronic (n = 1533) HBV submitted for strain analysis or reference genotype testing between 2006 and 2012 were analyzed. The HBsAg coding region was amplified to determine the HBV genotype by INNO-LiPA assay or sequence analysis. Single and multivariate analyses were used to describe genotypes' associations with known demographic and behavioral risk factors for 126 linked cases of acute HBV. Results Nine genotypes were detected (A to I), including mixed infections. Genotype C (HBV/C) dominated within chronic infections while HBV/D and A prevailed among acute HBV cases. History of incarceration and residing with a chronic HBV carrier or injection drug user were the most frequently reported risks for acute HBV infection. Over time, HBV/A increased among both acute and chronic infections, and HBV/C and HBV/D decreased among chronic infections. Conclusion Chronic and acute HBV genotypes in Canada differ in the relative distribution and their associations with known risk factors, suggesting different routes of transmission and clinical progression of infection.	[Osiowy, Carla; Giles, Elizabeth; Andonov, Anton] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Trubnikov, Max; Choudhri, Yogesh] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Ottawa, ON, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Osiowy, C (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	carla.osiowy@phac-aspc.gc.ca	Andonov, Anton/AAJ-6955-2021	Osiowy, Carla/0000-0002-5429-7220	Public Health Agency of Canada	Public Health Agency of Canada	The authors received no specific funding for this work. All funding for this work was through the Public Health Agency of Canada.	Alestig E, 2013, J MED VIROL, V85, P1148, DOI 10.1002/jmv.23580; Allain JP, 2009, BIOLOGICALS, V37, P71, DOI 10.1016/j.biologicals.2009.01.002; Andersson MI, 2012, J CLIN VIROL, V53, P125, DOI 10.1016/j.jcv.2011.10.012; Carballo M, 2014, VIRAL HEPATITIS, 4TH EDITION, P506; Deeks SL, 1998, CAN J PUBLIC HEALTH, V89, P98, DOI 10.1007/BF03404397; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; DOBSON S, 1995, JAMA-J AM MED ASSOC, V274, P1209, DOI 10.1001/jama.274.15.1209; Fisker N, 2004, J CLIN VIROL, V31, P46, DOI 10.1016/j.jcv.2004.05.004; Gilca V, 2006, PEDIATR INFECT DIS J, V25, P372, DOI 10.1097/01.inf.0000207468.04665.ad; Hahne S, 2004, J CLIN VIROL, V29, P211, DOI 10.1016/j.jcv.2003.09.016; Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ishigami M, 2014, LIVER TRANSPLANT, V20, P1211, DOI 10.1002/lt.23935; Ito K, 2014, HEPATOLOGY, V59, P89, DOI 10.1002/hep.26635; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Kobayashi M, 2008, J MED VIROL, V80, P1880, DOI 10.1002/jmv.21309; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Li D, 2012, CAN J GASTROENTEROL, V26, P597, DOI 10.1155/2012/705094; Liaw YF, 2014, VIRAL HEPATITIS, 4TH EDITION, P143; Lloyd C., 2010, SINNING SINNED STIGM; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; Merrill RM, 2011, INT J INFECT DIS, V15, pE78, DOI 10.1016/j.ijid.2010.09.005; Osiowy C, 2003, J CLIN MICROBIOL, V41, P5473, DOI 10.1128/JCM.41.12.5473-5477.2003; Osiowy C, 2002, J CLIN MICROBIOL, V40, P2566, DOI 10.1128/JCM.40.7.2566-2571.2002; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Page K, 2013, CLIN INFECT DIS, V57, pS32, DOI 10.1093/cid/cit300; Payne E, 2014, Can Commun Dis Rep, V40, P266; Public Health Agency of Canada, 2009, CAS DEF COMM DIS NAT, p35S2; Public Health Agency of Canada, 2011, BRIEF REP HEP B INF; Public Health Agency of Canada, NOT DIS ON LIN; Public Health Agency of Canada. The Chief Public Health Officer's Report on the State of Public Health, 2008, CHIEF PUBL HLTH OFF; Ramachandran S, 2014, J VIROL, V88, P13971, DOI 10.1128/JVI.01594-14; Rossi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078548; Rossi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044611; Rotermann M, 2013, STAT CANADA HLTH REP; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Sagnelli C, 2014, J MED VIROL, V86, P1683, DOI 10.1002/jmv.24005; Sherman M., 2013, LIVER DIS CANADA CRI; Sherman Morris, 2007, Can J Gastroenterol, V21 Suppl C, p5C; Sloan RD, 2009, J CLIN VIROL, V44, P157, DOI 10.1016/j.jcv.2008.11.010; Spradling PR, 2014, VIRAL HEPATITIS, 4TH EDITION, P81; Statistics Canada, 2011, IMMIGRATION ETHNOCUL; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; TAKAHASHI K, 1995, J GEN VIROL, V76, P3159, DOI 10.1099/0022-1317-76-12-3159; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanwar Sudeep, 2012, Curr Gastroenterol Rep, V14, P37, DOI 10.1007/s11894-011-0233-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Wong VWS, 2012, CURR OPIN INFECT DIS, V25, P570, DOI 10.1097/QCO.0b013e328357f2f8; Wong WWL, 2013, CAN J GASTROENTEROL, V27, P137, DOI 10.1155/2013/924640; Wu H X, 2005, Int J Med Sci, V2, P143; Yano K, 2010, INTERVIROLOGY, V53, P70, DOI 10.1159/000252788; Yotsuyanagi H, 2013, CLIN INFECT DIS, V57, P935, DOI 10.1093/cid/cit348; Zhang HW, 2008, GUT, V57, P1713, DOI 10.1136/gut.2008.157149	55	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136074	10.1371/journal.pone.0136074	http://dx.doi.org/10.1371/journal.pone.0136074			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406309	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700009
J	Schmole, AC; Lundt, R; Gennequin, B; Schrage, H; Beins, E; Kramer, A; Zimmer, T; Limmer, A; Zimmer, A; Otte, DM				Schmoele, Anne-Caroline; Lundt, Ramona; Gennequin, Benjamin; Schrage, Hanna; Beins, Eva; Kraemer, Alexandra; Zimmer, Till; Limmer, Andreas; Zimmer, Andreas; Otte, David-Marian			Expression Analysis of CB2-GFP BAC Transgenic Mice	PLOS ONE			English	Article							CANNABINOID CB2 RECEPTORS; B-CELL; MARGINAL ZONE; LYMPHOCYTES; ACTIVATION; RETENTION; SYSTEM	The endocannabinoid system (ECS) is a retrograde messenger system, consisting of lipid signaling molecules that bind to at least two G-protein-coupled receptors, Cannabinoid receptor 1 and 2 (CB1 and 2). As CB2 is primarily expressed on immune cells such as B cells, T cells, macrophages, dendritic cells, and microglia, it is of great interest how CB2 contributes to immune cell development and function in health and disease. Here, understanding the mechanisms of CB2 involvement in immune-cell function as well as the trafficking and regulation of CB2 expressing cells are crucial issues. Up to now, CB2 antibodies produce unclear results, especially those targeting the murine protein. Therefore, we have generated BAC transgenic GFP reporter mice (CB2-GFPTg) to trace CB2 expression in vitro and in situ. Those mice express GFP under the CB2 promoter and display GFP expression paralleling CB2 expression on the transcript level in spleen, thymus and brain tissue. Furthermore, by using fluorescence techniques we show that the major sources for GFP-CB2 expression are B cells in spleen and blood and microglia in the brain. This novel CB2-GFP transgenic reporter mouse line represents a powerful resource to study CB2 expression in different cell types. Furthermore, it could be used for analyzing CB2-mediated mobilization and trafficking of immune cells as well as studying the fate of recruited immune cells in models of acute and chronic inflammation.	[Schmoele, Anne-Caroline; Lundt, Ramona; Gennequin, Benjamin; Schrage, Hanna; Beins, Eva; Kraemer, Alexandra; Zimmer, Till; Zimmer, Andreas; Otte, David-Marian] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Limmer, Andreas] Univ Bonn, Clin Orthopaed & Trauma Surg, Bonn, Germany	University of Bonn; University of Bonn	Schmole, AC (corresponding author), Univ Bonn, Inst Mol Psychiat, Bonn, Germany.	anne.schmoele@uni-bonn.de; d.otte@uni-bonn.de	Zimmer, Andreas/B-8357-2009; Schmöle, Anne/AAH-5325-2019	Beins, Eva/0000-0002-7779-0210; Zimmer, Till/0000-0002-6869-3697	Medical Faculty of the University of Bonn "Bonfor"; Deutsche Forschungsgemeinschaft [FOR 926]	Medical Faculty of the University of Bonn "Bonfor"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partly supported by a start-up grant from the Medical Faculty of the University of Bonn "Bonfor" (to ACS and HS) and the Deutsche Forschungsgemeinschaft, FOR 926 (to ACS, RL, BG and AZ). ACS, RL, EB, DMO and AZ are members of the DFG Cluster of Excellence "Immunosensation." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Baek JH, 2013, J NEUROSCI METH, V216, P87, DOI 10.1016/j.jneumeth.2013.03.021; Basu S, 2011, J IMMUNOL, V187, P5720, DOI 10.4049/jimmunol.1102195; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Benito C, 2005, J NEUROSCI, V25, P2530, DOI 10.1523/JNEUROSCI.3923-04.2005; Benito C, 2003, J NEUROSCI, V23, P11136; BOUABOULA M, 1993, EUR J BIOCHEM, V214, P173, DOI 10.1111/j.1432-1033.1993.tb17910.x; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Carayon P, 1998, BLOOD, V92, P3605, DOI 10.1182/blood.V92.10.3605.422k05_3605_3615; DEROCQ JM, 1995, FEBS LETT, V369, P177, DOI 10.1016/0014-5793(95)00746-V; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; Karlsson MCI, 2003, J EXP MED, V198, P333, DOI 10.1084/jem.20030684; Lee SF, 2001, EUR J PHARMACOL, V423, P235, DOI 10.1016/S0014-2999(01)01122-0; Lundberg Pontus, 2011, Curr Protoc Mouse Biol, V1, P323, DOI 10.1002/9780470942390.mo110088; Malfitano AM, 2014, SEMIN IMMUNOL, V26, P369, DOI 10.1016/j.smim.2014.04.002; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Otte DM, 2009, EUR NEUROPSYCHOPHARM, V19, P339, DOI 10.1016/j.euroneuro.2008.12.009; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rayman N, 2004, J IMMUNOL, V172, P2111, DOI 10.4049/jimmunol.172.4.2111; Schatz AR, 1997, TOXICOL APPL PHARM, V142, P278, DOI 10.1006/taap.1996.8034; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Suarez J, 2008, J COMP NEUROL, V509, P400, DOI 10.1002/cne.21774; Suarez J, 2009, HIPPOCAMPUS, V19, P623, DOI 10.1002/hipo.20537; Tanikawa T, 2007, MICROBIOL IMMUNOL, V51, P1013, DOI 10.1111/j.1348-0421.2007.tb03985.x; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Xi ZX, 2011, NAT NEUROSCI, V14, P1160, DOI 10.1038/nn.2874; Xu H, 2008, IMMUNOLOGY, V125, P218, DOI 10.1111/j.1365-2567.2008.02832.x; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE5007, DOI 10.1073/pnas.1413210111; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Ziring D, 2006, IMMUNOGENETICS, V58, P714, DOI 10.1007/s00251-006-0138-x	40	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138986	10.1371/journal.pone.0138986	http://dx.doi.org/10.1371/journal.pone.0138986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406232	Green Published, gold			2022-12-27	WOS:000361800700138
J	Seeger, T; Hart, M; Patarroyo, M; Rolauffs, B; Aicher, WK; Klein, G				Seeger, Tanja; Hart, Melanie; Patarroyo, Manuel; Rolauffs, Bernd; Aicher, Wilhelm K.; Klein, Gerd			Mesenchymal Stromal Cells for Sphincter Regeneration: Role of Laminin Isoforms upon Myogenic Differentiation	PLOS ONE			English	Article							STEM-CELLS; SMOOTH-MUSCLE; GROWTH-FACTOR; SELF-RENEWAL; MATRIX; EXPRESSION; THERAPY; NICHE	Multipotent mesenchymal stromal cells (MSCs) are well known for their tri-lineage potential and ability to differentiate in vitro into osteogenic, chondrogenic or adipogenic lineages. By selecting appropriate conditions MSCs can also be differentiated in vitro into the myogenic lineage and are therefore a promising option for cell-based regeneration of muscle tissue such as an aged or damaged sphincter muscle. For the differentiation into the myogenic lineage there is still a need to evaluate the effects of extracellular matrix proteins such as laminins (LM) which are crucial for different stem cell types and for normal muscle function. The laminin family consists of 16 functionally different isoforms with LM-211 being the most abundant isoform of adult muscle tissues. In the sphincter tissue a strong expression of the isoforms LM-211/221, LM-411/421 and LM-511/521 can be detected in the different cell layers. Bone marrow-derived MSCs in culture, however, mainly express the isoforms LM-411 and LM-511, but not LM-211. Even after myogenic differentiation, LM-211 can hardly be detected. All laminin isoforms tested (LM-211, LM-411, LM-511 and LM-521) showed a significant inhibition of the proliferation of undifferentiated MSCs but, with the exception of LM-521, they had no influence on the proliferation of MSCs cultivated in myogenic medium. The strongest cellular adhesion of MSCs was to LM-511 and LM-521, whereas LM-211 was only a weakly-adhesive substrate for MSCs. Myogenic differentiation of MSCs even reduced the interaction with LM-211, but it did not affect the interaction with LM-511 and LM-521. Since during normal myogenesis the latter two isoforms are the major laminins surrounding developing myogenic progenitors, alpha 5 chain-containing laminins are recommended for further improvements of myogenic differentiation protocols of MSCs into smooth muscle cells.	[Seeger, Tanja; Klein, Gerd] Univ Tubingen, Med Res Ctr, Univ Med Clin Dept 2, Tubingen, Germany; [Hart, Melanie; Aicher, Wilhelm K.] Univ Tubingen, Dept Urol, Tubingen, Germany; [Patarroyo, Manuel] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Rolauffs, Bernd] Univ Tubingen, BG Trauma Clin, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Karolinska Institutet; Eberhard Karls University of Tubingen	Klein, G (corresponding author), Univ Tubingen, Med Res Ctr, Univ Med Clin Dept 2, Tubingen, Germany.	gerd.klein@uni-tuebingen.de	Klein, Gerd/C-8499-2013	Aicher, Wilhelm K/0000-0003-2210-6773; Rolauffs, Bernd/0000-0002-3275-8196	German Research Council [KFO273: RO 2511/3-1, AI 16/23-1, KL 709/13-1]	German Research Council(German Research Foundation (DFG))	This work was funded in part by the German Research Council (KFO273: RO 2511/3-1 to B.R.; AI 16/23-1 to W.K.A.; KL 709/13-1 to G.K.) and in part by institutional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimperti S, 2014, J CELL SCI, V127, P2627, DOI 10.1242/jcs.134833; Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bolcato-Bellemin AL, 2003, DEV BIOL, V260, P376, DOI 10.1016/S0012-1606(03)00254-9; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; de la Garza-Rodea AS, 2012, CELL TRANSPLANT, V21, P153, DOI 10.3727/096368911X580554; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Furuta Akira, 2007, Rev Urol, V9, P106; Galli D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/762695; Garcia-Castro J, 2008, J CELL MOL MED, V12, P2552, DOI 10.1111/j.1582-4934.2008.00516.x; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; Ghosh D, 2014, STEM CELLS DEV, V23, P245, DOI 10.1089/scd.2013.0240; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hart ML, 2013, CURR UROL REP, V14, P476, DOI 10.1007/s11934-013-0352-7; Hergeth SP, 2008, EXP HEMATOL, V36, P1022, DOI 10.1016/j.exphem.2008.03.013; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Holmberg J, 2013, CELL ADHES MIGR, V7, P111, DOI 10.4161/cam.22618; Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074; Klein G, 2015, ADV DRUG DELIVER REV, V82-83, P123, DOI 10.1016/j.addr.2014.10.026; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116183; Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Nguyen NM, 2006, DEV BIOL, V294, P271, DOI 10.1016/j.ydbio.2006.03.032; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Ragni E, 2013, EXP CELL RES, V319, P1562, DOI 10.1016/j.yexcr.2013.04.002; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001; Ulrich C, 2013, STEM CELLS DEV, V22, P2859, DOI 10.1089/scd.2012.0693; Vaegler M, 2014, CURR STEM CELL RES T, V9, P444, DOI 10.2174/1574888X09666140521144559; Wallner C, 2009, EUR UROL, V55, P932, DOI 10.1016/j.eururo.2008.08.032; Williams C, 2012, TISSUE ENG PT A, V18, P986, DOI [10.1089/ten.tea.2011.0172, 10.1089/ten.TEA.2011.0172]; Wondimu Z, 2004, BLOOD, V104, P1859, DOI 10.1182/blood-2004-01-0396; Wondimu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053648; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Yu HY, 2013, STEM CELLS DEV, V22, P136, DOI 10.1089/scd.2012.0160	45	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137419	10.1371/journal.pone.0137419	http://dx.doi.org/10.1371/journal.pone.0137419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406476	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700020
J	Zougman, A; Banks, RE				Zougman, Alexandre; Banks, Rosamonde E.			C-STrap Sample Preparation Method-In-Situ Cysteinyl Peptide Capture for Bottom-Up Proteomics Analysis in the STrap Format	PLOS ONE			English	Article							PROTEIN MIXTURES; ENRICHMENT; IDENTIFICATION; CHROMATOGRAPHY; RANGE	Recently we introduced the concept of Suspension Trapping (STrap) for bottom-up proteomics sample processing that is based upon SDS-mediated protein extraction, swift detergent removal and rapid reactor-type protein digestion in a quartz depth filter trap. As the depth filter surface is made of silica, it is readily modifiable with various functional groups using the silane coupling chemistries. Thus, during the digest, peptides possessing specific features could be targeted for enrichment by the functionalized depth filter material while non-targeted peptides could be collected as an unbound distinct fraction after the digest. In the example presented here the quartz depth filter surface is functionalized with the pyridyl-dithiol group therefore enabling reversible in-situ capture of the cysteine-containing peptides generated during the STrap-based digest. The described C-STrap method retains all advantages of the original STrap methodology and provides robust foundation for the conception of the targeted in-situ peptide fractionation in the STrap format for bottom-up proteomics. The presented data support the method's use in qualitative and semi-quantitative proteomics experiments.	[Zougman, Alexandre; Banks, Rosamonde E.] St James Univ Hosp, Leeds Inst Canc & Pathol, Canc Res UK Ctr, Clin & Biomed Prote Grp, Leeds LS9 7TF, W Yorkshire, England	Cancer Research UK; Saint James's University Hospital	Zougman, A (corresponding author), St James Univ Hosp, Leeds Inst Canc & Pathol, Canc Res UK Ctr, Clin & Biomed Prote Grp, Leeds LS9 7TF, W Yorkshire, England.	a.zougman@leeds.ac.uk			Medical Research Council [MR/L01629X/1] Funding Source: Medline; MRC [MR/L01629X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bandhakavi S, 2010, MOL CELL PROTEOMICS, V9, P403, DOI 10.1074/mcp.M900326-MCP200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Fujioka H, 2014, J SEP SCI, V37, P1601, DOI 10.1002/jssc.201400135; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hansen KC, 2003, MOL CELL PROTEOMICS, V2, P299, DOI 10.1074/mcp.M300021-MCP200; HARADA K, 1995, EMBO J, V14, P5798, DOI 10.1002/j.1460-2075.1995.tb00268.x; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Liu T, 2005, PROTEOMICS, V5, P1263, DOI 10.1002/pmic.200401055; NAKANO K, 1980, J BIOCHEM-TOKYO, V87, P919, DOI 10.1093/oxfordjournals.jbchem.a132822; Palani A, 2008, J PROTEOME RES, V7, P3591, DOI 10.1021/pr800067x; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; WEITH HL, 1970, BIOCHEMISTRY-US, V9, P4396, DOI 10.1021/bi00824a021; Wisniewski JR, 2013, JOVE-J VIS EXP, DOI 10.3791/50589; Xie XY, 2011, CELL METAB, V14, P378, DOI 10.1016/j.cmet.2011.06.015; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553; Zubarev RA, 2013, PROTEOMICS, V13, P723, DOI 10.1002/pmic.201200451	16	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138775	10.1371/journal.pone.0138775	http://dx.doi.org/10.1371/journal.pone.0138775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407052	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700094
J	Calvao, AM; Crokidakis, N; Anteneodo, C				Calvao, Angelo Mondaini; Crokidakis, Nuno; Anteneodo, Celia			Stylized Facts in Brazilian Vote Distributions	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; SZNAJD MODEL; COMPLEX NETWORKS; DRAGON-KINGS; OPINION; UNIVERSALITY; BEHAVIOR; CHOICE	Elections, specially in countries such as Brazil, with an electorate of the order of 100 million people, yield large-scale data-sets embodying valuable information on the dynamics through which individuals influence each other and make choices. In this work we perform an extensive analysis of data sets available for Brazilian proportional elections of legislators and city councilors throughout the period 1970-2014, which embraces two distinct political regimes: a military regime followed by a democratic one. We perform a comparative analysis of elections for legislative positions, in different states and years, through the distribution p(v) of the number of candidates receiving v votes. We show the impact of the different political regimes on the vote distributions. Although p(v) has a common shape, with a scaling behavior, quantitative details change over time and from one electorate to another. In order to interpret the observed features, we propose a multi-species model consisting in a system of nonlinear differential equations, with values of the parameters that reflect the heterogeneity of candidates. In its simplest setting, the model can not explain the cutoff, formed by the most voted candidates, whose success is determined mainly by their peculiar, intrinsic characteristics, such as previous publicity. However, the modeling allows to interpret the scaling of p(v), yielding a predictor of the degree of feedback in the interactions of the electorate. Knowledge of the feedback is relevant beyond the context of elections, since a similar inter-activity may occur for other social contagion processes in the same population.	[Calvao, Angelo Mondaini; Anteneodo, Celia] Pontificia Univ Catolica Rio de Janeiro, Dept Phys, Rio de Janeiro, Brazil; [Crokidakis, Nuno] Univ Fed Fluminense, Inst Phys, Niteroi, RJ, Brazil; [Anteneodo, Celia] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, RJ, Brazil	Pontificia Universidade Catolica do Rio de Janeiro; Universidade Federal Fluminense	Anteneodo, C (corresponding author), Pontificia Univ Catolica Rio de Janeiro, Dept Phys, Rio de Janeiro, Brazil.	celia.fis@puc-rio.br	Anteneodo, Celia/C-7179-2013; Crokidakis, Nuno/C-5385-2013; Anteneodo, Celia/B-2021-2009	Anteneodo, Celia/0000-0001-9130-2933; Anteneodo, Celia/0000-0001-9130-2933; Crokidakis, Nuno/0000-0002-3611-534X	CAPES; CNPq; FAPERJ	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Brazilian funding agencies CAPES (http://www.capes.gov.br/), CNPq (http://www.cnpq.br/) and FAPERJ (http://www.faperj.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	ALLEN PM, 1994, FUTURES, V26, P583, DOI 10.1016/0016-3287(94)90030-2; Andresen CA, 2008, INT J MOD PHYS C, V19, P1647, DOI 10.1142/S0129183108013187; Araripe LE, 2009, PHYSICA A, V388, P4167, DOI 10.1016/j.physa.2009.06.023; Araujo NAM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012446; Barabasi A. L., NETWORK SCI; Bernardes AT, 2002, EUR PHYS J B, V25, P123, DOI 10.1140/e10051-002-0013-y; Bernardes AT, 2001, INT J MOD PHYS C, V12, P159, DOI 10.1142/S0129183101001584; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borghesi C, 2010, EUR PHYS J B, V75, P395, DOI 10.1140/epjb/e2010-00151-1; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chatterjee A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01049; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Costa RN, 1999, PHYS REV E, V60, P1067, DOI 10.1103/PhysRevE.60.1067; Dalton-Hoffman M, 2013, EFFECT SOCIAL MEDIA; Duflo E, DOES MASS MEDIA HAVE; Easley D, 2010, NETWORKS CROWDS MARK; Fernandez-Gracia J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.158701; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Galam S, 2012, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-1-4614-2032-3; Galam S, 2008, INT J MOD PHYS C, V19, P409, DOI 10.1142/S0129183108012297; Goltsev AV, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056101; Gonzalez MC, 2004, INT J MOD PHYS C, V15, P45, DOI 10.1142/S0129183104005577; Haswell S, 1999, AUSTR JOURNALISM REV, V21, P165; Hernandez-Saldana H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082584; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Klimek P, 2012, P NATL ACAD SCI USA, V109, P16469, DOI 10.1073/pnas.1210722109; Laslier JF, 2006, POLIT ANAL, V14, P160, DOI 10.1093/pan/mpj002; Laslier JF, 2004, VOTE REGLE MAJORITAI; Lyra ML, 2003, EUROPHYS LETT, V62, P131, DOI 10.1209/epl/i2003-00371-6; Mantovani MC, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.024802; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; MCALLISTER I, 1991, J POLIT, V53, P720, DOI 10.2307/2131577; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Pisarenko VF, 2012, EUR PHYS J-SPEC TOP, V205, P95, DOI 10.1140/epjst/e2012-01564-8; Radmann ERH, 2001, THESIS UFRGS; Roett Riordan, 1999, BRAZIL POLITICS PATR; Rothschild D, 2014, RES POLITICS, V1, DOI 10.1177/2053168014547667; Sonck N, 2010, INT J PUBLIC OPIN R, V22, P230, DOI 10.1093/ijpor/edp045; Sornette D, 2012, EUR PHYS J-SPEC TOP, V205, P1, DOI 10.1140/epjst/e2012-01559-5; Sornette D, 2002, INT J MOD PHYS C, V13, P171, DOI 10.1142/S0129183102003085; Steele C, ELECTION 2012 SOCIAL; Stein EA, 2013, INT J PRESS/POLIT, V18, P85, DOI 10.1177/1940161212460762; Sznajd-Weron K, 2005, ACTA PHYS POL B, V36, P2537; Travieso G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036112; Vannucchi FS, 2009, INT J MOD PHYS C, V20, P979, DOI 10.1142/S0129183109014102; Virkar Y, 2014, ANN APPL STAT, V8, P89, DOI 10.1214/13-AOAS710; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Wellman B, 2001, AM BEHAV SCI, V45, P436, DOI 10.1177/00027640121957286	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0137732	10.1371/journal.pone.0137732	http://dx.doi.org/10.1371/journal.pone.0137732			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418863	Green Submitted, Green Published, gold			2022-12-27	WOS:000362171400008
J	Wang, K; Kelley, MH; Wu, WW; Adelman, JP; Maylie, J				Wang, Kang; Kelley, Melissa H.; Wu, Wendy W.; Adelman, John P.; Maylie, James			Apamin Boosting of Synaptic Potentials in Ca(V)2.3 R-Type Ca2+ Channel Null Mice	PLOS ONE			English	Article							ACTIVITY-DEPENDENT TRAFFICKING; DENDRITIC SPINES; CALCIUM-CHANNELS; HIPPOCAMPAL-NEURONS; NICKEL BLOCK; CA1 NEURONS; SUBUNIT; EXPRESSION; CONTRIBUTES; RECEPTORS	SK2- and K(V)4.2-containing K+ channels modulate evoked synaptic potentials in CA1 pyramidal neurons. Each is coupled to a distinct Ca2+ source that provides Ca2+-dependent feedback regulation to limit AMPA receptor (AMPAR)-and NMDA receptor (NMDAR)-mediated postsynaptic depolarization. SK2-containing channels are activated by Ca2+ entry through NMDARs, whereas K(V)4.2-containing channel availability is increased by Ca2+ entry through SNX-482 (SNX) sensitive Ca(V)2.3 R-type Ca2+ channels. Recent studies have challenged the functional coupling between NMDARs and SK2-containing channels, suggesting that synaptic SK2-containing channels are instead activated by Ca2+ entry through R-type Ca2+ channels. Furthermore, SNX has been implicated to have off target affects, which would challenge the proposed coupling between R-type Ca2+ channels and K(V)4.2-containing K+ channels. To reconcile these conflicting results, we evaluated the effect of SK channel blocker apamin and R-type Ca2+ channel blocker SNX on evoked excitatory postsynaptic potentials (EPSPs) in CA1 pyramidal neurons from Ca(V)2.3 null mice. The results show that in the absence of Ca(V)2.3 channels, apamin application still boosted EPSPs. The boosting effect of Ca(V)2.3 channel blockers on EPSPs observed in neurons from wild type mice was not observed in neurons from Ca(V)2.3 null mice. These data are consistent with a model in which SK2-containing channels are functionally coupled to NMDARs and K(V)4.2-containing channels to Ca(V)2.3 channels to provide negative feedback regulation of EPSPs in the spines of CA1 pyramidal neurons.	[Wang, Kang; Kelley, Melissa H.; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Wu, Wendy W.; Maylie, James] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Maylie, J (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA.	mayliej@ohsu.edu	Wang, Kang/AAE-1168-2019	Wang, Kang/0000-0002-4563-7385	National Institute of Health [5R01NS038880-15, 5R01MH093599-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038880] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institute of Health, 5R01NS038880-15, JPA; National Institute of Health, 5R01MH093599-03, JPA.	Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Ballesteros-Merino C, 2012, HIPPOCAMPUS, V22, P1467, DOI 10.1002/hipo.20986; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Giessel AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020939; Heath NC, 2014, J NEUROSCI, V34, P8800, DOI 10.1523/JNEUROSCI.0981-14.2014; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kimm T, 2014, J NEUROSCI, V34, P9182, DOI 10.1523/JNEUROSCI.0339-14.2014; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lin MT, 2010, J NEUROSCI, V30, P11726, DOI 10.1523/JNEUROSCI.1411-10.2010; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Parajuli LK, 2012, J NEUROSCI, V32, P13555, DOI 10.1523/JNEUROSCI.1142-12.2012; Sochivko D, 2002, J PHYSIOL-LONDON, V542, P699, DOI 10.1113/jphysiol.2002.020677; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Wang K, 2014, NEURON, V81, P379, DOI 10.1016/j.neuron.2013.11.004; Zamponi GW, 1996, J MEMBRANE BIOL, V151, P77, DOI 10.1007/s002329900059; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139332	10.1371/journal.pone.0139332	http://dx.doi.org/10.1371/journal.pone.0139332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418566	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400078
J	Banat, GA; Tretyn, A; Pullamsetti, SS; Wilhelm, J; Weigert, A; Olesch, C; Ebel, K; Stiewe, T; Grimminger, F; Seeger, W; Fink, L; Savai, R				Banat, G-Andre; Tretyn, Aleksandra; Pullamsetti, Soni Savai; Wilhelm, Jochen; Weigert, Andreas; Olesch, Catherine; Ebel, Katharina; Stiewe, Thorsten; Grimminger, Friedrich; Seeger, Werner; Fink, Ludger; Savai, Rajkumar			Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; MYELOID CELLS; PLASMA-CELLS; MACROPHAGES; SURVIVAL; PROMOTION; PD-1	Recent studies indicate that the abnormal microenvironment of tumors may play a critical role in carcinogenesis, including lung cancer. We comprehensively assessed the number of stromal cells, especially immune/inflammatory cells, in lung cancer and evaluated their infiltration in cancers of different stages, types and metastatic characteristics potential. Immunohistochemical analysis of lung cancer tissue arrays containing normal and lung cancer sections was performed. This analysis was combined with cyto-/histomorphological assessment and quantification of cells to classify/subclassify tumors accurately and to perform a high throughput analysis of stromal cell composition in different types of lung cancer. In human lung cancer sections we observed a significant elevation/infiltration of total-T lymphocytes (CD3(+)), cytotoxic-T cells (CD8(+)), T-helper cells (CD4(+)), B cells (CD20(+)), macrophages (CD68(+)), mast cells (CD117(+)), mononuclear cells (CD11c(+)), plasma cells, activated-T cells (MUM1(+)), B cells, myeloid cells (PD1(+)) and neutrophilic granulocytes (myeloperoxidase(+)) compared with healthy donor specimens. We observed all of these immune cell markers in different types of lung cancers including squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma, small cell carcinoma, papillary adenocarcinoma, metastatic adenocarcinoma, and bronchioloalveolar carcinoma. The numbers of all tumor-associated immune cells (except MUM1(+) cells) in stage III cancer specimens was significantly greater than those in stage I samples. We observed substantial stage-dependent immune cell infiltration in human lung tumors suggesting that the tumormicroenvironment plays a critical role during lung carcinogenesis. Strategies for therapeutic interference with lung cancer microenvironment should consider the complexity of its immune cell composition.	[Banat, G-Andre; Pullamsetti, Soni Savai; Wilhelm, Jochen; Grimminger, Friedrich; Seeger, Werner; Savai, Rajkumar] Univ Giessen & Marburg, Lung Ctr, Internal Med, Giessen, Germany; [Tretyn, Aleksandra; Pullamsetti, Soni Savai; Ebel, Katharina; Seeger, Werner; Savai, Rajkumar] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany; [Weigert, Andreas; Olesch, Catherine] Goethe Univ Frankfurt, Inst Biochem 1, D-60054 Frankfurt, Germany; [Stiewe, Thorsten] Univ Marburg, Mol Oncol, Marburg, Germany; [Fink, Ludger] UEGP, Inst Pathol & Cytol, Wetzlar, Germany	Max Planck Society; Goethe University Frankfurt; Philipps University Marburg	Savai, R (corresponding author), Univ Giessen & Marburg, Lung Ctr, Internal Med, Giessen, Germany.	rajkumar.savai@mpi-bn.mpg.de	Wilhelm, Jochen/AAX-4302-2021; Weigert, Andreas/E-6540-2010	Wilhelm, Jochen/0000-0001-5544-9647; Pullamsetti, Soni Savai/0000-0003-0440-8831; Seeger, Werner/0000-0003-1946-0894; Stiewe, Thorsten/0000-0003-0134-7826; Grimminger, Friedrich/0000-0001-8725-6276; Weigert, Andreas/0000-0002-7529-1952	Verein zur Forderung der Krebsforschung in Giessen e.V; LOEWE Universities of Giessen and Marburg Lung Center (UGMLC)	Verein zur Forderung der Krebsforschung in Giessen e.V; LOEWE Universities of Giessen and Marburg Lung Center (UGMLC)	This work was supported by Verein zur Forderung der Krebsforschung in Giessen e.V, and the LOEWE Universities of Giessen and Marburg Lung Center (UGMLC).	Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Bellocq A, 1998, AM J PATHOL, V152, P83; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bremnes RM, 2011, J THORAC ONCOL, V6, P824, DOI 10.1097/JTO.0b013e3182037b76; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; El-Nikhely N, 2012, EXPERT OPIN INV DRUG, V21, P1107, DOI 10.1517/13543784.2012.693478; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Fujimoto M, 2013, HUM PATHOL, V44, P1569, DOI 10.1016/j.humpath.2013.01.002; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kataki A, 2002, J LAB CLIN MED, V140, P320, DOI 10.1067/mlc.2002.128317; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Kilic A, 2011, J SURG RES, V167, P207, DOI 10.1016/j.jss.2009.08.029; Lohr M, 2013, CANCER LETT, V333, P222, DOI 10.1016/j.canlet.2013.01.036; LORENZ J, 1994, CLIN INVESTIGATOR, V72, P156; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nana-Sinkam SP, 2013, CHEST, V143, pE30, DOI 10.1378/chest.12-2346; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ohnuki H, 2014, CANCER RES, V74, P2038, DOI 10.1158/0008-5472.CAN-13-3118; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Perrot I, 2007, J IMMUNOL, V178, P2763, DOI 10.4049/jimmunol.178.5.2763; Prado-Garcia H, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/741741; Remark R, 2015, AM J RESP CRIT CARE, V191, P377, DOI 10.1164/rccm.201409-1671PP; Ruffini E, 2009, ANN THORAC SURG, V87, P365, DOI 10.1016/j.athoracsur.2008.10.067; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Schmall A, 2015, AM J RESP CRIT CARE, V191, P437, DOI 10.1164/rccm.201406-1137OC; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Tartour E, 2013, LANCET RESP MED, V1, P551, DOI 10.1016/S2213-2600(13)70159-0; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; TURNER H, 2011, R J, V3, P3; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; Zaynagetdinov R, 2011, J IMMUNOL, V187, P5703, DOI 10.4049/jimmunol.1100558	42	79	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139073	10.1371/journal.pone.0139073	http://dx.doi.org/10.1371/journal.pone.0139073			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413839	gold, Green Submitted, Green Published			2022-12-27	WOS:000362170700037
J	Poole, CB; Ettwiller, L; Tanner, NA; Evans, TC; Wanji, S; Carlow, CKS				Poole, Catherine B.; Ettwiller, Laurence; Tanner, Nathan A.; Evans, Thomas C., Jr.; Wanji, Samuel; Carlow, Clotilde K. S.			Genome Filtering for New DNA Biomarkers of Loa loa Infection Suitable for Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; WUCHERERIA-BANCROFTI INFECTION; RAPID ASSESSMENT PROCEDURE; REPETITIVE DNA; BRUGIA-MALAYI; HUMAN BLOOD; DIAGNOSTIC SENSITIVITY; FILARIAL PARASITE; LOIASIS RAPLOA; OCCULT LOIASIS	Loa loa infections have emerged as a serious public health problem in patients co-infected with Onchocerca volvulus or Wuchereria bancrofti because of severe adverse neurological reactions after treatment with ivermectin. Accurate diagnostic tests are needed for careful mapping in regions where mass drug administration is underway. Loop-mediated isothermal amplification (LAMP) has become a widely adopted screening method because of its operational simplicity, rapidity and versatility of visual detection readout options. Here, we present a multi-step bioinformatic pipeline to generate diagnostic candidates suitable for LAMP and experimentally validate this approach using one of the identified candidates to develop a species-specific LAMP assay for L. loa. The pipeline identified similar to 140 new L. loa specific DNA repeat families as putative biomarkers of infection. The consensus sequence of one family, repeat family 4 (RF4), was compiled from similar to 350 sequences dispersed throughout the L. loa genome and maps to a L. loa-specific region of the long terminal repeats found at the boundaries of Bel/Pao retrotransposons. PCR and LAMP primer sets targeting RF4 specifically amplified L. loa but not W. bancrofti, O. volvulus, Brugia malayi, human or mosquito DNA. RF4 LAMP detects the DNA equivalent of one microfilaria (100 pg) in 25-30 minutes and as little as 0.060 pg of L. loa DNA (similar to 1/1600th of a microfilaria) purified from spiked blood samples in approximately 50 minutes. In summary, we have successfully employed a bioinformatic approach to mine the L. loa genome for species-specific repeat families that can serve as new DNA biomarkers for LAMP. The RF4 LAMP assay shows promise as a field tool for the implementation and management of mass drug administration programs and warrants further testing on clinical samples as the next stage in development towards this goal.	[Poole, Catherine B.; Ettwiller, Laurence; Tanner, Nathan A.; Evans, Thomas C., Jr.; Carlow, Clotilde K. S.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Wanji, Samuel] Res Fdn Trop Dis & Environm, Buea, Cameroon	New England Biolabs	Carlow, CKS (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	carlow@neb.com		Ettwiller, Laurence/0000-0002-3957-6539	New England Biolabs	New England Biolabs	The funder, New England Biolabs, provided support in the form of salaries for authors CKSC, CBP, NAT, LE and TCE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbasi I, 1999, PARASITOL RES, V85, P844, DOI 10.1007/s004360050643; AEBY P, 1986, EMBO J, V5, P3353, DOI 10.1002/j.1460-2075.1986.tb04650.x; Alhassan A, 2015, TRENDS PARASITOL, V31, P391, DOI 10.1016/j.pt.2015.04.006; Azzibrouck GB, 2010, PARASITOLOGY, V137, P1119, DOI 10.1017/S0031182009991740; Bennuru S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003180; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boussinesq M, 2006, ANN TROP MED PARASIT, V100, P715, DOI 10.1179/136485906X112194; Boussinesq M, 2001, J TOXICOL ENV HEAL A, V63, P495; Bowen NJ, 1999, GENOME RES, V9, P924, DOI 10.1101/gr.9.10.924; Burbelo PD, 2008, J CLIN MICROBIOL, V46, P2298, DOI 10.1128/JCM.00490-08; Chakrabarti R, 2001, NUCLEIC ACIDS RES, V29, P2377, DOI 10.1093/nar/29.11.2377; Chippaux JP, 1996, PARASITOL TODAY, V12, P448, DOI 10.1016/0169-4758(96)40006-0; CHULARERK P, 1970, J PARASITOL, V56, P623, DOI 10.2307/3277640; Copeland CS, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-20; D'Ambrosio MV, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3480; Davis PS, 1995, DROSOPH INF SERV, V76, P134; Desjardins CA, 2013, NAT GENET, V45, P495, DOI 10.1038/ng.2585; Drame PM, 2014, J CLIN MICROBIOL, V52, P2071, DOI 10.1128/JCM.00525-14; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Fink DL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001299; Fink DL, 2011, J CLIN MICROBIOL, V49, P42, DOI 10.1128/JCM.01697-10; Fischer P, 2000, AM J TROP MED HYG, V62, P291, DOI 10.4269/ajtmh.2000.62.291; Gardon J, 1997, T ROY SOC TROP MED H, V91, P593, DOI 10.1016/S0035-9203(97)90041-9; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; GONZALEZ A, 1984, P NATL ACAD SCI-BIOL, V81, P3356, DOI 10.1073/pnas.81.11.3356; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/erm.12.144, 10.1586/ERM.12.144]; Hoerauf A, 2011, CLIN MICROBIOL INFEC, V17, P977, DOI 10.1111/j.1469-0691.2011.03586.x; Jimenez M, 2011, EXP PARASITOL, V127, P282, DOI 10.1016/j.exppara.2010.06.019; Kelly-Hope LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001605; Klion AD, 2003, J INFECT DIS, V187, P128, DOI 10.1086/345873; KLION AD, 1994, J INFECT DIS, V169, P604, DOI 10.1093/infdis/169.3.604; KLION AD, 1993, J INFECT DIS, V168, P202, DOI 10.1093/infdis/168.1.202; KLION AD, 1991, MOL BIOCHEM PARASIT, V45, P297, DOI 10.1016/0166-6851(91)90098-Q; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; LIZOTTE MR, 1994, AM J TROP MED HYG, V51, P314, DOI 10.4269/ajtmh.1994.51.314; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; MCREYNOLDS LA, 1986, P NATL ACAD SCI USA, V83, P797, DOI 10.1073/pnas.83.3.797; Molyneux DH, 2009, T ROY SOC TROP MED H, V103, P338, DOI 10.1016/j.trstmh.2008.12.016; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Okorie PN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002416; Pion SDS, 2004, PARASITOLOGY, V129, P613, DOI 10.1017/S0031182004005694; Pion SDS, 2005, ANN TROP MED PARASIT, V99, P491, DOI 10.1179/136485905X51300; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SIRIDEWA K, 1994, AM J TROP MED HYG, V51, P495, DOI 10.4269/ajtmh.1994.51.495; Takagi H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/j.parint.2011.08.018; Tallon LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-788; Tanner N, 2013, COMPOSITIONS METHODS; Tanner NA, 2015, BIOTECHNIQUES, V58, P59, DOI 10.2144/000114253; Toure FS, 1998, AM J TROP MED HYG, V59, P144, DOI 10.4269/ajtmh.1998.59.144; Toure FS, 1999, B SOC PATHOL EXOT, V92, P167; Toure FS, 1997, AM J TROP MED HYG, V56, P57, DOI 10.4269/ajtmh.1997.56.57; Uttah E, 2011, J VECTOR DIS, V48, P197; Vasuki V, 2003, ACTA TROP, V86, P109, DOI 10.1016/S0001-706X(02)00267-X; Wanji S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-25; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; XIONG Y, 1993, NUCLEIC ACIDS RES, V21, P2117, DOI 10.1093/nar/21.9.2117; Zhong M, 1996, AM J TROP MED HYG, V54, P357, DOI 10.4269/ajtmh.1996.54.357; Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210	62	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139286	10.1371/journal.pone.0139286	http://dx.doi.org/10.1371/journal.pone.0139286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414073	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700053
J	Anderson, JC; Willey, CD; Mehta, A; Welaya, K; Chen, DQ; Duarte, CW; Ghatalia, P; Arafat, W; Madan, A; Sudarshan, S; Naik, G; Grizzle, WE; Choueiri, TK; Sonpavde, G				Anderson, Joshua C.; Willey, Christopher D.; Mehta, Amitkumar; Welaya, Karim; Chen, Dongquan; Duarte, Christine W.; Ghatalia, Pooja; Arafat, Waleed; Madan, Ankit; Sudarshan, Sunil; Naik, Gurudatta; Grizzle, William E.; Choueiri, Toni K.; Sonpavde, Guru			High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes	PLOS ONE			English	Article							BIOMARKERS; EVOLUTION; TUMORS; EXOME	Despite the widespread use of kinase-targeted agents in clear cell renal cell carcinoma (CC-RCC), comprehensive kinase activity evaluation (kinomic profiling) of these tumors is lacking. Thus, kinomic profiling of CC-RCC may assist in devising a classification system associated with clinical outcomes, and help identify potential therapeutic targets. Fresh frozen CC-RCC tumor lysates from 41 clinically annotated patients who had localized disease at diagnosis were kinomically profiled using the PamStation (R) 12 high-content phospho-peptide substrate microarray system (PamGene International). Twelve of these patients also had matched normal kidneys available that were also profiled. Unsupervised hierarchical clustering and supervised comparisons based on tumor vs. normal kidney and clinical outcome (tumor recurrence) were performed and coupled with advanced network modeling and upstream kinase prediction methods. Unsupervised clustering analysis of localized CC-RCC tumors identified 3 major kinomic groups associated with inflammation (A), translation initiation (B), and immune response and cell adhesions (C) processes. Potential driver kinases implicated include PFTAIRE (PFTK1), PKG1, and SRC, which were identified in groups A, B, and C, respectively. Of the 9 patients who had tumor recurrence, only one was found in Group B. Supervised analysis showed decreased kinase activity of CDK1 and RSK1-4 substrates in those which progressed compared to others. Twelve tumors with matching normal renal tissue implicated increased PIM's and MAPKAPK's in tumors compared to adjacent normal renal tissue. As such, comprehensive kinase profiling of CC-RCC tumors could provide a functional classification strategy for patients with localized disease and identify potential therapeutic targets.	[Anderson, Joshua C.; Willey, Christopher D.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA; [Mehta, Amitkumar; Ghatalia, Pooja; Madan, Ankit; Naik, Gurudatta; Sonpavde, Guru] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Chen, Dongquan] Univ Alabama Birmingham, Div Preventat Med, Birmingham, AL USA; [Sudarshan, Sunil] Univ Alabama Birmingham, Dept Urol, Birmingham, AL USA; [Grizzle, William E.] Univ Alabama Birmingham, Div Anat Pathol, Birmingham, AL USA; [Welaya, Karim; Arafat, Waleed] Univ Alexandria, Dept Clin Oncol, Alexandria, Egypt; [Duarte, Christine W.] MMCRI, CORE, Portland, ME USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Kidney Canc Ctr, Dept Med Oncol, Boston, MA 02115 USA; [Choueiri, Toni K.] Harvard Univ, Sch Med, Boston, MA USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Egyptian Knowledge Bank (EKB); Alexandria University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sonpavde, G (corresponding author), Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL 35294 USA.	gsonpavde@uabmc.edu	Sonpavde/L-7107-2019; naik, Gurudatta/O-7284-2015; Madan, Ankit/ADN-3478-2022; Choueiri, Toni/K-5238-2019	Sonpavde/0000-0002-1010-9611; naik, Gurudatta/0000-0001-7265-6605; Choueiri, Toni/0000-0002-9201-3217; arafat, waleed/0000-0002-6617-5992; Mehta, Amitkumar/0000-0003-0537-4207; Anderson, Joshua/0000-0002-6977-9054	Egyptian Partnership & Ownership Initiative Fellowship Grant; Comprehensive Cancer Center Pilot Grant Program [P30CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER	Egyptian Partnership & Ownership Initiative Fellowship Grant; Comprehensive Cancer Center Pilot Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Egyptian Partnership & Ownership Initiative Fellowship Grant provided the stipend support for UAB Kinome Core Fellow (KW). The UAB Comprehensive Cancer Center Pilot Grant Program (P30CA013148) provided funding for the experimental work (to GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2014, INT J CANCER, V135, P1330, DOI 10.1002/ijc.28768; Audenet F, 2012, BJU INT, V109, P1864, DOI 10.1111/j.1464-410X.2011.10661.x; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Buczek M, 2014, BBA-REV CANCER, V1845, P31, DOI 10.1016/j.bbcan.2013.10.001; Choueiri TK, 2014, ANN ONCOL, V25, P1603, DOI 10.1093/annonc/mdu184; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Duverger A, 2014, J VIROL, V88, P364, DOI 10.1128/JVI.02682-13; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Grizzle W.E., 2005, MOL DIAGNOSTICS, V33, P421; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Jarboe JS, 2012, RADIOTHER ONCOL, V103, P380, DOI 10.1016/j.radonc.2012.03.014; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Maroto P, 2014, CLIN CANCER RES, V20, P2060, DOI 10.1158/1078-0432.CCR-13-1351; McGuire JL, 2014, BRAIN RES, V1568, P42, DOI 10.1016/j.brainres.2014.04.029; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Motzer R, 2015, J CLIN ONCOL SUPPL, V33; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; ROSENBERG SA, 1994, JAMA-J AM MED ASSOC, V271, P907, DOI 10.1001/jama.271.12.907; Ruijtenbeek R HL, 2009, AACR ANNUAL CONFEREN; Schutz FAB, 2013, LANCET ONCOL, V14, P81, DOI 10.1016/S1470-2045(12)70517-X; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sikkema AH, 2009, CANCER RES, V69, P5987, DOI 10.1158/0008-5472.CAN-08-3660; Sonpavde G, 2012, BRIT J CANCER, V107, P1009, DOI 10.1038/bjc.2012.399; Sonpavde G, 2014, EXPERT OPIN INV DRUG, V23, P305, DOI 10.1517/13543784.2014.871259; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Versele M, 2009, MOL CANCER THER, V8, P1846, DOI 10.1158/1535-7163.MCT-08-1029	33	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139267	10.1371/journal.pone.0139267	http://dx.doi.org/10.1371/journal.pone.0139267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406598	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700201
J	Nagarajan, R; Miller, CS; Dawson, D; Al-Sabbagh, M; Ebersole, JL				Nagarajan, Radhakrishnan; Miller, Craig S.; Dawson, Dolph, III; Al-Sabbagh, Mohanad; Ebersole, Jeffrey L.			Patient-Specific Variations in Biomarkers across Gingivitis and Periodontitis	PLOS ONE			English	Article							SALIVARY BIOMARKERS; CLINICAL-COURSE; TISSUE DESTRUCTION; HOST-RESPONSE; UNITED-STATES; RISK-FACTOR; DISEASE; IDENTIFICATION; BACTERIAL; TRANSCRIPTOMES	This study investigates the use of saliva, as an emerging diagnostic fluid in conjunction with classification techniques to discern biological heterogeneity in clinically labelled gingivitis and periodontitis subjects (80 subjects; 40/group) A battery of classification techniques were investigated as traditional single classifier systems as well as within a novel selective voting ensemble classification approach (SVA) framework. Unlike traditional single classifiers, SVA is shown to reveal patient-specific variations within disease groups, which may be important for identifying proclivity to disease progression or disease stability. Salivary expression profiles of IL-1 beta, IL-6, MMP-8, and MIP-1 alpha from 80 patients were analyzed using four classification algorithms (LDA: Linear Discriminant Analysis [LDA], Quadratic Discriminant Analysis [QDA], Naive Bayes Classifier [NBC] and Support Vector Machines [SVM]) as traditional single classifiers and within the SVA framework (SVA-LDA, SVA-QDA, SVA-NB and SVA-SVM). Our findings demonstrate that performance measures (sensitivity, specificity and accuracy) of traditional classification as single classifier were comparable to that of the SVA counterparts using clinical labels of the samples as ground truth. However, unlike traditional single classifier approaches, the normalized ensemble vote-counts from SVA revealed varying proclivity of the subjects for each of the disease groups. More importantly, the SVA identified a subset of gingivitis and periodontitis samples that demonstrated a biological proclivity commensurate with the other clinical group. This subset was confirmed across SVA-LDA, SVA-QDA, SVA-NB and SVA-SVM. Heatmap visualization of their ensemble sets revealed lack of consensus between these subsets and the rest of the samples within the respective disease groups indicating the unique nature of the patients in these subsets. While the source of variation is not known, the results presented clearly elucidate the need for novel approaches that accommodate inherent heterogeneity and personalized variations within disease groups in diagnostic characterization. The proposed approach falls within the scope of P4 medicine (predictive, preventive, personalized, and participatory) with the ability to identify unique patient profiles that may predict specific disease trajectories and targeted disease management.	[Nagarajan, Radhakrishnan] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Div Biomed Informat, Lexington, KY 40506 USA; [Miller, Craig S.; Dawson, Dolph, III; Ebersole, Jeffrey L.] Univ Kentucky, Coll Dent, Ctr Oral Hlth Res, Lexington, KY 40506 USA; [Miller, Craig S.] Univ Kentucky, Coll Dent, Dept Oral Hlth Practice, Div Oral Med, Lexington, KY USA; [Dawson, Dolph, III; Al-Sabbagh, Mohanad] Univ Kentucky, Coll Dent, Dept Oral Hlth Practice, Div Periodont, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Ebersole, JL (corresponding author), Univ Kentucky, Coll Dent, Ctr Oral Hlth Res, Lexington, KY 40506 USA.	Jeffrey.ebersole@uky.edu	Miller, Craig/GWQ-5012-2022		National Center for Applied and Translational Science (NCATS) [NIH U01 DE017793, M01-RR02602, P20 GM103538, P20 RR020145, 20 UL1TR000117]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020145, M01RR002602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE017793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103538] Funding Source: NIH RePORTER	National Center for Applied and Translational Science (NCATS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants NIH U01 DE017793, M01-RR02602, P20 GM103538 (P20 RR020145) and 20 UL1TR000117 from the National Center for Applied and Translational Science (NCATS).	Al-Sabbagh M, 2012, J PERIODONTAL RES, V47, P389, DOI 10.1111/j.1600-0765.2011.01445.x; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; [Anonymous], 2002, HDB BRAIN THEORY NEU, DOI DOI 10.1007/SPRINGERREFERENCE_71011; Armitage GC, 2013, PERIODONTOL 2000, V62, P20, DOI 10.1111/prd.12006; Benakanakere M, 2012, FRONT ORAL BIOL, V15, P41, DOI 10.1159/000329670; Buduneli N, 2011, J CLIN PERIODONTOL, V38, P85, DOI 10.1111/j.1600-051X.2010.01670.x; Choi Y, 2001, EUR J IMMUNOL, V31, P2179, DOI 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X; Davanian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046440; Demmer RT, 2008, J PERIODONTOL, V79, P2112, DOI [10.1902/jop.2008.080139, 10.1902/jop.2008.080139 ]; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Duarte PM, 2012, J PERIODONTOL, V83, P426, DOI 10.1902/jop.2011.110324; Ebersole JL, 2013, PERIODONTOL 2000, V62, P163, DOI 10.1111/prd.12005; Ebersole JL, 2013, J CLIN IMMUNOL, V33, P271, DOI 10.1007/s10875-012-9771-3; Fine DH, 2009, J PERIODONTOL, V80, P106, DOI [10.1902/jop.2009.080296, 10.1902/jop.2009.080296 ]; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Giannobile W V, 2011, Adv Dent Res, V23, P375, DOI 10.1177/0022034511420434; Giannobile WV, 2009, PERIODONTOL 2000, V50, P52, DOI 10.1111/j.1600-0757.2008.00288.x; Giuliani N, 2004, EXP HEMATOL, V32, P685, DOI 10.1016/j.exphem.2004.03.015; Goncalves LD, 2010, J PROTEOMICS, V73, P1334, DOI 10.1016/j.jprot.2010.02.018; Hu S, 2005, PROTEOMICS, V5, P1714, DOI 10.1002/pmic.200401037; Hujoel PP, 2008, JAMA-J AM MED ASSOC, V299, P574, DOI 10.1001/jama.299.5.574; Javed F, 2014, J PERIODONTOL, V85, pE130, DOI 10.1902/jop.2013.130514; Jonsson D, 2011, J CLIN PERIODONTOL, V38, P599, DOI 10.1111/j.1600-051X.2011.01719.x; Kardesler L, 2011, INFLAMM RES, V60, P143, DOI 10.1007/s00011-010-0248-7; Kebschull M, 2013, J DENT RES, V92, P1081, DOI 10.1177/0022034513506011; Kebschull M, 2010, METHODS MOL BIOL, V666, P385, DOI 10.1007/978-1-60761-820-1_24; Kinane DF, 2007, PERIODONTOL 2000, V43, P278, DOI 10.1111/j.1600-0757.2006.00169.x; Kinney JS, 2011, J DENT RES, V90, P752, DOI 10.1177/0022034511399908; Kodell RL, 2012, ARTIF INTELL MED, V54, P171, DOI 10.1016/j.artmed.2011.10.003; Kornman KS, 1997, PERIODONTOL 2000, V14, P33, DOI 10.1111/j.1600-0757.1997.tb00191.x; Lang NP, 2009, J CLIN PERIODONTOL, V36, P3, DOI 10.1111/j.1600-051X.2009.01415.x; Lee A, 2012, J PERIODONTOL, V83, P79, DOI 10.1902/jop.2011.110060; Miller CS, 2010, BIOMARK MED, V4, P171, DOI 10.2217/BMM.09.68; Miller CS, 2006, J AM DENT ASSOC, V137, P322, DOI 10.14219/jada.archive.2006.0181; Mirnezami R, 2012, ANN SURG, V255, P881, DOI 10.1097/SLA.0b013e31823e3c43; Nagarajan Radhakrishnan, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P87; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Novak MJ, 2008, J PERIODONTOL, V79, P33, DOI 10.1902/jop.2008.070237 ; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; Offenbacher S, 2009, J PERIODONTOL, V80, P1963, DOI 10.1902/jop.2009.080645; Papapanou PN, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-221; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Prakasam S, 2014, ORAL DIS, V20, P171, DOI 10.1111/odi.12085; Ramseier CA, 2009, J PERIODONTOL, V80, P436, DOI [10.1902/jop.2009.080480, 10.1902/jop.2009.080480 ]; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Rokach L, 2009, COMPUT STAT DATA AN, V53, P1015, DOI 10.1016/j.csda.2008.12.001; Salazar MG, 2013, J CLIN PERIODONTOL, V40, P825, DOI 10.1111/jcpe.12130; Salminen A, 2014, J CLIN PERIODONTOL, V41, P442, DOI 10.1111/jcpe.12234; Schatzle M, 2009, J CLIN PERIODONTOL, V36, P365, DOI 10.1111/j.1600-051X.2009.01391.x; Schatzle M, 2004, J CLIN PERIODONTOL, V31, P1122, DOI 10.1111/j.1600-051X.2004.00634.x; Schatzle M, 2003, J CLIN PERIODONTOL, V30, P887, DOI 10.1034/j.1600-051X.2003.00414.x; Sexton WM, 2011, J CLIN PERIODONTOL, V38, P434, DOI 10.1111/j.1600-051X.2011.01706.x; Sorsa T, 1999, ANN NY ACAD SCI, V878, P130, DOI 10.1111/j.1749-6632.1999.tb07679.x; Stoecklin-Wasmer C, 2012, J DENT RES, V91, P934, DOI 10.1177/0022034512456551; Syndergaard B, 2014, J PERIODONTOL, V85, pE295, DOI 10.1902/jop.2014.130696; Teles FR, 2012, J PERIODONTOL, V83, P1183, DOI 10.1902/jop.2011.110346; Teles R, 2010, J PERIODONTOL, V81, P89, DOI 10.1902/jop.2009.090397; Terpos E, 2005, LEUKEMIA LYMPHOMA, V46, P1699, DOI 10.1080/10428190500175049; Thomas MV, 2009, J PERIODONTOL, V80, P1146, DOI 10.1902/jop.2009.080654; Tobon-Arroyave SI, 2008, ARCH ORAL BIOL, V53, P346, DOI 10.1016/j.archoralbio.2007.11.005; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Van Dyke Thomas E, 2005, J Int Acad Periodontol, V7, P3; Yoon AJ, 2012, J CLIN PERIODONTOL, V39, P434, DOI 10.1111/j.1600-051X.2012.01866.x; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8; Zhang L, 2009, MOL DIAGN THER, V13, P245, DOI 10.2165/11317160-000000000-00000; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X	66	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136792	10.1371/journal.pone.0136792	http://dx.doi.org/10.1371/journal.pone.0136792			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407063	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700014
J	Pan, R; Chen, HP; Zhang, ML; Wang, QH; Jiang, Y; Liu, X				Pan, Rong; Chen, Hong-Ping; Zhang, Ming-Lu; Wang, Qing-Hua; Jiang, Ying; Liu, Xin			Dissipation Pattern, Processing Factors, and Safety Evaluation for Dimethoate and Its Metabolite (Omethoate) in Tea (Camellia Sinensis)	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDE-RESIDUES; BEHAVIOR; DEGRADATION; METHAMIDOPHOS; INSECTICIDES; BIFENTHRIN; KINETICS; ACEPHATE; OOLONG; LEAVES	Residue levels of dimethoate and its oxon metabolite (omethoate) during tea planting, manufacturing, and brewing were investigated using a modified QuEChERS sample preparation and gas chromatography. Dissipation of dimethoate and its metabolite in tea plantation followed the first-order kinetic with a half-life of 1.08-1.27 d. Tea manufacturing has positive effects on dimethoate dissipation. Processing factors of dimethoate are in the range of 2.11-2.41 and 1.41-1.70 during green tea and black tea manufacturing, respectively. Omethoate underwent generation as well as dissipation during tea manufacturing. Sum of dimethoate and omethoate led to a large portion of 80.5-84.9% transferring into tea infusion. Results of safety evaluation indicated that omethoate could bring higher human health risk than dimethoate due to its higher hazard quotient by drinking tea. These results would provide information for the establishment of maximum residue limit and instruction for the application of dimethoate formulation on tea crop.	[Pan, Rong; Chen, Hong-Ping; Zhang, Ming-Lu; Wang, Qing-Hua; Jiang, Ying; Liu, Xin] Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China; [Pan, Rong; Zhang, Ming-Lu] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Chen, Hong-Ping; Wang, Qing-Hua; Jiang, Ying; Liu, Xin] Minist Agr, Key Lab Tea Qual & Safety & Risk Assessment, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Ministry of Agriculture & Rural Affairs	Chen, HP (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China.	Thean27@mail.tricaas.com; Liuxin@mail.tricaas.com	Wang, Qinghua/GVT-3252-2022		Modern Agro-Industry Technology Research System [NYCYTX-26]; Innovative Research Team in Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2014-TRICAAS]	Modern Agro-Industry Technology Research System; Innovative Research Team in Chinese Academy of Agricultural Sciences	Funding provided by (1) Modern Agro-Industry Technology Research System (NYCYTX-26); http://119.253.58.231/; (2) Innovative Research Team in Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2014-TRICAAS); http://111.203.20.126/CaasTech/caas/index.jsp.	[Anonymous], 124952011 SANCO; Baruah A. A. L. H., 2010, Pesticide Research Journal, V22, P195; Bisen J. S., 2000, Journal of Plantation Crops, V28, P123; Chen HP, 2013, FOOD CHEM, V138, P976, DOI 10.1016/j.foodchem.2012.10.110; Chen L, 2012, FOOD CONTROL, V25, P433, DOI 10.1016/j.foodcont.2011.11.027; CHEN ZM, 1988, PESTIC SCI, V23, P109, DOI 10.1002/ps.2780230204; Chen ZM, 1997, ENVIRON MONIT ASSESS, V44, P303, DOI 10.1023/A:1005791514357; Diaz-Gomez R, 2014, LWT-FOOD SCI TECHNOL, V59, P896, DOI 10.1016/j.lwt.2014.06.049; Fernandez-Gonzalez R, 2015, CRIT REV FOOD SCI, V55, P1590, DOI 10.1080/10408398.2012.710279; Gupta M, 2009, FOOD ADDIT CONTAM A, V26, P157, DOI 10.1080/02652030802363782; Hou RY, 2013, FOOD ADDIT CONTAM A, V30, P1761, DOI 10.1080/19440049.2013.820356; Jaggi S, 2001, J AGR FOOD CHEM, V49, P5479, DOI 10.1021/jf010436d; Karthika Chinnachamy, 2010, Toxicological and Environmental Chemistry, V92, P1249, DOI 10.1080/02772240903362469; Kaushik G, 2009, FOOD RES INT, V42, P26, DOI 10.1016/j.foodres.2008.09.009; Kong ZQ, 2012, FOOD CONTROL, V23, P149, DOI 10.1016/j.foodcont.2011.07.001; Kumar V, 2006, FOOD CHEM TOXICOL, V44, P595, DOI 10.1016/j.fct.2005.10.009; Lu XS, 2013, FOOD CHEM, V141, P3415, DOI 10.1016/j.foodchem.2013.06.058; Lv YQ, 2007, BIOCHEM ENG J, V36, P221, DOI 10.1016/j.bej.2007.02.023; Mendoza A, 2014, ENVIRON INT, V70, P76, DOI 10.1016/j.envint.2014.05.009; Muthusami S, 2013, MOL BIOL REP, V40, P5587, DOI 10.1007/s11033-013-2660-x; Nagayama T, 1996, J AGR FOOD CHEM, V44, P2388, DOI 10.1021/jf950549v; Ozbey A, 2007, FOOD CHEM, V104, P237, DOI 10.1016/j.foodchem.2006.11.034; Ozbey A, 2007, INT J FOOD SCI TECH, V42, P380, DOI 10.1111/j.1365-2621.2006.01237.x; Pan R, 2015, J AGR FOOD CHEM, V63, P1300, DOI 10.1021/jf504916b; Pappas CJ, 2003, FOOD CHEM, V80, P23, DOI 10.1016/S0308-8146(02)00230-3; Paramasivam M, 2014, CHEMOSPHERE, V111, P291, DOI 10.1016/j.chemosphere.2014.03.111; Perez-Parada A, 2010, J ENVIRON SCI HEAL B, V45, P796, DOI 10.1080/03601234.2010.515180; Regueiro J, 2015, CRIT REV FOOD SCI, V55, P839, DOI 10.1080/10408398.2012.677872; Roast SD, 1999, WATER RES, V33, P319, DOI 10.1016/S0043-1354(98)00248-6; Satheshkumar A, 2014, FOOD CHEM, V145, P1092, DOI 10.1016/j.foodchem.2013.09.042; Seenivasan S, 2009, FOOD CHEM TOXICOL, V47, P502, DOI 10.1016/j.fct.2008.12.010; Sharma D, 2010, TALANTA, V82, P1077, DOI 10.1016/j.talanta.2010.06.043; Shivani Jaggi, 2011, Journal of Environmental Protection, V2, P482, DOI 10.4236/jep.2011.24056; Sood C, 2004, J SCI FOOD AGR, V84, P2123, DOI 10.1002/jsfa.1774; Srinivas PS, 2012, J ENVIRON SCI HEAL B, V47, P700, DOI 10.1080/03601234.2012.669262; Tewary DK, 2005, FOOD CONTROL, V16, P231, DOI 10.1016/j.foodcont.2004.02.004; Utture SC, 2012, FOOD CHEM, V131, P787, DOI 10.1016/j.foodchem.2011.09.044; WAN H, 1991, FOOD ADDIT CONTAM, V8, P497, DOI 10.1080/02652039109374000; Wang J, 2014, J AGR FOOD CHEM, V62, P966, DOI 10.1021/jf404123h; Xia H, 2008, FOOD ADDIT CONTAM A, V25, P70, DOI 10.1080/02652030701523007	40	29	31	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138309	10.1371/journal.pone.0138309	http://dx.doi.org/10.1371/journal.pone.0138309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406463	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700040
J	R-Tavakoli, H; Atyabi, A; Rantanen, A; Laukka, SJ; Nefti-Meziani, S; Heikkila, J				R-Tavakoli, Hamed; Atyabi, Adham; Rantanen, Antti; Laukka, Seppo J.; Nefti-Meziani, Samia; Heikkila, Janne			Predicting the Valence of a Scene from Observers' Eye Movements	PLOS ONE			English	Article								Multimedia analysis benefits from understanding the emotional content of a scene in a variety of tasks such as video genre classification and content-based image retrieval. Recently, there has been an increasing interest in applying human bio-signals, particularly eye movements, to recognize the emotional gist of a scene such as its valence. In order to determine the emotional category of images using eye movements, the existing methods often learn a classifier using several features that are extracted from eye movements. Although it has been shown that eye movement is potentially useful for recognition of scene valence, the contribution of each feature is not well-studied. To address the issue, we study the contribution of features extracted from eye movements in the classification of images into pleasant, neutral, and unpleasant categories. We assess ten features and their fusion. The features are histogram of saccade orientation, histogram of saccade slope, histogram of saccade length, histogram of saccade duration, histogram of saccade velocity, histogram of fixation duration, fixation histogram, top-ten salient coordinates, and saliency map. We utilize machine learning approach to analyze the performance of features by learning a support vector machine and exploiting various feature fusion schemes. The experiments reveal that 'saliency map', 'fixation histogram', 'histogram of fixation duration', and 'histogram of saccade slope' are the most contributing features. The selected features signify the influence of fixation information and angular behavior of eye movements in the recognition of the valence of images.	[R-Tavakoli, Hamed; Heikkila, Janne] Univ Oulu, Dept Comp Sci & Engn, Ctr Machine Vis Res, Oulu, Finland; [Atyabi, Adham; Nefti-Meziani, Samia] Univ Salford Manchester, Autonomous Syst & Adv Robot Res Ctr, Salford, Lancs, England; [Atyabi, Adham] Flinders Univ South Australia, Sch Comp Sci Engn & Math, Adelaide, SA, Australia; [Rantanen, Antti; Laukka, Seppo J.] Univ Oulu, Learning Res Lab LearnLab, Oulu 90014, Finland	University of Oulu; Flinders University South Australia; University of Oulu	R-Tavakoli, H (corresponding author), Aalto Univ, Dept Comp Sci, Espoo, Finland.	Hamed.R-Tavakoli@aalto.fi	Tavakoli, Hamed R./O-9942-2016; Atyabi, Adham/I-9278-2017	Tavakoli, Hamed R./0000-0002-9466-9148; Atyabi, Adham/0000-0003-0232-7157; Nefti-Meziani, Samia/0000-0001-6500-2929	Nokia Scholarships	Nokia Scholarships(Nokia Corporation)	This work was partially supported by Nokia Scholarships. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ab Wahab MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122827; Anderson, 1951, PSYCHOMETRIKA, V16, P31, DOI [10.1007/BF02313425, DOI 10.1007/BF02313425]; [Anonymous], 2005, STUDIES FUZZINESS SO, DOI [DOI 10.1007/B95439, 10.1007/b95439]; Armstrong T, 2009, WHAT THEY SEE IS WHA; Borji A, 2014, J VISION, V14; Borji A, 2013, IEEE I CONF COMP VIS, P921, DOI 10.1109/ICCV.2013.118; Bulling A, 2011, IEEE T PATTERN ANAL, V33, P741, DOI 10.1109/TPAMI.2010.86; Chen NTM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086474; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Esfahani MS, 2014, BIOINFORMATICS, V30, P242, DOI 10.1093/bioinformatics/btt662; Goh JO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008238; Greene MR, 2012, VISION RES, V62, P1, DOI 10.1016/j.visres.2012.03.019; Henderson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064937; Humphrey K, 2012, J VISION, V12, DOI 10.1167/12.1.22; Irwin D. E., 2004, INTERFACE LANGUAGE V, P105; Isola P, 2011, PROC CVPR IEEE, P145, DOI 10.1109/CVPR.2011.5995721; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Judd T, 2009, IEEE I CONF COMP VIS, P2106, DOI 10.1109/ICCV.2009.5459462; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kanan C., 2014, ETRA 14 P S EYE TRAC, P287, DOI [10.1145/2578153.2578208, DOI 10.1145/2578153.2578208]; Kootstra G., 2008, P 19 BRIT MACH VIS C, P1115; Lang PJ, 2008, INT AFFECTIVE PICTUR, pA; Lang PJ., 2001, EMOTION, V1, DOI 10.1037/1528-3542.1.3.276; Le Meur Olivier, 2011, P 19 ACM INT C MULT, P373, DOI DOI 10.1145/2072298.2072347; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Ma KT, 2013, LECT NOTES COMPUT SC, V8212, P209, DOI 10.1007/978-3-319-02714-2_18; Mancas M, 2013, IEEE IMAGE PROC, P196, DOI 10.1109/ICIP.2013.6738041; Marcano-Cedeno A., 2010, IECON 2010 - 36th Annual Conference of IEEE Industrial Electronics, P2845, DOI 10.1109/IECON.2010.5675075; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Niu YQ, 2012, ACM T APPL PERCEPT, V9, DOI 10.1145/2325722.2325726; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Olson DL, 2002, ADV DATA MINING TECH; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Powers DMW, 2011, J MACHINE LEARNING T, V2; R-Tavakoli H, 2014, INT C PATT RECOG, P4666, DOI 10.1109/ICPR.2014.798; Ramanathan S, 2010, LECT NOTES COMPUT SC, V6314, P30, DOI 10.1007/978-3-642-15561-1_3; Sanei S, 2007, EEG SIGNAL PROCESSIN; Simola J, 2015, NEUROIMAGE, V106, P21, DOI 10.1016/j.neuroimage.2014.11.030; Subramanian R., 2011, INT C MULTIMEDIA ACM, P33; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tichon JG, 2014, AVIATION PSYCHOL APP, V4, DOI [10.1027/2192-0923/a000052, DOI 10.1027/2192-0923/A000052]; van Steenbergen H, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00281; Vitu F, 2001, VISION RES, V41, P3513, DOI 10.1016/S0042-6989(01)00166-3; Wadlinger HA, 2006, MOTIV EMOTION, V30, P89, DOI 10.1007/s11031-006-9021-1; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	46	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138198	10.1371/journal.pone.0138198	http://dx.doi.org/10.1371/journal.pone.0138198			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26407322	Green Published, gold, Green Accepted			2022-12-27	WOS:000361800700036
J	Draborg, AH; Lydolph, MC; Westergaard, M; Larsen, SO; Nielsen, CT; Duus, K; Jacobsen, S; Houen, G				Draborg, Anette H.; Lydolph, Magnus C.; Westergaard, Marie; Larsen, Severin Olesen; Nielsen, Christoffer T.; Duus, Karen; Jacobsen, Soren; Houen, Gunnar			Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies	PLOS ONE			English	Article							PRIMARY SJOGRENS-SYNDROME; BLOOD MONONUCLEAR-CELLS; INFECTIOUS-MONONUCLEOSIS; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; ADULT PATIENTS; IN-VIVO; PREVALENCE; ANTIGEN; SLE	Objective In this study, we examined the concentration of serum immunoglobulin free light chains (FLCs) in systemic lupus erythematosus (SLE) patients and investigated its association with various disease parameters in order to evaluate the role of FLCs as a potential biomarker in SLE. Furthermore, FLCs' association with Epstein-Barr virus (EBV) antibodies was examined. Methods Using a nephelometric assay, kappa FLC and lambda FLC concentrations were quantified in sera from 45 SLE patients and 40 healthy controls. SLE patients with renal insufficiency were excluded in order to preclude high concentrations of serum FLCs due to decreased clearance. Results Serum FLC concentrations were significantly elevated in SLE patients compared to healthy controls (p<0.0001) also after adjusting for Ig levels (p<0.0001). The concentration of serum FLCs correlated with a global disease activity (SLE disease activity index (SLEDAI)) score of the SLE patients (r = 0.399, p = 0.007). Furthermore, concentrations of FLCs correlated with titers of dsDNA antibodies (r = 0.383, p = 0.009), and FLC levels and SLEDAI scores correlated in the anti-dsDNA-positive SLE patients, but not in anti-dsDNA-negative SLE patients. Total immunoglobulin (IgG and IgA) concentrations correlated with FLC concentrations and elevated FLC levels were additionally shown to associate with the inflammatory marker C-reactive protein and also with complement consumption determined by low C4 in SLE patients. Collectively, results indicated that elevated serum FLCs reflects increased B cell activity in relation to inflammation. SLE patients had an increased seropositivity of EBV-directed antibodies that did not associate with elevated FLC concentrations. An explanation for this could be that serum FLC concentrations reflect the current EBV activity (reactivation) whereas EBV-directed antibodies reflect the extent of previous infection/reactivations. Conclusion SLE patients have elevated concentrations of serum FLCs that correlate with global disease activity scores and especially serologic markers for active disease. These findings are suggestive of circulating FLCs having potential as a new supplementary serologic biomarker in SLE.	[Draborg, Anette H.; Lydolph, Magnus C.; Westergaard, Marie; Larsen, Severin Olesen; Nielsen, Christoffer T.; Duus, Karen; Houen, Gunnar] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen, Denmark; [Nielsen, Christoffer T.; Jacobsen, Soren] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis & Rheumatol, Copenhagen, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen	Houen, G (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen, Denmark.	gh@ssi.dk	Jacobsen, Søren/T-2491-2019; Westergaard, Marie Christine Wulff/AGZ-9828-2022	Jacobsen, Søren/0000-0002-5654-4993; Westergaard, Marie/0000-0003-3446-4287				Aggarwal R, 2011, ARTHRIT CARE RES, V63, P891, DOI 10.1002/acr.20446; Auwaerter PG, 1999, JAMA-J AM MED ASSOC, V281, P454, DOI 10.1001/jama.281.5.454; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Berkun Y, 2009, LUPUS, V18, P1129, DOI 10.1177/0961203309345729; Berner BR, 2005, CELL IMMUNOL, V235, P29, DOI 10.1016/j.cellimm.2005.06.010; Chakravarty EF, 2007, ARTHRITIS RHEUM, V56, P2092, DOI 10.1002/art.22641; Chen CJ, 2005, J RHEUMATOL, V32, P44; Chen DY, 2010, J CLIN VIROL, V49, P290, DOI 10.1016/j.jcv.2010.08.015; Chiche L, 2011, CLIN RHEUMATOL, V30, P685, DOI 10.1007/s10067-010-1674-1; Csuka D, 2013, CLIN EXP IMMUNOL, V171, P255, DOI 10.1111/cei.12022; Dall'Era M, 2011, CURR RHEUMATOL REP, V13, P308, DOI 10.1007/s11926-011-0186-6; Draborg AH, 2012, SCAND J RHEUMATOL, V41, P280, DOI 10.3109/03009742.2012.665944; Draborg AH, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000015; Esen BA, 2012, RHEUMATOL INT, V32, P79, DOI 10.1007/s00296-010-1573-4; FAUCI AS, 1981, ARTHRITIS RHEUM, V24, P577, DOI 10.1002/art.1780240402; Gottenberg JE, 2007, ANN RHEUM DIS, V66, P23, DOI 10.1136/ard.2006.052159; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOPPER JE, 1989, J CLIN IMMUNOL, V9, P338, DOI 10.1007/BF00918666; HOPPER JE, 1986, CELL IMMUNOL, V101, P122, DOI 10.1016/0008-8749(86)90191-7; Hopper JE, 2000, J CLIN IMMUNOL, V20, P123, DOI 10.1023/A:1006686514743; Huggins ML, 2005, RHEUMATOL INT, V25, P183, DOI 10.1007/s00296-003-0420-2; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Jolly M, 2014, LUPUS, V23, P881, DOI 10.1177/0961203314530793; Joseph AM, 2000, J VIROL, V74, P9964, DOI 10.1128/JVI.74.21.9964-9971.2000; Kang I, 2004, J IMMUNOL, V172, P1287, DOI 10.4049/jimmunol.172.2.1287; Kaplan B, 2010, J NEUROIMMUNOL, V229, P263, DOI 10.1016/j.jneuroim.2010.09.002; Katzmann JA, 2002, CLIN CHEM, V48, P1437; Lu JJY, 2007, LUPUS, V16, P168, DOI 10.1177/0961203306075800; Mastroianni-Kirsztajn G, 2008, NEPHRON CLIN PRACT, V110, pC258, DOI 10.1159/000167874; McClain MT, 2006, ARTHRITIS RHEUM-US, V54, P360, DOI 10.1002/art.21682; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Nakano T, 2011, CLIN CHIM ACTA, V412, P843, DOI 10.1016/j.cca.2011.03.007; Namjou B, 2007, AUTOIMMUNITY, V40, P602, DOI 10.1080/08916930701510962; Parks CG, 2005, ARTHRITIS RHEUM-US, V52, P1148, DOI 10.1002/art.20997; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Presslauer S, 2008, J NEUROL, V255, P1508, DOI 10.1007/s00415-008-0954-z; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; SAKANE T, 1988, ARTHRITIS RHEUM, V31, P80, DOI 10.1002/art.1780310112; Schepers A, 1996, VIROLOGY, V220, P367, DOI 10.1006/viro.1996.0325; Smith PP, 2010, AUTOIMMUN REV, V10, P43, DOI 10.1016/j.autrev.2010.08.016; Stratta P, 1999, NEPHRON, V82, P145, DOI 10.1159/000045391; Tattevin P, 2006, J CLIN MICROBIOL, V44, P1873, DOI 10.1128/JCM.44.5.1873-1874.2006; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; TSOKOS GC, 1983, J IMMUNOL, V131, P1797; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Yu SF, 2005, MED MICROBIOL IMMUN, V194, P115, DOI 10.1007/s00430-004-0230-5; Zandman-Goddard G, 2009, ANN NY ACAD SCI, V1173, P658, DOI 10.1111/j.1749-6632.2009.04754.x	51	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138753	10.1371/journal.pone.0138753	http://dx.doi.org/10.1371/journal.pone.0138753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402865	Green Submitted, gold, Green Published			2022-12-27	WOS:000361798100035
J	Fleury, M; Le Vaillant, M; Pelletier-Fleury, N				Fleury, Marion; Le Vaillant, Marc; Pelletier-Fleury, Nathalie		IRSR Sleep Cohort Grp	Socio-Economic Status: A Barrier to Access to Mandibular Advancement Device Therapy for Patients with Obstructive Sleep Apnea Syndrome in France	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; ORAL APPLIANCE THERAPY; OBJECTIVE MEASUREMENT; DENTAL-CARE; INEQUALITIES; PREVALENCE; HEALTH	Background Obstructive sleep apnea syndrome (OSAS) is a major public health problem which affects between 5 to 10% of the general population. OSAS is known to be associated with high rates of morbidity and mortality mainly due to cardiovascular diseases and traffic accidents. The burden of illness is high for the individual and society. There are 2 treatment options for OSAS, Continuous Positive Airway Pressure (CPAP) and Mandibular Advancement Device therapy (MAD). CPAP is known to be an effective but very constraining treatment. Patients are usually poorly adherent. MAD is a more recent treatment easier to use and consequently better tolerated, but MAD can only be prescribed to patients with satisfactory oral hygiene. Oral health constitutes a real issue particularly among underprivileged groups in France. Through this link, the question of whether low socio-economic status constitutes a barrier to access to care for patients with OSAS is raised. Methods and Principal Findings In a multicenter prospective cohort of 2822 consecutive OSAS patients in whom MAD has been proposed as an alternative to CPAP between May 15, 2007 and December 1st, 2014, we identified the factors that lead to a patient diagnosed with OSAS to be treated by MAD instead of CPAP. A logistic regression was performed using a stepwise forward procedure. The main outcome of the study was that treatment by MAD was significantly associated with both educational attainment, as determined by the age at which the patient left full-time education, >= 18 years compared with <18 (adjusted odds ratio (aOR): 1.64, 95% CI 1.23 to 2.20), and the patient's occupational category. Executives and higher intellectual professions, intermediate professions, technicians, foremen and employees were significantly more likely to be treated by MAD than workers (aOR: 2.21, 95% CI 1.88 to 2.58; aOR: 1.74, 95% CI 1.15 to 2.63; aOR: 1.96, 95% CI 1.11 to 3.47, respectively). Conclusions Overall, these results suggest that low socio-economic status constitutes a barrier to access to MAD for patients with OSAS in France. MAD use in patients with OSAS highlights inequalities in health care access.	[Fleury, Marion; Le Vaillant, Marc] Univ Paris 05, CNRS INSERM EHESS, UMR 8211, Ctr Rech Med Sci,Sante,Sante Mentale,Soc, Paris, France; [Pelletier-Fleury, Nathalie] Univ Paris Saclay, INSERM, UMR 1018, Ctr Rech Epidemiol & Sante Populat,Equipe Econ Sa, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Pelletier-Fleury, N (corresponding author), Univ Paris Saclay, INSERM, UMR 1018, Ctr Rech Epidemiol & Sante Populat,Equipe Econ Sa, Paris, France.	nathalie.pelletier-fleury@inserm.fr	Pelletier-Fleury, Nathalie/R-4220-2018	Pelletier-Fleury, Nathalie/0000-0002-4821-4863				Azogui-Levy S, 2005, WUESTIONS EC SNATE; Beynet A, 2002, QUESTIONS EC SANTE; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; DEBONIS M, 1991, J AFFECT DISORDERS, V22, P55, DOI 10.1016/0165-0327(91)90084-6; Despres C, 2011, QUESTIONS EC SANTE; Dieltjens M, 2013, CHEST, V144, P1495, DOI 10.1378/chest.13-0613; Fleury B, 2014, J DENT SLEEP MED, V1, P123; Fuhrman C, 2012, SLEEP MED, V13, P852, DOI 10.1016/j.sleep.2012.04.005; Gagnadoux F, 2013, EUR RESPIR J, V42, P863, DOI 10.1183/09031936.00035713; Gagnadoux F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022503; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; Guessous I, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-121; INSEE, 2003, NOM PROF CAT SOC; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jusot F, 2013, REV EPIDEMIOL SANTE, V61, pS163, DOI 10.1016/j.respe.2013.05.011; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Kushida CA, 2006, SLEEP, V29, P240, DOI 10.1093/sleep/29.2.240; Lim J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004435.pub3; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Palencia L, 2014, COMMUNITY DENT ORAL, V42, P97, DOI 10.1111/cdoe.12056; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Petersen PE, 2008, INT DENT J, V58, P115, DOI 10.1922/IDJ_1930Petersen07; Petit FX, 2002, AM J RESP CRIT CARE, V166, P274, DOI 10.1164/rccm.2008167; Ramar K, 2015, J CLIN SLEEP MED, V11, P773, DOI 10.5664/jcsm.4858; SULLIVAN CE, 1981, LANCET, V1, P862; Tregear S, 2010, SLEEP, V33, P1373, DOI 10.1093/sleep/33.10.1373; Vanderveken OM, 2013, THORAX, V68, P91, DOI 10.1136/thoraxjnl-2012-201900; Weaver TE, 2012, AM J RESP CRIT CARE, V186, P677, DOI 10.1164/rccm.201202-0200OC; Wozniak DR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007736.pub2	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138689	10.1371/journal.pone.0138689	http://dx.doi.org/10.1371/journal.pone.0138689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402443	Green Submitted, Green Published, gold			2022-12-27	WOS:000361798100032
J	Katoh, H; Inoue, H; Iwanami, T				Katoh, Hiroshi; Inoue, Hiromitsu; Iwanami, Toru			Changes in Variable Number of Tandem Repeats in 'Candidatus Liberibacter asiaticus' through Insect Transmission	PLOS ONE			English	Article							GREENING DISEASE; DIAPHORINA-CITRI; 1ST REPORT; BACTERIUM	Citrus greening (huanglongbing) is the most destructive citrus disease worldwide. The disease is associated with three species of 'Candidatus Liberibacter' among which 'Ca. Liberibacter asiaticus' has the widest distribution. 'Ca. L. asiaticus' is commonly transmitted by a phloem-feeding insect vector, the Asian citrus psyllid Diaphorina citri. A previous study showed that isolates of 'Ca. L. asiaticus' were clearly differentiated by variable number of tandem repeat (VNTR) profiles at four loci in the genome. In this study, the VNTR analysis was further validated by assessing the stability of these repeats after multiplication of the pathogen upon host-to-host transmission using a 'Ca. L. asiaticus' strain from Japan. The results showed that some tandem repeats showed detectable changes after insect transmission. To our knowledge, this is the first report to demonstrate that the repeat numbers VNTR 002 and 077 of 'Ca. L. asiaticus' change through psyllid transmission. VNTRs in the recipient plant were apparently unrelated to the growing phase of the vector. In contrast, changes in the number of tandem repeats increased with longer acquisition and inoculation access periods, whereas changes were not observed through psyllid transmission after relatively short acquisition and inoculation access periods, up to 20 and 19 days, respectively.	[Katoh, Hiroshi; Iwanami, Toru] NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan; [Inoue, Hiromitsu] NARO Inst Fruit Tree Sci, Kuchinotsu Citrus Res Stn, Nagasaki 8592501, Japan		Katoh, H (corresponding author), Utsunomiya Univ, Ctr Biosci Res & Educ, Mine Machi 350, Utsunomiya, Tochigi 3218505, Japan.	katohh@cc.utsunomiya-u.ac.jp			National Agriculture and Food Research Organization; Center for Bioscience Research and Education, Utsunomiya University	National Agriculture and Food Research Organization; Center for Bioscience Research and Education, Utsunomiya University	Funding was provided by National Agriculture and Food Research Organization (http://www.naro.affrc.go.jp/fruit/) and Center for Bioscience Research and Education, Utsunomiya University, http://c-bio.mine.utsunomiya-u.ac.jp/.	AUBERT B, 1987, FRUITS, V42, P149; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brown SE, 2011, NEW DIS REP, V24, P25, DOI DOI 10.5197/J.2044-0588.2011.024.025; Chen J, 2010, PHYTOPATHOLOGY, V100, P567, DOI 10.1094/PHYTO-100-6-0567; Coletta HD, 2004, PLANT DIS, V88, P1382, DOI 10.1094/PDIS.2004.88.12.1382C; De Jensen CE, 2010, PHYTOPATHOLOGY, V100, pS34; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Halbert SE., 2005, PROC 2 INT CITRUS CA, pH3; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Islam MS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-39; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Katoh H, 2012, ANN APPL BIOL, V160, P291, DOI 10.1111/j.1744-7348.2012.00541.x; Katoh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106109; Katoh H, 2011, APPL ENVIRON MICROB, V77, P1910, DOI 10.1128/AEM.01571-10; Manjunath KL, 2010, PLANT DIS, V94, P781, DOI 10.1094/PDIS-94-6-0781A; Martinez Y, 2009, PLANT PATHOL, V58, P389, DOI 10.1111/j.1365-3059.2008.01997.x; Matos L, 2009, PLANT DIS, V93, P668, DOI 10.1094/PDIS-93-6-0668B; Matos LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078994; MIYAKAWA T, 1989, Annals of the Phytopathological Society of Japan, V55, P667, DOI 10.3186/jjphytopath.55.667; Oberholzer P. C. J., 1965, P 3 C IOCV, P213; ORISA (Organismo Internacional Regional de Sanidad Agropecuaria), 2011, TALL SENS CENTR PROD; Otake A., 1990, BIBLIO CITRUS GREENI; S. P. CAPOOR, 1963, Decline of Citrus trees in India., P48; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TIRTAWIDJAJA S, 1965, P AM SOC HORTIC SCI, V86, P235; Trujillo-Arriaga J, 2010, 2 TALL INT HUANGL PS; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Zhao XY, 1981, P INT SOC CITRICULTU, V1, P466	30	8	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138699	10.1371/journal.pone.0138699	http://dx.doi.org/10.1371/journal.pone.0138699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402645	Green Published, Green Submitted, gold			2022-12-27	WOS:000361798100033
J	Labocha, MK; Jung, SK; Aleman-Meza, B; Liu, Z; Zhong, WW				Labocha, Marta K.; Jung, Sang-Kyu; Aleman-Meza, Boanerges; Liu, Zheng; Zhong, Weiwei			WormGender - Open-Source Software for Automatic Caenorhabditis elegans Sex Ratio Measurement	PLOS ONE			English	Article							BEHAVIORAL-ANALYSIS; SYSTEM; INTERFERENCE; WORM; RNA	Fast and quantitative analysis of animal phenotypes is one of the major challenges of current biology. Here we report the WormGender open-source software, which is designed for accurate quantification of sex ratio in Caenorhabditis elegans. The software functions include, i) automatic recognition and counting of adult hermaphrodites and males, ii) a manual inspection feature that enables manual correction of errors, and iii) flexibility to use new training images to optimize the software for different imaging conditions. We evaluated the performance of our software by comparing manual and automated assessment of sex ratio. Our data showed that the WormGender software provided overall accurate sex ratio measurements. We further demonstrated the usage of WormGender by quantifying the high incidence of male (him) phenotype in 27 mutant strains. Mutants of nine genes (brc-1, C30G12.6, cep-1, coh-3, him-3, him-5, him-8, skr-1, unc-86) showed significant him phenotype. The WormGender is written in Java and can be installed and run on both Windows and Mac platforms. The source code is freely available together with a user manual and sample data at http://www.QuantWorm.org/. The source code and sample data are also available at http://dx.doi.org/10.6084/m9.figshare.1541248.	[Labocha, Marta K.; Jung, Sang-Kyu; Aleman-Meza, Boanerges; Liu, Zheng; Zhong, Weiwei] Rice Univ, Dept BioSci, Houston, TX 77005 USA	Rice University	Zhong, WW (corresponding author), Rice Univ, Dept BioSci, Houston, TX 77005 USA.	weiwei.zhong@rice.edu		Labocha-Derkowska, Marta/0000-0002-0101-4821	National Institutes of Health [HG004724, DA018341]; Searle Scholar grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG004724, K99HG004724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Institutes of Health grants (HG004724 and DA018341) and by a Searle Scholar grant to WZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2006, ELEGANS; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Bradley Derek, 2007, Journal of Graphics Tools, V12, P13; Buckingham SD, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-84; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; HODGKIN J, 1979, GENETICS, V91, P67; Jung SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084830; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mathew MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033483; Meyer BJ, 2000, TRENDS GENET, V16, P247, DOI 10.1016/S0168-9525(00)02004-7; Mohamed M, 2008, IEEE INT SYMP CIRC S, P1072, DOI 10.1109/ISCAS.2008.4541607; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Riddle DL, 1997, ELEGANS 2; Stiemagle T, 2006, MAINTENANCE C ELEGAN; Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Teotonio H, 2006, EVOLUTION, V60, P1300, DOI 10.1111/j.0014-3820.2006.tb01207.x; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Yu H, 2013, P NATL ACAD SCI USA, V110, P11940, DOI 10.1073/pnas.1310468110; Zheng MH, 2012, J NEUROSCI METH, V204, P234, DOI 10.1016/j.jneumeth.2011.11.015	27	5	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139724	10.1371/journal.pone.0139724	http://dx.doi.org/10.1371/journal.pone.0139724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421844	gold, Green Published			2022-12-27	WOS:000362175700137
J	Pieters, BJGE; Meulenbroeks, E; Belle, R; Mecinovic, J				Pieters, Bas J. G. E.; Meulenbroeks, Erik; Belle, Roman; Mecinovic, Jasmin			The Role of Electrostatic Interactions in Binding of Histone H3K4me2/3 to the Sgf29 Tandem Tudor Domain	PLOS ONE			English	Article							CHROMATIN-BINDING; PHD FINGER; MOLECULAR-BASIS; RECOGNITION; PROTEINS; MODULES; SAGA	Several reader domain proteins that specifically recognize methyllysine-containing histones contain the negatively-charged aspartate or glutamate residues as part of the aromatic cage. Herein, we report thermodynamic analyses for the recognition of histone H3K4me3 and H3K4me2 by the tandem tudor domain of Sgf29 and its recognition site variants. Small uncharged and large aromatic substitutions on the Asp266 site resulted in a significant decrease in binding affinities for both H3K4me3 and H3K4me2, demonstrating the role of the negative charge of Asp266 in the readout process by Sgf29. This study emphasizes the essential contribution of electrostatic interactions to the overall binding affinity, and reveals that the underlying mechanisms for the recognition of Kme2/3 depend on the composition and arrangement of the aromatic cage.	[Pieters, Bas J. G. E.; Meulenbroeks, Erik; Belle, Roman; Mecinovic, Jasmin] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Mecinovic, J (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands.	j.mecinovic@science.ru.nl	Mecinovic, Jasmin/F-9694-2015; Jeltsch, Albert/O-7404-2014	Mecinovic, Jasmin/0000-0002-5559-3822; Jeltsch, Albert/0000-0001-6113-9290	Netherlands Research School of Chemical Biology	Netherlands Research School of Chemical Biology	Funding was provided by Netherlands Research School of Chemical Biology.	Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; David Allis C., 2007, EPIGENETICS-US; Eisert RJ, 2011, CHEMBIOCHEM, V12, P2786, DOI 10.1002/cbic.201100555; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pieters B, 2013, CHEMBIOCHEM, V14, P2408, DOI 10.1002/cbic.201300525; Reinhard L, 2013, ACTA CRYSTALLOGR F, V69, P209, DOI 10.1107/S1744309112051858; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Samara NL, 2011, CURR OPIN STRUC BIOL, V21, P767, DOI 10.1016/j.sbi.2011.09.004; Schram AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070035; Sippl W., 2009, EPIGENETIC TARGETS D; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036	20	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139205	10.1371/journal.pone.0139205	http://dx.doi.org/10.1371/journal.pone.0139205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421618	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700079
J	Aldrich-Wolfe, L; Travers, S; Nelson, BD				Aldrich-Wolfe, Laura; Travers, Steven; Nelson, Berlin D., Jr.			Genetic Variation of Sclerotinia sclerotiorum from Multiple Crops in the North Central United States	PLOS ONE			English	Article							FUNGAL PLANT PATHOGEN; MICROSATELLITE MARKERS; COMPATIBILITY GROUPS; POPULATION-STRUCTURE; CLONAL LINEAGES; DIVERSITY; CANOLA; DIFFERENTIATION; AGGRESSIVENESS; PROGRAMS	Sclerotinia sclerotiorum is an important pathogen of numerous crops in the North Central region of the United States. The objective of this study was to examine the genetic diversity of 145 isolates of the pathogen from multiple hosts in the region. Mycelial compatibility groups (MCG) and microsatellite haplotypes were determined and analyzed for standard estimates of population genetic diversity and the importance of host and distance for genetic variation was examined. MCG tests indicated there were 49 different MCGs in the population and 52 unique microsatellite haplotypes were identified. There was an association between MCG and haplotype such that isolates belonging to the same MCG either shared identical haplotypes or differed at no more than 2 of the 12 polymorphic loci. For the majority of isolates, there was a one-to-one correspondence between MCG and haplotype. Eleven MCGs shared haplotypes. A single haplotype was found to be prevalent throughout the region. The majority of genetic variation in the isolate collection was found within rather than among host crops, suggesting little genetic divergence of S. sclerotiorum among hosts. There was only weak evidence of isolation by distance. Pairwise population comparisons among isolates from canola, dry bean, soybean and sunflower suggested that gene flow between host-populations is more common for some crops than others. Analysis of linkage disequilibrium in the isolates from the four major crops indicated primarily clonal reproduction, but also evidence of genetic recombination for isolates from canola and sunflower. Accordingly, genetic diversity was highest for populations from canola and sunflower. Distribution of microsatellite haplotypes across the study region strongly suggest that specific haplotypes of S. sclerotiorum are often found on multiple crops, movement of individual haplotypes among crops is common and host identity is not a barrier to gene flow for S. sclerotiorum in the north central United States.	[Aldrich-Wolfe, Laura] Concordia Coll, Dept Biol, Moorhead, MN USA; [Travers, Steven] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Nelson, Berlin D., Jr.] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA	North Dakota State University Fargo; North Dakota State University Fargo	Nelson, BD (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	berlin.nelson@ndsu.edu			USDA National Sclerotinia Initiative; Dept. Plant Pathology, North Dakota State University, Fargo, ND; USDA-ARS award [58-5442-8-233]	USDA National Sclerotinia Initiative; Dept. Plant Pathology, North Dakota State University, Fargo, ND; USDA-ARS award	The funding for this research was from the USDA National Sclerotinia Initiative. The grant was awarded to Berlin D. Nelson Jr., Professor, Dept. Plant Pathology, North Dakota State University, Fargo, ND. The title of the grant was Genetic diversity and virulence of S. sclerotiorum on six crops in the north central Region. USDA-ARS award 58-5442-8-233. The website of the Sclerotinia Initiative is: http://www.ars.usda.gov/Research/docs.htm?docid=20317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Ameen G, 2012, PHYTOPATHOLOGY, V102, P4; Atallah ZK, 2004, PHYTOPATHOLOGY, V94, P737, DOI 10.1094/PHYTO.2004.94.7.737; Attanayake RN, 2014, HEREDITY, V113, P353, DOI 10.1038/hdy.2014.37; Attanayake RN, 2012, SOIL BIOL BIOCHEM, V55, P28, DOI 10.1016/j.soilbio.2012.06.002; Attanayake RN, 2013, PHYTOPATHOLOGY, V103, P750, DOI 10.1094/PHYTO-07-12-0159-R; Barari H, 2012, ROM AGRIC RES, V29, P323; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; BROWN AHD, 1980, GENETICS, V96, P523; Brueggeman RS, 2013, PHYTOPATHOLOGY, V103, P21; Carbone I, 1999, EVOLUTION, V53, P11, DOI [10.1111/j.1558-5646.1999.tb05329.x, 10.2307/2640916]; Carbone I, 2001, MOL ECOL, V10, P947, DOI 10.1046/j.1365-294X.2001.01244.x; Carpenter MA, 1999, NEW ZEAL J CROP HORT, V27, P13, DOI 10.1080/01140671.1999.9514075; Clarkson JP, 2013, PLANT PATHOL, V62, P309, DOI 10.1111/j.1365-3059.2012.02635.x; Cubeta MA, 1997, PHYTOPATHOLOGY, V87, P1000, DOI 10.1094/PHYTO.1997.87.10.1000; Ekins MG, 2011, AUSTRALAS PLANT PATH, V40, P99, DOI 10.1007/s13313-010-0018-6; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gomes EV, 2011, J PHYTOPATHOL, V159, P94, DOI 10.1111/j.1439-0434.2010.01724.x; Hambleton S, 2002, CAN J PLANT PATHOL, V24, P309; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; Hemmati R, 2009, EUR J PLANT PATHOL, V125, P617, DOI 10.1007/s10658-009-9510-7; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; KOHLI Y, 1992, PHYTOPATHOLOGY, V82, P875, DOI 10.1094/Phyto-82-875; Kohli Y, 1996, MOL ECOL, V5, P773, DOI 10.1111/j.1365-294X.1996.tb00373.x; Kull LS, 2004, PLANT DIS, V88, P325, DOI 10.1094/PDIS.2004.88.4.325; Li ZQ, 2009, PHYTOPARASITICA, V37, P77, DOI 10.1007/s12600-008-0003-6; Litholdo CG, 2011, GENET MOL RES, V10, P868, DOI 10.4238/vol10-2gmr937; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Mandal AK, 2012, WORLD J MICROB BIOT, V28, P1849, DOI 10.1007/s11274-011-0981-2; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mert-Turk F, 2007, J PHYTOPATHOL, V155, P182, DOI 10.1111/j.1439-0434.2007.01223.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Otto-Hanson L, 2011, PLANT DIS, V95, P1370, DOI 10.1094/PDIS-11-10-0865; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Schafer MR, 2006, MYCOLOGIA, V98, P593, DOI 10.3852/mycologia.98.4.593; Sexton AC, 2004, CURR GENET, V46, P357, DOI 10.1007/s00294-004-0543-3; Sexton AC, 2006, GENOME, V49, P1408, DOI 10.1139/G06-101; Sirjusingh C, 2001, MOL ECOL NOTES, V1, P267, DOI 10.1046/j.1471-8278.2001.00102.x; Winton LM, 2006, CAN J PLANT PATHOL, V28, P426, DOI 10.1080/07060660609507316; Wu BM, 2006, PHYTOPATHOLOGY, V96, P1322, DOI 10.1094/PHYTO-96-1322	42	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139188	10.1371/journal.pone.0139188	http://dx.doi.org/10.1371/journal.pone.0139188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417989	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400059
J	Le Sant, G; Ates, F; Brasseur, JL; Nordez, A				Le Sant, Guillaume; Ates, Filiz; Brasseur, Jean-Louis; Nordez, Antoine			Elastography Study of Hamstring Behaviors during Passive Stretching	PLOS ONE			English	Article							SHEAR ELASTIC-MODULUS; MUSCLE-TENDON UNITS; SKELETAL-MUSCLE; GASTROCNEMIUS-MUSCLE; CLINICAL-SIGNIFICANCE; WAVE ELASTOGRAPHY; PELVIC POSITION; STRAIN INJURIES; RISK-FACTORS; LENGTH	Introduction The mechanical properties of hamstring muscles are usually inferred from global passive torque/angle relationships, in combination with adjoining tissues crossing the joint investigated. Shear modulus measurement provides an estimate of changes in muscle-tendon stiffness and passive tension. This study aimed to assess the passive individual behavior of each hamstring muscle in different stretching positions using shear wave elastography. Methods/Results The muscle shear modulus of each hamstring muscle was measured during a standardized slow passive knee extension (PKE, 80% of maximal range of motion) on eighteen healthy male volunteers. Firstly, we assessed the reliability of the measurements. Results were good for semitendinosus (ST, CV: 8.9%-13.4%), semimembranosus (SM, CV: 10.3%-11.2%) and biceps femoris long-head (BF-lh, CV: 8.6%-13.3%), but not for biceps femoris short-head (BF-sh, CV: 20.3%-44.9%). Secondly, we investigated each reliable muscle in three stretch positions: 70 degrees, 90 degrees and 110 degrees of hip flexion. The results showed different values of shear modulus for the same amount of perceived stretch, with the highest measurements in the high-flexed hip situation. Moreover, individual muscles displayed different values, with values increasing or BF-lh, SM and ST, respectively. The inter-subject variability was 35.3% for ST, 27.4% for SM and 30.2% for BF-lh. Conclusion This study showed that the hip needs to be high-flexed to efficiently tension the hamstrings, and reports a higher muscle-tendon stress tolerance at 110 degrees of hip angle. In addition muscles have different passive behaviors, and future works will clarify if it can be linked with rate of injury.	[Le Sant, Guillaume; Ates, Filiz; Nordez, Antoine] Univ Nantes, Fac Sports Sci, Lab Movement Interact Performance EA 4334, Nantes, France; [Le Sant, Guillaume] Sch Physiotherapy IFM3R, Nantes, France; [Brasseur, Jean-Louis] Hop La Pitie Salpetriere, AP HP, Serv Radiol, Paris, France	Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Nordez, A (corresponding author), Univ Nantes, Fac Sports Sci, Lab Movement Interact Performance EA 4334, Nantes, France.	antoine.nordez@univ-nantes.fr	ates, filiz/AAB-2652-2022	Le Sant, Guillaume/0000-0001-7614-6389; Ates, Filiz/0000-0002-5634-3913	European Regional Development Fund [37400]; University of Nantes	European Regional Development Fund(European Commission); University of Nantes	The study was sponsored by grants from the European Regional Development Fund (no. 37400) and the University of Nantes (interdisciplinary program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade RJ, 2015, EFFECTS HIP HEAD POS; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Brasseur J-L, 2011, ACTUALITES ECHOGRAPH, V8, P263; Catheline S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.064301; Chaitow L, 2013, MUSCLE ENERGY TECHNI, V4th; Decoster LC, 2005, J ORTHOP SPORT PHYS, V35, P377, DOI 10.2519/jospt.2005.35.6.377; Decoster LC, 2004, J ATHL TRAINING, V39, P330; Diong J, 2012, CLIN BIOMECH, V27, P893, DOI 10.1016/j.clinbiomech.2012.07.003; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Freckleton G, 2013, BRIT J SPORT MED, V47, P351, DOI 10.1136/bjsports-2011-090664; Freitas SR, 2015, EUR J APPL PHYSIOL, V115, P1263, DOI 10.1007/s00421-015-3104-1; Gajdosik RL, 2005, EUR J APPL PHYSIOL, V95, P131, DOI 10.1007/s00421-005-1394-4; Gajdosik RL, 2001, CLIN BIOMECH, V16, P87, DOI 10.1016/S0268-0033(00)00061-9; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Goldman EF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006782.pub2; Hallen A, 2014, J SPORT SCI, V32, P1229, DOI 10.1080/02640414.2014.905695; Herbert RD, 2015, J PHYSIOL-LONDON, V593, P441, DOI 10.1113/jphysiol.2014.279166; Herbert RD, 2002, J PHYSIOL-LONDON, V539, P637, DOI 10.1113/jphysiol.2001.012756; Herbert RD, 2011, J PHYSIOL-LONDON, V589, P5257, DOI 10.1113/jphysiol.2011.212175; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Herrington L, 2013, J SPORT REHABIL, V22, P254, DOI 10.1123/jsr.22.4.254; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hug F, 2013, J BIOMECH, V46, P2534, DOI 10.1016/j.jbiomech.2013.07.015; Kallerud H, 2013, SPORTS MED, V43, P733, DOI 10.1007/s40279-013-0053-x; Kellis E, 2012, J ELECTROMYOGR KINES, V22, P520, DOI 10.1016/j.jelekin.2012.03.012; Kellis E, 2010, J ELECTROMYOGR KINES, V20, P1237, DOI 10.1016/j.jelekin.2010.07.012; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Koo TK, 2013, J BIOMECH, V46, P2053, DOI 10.1016/j.jbiomech.2013.05.016; Koo TK, 2015, J BIOMECH IN PRESS; Kwah LK, 2013, J APPL PHYSIOL, V114, P761, DOI 10.1152/japplphysiol.01430.2011; Lacourpaille L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053159; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; Lieber RL, 2001, CLIN ORTHOP RELAT R, P140; Magnusson SP, 1998, SCAND J MED SCI SPOR, V8, P65; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; McHugh MP, 1999, AM J SPORT MED, V27, P594, DOI 10.1177/03635465990270050801; Mendiguchia J, 2012, BRIT J SPORT MED, V46, P81, DOI 10.1136/bjsm.2010.081695; Mitchell B, 2008, PHYS THER SPORT, V9, P202, DOI 10.1016/j.ptsp.2008.08.002; Morris CE, 2006, SPINE, V31, P1060, DOI 10.1097/01.brs.0000214879.93102.4e; Nordez A, 2006, CLIN BIOMECH, V21, P755, DOI 10.1016/j.clinbiomech.2006.03.005; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Opar DA, 2012, SPORTS MED, V42, P209, DOI 10.2165/11594800-000000000-00000; Riemann BL, 2001, J ATHL TRAINING, V36, P369; Schuermans J, 2014, BRIT J SPORT MED, V48, P1599, DOI 10.1136/bjsports-2014-094017; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SULLIVAN MK, 1992, MED SCI SPORT EXER, V24, P1383; Umegaki H, 2015, MANUAL THER, V20, P610, DOI 10.1016/j.math.2015.02.006; Umegaki H, 2015, MANUAL THER, V20, P134, DOI 10.1016/j.math.2014.07.016; Wang M, 2013, IEEE T MED IMAGING, V32, P1671, DOI 10.1109/TMI.2013.2262948; Webright WG, 1997, J ORTHOP SPORT PHYS, V26, P7, DOI 10.2519/jospt.1997.26.1.7; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Weppler CH, 2010, PHYS THER, V90, P438, DOI 10.2522/ptj.20090012; Witvrouw E, 2003, AM J SPORT MED, V31, P41, DOI 10.1177/03635465030310011801; Witvrouw E, 2000, AM J SPORT MED, V28, P480, DOI 10.1177/03635465000280040701; Woodley SJ, 2005, CELLS TISSUES ORGANS, V179, P125, DOI 10.1159/000085004	56	43	44	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139272	10.1371/journal.pone.0139272	http://dx.doi.org/10.1371/journal.pone.0139272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418862	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400068
J	Sirimahachaiyakul, P; Sood, RF; Muffley, LA; Seaton, M; Lin, CT; Qiao, L; Armaly, JS; Hocking, AM; Gibran, NS				Sirimahachaiyakul, Pornthep; Sood, Ravi F.; Muffley, Lara A.; Seaton, Max; Lin, Cheng-Ta; Qiao, Liang; Armaly, Jeffrey S.; Hocking, Anne M.; Gibran, Nicole S.			Race Does Not Predict Melanocyte Heterogeneous Responses to Dermal Fibroblast-Derived Mediators	PLOS ONE			English	Article							CULTURED HUMAN MELANOCYTES; HYPERTROPHIC SCAR; GENE-EXPRESSION; CUTANEOUS SCARS; PIGMENTATION; GROWTH; SKIN; ASSOCIATION; DIFFERENTIATION; PROLIFERATION	Introduction Abnormal pigmentation following cutaneous injury causes significant patient distress and represents a barrier to recovery. Wound depth and patient characteristics influence scar pigmentation. However, we know little about the pathophysiology leading to hyperpigmentation in healed shallow wounds and hypopigmentation in deep dermal wound scars. We sought to determine whether dermal fibroblast signaling influences melanocyte responses. Methods and Materials Epidermal melanocytes from three Caucasians and three African-Americans were genotyped for single nucleotide polymorphisms (SNPs) across the entire genome. Melanocyte genetic profiles were determined using principal component analysis. We assessed melanocyte phenotype and gene expression in response to dermal fibroblast-conditioned medium and determined potential mesenchymal mediators by proteome profiling the fibroblast-conditioned medium. Results Six melanocyte samples demonstrated significant variability in phenotype and gene expression at baseline and in response to fibroblast-conditioned medium. Genetic profiling for SNPs in receptors for 13 identified soluble fibroblast-secreted mediators demonstrated considerable heterogeneity, potentially explaining the variable melanocyte responses to fibroblast-conditioned medium. Discussion Our data suggest that melanocytes respond to dermal fibroblast-derived mediators independent of keratinocytes and raise the possibility that mesenchymal-epidermal interactions influence skin pigmentation during cutaneous scarring.	[Sirimahachaiyakul, Pornthep; Sood, Ravi F.; Muffley, Lara A.; Seaton, Max; Lin, Cheng-Ta; Qiao, Liang; Armaly, Jeffrey S.; Hocking, Anne M.; Gibran, Nicole S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gibran, NS (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	nicoleg@uw.edu		Qiao, Liang/0000-0002-9731-4166; Sirimahachaiyakul, Pornthep/0000-0002-8313-9168	National Institutes of Health [R01GM089704, T32 GM007037]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089704, T32GM007037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by National Institutes of Health grants (R01GM089704; T32 GM007037).	ABDELMALEK Z, 1992, J CELL PHYSIOL, V150, P416, DOI 10.1002/jcp.1041500226; Adini I, 2014, FASEB J OFFICIAL PUB; Adini I, 2014, J CLIN INVEST, V124, P425, DOI 10.1172/JCI69404; Andersen GN, 2005, SCAND J IMMUNOL, V61, P279, DOI 10.1111/j.1365-3083.2005.01565.x; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Cario-Andre M, 2006, PIGM CELL RES, V19, P434, DOI 10.1111/j.1600-0749.2006.00326.x; Catania A, 2007, J LEUKOCYTE BIOL, V81, P383, DOI 10.1189/jlb.0706426; Chadwick S, 2012, INDIAN J PLAST SURG, V45, P403, DOI 10.4103/0970-0358.101328; Chadwick SL, 2013, J ANAT, V223, P74, DOI 10.1111/joa.12052; Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774; Chou WC, 2013, NAT MED, V19, P924, DOI 10.1038/nm.3194; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; EHRLICH HP, 1992, PLAST RECONSTR SURG, V90, P993, DOI 10.1097/00006534-199212000-00009; Engrav LH, 2007, J BURN CARE RES, V28, P593, DOI 10.1097/BCR.0B013E318093E482; GORDON PR, 1989, J INVEST DERMATOL, V92, P565, DOI 10.1111/1523-1747.ep12709595; Hedley S, 1996, BRIT J DERMATOL, V135, P888, DOI 10.1046/j.1365-2133.1996.d01-1091.x; Hedley SJ, 2002, PIGM CELL RES, V15, P49, DOI 10.1034/j.1600-0749.2002.00067.x; HIROBE T, 1988, J CELL PHYSIOL, V135, P262, DOI 10.1002/jcp.1041350213; Hirobe T, 2013, J DERMATOL SCI, V71, P45, DOI 10.1016/j.jdermsci.2013.03.012; Holavanahalli RK, 2010, J BURN CARE RES, V31, P631, DOI 10.1097/BCR.0b013e3181e4ca62; Imokawa G, 1998, BIOCHEM J, V330, P1235, DOI 10.1042/bj3301235; Jagirdar K, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12253; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee DY, 2003, ARCH DERMATOL RES, V294, P444, DOI 10.1007/s00403-002-0359-2; Levesque M, 2013, DIS MODEL MECH, V6, P508, DOI 10.1242/dmm.010371; Matsumura H, 2001, WOUND REPAIR REGEN, V9, P269, DOI 10.1046/j.1524-475X.2001.00269.x; Muffley LA, 2012, EXP CELL RES, V318, P2085, DOI 10.1016/j.yexcr.2012.06.002; Muffley LA, 2011, J HISTOCHEM CYTOCHEM, V59, P278, DOI 10.1369/0022155410397999; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Peng HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095186; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Travis TE, 2014, J BURN CARE RES 0826; Tyack Z. F., 1997, Journal of Burn Care and Rehabilitation, V18, P435, DOI 10.1097/00004630-199709000-00012; van der Wal MBA, 2012, WOUND REPAIR REGEN, V20, P676, DOI 10.1111/j.1524-475X.2012.00820.x; Wakamatsu K, 2006, PIGM CELL RES, V19, P154, DOI 10.1111/j.1600-0749.2006.00293.x; Yaar M, 2001, CLIN EXP DERMATOL, V26, P583, DOI 10.1046/j.1365-2230.2001.00895.x; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Yamaguchi Y, 2007, J INVEST DERMATOL, V127, P1217, DOI 10.1038/sj.jid.5700629; Zhang F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003392; Zhang Zheng, 2012, Mol Biol (Mosk), V46, P628	44	3	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139135	10.1371/journal.pone.0139135	http://dx.doi.org/10.1371/journal.pone.0139135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418010	Green Submitted, Green Published, gold			2022-12-27	WOS:000362171400051
J	Zhou, S; Jin, X; Chen, XJ; Zhu, JF; Xu, ZP; Wang, XF; Liu, F; Hu, W; Zhou, L; Su, CA				Zhou, Sha; Jin, Xin; Chen, Xiaojun; Zhu, Jifeng; Xu, Zhipeng; Wang, Xuefeng; Liu, Feng; Hu, Wei; Zhou, Liang; Su, Chuan			Heat Shock Protein 60 in Eggs Specifically Induces Tregs and Reduces Liver Immunopathology in Mice with Schistosomiasis Japonica	PLOS ONE			English	Article							REGULATORY T-CELLS; MURINE MODEL; MANSONI; MODULATE; INFLAMMATION; INFECTIONS; INDUCTION; HEPATITIS; PROTEINS; PATHOGEN	Background Parasitic helminths need to suppress the host immune system to establish chronic infections. Paradoxically, immunosuppression induced by the worm also benefits the host by limiting excessive inflammation and tissue damage, which remains the major cause leading to serious morbidity and mortality. Regulatory T cells (Tregs) are key immune regulators of this mutualism. The successive rise in Tregs during schistosome infection plays a critical role in immunoregulation. We and others previously showed that Schistosoma japonicum (S. japonicum) egg antigens (SEA) induce Tregs both in vitro and in vivo. In addition, we identified that SjHSP60 derived from SEA significantly induces Tregs in vivo and in vitro. However, the contribution of SjHSP60 in SEA to Treg induction and the related mechanisms of the Treg induction have not yet been identified. Methodology/Principal Findings In this study, we showed that S. japonicum stress protein HSP60 (SjHSP60) was constitutively and extensively expressed in eggs of S. japonicum. SjHSP60 specially induced Tregs in vivo and in vitro without inducing other CD4(+) T sub-populations including Th1, Th2 and Th17 cells. Furthermore, we showed that the SjHSP60-depleted SEA almost lost the ability in vitro and displayed a significant impaired ability to induce Tregs in vivo. Finally, our study illustrated that the mechanisms of SjHSP60-mediated induction of Tregs are through both conversion of CD4(+) CD25(-) T cells into CD4(+) CD25(+) Foxp3(+) Tregs and expansion of preexisting CD4(+) CD25(+) Foxp3(+) Tregs in a TLR4-dependent manner. Conclusions/Significance Collectively, our findings identify SjHSP60 as a major parasitic contributor of Treg induction in S. japonicum egg antigens, which not only contributes to the better understanding of the mechanism of immunoregulation during helminth infection, but also suggests its potential as a therapeutic target for control of immunopathology, allergic and autoimmune diseases.	[Zhou, Sha; Jin, Xin; Chen, Xiaojun; Zhu, Jifeng; Xu, Zhipeng; Wang, Xuefeng; Liu, Feng; Su, Chuan] Nanjing Med Univ, Jiangsu Key Lab Pathogen Biol, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China; [Hu, Wei] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China; [Zhou, Liang] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	Nanjing Medical University; Fudan University; Northwestern University; Feinberg School of Medicine	Su, CA (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Pathogen Biol, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China.	chuansu@njmu.edu.cn	Chen, Xiaojun/P-8288-2017; xu, zhipeng/M-7708-2019; Chen, Xiaojun/AAD-9401-2022	Chen, Xiaojun/0000-0002-3698-2814; xu, zhipeng/0000-0002-8853-5303; Chen, Xiaojun/0000-0002-3698-2814	National Natural Science Foundation of China [81271861]; Research Foundation of Jiangsu Province, China [12KJA310001]; National Institutes of Health, US [AI089954, AI091962]; Jiangsu Provincial Natural Science Foundation of China [BK20130896]; Priority Academic Program for Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105562] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Jiangsu Province, China; National Institutes of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Priority Academic Program for Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Natural Science Foundation of China (No. 81271861) and the Research Foundation of Jiangsu Province, China (12KJA310001) to Chuan Su, the National Institutes of Health, US (AI089954 and AI091962) to Liang Zhou, the Jiangsu Provincial Natural Science Foundation of China (BK20130896) to Sha Zhou, and the Priority Academic Program for Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Ausiello CM, 2006, MICROBES INFECT, V8, P714, DOI 10.1016/j.micinf.2005.09.007; Boamah Daniel, 2012, Tropical Medicine and Health, V40, P89, DOI 10.2149/tmh.2012-16; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Compte M, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28810; El-Ahwany E, 2012, KOREAN J PARASITOL, V50, P29, DOI 10.3347/kjp.2012.50.1.29; Finlay CM, 2014, IMMUNOL REV, V259, P206, DOI 10.1111/imr.12164; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Grimes JET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003296; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Korenjak M, 2014, NUCLEIC ACIDS RES, V42, P8939, DOI 10.1093/nar/gku609; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; Lee KA, 2012, EUR J IMMUNOL, V42, P1685, DOI 10.1002/eji.201142322; Lewis CJ, 2011, EUR J IMMUNOL, V41, P2562, DOI 10.1002/eji.201141396; Linsuke S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003387; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Maizels Rick M., 2008, V94, P112, DOI 10.1159/000154944; MALKUSCH W, 1995, EXP LUNG RES, V21, P67, DOI 10.3109/01902149509031745; Marquis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086681; Milanez-Almeida P, 2015, EUR J IMMUNOL, V45, P153, DOI 10.1002/eji.201444480; Mo HM, 2007, EXP PARASITOL, V116, P385, DOI 10.1016/j.exppara.2007.02.009; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Pacifico LGG, 2009, INFECT IMMUN, V77, P98, DOI 10.1128/IAI.00783-07; Raghavan S, 2005, FEMS IMMUNOL MED MIC, V44, P121, DOI 10.1016/j.femsim.2004.10.017; Rodrigues V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002567; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Turner JD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001269; Wang XF, 2009, EUR J IMMUNOL, V39, P3052, DOI 10.1002/eji.200939335; Weissler KA, 2015, J IMMUNOL; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; WYNN TA, 1995, NATURE, V376, P594, DOI 10.1038/376594a0; Yang JH, 2007, IMMUNOLOGY, V120, P8, DOI 10.1111/j.1365-2567.2006.02472.x; Zaccone P, 2009, EUR J IMMUNOL, V39, P1098, DOI 10.1002/eji.200838871	38	22	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139133	10.1371/journal.pone.0139133	http://dx.doi.org/10.1371/journal.pone.0139133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418003	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400050
J	Awan, FM; Naz, A; Obaid, A; Ali, A; Ahmad, J; Anjum, S; Janjua, HA				Awan, Faryal Mehwish; Naz, Anam; Obaid, Ayesha; Ali, Amjad; Ahmad, Jamil; Anjum, Sadia; Janjua, Hussnain Ahmed			Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach	PLOS ONE			English	Article							PLASMA PROTEOME DATABASE; HUMAN HEPATOMA-CELL; ALPHA-FETOPROTEIN; SERUM BIOMARKER; CLINICAL-IMPLICATIONS; CANCER BIOMARKERS; LIVER-CANCER; EXPRESSION; PREDICTION; DIAGNOSIS	Hepatocellular carcinoma (HCC) is the world's third most widespread cancer. Currently available circulating biomarkers for this silently progressing malignancy are not sufficiently specific and sensitive to meet all clinical needs. There is an imminent and pressing need for the identification of novel circulating biomarkers to increase disease-free survival rate. In order to facilitate the selection of the most promising circulating protein biomarkers, we attempted to define an objective method likely to have a significant impact on the analysis of vast data generated from cutting-edge technologies. Current study exploits data available in seven publicly accessible gene and protein databases, unveiling 731 liver-specific proteins through initial enrichment analysis. Verification of expression profiles followed by integration of proteomic datasets, enriched for the cancer secretome, filtered out 20 proteins including 6 previously characterized circulating HCC biomarkers. Finally, interactome analysis of these proteins with midkine (MDK), dickkopf-1 (DKK-1), current standard HCC biomarker alpha-fetoprotein (AFP), its interacting partners in conjunction with HCC-specific circulating and liver deregulated miRNAs target filtration highlighted seven novel statistically significant putative biomarkers including complement component 8, alpha (C8A), mannose binding lectin (MBL2), antithrombin III (SERPINC1), 11 beta-hydroxysteroid dehydrogenase type 1 (HSD11B1), alcohol dehydrogenase 6 (ADH6), beta-ureidopropionase (UPB1) and cytochrome P450, family 2, subfamily A, polypeptide 6 (CYP2A6). Our proposed methodology provides a swift assortment process for biomarker prioritization that eventually reduces the economic burden of experimental evaluation. Further dedicated validation studies of potential putative biomarkers on HCC patient blood samples are warranted. We hope that the use of such integrative secretome, interactome and miRNAs target filtration approach will accelerate the selection of high-priority biomarkers for other diseases as well, that are more amenable to downstream clinical validation experiments.	[Awan, Faryal Mehwish; Naz, Anam; Obaid, Ayesha; Ali, Amjad; Anjum, Sadia; Janjua, Hussnain Ahmed] Natl Univ Sci & Technol, ASAB, Islamabad, Pakistan; [Ahmad, Jamil] Natl Univ Sci & Technol, RCMS, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan	Anjum, S (corresponding author), Univ Hail, Dept Biol, Hayil, Saudi Arabia.	sadiaezza@gmail.com; janjua.hussnain@gmail.com	Anjum, Sadia/AAR-7732-2021; Ali, Amjad/AAG-4441-2021; Naz, Anam/AAU-2282-2020; Ahmad, Jamil/AAF-5499-2021	Anjum, Sadia/0000-0001-9678-7861; Ali, Amjad/0000-0002-0486-4661; Naz, Anam/0000-0002-6514-5417; Ahmad, Jamil/0000-0001-6618-6811; Awan, Faryal Mehwish/0000-0002-8146-8929				Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Ang IL, 2006, J PROTEOME RES, V5, P2691, DOI 10.1021/pr060109r; Behne T, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/859076; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhatt AN, 2010, INDIAN J MED RES, V132, P129; Boutet Emmanuel, 2007, V406, P89; Chai S, 2013, CHIN J CANCER, V32, P419, DOI 10.5732/cjc.013.10038; Chrostek L, 2000, CLIN CHEM LAB MED, V38, P409, DOI 10.1515/CCLM.2000.059; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Elfilali A, 2006, NUCLEIC ACIDS RES, V34, pD613, DOI 10.1093/nar/gkj022; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferrin G, 2014, LIVER INT, V34, P438, DOI 10.1111/liv.12277; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gellert P, 2010, BIOINFORMATICS, V26, P2328, DOI 10.1093/bioinformatics/btq417; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Gyorffy B, 2012, BREAST CANCER RES TR, V132, P1025, DOI 10.1007/s10549-011-1676-y; He X, 2014, NEOPLASMA, V61, P17, DOI 10.4149/neo_2014_001; Hisai H, 2003, CLIN CANCER RES, V9, P4852; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077161; Imperlini E, 2013, J CELL BIOCHEM, V114, P2577, DOI 10.1002/jcb.24600; Jelski W, 2008, J CLIN LAB ANAL, V22, P204, DOI 10.1002/jcla.20241; Jezequel P, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas060; Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063468; Kimhofer T, 2015, BRIT J CANCER, V112, P1141, DOI 10.1038/bjc.2015.38; Kimura Asako, 2012, Int J Proteomics, V2012, P623190, DOI 10.1155/2012/623190; Klee EW, 2006, CLIN CHEM, V52, P2162, DOI 10.1373/clinchem.2006.072868; Klee EW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-256; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Kotlyar M, 2015, NAT METHODS, V12, P79, DOI [10.1038/NMETH.3178, 10.1038/nmeth.3178]; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Kulasingam V, 2008, INT J CANCER, V123, P2007, DOI 10.1002/ijc.23844; Lee HJ, 2014, J PROTEOME RES, V13, P2328, DOI 10.1021/pr4011519; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li MS, 2011, INT J CANCER, V128, P524, DOI 10.1002/ijc.25373; Li MS, 2009, INT J CANCER, V124, P2845, DOI 10.1002/ijc.24272; Li P, 2011, WORLD J GASTROENTERO, V17, P4563, DOI 10.3748/wjg.v17.i41.4563; Lin P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069747; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Noh CK, 2014, CLIN BIOCHEM, V47, P1257, DOI 10.1016/j.clinbiochem.2014.05.002; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Qi J, 2013, NEOPLASMA, V60, P135, DOI 10.4149/neo_2013_018; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Rong YF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-68; Scaggiante B, 2014, WORLD J GASTROENTERO, V20, P1268, DOI 10.3748/wjg.v20.i5.1268; Shan SW, 2013, J CELL SCI, V126, P1517, DOI 10.1242/jcs.122895; Shen J, 2013, CANCER EPIDEM BIOMAR, V22, P2364, DOI 10.1158/1055-9965.EPI-13-0237; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Slany A, 2010, J PROTEOME RES, V9, P6, DOI 10.1021/pr900057t; Song P, 2014, TRANSLATIONAL GASTRO, V3, P103; Srisomsap C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/437143; Stastna M, 2012, PROTEOMICS, V12, P722, DOI 10.1002/pmic.201100346; Thio CL, 2005, J VIROL, V79, P9192, DOI 10.1128/JVI.79.14.9192-9196.2005; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Wang HJ, 2014, CLIN SCI, V126, P857, DOI 10.1042/CS20130301; Wang J, 2009, PROTEOM CLIN APPL, V3, P541, DOI 10.1002/prca.200800145; Wang L, 2014, TUMOR BIOL, V35, P9, DOI 10.1007/s13277-013-1141-0; Wang XP, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-25; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wu CC, 2008, PROTEOMICS, V8, P316, DOI 10.1002/pmic.200700819; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Yamashita R, 2007, MOL CELL BIOCHEM, V298, P83, DOI 10.1007/s11010-006-9354-9; Yang XQ, 2011, PHYSIOL GENOMICS, V43, P457, DOI 10.1152/physiolgenomics.00178.2010; Zhao X, 2012, SCI CHINA LIFE SCI, V55, P906, DOI 10.1007/s11427-012-4384-x; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu WW, 2013, CLIN CANCER RES, V19, P3944, DOI 10.1158/1078-0432.CCR-12-3363	89	34	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138913	10.1371/journal.pone.0138913	http://dx.doi.org/10.1371/journal.pone.0138913			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414287	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700027
J	Chen, HW; An, J; Wei, SH; Gu, J				Chen, Hongwei; An, Jing; Wei, Shuhe; Gu, Jian			Spatial Patterns and Risk Assessment of Heavy Metals in Soils in a Resource-Exhausted City, Northeast China	PLOS ONE			English	Article							GIS-BASED APPROACH; HEALTH-RISK; AGRICULTURAL SOILS; PADDY FIELD; CONTAMINATION; POLLUTION; ELEMENTS; BASIN	Northeast China is an intensive area of resource-exhausted city, which is facing the challenges of industry conversion and sustainable development. In order to evaluate the soil environmental quality influenced by mining activities over decades, the concentration and spatial distribution of arsenic (As), cadmium (Cd), chromium (Cr), copper (Cu), nickel (Ni), lead (Pb), and Zinc (Zn) in surface soils (0-20cm) of a typical resource-exhausted city were investigated by analyzing 306 soil samples. The results showed that the average concentrations in the samples were 6.17 mg/kg for As, 0.19 mg/kg for Cd, 51.08 mg/kg for Cr, 23.27 mg/kg for Cu, 31.15 mg/kg for Ni, 22.17 mg/kg for Pb, and 54.21 mg/kg for Zn. Metals distribution maps produced by using the inverse distance weighted interpolation method and results revealed that all investigated metals showed distinct geographical patterns, and the concentrations were higher in urban and industrial areas than in farmland. Pearson correlation and principal component analysis showed that there were significant positive correlations (p<0.05) between all of the metals, and As, Cd, Cr, Mn, Ni, Pb, and Zn were closely associated with the first principal component (PC1), which explained 39.81% of the total variance. Cu and As were mainly associated with the second component (PC2). Based on the calculated Nemerow pollution index, percentage for slightly polluted (1<P <= 2) surface soils were reached 57.33%, while 42.65% topsoil samples are moderate polluted (2<P <= 3). According to the results above-mentioned, different soil environmental function areas were classified and proper soil environmental management policy was proposed to decrease the environmental risks in the process of industrial city transformation.	[An, Jing; Wei, Shuhe] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China; [Chen, Hongwei; An, Jing; Wei, Shuhe; Gu, Jian] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Chen, Hongwei] Shenyang Univ, Shenyang, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Shenyang University	An, J (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China.	anjing@iae.ac.cn			National Natural Science Foundation of China [21277150, 31370523, 41001340, 41201185]; Ministry of Environmental Protection of the PRC [201209030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Environmental Protection of the PRC	The research was financially supported by the research fund for the National Natural Science Foundation of China (No. 21277150, 31370523, 41001340, 41201185). The authors JA and JG receive the the research fund for public welfare, granted by the Ministry of Environmental Protection of the PRC (No. 201209030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 156182008 GB MIN ENV; Chen X, 2010, J HAZARD MATER, V181, P640, DOI 10.1016/j.jhazmat.2010.05.060; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Gu YG, 2012, ENVIRON POLLUT, V163, P248, DOI 10.1016/j.envpol.2011.12.041; Kelepertzis E, 2014, GEODERMA, V221, P82, DOI 10.1016/j.geoderma.2014.01.007; Krami LK, 2013, ENVIRON MONIT ASSESS, V185, P9871, DOI 10.1007/s10661-013-3298-9; Li QS, 2012, J HAZARD MATER, V227, P148, DOI 10.1016/j.jhazmat.2012.05.023; Li XY, 2013, GEODERMA, V192, P50, DOI 10.1016/j.geoderma.2012.08.011; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Liu XM, 2006, ENVIRON POLLUT, V141, P257, DOI 10.1016/j.envpol.2005.08.048; Modis K, 2014, SOIL SEDIMENT CONTAM, V23, P63, DOI 10.1080/15320383.2013.777393; Navas A, 2002, APPL GEOCHEM, V17, P961, DOI 10.1016/S0883-2927(02)00006-9; Nicholson FA, 2003, SCI TOTAL ENVIRON, V311, P205, DOI 10.1016/S0048-9697(03)00139-6; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Rosen G. D., 1996, COMPREHENSIVE SURVEY; Schloeder CA, 2001, SOIL SCI SOC AM J, V65, P470, DOI 10.2136/sssaj2001.652470x; Smith TB, 2014, SCI TOTAL ENVIRON, V496, P435, DOI 10.1016/j.scitotenv.2014.07.014; Song S., 2013, INT BUSINESS TIMES; Sow AY, 2013, ENVIRON SCI POLLUT R, V20, P8964, DOI 10.1007/s11356-013-1857-9; Spijker J, 2005, GEODERMA, V127, P24, DOI 10.1016/j.geoderma.2004.11.002; Sun YB, 2011, J HAZARD MATER, V186, P2075, DOI 10.1016/j.jhazmat.2010.12.116; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Tembo BD, 2006, CHEMOSPHERE, V63, P497, DOI 10.1016/j.chemosphere.2005.08.002; Wang J, 2014, J SOLID STATE CHEM, V216, P1, DOI 10.1016/j.jssc.2014.04.008; Wu LH, 2013, ENVIRON SCI POLLUT R, V20, P8342, DOI 10.1007/s11356-013-1532-1; Yang CL, 2013, ENVIRON EARTH SCI, V70, P1903, DOI 10.1007/s12665-013-2282-6; Yang LQ, 2014, CHEMOSPHERE, V103, P121, DOI 10.1016/j.chemosphere.2013.11.047; Yu BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092459; Zhao HR, 2012, SCI TOTAL ENVIRON, V417, P45, DOI 10.1016/j.scitotenv.2011.12.047	29	20	22	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137694	10.1371/journal.pone.0137694	http://dx.doi.org/10.1371/journal.pone.0137694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413806	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700011
J	Mollah, MMH; Jamal, R; Mokhtar, NM; Harun, R; Mollah, MNH				Mollah, Mohammad Manir Hossain; Jamal, Rahman; Mokhtar, Norfilza Mohd; Harun, Roslan; Mollah, Md. Nurul Haque			A Hybrid One-Way ANOVA Approach for the Robust and Efficient Estimation of Differential Gene Expression with Multiple Patterns	PLOS ONE			English	Article							ENRICHMENT ANALYSIS; BETA-DIVERGENCE; MICROARRAYS; MODELS; TUMOR; SETS	Background Identifying genes that are differentially expressed (DE) between two or more conditions with multiple patterns of expression is one of the primary objectives of gene expression data analysis. Several statistical approaches, including one-way analysis of variance (ANOVA), are used to identify DE genes. However, most of these methods provide misleading results for two or more conditions with multiple patterns of expression in the presence of outlying genes. In this paper, an attempt is made to develop a hybrid one-way ANOVA approach that unifies the robustness and efficiency of estimation using the minimum beta-divergence method to overcome some problems that arise in the existing robust methods for both small-and large-sample cases with multiple patterns of expression. Results The proposed method relies on a beta-weight function, which produces values between 0 and 1. The beta-weight function with beta = 0.2 is used as a measure of outlier detection. It assigns smaller weights (>= 0) to outlying expressions and larger weights (<= 1) to typical expressions. The distribution of the beta-weights is used to calculate the cut-off point, which is compared to the observed beta-weight of an expression to determine whether that gene expression is an outlier. This weight function plays a key role in unifying the robustness and efficiency of estimation in one-way ANOVA. Conclusion Analyses of simulated gene expression profiles revealed that all eight methods (ANOVA, SAM, LIMMA, EBarrays, eLNN, KW, robust BetaEB and proposed) perform almost identically for m = 2 conditions in the absence of outliers. However, the robust BetaEB method and the proposed method exhibited considerably better performance than the other six methods in the presence of outliers. In this case, the BetaEB method exhibited slightly better performance than the proposed method for the small-sample cases, but the the proposed method exhibited much better performance than the BetaEB method for both the small-and large-sample cases in the presence of more than 50% outlying genes. The proposed method also exhibited better performance than the other methods for m > 2 conditions with multiple patterns of expression, where the BetaEB was not extended for this condition. Therefore, the proposed approach would be more suitable and reliable on average for the identification of DE genes between two or more conditions with multiple patterns of expression.	[Mollah, Mohammad Manir Hossain; Jamal, Rahman; Mokhtar, Norfilza Mohd; Harun, Roslan] Univ Kebangsaan Malaysia UKM, Inst Perubatan Molekul UKM UMBI, Kuala Lumpur 56000, Malaysia; [Mokhtar, Norfilza Mohd] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Mollah, Md. Nurul Haque] Rajshahi Univ, Dept Stat, Lab Bioinformat, Rajshahi 6205, Bangladesh	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; University of Rajshahi	Mollah, MMH (corresponding author), Univ Kebangsaan Malaysia UKM, Inst Perubatan Molekul UKM UMBI, Kuala Lumpur 56000, Malaysia.	mhmollah06@yahoo.com	Mokhtar, Norfilza Mohd/AAK-8196-2020	Mokhtar, Norfilza Mohd/0000-0002-4863-100X	Ministry of Education under the Higher Institution Centre of Excellence (HICoE) programme [10-64-01-005]	Ministry of Education under the Higher Institution Centre of Excellence (HICoE) programme	This research was funded by a grant from the Ministry of Education under the Higher Institution Centre of Excellence (HICoE) programme (10-64-01-005).	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Basu A, 1998, BIOMETRIKA, V85, P549, DOI 10.1093/biomet/85.3.549; Casella G., 2002, STAT INFERENCE, V2nd; Cheng YY, 2008, BRIT J CANCER, V99, P2083, DOI 10.1038/sj.bjc.6604760; Chiogna M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-61; Deb S, 2014, BRIT J CANCER, V110, P1606, DOI 10.1038/bjc.2014.31; Dembele D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-14; Do KA, 2005, J R STAT SOC C-APPL, V54, P627, DOI 10.1111/j.1467-9876.2005.05593.x; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Geistlinger L, 2011, BIOINFORMATICS, V27, pI366, DOI 10.1093/bioinformatics/btr228; Gottardo R, 2006, BIOMETRICS, V62, P10, DOI 10.1111/j.1541-0420.2005.00397.x; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lo K, 2007, BIOINFORMATICS, V23, P328, DOI 10.1093/bioinformatics/btl612; Mihoko M, 2002, NEURAL COMPUT, V14, P1859, DOI 10.1162/089976602760128045; Mollah MNH, 2010, NEURAL NETWORKS, V23, P226, DOI 10.1016/j.neunet.2009.11.011; Mollah MMH, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-135; Mood AM, 1974, INTRODUCTION TO THE; Newton MA, 2003, ANAL GENE EXPRESSION; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Posekany A, 2011, BIOINFORMATICS, V27, P807, DOI 10.1093/bioinformatics/btr018; Ruan LY, 2011, BIOMETRICS, V67, P1617, DOI 10.1111/j.1541-0420.2011.01602.x; Sergeant G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-527; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020060; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xu ZJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000659; Yang M, 2009, PARAMETRIC EMPIRICAL; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang S, 2013, ONCOL REP, V29, P1819, DOI 10.3892/or.2013.2309; Zhu QQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-285	35	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138810	10.1371/journal.pone.0138810	http://dx.doi.org/10.1371/journal.pone.0138810			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413858	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700023
J	Barbosa, GM; Colombo, AV; Rodrigues, PH; Simionato, MRL				Barbosa, Graziela Murta; Colombo, Andrea Vieira; Rodrigues, Paulo Henrique; Lorenzetti Simionato, Maria Regina			Intraspecies Variability Affects Heterotypic Biofilms of Porphyromonas gingivalis and Prevotella intermedia: Evidences of Strain-Dependence Biofilm Modulation by Physical Contact and by Released Soluble Factors	PLOS ONE			English	Article							EPITHELIAL-CELLS; PERIODONTITIS; VIRULENCE; ADHERENCE; DYSBIOSIS; BACTERIA; SYNERGY	It is well known that strain and virulence diversity exist within the population structure of Porphyromonas gingivalis. In the present study we investigate intra-and inter-species variability in biofilm formation of Porphyromonas gingivalis and partners Prevotella intermedia and Prevotella nigrescens. All strains tested showed similar hydrophobicity, except for P. gingivalis W83 which has roughly half of the hydrophobicity of P. gingivalis ATCC33277. An intraspecies variability in coaggregation of P. gingivalis with P. intermedia was also found. The association P. gingivalis W83/P. intermedia 17 produced the thickest biofilm and strain 17 was prevalent. In a two-compartment system P. gingivalisW83 stimulates an increase in biomass of strain 17 and the latter did not stimulate the growth of P. gingivalis W83. In addition, P. gingivalis W83 also stimulates the growth of P. intermedia ATCC25611 although strainW83 was prevalent in the association with P. intermedia ATCC25611. P. gingivalis ATCC33277 was prevalent in both associations with P. intermedia and both strains of P. intermedia stimulate the growth of P. gingivalis ATCC33277. FISH images also showed variability in biofilm structure. Thus, the outcome of the association P. gingivalis/P. intermedia seems to be strain-dependent, and both soluble factors and physical contact are relevant. The association P. gingivalis-P. nigrescens ATCC33563 produced larger biomass than each monotypic biofilm, and P. gingivalis was favored in consortia, while no differences were found in the two-compartment system. Therefore, in consortia P. gingivalis-P. nigrescens physical contact seems to favor P. gingivalis growth. The intraspecies variability found in our study suggests strain-dependence in ability of microorganisms to recognize molecules in other bacteria which may further elucidate the dysbiosis event during periodontitis development giving additional explanation for periodontal bacteria, such as P. gingivalis and P. intermedia, among others, to persist and establish chronic infections in the host.	[Barbosa, Graziela Murta; Colombo, Andrea Vieira; Rodrigues, Paulo Henrique; Lorenzetti Simionato, Maria Regina] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo	Rodrigues, PH (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.	phrodrigues@usp.br; mrsimion@usp.br	Rodrigues, Paulo H/J-6927-2012; Simionato, Maria Regina L./I-2400-2013; Colombo, Andrea V/A-5018-2018; Rodrigues, Paulo/O-2689-2017	Simionato, Maria Regina L./0000-0002-0187-4661; Colombo, Andrea V/0000-0001-8317-4302; Rodrigues, Paulo/0000-0002-4646-6805	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/11199-4, 2013/15977-7]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by GMB Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, http://www.capes.gov.br/; PHR Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant number 2008/11199-4, http://www.fapesp.br/; MRLS Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant number 2013/15977-7, http://www.fapesp.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colombo AV, 2013, J MED MICROBIOL, V62, P1592, DOI 10.1099/jmm.0.055830-0; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dorn BR, 2000, FEMS MICROBIOL LETT, V187, P139, DOI 10.1016/S0378-1097(00)00191-9; Durso SC, 2014, CARIES RES, V48, P214, DOI 10.1159/000354410; Frandsen EVG, 2001, INFECT IMMUN, V69, P4479, DOI 10.1128/IAI.69.7.4479-4485.2001; GIBBONS RJ, 1983, INFECT IMMUN, V41, P1190, DOI 10.1128/IAI.41.3.1190-1196.1983; Guentsch A, 2013, J PERIODONTAL RES, V48, P458, DOI 10.1111/jre.12027; Haffajee AD, 2004, J CLIN PERIODONTOL, V31, P996, DOI 10.1111/j.1600-051X.2004.00597.x; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hyvarinen K, 2009, INNATE IMMUN-LONDON, V15, P195, DOI 10.1177/1753425908101920; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; Jiao Y, 2014, J DENT RES, V93, P539, DOI 10.1177/0022034514528212; Kamaguchi A, 2001, MICROBIOL IMMUNOL, V45, P649, DOI 10.1111/j.1348-0421.2001.tb01298.x; Kuboniwa M, 2012, EXPERT REV PROTEOMIC, V9, P311, DOI [10.1586/EPR.12.16, 10.1586/epr.12.16]; Leys EJ, 1999, J CLIN MICROBIOL, V37, P3906, DOI 10.1128/JCM.37.12.3906-3911.1999; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; NAITO Y, 1993, ORAL MICROBIOL IMMUN, V8, P195, DOI 10.1111/j.1399-302X.1993.tb00559.x; Okamoto M, 1999, FEMS MICROBIOL LETT, V178, P299, DOI 10.1016/S0378-1097(99)00372-9; Okuda T, 2012, ANAEROBE, V18, P110, DOI 10.1016/j.anaerobe.2011.09.003; Ramsey MM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002012; Rodrigues PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052606; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schillinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037583; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Teles FR, 2012, J PERIODONTOL, V83, P1139, DOI 10.1902/jop.2012.110506; Yamanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-228; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138687	10.1371/journal.pone.0138687	http://dx.doi.org/10.1371/journal.pone.0138687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406499	gold, Green Published			2022-12-27	WOS:000361800700070
J	Beckwith, MS; Beckwith, KS; Sikorski, P; Skogaker, NT; Flo, TH; Halaas, O				Beckwith, Marianne Sandvold; Beckwith, Kai Sandvold; Sikorski, Pawel; Skogaker, Nan Tostrup; Flo, Trude Helen; Halaas, Oyvind			Seeing a Mycobacterium-Infected Cell in Nanoscale 3D: Correlative Imaging by Light Microscopy and FIB/SEM Tomography	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; PHAGOSOME MATURATION; MAMMALIAN-CELLS; FLUORESCENCE; TUBERCULOSIS; AUTOPHAGY; TRANSMISSION; TISSUE; PHAGOLYSOSOME; DEHYDRATION	Mycobacteria pose a threat to the world health today, with pathogenic and opportunistic bacteria causing tuberculosis and non-tuberculous disease in large parts of the population. Much is still unknown about the interplay between bacteria and host during infection and disease, and more research is needed to meet the challenge of drug resistance and inefficient vaccines. This work establishes a reliable and reproducible method for performing correlative imaging of human macrophages infected with mycobacteria at an ultra-high resolution and in 3D. Focused Ion Beam/Scanning Electron Microscopy (FIB/SEM) tomography is applied, together with confocal fluorescence microscopy for localization of appropriately infected cells. The method is based on an Aclar poly(chloro-tri-fluoro) ethylene substrate, micropatterned into an advantageous geometry by a simple thermomoulding process. The platform increases the throughput and quality of FIB/SEM tomography analyses, and was successfully applied to detail the intracellular environment of a whole mycobacterium-infected macrophage in 3D.	[Beckwith, Marianne Sandvold; Flo, Trude Helen] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway; [Beckwith, Marianne Sandvold; Flo, Trude Helen; Halaas, Oyvind] NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Beckwith, Kai Sandvold; Sikorski, Pawel] NTNU, Dept Phys, Trondheim, Norway; [Skogaker, Nan Tostrup] NTNU, Dept Lab Med Childrens & Womens Hlth, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Beckwith, MS (corresponding author), Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway.	marianne.beckwith@ntnu.no	Halaas, Øyvind/O-2197-2015; Flo, Trude Helen/E-1311-2013; Sikorski, Pawel/A-2304-2009	Halaas, Øyvind/0000-0002-7968-2483; Flo, Trude Helen/0000-0002-2569-0381; Sikorski, Pawel/0000-0001-9413-1623; Beckwith, Marianne Sandvold/0000-0001-8235-3755; Beckwith, Kai Sandvold/0000-0001-5598-5482	Research Council of Norway through its Centres of Excellence [223255/F50];  [197411/V30]	Research Council of Norway through its Centres of Excellence(Research Council of Norway); 	This work was supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223255/F50, and through support to the Norwegian Micro- and Nano-Fabrication Facility, NorFab, project number 197411/V30; http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agronskaia AV, 2008, J STRUCT BIOL, V164, P183, DOI 10.1016/j.jsb.2008.07.003; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Armer HEJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007716; Bennett AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000591; BUNGE RP, 1973, BRAIN RES, V57, P261, DOI 10.1016/0006-8993(73)90135-2; Bushby AJ, 2011, NAT PROTOC, V6, P845, DOI 10.1038/nprot.2011.332; COLLINS JS, 1981, J HISTOCHEM CYTOCHEM, V29, P411, DOI 10.1177/29.3.6787116; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; De Winter DAM, 2009, J MICROSC-OXFORD, V233, P372, DOI 10.1111/j.1365-2818.2009.03139.x; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Glauert AM, 1998, BIOL SPECIMEN PREPAR, Vxxi; Griffith DE, 2010, CURR OPIN INFECT DIS, V23, P185, DOI 10.1097/QCO.0b013e328336ead6; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; GUSNARD D, 1977, J MICROSC-OXFORD, V110, P51, DOI 10.1111/j.1365-2818.1977.tb00012.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Halaas O, 2010, J INFECT DIS, V201, P783, DOI 10.1086/650493; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Hosseini R, 2014, AUTOPHAGY, V10, P1844, DOI 10.4161/auto.29992; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Jimenez N, 2006, J MICROSC-OXFORD, V221, P216, DOI 10.1111/j.1365-2818.2006.01558.x; Jimenez N, 2010, J MICROSC-OXFORD, V237, P208, DOI 10.1111/j.1365-2818.2009.03329.x; Jo EK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00097; Kelley VA, 2003, MOL BIOL CELL, V14, P3366, DOI 10.1091/mbc.E02-12-0780; KINGSLEY RE, 1988, J ELECTRON MICR TECH, V10, P77, DOI 10.1002/jemt.1060100110; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009; MOLLENHAUER HH, 1993, MICROSC RES TECHNIQ, V26, P496, DOI 10.1002/jemt.1070260604; Murphy GE, 2011, J STRUCT BIOL, V176, P268, DOI 10.1016/j.jsb.2011.08.013; Narayan K, 2014, J STRUCT BIOL, V185, P278, DOI 10.1016/j.jsb.2013.11.008; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Sartori A, 2007, J STRUCT BIOL, V160, P135, DOI 10.1016/j.jsb.2007.07.011; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwarz Heinz, 2007, Methods Mol Biol, V369, P229; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Spiegelhalter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009014; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Ingen J, 2012, AM J RESP CRIT CARE, V186, P559, DOI 10.1164/rccm.201204-0682OC; van Rijnsoever C, 2008, NAT METHODS, V5, P973, DOI 10.1038/nmeth.1263; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Wagner D, 2004, INFECTION, V32, P257, DOI 10.1007/s15010-004-4001-4; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wei DG, 2012, BIOTECHNIQUES, V53, P41, DOI 10.2144/000113850; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	53	16	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0134644	10.1371/journal.pone.0134644	http://dx.doi.org/10.1371/journal.pone.0134644			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406896	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700002
J	Blein, S; Barjhoux, L; Damiola, F; Dondon, MG; Eon-Marchais, S; Marcou, M; Caron, O; Lortholary, A; Buecher, B; Vennin, P; Berthet, P; Nogues, C; Lasset, C; Gauthier-Villars, M; Mazoyer, S; Stoppa-Lyonnet, D; Andrieu, N; Thomas, G; Sinilnikova, OM; Cox, DG				Blein, Sophie; Barjhoux, Laure; Damiola, Francesca; Dondon, Marie-Gabrielle; Eon-Marchais, Severine; Marcou, Morgane; Caron, Olivier; Lortholary, Alain; Buecher, Bruno; Vennin, Philippe; Berthet, Pascaline; Nogues, Catherine; Lasset, Christine; Gauthier-Villars, Marion; Mazoyer, Sylvie; Stoppa-Lyonnet, Dominique; Andrieu, Nadine; Thomas, Gilles; Sinilnikova, Olga M.; Cox, David G.		GENESIS Invest	Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2	PLOS ONE			English	Article								Breast Cancer is a complex multifactorial disease for which high-penetrance mutations have been identified. Approaches used to date have identified genomic features explaining about 50% of breast cancer heritability. A number of low-to medium penetrance alleles (per-allele odds ratio < 1.5 and 4.0, respectively) have been identified, suggesting that the remaining heritability is likely to be explained by the cumulative effect of such alleles and/or by rare high-penetrance alleles. Relatively few studies have specifically explored the mitochondrial genome for variants potentially implicated in breast cancer risk. For these reasons, we propose an exploration of the variability of the mitochondrial genome in individuals diagnosed with breast cancer, having a positive breast cancer family history but testing negative for BRCA1/2 pathogenic mutations. We sequenced the mitochondrial genome of 436 index breast cancer cases from the GENESIS study. As expected, no pathogenic genomic pattern common to the 436 women included in our study was observed. The mitochondrial genes MT-ATP6 and MT-CYB were observed to carry the highest number of variants in the study. The proteins encoded by these genes are involved in the structure of the mitochondrial respiration chain, and variants in these genes may impact reactive oxygen species production contributing to carcinogenesis. More functional and epidemiological studies are needed to further investigate to what extent variants identified may influence familial breast cancer risk.	[Blein, Sophie; Barjhoux, Laure; Damiola, Francesca; Mazoyer, Sylvie; Sinilnikova, Olga M.; Cox, David G.] Univ Lyon 1, INSERM U1052, CNRS UMR5286, Ctr Rech Cancerol Lyon, F-69365 Lyon, France; [Dondon, Marie-Gabrielle; Eon-Marchais, Severine; Marcou, Morgane; Andrieu, Nadine] INSERM, U900, Paris, France; [Dondon, Marie-Gabrielle; Eon-Marchais, Severine] Inst Curie, Paris, France; [Dondon, Marie-Gabrielle; Eon-Marchais, Severine; Andrieu, Nadine] Mines Paris Tech, Fontainebleau, France; [Caron, Olivier; Gauthier-Villars, Marion; Stoppa-Lyonnet, Dominique] Inst Cancerol Gustave Roussy, Consultat Gen, Dept Med, Villejuif, France; [Lortholary, Alain] Ctr Catherine Sienne, Nantes, France; [Eon-Marchais, Severine] Inst Curie, Dept Tumour Biol, Paris, France; [Vennin, Philippe] CLCC Oscar Lambret, Dept Cancerol Senol, Lille, France; [Berthet, Pascaline] Ctr Francois Baclesse, F-14021 Caen, France; [Nogues, Catherine] Inst Curie, Oncogenet Clin, Hop Rene Huguenin, St Cloud, France; [Lasset, Christine] Univ Lyon 1, CNRS UMR5558, F-69365 Lyon, France; [Lasset, Christine] Ctr Leon Berard, Unit Prevent & dEpidemiol Genet, F-69373 Lyon, France; [Stoppa-Lyonnet, Dominique] Inst Curie, INSERM U830, Paris, France; [Stoppa-Lyonnet, Dominique] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Thomas, Gilles] Univ Lyon 1, INCa Synergie, Ctr Leon Beard, F-69365 Lyon 08, France; [Cox, David G.] Ctr Leon Berard, Unit Mixte Genet Constitutionnelle Cancers Freque, F-69373 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Oscar Lambret; UNICANCER; Centre Francois Baclesse; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Cox, DG (corresponding author), Univ Lyon 1, INSERM U1052, CNRS UMR5286, Ctr Rech Cancerol Lyon, F-69365 Lyon, France.	david.cox@inserm.fr	Mazoyer, Sylvie/N-7559-2017; Cox, David/ABA-7454-2020; Cox, David G/A-2023-2009; ANDRIEU, Nadine/H-4255-2014; Caron, Olivier/Q-1782-2018	Cox, David G/0000-0002-2152-9259; Caron, Olivier/0000-0001-8934-2071; Cox, David/0000-0003-2047-4687; Damiola, Francesca/0000-0002-0238-1252; Mazoyer, Sylvie/0000-0002-2135-0160; Dondon, Marie-Gabrielle/0000-0001-6016-8524	Ligue Nationale contre le Cancer [PRE05/DSL, PRE07/DSL, PRE11/NA]; French National Institute of Cancer [2008-029/LL-LC]; comprehensive cancer center SiRIC Curie (Site de Recherche Integree sur Cancer) [INCa-DGOS-4654]; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); French National Institute of Cancer; comprehensive cancer center SiRIC Curie (Site de Recherche Integree sur Cancer); National Breast Cancer Foundation	This work was supported by Ligue Nationale contre le Cancer (3 grants: PRE05/DSL, PRE07/DSL, PRE11/NA), www.ligue-cancer.net. GENESIS: study design and data collection. This work also received support from the French National Institute of Cancer (Grant INCa no 2008-029/LL-LC), http://www.e-cancer.fr/. (GENESIS: study design and data collection); and the comprehensive cancer center SiRIC Curie, (Site de Recherche Integree sur Cancer: Grant INCa-DGOS-4654), http://www.institut-curie.org/research/institut-curie-integratedcancer-research-site-siric; www.ligue-cancer.net. GENESIS: study design and data collection.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrieu N, 2014 AM SOC HUM GEN; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bai R- K, 2007, CANC RES, V67; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cheng M, 2014, TUMOUR BIOL, V35; DePristo MA, 2011, NAT GENET, V43; Evans DG., 2008, BMC CANCER, P8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hall J, 1990, SCIENCE, V250, P17; Ion Torrent Sequencing on Humans, ION TORR SEQ HUM; Jezierska-Drutel A, 2013, ADV CANCER RES, P119; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678; Li H, 2009, BIOINFORMATICS, V25, DOI 10.1093/bioinformatics/btp324; Loft S, 2013, CANC EPIDEMIOL BIOMA, V22; Loman NJ, 2012, NAT BIOTECHNOL, V30; Lynch H, 2013, BREAST J, V19, P520, DOI 10.1111/tbj.12145; Lynch HT, 2013, ANN ONCOL, P24; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26; Melchor L, 2013, HUM GENET, V132, P845, DOI 10.1007/s00439-013-1299-y; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Parson W, 2013, FORENSIC SCI INT-GEN, V7, P632, DOI 10.1016/j.fsigen.2013.09.007; Picardi E, 2012, NAT METHODS, V9, P523, DOI 10.1038/nmeth.2029; Quail MA, 2012, BMC GENOMICS, V13; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, P35; Snape K, 2012, BREAST CANC RES TREA, V134; Soini HK, 2013, BMC MED GENET, P14; Southey MC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3434; Thompson ER, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002894; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tommasi S, 2014, INT J ONCOL, V44, P1691, DOI 10.3892/ijo.2014.2324; Van der Auwera GA, 2002, CURRENT PROTOCOLS BI; Wallace DC, 2012, NAT REV CANC, V12	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136192	10.1371/journal.pone.0136192	http://dx.doi.org/10.1371/journal.pone.0136192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406445	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700010
J	Bu, S; Ruan, DJ; Yang, ZJ; Xing, XY; Zhao, WH; Wang, N; Xie, LD; Yang, WY				Bu, Shi; Ruan, Danjie; Yang, Zhaojun; Xing, Xiaoyan; Zhao, Wenhui; Wang, Na; Xie, Lingding; Yang, Wenying			Sex-Specific Prevalence of Diabetes and Cardiovascular Risk Factors in the Middle-Aged Population of China: A Subgroup Analysis of the 2007-2008 China National Diabetes and Metabolic Disorders Study	PLOS ONE			English	Article							MEN; WOMEN	The sex difference in the prevalence rates of diabetes and cardiovascular diseases (CVDs) among the middle-aged population in China remain largely unknown. Therefore, we analyzed differences in the prevalence of diabetes, self-reported CVDs, and some CVD risk factors among men and women in the middle-aged population (30-49 years) and in individuals aged 50 years and older using data from the China National Diabetes and Metabolic Disorders Study of 2007-2008. Middle-aged men appeared to have significantly a higher prevalence of diabetes and self-reported CVDs than middle-aged women (8.07% vs 5.06% for diabetes, P < 0.001; 0.64% vs 0.22% for CVDs, P < 0.001). Men also showed higher rates of central obesity, hypertension, and dyslipidemia than women (all P < 0.01). Compared with women, men were more likely to drink alcohol and smoke cigarettes but less likely to be under diet control. The sex-specific differences in prediabetes, CVD, and CVD risk factors between men and women were diminished or even reversed in the population aged 50 years and older. No sex-specific differences were found in the prevalences of a family history of diabetes, coronary heart disease, and hypertension (P > 0.05) in middle-aged population. Specific strategies to reduce modifiable risk factors for the prevention and control of diabetes and CVD may be warranted in this population.	[Bu, Shi; Yang, Zhaojun; Xing, Xiaoyan; Zhao, Wenhui; Wang, Na; Xie, Lingding; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China; [Ruan, Danjie] Ist Hosp Huairou Dist, Dept Endocrinol, Beijing 101400, Peoples R China	China-Japan Friendship Hospital	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China.	13366901921@163.com		Yang, Wenying/0000-0002-7997-9404				Chang HY, 2010, DIABETES RES CLIN PR, V90, P358, DOI 10.1016/j.diabres.2010.09.032; Chiou CJ, 2002, PREV MED, V35, P264, DOI 10.1006/pmed.2002.1080; Davies J, 2000, J AM COLL HEALTH, V48, P259, DOI 10.1080/07448480009596267; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Minges KE, 2011, DIABETES RES CLIN PR, V93, P139, DOI 10.1016/j.diabres.2011.06.012; Ofori SN, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0006-4; Pan X, 1997, CHINESE J INTERN MED, V36, P6; Tang M, 2003, INT J EPIDEMIOL, V32, P381, DOI 10.1093/ije/dyg075; Wang K, 1998, CHIN J EPIDEMIOL, V19, P4; Welin L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-403; WHO / IDF, 2006, DEF DIAGN DIAB MELL; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	13	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139039	10.1371/journal.pone.0139039	http://dx.doi.org/10.1371/journal.pone.0139039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406982	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700153
J	Kim, BJ; Park, DR; Nam, TS; Lee, SH; Kim, UH				Kim, Byung-Ju; Park, Dae-Ryoung; Nam, Tae-Sik; Lee, Seo Ho; Kim, Uh-Hyun			Seminal CD38 Enhances Human Sperm Capacitation through Its Interaction with CD31	PLOS ONE			English	Article							ADP-RIBOSYL CYCLASE; TYROSINE PHOSPHORYLATION; PECAM-1; RECEPTOR; PLATELET; KINASE; MOUSE; IDENTIFICATION; PROSTASOMES; ACTIVATION	Human sperm have to undergo a maturational process called capacitation in the female reproductive tract. Capacitation confers upon the sperm an ability to gain hypermotility and undergo acrosome reaction. Previous studies have suggested that seminal plasma proteins induce the capacitation of sperm in the female reproductive tract for the successful fertilization of the oocyte. However, the function of seminal plasma proteins in capacitation remains largely unclear. To the end, we found that soluble CD38 (sCD38) in seminal plasma increases the capacitation of sperm via specific interactions between sCD38 and the CD31 on the sperm. Upon the association of sCD38 with CD31, tyrosine kinase Src phosphorylates CD31, a process blocked by Src inhibitors. Shc, SHP-2, Grb2, and SOS, as well as Src kinase were found to associate with the phosphorylated CD31. The sCD38-induced phosphorylation of CD31 initiates a cascade reaction through the phosphorylation of Erk1/2, which results in the acrosome reaction, and sperm hypermotility. These processes were prevented by Src, Ras and MEK inhibitors. Taken together, these data indicate that the sCD38 present in seminal plasma plays a critical role in the capacitation of sperm.	[Kim, Byung-Ju; Park, Dae-Ryoung; Nam, Tae-Sik; Lee, Seo Ho; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju 561180, South Korea; [Kim, Byung-Ju; Park, Dae-Ryoung; Nam, Tae-Sik; Lee, Seo Ho; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561180, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Inst Cardiovasc Res, Jeonju 561180, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju 561180, South Korea.	uhkim@chonbuk.ac.kr		Kim, Uh-Hyun/0000-0003-3304-7190	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2012R1A3A2026453]; Ministry of Education [2015R1D1A4A01016904]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Ministry of Education	This study was supported by the National Research Foundation of Korea (NRF), funded by the Korean government (MSIP) (2012R1A3A2026453) and by the Ministry of Education (2015R1D1A4A01016904).	Aalberts M, 2013, BBA-PROTEINS PROTEOM, V1834, P2326, DOI 10.1016/j.bbapap.2012.08.008; Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; An NH, 2001, BIOCHEM BIOPH RES CO, V282, P781, DOI 10.1006/bbrc.2001.4654; Anderson B M, 1980, Methods Enzymol, V66, P144; Ashizawa K, 1997, BIOCHEM BIOPH RES CO, V240, P116, DOI 10.1006/bbrc.1997.7626; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Cao MY, 1998, J BIOL CHEM, V273, P15765, DOI 10.1074/jbc.273.25.15765; de Lamirande E, 2002, MOL HUM REPROD, V8, P124, DOI 10.1093/molehr/8.2.124; Deaglio S, 1998, J IMMUNOL, V160, P395; ESHRE Andrology Special Interest Grp, 1998, HUM REPROD, V13, P142; Funaro A, 1996, INT IMMUNOL, V8, P1643; Groyer E, 2007, J AM COLL CARDIOL, V50, P344, DOI 10.1016/j.jacc.2007.04.040; Horenstein AL, 1998, BIOCHEM J, V330, P1129; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Kim BJ, 2015, P NATL ACAD SCI USA, V112, P1559, DOI 10.1073/pnas.1413493112; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; MANN T, 1978, INT J FERTIL, V23, P133; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Newton-Nash DK, 1999, J IMMUNOL, V163, P682; Nixon B, 2005, J CELL SCI, V118, P4865, DOI 10.1242/jcs.02604; Ooi EH, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140230; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; Wang YJ, 2006, J CELL BIOCHEM, V98, P451, DOI 10.1002/jcb.20827; Wilkinson R, 2002, BLOOD, V100, P184, DOI 10.1182/blood-2002-01-0027; Yanagimachi R., 1994, P189; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	30	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139110	10.1371/journal.pone.0139110	http://dx.doi.org/10.1371/journal.pone.0139110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407101	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700174
J	Klein, S; Herath, CB; Schierwagen, R; Grace, J; Haltenhof, T; Uschner, FE; Strassburg, CP; Sauerbruch, T; Walther, T; Angus, PW; Trebicka, J				Klein, Sabine; Herath, Chandana B.; Schierwagen, Robert; Grace, Josephine; Haltenhof, Tom; Uschner, Frank E.; Strassburg, Christian P.; Sauerbruch, Tilman; Walther, Thomas; Angus, Peter W.; Trebicka, Jonel			Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis	PLOS ONE			English	Article							MAS-RECEPTOR AGONIST; BILE-DUCT LIGATION; PORTAL PRESSURE; AVE 0991; AVE-0991; RATS; ACTIVATION; KINASE; INHIBITION; PEPTIDES	Background & Aims Although in cirrhosis with portal hypertension levels of the vasoconstrictor angiotensin II are increased, this is accompanied by increased production of angiotensin (Ang)-(1-7), the endogenous ligand of the Mas receptor (MasR), which blunts hepatic fibrosis and decreases hepatic vascular resistance. Therefore, we investigated the effects of the non-peptidic Ang-(1-7) agonist, AVE0991, in experimental cirrhosis. Methods Cirrhosis was induced by bile duct ligation (BDL) or carbon tetrachloride (CCl4) intoxication. The coloured microsphere technique assessed portal and systemic hemodynamic effects of AVE0991 in vivo. Hepatic expression of eNOS, p-eNOS, iNOS, JAK2, ROCK and p-Moesin were analyzed by western blots. Activities of ACE and ACE2 were investigated fluorometrically. Moreover, fibrosis was assessed in BDL rats receiving AVE0991. Results In vivo, AVE0991 decreased portal pressure (PP) in both rat models of cirrhosis. Importantly, systemic effects were not observed. The hepatic effects of AVE0991 were based on upregulation of vasodilating pathways involving p-eNOS and iNOS, as well as by down-regulation of the vasoconstrictive pathways (ROCK, p-Moesin). Short-term treatment with AVE0991 decreased the activity of ACE2, long-term treatment did not affect hepatic fibrosis in BDL rats. Conclusions The non-peptidic agonist of Ang-(1-7), AVE0991, decreases portal pressure without influencing systemic pressure. Thus, although it does not inhibit fibrosis, AVE0991 may represent a promising new therapeutic strategy for lowering portal pressure.	[Klein, Sabine; Schierwagen, Robert; Uschner, Frank E.; Strassburg, Christian P.; Sauerbruch, Tilman; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Herath, Chandana B.; Grace, Josephine] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia; [Haltenhof, Tom; Walther, Thomas] Univ Leipzig, Div Women & Child Hlth, Ctr Perinatal Med, Dept Obstet, D-04109 Leipzig, Germany; [Walther, Thomas] Univ Coll, Dept Pharmacol & Therapeut, Cork, Ireland; [Angus, Peter W.] Austin Hlth, Dept Gastroenterol & Hepatol, Heidelberg, Vic, Australia	University of Bonn; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Leipzig University; University College Cork; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jonel.trebicka@ukb.uni-bonn.de	Herath, Chandana/AAT-3251-2021; Klein, Sabine/U-1098-2018; Schierwagen, Robert/AAE-6305-2019	Herath, Chandana/0000-0001-9151-8531; Klein, Sabine/0000-0001-6691-2895; Schierwagen, Robert/0000-0002-2195-3666; Trebicka, Jonel/0000-0002-7028-3881; Uschner, Frank Erhard/0000-0002-3760-2887	Deutsche Forschungsgemeinschaft [SFB TRR57 P18, WA1441/22-2]; J. & W. Hector- Foundation [M60.2]; National Health and Medical Research Council (NHMRC) of Australia [APP1008252]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); J. & W. Hector- Foundation; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB TRR57 P18; WA1441/22-2), J. & W. Hector- Foundation (M60.2) and National Health and Medical Research Council (NHMRC) of Australia (APP1008252).	Barroso LC, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/808726; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bosnyak S, 2011, CLIN SCI, V121, P297, DOI 10.1042/CS20110036; Chen SL, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/958298; Ferreira AJ, 2001, HYPERTENSION, V38, P665, DOI 10.1161/01.HYP.38.3.665; Ferreira AJ, 2007, AM J PHYSIOL-HEART C, V292, pH1113, DOI 10.1152/ajpheart.00828.2006; Gao RN, 2012, DRUG METAB DISPOS, V40, P556, DOI 10.1124/dmd.111.042689; Grace JA, 2013, GASTROENTEROLOGY, V145, P874, DOI 10.1053/j.gastro.2013.06.036; Grace JA, 2012, CLIN SCI, V123, P225, DOI 10.1042/CS20120030; Granzow M, 2014, HEPATOLOGY, V60, P334, DOI 10.1002/hep.27117; Heller J, 2005, LIVER INT, V25, P657, DOI 10.1111/j.1478-3231.2005.01053.x; Heller J, 2003, EUR J CLIN INVEST, V33, P1006, DOI 10.1046/j.1365-2362.2003.01251.x; Hennenberg M, 2008, GUT, V57, P1300, DOI 10.1136/gut.2007.144584; Herath CB, 2007, J HEPATOL, V47, P387, DOI 10.1016/j.jhep.2007.03.008; Herath CB, 2013, AM J PHYSIOL-GASTR L, V304, pG99, DOI 10.1152/ajpgi.00163.2012; Herath CB, 2009, AM J PHYSIOL-GASTR L, V297, pG98, DOI 10.1152/ajpgi.00045.2009; JAMES J, 1990, LIVER, V10, P1; Klein S, 2012, J HEPATOL, V57, P1220, DOI 10.1016/j.jhep.2012.07.033; Lemos VS, 2005, J CARDIOVASC PHARM, V46, P274, DOI 10.1097/01.fjc.0000175237.41573.63; Lubel JS, 2009, CLIN SCI, V117, P375, DOI 10.1042/CS20080647; Maul J, 2001, FASEB J, V15, P1640, DOI 10.1096/fj.00-097fje; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Moreno M, 2009, AM J PHYSIOL-GASTR L, V296, pG147, DOI 10.1152/ajpgi.00462.2007; Pinheiro SVB, 2004, HYPERTENSION, V44, P490, DOI 10.1161/01.HYP.0000141438.64887.42; Rodrigues-Machado MG, 2013, BRIT J PHARMACOL, V170, P835, DOI 10.1111/bph.12318; Santos RAS, 2006, CARDIOVASC DRUG REV, V24, P239, DOI 10.1111/j.1527-3466.2006.00239.x; Silva DMR, 2007, PEPTIDES, V28, P702, DOI 10.1016/j.peptides.2006.10.007; Singh K, 2012, J RENIN-ANGIO-ALDO S, V13, P334, DOI 10.1177/1470320311435534; Suski M, 2013, BBA-PROTEINS PROTEOM, V1834, P2463, DOI 10.1016/j.bbapap.2013.08.008; Trebicka J, 2008, HEPATOLOGY, V47, P1264, DOI 10.1002/hep.22170; Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673; Trebicka J, 2010, J HEPATOL, V53, P702, DOI 10.1016/j.jhep.2010.04.025; Trebicka J, 2009, HEPATOLOGY, V50, P1924, DOI 10.1002/hep.23222; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wiemer G, 2002, HYPERTENSION, V40, P847, DOI 10.1161/01.HYP.0000037979.53963.8F	35	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138732	10.1371/journal.pone.0138732	http://dx.doi.org/10.1371/journal.pone.0138732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406236	Green Published, gold			2022-12-27	WOS:000361800700078
J	Lebina, L; Taruberekera, N; Milovanovic, M; Hatzold, K; Mhazo, M; Nhlapo, C; Tshabangu, N; Manentsa, M; Kazangarare, V; Makola, M; Billy, S; Martinson, N				Lebina, Limakatso; Taruberekera, Noah; Milovanovic, Minja; Hatzold, Karin; Mhazo, Miriam; Nhlapo, Cynthia; Tshabangu, Nkeko; Manentsa, Mmatsie; Kazangarare, Victoria; Makola, Millicent; Billy, Scott; Martinson, Neil			Piloting PrePex for Adult and Adolescent Male Circumcision in South Africa - Pain Is an Issue	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RESOURCE-LIMITED SETTINGS; HIV PREVENTION; SHANG RING; UGANDA; DEVICE; SAFETY; RAKAI; ACCEPTABILITY; COHORT	Background The World Health Organisation and the Joint United Nations Programme on HIV/AIDS have recommended the scale-up of Medical Male Circumcision (MMC) in countries with high HIV and low MMC prevalence. PrePex device circumcision is proposed as an alternate method for scaling up MMC. Objective Evaluate safety and feasibility of PrePex in South Africa. Design A multisite prospective cohort PrePex study in adults and adolescents at three MMC clinics. Participants were followed-up 8 times, up to 56 days after PrePex placement. Results In total, 398 PrePex circumcisions were performed (315 adults and 83 adolescents) their median ages were 26 (IQR: 22-30) and 16 years (IQR: 15-17), respectively. The median time for device placement across both groups was 6 minutes (IQR: 5-9) with the leading PrePex sizes being B (30%) and C (35%) for adults (18-45 years), and A (31%) and B (38%) for adolescents (14-17 years). Additional sizes (size 12-20) were rarely used, even in the younger age group. Pain of device application was minimal but that of removal was severe. However, described pain abated rapidly and almost no pain was reported 1 hour after removal. The Adverse Events rate were experienced by 2.7% (11/398) of all participants, three of which were serious (2 displacements and 1 self-removal requiring prompt surgery). None of the Adverse Events required hospitalization. The majority of participants returned to work within a day of device placement. Conclusion Our study shows that PrePex is a safe MMC method, for males 14 years and above. PrePex circumcision had a similar adverse event rate to that reported for surgical MMC, but device removal caused high levels of pain, which subsided rapidly.	[Lebina, Limakatso; Milovanovic, Minja; Tshabangu, Nkeko; Manentsa, Mmatsie; Martinson, Neil] Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Taruberekera, Noah] Populat Serv Int, Johannesburg, South Africa; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Mhazo, Miriam; Nhlapo, Cynthia; Kazangarare, Victoria; Makola, Millicent; Billy, Scott] Soc Family Hlth, Johannesburg, South Africa; [Martinson, Neil] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of Witwatersrand; Johns Hopkins University	Lebina, L (corresponding author), Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa.	lebinal@phru.co.za	Manentsa, Mmatsie/B-8658-2017; Milovanovic, Minja/J-9832-2017	Manentsa, Mmatsie/0000-0003-4671-7122; Milovanovic, Minja/0000-0002-4654-8755	Bill and Melinda Gates Foundation [50748, 3333]; PEPFAR through CDC	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); PEPFAR through CDC	The Bill and Melinda Gates Foundation funded the project through a grant to Population Services International (PSI) South Africa. The grant number was 50748, and a sub grant was given to WITS Health Consortium by Population Services International, grant number 3333. The grant information for Bill and Melinda Gates Foundation can be accessed at (http://www.gatesfoundation.org). PEPFAR through CDC funded PSI/SFH in South Africa, who funds high volume male circumcision sites at Witbank and Tsakane. The funders had no role in data collection and analysis, decision to publish or preparation of the manuscript, however they had a role in the study design. The funders requested that the study design has followed the World Health Organization framework of evaluating medical male circumcision devices.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barone MA, 2011, JAIDS-J ACQ IMM DEF, V57, pE7, DOI 10.1097/QAI.0b013e3182158967; eMalahleni Local Municipality, 2013, INT DEV PLAN 2013 20; Fedlum PJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095357, DOI 10.1371/JOURNAL.PONE.0095357]; Galukande M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086631; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Kigozi G, 2014, BJU INT, V113, P127, DOI 10.1111/bju.12406; Kigozi G, 2013, JAIDS-J ACQ IMM DEF, V63, P617, DOI 10.1097/QAI.0b013e3182968dda; Millard PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121686; Moyo T, 2014, PREPEX COULD CUT BOT; Mutabazi V, 2013, JAIDS-J ACQ IMM DEF, V63, P315, DOI 10.1097/QAI.0b013e31828e6412; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Rech D, 2014, ADVERSE EVENT ACTION; Rech D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080577; Samuelson J, 2013, JAIDS-J ACQ IMM DEF, V64, P127, DOI 10.1097/QAI.0b013e3182a61dd3; Shisana O, 2014, S AFRICAN NATL HIV P; Sokal DC, 2014, JAIDS-J ACQ IMM DEF, V65, P447, DOI 10.1097/QAI.0000000000000061; Statistics South Africa, 2011, CENS 2011 TSAK; The South African National AIDS Council, 2011, NAT STRAT PLAN HIV S; WHO, 2013, PROGR SCAL VOL MED M; World Health Organisation, 2013, WHO GUID US DEV AD M; World Health Organisation, 2013, INF UPD PREPEX DEV A; World Health Organization, 2009, MAN MAL CIRC LOC AN; World Health Organization (WHO), 2012, FRAM CLIN EV DEV MAL	25	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138755	10.1371/journal.pone.0138755	http://dx.doi.org/10.1371/journal.pone.0138755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405786	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700087
J	Oelmann, E; Stein, H; Berdel, WE; Herbst, H				Oelmann, Elisabeth; Stein, Harald; Berdel, Wolfgang E.; Herbst, Hermann			Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma	PLOS ONE			English	Article							REED-STERNBERG CELLS; B-CELL; T-CELLS; ACCESSORY PROTEIN; PERIPHERAL-BLOOD; GENE TRANSCRIPTS; NATURAL-KILLER; TUMOR-CELLS; IFN-GAMMA; IL-1	Signaling through the IL-1-receptor type 1 (IL-1R1), IL-1 is required for initiation and maintenance of diverse activities of the immune system. A second receptor, IL-1R2, blocks IL-1 signal transduction. We studied expression of IL-1beta, IL-1R1, and IL-1R2 in 17 Hodgkin lymphomas (HL) by in situ hybridization (ISH). IL-1beta expressing cells, morphologically consistent with endothelial cells and fibroblasts, occurred in all HL tissues with elevated transcript levels in areas of active fibrosis. Hodgkin and Reed-Sternberg (HRS) cells of all cases expressed low IL-1R1 transcript levels in some tumor cells, and high levels of IL-1R2 in large proportions of HRS cells. Only few bystander cells showed low levels of IL-1R1 and IL-1R2 RNA. Supernatants of 4 out of 7 HL-derived cell lines contained soluble IL-1R2 protein at high levels. HL patient sera carried variably amounts of IL-1R2 protein with significantly increased titers in patients with active disease compared to patients in complete remission and control individuals without HL. Western blots and co-immunoprecipitations showed binding of the IL-1R2 to the intracellular IL-1R-accessory protein (IL-1IRAcP). These data suggest functions of the IL-1R2 as a, decoy-receptor" sequestrating paracrine IL-1 extracellularly and intracellularly by engaging IL-1IRAcP, thus depriving IL1-R1 molecules of their extracellular and intracellular ligands. Expression of IL1-R2 by HRS cells seems to contribute to local and systemic modulation of immune function in HL.	[Oelmann, Elisabeth; Berdel, Wolfgang E.] Univ Hosp Muenster, Dept Med A Hematol Oncol, Munster, Germany; [Stein, Harald] Pathodiagnostik Berlin, Berlin, Germany; [Herbst, Hermann] Vivantes Hosp, Inst Pathol, Berlin, Germany	University of Munster	Herbst, H (corresponding author), Vivantes Hosp, Inst Pathol, Berlin, Germany.	hermann.herbst@vivantes.de			Deutsche Forschungsgemeinschaft (DFG) [EXC 1003]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant: Excellence Cluster "Cells in Motion" (EXC 1003) to WEB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 2001, NAT IMMUNOL, V2, P1010, DOI 10.1038/ni722; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Ales-Martinez J E, 1992, Semin Immunol, V4, P195; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0; BERTOGLIO JH, 1987, LYMPHOKINE RES, V6, P83; BOMSZTYK K, 1990, J BIOL CHEM, V265, P9413; BOURDOULOUS S, 1995, EUR J IMMUNOL, V25, P1176, DOI 10.1002/eji.1830250507; Briscoe DM, 1997, J IMMUNOL, V159, P3247; CAROSELLA ED, 1989, CELL IMMUNOL, V121, P269, DOI 10.1016/0008-8749(89)90025-7; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; CONTI P, 1992, SCAND J IMMUNOL, V36, P27, DOI 10.1111/j.1365-3083.1992.tb02937.x; CRUMP WL, 1989, CANCER RES, V49, P149; DAMLE RN, 1990, BRIT J CANCER, V61, P404, DOI 10.1038/bjc.1990.88; DANFORTH DN, 1993, CANCER RES, V53, P1538; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI 10.1016/S0065-2776(08)60642-2; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; DREXLER HG, 1993, LEUKEMIA LYMPHOMA, V9, P1, DOI 10.3109/10428199309148499; EBINA N, 1990, BRIT J CANCER, V62, P619, DOI 10.1038/bjc.1990.341; FOSS HD, 1995, AM J PATHOL, V146, P33; FOSS HD, 1993, BRIT J HAEMATOL, V84, P627, DOI 10.1111/j.1365-2141.1993.tb03138.x; FUJIWARA T, 1992, J IMMUNOL, V148, P2941; Gabrilovich D, 2003, CURR DRUG TARGETS, V4, P525, DOI 10.2174/1389450033490849; GIRI JG, 1990, J BIOL CHEM, V265, P17416; GORDON J, 1991, ADV CANCER RES, V56, P313; GORSCHLUTER M, 1995, ANN ONCOL, V6, P477, DOI 10.1093/oxfordjournals.annonc.a059218; HAMBURGER AW, 1987, CANCER RES, V47, P5612; Heath VL, 2002, CURR TOP MICROBIOL, V266, P23; ITO R, 1993, CANCER RES, V53, P4102; IWASAKI T, 1993, CYTOKINE, V5, P416, DOI 10.1016/1043-4666(93)90031-Y; Jona A, 2013, EXP HEMATOL, V41, P995, DOI 10.1016/j.exphem.2013.09.014; Jundt F, 1999, BLOOD, V94, P2065, DOI 10.1182/blood.V94.6.2065.418k15_2065_2071; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Kanakaraj P, 1999, J EXP MED, V189, P1129, DOI 10.1084/jem.189.7.1129; KILIAN PL, 1991, CANCER RES, V51, P1823; Kovalovsky D, 2000, J NEUROIMMUNOL, V109, P23, DOI 10.1016/S0165-5728(00)00298-8; LACHMAN LB, 1986, J IMMUNOL, V136, P3098; LAHM H, 1992, EUR J CANCER, V28A, P1894, DOI 10.1016/0959-8049(92)90031-V; Lang D, 1998, J IMMUNOL, V161, P6871; LARRICK JW, 1989, IMMUNOL TODAY, V10, P61, DOI 10.1016/0167-5699(89)90308-3; Liu YX, 2014, SEMIN CANCER BIOL, V24, P15, DOI 10.1016/j.semcancer.2013.07.002; Malinowsky D, 1998, FEBS LETT, V429, P299, DOI 10.1016/S0014-5793(98)00467-0; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; MATSUSHIMA K, 1986, J IMMUNOL, V136, P2883; MUKHOPADHYAYA R, 1987, BRIT J CANCER, V56, P800, DOI 10.1038/bjc.1987.293; Nakae S, 2001, J IMMUNOL, V167, P90, DOI 10.4049/jimmunol.167.1.90; NAUME B, 1994, SCAND J IMMUNOL, V40, P128, DOI 10.1111/j.1365-3083.1994.tb03441.x; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; NUMEROF RP, 1990, CELL IMMUNOL, V130, P118, DOI 10.1016/0008-8749(90)90166-O; Oelmann E, 1997, INT J CANCER, V71, P1066, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1066::AID-IJC25>3.0.CO;2-A; ONOZAKI K, 1985, J IMMUNOL, V135, P3962; Poppema S, 1998, ANN ONCOL, V9, P21, DOI 10.1023/A:1008458023093; POSTLETHWAITE AE, 1988, J CELL BIOL, V106, P311, DOI 10.1083/jcb.106.2.311; REE HJ, 1987, CANCER, V59, P1717, DOI 10.1002/1097-0142(19870515)59:10<1717::AID-CNCR2820591007>3.0.CO;2-U; ROTHENBERG EV, 1994, EUR J IMMUNOL, V24, P24, DOI 10.1002/eji.1830240105; Saijo Y, 1999, CLIN CANCER RES, V5, P1203; SHIN SS, 1995, ARCH PATHOL LAB MED, V119, P247; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SKEEN MJ, 1995, J IMMUNOL, V154, P5832; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; SOULILLOU JP, 1985, EUR J CANCER CLIN ON, V21, P935, DOI 10.1016/0277-5379(85)90111-7; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401; Steigerwald-Mullen P, 2000, J VIROL, V74, P6748, DOI 10.1128/JVI.74.15.6748-6759.2000; STRICKER K, 1993, EUR J IMMUNOL, V23, P1475, DOI 10.1002/eji.1830230712; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; SYMONS JA, 1995, P NATL ACAD SCI USA, V92, P1714, DOI 10.1073/pnas.92.5.1714; SYMONS JA, 1990, FEBS LETT, V272, P133, DOI 10.1016/0014-5793(90)80466-V; TOSATO G, 1990, BLOOD, V75, P922; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; WILLIAMS JM, 1984, J IMMUNOL, V133, P2986; XERRI L, 1992, INT J CANCER, V50, P689, DOI 10.1002/ijc.2910500504; ZAMKOFF KW, 1985, CLIN IMMUNOL IMMUNOP, V35, P111, DOI 10.1016/0090-1229(85)90084-4; ZEKI K, 1993, J CLIN ENDOCR METAB, V76, P127, DOI 10.1210/jc.76.1.127	76	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138747	10.1371/journal.pone.0138747	http://dx.doi.org/10.1371/journal.pone.0138747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406983	Green Published, gold			2022-12-27	WOS:000361800700083
J	Tan, SP; Zhao, YL; Fan, FM; Zou, YZ; Jin, Z; Zen, YW; Zhu, XL; Yang, FD; Tan, YL; Zhou, DF				Tan, Shuping; Zhao, Yanli; Fan, Fengmei; Zou, Yizhuang; Jin, Zhen; Zen, Yawei; Zhu, Xiaolin; Yang, Fude; Tan, Yunlong; Zhou, Dongfeng			Brain Correlates of Self-Evaluation Deficits in Schizophrenia: A Combined Functional and Structural MRI Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FMRI; REFLECTION; AWARENESS; METAANALYSIS; ACTIVATION; INSIGHT	Self-evaluation plays an important role in adaptive functioning and is a process that is typically impaired in patients with schizophrenia. Underlying neural mechanisms for this dysfunction may be associated with manifested psychosis. However, the brain substrates underlying this deficit are not well known. The present study used brain blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) and gray matter voxel-based morphometry to explore the functional and structural brain correlates of self-evaluation deficits in schizophrenia. Eighteen patients with schizophrenia and 17 healthy controls were recruited and asked to judge whether a set of personality-trait adjectives were appropriate for describing themselves, a familiar other, or whether the adjectives were of positive or negative valence. Patients had slower response times for negative trait attributions than controls did; responses to positive trait attributions were faster than those for negative traits among the patient group, while no differences were observed in the control group. Control subjects showed greater activation within the dorsal medial prefrontal cortex (dMPFC) and the anterior cingulate cortex (ACC) than the patient group during the self-evaluation > semantic positivity-evaluation contrast. Patients showed greater activation mainly within the posterior cingulate gyrus (PCC) as compared to controls for the other-evaluation > semantic positivity-evaluation contrast. Furthermore, gray matter volume was reduced in the MPFC, temporal lobe, cuneus, and the dorsal lateral prefrontal cortex (DLPFC) among the patient group when compared to controls. The present study adds to previous findings regarding self-and other-referential processing in schizophrenia, providing support for neurobiological models of self-reflection impairment.	[Tan, Shuping; Zhou, Dongfeng] Peking Univ, Inst Mental Hlth, Beijing 100191, Peoples R China; [Tan, Shuping; Zhao, Yanli; Fan, Fengmei; Zou, Yizhuang; Zhu, Xiaolin; Yang, Fude; Tan, Yunlong] Beijing Huilongguan Hosp, Ctr Psychiat Res, Beijing 100096, Peoples R China; [Jin, Zhen; Zen, Yawei] 306th Hosp PLA, Magnet Res Imaging Unit, Beijing 100101, Peoples R China	Peking University	Zou, YZ (corresponding author), Beijing Huilongguan Hosp, Ctr Psychiat Res, Beijing 100096, Peoples R China.	yzouy@263.net; zhoudf@bjmu.edu.cn	zhao, yan/GWC-9174-2022		Fund of Capital Medical Development and Research grant [2011-2013-02]; Beijing Municipal Science & Technology Commission [Z141107002514016, D121100005012005]; International Cooperation and Exchange of the National Natural Science Foundation of China [81461130016]; Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding [zy201409]; National Natural Science Foundation of China [81401133]	Fund of Capital Medical Development and Research grant; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Fund of Capital Medical Development and Research grant (2011-2013-02)(SPT), Beijing Municipal Science & Technology Commission (Z141107002514016)(SPT), Beijing Municipal Science & Technology Commission (D121100005012005)(FDY), International Cooperation and Exchange of the National Natural Science Foundation of China (81461130016) (YLT), Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding (zy201409) (FDY) and the National Natural Science Foundation of China (81401133) (YLZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 1994, DIAGN STAT MAN MENT; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bedford NJ, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-106; BELL MD, 1994, PSYCHIAT RES, V52, P295, DOI 10.1016/0165-1781(94)90075-2; Blackwood NJ, 2004, PSYCHOL MED, V34, P591, DOI 10.1017/S0033291703008997; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Gilleen J, 2011, SCHIZOPHRENIA BULL, V37, P61, DOI 10.1093/schbul/sbq100; Harvey PO, 2011, SCHIZOPHR RES, V127, P171, DOI 10.1016/j.schres.2010.11.011; Holt DJ, 2011, BIOL PSYCHIAT, V69, P415, DOI 10.1016/j.biopsych.2010.10.003; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Liu JC, 2014, PSYCHIAT RES-NEUROIM, V222, P165, DOI 10.1016/j.pscychresns.2014.04.003; Lysaker PH, 2011, COMPR PSYCHIAT, V52, P253, DOI 10.1016/j.comppsych.2010.07.007; Lysaker PH, 2010, SCHIZOPHR RES, V122, P124, DOI 10.1016/j.schres.2009.04.024; Modinos G, 2011, NEUROPSYCHOLOGY, V25, P295, DOI 10.1037/a0021747; Modinos G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004618; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Murphy ER, 2010, SCHIZOPHR RES, V116, P252, DOI 10.1016/j.schres.2009.11.009; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Pauly KD, 2014, SOC COGN AFFECT NEUR, V9, P1779, DOI 10.1093/scan/nst174; Shad MU, 2011, ASIAN J PSYCHIATR, V4, P248, DOI 10.1016/j.ajp.2011.09.002; Shad MU, 2012, SCHIZOPHR RES, V138, P113, DOI 10.1016/j.schres.2012.03.016; Silva JR, 2008, BIOL RES, V41, P143, DOI [/S0716-97602008000200003, 10.4067/S0716-97602008000200003]; van der Meer L, 2013, SCHIZOPHRENIA BULL, V39, P1352, DOI 10.1093/schbul/sbs122; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; 张智勇, 1998, [心理学报, Acta Psychologica Sinica], V30, P85	28	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138737	10.1371/journal.pone.0138737	http://dx.doi.org/10.1371/journal.pone.0138737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406464	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700080
J	Meher, BR; Dixit, A; Bousfield, GR; Lushington, GH				Meher, Biswa Ranjan; Dixit, Anshuman; Bousfield, George R.; Lushington, Gerald H.			Glycosylation Effects on FSH-FSHR Interaction Dynamics: A Case Study of Different FSH Glycoforms by Molecular Dynamics Simulations	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; IN-VITRO; RECEPTOR; ROLES; WATER; RESIDUES; COMPLEX; BINDING; MODELS; SYSTEM	The gonadotropin known as follicle-stimulating hormone (FSH) plays a key role in regulating reproductive processes. Physiologically active FSH is a glycoprotein that can accommodate glycans on up to four asparagine residues, including two sites in the FSH alpha subunit that are critical for biochemical function, plus two sites in the beta subunit, whose differential glycosylation states appear to correspond to physiologically distinct functions. Some degree of FSH beta hypo-glycosylation seems to confer advantages toward reproductive fertility of childbearing females. In order to identify possible mechanistic underpinnings for this physiological difference we have pursued computationally intensive molecular dynamics simulations on complexes between the high affinity site of the gonadal FSH receptor (FSHR) and several FSH glycoforms including fully-glycosylated (FSH24), hypo-glycosylated (e.g., FSH15), and completely deglycosylated FSH (dgFSH). These simulations suggest that deviations in FSH/FSHR binding profile as a function of glycosylation state are modest when FSH is adorned with only small glycans, such as single N-acetylglucosamine residues. However, substantial qualitative differences emerge between FSH15 and FSH24 when FSH is decorated with a much larger, tetra-antennary glycan. Specifically, the FSHR complex with hypo-glycosylated FSH15 is observed to undergo a significant conformational shift after 5-10 ns of simulation, indicating that FSH15 has greater conformational flexibility than FSH24 which may explain the more favorable FSH15 kinetic profile. FSH15 also exhibits a stronger binding free energy, due in large part to formation of closer and more persistent salt-bridges with FSHR.	[Meher, Biswa Ranjan] Univ Kansas, Bioinformat Core Facil, Lawrence, KS 66045 USA; [Dixit, Anshuman] Inst Life Sci, Bhubaneswar 751023, Orissa, India; [Bousfield, George R.] Wichita State Univ, Dept Biol Sci, Wichita, KS 67208 USA; [Lushington, Gerald H.] LiS Consulting, Lawrence, KS USA	University of Kansas; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Wichita State University	Meher, BR (corresponding author), Univ Kansas, Bioinformat Core Facil, Lawrence, KS 66045 USA.	brmeher@gmail.com; lushington_insilico@yahoo.com	BOUSFIELD, George/R-5726-2019; Lushington, Gerald/P-8421-2019; Meher, Biswa/GPX-7920-2022; Lushington, Gerald/AAH-3205-2020	Lushington, Gerald/0000-0001-5821-4253; Meher, Biswa Ranajn/0000-0003-0519-9074	National Institute of Health [P01 AG-029531]; LiS Consulting	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LiS Consulting	This research was supported by National Institute of Health Grant P01 AG-029531 to GRB. LiS Consulting provided support in the form of a salary for GHL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2008, SYBYL 8 1; BISHOP LA, 1994, MOL ENDOCRINOL, V8, P722, DOI 10.1210/me.8.6.722; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Bousfield GR, 2007, MOL CELL ENDOCRINOL, V260, P40, DOI 10.1016/j.mce.2006.02.017; Bousfield GR, 2014, MOL CELL ENDOCRINOL, V382, P989, DOI 10.1016/j.mce.2013.11.008; CALVO FO, 1986, BIOCHEMISTRY-US, V25, P3938, DOI 10.1021/bi00361a030; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHENG KW, 1975, BIOCHEM J, V149, P123, DOI 10.1042/bj1490123; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; Davis John S, 2014, J Glycomics Lipidomics, V4, pe117; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; FLACK MR, 1994, J BIOL CHEM, V269, P14015; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Harvey DJ, 2011, PROTEOMICS, V11, P4291, DOI 10.1002/pmic.201100300; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jankovic M, 2011, J MED BIOCHEM, V30, P213, DOI 10.2478/v10011-011-0023-5; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1985, MOL PHYS, V56, P1381, DOI 10.1080/00268978500103111; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mizunuma H, 2011, SAISHIN IGAKU, V66, P862; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Ulloa-Aguirre A, 2003, BIOL REPROD, V69, P379, DOI 10.1095/biolreprod.103.016915; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Walton WJ, 2001, J CLIN ENDOCR METAB, V86, P3675, DOI 10.1210/jcem.86.8.7712	32	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0137897	10.1371/journal.pone.0137897	http://dx.doi.org/10.1371/journal.pone.0137897			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402790	Green Published, gold, Green Submitted			2022-12-27	WOS:000361798100014
J	van Zonneveld, M; Ramirez, M; Williams, DE; Petz, M; Meckelmann, S; Avila, T; Bejarano, C; Rios, L; Pena, K; Jager, M; Libreros, D; Amaya, K; Scheldeman, X				van Zonneveld, Maarten; Ramirez, Marleni; Williams, David E.; Petz, Michael; Meckelmann, Sven; Avila, Teresa; Bejarano, Carlos; Rios, Llerme; Pena, Karla; Jaeger, Matthias; Libreros, Dimary; Amaya, Karen; Scheldeman, Xavier			Screening Genetic Resources of Capsicum Peppers in Their Primary Center of Diversity in Bolivia and Peru	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; STABILITY ANALYSIS; CAPSAICINOIDS; SOLANACEAE; BACCATUM; BIODIVERSITY; ACCESSIONS; CULTIVARS; EVOLUTION; SOLANUM	For most crops, like Capsicum, their diversity remains under-researched for traits of interest for food, nutrition and other purposes. A small investment in screening this diversity for a wide range of traits is likely to reveal many traditional varieties with distinguished values. One objective of this study was to demonstrate, with Capsicum as model crop, the application of indicators of phenotypic and geographic diversity as effective criteria for selecting promising genebank accessions for multiple uses from crop centers of diversity. A second objective was to evaluate the expression of biochemical and agromorphological properties of the selected Capsicum accessions in different conditions. Four steps were involved: 1) Develop the necessary diversity by expanding genebank collections in Bolivia and Peru; 2) Establish representative subsets of similar to 100 accessions for biochemical screening of Capsicum fruits; 3) Select promising accessions for different uses after screening; and 4) Examine how these promising accessions express biochemical and agromorphological properties when grown in different environmental conditions. The Peruvian Capsicum collection now contains 712 accessions encompassing all five domesticated species (C. annuum, C. chinense, C. frutescens, C. baccatum, and C. pubescens). The collection in Bolivia now contains 487 accessions, representing all five domesticates plus four wild taxa (C. baccatum var. baccatum, C. caballeroi, C. cardenasii, and C. eximium). Following the biochemical screening, 44 Bolivian and 39 Peruvian accessions were selected as promising, representing wide variation in levels of antioxidant capacity, capsaicinoids, fat, flavonoids, polyphenols, quercetins, tocopherols, and color. In Peru, 23 promising accessions performed well in different environments, while each of the promising Bolivian accessions only performed well in a certain environment. Differences in Capsicum diversity and local contexts led to distinct outcomes in each country. In Peru, mild landraces with high values in health-related attributes were of interest to entrepreneurs. In Bolivia, wild Capsicum have high commercial demand.	[van Zonneveld, Maarten] Biovers Int, Costa Rica Off, Turrialba, Costa Rica; [Ramirez, Marleni; Jaeger, Matthias; Libreros, Dimary; Amaya, Karen; Scheldeman, Xavier] Biovers Int, Reg Off Amer, Cali, Colombia; [Williams, David E.] Interamer Inst Cooperat Agr, San Jose, Costa Rica; [Petz, Michael; Meckelmann, Sven] Univ Wuppertal, Fac Math & Nat Sci, Dept Food Chem, Wuppertal, Germany; [Avila, Teresa] Ctr Invest Fitoecogenet Pairumani, Cochabamba, Bolivia; [Bejarano, Carlos] Fdn Promoc & Invest Prod Andinos PROINPA, Oficina Reg Valle Sur, Sucre, Bolivia; [Rios, Llerme; Pena, Karla] Inst Nacl Innovac Agr, Lima, Peru	Alliance; Bioversity International; Alliance; Bioversity International; University of Wuppertal	van Zonneveld, M (corresponding author), Biovers Int, Costa Rica Off, Turrialba, Costa Rica.	m.vanzonneveld@cgiar.org	Scheldeman, Xavier/AAF-7960-2021; Scheldeman, Xavier/ABE-9909-2021	Scheldeman, Xavier/0000-0001-7967-7361; PENA PINEDA, KARLA MONICA/0000-0003-4877-645X	German Society for International Collaboration; Gesellschaft fur Internationale Zusammenarbeit (GIZ); Climate Change, Agriculture and Food Security (CCAFS)	German Society for International Collaboration; Gesellschaft fur Internationale Zusammenarbeit (GIZ); Climate Change, Agriculture and Food Security (CCAFS)	This study is part of the international and interdisciplinary project 'Unravelling the potential of underutilized crop diversity for high-value product differentiation: the case of chilli peppers in Bolivia and Peru' funded by the German Society for International Collaboration, Gesellschaft fur Internationale Zusammenarbeit (GIZ), and contributes to the CGIAR Research Programs on Policies, Institutions and Markets (PIM) and Climate Change, Agriculture and Food Security (CCAFS).	Agricolae Mendiburu F., 2014, STAT PROCEDURES AGR; Albrecht E, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-68; Annicchiarico, 2002, GENOTYPE X ENV INTER; [Anonymous], 2010, R LANG ENV STAT COMP; Antonious GF, 2006, J ENVIRON SCI HEAL B, V41, P717, DOI 10.1080/03601230600701908; APEGA UNALM INIA USMP, 2009, AJ PER SAZ MUND; Azurdia C, 2011, ATLAS GUATERMALTECO; Barboza Gloria E., 2010, PhytoKeys, V2, P23, DOI [10.3897/phytokeys.2.730, 10.3897/PhytoKeys.2.730]; BECKER HC, 1988, PLANT BREEDING, V101, P1, DOI 10.1111/j.1439-0523.1988.tb00261.x; Bosland P. W., 1996, Progress in new crops: Proceedings of the Third National Symposium, Indianapolis, Indiana, USA, 22-25 October, 1996., P479; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Cadima X, 2014, J NAT CONSERV, V22, P113, DOI 10.1016/j.jnc.2013.09.007; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; Devaux A, 2009, FOOD POLICY, V34, P31, DOI 10.1016/j.foodpol.2008.10.007; Eggink PM, 2014, THEOR APPL GENET, V127, P373, DOI 10.1007/s00122-013-2225-3; Eshbaugh WH, 2012, PEPPERS: BOTANY, PRODUCTION AND USES, P14, DOI 10.1079/9781845937676.0014; Grum M., 2007, HDB GENEBANKS, V9; Gurung T, 2012, EUPHYTICA, V187, P11, DOI 10.1007/s10681-012-0672-6; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Howard LR, 2000, J AGR FOOD CHEM, V48, P1713, DOI 10.1021/jf990916t; Ibiza VP, 2012, GENET RESOUR CROP EV, V59, P1077, DOI 10.1007/s10722-011-9744-z; IPGRI AVRDC CATIE, 1995, DESCR CAPS; Jager M, 2013, TALLERES ANALISIS MU; Jager M, 2013, RESCATE PROMOCION AJ; Jano P, 2007, CACAO MARKETING CHAI; Kahane R, 2013, AGRON SUSTAIN DEV, V33, P671, DOI 10.1007/s13593-013-0147-8; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kollmannsberger H, 2011, J SCI FOOD AGR, V91, P1598, DOI 10.1002/jsfa.4354; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Libreros D, 2014, CATALOGO AJIES CAPSI; Libreros D, 2013, CATALOGO AJIES CAPSI; Materska M, 2005, J AGR FOOD CHEM, V53, P1750, DOI 10.1021/jf035331k; Meckelmann SW, 2015, EUR FOOD RES TECHNOL, V241, P817, DOI 10.1007/s00217-015-2506-y; Meckelmann SW, 2015, EUR FOOD RES TECHNOL, V240, P273, DOI 10.1007/s00217-014-2325-6; Meckelmann SW, 2013, J AGR FOOD CHEM, V61, P2530, DOI [10.1021/jf304986q, 10.1021/jf304986]; Moscone EA, 2007, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2007.745.5; Moses M, 2014, GENET RESOUR CROP EV, V61, P741, DOI 10.1007/s10722-013-0069-y; Nee M, 2006, BRITTONIA, V58, P322, DOI 10.1663/0007-196X(2006)58[322:NSOSAC]2.0.CO;2; OECD, 2006, SER HARM REG OV BIOT; Oksanen J., 2013, PACKAGE VEGAN R PACK, V254; Ortiz R, 2010, SCI HORTIC-AMSTERDAM, V126, P186, DOI 10.1016/j.scienta.2010.07.007; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; Perry L, 2012, PEPPERS: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9781845937676.0001; Phimchan P, 2012, HORTSCIENCE, V47, P1204, DOI 10.21273/HORTSCI.47.9.1204; Pickersgill B., 1991, Chromosome engineering in plants: genetics, breeding, evolution. Part B., P139; Reifschneider FJB, 2009, CHRON HORTICULT, V49, P19; Thampi PSS, 2003, MED AROM PLANTS, V33, P16; Ugas R, 2013, SERIE PUNTO AJI, V1- 2; Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y; Vincent H, 2013, BIOL CONSERV, V167, P265, DOI 10.1016/j.biocon.2013.08.011; Wahyuni Y, 2011, PHYTOCHEMISTRY, V72, P1358, DOI 10.1016/j.phytochem.2011.03.016; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; White D., 2012, MAPTREE MAPPING PRUN; Williams DE, 2004, HOME GARDENS AGROBIO, P256	55	44	44	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0134663	10.1371/journal.pone.0134663	http://dx.doi.org/10.1371/journal.pone.0134663			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402618	Green Published, Green Submitted, gold			2022-12-27	WOS:000361798100003
J	Martic-Kehl, MI; Wernery, J; Folkers, G; Schubiger, PA				Martic-Kehl, Marianne Isabelle; Wernery, Jannis; Folkers, Gerd; Schubiger, Pius August			Quality of Animal Experiments in Anti-Angiogenic Cancer Drug Development - A Systematic Review	PLOS ONE			English	Article							TRANSLATION; HUMANS; MOUSE	Translation from preclinical animal research to clinical bedside has proven to be difficult to impossible in many fields of research (e.g. acute stroke, ALS and HIV vaccination development) with oncology showing particularly low translation rates (5% vs. 20% for cardiovascular diseases). Several investigations on published preclinical animal research have revealed that apart from plain species differences, translational problems can arise from low study quality (e.g. study design) or non-representative experimental conditions (e.g. treatment schedule). This review assessed the published experimental circumstances and quality of antiangiogenic cancer drug development in 232 in vivo studies. The quality of study design was often insufficient; at least the information published about the experiments was not satisfactory in most cases. There was no quality improvement over time, with the exception of conflict of interest statements. This increase presumably arose mainly because journal guidelines request such statements more often recently. Visual inspection of data and a cluster analysis confirmed a trend described in literature that low study quality tends to overestimate study outcome. It was also found that experimental outcome was more favorable when a potential drug was investigated as the main focus of a study, compared to drugs that were used as comparison interventions. We assume that this effect arises from the frequent neglect of blinding investigators towards treatment arms and refer to it as hypothesis bias. In conclusion, the reporting and presumably also the experimental performance of animal studies in drug development for oncology suffer from similar shortcomings as other fields of research (such as stroke or ALS). We consider it necessary to enforce experimental quality and reporting that corresponds to the level of clinical studies. It seems that only clear journal guidelines or guidelines from licensing authorities, where failure to fulfill prevents publication or experimental license, can help to improve this situation.	[Martic-Kehl, Marianne Isabelle] ETH, Coll Helveticum, Zurich, Switzerland; Univ Zurich, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Martic-Kehl, MI (corresponding author), ETH, Coll Helveticum, Zurich, Switzerland.	martic@collegium.ethz.ch		Folkers, Gerd/0000-0002-3620-705X; , Jannis/0000-0001-6819-9683	ETH-grants, the OPO Stiftung foundation Zurich [2012/13-0005]	ETH-grants, the OPO Stiftung foundation Zurich	This study was financed by ETH-grants, the OPO Stiftung foundation Zurich, grant number 2012/13-0005. Additional funding was provided by Dr. Richard Dahler.	Ameen N, 2000, HISTOCHEM CELL BIOL, V114, P69; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Bailey J, 2008, ATLA-ALTERN LAB ANIM, V36, P381, DOI 10.1177/026119290803600403; Bailey Jarrod, 2005, Biogenic Amines, V19, P235, DOI 10.1163/156939105774647385; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Bertotti A, 2003, JNCI-J NATL CANCER I, V105, P1426; Buckland G., REPLACING PRIMATES M; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eisen JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001757; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hackam DG, 2007, BMJ-BRIT MED J, V334, P163, DOI 10.1136/bmj.39104.362951.80; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hooijmans CR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001482; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Knight A, 2007, ALTEX, V14, P125; Langley G, 2009, REV SEMESTRIELLE DRO, V1, P161; Manolagas SC, 2014, J BONE MINER RES, V29, P2131, DOI 10.1002/jbmr.2293; Martic-Kehl MI, 2012, EUR J NUCL MED MOL I, V39, P1492, DOI 10.1007/s00259-012-2175-z; Martic-Kehl MI, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-26; Matthews RAJ, 2008, J ROY SOC MED, V101, P95, DOI 10.1258/jrsm.2007.070164; Muhlhausler BS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001481; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Royal Society, 2002, STAT ROYAL SOC POS U; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; The PLOS Medicine Editors, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001493, DOI 10.1371/JOURNAL.PMED.1001493]; UK Department of Health, 2001, MEM HOUS LORDS SEL C; US Department of Public Health, 1994, PHYSIOLOGIST, V37, P107	30	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137235	10.1371/journal.pone.0137235	http://dx.doi.org/10.1371/journal.pone.0137235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421849	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700011
J	Okoshi, T; Yamaguchi, I; Ozawa, D; Hasegawa, K; Naiki, H				Okoshi, Tadakazu; Yamaguchi, Itaru; Ozawa, Daisaku; Hasegawa, Kazuhiro; Naiki, Hironobu			Endocytosed 2-Microglobulin Amyloid Fibrils Induce Necrosis and Apoptosis of Rabbit Synovial Fibroblasts by Disrupting Endosomal/Lysosomal Membranes: A Novel Mechanism on the Cytotoxicity of Amyloid Fibrils	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CELL-DEATH; PROTEIN; BETA(2)-MICROGLOBULIN; BETA-2-MICROGLOBULIN; OLIGOMERS; POLYMERIZATION; HEMODIALYSIS; AGGREGATION; DYSFUNCTION	Dialysis-related amyloidosis is a major complication in long-term hemodialysis patients. In dialysis-related amyloidosis, beta 2-microglobulin (beta 2-m) amyloid fibrils deposit in the osteoarticular tissue, leading to carpal tunnel syndrome and destructive arthropathy with cystic bone lesions, but the mechanism by which these amyloid fibrils destruct bone and joint tissue is not fully understood. In this study, we assessed the cytotoxic effect of beta 2-m amyloid fibrils on the cultured rabbit synovial fibroblasts. Under light microscopy, the cells treated with amyloid fibrils exhibited both necrotic and apoptotic changes, while the cells treated with beta 2-m monomers and vehicle buffer exhibited no morphological changes. As compared to beta 2-m monomers and vehicle buffer, beta 2-m amyloid fibrils significantly reduced cellular viability as measured by the lactate dehydrogenase release assay and the 3-(4,5-di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction assay and significantly increased the percentage of apoptotic cells as measured by the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling method. beta 2-m amyloid fibrils added to the medium adhered to cell surfaces, but did not disrupt artificial plasma membranes as measured by the liposome dye release assay. Interestingly, when the cells were incubated with amyloid fibrils for several hours, many endosomes/lysosomes filled with amyloid fibrils were observed under confocal laser microscopy and electron microscopy, Moreover, some endosomal/lysosomal membranes were disrupted by intravesicular fibrils, leading to the leakage of the fibrils into the cytosol and adjacent to mitochondria. Inhibition of actin-dependent endocytosis by cytochalasin D attenuated the toxicity of amyloid fibrils. These results suggest that endocytosed beta 2-m amyloid fibrils induce necrosis and apoptosis by disrupting endosomal/lysosomal membranes, and this novel mechanism on the cytotoxicity of amyloid fibrils is described.	[Okoshi, Tadakazu; Yamaguchi, Itaru; Ozawa, Daisaku; Hasegawa, Kazuhiro; Naiki, Hironobu] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Mol Pathol, Fukui 910, Japan	University of Fukui	Naiki, H (corresponding author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Mol Pathol, Fukui 910, Japan.	naiki@u-fukui.ac.jp	Naiki, Hironobu/G-5599-2014		Ministry of Education, Culture, Sports, Science, and Technology, Japan [26860236, 25293094]; Ministry of Health, Labour and Welfare, Japan [H23-012]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants-in-aid for young scientists (B) 26860236 (TO) and scientific research (B) 25293094 (HN) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.mext.go.jp/), and for research on specific diseases "amyloidosis" H23-012 (HN) from the Ministry of Health, Labour and Welfare, Japan (http://www.mhlw.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles A, 2002, NEPHROL DIAL TRANSPL, V17, P1136, DOI 10.1093/ndt/17.6.1136; BARLAND P, 1962, J CELL BIOL, V14, P207, DOI 10.1083/jcb.14.2.207; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Bucciantini M, 2012, FASEB J, V26, P818, DOI 10.1096/fj.11-189381; Bullough PG, 2012, HISTOLOGY PATHOLOGIS, P107; CAMPISTOL JM, 1992, AM J PATHOL, V141, P241; Campistol JM, 1996, KIDNEY INT, V50, P1262, DOI 10.1038/ki.1996.436; Cecchi C, 2013, BIOPHYS CHEM, V182, P30, DOI 10.1016/j.bpc.2013.06.003; CHARRA B, 1985, P EUR DIAL TRANS, V21, P291; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Davies P, 1978, Front Biol, V46, P143; Davison AM, 1995, NEPHROL DIAL TRANSPL, V10, P48; Demuro A, 2013, J NEUROSCI, V33, P3824, DOI 10.1523/JNEUROSCI.4367-12.2013; DESTRIHOU CV, 1991, KIDNEY INT, V39, P1012, DOI 10.1038/ki.1991.128; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fell H B, 1978, J Clin Pathol Suppl (R Coll Pathol), V12, P14; Floege J, 1996, NEPHRON, V72, P9, DOI 10.1159/000188801; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; Garcia-Garcia M, 1999, KIDNEY INT, V55, P899, DOI 10.1046/j.1523-1755.1999.055003899.x; Gargar C, 1999, KIDNEY INT, V55, P1983, DOI 10.1046/j.1523-1755.1999.00430.x; Gejyo F, 1990, Contrib Nephrol, V78, P47; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; GEJYO F, 1986, NEW ENGL J MED, V314, P585; GEORGESCU HI, 1988, IN VITRO CELL DEV B, V24, P1015; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; GOREVIC PD, 1986, P NATL ACAD SCI USA, V83, P7908, DOI 10.1073/pnas.83.20.7908; Guan J, 2014, EMBO MOL MED, V6, P1493, DOI 10.15252/emmm.201404190; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Habib LK, 2010, J BIOL CHEM, V285, P38933, DOI 10.1074/jbc.M110.132860; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Huang B, 2009, BIOCHEMISTRY-US, V48, P5794, DOI 10.1021/bi900219c; Jakhria T, 2014, J BIOL CHEM, V289, P35781, DOI 10.1074/jbc.M114.586222; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kiichle C, 1996, AM J NEPHROL, V16, P484, DOI 10.1159/000169048; KOCH KM, 1992, KIDNEY INT, V41, P1416, DOI 10.1038/ki.1992.207; Kumar V., 2012, ROBBINS BASIC PATHOL, V9, P1; Leung E, 2011, NEUROBIOL AGING, V32, P387, DOI 10.1016/j.neurobiolaging.2009.02.025; Lonnemann G, 2002, J AM SOC NEPHROL, V13, pS72; Malchiodi-Albedi F, 2010, BBA-MOL BASIS DIS, V1802, P406, DOI 10.1016/j.bbadis.2010.01.007; Meratan AA, 2011, J MOL BIOL, V409, P826, DOI 10.1016/j.jmb.2011.04.045; Naiki H, 2009, J BIOCHEM, V146, P751, DOI 10.1093/jb/mvp119; OHASHI K, 1992, KIDNEY INT, V41, P1646, DOI 10.1038/ki.1992.237; Okada T, 2008, J MOL BIOL, V382, P1066, DOI 10.1016/j.jmb.2008.07.072; Okada T, 2007, J MOL BIOL, V371, P481, DOI 10.1016/j.jmb.2007.05.069; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; Porter MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027353; Ritchlin C, 2000, ARTHRITIS RES, V2, P356, DOI 10.1186/ar112; Sheynis T, 2013, BIOPHYS J, V105, P745, DOI 10.1016/j.bpj.2013.06.015; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Wakabayashi M, 2007, J MOL BIOL, V371, P924, DOI 10.1016/j.jmb.2007.06.008; Walsh P, 2014, J BIOL CHEM, V289, P10419, DOI 10.1074/jbc.M113.515866; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	58	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139330	10.1371/journal.pone.0139330	http://dx.doi.org/10.1371/journal.pone.0139330			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421922	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700096
J	Almutairi, A; Sun, ZH; Poovathumkadavi, A; Assar, T				Almutairi, Abdulrahman; Sun, Zhonghua; Poovathumkadavi, Abduljaleel; Assar, Tarek			Dual Energy CT Angiography of Peripheral Arterial Disease: Feasibility of Using Lower Contrast Medium Volume	PLOS ONE			English	Article							REDUCED IODINE LOAD; PROSPECTIVE RANDOMIZED-TRIAL; PULMONARY ANGIOGRAPHY; CORONARY-ANGIOGRAPHY; MULTIDETECTOR CT; IMAGE QUALITY; OPTIMIZATION; EXPERIENCE; REDUCTION	Objective One of the main drawbacks associated with Dual Energy Computed Tomography Angiography (DECTA) is the risk of developing contrast medium-induced nephropathy (CIN). The aim of the present study was firstly, to design an optimal CT imaging protocol by determining the feasibility of using a reduced contrast medium volume in peripheral arterial DECTA, and secondly, to compare the results with those obtained from using routine contrast medium volume. Methods Thirty four patients underwent DECTA for the diagnosis of peripheral arterial disease. They were randomly divided into two groups: Group 1 (routine contrast volume group) with n = 17, injection rate 4-5 ml/s, and 1.5 ml/kg of contrast medium, and Group 2 ((low contrast volume group), with n = 17, injection rate 4-5ml/s, and contrast medium volume 0.75 ml/kg. A fast kilovoltage-switching 64-slice CT scanner in the dual-energy mode was employed for the study. A total of 6 datasets of monochromatic images at 50, 55, 60, 65, 70 and 75 keV levels were reconstructed with adaptive statistical iterative reconstruction (ASIR) at 50%. A 4-point scale was the tool for qualitative analysis of results. The two groups were compared and assessed quantitatively for image quality on the basis of signal-to-noise ratio (SNR) and contrast-to-noise-ratio (CNR). Radiation and contrast medium doses were also compared. Results The overall mean CT attenuation and mean noise for all lower extremity body parts was significantly lower for the low volume contrast group (p<0.001), and varied significantly between groups (p = 0.001), body parts (p<0.001) and keVs (p<0.001). The interaction between group body parts was significant with CT attenuation and CNR (p = 0.002 and 0.003 respectively), and marginally significant with SNR (p = 0.047), with minimal changes noticed between the two groups. Group 2 (low contrast volume group) displayed the lowest image noise between 65 and 70 keV, recorded the highest SNR and CNR at 65 keV, and produced significantly lower results with respect to contrast medium volume and duration of contrast injection (p<0.001). The effect of radiation dose was not statistically significant between the two groups. Conclusions DECTA images created at 65 keV and 50% ASIR with low contrast medium volume protocol, yielded results that were comparable to routine contrast medium volume, with acceptable diagnostic images produced during the evaluation of peripheral arteries.	[Almutairi, Abdulrahman; Sun, Zhonghua] Curtin Univ, Sch Sci, Dept Med Radiat Sci, Perth, WA 6845, Australia; [Almutairi, Abdulrahman; Poovathumkadavi, Abduljaleel; Assar, Tarek] King Fahad Specialist Hosp, Dept Med Imaging, Dammam 31444, Saudi Arabia	Curtin University	Sun, ZH (corresponding author), Curtin Univ, Sch Sci, Dept Med Radiat Sci, Perth, WA 6845, Australia.	z.sun@curtin.edu.au	Sun, Zhonghua/B-3125-2010; Sun, Zhonghua/N-1648-2019	Sun, Zhonghua/0000-0002-7538-4761; Sun, Zhonghua/0000-0002-7538-4761				Almutairi A, 2015, INT J MOL SCI, V16, P11531, DOI 10.3390/ijms160511531; Anzidei M, 2013, CARDIOVASCULAR CT MR, P1; Baxa J, 2014, EUR J RADIOL, V83, pE147, DOI 10.1016/j.ejrad.2013.12.004; Brown JR, 2010, CIRC-CARDIOVASC INTE, V3, P346, DOI 10.1161/CIRCINTERVENTIONS.109.910638; Carrascosa P, 2014, INT J CARDIOVAS IMAG, V30, P1613, DOI 10.1007/s10554-014-0501-1; Coursey CA, 2010, RADIOGRAPHICS, V30, P1037, DOI 10.1148/rg.304095175; Delesalle MA, 2013, RADIOLOGY, V267, P256, DOI 10.1148/radiol.12120195; Dong J, 2013, J COMPUT ASSIST TOMO, V37, P618, DOI 10.1097/RCT.0b013e31828f5020; Karcaaltincaba M, 2011, DIAGN INTERV RADIOL, V17, P181, DOI 10.4261/1305-3825.DIR.3860-10.0; Maturen KE, 2012, J COMPUT ASSIST TOMO, V36, P83, DOI 10.1097/RCT.0b013e31824258cb; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Meyer BC, 2008, EUR J RADIOL, V68, P414, DOI 10.1016/j.ejrad.2008.09.016; Nijhof WH, 2013, EUR J RADIOL, V82, P1373, DOI 10.1016/j.ejrad.2013.03.027; Owen AR, 2011, POSTGRAD MED J, V87, P189, DOI 10.1136/pgmj.2009.082040; Pernas RO, 2014, RADIOLOGIA-MADRID, V56, P541, DOI 10.1016/j.rx.2012.06.013; Pinho DF, 2013, EUR RADIOL, V23, P351, DOI 10.1007/s00330-012-2624-x; Raju R, 2014, J CARDIOVASC COMPUT, V8, P282, DOI 10.1016/j.jcct.2014.06.003; Rubin GD, 2014, RADIOLOGY, V271, P633, DOI 10.1148/radiol.14132232; Saltybaeva N, 2014, RADIOLOGY, V273, P153, DOI 10.1148/radiol.14132903; Seehofnerova A, 2015, EUR J RADIOL OPEN, V2, P58, DOI 10.1016/j.ejro.2015.03.001; Shen YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117469; Sudarski S, 2013, EUR J RADIOL, V82, pE574, DOI 10.1016/j.ejrad.2013.04.040; Utsunomiya D, 2010, EUR RADIOL, V20, P2758, DOI 10.1007/s00330-010-1841-4; Vlahos I, 2012, AM J ROENTGENOL, V199, pS87, DOI 10.2214/AJR.12.9114; Wang H, 2015, J COMPUT ASSIST TOMO, V39, P112, DOI 10.1097/RCT.0000000000000162; Yagi M, 2013, J APPL CLIN MED PHYS, V14, P173, DOI 10.1120/jacmp.v14i5.4335; Yu LF, 2012, AM J ROENTGENOL, V199, pS9, DOI 10.2214/AJR.12.9121; Yuan R, 2012, RADIOLOGY, V262, P290, DOI 10.1148/radiol.11110648; Zheng MW, 2014, EUR J RADIOL, V83, pE92, DOI 10.1016/j.ejrad.2013.11.006	29	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139275	10.1371/journal.pone.0139275	http://dx.doi.org/10.1371/journal.pone.0139275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418007	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400070
J	Torres-Climent, A; Gomis, P; Martin-Mata, J; Bustamante, MA; Marhuenda-Egea, FC; Perez-Murcia, MD; Perez-Espinosa, A; Paredes, C; Moral, R				Torres-Climent, A.; Gomis, P.; Martin-Mata, J.; Bustamante, M. A.; Marhuenda-Egea, F. C.; Perez-Murcia, M. D.; Perez-Espinosa, A.; Paredes, C.; Moral, R.			Chemical, Thermal and Spectroscopic Methods to Assess Biodegradation of Winery-Distillery Wastes during Composting	PLOS ONE			English	Article							STATE C-13 NMR; FT-IR SPECTROSCOPY; ORGANIC-MATTER; BIOLOGICAL STABILITY; BY-PRODUCTS; GRAPE MARC; EVOLUTION; RESIDUES; NITROGEN; CARBON	The objective of this work was to study the co-composting process of wastes from the winery and distillery industry with animal manures, using the classical chemical methods traditionally used in composting studies together with advanced instrumental methods (thermal analysis, FT-IR and CPMAS C-13 NMR techniques), to evaluate the development of the process and the quality of the end-products obtained. For this, three piles were elaborated by the turning composting system, using as raw materials winery-distillery wastes (grape marc and exhausted grape marc) and animal manures (cattle manure and poultry manure). The classical analytical methods showed a suitable development of the process in all the piles, but these techniques were ineffective to study the humification process during the composting of this type of materials. However, their combination with the advanced instrumental techniques clearly provided more information regarding the turnover of the organic matter pools during the composting process of these materials. Thermal analysis allowed to estimate the degradability of the remaining material and to assess qualitatively the rate of OM stabilization and recalcitrant C in the compost samples, based on the energy required to achieve the same mass losses. FT-IR spectra mainly showed variations between piles and time of sampling in the bands associated to complex organic compounds (mainly at 1420 and 1540 cm(-1)) and to nitrate and inorganic components (at 875 and 1384 cm(-1), respectively), indicating composted material stability and maturity; while CPMAS C-13 NMR provided semi-quantitatively partition of C compounds and structures during the process, being especially interesting their variation to evaluate the biotransformation of each C pool, especially in the comparison of recalcitrant C vs labile C pools, such as Alkyl /O-Alkyl ratio.	[Torres-Climent, A.; Gomis, P.; Martin-Mata, J.; Bustamante, M. A.; Perez-Murcia, M. D.; Perez-Espinosa, A.; Paredes, C.; Moral, R.] Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain; [Marhuenda-Egea, F. C.] Univ Alicante, Dept Agrochem & Biochem, E-03080 Alicante, Spain	Universidad Miguel Hernandez de Elche; Universitat d'Alacant	Bustamante, MA (corresponding author), Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain.	marian.bustamante@umh.es	Perez Espinosa, Aurelia/ABC-4951-2021; murcia, perez MD/O-9753-2014; Paredes, Concepcion/C-9325-2012; Marhuenda-Egea, Frutos C/B-3412-2018; Bustamante, Maria Angeles/ABF-3793-2020; Bustamante, Maria Angeles/H-9171-2013; Torres-Climent, Angel/K-7875-2017; Moral, Raul/C-7473-2009	Perez Espinosa, Aurelia/0000-0003-2881-3073; murcia, perez MD/0000-0003-0722-9599; Marhuenda-Egea, Frutos C/0000-0002-0402-9770; Bustamante, Maria Angeles/0000-0001-9931-1711; Bustamante, Maria Angeles/0000-0001-9931-1711; Torres-Climent, Angel/0000-0002-4347-9707; Moral, Raul/0000-0002-4881-480X; Marhuenda-Egea, Frutos/0000-0002-7457-1805; Paredes, Concepcion/0000-0002-9735-5099	Spanish Ministry of Economy and Competitiveness (Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+i)); EU [PTQ-12-05655]	Spanish Ministry of Economy and Competitiveness (Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+i)); EU(European Commission)	This work was supported by a contract to MABM, Spanish Ministry of Economy and Competitiveness (Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+i) 2008-2011), co-funded by the EU through the Social Funds (contract reference PTQ-12-05655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2015, TALANTA, V134, P453, DOI 10.1016/j.talanta.2014.11.056; Ali M, 2012, BIODEGRADATION, V23, P231, DOI 10.1007/s10532-011-9502-0; Almendros G, 2000, SOIL BIOL BIOCHEM, V32, P793, DOI 10.1016/S0038-0717(99)00202-3; Arvanitoyannis IS, 2006, INT J FOOD SCI TECH, V41, P475, DOI 10.1111/j.1365-2621.2005.01111.x; Baffi C, 2007, SOIL BIOL BIOCHEM, V39, P1284, DOI 10.1016/j.soilbio.2006.12.004; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bernal MP, 1996, BIOL FERT SOILS, V22, P141, DOI 10.1007/BF00384446; Bustamante MA, 2008, CHEMOSPHERE, V72, P551, DOI 10.1016/j.chemosphere.2008.03.030; Bustamante MA, 2008, WASTE MANAGE, V28, P372, DOI 10.1016/j.wasman.2007.01.013; Bustamante MA, 2007, WATER SCI TECHNOL, V56, P187, DOI 10.2166/wst.2007.488; Bustamante MA, 2013, J CLEAN PROD, V47, P61, DOI 10.1016/j.jclepro.2012.07.018; Bustamante MA, 2012, BIOMASS BIOENERG, V43, P26, DOI 10.1016/j.biombioe.2012.04.010; Bustamante MA, 2010, BIORESOURCE TECHNOL, V101, P4068, DOI 10.1016/j.biortech.2010.01.085; Caricasole P, 2011, WASTE MANAGE, V31, P411, DOI 10.1016/j.wasman.2010.09.020; Castaldi P, 2005, WASTE MANAGE, V25, P209, DOI 10.1016/j.wasman.2004.12.011; Chen YN, 2003, COMPOST SCI UTIL, V11, P152; Dell'Abate MT, 2000, J THERM ANAL CALORIM, V61, P389, DOI 10.1023/A:1010157115211; EC. European Commission, BIOL TREATM IN PRESS; El Ouaqoudi FZ, 2015, ECOL ENG, V75, P217, DOI 10.1016/j.ecoleng.2014.12.004; El Ouaqoudi FZ, 2014, COMPOST SCI UTIL, V22, P188, DOI 10.1080/1065657X.2014.910148; Fernandez FJ, 2008, CHEMOSPHERE, V73, P670, DOI 10.1016/j.chemosphere.2008.07.007; Fernandez JM, 2012, WASTE MANAGE, V32, P158, DOI 10.1016/j.wasman.2011.08.011; Fialho LL, 2010, BIORESOURCE TECHNOL, V101, P1927, DOI 10.1016/j.biortech.2009.10.039; Friedman M, 2014, J AGR FOOD CHEM, V62, P6025, DOI 10.1021/jf501266s; Gomez X, 2007, CHEMOSPHERE, V68, P1889, DOI 10.1016/j.chemosphere.2007.02.065; Haberhauer G, 1998, GEODERMA, V83, P331, DOI 10.1016/S0016-7061(98)00008-1; Hogg D, 2002, COMP COMPOST STANDAR; Keeler C, 2006, GEODERMA, V130, P124, DOI 10.1016/j.geoderma.2005.01.015; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Marhuenda-Egea FC, 2007, CHEMOSPHERE, V68, P301, DOI 10.1016/j.chemosphere.2006.12.075; Martinez-Sabater E, 2009, J AGR FOOD CHEM, V57, P9613, DOI 10.1021/jf901027v; Mathers NJ, 2003, FOREST ECOL MANAG, V175, P467, DOI 10.1016/S0378-1127(02)00182-2; Moldes AB, 2007, APPL BIOCHEM BIOTECH, V141, P27, DOI 10.1007/s12010-007-9208-2; Nelson PN, 2005, BIOGEOCHEMISTRY, V72, P1, DOI 10.1007/s10533-004-0076-3; OIV, OIVS ASS WORLD VIT S; Paradelo R, 2013, J ENVIRON MANAGE, V116, P18, DOI 10.1016/j.jenvman.2012.12.001; Paredes C, 2000, BIOL FERT SOILS, V32, P222, DOI 10.1007/s003740000239; Ranalli G, 2001, J ENVIRON SCI HEAL A, V36, P415, DOI 10.1081/ESE-100103473; Said-Pullicino D, 2007, BIORESOURCE TECHNOL, V98, P1822, DOI 10.1016/j.biortech.2006.06.018; Smernik RJ, 2000, GEODERMA, V96, P159, DOI 10.1016/S0016-7061(00)00007-0; Smidt E, 2002, APPL SPECTROSC, V56, P1170, DOI 10.1366/000370202760295412; Smidt E, 2005, BIODEGRADATION, V16, P67, DOI 10.1007/s10531-004-0430-8; Smidt E, 2005, THERMOCHIM ACTA, V438, P22, DOI 10.1016/j.tca.2005.08.013; Stevenson FJ, 1982, HUMUS CHEM; Wilson M. A., 1987, NMR TECHNIQUES APPL; Zbytniewski R, 2005, BIORESOURCE TECHNOL, V96, P471, DOI 10.1016/j.biortech.2004.05.018; ZUCCONI F, 1981, BIOCYCLE, V22, P54	48	24	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138925	10.1371/journal.pone.0138925	http://dx.doi.org/10.1371/journal.pone.0138925			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418458	Green Published, gold			2022-12-27	WOS:000362171400026
J	Ayoub, I; Oh, MS; Gupta, R; McFarlane, M; Babinska, A; Salifu, MO				Ayoub, Isabelle; Oh, Man S.; Gupta, Raavi; McFarlane, Michael; Babinska, Anna; Salifu, Moro O.			Colon Necrosis Due to Sodium Polystyrene Sulfonate with and without Sorbitol: An Experimental Study in Rats	PLOS ONE			English	Article							INTESTINAL NECROSIS; KAYEXALATE; PERFORATION	Introduction Based on a single rat study by Lillemoe et al, the consensus has been formed to implicate sorbitol rather than sodium polystyrene sulfonate (SPS) as the culprit for colon necrosis in humans treated with SPS and sorbitol. We tested the hypothesis that colon necrosis by sorbitol in the experiment was due to the high osmolality and volume of sorbitol rather than its chemical nature. Methods 26 rats underwent 5/6 nephrectomy. They were divided into 6 groups and given enema solutions under anesthesia (normal saline, 33% sorbitol, 33% mannitol, SPS in 33% sorbitol, SPS in normal saline, and SPS in distilled water). They were sacrificed after 48 hours of enema administration or earlier if they were very sick. The gross appearance of the colon was visually inspected, and then sliced colon tissues were examined under light microscopy. Results 1 rat from the sorbitol and 1 from the mannitol group had foci of ischemic colonic changes. The rats receiving SPS enema, in sorbitol, normal saline, distilled water, had crystal deposition with colonic necrosis and mucosal erosion. All the rats not given SPS survived until sacrificed at 48 h whereas 11 of 13 rats that received SPS in sorbitol, normal saline or distilled water died or were clearly dying and sacrificed sooner. There was no difference between sorbitol and mannitol when given without SPS. Conclusions In a surgical uremic rat model, SPS enema given alone or with sorbitol or mannitol seemed to cause colon necrosis and high mortality rate, whereas 33% sorbitol without SPS did not.	[Ayoub, Isabelle; Oh, Man S.; McFarlane, Michael; Babinska, Anna; Salifu, Moro O.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Ayoub, Isabelle] Ohio State Univ, Dept Med, Columbus, OH 43210 USA; [Gupta, Raavi] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Salifu, MO (corresponding author), Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA.	moro.salifu@downstate.edu						Abraham SC, 2001, AM J SURG PATHOL, V25, P637, DOI 10.1097/00000478-200105000-00011; Akagun T, 2011, CLIN KIDNEY J, V4, P402, DOI 10.1093/ndtplus/sfr113; ARVANITAKIS C, 1973, GASTROENTEROLOGY, V64, P533; Cheng ES, 2002, BURNS, V28, P189, DOI 10.1016/S0305-4179(01)00099-7; Dardik A, 2000, SOUTH MED J, V93, P511; Endeward V, 2005, J PHYSIOL-LONDON, V567, P253, DOI 10.1113/jphysiol.2005.085761; Gardiner GW, 1997, CAN J GASTROENTEROL, V11, P573, DOI 10.1155/1997/370814; GERSTMAN BB, 1992, AM J KIDNEY DIS, V20, P159, DOI 10.1016/S0272-6386(12)80544-0; Harel Z, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.08.016; Kao CC, 2013, J FORMOS MED ASS; Laforenza U, 2012, MOL ASPECTS MED, V33, P642, DOI 10.1016/j.mam.2012.03.001; LILLEMOE KD, 1987, SURGERY, V101, P267; McGowan CE, 2009, SOUTH MED J, V102, P493, DOI 10.1097/SMJ.0b013e31819e8978; Shioya Takeshi, 2007, Journal of Nippon Medical School, V74, P359, DOI 10.1272/jnms.74.359; Thomas A, 2009, AM J MED SCI, V337, P305, DOI 10.1097/MAJ.0b013e31818dd715; THOROUGHMAN J C, 1959, Am Surg, V25, P533; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG463, DOI 10.1152/ajpgi.2000.279.2.G463	17	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137636	10.1371/journal.pone.0137636	http://dx.doi.org/10.1371/journal.pone.0137636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413782	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700010
J	Johnston, SC; Lin, KL; Twenhafel, NA; Raymond, JLW; Shamblin, JD; Wollen, SE; Wlazlowski, CB; Wilkinson, ER; Botto, MA; Goff, AJ				Johnston, Sara C.; Lin, Kenny L.; Twenhafel, Nancy A.; Raymond, Jo Lynne W.; Shamblin, Joshua D.; Wollen, Suzanne E.; Wlazlowski, Carly B.; Wilkinson, Eric R.; Botto, Miriam A.; Goff, Arthur J.			Dose Response of MARV/Angola Infection in Cynomolgus Macaques following IM or Aerosol Exposure	PLOS ONE			English	Article							MARBURG-VIRUS-DISEASE; HEMORRHAGIC-FEVER; ANGOLA INFECTION; PATHOGENESIS; OUTBREAK	Marburg virus infection in humans causes a hemorrhagic disease with a high case fatality rate. Countermeasure development requires the use of well-characterized animal models that mimic human disease. To further characterize the cynomolgus macaque model of MARV/Angola, two independent dose response studies were performed using the intramuscular or aerosol routes of exposure. All animals succumbed at the lowest target dose; therefore, a dose effect could not be determined. For intramuscular-exposed animals, 100 PFU was the first target dose that was not significantly different than higher target doses in terms of time to disposition, clinical pathology, and histopathology. Although a significant difference was not observed between aerosol-exposed animals in the 10 PFU and 100 PFU target dose groups, 100 PFU was determined to be the lowest target dose that could be consistently obtained and accurately titrated in aerosol studies.	[Johnston, Sara C.; Shamblin, Joshua D.; Wollen, Suzanne E.; Wlazlowski, Carly B.; Wilkinson, Eric R.; Botto, Miriam A.; Goff, Arthur J.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Lin, Kenny L.] US Army, Med Res Inst Infect Dis, Nonclin Dev Div, Ft Detrick, MD 21702 USA; [Twenhafel, Nancy A.; Raymond, Jo Lynne W.] US Army, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA		Johnston, SC (corresponding author), US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.	sara.c.johnston2.ctr@mail.mil	Twenhafel, Nancy/Z-1522-2019	Wollen-Roberts, Suzanne/0000-0002-9409-2756	Translational Medical Technologies; Joint Science and Technology Office for Chemical and Biological Defense	Translational Medical Technologies; Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Translational Medical Technologies and the Joint Science and Technology Office for Chemical and Biological Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves DA, 2010, VET PATHOL, V47, P831, DOI 10.1177/0300985810378597; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; Beer B, 1999, NATURWISSENSCHAFTEN, V86, P8, DOI 10.1007/s001140050562; Borchert M, 2002, TROP MED INT HEALTH, V7, P902, DOI 10.1046/j.1365-3156.2002.00945.x; Bray M, 2002, ANTIVIR RES, V54, P1, DOI 10.1016/S0166-3542(02)00005-0; Colebunders R, 2007, J INFECT DIS, V196, pS148, DOI 10.1086/520543; Fauci AS, 2005, ACAD MED, V80, P1079, DOI 10.1097/00001888-200512000-00002; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Geisbert TW, 2007, J INFECT DIS, V196, pS372, DOI 10.1086/520608; KILEY MP, 1988, J GEN VIROL, V69, P1957, DOI 10.1099/0022-1317-69-8-1957; Ligon B Lee, 2005, Semin Pediatr Infect Dis, V16, P219, DOI 10.1053/j.spid.2005.05.001; Lin KL, 2015, J VIROL, V89, P9875, DOI 10.1128/JVI.01147-15; Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X; Martini G A, 1968, Ger Med Mon, V13, P457; Sanchez A, 2007, FIELDS VIROLOGY, V1, P1409; Slenczka WG, 1999, CURR TOP MICROBIOL, V235, P49; SMITH DH, 1982, LANCET, V1, P816	18	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138843	10.1371/journal.pone.0138843	http://dx.doi.org/10.1371/journal.pone.0138843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413900	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700024
J	Brunjes, PC; Osterberg, SK				Brunjes, Peter C.; Osterberg, Stephen K.			Developmental Markers Expressed in Neocortical Layers Are Differentially Exhibited in Olfactory Cortex	PLOS ONE			English	Article							INTERMEDIATE PROGENITOR CELLS; COMMISSURAL FIBER SYSTEMS; POSTMITOTIC NEURONS; PIRIFORM CORTEX; LAMINAR FATE; RAT; EVOLUTION; DOPAMINE; NUCLEUS; GENES	Neurons in the cerebral cortex stratify on the basis of their time of origin, axonal terminations and the molecular identities assigned during early development. Olfactory cortices share many feature with the neocortex, including clear lamination and similar cell types. The present study demonstrates that the markers differentially expressed in the projection neurons of the cerebral cortex are also found in olfactory areas. Three of the four regions examined (pars principalis of the anterior olfactory nucleus: AONpP, anterior and posterior piriform cortices: APC, PPC, and the olfactory tubercle) expressed transcription factors found in deep or superficial neurons in the developing neocortex, though large differences were found between areas. For example, while the AONpP, APC and PPC all broadly expressed the deep cortical marker CTIP2, NOR1 (NR4a3) levels were higher in AONpP and DAARP32 was more prevalent in the APC and PPC. Similar findings were encountered for superficial cortical markers: all three regions broadly expressed CUX1, but CART was only observed in the APC and PPC. Furthermore, regional variations were observed even within single structures (e.g., NOR1 was found primarily in in the dorsal region of AONpP and CART expression was observed in a discrete band in the middle of layer 2 of both the APC and PPC). Experiments using the mitotic marker EDU verified that the olfactory cortices and neocortex share similar patterns of neuronal production: olfactory cells that express markers found in the deep neocortex are produced earlier than those that express superficial makers. Projection neurons were filled by retrograde tracers injected into the olfactory bulb to see if olfactory neurons with deep and superficial markers had different axonal targets. Unlike the cerebral cortex, no specificity was observed: neurons with each of the transcription factors examined were found to be labelled. Together the results indicate that olfactory cortices are complex: they differ from each other and each is formed from a variable mosaic of neurons. The results suggest that the olfactory cortices are not merely a remnant architype of the primordial forebrain but varied and independent regions.	[Brunjes, Peter C.; Osterberg, Stephen K.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	University of Virginia	Brunjes, PC (corresponding author), Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA.	brunjes@virginia.edu			National Institute for Deafness and Communicative Disorders of the National Institutes of Health [DC00338]	National Institute for Deafness and Communicative Disorders of the National Institutes of Health	Funded by grant DC00338 from the National Institute for Deafness and Communicative Disorders of the National Institutes of Health, http://www.nidcd.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei S, 2011, NEUROSCIENCE, V287, P137; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BAYER SA, 1985, INT J DEV NEUROSCI, V3, P135, DOI 10.1016/0736-5748(85)90004-8; BAYER SA, 1986, INT J DEV NEUROSCI, V4, P225, DOI 10.1016/0736-5748(86)90062-6; BAYER SA, 1986, INT J DEV NEUROSCI, V4, P251, DOI 10.1016/0736-5748(86)90063-8; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bekkers JM, 2013, TRENDS NEUROSCI, V36, P429, DOI 10.1016/j.tins.2013.04.005; Blackstad T, 1976, THE NEURON, P49; Brox A, 2004, J COMP NEUROL, V474, P562, DOI 10.1002/cne.20152; Brunjes PC, 2005, BRAIN RES REV, V50, P305, DOI 10.1016/j.brainresrev.2005.08.005; Brunjes PC, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00044; Brunjes PC, 2013, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00051; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Ceci ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044716; Dehay C, 2015, NEURON, V85, P683, DOI 10.1016/j.neuron.2014.12.060; Dugas-Ford J, 2015, ANNU REV NEUROSCI, V38, P351, DOI 10.1146/annurev-neuro-071714-033911; Ekstrand JJ, 2001, J COMP NEUROL, V434, P289, DOI 10.1002/cne.1178; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Moreno FG, 2008, CEREB CORTEX, V18, P1239, DOI 10.1093/cercor/bhm154; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; HABERLY LB, 1978, J COMP NEUROL, V181, P781, DOI 10.1002/cne.901810407; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Heimer L, 1987, LIMBIC MECH, P95; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hoerder-Suabedissen A, 2013, CEREB CORTEX, V23, P1473, DOI 10.1093/cercor/bhs137; Huang ZJ, 2014, NEURON, V83, P1284, DOI 10.1016/j.neuron.2014.08.041; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Kadohisa M, 2006, P NATL ACAD SCI USA, V103, P15206, DOI 10.1073/pnas.0604313103; Karten HJ, 2013, CURR BIOL, V23, pR12, DOI 10.1016/j.cub.2012.11.013; Kay RB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00111; KRIEGSTEIN AR, 1986, J NEUROSCI, V6, P178; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu SL, 2013, J NEUROSCI, V33, P2916, DOI 10.1523/JNEUROSCI.3607-12.2013; Lodato S, 2015, TRENDS NEUROSCI, V38, P117, DOI 10.1016/j.tins.2014.11.003; Luzzati F, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00162; MacDonald JL, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: PATTERNING AND CELL TYPE SPECIFICATION IN THE DEVELOPING CNS AND PNS, P475, DOI 10.1016/B978-0-12-397265-1.00098-8; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Medina L, 2009, SEMIN CELL DEV BIOL, V20, P698, DOI 10.1016/j.semcdb.2009.04.008; MILLHOUSE OE, 1984, J COMP NEUROL, V228, P571, DOI 10.1002/cne.902280409; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; Molnar Z, 2002, BIOESSAYS, V24, P530, DOI 10.1002/bies.10100; Molnar Z, 2011, BRAIN BEHAV EVOLUT, V78, P94, DOI 10.1159/000327325; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mori K, 2004, OLFACTORY SYSTEM ODO, P1; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Nieuwenhuys R, 1998, CENTRAL NERVOUS SYST, V3, P1932; OUIMET CC, 1984, J NEUROSCI, V4, P111; Petrof I, 2012, J COMP NEUROL, V520, P1678, DOI 10.1002/cne.23006; Pigache R M, 1970, Ergeb Anat Entwicklungsgesch, V43, P3; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Root DH, 2015, PROG NEUROBIOL, V130, P29, DOI 10.1016/j.pneurobio.2015.03.005; Sarma AA, 2011, CEREB CORTEX, V21, P1231, DOI 10.1093/cercor/bhq199; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; Shepherd GM, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00030; Smith Y, 1999, J COMP NEUROL, V407, P491, DOI 10.1002/(SICI)1096-9861(19990517)407:4<491::AID-CNE3>3.0.CO;2-0; Striedter GF, 2005, PRINCIPLES BRAIN EVO, P259; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Takahashi T, 1999, J NEUROSCI, V19, P10357; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vasistha NA, 2015, CEREB CORTEX, V25, P3290, DOI 10.1093/cercor/bhu125; Vyas A, 2003, J COMP NEUROL, V466, P545, DOI 10.1002/cne.10900; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Wesson DW, 2011, NEUROSCI BIOBEHAV R, V35, P655, DOI 10.1016/j.neubiorev.2010.08.004; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027	74	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138541	10.1371/journal.pone.0138541	http://dx.doi.org/10.1371/journal.pone.0138541			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407299	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700056
J	Dekerle, J; de Souza, KM; de Lucas, RD; Guglielmo, LGA; Greco, CC; Denadai, BS				Dekerle, Jeanne; de Souza, Kristopher Mendes; de Lucas, Ricardo Dantas; Antonacci Guglielmo, Luiz Guilherme; Greco, Camila Coelho; Denadai, Benedito Sergio			Exercise Tolerance Can Be Enhanced through a Change in Work Rate within the Severe Intensity Domain: Work above Critical Power Is Not Constant	PLOS ONE			English	Article							MUSCLE METABOLIC-RESPONSES; DURATION RELATIONSHIP; PACING STRATEGY; BLOOD-FLOW; CRITICAL SPEED; OXYGEN-UPTAKE; TIME; EXHAUSTION; FATIGUE; VELOCITY	Introduction The characterization of the hyperbolic power-time (P-t(lim)) relationship using a two-parameter model implies that exercise tolerance above the asymptote (Critical Power; CP), i.e. within the severe intensity domain, is determined by the curvature (W') of the relationship. Purposes The purposes of this study were (1) to test whether the amount of work above CP (W> CP) remains constant for varied work rate experiments of high volatility change and (2) to ascertain whether W' determines exercise tolerance within the severe intensity domain. Methods Following estimation of CP (208 +/- 19 W) and W' (21.4 +/- 4.2 kJ), 14 male participants (age: 26 +/- 3; peak VO2 : 3708 +/- 389 ml.min(-1)) performed two experimental trials where the work rate was initially set to exhaust 70% of W' in 3 ('THREE') or 10 minutes ('TEN') before being subsequently dropped to CP plus 10 W. Results W> CP for TEN (104 +/- 22% W') andW' were not significantly different (P> 0.05) but lower than W> CP for THREE (119 +/- 17% W', P< 0.05). For both THREE (r = 0.71, P< 0.01) and TEN (r = 0.64, P< 0.01), a significant bivariate correlation was found between W' and t(lim). Conclusion W>CP and t(lim) can be greater than predicted by the P-t(lim) relationship when a decrement in the work rate of high-volatility is applied. Exercise tolerance can be enhanced through a change in work rate within the severe intensity domain. W>CP is not constant.	[Dekerle, Jeanne] Univ Brighton, Ctr Sport & Exercise Sci & Med, Eastbourne, East Sussex, England; [de Souza, Kristopher Mendes; de Lucas, Ricardo Dantas; Antonacci Guglielmo, Luiz Guilherme] Univ Fed Santa Catarina, Sports Ctr, Phys Effort Lab, Florianopolis, SC, Brazil; [Greco, Camila Coelho; Denadai, Benedito Sergio] UNESP, Human Performance Lab, Rio Claro, Brazil	University of Brighton; Universidade Federal de Santa Catarina (UFSC); Universidade Estadual Paulista	Dekerle, J (corresponding author), Univ Brighton, Ctr Sport & Exercise Sci & Med, Eastbourne, East Sussex, England.	j.dekerle@bton.ac.uk	Dekerle, Jeanne/M-8367-2019; de Lucas, Ricardo Dantas/R-7382-2019; Guglielmo, Luiz Guilherme GA Antonacci/I-1160-2015; Denadai, Benedito S/A-7263-2012	Dekerle, Jeanne/0000-0002-4482-4576; de Lucas, Ricardo Dantas/0000-0002-8566-3086; Guglielmo, Luiz Guilherme GA Antonacci/0000-0001-6757-5050; Denadai, Benedito S/0000-0003-0775-1889				Abbiss CR, 2008, SPORTS MED, V38, P239, DOI 10.2165/00007256-200838030-00004; Aisbett B, 2009, MED SCI SPORT EXER, V41, P1965, DOI 10.1249/MSS.0b013e3181a2aa78; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Babcock MA, 2002, J APPL PHYSIOL, V93, P201, DOI 10.1152/japplphysiol.00612.2001; Bailey SJ, 2011, MED SCI SPORT EXER, V43, P457, DOI 10.1249/MSS.0b013e3181ef3dce; Billat LV, 1999, SPORTS MED, V27, P359, DOI 10.2165/00007256-199927060-00002; BILLAT V, 1994, EUR J APPL PHYSIOL O, V69, P271, DOI 10.1007/BF01094801; BILLAT V, 1995, ARCH PHYSIOL BIOCHEM, V103, P129, DOI 10.3109/13813459508996126; Bishop D, 2002, MED SCI SPORT EXER, V34, P1041, DOI 10.1097/00005768-200206000-00022; Black MI, 2015, APPL PHYSIOL NUTR ME, V40, P662, DOI 10.1139/apnm-2014-0442; Bosquet L, 2002, SPORTS MED, V32, P675, DOI 10.2165/00007256-200232110-00002; Broxterman RM, 2015, J APPL PHYSIOL, V118, P880, DOI 10.1152/japplphysiol.00875.2014; Bull AJ, 2000, MED SCI SPORT EXER, V32, P526, DOI 10.1097/00005768-200002000-00040; Burnley M, 2011, MED SCI SPORT EXER, V43, P2171, DOI 10.1249/MSS.0b013e31821ff26d; Carter H, 2005, MED SCI SPORT EXER, V37, P775, DOI 10.1249/01.MSS.0000162631.07404.7C; Carter H, 2002, EUR J APPL PHYSIOL, V86, P347, DOI 10.1007/s00421-001-0556-2; Chidnok W, 2013, MED SCI SPORT EXER, V45, P1377, DOI 10.1249/MSS.0b013e3182860325; Copp SW, 2010, J PHYSIOL-LONDON, V588, P5077, DOI 10.1113/jphysiol.2010.198382; Corn SD, 2011, RESP PHYSIOL NEUROBI, V178, P261, DOI 10.1016/j.resp.2011.06.020; Dekerle J, 2012, EUR J APPL PHYSIOL, V112, P327, DOI 10.1007/s00421-011-1979-z; di Prampero PE, 1999, EUR J APPL PHYSIOL O, V80, P162, DOI 10.1007/s004210050574; Fukuba Y, 2003, MED SCI SPORT EXER, V35, P1413, DOI 10.1249/01.MSS.0000079047.84364.70; Fukuba Y, 1999, J APPL PHYSIOL, V87, P853, DOI 10.1152/jappl.1999.87.2.853; Grassi B, 2015, EXERC SPORT SCI REV, V43, P75, DOI 10.1249/JES.0000000000000043; GREEN S, 1993, SPORTS MED, V15, P312, DOI 10.2165/00007256-199315050-00003; Hettinga FJ, 2007, MED SCI SPORT EXER, V39, P2212, DOI 10.1249/mss.0b013e318156e8d4; Hettinga FJ, 2009, MED SCI SPORT EXER, V41, P230, DOI 10.1249/MSS.0b013e3181831f0f; HILL DW, 1993, SPORTS MED, V16, P237, DOI 10.2165/00007256-199316040-00003; Hill DW, 1999, EUR J APPL PHYSIOL O, V79, P290, DOI 10.1007/s004210050509; Hinckson EA, 2005, MED SCI SPORT EXER, V37, P696, DOI 10.1249/01.MSS.0000159023.06934.53; HOUSH DJ, 1989, ERGONOMICS, V32, P997, DOI 10.1080/00140138908966860; Jones AM, 2008, SCAND J MED SCI SPOR, V18, P615, DOI 10.1111/j.1600-0838.2007.00725.x; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Jones AM, 2010, MED SCI SPORT EXER, V42, P1876, DOI 10.1249/MSS.0b013e3181d9cf7f; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Kelly J, 2013, MED SCI SPORT EXER, V45, P1798, DOI 10.1249/MSS.0b013e31828e885c; Mclaughlin JE, 2010, MED SCI SPORT EXER, V42, P991, DOI 10.1249/MSS.0b013e3181c0669d; Morton RH, 2006, EUR J APPL PHYSIOL, V96, P339, DOI 10.1007/s00421-005-0088-2; Murgatroyd SR, 2011, J PHYSIOL-LONDON, V589, P2443, DOI 10.1113/jphysiol.2011.209346; Noordhof DA, 2010, SPORTS MED, V40, P285, DOI 10.2165/11530390-000000000-00000; Nybo L, 2008, J APPL PHYSIOL, V104, P871, DOI 10.1152/japplphysiol.00910.2007; POOLE DC, 1988, ERGONOMICS, V31, P1265, DOI 10.1080/00140138808966766; Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054; Rossiter HB, 2001, J PHYSIOL-LONDON, V537, P291, DOI 10.1111/j.1469-7793.2001.0291k.x; Sawyer BJ, 2012, MED SCI SPORT EXER, V44, P1533, DOI 10.1249/MSS.0b013e31824d2587; Smith JR, 2014, EUR J APPL PHYSIOL, V114, P1767, DOI 10.1007/s00421-014-2905-y; Vanhatalo A, 2011, AM J PHYSIOL-REG I, V300, pR700, DOI 10.1152/ajpregu.00761.2010; Vanhatalo A, 2010, EXP PHYSIOL, V95, P528, DOI 10.1113/expphysiol.2009.050500; Walsh ML, 2000, SPORTS MED, V29, P153, DOI 10.2165/00007256-200029030-00002	49	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138428	10.1371/journal.pone.0138428	http://dx.doi.org/10.1371/journal.pone.0138428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407169	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700045
J	He, SL; Yang, LY; Li, DZ; Li, M				He, Shaolin; Yang, Liyuan; Li, Dazhu; Li, Ming			Kruppel-Like Factor 2-Mediated Suppression of MicroRNA-155 Reduces the Proinflammatory Activation of Macrophages	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ATHEROSCLEROSIS; EXPRESSION; KLF2; INHIBITION; MODELS; CELLS	Objective Recent evidence indicates that significant interactions exist between Kruppel-like factor 2 (KLF2) and microRNAs (miRNAs) in endothelial cells. Because KLF2 is known to exert anti-inflammatory effects and inhibit the pro-inflammatory activation of monocytes, we sought to identify how inflammation-associated miR-155 is regulated by KLF2 in macrophages. Approach and Results Peritoneal macrophages from wild-type (WT) C57Bl6 mice were transfected with either recombinant adenovirus vector expressing KLF2 (Ad-KLF2) or siRNA targeting KLF2 (KLF2-siRNA) for 24 h-48 h, then stimulated with oxidized low-density lipoproteins (ox-LDL, 50 mu g/mL) for 24 h. Quantitative real-time polymerase chain reaction showed that KLF2 markedly reduced the expression of miR-155 in quiescentox-LDL-stimulated macrophages. We also found that the increased expression of miR-155, monocyte chemoattractant protein (MCP-1) and interleukin (IL)-6 and the decreased expression of the suppressor of cytokine signaling (SOCS)-1 and IL-10 in ox-LDL-treated macrophages were significantly suppressed by KLF2. Most importantly, over-expression of miR-155 could partly reverse the suppressive effects of KLF2 on the inflammatory response of macrophages. Conversely, the suppression of miR-155 in KLF2 knockdown macrophages significantly overcame the pro-inflammatory properties associated with KLF2 knockdown. Finally, Ad-KLF2 significantly attenuated the diet-induced formation of atherosclerotic lesions in apolipoprotein E-deficient (apoE(-/-)) mice, which was associated with a significantly reduced expression of miR-155 and its relative inflammatory cytokine genes in the aortic arch and inmacrophages. Conclusion KLF2-mediated suppression of miR-155 reduced the inflammatory response of macrophages.	[He, Shaolin; Li, Dazhu; Li, Ming] Huazhong Univ Sci & Technol, Dept Cardiol, Inst Cardiovasc Dis, Union Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China; [Yang, Liyuan] HuBei Univ Med, XiangYang Peoples Hosp 1, Dept Cardiol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Hubei University of Medicine	Li, M (corresponding author), Huazhong Univ Sci & Technol, Dept Cardiol, Inst Cardiovasc Dis, Union Hosp,Tongji Med Coll, Wuhan 430074, Peoples R China.	liming518888cn@163.com		li, ming/0000-0002-8934-1084	National Natural Science Foundation of China [81172781, 81500338]; Independent Innovation Foundation of Huazhong University of Science and Technology [0118530232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Huazhong University of Science and Technology	This work was supported by the National Natural Science Foundation of China to Dr. Ming Li (No. 81172781) and Dr. Shaolin He (No. 81500338). The Independent Innovation Foundation of Huazhong University of Science and Technology (No. 0118530232) to Dr. Shaolin He.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; Du F, 2014, ARTERIOSCL THROM VAS, V34, P759, DOI 10.1161/ATVBAHA.113.302701; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lin J, 2010, J LIPID RES, V51, P1208, DOI 10.1194/jlr.D000497; Lingrel JB, 2012, CIRC RES, V110, P1294, DOI 10.1161/CIRCRESAHA.112.267310; Loyer X, 2014, CIRC RES, V114, P434, DOI 10.1161/CIRCRESAHA.114.302213; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Manoharan P, 2014, J BIOL CHEM, V289, P31638, DOI 10.1074/jbc.M114.579763; Merhi-Soussi F, 2005, CARDIOVASC RES, V66, P583, DOI 10.1016/j.cardiores.2005.01.008; Montgomery RL, 2010, CURR DRUG TARGETS, V11, P936; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Nazari-Jahantigh M, 2012, THROMB HAEMOSTASIS, V107, P611, DOI 10.1160/TH11-12-0826; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tian FJ, 2014, CARDIOVASC RES, V103, P100, DOI 10.1093/cvr/cvu070; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Yang K, 2011, FEBS LETT, V585, P854, DOI 10.1016/j.febslet.2011.02.009; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Yu JC, 2013, NEUROL SCI, V34, P1283, DOI 10.1007/s10072-012-1228-1; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	36	10	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139060	10.1371/journal.pone.0139060	http://dx.doi.org/10.1371/journal.pone.0139060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406238	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700158
J	Rylance, J; Chimpini, C; Semple, S; Russell, DG; Jackson, MJ; Heyderman, RS; Gordon, SB				Rylance, Jamie; Chimpini, Chikondi; Semple, Sean; Russell, David G.; Jackson, Malcolm J.; Heyderman, Robert S.; Gordon, Stephen B.			Chronic Household Air Pollution Exposure Is Associated with Impaired Alveolar Macrophage Function in Malawian Non-Smokers	PLOS ONE			English	Article							NF-KAPPA-B; WOOD SMOKE; STREPTOCOCCUS-PNEUMONIAE; INFLAMMATORY RESPONSE; EPITHELIAL-CELLS; CIGARETTE-SMOKE; TNF-ALPHA; PULMONARY; ACTIVATION; PARTICLES	Background Household air pollution in low income countries is an important cause of mortality from respiratory infection. We hypothesised that chronic smoke exposure is detrimental to alveolar macrophage function, causing failure of innate immunity. We report the relationship between macrophage function and prior smoke exposure in healthy Malawians. Methods Healthy subjects exposed daily to cooking smoke at home volunteered for bronchoalveolar lavage. Alveolar macrophage particulate content was measured as a known correlate of smoke exposure. Phagocytosis and intraphagosomal function (oxidative burst and proteolysis) were measured by a flow cytometric assay. Cytokine responses in macrophages were compared following re-exposure in vitro to wood smoke, before and after glutathione depletion. Results Volunteers had a range of alveolar macrophage particulate loading. The macrophage capacity for phagosomal oxidative burst was negatively associated with alveolar macrophage particulate content (n = 29, r(2) = 0.16, p = 0.033), but phagocytosis per se and proteolytic function were unaffected. High particulate content was associated with lower baseline CXCL8 release (ratio 0.51, CI 0.29-0.89) and lower final concentrations on re-exposure to smoke in vitro (ratio 0.58, CI 0.34-0.97). Glutathione depletion augmented CXCL8 responses by 1.49x (CI 1.02-2.17) compared with wood smoke alone. This response was specific to smoke as macrophages response to LPS were not modulated by glutathione. Conclusion Chronic smoke exposure is associated with reduced human macrophage oxidative burst, and dampened inflammatory cytokine responses. These are critical processes in lung defence against infection and likely to underpin the relationship between air pollution and pneumonia.	[Rylance, Jamie; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Rylance, Jamie; Gordon, Stephen B.] Aintree Univ Hosp NHS Fdn Trust, Dept Resp Med, Ctr Clin Sci, Liverpool L9 7AL, Merseyside, England; [Rylance, Jamie; Chimpini, Chikondi; Heyderman, Robert S.; Gordon, Stephen B.] Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi; [Semple, Sean] Univ Aberdeen, Scottish Ctr Indoor Air, Div Appl Hlth Sci, Aberdeen AB9 1FX, Scotland; [Russell, David G.] Cornell Univ, Coll Vet Med, Microbiol & Immunol, Ithaca, NY 14853 USA; [Jackson, Malcolm J.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; Aintree University Hospitals NHS Foundation Trust; University of Liverpool; University of Aberdeen; Cornell University; University of Liverpool	Rylance, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	jamie.rylance@lstmed.ac.uk	Russell, David G/N-5280-2019; Rylance, Jamie/ABD-9314-2021	Russell, David G/0000-0002-9748-750X; Semple, Sean/0000-0002-0462-7295; Rylance, Jamie/0000-0002-2323-3611; Heyderman, Robert/0000-0003-4573-449X; Jackson, Malcolm/0000-0003-3683-8297; Gordon, Stephen/0000-0001-6576-1116	Wellcome Trust [086756/B/08/Z, 083606/A/07/Z]; Malawi-Liverpool-Wellcome Trust [084679/Z/08/Z]; MRC [MR/L009242/1, G1002120, MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1, G1002120, MR/L009242/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Malawi-Liverpool-Wellcome Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded and supported by a Wellcome Trust grant 086756/B/08/Z (JR); a Wellcome Trust Project Grant 083606/A/07/Z (RSH); and Malawi-Liverpool-Wellcome Trust Clinical Research Programme 084679/Z/08/Z (RSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdein JD, 2013, CLIN EXP IMMUNOL, V174, P193, DOI 10.1111/cei.12170; Antonicelli F, 2004, AM J PHYSIOL-LUNG C, V286, pL1319, DOI 10.1152/ajplung.00329.2003; Barlow PG, 2008, CELL BIOL TOXICOL, V24, P243, DOI 10.1007/s10565-007-9033-y; Barregard L, 2008, OCCUP ENVIRON MED, V65, P319, DOI 10.1136/oem.2006.032458; Becher R, 2007, INHAL TOXICOL, V19, P645, DOI 10.1080/08958370701353528; Chen H, 2007, J IMMUNOL, V179, P6097, DOI 10.4049/jimmunol.179.9.6097; de Oliveira S, 2015, J IMMUNOL, V194, P1523, DOI 10.4049/jimmunol.1402386; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Dockrell DH, 2003, J IMMUNOL, V171, P5380, DOI 10.4049/jimmunol.171.10.5380; Fullerton DG, 2009, TROP MED INT HEALTH, V14, P349, DOI 10.1111/j.1365-3156.2009.02230.x; Gordon SB, 2000, INFECT IMMUN, V68, P2286, DOI 10.1128/IAI.68.4.2286-2293.2000; Gosset P, 1999, EUR RESPIR J, V14, P98, DOI 10.1034/j.1399-3003.1999.14a17.x; Jimenez LA, 2002, AM J PHYSIOL-LUNG C, V282, pL237, DOI 10.1152/ajplung.00024.2001; Kampfrath T, 2011, CIRC RES, V108, P716, DOI 10.1161/CIRCRESAHA.110.237560; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Kocbach A, 2008, TOXICOLOGY, V247, P123, DOI 10.1016/j.tox.2008.02.014; Kubatova A, 2006, CHEM RES TOXICOL, V19, P255, DOI 10.1021/tx050172f; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Leonard SS, 2000, TOXICOLOGY, V150, P147, DOI 10.1016/S0300-483X(00)00256-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Marriott HM, 2006, J IMMUNOL, V177, P6480, DOI 10.4049/jimmunol.177.9.6480; Metcalfe HJ, 2014, CLIN EXP IMMUNOL, V176, P461, DOI 10.1111/cei.12289; Nadigel J, 2013, PULM PHARMACOL THER, V26, P596, DOI 10.1016/j.pupt.2013.03.002; Okuma T, 2006, INT J EXP PATHOL, V87, P475, DOI 10.1111/j.1365-2613.2006.00502.x; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Rylance J, 2014, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2014-0188OC, DOI 10.1165/RCMB.2014-01880C]; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwartz J, 2000, EPIDEMIOLOGY, V11, P666, DOI 10.1097/00001648-200011000-00009; Seagrave JC, 2005, INHAL TOXICOL, V17, P657, DOI 10.1080/08958370500189529; Semple S, 2010, ENVIRON HEALTH PERSP, V118, P988, DOI 10.1289/ehp.0901605; Sigaud S, 2007, TOXICOL APPL PHARM, V223, P1, DOI 10.1016/j.taap.2007.04.014; Stone WL, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-1; Swiston JR, 2008, EUR RESPIR J, V32, P129, DOI 10.1183/09031936.00097707; Tellabati A, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-30; Tesfaigzi Y, 2005, TOXICOL SCI, V88, P505, DOI 10.1093/toxsci/kfi317; Xu F, 2008, AM J RESP CELL MOL, V39, P522, DOI 10.1165/rcmb.2007-0328OC	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138762	10.1371/journal.pone.0138762	http://dx.doi.org/10.1371/journal.pone.0138762			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406307	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000361800700089
J	Stanfill, A; Hathaway, D; Cashion, A; Homayouni, R; Cowan, P; Thompson, C; Madahian, B; Conley, Y				Stanfill, Ansley; Hathaway, Donna; Cashion, Ann; Homayouni, Ramin; Cowan, Patricia; Thompson, Carol; Madahian, Behrouz; Conley, Yvette			A Pilot Study of Demographic and Dopaminergic Genetic Contributions to Weight Change in Kidney Transplant Recipients	PLOS ONE			English	Article							OBESITY; POLYMORPHISMS; VARIABLES; GAIN	Kidney transplant recipients often experience a significant amount of weight gain in the first year post-transplantation. While demographic factors such as age, race, and sex have been associated with weight gain in this population, these factors do not explain all of the variability seen. A number of studies have suggested that genetics also plays a critical role in weight changes. Recently, alterations in the activity of the neurotransmitter dopamine have been associated with weight change, and gene expression studies in kidney transplant recipients have supported this association. The purpose of this pilot study is to first examine the feasibility and methodology, and then to examine the associations of age, race, sex, and genotype for 13 SNPs and 3 VNTRs in 9 dopaminergic pathway genes (ANKK1, DRD2, DRD3, DRD4, SLC6A3/DAT1, MAOA, MAOB, COMT, CPE) for associations with percent weight change at 12 months post-transplantation. Seventy kidney transplant recipients had demographic and clinical data collected as a part of a larger observational study. DNA was extracted from repository buffy coat samples taken at the time of transplant, and genotyped using Taqman and PCR based methods. Three SNPs were independently associated with percent weight change: ANKK1 rs1800497 (r = -0.28, p = 0.05), SLC6A3/DAT1 rs6347 (p = 0.046), and CPE rs1946816 (p = 0.028). Stepwise regression modelling confirmed the combined associations of age (p = 0.0021), DRD4 VNTR 4/5 genotype (p = 0.0074), and SLC6A3/DAT1 rs6347 CC genotype (p = 0.0009) and TT genotype (p = 0.0004) with percent weight change in a smaller sample (n = 35) of these kidney transplant recipients that had complete genotyping. These associations indicate that there may be a genetic, and an age component to weight changes post transplantation.	[Stanfill, Ansley; Conley, Yvette] Univ Pittsburgh, Hlth Promot & Dev, Pittsburgh, PA 15260 USA; [Hathaway, Donna; Cowan, Patricia] Univ Tennessee, Ctr Hlth Sci, Coll Nursing, Memphis, TN 38163 USA; [Cashion, Ann] NINR, NIH, Bethesda, MD 20892 USA; [Homayouni, Ramin; Madahian, Behrouz] Univ Memphis, Bioinformat, Memphis, TN 38152 USA; [Thompson, Carol] Univ Kentucky, Coll Nursing, Lexington, KY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); University of Memphis; University of Kentucky	Stanfill, A (corresponding author), Univ Pittsburgh, Hlth Promot & Dev, Pittsburgh, PA 15260 USA.	Stanfill@pitt.edu	Homayouni, Ramin/U-2837-2019; Cowan, Patricia/S-4430-2019; Homayouni, Ramin/B-3547-2009	Homayouni, Ramin/0000-0003-0186-5076; Homayouni, Ramin/0000-0003-0186-5076; Stanfill, Ansley/0000-0001-7620-1130; Conley, Yvette/0000-0002-1784-6067	National Institute of Nursing Resarch [1F31NR013812, T32 NR009759]; Southern Nursing Research Society; NATIONAL INSTITUTE OF NURSING RESEARCH [ZIANR000030, F31NR013812, T32NR009759] Funding Source: NIH RePORTER	National Institute of Nursing Resarch; Southern Nursing Research Society; NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funding: This work was supported by the National Institute of Nursing Resarch grant 1F31NR013812 to AS; by the National Institute of Nursing Resarch grant T32 NR009759 to YC; and by the Southern Nursing Research Society Dissertation award to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.7569; Asico L, 2011, J AM SOC NEPHROL, V22, P82, DOI 10.1681/ASN.2010050533; Azzato EM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-9; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cashion A, 2014, CLIN TRANSP IN PRESS; Cashion A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059962; Cashion Ann K, 2007, Prog Transplant, V17, P40; Clunk JM, 2001, AM J KIDNEY DIS, V38, P349, DOI 10.1053/ajkd.2001.26100; Cupples CK, 2012, PROG TRANSPLANT, V22, P62, DOI 10.7182/pit2012888; Jenkinson CP, 2000, INT J OBESITY, V24, P580, DOI 10.1038/sj.ijo.0801200; Jezior D, 2007, TRANSPL P, V39, P2772, DOI 10.1016/j.transproceed.2007.09.001; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Miles J., TOLERANCE VARIANCE I; Moore LW, 1996, J RENAL NUTR, V6, P21, DOI DOI 10.1016/S1051-2276(96)90104-1; Patel M G, 1998, J Ren Nutr, V8, P137, DOI 10.1016/S1051-2276(98)90005-X; R Core Team, 2021, R LANGUAGE ENV STAT; Spreckelmeyer KN, 2011, BIOL PSYCHIAT; van den Ham ECH, 2003, TRANSPL INT, V16, P300, DOI 10.1111/j.1432-2277.2003.tb00304.x; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wang GJ, 2011, MOL PSYCHIAT, DOI 10.1038/mp.2011.86; Woodle ES, 2008, ANN SURG, V248, P564, DOI 10.1097/SLA.0b013e318187d1da; Zhang HP, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-10	25	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138885	10.1371/journal.pone.0138885	http://dx.doi.org/10.1371/journal.pone.0138885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406335	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700109
J	Su, JH; Aryal, A; Nan, ZB; Ji, WH				Su, Junhu; Aryal, Achyut; Nan, Zhibiao; Ji, Weihong			Climate Change-Induced Range Expansion of a Subterranean Rodent: Implications for Rangeland Management in Qinghai-Tibetan Plateau	PLOS ONE			English	Article							ZOKORS MYOSPALAX-FONTANIERII; NICHE CONSERVATISM; COMMUNITY; RESPONSES; ECOLOGY; VARIABILITY; PREDICTION; IMPACTS; FACE	Disturbances, both human-induced and natural, may re-shape ecosystems by influencing their composition, structure, and functional processes. Plateau zokor (Eospalax baileyi) is a typical subterranean rodent endemic to Qinghai-Tibetan Plateau (QTP), which are considered ecosystem engineers influencing the alpine ecosystem function. It is also regarded as a pest aggravating the degradation of overgrazed grassland and subject to regular control in QTP since 1950s. Climate change has been predicted in this region but little research exists exploring its impact on such subterranean rodent populations. Using plateau zokor as a model, through maximum entropy niche-based modeling (Maxent) and sustainable habitat models, we investigate zokor habitat dynamics driven by the future climate scenarios. Our models project that zokor suitable habitat will increase by 6.25% in 2050 in QTP. The predication indicated more threats in terms of grassland degradation as zokor suitable habitat will increase in 2050. Distribution of zokors will shift much more in their southern range with lower elevation compare to northern range with higher elevation. The estimated distance of shift ranges from 1 km to 94 km from current distribution. Grassland management should take into account such predictions in order to design mitigation measures to prevent further grassland degradation in QTP under climate change scenarios.	[Su, Junhu; Ji, Weihong] Gansu Agr Univ, Coll Grassland Sci, Key Lab Grassland Ecosyst, Minist Educ,Pratacultural Engn Lab Gansu Prov,Sin, Lanzhou 730070, Peoples R China; [Su, Junhu; Aryal, Achyut; Ji, Weihong] Gansu Agr Univ, Gansu Agr Univ Massey Univ Res Ctr Grassland Biod, Lanzhou 730070, Peoples R China; [Su, Junhu; Nan, Zhibiao] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China; [Aryal, Achyut; Ji, Weihong] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand	Gansu Agricultural University; Gansu Agricultural University; Lanzhou University; Massey University	Ji, WH (corresponding author), Gansu Agr Univ, Coll Grassland Sci, Key Lab Grassland Ecosyst, Minist Educ,Pratacultural Engn Lab Gansu Prov,Sin, Lanzhou 730070, Peoples R China.	j.j.weihong@massey.ac.nz		Aryal, Achyut/0000-0001-6658-8714; Aryal, Achyut/0000-0002-2695-9901	National Natural Science Foundation of China [31460566]; National Science Foundation for Post-doctoral Scientists of China [2015M572614]; Agricultural Innovation Research Project of Gansu Province [GNCX-2014-27]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Agricultural Innovation Research Project of Gansu Province	Funding: Funding for this project was provided by the National Natural Science Foundation of China (Grant No. 31460566), National Science Foundation for Post-doctoral Scientists of China (Grant No. 2015M572614) and Agricultural Innovation Research Project of Gansu Province (Grant No. GNCX-2014-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly David D., 2003, International Journal of Plant Sciences, V164, pS165, DOI 10.1086/368401; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Arthur A. D., 2007, ACIAR Technical Reports Series; Calkins MT, 2012, ECOGRAPHY, V35, P780, DOI 10.1111/j.1600-0587.2011.07227.x; CAMMELL ME, 1992, ADV ECOL RES, V22, P117, DOI 10.1016/S0065-2504(08)60135-X; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Davis MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131067; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fan NaiChang, 1999, Ecologically-based management of rodent pests., P285; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; FRANK CL, 1988, J MAMMAL, V69, P358, DOI 10.2307/1381386; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gottfried Michael, 1999, Diversity and Distributions, V5, P241, DOI 10.1046/j.1472-4642.1999.00058.x; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill JK, 2011, ANNU REV ENTOMOL, V56, P143, DOI 10.1146/annurev-ento-120709-144746; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Latham J, 2014, INT S LAND COVER MAP; Lu XM, 2015, ECOL LETT, V18, P48, DOI 10.1111/ele.12391; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Sharmila S, 2015, GLOBAL PLANET CHANGE, V124, P62, DOI 10.1016/j.gloplacha.2014.11.004; Smith AT, 2010, GUIDE ESTIMATES PRB; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sperber K, 2013, CLIM DYNAM, V41, P2711, DOI 10.1007/s00382-012-1607-6; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Su JH, 2014, BIOCHEM SYST ECOL, V57, P128, DOI 10.1016/j.bse.2014.07.017; Tang LZ, 2010, J BIOGEOGR, V37, P657, DOI 10.1111/j.1365-2699.2009.02232.x; Tang LZ, 2013, TURK J ZOOL, V37, P143, DOI 10.3906/zoo-1204-18; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang Quanye, 1993, Acta Theriologica Sinica, V13, P31; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilkes A., 2008, 67 ICRAF; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; Zeng J.X., 1984, ACTA BIOL PLAT SIN, V3, P163; Zhang YM, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P237, DOI 10.1007/978-3-540-69276-8_17; Zhang YM, 2003, MAMMAL REV, V33, P284, DOI 10.1046/j.1365-2907.2003.00020.x; Zhang YM, 2003, J MAMMAL, V84, P644, DOI 10.1644/1545-1542(2003)084&lt;0644:EOPZMF&gt;2.0.CO;2; Zhao Fang, 2015, Zhongguo Zhong Yao Za Zhi, V40, P399; Zhou Huakun, 2005, Grassland Science, V51, P191, DOI 10.1111/j.1744-697X.2005.00028.x	53	37	47	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138969	10.1371/journal.pone.0138969	http://dx.doi.org/10.1371/journal.pone.0138969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406891	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700132
J	Trogden, KP; Rogers, SL				Trogden, Kathryn P.; Rogers, Stephen L.			TOG Proteins Are Spatially Regulated by Rac-GSK3 beta to Control Interphase Microtubule Dynamics	PLOS ONE			English	Article							PLUS END-TRACKING; MINI SPINDLES; XMAP215; EB1; DOMAINS; RAC1; CELL; LOCALIZATION; ASSOCIATION; DOWNSTREAM	Microtubules are regulated by a diverse set of proteins that localize to microtubule plus ends (+TIPs) where they regulate dynamic instability and mediate interactions with the cell cortex, actin filaments, and organelles. Although individual + TIPs have been studied in depth and we understand their basic contributions to microtubule dynamics, there is a growing body of evidence that these proteins exhibit cross-talk and likely function to collectively integrate microtubule behavior and upstream signaling pathways. In this study, we have identified a novel protein-protein interaction between the XMAP215 homologue in Drosophila, Mini spindles (Msps), and the CLASP homologue, Orbit. These proteins have been shown to promote and suppress microtubule dynamics, respectively. We show that microtubule dynamics are regionally controlled in cells by Rac acting to suppress GSK3 beta in the peripheral lamellae/lamellipodium. Phosphorylation of Orbit by GSK3 beta triggers a relocalization of Msps from the microtubule plus end to the lattice. Mutation of the Msps-Orbit binding site revealed that this interaction is required for regulating microtubule dynamic instability in the cell periphery. Based on our findings, we propose that Msps is a novel Rac effector that acts, in partnership with Orbit, to regionally regulate microtubule dynamics.	[Trogden, Kathryn P.; Rogers, Stephen L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Rogers, Stephen L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Rogers, Stephen L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rogers, SL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	srogers@bio.unc.edu		Trogden, Kathryn/0000-0003-3288-3859	NIH [R01GM081645, R03HD077523]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD077523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081645] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Funded by NIH Grant numbers: R01GM081645 and R03HD077523, http://www.nimh.nih.gov/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Applewhite DA, 2013, MOL BIOL CELL, V24, P2885, DOI 10.1091/mbc.E12-11-0798; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brittle AL, 2005, EMBO J, V24, P1387, DOI 10.1038/sj.emboj.7600629; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Currie JD, 2011, MOL BIOL CELL, V22, P4343, DOI 10.1091/mbc.E11-06-0520; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gard DL, 2004, INT REV CYTOL, V239, P179, DOI 10.1016/S0074-7696(04)39004-2; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Grimaldi AD, 2014, DEV CELL, V30, P343, DOI 10.1016/j.devcel.2014.06.026; Grode KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123912; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lacroix B, 2014, DEV CELL, V29, P203, DOI 10.1016/j.devcel.2014.03.007; Leano JB, 2013, STRUCTURE, V21, P939, DOI 10.1016/j.str.2013.04.018; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Lowery LA, 2010, GENETICS, V185, P1311, DOI 10.1534/genetics.110.115626; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051442; Peters KA, 2013, MOL BIOL CELL, V24, P3460, DOI 10.1091/mbc.E12-11-0813; Roberts DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031284; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2009, BIOCHEM SOC T, V37, P1002, DOI 10.1042/BST0371002; Sousa A, 2007, CELL MOTIL CYTOSKEL, V64, P605, DOI 10.1002/cm.20208; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Xia P, 2014, MOL BIOL CELL, V25, P4166, DOI 10.1091/mbc.E14-06-1133; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	44	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138966	10.1371/journal.pone.0138966	http://dx.doi.org/10.1371/journal.pone.0138966			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406596	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700131
J	Waris, O; Soveri, A; Laine, M				Waris, Otto; Soveri, Anna; Laine, Matti			Transfer after Working Memory Updating Training	PLOS ONE			English	Article							FLUID INTELLIGENCE; EXECUTIVE FUNCTIONS; AGE-DIFFERENCES; CAPACITY; COMPATIBILITY; PERFORMANCE; GAINS; TESTS; SPAN; ADHD	During the past decade, working memory training has attracted much interest. However, the training outcomes have varied between studies and methodological problems have hampered the interpretation of results. The current study examined transfer after working memory updating training by employing an extensive battery of pre-post cognitive measures with a focus on near transfer. Thirty-one healthy Finnish young adults were randomized into either a working memory training group or an active control group. The working memory training group practiced with three working memory tasks, while the control group trained with three commercial computer games with a low working memory load. The participants trained thrice a week for five weeks, with one training session lasting about 45 minutes. Compared to the control group, the working memory training group showed strongest transfer to an n-back task, followed by working memory updating, which in turn was followed by active working memory capacity. Our results support the view that working memory training produces near transfer effects, and that the degree of transfer depends on the cognitive overlap between the training and transfer measures.	[Waris, Otto; Soveri, Anna; Laine, Matti] Abo Akad Univ, Dept Psychol, Turku, Finland; [Laine, Matti] Turku Brain & Mind Ctr, Turku, Finland	Abo Akademi University	Waris, O (corresponding author), Abo Akad Univ, Dept Psychol, Turku, Finland.	owaris@abo.fi		Soveri, Anna/0000-0002-1443-6097; Waris, Otto/0000-0002-4812-9597	Academy of Finland [260276]; Abo Akademi Endowment (BrainTrain project); Graduate School at Abo Akademi University	Academy of Finland(Academy of Finland); Abo Akademi Endowment (BrainTrain project); Graduate School at Abo Akademi University	This work was supported by Academy of Finland, Grant # 260276 (http://www.aka.fi/en-GB/A/) and Abo Akademi Endowment (BrainTrain project) to ML, while OW was financially supported by The Graduate School at Abo Akademi University.	Alloway TP, 2013, FRONT COGN PSYCHOL, P63; Alloway TP, 2013, COMPUT HUM BEHAV, V29, P632, DOI 10.1016/j.chb.2012.10.023; Au J, 2014, PSYCHON B REV; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beck A, 2004, BDI 2 KASIKIRJA MANU; Bruyer R, 1998, ACTA PSYCHOL, V98, P17, DOI 10.1016/S0001-6918(97)00053-X; Carretti B, 2007, BRIT J PSYCHOL, V98, P45, DOI 10.1348/000712606X104175; Cattell RB, 1973, MEASURING INTELLIGEN; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Chooi WT, 2012, INTELLIGENCE, V40, P531, DOI 10.1016/j.intell.2012.07.004; Colom R, 2013, INTELLIGENCE, V41, P712, DOI 10.1016/j.intell.2013.09.002; Corsi PM, 1972, DEP PSYCHOL; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Dimitrov Dimiter M, 2003, Work, V20, P159; Ellenbogen R, 2008, MEM COGNITION, V36, P968, DOI 10.3758/MC.36.5.968; Gignac GE, 2014, INTELLIGENCE, V47, P122, DOI 10.1016/j.intell.2014.09.004; Hambrick DZ, 2010, APPL COGNITIVE PSYCH, V24, P1149, DOI 10.1002/acp.1624; Harrison TL, 2013, PSYCHOL SCI, V24, P2409, DOI 10.1177/0956797613492984; Hulme C, 2012, J APPL RES MEM COGN, V1, P197, DOI 10.1016/j.jarmac.2012.06.006; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jausovec N, 2012, BRAIN COGNITION, V79, P96, DOI 10.1016/j.bandc.2012.02.007; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2012, J APPL RES MEM COGN, V1, P194, DOI 10.1016/j.jarmac.2012.07.004; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kundu B, 2013, J NEUROSCI, V33, P8705, DOI 10.1523/JNEUROSCI.5565-12.2013; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Morrison AB, 2012, J APPL RES MEM COGN, V1, P208, DOI 10.1016/j.jarmac.2012.07.005; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Murty VP, 2011, NEUROIMAGE, V57, P1264, DOI 10.1016/j.neuroimage.2011.05.006; Oelhafen S, 2013, NEUROPSYCHOLOGIA, V51, P2781, DOI 10.1016/j.neuropsychologia.2013.08.012; Redick TS, 2013, PSYCHON B REV, V20, P1102, DOI 10.3758/s13423-013-0453-9; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Salminen T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00166; Schmiedek F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01475; Shah P, 2012, J APPL RES MEM COGN, V1, P204, DOI 10.1016/j.jarmac.2012.07.001; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith SP, 2013, COMPUT HUM BEHAV, V29, P2388, DOI 10.1016/j.chb.2013.05.014; Soveri A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00183; Suss HM, 2002, INTELLIGENCE, V30, P261, DOI 10.1016/S0160-2896(01)00100-3; Szmalec A, 2011, J EXP PSYCHOL HUMAN, V37, P137, DOI 10.1037/a0020365; Thompson TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063614; Vecchi T, 2005, EUR J COGN PSYCHOL, V17, P521, DOI 10.1080/09541440440000140; Virtanen, 1999, WORDMILL LEXICAL SEA; von Bastian CC, 2014, PSYCHOL RES-PSYCH FO, V78, P803, DOI 10.1007/s00426-013-0524-6; von Bastian CC, 2013, J MEM LANG, V69, P36, DOI 10.1016/j.jml.2013.02.002; Wechsler D, 2005, WAIS 3 KASIKIRJA MAN	57	30	31	7	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138734	10.1371/journal.pone.0138734	http://dx.doi.org/10.1371/journal.pone.0138734			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406319	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700079
J	Williams, LA; Masser, B; Sun, J				Williams, Lisa A.; Masser, Barbara; Sun, Jessie			Revisiting the Effect of Anthropomorphizing a Social Cause Campaign	PLOS ONE			English	Article							ANTICIPATED GUILT; PLANNED BEHAVIOR; EXTENDED THEORY; BLOOD-DONORS; REGRET; PRIDE; SELF; PSYCHOLOGY; EMOTIONS; APPEALS	Recent research suggests that anthropomorphism can be harnessed as a tool to boost intentions to comply with social cause campaigns. Drawing on the human tendency to extend moral concern to entities portrayed as humanlike, it has been argued that adding personified features to a social campaign elevates anticipated guilt at failing to comply, and this subsequently boosts intentions to comply with that campaign. The present research aimed to extend extant research by disentangling the effects of emotional and non-emotional anthropomorphism, and differentiating amongst other emotional mechanisms of the anthropomorphism- compliance effect (namely, anticipated pride and anticipated regret). Experiment 1 (N = 294) compared the effectiveness of positive, negative, and emotionally-neutral anthropomorphized campaign posters for boosting campaign compliance intentions against non-anthropomorphized posters. We also measured potential mechanisms including anticipated guilt, regret, and pride. Results failed to support the anthropomorphism-compliance effect, and no changes in anticipated emotion according to anthropomorphism emerged. Experiments 2 (N = 150) and 3 (N = 196) represented further tests of the anthropomorphism-compliance effect. Despite high statistical power and efforts to closely replicate the conditions under which the anthropomorphism-compliance effect had been previously observed, no differences in compliance intention or anticipated emotion according to anthropomorphism emerged. A meta-analysis of the effects of anthropomorphism on compliance and anticipated emotion across the three experiments revealed effect size estimates that did not differ significantly from zero. The results of these three experiments suggest that the anthropomorphism-compliance effect is fragile and perhaps subject to contextual and idiographic influences. Thus, this research provides important insight and impetus for future research on the applied and theoretical utility of anthropomorphizing social cause campaigns.	[Williams, Lisa A.] UNSW Australia, Sch Psychol, Sydney, NSW, Australia; [Masser, Barbara] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Sun, Jessie] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia	University of New South Wales Sydney; University of Queensland; University of Melbourne	Williams, LA (corresponding author), UNSW Australia, Sch Psychol, Sydney, NSW, Australia.	lwilliams@unsw.edu.au	Masser, Barbara M/A-7900-2018	Masser, Barbara M/0000-0001-9385-6497; Williams, Lisa A/0000-0002-0021-5613; Sun, Jessie/0000-0001-6764-0721				Ahn HK, 2014, PSYCHOL SCI, V25, P224, DOI 10.1177/0956797613496823; Bagot KL, 2015, ANN BEHAV MED, V49, P510, DOI 10.1007/s12160-014-9677-9; Basil DZ, 2008, PSYCHOL MARKET, V25, P1, DOI 10.1002/mar.20200; Basil DZ, 2006, PSYCHOL MARKET, V23, P1035, DOI 10.1002/mar.20145; Bateson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082055; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Baumeister RF, 2007, PERSPECT PSYCHOL SCI, V2, P396, DOI 10.1111/j.1745-6916.2007.00051.x; Bell DE, 1981, P 4 INT C MULT CRIT, P28, DOI [10.1007/978-3-642-45527-8_3, DOI 10.1007/978-3-642-45527-8_3]; Cole LM, 2014, PSYCHOL CRIME LAW, V20, P722, DOI 10.1080/1068316X.2013.854794; Ekstrom M, 2012, EXP ECON, V15, P530, DOI 10.1007/s10683-011-9312-6; Elgaaied L, 2012, J CONSUM MARK, V29, P369; Epley N, 2007, PSYCHOL REV, V114, P864, DOI 10.1037/0033-295X.114.4.864; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Francey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037397; Funder DC, 2014, PERS SOC PSYCHOL REV, V18, P3, DOI 10.1177/1088868313507536; Godin G, 2014, HEALTH PSYCHOL, V33, P646, DOI 10.1037/a0033505; GOSSELIN P, 1995, J PERS SOC PSYCHOL, V68, P83, DOI 10.1037/0022-3514.68.1.83; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Kaiser FG, 2006, PERS INDIV DIFFER, V41, P71, DOI 10.1016/j.paid.2005.11.028; Kaiser FG, 2008, EUR PSYCHOL, V13, P288, DOI 10.1027/1016-9040.13.4.288; KEITH LT, 1974, J EXP EDUC, V42, P30, DOI 10.1080/00220973.1974.11011490; Koch EJ, 2014, BASIC APPL SOC PSYCH, V36, P397, DOI 10.1080/01973533.2014.935379; Lindsey LLM, 2005, HUM COMMUN RES, V31, P453, DOI 10.1093/hcr/31.4.453; Lipsey M, 2000, PRACTICAL META ANALY; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Mascolo Michael F., 1995, P64; Masser BM, 2009, TRANSFUSION, V49, P320, DOI 10.1111/j.1537-2995.2008.01981.x; Meijnders AL, 2001, J APPL SOC PSYCHOL, V31, P754, DOI 10.1111/j.1559-1816.2001.tb01412.x; Nelissen RMA, 2011, EUR J SOC PSYCHOL, V41, P78, DOI 10.1002/ejsp.735; Nelissen RMA, 2009, J EXP SOC PSYCHOL, V45, P1227, DOI 10.1016/j.jesp.2009.06.004; O'Carroll RE, 2011, HEALTH PSYCHOL, V30, P236, DOI 10.1037/a0022379; Onwezen M. C., 2013, EUROPEAN J SOCIAL PS, V44, P53, DOI DOI 10.1002/EJSP; Onwezen MC, 2014, J ENVIRON PSYCHOL, V40, P239, DOI 10.1016/j.jenvp.2014.07.003; Onwezen MC, 2013, J ECON PSYCHOL, V39, P141, DOI 10.1016/j.joep.2013.07.005; Patrick VM, 2009, J CONSUM PSYCHOL, V19, P537, DOI 10.1016/j.jcps.2009.05.006; Peloza J, 2013, J MARKETING, V77, P104, DOI 10.1509/jm.11.0454; Perrin J.L., 2011, APPL ENV ED COMMUNIC, V10, P146, DOI [10.1080/1533015X.2011.603612, DOI 10.1080/1533015X.2011.603612]; Powell KL, 2012, ETHOLOGY, V118, P1096, DOI 10.1111/eth.12011; Provine RR, 2009, EVOL PSYCHOL, V7, P52, DOI 10.1177/147470490900700107; Rivis A, 2009, J APPL SOC PSYCHOL, V39, P2985, DOI 10.1111/j.1559-1816.2009.00558.x; ROSENFELD HM, 1966, J PERS SOC PSYCHOL, V4, P597, DOI 10.1037/h0023996; ROSENFELD HM, 1967, J EXP SOC PSYCHOL, V3, P102, DOI 10.1016/0022-1031(67)90040-6; Rottman J, 2015, PHILOS COMPASS, V10, P134, DOI 10.1111/phc3.12195; Sandberg T, 2008, BRIT J SOC PSYCHOL, V47, P589, DOI 10.1348/014466607X258704; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Searles K., 2010, APPL ENV ED COMMUN, V9, P173, DOI [10.1080/1533015X.2010.510025, DOI 10.1080/1533015X.2010.510025]; Smithson M., 2003, CONFIDENCE INTERVALS; Stanger N, 2012, J SPORT EXERCISE PSY, V34, P208, DOI 10.1123/jsep.34.2.208; Steenhaut S, 2006, J BUS ETHICS, V69, P269, DOI 10.1007/s10551-006-9090-9; Stephan BCM, 2006, J INT NEUROPSYCH SOC, V12, P884, DOI 10.1017/S1355617706061066; Stevens C, 2011, RES AUTISM SPECT DIS, V5, P666, DOI 10.1016/j.rasd.2010.08.003; SWIM JK, 2013, ECOPSYCHOLOGY, V5, P24, DOI DOI 10.1089/ECO.2012.0065; Tam KP, 2015, BRIT J SOC PSYCHOL, V54, P187, DOI 10.1111/bjso.12076; Tam KP, 2014, SOC COGNITION, V32, P276, DOI 10.1521/soco.2014.32.3.276; Tam KP, 2013, J EXP SOC PSYCHOL, V49, P514, DOI 10.1016/j.jesp.2013.02.001; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; van der Schalk J, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00513; Wang X, 2011, HEALTH COMMUN, V26, P683, DOI 10.1080/10410236.2011.563350; Waytz A, 2010, CURR DIR PSYCHOL SCI, V19, P58, DOI 10.1177/0963721409359302; Webster JM, 2003, J SOC PSYCHOL, V143, P209, DOI 10.1080/00224540309598441; Williams LA, 2008, J PERS SOC PSYCHOL, V94, P1007, DOI 10.1037/0022-3514.94.6.1007; Williams LA, 2009, PSYCHOL SCI, V20, P284, DOI 10.1111/j.1467-9280.2009.02292.x; Wilson D. B, 2006, META ANALYSIS MACROS; Wuensch KL, 2012, USING SPSS TO OBTAIN; Zeelenberg M, 1999, J BEHAV DECIS MAKING, V12, P93, DOI 10.1002/(SICI)1099-0771(199906)12:2<93::AID-BDM311>3.0.CO;2-S; Zeelenberg M, 1998, ORGAN BEHAV HUM DEC, V75, P117, DOI 10.1006/obhd.1998.2784; Zeelenberg M, 2008, EMOTION, V8, P589, DOI 10.1037/a0012894	69	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138886	10.1371/journal.pone.0138886	http://dx.doi.org/10.1371/journal.pone.0138886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406494	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700110
J	Cox, F; Roos, A; Hafkemeijer, N; Baart, M; Tolboom, J; Dekking, L; Stittelaar, K; Goudsmit, J; Radosevic, K; Saeland, E				Cox, Freek; Roos, Anna; Hafkemeijer, Nicole; Baart, Matthijs; Tolboom, Jeroen; Dekking, Liesbeth; Stittelaar, Koert; Goudsmit, Jaap; Radosevic, Katarina; Saeland, Eirikur			Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; MONOCLONAL-ANTIBODIES; VIRAL NEURAMINIDASE; VIRUS INFECTION; A VIRUSES; HEMAGGLUTININ; PROSPECTS; SEVERITY; IMMUNITY; CELLS	There is a constant threat of zoonotic influenza viruses causing a pandemic outbreak in humans. It is virtually impossible to predict which virus strain will cause the next pandemic and it takes a considerable amount of time before a safe and effective vaccine will be available once a pandemic occurs. In addition, development of pandemic vaccines is hampered by the generally poor immunogenicity of avian influenza viruses in humans. An effective pre-pandemic vaccine is therefore required as a first line of defense. Broadening of the protective efficacy of current seasonal vaccines by adding an adjuvant may be a way to provide such first line of defense. Here we evaluate whether a seasonal trivalent virosomal vaccine (TVV) adjuvated with the saponin-based adjuvant Matrix-M (MM) can confer protection against avian influenza H5 and H7 virus strains in mice and ferrets. We demonstrate that mice were protected from death against challenges with H5N1 and H7N7, but that the protection was not complete as evidenced by severe clinical signs. In ferrets, protection against H7N9 was not observed. In contrast, reduced upper and lower respiratory tract viral loads and reduced lung pathology, was achieved in H5N1 challenged ferrets. Together these results suggest that, at least to some extent, Matrix-M adjuvated seasonal virosomal influenza vaccine can serve as an interim measure to decrease morbidity and mortality associated with a pandemic outbreak.	[Cox, Freek; Roos, Anna; Hafkemeijer, Nicole; Baart, Matthijs; Tolboom, Jeroen; Dekking, Liesbeth; Goudsmit, Jaap; Radosevic, Katarina; Saeland, Eirikur] Ctr Excellence Janssen Res & Dev, Janssen Prevent Ctr, Leiden, Netherlands; [Stittelaar, Koert] Viroclin Biosci, Rotterdam, Netherlands		Saeland, E (corresponding author), Janssen Res & Dev, Infect Dis & Vaccines Therapeut Area, Leiden, Netherlands.	Esaeland@its.jnj.com						Baras B, 2011, VACCINE, V29, P2120, DOI 10.1016/j.vaccine.2010.12.125; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Doyle TM, ANTIVIRAL RES; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hannoun C, 2013, EXPERT REV VACCINES, V12, P1085, DOI 10.1586/14760584.2013.824709; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Jegaskanda S, 2014, J INFECT DIS; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Kreijtz J. H., 2014, J INFECT DIS; Kreijtz JHCM, 2013, VACCINE, V31, P4995, DOI 10.1016/j.vaccine.2013.06.071; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mischler R, 2002, VACCINE, V20, pB17, DOI 10.1016/S0264-410X(02)00512-1; MOREIN B, 1984, NATURE, V308, P457, DOI 10.1038/308457a0; Pedersen G, 2011, INFLUENZA OTHER RESP, V5, P426, DOI 10.1111/j.1750-2659.2011.00256.x; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Radosevic K, 2008, VACCINE, V26, P3640, DOI 10.1016/j.vaccine.2008.04.071; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rockman S, 2013, J VIROL, V87, P3053, DOI 10.1128/JVI.02434-12; Sambhara S, 1998, J INFECT DIS, V177, P1266, DOI 10.1086/515285; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; SCHULMAN JL, 1962, NATURE, V195, P1129, DOI 10.1038/1951129a0; SMITH H, 1988, REV INFECT DIS, V10, P56; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; van den Brand JMA, 2011, J VIROL, V85, P2851, DOI 10.1128/JVI.01939-10; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2013, INFL HUM AN INT SUMM; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; World Health Organization, 9 WHO	47	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0135723	10.1371/journal.pone.0135723	http://dx.doi.org/10.1371/journal.pone.0135723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402787	Green Published, Green Submitted, gold			2022-12-27	WOS:000361798100004
J	Jokerst, JV; Chen, Z; Xu, L; Nolley, R; Chang, E; Mitchell, B; Brooks, JD; Gambhir, SS				Jokerst, Jesse V.; Chen, Zuxiong; Xu, Lingyun; Nolley, Rosalie; Chang, Edwin; Mitchell, Breeana; Brooks, James D.; Gambhir, Sanjiv S.			A Magnetic Bead-Based Sensor for the Quantification of Multiple Prostate Cancer Biomarkers	PLOS ONE			English	Article							SOLUBLE RECEPTOR; ANTIGEN; PROGRESSION; CELLS; INTERLEUKIN-6; MICROBUBBLES; METAANALYSIS; METASTASIS; MEDICINE; REVEALS	Novel biomarker assays and upgraded analytical tools are urgently needed to accurately discriminate benign prostatic hypertrophy (BPH) from prostate cancer (CaP). To address this unmet clinical need, we report a piezeoelectric/magnetic bead-based assay to quantitate prostate specific antigen (PSA; free and total), prostatic acid phosphatase, carbonic anhydrase 1 (CA1), osteonectin, IL-6 soluble receptor (IL-6sr), and spondin-2. We used the sensor to measure these seven proteins in serum samples from 120 benign prostate hypertrophy patients and 100 Gleason score 6 and 7 CaP using serum samples previously collected and banked. The results were analyzed with receiver operator characteristic curve analysis. There were significant differences between BPH and CaP patients in the PSA, CA1, and spondin-2 assays. The highest AUC discrimination was achieved with a spondin2 OR free/total PSA operation-the area under the curve was 0.84 with a p value below 10 -6. Some of these data seem to contradict previous reports and highlight the importance of sample selection and proper assay building in the development of biomarker measurement schemes. This bead-based system offers important advantages in assay building including low cost, high throughput, and rapid identification of an optimal matched antibody pair.	[Jokerst, Jesse V.; Xu, Lingyun; Chang, Edwin; Mitchell, Breeana; Gambhir, Sanjiv S.] Stanford Univ, MIPS, Dept Radiol, Stanford, CA 94305 USA; [Chen, Zuxiong; Nolley, Rosalie; Brooks, James D.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, BioX, Mat Sci & Engn, Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Brooks, JD (corresponding author), Stanford Univ, Dept Urol, Stanford, CA 94305 USA.	jdbrooks@stanford.edu; sgambhir@stanford.edu	Chang, Edwin/AAL-4232-2020	Kumar, Chandan/0000-0002-8696-3400; Jokerst, Jesse/0000-0003-2829-6408	USA National Cancer Institute Grant [U01 CA152737, R25-T CA118681]; Canary Foundation; NATIONAL CANCER INSTITUTE [U01CA152737] Funding Source: NIH RePORTER	USA National Cancer Institute Grant; Canary Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the USA National Cancer Institute Grant U01 CA152737, R25-T CA118681 and the Canary Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2010, UROL INT, V44, P135; Augustsson P, 2012, ANAL CHEM, V84, P7954, DOI 10.1021/ac301723s; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Cann GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049144; Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542; Chen ZX, 1997, J UROLOGY, V157, P2166, DOI 10.1016/S0022-5347(01)64704-9; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Dewitte K, 2002, CLIN CHEM, V48, P799; Dickerson M, 2011, JOVE-J VIS EXP, DOI 10.3791/2493; Djavan B, 1999, UROLOGY, V54, P517, DOI 10.1016/S0090-4295(99)00153-3; Dolgin E, 2011, NAT MED, V17, P768, DOI 10.1038/nm0711-768; Fischer T, 2010, INVEST RADIOL, V45, P675, DOI 10.1097/RLI.0b013e3181efd6b2; FOTI AG, 1977, NEW ENGL J MED, V297, P1357, DOI 10.1056/NEJM197712222972501; Gaster RS, 2009, NAT MED, V15, P1327, DOI 10.1038/nm.2032; Jacob K, 1999, CANCER RES, V59, P4453; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jokerst JV, 2009, BIOSENS BIOELECTRON, V24, P3622, DOI 10.1016/j.bios.2009.05.026; Kattan MW, 2003, J CLIN ONCOL, V21, P3573, DOI 10.1200/JCO.2003.12.037; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897; Lee R, 2006, UROLOGY, V67, P762, DOI 10.1016/j.urology.2005.10.052; Lucarelli G, 2013, J UROLOGY, V190, P2271, DOI 10.1016/j.juro.2013.05.004; Malhotra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020293; Mikolajczyk SD, 2004, CLIN BIOCHEM, V37, P519, DOI 10.1016/j.clinbiochem.2004.05.016; Prensner JR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003180; Psaltis PJ, 2010, J CARDIOVASC TRANSL, V3, P135, DOI 10.1007/s12265-009-9138-1; Qian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037225; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; Roddam AW, 2005, EUR UROL, V48, P386, DOI 10.1016/j.eururo.2005.04.015; Sardana G, 2008, J PROTEOME RES, V7, P3329, DOI 10.1021/pr8003216; Schutt CE, 2014, SMALL, V10, P3316, DOI 10.1002/smll.201302786; Shariat SF, 2001, UROLOGY, V58, P1008, DOI 10.1016/S0090-4295(01)01405-4; Shariat SF, 2008, BJU INT, V101, P675, DOI 10.1111/j.1464-410X.2007.07283.x; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Takakura Michiko, 2012, ISRN Oncol, V2012, P768190, DOI 10.5402/2012/768190; Tavoosidana G, 2011, P NATL ACAD SCI USA, V108, P8809, DOI 10.1073/pnas.1019330108; Thomas S, 2011, J NANOMEDICINE NANOT, V2; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Yan ZH, 2011, ANAL BIOCHEM, V410, P13, DOI 10.1016/j.ab.2010.11.012	42	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139484	10.1371/journal.pone.0139484	http://dx.doi.org/10.1371/journal.pone.0139484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421725	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700122
J	Kim, YD; Song, D; Heo, JH; Kim, SU; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Kim, KJ; Han, KH				Kim, Young Dae; Song, Dongbeom; Heo, Ji Hoe; Kim, Seung Up; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Kim, Kwang Joon; Han, Kwang-Hyub			Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography	PLOS ONE			English	Article							WHITE-MATTER LESIONS; SILENT BRAIN INFARCTS; SMALL VESSEL DISEASE; ROTTERDAM SCAN; INTRACEREBRAL HEMORRHAGE; ARTERIAL STIFFNESS; ISCHEMIC ATTACK; RISK-FACTORS; STROKE RISK; FIBROSIS	Background & Aims Liver fibrosis is a multifactorial disease that can affect the development of cerebral small vessel diseases (SVDs) including cerebral microbleeds (CMBs), leukoaraiosis, and silent infarctions. Transient elastography can accurately assess the degree of liver fibrosis by measuring liver stiffness (LS). In the present study, we investigated the association between SVDs and LS values. Methods We recruited 300 participants (mean age 56 years, 170 men) who underwent a comprehensive medical health check-up between January 2011 and December 2012. Transient elastography was taken on the right lobe of the liver through intercostal space with patients lying in the dorsal decubitus position with the right arm in maximal abduction. Mild and significant fibrosis were defined as LS values >5.6 and >8.0 kPa, respectively. The presence of each SVD was determined using the FLAIR, GRE MR imaging as well as T1-, T2-weighted MR images. We tested whether the presence and burden of each type of SVD were different by LS values. Results Of the different types of SVDs, only the presence (p = 0.001) and number of CMBs (p<0.001) were positively associated with LS values. Multivariate analysis revealed that significant fibrosis (>8.0 kPa) was an independent predictor of CMBs (odds ratio 6.079, 95% confidence interval 1.489-24.819, p = 0.012). However, leukoaraiosis and silent infarctions were not associated with LS values (all p>0.05). Conclusions The degree of liver fibrosis, as assessed using transient elastography, was independently associated with the presence and burden of CMBs in healthy, asymptomatic participants. Understanding the link between the brain and liver may advance future research on the pathomechanisms of CMBs.	[Kim, Young Dae; Song, Dongbeom; Heo, Ji Hoe] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Seung Up; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea; [Kim, Kwang Joon] Yonsei Univ Hlth Syst, Severance Execut Healthcare Clin, Seoul, South Korea; [Kim, Kwang Joon] Yonsei Univ Hlth Syst, Severance Check Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea.	ksukorea@yuhs.ac; preppie@yuhs.ac	Park, Jun Yong/H-7127-2019	Ahn, Sang Hoon/0000-0002-3629-4624; Kim, Seung Up/0000-0002-9658-8050; Kim, Beom Kyung/0000-0002-5363-2496; Han, Kwang-Hyub/0000-0003-3960-6539; Heo, Ji Hoe/0000-0001-9898-3321; Park, Jun Yong/0000-0001-6324-2224; Kim, Young Dae/0000-0001-5750-2616	Liver Cirrhosis Clinical Research Center; Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Liver Cirrhosis Clinical Research Center; Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea (no. HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding does not alter the authors' adherence to all the journal policies on sharing data and materials.	Branchi F, 2014, WORLD J GASTROENTERO, V20, P14568, DOI 10.3748/wjg.v20.i40.14568; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Charidimou A, 2013, STROKE, V44, P995, DOI 10.1161/STROKEAHA.111.000038; Fargion S, 2014, WORLD J GASTROENTERO, V20, P13306, DOI 10.3748/wjg.v20.i37.13306; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; FUJII Y, 1994, NEUROSURGERY, V35, P592, DOI 10.1227/00006123-199410000-00003; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Martinez RG, 2010, TRANSPLANTATION, V89, P589, DOI 10.1097/TP.0b013e3181ca7bb3; Hoya K, 2012, NEUROL MED-CHIR, V52, P181, DOI 10.2176/nmc.52.181; Huang Y, 2012, ARTERIOSCL THROM VAS, V32, P2321, DOI 10.1161/ATVBAHA.112.252957; Kim SU, 2010, LIVER INT, V30, P268, DOI 10.1111/j.1478-3231.2009.02172.x; Kobayashi S, 1997, STROKE, V28, P1932, DOI 10.1161/01.STR.28.10.1932; Lahousse L, 2013, AM J RESP CRIT CARE, V188, P783, DOI 10.1164/rccm.201303-0455OC; Lee YJ, 2012, DIGEST DIS SCI, V57, P196, DOI 10.1007/s10620-011-1819-3; Matsusue E, 2005, AM J NEURORADIOL, V26, P347; Miwa K, 2011, STROKE, V42, P3202, DOI 10.1161/STROKEAHA.111.621193; Ovbiagele B, 2010, ARCH NEUROL-CHICAGO, V67, P45, DOI 10.1001/archneurol.2009.310; Poels MMF, 2012, STROKE, V43, P2637, DOI 10.1161/STROKEAHA.111.642264; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rovira A, 2007, HEPATOLOGY, V46, P1485, DOI 10.1002/hep.21911; Song TJ, 2014, EUR J NEUROL, V21, P463, DOI 10.1111/ene.12332; Sunbul M, 2014, ATHEROSCLEROSIS, V237, P490, DOI 10.1016/j.atherosclerosis.2014.10.004; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vergouwen MDI, 2008, STROKE, V39, P497, DOI 10.1161/STROKEAHA.107.488791; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; WIJDICKS EFM, 1995, MAYO CLIN PROC, V70, P443, DOI 10.4065/70.5.443	33	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139227	10.1371/journal.pone.0139227	http://dx.doi.org/10.1371/journal.pone.0139227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421848	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700081
J	Carmona-Antonanzas, G; Carmichael, SN; Heumann, J; Taggart, JB; Gharbi, K; Bron, JE; Bekaert, M; Sturm, A				Carmona-Antonanzas, Greta; Carmichael, Stephen N.; Heumann, Jan; Taggart, John B.; Gharbi, Karim; Bron, James E.; Bekaert, Michael; Sturm, Armin			A Survey of the ATP-Binding Cassette (ABC) Gene Superfamily in the Salmon Louse (Lepeophtheirus salmonis)	PLOS ONE			English	Article							FARMED ATLANTIC SALMON; MULTIDRUG-RESISTANCE; SEA LICE; P-GLYCOPROTEIN; MULTIXENOBIOTIC RESISTANCE; IVERMECTIN RESISTANCE; PESTICIDE RESISTANCE; EFFLUX TRANSPORTERS; DROSOPHILA; FAMILY	Salmon lice, Lepeophtheirus salmonis (Kroyer, 1837), are fish ectoparasites causing significant economic damage in the mariculture of Atlantic salmon, Salmo salar Linnaeus, 1758. The control of L. salmonis at fish farms relies to a large extent on treatment with anti-parasitic drugs. A problem related to chemical control is the potential for development of resistance, which in L. salmonis is documented for a number of drug classes including organophosphates, pyrethroids and avermectins. The ATP-binding cassette (ABC) gene superfamily is found in all biota and includes a range of drug efflux transporters that can confer drug resistance to cancers and pathogens. Furthermore, some ABC transporters are recognised to be involved in conferral of insecticide resistance. While a number of studies have investigated ABC transporters in L. salmonis, no systematic analysis of the ABC gene family exists for this species. This study presents a genome-wide survey of ABC genes in L. salmonis for which, ABC superfamily members were identified through homology searching of the L. salmonis genome. In addition, ABC proteins were identified in a reference transcriptome of the parasite generated by high-throughput RNA sequencing (RNA-seq) of a multi-stage RNA library. Searches of both genome and transcriptome allowed the identification of a total of 33 genes / transcripts coding for ABC proteins, of which 3 were represented only in the genome and 4 only in the transcriptome. Eighteen sequences were assigned to ABC subfamilies known to contain drug transporters, i.e. subfamilies B (4 sequences), C (11) and G (2). The results suggest that the ABC gene family of L. salmonis possesses fewer members than recorded for other arthropods. The present survey of the L. salmonis ABC gene superfamily will provide the basis for further research into potential roles of ABC transporters in the toxicity of salmon delousing agents and as potential mechanisms of drug resistance.	[Carmona-Antonanzas, Greta; Carmichael, Stephen N.; Heumann, Jan; Taggart, John B.; Bron, James E.; Bekaert, Michael; Sturm, Armin] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Gharbi, Karim] Univ Edinburgh, Edinburgh Genom, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland	University of Stirling; University of Edinburgh	Sturm, A (corresponding author), Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.	armin.sturm@stir.ac.uk	Bron, James E/B-6231-2018; Gharbi, Karim/C-5771-2012	Bron, James E/0000-0003-3544-0519; Gharbi, Karim/0000-0003-1092-4488; Taggart, John/0000-0002-3843-9663; Bekaert, Michael/0000-0002-1206-7654; Sturm, Armin/0000-0003-2632-1999	United Kingdom Biotechnology and Biological Sciences Research Council [BB/L022923/1]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Scottish Salmon Producer's Organisation; Moredun Foundation; Merck Animal Health; Natural Environment Research Council [R8/H10/56]; Medical Research Council [MR/K001744/1]; Biotechnological and Biological Research Council [BB/J004243/1]; BBSRC [BB/L024004/1, BB/L022923/1] Funding Source: UKRI; MRC [MR/K001744/1, G0900740] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L024004/1, BB/L022923/1] Funding Source: researchfish; Medical Research Council [G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Scottish Salmon Producer's Organisation; Moredun Foundation; Merck Animal Health(Merck & Company); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnological and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by United Kingdom Biotechnology and Biological Sciences Research Council grant BB/L022923/1 awarded to Armin Sturm. The authors further gratefully acknowledge funding received from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland). MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. The authors are further thankful to the Scottish Salmon Producer's Organisation and the Moredun Foundation for financial support to Stephen N. Carmichael, and to Merck Animal Health for financial support to Jan Heumann. Illumina RNA-seq was carried out by Edinburgh Genomics, the University of Edinburgh. Edinburgh Genomics is partly supported through core grants from Natural Environment Research Council (R8/H10/56), Medical Research Council (MR/K001744/1) and Biotechnological and Biological Research Council (BB/J004243/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergen AAB, 2007, PFLUG ARCH EUR J PHY, V453, P685, DOI 10.1007/s00424-005-0039-0; Besnier F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-937; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; Campos B, 2014, AQUAT TOXICOL, V148, P139, DOI 10.1016/j.aquatox.2014.01.001; Carmichael SN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-408; Chahine S, 2009, J INSECT PHYSIOL, V55, P927, DOI 10.1016/j.jinsphys.2009.06.005; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dermauw W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-317; Dermauw W, 2013, P NATL ACAD SCI USA, V110, pE113, DOI 10.1073/pnas.1213214110; Dicker AJ, 2011, INT J PARASITOL, V41, P935, DOI 10.1016/j.ijpara.2011.03.015; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epel D, 2008, ENVIRON SCI TECHNOL, V42, P3914, DOI 10.1021/es087187v; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052; Gokirmak T, 2012, J BIOL CHEM, V287, P43876, DOI 10.1074/jbc.M112.424879; Gonzalez-Cabo P, 2011, J BIOL CHEM, V286, P21304, DOI 10.1074/jbc.M110.211201; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Herget M, 2007, PFLUG ARCH EUR J PHY, V453, P591, DOI 10.1007/s00424-006-0083-4; Heumann J, 2014, AQUACULTURE, V424, P207, DOI 10.1016/j.aquaculture.2013.12.015; Heumann J, 2012, COMP BIOCHEM PHYS C, V155, P198, DOI 10.1016/j.cbpc.2011.08.004; Huang H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004844; Igboeli OO, 2012, AQUACULTURE, V344, P40, DOI 10.1016/j.aquaculture.2012.03.026; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; James CE, 2009, INT J PARASITOL, V39, P213, DOI 10.1016/j.ijpara.2008.06.009; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124220; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KURELEC B, 1992, CRIT REV TOXICOL, V22, P23, DOI 10.3109/10408449209145320; Lanning CL, 1996, BBA-GEN SUBJECTS, V1291, P155, DOI 10.1016/0304-4165(96)00060-8; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Luckenbach T, 2008, AM J PHYSIOL-REG I, V294, pR1919, DOI 10.1152/ajpregu.00563.2007; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Mayer F, 2009, J NEUROSCI, V29, P3538, DOI 10.1523/JNEUROSCI.5564-08.2009; Miller DS, 2002, AM J PHYSIOL-REG I, V282, pR191, DOI 10.1152/ajpregu.00305.2001; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Porretta D, 2008, MED VET ENTOMOL, V22, P48, DOI 10.1111/j.1365-2915.2008.00712.x; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roth M, 1996, AQUACULTURE, V140, P217, DOI 10.1016/0044-8486(95)01181-1; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sebastian A, 2013, GENE, V523, P137, DOI 10.1016/j.gene.2013.02.050; Sevatdal S, 2005, PEST MANAG SCI, V61, P772, DOI 10.1002/ps.1057; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Skern-Mauritzen R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-32; SlimIt Bekaert M., 2013, SLIMLT; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; Szeri F, 2009, BBA-BIOMEMBRANES, V1788, P402, DOI 10.1016/j.bbamem.2008.11.007; Tarnay JN, 2004, INSECT MOL BIOL, V13, P539, DOI 10.1111/j.0962-1075.2004.00512.x; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Treasurer JW, 2000, AQUAC RES, V31, P855, DOI 10.1046/j.1365-2109.2000.00517.x; Tribble ND, 2007, MOL BIOCHEM PARASIT, V153, P59, DOI 10.1016/j.molbiopara.2007.02.002; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Vache C, 2007, ENVIRON TOXICOL CHEM, V26, P1418, DOI 10.1897/06-552R.1; Wenzel JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3177, DOI 10.2741/2305; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Xu JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-874; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zaja R, 2008, AQUAT TOXICOL, V90, P322, DOI 10.1016/j.aquatox.2008.09.012	77	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0137394	10.1371/journal.pone.0137394	http://dx.doi.org/10.1371/journal.pone.0137394			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418738	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400006
J	Ghosh, N; Sircar, G; Saha, B; Pandey, N; Bhattacharya, SG				Ghosh, Nandini; Sircar, Gaurab; Saha, Bodhisattwa; Pandey, Naren; Bhattacharya, Swati Gupta			Search for Allergens from the Pollen Proteome of Sunflower (Helianthus annuus L.): A Major Sensitizer for Respiratory Allergy Patients	PLOS ONE			English	Article							IMMUNOPROTEOMIC APPROACH; IMMUNOGLOBULIN-E; MUGWORT POLLEN; FOOD ALLERGY; IDENTIFICATION; RAGWEED; RESPONSES; PROTEINS; WHEAT	Background Respiratory allergy triggered by pollen allergens is increasing at an alarming rate worldwide. Sunflower pollen is thought to be an important source of inhalant allergens. Present study aims to identify the prevalence of sunflower pollinosis among the Indian allergic population and characterizes the pollen allergens using immuno-proteomic tools. Methodology Clinico-immunological tests were performed to understand the prevalence of sensitivity towards sunflower pollen among the atopic population. Sera from selected sunflower positive patients were used as probe to detect the IgE-reactive proteins from the one and two dimensional electrophoretic separated proteome of sunflower pollen. The antigenic nature of the sugar moiety of the glycoallergens was studied by meta-periodate modification of IgE-immunoblot. Finally, these allergens were identified by mass-spectrometry. Results Prevalence of sunflower pollen sensitization was observed among 21% of the pollen allergic population and associated with elevated level of specific IgE and histamine in the sera of these patients. Immunoscreening of sunflower pollen proteome with patient sera detected seven IgE-reactive proteins with varying molecular weight and pI. Hierarchical clustering of 2D-immunoblot data highlighted three allergens characterized by a more frequent immunoreactivity and increased levels of IgE antibodies in the sera of susceptible patients. These allergens were considered as the major allergens of sunflower pollen and were found to have their glycan moiety critical for inducing IgE response. Homology driven search of MS/MS data of these IgE-reactive proteins identified seven previously unreported allergens from sunflower pollen. Three major allergenic proteins were identified as two pectate lyases and a cysteine protease. Conclusion Novelty of the present report is the identification of a panel of seven sunflower pollen allergens for the first time at immuno-biochemical and proteomic level, which substantiated the clinical evidence of sunflower allergy. Further purification and recombinant expression of these allergens will improve component-resolved diagnosis and therapy of pollen allergy.	[Ghosh, Nandini; Sircar, Gaurab; Saha, Bodhisattwa; Bhattacharya, Swati Gupta] Bose Inst, Div Plant Biol, Kolkata, W Bengal, India; [Pandey, Naren] Belle Vue Clin, Dept Allergy & Asthma, Kolkata, India	Department of Science & Technology (India); Bose Institute	Bhattacharya, SG (corresponding author), Bose Inst, Div Plant Biol, Kolkata, W Bengal, India.	swati@jcbose.ac.in	Ghosh, Nandini/AAX-9639-2021	Ghosh, Nandini/0000-0003-0422-6923; Sircar, Gaurab/0000-0002-9067-4564	Indian Council of Medical Research [3/1/3/WL/JRF-2011/HRD-102 (41416)]; Council of Scientific and Industrial Research [03/015(0414)/2011-EMR-I]; University Grant Commission [F.2-8/2002(SA-I)]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission(University Grants Commission, India)	NG, GS and BS received funding from Indian Council of Medical Research (Grant No. 3/1/3/WL/JRF-2011/HRD-102 (41416) Dated 19.3.2012), Council of Scientific and Industrial Research (Grant No.03/015(0414)/2011-EMR-I) and University Grant Commission (Grant No. F.2-8/2002(SA-I)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Asero R, 2014, ANN ALLERG ASTHMA IM, V113, P307, DOI 10.1016/j.anai.2014.06.009; Asturias JA, 1998, MOL IMMUNOL, V35, P469, DOI 10.1016/S0161-5890(98)00036-4; Atis S, 2002, ALLERGY, V57, P35, DOI 10.1034/j.1398-9995.2002.01012.x; Benndorf D, 2008, ALLERGY, V63, P454, DOI 10.1111/j.1398-9995.2007.01603.x; Bodinier M, 2008, INT ARCH ALLERGY IMM, V146, P307, DOI 10.1159/000121465; Bouley J, 2015, J ALLERGY CLIN IMMUN; Calcedo R, 2012, REV IBEROAM MICOL, V29, P172, DOI 10.1016/j.riam.2011.07.004; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Chevalier F, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-23; Crameri R, 1998, INT ARCH ALLERGY IMM, V115, P99, DOI 10.1159/000023889; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; DELAHOZ F, 1994, ALLERGY, V49, P848, DOI 10.1111/j.1398-9995.1994.tb00786.x; Dey D, 2014, INT ARCH ALLERGY IMM, V164, P218, DOI 10.1159/000365629; Erler A, 2011, PROTEOMICS, V11, P1486, DOI 10.1002/pmic.201000624; Gadermaier G, 2009, MOL IMMUNOL, V46, P1919, DOI 10.1016/j.molimm.2009.03.021; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; Hosoki K, 2015, CURR OPIN ALLERGY CL, V15, P79, DOI 10.1097/ACI.0000000000000136; Jeong KY, 2005, CLIN DIAGN LAB IMMUN, V12, P1451, DOI 10.1128/CDLI.12.12.1451-1454.2005; JIMENEZ A, 1994, INT ARCH ALLERGY IMM, V105, P297, DOI 10.1159/000236772; Kanter U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061518; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonard R, 2010, J BIOL CHEM, V285, P27192, DOI 10.1074/jbc.M110.127118; Luoto Susanne, 2008, Clin Mol Allergy, V6, P7, DOI 10.1186/1476-7961-6-7; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marin-Rodriguez MC, 2002, J EXP BOT, V53, P2115, DOI 10.1093/jxb/erf089; Monaci L, 2009, TRAC-TREND ANAL CHEM, V28, P581, DOI 10.1016/j.trac.2009.02.013; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Pazmandi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052085; Petersen A, 2006, PROTEOMICS, V6, P6317, DOI 10.1002/pmic.200600173; PLATTSMILLS TAE, 1981, J ALLERGY CLIN IMMUN, V67, P129, DOI 10.1016/0091-6749(81)90008-7; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; RAO M, 1985, CLIN ALLERGY, V15, P449, DOI 10.1111/j.1365-2222.1985.tb02294.x; Sander I, 2011, ALLERGY, V66, P1208, DOI 10.1111/j.1398-9995.2011.02636.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh AB, 2012, ASIA PAC ALLERGY, V2, P210, DOI 10.5415/apallergy.2012.2.3.210; Sircar G, 2012, J PROTEOMICS, V77, P455, DOI 10.1016/j.jprot.2012.09.023; Sousa R, 2014, J INVEST ALLERG CLIN, V24, P177; SRIRAMARAO P, 1991, CLIN EXP ALLERGY, V21, P55, DOI 10.1111/j.1365-2222.1991.tb00804.x; Yang C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-4; Yoshida K, 2007, TREE PHYSIOL, V27, P1	42	28	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138992	10.1371/journal.pone.0138992	http://dx.doi.org/10.1371/journal.pone.0138992			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418046	Green Submitted, Green Published, gold			2022-12-27	WOS:000362171400031
J	Inoue, O; Hokamura, K; Shirai, T; Osada, M; Tsukiji, N; Hatakeyama, K; Umemura, K; Asada, Y; Suzuki-Inoue, K; Ozaki, Y				Inoue, Osamu; Hokamura, Kazuya; Shirai, Toshiaki; Osada, Makoto; Tsukiji, Nagaharu; Hatakeyama, Kinta; Umemura, Kazuo; Asada, Yujiro; Suzuki-Inoue, Katsue; Ozaki, Yukio			Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis	PLOS ONE			English	Article							LECTIN RECEPTOR CLEC-2; ATHEROSCLEROTIC LESIONS; IN-VIVO; GLYCOPROTEIN-VI; TISSUE FACTOR; ACTIVATION; S100A13; AGGREGATION; INVOLVEMENT; PODOPLANIN	The platelet receptor CLEC-2 is involved in thrombosis/hemostasis, but its ligand, podoplanin, is expressed only in advanced atherosclerotic lesions. We investigated CLEC-2 ligands in vessel walls. Recombinant CLEC-2 bound to early atherosclerotic lesions and normal arterial walls, co-localizing with vascular smooth muscle cells (VSMCs). Flow cytometry and immunocytochemistry showed that recombinant CLEC-2, but not an anti-podoplanin antibody, bound to VSMCs, suggesting that CLEC-2 ligands other than podoplanin are present in VSMCs. VSMCs stimulated platelet granule release and supported thrombus formation under flow, dependent on CLEC-2. The time to occlusion in a FeCl3-induced animal thrombosis model was significantly prolonged in the absence of CLEC-2. Because the internal elastic lamina was lacerated in our FeCl3-induced model, we assume that the interaction between CLEC-2 and its ligands in VSMCs induces thrombus formation. Protein arrays and Biacore analysis were used to identify S100A13 as a CLEC-2 ligand in VSMCs. However, S100A13 is not responsible for the above-described VSMC-induced platelet activation, because S100A13 is not expressed on the surface of normal VSMCs. S100A13 was released upon oxidative stress and expressed in the luminal area of atherosclerotic lesions. Suspended S100A13 did not activate platelets, but immobilized S100A13 significantly increased thrombus formation on collagen-coated surfaces. Taken together, we proposed that VSMCs stimulate platelets through CLEC-2, possibly leading to thrombus formation after plaque erosion and stent implantation, where VSMCs are exposed to blood flow. Furthermore, we identified S100A13 as one of the ligands on VSMCs.	[Inoue, Osamu; Shirai, Toshiaki; Osada, Makoto; Tsukiji, Nagaharu; Suzuki-Inoue, Katsue; Ozaki, Yukio] Univ Yamanashi, Fac Med, Dept Clin & Lab Med, Chuo Ku, Yamanashi 4093898, Japan; [Hokamura, Kazuya] Hamamatsu Univ, Dept Pharmacol, Sch Med, Shizuoka, Japan; [Hatakeyama, Kinta; Umemura, Kazuo; Asada, Yujiro] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki, Japan	University of Yamanashi; Hamamatsu University School of Medicine; University of Miyazaki	Suzuki-Inoue, K (corresponding author), Univ Yamanashi, Fac Med, Dept Clin & Lab Med, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	katsuei@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [20390268]; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program); Council for Science and Technology Policy (CSTP) [LS052]; Grants-in-Aid for Scientific Research [26461399] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (YO, No. 20390268, https://www.jsps.go.jp/english/e-grants/index.html), the Takeda Science Foundation (OI, http://www.takeda-sci.or.jp/), and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (CSTP) (KS-I, LS052, http://www.jsps.go.jp/english/e-jisedai/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender M, 2013, ARTERIOSCL THROM VAS, V33, P926, DOI 10.1161/ATVBAHA.112.300672; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Blanc A, 2003, INT J MOL MED, V11, P229; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; Cosemans JMEM, 2013, CARDIOVASC RES, V99, P342, DOI 10.1093/cvr/cvt110; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Hatakeyama K, 1997, ATHEROSCLEROSIS, V133, P213, DOI 10.1016/S0021-9150(97)00132-9; Hatakeyama K, 2012, THROMB RES, V129, pE70, DOI 10.1016/j.thromres.2012.01.003; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; HIRATA Y, 1994, ATHEROSCLEROSIS, V107, P117, DOI 10.1016/0021-9150(94)90147-3; Hughes CE, 2010, J THROMB HAEMOST, V8, P2328, DOI 10.1111/j.1538-7836.2010.04006.x; Inoue O, 2006, BLOOD, V107, P1405, DOI 10.1182/blood-2005-06-2406; Ishikawa T, 2004, HEART, V90, P1206, DOI 10.1136/hrt.2003.017921; Kathir KM, 2010, BBA-BIOMEMBRANES, V1798, P297, DOI 10.1016/j.bbamem.2009.09.024; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kikuchi S, 1998, ARTERIOSCL THROM VAS, V18, P1069, DOI 10.1161/01.ATV.18.7.1069; Lambros MP, 2011, BIOCHEM BIOPH RES CO, V405, P102, DOI 10.1016/j.bbrc.2010.12.135; Landriscina M, 2006, J NEURO-ONCOL, V80, P251, DOI 10.1007/s11060-006-9189-y; Li CY, 2010, MOL VIS, V16, P2225; Mandinov L, 2003, P NATL ACAD SCI USA, V100, P6700, DOI 10.1073/pnas.1231994100; Mandinova A, 2003, J CELL SCI, V116, P2687, DOI 10.1242/jcs.00471; Massi D, 2010, MODERN PATHOL, V23, P804, DOI 10.1038/modpathol.2010.54; Matsunaga H, 2010, CELL DEATH DIFFER, V17, P1760, DOI 10.1038/cdd.2010.52; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Mohan SK, 2011, J BIOL CHEM, V286, P14608, DOI 10.1074/jbc.M110.201954; Morowski M, 2013, BLOOD, V121, P4938, DOI 10.1182/blood-2012-10-461459; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Pierce A, 2008, EUR J CANCER, V44, P151, DOI 10.1016/j.ejca.2007.10.017; Ridinger K, 2000, J BIOL CHEM, V275, P8686, DOI 10.1074/jbc.275.12.8686; Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569; Shin Y, 1998, BIOCHEM BIOPH RES CO, V245, P741, DOI 10.1006/bbrc.1998.8516; Siddiqi OK, 2012, CURR OPIN CARDIOL, V27, P634, DOI 10.1097/HCO.0b013e3283587c7e; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2001, BLOOD, V98, P3708, DOI 10.1182/blood.V98.13.3708; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Tsuruo T, 2008, P JPN ACAD A-MATH, V84, P189, DOI 10.2183/pjab/84.189	42	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139357	10.1371/journal.pone.0139357	http://dx.doi.org/10.1371/journal.pone.0139357			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418160	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400083
J	Singh, AK; Berbis, MA; Ballmann, MZ; Kilcoyne, M; Menendez, M; Nguyen, TH; Joshi, L; Canada, FJ; Jimenez-Barbero, J; Benko, M; Harrach, B; van Raaij, MJ				Singh, Abhimanyu K.; Berbis, M. Alvaro; Ballmann, Monika Z.; Kilcoyne, Michelle; Menendez, Margarita; Nguyen, Thanh H.; Joshi, Lokesh; Javier Canada, F.; Jimenez-Barbero, Jesus; Benko, Maria; Harrach, Balazs; van Raaij, Mark J.			Structure and Sialyllactose Binding of the Carboxy-Terminal Head Domain of the Fibre from a Siadenovirus, Turkey Adenovirus 3	PLOS ONE			English	Article							HEMORRHAGIC ENTERITIS VIRUS; MARBLE SPLEEN DISEASE; CELLULAR RECEPTOR; CRYSTAL-STRUCTURE; GENE-THERAPY; SIALIC-ACID; GENOME ORGANIZATION; ATTACHMENT PROTEIN; NMR-SPECTROSCOPY; AVIAN ADENOVIRUS	The virulent form of turkey adenovirus 3 (TAdV-3), also known as turkey hemorrhagic enteritis virus (THEV), is an economically important poultry pathogen, while the avirulent form is used as a vaccine. TAdV-3 belongs to the genus Siadenovirus. The carboxy-terminal region of its fibre does not have significant sequence similarity to any other adenovirus fibre heads of known structure. Two amino acid sequence differences between virulent and avirulent TAdV-3 map on the fibre head: where virulent TAdV-3 contains Ile354 and Thr376, avirulent TAdV-3 contains Met354 and Met376. We determined the crystal structures of the trimeric virulent and avirulent TAdV-3 fibre head domains at 2.2 angstrom resolution. Each monomer contains a beta-sandwich, which, surprisingly, resembles reovirus fibre head more than other adenovirus fibres, although the ABCJ-GHID topology is conserved in all. A beta-hairpin insertion in the C-strand of each trimer subunit embraces its neighbouring monomer. The avirulent and virulent TAdV-3 fibre heads are identical apart from the exact orientation of the beta-hairpin insertion. In vitro, sialyllactose was identified as a ligand by glycan microarray analysis, nuclear magnetic resonance spectroscopy, and crystallography. Its dissociation constant was measured to be in the mM range by isothermal titration calorimetry. The ligand binds to the side of the fibre head, involving amino acids Glu392, Thr419, Val420, Lys421, Asn422, and Gly423 binding to the sialic acid group. It binds slightly more strongly to the avirulent form. We propose that, in vivo, the TAdV-3 fibre may bind a sialic acid-containing cell surface component.	[Singh, Abhimanyu K.; Nguyen, Thanh H.; van Raaij, Mark J.] CSIC, CNB, Dept Estruct Macromol, Madrid, Spain; [Berbis, M. Alvaro; Javier Canada, F.; Jimenez-Barbero, Jesus] CSIC, CIB, Dept Biol Fis Quim, Madrid, Spain; [Ballmann, Monika Z.; Benko, Maria; Harrach, Balazs] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, H-1581 Budapest, Hungary; [Kilcoyne, Michelle; Joshi, Lokesh] Natl Univ Ireland Galway, Natl Ctr Biomed Engn Sci, Glycosci Grp, Galway, Ireland; [Kilcoyne, Michelle] Natl Univ Ireland Galway, Sch Nat Sci, Microbiol, Galway, Ireland; [Menendez, Margarita] CSIC, IQFR, Dept Quim Fis Biol, E-28006 Madrid, Spain; [Menendez, Margarita] CIBER Enfermedades Resp CIBERES, E-28006 Madrid, Spain; [Jimenez-Barbero, Jesus] Ctr Invest Cooperat Biociencias CIC BioGUNE, Derio, Spain; [Jimenez-Barbero, Jesus] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Basque Foundation for Science	van Raaij, MJ (corresponding author), CSIC, CNB, Dept Estruct Macromol, Madrid, Spain.	mjvanraaij@cnb.csic.es	Harrach, Balázs/A-3680-2008; Cañada, Francisco J./D-5837-2014; JIMENEZ-BARBERO, JESUS/D-4431-2014; Singh, Abhimanyu K./U-5881-2019; BENKO, Maria/A-4135-2008; Harrach, Balazs/AAC-2154-2020; Menendez, Margarita/M-1795-2014; van Raaij, Mark J/B-3678-2009; Singh, Abhimanyu K./C-2243-2019	Harrach, Balázs/0000-0002-1410-6469; Cañada, Francisco J./0000-0003-4462-1469; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Singh, Abhimanyu K./0000-0002-9998-020X; Menendez, Margarita/0000-0002-3267-4443; van Raaij, Mark J/0000-0002-4781-1375; Singh, Abhimanyu K./0000-0002-9998-020X; NGUYEN, THANH-HONG/0000-0002-7079-4200; Kilcoyne, Michelle/0000-0002-8870-1308; Joshi, Lokesh/0000-0002-3612-0747	Spanish Ministry of Economy and Competitiveness [BFU2011-24843, CTQ2012-32025, BFU2012-36825]; MHit; Comunidad de Madrid [BIPEDD2-CM]; CIBER of Respiratory Diseases (CIBERES) from the Institute of Health Carlos III; European Union [BM1003, CM1102 COST actions]; GLYCOPHARM ITN project; GlycoHIT project [260600]; TIDA award from Science Foundation Ireland [13/TIDA/B2687]; Enterprise Ireland; Hungarian Scientific Research Fund [OTKA K100163]; La Caixa; Spanish Ministry of Economy and Competitiveness (FPI); CSIC-VAST	Spanish Ministry of Economy and Competitiveness(Spanish Government); MHit; Comunidad de Madrid(Comunidad de Madrid); CIBER of Respiratory Diseases (CIBERES) from the Institute of Health Carlos III; European Union(European Commission); GLYCOPHARM ITN project; GlycoHIT project; TIDA award from Science Foundation Ireland(Science Foundation Ireland); Enterprise Ireland; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); La Caixa(La Caixa Foundation); Spanish Ministry of Economy and Competitiveness (FPI)(Spanish Government); CSIC-VAST	This research was sponsored by grants BFU2011-24843 (to MJvR), CTQ2012-32025 (to JJB) and BFU2012-36825 (to MM) from the Spanish Ministry of Economy and Competitiveness, the MHit (to JJB) and BIPEDD2-CM (to MM) projects from the Comunidad de Madrid, the CIBER of Respiratory Diseases (CIBERES) from the Institute of Health Carlos III (to MM), the European Union-funded BM1003 and CM1102 COST actions (to JJB), the GLYCOPHARM ITN project (to JJB), the GlycoHIT project (grant no. 260600; to MK and LJ), a TIDA (13/TIDA/B2687) award from Science Foundation Ireland and Enterprise Ireland (to MK) and by grant OTKA K100163 from the Hungarian Scientific Research Fund (to MB and BH). AKS, MAB and THN were recipients of pre-doctoral fellowships from La Caixa, the Spanish Ministry of Economy and Competitiveness (FPI) and CSIC-VAST, respectively.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Arnberg N, 2002, VIROLOGY, V302, P33, DOI 10.1006/viro.2002.1503; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Bachtarzi H, 2008, EXPERT OPIN DRUG DEL, V5, P1231, DOI [10.1517/17425240802507636, 10.1517/17425240802507636 ]; Ballmann MZ, 2013, MAGY ALLATORVOSOK, V135, P78; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beach NM, 2009, AVIAN DIS, V53, P370, DOI 10.1637/8575-010509-Reg.1; Beach NM, 2009, J GEN VIROL, V90, P1978, DOI 10.1099/vir.0.010090-0; Benko M, 1998, ARCH VIROL, V143, P829, DOI 10.1007/s007050050335; Benko M., 2008, ENCY VIROLOGY, V3rd, P24; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Calvo PG, 2005, J MOL BIOL, V354, P137, DOI 10.1016/j.jmb.2005.09.034; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2000, J GEN VIROL, V81, P2431, DOI 10.1099/0022-1317-81-10-2431; DOMERMUTH CH, 1979, AVIAN DIS, V23, P30, DOI 10.2307/1589668; DOMERMUTH CH, 1977, AVIAN DIS, V21, P557, DOI 10.2307/1589414; DOMERMUTH CH, 1979, AVIAN DIS, V23, P479, DOI 10.2307/1589578; Dupeux F, 2011, ACTA CRYSTALLOGR D, V67, P915, DOI 10.1107/S0907444911036225; El Bakkouri M, 2008, VIROLOGY, V378, P169, DOI 10.1016/j.virol.2008.05.011; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Farkas SL, 2008, VIRUS RES, V132, P132, DOI 10.1016/j.virusres.2007.11.009; Gerlach JQ, 2011, ADV EXP MED BIOL, V705, P257, DOI 10.1007/978-1-4419-7877-6_12; Guardado-Calvo P, 2007, J GEN VIROL, V88, P2407, DOI 10.1099/vir.0.82845-0; Guardado-Calvo P, 2010, J VIROL, V84, P10558, DOI 10.1128/JVI.00997-10; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; HESS M, 1995, J MOL BIOL, V252, P379, DOI 10.1006/jmbi.1995.0504; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joseph HM, 2014, VET MICROBIOL, V172, P35, DOI 10.1016/j.vetmic.2014.04.006; Kilcoyne M, 2012, ANAL METHODS-UK, V4, P2721, DOI 10.1039/c2ay25532d; Kilcoyne M, 2012, ANAL CHEM, V84, P3330, DOI 10.1021/ac203404n; Kirchner E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000235; Kovacs ER, 2011, INFECT GENET EVOL, V11, P1058, DOI 10.1016/j.meegid.2011.03.021; Kovacs ER, 2010, J VIROL METHODS, V163, P262, DOI 10.1016/j.jviromet.2009.10.007; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Lenman A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004657; Lortat-Jacob H, 2001, J BIOL CHEM, V276, P9009, DOI 10.1074/jbc.M009304200; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Mitraki A, 2006, ADV PROTEIN CHEM, V73, P97, DOI 10.1016/S0065-3233(06)73004-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; Noureddini SC, 2005, MOL PHARMACEUT, V2, P341, DOI 10.1021/mp050045c; Palya V, 2007, ACTA VET HUNG, V55, P135, DOI 10.1556/AVet.55.2007.1.13; Park YM, 2012, VIROLOGY, V422, P144, DOI 10.1016/j.virol.2011.10.008; Penzes JJ, 2014, J VIROL, V88, P11304, DOI 10.1128/JVI.00306-14; Pitcovski J, 1998, VIROLOGY, V249, P307, DOI 10.1006/viro.1998.9336; Rivera S, 2009, J VET DIAGN INVEST, V21, P415, DOI 10.1177/104063870902100402; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Martin CS, 2012, VIRUSES-BASEL, V4, P847, DOI 10.3390/v4050847; Schelling P, 2007, J BIOL CHEM, V282, P11582, DOI 10.1074/jbc.M610805200; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; SILIM A, 1978, AVIAN DIS, V22, P106, DOI 10.2307/1589513; Singh AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114373; Singh AK, 2013, ACTA CRYSTALLOGR F, V69, P1135, DOI 10.1107/S174430911302397X; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Thacker EE, 2009, EXPERT REV VACCINES, V8, P761, DOI [10.1586/erv.09.29, 10.1586/ERV.09.29]; Thomson D, 2002, VIRUS RES, V83, P189, DOI 10.1016/S0168-1702(01)00437-3; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; van Raaij MJ, 1999, VIROLOGY, V262, P333, DOI 10.1006/viro.1999.9849; Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wang LL, 2014, GLYCOBIOLOGY, V24, P507, DOI 10.1093/glycob/cwu019; Wellehan JFX, 2009, AVIAN PATHOL, V38, P413, DOI 10.1080/03079450903183660; Wellehan JFX, 2004, J VIROL, V78, P13366, DOI 10.1128/JVI.78.23.13366-13369.2004; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; XIA D, 1994, STRUCTURE, V2, P1259, DOI 10.1016/S0969-2126(94)00126-X	81	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139339	10.1371/journal.pone.0139339	http://dx.doi.org/10.1371/journal.pone.0139339			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418008	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400080
J	Fan, LY; Sun, Y; Lee, HJ; Yang, SC; Chen, TF; Lin, KN; Lin, CC; Wang, PN; Tang, LY; Chiu, MJ				Fan, Ling-Yun; Sun, Yu; Lee, Huey-Jane; Yang, Shu-Chien; Chen, Ta-Fu; Lin, Ker-Neng; Lin, Chung-Chi; Wang, Pei-Ning; Tang, Li-Yu; Chiu, Ming-Jang			Marital Status, Lifestyle and Dementia: A Nationwide Survey in Taiwan	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; COGNITIVE DECLINE; ALZHEIMERS-DISEASE; INDIVIDUALS; POPULATION; IMPAIRMENT; PREVALENCE; AGE; DURATION; SUBTYPES	Background Evidence of an association between lifestyle and marital status and risk of dementia is limited in Asia. Methods In this nationwide population-based cross-sectional survey, participants were selected by computerized random sampling from all 19 counties in Taiwan. A total of 10432 residents were assessed by a door-to-door in-person survey, among whom 7035 were normal and 929 were diagnosed with dementia using the criteria recommended by National Institute on Aging-Alzheimer's Association. Premorbid lifestyle habits and demographic data including marital status were compared between normal subjects and participants with dementia. Results After adjustment for age, gender, education, body mass index, smoking, drinking, marital status, sleep habits, exercise, social engagement and co-morbidities including hypertension, diabetes and cerebrovascular diseases, an increased risk for dementia was found in people with widow or widower status (OR 1.42, 95% CI 1.15-1.77) and people who used to take a nap in the afternoon (OR 1.33, 95% CI 1.02-1.72). Decreased risk was found in people with the habit of regular exercise (OR 0.12, 95% CI 0.09-0.16), adequate night sleep (OR 0.55, 95% CI 0.39-0.76) and regular social engagement (OR 0.53, 95% CI 0.36-0.77). Conclusions Our results provide preliminary evidence of possible risk-reduction effects for dementia, including regular exercise even in modest amounts, social engagement and adequate night sleep, whereas people with the widow/widower status or who used to take an afternoon nap might have increased risk of dementia.	[Fan, Ling-Yun; Sun, Yu] En Chu Kong Hosp, Dept Neurol, New Taipei, Taiwan; [Fan, Ling-Yun; Chen, Ta-Fu; Chiu, Ming-Jang] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Huey-Jane; Yang, Shu-Chien; Tang, Li-Yu] Taiwan Alzheimers Dis Assoc, Taipei, Taiwan; [Lin, Ker-Neng; Wang, Pei-Ning] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Chung-Chi] Chung Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei 10764, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Psychol, Coll Sci, Taipei 10764, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Coll Elect Engn & Comp Sci, Grad Inst Biomed Engn & Bioinformat, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Chiu, MJ (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.	mjchiu@ntu.edu.tw	Chiu, Ming-Jang/AAR-3940-2020	Chiu, Ming-Jang/0000-0002-4158-4423; Chen, Ta-Fu/0000-0003-1988-6924	Ministry of Health and Welfare [DOH100-TD-M113-100001]; Taiwan Alzheimer's Disease Association	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Taiwan Alzheimer's Disease Association	The project was supported in part by Ministry of Health and Welfare (DOH100-TD-M113-100001) and in part by Taiwan Alzheimer's Disease Association. The Ministry of Health and Welfare has contributed in part to the study design by setting the aims for this project.	Aartsen MJ, 2005, PSYCHOL MED, V35, P217, DOI 10.1017/S0033291704002831; Asada T, 2000, SLEEP, V23, P629; Auyeung TW, 2013, AGE, V35, P479, DOI 10.1007/s11357-011-9366-6; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Brooks A, 2006, SLEEP, V29, P831, DOI 10.1093/sleep/29.6.831; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Elcombe EL, 2014, JAD; Ficca G, 2010, SLEEP MED REV, V14, P249, DOI 10.1016/j.smrv.2009.09.005; Glei DA, 2005, INT J EPIDEMIOL, V34, P864, DOI 10.1093/ije/dyi049; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Keage HAD, 2012, SLEEP MED, V13, P886, DOI 10.1016/j.sleep.2012.02.003; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; Lim ASP, 2013, SLEEP, V36, P1027, DOI 10.5665/sleep.2802; Lin KP, 2015, ARCH GERONTOL GERIAT, V60, P501, DOI 10.1016/j.archger.2015.01.009; Liu CK, 1996, J FORMOS MED ASSOC, V95, P762; Liu CK TC, 2007, RES APPL PSYCHOL, V7, P157; LIU HC, 1994, PSYCHOL MED, V24, P763, DOI 10.1017/S0033291700027914; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Liu HC, 1998, ALZ DIS ASSOC DIS, V12, P127, DOI 10.1097/00002093-199809000-00002; Merlino G, 2010, SLEEP MED, V11, P372, DOI 10.1016/j.sleep.2009.07.018; Mousavi-Nasab SMH, 2012, SCAND J PSYCHOL, V53, P1, DOI 10.1111/j.1467-9450.2011.00926.x; Potvin O, 2012, SLEEP, V35, P491, DOI 10.5665/sleep.1732; Shyu YIL, 2001, J FORMOS MED ASSOC, V100, P676; Solomon A, 2014, J INTERN MED, V275, P229, DOI 10.1111/joim.12178; Sorman DE, 2014, J GERONTOL B-PSYCHOL, V69, P493, DOI 10.1093/geronb/gbt056; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100303; van Gelder BM, 2006, J GERONTOL B-PSYCHOL, V61, pP213, DOI 10.1093/geronb/61.4.P213; Xavier FMF, 2002, J CLIN EXP NEUROPSYC, V24, P294, DOI 10.1076/jcen.24.3.294.983; Yang SY, 2014, J FORMOSAN MED ASS	33	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139154	10.1371/journal.pone.0139154	http://dx.doi.org/10.1371/journal.pone.0139154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EO	26413719	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700046
J	Arias, CI; Siri, SO; Conde, C				Arias, Cristina Isabel; Siri, Sebastian Omar; Conde, Cecilia			Involvement of SARA in Axon and Dendrite Growth	PLOS ONE			English	Article							RECEPTOR ACTIVATION SARA; FYVE DOMAIN PROTEIN; SMAD ANCHOR; RECYCLING COMPARTMENT; SECRETORY TRAFFICKING; MEMBRANE DYNAMICS; EARLY ENDOSOMES; RAB PROTEINS; CELL-SURFACE; TRANSPORT	SARA (Smad Anchor for Receptor Activation) plays a crucial role in Rab5-mediated endocytosis in cell lines localizing to early endosomes where it regulates morphology and function. Here, we analyzed the role of SARA during neuronal development and tested whether it functions as a regulator of endocytic trafficking of selected axonal and membrane proteins. Suppression of SARA perturbs the appearance of juxtanuclear endocytic recycling compartments and the neurons show long axons with large growth cones. Furthermore, surface distribution of the cell adhesion molecule L1 in axons and the fusion of vesicles containing transferring receptor (TfR) in dendrites were increased in neurons where SARA was silenced. Conversely, SARA overexpression generated large early endosomes and reduced neurite outgrowth. Taken together, our findings suggest a significant contribution of SARA to key aspects of neuronal development, including neurite formation.	[Arias, Cristina Isabel; Siri, Sebastian Omar; Conde, Cecilia] INIMEC CONICET, Lab Neurobiol, Cordoba, Argentina; [Siri, Sebastian Omar; Conde, Cecilia] Natl Univ Cordoba, Cordoba, Argentina; [Siri, Sebastian Omar; Conde, Cecilia] Inst Univ Ciencias Biomed Cordoba, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Conde, C (corresponding author), INIMEC CONICET, Lab Neurobiol, Cordoba, Argentina.	cconde@immf.uncor.edu		Conde, Cecilia/0000-0002-5103-6391	FONCyT (Argentina) [PICT 2008-0671, PICT V 2010-1277]; Agencia Cordoba Ciencia (Argentina); CONICET (Argentina)	FONCyT (Argentina)(FONCyT); Agencia Cordoba Ciencia (Argentina); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding: This work was supported by grants from FONCyT (Argentina): PICT 2008-0671 to CC and PICT V 2010-1277 and Agencia Cordoba Ciencia (Argentina) to A. Caceres and CC. CIA and SOS hold a doctoral fellowship from CONICET (Argentina).	Bakkebo M, 2012, FEBS LETT, V586, P3367, DOI 10.1016/j.febslet.2012.07.027; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Bisbal M, 2009, J BIOL CHEM, V284, P9489, DOI 10.1074/jbc.M808586200; Bonanomi D, 2008, J CELL SCI, V121, P3757, DOI 10.1242/jcs.033803; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chang HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105299; Chavrier P, 1997, CYTOMETRY, V29, P41, DOI 10.1002/(SICI)1097-0320(19970901)29:1<41::AID-CYTO4>3.0.CO;2-G; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Corbeel L, 2008, EUR J PEDIATR, V167, P723, DOI 10.1007/s00431-008-0740-z; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Falk J, 2014, J NEUROSCI, V34, P373, DOI 10.1523/JNEUROSCI.0876-13.2014; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Hu Y, 2002, J CELL SCI, V115, P4755, DOI 10.1242/jcs.00177; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Itofusa R, 2011, MOL CELL NEUROSCI, V48, P332, DOI 10.1016/j.mcn.2011.03.007; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kostaras E, 2013, ONCOGENE, V32, P5220, DOI 10.1038/onc.2012.554; Krauss M, 2011, REV PHYSIOL BIOCH P, V161, P45, DOI 10.1007/112_2008_2; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lasiecka ZM, 2011, MOL CELL NEUROSCI, V48, P278, DOI 10.1016/j.mcn.2011.06.013; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Long KE, 2001, J BIOL CHEM, V276, P1285, DOI 10.1074/jbc.M006658200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Runyan CE, 2012, J BIOL CHEM, V287, P35815, DOI 10.1074/jbc.M112.380493; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Shieh JC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017802, 10.1371/journal.pone.0019481]; Shilo BZ, 2011, EMBO J, V30, P3516, DOI 10.1038/emboj.2011.269; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takano T, 2012, J NEUROSCI, V32, P6587, DOI 10.1523/JNEUROSCI.5317-11.2012; Trenchi A, 2009, BIOCHEM J, V421, P357, DOI 10.1042/BJ20090484; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Villarroel-Campos D, 2014, J NEUROCHEM, V129, P240, DOI 10.1111/jnc.12676; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Winckler B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001826; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Yap CC, 2008, J CELL SCI, V121, P1514, DOI 10.1242/jcs.022442; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	80	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138792	10.1371/journal.pone.0138792	http://dx.doi.org/10.1371/journal.pone.0138792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405814	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700097
J	Koh, SH; Liang, AC; Takahashi, Y; Maki, T; Shindo, A; Osumi, N; Zhao, J; Lin, H; Holder, JC; Chuang, TT; McNeish, JD; Arai, K; Lo, EH				Koh, Seong-Ho; Liang, Anna C.; Takahashi, Yoko; Maki, Takakuni; Shindo, Akihiro; Osumi, Noriko; Zhao, Jing; Lin, Hong; Holder, Julie C.; Chuang, Tsu Tshen; McNeish, John D.; Arai, Ken; Lo, Eng H.			Differential Effects of Isoxazole-9 on Neural Stem/Progenitor Cells, Oligodendrocyte Precursor Cells, and Endothelial Progenitor Cells	PLOS ONE			English	Article							STROKE RECOVERY; SMALL-MOLECULE; STEM-CELLS; BRAIN; ANGIOGENESIS; NEUROGENESIS; PROLIFERATION; TRANSLATION; THERAPY; FATE	Adult mammalian brain can be plastic after injury and disease. Therefore, boosting endogenous repair mechanisms would be a useful therapeutic approach for neurological disorders. Isoxazole-9 (Isx-9) has been reported to enhance neurogenesis from neural stem/progenitor cells (NSPCs). However, the effects of Isx-9 on other types of progenitor/precursor cells remain mostly unknown. In this study, we investigated the effects of Isx-9 on the three major populations of progenitor/precursor cells in brain: NSPCs, oligodendrocyte precursor cells (OPCs), and endothelial progenitor cells (EPCs). Cultured primary NSPCs, OPCs, or EPCs were treated with various concentrations of Isx-9 (6.25, 12.5, 25, 50 mu M), and their cell numbers were counted in a blinded manner. Isx-9 slightly increased the number of NSPCs and effectively induced neuronal differentiation of NSPCs. However, Isx-9 significantly decreased OPC number in a concentration-dependent manner, suggesting cytotoxicity. Isx-9 did not affect EPC cell number. But in a matrigel assay of angiogenesis, Isx-9 significantly inhibited tube formation in outgrowth endothelial cells derived from EPCs. This potential anti-tube-formation effect of Isx-9 was confirmed in a brain endothelial cell line. Taken together, our data suggest that mechanisms and targets for promoting stem/progenitor cells in the central nervous system may significantly differ between cell types.	[Koh, Seong-Ho; Liang, Anna C.; Takahashi, Yoko; Maki, Takakuni; Shindo, Akihiro; Arai, Ken; Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol & Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Koh, Seong-Ho; Liang, Anna C.; Takahashi, Yoko; Maki, Takakuni; Shindo, Akihiro; Arai, Ken; Lo, Eng H.] Harvard Univ, Sch Med, Charlestown, MA USA; [Koh, Seong-Ho] Hanyang Univ, Coll Med, Dept Neurol, Seoul 133791, South Korea; [Takahashi, Yoko; Osumi, Noriko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Dept Dev Neurosci, Sendai, Miyagi 980, Japan; [Zhao, Jing; Lin, Hong; Holder, Julie C.; Chuang, Tsu Tshen; McNeish, John D.] GlaxoSmithKline, Regenerat Med Discovery Performance Unit, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Hanyang University; Tohoku University; GlaxoSmithKline	Lo, EH (corresponding author), Massachusetts Gen Hosp, Dept Radiol & Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA.	Lo@helix.mgh.harvard.edu	眞木, 崇州/AAO-1160-2020; Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452	National Institutes of Health [P01-NS55104]; Uehara Memorial Foundation; Glaxo-Smith-Kline-Harvard-Stem-Cell-Institute consortium; Glaxo-Smith-Kline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065089, P01NS055104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Glaxo-Smith-Kline-Harvard-Stem-Cell-Institute consortium; Glaxo-Smith-Kline(GlaxoSmithKline); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work was supported in part by grants from the National Institutes of Health (P01-NS55104), the Uehara Memorial Foundation, and the Glaxo-Smith-Kline-Harvard-Stem-Cell-Institute consortium. Salaries for authors with primary appointments with Glaxo-Smith-Kline (JZ, HL, JCH, TTC, and JDM) were paid by Glaxo-Smith-Kline. JZ, HL, JCH, TTC, and JDM participated in study design and data analysis.	Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Diamandis T, 2015, STROKE, V46, P588, DOI 10.1161/STROKEAHA.114.007105; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Hayakawa K, 2012, P NATL ACAD SCI USA, V109, P7505, DOI 10.1073/pnas.1121146109; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Jang W, 2015, MOL NEUROBIOL, V51, P558, DOI 10.1007/s12035-014-8835-1; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li Y, 2014, GLIA, V62, P1, DOI 10.1002/glia.22585; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; Lok J, 2015, CNS NEUROSCI THER, V21, P304, DOI 10.1111/cns.12359; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Miyamoto N, 2013, STROKE, V44, P3516, DOI 10.1161/STROKEAHA.113.002813; Park HH, 2014, NEUROBIOL AGING, V35, P1255, DOI 10.1016/j.neurobiolaging.2013.12.015; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Rosell A, 2009, J CEREBR BLOOD F MET, V29, P933, DOI 10.1038/jcbfm.2009.17; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; SCHONK DM, 1989, HUM GENET, V83, P297, DOI 10.1007/BF00285178; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Xing CH, 2012, J CEREBR BLOOD F MET, V32, P983, DOI 10.1038/jcbfm.2012.48; Zhang J, 2009, J CEREBR BLOOD F MET, V29, P1166, DOI 10.1038/jcbfm.2009.41; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	25	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138724	10.1371/journal.pone.0138724	http://dx.doi.org/10.1371/journal.pone.0138724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407349	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700076
J	Mali, I; Wang, HH; Grant, WE; Feldman, M; Forstner, MRJ				Mali, Ivana; Wang, Hsiao-Hsuan; Grant, William E.; Feldman, Mark; Forstner, Michael R. J.			Modeling Commercial Freshwater Turtle Production on US Farms for Pet and Meat Markets	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; HARVEST; TRADE; EXTINCTION; CHINA; ASIA	Freshwater turtles are being exploited for meat, eggs, traditional medicine, and pet trade. As a response, turtle farming became a booming aquaculture industry in the past two decades, specifically in the southeastern states of the United States of America (US) and across Southeast Asia. However, US turtle farms are currently producing turtles only for the pet trade while commercial trappers remain focused on catching the largest individuals from the wild. In our analyses we have created a biological and economic model that describes farming operations on a representative turtle farm in Louisiana. We first modeled current production of hatchling and yearling red-eared slider turtles (Trachemys scripta elegans) (i.e., traditional farming) for foreign and domestic pet markets, respectively. We tested the possibility of harvesting adult turtles from the breeding stock for sale to meat markets to enable alternative markets for the farmers, while decreasing the continued pressures on wild populations (i.e., non-traditional farming). Our economic model required current profit requirements of similar to$13/turtle or similar to$20.31/kg of meat from non-traditional farming in order to acquire the same profit as traditional farming, a value which currently exceeds market values of red-eared sliders. However, increasing competition with Asian turtle farms and decreasing hatchling prices may force the shift in the US toward producing turtles for meat markets. In addition, our model can be modified and applied to more desirable species on the meat market once more knowledge is acquired about species life histories and space requirements under farmed conditions.	[Mali, Ivana; Forstner, Michael R. J.] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Wang, Hsiao-Hsuan; Grant, William E.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas State University System; Texas State University San Marcos; Texas A&M University System; Texas A&M University College Station	Mali, I (corresponding author), Eastern New Mexico Univ, Dept Biol, Portales, NM 88130 USA.	im1040@txstate.edu	Wang, Hsiao-Hsuan/AAE-7933-2020	Wang, Hsiao-Hsuan/0000-0002-7850-0406				Alves RRN, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-3; Brown DJ, 2011, J WILDLIFE MANAGE, V75, P486, DOI 10.1002/jwmg.73; Ceballos CP, 2004, WILDLIFE SOC B, V32, P881, DOI 10.2193/0091-7648(2004)032[0881:TTINAE]2.0.CO;2; Chen TH, 2009, CHELONIAN CONSERV BI, V8, P11, DOI 10.2744/CCB-0747.1; Cheung SM, 2006, AQUAT CONSERV, V16, P751, DOI 10.1002/aqc.803; Close Lisa M., 1997, Chelonian Conservation and Biology, V2, P563; Eagle J, 2004, MAR POLICY, V28, P259, DOI 10.1016/j.marpol.2003.08.001; Eisemberg CC, 2011, BIOL CONSERV, V144, P2282, DOI 10.1016/j.biocon.2011.06.005; Ernst CH, 2009, TURTLES US CANADA; EWERT MA, 1994, J EXP ZOOL, V270, P3, DOI 10.1002/jez.1402700103; Fordham DA, 2008, J APPL ECOL, V45, P52, DOI 10.1111/j.1365-2664.2007.01414.x; Gong SP, 2009, ORYX, V43, P213, DOI 10.1017/S0030605308000902; HALLIDAY TR, 1980, BIOL CONSERV, V17, P157, DOI 10.1016/0006-3207(80)90046-4; Harris JR, 2010, CLIN INFECT DIS, V50, P554, DOI 10.1086/649932; Heinsohn R, 2004, ANIM CONSERV, V7, P417, DOI 10.1017/S1367943004001593; Heykoop J., 2001, Marine Resource Economics, V16, P127; Hughes DW, 1999, AQUACULT ECON MANAG, V3, P250; Jonzen N, 2001, MAR ECOL PROG SER, V210, P291, DOI 10.3354/meps210291; Klemens MW, 2000, TURTLE CONSERVATION; Louisiana State University AgCenter, 2013, AGR IS BACKB LOUIS E; Mali I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086478; Meng Xianlin, 2002, Turtle and Tortoise Newsletter, V5, P15; Nijman V, 2007, CONTRIB ZOOL, V76, P207, DOI 10.1163/18759866-07603007; Pongtanapanich T., 2007, WITTHAYASAN KASETSAR, V22, P42; Porter M.E, 1980, COMPETITIVE STRATEGY; Shi HT, 2008, ORYX, V42, P147, DOI 10.1017/S0030605308000562; Shi HT, 2007, CONSERV BIOL, V21, P5, DOI 10.1111/j.1523-1739.2006.00622_2.x; Wibbels T, 1998, J EXP ZOOL, V281, P409, DOI 10.1002/(SICI)1097-010X(19980801)281:5<409::AID-JEZ6>3.0.CO;2-S; Zimmer-Shaffer SA, 2014, CHELONIAN CONSERV BI, V13, P227, DOI 10.2744/CCB-1109.1	29	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139053	10.1371/journal.pone.0139053	http://dx.doi.org/10.1371/journal.pone.0139053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407157	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700155
J	Petric, RC; Braicu, C; Bassi, C; Pop, L; Taranu, I; Dragos, N; Dumitrascu, D; Negrini, M; Berindan-Neagoe, I				Petric, Roxana Cojocneanu; Braicu, Cornelia; Bassi, Cristian; Pop, Laura; Taranu, Ionelia; Dragos, Nicolae; Dumitrascu, Dan; Negrini, Massimo; Berindan-Neagoe, Ioana			Interspecies Gene Name Extrapolation-A New Approach	PLOS ONE			English	Article							MICROBIOTA	The use of animal models has facilitated numerous scientific developments, especially when employing "omics" technologies to study the effects of various environmental factors on humans. Our study presents a new bioinformatics pipeline suitable when the generated microarray data from animal models does not contain the necessary human gene name annotation. We conducted single color gene expression microarray on duodenum and spleen tissue obtained from pigs which have been exposed to zearalenone and Escherichia coli contamination, either alone or combined. By performing a combination of file format modifications and data alignments using various online tools as well as a command line environment, we performed the pig to human gene name extrapolation with an average yield of 58.34%, compared to 3.64% when applying more simple methods. In conclusion, while online data analysis portals on their own are of great importance in data management and assessment, our new pipeline provided a more effective approach for a situation which can be frequently encountered by researchers in the "omics" era.	[Petric, Roxana Cojocneanu] Univ Babes Bolyai, Dept Biol, R-3400 Cluj Napoca, Romania; [Petric, Roxana Cojocneanu; Braicu, Cornelia; Pop, Laura; Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Genom Biomed & Translat Med, Cluj Napoca, Romania; [Bassi, Cristian] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Taranu, Ionelia] Natl Inst Res & Dev Biol & Anim Nutr, Balotesti, Romania; [Dragos, Nicolae] Inst Biol Res, Taxon & Ecol Dept, Cluj Napoca, Romania; [Dumitrascu, Dan] Iuliu Hatieganu Univ Med & Pharm, Dept Internal Med 2, Cluj Napoca, Romania; [Negrini, Massimo] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Negrini, Massimo] Univ Ferrara, LTTA, I-44100 Ferrara, Italy; [Berindan-Neagoe, Ioana] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Braicu, Cornelia; Berindan-Neagoe, Ioana] Oncol Inst Prof Dr Ion Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca, Romania; [Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Dept Immunol, Cluj Napoca, Romania	Babes Bolyai University from Cluj; Iuliu Hatieganu University of Medicine & Pharmacy; University of Ferrara; National Research Institute for Biological Sciences; Iuliu Hatieganu University of Medicine & Pharmacy; University of Ferrara; University of Ferrara; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy	Petric, RC (corresponding author), Univ Babes Bolyai, Dept Biol, R-3400 Cluj Napoca, Romania.	cojocneanur@gmail.com	Pop, Laura/AAY-8349-2020; Negrini, Massimo/J-2377-2016; Berindan-Neagoe, Ioana/AAH-9854-2019; Bassi, Cristian/K-2356-2018	Pop, Laura/0000-0002-5806-0220; Negrini, Massimo/0000-0002-0007-1920; Bassi, Cristian/0000-0002-5823-709X; Taranu, Ionelia/0000-0003-0727-5827; Cojocneanu, Roxana-Maria/0000-0002-7450-9454	Romanian Ministry of Research and Technology [PNII-PCCA-102/2011-2016]	Romanian Ministry of Research and Technology	This work was supported by funds from the Romanian Ministry of Research and Technology: PNII-PCCA-102/2011-2016 with title "Impact of feed co-contamination and mitigating solutions to increase feed safety, animal health and food quality" (CB IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cekanova M, 2014, DRUG DES DEV THER, V8, P1911, DOI 10.2147/DDDT.S49584; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Huffnagle Gary, 2008, Adv Exp Med Biol, V635, pv; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kollarczik Birgit, 1994, Natural Toxins, V2, P105, DOI 10.1002/nt.2620020303; Piotrowska M, 2014, TOXINS, V6, P2064, DOI 10.3390/toxins6072064; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Zammataro L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S8	11	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138751	10.1371/journal.pone.0138751	http://dx.doi.org/10.1371/journal.pone.0138751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407293	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700086
J	Wang, HM; Zhao, X; Guo, CH; Ren, DQ; Zhao, YD; Xiao, W; Jiao, WJ				Wang, Hongmei; Zhao, Xin; Guo, Caihong; Ren, Dunqiang; Zhao, Yandong; Xiao, Wei; Jiao, Wenjie			Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GENE-DELIVERY; DRUG; P53; APOPTOSIS; DEATH; BCL-2	Metastasis and drug resistance are major barriers for the treatment of non-small cell lung cancer (NSCLC). To explore new therapeutic options, we successfully encapsulated MicroRNA-34a (miR-34a), a potent endogenous tumor suppressor in NSCLC into S6 aptamer-conjugated dendrimer to form lung cancer-targeted gene delivery nanoparticles (PAM-Ap/pMiR-34a NPs). PAM-Ap/pMiR-34a NPs had a diameter of 100-200 nm and Zeta potential of similar to 30 mV at applied N/P ratio. The aptamer conjugation significantly improved cellular uptake as well as gene transfection efficiency of PAM-Ap/pMiR-34a NPs in cultured NSCLC cells. We showed that PAM-Ap/pMiR-34a NPs enhanced the regulation of targeted genes, BCL-2 and p53 in vitro. In addition, we revealed PAM-Ap/pMiR-34a NPs significantly inhibited cell growth, migration, invasion and induced apoptosis of lung cancer cells compared with non-targeted NPs. The method provided a novel therapeutic strategy for the experimental treatment of NSCLC.	[Wang, Hongmei; Guo, Caihong; Ren, Dunqiang] Qingdao Univ, Affiliated Hosp, Dept Resp, Qingdao 266071, Peoples R China; [Zhao, Yandong; Jiao, Wenjie] Qingdao Univ, Affiliated Hosp, Dept Thorac Surg, Qingdao 266071, Peoples R China; [Wang, Hongmei; Xiao, Wei] Shandong Univ, Sch Med, Qilu Hosp, Dept Resp, Jinan 250100, Peoples R China; [Zhao, Xin] Clin North Sea Fleet PLA Navy, Qingdao, Peoples R China	Qingdao University; Qingdao University; Shandong University	Jiao, WJ (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Thorac Surg, Qingdao 266071, Peoples R China.	jiaowenjie@163.com		Dunqiang, Ren/0000-0002-9601-7899	Science and Technology Development Plan Project of Shandong Province [2013WS0273]	Science and Technology Development Plan Project of Shandong Province	This research was supported by Science and Technology Development Plan Project of Shandong Province (2013WS0273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi E, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-247; Basarkar A, 2007, INT J NANOMED, V2, P353; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Clarke DTW, 2014, NAT NANOTECHNOL, V9, P568, DOI 10.1038/nnano.2014.155; Du YZ, 2011, INT J NANOMED, V6, P1559, DOI 10.2147/IJN.S23828; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Jabr-Milane LS, 2008, CANCER TREAT REV, V34, P592, DOI 10.1016/j.ctrv.2008.04.003; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kesharwani P, 2014, PROG POLYM SCI, V39, P268, DOI 10.1016/j.progpolymsci.2013.07.005; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Liang X, 2014, INT J NANOMED, V9, P419, DOI 10.2147/IJN.S51919; Liu HM, 2012, J AM CHEM SOC, V134, P17680, DOI 10.1021/ja307290j; Ma D, 2014, BIOMATERIALS, V35, P4357, DOI 10.1016/j.biomaterials.2014.01.070; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Pryor JB, 2014, INT J NANOMED, V9, P1947, DOI 10.2147/IJN.S60220; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Sung HJ, 2008, BMB REP, V41, P615, DOI 10.5483/BMBRep.2008.41.9.615; Tan WH, 2011, TRENDS BIOTECHNOL, V29, P634, DOI 10.1016/j.tibtech.2011.06.009; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Walsh CM, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00003; Wang MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4053; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeng Y, 2006, ONCOGENE, V25, P6156, DOI 10.1038/sj.onc.1209908; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k; Zhou Jiehua, 2010, Silence, V1, P4, DOI 10.1186/1758-907X-1-4	40	50	51	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139136	10.1371/journal.pone.0139136	http://dx.doi.org/10.1371/journal.pone.0139136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406332	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700179
J	Wang, XY; Xu, XD; Lu, XY; Zhang, YB; Pan, WQ				Wang, Xinye; Xu, Xindong; Lu, Xingyu; Zhang, Yuanbin; Pan, Weiqing			Transcriptome Bioinformatical Analysis of Vertebrate Stages of Schistosoma japonicum Reveals Alternative Splicing Events	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; PRE-MESSENGER-RNA; GENE; REGULATORS; RECEPTORS; PROTEINS; FAMILY; DATABASE; INTRONS; TOPHAT	Alternative splicing is a molecular process that contributes greatly to the diversification of proteome and to gene functions. Understanding the mechanisms of stage-specific alternative splicing can provide a better understanding of the development of eukaryotes and the functions of different genes. Schistosoma japonicum is an infectious blood-dwelling trematode with a complex lifecycle that causes the tropical disease schistosomiasis. In this study, we analyzed the transcriptome of Schistosoma japonicum to discover alternative splicing events in this parasite, by applying RNA-seq to cDNA library of adults and schistosomula. Results were validated by RT-PCR and sequencing. We found 11,623 alternative splicing events among 7,099 protein encoding genes and average proportion of alternative splicing events per gene was 42.14%. We showed that exon skip is the most common type of alternative splicing events as found in high eukaryotes, whereas intron retention is the least common alternative splicing type. According to intron boundary analysis, the parasite possesses same intron boundaries as other organisms, namely the classic "GT-AG" rule. And in alternative spliced introns or exons, this rule is less strict. And we have attempted to detect alternative splicing events in genes encoding proteins with signal peptides and transmembrane helices, suggesting that alternative splicing could change subcellular locations of specific gene products. Our results indicate that alternative splicing is prevalent in this parasitic worm, and that the worm is close to its hosts. The revealed secretome involved in alternative splicing implies new perspective into understanding interaction between the parasite and its host.	[Wang, Xinye; Xu, Xindong; Zhang, Yuanbin; Pan, Weiqing] Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai 200092, Peoples R China; [Lu, Xingyu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Pan, Weiqing] Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University; Naval Medical University	Pan, WQ (corresponding author), Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai 200092, Peoples R China.	wqpan0912@aliyun.com			National Natural Science Foundation of China [81430051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 81430051). The URL of funder's website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrotis A, 2000, FEBS LETT, V467, P128, DOI 10.1016/S0014-5793(00)01132-7; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BORSI L, 1990, FEBS LETT, V261, P175, DOI 10.1016/0014-5793(90)80664-5; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Chacko E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S11; David CJ, 2008, GENE DEV, V22, P279, DOI 10.1101/gad.1643108; DeMarco R, 2006, MOL BIOCHEM PARASIT, V150, P123, DOI 10.1016/j.molbiopara.2006.07.002; DeMarco R, 2010, GENOME RES, V20, P1112, DOI 10.1101/gr.100099.109; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Garg G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S8; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Harr B, 2010, MOL ECOL, V19, P228, DOI 10.1111/j.1365-294X.2009.04490.x; Irimia M, 2007, TRENDS GENET, V23, P321, DOI 10.1016/j.tig.2007.04.001; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Korner M, 2009, AM J PATHOL, V175, P461, DOI 10.2353/ajpath.2009.081135; Konrad L, 2008, ANDROLOGIA, V40, P358, DOI 10.1111/j.1439-0272.2008.00869.x; Konrad L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-318; Labadorf A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-114; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lutz M, 2002, CELL SIGNAL, V14, P977, DOI 10.1016/S0898-6568(02)00058-X; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Markovic D, 2009, CELL MOL LIFE SCI, V66, P3337, DOI 10.1007/s00018-009-0093-4; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Piao XY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-715; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Ram D, 2004, PARASITOLOGY, V129, P587, DOI 10.1017/S003118200400602X; Ramani AK, 2011, GENOME RES, V21, P342, DOI 10.1101/gr.114645.110; Roger E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000330; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; SHOEMAKER CB, 1992, MOL BIOCHEM PARASIT, V53, P17, DOI 10.1016/0166-6851(92)90003-3; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; YASURAOKA K, 1979, Southeast Asian Journal of Tropical Medicine and Public Health, V10, P630; Ye Xiao-Ping, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P575; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	55	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138470	10.1371/journal.pone.0138470	http://dx.doi.org/10.1371/journal.pone.0138470			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407301	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700046
J	Weissler-Snir, A; Gurevitz, C; Assali, A; Vaknin-Assa, H; Bental, T; Lador, A; Yavin, H; Perl, L; Kornowski, R; Lev, E				Weissler-Snir, Adaya; Gurevitz, Chen; Assali, Abid; Vaknin-Assa, Hana; Bental, Tamir; Lador, Adi; Yavin, Hagai; Perl, Leor; Kornowski, Ran; Lev, Eli			Prognosis of STEMI Patients with Multi-Vessel Disease Undergoing Culprit-Only PCI without Significant Residual Ischemia on Non-Invasive Stress Testing	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; MULTIVESSEL DISEASE; RANDOMIZED-TRIAL; REVASCULARIZATION; METAANALYSIS; ANGIOPLASTY; REPERFUSION	Aims In about 50-80% of ST-segment elevation myocardial infarction (STEMI) patients there is significant atherosclerotic disease in other coronary arteries in addition to the culprit vessel. There is substantial controversy as to the optimal revascularization approach in these patients. We sought to compare the outcomes of STEMI patients with multi-vessel disease (MVD) treated with culprit-only primary percutaneous coronary intervention (PPCI) without significant ischemia on subsequent non-invasive testing, to those of STEMI patients with single-vessel disease (SVD). Methods and Results Between 2001-2010, 1,540 consecutive patients treated with primary PCI for STEMI were prospectively observed and entered into a comprehensive clinical database. The primary end point was a composite of major adverse cardiac events (MACE), consisting of mortality, re-infarction and revascularization within 1 and 3 years following PPCI (excluding events occurring during the first 30 days). Patients with cardiogenic shock were excluded. The study included 720 patients with SVD and 185 patients with MVD who underwent culprit-only PPCI and had no residual ischemia on subsequent non-invasive stress testing. Patients with MVD were older, more likely to have hypertension or previous MI and less likely to be smokers and present with anterior MI than patients with SVD. One and 3-year MACE rates were similar between the groups. On cox proportional-hazards regression MVD without residual ischemia was not independently associated with MACE and its components. Conclusions STEMI patients with MVD treated with culprit only-PCI without significant residual ischemia on non-invasive stress testing appear to have similar prognosis to STEMI patients with SVD.	[Weissler-Snir, Adaya; Assali, Abid; Vaknin-Assa, Hana; Bental, Tamir; Lador, Adi; Yavin, Hagai; Perl, Leor; Kornowski, Ran; Lev, Eli] Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel; [Gurevitz, Chen; Assali, Abid; Perl, Leor; Kornowski, Ran; Lev, Eli] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Weissler-Snir, A (corresponding author), Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel.	adayawe@clalit.org.il	Lador, Adi/AAV-2380-2021	Gurevitz, Chen/0000-0003-2632-6669; yavin, hagai/0000-0003-0019-1102; Lador, Adi/0000-0001-9678-7474				Bagai A, 2013, AM HEART J, V166, P684, DOI 10.1016/j.ahj.2013.07.027; Bainey Kevin R, 2014, Am Heart J, V167, P1, DOI 10.1016/j.ahj.2013.09.018; Biondi-Zoccai G, 2010, AM HEART J, V160, DOI 10.1016/j.ahj.2010.10.013; Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016; Corpus RA, 2004, AM HEART J, V148, P493, DOI 10.1016/j.ahj.2004.03.051; Dahal K, 2014, CARDIOVASC REVASCULA, V15, P408, DOI 10.1016/j.carrev.2014.10.007; Dambrink JHE, 2010, EUROINTERVENTION, V5, P968, DOI 10.4244/; Di Mario Carlo, 2004, Int J Cardiovasc Intervent, V6, P128; Elgendy IY, 2015, INT J CARDIOL, V186, P98, DOI 10.1016/j.ijcard.2015.03.163; FUSTER V, 1990, CIRCULATION, V82, P47; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Gibson CM, 1999, J AM COLL CARDIOL, V34, P974, DOI 10.1016/S0735-1097(99)00335-6; Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017; Hanratty CG, 2002, J AM COLL CARDIOL, V40, P911, DOI 10.1016/S0735-1097(02)02049-1; HEMPEL SL, 1993, AM J PHYSIOL, V264, pC1448, DOI 10.1152/ajpcell.1993.264.6.C1448; Ijsselmuiden AJJ, 2004, AM HEART J, V148, P467, DOI 10.1016/j.ahj.2004.03.026; Kornowski R, J AM COLL CARDIOL, V58, P7; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Qarawani D, 2008, INT J CARDIOL, V123, P288, DOI 10.1016/j.ijcard.2006.12.013; Reilly MP, 1997, CIRCULATION, V96, P3314; Sorajja P, 2007, EUR HEART J, V28, P1709, DOI 10.1093/eurheartj/ehm184; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; STEWART DJ, 1991, J AM COLL CARDIOL, V18, P38, DOI 10.1016/S0735-1097(10)80214-1; Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129; Varani E, 2008, CATHETER CARDIO INTE, V72, P927, DOI 10.1002/ccd.21722; Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; Webb JG, 2003, J AM COLL CARDIOL, V42, P1380, DOI 10.1016/S0735-1097(03)01050-7; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]	29	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138474	10.1371/journal.pone.0138474	http://dx.doi.org/10.1371/journal.pone.0138474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406235	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700048
J	Werner, M; Driftmann, S; Kleinehr, K; Kaiser, GM; Mathe, Z; Treckmann, JW; Paul, A; Skibbe, K; Timm, J; Canbay, A; Gerken, G; Schlaak, JF; Broering, R				Werner, Melanie; Driftmann, Sabrina; Kleinehr, Kathrin; Kaiser, Gernot M.; Mathe, Zotlan; Treckmann, Juergen-Walter; Paul, Andreas; Skibbe, Kathrin; Timm, Joerg; Canbay, Ali; Gerken, Guido; Schlaak, Joerg F.; Broering, Ruth			All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; SINUSOIDAL ENDOTHELIAL-CELLS; CARBOHYDRATE-RECOGNITION SYSTEMS; RAT-LIVER; HUMAN HEPATOCYTES; KUPFFER CELLS; FIBROTIC HUMAN; CULTURE; EXPRESSION; INFORMATION	Background & Aims Liver cells are key players in innate immunity. Thus, studying primary isolated liver cells is necessary for determining their role in liver physiology and pathophysiology. In particular, the quantity and quality of isolated cells are crucial to their function. Our aim was to isolate a large quantity of high-quality human parenchymal and non-parenchymal cells from a single liver specimen. Methods Hepatocytes, Kupffer cells, liver sinusoidal endothelial cells, and stellate cells were isolated from liver tissues by collagenase perfusion in combination with low-speed centrifugation, density gradient centrifugation, and magnetic-activated cell sorting. The purity and functionality of cultured cell populations were controlled by determining their morphology, discriminative cell marker expression, and functional activity. Results Cell preparation yielded the following cell counts per gram of liver tissue: 2.0 +/- 0.4x10(7) hepatocytes, 1.8 +/- 0.5x10(6) Kupffer cells, 4.3 +/- 1.9x10(5) liver sinusoidal endothelial cells, and 3.2 +/- 0.5x10(5) stellate cells. Hepatocytes were identified by albumin (95.5 +/- 1.7%) and exhibited time-dependent activity of cytochrome P450 enzymes. Kupffer cells expressed CD68 (94.5 +/- 1.2%) and exhibited phagocytic activity, as determined with 1 mu m latex beads. Endothelial cells were CD146+ (97.8 +/- 1.1%) and exhibited efficient uptake of acetylated low-density lipoprotein. Hepatic stellate cells were identified by the expression of a-smooth muscle actin (97.1 +/- 1.5%). These cells further exhibited retinol (vitamin A)-mediated autofluorescence. Conclusions Our isolation procedure for primary parenchymal and non-parenchymal liver cells resulted in cell populations of high purity and quality, with retained physiological functionality in vitro. Thus, this system may provide a valuable tool for determining liver function and disease.	[Werner, Melanie; Driftmann, Sabrina; Kleinehr, Kathrin; Canbay, Ali; Gerken, Guido; Schlaak, Joerg F.; Broering, Ruth] Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, D-45147 Essen, Germany; [Kaiser, Gernot M.; Mathe, Zotlan; Treckmann, Juergen-Walter; Paul, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, D-45147 Essen, Germany; [Mathe, Zotlan] Semmelweis Univ, Dept Transplantat Surg, H-1085 Budapest, Hungary; [Skibbe, Kathrin; Timm, Joerg] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, D-45147 Essen, Germany; [Timm, Joerg] Univ Hosp Dusseldorf, Inst Virol, Dusseldorf, Germany	University of Duisburg Essen; University of Duisburg Essen; Semmelweis University; University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Broering, R (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Hufelandstr 55, D-45147 Essen, Germany.	ruth.broering@uni-duisburg-essen.de	Timm, Jörg/P-7652-2019; Broering, Ruth/W-9401-2019; Canbay, Ali/AAL-9620-2020	Timm, Jörg/0000-0001-7799-3045; Broering, Ruth/0000-0002-7125-3246; Canbay, Ali/0000-0001-6069-7899	Deutsche Forschungsgemeinschaft [SCHL377/2-4, SCHL377/6-2, TRR60]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SCHL377/2-4 & 6-2 to JFS, TRR60 to JFS and RB, http://dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabraba EB, 2007, J IMMUNOL METHODS, V326, P139, DOI 10.1016/j.jim.2007.06.014; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2005, ANTIOXID REDOX SIGN, V7, P1346, DOI 10.1089/ars.2005.7.1346; Beilfuss A, 2014, GUT; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; BRAET F, 1994, LAB INVEST, V70, P944; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Broering R, 2014, J VIRAL HEPATITIS, V21, P480, DOI 10.1111/jvh.12174; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Chang WJ, 2014, ACTA BIOCH BIOPH SIN, V46, P291, DOI 10.1093/abbs/gmt143; Clavien PA, 1996, GASTROENTEROLOGY, V110, P1891, DOI 10.1053/gast.1996.v110.pm8964415; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Daneker GW, 1998, IN VITRO CELL DEV-AN, V34, P370, DOI 10.1007/s11626-998-0018-9; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; Dini L, 2002, MICROSC RES TECHNIQ, V57, P530, DOI 10.1002/jemt.10107; DIXON JL, 1993, J LIPID RES, V34, P167; Elvevold K H, 2004, COMP HEPATOL, V3, P1; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gerlach JC, 2001, J SURG RES, V100, P39, DOI 10.1006/jsre.2001.6224; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Heinzelmann M, 2005, J IMMUNOL, V174, P2280, DOI 10.4049/jimmunol.174.4.2280; HUBBARD AL, 1979, J CELL BIOL, V83, P65, DOI 10.1083/jcb.83.1.65; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; Ikejima K, 1999, AM J PHYSIOL-GASTR L, V276, pG591, DOI 10.1152/ajpgi.1999.276.3.G591; IRVING MG, 1984, GASTROENTEROLOGY, V87, P1233; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Kawai S, 2003, VIRCHOWS ARCH, V443, P78, DOI 10.1007/s00428-003-0804-4; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; KNOOK DL, 1982, EXP CELL RES, V139, P468, DOI 10.1016/0014-4827(82)90283-X; Kolios G, 2006, WORLD J GASTROENTERO, V12, P7413, DOI 10.3748/wjg.v12.i46.7413; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Laba A, 2005, ARCH IMMUNOL THER EX, V53, P442; Lacroix D, 1997, EUR J BIOCHEM, V247, P625, DOI 10.1111/j.1432-1033.1997.00625.x; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010; Liu ZX, 2006, EXPERT OPIN DRUG MET, V2, P493, DOI 10.1517/17425255.2.4.493; Mason TM, 1998, CRIT REV CL LAB SCI, V35, P461, DOI 10.1080/10408369891234246; McCune JS, 2000, CLIN PHARMACOL THER, V68, P356, DOI 10.1067/mcp.2000.110215; McCuskey R, 2012, ZAKIM BOYERS HEPATOL, V6th, P3; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mezaki Y, 2013, MED HYPOTHESES, V81, P222, DOI 10.1016/j.mehy.2013.04.045; Milosevic N, 1999, EUR J PHARMACOL, V368, P75, DOI 10.1016/S0014-2999(98)00988-1; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Motoyama H, 2014, LAB INVEST, V94, P192, DOI 10.1038/labinvest.2013.135; Nakamura A, 2010, MED MOL MORPHOL, V43, P107, DOI 10.1007/s00795-009-0484-5; Pfeiffer E, 2015, EXP BIOL MED, V240, P645, DOI 10.1177/1535370214558025; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Sato M, 2003, CELL STRUCT FUNCT, V28, P105; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Valatas V, 2003, CELL BIOL INT, V27, P67, DOI 10.1016/S1065-6995(02)00249-4; von Kupffer K. W., 1876, ARCH MIKROSK ANAT, V12, P353, DOI DOI 10.1007/BF02933897; WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404; WISSE E, 1976, CELL TISSUE RES, V173, P423, DOI 10.1007/BF00224305; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zeng WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070832	63	54	57	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138655	10.1371/journal.pone.0138655	http://dx.doi.org/10.1371/journal.pone.0138655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407160	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700065
J	Wang, LX; Mogami, S; Yakabi, S; Karasawa, H; Yamada, C; Yakabi, K; Hattori, T; Tache, Y				Wang, Lixin; Mogami, Sachiko; Yakabi, Seiichi; Karasawa, Hiroshi; Yamada, Chihiro; Yakabi, Koji; Hattori, Tomohisa; Tache, Yvette			Patterns of Brain Activation and Meal Reduction Induced by Abdominal Surgery in Mice and Modulation by Rikkunshito	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; HYPOTHALAMIC ARCUATE NUCLEUS; STRESS-RELATED ALTERATIONS; POSTOPERATIVE GASTRIC ILEUS; CISPLATIN-INDUCED ANOREXIA; GHRELIN RECEPTOR AGONIST; COLONIC MOTOR FUNCTION; CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE; PARABRACHIAL NUCLEUS	Abdominal surgery inhibits food intake and induces c-Fos expression in the hypothalamic and medullary nuclei in rats. Rikkunshito (RKT), a Kampo medicine improves anorexia. We assessed the alterations in meal microstructure and c-Fos expression in brain nuclei induced by abdominal surgery and the modulation by RKT in mice. RKT or vehicle was gavaged daily for 1 week. On day 8 mice had no access to food for 6-7 h and were treated twice with RKT or vehicle. Abdominal surgery (laparotomy-cecum palpation) was performed 1-2 h before the dark phase. The food intake and meal structures were monitored using an automated monitoring system for mice. Brain sections were processed for c-Fos immunoreactivity (ir) 2-h after abdominal surgery. Abdominal surgery significantly reduced bouts, meal frequency, size and duration, and time spent on meals, and increased inter-meal interval and satiety ratio resulting in 92-86% suppression of food intake at 2-24 h post-surgery compared with control group (no surgery). RKT significantly increased bouts, meal duration and the cumulative 12-h food intake by 11%. Abdominal surgery increased c-Fos in the prelimbic, cingulate and insular cortexes, and autonomic nuclei, such as the bed nucleus of the stria terminalis, central amygdala, hypothalamic supraoptic (SON), paraventricular and arcuate nuclei, Edinger-Westphal nucleus (E-W), lateral periaqueduct gray (PAG), lateral parabrachial nucleus, locus coeruleus, ventrolateral medulla and nucleus tractus solitarius (NTS). RKT induced a small increase in c-Fos-ir neurons in the SON and E-W of control mice, and in mice with surgery there was an increase in the lateral PAG and a decrease in the NTS. These findings indicate that abdominal surgery inhibits food intake by increasing both satiation (meal duration) and satiety (meal interval) and activates brain circuits involved in pain, feeding behavior and stress that may underlie the alterations of meal pattern and food intake inhibition. RKT improves food consumption post-surgically that may involve modulation of pain pathway.	[Wang, Lixin; Yakabi, Seiichi; Karasawa, Hiroshi; Tache, Yvette] Univ Calif Los Angeles, CURE Digest Dis Ctr, Los Angeles, CA 90089 USA; [Wang, Lixin; Yakabi, Seiichi; Karasawa, Hiroshi; Tache, Yvette] Univ Calif Los Angeles, Dept Med, Ctr Neurobiol Stress, Div Digest Dis, Los Angeles, CA 90024 USA; [Wang, Lixin; Yakabi, Seiichi; Karasawa, Hiroshi; Tache, Yvette] VA Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; [Mogami, Sachiko; Yamada, Chihiro; Hattori, Tomohisa] Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Tsukuba, Ibaraki, Japan; [Yakabi, Koji] Saitama Med Univ, Saitama Med Ctr, Dept Gastroenterol & Hepatol, Saitama, Japan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Tsumura & Company; Saitama Medical University	Wang, LX (corresponding author), Univ Calif Los Angeles, CURE Digest Dis Ctr, Los Angeles, CA 90089 USA.	lixinw@ucla.edu		Mogami, Sachiko/0000-0001-7914-4928; Yamada, Chihiro/0000-0002-3690-893X; Karasawa, Hiroshi/0000-0003-1798-2277	Veterans Administration Research Career Scientist Award; VA Merit Award; Tsumura Co.;  [NIHDDK-41303]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	Veterans Administration Research Career Scientist Award; VA Merit Award(US Department of Veterans Affairs); Tsumura Co.(Tsumura & Company); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by NIHDDK-41303 (Animal core, YT, LW), Veterans Administration Research Career Scientist Award (YT), VA Merit Award (YT) and Tsumura & Co. Drs. SM, CY and TH are employees of Tsumura & Co. The funders of Tsumura & Co. had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	Abbott SBG, 2013, J NEUROSCI, V33, P3164, DOI 10.1523/JNEUROSCI.1046-12.2013; Alhadeff AL, 2014, NEUROPSYCHOPHARMACOL, V39, P2233, DOI 10.1038/npp.2014.74; Arai M, 2012, HEPATO-GASTROENTEROL, V59, P62, DOI 10.5754/hge11246; Augestad KM, 2010, WORLD J GASTROENTERO, V16, P2067, DOI 10.3748/wjg.v16.i17.2067; Barletta JF, 2014, WORLD J SURG, V38, P1966, DOI 10.1007/s00268-014-2506-2; Barquist E, 1996, AM J PHYSIOL-REG I, V270, pR888, DOI 10.1152/ajpregu.1996.270.4.R888; Becskei C, 2008, J NEUROENDOCRINOL, V20, P85, DOI 10.1111/j.1365-2826.2007.01619.x; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Benarroch EE, 2006, NEUROL SCI, V27, pS130, DOI 10.1007/s10072-006-0587-x; Bisgaard T, 2002, NUTRITION, V18, P944, DOI 10.1016/S0899-9007(02)00990-5; BLOCK CH, 1987, PEPTIDES, V8, P267, DOI 10.1016/0196-9781(87)90102-1; BONAZ B, 1994, J COMP NEUROL, V349, P212, DOI 10.1002/cne.903490205; Bonaz B, 1997, BRAIN RES, V748, P12, DOI 10.1016/S0006-8993(96)01281-4; Browning KN, 2011, AUTON NEUROSCI-BASIC, V161, P6, DOI 10.1016/j.autneu.2010.11.001; Cailotto C, 2012, NEUROGASTROENT MOTIL, V24, P191, DOI 10.1111/j.1365-2982.2011.01824.x; Card JP, 2006, J COMP NEUROL, V499, P840, DOI 10.1002/cne.21140; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chan RKW, 1998, J NEUROSCI, V18, P371; Costantino L, 2014, EXPERT OPIN THER PAT, V24, P1007, DOI 10.1517/13543776.2014.941531; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; Endo M, 2014, J PHARMACOL SCI, V124, P374, DOI 10.1254/jphs.13182FP; Franklin KBJ, 2008, MOUSE BRAIN STEROSTA; Fraser GL, 2009, EUR J PHARMACOL, V604, P132, DOI 10.1016/j.ejphar.2008.12.011; Fraser GL, 2008, ENDOCRINOLOGY, V149, P6280, DOI 10.1210/en.2008-0804; Fukuda H, 2005, NEUROGASTROENT MOTIL, V17, P245, DOI 10.1111/j.1365-2982.2004.00602.x; Furukawa N, 2013, AUTON NEUROSCI-BASIC, V179, P14, DOI 10.1016/j.autneu.2013.06.003; Greenwood-Van Meerveld B, 2011, PEPTIDES, V32, P2352, DOI 10.1016/j.peptides.2011.03.014; Hattori T, 2010, INT J PEPT, V2010, P2010; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Joly-Amado A, 2014, BEST PRACT RES CL EN, V28, P725, DOI 10.1016/j.beem.2014.03.003; Karimnamazi H, 2002, BRAIN RES, V957, P193, DOI 10.1016/S0006-8993(02)03438-8; Kito Y, 2010, AM J PHYSIOL-GASTR L, V298, pG755, DOI 10.1152/ajpgi.00333.2009; Kozicz T, 1998, J COMP NEUROL, V391, P1, DOI 10.1002/(SICI)1096-9861(19980202)391:1<1::AID-CNE1>3.0.CO;2-6; Kozicz T, 2007, GEN COMP ENDOCR, V153, P235, DOI 10.1016/j.ygcen.2007.04.005; Kusunoki H, 2010, INTERNAL MED, V49, P2195, DOI 10.2169/internalmedicine.49.3803; LANTERIMINET M, 1993, NEUROSCIENCE, V55, P737, DOI 10.1016/0306-4522(93)90439-M; Li L, 2006, BRAIN RES, V1114, P41, DOI 10.1016/j.brainres.2006.07.042; Ll RX, 2007, CHIN J INTEGR MED, V13, P59, DOI 10.1007/s11655-007-0059-z; Lomax AE, 2010, NEUROGASTROENT MOTIL, V22, P7, DOI 10.1111/j.1365-2982.2009.01381.x; Luckey A, 2003, GASTROENTEROLOGY, V125, P654, DOI 10.1016/S0016-5085(03)01069-2; Martinez V, 1997, J PHARMACOL EXP THER, V280, P754; Mogami S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/519035; Mueller MH, 2006, LANGENBECK ARCH SURG, V391, P88, DOI 10.1007/s00423-006-0042-8; Owyang C, 2011, J NEUROGASTROENTEROL, V17, P338, DOI 10.5056/jnm.2011.17.4.338; PACAK K, 1995, FRONT NEUROENDOCRIN, V16, P89, DOI 10.1006/frne.1995.1004; Richard S, 2005, J COMP NEUROL, V481, P210, DOI 10.1002/cne.20384; Sadakane C, 2011, BIOCHEM BIOPH RES CO, V412, P506, DOI 10.1016/j.bbrc.2011.08.002; Saegusa Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE685, DOI 10.1152/ajpendo.00121.2011; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Stengel A, 2011, NEUROGASTROENT MOTIL, V23, pE294, DOI 10.1111/j.1365-2982.2011.01721.x; Stengel A, 2011, NEUROGASTROENT MOTIL, V23, pE223, DOI 10.1111/j.1365-2982.2011.01706.x; Stengel A, 2009, ENDOCRINOLOGY, V150, P153, DOI 10.1210/en.2008-0723; Stengel A, 2014, CURR OPIN PHARMACOL, V19, P31, DOI 10.1016/j.coph.2014.06.006; Stengel A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI [10.3389/fnins.2014.00052, 10.3389/fnhum.2014.00595]; Stengel A, 2011, AM J PHYSIOL-GASTR L, V301, pG239, DOI 10.1152/ajpgi.00018.2011; Stengel A, 2010, PHYSIOL BEHAV, V101, P614, DOI 10.1016/j.physbeh.2010.09.009; Stengel A, 2010, PEPTIDES, V31, P263, DOI 10.1016/j.peptides.2009.11.015; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; Tache Y, 2014, CURR PHARM DESIGN, V20, P2725, DOI 10.2174/13816128113199990578; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Takeda H, 2012, METHOD ENZYMOL, V514, P333, DOI 10.1016/B978-0-12-381272-8.00021-0; TATSUTA M, 1993, ALIMENT PHARM THERAP, V7, P459; Tewari N, 2013, CURR OPIN CLIN NUTR, V16, P569, DOI 10.1097/MCO.0b013e3283638e97; Tominaga K, 2013, J GASTROENTEROL, V48, P452, DOI 10.1007/s00535-013-0788-z; Tsubouchi H, 2014, AM J PHYSIOL-LUNG C, V306, pL233, DOI 10.1152/ajplung.00096.2013; Vather R, 2014, CLIN EXP PHARMACOL P, V41, P358, DOI 10.1111/1440-1681.12220; Veenema AH, 2007, BRAIN BEHAV EVOLUT, V70, P274, DOI 10.1159/000105491; Venkova K, 2007, DIGEST DIS SCI, V52, P2241, DOI 10.1007/s10620-007-9783-7; Wang L, 2012, NEUROGASTROENT MOTIL, V24, pe425, DOI 10.1111/j.1365-2982.2012.01974.x; Wang L, 1998, BRAIN RES, V791, P157, DOI 10.1016/S0006-8993(98)00091-2; Wang LX, 2014, PEPTIDES, V55, P136, DOI 10.1016/j.peptides.2014.02.011; Wang LX, 2011, BRAIN RES, V1415, P34, DOI 10.1016/j.brainres.2011.07.024; Wang LX, 2011, PEPTIDES, V32, P51, DOI 10.1016/j.peptides.2010.10.017; Wang LX, 2002, NEUROSCI LETT, V325, P47; Warren J, 2011, NUTR CLIN PRACT, V26, P115, DOI 10.1177/0884533611400231; Wu QL, 2014, ENDOCRINOLOGY, V155, P840, DOI 10.1210/en.2013-1831; Wu ZQ, 2015, EUR SURG RES, V54, P127, DOI 10.1159/000369529; Yagi M, 2004, PEDIATR SURG INT, V19, P760, DOI 10.1007/s00383-003-1053-y; Yakabi K, 2011, AM J PHYSIOL-ENDOC M, V301, pE72, DOI 10.1152/ajpendo.00695.2010; Yamada C, 2015, PSYCHONEUROENDOCRINO, V55, P81, DOI 10.1016/j.psyneuen.2015.02.006; Yamada C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/792940; Yamamoto T, 2009, ANN NY ACAD SCI, V1170, P378, DOI 10.1111/j.1749-6632.2009.03883.x; Yu DY, 1996, NEUROSCI LETT, V205, P21, DOI 10.1016/0304-3940(96)12383-1; Zittel TT, 1998, SURGERY, V123, P518, DOI 10.1067/msy.1998.88090; ZITTEL TT, 1993, NEUROSCI LETT, V159, P79, DOI 10.1016/0304-3940(93)90803-S	85	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139325	10.1371/journal.pone.0139325	http://dx.doi.org/10.1371/journal.pone.0139325			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421719	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700094
J	Zhang, AY; Lai, CL; Huang, FY; Seto, WK; Fung, J; Wong, DKH; Yuen, MF				Zhang, An-Ye; Lai, Ching-Lung; Huang, Fung-Yu; Seto, Wai-Kay; Fung, James; Wong, Danny Ka-Ho; Yuen, Man-Fung			Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma	PLOS ONE			English	Article							INTRACELLULAR RETENTION; SURFACE-ANTIGEN; CELL EPITOPES; GENOTYPE-B; RISK; DELETIONS; PROTEIN; MUTANT	Background and Aims Deletions/mutations in the hepatitis B virus (HBV) pre-S region have been associated with hepatocellular carcinoma (HCC). We aimed to study the evolutionary changes of pre-S mutations prior to HCC development. Methods We studied the HBV pre-S sequences at 1 to 10 years preceding diagnosis of HCC in 74 patients with HBV-related HCC (HCC group). 148 chronic hepatitis B patients matched for sex and age in 2: 1 ratio, who had been followed up for at least 3 years without HCC (HCC-free group) were recruited as controls. 56 and 47 patients of HCC and HCC-free groups respectively had serially stored sera for longitudinally examination at 1-3 years, 4-6 years, 7-9 years and >= 10 years prior to the recruitment of the study. Results Compared to the HCC-free group, higher frequencies of pre-S deletions and pointmutations (at 11 codons) were observed in the HCC group (p<0.05). Multiple logistic regression analysis showed that pre-S deletions, point mutations at codon 51 and 167 were independent factors associated with HCC. Longitudinal observation showed that pre-S deletions andmost of the 11 HCC-associated pre-S point mutations existed at least 10 years before HCC development, and were more prevalent preceding HCC development in patients from HCC groups than HCC-free group. The number of HCC-associated pre-S point mutations increased over time preceding HCC development, and correlated positively with the time to HCC diagnosis (r = 0.220, p = 0.005). Conclusions High prevalence and cumulative evolution of pre-S mutations preceding HCC development suggested a possible carcinogenic role of pre-S mutations and their potential application in HCC risk prediction.	[Zhang, An-Ye; Lai, Ching-Lung; Huang, Fung-Yu; Seto, Wai-Kay; Fung, James; Wong, Danny Ka-Ho; Yuen, Man-Fung] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lai, Ching-Lung; Seto, Wai-Kay; Fung, James; Wong, Danny Ka-Ho; Yuen, Man-Fung] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, DKH (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	danywong@hku.hk; mfyuen@hkucc.hku.hk	Fung, James/AAG-4832-2020; SETO, Wai-Kay/H-4452-2012; Wong, Danny/S-6230-2019; Wong, Danny/H-6819-2016	SETO, Wai-Kay/0000-0002-9012-313X; /0000-0001-9078-5005; Fung, James/0000-0002-1286-8902; Lai, Ching-Lung/0000-0002-5927-2436				Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen BF, 2006, J GEN VIROL, V87, P39, DOI 10.1099/vir.0.81357-0; Chen CH, 2008, J INFECT DIS, V198, P1634, DOI 10.1086/592990; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Desmond CP, 2008, ANTIVIR THER, V13, P161; Dong QM, 2008, BIOCHEM BIOPH RES CO, V374, P773, DOI 10.1016/j.bbrc.2008.07.115; GALLINA A, 1994, J GEN VIROL, V75, P449, DOI 10.1099/0022-1317-75-2-449; GANEM D, 1991, CURR TOP MICROBIOL, V168, P61; Hildt E, 2002, EMBO J, V21, P525, DOI 10.1093/emboj/21.4.525; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Hsu Axel, 2011, Curr Hepat Rep, V10, P106, DOI 10.1007/s11901-011-0094-2; KUROKI K, 1990, VIROLOGY, V176, P620, DOI 10.1016/0042-6822(90)90032-M; Lai CL, 2013, HEPATOLOGY, V57, P399, DOI 10.1002/hep.25937; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Pollicino T, 2012, HEPATOLOGY, V56, P434, DOI 10.1002/hep.25592; Qu LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059583; Sobotta D, 2000, J GEN VIROL, V81, P369, DOI 10.1099/0022-1317-81-2-369; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xu ZC, 1996, J VIROL, V70, P133, DOI 10.1128/JVI.70.1.133-140.1996; Yang JC, 2009, HEPATOLOGY, V49, P1962, DOI 10.1002/hep.22889; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096; Yeung P, 2010, J MED VIROL, V82, P1843, DOI 10.1002/jmv.21901; Yin JH, 2010, J GASTROENTEROL, V45, P1063, DOI 10.1007/s00535-010-0253-1; Yousif M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095377	26	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139478	10.1371/journal.pone.0139478	http://dx.doi.org/10.1371/journal.pone.0139478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421619	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700121
J	Zhou, P; Zhang, L; Li, JL; Luo, YQ; Zhang, BL; Xing, S; Zhu, YP; Sun, H; Gao, F; Zhou, GH				Zhou, Ping; Zhang, Lin; Li, Jiaolong; Luo, Yiqiu; Zhang, Bolin; Xing, Shen; Zhu, Yuping; Sun, Hui; Gao, Feng; Zhou, Guanghong			Effects of Dietary Crude Protein Levels and Cysteamine Supplementation on Protein Synthetic and Degradative Signaling in Skeletal Muscle of Finishing Pigs	PLOS ONE			English	Article							GROWTH-FACTOR-I; AMINO-ACIDS; HORMONE RECEPTOR; CARCASS TRAITS; PERFORMANCE; INSULIN; EXPRESSION; ATROPHY; BARROWS; PIGLETS	Dietary protein levels and cysteamine (CS) supplementation can affect growth performance and protein metabolism of pigs. However, the influence of dietary protein intake on the growth response of CS-treated pigs is unclear, and the mechanisms involved in protein metabolism remain unknown. Hence, we investigated the interactions between dietary protein levels and CS supplementation and the effects of dietary crude protein levels and CS supplementation on protein synthetic and degradative signaling in skeletal muscle of finishing pigs. One hundred twenty barrows (65.84 +/- 0.61 kg) were allocated to a 2 x 2 factorial arrangement with five replicates of six pigs each. The primary variations were dietary crude protein (CP) levels (14% or 10%) and CS supplemental levels (0 or 700 mg/kg). The low-protein (LP) diets (10% CP) were supplemented with enough essential amino acids (EAA) to meet the NRC AA requirements of pigs and maintain the balanced supply of eight EAA including lysine, methionine, threonine, tryptophan, valine, phenylalanine, isoleucine, and leucine. After 41 days, 10 pigs per treatment were slaughtered. We found that LP diets supplemented with EAA resulted in decreased concentrations of plasma somatostatin (SS) (P<0.01) and plasma urea nitrogen (PUN) (P<0.001), while dietary protein levels did not affect other traits. However, CS supplementation increased the average daily gain (P<0.001) and lean percentage (P<0.05), and decreased the feed conversion ratio (P<0.05) and back fat (P<0.05). CS supplementation also increased the concentrations of plasma insulin-like growth factor 1 (IGF-1) (P<0.001), and reduced the concentrations of leptin, SS, and PUN (P<0.001). Increased mRNA abundance of Akt1 and IGF-1 signaling (P<0.001) and decreased mRNA abundance of Forkhead Box O (FOXO) 4 (P<0.01) and muscle atrophy F-box (P<0.001) were observed in pigs receiving CS. Additionally, CS supplementation increased the protein levels for the phosphorylated mammalian target of rapamycin (mTOR), eIF-4E binding protein 1, and ribosomal protein S6 kinase 1 (P<0.001). There were no interactions between dietary protein levels and CS supplementation for all traits. In conclusion, dietary protein levels and CS supplementation influenced growth and protein metabolism through independent mechanisms in pigs. In addition, LP diets supplemented with EAA did not affect growth performance and other traits except the concentrations of SS and PUN probably through maintenance of protein synthesis and degradation signaling. Moreover, CS supplementation improved growth performance by increasing plasma IGF-1 concentrations possibly through alterations of mTOR and Akt/FOXO signaling pathways in skeletal muscle of finishing pigs.	[Zhou, Ping; Zhang, Lin; Li, Jiaolong; Luo, Yiqiu; Zhang, Bolin; Xing, Shen; Zhu, Yuping; Gao, Feng; Zhou, Guanghong] Nanjing Agr Univ, Synerget Innovat Ctr Food Safety & Nutr, Key Lab Anim Origin Food Prod & Safety Guarantee, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Sun, Hui] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun 130118, Peoples R China	Nanjing Agricultural University; Jilin Agricultural University	Gao, F (corresponding author), Nanjing Agr Univ, Synerget Innovat Ctr Food Safety & Nutr, Key Lab Anim Origin Food Prod & Safety Guarantee, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.	gaofeng0629@sina.com	Zhang, Lin/AAL-3573-2020; Zhang, bolin/GZN-2017-2022	Zhang, Lin/0000-0003-1555-1086; 	National Key Basic Research Program of China [2013CB127306]	National Key Basic Research Program of China(National Basic Research Program of China)	The present study was supported by National Key Basic Research Program of China (no. 2013CB127306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NUTR REQ SWIN; [Anonymous], 2012, CHINA FEED; Barb CR, 2001, DOMEST ANIM ENDOCRIN, V21, P297, DOI 10.1016/S0739-7240(01)00123-0; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brameld JM, 1996, J ANIM SCI, V74, P1832; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Deng D, 2007, LIVEST SCI, V109, P220, DOI 10.1016/j.livsci.2007.01.122; Deng D, 2007, LIVEST SCI, V109, P224, DOI 10.1016/j.livsci.2007.01.104; Deng D, 2009, J NUTR BIOCHEM, V20, P544, DOI 10.1016/j.jnutbio.2008.05.014; DEVOL DL, 1988, J ANIM SCI, V66, P385; ETHERTON TD, 1987, J ANIM SCI, V64, P433, DOI 10.2527/jas1987.642433x; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Gomez RS, 2002, J ANIM SCI, V80, P644; Guay F, 2006, J ANIM SCI, V84, P3010, DOI 10.2527/jas.2005-559; Han B, 2008, MOL REPROD DEV, V75, P810, DOI 10.1002/mrd.20832; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kendall D, 2000, THESIS PURDUE U W LA; KERR BJ, 1995, J ANIM SCI, V73, P433; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Li YeGuo, 2006, Journal of Northwest Sci Tech University of Agriculture and Forestry - Natural Science Edition, V34, P27; Liu GM, 2008, J AGR FOOD CHEM, V56, P5422, DOI 10.1021/jf800575p; Liu GM, 2009, LIVEST SCI, V122, P86, DOI 10.1016/j.livsci.2008.07.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lordelo MM, 2008, J ANIM SCI, V86, P2936, DOI 10.2527/jas.2007-0222; Luo JQ, 2010, BRIT J NUTR, V104, P1421, DOI 10.1017/S000711451000231X; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Madrid J, 2013, ANIM PROD SCI, V53, P146, DOI 10.1071/AN12067; Nyachoti CM, 2006, J ANIM SCI, V84, P125, DOI 10.2527/2006.841125x; O'Connor PMJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE40, DOI 10.1152/ajpendo.00563.2002; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Shriver JA, 2003, J ANIM SCI, V81, P492; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Toledo JB, 2014, LIVEST SCI, V168, P94, DOI 10.1016/j.livsci.2014.07.006; Tse MCL, 2006, BRIT J NUTR, V96, P650, DOI 10.1079/BJN20061870; Wen C, 2014, BRIT J NUTR, V111, P201, DOI 10.1017/S0007114513002419; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2013, AMINO ACIDS, V45, P241, DOI 10.1007/s00726-013-1515-z; Yang CM, 2006, POULTRY SCI, V85, P1912, DOI 10.1093/ps/85.11.1912; Yang CB, 2005, J SCI FOOD AGR, V85, P1947, DOI 10.1002/jsfa.2123; Yang X, 2008, J Anim Sci, V86, pE36; YOKOGOSHI H, 1980, J NUTR, V110, P375, DOI 10.1093/jn/110.3.375; Yuan YL, 2012, ANIM PROD SCI, V52, P911, DOI 10.1071/AN11222; Yue LY, 2008, LIVEST SCI, V115, P144, DOI 10.1016/j.livsci.2007.06.018; Zhang BL, 2015, NUTRITION, V31, P749, DOI 10.1016/j.nut.2014.11.010; Zhang SH, 2013, AMINO ACIDS, V45, P1191, DOI 10.1007/s00726-013-1577-y	49	12	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139393	10.1371/journal.pone.0139393	http://dx.doi.org/10.1371/journal.pone.0139393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422009	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700111
J	Chan, R; Wong, VWS; Chu, WCW; Wong, GLH; Li, LS; Leung, J; Chim, AML; Yeung, DKW; Sea, MMM; Woo, J; Chan, FKL; Chan, HLY				Chan, Ruth; Wong, Vincent Wai-Sun; Chu, Winnie Chiu-Wing; Wong, Grace Lai-Hung; Li, Liz Sin; Leung, Jason; Chim, Angel Mei-Ling; Yeung, David Ka-Wai; Sea, Mandy Man-Mei; Woo, Jean; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen			Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							MEDITERRANEAN DIET; INSULIN-RESISTANCE; CHINESE POPULATION; RISK-FACTORS; PATTERN; CONSUMPTION; OVERWEIGHT; STEATOSIS; ADHERENCE; SEVERITY	Dietary pattern analysis is an alternative approach to examine the association between diet and nonalcoholic fatty liver disease (NAFLD). This study examined the association of two diet-quality scores, namely Diet Quality Index-International (DQI-I) and Mediterranean Diet Score (MDS) with NAFLD prevalence. Apparently healthy Chinese adults (332 male, 465 female) aged 18 years or above were recruited through a population screening between 2008 and 2010 in a cross-sectional population-based study in Hong Kong. DQI-I and MDS, as well as major food group and nutrient intakes were calculated based on dietary data from a food frequency questionnaire. NAFLD was defined as intrahepatic triglyceride content at >= 5% by proton-magnetic resonance spectroscopy. Multivariate logistic regression models were used to examine the association between each diet-quality score or dietary component and prevalent NAFLD with adjustment for potential lifestyle, metabolic and genetic factors. A total of 220 subjects (27.6%) were diagnosed with NAFLD. DQI-I but not MDS was associated with the prevalence of NAFLD. A 10-unit decrease in DQI-I was associated with 24% increase in the likelihood of having NAFLD in the age and sex adjusted model (95% CI: 1.06-1.45, p = 0.009), and the association remained significant when the model was further adjusted for other lifestyle factors, metabolic and genetic factors [OR: 1.26 (95% CI: 1.03-1.54), p = 0.027]. Multivariate regression analyses showed an inverse association of the intake of vegetables and legumes, fruits and dried fruits, as well as vitamin C with the NAFLD prevalence (p<0.05). In conclusion, a better diet quality as characterized by a higher DQI-I and a higher consumption of vegetables, legumes and fruits was associated with a reduced likelihood of having NAFLD in Hong Kong Chinese.	[Chan, Ruth; Wong, Vincent Wai-Sun; Chu, Winnie Chiu-Wing; Wong, Grace Lai-Hung; Li, Liz Sin; Chim, Angel Mei-Ling; Sea, Mandy Man-Mei; Woo, Jean; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chan, Ruth; Sea, Mandy Man-Mei; Woo, Jean] Chinese Univ Hong Kong, Ctr Nutr Studies, Hong Kong, Hong Kong, Peoples R China; [Wong, Vincent Wai-Sun; Wong, Grace Lai-Hung; Chim, Angel Mei-Ling; Chan, Francis Ka-Leung; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Chu, Winnie Chiu-Wing] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China; [Yeung, David Ka-Wai] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	ruthchansm@cuhk.edu.hk	Woo, Jean/K-2625-2014; Wong, Vincent WS/K-3864-2014; Chan, Henry Lik-Yuen/B-9636-2008; Chu, Winnie CW/F-8449-2014; Wong, Grace LH/L-8586-2014; Chan, Ruth/K-4995-2014; Chan, Francis K. L./F-4851-2010	Woo, Jean/0000-0001-7593-3081; Wong, Vincent WS/0000-0003-2215-9410; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Chu, Winnie CW/0000-0003-4962-4132; Wong, Grace LH/0000-0002-2863-9389; Chan, Francis K. L./0000-0001-7388-2436; Chan, Ruth/0000-0002-5725-4066	Health and Health Services Research Fund - Government of Hong Kong SAR [07080081]; Centre for Nutritional Studies, under Chinese University of Hong Kong	Health and Health Services Research Fund - Government of Hong Kong SAR; Centre for Nutritional Studies, under Chinese University of Hong Kong	The study was supported by funding from the Health and Health Services Research Fund sponsored by the Government of Hong Kong SAR (Reference number 07080081) and the Centre for Nutritional Studies, under the auspices of The Chinese University of Hong Kong. The Centre for Nutritional Studies did have a role in the data collection and analysis.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abenavoli L, 2014, WORLD J GASTROENTERO, V20, P16831, DOI 10.3748/wjg.v20.i45.16831; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alkerwi A, 2014, BR J NUTR, V5, P1; Allard JP, 2008, J HEPATOL, V48, P300, DOI 10.1016/j.jhep.2007.09.009; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Centre for Food Safety, 2006, NUTR INF INQ; Chan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122406; Chang JiHo, 2014, Journal of Nutrition and Health, V47, P330, DOI 10.4163/jnh.2014.47.5.330; Chitturi S, 2011, J GASTROEN HEPATOL, V26, P163, DOI 10.1111/j.1440-1746.2010.06548.x; Cortez-Pinto H, 2006, CLIN NUTR, V25, P816, DOI 10.1016/j.clnu.2006.01.027; Davis JN, 2010, AM J CLIN NUTR, V92, P1522, DOI 10.3945/ajcn.2010.30185; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Ferolla SM, 2013, CLINICS, V68, P11, DOI 10.6061/clinics/2013(01)OA03; George SM, 2014, AM J EPIDEMIOL, V180, P616, DOI 10.1093/aje/kwu173; Guerrerio AL, 2012, AM J CLIN NUTR, V95, P892, DOI 10.3945/ajcn.111.020156; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Kani AH, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10943; Kim CH, 2010, OBES SURG, V20, P154, DOI 10.1007/s11695-008-9549-0; Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476; Koch M, 2014, AM J CLIN NUTR, V99, P369, DOI 10.3945/ajcn.113.070219; Kontogianni MD, 2014, CLIN NUTR, V33, P678, DOI 10.1016/j.clnu.2013.08.014; Krupp D, 2012, J NUTR, V142, P313, DOI 10.3945/jn.111.150540; Leung S, 1998, AUST J NUTR DIET, V55, pS11; Masarone M, 2014, REV RECENT CLIN TRIA, V9, P126, DOI 10.2174/1574887109666141216111143; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Oddy WH, 2013, AM J GASTROENTEROL, V108, P778, DOI 10.1038/ajg.2013.95; Oya J, 2010, EUR J CLIN NUTR, V64, P1179, DOI 10.1038/ejcn.2010.139; Ricci G, 2011, NUTRITION, V27, P672, DOI 10.1016/j.nut.2010.07.014; Santoro N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037827; Sathiaraj E, 2011, EUR J CLIN NUTR, V65, P533, DOI 10.1038/ejcn.2011.3; Shen J, 2014, ALIMENT PHARM THER, V39, P532, DOI 10.1111/apt.12609; Slattery ML, 2008, AM J CLIN NUTR, V88, P14, DOI 10.1093/ajcn/88.1.14; Sofi F, 2014, WORLD J GASTROENTERO, V20, P7339, DOI 10.3748/wjg.v20.i23.7339; Solga S, 2004, DIGEST DIS SCI, V49, P1578, DOI 10.1023/B:DDAS.0000043367.69470.b7; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Trovato GM, 2013, AM J GASTROENTEROL, V108, P1932, DOI 10.1038/ajg.2013.356; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; WHO, 2003, DIET NUTR PREVENTION, V916; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wong VWS, 2013, J HEPATOL, V59, P536, DOI 10.1016/j.jhep.2013.04.013; Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Wong VWS, 2011, GUT, V60, P1721, DOI 10.1136/gut.2011.242016; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974; Woo J, 2008, EUR J CLIN NUTR, V62, P480, DOI 10.1038/sj.ejcn.1602702; Woo J, 2001, EUR J CLIN NUTR, V55, P215, DOI 10.1038/sj.ejcn.1601150; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yang YX, 2004, CHINA FOOD COMPOSITI; Yu R, 2011, PUBLIC HEALTH NUTR, V14, P1133, DOI 10.1017/S136898001100053X; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020	56	53	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139310	10.1371/journal.pone.0139310	http://dx.doi.org/10.1371/journal.pone.0139310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418083	Green Submitted, gold, Green Published			2022-12-27	WOS:000362171400074
J	Chang, HP; Cheng, TC; Wu, YQ; Hu, WB; Long, RW; Liu, C; Zhao, P; Xia, QY				Chang, Huaipu; Cheng, Tingcai; Wu, Yuqian; Hu, Wenbo; Long, Renwen; Liu, Chun; Zhao, Ping; Xia, Qingyou			Transcriptomic Analysis of the Anterior Silk Gland in the Domestic Silkworm (Bombyx mori) - Insight into the Mechanism of Silk Formation and Spinning	PLOS ONE			English	Article							CUTICULAR PROTEINS; FIBROIN; GENES; CUTICLE; GENOME; IONS; PH; IDENTIFICATION; PROFILES; SEQUENCE	Silk proteins are synthesized in the middle and posterior silk glands of silkworms, then transit into the anterior of the silk gland, where the silk fibers are produced, stored and processed. The mechanism of formation and spinning of the silk fibers has not been fully elucidated, and transcriptome analyses specific to the anterior silk gland have not been reported. In the present study, we explored gene expression profiles in five regions of silk gland samples using the RNA-Seq method. As a result, there were 959,979,570 raw reads obtained, of which 583,068,172 reads were mapped to the silkworm genome. A total of 7419 genes were found to be expressed in terms of reads per kilobase of exon model per million mapped reads >= 5 in at least one sample. The gene numbers and expression levels of the expressed genes differed between these regions. The differentially expressed genes were analyzed, and 282 genes were detected as up-regulated in the anterior silk gland, compared with the other parts. Functions of these genes were addressed using the gene ontology and Kyoto Encyclopedia of Genes and Genomes databases, and seven key pathways were enriched. It suggested that the ion transportation, energy metabolism, protease inhibitors and cuticle proteins played essential roles in the process of silk formation and spinning in the anterior silk gland. In addition, 210 genes were found differently expressed between males and females, which should help to elucidate the mechanism of the quality difference in silk fibers from male and female silkworms.	[Chang, Huaipu; Cheng, Tingcai; Wu, Yuqian; Hu, Wenbo; Long, Renwen; Liu, Chun; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Chang, Huaipu] Southwest Univ, Coll Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		Xia, Qingyou/0000-0002-9263-2886; cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China [2012CB114600]; Fundamental Research Funds for the Central Universities [XDJK2013A019, XDJK2013C128]; Chongqing Fundamental and Frontier Research Program [cstc2013jcyjA0500]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chongqing Fundamental and Frontier Research Program	QX was supported by the National Basic Research Program of China (2012CB114600), and the Fundamental Research Funds for the Central Universities (XDJK2013A019). HC was supported by Chongqing Fundamental and Frontier Research Program (cstc2013jcyjA0500), and the Fundamental Research Funds for the Central Universities (XDJK2013C128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1972, ACTA CHEM SCAND, V26, P3097, DOI 10.3891/acta.chem.scand.26-3097; Andersen SO, 2000, INSECT BIOCHEM MOLEC, V30, P569, DOI 10.1016/S0965-1748(00)00029-1; Andersen SO, 1998, INSECT BIOCHEM MOLEC, V28, P421, DOI 10.1016/S0965-1748(98)00028-9; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Boggavarapu R, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0167-8; Dang QQ, 2010, BIOMACROMOLECULES, V11, P1796, DOI 10.1021/bm1002398; Davies GJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073225; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fang SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1287-9; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; He YX, 2012, J MOL BIOL, V418, P197, DOI 10.1016/j.jmb.2012.02.040; Hou Y, 2007, INSECT BIOCHEM MOLEC, V37, P486, DOI 10.1016/j.ibmb.2007.02.011; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; Lee SM, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-52; Li XG, 2008, BIOPOLYMERS, V89, P497, DOI 10.1002/bip.20905; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Ma L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-182; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qin LG, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu088; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Royer C, 2011, INSECT BIOCHEM MOLEC, V41, P118, DOI 10.1016/j.ibmb.2010.11.003; Ruan QX, 2008, FEBS J, V275, P219, DOI 10.1111/j.1742-4658.2007.06191.x; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010; Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v; Togawa T, 2007, INSECT BIOCHEM MOLEC, V37, P675, DOI 10.1016/j.ibmb.2007.03.011; Utturkar SM, 2014, BIOINFORMATICS, V30, P2709, DOI 10.1093/bioinformatics/btu391; Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P227, DOI 10.1016/S0141-8130(99)00005-7; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wang SH, 2014, J PROTEOME RES, V13, P735, DOI 10.1021/pr4008333; Wang Xin, 2014, Scientia Agricultura Sinica, V47, P1611; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xie F, 2006, INT J BIOL MACROMOL, V38, P284, DOI 10.1016/j.ijbiomac.2006.03.021; Yi QY, 2013, PROTEOMICS, V13, P2657, DOI 10.1002/pmic.201200443; Zhang PB, 2006, PROTEOMICS, V6, P2586, DOI 10.1002/pmic.200500348; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005; Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m; Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	46	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139424	10.1371/journal.pone.0139424	http://dx.doi.org/10.1371/journal.pone.0139424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418001	Green Submitted, gold, Green Published			2022-12-27	WOS:000362171400090
J	Kang, JH; Kwak, HJ; Choi, HE; Kim, J; Hong, S; Kim, OH; Oh, BC; Cheon, HG				Kang, Ju-Hee; Kwak, Hyun Jeong; Choi, Hye-Eun; Kim, Juyoung; Hong, Sangmee; Kim, Ok-Hee; Oh, Byung Chul; Cheon, Hyae Gyeong			Involvement of Prolyl Hydroxylase Domain Protein in the Rosiglitazone-Induced Suppression of Osteoblast Differentiation	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PPAR-GAMMA; HIF-ALPHA; IN-VITRO; THIAZOLIDINEDIONES; EXPRESSION; ADIPOCYTE; UBIQUITINATION; OSTEOGENESIS; DESTRUCTION	Rosiglitazone is a well-known anti-diabetic drug that increases insulin sensitivity via peroxisome proliferator-activated receptor. (PPAR.) activation, but unfortunately it causes bone loss in animals and humans. A previous study showed that prolyl hydroxylase domain protein (PHD) plays a role in rosiglitazone-induced adipocyte differentiation. Based on the inverse relationship between adipocyte and osteoblast differentiation, we investigated whether PHD is involved in the effects of rosiglitazone on osteoblast differentiation. Rosiglitazone inhibited osteoblast differentiation in a concentration-dependent manner, and in parallel induced three PHD isoforms (PHD1, 2, and 3). PHD inhibitors and knockdown of each isoform prevented the inhibitory effects of rosiglitazone on osteoblast differentiation and increased the expression of Runx2, a transcription factor essential for osteoblastogenesis. MG-132, a proteasomal inhibitor also prevented the rosiglitazone-induced degradation of Runx2. Furthermore, both increased PHD isoform expressions and reduced osteoblast differentiation by rosiglitazone were prevented by PPAR. antagonists, indicating these effects were mediated via PPAR. activation. In vivo oral administration of rosiglitazone to female ICR mice for 8 weeks reduced bone mineral densities and plasma alkaline phosphatase (ALP) activity, and increased PHD expression in femoral primary bone marrow cells and the ubiquitination of Runx2. Together, this suggests that the rosiglitazone-induced suppression of osteoblast differentiation is at least partly induced via PPAR.-mediated PHD induction and subsequent promotion of the ubiquitination and degradation of Runx2.	[Kang, Ju-Hee; Kwak, Hyun Jeong; Choi, Hye-Eun; Kim, Juyoung; Cheon, Hyae Gyeong] Gachon Univ, Sch Med, Dept Pharmacol, Inchon, South Korea; [Hong, Sangmee; Kim, Ok-Hee; Oh, Byung Chul] Gachon Univ, Dept Mol Med, Inchon, South Korea; [Cheon, Hyae Gyeong] Gil Med Ctr, Gachon Med Res Inst, Inchon, South Korea	Gachon University; Gachon University; Gachon University	Cheon, HG (corresponding author), Gachon Univ, Sch Med, Dept Pharmacol, Inchon, South Korea.	hgcheon@gachon.ac.kr		Kim, Ok-Hee/0000-0003-3801-9463; Oh, Byung-Chul/0000-0002-4277-7083	Korean National Research Foundation (NRF) - Korean government (MEST) [2011-0013253]	Korean National Research Foundation (NRF) - Korean government (MEST)	This work was supported by the Korean National Research Foundation (NRF) funded by the Korean government (MEST) (Grant no. 2011-0013253).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Beck GR, 2013, TRANSL RES, V161, P145, DOI 10.1016/j.trsl.2012.08.006; BERESFORD JN, 1992, J CELL SCI, V102, P341; Broulik PD, 2013, FOLIA BIOL PRAHA, V57, P133; Bruedigam C, 2010, STEM CELLS, V28, P916, DOI 10.1002/stem.405; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Irwin R, 2007, J CELL BIOCHEM, V100, P762, DOI 10.1002/jcb.21083; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kim J, 2014, J BIOL CHEM, V289, P2755, DOI 10.1074/jbc.M113.493650; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Liu XD, 2014, CELL BIOCHEM BIOPHYS, V69, P141, DOI 10.1007/s12013-013-9780-8; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; McDonough AK, 2008, NAT CLIN PRACT ENDOC, V4, P507, DOI 10.1038/ncpendmet0920; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Schwartz AV, 2006, PPAR RES, V2006, P1; Solomon DH, 2009, J CLIN ENDOCR METAB, V94, P2792, DOI 10.1210/jc.2008-2157; Soroceanu MA, 2004, J ENDOCRINOL, V183, P203, DOI 10.1677/joe.1.05723; Sottile V, 2014, CALCIFIED TISSUE INT, V75, P329; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Xing WR, 2011, PHYSIOL GENOMICS, V43, P749, DOI 10.1152/physiolgenomics.00229.2010; Yaturu S, 2007, DIABETES CARE, V30, P1574, DOI 10.2337/dc06-2606; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zipori Dov, 2006, Curr Stem Cell Res Ther, V1, P95, DOI 10.2174/157488806775269133; Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024; Zou D, 2011, CELL PROLIFERAT, V44, P234, DOI 10.1111/j.1365-2184.2011.00747.x	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139093	10.1371/journal.pone.0139093	http://dx.doi.org/10.1371/journal.pone.0139093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418009	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400040
J	Leve, F; Peres-Moreira, RJ; Binato, R; Abdelhay, E; Morgado-Diaz, JA				Leve, Fernanda; Peres-Moreira, Rubem J.; Binato, Renata; Abdelhay, Eliana; Morgado-Diaz, Jose A.			LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; COLORECTAL-CANCER; CYCLIN D1; STIMULATE PROLIFERATION; PROTEIN EXPRESSION; TUMOR-CELLS; CROSS-TALK; ACTIVATION; INVASION; MOTILITY	Lysophosphatidic acid (LPA) plays a critical role in the proliferation and migration of colon cancer cells; however, the downstream signaling events underlying these processes remain poorly characterized. The aim of this study was to investigate the signaling pathways triggered by LPA to regulate the mechanisms involved in the progression of colorectal cancer (CRC). We have used three cell line models of CRC, and initially analyzed the expression profile of LPA receptors (LPAR). Then, we treated the cells with LPA and events related to their tumorigenic potential, such as migration, invasion, anchorage-independent growth, proliferation as well as apoptosis and cell cycle were evaluated. We used the Chip array technique to analyze the global gene expression profiling that occurs after LPA treatment, and we identified cell signaling pathways related to the cell cycle. The inhibition of these pathways verified the conclusions of the transcriptomic analysis. We found that the cell lines expressed LPAR1, -2 and -3 in a differential manner and that 10 mu M LPA did not affect cell migration, invasion and anchorage-independent growth, but it did induce proliferation and cell cycle progression in HCT-116 cells. Although LPA in this concentration did not induce transcriptional activity of beta-catenin, it promoted the activation of Rho and STAT3. Moreover, ROCK and STAT-3 inhibitors prevented LPA-induced proliferation, but ROCK inhibition did not prevent STAT-3 activation. Finally, we observed that LPA regulates the expression of genes related to the cell cycle and that the combined inhibition of ROCK and STAT-3 prevented cell cycle progression and increased the LPA-induced expression of cyclins E1, A2 and B1 to a greater degree than either inhibitor alone. Overall, these results demonstrate that LPA increases the proliferative potential of colon adenocarcinoma HCT-116 cells through a mechanism involving cooperation between the Rho-ROCK and STAT3 pathways involved in cell cycle control.	[Leve, Fernanda] Inst Nacl Metrol Qualidade & Tecnol INMETRO, Diretoria Metrol Aplicada Ciencias Vida Dimav, Duque De Caxias, RJ, Brazil; [Peres-Moreira, Rubem J.; Morgado-Diaz, Jose A.] Inst Nacl Canc INCA, Ctr Pesquisas, Grp Biol Estrutural, Div Biol Celular, Rio De Janeiro, RJ, Brazil; [Binato, Renata; Abdelhay, Eliana] Inst Nacl Canc INCA, Ctr Transplante Medula Ossea CEMO, Rio De Janeiro, RJ, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); National Cancer Institute (Inca)	Morgado-Diaz, JA (corresponding author), Inst Nacl Canc INCA, Ctr Pesquisas, Grp Biol Estrutural, Div Biol Celular, Rio De Janeiro, RJ, Brazil.	jmorgado@inca.gov.br	Morgado-Diaz, Jose A./A-9649-2010	Leve, Fernanda/0000-0001-5466-0950	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia em Cancer-INCT [573806/2008-0, 170.026/2008]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) [26/11703/2013]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Cancer-INCT; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) and Instituto Nacional de Ciencia e Tecnologia em Cancer-INCT (573806/2008-0 and 170.026/2008) to JAMD; and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) (26/11703/2013) to JAMD.	Arsic N, 2012, J CELL BIOL, V196, P147, DOI 10.1083/jcb.201102085; Bharadwaj U, 2008, MOL CANCER RES, V6, P1755, DOI 10.1158/1541-7786.MCR-08-0095; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Erickson A, 2001, PROSTAGLANDINS, V64, P63; Fukui R, 2012, TUMOR BIOL, V33, P1899, DOI 10.1007/s13277-012-0450-z; Grabsch H, 2004, AM J CLIN PATHOL, V122, P511, DOI 10.1309/54H4Q88A1UBBWPTE; Guo L, 2015, CELL SIGNAL; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hozumi H, 2013, LAB INVEST, V93, P508, DOI 10.1038/labinvest.2013.45; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Kusaba T, 2005, J CLIN PATHOL, V58, P833, DOI 10.1136/jcp.2004.023416; Lassmann S, 2007, J CLIN PATHOL, V60, P173, DOI 10.1136/jcp.2005.035113; Lee SJ, 2013, J BIOL CHEM, V288, P25244, DOI 10.1074/jbc.M113.489708; Lee SJ, 2010, INT J BIOCHEM CELL B, V42, P1907, DOI 10.1016/j.biocel.2010.09.021; Leve F, 2012, J CELL BIOCHEM, V113, P2549, DOI 10.1002/jcb.24153; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Mishra R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0300-x; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Muller R, 2010, TUMOR BIOL, V31, P341, DOI 10.1007/s13277-010-0043-7; PartekInc, 2008, PART DISC SUIT TM; Pramanik KC, 2015, ONCOTARGET; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rusovici R, 2007, BBA-GEN SUBJECTS, V1770, P1194, DOI 10.1016/j.bbagen.2007.04.008; Samsonov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068391; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Seo JH, 2010, CANCER LETT, V288, P50, DOI 10.1016/j.canlet.2009.06.023; Shida D, 2003, CANCER RES, V63, P1706; Shida D, 2008, CANCER RES, V68, P6569, DOI 10.1158/0008-5472.CAN-08-0411; Shin KJ, 2009, J CANCER RES CLIN, V135, P45, DOI 10.1007/s00432-008-0441-z; Slattery ML, 2013, MOL CARCINOGEN, V52, P155, DOI 10.1002/mc.21841; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sun H, 2009, WORLD J GASTROENTERO, V15, P4547, DOI 10.3748/wjg.15.4547; Lopez PJT, 2014, CLIN MED INSIGHTS-GA, V7, P33, DOI 10.4137/CGast.S14039; Tsujino M, 2010, VIRCHOWS ARCH, V457, P669, DOI 10.1007/s00428-010-0960-2; Wang A, 1996, J CANCER RES CLIN, V122, P122, DOI 10.1007/BF01226270; Willier S, 2013, BIOL CELL, V105, P317, DOI 10.1111/boc.201300011; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P636, DOI 10.1167/iovs.06-0203; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zhang P, 2011, MOL CANCER RES, V9, P1418, DOI 10.1158/1541-7786.MCR-11-0147; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248; Zhao M, 2011, CURR MED CHEM, V18, P4012, DOI 10.2174/092986711796957284; Zhao Y, 2013, BIOCHEM BIOPH RES CO, V432, P488, DOI 10.1016/j.bbrc.2013.02.009; Zhao ZW, 2007, J CLIN ONCOL, V25, P2696, DOI 10.1200/JCO.2006.08.5571	51	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139094	10.1371/journal.pone.0139094	http://dx.doi.org/10.1371/journal.pone.0139094			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418031	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400041
J	Shi, HL; Luo, SQ; Yang, Z; Wu, GM				Shi, Hongli; Luo, Shuqian; Yang, Zhi; Wu, Geming			A Novel Iterative CT Reconstruction Approach Based on FBP Algorithm	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION	The Filtered Back-Projection (FBP) algorithm and its modified versions are the most important techniques for CT (Computerized tomography) reconstruction, however, it may produce aliasing degradation in the reconstructed images due to projection discretization. The general iterative reconstruction (IR) algorithms suffer from their heavy calculation burden and other drawbacks. In this paper, an iterative FBP approach is proposed to reduce the aliasing degradation. In the approach, the image reconstructed by FBP algorithm is treated as the intermediate image and projected along the original projection directions to produce the reprojection data. The difference between the original and reprojection data is filtered by a special digital filter, and then is reconstructed by FBP to produce a correction term. The correction term is added to the intermediate image to update it. This procedure can be performed iteratively to improve the reconstruction performance gradually until certain stopping criterion is satisfied. Some simulations and tests on real data show the proposed approach is better than FBP algorithm or some IR algorithms in term of some general image criteria. The calculation burden is several times that of FBP, which is much less than that of general IR algorithms and acceptable in the most situations. Therefore, the proposed algorithm has the potential applications in practical CT systems.	[Shi, Hongli; Luo, Shuqian; Yang, Zhi; Wu, Geming] Capital Med Univ China, Sch Biomed Engn, Beijing, Peoples R China	Capital Medical University	Wu, GM (corresponding author), Capital Med Univ China, Sch Biomed Engn, Beijing, Peoples R China.	shi@ccmu.edu.cn			National Natural Science Foundation of China (NSFC) [60972156, 61227802]; Beijing Natural Science Foundation [7142022]; Scientific Research Common Program of Beijing Municipal Commission of Education [KM201410025011]; Marie Curie International Research Staff Exchange Scheme (IRSES) actions under European Community [PIRSES-GA-2009-269124]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Marie Curie International Research Staff Exchange Scheme (IRSES) actions under European Community	This work has been supported by National Natural Science Foundation of China (NSFC) under Grant No. 60972156 and No. 61227802, Beijing Natural Science Foundation under Grant No. 7142022, Scientific Research Common Program of Beijing Municipal Commission of Education No. KM201410025011, and Marie Curie International Research Staff Exchange Scheme (IRSES) actions under the 7th Framework Programme of the European Community under Grant No. PIRSES-GA-2009-269124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian JG, 2010, PHYS MED BIOL, V55, P6575, DOI 10.1088/0031-9155/55/22/001; Borsdorf A, 2008, IEEE T MED IMAGING, V27, P1685, DOI 10.1109/TMI.2008.923983; Brandt A, 2000, SIAM J APPL MATH, V60, P437, DOI 10.1137/S003613999732425X; Dong Baoyu, 2012, J COMPUTATIONAL INFO, V8, P7839; Faridani A, 2003, MATH SCI R, V47, P1; Han X, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5245; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Horbelt S, 2002, P SPIE, V4684; Hsieh J., 2003, COMPUTED TOMOGRAPHY; Ivakhnenko VI, 2010, IEEE T NUCL SCI, V57, P870, DOI 10.1109/TNS.2010.2042066; Kak Avinash C, 1988, PRINCIPLES COMPUTERI; Krol A, 2001, IEEE T MED IMAGING, V20, P218, DOI 10.1109/42.918472; Natterer F., 2001, MATH COMPUTERIZED TO, DOI DOI 10.1137/1.9780898719284; Nilchian M, 2013, OPT EXPRESS, V21, P5511, DOI 10.1364/OE.21.005511; Rieder A, 2003, SIAM J NUMER ANAL, V41, P869, DOI 10.1137/S0036142902405643; Shi HL, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-50; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Sidky EY, 2007, IEEE NUCL SCI CONF R, P3526, DOI 10.1109/NSSMIC.2007.4436889; Tessa Van, IMPLEMENTATION ITERA; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Xu JY, 2010, IEEE T MED IMAGING, V29, P1528, DOI 10.1109/TMI.2010.2048335; Xu Q, 2012, IEEE T MED IMAGING, V31, P1682, DOI 10.1109/TMI.2012.2195669; Ye YB, 2005, MED PHYS, V32, P42, DOI 10.1118/1.1828673; Zamyatin AA, 2006, IEEE T NUCL SCI, V53, P167, DOI 10.1109/TNS.2005.862973	25	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138498	10.1371/journal.pone.0138498	http://dx.doi.org/10.1371/journal.pone.0138498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418739	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400016
J	Li, LH; Mo, R				Li, Lian-hui; Mo, Rong			Production Task Queue Optimization Based on Multi-Attribute Evaluation for Complex Product Assembly Workshop	PLOS ONE			English	Article							LINE BALANCING PROBLEM; BP NEURAL-NETWORK; ROUGH-SET; ALGORITHM; PREDICTION; EXAMPLE; DESIGN; SYSTEM; TOPSIS; MODEL	The production task queue has a great significance for manufacturing resource allocation and scheduling decision. Man-made qualitative queue optimization method has a poor effect and makes the application difficult. A production task queue optimization method is proposed based on multi-attribute evaluation. According to the task attributes, the hierarchical multi-attribute model is established and the indicator quantization methods are given. To calculate the objective indicator weight, criteria importance through intercriteria correlation (CRITIC) is selected from three usual methods. To calculate the subjective indicator weight, BP neural network is used to determine the judge importance degree, and then the trapezoid fuzzy scale-rough AHP considering the judge importance degree is put forward. The balanced weight, which integrates the objective weight and the subjective weight, is calculated base on multi-weight contribution balance model. The technique for order preference by similarity to an ideal solution (TOPSIS) improved by replacing Euclidean distance with relative entropy distance is used to sequence the tasks and optimize the queue by the weighted indicator value. A case study is given to illustrate its correctness and feasibility.	[Li, Lian-hui; Mo, Rong] Northwestern Polytech Univ, Minist Educ, Key Lab Contemporary Design & Integrated Mfg Tech, Xian 710072, Peoples R China	Northwestern Polytechnical University	Mo, R (corresponding author), Northwestern Polytech Univ, Minist Educ, Key Lab Contemporary Design & Integrated Mfg Tech, Xian 710072, Peoples R China.	mr_nwpu@sina.com						Aksoy A, 2011, EXPERT SYST APPL, V38, P6351, DOI 10.1016/j.eswa.2010.11.104; Awasthi A, 2012, APPL MATH MODEL, V36, P573, DOI 10.1016/j.apm.2011.07.033; Becker C, 2006, EUR J OPER RES, V168, P694, DOI 10.1016/j.ejor.2004.07.023; Calleja G, 2013, INT J PROD RES, V51, P3549, DOI 10.1080/00207543.2012.751514; Chang DY, 1996, EUR J OPER RES, V95, P649, DOI 10.1016/0377-2217(95)00300-2; Chang Zhiyong, 2009, Journal of Nanjing University of Aeronautics & Astronautics, V41, P564; Chen CT, 2000, FUZZY SET SYST, V114, P1, DOI 10.1016/S0165-0114(97)00377-1; [迟国泰 CHI Guotai], 2010, [管理学报, Chinese Journal of Management], V7, P301; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Cyran KA, 2001, INT J INTELL SYST, V16, P149, DOI 10.1002/1098-111X(200102)16:2<149::AID-INT10>3.0.CO;2-S; Dan H., 2009, J CHONGQING JIAOTONG, V9, P142; DIAKOULAKI D, 1995, COMPUT OPER RES, V22, P763, DOI 10.1016/0305-0548(94)00059-H; Hamta N, 2013, INT J PROD ECON, V141, P99, DOI 10.1016/j.ijpe.2012.03.013; [胡一繁 HU Yifan], 2007, [兵工学报, Acta Armamentarii], V28, P1540; [华小义 Hua Xiaoyi], 2004, [系统工程理论与实践, Systems Engineering-Theory & Practice], V24, P114; Huang BQ, 2013, INT J ADV MANUF TECH, V65, P1261, DOI 10.1007/s00170-012-4255-4; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Lan HB, 2004, COMPUT IND, V54, P51, DOI 10.1016/j.compind.2003.07.006; Li Lian-Hui, 2013, Computer Integrated Manufacturing Systems, V19, P3087; Li N, 2012, MECH SYST SIGNAL PR, V28, P608, DOI 10.1016/j.ymssp.2011.10.016; Liu YL, 2014, ADV MATER RES-SWITZ, V886, P519, DOI 10.4028/www.scientific.net/AMR.886.519; Lou YuHong, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P79; Luo ZM, 2010, EXPERT SYST APPL, V37, P8379, DOI 10.1016/j.eswa.2010.05.044; Mathew T, 2014, 2014 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P658, DOI 10.1109/ICACCI.2014.6968517; Naderi B, 2014, EUR J OPER RES, V239, P323, DOI 10.1016/j.ejor.2014.05.024; Niu W, 2013, J COMPUT THEOR NANOS, V10, P1460, DOI 10.1166/jctn.2013.2872; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Othman ML, 2011, INT J ELEC POWER, V33, P1437, DOI 10.1016/j.ijepes.2011.06.024; Otto A, 2013, EUR J OPER RES, V228, P33, DOI 10.1016/j.ejor.2012.12.029; Polkowski L., 2013, ROUGH SETS MATH FDN; Qin X, 2005, J PARALLEL DISTR COM, V65, P885, DOI [10.1016/j.jpds.2005.02.003, 10.1016/j.jpdc.2005.02.003]; Qiu WH, 2011, MANAGEMENT DECISION; Ragowsky A, 2002, J MANAGE INFORM SYST, V19, P11; Ren C, 2014, KNOWL-BASED SYST, V56, P226, DOI 10.1016/j.knosys.2013.11.015; Saaty T., 2001, ANAL HIERARCHY PROCE, P19, DOI [10.1007/1-4020-0611-X_31, DOI 10.1007/1-4020-0611-X_31]; Saaty T.L., 2001, ENCY OPERATIONS RES; Shulin L, 1996, SYSTEMS ENG THEORY P, V16, P12; Sun QY, 2013, NEURAL COMPUT APPL, V23, P2023, DOI 10.1007/s00521-012-1116-x; Wang Pei, 2012, Journal of Aerospace Power, V27, P2075; Wang Xiao-tun, 2010, Computer Integrated Manufacturing Systems, V16, P763; [王中兴 Wang Zhongxing], 2006, [应用数学与计算数学学报, Communication on Applied Mathematics and Computation], V20, P87; Wu N., 2012, MAXIMUM ENTROPY METH; Xiao Z, 2012, KNOWL-BASED SYST, V26, P196, DOI 10.1016/j.knosys.2011.08.001; Xiao Z, 2009, EXPERT SYST APPL, V36, P273, DOI 10.1016/j.eswa.2007.09.031; Yadav S, 2014, INT J COMPUTER APPL, V91; [杨皓翔 Yang Haoxiang], 2012, [南水北调与水利科技, South-to-North Water Diversion and Water Science & Technology], V10, P51; Yasuhiro Monden, 2011, TOYOTA PRODUCTION SY; Yu H, 2000, COMPUTER INTEGRATED, V6, P1; [翟治芬 Zhai Zhifen], 2012, [生态学报, Acta Ecologica Sinica], V32, P931; Zhang JB, 2014, INFORM SCIENCES, V257, P81, DOI 10.1016/j.ins.2013.08.016; Zhang JB, 2012, INT J INTELL SYST, V27, P317, DOI 10.1002/int.21523; Zhao Meng, 2010, Control and Decision, V25, P1098; Zhong RY, 2013, ROBOT CIM-INT MANUF, V29, P283, DOI 10.1016/j.rcim.2012.08.001	53	23	25	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0134343	10.1371/journal.pone.0134343	http://dx.doi.org/10.1371/journal.pone.0134343			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414758	gold, Green Submitted, Green Published			2022-12-27	WOS:000362170700002
J	Cohen-Manheim, I; Doniger, GM; Sinnreich, R; Simon, ES; Pinchas-Mizrachi, R; Otvos, JD; Kark, JD				Cohen-Manheim, Irit; Doniger, Glen M.; Sinnreich, Ronit; Simon, Ely S.; Pinchas-Mizrachi, Ronit; Otvos, James D.; Kark, Jeremy D.			Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DECLINE; DEMENTIA; DISEASE; IMPAIRMENT; PLASMA; INTERLEUKIN-6; PERFORMANCE; PREDICTORS; CYTOKINES	Background Inflammatory markers are elevated in patients with dementia. Evidence for an association between inflammation and cognitive function in dementia-free individuals is sparse, inconsistent, and predominantly restricted to the elderly. Assessment of inflammatory markers in young adults as predictors of cognitive function in midlife, well before the onset of overt dementia, is lacking. Furthermore, rarely has the relation with longitudinal change in inflammatory markers been examined. Objective To examine the association of the inflammatory markers C-reactive protein (CRP), fibrinogen, white blood cell count (WBC) and GlycA, a novel NMR-determined biomarker of systemic inflammation, measured in young adulthood and of GlycA change over 13 years follow-up with cognitive function in midlife. Methods 507 participants of the Jerusalem Lipid Research Clinic (LRC) study were assessed at 3 time points over 18-22 years. First, the inflammatory variables GlycA, CRP, fibrinogen, and WBC were measured in blood samples drawn at ages 28-32. Then, in blood samples drawn a mean 13 years later (range, 12-16 years) at ages 41-46, GlycA was again measured (in 484 individuals). Subsequently at ages 48-52, on average 7 years later, global cognitive function and its five specific component domains were assessed with a NeuroTrax computerized test battery. Multiple regression and multivariable logistic models were applied. Results Inverse unadjusted associations were shown for baseline levels and longitudinal change in inflammatory markers and measures of cognition. Multiple regression models were adjusted for age at cognitive assessment, sex, socio-demographic characteristics, baseline measures of leisure-time vigorous activity, smoking status and body mass index (BMI) at ages 28-32, change in smoking status and BMI between ages 28-32 and 41-46, and depression assessed at the time of cognitive testing. The highest quintile of GlycA change, but not the baseline inflammation measures, was inversely related to global cognition (standardized beta = -.109, p =.011) as well as to the information processing speed and memory domains (standardized beta = -.124, p =.008 and -.117, p =.014, respectively). The multivariable-adjusted odds ratio for low ranked global cognitive function (lowest fifth) comparing the extreme quintiles of GlycA change was 4.8 (95% CI, 1.7-13.5, p =.003; p for trend =.031). Conclusions In this longitudinal study of a novel systemic inflammatory marker in a population-based cohort of young adults, GlycA increase over 13 years, but not baseline measures of inflammation, was associated with poorer cognitive function in midlife.	[Cohen-Manheim, Irit; Sinnreich, Ronit; Pinchas-Mizrachi, Ronit; Kark, Jeremy D.] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth & Community Med, IL-91120 Jerusalem, Israel; [Doniger, Glen M.; Simon, Ely S.] NeuroTrax Corp, Dept Clin Res, IL-71711 Modiin, Israel; [Doniger, Glen M.] Ono Acad Coll, Ctr Med Decis Making, IL-55000 Kiryat Ono, Israel; [Simon, Ely S.] Albert Einstein Coll Med, Dept Neurol, New York, NY 10461 USA; [Otvos, James D.] LabCorp, Raleigh, NC 27616 USA	Hebrew University of Jerusalem; Yeshiva University	Kark, JD (corresponding author), Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth & Community Med, IL-91120 Jerusalem, Israel.	jeremy@mail.huji.ac.il		Doniger, Glen M/0000-0003-2690-3569	Israel Ministry of Health [300000-5352]; Israel Science Foundation [593/01]; US-Israel Binational Science Foundation [87-00419]	Israel Ministry of Health; Israel Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	The study was supported by grants to JDK from the Chief Scientist of the Israel Ministry of Health [300000-5352] (http://www.health.gov.il/English/MinistryUnits/PH/Scientist/Pages/default.aspx), the Israel Science Foundation [593/01] (http://www.isf.org.il/english/), and the US-Israel Binational Science Foundation [87-00419] (http://www.bsf.org.il/BSFPublic/Default.aspx). NeuroTrax Corp & LabCorp provided support in the form of salaries for authors ESS, GMD and JDO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. LabCorp provided blinded NMR measures of GlycA.	Alley DE, 2008, J GERONTOL A-BIOL, V63, P50, DOI 10.1093/gerona/63.1.50; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Burazeri G, 2008, J EPIDEMIOL COMMUN H, V62, P620, DOI 10.1136/jech.2007.066001; Chakrabarty P, 2015, NEURON, V85, P519, DOI 10.1016/j.neuron.2014.11.020; Dik MG, 2005, NEUROLOGY, V64, P1371, DOI 10.1212/01.WNL.0000158281.08946.68; Dowd JB, 2008, AM J EPIDEMIOL, V167, P112, DOI 10.1093/aje/kwm247; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gimeno D, 2008, PSYCHONEUROENDOCRINO, V33, P1322, DOI 10.1016/j.psyneuen.2008.07.006; Gorelick PB, 2010, ANN NY ACAD SCI, V1207, P155, DOI 10.1111/j.1749-6632.2010.05726.x; Guillot-Sestier MV, 2015, NEURON, V85, P534, DOI 10.1016/j.neuron.2014.12.068; Hartman SJ, 2015, PSYCHO-ONCOLOGY, V24, P669, DOI 10.1002/pon.3626; Hoshi T, 2005, STROKE, V36, P768, DOI 10.1161/01.STR.0000158915.28329.51; Hutchinson WL, 2000, CLIN CHEM, V46, P934; Jefferson AL, 2011, NEUROEPIDEMIOLOGY, V37, P21, DOI 10.1159/000328864; Jenny NS, 2012, J GERONTOL A-BIOL, V67, P970, DOI 10.1093/gerona/glr261; Kao TW, 2011, EUR J CLIN INVEST, V41, P513, DOI 10.1111/j.1365-2362.2010.02438.x; Kark JD, 2000, ATHEROSCLEROSIS, V151, P509, DOI 10.1016/S0021-9150(99)00408-6; Kark JD, 2012, AM J CLIN NUTR, V95, P479, DOI 10.3945/ajcn.111.024521; Koyama A, 2013, J GERONTOL A-BIOL, V68, P433, DOI 10.1093/gerona/gls187; KRAUS V, 1978, SOC FORCES, V56, P900, DOI 10.2307/2577225; Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Melton J, 2005, 0610 NEDU; Noble JM, 2010, ARCH NEUROL-CHICAGO, V67, P87, DOI 10.1001/archneurol.2009.308; Otvos JD, 2015, CLIN CHEM, V61, P714, DOI 10.1373/clinchem.2014.232918; Palta P, 2015, J GERONTOL A-BIOL, V70, P873, DOI 10.1093/gerona/glu132; Parsey CM, 2013, CLIN NEUROPSYCHOL, V27, P1328, DOI 10.1080/13854046.2013.834971; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Quinn TJ, 2011, J THROMB HAEMOST, V9, P1475, DOI 10.1111/j.1538-7836.2011.04403.x; Rafnsson S, 2010, AGE AGEING, V39, P217, DOI 10.1093/ageing/afp227; Rafnsson SB, 2007, J AM GERIATR SOC, V55, P700, DOI 10.1111/j.1532-5415.2007.01158.x; Rom O, 2013, RESP PHYSIOL NEUROBI, V187, P5, DOI 10.1016/j.resp.2013.01.013; Rumley A, 2006, J THROMB HAEMOST, V4, P982, DOI 10.1111/j.1538-7836.2006.01889.x; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Sasson E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00032; Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x; Schweiger A., 2003, ACTA NEUROPSYCHOL, V1, P407, DOI [10.1016/S0028-3932(02)00173-2, 10.1186/1471-2318-3-4, DOI 10.1186/1471-2318-3-4]; Singh-Manoux A, 2014, NEUROLOGY, V83, P486, DOI 10.1212/WNL.0000000000000665; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; SLATER PE, 1982, ISRAEL J MED SCI, V18, P1106; Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Thaler A, 2012, NEUROLOGY, V79, P1027, DOI 10.1212/WNL.0b013e3182684646; Weuve J, 2006, EPIDEMIOLOGY, V17, P183, DOI 10.1097/01.ede.0000198183.60572.c9; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Windham BG, 2014, J AM GERIATR SOC, V62, P2303, DOI 10.1111/jgs.13165; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zur D, 2015, J NEURO-OPHTHALMOL, V35, P26, DOI 10.1097/WNO.0000000000000199	52	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138036	10.1371/journal.pone.0138036	http://dx.doi.org/10.1371/journal.pone.0138036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406330	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700029
J	Lee, S; Xu, S; Bivila, CP; Lee, H; Park, MS; Lim, YW; Yamamoto, N				Lee, Seungeun; Xu, Siyu; Bivila, Chemmeri Padasseri; Lee, Hyeyoung; Park, Myung Soo; Lim, Young Woon; Yamamoto, Naomichi			Triazole Susceptibilities in Thermotolerant Fungal Isolates from Outdoor Air in the Seoul Capital Area in South Korea	PLOS ONE			English	Article							RESISTANT ASPERGILLUS-FUMIGATUS; AZOLE RESISTANCE; ANTIFUNGAL AGENTS; AIRBORNE FUNGI; CYP51A; ITRACONAZOLE; VORICONAZOLE; ENVIRONMENT; MECHANISMS; MUTATIONS	Emerging fungi resistant to triazoles are a concern because of the increased use of medical triazoles and exposure to agricultural triazoles. However, little is known about the levels of triazole susceptibility in outdoor airborne fungi making it difficult to assess the risks of inhalation exposure to airborne, antifungal-resistant fungi. This study examined triazole susceptibilities of the airborne thermotolerant fungi isolated from the ambient air of the Seoul Capital Area of South Korea. We used impactor air sampling with triazole-containing nutrient agar plates as the collection substrates to screen for airborne fungal isolates based on their triazole susceptibilities. This study estimated that 0.17% of all the culturable fungi belong to the pathogenic thermotolerant taxa, among which each isolate of Aspergillus niger and Aspergillus tubingensis showed a minimum inhibitory concentration (MIC) of 2 mu g/mL or greater for itraconazole. Their concentration in air was 0.4 CFU/m(3). Seven human pathogenic Paecilomyces variotii isolates had MICs of 32 mu g/mL or greater and lower than 2 mu g/mL for the agricultural fungicide tebuconazole and the medical triazole itraconazole, respectively. Though the concentration was low, our results confirm the presence of airborne fungi with high MICs for itraconazole in ambient air. Inhalation is an important exposure route because people inhale more than 10 m(3) of air each day. Vigilance is preferred over monitoring for the emergence of triazole-resistant fungal pathogens in ambient outdoor air.	[Lee, Seungeun; Xu, Siyu; Bivila, Chemmeri Padasseri; Lee, Hyeyoung; Yamamoto, Naomichi] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth Sci, Seoul 151742, South Korea; [Park, Myung Soo; Lim, Young Woon] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Yamamoto, N (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth Sci, Seoul 151742, South Korea.	nyamamoto@snu.ac.kr	Yamamoto, Naomichi/D-4099-2014	Yamamoto, Naomichi/0000-0002-5969-5500	National Research Foundation of Korea - Ministry of Education, Science and Technology [2013R1A1A1004497]	National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.re.kr/) funded by the Ministry of Education, Science and Technology (2013R1A1A1004497) (N.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 1998, ANTIMICROB AGENTS CH, V42, P1601, DOI 10.1128/AAC.42.7.1601; Ahmad S, 2014, ENVIRON RES, V133, P20, DOI 10.1016/j.envres.2014.05.009; Alcazar-Fuoli L, 2009, ANTIMICROB AGENTS CH, V53, P4514, DOI 10.1128/AAC.00585-09; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Audenaert K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-112; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Bartlett KH, 2004, ANN OCCUP HYG, V48, P547, DOI 10.1093/annhyg/meh051; Brochu P, 2006, HUM ECOL RISK ASSESS, V12, P675, DOI 10.1080/10807030600801550; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Chowdhary A, 2014, J ANTIMICROB CHEMOTH, V69, P2979, DOI 10.1093/jac/dku259; Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871; CLSI, 2008, APPROVED STANDARD M3; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003; Domson, 1984, MOULD ALLERGY, P66; Espinel-Ingroff A, 2010, J CLIN MICROBIOL, V48, P3251, DOI 10.1128/JCM.00536-10; Espinel-Ingroff A, 2001, MYCOPATHOLOGIA, V150, P101, DOI 10.1023/A:1010954803886; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gheith S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-19; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gutierrez F, 2005, EUR J CLIN MICROBIOL, V24, P607, DOI 10.1007/s10096-005-0013-y; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Kahle M, 2008, ENVIRON SCI TECHNOL, V42, P7193, DOI 10.1021/es8009309; Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011; KWOK IMY, 1993, PESTIC SCI, V39, P1, DOI 10.1002/ps.2780390102; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; MACHER JM, 1989, AM IND HYG ASSOC J, V50, P561, DOI 10.1080/15298668991375164; MADELIN TM, 1992, J APPL BACTERIOL, V72, P400, DOI 10.1111/j.1365-2672.1992.tb01853.x; McGrath JJ, 1999, CURR MICROBIOL, V38, P33, DOI 10.1007/PL00006768; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001; MORRING KL, 1983, AM IND HYG ASSOC J, V44, P662, DOI 10.1080/15298668391405526; Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Pitman SK, 2011, EXPERT OPIN EMERG DR, V16, P559, DOI 10.1517/14728214.2011.607811; Reponen T, 1996, ATMOS ENVIRON, V30, P3967, DOI 10.1016/1352-2310(96)00128-8; Rial-Otero R, 2005, J AGR FOOD CHEM, V53, P4471, DOI 10.1021/jf047848h; Seo Young-Ho, 2013, Prev Nutr Food Sci, V18, P145, DOI 10.3746/pnf.2013.18.2.145; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Spiess B, 2012, ANTIMICROB AGENTS CH, V56, P3905, DOI 10.1128/AAC.05902-11; Spolti P, 2014, PLANT DIS, V98, P607, DOI 10.1094/PDIS-10-13-1051-RE; Steiner B, 2013, CASE REP INFECT DIS, V2013, DOI 10.1155/2013/273848; STREIFEL AJ, 1983, APPL ENVIRON MICROB, V46, P375, DOI 10.1128/AEM.46.2.375-378.1983; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320; VANDENBOSSCHE H, 1993, ANTIMICROB AGENTS CH, V37, P2101, DOI 10.1128/AAC.37.10.2101; Vermeulen E, 2013, CURR OPIN INFECT DIS, V26, P493, DOI 10.1097/QCO.0000000000000005; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; Wei XL, 2015, J MICROBIOL, V53, P91, DOI 10.1007/s12275-015-5014-7; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yamamoto N, 2011, INDOOR AIR, V21, P521, DOI 10.1111/j.1600-0668.2011.00732.x; Yamamoto N, 2015, ENVIRON SCI TECHNOL, V49, P5098, DOI 10.1021/es506165z; Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30; Yoshida T, 1997, ANTIMICROB AGENTS CH, V41, P1349, DOI 10.1128/AAC.41.6.1349	62	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138725	10.1371/journal.pone.0138725	http://dx.doi.org/10.1371/journal.pone.0138725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405807	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700077
J	Rockwood, N; Abdullahi, LH; Wilkinson, RJ; Meintjes, G				Rockwood, Neesha; Abdullahi, Leila H.; Wilkinson, Robert J.; Meintjes, Graeme			Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; FIXED-DOSE COMBINATION; TUBERCULOSIS TREATMENT OUTCOMES; HUMAN-IMMUNODEFICIENCY-VIRUS; INITIAL-DRUG RESISTANCE; NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; HIGH PREVALENCE; HIV	Background Studies looking at acquired drug resistance (ADR) are diverse with respect to geographical distribution, HIV co-infection rates, retreatment status and programmatic factors such as regimens administered and directly observed therapy. Our objective was to examine and consolidate evidence from clinical studies of the multifactorial aetiology of acquired rifamycin and/or isoniazid resistance within the scope of a single systematic review. This is important to inform policy and identify key areas for further studies. Methods Case-control and cohort studies and randomised controlled trials that reported ADR as an outcome during antitubercular treatment regimens including a rifamycin and examined the association of at least 1 risk factor were included. Post hoc, we carried out random effects Mantel-Haenszel weighted meta-analyses of the impact of 2 key risk factors 1) HIV and 2) baseline drug resistance on the binary outcome of ADR. Heterogeneity was assessed used I-2 statistic. As a secondary outcome, we calculated median cumulative incidence of ADR, weighted by the sample size of the studies. Results Meta-analysis of 15 studies showed increased risk of ADR with baseline mono-or polyresistance (RR 4.85 95% CI 3.26 to 7.23, heterogeneity I-2 58%, 95% CI 26 to 76%). Meta-analysis of 8 studies showed that HIV co-infection was associated with increased risk of ADR (RR 3.02, 95% CI 1.28 to 7.11); there was considerable heterogeneity amongst these studies (I-2 81%, 95% CI 64 to 90%). Non-adherence, extrapulmonary/disseminated disease and advanced immunosuppression in HIV co-infection were other risk factors noted. The weighted median cumulative incidence of acquired multi drug resistance calculated in 24 Conclusion Baseline drug resistance and HIV co-infection were significant risk factors for ADR. There was a trend of positive association with non-adherence which is likely to contribute to the outcome of ADR. The multifactorial aetiology of ADR in a programmatic setting should be further evaluated via appropriately designed studies.	[Rockwood, Neesha; Wilkinson, Robert J.; Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1PG, England; [Rockwood, Neesha; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Wilkinson, Robert J.] Francis Crick Inst, Mill Hill Lab, London, England; [Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Abdullahi, Leila H.] Univ Cape Town, Inst Infect Dis & Mol Med, Vaccines Africa Initiat, ZA-7925 Cape Town, South Africa	Imperial College London; University of Cape Town; Francis Crick Institute; University of Cape Town; University of Cape Town	Rockwood, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1PG, England.	neesha.rockwood@doctors.org.uk		Wilkinson, Robert/0000-0002-2753-1800; Meintjes, Graeme/0000-0003-1196-4414; Rockwood, Neesha/0000-0002-7830-1394	Wellcome Trust [WT 104803, WT084323, WT 098316]; UK MRC [UKMRC U1175.02.002.00014]; UK MRC [MRC-SHIP]; European Union [EU FP7 HEALTH-F3-2012-305578]; National Research Foundation (NRF) of South Africa [UID: 85858]; Wellcome Trust [104803/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10218] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC [MRC-SHIP](UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	Robert J. Wilkinson is supported by the Wellcome Trust www.wellcome.ac.uk [WT 104803; WT084323], UK MRC www.mrc.ac.uk [UKMRC U1175.02.002.00014 and MRC-SHIP] and the European Union Grants [EU FP7 HEALTH-F3-2012-305578; FP7-PEOPLE-2011-IRSES], UK MRC [UKMRC U1175.02.002.00014] and the European Union ec.europa.eu [EU FP7 HEALTH-F3-2012-305578; FP7-PEOPLE-2011-IRSES]. Graeme Meintjes was supported by a Wellcome Trust fellowship www.wellcome.ac.uk [WT 098316] and in part by the National Research Foundation (NRF) www.nrf.ac.za of South Africa [UID: 85858]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanna AS, 2013, EUR RESPIR J, V42, P721, DOI 10.1183/09031936.00180612; [Anonymous], TUBERCULOSIS MULTIDR; Aung KJM, 2012, INT J TUBERC LUNG D, V16, P455, DOI 10.5588/ijtld.11.0216; Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x; Bradford WZ, 1996, LANCET, V348, P928, DOI 10.1016/S0140-6736(96)03027-9; Burman W, 2006, AM J RESP CRIT CARE, V173, P350, DOI 10.1164/rccm.200503-417OC; Chideya S, 2009, CLIN INFECT DIS, V48, P1685, DOI 10.1086/599040; Chien JY, 2013, J ANTIMICROB CHEMOTH, V68, P1910, DOI 10.1093/jac/dkt103; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; DARBYSHIRE J, 1991, TUBERCLE, V72, P88; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Driver CR, 2001, CLIN INFECT DIS, V33, P1762, DOI 10.1086/323784; El Sahly HM, 2006, J INFECTION, V53, P5, DOI 10.1016/j.jinf.2005.10.002; Fenner L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003318; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; GIRLING DJ, 1991, AM REV RESPIR DIS, V143, P262; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P561, DOI 10.1164/rccm.200401-095OC; Kim YH, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-6; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Li JH, 2005, CLIN INFECT DIS, V41, P83, DOI 10.1086/430377; Lienhardt C, 2011, JAMA-J AM MED ASSOC, V305, P1415, DOI 10.1001/jama.2011.436; Matthys F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007954; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Menzies D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000146; Moulding TS, 2004, INT J TUBERC LUNG D, V8, P743; Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005; Munsiff SS, 1997, CLIN INFECT DIS, V25, P1465, DOI 10.1086/516146; Murray J, 2000, S AFR MED J, V90, P381; Nettles RE, 2004, CLIN INFECT DIS, V38, P731, DOI 10.1086/381675; Pasipanodya J, 2011, ANTIMICROB AGENTS CH, V55, P24, DOI 10.1128/AAC.00749-10; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Pasipanodya JG, 2012, CLIN INFECT DIS, V55, P169, DOI 10.1093/cid/cis353; Peloquin CA, 1999, INT J TUBERC LUNG D, V3, P1143; Porco TC, 2013, CLIN INFECT DIS, V56, P761, DOI 10.1093/cid/cis989; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Spellman CW, 1998, AIDS, V12, P191, DOI 10.1097/00002030-199802000-00009; Srivastava S, 2011, J INFECT DIS, V204, P1951, DOI 10.1093/infdis/jir658; Strauss OJ, 2008, J CLIN MICROBIOL, V46, P1514, DOI 10.1128/JCM.01938-07; Swaminathan S, 2010, AM J RESP CRIT CARE, V181, P743, DOI 10.1164/rccm.200903-0439OC; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Tuberculosis Research Centre ICoMR, INT J TUBERC LUNG DI, V1, P509; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; Weiner M, 2005, CLIN INFECT DIS, V40, P1481, DOI 10.1086/429321; WEIS SE, 1994, NEW ENGL J MED, V330, P1179, DOI 10.1056/NEJM199404283301702; Yoshiyama T, 2004, INT J TUBERC LUNG D, V8, P31; Yuen CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083006	55	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139017	10.1371/journal.pone.0139017	http://dx.doi.org/10.1371/journal.pone.0139017			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406228	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700148
J	Sherman, LS; Schrankel, CS; Brown, KJ; Smith, LC				Sherman, Lauren S.; Schrankel, Catherine S.; Brown, Kristy J.; Smith, L. Courtney			Extraordinary Diversity of Immune Response Proteins among Sea Urchins: Nickel-Isolated Sp185/333 Proteins Show Broad Variations in Size and Charge	PLOS ONE			English	Article							STRONGYLOCENTROTUS-PURPURATUS; SHOTGUN PROTEOMICS; GENE FAMILY; PEPTIDE IDENTIFICATION; COMPLEMENT HOMOLOG; CELOMIC FLUID; EXPRESSION; CELOMOCYTES; CELLS; LOCALIZATION	Effective protection against pathogens requires the host to produce a wide range of immune effector proteins. The Sp185/333 gene family, which is expressed by the California purple sea urchin Strongylocentrotus purpuratus in response to bacterial infection, encodes a highly diverse repertoire of anti-pathogen proteins. A subset of these proteins can be isolated by affinity to metal ions based on multiple histidines, resulting in one to four bands of unique molecular weight on standard Western blots, which vary depending on the individual sea urchin. Two dimensional gel electrophoresis (2DE) of nickel-isolated protein samples followed by Western blot was employed to detect nickel-isolated Sp185/333 (Ni-Sp185/333) proteins and to evaluate protein diversity in animals before and after immune challenge with marine bacteria. Ni-Sp185/333 proteins of the same molecular weight on standard Western blots appear as a broad complex of variants that differ in pI on 2DE Western blots. The Ni-Sp185/333 protein repertoire is variable among animals, and shows a variety of changes among individual sea urchins in response to immune challenges with both the same and different species of bacteria. The extraordinary diversity of the Ni-Sp185/333 proteins may provide significant anti-pathogen capabilities for sea urchins that survive solely on innate immunity.	[Sherman, Lauren S.; Schrankel, Catherine S.; Smith, L. Courtney] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Brown, Kristy J.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA	George Washington University; Children's National Health System	Smith, LC (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	csmith@gwu.edu		Sherman, Lauren/0000-0001-5534-5725	National Science Foundation [MCB-0744999, IOS-1146124]; National Institutes of Health [5R24HD050846-10, 2P30HD040677-14, UL1TR000075]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, P30HD040677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding: This work was supported by the National Science Foundation, www.nsf.gov (MCB-0744999, IOS-1146124 to LCS), and the National Institutes of Health, www.nih.gov (5R24HD050846-10, 2P30HD040677-14, UL1TR000075 to KJB).	Anholt RRH, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00006; Asahida T, 1996, FISHERIES SCI, V62, P727, DOI 10.2331/fishsci.62.727; Brockton V, 2008, J CELL SCI, V121, P339, DOI 10.1242/jcs.012096; Buckley KM, 2008, J MOL BIOL, V379, P912, DOI 10.1016/j.jmb.2008.04.037; Buckley KM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-68; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Buckley KM, 2008, J IMMUNOL, V181, P8585, DOI 10.4049/jimmunol.181.12.8585; Clow LA, 2004, J EXP BIOL, V207, P2147, DOI 10.1242/jeb.01001; Courtney Smith L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00070; D'Andrea-Winslow L, 2012, INTEGR ZOOL, V7, P61, DOI [10.1111/j.1749-4877.2012.00276.x, 10.1111/j.1749-4877.2011.00279.x]; Dheilly NM, 2013, DEV COMP IMMUNOL, V40, P35, DOI 10.1016/j.dci.2013.01.007; Dheilly NM, 2011, IMMUNOL CELL BIOL, V89, P861, DOI 10.1038/icb.2011.3; Dheilly NM, 2009, J IMMUNOL, V182, P2203, DOI 10.4049/jimmunol.07012766; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Ghosh J, 2010, DEV COMP IMMUNOL, V34, P235, DOI 10.1016/j.dci.2009.10.008; Gross PS, 2000, IMMUNOGENETICS, V51, P1034, DOI 10.1007/s002510000234; GUERINOT ML, 1982, INT J SYST BACTERIOL, V32, P350, DOI 10.1099/00207713-32-3-350; Hathout Y, 2002, J PROTEOME RES, V1, P435, DOI 10.1021/pr020006i; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hillier BJ, 2007, GENOMICS, V89, P721, DOI 10.1016/j.ygeno.2007.02.009; HUTCHINSON F, 1975, BRIT J DERMATOL, V93, P557, DOI 10.1111/j.1365-2133.1975.tb02249.x; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Lambert LA, 2012, BBA-GEN SUBJECTS, V1820, P244, DOI 10.1016/j.bbagen.2011.06.002; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Majeske AJ, 2014, J IMMUNOL, V193, P5678, DOI 10.4049/jimmunol.1401681; Majeske AJ, 2013, INNATE IMMUN-LONDON, V19, P569, DOI 10.1177/1753425912473850; Multerer KA, 2004, IMMUNOGENETICS, V56, P89, DOI 10.1007/s00251-004-0665-2; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; Oren M, EVOLUTION I IN PRESS; Pancer Z, 2000, P NATL ACAD SCI USA, V97, P13156, DOI 10.1073/pnas.230096397; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Rast JP, 2000, CURR TOP MICROBIOL, V248, P3; Reeves EKM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-26; SERVICE M, 1984, COMP BIOCHEM PHYS B, V79, P161, DOI 10.1016/0305-0491(84)90008-7; Smith LC, 2010, DIS MODEL MECH, V3, P274, DOI 10.1242/dmm.004697; SMITH LC, 1992, MOL BIOL CELL, V3, P403, DOI 10.1091/mbc.3.4.403; SMITH LC, 1995, DEV COMP IMMUNOL, V19, P217, DOI 10.1016/0145-305X(95)00009-I; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Terwilliger DP, 2006, PHYSIOL GENOMICS, V26, P134, DOI 10.1152/physiolgenomics.00011.2006	41	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138892	10.1371/journal.pone.0138892	http://dx.doi.org/10.1371/journal.pone.0138892			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406912	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700112
J	Siddique, J; Ruhnke, GW; Flores, A; Prochaska, MT; Paesch, E; Meltzer, DO; Whelan, CT				Siddique, Juned; Ruhnke, Gregory W.; Flores, Andrea; Prochaska, Micah T.; Paesch, Elizabeth; Meltzer, David O.; Whelan, Chad T.			Applying Classification Trees to Hospital Administrative Data to Identify Patients with Lower Gastrointestinal Bleeding	PLOS ONE			English	Article							EPIDEMIOLOGY; OUTCOMES	Background Lower gastrointestinal bleeding (LGIB) is a common cause of acute hospitalization. Currently, there is no accepted standard for identifying patients with LGIB in hospital administrative data. The objective of this study was to develop and validate a set of classification algorithms that use hospital administrative data to identify LGIB. Methods Our sample consists of patients admitted between July 1, 2001 and June 30, 2003 (derivation cohort) and July 1, 2003 and June 30, 2005 (validation cohort) to the general medicine inpatient service of the University of Chicago Hospital, a large urban academic medical center. Confirmed cases of LGIB in both cohorts were determined by reviewing the charts of those patients who had at least 1 of 36 principal or secondary International Classification of Diseases, Ninth revision, Clinical Modification (ICD-9-CM) diagnosis codes associated with LGIB. Classification trees were used on the data of the derivation cohort to develop a set of decision rules for identifying patients with LGIB. These rules were then applied to the validation cohort to assess their performance. Results Three classification algorithms were identified and validated: a high specificity rule with 80.1% sensitivity and 95.8% specificity, a rule that balances sensitivity and specificity (87.8% sensitivity, 90.9% specificity), and a high sensitivity rule with 100% sensitivity and 91.0% specificity. Conclusion These classification algorithms can be used in future studies to evaluate resource utilization and assess outcomes associated with LGIB without the use of chart review.	[Siddique, Juned] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Ruhnke, Gregory W.; Flores, Andrea; Prochaska, Micah T.; Paesch, Elizabeth; Meltzer, David O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Whelan, Chad T.] Loyola Univ, Stritch Sch Med, Dept Med, Maywood, IL 60153 USA	Northwestern University; Feinberg School of Medicine; University of Chicago; Loyola University Chicago	Siddique, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.	siddique@northwestern.edu			NIH [K07 CA154862, KM1 CA156717]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS023007] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA154862, KM1CA156717] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Siddique was supported by NIH grant K07 CA154862 (www.nih.gov). Ruhnke was supported by NIH grant KM1 CA156717 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 1984, CLASSIFICATION REGRE; Fisher DA, 2010, DIGEST DIS SCI, V55, P1721, DOI 10.1007/s10620-010-1200-y; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Hastie T., 2015, STAT LEARNING SPARSI; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; R Core Team, 2012, R LANG ENV STAT COMP; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Strate LL, 2005, GASTROENTEROL CLIN N, V34, P643, DOI 10.1016/j.gtc.2005.08.007; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Therneau T.M., 2012, R PACKAGE SURVIVAL V, P1; Whelan CT, 2010, J HOSP MED, V5, P141, DOI 10.1002/jhm.606; Yu O, 2011, EPIDEMIOL INFECT, V139, P1296, DOI 10.1017/S0950268810002529	17	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138987	10.1371/journal.pone.0138987	http://dx.doi.org/10.1371/journal.pone.0138987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406318	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700139
J	Soder, B; Meurman, JH; Soder, PO				Soder, Birgitta; Meurman, Jukka H.; Soder, Per-Osten			Gingival Inflammation Associates with Stroke - A Role for Oral Health Personnel in Prevention: A Database Study	PLOS ONE			English	Article							PERIODONTAL-DISEASE; CONTRIBUTE; SWEDEN	Objectives Gingival inflammation is the physiological response to poor oral hygiene. If gingivitis is not resolved the response will become an established lesion. We studied whether gingivitis associates with elevated risk for stroke. The hypothesis was based on the periodontitis-atherosclerosis paradigm. Methods In our prospective cohort study from Sweden 1676 randomly selected subjects were followed up from 1985 to 2012. All subjects underwent clinical oral examination and answered a questionnaire assessing background variables such as socio-economic status and pack-years of smoking. Cases with stroke were recorded from the Center of Epidemiology, Swedish National Board of Health and Welfare, Sweden, and classified according to the WHO International Classification of Diseases. Unpaired t-test, chi-square tests, and multiple logistic regression analyses were used. Results Of the 1676 participants, 39 subjects (2.3%) had been diagnosed with stroke. There were significant differences between the patients with stroke and subjects without in pack-years of smoking (p = 0.01), prevalence of gingival inflammation (GI) (p = 0.03), and dental calculus (p = 0.017). In a multiple regression analysis the association between GI, confounders and stroke, GI showed odds ratio 2.20 (95% confidence interval 1.02-4.74) for stroke. Conclusion Our present findings showed that gingival inflammation clearly associated with stroke in this 26-year cohort study. The results emphasize the role of oral health personnel in prevention.	[Soder, Birgitta; Soder, Per-Osten] Karolinska Inst, Dept Dent Med, S-14104 Huddinge, Sweden; [Meurman, Jukka H.] Univ Helsinki, Dept Oral & Maxillofacial Dis, FI-00014 Helsinki, Finland; [Meurman, Jukka H.] Helsinki Univ Hosp, FI-00014 Helsinki, Finland	Karolinska Institutet; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Soder, B (corresponding author), Karolinska Inst, Dept Dent Med, Box 4064, S-14104 Huddinge, Sweden.	birgitta.soder@ki.se		Meurman, Jukka/0000-0001-6702-6836	Swedish Ministry of Health and Social Affairs [F84/189]; Karolinska Institutet, Stockholm, Sweden; Philips Oral Healthcare, Inc. Snoqualmie USA; Finnish Medical Society, Helsinki, Finland [T1020Y003]; Helsinki University Central Hospital	Swedish Ministry of Health and Social Affairs; Karolinska Institutet, Stockholm, Sweden; Philips Oral Healthcare, Inc. Snoqualmie USA; Finnish Medical Society, Helsinki, Finland; Helsinki University Central Hospital	The study was supported by the Swedish Ministry of Health and Social Affairs (grants F84/189), by the Karolinska Institutet, Stockholm, Sweden, Philips Oral Healthcare, Inc. Snoqualmie USA and by the Finnish Medical Society (grant T1020Y003), Helsinki, Finland and by Helsinki University Central Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, LANCET, V383, P383, DOI 10.1016/S0140-6736(14)60134-3; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Danielsson M, 2012, SCAND J PUBLIC HEALT, V40, P197, DOI 10.1177/1403494812459607; Grau AJ, 2004, STROKE, V35, P496, DOI 10.1161/01.STR.0000110789.20526.9D; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Hallstrom B, 2008, STROKE, V39, P10, DOI 10.1161/STROKEAHA.107.491779; Joshipura K, 2002, J AM DENT ASSOC, V133, p23S, DOI 10.14219/jada.archive.2002.0373; Kinane DF, 2000, PERIODONTOL 2000, V23, P121, DOI 10.1034/j.1600-0757.2000.2230112.x; Lafon A, 2014, EUR J NEUROL, V21, P1155, DOI 10.1111/ene.12415; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Palm F, 2014, INNATE IMMUN-LONDON, V20, P511, DOI 10.1177/1753425913501214; Persson G, 2001, SCANDINAVIAN J PUBLI, V58, P41; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; Sacco RL, 2001, NEUROLOGY, V57, pS31, DOI 10.1212/WNL.57.suppl_2.S31; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Soder B, 2007, J PERIODONTAL RES, V42, P361, DOI 10.1111/j.1600-0765.2006.00957.x; SODER B, 1995, SWED DENT J, V19, P9; Soder PO, 2005, STROKE, V36, P1195, DOI 10.1161/01.STR.0000165916.90593.cb; SODER PO, 1994, COMMUNITY DENT ORAL, V22, P106, DOI 10.1111/j.1600-0528.1994.tb01582.x; Teles RP, 2007, J CLIN PERIODONTOL, V34, P7, DOI 10.1111/j.1600-051X.2006.01015.x; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Van Dyke TE, 2008, J PERIODONTOL, V79, P1601, DOI 10.1902/jop.2008.080173; Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789	27	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137142	10.1371/journal.pone.0137142	http://dx.doi.org/10.1371/journal.pone.0137142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405803	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700017
J	Vermeer, ABL; Sanfey, AG				Vermeer, Annabel B. Losecaat; Sanfey, Alan G.			The Effect of Positive and Negative Feedback on Risk-Taking across Different Contexts	PLOS ONE			English	Article							COGNITIVE FEEDBACK; PROSPECT-THEORY; NEURAL BASIS; REWARD; PERFORMANCE; ACTIVATION; MECHANISMS; DECISIONS; RESPONSES; FAILURE	Preferences for risky choices have often been shown to be unstable and context-dependent. Though people generally avoid gambles with mixed outcomes, a phenomenon often attributed to loss aversion, contextual factors can impact this dramatically. For example, people typically prefer risky options after a financial loss, while generally choosing safer options after a monetary gain. However, it is unclear what exactly contributes to these preference shifts as a function of prior outcomes, as these gain/loss outcomes are usually confounded with participant performance, and therefore it is unclear whether these effects are driven purely by the monetary gains or losses, or rather by success or failure at the actual task. Here, we experimentally separated the effects of monetary gains/losses from performance success/failure prior to a standard risky choice. Participants performed a task in which they experienced contextual effects: 1) monetary gain or loss based directly on performance, 2) monetary gain or loss that was randomly awarded and was, crucially, independent from performance, and 3) success or failure feedback based on performance, but without any monetary incentive. Immediately following these positive/negative contexts, participants were presented with a gain-loss gamble that they had to decide to either play or pass. We found that risk preferences for identical sets of gambles were biased by positive and negative contexts containing monetary gains and losses, but not by contexts containing performance feedback. This data suggests that the observed framing effects are driven by aversion for monetary losses and not simply by the positive or negative valence of the context, or by potential moods resulting from positive or negative contexts. These results highlight the specific context dependence of risk preferences.	[Vermeer, Annabel B. Losecaat; Sanfey, Alan G.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Vermeer, Annabel B. Losecaat; Sanfey, Alan G.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Vermeer, ABL (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	a.b.losecaatvermeer@gmail.com	Losecaat Vermeer, Annabel B/S-5461-2019; Sanfey, Alan G/D-2350-2010	Losecaat Vermeer, Annabel B/0000-0001-5631-0233; Sanfey, Alan/0000-0002-7421-8294	European Research Council [ERC 313454]	European Research Council(European Research Council (ERC)European Commission)	AGS was supported by the European Research Council (ERC 313454).	Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barkan R, 2003, J BEHAV DECIS MAKING, V16, P235, DOI 10.1002/bdm.444; Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barto A.G., 1997, ADV PSYCHOL, V121, P358; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boksem MAS, 2011, PSYCHOPHYSIOLOGY, V48, P973, DOI 10.1111/j.1469-8986.2010.01163.x; Bretz F, 2008, COMPSTAT 2008: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P423, DOI 10.1007/978-3-7908-2084-3_35; Brown KC, 1996, J FINANC, V51, P85, DOI 10.2307/2329303; Campbell-Meiklejohn DK, 2008, BIOL PSYCHIAT, V63, P293, DOI 10.1016/j.biopsych.2007.05.014; Daniel R, 2010, J NEUROSCI, V30, P47, DOI 10.1523/JNEUROSCI.2205-09.2010; Del Missier F, 2012, J BEHAV DECIS MAKING, V25, P331, DOI 10.1002/bdm.731; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Gonzalez C, 2005, J ECON PSYCHOL, V26, P1, DOI 10.1016/j.joep.2004.08.004; Hausch DB, 1995, MANAGE SCI, P1; Henkel JM, 2004, SOC BEHAV PERSONAL, V32, P715, DOI 10.2224/sbp.2004.32.8.715; Hytonen K, 2014, J ECON BEHAV ORGAN, V107, P566, DOI 10.1016/j.jebo.2014.01.016; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lenth R, 2014, PACKAGE LSMEANS; Levin IP, 2002, ORGAN BEHAV HUM DEC, V88, P411, DOI 10.1006/obhd.2001.2983; Lutz K, 2012, NEUROPSYCHOLOGIA, V50, P1739, DOI 10.1016/j.neuropsychologia.2012.03.030; Singmann H, 2014, ANAL FACTORIAL EXPT; Slovic P, 2002, HEURISTICS BIASES PS, P217, DOI DOI 10.1017/CBO9780511808098.014; Stanton SJ, 2014, JUDGM DECIS MAK, V9, P167; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Vermeer ABL, 2014, NEUROIMAGE, V103, P355, DOI 10.1016/j.neuroimage.2014.09.054; Weber M, 1998, J ECON BEHAV ORGAN, V33, P167, DOI 10.1016/S0167-2681(97)00089-9; Xue G, 2011, HUM BRAIN MAPP, V32, P271, DOI 10.1002/hbm.21015	36	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139010	10.1371/journal.pone.0139010	http://dx.doi.org/10.1371/journal.pone.0139010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26407298	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700146
J	Xiao, ZC; Guo, WT; Yuen, SMWK; Wang, RW; Zhang, L; Van Petegem, F; Chen, SRW				Xiao, Zhichao; Guo, Wenting; Yuen, Siobhan M. Wong King; Wang, Ruiwu; Zhang, Lin; Van Petegem, Filip; Chen, S. R. Wayne			The H29D Mutation Does Not Enhance Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor	PLOS ONE			English	Article							VENTRICULAR-TACHYCARDIA; CRYSTAL-STRUCTURES; RELEASE; REGION; SENSITIVITY; THRESHOLD; PROTEINS; DOMAINS; ROLES; FORMS	The N-terminal domain of the cardiac ryanodine receptor (RyR2) harbors a large number of naturally occurring mutations that are associated with stress-induced ventricular tachyarrhythmia and sudden death. Nearly all these disease-associated N-terminal mutations are located at domain interfaces or buried within domains. Mutations at these locations would alter domain-domain interactions or the stability/folding of domains. Recently, a novel RyR2 mutation H29D associated with ventricular arrhythmia at rest was found to enhance the activation of single RyR2 channels by diastolic levels of cytosolic Ca2+. Unlike other N-terminal disease-associated mutations, the H29D mutation is located on the surface of the N-terminal domain. It is unclear how this surface-exposed H29D mutation that does not appear to interact with other parts of the RyR2 structure could alter the intrinsic properties of the channel. Here we carried out detailed functional characterization of the RyR2-H29D mutant at the molecular and cellular levels. We found that the H29D mutation has no effect on the basal level or the Ca2+ dependent activation of [H-3]ryanodine binding to RyR2, the cytosolic Ca2+ activation of single RyR2 channels, or the cytosolic Ca2+- or caffeine-induced Ca2+ release in HEK293 cells. In addition, the H29D mutation does not alter the propensity for spontaneous Ca2+ release or the thresholds for Ca2+ release activation or termination. Furthermore, the H29D mutation does not have significant impact on the thermal stability of the N-terminal region (residues 1-547) of RyR2. Collectively, our data show that the H29D mutation exerts little or no effect on the function of RyR2 or on the folding stability of the N-terminal region. Thus, our results provide no evidence that the H29D mutation enhances the cytosolic Ca2+ activation of RyR2.	[Xiao, Zhichao; Guo, Wenting; Wang, Ruiwu; Zhang, Lin; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Xiao, Zhichao; Guo, Wenting; Wang, Ruiwu; Zhang, Lin; Chen, S. R. Wayne] Univ Calgary, Dept Biochem Mol Biol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Yuen, Siobhan M. Wong King; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of British Columbia	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537	Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; CIHR [125893]; Alberta Innovates [201500221] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was supported by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Alberta, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research to S.R.W.C., who is an Alberta Innovates-Health Solutions (AIHS) Scientist. FVP is supported by the CIHR (125893).	Amador FJ, 2013, J MOL BIOL, V425, P4034, DOI 10.1016/j.jmb.2013.08.015; Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Cheung JW, 2015, INT J CARDIOL, V180, P228, DOI 10.1016/j.ijcard.2014.11.119; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang DW, 2010, CHANNELS, V4, P302, DOI 10.4161/chan.4.4.12666; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kimlicka L, 2013, STRUCTURE, V21, P1440, DOI 10.1016/j.str.2013.06.012; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6397; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Liu YJ, 2013, BIOCHEM J, V454, P123, DOI 10.1042/BJ20130594; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Meli AC, 2011, CIRC RES, V109, P281, DOI 10.1161/CIRCRESAHA.111.244970; Mohamed U, 2007, J CARDIOVASC ELECTR, V18, P791, DOI 10.1111/j.1540-8167.2007.00766.x; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tian XX, 2013, J BIOL CHEM, V288, P4066, DOI 10.1074/jbc.M112.427864; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Van Petegem F, 2015, J MOL BIOL, V427, P31, DOI 10.1016/j.jmb.2014.08.004; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	37	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139058	10.1371/journal.pone.0139058	http://dx.doi.org/10.1371/journal.pone.0139058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405799	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700157
J	Villanueva, S; Burgos, J; Lopez-Cayuqueo, KI; Lai, KMV; Valenzuela, DM; Cid, LP; Sepulveda, FV				Villanueva, Sandra; Burgos, Johanna; Lopez-Cayuqueo, Karen I.; Lai, Ka-Man Venus; Valenzuela, David M.; Pablo Cid, L.; Sepulveda, Francisco V.			Cleft Palate, Moderate Lung Developmental Retardation and Early Postnatal Lethality in Mice Deficient in the Kir7.1 Inwardly Rectifying K+ Channel	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; LEBER CONGENITAL AMAUROSIS; PERMEATION PROPERTIES; POTASSIUM CHANNELS; KCNJ13; CELLS; PALATOGENESIS; LOCALIZATION; EXPRESSION; DISRUPTION	Kir7.1 is an inwardly rectifying K+ channel of the Kir superfamily encoded by the kcnj13 gene. Kir7.1 is present in epithelial tissues where it colocalizes with the Na+/K+-pump probably serving to recycle K+ taken up by the pump. Human mutations affecting Kir7.1 are associated with retinal degeneration diseases. We generated a mouse lacking Kir7.1 by ablation of the Kcnj13 gene. Homozygous mutant null mice die hours after birth and show cleft palate and moderate retardation in lung development. Kir7.1 is expressed in the epithelium covering the palatal processes at the time at which palate sealing takes place and our results suggest it might play an essential role in late palatogenesis. Our work also reveals a second unexpected role in the development and the physiology of the respiratory system, where Kir7.1 is expressed in epithelial cells all along the respiratory tree.	[Villanueva, Sandra; Burgos, Johanna; Lopez-Cayuqueo, Karen I.; Pablo Cid, L.; Sepulveda, Francisco V.] Ctr Estudios Cientif CECs, Valdivia, Chile; [Burgos, Johanna] Univ Austral Chile, Ciencias Vet, Valdivia, Chile; [Lai, Ka-Man Venus; Valenzuela, David M.] Regeneron Pharmaceut Inc, Tarrytown, NY USA	Universidad Austral de Chile; Regeneron	Sepulveda, FV (corresponding author), Ctr Estudios Cientif CECs, Valdivia, Chile.	fsepulveda@cecs.cl	Lopez-Cayuqueo, Karen/ABA-1967-2020	Lopez-Cayuqueo, Karen/0000-0001-8409-7345; Cid, Pablo/0000-0003-0394-0498; Sepulveda Valenzuela, Francisco Leandro/0000-0003-0022-6598; Villanueva, Sandra/0000-0002-2515-145X	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile (FONDECYT) [1120743]; Centres of Excellence Base Financing Programme of the Comision Nacional de Investigacion Cientifica y Tecnologica, Chile (Conicyt)	Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Centres of Excellence Base Financing Programme of the Comision Nacional de Investigacion Cientifica y Tecnologica, Chile (Conicyt)	This work was funded funded by the Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile (FONDECYT) grant 1120743. The Centro de Estudios Cientificos (CECs) is funded by the Centres of Excellence Base Financing Programme of the Comision Nacional de Investigacion Cientifica y Tecnologica, Chile (Conicyt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORN D, 1977, J ANAT, V123, P649; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Dahal GR, 2012, DEVELOPMENT, V139, P3653, DOI 10.1242/dev.078592; Derst C, 2001, KIDNEY INT, V59, P2197; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Doring F, 1998, J NEUROSCI, V18, P8625; Ghamari-Langroudi M, 2015, NATURE, V520, P94, DOI 10.1038/nature14051; Girault A, 2014, AM J PHYSIOL-CELL PH, V306, pC307, DOI 10.1152/ajpcell.00226.2013; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Huang X, 2014, J CELL BIOL, V206, P151, DOI 10.1083/jcb.201404136; Iseki S, 2011, DEV GROWTH DIFFER, V53, P259, DOI 10.1111/j.1440-169X.2010.01245.x; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Kusaka S, 2001, J PHYSIOL-LONDON, V531, P27, DOI 10.1111/j.1469-7793.2001.0027j.x; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Levi B, 2011, ORGANOGENESIS, V7, P242, DOI 10.4161/org.7.4.17926; McCloskey C, 2014, EMBO MOL MED, V6, P1161, DOI 10.15252/emmm.201403944; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nakamura N, 1999, BIOCHEM J, V342, P329, DOI 10.1042/0264-6021:3420329; Navis A, 2015, CURR OPIN GENET DEV, V32, P24, DOI 10.1016/j.gde.2015.01.010; Ookata K, 2000, J AM SOC NEPHROL, V11, P1987, DOI 10.1681/ASN.V11111987; Ozturk F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-113; Partiseti M, 1998, FEBS LETT, V434, P171, DOI 10.1016/S0014-5793(98)00972-7; Pattnaik BR, 2015, HUM MUTAT, V36, P720, DOI 10.1002/humu.22807; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Sepulveda FV, 2015, PHYSIOL REV, V95, P179, DOI 10.1152/physrev.00016.2014; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Shimura M, 2001, J PHYSIOL-LONDON, V531, P329, DOI 10.1111/j.1469-7793.2001.0329i.x; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Yang DL, 2003, INVEST OPHTH VIS SCI, V44, P3178, DOI 10.1167/iovs.02-1189; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	39	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139284	10.1371/journal.pone.0139284	http://dx.doi.org/10.1371/journal.pone.0139284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402555	Green Published, Green Submitted, gold			2022-12-27	WOS:000361798100064
J	Hu, XK; Wang, J; Li, YB; Wang, YZ; Ding, CH; Zeng, YH; Xu, YW; Zhou, CQ				Hu, Xiaokun; Wang, Jing; Li, Yubin; Wang, Yizi; Ding, Chenhui; Zeng, Yanhong; Xu, Yanwen; Zhou, Canquan			Clinical Considerations of Preimplantation Genetic Diagnosis for Monogenic Diseases	PLOS ONE			English	Article							CONTROLLED OVARIAN STIMULATION; IN-VITRO FERTILIZATION; PREGNANCY FOLLOW-UP; DATA-COLLECTION; MYOTONIC-DYSTROPHY; ALPHA-THALASSEMIA; EMBRYOS; CYCLES; PGD; BIOPSY	Purpose The aim of this study was to explore factors contribute to the success of PGD cycles for monogenic diseases. Methods During a 3-year period (January 2009 to December 2012), 184 consecutive ICSI-PGD cycles for monogenic diseases reaching the ovum pick-up and fresh embryo-transfer stage performed at the Reproductive Medicine Center of The First Affiliated Hospital Of Sun Yat-sen University were evaluated. Results ICSI was performed on 2206 metaphase II oocytes, and normal fertilization and cleavage rates were 83.4% (1840/2206) and 96.2%(1770/1840), respectively. In the present study, 60.5% (181/299) of day 3 good-quality embryos developed into good-quality embryos on day 4 after biopsy. Collectively, 42.9% clinical pregnancy rate (79/184) and 28.5% implantation rate (111/389) were presented. In the adjusted linear regression model, the only two significant factors affecting the number of genetically unaffected embryos were the number of biopsied embryos (coefficient: 0.390, 95% CI 0.317-0.463, P = 0.000) and basal FSH level (coefficient: 0.198, 95% CI 0.031-0.365, P = 0.021). In the adjusted binary logistic regression model, the only two significant factors affecting pregnancy outcome were the number of genetically available transferable embryos after PGD (adjusted OR 1.345, 95% CI 1.148-1.575, P = 0.000) and number of oocyte retrieved (adjusted OR 0.934, 95% CI 0.877-0.994, P = 0.031). Conclusion There should be at least four biopsied embryos to obtain at least one unaffected embryos in a PGD system for patients with single gene disorder and under the condition of basal FSH level smaller than 8.0mmol/L. Moreover, if only a low number (<4) of biopsied embryos are available on day 3, the chance of unaffected embryos for transfer was small, with poor outcome.	[Xu, Yanwen] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China; Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xu, YW (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China.	xuyanwen@live.cn; zhoucanquan@hotmail.com			Ministry of Health Public Welfare Scientific Research Special Fund [201402004]; Science and Technology Program of Guangzhou [201300000097]	Ministry of Health Public Welfare Scientific Research Special Fund; Science and Technology Program of Guangzhou	The study was supported by The Ministry of Health Public Welfare Scientific Research Special Fund (Grant No. 201402004, Recipient Yanwen Xu) and Science and Technology Program of Guangzhou (Grant No. 201300000097, Recipient Canquan Zhou).	Chang LJ, 2013, HUM REPROD, V28, P1435, DOI 10.1093/humrep/det048; Chen SH, 2005, FERTIL STERIL, V83, P1504, DOI 10.1016/j.fertnstert.2004.11.058; Dechanet C, 2011, HUM REPROD, V26, P1232, DOI 10.1093/humrep/der032; Feyereisen E, 2006, HUM REPROD, V21, P175, DOI 10.1093/humrep/dei310; Goossens V, 2008, HUM REPROD, V23, P2629, DOI 10.1093/humrep/den238; Goossens V, 2008, HUM REPROD, V23, P481, DOI 10.1093/humrep/dem327; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Harper JC, 2012, HUM REPROD UPDATE, V18, P234, DOI 10.1093/humupd/dmr052; Jie D, 2006, PRENATAL DIAG, V26, P1021, DOI 10.1002/pd.1549; KO TM, 1992, HUM GENET, V88, P245; Konstantinidis M, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1233; Liang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061838; Liu Y, 2009, FERTIL STERIL, V91, P1355, DOI 10.1016/j.fertnstert.2008.03.054; Lukaszuk K, 2015, FERTIL STERIL, V103, P1031, DOI 10.1016/j.fertnstert.2014.12.123; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Platteau P, 2002, HUM REPROD, V17, P2807, DOI 10.1093/humrep/17.11.2807; Ren Z, 2007, MOL HUM REPROD, V13, P431, DOI 10.1093/molehr/gam020; Renwick P, 2006, REPROD BIOMED ONLINE, V13, P110, DOI 10.1016/S1472-6483(10)62024-X; Sahu B, 2008, J ASSIST REPROD GEN, V25, P1, DOI 10.1007/s10815-007-9193-y; Sermon K, 2004, LANCET, V363, P1633, DOI 10.1016/S0140-6736(04)16209-0; Sermon KD, 2007, HUM REPROD, V22, P323, DOI 10.1093/humrep/del402; Shen Xiao-ting, 2013, Beijing Da Xue Xue Bao Yi Xue Ban, V45, P852; Shen XT, 2011, J ASSIST REPROD GEN, V28, P957, DOI 10.1007/s10815-011-9598-5; Sunkara SK, 2011, HUM REPROD, V26, P1768, DOI 10.1093/humrep/der106; Tao J, 2002, HUM REPROD, V17, P1513, DOI 10.1093/humrep/17.6.1513; Treff NR, 2013, FERTIL STERIL, V99, P1377, DOI 10.1016/j.fertnstert.2012.12.018; Tur-Kaspa I, 2007, FERTIL STERIL, V88, pS231, DOI 10.1016/j.fertnstert.2007.07.790; Tur-Kaspa I, 2012, SEMIN REPROD MED, V30, P309, DOI 10.1055/s-0032-1313910; Vandervorst M, 1998, HUM REPROD, V13, P3169, DOI 10.1093/humrep/13.11.3169; VERLINSKY Y, 1990, HUM REPROD, V5, P826, DOI 10.1093/oxfordjournals.humrep.a137192; Verpoest W, 2009, HUM REPROD, V24, P2951, DOI 10.1093/humrep/dep272; Xu YW, 2009, J ASSIST REPROD GEN, V26, P399, DOI 10.1007/s10815-009-9336-4	32	7	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139613	10.1371/journal.pone.0139613	http://dx.doi.org/10.1371/journal.pone.0139613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421428	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700134
J	Mhalu, G; Hella, J; Doulla, B; Mhimbira, F; Mtutu, H; Hiza, H; Sasamalo, M; Rutaihwa, L; Rieder, HL; Seimon, T; Mutayoba, B; Weiss, MG; Fenner, L				Mhalu, Grace; Hella, Jerry; Doulla, Basra; Mhimbira, Francis; Mtutu, Hawa; Hiza, Helen; Sasamalo, Mohamed; Rutaihwa, Liliana; Rieder, Hans L.; Seimon, Tamsyn; Mutayoba, Beatrice; Weiss, Mitchell G.; Fenner, Lukas			Do Instructional Videos on Sputum Submission Result in Increased Tuberculosis Case Detection? A Randomized Controlled Trial	PLOS ONE			English	Article							DIAGNOSIS; IMPACT	Objective We examined the effect of an instructional video about the production of diagnostic sputum on case detection of tuberculosis (TB), and evaluated the acceptance of the video. Trial Design Randomized controlled trial. Methods We prepared a culturally adapted instructional video for sputum submission. We analyzed 200 presumptive TB cases coughing for more than two weeks who attended the outpatient department of the governmental Municipal Hospital in Mwananyamala (Dar es Salaam, Tanzania). They were randomly assigned to either receive instructions on sputum submission using the video before submission (intervention group, n = 100) or standard of care (control group, n = 100). Sputum samples were examined for volume, quality and presence of acid-fast bacilli by experienced laboratory technicians blinded to study groups. Results Median age was 39.1 years (interquartile range 37.0-50.0); 94 (47%) were females, 106 (53%) were males, and 49 (24.5%) were HIV-infected. We found that the instructional video intervention was associated with detection of a higher proportion of microscopically confirmed cases (56%, 95% confidence interval [ 95% CI] 45.7-65.9%, sputum smear positive patients in the intervention group versus 23%, 95% CI 15.2-32.5%, in the control group, p <0.0001), an increase in volume of specimen defined as a volume >= 3ml (78%, 95% CI 68.6-85.7%, versus 45%, 95% CI 35.0-55.3%, p <0.0001), and specimens less likely to be salivary (14%, 95% CI 7.9-22.4%, versus 39%, 95% CI 29.4-49.3%, p = 0.0001). Older age, but not the HIV status or sex, modified the effectiveness of the intervention by improving it positively. When asked how well the video instructions were understood, the majority of patients in the intervention group reported to have understood the video instructions well (97%). Most of the patients thought the video would be useful in the cultural setting of Tanzania (92%). Conclusions Sputum submission instructional videos increased the yield of tuberculosis cases through better quality of sputum samples. If confirmed in larger studies, instructional videos may have a substantial effect on the case yield using sputum microscopy and also molecular tests. This low-cost strategy should be considered as part of the efforts to control TB in resource-limited settings.	[Mhalu, Grace; Hella, Jerry; Mhimbira, Francis; Hiza, Helen; Sasamalo, Mohamed; Rutaihwa, Liliana; Fenner, Lukas] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Mhalu, Grace; Hella, Jerry; Mhimbira, Francis; Hiza, Helen; Sasamalo, Mohamed; Rutaihwa, Liliana; Fenner, Lukas] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Mhalu, Grace; Hella, Jerry; Mhimbira, Francis; Sasamalo, Mohamed; Rutaihwa, Liliana; Weiss, Mitchell G.; Fenner, Lukas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Mhalu, Grace; Hella, Jerry; Mhimbira, Francis; Sasamalo, Mohamed; Rutaihwa, Liliana; Weiss, Mitchell G.; Fenner, Lukas] Univ Basel, Basel, Switzerland; [Doulla, Basra] Cent TB Reference Lab, Dar Es Salaam, Tanzania; [Doulla, Basra; Mutayoba, Beatrice] Natl TB & Leprosy Programme, Dar Es Salaam, Tanzania; [Mtutu, Hawa] Mwananyamala Reg Hosp, Dar Es Salaam, Tanzania; [Rieder, Hans L.] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Rieder, Hans L.] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Borstel, Germany; [Seimon, Tamsyn] Interact Res & Dev, Lausanne, Switzerland; [Seimon, Tamsyn] Interact Res & Dev, Lausanne, Pakistan; [Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	Ifakara Health Institute; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zurich; Forschungszentrum Borstel; University of Bern	Fenner, L (corresponding author), Ifakara Hlth Inst, Bagamoyo, Tanzania.	lukasfenner@unibas.ch	; Hella, Jerry/I-6738-2017	Rutaihwa, Liliana K/0000-0002-4092-2291; Fenner, Lukas/0000-0003-3309-4835; Hella, Jerry/0000-0003-2392-8592; Mhimbira, Francis/0000-0001-8989-6832	Center for Disease Control; Muhimbili University, of Dar es Salaam, Tanzania; National Tuberculosis and Leprosy Control Programme, Tanzania	Center for Disease Control; Muhimbili University, of Dar es Salaam, Tanzania; National Tuberculosis and Leprosy Control Programme, Tanzania	Research reported in this publication was supported by a Master grant from Center for Disease Control in collaboration with the Muhimbili University, of Dar es Salaam, Tanzania (Grace Mhalu). The adaption and production of the video was funded through the National Tuberculosis and Leprosy Control Programme, Tanzania. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnadottir T., 2009, INT UNION TUBERCULOS, P1; Bieri FA, 2012, AM J TROP MED HYG, V87, P972, DOI 10.4269/ajtmh.2012.12-0375; Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Dheda K, 2013, RESPIROLOGY, V18, P217, DOI 10.1111/resp.12022; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; Fenner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077697; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Li LM, 1999, INT J TUBERC LUNG D, V3, P1137; National Tuberculosis and Leprosy Control Program, 2013, MAN MAN TUB LEPR; National Tuberculosis and Leprosy Control Program T, 2013, 1 NAT TB PREV SURV; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Rieder H. L., 1999, Epidemiologic basis of tuberculosis control., P1; Rieder HL, 2002, INTERVENTIONS TUBERC, P1; Stop TB, 2013, HDB LAB DIAGN TUB SP; Weiss MG, 2006, EC BEHAV RES REPORT; WHO, 2011, WHO TECH REP SER, V959, P1; World Health Organization, 2013, WHOHTMTB2013, V11, P1; World Health Organization, 2012, WHOHTMTB20121, P1, DOI DOI 10.1016/S0140-6736(12)61766-8; World Health Organization Stop TB Partnership. The Stop TB Strategy, 2006, WHOHTM200637, V37, P1; Yoon SH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-172	22	15	18	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138413	10.1371/journal.pone.0138413	http://dx.doi.org/10.1371/journal.pone.0138413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418678	Green Published, gold, Green Accepted			2022-12-27	WOS:000362171400015
J	Qiu, BJ; Zhang, JH; Qi, YT; Liu, Y				Qiu, Bao-Jian; Zhang, Jiang-Hua; Qi, Yuan-Tao; Liu, Yang			Grey-Theory-Based Optimization Model of Emergency Logistics Considering Time Uncertainty	PLOS ONE			English	Article							ALGORITHM; SELECTION	Natural disasters occur frequently in recent years, causing huge casualties and property losses. Nowadays, people pay more and more attention to the emergency logistics problems. This paper studies the emergency logistics problem with multi-center, multi-commodity, and single-affected-point. Considering that the path near the disaster point may be damaged, the information of the state of the paths is not complete, and the travel time is uncertainty, we establish the nonlinear programming model that objective function is the maximization of time-satisfaction degree. To overcome these drawbacks: the incomplete information and uncertain time, this paper firstly evaluates the multiple roads of transportation network based on grey theory and selects the reliable and optimal path. Then simplify the original model under the scenario that the vehicle only follows the optimal path from the emergency logistics center to the affected point, and use Lingo software to solve it. The numerical experiments are presented to show the feasibility and effectiveness of the proposed method.	[Qiu, Bao-Jian] Shandong Univ, Sch Math Sci, Jinan 250100, Shandong, Peoples R China; [Zhang, Jiang-Hua; Qi, Yuan-Tao; Liu, Yang] Shandong Univ, Sch Management, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Zhang, JH (corresponding author), Shandong Univ, Sch Management, Jinan 250100, Shandong, Peoples R China.	zhangjianghua@sdu.edu.cn	Zhang, Jianghua/AAL-4343-2021	Zhang, Jianghua/0000-0002-6734-3492	National Natural Science Foundation of China (NSFC) [71201093, 71571111]; Independent Innovation Foundation of Shandong University, IIFSDU [IFYT14011]; Foundation of University of Jinan [XKY1414]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University, IIFSDU; Foundation of University of Jinan	This paper was partially supported by the National Natural Science Foundation of China (NSFC) (Grant Nos. 71201093, 71571111), Independent Innovation Foundation of Shandong University, IIFSDU (Grant No. IFYT14011), and the Foundation of University of Jinan (Grant No XKY1414).	[Anonymous], 1964, TRAFF ASS MAN; Barbarosoglu G, 2004, J OPER RES SOC, V55, P43, DOI 10.1057/palgrave.jors.2601652; Bozorgi-Amiri A, 2013, OR SPECTRUM, V35, P905, DOI 10.1007/s00291-011-0268-x; BRANSTON D, 1976, TRANSPORT RES, V10, P223, DOI 10.1016/0041-1647(76)90055-1; Chang FS, 2014, EXPERT SYST APPL, V41, P2947, DOI 10.1016/j.eswa.2013.10.026; Haghani A, 1996, TRANSPORT RES A-POL, V30, P231, DOI 10.1016/0965-8564(95)00020-8; Liu S., 2008, GREY INFORM THEORY P, VVolume 37, P189, DOI [10.1108/03684920810851078, DOI 10.1108/03684920810851078]; Najafi M, 2013, TRANSPORT RES E-LOG, V49, P217, DOI 10.1016/j.tre.2012.09.001; Nolz PC, 2011, OR SPECTRUM, V33, P543, DOI 10.1007/s00291-011-0258-z; Ozdamar L, 2004, ANN OPER RES, V129, P217, DOI 10.1023/B:ANOR.0000030690.27939.39; Pal R, 2009, EUR J OPER RES, V198, P452, DOI 10.1016/j.ejor.2008.09.010; Sheu JB, 2007, TRANSPORT RES E-LOG, V43, P687, DOI 10.1016/j.tre.2006.04.004; Sheu JB, 2010, TRANSPORT RES E-LOG, V46, P1, DOI 10.1016/j.tre.2009.07.005; SPIESS H, 1990, TRANSPORT SCI, V24, P153, DOI 10.1287/trsc.24.2.153; Tzeng GH, 2007, TRANSPORT RES E-LOG, V43, P673, DOI 10.1016/j.tre.2006.10.012; Vitoriano B, 2011, J GLOBAL OPTIM, V51, P189, DOI 10.1007/s10898-010-9603-z; Yan S, 2009, COMPUT OPER RES, V36, P2049, DOI 10.1016/j.cor.2008.07.002; Yuan Y, 2009, COMPUT IND ENG, V56, P1081, DOI 10.1016/j.cie.2008.09.033; Zhang JH, 2012, EXPERT SYST APPL, V39, P11066, DOI 10.1016/j.eswa.2012.03.016; Zhang XG, 2013, SAFETY SCI, V54, P87, DOI 10.1016/j.ssci.2012.12.003	20	8	8	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139132	10.1371/journal.pone.0139132	http://dx.doi.org/10.1371/journal.pone.0139132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417946	gold, Green Submitted, Green Published			2022-12-27	WOS:000362171400049
J	Srivastava, V; Verma, PK				Srivastava, Vikas; Verma, Praveen Kumar			Genome Wide Identification of LIM Genes in Cicer arietinum and Response of Ca-2LIMs in Development, Hormone and Pathogenic Stress	PLOS ONE			English	Article							ACTIN-BINDING-PROTEIN; ORGAN SIZE; TRANSCRIPTION FACTORS; EXPRESSION ANALYSIS; FAMILY; DOMAIN; CHICKPEA; SEQUENCE; DA1; SEED	The eukaryotic lineage-specific LIM protein (LIN11, ISL1, and MEC3) family play pivotal role in modulation of actin dynamics and transcriptional regulation. The systematic investigation of this family has not been carried in detail and rare in legumes. Current study involves the mining of Cicer arietinum genome for the genes coding for LIM domain proteins and displayed significant homology with LIM genes of other species. The analysis led to the identification of 15 members, which were positioned on chickpea chromosomes. The phylogenetic and motif analysis suggested their categorization into two sub-families i.e., Ca-2LIMs and Ca-DA1/DAR, which comprised of nine and six candidates, respectively. Further sub-categories of Ca-2LIMs were recognised as alpha LIM, beta LIM, dLIM and delta LIM. The LIM genes within their sub-families displayed conserved genomic and motif organization. The expression pattern of Ca-2LIMs across developmental and reproductive tissues demonstrated strong correlation with established consensus. The Ca-2LIM belongs to PLIM and GLIM (XLIM) was found highly expressed in floral tissue. Others showed ubiquitous expression pattern with their dominance in stem. Under hormonal and pathogenic conditions these LIMs were found to up-regulate during salicylic acid, abscisic acid and Ascochyta rabiei treatment or infection; and down-regulated in response to jasmonic acid treatment. The findings of this work, particularly in terms of modulation of LIM genes under biotic stress will open up the way to further explore and establish the role of chickpea LIMs in plant defense response.	[Srivastava, Vikas; Verma, Praveen Kumar] Natl Inst Plant Genome Res, Plant Immun Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Verma, PK (corresponding author), Natl Inst Plant Genome Res, Plant Immun Lab, Aruna Asaf Ali Marg, New Delhi, India.	pkv@nipgr.ac.in	Srivastava, Vikas/R-4437-2016	Srivastava, Vikas/0000-0003-4168-3197	Department of Biotechnology, Government of India [BT/PR12919/AGR/02/676/2009]; National Institute of Plant Genome Research (NIPGR), New Delhi; NIPGR	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute of Plant Genome Research (NIPGR), New Delhi; NIPGR	This work is supported by a research grant provided by Department of Biotechnology, Government of India, for Next Generation Challenge Program on Chickpea Genomics project (Sanction No. BT/PR12919/AGR/02/676/2009), and National Institute of Plant Genome Research (NIPGR), New Delhi. VS acknowledges NIPGR for short term research fellowship. Authors also acknowledge Central Instrument Facility, NIPGR, for Real-Time PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud D, 2007, DNA RES, V14, P103, DOI 10.1093/dnares/dsm013; Arnaud Dominique, 2012, BMC Res Notes, V5, P102, DOI 10.1186/1756-0500-5-102; BALTZ R, 1992, PLANT CELL, V4, P1465, DOI 10.1105/tpc.4.12.1465; Bi DL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00071; Broun P, 2004, CURR OPIN PLANT BIOL, V7, P202, DOI 10.1016/j.pbi.2004.01.013; Du L, 2014, PLANT CELL, V26, P665, DOI 10.1105/tpc.114.122663; Eliasson A, 2000, MOL GEN GENET, V264, P257, DOI 10.1007/s004380000312; Ganguly M, 2014, THEOR APPL GENET, V127, P2555, DOI 10.1007/s00122-014-2397-5; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; HA CV, 2014, PLOS ONE, V0009; Han LB, 2013, PLANT CELL, V25, P4421, DOI 10.1105/tpc.113.116970; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kawaoka A, 2006, SILVAE GENET, V55, P269, DOI 10.1515/sg-2006-0035; Kawaoka A, 2001, PHYTOCHEMISTRY, V57, P1149, DOI 10.1016/S0031-9422(01)00054-1; Kawaoka A, 2000, PLANT J, V22, P289, DOI 10.1046/j.1365-313x.2000.00737.x; Li L, 2015, PLANT BIOLOGY, V17, P528, DOI 10.1111/plb.12243; Li Y, 2013, PLANT PHYSIOL BIOCH, V66, P34, DOI 10.1016/j.plaphy.2013.01.018; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Matthews JM, 2013, NAT REV CANCER, V13, P111, DOI 10.1038/nrc3418; Moes D, 2013, MOL PLANT, V6, P483, DOI 10.1093/mp/sss075; Nizam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095989; Nizam S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04013; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; Park JI, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-641; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Peng YC, 2015, PLANT CELL, V27, P649, DOI 10.1105/tpc.114.132274; Peng YC, 2013, PLANT PHYSIOL, V161, P1542, DOI 10.1104/pp.112.210237; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Schmeichel KL, 1997, MOL BIOL CELL, V8, P219, DOI 10.1091/mbc.8.2.219; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Singh K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033128; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703691200; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Wang HJ, 2008, PLANT PHYSIOL, V147, P1619, DOI 10.1104/pp.108.118604; Xia T, 2013, PLANT CELL, V25, P3347, DOI 10.1105/tpc.113.115063; Yang HB, 2010, PLANT J, V63, P283, DOI 10.1111/j.1365-313X.2010.04241.x; Zhao M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0519-0; Zhao M, 2014, GENOME BIOL EVOL, V6, P1000, DOI 10.1093/gbe/evu076; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	47	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138719	10.1371/journal.pone.0138719	http://dx.doi.org/10.1371/journal.pone.0138719			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418014	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400021
J	Wang, KJ; Liu, DW; Hernandez-Sanchez, J; Chen, J; Liu, CK; Wu, ZF; Fang, MY; Li, N				Wang, Kejun; Liu, Dewu; Hernandez-Sanchez, Jules; Chen, Jie; Liu, Chengkun; Wu, Zhenfang; Fang, Meiying; Li, Ning			Genome Wide Association Analysis Reveals New Production Trait Genes in a Male Duroc Population	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PROMOTER REGION; MEAT QUALITY; LOCI; GROWTH; PIGS; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; RELEVANCE	In this study, 796 male Duroc pigs were used to identify genomic regions controlling growth traits. Three production traits were studied: food conversion ratio, days to 100 KG, and average daily gain, using a panel of 39,436 single nucleotide polymorphisms. In total, we detected 11 genome-wide and 162 chromosome-wide single nucleotide polymorphism trait associations. The Gene ontology analysis identified 14 candidate genes close to significant single nucleotide polymorphisms, with growth-related functions: six for days to 100 KG (WT1, FBXO3, DOCK7, PPP3CA, AGPAT9, and NKX6-1), seven for food conversion ratio (MAP2, TBX15, IVL, ARL15, CPS1, VWC2L, and VAV3), and one for average daily gain (COL27A1). Gene ontology analysis indicated that most of the candidate genes are involved in muscle, fat, bone or nervous system development, nutrient absorption, and metabolism, which are all either directly or indirectly related to growth traits in pigs. Additionally, we found four haplotype blocks composed of suggestive single nucleotide polymorphisms located in the growth trait-related quantitative trait loci and further narrowed down the ranges, the largest of which decreased by similar to 60 Mb. Hence, our results could be used to improve pig production traits by increasing the frequency of favorable alleles via artificial selection.	[Wang, Kejun; Chen, Jie; Liu, Chengkun; Fang, Meiying] China Agr Univ, Coll Anim Sci & Technol, MOA Lab Anim Genet & Breeding, Dept Anim Genet & Breeding,Natl Engn Lab Anim Bre, Beijing 100193, Peoples R China; [Liu, Dewu; Wu, Zhenfang] South China Agr Univ, Coll Anim Sci, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou 510642, Guangdong, Peoples R China; [Hernandez-Sanchez, Jules] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Res Methods Grp, Kelvin Grove, Qld 4059, Australia; [Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University; South China Agricultural University; Queensland University of Technology (QUT); China Agricultural University	Fang, MY (corresponding author), China Agr Univ, Coll Anim Sci & Technol, MOA Lab Anim Genet & Breeding, Dept Anim Genet & Breeding,Natl Engn Lab Anim Bre, Beijing 100193, Peoples R China.	meiying@cau.edu.cn		Chengkun, Liu/0000-0002-1730-0136; Wu, Zhenfang/0000-0002-5586-6771	National High Technology and Science Development Plan of China [2011AA100302]; Natural Science Foundation of China (NSFC) [31072002, 31372275]; State Major Basic Research Development Program of China [2014CB138504]; Program for New Century Excellent Talents in University [NCET-11-0480]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National High Technology and Science Development Plan of China(National High Technology Research and Development Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Major Basic Research Development Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Changjiang Scholar and Innovation Research Team in University	This work was supported by the National High Technology and Science Development Plan of China (2011AA100302), Natural Science Foundation of China (NSFC, Grant 31072002, 31372275), State Major Basic Research Development Program of China 973 Project (2014CB138504), Program for New Century Excellent Talents in University (NCET-11-0480), and Program for Changjiang Scholar and Innovation Research Team in University (IRT1191).	Ai HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056001, 10.1371/journal.pone.0069836, 10.1371/journal.pone.0063641]; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bai Y, 2015, ANIM GENET, V46, P16, DOI 10.1111/age.12257; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055951; Dai XJ, 2008, J DERMATOL SCI, V50, P53, DOI 10.1016/j.jdermsci.2007.10.011; Doerge RW, 1996, GENETICS, V142, P285; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Fehm HL, 2004, MED KLIN, V99, P674, DOI 10.1007/s00063-004-1099-1; Finckh U, 1998, HUM MUTAT, V12, P206, DOI 10.1002/(SICI)1098-1004(1998)12:3<206::AID-HUMU8>3.3.CO;2-K; Fontanesi L, 2014, J ANIM SCI, V92, P1385, DOI 10.2527/jas.2013-7059; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; GEORGES M, 1995, GENETICS, V139, P907; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Grosse-Brinkhaus Christine, 2014, BMC Proc, V8, pS2, DOI 10.1186/1753-6561-8-S5-S2; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung J, 2008, INT J OBESITY, V32, P772, DOI 10.1038/sj.ijo.0803793; Jung EJ, 2014, ANIM GENET, V45, P442, DOI 10.1111/age.12117; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Liu G, 2007, ANIM GENET, V38, P241, DOI 10.1111/j.1365-2052.2007.01592.x; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nissen PM, 2004, J ANIM SCI, V82, P414; Ohyama Y, 2012, BIOCHEM BIOPH RES CO, V418, P12, DOI 10.1016/j.bbrc.2011.12.075; Onteru SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061756; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Sahana G, 2013, J ANIM SCI, V91, P1041, DOI 10.2527/jas.2012-5643; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Stringer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027964; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tu PA, 2012, ANIM BIOTECHNOL, V23, P291, DOI 10.1080/10495398.2012.709205; Wang JY, 2013, ANIM GENET, V44, P34, DOI 10.1111/j.1365-2052.2012.02366.x; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579	49	42	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139207	10.1371/journal.pone.0139207	http://dx.doi.org/10.1371/journal.pone.0139207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418247	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400062
J	Yao, LL; Shi, JY; Miao, XL				Yao, Lili; Shi, Jianye; Miao, Xiaoling			Mixed Wastewater Coupled with CO2 for Microalgae Culturing and Nutrient Removal	PLOS ONE			English	Article							LIPID PRODUCTION; MORPHOLOGICAL-CHANGES; AMMONIA INHIBITION; OIL ACCUMULATION; STRAIN; BIOMASS; ARTHROSPIRA; CULTIVATION; EFFICIENCY; OCULATA	Biomass, nutrient removal capacity, lipid productivity and morphological changes of Chlorella sorokiniana and Desmodesmus communis were investigated in mixed wastewaters with different CO2 concentrations. Under optimal condition, which was 1: 3 ratio of swine wastewater to second treated municipal wastewater with 5% CO2, the maximum biomass concentrations were 1.22 g L-1 and 0.84 g L-1 for C. sorokiniana and D. communis, respectively. Almost all of the ammonia and phosphorus were removed, the removal rates of total nitrogen were 88.05% for C. sorokiniana and 83.18% for D. communis. Lipid content reached 17.04% for C. sorokiniana and 20.37% for D. communis after 10 days culture. CO2 aeration increased intracellular particle numbers of both microalgae and made D. communis tend to be solitary. The research suggested the aeration of CO2 improve the tolerance of microalgae to high concentration of NH4-N, and nutrient excess stress could induce lipid accumulation of microalgae.	[Yao, Lili; Shi, Jianye; Miao, Xiaoling] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Yao, Lili; Shi, Jianye; Miao, Xiaoling] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Yao, Lili; Shi, Jianye; Miao, Xiaoling] Shanghai Jiao Tong Univ, Biomass Energy Res Ctr, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Miao, XL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	miaoxiaoling@sjtu.edu.cn			National High Technology Research and Development Program (863 Program) of China [2013AA065805]; NSFC [41476122, J1210047]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National High Technology Research and Development Program (863 Program) of China (No. 2013AA065805). It was also supported by NSFC (No. 41476122 and No. J1210047).	APHA, 2012, 3120 APHA, V22nd; AZOV Y, 1982, APPL ENVIRON MICROB, V43, P735, DOI 10.1128/AEM.43.4.735-739.1982; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cai T, 2013, RENEW SUST ENERG REV, V19, P360, DOI 10.1016/j.rser.2012.11.030; Chiu SY, 2009, BIORESOURCE TECHNOL, V100, P833, DOI 10.1016/j.biortech.2008.06.061; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Dai GZ, 2014, PLANT CELL ENVIRON, V37, P840, DOI 10.1111/pce.12202; Devi MP, 2012, RENEW ENERG, V43, P276, DOI 10.1016/j.renene.2011.11.021; Drath M, 2008, PLANT PHYSIOL, V147, P206, DOI 10.1104/pp.108.117218; Gentili FG, 2014, BIORESOURCE TECHNOL, V169, P27, DOI 10.1016/j.biortech.2014.06.061; Gonzalez LE, 1997, BIORESOURCE TECHNOL, V60, P259, DOI 10.1016/S0960-8524(97)00029-1; HESSEN DO, 1993, ARCH HYDROBIOL, V127, P129; Hu B, 2012, BIORESOURCE TECHNOL, V126, P71, DOI 10.1016/j.biortech.2012.09.031; Ji F, 2014, BIORESOURCE TECHNOL, V161, P200, DOI 10.1016/j.biortech.2014.03.034; Kerr RA, 2011, SCIENCE, V331, P1510, DOI 10.1126/science.331.6024.1510; Kumar K, 2011, BIORESOURCE TECHNOL, V102, P4945, DOI 10.1016/j.biortech.2011.01.054; Markou G, 2014, BIORESOURCE TECHNOL, V166, P259, DOI 10.1016/j.biortech.2014.05.040; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Molinuevo-Salces B, 2010, BIORESOURCE TECHNOL, V101, P5144, DOI 10.1016/j.biortech.2010.02.006; Olguin EJ, 2003, J APPL PHYCOL, V15, P249, DOI 10.1023/A:1023856702544; Pan YY, 2011, BIORESOURCE TECHNOL, V102, P10510, DOI 10.1016/j.biortech.2011.08.091; Pancha I, 2014, BIORESOURCE TECHNOL, V156, P146, DOI 10.1016/j.biortech.2014.01.025; Park JBK, 2011, BIORESOURCE TECHNOL, V102, P35, DOI 10.1016/j.biortech.2010.06.158; Peccia J, 2013, TRENDS BIOTECHNOL, V31, P134, DOI 10.1016/j.tibtech.2013.01.010; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Ruangsomboon S, 2012, BIORESOURCE TECHNOL, V109, P261, DOI 10.1016/j.biortech.2011.07.025; Sahu AK, 2013, J ENVIRON MANAGE, V122, P113, DOI 10.1016/j.jenvman.2013.02.038; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Singh NK, 2011, AGRON SUSTAIN DEV, V31, P605, DOI 10.1007/s13593-011-0018-0; Sydney EB, 2010, BIORESOURCE TECHNOL, V101, P5892, DOI 10.1016/j.biortech.2010.02.088; Tang DH, 2011, BIORESOURCE TECHNOL, V102, P3071, DOI 10.1016/j.biortech.2010.10.047; TILLBERG JE, 1989, PHYSIOL PLANTARUM, V75, P315, DOI 10.1111/j.1399-3054.1989.tb04633.x; Wang LA, 2010, APPL BIOCHEM BIOTECH, V162, P1174, DOI 10.1007/s12010-009-8866-7; Wu PF, 2013, BIORESOURCE TECHNOL, V133, P102, DOI 10.1016/j.biortech.2013.01.109	35	46	48	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139117	10.1371/journal.pone.0139117	http://dx.doi.org/10.1371/journal.pone.0139117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418261	gold, Green Submitted, Green Published			2022-12-27	WOS:000362171400044
J	Yi, GQ; Yuan, JW; Bi, HJ; Yan, W; Yang, N; Qu, LJ				Yi, Guoqiang; Yuan, Jingwei; Bi, Huijuan; Yan, Wei; Yang, Ning; Qu, Lujiang			In-Depth Duodenal Transcriptome Survey in Chickens with Divergent Feed Efficiency Using RNA-Seq	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; RENIN-ANGIOTENSIN SYSTEM; GASTROINTESTINAL-TRACT; PRODUCTION TRAITS; OXIDATIVE STRESS; WEIGHT-GAIN; PROTEIN; REVEALS; MUSCLE; FAT	Since the feed cost is a major determinant of profitability in poultry industry, how to improve feed efficiency through genetic selection is an intriguing subject for breeders and producers. As a more suitable indicator assessing feed efficiency, residual feed intake (RFI) is defined as the difference between observed and expected feed intake based on maintenance and growth. However, the genetic mechanisms responsible for RFI in chickens are still less well appreciated. In this study, we investigated the duodenal transcriptome architecture of extreme RFI phenotypes in the six brown-egg dwarf hens (three per group) using RNA sequencing technology. Among all mapped reads, an average of 75.62% fell into annotated exons, 5.50% were located in introns, and the remaining 18.88% were assigned to inter-genic regions. In total, we identified 41 promising candidate genes by differential expression analysis between the low and high RFI groups. Furthermore, qRT-PCR assays were designed for 10 randomly chosen genes, and nine (90.00%) were successfully validated. Functional annotation analyses revealed that these significant genes belong to several specific biological functions related to digestibility, metabolism and biosynthesis processes as well as energy homeostasis. We also predicted 253 intergenic coding transcripts, and these transcripts were mainly involved in fundamental biological regulation and metabolism processes. Our findings provided a pioneering exploration of biological basis underlying divergent RFI using RNA-Seq, which pinpoints promising candidate genes of functional relevance, is helpful to guide future breeding strategies to optimize feed efficiency and assists in improving the current gene annotation in chickens.	[Qu, Lujiang] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Qu, LJ (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	quluj@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	National High Technology Research and Development Program of China [2013AA102501]; National Natural Science Foundation of China [31320103905]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1191]; China Agriculture Research Systems [CARS-41]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Agriculture Research Systems	This work was funded in part by grants of the National High Technology Research and Development Program of China (2013AA102501), National Natural Science Foundation of China (31320103905), Program for Changjiang Scholars and Innovative Research Team in University (IRT1191), and China Agriculture Research Systems (CARS-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggrey SE, 2013, POULTRY SCI, V92, P2600, DOI 10.3382/ps.2013-03302; Aggrey SE, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-25; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boustany CM, 2004, AM J PHYSIOL-REG I, V287, pR943, DOI 10.1152/ajpregu.00265.2004; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; Burden CJ, 2014, PEERJ, V2, DOI 10.7717/peerj.576; Cassis LA, 1998, AM J PHYSIOL-ENDOC M, V274, pE867, DOI 10.1152/ajpendo.1998.274.5.E867; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Coble DJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1084; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; De Koning DJ, 2004, GENET RES, V83, P211, DOI 10.1017/S0016672304006846; de Koning DJ, 2003, J ANIM SCI, V81, P1158; de Verdal H, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-71; de Verdal H, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-59; Dogan A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-386; Do DN, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-27; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Grzincic EM, 2015, NANOSCALE, V7, P1349, DOI 10.1039/c4nr05166a; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Hamill RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-453; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoque MA, 2009, J ANIM SCI, V87, P3069, DOI 10.2527/jas.2008-1268; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Hussong M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.157; Iqbal M, 2004, POULTRY SCI, V83, P474, DOI 10.1093/ps/83.3.474; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071763; Karisa B, 2014, ANIM SCI J, V85, P374, DOI 10.1111/asj.12159; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LUITING P, 1991, BRIT POULTRY SCI, V32, P763, DOI 10.1080/00071669108417402; LUITING P, 1991, LIVEST PROD SCI, V27, P321, DOI 10.1016/0301-6226(91)90127-C; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nafikov RA, 2007, J NUTR, V137, P702, DOI 10.1093/jn/137.3.702; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Odawara J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-516; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Park KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-473; Parsanejad R, 2004, POULTRY SCI, V83, P1518, DOI 10.1093/ps/83.9.1518; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Rekaya R, 2013, POULTRY SCI, V92, P923, DOI 10.3382/ps.2012-02649; Saintilan R, 2013, J ANIM SCI, V91, P2542, DOI 10.2527/jas.2012-5687; Savary K, 2005, BLOOD, V105, P103, DOI 10.1182/blood-2004-04-1570; Schurch NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094270; Seyednasrollah F, 2013, BRIEF BIOINFORM; Sultan M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-675; Thomas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094650; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Eerden E, 2004, POULTRY SCI, V83, P1602, DOI 10.1093/ps/83.9.1602; Wang XG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112896; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weisinger RS, 1997, PEPTIDES, V18, P977, DOI 10.1016/S0196-9781(97)00077-6; Willems OW, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-26; Wolc A, 2013, POULTRY SCI, V92, P2270, DOI 10.3382/ps.2013-03085; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yi GQ, 2014, POULTRY SCI, V93, P2963, DOI 10.3382/ps.2014-04178; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang W, 2003, WORLD POULTRY SCI J, V59, P328, DOI 10.1079/WPS20030020	71	27	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0136765	10.1371/journal.pone.0136765	http://dx.doi.org/10.1371/journal.pone.0136765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418546	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400004
J	Hohenauer, E; Taeymans, J; Baeyens, JP; Clarys, P; Clijsen, R				Hohenauer, Erich; Taeymans, Jan; Baeyens, Jean-Pierre; Clarys, Peter; Clijsen, Ron			The Effect of Post-Exercise Cryotherapy on Recovery Characteristics: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							COLD-WATER IMMERSION; WHOLE-BODY CRYOTHERAPY; PHYSICAL PERFORMANCE; MUSCLE SORENESS; EXERCISE; SYMPTOMS; INJURY; INDEXES; BOUT; INTERVENTIONS	The aim of this review and meta-analysis was to critically determine the possible effects of different cooling applications, compared to non-cooling, passive post-exercise strategies, on recovery characteristics after various, exhaustive exercise protocols up to 96 hours (hrs). A total of n = 36 articles were processed in this study. To establish the research question, the PICO-model, according to the PRISMA guidelines was used. The Cochrane's risk of bias tool, which was used for the quality assessment, demonstrated a high risk of performance bias and detection bias. Meta-analyses of subjective characteristics, such as delayed-onset muscle soreness (DOMS) and ratings of perceived exertion (RPE) and objective characteristics like blood plasma markers and blood plasma cytokines, were performed. Pooled data from 27 articles revealed, that cooling and especially cold water immersions affected the symptoms of DOMS significantly, compared to the control conditions after 24 hrs recovery, with a standardized mean difference (Hedges' g) of -0.75 with a 95% confidence interval (CI) of -1.20 to -0.30. This effect remained significant after 48 hrs (Hedges' g: -0.73, 95% CI: -1.20 to -0.26) and 96 hrs (Hedges' g: -0.71, 95% CI: -1.10 to -0.33). A significant difference in lowering the symptoms of RPE could only be observed after 24 hrs of recovery, favouring cooling compared to the control conditions (Hedges' g: -0.95, 95% CI: -1.89 to -0.00). There was no evidence, that cooling affects any objective recovery variable in a significant way during a 96 hrs recovery period.	[Hohenauer, Erich; Clijsen, Ron] Univ Appl Sci & Arts Southern Switzerland, Dept Business Econ Hlth & Social Care, Landquart Manno, Switzerland; [Taeymans, Jan] Bern Univ Appl Sci, Dept Hlth, Bern, Switzerland; [Taeymans, Jan; Baeyens, Jean-Pierre; Clarys, Peter; Clijsen, Ron] Vrije Univ Brussel, Fac Phys Educ & Physiotherapy, Brussels, Belgium; [Hohenauer, Erich; Baeyens, Jean-Pierre; Clijsen, Ron] Univ Coll Physiotherapy Thim van der Laan, Landquart, GR, Switzerland; [Taeymans, Jan] Univ Antwerp, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [Baeyens, Jean-Pierre] Univ Antwerp, Fac Appl Engn, B-2020 Antwerp, Belgium	Vrije Universiteit Brussel; University of Antwerp; University of Antwerp	Hohenauer, E (corresponding author), Univ Appl Sci & Arts Southern Switzerland, Dept Business Econ Hlth & Social Care, Landquart Manno, Switzerland.	erich.hohenauer@supsi.ch		Taeymans, Jan/0000-0003-1583-4043; Baeyens, Jean-Pierre/0000-0003-2630-1912				Ascensao A, 2011, J SPORT SCI, V29, P217, DOI 10.1080/02640414.2010.526132; Bacon NT, 2012, J STRENGTH COND RES, V26, P1348, DOI 10.1519/JSC.0b013e318231a610; Bailey DM, 2007, J SPORT SCI, V25, P1163, DOI 10.1080/02640410600982659; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Barnett A, 2006, SPORTS MED, V36, P781, DOI 10.2165/00007256-200636090-00005; Bastos FN, 2012, INT J SPORTS MED, V33, P873, DOI 10.1055/s-0032-1301905; Bleakley CM, 2012, BRIT J SPORT MED, V46, P296, DOI 10.1136/bjsm.2011.086116; Bleakley C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008262.pub2; Borenstein M., 2009, INTRO META ANAL; Broatch JR, 2014, MED SCI SPORT EXER, V46, P2139, DOI 10.1249/MSS.0000000000000348; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Costello JT, 2012, SCAND J MED SCI SPOR, V22, P190, DOI 10.1111/j.1600-0838.2011.01292.x; Crowe MJ, 2007, INT J SPORTS MED, V28, P994, DOI 10.1055/s-2007-965118; Crystal NJ, 2013, EUR J APPL PHYSIOL, V113, P2577, DOI 10.1007/s00421-013-2693-9; De Pauw K, 2014, INT J SPORT PHYSIOL, V9, P240, DOI [10.1123/IJSPP.2012-0366, 10.1123/ijspp.2012-0366]; Delextrat A, 2013, J SPORT SCI, V31, P11, DOI 10.1080/02640414.2012.719241; Elias GP, 2012, INT J SPORT PHYSIOL, V7, P357, DOI 10.1123/ijspp.7.4.357; Eston R, 1999, J SPORT SCI, V17, P231, DOI 10.1080/026404199366136; Goodall S, 2008, J SPORT SCI MED, V7, P235; Grahn DA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3156812; Gregson W, 2011, AM J SPORT MED, V39, P1316, DOI 10.1177/0363546510395497; Guilhem G, 2013, AM J SPORT MED, V41, P1942, DOI 10.1177/0363546513490648; Hausswirth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027749; Herrera E, 2010, PHYS THER, V90, P581, DOI 10.2522/ptj.20090131; Heyman E, 2009, MED SCI SPORT EXER, V41, P1303, DOI 10.1249/MSS.0b013e318195107d; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howatson G, 2009, EUR J APPL PHYSIOL, V105, P615, DOI 10.1007/s00421-008-0941-1; Ingram J, 2009, J SCI MED SPORT, V12, P417, DOI 10.1016/j.jsams.2007.12.011; Jakeman JR, 2009, ERGONOMICS, V52, P456, DOI 10.1080/00140130802707733; King M, 2009, J STRENGTH COND RES, V23, P1795, DOI 10.1519/JSC.0b013e3181b3f81f; Koch AJ, 2014, J MUSCULOSKEL NEURON, V14, P68; Kuligowski LA, 1998, J ATHL TRAINING, V33, P222; Leal EC, 2011, LASER MED SCI, V26, P493, DOI 10.1007/s10103-010-0866-x; Leeder J, 2012, BRIT J SPORT MED, V46, P233, DOI 10.1136/bjsports-2011-090061; Marin DP, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/804873; MEEUSEN R, 1986, SPORTS MED, V3, P398, DOI 10.2165/00007256-198603060-00002; Minett GM, 2012, J SPORT SCI, V30, P907, DOI 10.1080/02640414.2012.679677; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Montgomery PG, 2008, J SPORT SCI, V26, P1135, DOI 10.1080/02640410802104912; Myrer JW, 2001, J ATHL TRAINING, V36, P32; Paddon-Jones DJ, 1997, INT J SPORTS MED, V18, P588, DOI 10.1055/s-2007-972686; Pointon M, 2012, EUR J APPL PHYSIOL, V112, P2483, DOI 10.1007/s00421-011-2218-3; Pointon M, 2012, MED SCI SPORT EXER, V44, P206, DOI 10.1249/MSS.0b013e31822b0977; Pointon M, 2011, EUR J APPL PHYSIOL, V111, P2977, DOI 10.1007/s00421-011-1924-1; Pournot H, 2011, EUR J APPL PHYSIOL, V111, P1287, DOI 10.1007/s00421-010-1754-6; Rowsell GJ, 2009, J SPORT SCI, V27, P565, DOI 10.1080/02640410802603855; Rupp KA, 2012, J STRENGTH COND RES, V26, P2043, DOI 10.1519/JSC.0b013e318239c3a1; Schaser KD, 2007, AM J SPORT MED, V35, P93, DOI 10.1177/0363546506294569; Sellwood KL, 2007, BRIT J SPORT MED, V41, P392, DOI 10.1136/bjsm.2006.033985; Stanley J, 2013, EUR J APPL PHYSIOL, V113, P371, DOI 10.1007/s00421-012-2445-2; Takagi R, 2011, J APPL PHYSIOL, V110, P382, DOI 10.1152/japplphysiol.01187.2010; Tiidus PM, 2015, CURR REV MUSCULOSKE, V8, P162, DOI 10.1007/s12178-015-9261-3; Tseng CY, 2013, J STRENGTH COND RES, V27, P1354, DOI 10.1519/JSC.0b013e318267a22c; Tucker TJ, 2012, J SPORT MED PHYS FIT, V52, P158; Vaile J, 2008, EUR J APPL PHYSIOL, V102, P447, DOI 10.1007/s00421-007-0605-6; White GE, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-26; Yanagisawa O, 2003, MED SCI SPORT EXER, V35, P1517, DOI 10.1249/01.MSS.0000084418.96898.2E; Yanagisawa O, 2003, EUR J APPL PHYSIOL, V89, P53, DOI 10.1007/s00421-002-0749-3	59	94	95	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139028	10.1371/journal.pone.0139028	http://dx.doi.org/10.1371/journal.pone.0139028			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413718	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700033
J	Maesako, M; Uemura, M; Tashiro, Y; Sasaki, K; Watanabe, K; Noda, Y; Ueda, K; Asada-Utsugi, M; Kubota, M; Okawa, K; Ihara, M; Shimohama, S; Uemura, K; Kinoshita, A				Maesako, Masato; Uemura, Maiko; Tashiro, Yoshitaka; Sasaki, Kazuki; Watanabe, Kiwamu; Noda, Yasuha; Ueda, Karin; Asada-Utsugi, Megumi; Kubota, Masakazu; Okawa, Katsuya; Ihara, Masafumi; Shimohama, Shun; Uemura, Kengo; Kinoshita, Ayae			High Fat Diet Enhances beta-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting beta-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SECRETASE PROTEIN; MEMORY DEFICITS; TRANSGENIC MICE; CELL-SURFACE; DEMENTIA; RISK; ENDOCYTOSIS; GENERATION; MUTATION	Obesity and type 2 diabetes are risk factors of Alzheimer's disease (AD). We reported that a high fat diet (HFD) promotes amyloid precursor protein (APP) cleavage by beta-site APP cleaving enzyme 1 (BACE1) without increasing BACE1 levels in APP transgenic mice. However, the detailed mechanism had remained unclear. Here we demonstrate that HFD promotes BACE1/Adaptor protein-2 (AP-2)/clathrin complex formation by increasing AP-2 levels in APP transgenic mice. In Swedish APP overexpressing Chinese hamster ovary (CHO) cells as well as in SH-SY5Y cells, overexpression of AP-2 promoted the formation of BACE1/AP2/ clathrin complex, increasing the level of the soluble form of APP beta (sAPP beta). On the other hand, mutant D495R BACE1, which inhibits formation of this trimeric complex, was shown to decrease the level of sAPP beta. Overexpression of AP-2 promoted the internalization of BACE1 from the cell surface, thus reducing the cell surface BACE1 level. As such, we concluded that HFD may induce the formation of the BACE1/AP-2/clathrin complex, which is followed by its transport of BACE1 from the cell surface to the intracellular compartments. These events might be associated with the enhancement of beta-site cleavage of APP in APP transgenic mice. Here we present evidence that HFD, by regulation of subcellular trafficking of BACE1, promotes APP cleavage.	[Maesako, Masato; Sasaki, Kazuki; Noda, Yasuha; Ueda, Karin; Asada-Utsugi, Megumi; Kubota, Masakazu; Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan; [Uemura, Maiko; Watanabe, Kiwamu; Uemura, Kengo] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Tashiro, Yoshitaka] Kyoto Univ, Grad Sch Med, SK Project Med Innovat Ctr, Kyoto, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co Ltd, Shizuoka, Japan; [Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Osaka, Japan; [Shimohama, Shun] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido, Japan; [Uemura, Kengo] Ishiki Hosp, Kagoshima, Japan	Kyoto University; Kyoto University; Kyoto University; Kyowa Kirin Ltd; National Cerebral & Cardiovascular Center - Japan; Sapporo Medical University	Kinoshita, A (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Alzheimers Dis Re, Charlestown, MA 02129 USA.	kinoshita.ayae.6v@kyoto-u.ac.jp	Ihara, Masafumi/O-5020-2019; Uemura, Maiko/L-7293-2016	Ihara, Masafumi/0000-0002-7102-4048; Uemura, Maiko/0000-0001-8356-1409	Ministry of Education, Culture, Sports, Science and Technology, Japan [24111524, 23591243, 13J00221]; Japan Society for the Promotion of Science [820130600001]; Kyowa Hakko Kirin Co., Ltd	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyowa Hakko Kirin Co., Ltd(Kyowa Kirin Ltd)	AK, K. Uemura and MM are funded with Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (AK: 24111524, K. Uemura: 23591243, MM: 13J00221, URL: http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm). MM is funded with Japan Society for the Promotion of Science research fellowship (820130600001, URL: http://www.jsps.go.jp/). Kyowa Hakko Kirin Co., Ltd provided support in the form of salary for author KO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charlwood J, 2001, J BIOL CHEM, V276, P16739, DOI 10.1074/jbc.M009361200; Chia PZC, 2013, TRAFFIC, V14, P997, DOI 10.1111/tra.12088; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; KOO EH, 1994, J BIOL CHEM, V269, P17386; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Maesako M, 2011, NEUROSCIENCE, V177, P298, DOI 10.1016/j.neuroscience.2010.12.017; Maesako M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072796; Maesako M, 2012, J BIOL CHEM, V287, P23024, DOI 10.1074/jbc.M112.367011; Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sun XL, 2006, FASEB J, V20, P1361, DOI 10.1096/fj.05-5628com; Tan JG, 2012, J NEUROCHEM, V120, P869, DOI 10.1111/j.1471-4159.2011.07623.x; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Uemura K, 2007, J BIOL CHEM, V282, P15823, DOI 10.1074/jbc.M610708200; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Wang RS, 2013, CELL METAB, V17, P685, DOI 10.1016/j.cmet.2013.03.016; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Zhang T, 2009, NEUROSCIENCE, V161, P1045, DOI 10.1016/j.neuroscience.2009.04.032; Zhu L., 2012, ADV DIFFERENTIAL EQU, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0045033	47	35	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0131199	10.1371/journal.pone.0131199	http://dx.doi.org/10.1371/journal.pone.0131199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414661	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700001
J	Mancini, G; Zazza, C				Mancini, Giordano; Zazza, Costantino			F429 Regulation of Tunnels in Cytochrome P450 2B4: A Top Down Study of Multiple Molecular Dynamics Simulations	PLOS ONE			English	Article							COMPOUND-I; MECHANISTIC IMPLICATIONS; CATALYTIC CYCLE; OXIDATION; QM/MM; SPIN; HYDROXYLATION; EQUILIBRIUM; METABOLISM; REACTIVITY	The root causes of the outcomes of the single-site mutation in enzymes remain by and large not well understood. This is the case of the F429H mutant of the cytochrome P450 (CYP) 2B4 enzyme where the substitution, on the proximal surface of the active site, of a conserved phenylalanine 429 residue with histidine seems to hamper the formation of the active species, Compound I (porphyrin cation radical-Fe-(IV) = O, Cpd I) from the ferric hydroperoxo (Fe-(III) OOH-, Cpd 0) precursor. Here we report a study based on extensive molecular dynamic (MD) simulations of 4 CYP-2B4 point mutations compared to the WT enzyme, having the goal of better clarifying the importance of the proximal Phe429 residue on CYP 2B4 catalytic properties. To consolidate the huge amount of data coming from five simulations and extract the most distinct structural features of the five species studied we made an extensive use of cluster analysis. The results show that all studied single polymorphisms of F429, with different side chain properties: i) drastically alter the reservoir of conformations accessible by the protein, perturbing global dynamics ii) expose the thiolate group of residue Cys436 to the solvent, altering the electronic properties of Cpd0 and iii) affect the various ingress and egress channels connecting the distal sites with the bulk environment, altering the reversibility of these channels. In particular, it was observed that the wild type enzyme exhibits unique structural features as compared to all mutant species in terms of weak interactions (hydrogen bonds) that generate a completely different dynamical behavior of the complete system. Albeit not conclusive, the current computational investigation sheds some light on the subtle and critical effects that proximal single-site mutations can exert on the functional mechanisms of human microsomal CYPs which should go rather far beyond local structure characterization.	[Mancini, Giordano] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Mancini, Giordano] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Zazza, Costantino] Univ Roma La Sapienza, I-00185 Rome, Italy	Scuola Normale Superiore di Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome	Mancini, G (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56126 Pisa, Italy.	giordano.mancini@sns.it		ZAZZA, Costantino/0000-0002-9050-1874	Futuro in Ricerca (FIRB) [RBFR12ETL5]	Futuro in Ricerca (FIRB)	This work was funded by Futuro in Ricerca (FIRB) project no RBFR12ETL5 (http://firb.miur.it/). Computational resources were granted by access to the Avogadro Computational Cluster at Scuola Normale Superiore.	Altarsha M, 2010, J BIOL INORG CHEM, V15, P361, DOI 10.1007/s00775-009-0608-3; Altarsha M, 2009, J AM CHEM SOC, V131, P4755, DOI 10.1021/ja808744k; Bathelt CM, 2005, J AM CHEM SOC, V127, P12900, DOI 10.1021/ja0520924; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bertz RJ, 1997, CLIN PHARMACOKINET, V32, P210, DOI 10.2165/00003088-199732030-00004; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cohen S, 2006, J AM CHEM SOC, V128, P11028, DOI 10.1021/ja063269c; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Daidone I, 2012, WIRES COMPUT MOL SCI, V2, P762, DOI 10.1002/wcms.1099; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Davydov R, 2008, BIOCHEMISTRY-US, V47, P9661, DOI 10.1021/bi800926x; DAWSON JH, 1987, CHEM REV, V87, P1255, DOI 10.1021/cr00081a015; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Fishelovitch D, 2010, J PHYS CHEM B, V114, P5964, DOI 10.1021/jp101894k; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001; GUNSALUS IC, 1975, ANNU REV BIOCHEM, V44, P377, DOI 10.1146/annurev.bi.44.070175.002113; HARRIS D, 1993, J AM CHEM SOC, V115, P8775, DOI 10.1021/ja00072a034; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isobe H, 2011, J PHYS CHEM B, V115, P10730, DOI 10.1021/jp206004y; Kumar D, 2005, J PHYS CHEM B, V109, P19946, DOI 10.1021/JP054754h; Kumar D, 2012, J PHYS CHEM B, V116, P718, DOI 10.1021/jp2113522; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Lian P, 2013, J PHYS CHEM B, V117, P7849, DOI 10.1021/jp312107r; LOIDA PJ, 1993, BIOCHEMISTRY-US, V32, P11530, DOI 10.1021/bi00094a009; Lonsdale R, 2011, J AM CHEM SOC, V133, P15464, DOI 10.1021/ja203157u; Lonsdale R, 2010, J PHYS CHEM B, V114, P1156, DOI 10.1021/jp910127j; Mancini G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010934; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Oprea TI, 1997, P NATL ACAD SCI USA, V94, P2133, DOI 10.1073/pnas.94.6.2133; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RAAG R, 1989, BIOCHEMISTRY-US, V28, P917, DOI 10.1021/bi00428a077; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z; Shahrokh K, 2012, BBA-GEN SUBJECTS, V1820, P1605, DOI 10.1016/j.bbagen.2012.05.011; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; Shaik S, 2011, J CHEM THEORY COMPUT, V7, P327, DOI 10.1021/ct100554g; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Sheng X, 2009, J AM CHEM SOC, V131, P2971, DOI 10.1021/ja808982g; Shimada T, 2013, CHEM RES TOXICOL, V26, P517, DOI 10.1021/tx300492j; SLIGAR SG, 1979, BIOCHEMISTRY-US, V18, P2290, DOI 10.1021/bi00578a024; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Tatoli S, 2009, BIOPHYS CHEM, V141, P87, DOI 10.1016/j.bpc.2008.12.015; Usharani D, 2012, J AM CHEM SOC, V134, P4053, DOI 10.1021/ja211905e; van Eldik R, 2012, INORGANIC BIOINORGAN; Wrighton SA, 2000, DRUG METAB REV, V32, P339, DOI 10.1081/DMR-100102338; Yang YT, 2014, BIOCHEMISTRY-US, V53, P5080, DOI 10.1021/bi5003794; Zheng JJ, 2006, J AM CHEM SOC, V128, P13204, DOI 10.1021/ja063439l	64	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137075	10.1371/journal.pone.0137075	http://dx.doi.org/10.1371/journal.pone.0137075			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26415031	Green Submitted, gold, Green Published			2022-12-27	WOS:000362170700006
J	Villalobos, JA; Yi, BR; Wallace, IS				Villalobos, Jose A.; Yi, Bo R.; Wallace, Ian S.			2-Fluoro-L-Fucose Is a Metabolically Incorporated Inhibitor of Plant Cell Wall Polysaccharide Fucosylation	PLOS ONE			English	Article							3-DEOXY-D-MANNO-2-OCTULOSONIC ACID KDO; DE-NOVO SYNTHESIS; GDP-L-FUCOSE; RHAMNOGALACTURONAN-II; ARABIDOPSIS-THALIANA; PECTIC POLYSACCHARIDE; MUR1 GENE; XYLOGLUCAN; GLYCANS; BIOSYNTHESIS	The monosaccharide L-fucose (L-Fuc) is a common component of plant cell wall polysaccharides and other plant glycans, including the hemicellulose xyloglucan, pectic rhamnogalacturonan-I (RG-I) and rhamnogalacturonan-II (RG-II), arabinogalactan proteins, and N-linked glycans. Mutations compromising the biosynthesis of many plant cell wall polysaccharides are lethal, and as a result, small molecule inhibitors of plant cell wall polysaccharide biosynthesis have been developed because these molecules can be applied at defined concentrations and developmental stages. In this study, we characterize novel small molecule inhibitors of plant fucosylation. 2-fluoro-L-fucose (2F-Fuc) analogs caused severe growth phenotypes when applied to Arabidopsis seedlings, including reduced root growth and altered root morphology. These phenotypic defects were dependent upon the L-Fuc salvage pathway enzyme L-Fucose Kinase/GDP-L-Fucose Pyrophosphorylase (FKGP), suggesting that 2F-Fuc is metabolically converted to the sugar nucleotide GDP-2F-Fuc, which serves as the active inhibitory molecule. The L-Fuc content of cell wall matrix polysaccharides was reduced in plants treated with 2F-Fuc, suggesting that this molecule inhibits the incorporation of L-Fuc into these polysaccharides. Additionally, phenotypic defects induced by 2F-Fuc treatment could be partially relieved by the exogenous application of boric acid, suggesting that 2F-Fuc inhibits RG-II biosynthesis. Overall, the results presented here suggest that 2F-Fuc is a metabolically incorporated inhibitor of plant cellular fucosylation events, and potentially suggest that other 2-fluorinated monosaccharides could serve as useful chemical probes for the inhibition of cell wall polysaccharide biosynthesis.	[Villalobos, Jose A.; Yi, Bo R.; Wallace, Ian S.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Wallace, IS (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA.	iwallace@unr.edu			National Science Foundation Integrative Organismal Systems grant [1449068]; Direct For Biological Sciences [1449068] Funding Source: National Science Foundation	National Science Foundation Integrative Organismal Systems grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by National Science Foundation Integrative Organismal Systems grant number 1449068 (www.nsf.gov/ios). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson CT, 2012, P NATL ACAD SCI USA, V109, P1329, DOI 10.1073/pnas.1120429109; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Baskin JM, 2010, P NATL ACAD SCI USA, V107, P10360, DOI 10.1073/pnas.0912081107; BAUER WD, 1973, PLANT PHYSIOL, V51, P174, DOI 10.1104/pp.51.1.174; Bonin CP, 2000, PLANT J, V21, P445, DOI 10.1046/j.1365-313x.2000.00698.x; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Chormova D, 2015, PHYTOCHEMISTRY, V117, P220, DOI 10.1016/j.phytochem.2015.06.016; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; Dehnert KW, 2011, ACS CHEM BIOL, V6, P547, DOI 10.1021/cb100284d; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; Dumont M, 2014, ANN BOT-LONDON, V114, P1177, DOI 10.1093/aob/mcu093; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Egelund J, 2006, PLANT CELL, V18, P2593, DOI 10.1105/tpc.105.036566; Faik A, 2000, J BIOL CHEM, V275, P15082, DOI 10.1074/jbc.M000677200; Glushka JN, 2003, CARBOHYD RES, V338, P341, DOI 10.1016/S0008-6215(02)00461-5; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; HEIM DR, 1990, PLANT PHYSIOL, V93, P695, DOI 10.1104/pp.93.2.695; Ishii T, 1999, J BIOL CHEM, V274, P13098, DOI 10.1074/jbc.274.19.13098; KEEGSTRA K, 1973, PLANT PHYSIOL, V51, P188, DOI 10.1104/pp.51.1.188; Kobayashi M, 2011, PLANT CELL PHYSIOL, V52, P1832, DOI 10.1093/pcp/pcr120; Kotake T, 2008, J BIOL CHEM, V283, P8125, DOI 10.1074/jbc.M710078200; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Lerouxel O, 2002, PLANT PHYSIOL, V130, P1754, DOI 10.1104/pp.011965; Liang Y, 2013, J EXP BOT, V64, P5537, DOI 10.1093/jxb/ert321; Lodowska J, 2013, CAN J MICROBIOL, V59, P645, DOI 10.1139/cjm-2013-0490; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Nakamura A, 2001, BIOSCI BIOTECH BIOCH, V65, P2249, DOI 10.1271/bbb.65.2249; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pellerin P, 1996, CARBOHYD RES, V290, P183, DOI 10.1016/0008-6215(96)00139-5; Perrin RM, 2003, PLANT PHYSIOL, V132, P768, DOI 10.1104/pp.102.016642; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Reuhs BL, 2004, PLANTA, V219, P147, DOI 10.1007/s00425-004-1205-x; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rodriguez-Carvajal MA, 2003, CARBOHYD RES, V338, P651, DOI 10.1016/S0008-6215(03)00003-X; Sarria R, 2001, PLANT PHYSIOL, V127, P1595, DOI 10.1104/pp.010596; Sawa M, 2006, P NATL ACAD SCI USA, V103, P12371, DOI 10.1073/pnas.0605418103; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; Seveno M, 2010, GLYCOBIOLOGY, V20, P617, DOI 10.1093/glycob/cwq011; Seveno M, 2009, PLANTA, V230, P947, DOI 10.1007/s00425-009-0996-1; Smyth KM, 2013, CARBOHYD RES, V380, P70, DOI 10.1016/j.carres.2013.07.006; Smyth KM, 2013, MOL PLANT, V6, P981, DOI 10.1093/mp/sst011; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Voxeur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051129; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095245	55	15	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139091	10.1371/journal.pone.0139091	http://dx.doi.org/10.1371/journal.pone.0139091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414071	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700042
J	Aseervatham, J; Tran, L; Machaca, K; Boudker, O				Aseervatham, Jaya; Tran, Lucky; Machaca, Khaled; Boudker, Olga			The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; INTRINSIC DISORDER; HENT1 EXPRESSION; CELLULAR UPTAKE; IDENTIFICATION; CLONING; FAMILY; ENT1; GEMCITABINE; ADENOSINE	Equilibrative nucleoside transporters (ENTs) are integral membrane proteins, which reside in plasma membranes of all eukaryotic cells and mediate thermodynamically downhill transport of nucleosides. This process is essential for nucleoside recycling, and also plays a key role in terminating adenosine-mediated cellular signaling. Furthermore, ENTs mediate the uptake of many drugs, including anticancer and antiviral nucleoside analogues. The structure and mechanism, by which ENTs catalyze trans-membrane transport of their substrates, remain unknown. To identify the core of the transporter needed for stability, activity, and for its correct trafficking to the plasma membrane, we have expressed human ENT deletion mutants in Xenopus laevis oocytes and determined their localization, transport properties and susceptibility to inhibition. We found that the carboxyl terminal trans-membrane segments are essential for correct protein folding and trafficking. In contrast, the soluble extracellular and intracellular loops appear to be dispensable, and must be involved in the fine-tuning of transport regulation.	[Tran, Lucky; Boudker, Olga] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Aseervatham, Jaya; Machaca, Khaled] Qatar Fdn, Weill Cornell Med Coll, Dept Physiol & Biophys, Doha, Qatar	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Boudker, O (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.	olb2003@med.cornell.edu	Aseervatham, Jaya/AFV-7295-2022; Machaca, Khaled/AAF-3579-2019	Aseervatham, Jaya/0000-0002-0160-0951; 	Qatar National Research Fund; National Priorities Research Program [08-233-1-045]	Qatar National Research Fund(Qatar National Research Fund (QNRF)); National Priorities Research Program	Support was provided by Qatar National Research Fund, National Priorities Research Program Grant #08-233-1-045 [http://www.qnrf.org/en-us/] to JA, LT, OB, and KM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acimovic Y, 2002, MOL BIOL EVOL, V19, P2199, DOI 10.1093/oxfordjournals.molbev.a004044; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Bone DBJ, 2007, MOL MEMBR BIOL, V24, P294, DOI 10.1080/09687860701210617; Borbath I, 2012, EUR J CANCER, V48, P990, DOI 10.1016/j.ejca.2011.11.006; Chen LM, 2011, J PHYSIOL-LONDON, V589, P877, DOI 10.1113/jphysiol.2010.198713; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Crawford CR, 1998, J BIOL CHEM, V273, P5288, DOI 10.1074/jbc.273.9.5288; Fusca T, 2009, J BIOL CHEM, V284, P30881, DOI 10.1074/jbc.M109.006148; GRIFFITH DA, 1991, ADV EXP MED BIOL, V309, P431; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; Handa M, 2001, GENE, V262, P301, DOI 10.1016/S0378-1119(00)00555-2; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Lee EW, 2006, J BIOL CHEM, V281, P16700, DOI 10.1074/jbc.M513825200; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Machaca K, 2000, J BIOL CHEM, V275, P38710, DOI 10.1074/jbc.M007887200; Magidovich E, 2007, P NATL ACAD SCI USA, V104, P13022, DOI 10.1073/pnas.0704059104; Mangravite LM, 2003, AM J PHYSIOL-RENAL, V284, pF902, DOI 10.1152/ajprenal.00215.2002; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Nivillac NMI, 2009, BBA-BIOMEMBRANES, V1788, P2326, DOI 10.1016/j.bbamem.2009.08.003; Nordh S, 2014, WORLD J GASTROENTERO, V20, P8482, DOI 10.3748/wjg.v20.i26.8482; Norholm AB, 2011, BIOCHEMISTRY-US, V50, P3469, DOI 10.1021/bi1019989; Reyes G, 2011, MOL MEMBR BIOL, V28, P412, DOI 10.3109/09687688.2011.604861; Reyes G, 2011, BIOCHEM CELL BIOL, V89, P246, DOI [10.1139/o10-155, 10.1139/O10-155]; Riegelhaupt PM, 2010, J BIOL CHEM, V285, P17001, DOI 10.1074/jbc.M110.115758; Robillard KR, 2008, MOL PHARMACOL, V74, P264, DOI 10.1124/mol.107.041871; Stolk M, 2005, BIOCHEM J, V386, P281, DOI 10.1042/BJ20041571; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Valdes R, 2014, J BIOL CHEM, V289, P8799, DOI 10.1074/jbc.M113.546960; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vickers MF, 1999, BIOCHEM J, V339, P21, DOI 10.1042/0264-6021:3390021; Wall MJ, 2014, J NEUROPHYSIOL; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Ward JL, 2003, ARCH BIOCHEM BIOPHYS, V411, P19, DOI 10.1016/S0003-9861(02)00718-X; Wu SK, 2005, J DRUG TARGET, V13, P521, DOI 10.1080/10611860500403099; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Yao SYM, 2011, J BIOL CHEM, V286, P32552, DOI 10.1074/jbc.M111.236117; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022	41	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136779	10.1371/journal.pone.0136779	http://dx.doi.org/10.1371/journal.pone.0136779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406980	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700013
J	Bennani-Baiti, B; Toegel, S; Viernstein, H; Urban, E; Noe, CR; Bennani-Baiti, IM				Bennani-Baiti, Barbara; Toegel, Stefan; Viernstein, Helmut; Urban, Ernst; Noe, Christian R.; Bennani-Baiti, Idriss M.			Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells	PLOS ONE			English	Article							ENDOGENOUS REFERENCE GENES; COLONIC EPITHELIAL-CELLS; LOW-GRADE INFLAMMATION; NECROSIS-FACTOR-ALPHA; REAL-TIME PCR; NF-KAPPA-B; ADHESION MOLECULES; OXIDATIVE STRESS; DRUG-RESISTANCE; EXPRESSION	Endothelial cells are often present at inflammation sites. This is the case of endothelial cells of the blood-brain barrier (BBB) of patients afflicted with neurodegenerative disorders such as Alzheimer's, Parkinson's, or multiple sclerosis, as well as in cases of bacterial meningitis, trauma, or tumor-associated ischemia. Inflammation is a known modulator of gene expression through the activation of transcription factors, mostly NF-kappa B. RLIP76 (a.k.a. RALBP1), an ATP-dependent transporter of electrophile-glutathione conjugates, modulates BBB permeability through the regulation of tight junction function, cell adhesion, and exocytosis. Genes and pathways regulated by RLIP76 are transcriptional targets of tumor necrosis factor alpha (TNF-alpha) pro-inflammatory molecule, suggesting that RLIP76 may also be an inflammation target. To assess the effects of TNF-alpha on RLIP76, we faced the problem of choosing reference genes impervious to TNF-alpha. Since such genes were not known in human BBB endothelial cells, we subjected these to TNF-alpha, and measured by quantitative RT-PCR the expression of housekeeping genes commonly used as reference genes. We find most to be modulated, and analysis of several inflammation datasets as well as a meta-analysis of more than 5000 human tissue samples encompassing more than 300 cell types and diseases show that no single housekeeping gene may be used as a reference gene. Using three different algorithms, however, we uncovered a reference geneset impervious to TNF-alpha, and show for the first time that RLIP76 expression is induced by TNF-alpha and follows the induction kinetics of inflammation markers, suggesting that inflammation can influence RLIP76 expression at the BBB. We also show that MRP1 (a.k.a. ABCC1), another electrophile-glutathione transporter, is not modulated in the same cells and conditions, indicating that RLIP76 regulation by TNF-alpha is not a general property of glutathione transporters. The reference geneset uncovered herein should aid in future gene expression studies in inflammatory conditions of the BBB.	[Bennani-Baiti, Barbara; Urban, Ernst; Noe, Christian R.] Univ Vienna, Inst Pharmaceut Chem, Dept Med Chem, A-1090 Vienna, Austria; [Bennani-Baiti, Barbara] Med Univ Vienna, Vienna Gen Hosp AKH, Dept Biomed Imaging & Image Guided Therapy, A-1090 Vienna, Austria; [Toegel, Stefan] Med Univ Vienna, Dept Orthopaed, Karl Chiari Lab Orthopaed Biol, A-1090 Vienna, Austria; [Viernstein, Helmut] Univ Vienna, Dept Pharmaceut Technol & Biopharmaceut, A-1090 Vienna, Austria; [Bennani-Baiti, Idriss M.] B2 Sci Grp, A-1010 Vienna, Austria	University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Vienna	Bennani-Baiti, IM (corresponding author), B2 Sci Grp, Werdertorgasse 12-3-6, A-1010 Vienna, Austria.	ibennani@refgd.com	Toegel, Stefan/J-6548-2019	Toegel, Stefan/0000-0003-4317-1769				Ammar Z, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003710; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Antoniades C, 2007, CLIN CARDIOL, V30, P295, DOI 10.1002/clc.20101; Arnaud C, 2005, ARCH MAL COEUR VAISS, V98, P661; Awasthi S, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-61; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; Bae YS, 2013, BIOCHEM BIOPH RES CO, V433, P175, DOI 10.1016/j.bbrc.2013.02.056; Bamias G, 2013, INFLAMM BOWEL DIS, V19, P2840, DOI 10.1097/01.MIB.0000435440.22484.e8; Barar J, 2010, MED SCI MONITOR, V16, pBR52; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Beekhuizen H, 1998, TRANSPL P, V30, P4251, DOI 10.1016/S0041-1345(98)01405-5; Bennani-Baiti B, 2012, GENE, V491, P103, DOI 10.1016/j.gene.2011.09.035; Bennani-Baiti IM, 2011, J PATHOL, V225, P353, DOI 10.1002/path.2966; Bennani-Baiti IM, 2010, CLIN CANCER RES, V16, P3769, DOI 10.1158/1078-0432.CCR-10-0558; Bennani-Baiti IM, 1998, P NATL ACAD SCI USA, V95, P10655, DOI 10.1073/pnas.95.18.10655; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Carvey PM, 2005, EUR J NEUROSCI, V22, P1158, DOI 10.1111/j.1460-9568.2005.04281.x; Chapouly C, 2015, BRAIN, V138, P1548, DOI 10.1093/brain/awv077; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067360; Cummings M, 2014, INFLAMMATION, V37, P1889, DOI 10.1007/s10753-014-9920-3; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Bernardino TCD, 2015, NEUROSCI LETT, V597, P154, DOI 10.1016/j.neulet.2015.04.046; Deban L, 2008, AM J PATHOL, V172, P1457, DOI 10.2353/ajpath.2008.070593; Dupuis N, 2015, CNS NEUROSCI THER, V21, P141, DOI 10.1111/cns.12371; Duret L, 1997, CURR OPIN STRUC BIOL, V7, P399, DOI 10.1016/S0959-440X(97)80058-9; Franscini N, 2004, CIRCULATION, V110, P2903, DOI 10.1161/01.CIR.0000146344.49689.BB; Garcia-Vallejo JJ, 2004, ANAL BIOCHEM, V329, P293, DOI 10.1016/j.ab.2004.02.037; GIMBRONE MA, 1990, ANN NY ACAD SCI, V598, P77, DOI 10.1111/j.1749-6632.1990.tb42279.x; Golias C, 2007, IN VIVO, V21, P757; Gonzalez-Burgos E, 2013, PLANTA MED, V79, P1545, DOI 10.1055/s-0033-1350797; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P115; Gorter JA, 2015, EPILEPSY BEHAV, V49, P13, DOI 10.1016/j.yebeh.2015.04.047; Gu J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-47; Higashi Y, 2008, HYPERTENSION, V51, P446, DOI 10.1161/HYPERTENSIONAHA.107.101535; Horowitz S, 2007, AM J PHYSIOL-GASTR L, V292, pG1323, DOI 10.1152/ajpgi.00499.2006; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Kalinowska A, 2006, EUR J NEUROL, V13, P1284, DOI 10.1111/j.1468-1331.2006.01640.x; Kaminski R, 1998, PHARMACOL RES, V37, P375, DOI 10.1006/phrs.1998.0309; Kerekes G, 2008, J RHEUMATOL, V35, P398; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Kupatt C, 2000, Z KARDIOL, V89, P96; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lahera V, 2007, CURR MED CHEM, V14, P243, DOI 10.2174/092986707779313381; Lee S, 2014, BIOCHEM BIOPH RES CO, V454, P560, DOI 10.1016/j.bbrc.2014.10.114; Lee S, 2014, FASEB J, V28, P4158, DOI 10.1096/fj.14-255711; Lee S, 2012, CANCER RES, V72, P5165, DOI 10.1158/0008-5472.CAN-12-0468; Lee YW, 2004, MOL MED, V10, P19, DOI 10.2119/2004-00024.Lee; Leinonen ES, 2004, J INTERN MED, V256, P119, DOI 10.1111/j.1365-2796.2004.01350.x; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Liu JYW, 2012, BRAIN, V135, P3115, DOI 10.1093/brain/aws147; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liverani E, 2013, INT J BIOCHEM CELL B, V45, P2715, DOI 10.1016/j.biocel.2013.09.009; Lok CAR, 2006, J LAB CLIN MED, V147, P310, DOI 10.1016/j.lab.2006.02.004; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marboeuf P, 2008, J THROMB HAEMOST, V6, P195; Minagar A, 2006, NEUROL RES, V28, P230, DOI 10.1179/016164106X98080; Minten C, 2014, BRAIN, V137, P1454, DOI 10.1093/brain/awu045; Montero-Melendez T, 2014, INFLAMMATION, V37, P1059, DOI 10.1007/s10753-014-9829-x; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Moutsopoulos NM, 2006, ANN NY ACAD SCI, V1088, P251, DOI 10.1196/annals.1366.032; Murthi P, 2008, PLACENTA, V29, P798, DOI 10.1016/j.placenta.2008.06.007; Neuhaus W, 2012, PHARMAZIE, V67, P432, DOI 10.1691/ph.2012.1742; Neuhaus W, 2011, BRAIN RES, V1394, P49, DOI 10.1016/j.brainres.2011.04.003; Novakova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086806; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinhu L, 2008, RESPIROLOGY, V13, P990, DOI 10.1111/j.1440-1843.2008.01396.x; Pitroda SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046104; Plattner VE, 2010, INT J PHARMACEUT, V387, P34, DOI 10.1016/j.ijpharm.2009.11.030; Poetsch V, 2010, PHARMAZIE, V65, P267, DOI 10.1691/ph.2010.9319; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Rodriguez-Gaztelumendi A, 2011, TOXICOL LETT, V207, P1, DOI 10.1016/j.toxlet.2011.08.014; Ruminy P, 2001, INFLAMM RES, V50, P383, DOI 10.1007/PL00000260; Schinzari F, 2008, CLIN PHARMACOL THER, V83, P70, DOI 10.1038/sj.clpt.6100229; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Seinost G, 2005, AM HEART J, V149, P1050, DOI 10.1016/j.ahj.2004.09.059; SHARIEF MK, 1992, J INFECT DIS, V166, P350, DOI 10.1093/infdis/166.2.350; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Singhal SS, 2010, INT J CANCER, V126, P1327, DOI 10.1002/ijc.24767; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P761, DOI 10.1016/j.bcp.2008.10.006; Singhal SS, 2005, BIOCHEM PHARMACOL, V70, P481, DOI 10.1016/j.bcp.2005.05.005; Stamatovic SM, 2006, ACTA NEUROCHIR SUPPL, V96, P444; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tian H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh119; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Tudur Smith C, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001911, DOI 10.1002/14651858.CD001911]; Untucht C, 2011, MICROBIOL-SGM, V157, P2933, DOI 10.1099/mic.0.049106-0; Vallance P, 1997, LANCET, V349, P1391, DOI 10.1016/S0140-6736(96)09424-X; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vatsyayan R, 2010, BIOCHEM PHARMACOL, V79, P1699, DOI 10.1016/j.bcp.2010.01.016; Vatsyayan R, 2009, INT J ONCOL, V34, P1505, DOI 10.3892/ijo_00000279; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; Wang GY, 2015, CELL MOL NEUROBIOL, V35, P1105, DOI 10.1007/s10571-015-0204-8; Wang LF, 2015, MOL NEUROBIOL, V52, P478, DOI 10.1007/s12035-014-8848-9; Wang Q, 2011, TOXICOL IN VITRO, V25, P991, DOI 10.1016/j.tiv.2009.11.006; Wei Ruoxin, 2013, BMC Res Notes, V6, P46, DOI 10.1186/1756-0500-6-46; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002; Zhao DZ, 2002, BIOCHEM J, V368, P665, DOI 10.1042/BJ20020950; Zhou J, 2002, INFLAMM RES, V51, P332, DOI 10.1007/PL00000312; Zyzynska-Granica B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051547	107	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139101	10.1371/journal.pone.0139101	http://dx.doi.org/10.1371/journal.pone.0139101			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406496	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700170
J	Chiang, JK; Kao, YH; Lai, NS				Chiang, Jui-Kun; Kao, Yee-Hsin; Lai, Ning-Sheng			The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan	PLOS ONE			English	Article							OF-LIFE CARE; PALLIATIVE-CARE; CARDIOPULMONARY-RESUSCITATION; COMORBIDITY INDEX; CONTROLLED-TRIAL; END; QUALITY; HOME; INDICATORS; AGGRESSIVENESS	Background The healthcare costs of cancer care are highest in the last month of life. The effect of hospice care on end-of-life (EOL) healthcare costs is not clearly understood. Purpose The purpose of this study was to evaluate the effect of hospice care on survival and healthcare costs for lung cancer patients in their final month of life. Methods We adopted Taiwan's National Health Insurance Research Claims Database to analyze data for 3399 adult lung cancer patients who died in 1997-2011. A logistic regression analysis was performed to determine the predictors of high healthcare cost, defined as costs falling above the 90th percentile. Patients who received hospice cares were assigned to a hospice (H) group and those who did not were assigned to a non-hospice (non-H) group. Results The patients in the H group had a longer mean (median) survival time than those in the non-H group did (1.40 +/- 1.61 y (0.86) vs. 1.10 +/- 1.47 (0.61), p<0.001). The non-H group had a lower mean healthcare cost than the H group (US $1,821 +/- 2,441 vs. US $1,839 +/- 1,638, p<0.001). And, there were a total of 340 patients (10%) with the healthcare costs exceeding the 90th percentile (US $4,721) as the cutoff value of high cost. The non-H group had a higher risk of high cost than the H group because many more cases in the non-H group had lower costs. Moreover, the risk of high health care costs were predicted for patients who did not receive hospice care (odds ratio [OR]: 3.68, 95% confidence interval [CI]: 2.44-5.79), received chemotherapy (OR: 1.51, 95% CI: 1.18-1.96) and intubation (OR: 2.63, 95% CI: 1.64-4.16), and those who had more emergency department visits (OR: 1.78, 95% CI: 1.24-2.52), longer hospital admission in days (OR: 1.08, 95% CI: 1.07-1.09), and received radiotherapy (OR: 1.33, 95% CI: 1.00-1.78). Lower risks of high health care costs were observed in patients with low socioeconomic status (OR: 0.58, 95% CI: 0.40-0.83), or previous employment (OR: 0.66, 95% CI: 0.47-0.92). After propensity-score matching, the patients of the non-H group had a higher mean cost and a higher risk of high cost. Similar results were obtained from logistic regression analysis in propensity score-matched patients. Conclusions The survival of the hospice group was longer than non-H group, and patients in the non-H group were 3.74 times more likely to have high healthcare costs at EOL. The positive predictors for high health care costs were patients who did not receive hospice care, who received chemotherapy and intubation, who had more emergency department visits and longer hospital admission, and who received radiotherapy. Negative predictors were patients who had a low socioeconomic status or previous employment. The issue of how to reduce the high health care costs for patients with lung cancer in the last month of life is a challenge for policy makers and health care providers.	[Chiang, Jui-Kun] Buddhist Dalin Tzu Chi Hosp, Dept Family Med, Chiayi, Taiwan; [Kao, Yee-Hsin] Tainan Municipal Hosp, Dept Family Med, Tainan, Taiwan; [Lai, Ning-Sheng] Buddhist Dalin Tzu Chi Hosp, Dept Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Chiang, JK (corresponding author), Tainan Municipal Hosp, Dept Family Med, Tainan, Taiwan.	m2200767@gmail.com; tzuchilai@gmail.com			Buddhist Dalin Tzu Chi Hospital [DTCRD 102(2)-E-01, DTCRD 103(2)-E-03]	Buddhist Dalin Tzu Chi Hospital	JK Chiang received research grants from Buddhist Dalin Tzu Chi Hospital (DTCRD 102(2)-E-01, DTCRD 103(2)-E-03).	Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Campbell DE, 2004, ANN INTERN MED, V140, P269, DOI 10.7326/0003-4819-140-4-200402170-00009; Carlson MDA, 2010, J CLIN ONCOL, V28, P4371, DOI 10.1200/JCO.2009.26.1818; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040590; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chastek B, 2012, J ONCOL PRACT, V8, p75S, DOI 10.1200/JOP.2011.000469; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Connor SR, 2007, J PAIN SYMPTOM MANAG, V33, P238, DOI 10.1016/j.jpainsymman.2006.10.010; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DiMartino LD, 2014, J PALLIAT MED, V17, P1384, DOI 10.1089/jpm.2014.0092; Dudgeon DJ, 2008, J PAIN SYMPTOM MANAG, V35, P573, DOI 10.1016/j.jpainsymman.2007.07.013; Dy SM, 2010, CANCER-AM CANCER SOC, V116, P3267, DOI 10.1002/cncr.25109; Earle CC, 2005, INT J QUAL HEALTH C, V17, P505, DOI 10.1093/intqhc/mzi061; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Fassbender K, 2005, PALLIATIVE MED, V19, P513, DOI 10.1191/0269216305pm1071oa; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Finlay IG, 2002, ANN ONCOL, V13, P257, DOI 10.1093/annonc/mdf668; Forrest LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001376; Gomes B, 2013, PROG PALLIAT CARE, V21, P204, DOI 10.1179/1743291X13Y.0000000065; Gomes B, 2014, JAMA-J AM MED ASSOC, V311, P1060, DOI 10.1001/jama.2014.553; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Gomez-Batiste X, 2012, J PAIN SYMPTOM MANAG, V43, P783, DOI 10.1016/j.jpainsymman.2011.05.006; Gonsalves WI, 2011, J PALLIAT MED, V14, P1231, DOI 10.1089/jpm.2011.0131; Grande GE, 2000, PALLIATIVE MED, V14, P375, DOI 10.1191/026921600701536200; Grunfeld E, 2008, CANCER, V112, P2301, DOI 10.1002/cncr.23428; Grunfeld E, 2006, PALLIATIVE MED, V20, P769, DOI 10.1177/0269216306072553; Hatziandreu E, 2008, THE POTENTIAL COST S; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Hughes SL, 2000, JAMA-J AM MED ASSOC, V284, P2877, DOI 10.1001/jama.284.22.2877; Hurria A, 2008, J CLIN ONCOL, V26, P5386, DOI 10.1200/JCO.2008.17.6891; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; KANE RL, 1984, LANCET, V1, P890; Kim YA, 2014, ANN SURG, V259, P569, DOI 10.1097/SLA.0b013e318291db9d; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klinger CA, 2014, PALLIATIVE MED, V28, P111, DOI 10.1177/0269216313493342; Kreng VB, 2011, HEALTH POLICY, V100, P203, DOI 10.1016/j.healthpol.2010.08.003; Langton JM, 2014, PALLIATIVE MED, V28, P1167, DOI 10.1177/0269216314533813; Lee CC, 2011, STROKE, V42, P48, DOI 10.1161/STROKEAHA.110.597070; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lo JC, 2002, SOC SCI MED, V54, P981, DOI 10.1016/S0277-9536(01)00071-5; Lorenz KA, 2006, J CLIN ONCOL, V24, P4933, DOI 10.1200/JCO.2006.06.8650; Marcus MW, 2015, ONCOL LETT, V9, P1902, DOI 10.3892/ol.2015.2916; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Morss S, 2011, J PALLIAT MED, V14, P451, DOI 10.1089/jpm.2010.0434; Obermeyer Z, 2014, JAMA-J AM MED ASSOC, V312, P1888, DOI 10.1001/jama.2014.14950; Rabow MW, 2004, ARCH INTERN MED, V164, P83, DOI 10.1001/archinte.164.1.83; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Rodrigues G, 2011, PRACT RADIAT ONCOL, V1, P60, DOI 10.1016/j.prro.2011.01.005; Saito AM, 2011, J PALLIAT MED, V14, P929, DOI 10.1089/jpm.2010.0522; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Seow H, 2009, CANCER-AM CANCER SOC, V115, P3820, DOI 10.1002/cncr.24439; Smith S, 2014, PALLIATIVE MED, V28, P130, DOI 10.1177/0269216313493466; Smith Thomas J, 2003, J Palliat Med, V6, P699, DOI 10.1089/109662103322515202; Tang ST, 2009, ANN ONCOL, V20, P343, DOI 10.1093/annonc/mdn602; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2014, JAMA-J AM MED ASSOC, V312, P1868, DOI 10.1001/jama.2014.14949; Wang HM, 2011, J PAIN SYMPTOM MANAG, V42, P400, DOI 10.1016/j.jpainsymman.2010.12.011; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yu KH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3806; Zhang Z, 2015, AM J HOSP PALLIAT ME, V32, P210, DOI 10.1177/1049909113520215	63	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138773	10.1371/journal.pone.0138773	http://dx.doi.org/10.1371/journal.pone.0138773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406871	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700092
J	Formenti, N; Trogu, T; Pedrotti, L; Gaffuri, A; Lanfranchi, P; Ferrari, N				Formenti, Nicoletta; Trogu, Tiziana; Pedrotti, Luca; Gaffuri, Alessandra; Lanfranchi, Paolo; Ferrari, Nicola			Toxoplasma gondii Infection in Alpine Red Deer (Cervuselaphus): Its Spread and Effects on Fertility	PLOS ONE			English	Article							CERVUS-ELAPHUS; ROE DEER; NEOSPORA-CANINUM; RISK-FACTORS; ANTIBODIES; PREVALENCE; SHEEP; SEROPREVALENCE; GOATS; REINDEER	In contrast to the depth of knowledge on the pathological effects of parasitism in domestic animals, the impact of the vast majority of parasites on wildlife hosts is poorly understood and, besides, information from domestics is rarely usable to disclose the parasites' impact on free-ranging populations' dynamics. Here we use Toxoplasmosis as a study model since, until now, the infection process and the protozoan's effects in natural conditions has received little attention. We analysed 81 sera from red deer (Cervuselaphus) sampled in Italian Alps and through generalized linear models we evaluated (1) the epidemiological factors influencing T. gondii infection dynamics; (2) its impact on female fertility. High seroprevalence of T. gondii infection was recorded in yearling (1 year-old; prevalence = 52.4%) and adult (> 2 year-old; prevalence = 51.3%) red deer, while calves (< 1 year-old) did not contract the infection suggesting horizontal transmission as the main route of infection. The stable prevalence between yearlings and adults and the higher serological titres of younger individuals lead to two alternative infection processes suggesting a difference between age classes or in acquiring the infection or in responding to the pathogen. No associations between T. gondii serological titres and pregnancy status was observed indicating no direct effect on the probability of being pregnant; nevertheless a relation between females' higher serological titres and lower foetal development emerged, suggesting potential effects of the parasite infection on deer reproduction. The results demonstrate high seroprevalence of T. gondii infection in free-ranging red deer and, furthermore, the effect on foetal development suggests the potential impact of the parasite on red deer fertility and thus on its population dynamics.	[Formenti, Nicoletta; Trogu, Tiziana; Lanfranchi, Paolo; Ferrari, Nicola] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Pedrotti, Luca] Consorzio Parco Nazl Stelvio, Bormio, Sondrio, Italy; [Gaffuri, Alessandra] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Bergamo, Italy	University of Milan; IZS Lombardia e Emilia	Formenti, N (corresponding author), Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy.	nicoletta_formenti@yahoo.it	gaffuri, alessandra/AFF-0288-2022; Ferrari, Nicola/E-6331-2013; Formenti, Nicoletta/AAC-5752-2022; Lanfranchi, Paolo/K-5976-2017	Ferrari, Nicola/0000-0001-8959-3495; Lanfranchi, Paolo/0000-0002-8266-5481; Formenti, Nicoletta/0000-0003-1516-1256	Progetto Giovani "Valorizzazione dei prodotti tipici dell'agroalimentare e sicurezza alimentare attraverso nuovi sistemi di caratterizzazione e garanzia di qualita"; Italian Ministry of University and Research (PRIN project) [2010P7LFW4]	Progetto Giovani "Valorizzazione dei prodotti tipici dell'agroalimentare e sicurezza alimentare attraverso nuovi sistemi di caratterizzazione e garanzia di qualita"; Italian Ministry of University and Research (PRIN project)(Ministry of Education, Universities and Research (MIUR))	This research was supported by a grant from Progetto Giovani 2009 "Valorizzazione dei prodotti tipici dell'agroalimentare e sicurezza alimentare attraverso nuovi sistemi di caratterizzazione e garanzia di qualita" (PL) and partially by the Italian Ministry of University and Research (PRIN project n. 2010P7LFW4) (PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM CL, 1988, ANIM PROD, V46, P131, DOI 10.1017/S0003356100003196; Alberti EG, 2014, SMALL RUMINANT RES, V120, P155, DOI 10.1016/j.smallrumres.2014.04.017; Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; ALBON SD, 1986, J ZOOL, V209, P447, DOI 10.1111/j.1469-7998.1986.tb03603.x; ANDERSON ML, 1994, VET CLIN N AM-FOOD A, V10, P439, DOI 10.1016/S0749-0720(15)30531-4; Aubert D, 2010, VET PARASITOL, V171, P346, DOI 10.1016/j.vetpar.2010.03.033; Beral M, 2012, ECOHEALTH, V9, P303, DOI 10.1007/s10393-012-0786-2; Cabezon O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029549; Chikweto A, 2011, J PARASITOL, V97, P950, DOI 10.1645/GE-2811.1; Chong CK, 2011, KOREAN J PARASITOL, V49, P207, DOI 10.3347/kjp.2011.49.3.207; Citterio CV, 2006, J PARASITOL, V92, P918, DOI 10.1645/GE-3551.1; Clementino MM, 2007, VET PARASITOL, V146, P199, DOI 10.1016/j.vetpar.2007.02.036; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Darabus G, 2014, J ZOO WILDLIFE MED, V45, P239, DOI 10.1638/2012-0170.1; Dubey JP, 2008, INT J PARASITOL, V38, P1057, DOI 10.1016/j.ijpara.2007.11.010; DUBEY JP, 1992, J PARASITOL, V78, P151, DOI 10.2307/3283705; Duncanson P, 2001, INT J PARASITOL, V31, P1699, DOI 10.1016/S0020-7519(01)00282-X; Elmore SA, 2012, VECTOR-BORNE ZOONOT, V12, P1, DOI 10.1089/vbz.2011.0705; European Food Safety Authority, 2007, EFSA J, V583, P28; Figliuolo LPC, 2004, SMALL RUMINANT RES, V55, P29, DOI 10.1016/j.smallrumres.2003.12.013; Fox MT, 1997, VET PARASITOL, V72, P285, DOI 10.1016/S0304-4017(97)00102-7; Gaffuri A, 2006, J WILDLIFE DIS, V42, P685, DOI 10.7589/0090-3558-42.3.685; Gamarra JA, 2008, VET PARASITOL, V153, P152, DOI 10.1016/j.vetpar.2008.01.028; Gauss CBL, 2006, VET PARASITOL, V136, P193, DOI 10.1016/j.vetpar.2005.11.013; Gebremedhin EZ, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0222-7; Gebremedhin EZ, 2013, RES VET SCI, V95, P894, DOI 10.1016/j.rvsc.2013.08.007; Gibson AK., 2011, PLOS NEGLECT TROP D, V5, P5; GUINNESS FE, 1978, J REPROD FERTIL, V54, P325, DOI 10.1530/jrf.0.0540325; Hejlicek K, 1997, J WILDLIFE DIS, V33, P480, DOI 10.7589/0090-3558-33.3.480; Hernandez M, 2014, TRANSBOUND EMERG DIS, V61, P477, DOI 10.1111/tbed.12049; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; Hudson PJ, 1995, ECOLOGY INFECT DIS N, P146; Huong LTT, 1998, VET PARASITOL, V75, P53, DOI 10.1016/S0304-4017(97)00178-7; Jittapalapong S, 2005, VET PARASITOL, V127, P17, DOI 10.1016/j.vetpar.2004.08.019; Jokelainen P, 2011, J WILDLIFE DIS, V47, P154, DOI 10.7589/0090-3558-47.1.154; Jokelainen P, 2010, VET PARASITOL, V171, P331, DOI 10.1016/j.vetpar.2010.04.008; Kapperud G, 1996, AM J EPIDEMIOL, V144, P405, DOI 10.1093/oxfordjournals.aje.a008942; Kijlstra A, 2008, INT J PARASITOL, V38, P1359, DOI 10.1016/j.ijpara.2008.06.002; KOJOLA I, 1989, EVOLUTION, V43, P1331, DOI [10.2307/2409370, 10.1111/j.1558-5646.1989.tb02582.x]; Lello J, 2005, INT J PARASITOL, V35, P1509, DOI 10.1016/j.ijpara.2005.06.002; Magnino S, 2011, GAME MEAT HYGIENE IN FOCUS: MICROBIOLOGY, EPIDEMIOLOGY, RISK ANALYSIS AND QUALITY ASSURANCE, P223; Masala G, 2003, VET PARASITOL, V117, P15, DOI 10.1016/j.vetpar.2003.07.012; Misurova L, 2009, ACTA VET BRNO, V78, P259, DOI 10.2754/avb200978020259; Morley EK, 2008, PARASITOLOGY, V135, P169, DOI 10.1017/S0031182007003721; Onyiche ThankGod Emmanuel, 2015, J Parasit Dis, V39, P309, DOI 10.1007/s12639-013-0350-1; Opsteegh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016240; Pedersen AB, 2015, TRENDS PARASITOL, V31, P200, DOI 10.1016/j.pt.2015.02.004; Pereira-Bueno J, 2004, VET PARASITOL, V121, P33, DOI 10.1016/j.vetpar.2004.02.004; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rossi GF, 2011, VET PARASITOL, V175, P252, DOI 10.1016/j.vetpar.2010.10.017; Shadfar S., 2012, Global Veterinaria, V9, P117; Sobrino R, 2007, VET PARASITOL, V148, P187, DOI 10.1016/j.vetpar.2007.06.038; Turchetto S, 2014, HYSTRIX, V25, P25, DOI 10.4404/hystrix-25.1-9460; van der Puije WNA, 2000, ACTA TROP, V76, P21, DOI 10.1016/S0001-706X(00)00084-X; Vikoren T, 2004, VET PARASITOL, V120, P159, DOI 10.1016/j.vetpar.2003.12.015	55	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138472	10.1371/journal.pone.0138472	http://dx.doi.org/10.1371/journal.pone.0138472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405785	Green Published, gold			2022-12-27	WOS:000361800700047
J	Marcolino-Gomes, J; Rodrigues, FA; Fuganti-Pagliarini, R; Nakayama, TJ; Reis, RR; Farias, JRB; Harmon, FG; Molinari, HBC; Molinari, MDC; Nepomuceno, A				Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Fuganti-Pagliarini, Renata; Nakayama, Thiago Jonas; Reis, Rafaela Ribeiro; Farias, Jose Renato Boucas; Harmon, Frank G.; Correa Molinari, Hugo Bruno; Correa Molinari, Mayla Daiane; Nepomuceno, Alexandre			Transcriptome-Wide Identification of Reference Genes for Expression Analysis of Soybean Responses to Drought Stress along the Day	PLOS ONE			English	Article							ARABIDOPSIS CIRCADIAN CLOCK; OSMOTIC ADJUSTMENT; QPCR DATA; TIME; NORMALIZATION; TOLERANCE; THALIANA; PCR; OVEREXPRESSION; VALIDATION	The soybean transcriptome displays strong variation along the day in optimal growth conditions and also in response to adverse circumstances, like drought stress. However, no study conducted to date has presented suitable reference genes, with stable expression along the day, for relative gene expression quantification in combined studies on drought stress and diurnal oscillations. Recently, water deficit responses have been associated with circadian clock oscillations at the transcription level, revealing the existence of hitherto unknown processes and increasing the demand for studies on plant responses to drought stress and its oscillation during the day. We performed data mining from a transcriptome-wide background using microarrays and RNA-seq databases to select an unpublished set of candidate reference genes, specifically chosen for the normalization of gene expression in studies on soybean under both drought stress and diurnal oscillations. Experimental validation and stability analysis in soybean plants submitted to drought stress and sampled during a 24 h timecourse showed that four of these newer reference genes (FYVE, NUDIX, Golgin-84 and CYST) indeed exhibited greater expression stability than the conventionally used housekeeping genes (ELF1-beta and beta-actin) under these conditions. We also demonstrated the effect of using reference candidate genes with different stability values to normalize the relative expression data from a drought-inducible soybean gene (DREB5) evaluated in different periods of the day.	[Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Fuganti-Pagliarini, Renata; Nakayama, Thiago Jonas; Reis, Rafaela Ribeiro; Farias, Jose Renato Boucas; Correa Molinari, Mayla Daiane; Nepomuceno, Alexandre] Brazilian Agr Res Corp, Embrapa Soybean, Londrina, Parana, Brazil; [Marcolino-Gomes, Juliana; Reis, Rafaela Ribeiro; Correa Molinari, Mayla Daiane] Univ Estadual Londrina, Dept Biol, Londrina, Parana, Brazil; [Nakayama, Thiago Jonas] Univ Fed Vicosa, Dept Crop Sci, Vicosa, MG, Brazil; [Harmon, Frank G.] USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA; [Harmon, Frank G.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Correa Molinari, Hugo Bruno] Brazilian Agr Res Corp, Embrapa Agroenergy, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Londrina; Universidade Federal de Vicosa; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Nepomuceno, A (corresponding author), Brazilian Agr Res Corp, Embrapa Soybean, Londrina, Parana, Brazil.	alexandre.nepomuceno@embrapa.br	Fuganti-Pagliarini, Renata/S-6089-2019; molinari, mayla/AAX-7450-2020	molinari, mayla/0000-0002-9135-0422; Fuganti-Pagliarini, Renata/0000-0001-9282-2826	National Council for Scientific and Technological Development (CNPq); Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the National Council for Scientific and Technological Development (CNPq) and the Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Babita M, 2010, ENVIRON EXP BOT, V69, P243, DOI 10.1016/j.envexpbot.2010.05.006; Bekh-Ochir D, 2013, PLANTA, V237, P1509, DOI 10.1007/s00425-013-1859-3; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056502; Molinari HBC, 2007, PHYSIOL PLANTARUM, V130, P218, DOI 10.1111/j.1399-3054.2007.00909.x; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Dong MA, 2011, P NATL ACAD SCI USA, V108, P7241, DOI 10.1073/pnas.1103741108; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Galeou A, 2012, PLANT SCI, V184, P141, DOI 10.1016/j.plantsci.2011.12.014; Goyer A, 2013, BIOCHEM J, V454, P533, DOI 10.1042/BJ20130516; Graf A, 2011, TRENDS PLANT SCI, V16, P169, DOI 10.1016/j.tplants.2010.12.003; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huang H, 2012, PLANT MOL BIOL REP, V30, P973, DOI 10.1007/s11105-011-0401-7; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; Jensen RB, 2001, IDENTIFICATION PTDIN, V173, P165; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Liu JZ, 2013, PLANT J, V74, P110, DOI 10.1111/tpj.12108; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075271; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Marcolino-Gomes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086402; Marcolino-Gomes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062294; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Nakamichi N, 2009, PLANT CELL PHYSIOL, V50, P447, DOI 10.1093/pcp/pcp004; Nakayama TJ, 2014, GENET MOL RES, V13, P860, DOI 10.4238/2014.February.13.4; Ogawa T, 2008, PLANT PHYSIOL, V148, P1412, DOI 10.1104/pp.108.128413; Osterrieder A, 2012, J MICROSC-OXFORD, V247, P68, DOI 10.1111/j.1365-2818.2012.03620.x; Oya T, 2004, PLANT PROD SCI, V7, P129, DOI 10.1626/pps.7.129; Pavlopoulou A, 2009, GENOMICS, V93, P350, DOI 10.1016/j.ygeno.2008.12.004; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rajan VBV, 2009, FUNCT INTEGR GENOMIC, V9, P433, DOI 10.1007/s10142-009-0132-0; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Rodrigues FA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1731-x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez A, 2011, PLANT SIGNAL BEHAV, V6, P223, DOI 10.4161/psb.6.2.14893; So HA, 2013, GENES GENOM, V35, P247, DOI 10.1007/s13258-013-0078-4; Song YH, 2012, PLANT J, V69, P332, DOI 10.1111/j.1365-313X.2011.04793.x; Squires JE, 2011, EPIGENETICS: A REFERENCE MANUAL, P227; Stolf-Moreira R, 2011, PESQUI AGROPECU BRAS, V46, P58, DOI 10.1590/S0100-204X2011000100008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GD, 2014, PLANT PHYSIOL BIOCH, V82, P95, DOI 10.1016/j.plaphy.2014.05.011; Wilkins O, 2010, PLANT J, V63, P715, DOI 10.1111/j.1365-313X.2010.04274.x; Wilkins O, 2009, PLANT J, V60, P703, DOI 10.1111/j.1365-313X.2009.03993.x; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x	58	26	27	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139051	10.1371/journal.pone.0139051	http://dx.doi.org/10.1371/journal.pone.0139051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407065	Green Published, gold			2022-12-27	WOS:000361800700154
J	Marrelec, G; Messe, A; Bellec, P				Marrelec, Guillaume; Messe, Arnaud; Bellec, Pierre			A Bayesian Alternative to Mutual Information for the Hierarchical Clustering of Dependent Random Variables	PLOS ONE			English	Article							BRAIN; INTEGRATION; ORGANIZATION; DISTANCE; MATRICES	The use of mutual information as a similarity measure in agglomerative hierarchical clustering (AHC) raises an important issue: some correction needs to be applied for the dimensionality of variables. In this work, we formulate the decision of merging dependent multivariate normal variables in an AHC procedure as a Bayesian model comparison. We found that the Bayesian formulation naturally shrinks the empirical covariance matrix towards a matrix set a priori (e.g., the identity), provides an automated stopping rule, and corrects for dimensionality using a term that scales up the measure as a function of the dimensionality of the variables. Also, the resulting log Bayes factor is asymptotically proportional to the plug-in estimate of mutual information, with an additive correction for dimensionality in agreement with the Bayesian information criterion. We investigated the behavior of these Bayesian alternatives (in exact and asymptotic forms) to mutual information on simulated and real data. An encouraging result was first derived on simulations: the hierarchical clustering based on the log Bayes factor outperformed off-the-shelf clustering techniques as well as raw and normalized mutual information in terms of classification accuracy. On a toy example, we found that the Bayesian approaches led to results that were similar to those of mutual information clustering techniques, with the advantage of an automated thresholding. On real functional magnetic resonance imaging (fMRI) datasets measuring brain activity, it identified clusters consistent with the established outcome of standard procedures. On this application, normalized mutual information had a highly atypical behavior, in the sense that it systematically favored very large clusters. These initial experiments suggest that the proposed Bayesian alternatives to mutual information are a useful new tool for hierarchical clustering.	[Marrelec, Guillaume] UPMC Univ Paris 06, Univ Sorbonne, CNRS,INSERM, LIB, F-75013 Paris, France; [Messe, Arnaud] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Computat Neurosci, Hamburg, Germany; [Bellec, Pierre] Univ Montreal, Ctr Rech Inst Univ Geriatrie Montreal, Dept Informat & Rech Operationnelle, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universite de Montreal	Marrelec, G (corresponding author), UPMC Univ Paris 06, Univ Sorbonne, CNRS,INSERM, LIB, F-75013 Paris, France.	marrelec@lib.upmc.fr	Messé, Arnaud/I-1738-2019	Messé, Arnaud/0000-0001-9081-3088; Bellec, Pierre/0000-0002-9111-0699	Deutsche Forschungsgemeinschaft (DFG) [SFB 936/Z3]; Fonds de Recherche du Quebec {Sante (FRQS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds de Recherche du Quebec {Sante (FRQS)	A.M. is supported by Deutsche Forschungsgemeinschaft (DFG) grant SFB 936/Z3. P.B. is supported by the Fonds de Recherche du Quebec {Sante (FRQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1972, HDB MATH FUNCTIONS, V55; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson TW, 1958, INTRO MULTIVARIATE S; Barnard J, 2000, STAT SINICA, V10, P1281; Batagelj V., 1988, Classification and Related Methods of Data Analysis. Proceedings of the First Conference of the International Federation of Classification Societies (IFCS), P67; Bellec P, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00007; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Benjaminsson S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00034; BINDER DA, 1981, BIOMETRIKA, V68, P275, DOI 10.1093/biomet/68.1.275; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butte A J, 2000, Pac Symp Biocomput, P418; Cooke EJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-399; Cover TM., 1999, ELEMENTS INFORM THEO; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Darkins R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059795; Dawy Z, 2006, IEEE ACM T COMPUT BI, V3, P47, DOI 10.1109/TCBB.2006.9; Duda R.O., 2000, PATTERN CLASSIFICATI; Fischer M, 2011, DEPENDENCE MODELING, P19; Fred ALN, 2005, IEEE T PATTERN ANAL, V27, P835, DOI 10.1109/TPAMI.2005.113; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gelman A., 2004, TEXTS STAT SCI; Heller K. A., 2007, EFFICIENT BAYESIAN M; Heller KA, 2005, BAYESIAN HIERARCHICA; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jaynes E.T., 2003, PROBABILITY THEORY L; JOE H, 1989, J AM STAT ASSOC, V84, P157, DOI 10.2307/2289859; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kelly C, 2012, NEUROIMAGE, V61, P1129, DOI 10.1016/j.neuroimage.2012.03.021; Kolchinsky A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00066; Kraskov A, 2009, INFORM THEORY STAT L, P101; KULLBACK S, 1968, INFORM THEORY STAT; Li M, 2001, BIOINFORMATICS, V17, P149, DOI 10.1093/bioinformatics/17.2.149; Lian H, 2011, J STAT PLAN INFER, V141, P2839, DOI 10.1016/j.jspi.2011.03.008; Marrelec G, 2008, MED IMAGE ANAL, V12, P484, DOI 10.1016/j.media.2008.02.002; Marrelec G, 2006, J MULTIVARIATE ANAL, V97, P1451, DOI 10.1016/j.jmva.2005.08.008; McQuarrie A. D, 1998, REGRESSION TIME SERI; Nelsen RB., 2007, INTRO COPULAS; Nijenhuis A., 1978, COMBINATORIAL ALGORI; Orban P, CEREBRAL CO IN PRESS; Papoulis A, 1965, MCGRAW HILL SERIES S; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Press S. J., 2005, APPL MULTIVARIATE AN; Priness I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-111; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Roverato A., 1999, CLASSIFICATION DATA, P335; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Savage RS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-242; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCOTT AJ, 1971, BIOMETRICS, V27, P387, DOI 10.2307/2529003; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sirinukunwattana K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075748; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Stausberg S, 2009, CLIN NEUROPHYSIOL, V120, pe33, DOI [10.1016/j.clinph.2008.07.072, DOI 10.1016/J.CLINPH.2008.07.072]; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Studeny M, 1998, NATO ADV SCI I D-BEH, V89, P261; Thirion B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00167; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; von Luxburg U, 2006, TR149 M PLANCK I BIO; WATANABE S, 1960, IBM J RES DEV, V4, P66, DOI 10.1147/rd.41.0066; Wilf H. S., 1999, E SIDE W SIDE; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhou XB, 2004, J COMPUT BIOL, V11, P147, DOI 10.1089/106652704773416939	65	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137278	10.1371/journal.pone.0137278	http://dx.doi.org/10.1371/journal.pone.0137278			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406245	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700018
J	Nehra, S; Bhardwaj, V; Ganju, L; Saraswat, D				Nehra, Sarita; Bhardwaj, Varun; Ganju, Lilly; Saraswat, Deepika			Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; INDUCED APOPTOSIS; GENE-EXPRESSION; HEART-FAILURE; P53; CURCUMIN; MECHANISMS; ACETYLTRANSFERASE	Hypoxia induced oxidative stress incurs pathophysiological changes in hypertrophied cardiomyocytes by promoting translocation of p53 to mitochondria. Here, we investigate the cardio-protective efficacy of nanocurcumin in protecting primary human ventricular cardiomyocytes (HVCM) from hypoxia induced damages. Hypoxia induced hypertrophy was confirmed by FITC-phenylalanine uptake assay, atrial natriuretic factor (ANF) levels and cell size measurements. Hypoxia induced translocation of p53 was investigated by using mitochondrial membrane permeability transition pore blocker cyclosporin A (blocks entry of p53 to mitochondria) and confirmed by western blot and immunofluorescence. Mitochondrial damage in hypertrophied HVCM cells was evaluated by analysing bio-energetic, anti-oxidant and metabolic function and substrate switching form lipids to glucose. Nanocurcumin prevented translocation of p53 to mitochondria by stabilizing mitochondrial membrane potential and de-stressed hypertrophied HVCM cells by significant restoration in lactate, acetyl-coenzyme A, pyruvate and glucose content along with lactate dehydrogenase (LDH) and 5' adenosine monophosphate-activated protein kinase (AMPK alpha) activity. Significant restoration in glucose and modulation of GLUT-1 and GLUT-4 levels confirmed that nanocurcumin mediated prevention of substrate switching. Nanocurcumin prevented of mitochondrial stress as confirmed by c-fos/c-jun/p53 signalling. The data indicates decrease in p-300 histone acetyl transferase (HAT) mediated histone acetylation and GATA-4 activation as pharmacological targets of nanocurcumin in preventing hypoxia induced hypertrophy. The study provides an insight into propitious therapeutic effects of nanocurcumin in cardio-protection and usability in clinical applications.	[Nehra, Sarita; Bhardwaj, Varun; Ganju, Lilly; Saraswat, Deepika] Def Res & Dev Org, Def Inst Physiol & Allied Sci, Dept Expt Biol, Expt Biol Div, New Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Saraswat, D (corresponding author), Def Res & Dev Org, Def Inst Physiol & Allied Sci, Dept Expt Biol, Expt Biol Div, New Delhi, India.	deepika_saras@yahoo.com			University Grants Commission fellowship; Council for Scientific and Industrial Research fellowship	University Grants Commission fellowship(University Grants Commission, India); Council for Scientific and Industrial Research fellowship	The present work was funded by research fellowship only. Sarita Nehra is a recipient of University Grants Commission fellowship. Varun Bhardwaj is a recipient of Council for Scientific and Industrial Research fellowship.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Akhtar F, 2012, BIOTECHNOL ADV, V30, P310, DOI 10.1016/j.biotechadv.2011.05.009; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Basnet P, 2011, MOLECULES, V16, P4567, DOI 10.3390/molecules16064567; Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3; Cardaci S, 2008, MOL PHARMACOL, V74, P1234, DOI 10.1124/mol.108.048975; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Chem JB, 2005, J BIOL CHEM, DOI [10.1074/jbc.M410670200, DOI 10.1074/JBC.M410670200]; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Feridooni T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022801; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127; Gowda PS, 2012, J BIOL CHEM, V287, P17554, DOI 10.1074/jbc.M111.319277; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Gusterson RJ, 2003, J BIOL CHEM, V278, P6838, DOI 10.1074/jbc.M211762200; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; HEBERT GA, 1981, J CLIN MICROBIOL, V13, P498; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Iosefson O, 2010, FEBS LETT, V584, P1080, DOI 10.1016/j.febslet.2010.02.019; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kang YJ, 2001, ENVIRON HEALTH PERSP, V109, P27, DOI 10.2307/3434844; Liu JF, 2008, FEBS LETT, V582, P1319, DOI 10.1016/j.febslet.2008.03.013; Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Moe KT, 2014, J PHYSIOL BIOCHEM, V70, P769, DOI 10.1007/s13105-014-0345-0; Montessuit C, 2004, CARDIOVASC RES, V64, P94, DOI 10.1016/j.cardiores.2004.06.005; Moribe K, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/138929; Nehra S, 2014, J CARDIOVASC PHARM, V64, P375, DOI 10.1097/FJC.0000000000000130; Nehra S, 2015, J PHYSIOL BIOCHEM, V71, P239, DOI 10.1007/s13105-015-0405-0; Ohno T, 1998, ALTERN ANIM TEST EXP, V145, P131; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pires IM, 2010, CELL CYCLE, V9, P2502, DOI 10.4161/cc.9.13.12059; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Reeve JLV, 2007, J CELL MOL MED, V11, P509, DOI 10.1111/j.1582-4934.2007.00042.x; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Rosenblatt-Velin N, 2001, CARDIOVASC RES, V52, P407, DOI 10.1016/S0008-6363(01)00393-5; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Sermeus A, 2011, Cell Death Dis, V2, pe164, DOI 10.1038/cddis.2011.48; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shehzad A, 2014, J NANOSCI NANOTECHNO, V14, P803, DOI 10.1166/jnn.2014.9103; Song ZM, 2011, J COLLOID INTERF SCI, V354, P116, DOI 10.1016/j.jcis.2010.10.024; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Tardy-Cantalupi I, 1999, J MOL CELL CARDIOL, V31, P1143, DOI 10.1006/jmcc.1999.0952; Tiwari MN, 2013, FREE RADICAL BIO MED, V65, P704, DOI 10.1016/j.freeradbiomed.2013.07.042; UTLEY HG, 1967, ARCH BIOCHEM BIOPHYS, V118, P29, DOI 10.1016/0003-9861(67)90273-1; van Berlo JH, 2011, P NATL ACAD SCI USA, V108, P12331, DOI 10.1073/pnas.1104499108; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; VENTURACLAPIER RF, 2003, J PHYSL, V555, P1, DOI DOI 10.1113/JPHYSIOL.2003.055095; Waterborg J. H., 1984, METHOD MOL BIOL, V1, P3; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	65	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139121	10.1371/journal.pone.0139121	http://dx.doi.org/10.1371/journal.pone.0139121			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406246	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700178
J	Raj, A; Shim, H; Gilad, Y; Pritchard, JK; Stephens, M				Raj, Anil; Shim, Heejung; Gilad, Yoav; Pritchard, Jonathan K.; Stephens, Matthew			msCentipede: Modeling Heterogeneity across Genomic Sites and Replicates Improves Accuracy in the Inference of Transcription Factor Binding	PLOS ONE			English	Article							OPEN CHROMATIN	Understanding global gene regulation depends critically on accurate annotation of regulatory elements that are functional in a given cell type. CENTIPEDE, a powerful, probabilistic framework for identifying transcription factor binding sites from tissue-specific DNase I cleavage patterns and genomic sequence content, leverages the hypersensitivity of factor-bound chromatin and the information in the DNase I spatial cleavage profile characteristic of each DNA binding protein to accurately infer functional factor binding sites. However, the model for the spatial profile in this framework fails to account for the substantial variation in the DNase I cleavage profiles across different binding sites. Neither does it account for variation in the profiles at the same binding site across multiple replicate DNase I experiments, which are increasingly available. In this work, we introduce new methods, based on multi-scale models for inhomogeneous Poisson processes, to account for such variation in DNase I cleavage patterns both within and across binding sites. These models account for the spatial structure in the heterogeneity in DNase I cleavage patterns for each factor. Using DNase-seq measurements assayed in a lymphoblastoid cell line, we demonstrate the improved performance of this model for several transcription factors by comparing against the Chip-seq peaks for those factors. Finally, we explore the effects of DNase I sequence bias on inference of factor binding using a simple extension to our framework that allows for a more flexible background model. The proposed model can also be easily applied to paired-end ATAC-seq and DNase-seq data. msCentipede, a Python implementation of our algorithm, is available at http://rajanil.github.io/msCentipede.	[Raj, Anil; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Shim, Heejung; Gilad, Yoav; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	Stanford University; University of Chicago; Stanford University; Howard Hughes Medical Institute; University of Chicago	Raj, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	rajanil@stanford.edu; hjshim@gmail.com; gilad@uchicago.edu; pritch@stanford.edu; mstephens@uchicago.edu		Raj, Anil/0000-0003-4412-0883; Shim, Heejung/0000-0002-1375-9310	NIH [HG02585, HG007036, MH084703]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007036, R01HG002585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084703] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by grants from the NIH (HG02585 to M.S., HG007036 to J.K.P., and MH084703 to Y.G. and J.K.P.), and by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal Matthew James, 2003, VARIATIONAL ALGORITH; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; He HH, 2014, NAT METHODS, V11, P73, DOI [10.1038/NEMTH.2762, 10.1038/nmeth.2762]; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kolaczyk ED, 1999, J AM STAT ASSOC, V94, P920, DOI 10.2307/2670007; Koohy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069853; Lazarovici A, 2013, P NATL ACAD SCI USA, V110, P6376, DOI 10.1073/pnas.1216822110; Luo Kaixuan, 2013, Pac Symp Biocomput, P80; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shim H, 2015, BAYESIAN MULTI UNPUB; Shim H, 2015, ANN APPL STAT, V9, P665, DOI 10.1214/14-AOAS776; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Varadhan R, 2008, SCAND J STAT, V35, P335, DOI 10.1111/j.1467-9469.2007.00585.x; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	25	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138030	10.1371/journal.pone.0138030	http://dx.doi.org/10.1371/journal.pone.0138030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406244	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700028
J	Zhao, H; Shao, JC; Han, GQ; Yang, DZ; Lv, JH				Zhao, Hui; Shao, Jinchao; Han, Guoqi; Yang, Dezhou; Lv, Jianhai			Influence of Typhoon Matsa on Phytoplankton Chlorophyll-a off East China	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; SUBSURFACE CHLOROPHYLL; TROPICAL CYCLONE; WATER; SATELLITE; PACIFIC; MAXIMUM; BLOOMS; STRAIT; OCEAN	Typhoons can cause strong disturbance, mixing, and upwelling in the upper layer of the oceans. Rich nutrients from the subsurface layer can be brought to the euphotic layer, which will induce the phytoplankton to breed and grow rapidly. In this paper, we investigate the impact of an intense and fast moving tropical storm, Typhoon Matsa, on phytoplankton chlorophyll-a (Chl-a) concentration off East China. By using satellite remote sensing data, we analyze the changes of Chl-a concentration, Sea Surface Temperature (SST) and wind speed in the pre- and post-typhoon periods. We also give a preliminary discussion on the different responses of the Chl-a concentration between nearshore and offshore waters. In nearshore/coastal regions where nutrients are generally rich, the Chl-a maximum occurs usually at the surface or at the layer close to the surface. And, in offshore tropical oligotrophic oceans, the subsurface maxima of Chl-a exist usually in the stratified water column. In an offshore area east of Taiwan, the Chl-a concentration rose gradually in about two weeks after the typhoon. However, in a coastal area north of Taiwan high Chl-a concentration decreased sharply before landfall, rebounded quickly to some degree after landfall, and restored gradually to the pre-typhoon level in about two weeks. The Chl-a concentration presented a negative correlation with the wind speed in the nearshore area during the typhoon, which is opposite to the response in the offshore waters. The phenomena may be attributable to onshore advection of low Chl-a water, coastal downwelling and intensified mixing, which together bring pre-typhoon surface Chl-a downward in the coastal area. In the offshore area, the typhoon may trigger increase of Chl-a concentration through uptake of nutrients by typhoon-induced upwelling and entrainment mixing.	[Zhao, Hui; Shao, Jinchao] Guangdong Ocean Univ, Guangdong Key Lab Climate Resource & Environm Con, Coll Ocean & Meteorol, Zhanjiang, Peoples R China; [Han, Guoqi] Fisheries & Oceans Canada, Northwest Atlantic Fisheries Ctr, St John, NF, Canada; [Yang, Dezhou] Chinese Acad Sci, Key Lab Ocean Circulat & Waves, Qingdao, Peoples R China; [Yang, Dezhou] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Lv, Jianhai] Marine & Fishery Environm Monitoring Ctr Guangzho, Guangzhou, Guangdong, Peoples R China	Guangdong Ocean University; Fisheries & Oceans Canada; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhao, H (corresponding author), Guangdong Ocean Univ, Guangdong Key Lab Climate Resource & Environm Con, Coll Ocean & Meteorol, Zhanjiang, Peoples R China.	huizhao1978@163.com	Han, Guoqi/T-7365-2019		Foundation for Distinguished Young Teacher in Higher Education of Guangdong [YQ2013092]; National Natural Science Foundation of China [41376125, 41006070]; Strategic Priority Research Program of the Chinese Academy of Sciences, China [XDA11020305, CDA11010301, XDA11010302]; Canadian Space Agency Government Related Initiative Program (GRIP)	Foundation for Distinguished Young Teacher in Higher Education of Guangdong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences, China; Canadian Space Agency Government Related Initiative Program (GRIP)	The present research is supported by the Foundation for Distinguished Young Teacher in Higher Education of Guangdong (YQ2013092), the National Natural Science Foundation of China (41376125 and 41006070), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA11020305, CDA11010301, and XDA11010302), China and the Canadian Space Agency Government Related Initiative Program (GRIP).	ANTHES RA, 1978, J ATMOS SCI, V35, P1240, DOI 10.1175/1520-0469(1978)035<1240:ROTHBL>2.0.CO;2; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Chen CTA, 2003, J MARINE SYST, V42, P65, DOI 10.1016/S0924-7963(03)00065-4; [陈光华 CHEN Guanghua], 2006, [地球科学进展, Advance in Earth Sciences], V21, P610; Chen XQ, 2000, OCEANOGRAPHY CHINA N, P151; Chen YQ, 2012, INT J REMOTE SENS, V33, P7444, DOI 10.1080/01431161.2012.685976; Elsner JB, 2003, CLIMATE RES, V25, P43, DOI 10.3354/cr025043; FALKOWSKI PG, 1994, PHOTOSYNTH RES, V39, P235, DOI 10.1007/BF00014586; FURUYA K, 1990, MAR BIOL, V107, P529, DOI 10.1007/BF01313438; [高姗 Gao Shan], 2010, [海洋学报, Acta Oceanologica Sinica], V32, P168; Gong X, 2015, BIOGEOSCIENCES, V12, P905, DOI 10.5194/bg-12-905-2015; [宫响 Gong Xiang], 2012, [地球科学进展, Advance in Earth Sciences], V27, P539; Han GQ, 2012, J MARINE SYST, V100, P19, DOI 10.1016/j.jmarsys.2012.03.012; Hein M, 1997, NATURE, V388, P526, DOI 10.1038/41457; Ke Zhi-xin, 2013, Journal of Tropical Oceanography, V32, P51, DOI 10.3969/j.issn.1009-5470.2013.04.008; Lin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017141; MARRA J, 1990, DEEP-SEA RES, V37, P127, DOI 10.1016/0198-0149(90)90032-Q; McClanahan T, 2015, FISH FISH, V16, P78, DOI 10.1111/faf.12045; Pennington JT, 2006, PROG OCEANOGR, V69, P285, DOI 10.1016/j.pocean.2006.03.012; PRICE JF, 1981, J PHYS OCEANOGR, V11, P153, DOI 10.1175/1520-0485(1981)011<0153:UORTAH>2.0.CO;2; Ren FM, 2002, ADV ATMOS SCI, V19, P943; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Stewart RH, 2002, INTRO PHYS OCEANOGRA, P148; Sun L, 2010, MAR ECOL PROG SER, V404, P39, DOI 10.3354/meps08477; Tang DL, 2002, REMOTE SENS ENVIRON, V83, P457, DOI 10.1016/S0034-4257(02)00062-7; Watson R, 2014, FISH FISH, V15, P231, DOI 10.1111/faf.12013; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Wu LG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022937; Yang Xiao-xia, 2010, Journal of Tropical Oceanography, V29, P26; YENTSCH CHARLES S., 1965, DEEP SEA RES, V12, P653, DOI 10.1016/0011-7471(65)91864-4; Zhang F, 2001, MAR SCI, V25, P1; Zhao H, 2008, MAR ECOL PROG SER, V365, P57, DOI 10.3354/meps07488; [赵辉 Zhao Hui], 2005, [海洋学报, Acta Oceanologica Sinica], V27, P45; Zhao H, 2013, J GEOPHYS RES-BIOGEO, V118, P412, DOI 10.1002/jgrg.20041; Zhao H, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005384; Zheng GM, 2007, MAR ECOL PROG SER, V333, P61, DOI 10.3354/meps333061; Zhou WH, 2012, ESTUAR COAST SHELF S, V111, P35, DOI 10.1016/j.ecss.2012.06.004	37	30	34	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137863	10.1371/journal.pone.0137863	http://dx.doi.org/10.1371/journal.pone.0137863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407324	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700026
J	Costa, RFA; Longatto, A; Pinheiro, C; Zeferino, LC; Fregnani, JH				Alves Costa, Ricardo Filipe; Longatto-Filho, Adhemar; Pinheiro, Celine; Zeferino, Luiz Carlos; Fregnani, Jose Humberto			Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A Time for Reflection	PLOS ONE			English	Article							PARTICIPANTS; MORTALITY; COVERAGE; SMEARS; RATES	Background The Cervical Cancer Database of the Brazilian National Health Service (SISCOLO) contains information regarding all cervical cytological tests and, if properly explored, can be used as a tool for monitoring and managing the cervical cancer screening program. The aim of this study was to perform a historical analysis of the cervical cancer screening program in Brazil from 2006 to 2013. Material and Methods The data necessary to calculate quality indicators were obtained from the SISCOLO, a Brazilian health system tool. Joinpoint analysis was used to calculate the annual percentage change. Results We observed important trends showing decreased rates of low-grade squamous intraepithelial lesions (LSIL) and high-grade squamous intraepithelial lesions (HSIL) and an increased rate of rejected exams from 2009 to 2013. The index of positivity was maintained at levels below those indicated by international standards; very low frequencies of unsatisfactory cases were observed over the study period, which partially contradicts the low rate of positive cases. The number of positive cytological diagnoses was below that expected, considering that developed countries with low frequencies of cervical cancer detect more lesions annually. Conclusions The evolution of indicators from 2006 to 2013 suggests that actions must be taken to improve the effectiveness of cervical cancer control in Brazil.	[Alves Costa, Ricardo Filipe] Barretos Canc Hosp, Grad Program Oncol, Sao Paulo, Brazil; [Alves Costa, Ricardo Filipe; Pinheiro, Celine] Barretos Sch Hlth Sci Dr Paulo Prata FACISB, Sao Paulo, Brazil; [Fregnani, Jose Humberto] Barretos Canc Hosp, Res & Teaching Inst, Sao Paulo, Brazil; [Longatto-Filho, Adhemar; Pinheiro, Celine] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil; [Longatto-Filho, Adhemar] Univ Sao Paulo, Fac Med, Lab Med Invest LIM 14, FMUSP, Sao Paulo, Brazil; [Longatto-Filho, Adhemar] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, ICVS, Braga, Portugal; [Longatto-Filho, Adhemar] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Zeferino, Luiz Carlos] Univ Estadual Campinas, Womens Hosp CAISM, Sch Med Sci, Campinas, SP, Brazil	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade de Sao Paulo; Universidade do Minho; Universidade Estadual de Campinas	Costa, RFA (corresponding author), Barretos Canc Hosp, Grad Program Oncol, Sao Paulo, Brazil.	ricardofacosta@gmail.com	Pinheiro, Celine/GWM-6044-2022; Filho, Adhemar Longatto/A-2889-2016; Costa, Ricardo FA/J-1349-2016; Pinheiro, Céline/B-5961-2009; Fregnani, José H/H-4238-2012; Zeferino, Luiz Carlos/AAQ-2140-2020; longatto-filho, adhemar/D-7039-2013; Longatto-Filho, Adhemar/N-3397-2019	Pinheiro, Celine/0000-0002-4685-8534; Costa, Ricardo FA/0000-0002-5988-9890; Pinheiro, Céline/0000-0002-4685-8534; Fregnani, José H/0000-0002-5235-6469; Zeferino, Luiz Carlos/0000-0002-5495-0971; longatto-filho, adhemar/0000-0002-5779-9752; Longatto-Filho, Adhemar/0000-0002-5779-9752				Adab P, 2004, MED CARE, V42, P600, DOI 10.1097/01.mlr.0000128007.04494.29; do Vale DBAP, 2010, CAD SAUDE PUBLICA, V26, P383, DOI 10.1590/S0102-311X2010000200017; Azara CZS, 2014, REV BRAS GINECOL OBS, V36, P398, DOI 10.1590/SO100-720320140004996; Brasil, 2011, DIR BRAS RASTR CANC; Brasil, 2010, PESQ NAC AM DOM PAN; Manrique EJC, 2007, REV BRAS GINECOL OBS, V29, P402, DOI 10.1590/S0100-72032007000800004; Correa MD, 2012, CAD SAUDE PUBLICA, V28, P2257, DOI [10.1590/S0102-311X2012001400005, 10.1590/S0102-311]; Davey DD, 2004, ARCH PATHOL LAB MED, V128, P1224; Freitas Hilda Guimarães de, 2012, Rev. Bras. Ginecol. Obstet., V34, P351, DOI 10.1590/S0100-72032012000800002; Dufloth RM, 2005, EUR J GYNAECOL ONCOL, V26, P186; Eversole GM, 2010, ARCH PATHOL LAB MED, V134, P331, DOI 10.1043/1543-2165-134.3.331; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Franco EL, 2009, ARCH MED RES, V40, P478, DOI 10.1016/j.arcmed.2009.06.003; Franco Rosana, 2006, Rev. Bras. Ginecol. Obstet., V28, P479, DOI 10.1590/S0100-72032006000800007; Freitas RAP, 2008, EUR J GYNAECOL ONCOL, V29, P479; Girianelli VR, 2014, REV SAUDE PUBL, V48, P459, DOI 10.1590/S0034-8910.2014048005214; HSCIC, 2012, CERV SCREEN PROGR EN; IBGE, 2013, PESQ NAC SAUD 2013; INCA, 2014, EST 2014 INC CANC BR; INCA, 2012, MAN GEST QUAL LAB CI; Instituto Nacional De Cancer Jose Alencar Gomes Da Silva (INCA), 2010, PROGR NAC CONTR CANC; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Madlensky L, 2003, EUR J CANCER, V39, P1648, DOI 10.1016/S0959-8049(03)00315-0; Mathew A, 2009, ASIAN PAC J CANCER P, V10, P645; da Silva DSM, 2014, CIENC SAUDE COLETIVA, V19, P1163, DOI 10.1590/1413-81232014194.00372013; Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86; Organizacion Panamericana de la Salud (OPS), 2000, MOD CIT PROC; Pinho Adriana de Araujo, 2003, Cad. Saúde Pública, V19, pS303, DOI 10.1590/S0102-311X2003000800012; Renshaw AA, 2011, DIAGN CYTOPATHOL, V39, P647, DOI 10.1002/dc.21439; Thuler Luiz Claudio Santos, 2007, J. Bras. Patol. Med. Lab., V43, P103, DOI 10.1590/S1676-24442007000200006; Zeferino LC, 2006, BEST PRACT RES CL OB, V20, P339, DOI 10.1016/j.bpobgyn.2006.01.018	31	35	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138945	10.1371/journal.pone.0138945	http://dx.doi.org/10.1371/journal.pone.0138945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402737	gold, Green Published, Green Submitted			2022-12-27	WOS:000361798100044
J	Jiaox, X; Khan, SY; Irum, B; Khan, AO; Wang, QW; Kabir, F; Khan, AA; Husnain, T; Akram, J; Riazuddin, S; Hejtmancik, JF; Riazuddin, SA				Jiaox, Xiaodong; Khan, Shahid Y.; Irum, Bushra; Khan, Arif O.; Wang, Qiwei; Kabir, Firoz; Khan, Asma A.; Husnain, Tayyab; Akram, Javed; Riazuddin, Sheikh; Hejtmancik, J. Fielding; Riazuddin, S. Amer			Missense Mutations in CRYAB Are Liable for Recessive Congenital Cataracts	PLOS ONE			English	Article							B-CRYSTALLIN MUTATION; CONSANGUINEOUS PAKISTANI FAMILIES; POSTERIOR POLAR CATARACT; NONSENSE MUTATION; NUCLEAR CATARACT; CHINESE FAMILY; GENE CAUSES; LOCUS; CARDIOMYOPATHY; BLINDNESS	Purpose This study was initiated to identify causal mutations responsible for autosomal recessive congenital cataracts in consanguineous familial cases. Methods Affected individuals underwent a detailed ophthalmological and clinical examination, and slit-lamp photographs were ascertained for affected individuals who have not yet been operated for the removal of the cataractous lens. Blood samples were obtained, and genomic DNA was extracted from white blood cells. A genome-wide scan was completed with short tandem repeat (STR) markers, and the logarithm of odds (LOD) scores were calculated. Protein coding exons of CRYAB were sequenced, bi-directionally. Evolutionary conservation was investigated by aligning CRYAB orthologues, and the expression of Cryab in embryonic and postnatal mice lens was investigated with TaqMan probe. Results The clinical and ophthalmological examinations suggested that all affected individuals had nuclear cataracts. Genome-wide linkage analysis suggested a potential region on chromosome 11q23 harboring CRYAB. DNA sequencing identified a missense variation: c.34C> T (p.R12C) in CRYAB that segregated with the disease phenotype in the family. Subsequent interrogation of our entire cohort of familial cases identified a second familial case localized to chromosome 11q23 harboring a c.31C> T (p.R11C) mutation. In silico analyses suggested that the mutations identified in familial cases, p.R11C and p.R12C will not be tolerated by the three-dimensional structure of CRYAB. Real-time PCR analysis identified the expression of Cryab in mouse lens as early as embryonic day 15 (E15) that increased significantly until postnatal day 6 (P6) with steady level of expression thereafter. Conclusion Here, we report two novel missense mutations, p.R11C and p.R12C, in CRYAB associated with autosomal recessive congenital nuclear cataracts.	[Jiaox, Xiaodong; Wang, Qiwei; Hejtmancik, J. Fielding] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Khan, Shahid Y.; Irum, Bushra; Kabir, Firoz; Riazuddin, S. Amer] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Irum, Bushra; Khan, Asma A.; Husnain, Tayyab; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Khan, Arif O.] King Khalid Eye Specialist Hosp, Riyadh 12329, Saudi Arabia; [Akram, Javed; Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54550, Pakistan; [Akram, Javed; Riazuddin, Sheikh] Shaheed Zulfiqar Ali Bhutto Med Univ, Natl Ctr Genet Dis, Islamabad, Pakistan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; King Khaled Eye Specialist Hospital; University of Health Science - Pakistan	Riazuddin, SA (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA.	riazuddin@jhmi.edu	Khan, Asma Al/AAH-5277-2021; Husnain, Tayyab/AAE-9033-2019		National Eye Institute [1R01EY022714]; Knight Templar Eye Foundation; King Khaled Eye Specialist Hospital-Johns Hopkins University; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan; NATIONAL EYE INSTITUTE [ZIAEY000281, R01EY022714] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knight Templar Eye Foundation; King Khaled Eye Specialist Hospital-Johns Hopkins University; National Academy of Sciences, Washington DC USA; Higher Education Commission, Islamabad Pakistan(Higher Education Commission of Pakistan); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the National Eye Institute, Grant 1R01EY022714 (SAR), Knight Templar Eye Foundation Grant (SAR), King Khaled Eye Specialist Hospital-Johns Hopkins University collaboration grant (SAR), the National Academy of Sciences, Washington DC USA and the Higher Education Commission, Islamabad Pakistan.	Abu Safieh L, 2009, MOL VIS, V15, P980; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Butt T, 2007, MOL VIS, V13, P1635; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Chen Q, 2009, MOL VIS, V15, P1359; Cohen D, 2007, INVEST OPHTH VIS SCI, V48, P2208, DOI 10.1167/iovs.06-1019; Del Bigio MR, 2011, ANN NEUROL, V69, P866, DOI 10.1002/ana.22331; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Devi RR, 2008, MOL VIS, V14, P1157; DUBIN RA, 1990, GENOMICS, V7, P594, DOI 10.1016/0888-7543(90)90204-8; FOSTER A, 1990, INT OPHTHALMOL, V14, P135, DOI 10.1007/BF00158310; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Hejtmancik JF, 2003, DEV OPHTHALMOL, V37, P67; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Kaul H, 2010, MOL VIS, V16, P511; Kaul H, 2010, MOL VIS, V16, P240; Khan AO, 2010, OPHTHALMIC GENET, V31, P30, DOI 10.3109/13816810903452047; Khan SY, 2015, MOL VIS, V21, P871; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Liu MG, 2006, INVEST OPHTH VIS SCI, V47, P3461, DOI 10.1167/iovs.05-1438; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Pilotto A, 2006, BIOCHEM BIOPH RES CO, V346, P1115, DOI 10.1016/j.bbrc.2006.05.203; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Pras E, 2004, INVEST OPHTH VIS SCI, V45, P1940, DOI 10.1167/iovs.03-1117; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pras E, 2001, ISR MED ASSOC J, V3, P559; Ramachandran RD, 2007, HUM GENET, V121, P475, DOI 10.1007/s00439-006-0319-6; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P623, DOI 10.1167/iovs.04-0955; ROBINSON GC, 1987, AM J DIS CHILD, V141, P1321, DOI 10.1001/archpedi.1987.04460120087041; Sabir N, 2010, MOL VIS, V16, P2911; Sabir N, 2010, MOL VIS, V16, P2634; Sacconi S, 2012, NEUROMUSCULAR DISORD, V22, P66, DOI 10.1016/j.nmd.2011.07.004; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Smaoui N, 2004, INVEST OPHTH VIS SCI, V45, P2716, DOI 10.1167/iovs.03-1370; Sun WM, 2011, MOL VIS, V17, P2197; van der Smagt JJ, 2014, CLIN GENET, V85, P381, DOI 10.1111/cge.12169; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	41	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0137973	10.1371/journal.pone.0137973	http://dx.doi.org/10.1371/journal.pone.0137973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402864	Green Submitted, gold, Green Published			2022-12-27	WOS:000361798100015
J	Mansourvar, M; Shamshirband, S; Raj, RG; Gunalan, R; Mazinani, I				Mansourvar, Marjan; Shamshirband, Shahaboddin; Raj, Ram Gopal; Gunalan, Roshan; Mazinani, Iman			An Automated System for Skeletal Maturity Assessment by Extreme Learning Machines	PLOS ONE			English	Article							BONE-AGE ASSESSMENT; SEGMENTATION; CARPAL; PREDICTION; NETWORKS; GREULICH; PYLE	Assessing skeletal age is a subjective and tedious examination process. Hence, automated assessment methods have been developed to replace manual evaluation in medical applications. In this study, a new fully automated method based on content-based image retrieval and using extreme learning machines (ELM) is designed and adapted to assess skeletal maturity. The main novelty of this approach is it overcomes the segmentation problem as suffered by existing systems. The estimation results of ELM models are compared with those of genetic programming (GP) and artificial neural networks (ANNs) models. The experimental results signify improvement in assessment accuracy over GP and ANN, while generalization capability is possible with the ELM approach. Moreover, the results are indicated that the ELM model developed can be used confidently in further work on formulating novel models of skeletal age assessment strategies. According to the experimental results, the new presented method has the capacity to learn many hundreds of times faster than traditional learning methods and it has sufficient overall performance in many aspects. It has conclusively been found that applying ELM is particularly promising as an alternative method for evaluating skeletal age.	[Mansourvar, Marjan; Shamshirband, Shahaboddin; Raj, Ram Gopal] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur 50603, Malaysia; [Gunalan, Roshan] Univ Malaya, Fac Med, Kuala Lumpur 50603, Malaysia; [Mazinani, Iman] Univ Malaya, Fac Engn, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Mansourvar, M (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur 50603, Malaysia.	mansourvar@um.edu.my	S.Band, Shahab/AAD-3311-2021; mansourvar, marjan/AAM-7846-2020; Gunalan, Roshan/AFK-0450-2022; Mansourvar, Marjan/AAE-2310-2019; S.Band, Shahab/ABI-7388-2020; Gunalan, Roshan/ABA-2001-2020; Raj, Ram Gopal/B-3399-2010	Gunalan, Roshan/0000-0002-5430-5542; Mansourvar, Marjan/0000-0001-6492-7858; S.Band, Shahab/0000-0002-8963-731X; Raj, Ram Gopal/0000-0002-8627-1113; Shamshirband, Shahaboddin/0000-0002-6605-498X	University of Malaya Research Grant (UMRG) [RP026-14AET]	University of Malaya Research Grant (UMRG)	University of Malaya Research Grant (UMRG), grant number. RP026-14AET.	Aja-Fernandez S, 2004, J BIOMED INFORM, V37, P99, DOI 10.1016/j.jbi.2004.01.002; Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Annema A, 1994, PRECISION REQUIREMEN; Babovic V., 2005, ENCY HYDROLOGICAL SC; Bull RK, 1999, ARCH DIS CHILD, V81, P172, DOI 10.1136/adc.81.2.172; Chai HY, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-87; Chai HY., 2011, INT J MATH MODELS ME, V5, P628; Choras R S., 2007, INT J BIOL BIOMEDICA, V1, P6; Deng Z, 2014, MINIMAX PROBABILITY; Drew PJ, 2000, SURGERY, V127, P3, DOI 10.1067/msy.2000.102173; Fischer B, 2011, BONE AGE ASSESSMENT; Fischer B, 2012, INT J COMPUT ASS RAD, V7, P389, DOI 10.1007/s11548-011-0627-8; Gertych A, 2007, PATTERN ANAL APPL, V10, P115, DOI 10.1007/s10044-006-0056-4; Ghouti L, 2013, PROCEDIA COMPUT SCI, V19, P305, DOI 10.1016/j.procs.2013.06.043; Giordano D, 2010, IEEE T INSTRUM MEAS, V59, P2539, DOI 10.1109/TIM.2010.2058210; Han CC, 2007, PATTERN RECOGN, V40, P2994, DOI 10.1016/j.patcog.2007.01.010; HOPFIELD JJ, 1988, IEEE CIRCUIT DEVIC, V4, P3, DOI 10.1109/101.8118; Huang G, 2015, NEURAL NETWORKS, V61, P32, DOI 10.1016/j.neunet.2014.10.001; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P863, DOI 10.1109/TNN.2006.875974; Jonsson K., 2002, ACTA RADIOL, V43, P236, DOI [10.1034/j.1600-0455.2002.430228_5.x, DOI 10.1034/J.1600-0455.2002.430228_5.X]; Khu ST, 2001, J AM WATER RESOUR AS, V37, P439, DOI 10.1111/j.1752-1688.2001.tb00980.x; Koza JR, 1992, GENETIC PROGRAMMING; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Liu J, 2008, COMPUT MED IMAG GRAP, V32, P678, DOI 10.1016/j.compmedimag.2008.08.005; Mahmoodi S, 2000, IEEE T INF TECHNOL B, V4, P292, DOI 10.1109/4233.897061; MANOS G, 1993, IMAGE VISION COMPUT, V11, P100, DOI 10.1016/0262-8856(93)90076-S; Mansourvar M, 2014, INT J INFORM TECHNOL, V20; Mansourvar M, 2014, QUANTITATIVE STUDY D, P659; Mansourvar M, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/391626; Mansourvar M, 2014, J FORENSIC LEG MED, V22, P26, DOI 10.1016/j.jflm.2013.11.011; Mansourvar M, 2012, MALAYS J COMPUT SCI, V25, P107; MICHAEL DJ, 1989, IEEE T MED IMAGING, V8, P64, DOI 10.1109/42.20363; Nian R, 2014, NEUROCOMPUTING, V128, P273, DOI 10.1016/j.neucom.2013.03.054; Patil ST, 2012, FORENSIC SCI INT, V216, DOI 10.1016/j.forsciint.2011.09.022; PIETKA E, 1993, IEEE T MED IMAGING, V12, P44, DOI 10.1109/42.222665; Sebastian TB, 2003, MED IMAGE ANAL, V7, P21, DOI 10.1016/S1361-8415(02)00065-8; Singh R., 2007, INT J INTELLIGENT TE, V2, P256; Takekawa T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00005; Tristan-Vega A, 2008, IEEE T BIO-MED ENG, V55, P1463, DOI 10.1109/TBME.2008.918554; Wang DA, 2014, NEUROCOMPUTING, V128, P258, DOI 10.1016/j.neucom.2012.12.062; Wang XY, 2014, NEUROCOMPUTING, V145, P90, DOI 10.1016/j.neucom.2014.05.068; Wong PK, 2015, RENEW ENERG, V74, P640, DOI 10.1016/j.renene.2014.08.075; Yazdani S, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0207-7; Yu Q, 2014, NEUROCOMPUTING, V128, P296, DOI 10.1016/j.neucom.2013.01.063; Zhan YB, 2011, NEUROCOMPUTING, V74, P1985, DOI 10.1016/j.neucom.2010.06.029; Zhang AF, 2007, COMPUT MED IMAG GRAP, V31, P299, DOI 10.1016/j.compmedimag.2007.02.008; Zhang RX, 2007, IEEE ACM T COMPUT BI, V4, P485, DOI 10.1109/TCBB.2007.1012	50	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138493	10.1371/journal.pone.0138493	http://dx.doi.org/10.1371/journal.pone.0138493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402795	Green Published, gold, Green Submitted			2022-12-27	WOS:000361798100026
J	Matsumoto, M; Koike, S; Kashima, S; Awai, K				Matsumoto, Masatoshi; Koike, Soichi; Kashima, Saori; Awai, Kazuo			Geographic Distribution of Radiologists and Utilization of Teleradiology in Japan: A Longitudinal Analysis Based on National Census Data	PLOS ONE			English	Article							HEALTH-CARE RESOURCES; GENERAL-PRACTITIONERS; PHYSICIANS; MALDISTRIBUTION; SPECIALTY; SERVICES; SYSTEM; IMPACT; US	Background Japan has the most CT and MRI scanners per unit population in the world, and as these technologies spread, their geographic distribution is becoming equalized. In contrast, the number of radiologists per unit population in Japan is the lowest among OECD countries and their geographic distribution is unknown. Likewise, little is known about the use of teleradiology, which can compensate for the uneven distribution of radiologists. Methods Based on the Survey of Physicians, Dentists and Pharmacists and the Static Survey of Medical Institutions by the Ministry of Health, Labour and Welfare, a dataset of radiologists and CT and MRI utilizations in each of Japan's 1811 municipalities was created. The inter-municipality equity of the number of radiologists was evaluated using Gini coefficient. Logistic regression analysis, based on Static Survey data, was performed to evaluate the association between hospital location and teleradiology use. Results Between 2006 and 2012 the number of radiologists increased by 21.7%, but the Gini coefficient remained unchanged. The number of radiologists per 1,000 CT (MRI) utilizations decreased by 17.9% (1.0%); the number was highest in metropolis and lowest in town/village and the disparity has widened from 1.9 to 2.2 (1.6 to 2.0) times. The number of hospitals and clinics using teleradiology has increased (by 69.6% and 18.1%, respectively). Hospitals located in towns/villages (odds ratio 1.61; 95% confidence interval 1.26-2.07) were more likely to use teleradiology than those in metropolises. Conclusions Contrary to the CT and MRI distributions, radiologist distribution has not been evened out by the increase in their number; in other words, the distribution of radiologists was not affected by market-derived spatial competition force. As a consequence, the gap of the radiologist shortage between urban and rural areas is increasing. Teleradiology, which is one way to ameliorate this gap, should be encouraged.	[Matsumoto, Masatoshi] Hiroshima Univ, Fac Med, Dept Community Based Med Syst, Hiroshima, Japan; [Koike, Soichi] Jichi Med Univ, Ctr Community Med, Div Hlth Policy & Management, Shimotsuke, Tochigi, Japan; [Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Awai, Kazuo] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Diagnost Radiol, Hiroshima, Japan	Hiroshima University; Jichi Medical University; Hiroshima University; Hiroshima University	Matsumoto, M (corresponding author), Hiroshima Univ, Fac Med, Dept Community Based Med Syst, Hiroshima, Japan.	matmo10@jb3.so-net.ne.jp	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303	Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare, Tokyo, Japan [H26 - Research on Statistics and Information - 001]	Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare, Tokyo, Japan	This study was supported by Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare, Tokyo, Japan (H26 - Research on Statistics and Information - 001). The funder provided part of the data to authors but had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Binkhuysen FHB, 2011, EUR J RADIOL, V78, P205, DOI 10.1016/j.ejrad.2010.08.027; BROWN MC, 1994, SOC SCI MED, V38, P1243, DOI 10.1016/0277-9536(94)90189-9; De Maio FG, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052969; Ebbert TL, 2007, AM J ROENTGENOL, V188, pW103, DOI 10.2214/AJR.06.1310; Hann M, 2004, BRIT J GEN PRACT, V54, P894; He D, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-39; Horev T, 2004, HEALTH POLICY, V68, P223, DOI 10.1016/j.healthpol.2003.09.011; Japanese Board of Medical Specialties, 2013, PRES NUMB MED SPEC; Kaidu M, 2004, J TELEMED TELECARE, V10, P214, DOI 10.1258/1357633041424430; Kawahara Ichiro, 2011, No Shinkei Geka, V39, P963; Khilji SUS, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-82; KOBAYASHI Y, 1992, LANCET, V340, P1391, DOI 10.1016/0140-6736(92)92569-2; Koike S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-180; Lewis RS, 2009, AM J ROENTGENOL, V193, P1333, DOI 10.2214/AJR.09.2984; Matsumoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126036; Matsumoto M, 2010, HEALTH POLICY, V96, P255, DOI 10.1016/j.healthpol.2010.02.012; Matsumoto M, 2010, HEALTH POLICY, V96, P239, DOI 10.1016/j.healthpol.2010.02.008; Mehta NR, 2014, ENCY HLTH EC, P143; Ministry of Health Labour and Welfare, 2013, ISH SHIK YAK CHOS; Ministry of Health Labour and Welfare, 2014, HEISEI26NENDO SHINR; Nakajima Y, 2008, RADIAT MED, V26, P455, DOI 10.1007/s11604-008-0259-2; NEWHOUSE JP, 1990, ANNU REV PUBL HEALTH, V11, P207, DOI 10.1146/annurev.pu.11.050190.001231; NIPSSR, 2012, POPULATION PROJECTIO; Organization for Economic Cooperation and Development, 2014, OECD HLTH STAT 2014; SCHWARTZ WB, 1980, NEW ENGL J MED, V303, P1032, DOI 10.1056/NEJM198010303031803; Scott A, 2013, SOC SCI MED, V96, P33, DOI 10.1016/j.socscimed.2013.07.002; Shinjo D, 2012, SOC SCI MED, V75, P1954, DOI 10.1016/j.socscimed.2012.07.032; Soni K, 2010, AM J ROENTGENOL, V194, P697, DOI 10.2214/AJR.09.2437; Statistics Bureau, 2013, STAT OBS SHI KU MACH; Takahashi T, 2001, INT J MED INFORM, V61, P131, DOI 10.1016/S1386-5056(01)00135-6; Tanihara S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-260; Toyabe S, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-5; Toyokawa S, 2010, SOC SCI MED, V71, P2014, DOI 10.1016/j.socscimed.2010.09.005	33	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139723	10.1371/journal.pone.0139723	http://dx.doi.org/10.1371/journal.pone.0139723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26421721	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700136
J	Ezpeleta, L; Granero, R; de la Osa, N; Domenech, JM				Ezpeleta, Lourdes; Granero, Roser; de la Osa, Nuria; Domenech, Josep M.			Clinical Characteristics of Preschool Children with Oppositional Defiant Disorder and Callous-Unemotional Traits	PLOS ONE			English	Article							CHILDHOOD FACTOR STRUCTURE; CONDUCT PROBLEMS; YOUNG-CHILDREN; EYE CONTACT; PSYCHOPATHY; DIMENSIONS; BEHAVIOR; ADOLESCENTS; STABILITY; PARENTS	There is a need to know whether callous-unemotional (CU) traits identify a more severe group of oppositional defiant children (ODD). The aim of this study is to ascertain cross-sectionally and longitudinally the specific contribution of CU levels and the presence of ODD in the psychological state of preschool children from the general population. A total of 622 children were assessed longitudinally at ages 3 and 5 with a semi-structured diagnostic interview and questionnaires filled out by parents and teachers. In multivariate models simultaneously including ODD diagnosis and CU levels, controlling by socioeconomic status, ethnicity, sex, severity of conduct disorder symptoms and other comorbidity, high CU scores were related to higher levels of aggression, withdrawn, externalizing and global symptomatology, functional impairment and higher probability of comorbid disorders and use of services. The contribution of CU traits on children's psychological state was not moderated by the presence/absence of ODD. Stability for CU traits and number of ODD-symptoms between ages 3 and 5 was statistically significant but moderate-low (intra-class correlation under .40). Assessment and identification of CU traits from preschool might help to identify a subset of children who could have socialization problems, not only among those with ODD but also among those without a diagnosis of conduct problems.	[Ezpeleta, Lourdes; Granero, Roser; de la Osa, Nuria; Domenech, Josep M.] SGR 312 Generalitat Catalunya, Grp Recerca 2014, Unitat Epidemiol & Diagnost Psicopatol Desenvolup, Barcelona, Spain; [Ezpeleta, Lourdes; de la Osa, Nuria] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, E-08193 Barcelona, Spain; [Granero, Roser; Domenech, Josep M.] Univ Autonoma Barcelona, Dept Psicobiol & Metodol Ciencies Salut, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Ezpeleta, L (corresponding author), SGR 312 Generalitat Catalunya, Grp Recerca 2014, Unitat Epidemiol & Diagnost Psicopatol Desenvolup, Barcelona, Spain.	Lourdes.Ezpeleta@uab.cat	Granero, Roser/S-3529-2019; Granero, Roser/F-9492-2016	Granero, Roser/0000-0001-6308-3198; Ezpeleta, Lourdes/0000-0002-8957-083X	Spanish Ministry of Economy and Competitiveness [PSI2012-32695]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [2014 SGR 312]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya)	Funding was from the Spanish Ministry of Economy and Competitiveness grant PSI2012-32695 and Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya (2014 SGR 312).	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bohlin G, 2012, J ABNORM CHILD PSYCH, V40, P449, DOI 10.1007/s10802-011-9574-7; Bufferd SJ, 2011, COMPR PSYCHIAT, V52, P359, DOI 10.1016/j.comppsych.2010.08.006; Christian RE, 1997, J AM ACAD CHILD PSY, V36, P233, DOI 10.1097/00004583-199702000-00014; Dadds MR, 2014, J CHILD PSYCHOL PSYC, V55, P771, DOI 10.1111/jcpp.12155; Dadds MR, 2012, BRIT J PSYCHIAT, V200, P191, DOI 10.1192/bjp.bp.110.085720; Dadds MR, 2012, PSYCHIAT RES, V199, P201, DOI 10.1016/j.psychres.2012.04.033; Dadds MR, 2005, J CONSULT CLIN PSYCH, V73, P400, DOI 10.1037/0022-006X.73.3.400; Drabick DAG, 2012, J AM ACAD CHILD PSY, V51, P384, DOI 10.1016/j.jaac.2012.01.010; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Ezpeleta L, 2014, SOC PSYCH PSYCH EPID, V49, P145, DOI 10.1007/s00127-013-0683-1; Ezpeleta L, 2013, J CLIN CHILD ADOLESC, V42, P91, DOI 10.1080/15374416.2012.734221; Ezpeleta L, 2012, J CHILD PSYCHOL PSYC, V53, P1128, DOI 10.1111/j.1469-7610.2012.02545.x; Ezpeleta L, 2011, PSYCHIAT RES, V190, P137, DOI 10.1016/j.psychres.2011.04.034; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Frick P. J, 2004, INVENTORY CALL UNPUB; Frick P. J., PROPOSAL DSM 5 CHILD; Frick PJ, 2008, J CHILD PSYCHOL PSYC, V49, P359, DOI 10.1111/j.1469-7610.2007.01862.x; Frick PJ, 2014, J CHILD PSYCHOL PSYC, V55, P532, DOI 10.1111/jcpp.12152; Frick PJ, 2014, PSYCHOL BULL, V140, P1, DOI 10.1037/a0033076; Frick PJ, 2004, J CLIN CHILD ADOLESC, V33, P54, DOI 10.1207/S15374424JCCP3301_6; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hawes DJ, 2007, J CLIN CHILD ADOLESC, V36, P347, DOI 10.1080/15374410701444298; Hawes DJ, 2013, AUST NZ J PSYCHIAT, V47, P646, DOI 10.1177/0004867413484092; Hawes DJ, 2011, J CLIN CHILD ADOLESC, V40, P507, DOI 10.1080/15374416.2011.581624; Hawes DJ, 2005, J CONSULT CLIN PSYCH, V73, P737, DOI 10.1037/0022-006X.73.4.737; Herpers PCM, 2012, SOC PSYCH PSYCH EPID, V47, P2045, DOI 10.1007/s00127-012-0513-x; Hollingshead A. B., 1975, 4 FACTOR INDEX UNPUB; Hyde LW, 2013, DEV PSYCHOPATHOL, V25, P347, DOI 10.1017/S0954579412001101; Kimonis E., 2006, J CHILD FAM STUD, V15, P745, DOI [DOI 10.1007/S10826-006-9047-8, 10.1007/s10826-006-9047-8]; Kochanska G, 2002, CHILD DEV, V73, P461, DOI 10.1111/1467-8624.00418; Kochanska G, 2013, J CHILD PSYCHOL PSYC, V54, P1251, DOI 10.1111/jcpp.12084; Kolko DJ, 2010, J ABNORM PSYCHOL, V119, P713, DOI 10.1037/a0020910; Lahey BB, 2012, J CHILD PSYCHOL PSYC, V53, P536, DOI 10.1111/j.1469-7610.2011.02509.x; McDonald R, 2011, J ABNORM CHILD PSYCH, V39, P1013, DOI 10.1007/s10802-011-9512-8; McKay K. E., 2008, CHILDRENS AGGRESSION; Obradovic J, 2007, J CLIN CHILD ADOLESC, V36, P276, DOI 10.1080/15374410701441633; Ray JV, 2016, PSYCHOL ASSESSMENT, V28, P394, DOI 10.1037/pas0000183; Roose A, 2010, ASSESSMENT, V17, P44, DOI 10.1177/1073191109344153; Rowe R, 2002, J CHILD PSYCHOL PSYC, V43, P365, DOI 10.1111/1469-7610.00027; Rowe R, 2010, J CHILD PSYCHOL PSYC, V51, P688, DOI 10.1111/j.1469-7610.2009.02199.x; Rutter M, 2012, BRIT J PSYCHIAT, V200, P175, DOI 10.1192/bjp.bp.111.092072; Scholte EM, 2007, INT J METH PSYCH RES, V16, P137, DOI 10.1002/mpr.222; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Skuse DH, 2005, BRIT J PSYCHIAT, V187, P568, DOI 10.1192/bjp.187.6.568; Somech LY, 2012, J AM ACAD CHILD PSY, V51, P412, DOI 10.1016/j.jaac.2012.01.019; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Viding E, 2012, DEV PSYCHOPATHOL, V24, P969, DOI 10.1017/S095457941200048X; Waller R, 2012, J CHILD PSYCHOL PSYC, V53, P946, DOI 10.1111/j.1469-7610.2012.02550.x; Willoughby MT, 2014, J PSYCHOPATHOL BEHAV, V36, P30, DOI 10.1007/s10862-013-9379-9; Willoughby MT, 2013, DEV PSYCHOPATHOL, V25, P903, DOI 10.1017/S0954579413000266; Willoughby MT, 2011, J PSYCHOPATHOL BEHAV, V33, P19, DOI 10.1007/s10862-010-9195-4	55	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139346	10.1371/journal.pone.0139346	http://dx.doi.org/10.1371/journal.pone.0139346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418062	gold, Green Submitted, Green Published			2022-12-27	WOS:000362171400082
J	Mori, K; Fujisawa, T; Kusagaya, H; Yamanaka, K; Hashimoto, D; Enomoto, N; Inui, N; Nakamura, Y; Maekawa, M; Suda, T				Mori, Kazutaka; Fujisawa, Tomoyuki; Kusagaya, Hideki; Yamanaka, Katsumasa; Hashimoto, Dai; Enomoto, Noriyuki; Inui, Naoki; Nakamura, Yutaro; Maekawa, Masato; Suda, Takafumi			Synergistic Proinflammatory Responses by IL-17A and Toll-Like Receptor 3 in Human Airway Epithelial Cells	PLOS ONE			English	Article							MESSENGER-RNA; IMMUNE-RESPONSES; SEVERE ASTHMA; P38 MAPK; EXPRESSION; ACTIVATION; INNATE; INFLAMMATION; PATHWAY; ALPHA	Viral respiratory infections activate the innate immune response in the airway epithelium through Toll-like receptors (TLRs) and induce airway inflammation, which causes acute exacerbation of asthma. Although increases in IL-17A expression were observed in the airway of severe asthma patients, the interaction between IL-17A and TLR activation in airway epithelium remains poorly understood. In this study, we demonstrated that IL-17A and polyI: C, the ligand of TLR3, synergistically induced the expression of proinflammatory cytokines and chemokines (G-CSF, IL-8, CXCL1, CXCL5, IL-1F9), but not type I interferon (IFN-alpha 1, -beta) in primary culture of normal human bronchial epithelial cells. Synergistic induction after co-stimulation with IL-17A and polyI: C was observed from 2 to 24 hours after stimulation. Treatment with cycloheximide or actinomycin D had no effect, suggesting that the synergistic induction occurred without de novo protein synthesis or mRNA stabilization. Inhibition of the TLR3, TLR/TIR-domain-containing adaptor-inducing interferon beta (TRIF), NF-kappa B, and IRF3 pathways decreased the polyI: C-and IL-17A/polyI: C-induced G-CSF and IL-8 mRNA expression. Comparing the levels of mRNA induction between co-treatment with IL-17A/polyI: C and treatment with polyI: C alone, blocking the of NF-kappa B pathway significantly attenuated the observed synergism. In western blotting analysis, activation of both NF-kappa B and IRF3 was observed in treatment with polyI: C and co-treatment with IL-17A/polyI: C; moreover, co-treatment with IL-17A/polyI: C augmented I kappa B-alpha phosphorylation as compared to polyI: C treatment alone. Collectively, these findings indicate that IL-17A and TLR3 activation cooperate to induce proinflammatory responses in the airway epithelium via TLR3/TRIF-mediated NF-kappa B/IRF3 activation, and that enhanced activation of the NF-kappa B pathway plays an essential role in synergistic induction after co-treatment with IL-17A and polyI: C in vitro.	[Mori, Kazutaka; Fujisawa, Tomoyuki; Kusagaya, Hideki; Hashimoto, Dai; Enomoto, Noriyuki; Nakamura, Yutaro; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Yamanaka, Katsumasa; Maekawa, Masato] Hamamatsu Univ Sch Med, Dept Lab Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Inui, Naoki] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Fujisawa, T (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	fujisawa@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264; Maekawa, Masato/0000-0001-9710-5324	Japan Society for the Promotion of Science (JSPS KAKENHI) [26,461,186]	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (C) 26,461,186 from the Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/ (JSPS KAKENHI Grant Number 26,461,186) (TF).	Agache I, 2010, RESP MED, V104, P1131, DOI 10.1016/j.rmed.2010.02.018; [Anonymous], 2014, THORAX, V69, P1; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x; Fujisawa T, 2011, AM J RESP CELL MOL, V45, P246, DOI 10.1165/rcmb.2009-0313OC; Fujisawa T, 2009, J IMMUNOL, V183, P6236, DOI 10.4049/jimmunol.0900614; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hirai Y, 2012, AM J PHYSIOL-RENAL, V302, pF244, DOI 10.1152/ajprenal.00113.2011; Hot A, 2012, ANN RHEUM DIS, V71, P768, DOI 10.1136/annrheumdis-2011-200468; Huang F, 2008, J ALLERGY CLIN IMMUN, V121, P1415, DOI 10.1016/j.jaci.2008.04.016; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Hung LY, 2008, CRIT REV IMMUNOL, V28, P269, DOI 10.1615/CritRevImmunol.v28.i4.10; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Kusagaya H, 2014, AM J RESP CELL MOL, V50, P30, DOI 10.1165/rcmb.2013-0130OC; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016; Mahmutovic-Persson I, 2014, ALLERGY, V69, P348, DOI 10.1111/all.12329; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Mizunoe S, 2012, J PHARMACOL SCI, V118, P512, DOI 10.1254/jphs.11240FP; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Tsai HC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267971; van den Berg A, 2005, AM J RESP CELL MOL, V33, P97, DOI 10.1165/rcmb.2005-0022OC; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001	38	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139491	10.1371/journal.pone.0139491	http://dx.doi.org/10.1371/journal.pone.0139491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418032	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400094
J	Patterson, D; Hicks, T; Dufilie, A; Grinstein, G; Plante, E				Patterson, Dianne; Hicks, Thomas; Dufilie, Andrew; Grinstein, Georges; Plante, Elena			Dynamic Data Visualization with Weave and Brain Choropleths	PLOS ONE			English	Article							SCHIZOPHRENIA; INFORMATION; COGNITION; CORTEX; ATLAS	This article introduces the neuroimaging community to the dynamic visualization workbench, Weave (https://www.oicweave.org/), and a set of enhancements to allow the visualization of brain maps. The enhancements comprise a set of brain choropleths and the ability to display these as stacked slices, accessible with a slider. For the first time, this allows the neuroimaging community to take advantage of the advanced tools already available for exploring geographic data. Our brain choropleths are modeled after widely used geographic maps but this mashup of brain choropleths with extant visualization software fills an important neuroinformatic niche. To date, most neuroinformatic tools have provided online databases and atlases of the brain, but not good ways to display the related data (e.g., behavioral, genetic, medical, etc). The extension of the choropleth to brain maps allows us to leverage general-purpose visualization tools for concurrent exploration of brain images and related data. Related data can be represented as a variety of tables, charts and graphs that are dynamically linked to each other and to the brain choropleths. We demonstrate that the simplified region-based analyses that underlay choropleths can provide insights into neuroimaging data comparable to those achieved by using more conventional methods. In addition, the interactive interface facilitates additional insights by allowing the user to filter, compare, and drill down into the visual representations of the data. This enhanced data visualization capability is useful during the initial phases of data analysis and the resulting visualizations provide a compelling way to publish data as an online supplement to journal articles.	[Patterson, Dianne; Plante, Elena] Univ Arizona, Speech Language & Hearing Sci Dept, Tucson, AZ 85721 USA; [Hicks, Thomas] Univ Arizona, Sch Informat Sci Technol & Arts, Tucson, AZ USA; [Dufilie, Andrew; Grinstein, Georges] Univ Massachusetts Lowell, Dept Comp Sci, Lowell, MA USA	University of Arizona; University of Arizona; University of Massachusetts System; University of Massachusetts Lowell	Patterson, D (corresponding author), Univ Arizona, Speech Language & Hearing Sci Dept, Tucson, AZ 85721 USA.	dkp@email.arizona.edu		Patterson, Dianne/0000-0001-7518-3110	National Institute of Deafness and Other Communication Disorders [1R01 DC011276]; Association of State & Territorial Health Office: Weave PHCP Integration; University of Massachusetts - Boston/National Institutes of Health: Visualizing Highway Pollution and its Effects; Pacific Northwest National Laboratories: VAST Challenge support; Association of State and Territorial Health Office/Centers for Disease Control: BRFSS on the Cloud - Demonstration of Internet Panel Recruitment, Management; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011276] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Association of State & Territorial Health Office: Weave PHCP Integration; University of Massachusetts - Boston/National Institutes of Health: Visualizing Highway Pollution and its Effects; Pacific Northwest National Laboratories: VAST Challenge support; Association of State and Territorial Health Office/Centers for Disease Control: BRFSS on the Cloud - Demonstration of Internet Panel Recruitment, Management; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was funded in part by a grant from the National Institute of Deafness and Other Communication Disorders 1R01 DC011276, http://www.nidcd.nih.gov/Pages/default.aspx (EP); the Association of State & Territorial Health Office: Weave PHCP Integration (2014-2015), http://www.astho.org/, (GG); University of Massachusetts - Boston/National Institutes of Health: Visualizing Highway Pollution and its Effects-(2014-2016), http://www.nih.gov/ (GG); Pacific Northwest National Laboratories: VAST Challenge 2014 support (2014), http://www.pnnl.gov/; (GG), and Association of State and Territorial Health Office/Centers for Disease Control: BRFSS on the Cloud - Demonstration of Internet Panel Recruitment, Management (2015), http://www.astho.org/, (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigouy B, 2013, NAT METHODS, V10, P1048, DOI 10.1038/nmeth.2692; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bakker R, 2013, CORD C P; Baumann A, 2011, EXPLORATORY PRESENTA, P200, DOI [10.1109/IV.2011.82, DOI 10.1109/IV.2011.82]; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bohland JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007200; Bostock M, 2013, CARTOGR J, V50, P129, DOI 10.1179/0008704113Z.00000000078; Butler H., 2008, GEOJSON FORMAT SPECI; Diedrichsen J, 2011, NEUROIMAGE, V54, P1786, DOI 10.1016/j.neuroimage.2010.10.035; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Friendly M, 2008, MICHAEL FRIENDLY; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Griffiths JD, 2013, CEREB CORTEX, V23, P139, DOI 10.1093/cercor/bhr386; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Kim C, 2015, NEUROSCI LETT, V595, P25, DOI 10.1016/j.neulet.2015.03.044; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Majka P, 2012, NEUROINFORMATICS, V10, P181, DOI 10.1007/s12021-011-9138-6; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Mattschey J, 2015, BNA NEUROSCIENCE FES, P309; Maye A, 2006, INT J NEUROSCI, V116, P431, DOI 10.1080/00207450500505860; Norman K, 2003, DYNAMIC QUERY CHOROP; Nurseitov Nurzhan, 2009, Proceedings on the ISCA 22nd International Conferenceon Computers and Their Applications in Industry and Engineering. CAINE-2009, P157; Patterson RE, 2014, COMPUT GRAPH-UK, V42, P42, DOI 10.1016/j.cag.2014.03.002; Pickle, 2003, CARTOGR GEOGR INF SC, V30, P237, DOI [DOI 10.1559/152304003100011171, 10.1559/152304003100011171]; Plante E, 2014, NEUROPSYCHOLOGIA, V62, P77, DOI 10.1016/j.neuropsychologia.2014.07.007; Sherif T, 2014, FRONT NEUROINFORM, V8, DOI [10.3389/fninf.2014.00054, 10.3389/fninf.2014.00089]; Shirer W, 2011, CEREB CORTEX; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837	29	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139453	10.1371/journal.pone.0139453	http://dx.doi.org/10.1371/journal.pone.0139453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418012	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400092
J	Parker, ML; Peng, FN; Boulanger, MJ				Parker, Michelle L.; Peng, Fangni; Boulanger, Martin J.			The Structure of Plasmodium falciparum Blood-Stage 6-Cys Protein Pf41 Reveals an Unexpected Intra-Domain Insertion Required for Pf12 Coordination	PLOS ONE			English	Article							TOXOPLASMA-GONDII; GENETIC DIVERSITY; SURFACE-ANTIGENS; MALARIA; IMMUNITY; IDENTIFICATION; PREDICTION; APOPTOSIS; DISTINCT; REGIONS	Plasmodium falciparum is an apicomplexan parasite and the etiological agent of severe human malaria. The complex P. falciparum life cycle is supported by a diverse repertoire of surface proteins including the family of 6-Cys s48/45 antigens. Of these, Pf41 is localized to the surface of the blood-stage merozoite through its interaction with the glycophosphatidylinositol-anchored Pf12. Our recent structural characterization of Pf12 revealed two juxtaposed 6-Cys domains (D1 and D2). Pf41, however, contains an additional segment of 120 residues predicted to form a large spacer separating its two 6-Cys domains. To gain insight into the assembly mechanism and overall architecture of the Pf12-Pf41 complex, we first determined the 2.45 angstrom resolution crystal structure of Pf41 using zinc single-wavelength anomalous dispersion. Structural analysis revealed an unexpected domain organization where the Pf41 6-Cys domains are, in fact, intimately associated and the additional residues instead map predominately to an inserted domain-like region (ID) located between two beta-strands in D1. Notably, the ID is largely proteolyzed in the final structure suggesting inherent flexibility. To assess the contribution of the ID to complex formation, we engineered a form of Pf41 where the ID was replaced by a short glycine-serine linker and showed by isothermal titration calorimetry that binding to Pf12 was abrogated. Finally, protease protection assays showed that the proteolytic susceptibility of the ID was significantly reduced in the complex, consistent with the Pf41 ID directly engaging Pf12. Collectively, these data establish the architectural organization of Pf41 and define an essential role for the Pf41 ID in promoting assembly of the Pf12-Pf41 heterodimeric complex.	[Parker, Michelle L.; Peng, Fangni; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Victoria	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	mboulang@uvic.ca			Canadian Institutes of Health Research (CIHR) [MOP82915]; Canada Research Chair program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs)	This work was supported by the Canadian Institutes of Health Research (CIHR) grant MOP82915 to MJB. MJB also acknowledges the Canada Research Chair program for salary support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Annoura T, 2014, FASEB J, V28, P2158, DOI 10.1096/fj.13-241570; Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crawford J, 2010, J BIOL CHEM, V285, P12063, DOI 10.1074/jbc.M109.054866; Crawford J, 2009, J BIOL CHEM, V284, P9192, DOI 10.1074/jbc.M808714200; Crosnier C, 2013, MOL CELL PROTEOMICS, V12, P3976, DOI 10.1074/mcp.O113.028357; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forero-Rodriguez J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-388; Fukuchi S, 2006, J MOL BIOL, V355, P845, DOI 10.1016/j.jmb.2005.10.037; Garcia J, 2009, VACCINE, V27, P3953, DOI 10.1016/j.vaccine.2009.04.039; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Osier FH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008705; Ramphul UN, 2015, P NATL ACAD SCI USA, V112, P1273, DOI 10.1073/pnas.1423586112; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Taechalertpaisarn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041937; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tonkin ML, 2013, J BIOL CHEM, V288, P12805, DOI 10.1074/jbc.M113.455667; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang Y, 2014, INFECT GENET EVOL, V28, P167, DOI 10.1016/j.meegid.2014.09.026; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	43	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139407	10.1371/journal.pone.0139407	http://dx.doi.org/10.1371/journal.pone.0139407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414347	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700057
J	Yumnam, B; Negi, T; Maldonado, JE; Fleischer, RC; Jhala, YV				Yumnam, Bibek; Negi, Tripti; Maldonado, Jesus E.; Fleischer, Robert C.; Jhala, Yadvendradev V.			Phylogeography of the Golden Jackal (Canis aureus) in India	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; RED FOX; SEQUENCES; REGION; AMPLIFICATION; VARIABILITY; EXPANSION	The golden jackal (Canis aureus) is one of the most common and widely distributed carnivores in India but phylogeographic studies on the species have been limited across its range. Recent studies have observed absence of mitochondrial (mt) DNA diversity in European populations while some North African populations of golden jackal were found to carry gray wolf (Canis lupus lupaster) mtDNA lineages. In the present study, we sequenced 440 basepairs (bp) of control region (CR) and 412 bp of cytochrome b (cyt b) gene of mtDNA from 62 golden jackals sampled from India (n = 55), Israel (n = 2) and Bulgaria (n = 5), to obtain a total of eighteen haplotypes, comprising sixteen from India and one each from Israel and Bulgaria. Except for three previously described haplotypes represented by one cyt b and one CR haplotype both from India, and one CR haplotype from Bulgaria, all haplotypes identified in this study are new. Genetic diversity was high in golden jackals compared to that reported for other canids in India. Unlike the paraphyletic status of African conspecifics with the gray wolf, the Indian (and other Eurasian) golden jackal clustered in a distinct but shallow monophyletic clade, displaying no evidence of admixture with sympatric and related gray wolf and domestic dog clades in the region. Phylogeographic analyses indicated no clear pattern of genetic structuring of the golden jackal haplotypes and the median joining network revealed a star-shaped polytomy indicative of recent expansion of the species from India. Indian haplotypes were observed to be interior and thus ancestral compared to haplotypes from Europe and Israel, which were peripheral and hence more derived. Molecular tests for demographic expansion confirmed a recent event of expansion of golden jackals in the Indian subcontinent, which can be traced back similar to 37,000 years ago during the late Pleistocene. Our results suggest that golden jackals have had a potentially longer evolutionary history in India than in other parts of the world, although further sampling from Africa, the Middle East and south-east Asia is needed to test this hypothesis.	[Yumnam, Bibek; Negi, Tripti; Jhala, Yadvendradev V.] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Maldonado, Jesus E.; Fleischer, Robert C.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Maldonado, Jesus E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20013 USA	Wildlife Institute of India; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History	Jhala, YV (corresponding author), Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India.	jhalay@wii.gov.in	Maldonado, Jesus/AIE-8664-2022; Jhala, Yadvendradev/AAL-9711-2020	Maldonado, Jesus/0000-0002-4282-1072; 	Wildlife Institute of India; Fulbright Fellowship; Smithsonian Conservation Biology Institute	Wildlife Institute of India; Fulbright Fellowship; Smithsonian Conservation Biology Institute(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute)	The field and laboratory study was supported by funding from the Wildlife Institute of India to YVJ; BY received a Fulbright Fellowship to work at the Smithsonian Institution; TN received a short term visitor grant from Smithsonian Conservation Biology Institute for data analysis at SCBI.	Adams J.M., 1997, REV ATLAS PALAEOVEGE; Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Aiyaduraj Ambika, 2006, Journal of the Bombay Natural History Society, V103, P5; [Anonymous], 2007, HDB WILDLIFE CHEM IM; Aubry KB, 2009, MOL ECOL, V18, P2668, DOI 10.1111/j.1365-294X.2009.04222.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bozarth CA, 2011, J MAMMAL, V92, P283, DOI 10.1644/10-MAMM-A-141.1; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Cohen TM, 2013, CONSERV GENET, V14, P55, DOI 10.1007/s10592-012-0423-1; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fabbri E, 2014, CONSERV GENET, V15, P187, DOI 10.1007/s10592-013-0530-7; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frenzel B, 1992, ATLAS PALEOCLIMATES; Fu YX, 1997, GENETICS, V147, P915; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Jhala YV, 2008, IUCN 2013 IUCN RED L; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Koepfli KP, 2015, CURR BIOL, V25, P2158, DOI 10.1016/j.cub.2015.06.060; KRYSTUFEK B, 1990, FOLIA ZOOL, V39, P291; Krystufek B, 1997, MAMMAL REV, V27, P109, DOI 10.1111/j.1365-2907.1997.tb00375.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Markina N, 2002, DOG JACKAL HYBRIDS A; Moehlman P.D., 1989, P143; MOEHLMAN PD, 1987, AM SCI, V75, P366; Moura AE, 2014, CONSERV GENET, V15, P405, DOI 10.1007/s10592-013-0547-y; Nei M., 1987, MOL EVOLUTIONARY GEN; Paxinos E, 1997, MOL ECOL, V6, P483, DOI 10.1046/j.1365-294X.1997.00206.x; Pilot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093828; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Simon C., 1991, NATO ASI Series Series H Cell Biology, V57, P33; Sterndale R.A., 1884, NATURAL HIST MAMMALI; Taberlet Pierre, 1996, P125; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Wayne RK, 1997, SYST BIOL, V46, P622, DOI 10.2307/2413498; Zachos FE, 2009, BIOCHEM GENET, V47, P241, DOI 10.1007/s10528-009-9221-y	48	10	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138497	10.1371/journal.pone.0138497	http://dx.doi.org/10.1371/journal.pone.0138497			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414163	gold, Green Published, Green Submitted			2022-12-27	WOS:000362170700017
J	Chang, CJ; Chen, NC; Lao, CK; Huang, YC				Chang, Chun-Jui; Chen, Ning-Chun; Lao, Chong-Kei; Huang, Yhu-Chering			Nasal Staphylococcus aureus and Methicillin-Resistant S. aureus Carriage among Janitors Working in Hospitals in Northern Taiwan	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; MOLECULAR EPIDEMIOLOGY; CLINICAL-FEATURES; RISK-FACTORS; COLONIZATION; CHILDREN; INFECTIONS; PREVALENCE	Background Staphylococcus aureus is an important cause of infection, and brings additional concern with methicillin resistance. In addition, nasal methicillin-resistant Staphylococcus aureus (MRSA) colonization rates among health care workers are higher than that for general population. To determine the prevalence rate and risk factors for the colonization of S. aureus, including MRSA, among janitors working in hospitals in northern Taiwan, we conducted this study. Methods Between June and August, 2014, a total of 186 janitors, 111 working in hospitals and 75 working in non-medical institutions, were recruited. Specimens were obtained from the nares of the subjects for the detection of S. aureus, with a questionnaire completed for each subject. All the S. aureus isolates, including MRSA and methicillin-susceptible S. aureus (MSSA), were further molecularly characterized. Results The nasal carriage rate of S. aureus was 15.3% for hospital janitors and 13.3% for non-medical janitors. The carriage rate of MRSA was 3.6% for hospital janitors and 1.3% for non-medical janitors. No statistically significant difference was found in the nasal carriage rate of S. aureus (p = 0.707) and MRSA (p = 0.65) between hospital janitors and non-medical janitors. Hospital janitors working in hospital more than 6 years and cleaning microbiologic laboratories were significantly associated with nasal S. aureus colonization. All 5 MRSA isolates carried either staphylococcal cassette chromosome type IV or V and three of them belonged to sequence type (ST) 59, the community clone prevailing in Taiwan. Of the 22 MSSA isolates, six pulsotypes were identified, with one major type for 14 isolates (shared by five STs) and another type for 4 isolates (all belonged to ST 188). Conclusion Exposure to the hospital environment may not increase the nasal carriage rate of S. aureus, including MRSA, among janitors in hospitals in Taiwan. However, for janitors in the hospital setting, working for more than six years in hospital and cleaning laboratories may be risks factors for carrying S. aureus.	[Chang, Chun-Jui; Chen, Ning-Chun; Lao, Chong-Kei; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp Linko, Dept Pediat, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan.	ychuang@adm.cgmh.org.tw			Ministry of Science and Technology, Executive Yuan of Taiwan [NSC 102-2628-B-182A-010-MY3]; Medical Foundation in Memory of Dr. Deh-Lin Cheng	Ministry of Science and Technology, Executive Yuan of Taiwan; Medical Foundation in Memory of Dr. Deh-Lin Cheng	Funding: This work was supported by a grant from Ministry of Science and Technology, Executive Yuan of Taiwan (NSC 102-2628-B-182A-010-MY3) and partly by a grant from Medical Foundation in Memory of Dr. Deh-Lin Cheng.	da Silva ECBF, 2008, BRAZ J INFECT DIS, V12, P504, DOI 10.1590/S1413-86702008000600012; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2005, PEDIATR INFECT DIS J, V24, P276, DOI 10.1097/01.inf.0000154333.46032.0f; Huang YC, 2004, J CLIN MICROBIOL, V42, P307, DOI 10.1128/JCM.42.1.307-310.2004; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Huang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082472; Huang YC, 2012, J PERINAT MED, V40, P307, DOI [10.1515/JPM.2011.114, 10.1515/jpm.2011.114]; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Institute CaLS, 2012, PERF STAND ANT DISK; Kuo CY, 2014, NEONATOLOGY, V105, P142, DOI 10.1159/000356733; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otter JA, 2012, J HOSP INFECT, V81, P143, DOI 10.1016/j.jhin.2012.04.009; Schmidlin M, 2010, J APPL MICROBIOL, V109, P1284, DOI 10.1111/j.1365-2672.2010.04749.x; Shiomori T, 2000, J ALLERGY CLIN IMMUN, V105, P449, DOI 10.1067/mai.2000.104256; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wang JT, 2009, J CLIN MICROBIOL, V47, P2957, DOI 10.1128/JCM.00853-09; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389	24	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138971	10.1371/journal.pone.0138971	http://dx.doi.org/10.1371/journal.pone.0138971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407070	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700134
J	Huber, M; Van Boven, L; Park, B; Pizzi, WT				Huber, Michaela; Van Boven, Leaf; Park, Bernadette; Pizzi, William T.			Seeing Red: Anger Increases How Much Republican Identification Predicts Partisan Attitudes and Perceived Polarization	PLOS ONE			English	Article							POLITICAL POLARIZATION; PARTY IDENTIFICATION; INTERGROUP EMOTIONS; ACTION TENDENCIES; INGROUP; FEAR; PREJUDICE; POLICY; ATTRIBUTIONS; TERRORISM	We examined the effects of incidental anger on perceived and actual polarization between Democrats and Republicans in the context of two national tragedies, Hurricane Katrina (Study 1) and the mass shooting that targeted Representative Gabrielle Giffords in Arizona (Study 2). We hypothesized that because of its relevance to intergroup conflict, incidental anger exacerbates the political polarization effects of issue partisanship (the correlation between partisan identification and partisan attitudes), and, separately, the correlation between conservative partisan identification and perceived polarization between Democrats and Republicans. We further hypothesized that these effects would be strongest for Republican identification because Republican leaders were targets of public criticism in both tragedies and because conservative (Republican) ideology tends to be more sensitive to threat. In the studies, participants first completed an emotion induction procedure by recalling autobiographical events that made them angry (Studies 1 & 2), sad (Studies 1 & 2), or that involved recalling emotionally neutral events (Study 2). Participants later reported their attitudes regarding the two tragedies, their perceptions of the typical Democrat's and Republican's attitudes on those issues, and their identification with the Democratic and Republican parties. Compared with incidental sadness (Studies 1 and 2) and a neutral condition (Study 2), incidental anger exacerbated the associations between Republican identification and partisan attitudes, and, separately between Republican identification and perceived polarization between the attitudes of Democrats and Republicans. We discuss implications for anger's influence on political attitude formation and perceptions of group differences in political attitudes.	[Huber, Michaela] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany; [Van Boven, Leaf; Park, Bernadette] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Pizzi, William T.] Univ Colorado, Colorado Law Sch, Boulder, CO 80309 USA	Technische Universitat Dresden; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Huber, M (corresponding author), Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany.	michaela.huber@tu-dresden.de	VAN BOVEN, LEAF/AAA-3319-2019	VAN BOVEN, LEAF/0000-0003-4187-8779; Essbach, Michaela/0000-0002-4266-5954	National Science Foundation [0552120, 0555137]; German Research Foundation; Open Access Publication Funds of the TU Dresden	National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	National Science Foundation grants 0552120 and 0555137 (to LVB) supported this work. The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden (to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R.M., 2002, HARD CHOICES EASY AN; Baldassarri D, 2008, AM J SOCIOL, V114, P408, DOI 10.1086/590649; Baldassarri D, 2007, AM SOCIOL REV, V72, P784, DOI 10.1177/000312240707200507; Benson TW., 2011, J CONT RHETORIC, V1, P22; BODENHAUSEN GV, 1994, J PERS SOC PSYCHOL, V66, P621, DOI 10.1037/0022-3514.66.4.621; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Crisp RJ, 2007, GROUP PROCESS INTERG, V10, P9, DOI 10.1177/1368430207071337; Dasgupta N, 2009, EMOTION, V9, P585, DOI 10.1037/a0015961; Davis MD, 2011, J APPL SOC PSYCHOL, V41, P196, DOI 10.1111/j.1559-1816.2010.00709.x; De Castella K, 2011, ANAL SOC ISS PUB POL, V11, P180, DOI 10.1111/j.1530-2415.2011.01243.x; DeSteno D, 2004, PSYCHOL SCI, V15, P319, DOI 10.1111/j.0956-7976.2004.00676.x; Dunn JR, 2005, J PERS SOC PSYCHOL, V88, P736, DOI 10.1037/0022-3514.88.5.736; Fiorina MorrisP., 2005, CULTURE WAR MYTH POL; Goren P, 2005, AM J POLIT SCI, V49, P881, DOI 10.1111/j.1540-5907.2005.00161.x; Greene S, 1999, POLIT PSYCHOL, V20, P393, DOI 10.1111/0162-895X.00150; Greene S, 2004, SOC SCI QUART, V85, P136, DOI 10.1111/j.0038-4941.2004.08501010.x; Greene S, 2002, POLIT BEHAV, V24, P171, DOI 10.1023/A:1021859907145; Halperin E, 2011, GROUP PROCESS INTERG, V14, P477, DOI 10.1177/1368430210377459; Halperin E, 2011, J CONFLICT RESOLUT, V55, P274, DOI 10.1177/0022002710383670; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Joslyn MR, 2013, SOC SCI QUART, V94, P410, DOI 10.1111/j.1540-6237.2012.00894.x; Jost JT, 2012, JUSTICE AND CONFLICTS: THEORETICAL AND EMPIRICAL CONTRIBUTIONS, P315, DOI 10.1007/978-3-642-19035-3_19; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Keltner D, 1999, COGNITION EMOTION, V13, P467, DOI 10.1080/026999399379140; Lerner JS, 2003, PSYCHOL SCI, V14, P144, DOI 10.1111/1467-9280.01433; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Lerner JS, 2004, PSYCHOL SCI, V15, P337, DOI 10.1111/j.0956-7976.2004.00679.x; MACKIE D, 1984, J PERS SOC PSYCHOL, V46, P575, DOI 10.1037/0022-3514.46.3.575; Mackie DM, 2000, J PERS SOC PSYCHOL, V79, P602, DOI 10.1037//0022-3514.79.4.602; MACKIE DM, 1986, J PERS SOC PSYCHOL, V50, P720, DOI 10.1037/0022-3514.50.4.720; Malhotra N, 2008, J POLIT, V70, P120, DOI 10.1017/S0022381607080097; MULLEN B, 1992, J EXP SOC PSYCHOL, V28, P422, DOI 10.1016/0022-1031(92)90040-Q; Pew Research Center, 2012, PARTISAN POLARIZATIO; Quigley BM, 1996, PERS SOC PSYCHOL B, V22, P1280, DOI 10.1177/01461672962212008; Ryan TJ, 2012, J POLIT, V1, P1; Sadler MS, 2005, BASIC APPL SOC PSYCH, V27, P249, DOI 10.1207/s15324834basp2703_6; Sherman DK, 2009, GROUP PROCESS INTERG, V12, P95, DOI 10.1177/1368430208098779; Skitka LJ, 2006, BASIC APPL SOC PSYCH, V28, P375, DOI 10.1207/s15324834basp2804_11; Small DA, 2008, POLIT PSYCHOL, V29, P149, DOI 10.1111/j.1467-9221.2008.00621.x; Smith ER, 2007, J PERS SOC PSYCHOL, V93, P431, DOI 10.1037/0022-3514.93.3.431; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V81, P973, DOI 10.1037//0022-3514.81.6.973; Turner J.C., 1987, REDISCOVERING SOCIAL; Van Boven L, 2012, J PERS SOC PSYCHOL, V103, P84, DOI 10.1037/a0028145; van Zomeren M, 2004, J PERS SOC PSYCHOL, V87, P649, DOI 10.1037/0022-3514.87.5.649; WEBER JG, 1994, J EXP SOC PSYCHOL, V30, P482, DOI 10.1006/jesp.1994.1023; Westfall J, PERSPECTIVES PSYCHOL	49	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139193	10.1371/journal.pone.0139193	http://dx.doi.org/10.1371/journal.pone.0139193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26407321	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700186
J	Wunderlich, R; Lau, P; Stein, A; Engell, A; Wollbrink, A; Rudack, C; Pantev, C				Wunderlich, Robert; Lau, Pia; Stein, Alwina; Engell, Alva; Wollbrink, Andreas; Rudack, Claudia; Pantev, Christo			Impact of Spectral Notch Width on Neurophysiological Plasticity and Clinical Effectiveness of the Tailor-Made Notched Music Training	PLOS ONE			English	Article							TINNITUS HANDICAP QUESTIONNAIRE; AUDITORY-CORTEX ACTIVITY; LATERAL INHIBITION; ENHANCEMENT; TRIALS	Tinnitus, the ringing in the ears that is unrelated to any external source, causes a significant loss in quality of life, involving sleep disturbance and depression for 1 to 3% of the general population. While in the first place tinnitus may be triggered by damage to the inner ear cells, the neural generators of subjective tinnitus are located in central regions of the nervous system. A loss of lateral inhibition, tonotopical reorganization and a gain-increase in response to the sensory deprivation result in hypersensitivity and hyperactivity in certain regions of the auditory cortex. In the tailor-made notched music training (TMNMT) patients listen to music from which the frequency spectrum of the tinnitus has been removed. This evokes strong lateral inhibition from neurons tuned to adjacent frequencies onto the neurons involved in the tinnitus percept. A reduction of tinnitus loudness and tinnitus-related neural activity was achieved with TMNMT in previous studies. As the effect of lateral inhibition depends on the bandwidth of the notch, in the current study we altered the notch width to find the most effective notch width for TMNMT. We compared 1-octave notch width with 1/2-octave and 1/4-octave. Participants chose their favorite music for the training that included three month of two hours daily listening. The outcome was measured by means of standardized questionnaires and magnetoencephalography. We found a general reduction of tinnitus distress in all administered tinnitus questionnaires after the training. Additionally, tinnitus-related neural activity was reduced after the training. Nevertheless, notch width did not have an influence on the behavioral or neural effects of TMNMT. This could be due to a non-linear resolution of lateral inhibition in high frequencies.	[Wunderlich, Robert; Lau, Pia; Stein, Alwina; Engell, Alva; Wollbrink, Andreas; Pantev, Christo] Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Wunderlich, Robert] Univ Bielefeld, Inst Physiol Psychol, D-33615 Bielefeld, Germany; [Rudack, Claudia] Univ Hosp Munster, Dept Otolaryngol, Munster, Germany	University of Munster; University of Bielefeld; University of Munster	Pantev, C (corresponding author), Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	pantev@uni-muenster.de			"Interdisziplinares Zentrum fur klinische Forschung" IZKF [CRA05]	"Interdisziplinares Zentrum fur klinische Forschung" IZKF	This research was funded by "Interdisziplinares Zentrum fur klinische Forschung" IZKF (CRA05). Website: http://campus.uni-muenster.de/izkf.html. The funding was recieved by CR and CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Diesch E, 2004, EUR J NEUROSCI, V19, P1093, DOI 10.1111/j.0953-816X.2004.03191.x; Diesch E, 2010, NEUROSCIENCE, V167, P540, DOI 10.1016/j.neuroscience.2010.02.003; Diesch E, 2010, NEUROIMAGE, V50, P1545, DOI 10.1016/j.neuroimage.2010.01.067; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Dobie RA, 1999, LARYNGOSCOPE, V109, P1202, DOI 10.1097/00005537-199908000-00004; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Engelien A, 2000, HEARING RES, V148, P153, DOI 10.1016/S0378-5955(00)00148-9; Figueiredo RR, 2011, BRAZ J OTORHINOLAR, V77, P293, DOI 10.1590/S1808-86942011000300004; GOEBEL G, 1994, HNO, V42, P166; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Henry JA, 2001, J REHABIL RES DEV, V38, P557; HOUTGAST T, 1972, J ACOUST SOC AM, V51, P1885, DOI 10.1121/1.1913048; KUK FK, 1990, EAR HEARING, V11, P434, DOI 10.1097/00003446-199012000-00005; Landgrebe M, 2012, J PSYCHOSOM RES, V73, P112, DOI 10.1016/j.jpsychores.2012.05.002; Maes IHL, 2013, EAR HEARING, V34, P508, DOI 10.1097/AUD.0b013e31827d113a; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; NEWMAN CW, 1995, ANN OTO RHINOL LARYN, V104, P718, DOI 10.1177/000348949510400910; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Okamoto H, 2005, EUR J NEUROSCI, V21, P1957, DOI 10.1111/j.1460-9568.2005.04022.x; Okamoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017022; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Pantev C, 2004, EUR J NEUROSCI, V19, P2337, DOI 10.1111/j.0953-816X.2004.03296.x; Pantev C, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-40; Rajan R, 1998, NAT NEUROSCI, V1, P138, DOI 10.1038/388; Ross B, 2002, HEARING RES, V165, P68, DOI 10.1016/S0378-5955(02)00285-X; Stein A, 2015, CLIN NEUROPHYSIOL, V126, P1007, DOI 10.1016/j.clinph.2014.08.017; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080899; Teismann H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089904; Teismann H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024685; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; Wunderlich R, 2015, J AM ACAD AUDIOL, V26, P205, DOI 10.3766/jaaa.26.2.9; Zirke N, 2010, HNO, V58, P726, DOI 10.1007/s00106-009-2050-9	36	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138595	10.1371/journal.pone.0138595	http://dx.doi.org/10.1371/journal.pone.0138595			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406446	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700060
J	Zhang, ZJ; Pan, XY; Zhang, ZY; He, KS; Li, B				Zhang, Zhijie; Pan, Xiaoyun; Zhang, Ziyan; He, Kate S.; Li, Bo			Specialist Insect Herbivore and Light Availability Do Not Interact in the Evolution of an Invasive Plant	PLOS ONE			English	Article							ALTERNANTHERA-PHILOXEROIDES; INTRODUCED POPULATIONS; PHENOTYPIC PLASTICITY; RESOURCE AVAILABILITY; SIMULATED HERBIVORY; COMPETITIVE ABILITY; BIOMASS ALLOCATION; GROWTH; TOLERANCE; RESPONSES	Release from specialist insect herbivores may allow invasive plants to evolve traits associated with decreased resistance and increased competitive ability. Given that there may be genetic trade-off between resistance and tolerance, invasive plants could also become more tolerant to herbivores. Although it is widely acknowledged that light availability affects tolerance to herbivores, little information is available for whether the effect of light availability on tolerance differ between the introduced and native populations. We conducted a common garden experiment in the introduced range of Alternanthera philoxeroides using ten invasive US and ten native Argentinean populations at two levels of light availability and in the presence or absence of a specialist stem-boring insect Agasicles hygrophila. Plant biomass (total and storage root biomass), two allocation traits (root/shoot ratio and branch intensity, branches biomass/main stem biomass) and two functional traits (specific stem length and specific leaf area), which are potentially associated with herbivore resistance and light capture, were measured. Overall, we found that A. philoxeroides from introduced ranges had comparable biomass and tolerance to specialist herbivores, lower branch intensity, lower specific stem length and specific leaf area. Moreover, introduced populations displayed higher shade tolerance of storage root biomass and lower plastic response to shading in specific stem length. Finally, light availability had no significant effect on evolution of tolerance to specialist herbivores of A. philoxeroides. Our results suggest that post-introduction evolution might have occurred in A. philoxeroides. While light availability did not influence the evolution of tolerance to specialist herbivores, increased shade tolerance and release from specialist insects might have contributed to the successful invasion of A. philoxeroides.	[Zhang, Zhijie; Pan, Xiaoyun; Zhang, Ziyan; Li, Bo] Fudan Univ, Inst Biodivers Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China; [He, Kate S.] Murray State Univ, Dept Biol Sci, Murray, KY 42071 USA	Fudan University; Murray State University	Pan, XY (corresponding author), Fudan Univ, Inst Biodivers Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	xypan@fudan.edu.cn	Li, Bo/AAA-8968-2020; Li, Bo/B-8016-2010; Zhang, Zhijie/S-9662-2019	Li, Bo/0000-0002-7294-6888; Li, Bo/0000-0002-0439-5666; Zhang, Zhijie/0000-0003-0463-2665	National Natural Science Foundation of China [31070369, 31370433]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (Grant Nos. 31070369, 31370433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWARD RD, 1993, OECOLOGIA, V95, P358, DOI 10.1007/BF00320989; Aphalo PJ, 1999, J EXP BOT, V50, P1629, DOI 10.1093/jexbot/50.340.1629; Atwood J. P., 2011, NeoBiota, P7, DOI 10.3897/neobiota.10.954; Bergman M, 2002, OIKOS, V96, P164, DOI 10.1034/j.1600-0706.2002.960118.x; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Blumenthal D, 2005, SCIENCE, V310, P243, DOI 10.1126/science.1114851; Bossdorf O, 2004, ECOL LETT, V7, P346, DOI 10.1111/j.1461-0248.2004.00583.x; Bossdorf O, 2004, AM J BOT, V91, P856, DOI 10.3732/ajb.91.6.856; Buckingham Gary R., 1996, Castanea, V61, P232; Cano L, 2008, J ECOL, V96, P468, DOI 10.1111/j.1365-2745.2008.01363.x; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeWalt SJ, 2004, OECOLOGIA, V138, P521, DOI 10.1007/s00442-003-1462-6; Flory SL, 2011, ECOLOGY, V92, P2248, DOI 10.1890/11-0363.1; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Geng XuYan, 2013, American Journal of Plant Sciences, V4, P1839, DOI 10.4236/ajps.2013.49226; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; Huang W, 2012, ECOLOGY, V93, P2343, DOI 10.1890/11-1964.1; Huang W, 2010, J ECOL, V98, P1157, DOI 10.1111/j.1365-2745.2010.01704.x; Jia X, 2009, BIOL INVASIONS, V11, P743, DOI 10.1007/s10530-008-9288-0; LONGSTRETH DJ, 1984, BOT GAZ, V145, P105, DOI 10.1086/337432; Ma RY, 2001, ECOLOGIEAL ADATATION; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MADDOX DM, 1971, BIOSCIENCE, V21, P985, DOI 10.2307/1296135; Martin PH, 2009, FRONT ECOL ENVIRON, V7, P142, DOI 10.1890/070096; Matlaga DP, 2012, INVAS PLANT SCI MANA, V5, P363, DOI 10.1614/IPSM-D-11-00056.1; Meyer GA, 2008, BIOL INVASIONS, V10, P303, DOI 10.1007/s10530-007-9131-z; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Orians CM, 2010, ANNU REV ENTOMOL, V55, P439, DOI 10.1146/annurev-ento-112408-085333; Pan XY, 2007, ACTA PHYTOTAXON SIN, V45, P884, DOI 10.1360/aps06134; Pan XY, 2013, J SYST EVOL, V51, P308, DOI 10.1111/j.1759-6831.2012.00239.x; Pan XY, 2013, J SYST EVOL, V51, P318, DOI 10.1111/jse.12001; Pan XY, 2012, BIOL INVASIONS, V14, P1, DOI 10.1007/s10530-011-9941-x; Pearcy RW, 2005, NEW PHYTOL, V166, P791, DOI 10.1111/j.1469-8137.2005.01328.x; Pigliucci M., 2001, SYN ECO EVO; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Reed C. F., 1970, USDA HDB, V366; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rogers WE, 2002, BASIC APPL ECOL, V3, P297, DOI 10.1078/1439-1791-00120; Salgado-Luarte C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011460; Schmitt J, 1999, AM NAT, V154, pS43, DOI 10.1086/303282; Sosa A, 2004, P 11 INT S BIOL CONT; Stastny M, 2005, J ECOL, V93, P27, DOI 10.1111/j.1365-2745.2004.00962.x; Stewart CA, 1999, NEW ZEAL J ZOOL, V26, P191, DOI 10.1080/03014223.1999.9518189; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Vogt G. B., 1979, PROBABLE EVOLUTION M; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wise MJ, 2005, OIKOS, V109, P417, DOI 10.1111/j.0030-1299.2005.13878.x; Xu CY, 2010, J ECOL, V98, P833, DOI 10.1111/j.1365-2745.2010.01668.x; Zhang DY, 2006, J THEOR BIOL, V242, P935, DOI 10.1016/j.jtbi.2006.05.016; Zou JW, 2008, ECOGRAPHY, V31, P663, DOI 10.1111/j.0906-7590.2008.05540.x; Zou JW, 2009, BASIC APPL ECOL, V10, P79, DOI 10.1016/j.baae.2007.11.010	55	5	6	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139234	10.1371/journal.pone.0139234	http://dx.doi.org/10.1371/journal.pone.0139234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407176	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700195
J	Alderton, S; Noble, J; Schaten, K; Welburn, SC; Atkinson, PM				Alderton, Simon; Noble, Jason; Schaten, Kathrin; Welburn, Susan C.; Atkinson, Peter M.			Exploiting Human Resource Requirements to Infer Human Movement Patterns for Use in Modelling Disease Transmission Systems: An Example from Eastern Province, Zambia	PLOS ONE			English	Article							SLEEPING-SICKNESS; TRYPANOSOMIASIS; EPIDEMIOLOGY; RESERVOIR; MOBILITY; NEEDS; RISK	In this research, an agent-based model (ABM) was developed to generate human movement routes between homes and water resources in a rural setting, given commonly available geospatial datasets on population distribution, land cover and landscape resources. ABMs are an object-oriented computational approach to modelling a system, focusing on the interactions of autonomous agents, and aiming to assess the impact of these agents and their interactions on the system as a whole. An A* pathfinding algorithm was implemented to produce walking routes, given data on the terrain in the area. A* is an extension of Dijkstra's algorithm with an enhanced time performance through the use of heuristics. In this example, it was possible to impute daily activity movement patterns to the water resource for all villages in a 75 km long study transect across the Luangwa Valley, Zambia, and the simulated human movements were statistically similar to empirical observations on travel times to the water resource (Chi-squared, 95% confidence interval). This indicates that it is possible to produce realistic data regarding human movements without costly measurement as is commonly achieved, for example, through GPS, or retrospective or real-time diaries. The approach is transferable between different geographical locations, and the product can be useful in providing an insight into human movement patterns, and therefore has use in many human exposure-related applications, specifically epidemiological research in rural areas, where spatial heterogeneity in the disease landscape, and space-time proximity of individuals, can play a crucial role in disease spread.	[Alderton, Simon; Noble, Jason] Univ Southampton, Sch Elect & Comp Sci, Inst Complex Syst Simulat, Southampton, Hants, England; [Alderton, Simon] Univ Southampton, Geog & Environm, Fac Social & Human Sci, Southampton, Hants, England; [Schaten, Kathrin; Welburn, Susan C.] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Div Pathway Med, Edinburgh, Midlothian, Scotland; [Schaten, Kathrin; Welburn, Susan C.] Univ Edinburgh, Coll Med & Vet Med, Sch Biomed Sci, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Atkinson, Peter M.] Univ Lancaster, Fac Sci & Technol, Lancaster, England; [Atkinson, Peter M.] Univ Utrecht, Fac Geosci, NL-3584 CS Utrecht, Netherlands; [Atkinson, Peter M.] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland	University of Southampton; University of Southampton; University of Edinburgh; University of Edinburgh; Lancaster University; Utrecht University; Queens University Belfast	Alderton, S (corresponding author), Univ Southampton, Sch Elect & Comp Sci, Inst Complex Syst Simulat, Southampton, Hants, England.	simon.alderton@soton.ac.uk	; Amblard, Frederic/B-9681-2009	Atkinson, Peter/0000-0002-5489-6880; Amblard, Frederic/0000-0002-2653-0857; Alderton, Simon/0000-0001-5645-2338	EPSRC [EP/G03690X/1]; NERC [NE-J001570-1]; Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC); Dynamic Drivers of Disease in Africa Consortium; NERC [NE/J000701/1, NE/J001422/1, NE/J001570/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1095435] Funding Source: researchfish; Natural Environment Research Council [NE/J001570/1, NE/J001422/1, NE/J000701/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Dynamic Drivers of Disease in Africa Consortium; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SA is supported by an EPSRC Doctoral Training Centre grant (EP/G03690X/1). PMA and SW are supported by, and the fieldwork in this investigation was carried out for, the Dynamic Drivers of Disease in Africa Consortium, NERC project no. NE-J001570-1, part of the Ecosystem Services for Poverty Alleviation (ESPA) programme. The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC).	Alderton S., 2013, ADV ARTIFICIAL LIFE, P27; Anderson NE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001211; Arifin S. M. Niaz, 2011, International Journal of Agent Technologies & Systems, V3, P17, DOI 10.4018/jats.2011070102; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Batty M, 2003, INT J GEOGR INF SCI, V17, P673, DOI 10.1080/1365881031000135474; Bian L, 2004, ENVIRON PLANN B, V31, P381, DOI 10.1068/b2833; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; BUYST H., 1970, Medical Journal of Zambia, V4, P181; BUYST H, 1974, MED J ZAMBIA, V8, P2; Chen X, 2008, J OPER RES SOC, V59, P25, DOI 10.1057/palgrave.jors.2602321; Cui X, 2011, INT J COMPUT SCI NET, V11, P125; Cummins SK, 2001, PEDIATR CLIN N AM, V48, P1241, DOI 10.1016/S0031-3955(05)70372-2; Dunham Jill Bigley, 2005, J ARTIFICIAL SOC SOC, V9; Epstein J.M., 1996, GROWING ARTIFICIAL S; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Gouteux JP, 2000, RECHERCHE, P34; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Legros D, 2002, LANCET INFECT DIS, V2, P437, DOI 10.1016/S1473-3099(02)00321-3; Muller G, 2004, CR BIOL, V327, P1, DOI 10.1016/j.crvi.2003.12.002; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; PEPIN J, 1994, ADV PARASIT, V33, P1, DOI 10.1016/S0065-308X(08)60410-8; Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642; PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259; Raney B, 2003, NETW SPAT ECON, V3, P23, DOI 10.1023/A:1022096916806; Rodricks JV., 1994, CALCULATED RISKS UND; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; VAUGHAN E, 1993, HEALTH PSYCHOL, V12, P74, DOI 10.1037/0278-6133.12.1.74; Welburn SC, 2006, TRENDS PARASITOL, V22, P123, DOI 10.1016/j.pt.2006.01.011; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; Wisner B., 1993, Geojournal, V30, P127, DOI 10.1007/BF00808129; Yang Y, 2008, J R SOC INTERFACE, V5, P759, DOI 10.1098/rsif.2007.1218	37	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139505	10.1371/journal.pone.0139505	http://dx.doi.org/10.1371/journal.pone.0139505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421926	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700124
J	Gui, JJ; Liu, ZF; Zhang, TF; Hua, QH; Jiang, ZG; Chen, B; Gu, H; Lv, HK; Dong, CZ				Gui, Juanjuan; Liu, Zhifang; Zhang, Tianfang; Hua, Qihang; Jiang, Zhenggang; Chen, Bin; Gu, Hua; Lv, Huakun; Dong, Changzheng			Epidemiological Characteristics and Spatial-Temporal Clusters of Hand, Foot, and Mouth Disease in Zhejiang Province, China, 2008-2012	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; MOLECULAR EPIDEMIOLOGY; CHILDREN; STRAINS; SEROEPIDEMIOLOGY; SURVEILLANCE; ANTIBODIES; MALAYSIA; ASSOCIATION; OUTBREAK	Hand, foot and mouth disease (HFMD) is one of the major public health concerns in China. Being the province with high incidence rates of HFMD, the epidemiological features and the spatial-temporal patterns of Zhejiang Province were still unknown. The objective of this study was to investigate the epidemiological characteristics and the high-incidence clusters, as well as explore some potential risk factors. The surveillance data of HFMD during 20082012 were collected from the communicable disease surveillance network system of Zhejiang Provincial Center for Disease Control and Prevention. The distributions of age, gender, occupation, season, region, pathogen's serotype and disease severity were analyzed to describe the epidemiological features of HFMD in Zhejiang Province. Seroprevalence survey for human enterovirus 71 (EV71) in 549 healthy children of Zhejiang Province was also performed, as well as 27 seroprevalence publications between 1997 and 2015 were summarized. The spatial-temporal methods were performed to explore the clusters at county level. Furthermore, pathogens' serotypes such as EV71 and coxsackievirus A16 (Cox A16) and meteorological factors were analyzed to explore the potential factors associated with the clusters. A total of 454,339 HFMD cases were reported in Zhejiang Province during 2008-2012, including 1688 (0.37%) severe cases. The annual average incidence rate was 172.98 per 100,000 (ranged from 72.61 to 270.04). The male-to-female ratio for mild cases was around 1.64:1, and up to 1.87:1 for severe cases. Of the total cases, children aged under three years old and under five years old accounted for almost 60% and 90%, respectively. Among all enteroviruses, the predominant serotype was EV71 (49.70%), followed by Cox A16 (26.05%) and other enteroviruses (24.24%) for mild cases. In severe cases, EV71 (82.85%) was the major causative agent. EV71 seroprevalence survey in healthy children confirmed that occult infection was common in children. Furthermore, literature summary for 26 seroprevalence studies during 1997-2015 confirmed that 0-5 years group showed lowest level of EV71 seroprevalence (29.1% on average) compared to the elder children (6-10 years group: 54.6%; 11-20 years group: 61.8%). Global positive spatial autocorrelation patterns (Moran's Is>0.25, P<0.05) were discovered not only for mild cases but also for severe cases, and local positive spatial autocorrelation patterns were revealed for counties from the eastern coastal and southern regions. The retrospective space-time cluster analysis also confirmed these patterns. Risk factors analyses implied that more EV71 and less sunshine were associated with the clusters of HFMD in Zhejiang Province. Our study confirmed that Zhejiang Province was one of the highly epidemic provinces in China and that the epidemiological characteristics of HFMD were similar to other provinces. Occult infection in elder children and adults was one of the important reasons why most HFMD cases were children aged under-five. Combining the results of spatial autocorrelation analysis and the space-time cluster analysis, the major spatial-temporal clusters were from the eastern coastal and southern regions. The distribution of pathogens' serotypes and the level of sunshine could be risk factors for, and serve as an early warning of, the outbreak of HFMD in Zhejiang Province.	[Gui, Juanjuan; Liu, Zhifang; Zhang, Tianfang; Hua, Qihang; Dong, Changzheng] Ningbo Univ, Sch Med, Dept Prevent Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Jiang, Zhenggang; Chen, Bin; Gu, Hua; Lv, Huakun] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Liu, Zhifang] Women & Childrens Hosp Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Ningbo University; Zhejiang Provincial Center for Disease Control & Prevention	Gu, H (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	hgu@cdc.zj.cn; hklv@cdc.zj.cn; dongchangzheng@nbu.edu.cn	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	Ningbo Natural Science Foundation [2015A610190]; Foundation of Zhejiang Province Educational Committee [Y201533182]; K.C. Wong Magna Fund and the research Fund in Ningbo University [XKL141060]; Zhejiang Leading Team of Science and Technology Innovation [2011R50021]; Zhejiang Provincial Public Technology Applied Research Projects [2012C33063]	Ningbo Natural Science Foundation; Foundation of Zhejiang Province Educational Committee; K.C. Wong Magna Fund and the research Fund in Ningbo University; Zhejiang Leading Team of Science and Technology Innovation; Zhejiang Provincial Public Technology Applied Research Projects	This work was supported by the Ningbo Natural Science Foundation (No. 2015A610190), the Foundation of Zhejiang Province Educational Committee (No. Y201533182), the K.C. Wong Magna Fund and the research Fund (No. XKL141060) in Ningbo University, the Zhejiang Leading Team of Science and Technology Innovation (2011R50021), and the Zhejiang Provincial Public Technology Applied Research Projects (2012C33063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmadishina LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097404; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064024; Castro Ceyla M.O., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P65, DOI 10.1590/S0036-46652005000200002; Chan YF, 2012, TROP BIOMED, V29, P451; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chau BNT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021116, 10.1371/journal.pone.0025969]; Chen D, 2012, CHINESE J HLTH LAB T, V22, P739; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Diedrich S, 2009, ARCH VIROL, V154, P1139, DOI 10.1007/s00705-009-0413-x; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gomes MDC, 2002, MEM I OSWALDO CRUZ, V97, P47, DOI 10.1590/S0074-02762002000100006; Guan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044386; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Honkanen H, 2013, J CLIN VIROL, V56, P348, DOI 10.1016/j.jcv.2012.11.018; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang WC, 2012, J MICROBIOL IMMUNOL, V45, P96, DOI 10.1016/j.jmii.2011.09.025; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Ji H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-248; [邝璐 KUANG Lu], 2011, [中国循证儿科杂志, Chinese JOurnal of Evidence Based Pediatrics], V6, P211; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Lee MS, 2012, PLOS NEGLECT TROP D, V6, P145; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080515; Linsuwanon P, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-16; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Lu S, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.29; Luchs A, 2010, REV INST MED TROP SP, V52, P339, DOI 10.1590/S0036-46652010000600010; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Miao ZiPing, 2012, Disease Surveillance, V27, P530; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Ni H, 2012, J CLIN VIROL, V54, P342, DOI DOI 10.1016/J.JCV; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; ROBINSON C R, 1958, Can Med Assoc J, V79, P615; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Seddon JH, 1961, RES NEWSLETTER 2 RES; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sun Jun-ling, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P973; Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006; Valdazo-Gonzalez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049650; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang SY, 2004, J VIROL METHODS, V119, P37, DOI 10.1016/j.jviromet.2004.02.017; Wang X, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.30; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011388; Yang CF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-306; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Yu HY, 2011, JPN J INFECT DIS, V64, P528; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923; Zhu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056318; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	70	36	57	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139109	10.1371/journal.pone.0139109	http://dx.doi.org/10.1371/journal.pone.0139109			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422015	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700069
J	Tang, YR; Xie, C; Wang, MF; Jiang, LQ; Shi, RH; Lin, L				Tang, Yurong; Xie, Chen; Wang, Meifeng; Jiang, Liuqin; Shi, Ruihua; Lin, Lin			Association of High-Resolution Manometry Metrics with the Symptoms of Achalasia and the Symptomatic Outcomes of Peroral Esophageal Myotomy	PLOS ONE			English	Article							PRESSURE TOPOGRAPHY METRICS; ENDOSCOPIC MYOTOMY; CHICAGO CLASSIFICATION; FOLLOW-UP; MOTILITY DISORDERS; DIAGNOSIS; POEM; MANAGEMENT	Background High-resolution manometry (HRM) has improved the accuracy of manometry in detecting achalasia and has helped distinguish between clinically relevant subtypes. This study investigated whether HRM metrics correlate with the achalasia symptoms and symptomatic outcomes of peroral esophageal myotomy (POEM). Methods Of the 30 patients who were enrolled, 25 were treated with POEM, 12 of who underwent HRM after 3 months. All the patients completed the Eckardt score questionnaires, and those who underwent POEM were followed up for about 6 months. Pearson correlation was used to assess the relationship between the HRM metrics and symptoms and outcomes. Key results The integrated relaxation pressure (IRP) score positively correlated with the total Eckardt score, regurgitation score and weight loss score in all the patients, and with the weight loss score in type I achalasia. In 25 patients (10 patients, type I; 15 patients, type II) who underwent POEM, the total Eckardt scores and individual symptom scores significantly decreased after surgery. Changes in the Eckardt scores were similar between type I and type II. Further, the Eckardt scores and weight loss score changes were positively correlated with baseline IRP. Twelve patients (4 patients, type I; 8 patients, type II) underwent HRM again after POEM. IRP changed significantly after POEM, as did the DEP in type II. The IRP changes after POEM were positively correlated with the Eckardt score changes. Conclusions & Inferences IRP is correlated with the symptoms and outcomes of achalasia patients. Thus, HRM is effective for assessing the severity of achalasia and can predict the efficacy of POEM.	[Tang, Yurong; Xie, Chen; Wang, Meifeng; Jiang, Liuqin; Lin, Lin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Shi, Ruihua] Southeast Univ, Zhongda Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Lin, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	lin9100@aliyun.com	Jiang, Liuqin/AAW-1158-2021		National Natural Science Foundation of China [81400599]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 81400599). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boztas G, 2005, HEPATO-GASTROENTEROL, V52, P475; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Chavez YH, 2015, J CLIN GASTROENTEROL, V49, P17, DOI 10.1097/MCG.0000000000000157; Chen X, 2015, EUR J CARDIO-THORAC, V47, P890, DOI 10.1093/ejcts/ezu320; Eckardt V F, 2001, Gastrointest Endosc Clin N Am, V11, P281; Familiari P, 2014, ANN SURG; Fisichella PM, 2014, J GASTROINTEST SURG, V18, P1870, DOI 10.1007/s11605-014-2547-8; Ghosh SK, 2007, AM J PHYSIOL-GASTR L, V293, pG878, DOI 10.1152/ajpgi.00252.2007; Kumar P, 1998, CLIN MED, P229; Lee JY, 2013, J NEUROGASTROENTEROL, V19, P485, DOI 10.5056/jnm.2013.19.4.485; Ling TS, 2014, J DIGEST DIS, V15, P352, DOI 10.1111/1751-2980.12153; Ling TS, 2014, J GASTROEN HEPATOL, V29, P1609, DOI 10.1111/jgh.12570; Nicodeme F, 2013, CLIN GASTROENTEROL H, V11, P131, DOI 10.1016/j.cgh.2012.10.015; Pandolfino JE, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12097; Pandolfino JE, 2008, GASTROENTEROLOGY, V135, P1526, DOI 10.1053/j.gastro.2008.07.022; Pandolfino JE, 2015, JAMA-J AM MED ASSOC, V313, P1841, DOI 10.1001/jama.2015.2996; Pandolfino JE, 2013, CLIN GASTROENTEROL H, V11, P887, DOI 10.1016/j.cgh.2013.01.032; Park JH, 2015, J GASTROEN HEPATOL, V30, P59, DOI 10.1111/jgh.12642; Rohof WO, 2013, GASTROENTEROLOGY, V144, P718, DOI 10.1053/j.gastro.2012.12.027; Ryu JS, 2015, J NEUROGASTROENTEROL, V21, P283, DOI 10.5056/15009; Salvador R, 2010, J GASTROINTEST SURG, V14, P1635, DOI 10.1007/s11605-010-1318-4; Sharata A, 2014, SURG ENDOSC, V28, P1333, DOI 10.1007/s00464-013-3332-6; Sharata A, 2013, J GASTROINTEST SURG, V17, P1188, DOI 10.1007/s11605-013-2193-6; Teitelbaum EN, 2014, SURG ENDOSC, V28, P3359, DOI 10.1007/s00464-014-3628-1; Torres-Villalobos G, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/708327; Vaezi MF, 2013, AM J GASTROENTEROL, V108, P1238, DOI 10.1038/ajg.2013.196; Verlaan T, 2013, GASTROINTEST ENDOSC, V78, P39, DOI 10.1016/j.gie.2013.01.006; Xiao Y, 2012, NEUROGASTROENT MOTIL, V24, pe509, DOI 10.1111/j.1365-2982.2012.02001.x; Xiao YL, 2014, AM J GASTROENTEROL, V109, P521, DOI 10.1038/ajg.2014.13	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139385	10.1371/journal.pone.0139385	http://dx.doi.org/10.1371/journal.pone.0139385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421919	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700110
J	Yang, Z; Zan, YL; Zheng, XJ; Hai, WX; Chen, KW; Huang, Q; Xu, YH; Peng, JL				Yang, Zhen; Zan, Yunlong; Zheng, Xiujuan; Hai, Wangxi; Chen, Kewei; Huang, Qiu; Xu, Yuhong; Peng, Jinliang			Dynamic FDG-PET Imaging to Differentiate Malignancies from Inflammation in Subcutaneous and In Situ Mouse Model for Non-Small Cell Lung Carcinoma (NSCLC)	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL METABOLIC-RATE; F-18-FDG PET; INPUT FUNCTION; LYMPH-NODES; GLUCOSE; CANCER; TUMOR; RECONSTRUCTION; EXPRESSIONS	Background [F-18]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) has been widely used in oncologic procedures such as tumor diagnosis and staging. However, false-positive rates have been high, unacceptable and mainly caused by inflammatory lesions. Misinterpretations take place especially when non-subcutaneous inflammations appear at the tumor site, for instance in the lung. The aim of the current study is to evaluate the use of dynamic PET imaging procedure to differentiate in situ and subcutaneous non-small cell lung carcinoma (NSCLC) from inflammation, and estimate the kinetics of inflammations in various locations. Methods Dynamic FDG-PET was performed on 33 female mice inoculated with tumor and/or inflammation subcutaneously or inside the lung. Standardized Uptake Values (SUVs) from static imaging (SUVmax) as well as values of influx rate constant (Ki) of compartmental modeling from dynamic imaging were obtained. Static and kinetic data from different lesions (tumor and inflammations) or different locations (subcutaneous, in situ and spontaneous group) were compared. Results Values of SUVmax showed significant difference in subcutaneous tumor and inflammation (p<0.01), and in inflammations from different locations (p<0.005). However, SUVmax showed no statistical difference between in situ tumor and inflammation (p = 1.0) and among tumors from different locations (subcutaneous and in situ, p = 0.91). Values of Ki calculated from compartmental modeling showed significant difference between tumor and inflammation both subcutaneously (p<0.005) and orthotopically (p<0.01). Ki showed also location specific values for inflammations (subcutaneous, in situ and spontaneous, p<0.015). However, Ki of tumors from different locations (subcutaneous and in situ) showed no significant difference (p = 0.46). Conclusion In contrast to static PET based SUVmax, both subcutaneous and in situ inflammations and malignancies can be differentiated via dynamic FDG-PET based Ki. Moreover, Values of influx rate constant Ki from compartmental modeling can offer an assessment for inflammations at different locations of the body, which also implies further validation is necessary before the replacement of in situ inflammation with its subcutaneous counterpart in animal experiments.	[Yang, Zhen; Zan, Yunlong; Chen, Kewei; Huang, Qiu] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Zheng, Xiujuan] Sichuan Univ, Sch Elect & Informat, Dept Automat, Chengdu 610064, Sichuan, Peoples R China; [Hai, Wangxi; Xu, Yuhong; Peng, Jinliang] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Chen, Kewei] Banner Good Samaritan Med Ctr, Phoenix, AZ USA	Shanghai Jiao Tong University; Sichuan University; Shanghai Jiao Tong University; Banner Research; Banner Health	Huang, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	qiuhuang@sjtu.edu.cn; yhxu@sjtu.edu.cn; pjl76@sjtu.edu.cn	Hay, Vincent/AAW-1791-2020	Zheng, Xiujuan/0000-0002-4703-9530	Medical-Engineering Joint Fund of Shanghai Jiao Tong University [YG2011MS41, YG2012MS47]; National Science Foundation of China [81201114]; Innovation Program of Shanghai Municipal Education Commission [13ZZ017]; Shanghai Municipal Natural Science Foundation [15ZR1422700]	Medical-Engineering Joint Fund of Shanghai Jiao Tong University; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Municipal Natural Science Foundation	This work is funded by the Medical-Engineering Joint Fund of Shanghai Jiao Tong University (No. YG2011MS41 and YG2012MS47), the National Science Foundation of China (No. 81201114), the Innovation Program of Shanghai Municipal Education Commission (No. 13ZZ017), and the Shanghai Municipal Natural Science Foundation (No. 15ZR1422700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodvarsson B, 2006, ANAL DYNAMIC PET DAT; Chang JM, 2006, KOREAN J RADIOL, V7, P57, DOI 10.3348/kjr.2006.7.1.57; Chen DL, 2004, J NUCL MED, V45, P1583; Chen K, 1998, J CEREBR BLOOD F MET, V18, P716, DOI 10.1097/00004647-199807000-00002; Chung JH, 2004, J NUCL MED, V45, P999; Cobben DCP, 2004, J NUCL MED, V45, P226; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; HUANG SC, 1980, AM J PHYSIOL, V238, pE69, DOI 10.1152/ajpendo.1980.238.1.E69; Hustinx R, 1999, EUR J NUCL MED, V26, P1345, DOI 10.1007/s002590050593; KEYES JW, 1995, J NUCL MED, V36, P1836; Krak NC, 2005, EUR J NUCL MED MOL I, V32, P294, DOI 10.1007/s00259-004-1566-1; Love C, 2005, RADIOGRAPHICS, V25, P1357, DOI 10.1148/rg.255045122; Lu LJ, 2012, PHYS MED BIOL, V57, P5035, DOI 10.1088/0031-9155/57/15/5035; Maity A, 2010, CLIN CANCER RES, V16, P4685, DOI 10.1158/1078-0432.CCR-10-2004; Mamede M, 2005, NEOPLASIA, V7, P369, DOI 10.1593/neo.04577; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mochizuki TA, 2001, J NUCL MED, V42, P1551; OHTAKE T, 1991, J NUCL MED, V32, P1432; Paik JY, 2004, J NUCL MED, V45, P124; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Rau FC, 2002, EUR J NUCL MED MOL I, V29, P1039, DOI 10.1007/s00259-002-0821-6; Rosenbaum SJ, 2006, EUR RADIOL, V16, P1054, DOI 10.1007/s00330-005-0088-y; Strauss LG, 1996, EUR J NUCL MED, V23, P1409, DOI 10.1007/BF01367602; Thie JA, 2004, J NUCL MED, V45, P1431; Troost EGC, 2007, J NUCL MED, V48, P726, DOI 10.2967/jnumed.106.037473; van der Weerdt AP, 2001, J NUCL MED, V42, P1622; van Waarde A, 2006, J NUCL MED, V47, P150; Wester HJ, 1999, J NUCL MED, V40, P205; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; Yamamoto Y, 2008, EUR J NUCL MED MOL I, V35, P236, DOI 10.1007/s00259-007-0613-0; Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7; Yao RT, 2000, IEEE T MED IMAGING, V19, P798, DOI 10.1109/42.876305; ZASADNY KR, 1993, RADIOLOGY, V189, P847, DOI 10.1148/radiology.189.3.8234714; Zhuang HM, 2001, J NUCL MED, V42, P1412; Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278	37	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139089	10.1371/journal.pone.0139089	http://dx.doi.org/10.1371/journal.pone.0139089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421925	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700068
J	Morou-Bermudez, E; Rodriguez, S; Bello, AS; Dominguez-Bello, MG				Morou-Bermudez, Evangelia; Rodriguez, Selena; Bello, Angel S.; Dominguez-Bello, Maria G.			Urease and Dental Plaque Microbial Profiles in Children	PLOS ONE			English	Article							STREPTOCOCCUS-SALIVARIUS UREASE; ORAL BACTERIA; CARIES; 3-YEAR; PERIOD; QIIME	Objective Urease enzymes produced by oral bacteria generate ammonia, which can have a significant impact on the oral ecology and, consequently, on oral health. To evaluate the relationship of urease with dental plaque microbial profiles in children as it relates to dental caries, and to identify the main contributors to this activity. Methods 82 supragingival plaque samples were collected from 44 children at baseline and one year later, as part of a longitudinal study on urease and caries in children. DNA was extracted; the V3-V5 region of the 16S rRNA gene was amplified and sequenced using 454 pyrosequencing. Urease activity was measured using a spectrophotometric assay. Data were analyzed with Qiime. Results Plaque urease activity was significantly associated with the composition of the microbial communities of the dental plaque (Baseline P = 0.027, One Year P = 0.012). The bacterial taxa whose proportion in dental plaque exhibited significant variation by plaque urease levels in both visits were the family Pasteurellaceae (Baseline P<0.001; One Year P = 0.0148), especially Haemophilus parainfluenzae. No association was observed between these bacteria and dental caries. Bacteria in the genus Leptotrichia were negatively associated with urease and positively associated with dental caries (Bonferroni P<0.001). Conclusions Alkali production by urease enzymes primarily from species in the family Pasteurellaceae can be an important ecological determinant in children's dental plaque. Further studies are needed to establish the role of urease-associated bacteria in the acid/base homeostasis of the dental plaque, and in the development and prediction of dental caries in children.	[Morou-Bermudez, Evangelia; Bello, Angel S.] Univ Puerto Rico, Sch Dent Med, San Juan, PR 00936 USA; [Rodriguez, Selena] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; [Dominguez-Bello, Maria G.] NYU, Sch Med, New York, NY USA; [Dominguez-Bello, Maria G.] Univ Puerto Rico, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; New York University; University of Puerto Rico	Morou-Bermudez, E (corresponding author), Univ Puerto Rico, Sch Dent Med, Med Sci Campus, San Juan, PR 00936 USA.	evangelia.morou@upr.edu			National Institute for Dental and Craniofacial Research [K23 DE015285]; National Institute On Minority Health And Health Disparities of the National Institutes of Health [2U54MD007587]; RCMI grant [G12 MD007600]; NSF [MRI-R2-0959864]; National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103475]; Molecular Science Research Center of the UPR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K23DE015285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103475] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600, U54MD007587] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute On Minority Health And Health Disparities of the National Institutes of Health; RCMI grant; NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Molecular Science Research Center of the UPR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by K23 DE015285 (PI: Morou-Bermudez, Evangelia) from the National Institute for Dental and Craniofacial Research, by 2U54MD007587 from the National Institute On Minority Health And Health Disparities of the National Institutes of Health (PI: Cruz, M and Luciano C), and by RCMI grant #G12 MD007600 (PI: Emma Fernandez-Repollet). Data generation for this publication was performed at the Sequencing and Genomics Facility (SGF) of the University of Puerto Rico. Data was generated from equipment financially supported by an NSF MRI-R2-0959864. SGF is supported in part by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health, P20 GM103475, and the Molecular Science Research Center of the UPR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Burne RA, 2000, MICROBES INFECT, V2, P533, DOI 10.1016/S1286-4579(00)00312-9; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YYM, 1996, FEMS MICROBIOL LETT, V135, P223, DOI 10.1016/0378-1097(95)00454-8; Chen YYM, 1998, J BACTERIOL, V180, P5769, DOI 10.1128/JB.180.21.5769-5775.1998; Chen YYM, 2000, J BACTERIOL, V182, P4667, DOI 10.1128/JB.182.16.4667-4669.2000; Cortes DF, 2003, CARIES RES, V37, P8, DOI 10.1159/000068230; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Faith DP, 2006, EVOL BIOINFORM, V2, P277; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; Kianoush N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092940; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; KOPSTEIN J, 1977, CLIN SCI MOL MED, V52, P9, DOI 10.1042/cs0520009; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Morou-Bermudez E, 2011, ARCH ORAL BIOL, V56, P1560, DOI 10.1016/j.archoralbio.2011.06.017; Morou-Bermudez E, 2011, ARCH ORAL BIOL, V56, P1282, DOI 10.1016/j.archoralbio.2011.04.015; Morou-Bermudez E, 1999, INFECT IMMUN, V67, P504, DOI 10.1128/IAI.67.2.504-512.1999; Nascimento MM, 2009, ORAL MICROBIOL IMMUN, V24, P89, DOI 10.1111/j.1399-302X.2008.00477.x; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; SALAKO NO, 1989, ARCH ORAL BIOL, V34, P787, DOI 10.1016/0003-9969(89)90029-0; Shu M, 2007, ORAL MICROBIOL IMMUN, V22, P61, DOI 10.1111/j.1399-302X.2007.00325.x; Shu M, 2003, INFECT IMMUN, V71, P7188, DOI 10.1128/IAI.71.12.7188-7192.2003; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; SISSONS CH, 1988, ARCH ORAL BIOL, V33, P727, DOI 10.1016/0003-9969(88)90006-4; Thompson J, 2012, MOL ORAL MICROBIOL, V27, P34, DOI 10.1111/j.2041-1014.2011.00627.x	28	16	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139315	10.1371/journal.pone.0139315	http://dx.doi.org/10.1371/journal.pone.0139315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418220	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400075
J	Ziperstein, MJ; Guzman, A; Kaufman, LJ				Ziperstein, Michelle J.; Guzman, Asja; Kaufman, Laura J.			Breast Cancer Cell Line Aggregate Morphology Does Not Predict Invasive Capacity	PLOS ONE			English	Article							GENE-EXPRESSION; EXTRACELLULAR-MATRIX; 3-DIMENSIONAL CULTURE; EPITHELIAL-CELLS; MIGRATION; COLLAGEN; TUMORS; MODELS; 3D; REORGANIZATION	To invade and metastasize to distant loci, breast cancer cells must breach the layer of basement membrane surrounding the tumor and then invade through the dense collagen I-rich extracellular environment of breast tissue. Previous studies have shown that breast cancer cell aggregate morphology in basement membrane extract correlated with cell invasive capacity in some contexts. Moreover, cell lines from the same aggregate morphological class exhibited similarities in gene expression patterns. To further assess the capacity of cell and aggregate morphology to predict invasive capacity in physiologically relevant environments, six cell lines with varied cell aggregate morphologies were assessed in a variety of assays including a 3D multicellular invasion assay that recapitulates cell-cell and cell-environment contacts as they exist in vivo in the context of the primary breast tumor. Migratory and invasive capacities as measured through a 2D gap assay and a 3D spheroid invasion assay reveal that breast cancer cell aggregate morphology alone is insufficient to predict migratory speed in 2D or invasive capacity in 3D. Correlations between the 3D spheroid invasion assay and gene expression profiles suggest this assay as an inexpensive functional method to predict breast cancer invasive capacity.	[Ziperstein, Michelle J.; Guzman, Asja; Kaufman, Laura J.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Kaufman, LJ (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	kaufman@chem.columbia.edu	Kaufman, Laura/ABC-7682-2021	Kaufman, Laura/0000-0002-3754-0831	National Science Foundation; National Institutes of Health [PESO 1227297]; Columbia University	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University	This work was supported by the National Science Foundation and the National Institutes of Health (http://www.nsf.gov/pubs/2012/nsf12514/nsf12514.htm) via PESO 1227297 to LJK. Additional funding provided by Columbia University through support of graduate student teaching assistants (MJZ) and through discretionary funds for LJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Boyd NF, 2011, BREAST CANCER RES, V13, P12; Bredfeldt Jeremy S, 2014, J Pathol Inform, V5, P28, DOI 10.4103/2153-3539.139707; Calvo V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3359; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gehler S, 2013, CRIT REV EUKAR GENE, V23, P139, DOI 10.1615/CritRevEukarGeneExpr.2013006647; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kraning-Rush CM, 2013, INTEGR BIOL-UK, V5, P606, DOI 10.1039/c3ib20196a; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Liu Y, 2014, BRIT J CANCER, V110, P2063, DOI 10.1038/bjc.2014.105; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Rubenstein BM, 2008, BIOPHYS J, V95, P5661, DOI 10.1529/biophysj.108.140624; Shi QM, 2014, P NATL ACAD SCI USA, V111, P658, DOI 10.1073/pnas.1311312110; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zaman MH, 2007, ANN BIOMED ENG, V35, P91, DOI 10.1007/s10439-006-9205-6	51	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139523	10.1371/journal.pone.0139523	http://dx.doi.org/10.1371/journal.pone.0139523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418047	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400095
J	Ainembabazi, JH; Tripathi, L; Rusike, J; Abdoulaye, T; Manyong, V				Ainembabazi, John Herbert; Tripathi, Leena; Rusike, Joseph; Abdoulaye, Tahirou; Manyong, Victor			Ex-Ante Economic Impact Assessment of Genetically Modified Banana Resistant to Xanthomonas Wilt in the Great Lakes Region of Africa	PLOS ONE			English	Article							FARM-LEVEL; MODIFIED COTTON; BACTERIAL WILT; GM RICE; ADOPTION; WELFARE; PRODUCTIVITY; EXPRESSION; BENEFITS; DISEASE	Background Credible empirical evidence is scanty on the social implications of genetically modified (GM) crops in Africa, especially on vegetatively propagated crops. Little is known about the future success of introducing GM technologies into staple crops such as bananas, which are widely produced and consumed in the Great Lakes Region of Africa (GLA). GM banana has a potential to control the destructive banana Xanthomonas wilt disease. Objective To gain a better understanding of future adoption and consumption of GM banana in the GLA countries which are yet to permit the production of GMcrops; specifically, to evaluate the potential economic impacts of GM cultivars resistant to banana Xanthomonas wilt disease. Data Sources The paper uses data collected from farmers, traders, agricultural extension agents and key informants in the GLA. Analysis We analyze the perceptions of the respondents about the adoption and consumption of GM crop. Economic surplus model is used to determine future economic benefits and costs of producing GM banana. Results On the release of GM banana for commercialization, the expected initial adoption rate ranges from 21 to 70%, while the ceiling adoption rate is up to 100%. Investment in the development of GM banana is economically viable. However, aggregate benefits vary substantially across the target countries ranging from US$20 million to 953 million, highest in countries where disease incidence and production losses are high, ranging from 51 to 83% of production. Conclusion The findings support investment in the development of GM banana resistant to Xanthomonas wilt disease. The main beneficiaries of this technology development are farmers and consumers, although the latter benefit more than the former from reduced prices. Designing a participatory breeding program involving farmers and consumers signifies the successful adoption and consumption of GM banana in the target countries.	[Ainembabazi, John Herbert] Int Inst Trop Agr, Kampala, Uganda; [Tripathi, Leena] Int Inst Trop Agr, Nairobi, Kenya; [Rusike, Joseph; Manyong, Victor] Int Inst Trop Agr, Dar Es Salaam, Tanzania; [Abdoulaye, Tahirou] Int Inst Trop Agr, Ibadan, Nigeria; [Rusike, Joseph] AGRA, Nairobi, Kenya	CGIAR; International Institute of Tropical Agriculture (IITA)	Ainembabazi, JH (corresponding author), Int Inst Trop Agr, Kampala, Uganda.	J.Ainembabazi@cgiar.org			United States Agency for International Development [MTO 069018]	United States Agency for International Development(United States Agency for International Development (USAID))	The study was funded by the United States Agency for International Development. Grant number: MTO 069018. Funding received was by LT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele S, 2007, J CROP IMPROV, V19, P173, DOI 10.1300/J411v19n01_09; Ali A, 2010, J AGR ECON, V61, P175, DOI 10.1111/j.1477-9552.2009.00227.x; Alston JM, 1998, SCI SCARCITY PRINCIP; Bennett R, 2006, REV AGR ECON, V28, P59, DOI 10.1111/j.1467-9353.2006.00273.x; Blomme G, 2013, BANANA SYSTEMS HUMID; Cabanilla LS, 2004, INT J BIOTECHNOL, V10, P1; Demont M, 2013, NEW BIOTECHNOL, V30, P426, DOI 10.1016/j.nbt.2013.04.004; Finger R, 2011, SUSTAINABILITY-BASEL, V3, P743, DOI 10.3390/su3050743; Fulton M, 2004, AM J AGR ECON, V86, P42, DOI 10.1111/j.0092-5853.2004.00561.x; Gouse M., 2006, AgBioForum, V9, P15; Hareau GG, 2006, FOOD POLICY, V31, P162, DOI 10.1016/j.foodpol.2005.10.005; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; Hudson D., 2014, AgBioForum, V17, P1; Kalyebara M. R., 2006, African Crop Science Journal, V14, P93; Karamura E, 2010, ACTA HORTIC, V879, P749, DOI 10.17660/ActaHortic.2010.879.81; Kayobyo G, 2005, ASS IMP BAN BACT WIL; Kikulwe EM, 2011, AGR ECON-BLACKWELL, V42, P547, DOI 10.1111/j.1574-0862.2010.00529.x; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Namukwaya B, 2012, TRANSGENIC RES, V21, P855, DOI 10.1007/s11248-011-9574-y; Napasintuwong O., 2009, AgBioForum, V12, P209; Qaim M, 2006, REV AGR ECON, V28, P48, DOI 10.1111/j.1467-9353.2006.00272.x; Qaim M, 2005, AGR ECON, V32, P73, DOI 10.1111/j.0169-5150.2005.00006.x; Qaim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064879; Qaim M, 2005, AM J AGR ECON, V87, P1317, DOI 10.1111/j.1467-8276.2005.00825.x; Smale M., 2007, Research Report - International Food Policy Research Institute; Tripathi JN, 2014, PLANT BIOTECHNOL J, V12, P663, DOI 10.1111/pbi.12170; Tripathi L, 2013, ACTA HORTIC, V974, P81; Tripathi L, 2014, NAT BIOTECHNOL, V32, P868, DOI 10.1038/nbt.3007; Tripathi L, 2010, MOL PLANT PATHOL, V11, P721, DOI 10.1111/j.1364-3703.2010.00639.x; Tripathi L, 2009, PLANT DIS, V93, P440, DOI 10.1094/PDIS-93-5-0440; Yorobe Jr JM, 2009, PROJECTED IMPACTS AG, P23	31	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138998	10.1371/journal.pone.0138998	http://dx.doi.org/10.1371/journal.pone.0138998			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EO	26414379	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700032
J	Darrouzet, E; Gevar, J; Guignard, Q; Aron, S				Darrouzet, Eric; Gevar, Jeremy; Guignard, Quentin; Aron, Serge			Production of Early Diploid Males by European Colonies of the Invasive Hornet Vespa velutina nigrithorax	PLOS ONE			English	Article							CHINENSIS-ANTENNALIS HYMENOPTERA; JAPANESE PAPER WASP; COMPLEMENTARY SEX DETERMINATION; ANT SOLENOPSIS-INVICTA; YELLOW-LEGGED HORNET; POLISTES-CHINENSIS; SNELLENI HYMENOPTERA; GENETIC-VARIATION; WORKER; POPULATION	The invasive yellow-legged hornet Vespa velutina nigrithorax was accidentally introduced in Europe in the early 2000s. As is the case in colonies of other wasp and hornet species, V. velutina colonies are known to produce sexuals (males and new queens) at the end of the summer. We show that early-stage colonies in French populations frequently produce males well before the usual reproductive period. The vast majority of the males produced are diploid, which is consistent with the loss of genetic diversity previously reported in introduced populations in France. Since males do not participate in colony activities, the production of early diploid males at the expense of workers is expected to hamper colony growth and, ultimately, decrease the expansion of the species in its invasive range in Europe.	[Darrouzet, Eric; Gevar, Jeremy; Guignard, Quentin] Univ Tours, CNRS, UMR 7261, IRBI,Fac Sci, F-37200 Tours, France; [Aron, Serge] Univ Libre Bruxelles, Evolut Biol & Ecol, B-1050 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours; Universite Libre de Bruxelles	Darrouzet, E (corresponding author), Univ Tours, CNRS, UMR 7261, IRBI,Fac Sci, Parc Grandmt, F-37200 Tours, France.	eric.darrouzet@univ-tours.fr	Guignard, Quentin/ABB-6250-2021	Guignard, Quentin/0000-0002-9566-4365	local government (Region Centre, France); Belgium's National Fund for Scientific Research	local government (Region Centre, France)(Region Centre-Val de Loire); Belgium's National Fund for Scientific Research	This work was funded by the local government (Region Centre, France) (ED) and several grants from Belgium's National Fund for Scientific Research (SA).	ADAMS J, 1977, GENETICS, V86, P583; Arca M, 2015, BIOL INVASIONS, V17, P2357, DOI 10.1007/s10530-015-0880-9; Aron S, 2005, CURR BIOL, V15, P824, DOI 10.1016/j.cub.2005.03.017; Ayabe T, 2004, CHROMOSOME RES, V12, P215, DOI 10.1023/B:CHRO.0000021880.83639.4b; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cournault L, 2008, INSECT SOC, V55, P283, DOI 10.1007/s00040-008-1003-8; Cournault L, 2009, NATURWISSENSCHAFTEN, V96, P1393, DOI 10.1007/s00114-009-0590-1; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; Darrouzet E., 2014, SANTE ABEILLE, V259, P49; Darrouzet E., 2012, ESPECES, V6, P30; Darrouzet E, 2015, APIDOLOGIE, V46, P130, DOI 10.1007/s13592-014-0297-y; Darvill B, 2012, MOL ECOL, V21, P3988, DOI 10.1111/j.1365-294X.2012.05679.x; de Boer JG, 2007, HEREDITY, V99, P288, DOI 10.1038/sj.hdy.6800995; de Haro L, 2010, TOXICON, V55, P650, DOI 10.1016/j.toxicon.2009.08.005; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duchateau MJ, 1994, INSECT SOC, V42, P255; Elias J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006024; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Goldarazena A., 2015, Bulletin OEPP, V45, P133, DOI 10.1111/epp.12185; Hagiwara Y, 2002, INSECT SOC, V49, P191, DOI 10.1007/s00040-002-8300-4; Harpur BA, 2013, ENTOMOL EXP APPL, V146, P156, DOI 10.1111/j.1570-7458.2012.01306.x; Haxaire Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P194; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hughes WOH, 2008, J EVOLUTION BIOL, V21, P1090, DOI 10.1111/j.1420-9101.2008.01532.x; KASUYA E, 1983, RES POPUL ECOL, V25, P143, DOI 10.1007/BF02528789; KASUYA E, 1981, INSECT SOC, V28, P341, DOI 10.1007/BF02224190; KERR WE, 1987, INSECT SOC, V34, P274, DOI 10.1007/BF02224359; Liebert AE, 2004, INSECT SOC, V51, P205, DOI 10.1007/s00040-004-0754-0; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; NAITO T, 1991, J HERED, V82, P101, DOI 10.1093/oxfordjournals.jhered.a111042; Packer L, 2001, CONSERV ECOL, V5; PAGE RE, 1982, AM NAT, V119, P263, DOI 10.1086/283907; PAGE RE, 1989, AM NAT, V134, P731, DOI 10.1086/285008; PAMILO P, 1994, ETHOL ECOL EVOL, V6, P221, DOI 10.1080/08927014.1994.9522996; PLOWRIGHT RC, 1979, CAN ENTOMOL, V111, P289, DOI 10.4039/Ent111289-3; ROSS KG, 1986, BEHAV ECOL SOCIOBIOL, V19, P283, DOI 10.1007/BF00300643; ROSS KG, 1993, AM NAT, V141, P554, DOI 10.1086/285491; ROSS KG, 1993, GENETICS, V135, P843; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; STRASSMANN JE, 1981, BEHAV ECOL SOCIOBIOL, V8, P55, DOI 10.1007/BF00302844; Suzuki T, 1997, NATURWISSENSCHAFTEN, V84, P304, DOI 10.1007/s001140050399; Suzuki T, 1998, ETHOL ECOL EVOL, V10, P347, DOI 10.1080/08927014.1998.9522848; SUZUKI T, 1985, ANN ENTOMOL SOC AM, V78, P736, DOI 10.1093/aesa/78.6.736; Tsuchida K, 2004, J ETHOL, V22, P119, DOI 10.1007/s10164-003-0109-8; Tsuchida K, 2002, INSECT SOC, V49, P120, DOI 10.1007/s00040-002-8289-8; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Villemant C, 2011, BIOL CONSERV, V144, P2142, DOI 10.1016/j.biocon.2011.04.009; Whitehorn PR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-152; Wright LI, 2008, CONSERV GENET, V9, P833, DOI 10.1007/s10592-007-9405-0; Yamasaki K, 2011, ENTOMOL SCI, V14, P383, DOI 10.1111/j.1479-8298.2011.00460.x; Zayed A, 2001, HEREDITY, V87, P631, DOI 10.1046/j.1365-2540.2001.00952.x; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zayed A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000868	58	32	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0136680	10.1371/journal.pone.0136680	http://dx.doi.org/10.1371/journal.pone.0136680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414951	gold, Green Published, Green Submitted			2022-12-27	WOS:000362170700004
J	Munoz, ML; van Roon, A; Riese, H; Thio, C; Oostenbroek, E; Westrik, I; de Geus, EJC; Gansevoort, R; Lefrandt, J; Nolte, IM; Snieder, H				Munoz, M. Loretto; van Roon, Arie; Riese, Harriette; Thio, Chris; Oostenbroek, Emma; Westrik, Iris; de Geus, Eco J. C.; Gansevoort, Ron; Lefrandt, Joop; Nolte, Ilja M.; Snieder, Harold			Validity of (Ultra-)Short Recordings for Heart Rate Variability Measurements	PLOS ONE			English	Article							POPULATION; MORTALITY	Objectives In order to investigate the applicability of routine 10s electrocardiogram (ECG) recordings for time-domain heart rate variability (HRV) calculation we explored to what extent these (ultra-)short recordings capture the "actual" HRV. Methods The standard deviation of normal-to-normal intervals (SDNN) and the root mean square of successive differences (RMSSD) were measured in 3,387 adults. SDNN and RMSSD were assessed from (ultra) short recordings of 10s(3x), 30s, and 120s and compared to 240s-300s (gold standard) measurements. Pearson's correlation coefficients (r), Bland-Altman 95% limits of agreement and Cohen's d statistics were used as agreement analysis techniques. Results Agreement between the separate 10s recordings and the 240s-300s recording was already substantial (r = 0.758-0.764/Bias = 0.398-0.416/d = 0.855-0.894 for SDNN; r = 0.8530.862/Bias = 0.079-0.096/d = 0.150-0.171 for RMSSD), and improved further when three 10s periods were averaged (r = 0.863/Bias = 0.406/d = 0.874 for SDNN; r = 0.941/Bias = 0.088/d = 0.167 for RMSSD). Agreement increased with recording length and reached near perfect agreement at 120s (r = 0.956/Bias = 0.064/d = 0.137 for SDNN; r = 0.986/Bias = 0.014/d = 0.027 for RMSSD). For all recording lengths and agreement measures, RMSSD outperformed SDNN. Conclusions Our results confirm that it is unnecessary to use recordings longer than 120s to obtain accurate measures of RMSSD and SDNN in the time domain. Even a single 10s (standard ECG) recording yields a valid RMSSD measurement, although an average over multiple 10s ECGs is preferable. For SDNN we would recommend either 30s or multiple 10s ECGs. Future research projects using time-domain HRV parameters, e.g. genetic epidemiological studies, could calculate HRV from (ultra-)short ECGs enabling such projects to be performed at a large scale.	[Munoz, M. Loretto; Riese, Harriette; Thio, Chris; Nolte, Ilja M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Roon, Arie; Oostenbroek, Emma; Westrik, Iris; Lefrandt, Joop] Univ Groningen, Univ Med Ctr Groningen, Dept Vasc Med, Groningen, Netherlands; [Riese, Harriette] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [de Geus, Eco J. C.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [de Geus, Eco J. C.] Vrije Univ Amsterdam Med Ctr, Inst Hlth & Care Res EMGO, Amsterdam, Netherlands; [Gansevoort, Ron] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen	Nolte, IM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	i.m.nolte@umcg.nl; h.snieder@umcg.nl	de Geus, Eco J.C./M-9318-2015; Riese, Harriëtte/E-7234-2012; Munoz, Loretto/K-1229-2017	de Geus, Eco J.C./0000-0001-6022-2666; Riese, Harriëtte/0000-0003-3661-3151; Munoz, Loretto/0000-0003-2308-4158; Thio, Chris/0000-0003-2623-7172				Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Altman DG., 1999, PRACTICAL STAT MED R; Billman GE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00086; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Camm AJ, 1996, CIRCULATION, V93, P1043; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Bruyne MC, 1999, AM J EPIDEMIOL, V150, P1282; Dekker JM, 1997, AM J EPIDEMIOL, V145, P899, DOI 10.1093/oxfordjournals.aje.a009049; Dekker JM, 1996, ANN NONINVAS ELECTRO, V1, P287; Greaves-Lord K, 2010, PSYCHIAT RES, V179, P187, DOI 10.1016/j.psychres.2009.04.014; Joosten H, 2011, CLIN J AM SOC NEPHRO, V6, P1400, DOI 10.2215/CJN.05530610; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Liao DP, 1997, AM J EPIDEMIOL, V145, P696, DOI 10.1093/aje/145.8.696; MULDER LJM, 1995, CARSPAN CARDIOVASCUL; Nussinovitch U, 2011, ANN NONINVAS ELECTRO, V16, P117, DOI 10.1111/j.1542-474X.2011.00417.x; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; ROSENTHAL R, 1990, AM PSYCHOL, V45, P775, DOI 10.1037/0003-066X.45.6.775; Routledge HC, 2002, J CLIN PHARM THER, V27, P85, DOI 10.1046/j.1365-2710.2002.00404.x; Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004; Shah SA, 2013, AM J CARDIOL, V112, P533, DOI 10.1016/j.amjcard.2013.04.018; Thong T, 2003, P ANN INT IEEE EMBS, V25, P2424, DOI 10.1109/IEMBS.2003.1280405	22	166	167	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138921	10.1371/journal.pone.0138921	http://dx.doi.org/10.1371/journal.pone.0138921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414314	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700028
J	Golz, G; Karadas, G; Alutis, ME; Fischer, A; Kuhl, AA; Breithaupt, A; Gobel, UB; Alter, T; Bereswill, S; Heimesaat, MM				Goelz, Greta; Karadas, Guel; Alutis, Marie E.; Fischer, Andre; Kuehl, Anja A.; Breithaupt, Angele; Goebel, Ulf B.; Alter, Thomas; Bereswill, Stefan; Heimesaat, Markus M.			Arcobacter butzleri Induce Colonic, Extra-Intestinal and Systemic Inflammatory Responses in Gnotobiotic IL-10 Deficient Mice in a Strain-Dependent Manner	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI INFECTION; SPP.; ENTEROCOLITIS; ADHERENCE; INVASION; HUMANS; VIBRIO; CELLS	Background The immunopathological impact of human Arcobacter (A.) infections is under current debate. Episodes of gastroenteritis with abdominal pain and acute or prolonged watery diarrhea were reported for A. butzleri infected patients. Whereas adhesive, invasive and cytotoxic capacities have been described for A. butzleri in vitro, only limited information is available about the immunopathogenic potential and mechanisms of infection in vivo. Methodology/Principal Findings Gnotobiotic IL-10(-/-) mice were generated by broad-spectrum antibiotic treatment and perorally infected with the A. butzleri strains CCUG 30485 and C1 shown to be invasive in cell culture assays. Bacterial colonization capacities, clinical conditions, intestinal, extra-intestinal and systemic immune responses were monitored at day six and 16 postinfection (p.i.). Despite stable intestinal A. butzleri colonization at high loads, gnotobiotic IL-10(-/-) mice were virtually unaffected and did not display any overt symptoms at either time point. Notably, A. butzleri infection induced apoptosis of colonic epithelial cells which was paralleled by increased abundance of proliferating cells. Furthermore A. butzleri infection caused a significant increase of distinct immune cell populations such as T and B cells, regulatory T cells, macrophages and monocytes in the colon which was accompanied by elevated colonic TNF, IFN-gamma, nitric oxide (NO), IL-6, IL-12p70 and MCP-1 concentrations. Strikingly, A. butzleri induced extra-intestinal and systemic immune responses as indicated by higher NO concentrations in kidney and increased TNF, IFN-gamma, IL-12p70 and IL-6 levels in serum samples of infected as compared to naive mice. Overall, inflammatory responses could be observed earlier in the course of infection by the CCUG 30485 as compared to the C1 strain. Conclusion/Significance Peroral A. butzleri infection induced not only intestinal but also extra-intestinal and systemic immune responses in gnotobiotic IL-10(-/-) mice in a strain-dependent manner. These findings point towards an immunopathogenic potential of A. butzleri in vertebrate hosts.	[Goelz, Greta; Karadas, Guel; Alter, Thomas] Free Univ Berlin, Inst Food Hyg, Berlin, Germany; [Alutis, Marie E.; Fischer, Andre; Goebel, Ulf B.; Bereswill, Stefan; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.] Charite, Dept Med Gastroenterol Infect Dis & Rheumatol, Res Ctr ImmunoSci RCIS, D-13353 Berlin, Germany; [Breithaupt, Angele] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Golz, G (corresponding author), Free Univ Berlin, Inst Food Hyg, Berlin, Germany.	greta.goelz@fu-berlin.de	Breithaupt, Angele/GON-7227-2022; Breithaupt, Angele/B-6155-2013; Alter, Thomas/J-4810-2014	Breithaupt, Angele/0000-0002-6373-5923; Alter, Thomas/0000-0002-6048-5666; Heimesaat, Markus/0000-0001-6399-651X; Kuhl, Anja/0000-0003-2293-5387	German Research Foundation (DFG) [SFB633, TP A7, TP Z1, TP B6]; German Federal Ministery of Education and Research (BMBF) [TP1.1]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foundation (DFG) to AF, SB and UBG (SFB633, TP A7), AAK (SFB633, TP Z1), MMH (SFB633, TP B6), and from the German Federal Ministery of Education and Research (BMBF) to SB (TP1.1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adesiji Y O, 2012, West Afr J Med, V31, P186; Adesiji YO, 2010, CENT EUR J MED, V5, P470, DOI 10.2478/s11536-009-0109-3; Adesiji YO, 2009, SIERRA LEONE J BIOME, V1, P4; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bucker R, 2009, J INFECT DIS, V200, P756, DOI 10.1086/600868; Carbone M, 2003, FOOD MICROBIOL, V20, P611, DOI 10.1016/S0740-0020(02)00172-7; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Ferreira S, 2015, CRIT REV MICROBIOL; Golla SC, 2002, J FOOD PROTECT, V65, P1849, DOI 10.4315/0362-028X-65.12.1849; Gugliandolo C, 2008, MAR POLLUT BULL, V56, P600, DOI 10.1016/j.marpolbul.2007.12.001; Haag LM, 2012, EUR J MICROBIOL IMMU, V2, P2, DOI 10.1556/EuJMI.2.2012.1.2; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00077; Heimesaat MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090148; Ho HTK, 2007, FEMS IMMUNOL MED MIC, V50, P51, DOI 10.1111/j.1574-695X.2007.00230.x; Ho HTK, 2006, VET MICROBIOL, V115, P1, DOI 10.1016/j.vetmic.2006.03.004; Karadas G, 2013, J APPL MICROBIOL, V115, P583, DOI 10.1111/jam.12245; KIEHLBAUCH JA, 1991, J CLIN MICROBIOL, V29, P376, DOI 10.1128/JCM.29.2.376-385.1991; Lappi V, 2013, FOODBORNE PATHOG DIS, V10, P250, DOI 10.1089/fpd.2012.1307; Levican A, 2013, APPL ENVIRON MICROB, V79, P4951, DOI 10.1128/AEM.01073-13; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Musmanno RA, 1997, MICROBIOLOGICA, V20, P63; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Tompkin RB, 2002, MICROBIOLOGICAL TEST, P171; Van den Abeele AM, 2014, EMERG INFECT DIS, V20, P1731, DOI 10.3201/eid2010.140433; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Villarruel-Lopez A, 2003, J FOOD PROTECT, V66, P1374, DOI 10.4315/0362-028X-66.8.1374; Wesley IV, 1996, INFECT IMMUN, V64, P2295, DOI 10.1128/IAI.64.6.2295-2299.1996; Wesley IV, 1999, POULTRY SCI, V78, P536, DOI 10.1093/ps/78.4.536; zur Bruegge J, 2014, INT J MED MICROBIOL, V304, P1209, DOI 10.1016/j.ijmm.2014.08.017	32	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139402	10.1371/journal.pone.0139402	http://dx.doi.org/10.1371/journal.pone.0139402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406497	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700210
J	Harvey, TJ; Murphy, RM; Morrison, JL; Posterino, GS				Harvey, Thomas J.; Murphy, Robyn M.; Morrison, Janna L.; Posterino, Giuseppe S.			Maternal Nutrient Restriction Alters Ca2+ Handling Properties and Contractile Function of Isolated Left Ventricle Bundles in Male But Not Female Juvenile Rats	PLOS ONE			English	Article							TROPONIN-I PHOSPHORYLATION; HIGH-ALTITUDE HYPOXIA; CARDIAC-MUSCLE; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; GROWTH RESTRICTION; GESTATIONAL-AGE; BIRTH-WEIGHT; FETAL SHEEP; CAFFEINE	Intrauterine growth restriction (IUGR), defined as a birth weight below the 10th centile, may be caused by maternal undernutrition, with evidence that IUGR offspring have an increased risk of cardiovascular disease (CVD) in adulthood. Calcium ions (Ca2+) are an integral messenger for several steps associated with excitation-contraction coupling (ECC); the cascade of events from the initiation of an action potential at the surface membrane, to contraction of the cardiomyocyte. Any changes in Ca2+ storage and release from the sarcoplasmic reticulum (SR), or sensitivity of the contractile apparatus to Ca2+ may underlie the mechanism linking IUGR to an increased risk of CVD. This study aimed to explore the effects of maternal nutrient restriction on cardiac function, including Ca2+ handling by the SR and force development by the contractile apparatus. Juvenile Long Evans hooded rats born to Control (C) and nutrient restricted (NR) dams were anaesthetized for collection of the heart at 1012 weeks of age. Left ventricular bundles from male NR offspring displayed increased maximum Ca2+-activated force, and decreased protein content of troponin I (cTnI) compared to C males. Furthermore, male NR offspring showed a reduction in rate of rise of the caffeine-induced Ca2+ force response and a decrease in the protein content of ryanodine receptor (RYR2). These physiological and biochemical findings observed in males were not evident in female offspring. These findings illustrate a sex-specific effect of maternal NR on cardiac development, and also highlight a possible mechanism for the development of hypertension and hypertrophy in male NR offspring.	[Harvey, Thomas J.; Posterino, Giuseppe S.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia; [Murphy, Robyn M.] La Trobe Univ, Dept Biochem & Genet, Melbourne, Vic, Australia; [Morrison, Janna L.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	La Trobe University; La Trobe University; University of South Australia	Harvey, TJ (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia.	tj3harvey@students.latrobe.edu.au	Morrison, Janna/B-8308-2009; Moro, Valentina/K-6464-2016; Moro, Valentina/AAM-2224-2021; Scandola, Michele/D-8107-2013; Aglioti, Salvatore M/E-9829-2012	Morrison, Janna/0000-0002-8602-8519; Moro, Valentina/0000-0002-7119-7264; Moro, Valentina/0000-0002-7119-7264; Scandola, Michele/0000-0003-0853-8975; Murphy, Robyn/0000-0003-3697-589X; Posterino, Giuseppe/0000-0003-2539-1469	School of Life Sciences, La Trobe University; National Health and Medical Research Council of Australia [1051460]; South Australian Cardiovascular Research Network Fellowship [CR10A4988]; National Health and Medical Research Council of Australia Career Development Fellowship [APP1066916]	School of Life Sciences, La Trobe University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); South Australian Cardiovascular Research Network Fellowship; National Health and Medical Research Council of Australia Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by internal funds from the School of Life Sciences, La Trobe University, GP, TH. RMM was funded by the National Health and Medical Research Council of Australia (grant number 1051460, https://www.nhmrc.gov.au). JLM was funded by a South Australian Cardiovascular Research Network Fellowship (CR10A4988, http://www.heartfoundation.org.au/research/funding/Pages/south-australian-cardiovascular-research-development-program.aspx), and the National Health and Medical Research Council of Australia Career Development Fellowship (APP1066916 (https://www.nhmrc.gov.au/grants-funding/apply-funding/career-development-fellowships).	Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; ARNER A, 1995, J MOL CELL CARDIOL, V27, P615, DOI 10.1016/S0022-2828(08)80055-7; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bertram C, 2008, J PHYSIOL-LONDON, V586, P2217, DOI 10.1113/jphysiol.2007.147967; BRILLANTES AM, 1992, CIRC RES, V71, P18, DOI 10.1161/01.RES.71.1.18; Browne VA, 1997, AM J PHYSIOL-HEART C, V272, pH1196, DOI 10.1152/ajpheart.1997.272.3.H1196; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Fryer MW, 1996, J PHYSIOL-LONDON, V493, P357, DOI 10.1113/jphysiol.1996.sp021388; GO LO, 1995, J CLIN INVEST, V95, P888, DOI 10.1172/JCI117739; Haugaard CT, 2001, SCAND J LAB ANIM SCI, V28, P10; Hauton D, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-1; HERLAND JS, 1990, J PHYSIOL-LONDON, V426, P1; Herron TJ, 2001, CIRC RES, V89, P1184, DOI 10.1161/hh2401.101908; Imdad A, 2013, J PEDIATR-US, V162, pS107, DOI 10.1016/j.jpeds.2012.11.060; Kabbara AA, 1997, AM J PHYSIOL-HEART C, V273, pH1347, DOI 10.1152/ajpheart.1997.273.3.H1347; KABBARA AA, 1994, PFLUG ARCH EUR J PHY, V428, P331, DOI 10.1007/BF00724515; Kabbara AA, 1997, AM J PHYSIOL-HEART C, V272, pH1001, DOI 10.1152/ajpheart.1997.272.2.H1001; Kentish JC, 1997, CARDIOVASC RES, V33, P314, DOI 10.1016/S0008-6363(96)00217-9; Kruger M, 2006, AM J PHYSIOL-HEART C, V291, pH496, DOI 10.1152/ajpheart.00114.2006; Li ZC, 2012, PROCEEDINGS OF THE ASME 6TH INTERNATIONAL CONFERENCE ON ENERGY SUSTAINABILITY - 2012, PTS A AND B, P1; Mach Mojmir, 2009, Interdiscip Toxicol, V2, P28, DOI 10.2478/v10102-009-0005-3; Mollica JP, 2009, ANAL BIOCHEM, V386, P270, DOI 10.1016/j.ab.2008.12.029; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; Murphy RM, 2011, AM J PHYSIOL-HEART C, V300, pH595, DOI 10.1152/ajpheart.00902.2010; Ojeda NB, 2007, AM J PHYSIOL-REG I, V292, pR758, DOI 10.1152/ajpregu.00311.2006; Onishi J, 2004, J SOC GYNECOL INVEST, V11, P1, DOI 10.1016/j.jsgi.2003.07.003; Onishi J, 2003, J SOC GYNECOL INVEST, V10, P189, DOI 10.1016/S1071-5576(03)00042-X; Palmer S, 1997, CIRC RES, V80, P682, DOI 10.1161/01.RES.80.5.682; Posterino GS, 2011, J APPL PHYSIOL, V111, P236, DOI 10.1152/japplphysiol.00067.2011; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Schillinger W, 1996, MOL CELL BIOCHEM, V161, P297, DOI 10.1007/BF00240062; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731; Stephenson DG, 2008, J PHYSIOL-LONDON, V586, P695, DOI 10.1113/jphysiol.2007.148270; Tare M, 2014, CLIN SCI LOND; Unterscheider J, 2014, EUR J OBSTET GYN R B, V174, P41, DOI 10.1016/j.ejogrb.2013.11.022; VIJAYAKUMAR M, 1995, BRIT HEART J, V73, P363; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; Wagner R, 2004, BRIT J PHARMACOL, V141, P624, DOI 10.1038/sj.bjp.0705655; Weiwad WKK, 2000, J MOL CELL CARDIOL, V32, P247, DOI 10.1006/jmcc.1999.1069; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; Yaras N, 2005, DIABETES, V54, P3082, DOI 10.2337/diabetes.54.11.3082	49	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138388	10.1371/journal.pone.0138388	http://dx.doi.org/10.1371/journal.pone.0138388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406887	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000361800700042
J	Luo, YW; Wang, XY; Wang, HR; Xu, Y; Wen, QY; Fan, SQ; Zhao, R; Jiang, SH; Yang, J; Liu, YK; Li, XY; Xiong, W; Ma, J; Peng, SP; Zeng, ZY; Li, XL; Phillips, JB; Li, GY; Tan, M; Zhou, M				Luo, Yanwei; Wang, Xinye; Wang, Heran; Xu, Yang; Wen, Qiuyuan; Fan, Songqing; Zhao, Ran; Jiang, Shihe; Yang, Jing; Liu, Yukun; Li, Xiayu; Xiong, Wei; Ma, Jian; Peng, Shuping; Zeng, Zhaoyang; Li, Xiaoling; Phillips, Joshua B.; Li, Guiyuan; Tan, Ming; Zhou, Ming			High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel	PLOS ONE			English	Article							PRO-APOPTOTIC BAK; BCL-2 EXPRESSION; MITOCHONDRIAL; RESISTANCE; DEATH; MCL-1; GENE; TRASTUZUMAB; SUPPRESSION; CARCINOMA	Breast cancer has become the leading cause of cancer-related death among women. A large number of patients become resistant to drug chemotherapy. Paclitaxel (Taxol) is an effective chemotherapeutic agent used to treat cancer patients. Taxol has been widely used in human malignancies including breast cancer because it can stabilize microtubules resulting in cell death by causing an arrest during the G2/M phase of the cell cycle. Pro-apoptotic Bcl-2 antagonist killer 1 (Bak) plays an important role in Taxol-induced apoptosis in breast cancer. In our present study, we investigated the expression of the Bak protein and clinicopathological correlations in a large sample of breast cancer tissues by immunohistochemistry. We found that the percentage of high scores of Bak expression in breast cancer was significantly lower than that of the non-cancerous breast control tissue. In addition, lower Bak expression was positively associated with the clinical TNM stage of breast cancer with a significant decrease in overall survival compared with those with higher Bak expression especially in the Luminal and HER2 subtypes. Importantly, higher Bak expression predicted a favorable clinical outcome in the cases treated with Taxol indicated by a higher overall survival than that of patients with lower Bak expression especially in Luminal and HER2 subtypes. Furthermore, these results were confirmed in vitro since overexpression of Bak sensitized breast cancer cells to Taxol by inhibiting proliferation and promoting apoptosis; in contrast, downregulation of Bak through siRNA transfection inhibited Taxol induced-apoptosis. Therefore, our results demonstrate that Bak acts as a sensitive biomarker and favorable prognostic factor for Taxol treatment in breast cancer. The restoration of Bak expression would be therapeutically beneficial for Taxol resistant breast cancer patients.	[Luo, Yanwei; Wang, Xinye; Wang, Heran; Xu, Yang; Zhao, Ran; Jiang, Shihe; Yang, Jing; Liu, Yukun; Xiong, Wei; Ma, Jian; Peng, Shuping; Zeng, Zhaoyang; Li, Xiaoling; Li, Guiyuan; Zhou, Ming] Cent South Univ, Canc Res Inst, Xiangya Med Sch, Affiliated Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Phillips, Joshua B.; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Wen, Qiuyuan; Fan, Songqing] Cent South Univ, Xiang Ya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Li, Xiayu] Cent South Univ, Xiang Ya Hosp 3, Changsha 410013, Hunan, Peoples R China	Central South University; University of South Alabama; Central South University; Central South University	Tan, M (corresponding author), Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA.	mtan@health.southalabama.edu; zhouming2001@163.com	li, xia/HHZ-7468-2022; Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898	National Natural Science Foundation of China [81328019, 81171934, 81572748]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by grants obtained from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Nos. 81328019, 81171934, 81572748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Hern RP, 2013, NAT REV CLIN ONCOL, V10, P357, DOI 10.1038/nrclinonc.2013.67; Austreid E, 2014, EXPERT OPIN PHARMACO, V15, P681, DOI 10.1517/14656566.2014.885952; Barille-Nion S, 2012, ANTICANCER RES, V32, P4225; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Bonnefoi H, 2015, ANN ONCOL, V26, P325, DOI 10.1093/annonc/mdu551; Chang J, 2003, CANCER-AM CANCER SOC, V97, P545, DOI 10.1002/cncr.11083; Chen LY, 2015, BREAST CANCER RES TR, V149, P631, DOI 10.1007/s10549-015-3288-4; Courneya KS, 2014, BRIT J CANCER, V111, P1718, DOI 10.1038/bjc.2014.466; Duckworth CA, 2015, AM J PHYSIOL-GASTR L, V309, pG420, DOI 10.1152/ajpgi.00404.2014; Eguchi H, 2000, CELL DEATH DIFFER, V7, P439, DOI 10.1038/sj.cdd.4400675; Fan SQ, 2006, HUM PATHOL, V37, P593, DOI 10.1016/j.humpath.2006.01.010; Gordon LI, 2009, J BIOL CHEM, V284, P2080, DOI 10.1074/jbc.M804570200; Grabow S, 2014, BLOOD, V124, P3939, DOI 10.1182/blood-2014-09-601567; Gratas C, 2014, ONCOTARGET, V5, P2428, DOI 10.18632/oncotarget.1642; Janssen K, 2009, J CELL SCI, V122, P4481, DOI 10.1242/jcs.055772; Kanczuga-Koda L, 2010, ONCOL LETT, V1, P1067, DOI 10.3892/ol.2010.178; Kenicer J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-762; Kondo S, 2000, CANCER RES, V60, P4328; Kutuk O, 2008, CANCER RES, V68, P7985, DOI 10.1158/0008-5472.CAN-08-1418; Li R, 2005, CELL DEATH DIFFER, V12, P292, DOI 10.1038/sj.cdd.4401554; Lian JQ, 2012, MOL CANCER THER, V11, P416, DOI 10.1158/1535-7163.MCT-11-0559; Matissek KJ, 2014, PHARM RES-DORDR, V31, P2503, DOI 10.1007/s11095-014-1346-y; Miller AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060685; Miura D, 2014, J NIPPON MED SCH, V81, P211, DOI 10.1272/jnms.81.211; Naresh A, 2008, CANCER RES, V68, P6387, DOI 10.1158/0008-5472.CAN-08-0538; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Shinde AM, 2015, BREAST, V24, P18, DOI 10.1016/j.breast.2014.10.008; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tabuchi Y, 2009, INT J ONCOL, V34, P313, DOI 10.3892/ijo_00000153; Thomas S, 2011, BREAST CANCER RES TR, V130, P437, DOI 10.1007/s10549-011-1364-y; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Tong QS, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-33; Wang H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-37; Yao Q, 2011, TUMOR BIOL, V32, P1163, DOI 10.1007/s13277-011-0219-9; Ye CG, 2013, BBA-MOL CELL RES, V1833, P2970, DOI 10.1016/j.bbamcr.2013.08.001; Yoshino T, 2006, CLIN CANCER RES, V12, P6116, DOI 10.1158/1078-0432.CCR-06-0147; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	37	19	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138955	10.1371/journal.pone.0138955	http://dx.doi.org/10.1371/journal.pone.0138955			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406239	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700128
J	Meyers, K; Qian, HY; Wu, YF; Lao, YF; Chen, QL; Dong, XQ; Li, HQ; Yang, YQ; Jiang, CQ; Zhou, ZQ				Meyers, Kathrine; Qian, Haoyu; Wu, Yingfeng; Lao, Yunfei; Chen, Qingling; Dong, Xingqi; Li, Huiqin; Yang, Yiqing; Jiang, Chengqin; Zhou, Zengquan			Early Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PREVENTION; PROPHYLAXIS; WOMEN; RECOMMENDATIONS; INFECTION; AFRICA; CARE	Objective To identify factors associated with mother-to-child-transmission and late access to prevention of maternal to child transmission (PMTCT) services among HIV-infected women; and risk factors for infant mortality among HIV-exposed infants in order to assess the feasibility of virtual elimination of vertical transmission and pediatric HIV in this setting. Design Observational study evaluating the impact of a provincial PMTCT program. Methods The intervention was implemented in 26 counties of Yunnan Province, China at municipal and tertiary health care settings. Log linear regression models with generalized estimating equations were used to identify unadjusted and adjusted correlates for late ARV intervention and MTCT. Cox proportional hazard models with robust sandwich estimation were applied to examine correlates of infant mortality. Results Mother-to-child-transmission rate of HIV was controlled to 2%, with late initiation of maternal ARV showing a strong association with vertical transmission and infant mortality. Risk factors for late initiation of maternal ARV were age, ethnicity, education, and having a husband not tested for HIV. Mortality rate among HIV-exposed infants was 2.9/100 person-years. In addition to late initiation of maternal ARV, ethnicity, low birth weight and preterm birth were associated with infant mortality. Conclusions This PMTCT program in Yunnan achieved low rates of MTCT. However the infant mortality rate in this cohort of HIV-exposed children was almost three times the provincial rate. Virtual elimination of MTCT of HIV is an achievable goal in China, but more attention needs to be paid to HIV-free survival.	[Meyers, Kathrine; Qian, Haoyu] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Lao, Yunfei; Chen, Qingling; Dong, Xingqi; Li, Huiqin; Zhou, Zengquan] Yunnan AIDS Care Ctr, Kunming, Yunnan, Peoples R China; [Yang, Yiqing] Linxiang Maternal & Child Hosp, Lincang, Yunnan, Peoples R China; [Jiang, Chengqin] Mangshi Maternal & Child Hosp, Dehong, Yunnan, Peoples R China; [Zhou, Zengquan] Yunnan AIDS Initiat, Kunming, Yunnan, Peoples R China		Zhou, ZQ (corresponding author), Yunnan AIDS Care Ctr, Kunming, Yunnan, Peoples R China.	ynzzq@263.com			National Health and Family Planning Commission; Zeshan Foundation	National Health and Family Planning Commission; Zeshan Foundation	The project was supported by funding from the National Health and Family Planning Commission and a grant from the Zeshan Foundation. This was a collaborative project of the Yunnan Bureau of Health, Yunnan Maternal and Child Health Hospital, Yunnan AIDS Care Center, Yunnan AIDS Initiative, and the Aaron Diamond AIDS Research Center.	Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Barry OM, 2012, AIDS CARE, V24, P680, DOI 10.1080/09540121.2011.630369; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Colombini M, 2014, AIDS CARE, V26, P914, DOI 10.1080/09540121.2013.869539; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Dao H, 2007, AM J OBSTET GYNECOL, V197, pS42, DOI 10.1016/j.ajog.2007.03.001; Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Jamieson DJ, 2007, AM J OBSTET GYNECOL, V197, pS26, DOI 10.1016/j.ajog.2007.03.087; Jaspan HB, 2003, CURR HIV RES, V1, P321, DOI 10.2174/1570162033485221; Korhonen C, 2012, ADV EXP MED BIOL, V743, P237, DOI 10.1007/978-1-4614-2251-8_17; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Mou J, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-214; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nielsen-Saines K, 2012, NEW ENGL J MED, V366, P2368, DOI 10.1056/NEJMoa1108275; Peng YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-69; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; UNAIDS, 2012, REPORT ON THE GLOBAL; WHO, 2014, GLOB PLAN EL HIV CHI; Yuan B, 2013, GLOBAL HLTH ACTION, V6, DOI [10.3402/gha.v6i0.19542, DOI 10.3402/GHA.V6I0.19542.D0I:10.3402/GHA.V6I0.19542]	24	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138104	10.1371/journal.pone.0138104	http://dx.doi.org/10.1371/journal.pone.0138104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407096	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700034
J	Barrera, SP; Castrejon-Tellez, V; Trinidad, M; Robles-Escajeda, E; Vargas-Medrano, J; Varela-Ramirez, A; Miranda, M				Barrera, Susana P.; Castrejon-Tellez, Vicente; Trinidad, Margarita; Robles-Escajeda, Elisa; Vargas-Medrano, Javier; Varela-Ramirez, Armando; Miranda, Manuel			PKC-Dependent GlyT1 Ubiquitination Occurs Independent of Phosphorylation: Inespecificity in Lysine Selection for Ubiquitination	PLOS ONE			English	Article							PROTEIN-KINASE-C; NEURONAL GLYCINE TRANSPORTER-2; NMDA RECEPTOR ACTIVATION; DOPAMINE TRANSPORTER; GLUTAMATE TRANSPORTER; PHORBOL-ESTER; REGULATED ENDOCYTOSIS; SURFACE EXPRESSION; TERMINAL DOMAIN; SYNTAXIN 1A	Neurotransmitter transporter ubiquitination is emerging as the main mechanism for endocytosis and sorting of cargo into lysosomes. In this study, we demonstrate PKC-dependent ubiquitination of three different isoforms of the glycine transporter 1 (GlyT1). Incubation of cells expressing transporter with the PKC activator phorbol ester induced a dramatic, time-dependent increase in GlyT1 ubiquitination, followed by accumulation of GlyT1 in EEA1 positive early endosomes. This occurred via a mechanism that was abolished by inhibition of PKC. GlyT1 endocytosis was confirmed in both retinal sections and primary cultures of mouse amacrine neurons. Replacement of only all lysines in the N- and C-termini to arginines prevented ubiquitination and endocytosis, displaying redundancy in the mechanism of ubiquitination. Interestingly, a 40-50% reduction in glycine uptake was detected in phorbol-ester stimulated cells expressing the WT-GlyT1, whereas no significant change was for the mutant protein, demonstrating that endocytosis participates in the reduction of uptake. Consistent with previous findings for the dopamine transporter DAT, ubiquitination of GlyT1 tails functions as sorting signal to deliver transporter into the lysosome and removal of ubiquitination sites dramatically attenuated the rate of GlyT1 degradation. Finally, we showed for the first time that PKC-dependent GlyT1 phosphorylation was not affected by removal of ubiquitination sites, suggesting separate PKC-dependent signaling events for these post-translational modifications.	[Miranda, Manuel] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Miranda, M (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	mmiranda3@utep.edu	Varela-Ramirez, Armando/ABI-4315-2020; Vargas Medrano, Javier/AAW-4666-2021	Varela-Ramirez, Armando/0000-0002-2071-4874; Vargas Medrano, Javier/0000-0002-5424-4225; Castrejon Tellez, Vicente/0000-0002-8518-6961	National Institutes of Mental Health (NIMH) [NIMH 5SC1MH 086070-04]; National Institute on Minority Health and Health Disparities (NIMHD-NIH) [2G12MD007592]; Vulnerability Issues in Drug Abuse (VIDA) [DA029989]; HHMI grant [52005908]; National Institute of General Medical Sciences, Research Initiative for Scientific Enhancement (NIGMS RISE) [R25 GM069621-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM069621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [SC1MH086070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA029989] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities (NIMHD-NIH); Vulnerability Issues in Drug Abuse (VIDA); HHMI grant(Howard Hughes Medical Institute); National Institute of General Medical Sciences, Research Initiative for Scientific Enhancement (NIGMS RISE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grant NIMH 5SC1MH 086070-04 to MM from the National Institutes of Mental Health (NIMH) and also in part by the grant 2G12MD007592 to the Border Biomedical Research Center at University of Texas at El Paso (UTEP) from the National Institute on Minority Health and Health Disparities (NIMHD-NIH) and by the Vulnerability Issues in Drug Abuse (VIDA) grant DA029989. SB was supported by a fellowship from the HHMI grant #52005908 and ERE by National Institute of General Medical Sciences, Research Initiative for Scientific Enhancement (NIGMS RISE) training grant R25 GM069621-10.	Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Chen R, 2009, J PHARMACOL EXP THER, V328, P912, DOI 10.1124/jpet.108.147959; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; de Juan-Sanz J, 2011, TRAFFIC; de Juan-Sanz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058863; Dipace C, 2007, MOL PHARMACOL, V71, P230, DOI 10.1124/mol.106.026690; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Fernandez-Sanchez E, 2009, J BIOL CHEM, V284, P19482, DOI 10.1074/jbc.M109.005165; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Fornes A, 2004, J BIOL CHEM, V279, P22934, DOI 10.1074/jbc.M401337200; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gabriel LR, 2013, J NEUROSCI, V33, P17836, DOI 10.1523/JNEUROSCI.3284-13.2013; Gant VU, 2014, J VIROL, V88, P5912, DOI 10.1128/JVI.03032-13; Garcia-Tardon N, 2012, J BIOL CHEM, V287, P19177, DOI 10.1074/jbc.M112.355909; Geerlings A, 2000, FEBS LETT, V470, P51, DOI 10.1016/S0014-5793(00)01297-7; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Hanley JG, 2000, J BIOL CHEM, V275, P840, DOI 10.1074/jbc.275.2.840; Hong WMC, 2013, FASEB J, V27, P2995, DOI 10.1096/fj.12-218727; Horiuchi M, 2005, J NEUROCHEM, V94, P307, DOI 10.1111/j.1471-4159.2005.03198.x; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Imamura Y, 2008, J NEUROCHEM, V105, P2454, DOI 10.1111/j.1471-4159.2008.05324.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Jursky F, 1996, J NEUROCHEM, V67, P336; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Mohler H, 2011, BIOCHEM PHARMACOL, V81, P1065, DOI 10.1016/j.bcp.2011.02.003; Moritz AE, 2013, J BIOL CHEM, V288, P20, DOI 10.1074/jbc.M112.407874; Mortensen OV, 2008, MOL BIOL CELL, V19, P2818, DOI 10.1091/mbc.E07-09-0980; Nissen-Meyer LSH, 2011, J NEUROSCI, V31, P6565, DOI 10.1523/JNEUROSCI.3694-10.2011; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Rao A, 2011, MOL CELL NEUROSCI, V46, P148, DOI 10.1016/j.mcn.2010.08.016; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; SATO K, 1995, J NEUROCHEM, V65, P1967; Sheldon AL, 2008, NEUROCHEM INT, V53, P296, DOI 10.1016/j.neuint.2008.07.010; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sung U, 2003, J NEUROSCI, V23, P1697; Supplisson S, 1997, J NEUROSCI, V17, P4580; Susarla BTS, 2008, NEUROCHEM INT, V52, P709, DOI 10.1016/j.neuint.2007.08.020; Vargas-Medrano J, 2011, NEUROCHEM INT, V59, P1123, DOI 10.1016/j.neuint.2011.08.006; Wassle H, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.006.2009; Yamada H, 2012, BIOMED RES-TOKYO, V33, P1; Yang XF, 2013, J CELL SCI, V126, P4230, DOI 10.1242/jcs.128603; ZAFRA F, 1995, J NEUROSCI, V15, P3952	55	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138897	10.1371/journal.pone.0138897	http://dx.doi.org/10.1371/journal.pone.0138897			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418248	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400024
J	Fang, XM; Chen, FS; Wan, SZ; Yang, QP; Shi, JM				Fang, Xiang-Min; Chen, Fu-Sheng; Wan, Song-Ze; Yang, Qing-Pei; Shi, Jian-Min			Topsoil and Deep Soil Organic Carbon Concentration and Stability Vary with Aggregate Size and Vegetation Type in Subtropical China	PLOS ONE			English	Article							MICROBIAL BIOMASS; FOREST SOIL; LAND-USE; STOICHIOMETRIC CONTROLS; RAPID ACCUMULATION; MATTER; SEQUESTRATION; NITROGEN; STABILIZATION; DYNAMICS	The impact of reforestation on soil organic carbon (OC), especially in deep layer, is poorly understood and deep soil OC stabilization in relation with aggregation and vegetation type in afforested area is unknown. Here, we collected topsoil (0-15 cm) and deep soil (30-45 cm) from six paired coniferous forests (CF) and broad-leaved forests (BF) reforested in the early 1990s in subtropical China. Soil aggregates were separated by size by dry sieving and OC stability was measured by closed-jar alkali-absorption in 71 incubation days. Soil OC concentration and mean weight diameter were higher in BF than CF. The cumulative carbon mineralization (C-min, mgCO(2)-C kg(-1) soil) varied with aggregate size in BF and CF topsoils, and in deep soil, it was higher in larger aggregates than in smaller aggregates in BF, but not CF. The percentage of soil OC mineralized (SOCmin,% SOC) was in general higher in larger aggregates than in smaller aggregates. Meanwhile, SOCmin was greater in CF than in BF at topsoil and deep soil aggregates. In comparison to topsoil, deep soil aggregates generally exhibited a lower C-min, and higher SOCmin. Total nitrogen (N) and the ratio of carbon to phosphorus (C/P) were generally higher in BF than in CF in topsoil and deep soil aggregates, while the same trend of N/P was only found in deep soil aggregates. Moreover, the SOCmin negatively correlated with OC, total N, C/P and N/P. This work suggests that reforested vegetation type might play an important role in soil OC storage through internal nutrient cycling. Soil depth and aggregate size influenced OC stability, and deep soil OC stability could be altered by vegetation reforested about 20 years.	[Fang, Xiang-Min; Chen, Fu-Sheng; Wan, Song-Ze; Yang, Qing-Pei; Shi, Jian-Min] Jiangxi Agr Univ, Coll Forestry, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang 330045, Peoples R China	Jiangxi Agricultural University	Chen, FS (corresponding author), Jiangxi Agr Univ, Coll Forestry, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang 330045, Peoples R China.	chenfush@yahoo.com			National Basic Research Program of China (973 Program) [2012CB416903]; National Natural Science Foundation of China [31160107, 31360179]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Basic Research Program of China (973 Program, 2012CB416903) and the National Natural Science Foundation of China (31160107 & 31360179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli A, 2004, SOIL BIOL BIOCHEM, V36, P859, DOI 10.1016/j.soilbio.2004.02.004; Allen SE, 1989, CHEM ANAL ECOLOGICAL; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Blume E, 2002, APPL SOIL ECOL, V20, P171, DOI 10.1016/S0929-1393(02)00025-2; Buchkowski RW, 2015, ECOLOGY, V96, P1139, DOI 10.1890/14-1327.1; Casals P, 2014, PLANT SOIL, V374, P643, DOI 10.1007/s11104-013-1884-9; Chen FS, 2014, APPL SOIL ECOL, V75, P181, DOI 10.1016/j.apsoil.2013.11.011; Chen FS, 2014, GEODERMA, V214, P19, DOI 10.1016/j.geoderma.2013.10.009; Creamer CA, 2014, SOIL BIOL BIOCHEM, V79, P50, DOI 10.1016/j.soilbio.2014.08.019; Drury CF, 2004, SOIL TILL RES, V79, P87, DOI 10.1016/j.still.2004.03.020; Fang XM, 2014, CHINESE GEOGR SCI, V24, P297, DOI 10.1007/s11769-014-0670-9; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gaudinski JB, 2000, BIOGEOCHEMISTRY, V51, P33, DOI 10.1023/A:1006301010014; Gong X, 2013, FOREST ECOL MANAG, V300, P77, DOI 10.1016/j.foreco.2012.12.002; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Harper RJ, 2013, PLANT SOIL, V368, P641, DOI 10.1007/s11104-013-1600-9; Hirsch AI, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000921; Huang WJ, 2013, PLANT SOIL, V364, P181, DOI 10.1007/s11104-012-1355-8; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jastrow JD, 1996, SOIL SCI SOC AM J, V60, P801, DOI 10.2136/sssaj1996.03615995006000030017x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kaiser C, 2014, ECOL LETT, V17, P680, DOI 10.1111/ele.12269; Kemper WD, 1986, METHODS SOIL ANAL 1; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Lewandrowski J, 2014, FOREST POLICY ECON, V38, P90, DOI 10.1016/j.forpol.2013.06.014; Li CH, 2013, PLANT SOIL, V369, P645, DOI 10.1007/s11104-013-1605-4; Li SZ, 2009, THESIS CENTRAL S U F; Liu Yuanqiu, 2005, Yingyong Shengtai Xuebao, V16, P1735; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Martens DA, 2000, SOIL BIOL BIOCHEM, V32, P361, DOI 10.1016/S0038-0717(99)00162-5; Nottingham AT, 2015, SOIL BIOL BIOCHEM, V80, P26, DOI 10.1016/j.soilbio.2014.09.012; Ota M, 2013, J GEOPHYS RES-BIOGEO, V118, P1646, DOI 10.1002/2013JG002379; Paul EA, 1997, SOIL SCI SOC AM J, V61, P1058, DOI 10.2136/sssaj1997.03615995006100040011x; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Puget P, 2000, EUR J SOIL SCI, V51, P595, DOI 10.1046/j.1365-2389.2000.00353.x; Qayyum MF, 2012, J ENVIRON QUAL, V41, P1210, DOI 10.2134/jeq2011.0058; Rabbi SMF, 2014, GEODERMA, V216, P10, DOI 10.1016/j.geoderma.2013.10.023; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Rumpel C, 2008, GEODERMA, V145, P347, DOI 10.1016/j.geoderma.2008.04.001; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Sainju UM, 2006, SOIL SCI, V171, P937, DOI 10.1097/01.ss0000228062.30958.5a; Sanderman J, 2009, BIOGEOCHEMISTRY, V92, P41, DOI 10.1007/s10533-008-9249-9; SCHARPENSEEL HW, 1989, SCI TOTAL ENVIRON, V81-2, P99, DOI 10.1016/0048-9697(89)90115-0; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Shi SW, 2013, FOREST ECOL MANAG, V296, P53, DOI 10.1016/j.foreco.2013.01.026; Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x; Six J, 2002, SOIL SCI SOC AM J, V66, P1981, DOI 10.2136/sssaj2002.1981; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Six J., 2002, ENCY SOIL SCI, P936, DOI DOI 10.1081/E-ESS-120001812; Six J, 2014, SOIL BIOL BIOCHEM, V68, pA4, DOI 10.1016/j.soilbio.2013.06.014; Sommer R, 2000, PLANT SOIL, V219, P231, DOI 10.1023/A:1004772301158; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Taylor JP, 2002, SOIL BIOL BIOCHEM, V34, P387, DOI 10.1016/S0038-0717(01)00199-7; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wei XH, 2013, FOREST ECOL MANAG, V300, P60, DOI 10.1016/j.foreco.2012.06.018; Wei XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032054; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; Wigley BJ, 2013, ACTA OECOL, V51, P17, DOI 10.1016/j.actao.2013.05.007; Xie JS, 2013, FOREST ECOL MANAG, V300, P53, DOI 10.1016/j.foreco.2012.06.038; Zou LQ, 2015, CAN J FOREST RES, V45, P26, DOI 10.1139/cjfr-2014-0275	64	32	37	9	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139380	10.1371/journal.pone.0139380	http://dx.doi.org/10.1371/journal.pone.0139380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418563	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400086
J	Frey, S; Reschka, EJ; Poggeler, S				Frey, Stefan; Reschka, Eva J.; Poeggeler, Stefanie			Germinal Center Kinases SmKIN3 and SmKIN24 Are Associated with the Sordaria macrospora Striatin-Interacting Phosphatase and Kinase (STRIPAK) Complex	PLOS ONE			English	Article							SEPTATION INITIATION NETWORK; PROTEIN-PROTEIN INTERACTIONS; FRUITING BODY DEVELOPMENT; MATING-TYPE GENES; SEXUAL DEVELOPMENT; FISSION YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; ASCOSPORE GERMINATION; ENDOPLASMIC-RETICULUM	The striatin-interacting phosphatase and kinase (STRIPAK) complex is composed of striatin, protein phosphatase PP2A and protein kinases that regulate development in animals and fungi. In the filamentous ascomycete Sordaria macrospora, it is required for fruitingbody development and cell fusion. Here, we report on the presence and function of STRI-PAK-associated kinases in ascomycetes. Using the mammalian germinal center kinases (GCKs) MST4, STK24, STK25 and MINK1 as query, we identified the two putative homologs SmKIN3 and SmKIN24 in S. macrospora. A BLASTP search revealed that both kinases are conserved among filamentous ascomycetes. The physical interaction of the striatin homolog PRO11 with SmKIN3 and SmKIN24 were verified by yeast two-hybrid (Y2H) interaction studies and for SmKIN3 by co-Immunoprecipitation (co-IP). In vivo localization found that both kinases were present at the septa and deletion of both Smkin3 and Smkin24 led to abnormal septum distribution. While deletion of Smkin3 caused larger distances between adjacent septa and increased aerial hyphae, deletion of Smkin24 led to closer spacing of septa and to sterility. Although phenotypically distinct, both kinases appear to function independently because the double-knockout strain Delta Smkin3/Delta Smkin24 displayed the combined phenotypes of each single-deletion strain.	[Frey, Stefan; Reschka, Eva J.; Poeggeler, Stefanie] Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, D-37073 Gottingen, Germany; [Poeggeler, Stefanie] Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Poggeler, S (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, D-37073 Gottingen, Germany.	spoegge@gwdg.de			Deutsche Forschungsgemeinschaft (DFG) [PO523/4-1, PO523/4-2]; Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft) [GSC 226/1, GSC 226/2]; Hans-Bockler Stiftung [Forder-Nr 377645]; Gottingen University	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft); Hans-Bockler Stiftung; Gottingen University	Deutsche Forschungsgemeinschaft (DFG) (Grants PO523/4-1, PO523/4-2) SP. SF and EJR were supported by the Gottingen Graduate School for Neurosciences, Biophysics und Molecular Biosciences (Deutsche Forschungsgemeinschaft Grants GSC 226/1, GSC 226/2), EJR was supported by the Hans-Bockler Stiftung (Forder-Nr 377645). The authors acknowledge support by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker D M, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1307s27; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Bernhards Y, 2011, CURR GENET, V57, P133, DOI 10.1007/s00294-010-0333-z; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Bloemendal S, 2010, EUKARYOT CELL, V9, P1856, DOI 10.1128/EC.00186-10; Boyce KJ, 2011, TRENDS MICROBIOL, V19, P400, DOI 10.1016/j.tim.2011.04.006; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Chen CC, 2014, J BIOL CHEM, V289, P9651, DOI 10.1074/jbc.M113.529297; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Dettmann A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004762; Dettmann A, 2013, MOL MICROBIOL, V90, P796, DOI 10.1111/mmi.12399; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Dirschnabel DE, 2014, GENETICS, V196, P729, DOI 10.1534/genetics.113.159368; Dvash E, 2010, EUKARYOT CELL, V9, P502, DOI 10.1128/EC.00230-09; Elleuche S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005177; Engh I, 2007, EUKARYOT CELL, V6, P831, DOI 10.1128/EC.00269-06; Engh I, 2010, EUR J CELL BIOL, V89, P864, DOI 10.1016/j.ejcb.2010.07.002; ESSER K, 1982, CRYPTOGAMS CYANAOBAC; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Frey S, 2015, MOL MICROBIOL, V97, P676, DOI 10.1111/mmi.13054; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heilig Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004306; Heilig Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079464; Hergovich A, 2012, SEMIN CELL DEV BIOL, V23, P794, DOI 10.1016/j.semcdb.2012.04.001; Hergovich A, 2012, BIOCHEM SOC T, V40, P124, DOI 10.1042/BST20110619; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Hyodo T, 2012, J BIOL CHEM, V287, P25019, DOI 10.1074/jbc.M112.372342; Jacobsen S, 2002, CURR GENET, V41, P150, DOI 10.1007/s00294-002-0276-0; James P, 1996, GENETICS, V144, P1425; Kanai M, 2005, EMBO J, V24, P3012, DOI 10.1038/sj.emboj.7600782; Kawabata T, 2007, FUNGAL GENET NEWSL, V54, P5, DOI [10.4148/1941-4765.1096, DOI 10.4148/1941-4765.1096]; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kemp HA, 2003, MOL CELL BIOL, V23, P1750, DOI 10.1128/MCB.23.5.1750-1763.2003; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Kuck U, 2009, MYCOTA, V15, P17; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai FJ, 2011, FEMS YEAST RES, V11, P72, DOI 10.1111/j.1567-1364.2010.00691.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee WS, 2004, FEBS LETT, V572, P41, DOI 10.1016/j.febslet.2004.07.007; Lord KM, 2011, FUNGAL GENET BIOL, V48, P388, DOI 10.1016/j.fgb.2010.11.009; Delgado-Alvarez DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096744; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Maerz S, 2010, CURR OPIN MICROBIOL, V13, P663, DOI 10.1016/j.mib.2010.08.010; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Masloff S, 1999, GENETICS, V152, P191; MCNALLY MT, 1988, CURR GENET, V14, P545, DOI 10.1007/BF00434079; Morrell JL, 2004, CURR BIOL, V14, P579, DOI 10.1016/j.cub.2004.03.036; Nicholas K.B., 1997, EMBNET NEWS, V4, P4; Nordzieke S, 2015, EUKARYOT CELL, V14, P345, DOI 10.1128/EC.00241-14; Nowrousian M, 1999, MOL CELL BIOL, V19, P450; Nowrousian M, 2007, MOL MICROBIOL, V64, P923, DOI 10.1111/j.1365-2958.2007.05694.x; Nowrousian M, 2012, G3-GENES GENOM GENET, V2, P261, DOI 10.1534/g3.111.001479; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Poggeler S, 2006, GENE, V378, P1, DOI 10.1016/j.gene.2006.03.020; Poggeler S, 2004, EUKARYOT CELL, V3, P232, DOI 10.1128/EC.3.1.232-240.2004; Poggeler S, 1997, J MICROBIOL METH, V29, P49, DOI 10.1016/S0167-7012(97)00018-3; Poggeler S, 1997, GENETICS, V147, P567; Poggeler S., 2008, FUNGAL GENET REP, V55, P8, DOI [10.4148/1941-4765.1083, DOI 10.4148/1941-4765.1083]; Poggeler S, 2006, MYCOTA, P325; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Pracheil T, 2013, J BIOL CHEM, V288, P16986, DOI 10.1074/jbc.M113.451674; Pracheil T, 2012, GENETICS, V190, P1325, DOI 10.1534/genetics.111.138305; Ray S, 2010, J CELL BIOL, V190, P793, DOI 10.1083/jcb.201002055; Record CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011905; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Sambrook J., 2001, MOL CLONING LAB MANU; Singh NS, 2011, CURR BIOL, V21, P1968, DOI 10.1016/j.cub.2011.10.051; Sugden PH, 2013, BIOCHEM J, V454, P13, DOI 10.1042/BJ20130219; Teichert I., 2014, ADV GENET, V87, P201; Teichert I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-511; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker CL, 2009, GENETICS, V182, P1377, DOI 10.1534/genetics.109.103069; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Wang CL, 2010, FUNGAL GENET BIOL, V47, P789, DOI 10.1016/j.fgb.2010.06.007; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Weiss EL, 2012, GENETICS, V192, P1165, DOI 10.1534/genetics.112.145516; Wu HY, 2011, INT J BIOCHEM CELL B, V43, P742, DOI 10.1016/j.biocel.2011.01.015; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	90	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139163	10.1371/journal.pone.0139163	http://dx.doi.org/10.1371/journal.pone.0139163			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418262	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400055
J	Portero, R; Quaine, F; Cahouet, V; Leouffre, M; Serviere, C; Portero, P				Portero, Raphael; Quaine, Franck; Cahouet, Violaine; Leouffre, Marc; Serviere, Christine; Portero, Pierre			Influence of Cervical Muscle Fatigue on Musculo-Tendinous Stiffness of the Head-Neck Segment during Cervical Flexion	PLOS ONE			English	Article							MYOFIBRILLAR FATIGUE; EXTENSOR MUSCLES; SPINAL STABILITY; ACTIVATION; FAILURE; FIBERS	Aim The aim of this study is to determine if the fatigue of cervical muscles has a significant influence on the head-neck segment musculo-tendinous stiffness. Methods Ten men (aged 21.2 +/- 1.9 years) performed four quick-release trials of flexion at 30 and 50% MVC before and after the induction of muscular fatigue on cervical flexors. Electromyographic activity was recorded on the sternocleidomastoids (SCM) and spinal erectors (SE), bilaterally. Musculo-tendinous stiffness was calculated through the quick-release method adapted to the head-neck segment. Results We noticed a significant linear increase of the head-neck segment musculo-tendinous stiffness with the increase of exertion level both before (P < 0.0001) and after the fatigue procedure (P < 0.0001). However, this linear relationship was not different before and after the fatigue procedure. EMG analysis revealed a significant increase of the root mean square for the right SCM (P = 0.0002), the left SCM (P < 0.0001), the right SE (P < 0.0001), and the left SE (P < 0.0001) and a significant decrease of the median power frequency only for the right (P = 0.0006) and the left (P = 0.0003) SCM with muscular fatigue. Discussion We did not find significant changes in the head-neck segment musculo-tendinous stiffness with fatigue of cervical muscles. We found a significant increase in EMG activity in the SCM and the SE after the induction of fatigue of the SCM. Our findings suggest that with fatigue of cervical flexors, neck muscle activity is modulated in order to maintain the musculo-tendinous stiffness at a steady state.	[Portero, Raphael; Quaine, Franck; Cahouet, Violaine; Leouffre, Marc; Serviere, Christine] Univ Grenoble 1, UMR CNRS 5216, GIPSA Lab, Dept Automat, Grenoble, France; [Portero, Pierre] Univ Paris Est, UPEC, Bioingn Tissus & Neuroplasticite, EA 7377, Creteil, France; [Portero, Raphael; Portero, Pierre] Hop Rothschild, AP HP, Serv Reeduc Neuroorthoped, F-75571 Paris, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite	Portero, P (corresponding author), Univ Paris Est, UPEC, Bioingn Tissus & Neuroplasticite, EA 7377, Creteil, France.	pierre.portero@u-pec.fr		Portero, Raphael/0000-0003-3406-1736				Basmajian J., 1985, MUSCLES ALIVE THEIR; Cholewicki J, 1997, SPINE, V22, P2207, DOI 10.1097/00007632-199710010-00003; Cornu C, 2001, J PHYSIOL-LONDON, V533, P605, DOI 10.1111/j.1469-7793.2001.0605a.x; Dupeyron A, 2010, J ELECTROMYOGR KINES, V20, P426, DOI 10.1016/j.jelekin.2009.05.004; EDMAN KAP, 1990, J PHYSIOL-LONDON, V424, P133, DOI 10.1113/jphysiol.1990.sp018059; EDMAN KAP, 1992, J PHYSIOL-LONDON, V457, P655, DOI 10.1113/jphysiol.1992.sp019400; Edman KAP, 1995, ADV EXP MED BIOL, V384, P29; Edwards R H, 1981, Ciba Found Symp, V82, P1; Enoka M, 2008, J PHYSL, V586, P11; Ettema GJC, 1997, EXP PHYSIOL, V82, P107, DOI 10.1113/expphysiol.1997.sp004001; GOUBEL F, 1973, ARCH INT PHYSIOL BIO, V81, P697; Granata KP, 2001, J BIOMECH, V34, P1117, DOI 10.1016/S0021-9290(01)00081-1; Granata KR, 2004, HUM FACTORS, V46, P81, DOI 10.1518/hfes.46.1.81.30391; Grondin Diane E, 2009, J Electromyogr Kinesiol, V19, pe237, DOI 10.1016/j.jelekin.2008.05.006; Herrmann CM, 2006, J ELECTROMYOGR KINES, V16, P637, DOI 10.1016/j.jelekin.2005.11.004; Lambertz D, 2008, J BIOMECH, V41, P3270, DOI 10.1016/j.jbiomech.2008.08.022; Oksa J, 1999, AVIAT SPACE ENVIR MD, V70, P556; Oksa J, 1996, AVIAT SPACE ENVIR MD, V67, P1138; Piscione J., 2004, Archives of Physiology and Biochemistry, V112, P74; Portero R, 2013, J BIOMECH, V46, P925, DOI 10.1016/j.jbiomech.2012.12.009; Rezasoltani A, 2005, BRIT J SPORT MED, V39, P440, DOI 10.1136/bjsm.2004.013961; Richmond F.J., 1988, CONTROL HEAD MOVEMEN, P1; Sacher N, 2012, TRAFFIC INJ PREV, V13, P529, DOI 10.1080/15389588.2012.672783; Sanchez-Zuriaga D, 2010, SPINE, V35, P517; Sanchez-Zuriaga D, 2010, SPINE, V35, P517, DOI 10.1097/BRS.0b013e3181b967ea; Schieppati M, 2003, NEUROSCIENCE, V121, P277, DOI 10.1016/S0306-4522(03)00439-1; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Sparto PJ, 1998, SPINE, V23, P2563, DOI 10.1097/00007632-199812010-00011; Sparto PJ, 1997, J SPINAL DISORD, V10, P145; Vibert N, 2001, J PHYSIOL-LONDON, V532, P851, DOI 10.1111/j.1469-7793.2001.0851e.x; VIGREUX B, 1980, EUR J APPL PHYSIOL O, V45, P11, DOI 10.1007/BF00421196; Zajac FE, 1989, CRC CRITICAL REV BIO, V17, P359; Zhang LQ, 2001, J NEUROPHYSIOL, V86, P1086, DOI 10.1152/jn.2001.86.3.1086	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139333	10.1371/journal.pone.0139333	http://dx.doi.org/10.1371/journal.pone.0139333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418000	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400079
J	Chowers, M; Carmeli, Y; Shitrit, P; Elhayany, A; Geffen, K				Chowers, Michal; Carmeli, Yehuda; Shitrit, Pnina; Elhayany, Asher; Geffen, Keren			Cost Analysis of an Intervention to Prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) Transmission	PLOS ONE			English	Article							NOSOCOMIAL INFECTIONS; HOSPITAL ADMISSION; COLONIZATION; SURVEILLANCE; BACTEREMIA; DESTROY; SEARCH; RISK	Introduction Our objective was to assess the cost implications of a vertical MRSA prevention program that led to a reduction in MRSA bacteremia. Methods We performed a matched historical cohort study and cost analysis in a single hospital in Israel for the years 2005-2011. The cost of MRSA bacteremia was calculated as total hospital cost for patients admitted with bacteremia and for patients with hospital-acquired bacteremia, the difference in cost compared to matched controls. The cost of prevention was calculated as the sum of the cost of microbiology tests, single-use equipment used for patients in isolation, and infection control personnel. Results An average of 20,000 patients were screened yearly. The cost of prevention was $208,100 per year, with the major contributor being laboratory cost. We calculated that our intervention averted 34 cases of bacteremia yearly: 17 presenting on admission and 17 acquired in the hospital. The average cost of a case admitted with bacteremia was $14,500, and the net cost attributable to nosocomial bacteremia was $9,400. Antibiotics contributed only 0.4% of the total disease management cost. When the annual cost of averted cases of bacteremia and that of prevention were compared, the intervention resulted in annual cost savings of $199,600. Conclusions A vertical MRSA prevention program targeted at high-risk patients, which was highly effective in preventing bacteremia, is cost saving. These results suggest that allocating resources to targeted prevention efforts might be beneficial even in a single institution in a high incidence country.	[Chowers, Michal; Shitrit, Pnina] Meir Med Ctr, Infect Dis Unit, Kefar Sava, Israel; [Chowers, Michal; Carmeli, Yehuda; Shitrit, Pnina] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Carmeli, Yehuda] Tel Aviv Med Ctr & Sch Med, Natl Ctr Infect & Antibiot Resistance Control, Tel Aviv, Israel; [Elhayany, Asher] Bar Ilan Univ, Dept Management, Ramat Gan, Israel; [Geffen, Keren] Meir Med Ctr, Dept Econ, Kefar Sava, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine	Chowers, M (corresponding author), Meir Med Ctr, Infect Dis Unit, Kefar Sava, Israel.	chowersm@post.tau.ac.il		Chowers, Michal/0000-0001-6148-254X	Israel National Institute for Health Policy Research [2011/164]	Israel National Institute for Health Policy Research	This work was supported by the Israel National Institute for Health Policy Research (2011/164).	Chowers MY, 2009, INFECT CONT HOSP EP, V30, P778, DOI 10.1086/599019; Clancy M, 2006, INFECT CONT HOSP EP, V27, P1009, DOI 10.1086/507915; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; European Antimicrobial Resistance Surveillance System (EARSS), 2009, EARSS ANN REP 2008 O; Farbman L, 2013, CLIN MICROBIOL INFEC, V19, pE582, DOI 10.1111/1469-0691.12280; Fatkenheuer G, 2014, LANCET; Gavalda L, 2006, INFECT CONT HOSP EP, V27, P1264, DOI 10.1086/507968; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Jones M, 2014, CLIN INFECT DIS, V58, P32, DOI 10.1093/cid/cit668; Merrer J, 2000, INFECT CONT HOSP EP, V21, P718, DOI 10.1086/501721; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; Rubio-Terres C, 2010, CLIN MICROBIOL INFEC, V16, P722, DOI 10.1111/j.1469-0691.2009.02902.x; Schulgen G, 2000, J CLIN EPIDEMIOL, V53, P409, DOI 10.1016/S0895-4356(99)00182-1; Septimus E, 2014, INFECT CONT HOSP EP, V35, P797, DOI [10.1086/676535, 10.1017/S0899823X00193808]; Shitrit P, 2006, INFECT CONT HOSP EP, V27, P1004, DOI 10.1086/507914; Tubbicke A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-438; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Vos MC, 2005, J CLIN MICROBIOL, V43, P2034, DOI 10.1128/JCM.43.4.2034-2035.2005; Wassenberg MWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011562; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; West TE, 2006, INFECT CONT HOSP EP, V27, P233, DOI 10.1086/500372	22	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138999	10.1371/journal.pone.0138999	http://dx.doi.org/10.1371/journal.pone.0138999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406889	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700142
J	Ding, GH; Li, CY; Han, X; Chi, CY; Zhang, DW; Liu, BD				Ding, Guohua; Li, Chunye; Han, Xu; Chi, Chunyu; Zhang, Dawei; Liu, Baodong			Effects of Lead on Ultrastructure of Isoetes sinensis Palmer (Isoetaceae), a Critically Endangered Species in China	PLOS ONE			English	Article							ACCUMULATION	Isoetes sinensis Palmer (Isoetaceae) is a critically endangered fern that is a marsh plant (that is an aquatic or amphibious plant) in China. To evaluate damage or influence of lead (Pb) on cell ultrastructure in I. sinensis, we used 2000 mg.L-1 Pb(NO3)(2) solution to treat I. sinensis for 35d, and used transmission electron microscope (TEM) to observe the cell ultrastructure of leaf blades and roots of the plant. Our results indicated that Pb induced distinct changes of the organelles including chloroplast, mitochondria, nucleolus and vacuole. The level of damage organ was lower leaf > upper leaf > root The typical performance of the damages caused by lead shown that part of the nucleolus cracked; the cristae dilated, matrix vacuolized and membrane structure blurred in mitochondria; the vacuole cracked; grana lamella decreased, stroma lamella loosed, starch grains decreased, and membrane structure was disrupted in chloroplasts; Pb deposits were present on cell wall. The damages to chloroplasts and mitochondria were relatively severe, while damage to the nucleus was relatively lighter. The damage to the cell ultrastructure of leaf blades with direct contact with Pb was more severe than that without direct contact with Pb.	[Ding, Guohua; Chi, Chunyu; Liu, Baodong] Key Lab Plant Biol Coll Heilongjiang Prov, Harbin 150025, Peoples R China; [Ding, Guohua; Li, Chunye; Han, Xu; Chi, Chunyu; Liu, Baodong] Harbin Normal Univ, Coll Life Sci & Technol, Harbin 150025, Peoples R China; [Zhang, Dawei] Harbin Normal Univ, Modern Expt Ctr, Harbin 150025, Peoples R China	Harbin Normal University; Harbin Normal University	Liu, BD (corresponding author), Key Lab Plant Biol Coll Heilongjiang Prov, Harbin 150025, Peoples R China.	99bd@163.com	Ding, Guohua/L-3429-2013	Ding, Guohua/0000-0002-1714-5324	National Science Foundation of China [31170294]; Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Heilongjiang Province; Harbin Normal University [KJTD2011-2]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Heilongjiang Province; Harbin Normal University	The paper was supported by the National Science Foundation of China (31170294) and by the Aid program for Science and Technology Innovative Research Team in Higher Educational Institutions of Heilongjiang Province and Harbin Normal University (KJTD2011-2).	Alkhatib R, 2012, BIOL PLANTARUM, V56, P711, DOI 10.1007/s10535-012-0241-9; Chen YY, 2012, AQUAT BOT, V96, P52, DOI 10.1016/j.aquabot.2011.09.001; DOLLARD GJ, 1986, ENVIRON POLLUT A, V40, P109, DOI 10.1016/0143-1471(86)90078-4; IRMER U, 1986, ENVIRON EXP BOT, V26, P97, DOI 10.1016/0098-8472(86)90002-X; Jiang XingYu, 2001, Chinese Journal of Applied and Environmental Biology, V7, P92; Kang M, 2005, ANN BOT-LONDON, V96, P1265, DOI 10.1093/aob/mci277; Kaur G, 2013, PROTOPLASMA, V250, P53, DOI 10.1007/s00709-011-0372-4; Krzeslowska M, 1996, BIOL PLANTARUM, V38, P253, DOI 10.1007/BF02873855; Li ZZ, 2012, AM J BOT, V99, pE184, DOI 10.3732/ajb.1100319; Liu Yansheng, 2007, Chinese Journal of Applied and Environmental Biology, V13, P647; Poonanm G, 1994, APOSSIBLE BIOINDICAT, V44, P201; Rebechin H, 1972, J CELL BIOL, V55, P213; Wang JY, 2005, J NATURAL HIST INT J, V60, P358; Wiwanitkit Viroj, 2008, Indian J Occup Environ Med, V12, P116, DOI 10.4103/0019-5278.44692; Zhang H, 2014, J PHOTOCH PHOTOBIO B, V136, P46, DOI 10.1016/j.jphotobiol.2014.04.020; Zhang ZW, 2014, ENVIRON SCI POLLUT R, V21, P11938, DOI 10.1007/s11356-014-3100-8	16	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139231	10.1371/journal.pone.0139231	http://dx.doi.org/10.1371/journal.pone.0139231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407078	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700194
J	Hao, XY; Yan, QY; Zhao, J; Wang, WR; Huang, YB; Chen, YX				Hao, Xueyu; Yan, Qiuyan; Zhao, Jing; Wang, Wenren; Huang, Yibing; Chen, Yuxin			TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; ANTIMICROBIAL PEPTIDES; MECHANISMS; ENDOCYTOSIS; ANTIBACTERIAL; MITOCHONDRIA; MEMBRANE; DELIVERY; SULFATE; PROTEIN	HPRP-A1 is an amphipathic a-helical anticancer peptide (ACP) derived from the N-terminus of ribosomal protein L1 (RpL1) of Helicobacter pylori. In our previously study, HPRP-A1 has been reported that induced HeLa cell apoptosis in a caspase-dependent approach and involved both by the death receptor 'extrinsic' pathway and the mitochondria 'intrinsic' pathway. Here we report the construction of a new hybrid peptide, HPRP-A1-TAT, comprising the cell-permeating peptide TAT linked to the C-terminus of HPRP-A1. This peptide exhibits higher anticancer activity against HeLa cells with lower toxicity against human RBC than HPRP-A1. Two FITC-labeled peptides, FITC-HPRP-A1 and FITC-HPRP-A1-TAT, were used to investigate and compare the cellular uptake mechanism using fluorescence spectra and flow cytometry. Compared with HPRP-A1, HPRP-A1-TAT quickly crossed cell, entered the cytoplasm via endocytosis, and disrupted the cell membrane integrity. HPRP-A1-TAT exhibited stronger anticancer activity than HPRP-A1 at the same concentration by increasing early apoptosis of HeLa cells and inducing caspase activity. Notably, after 24 h, the cellular concentration of HPRP-A1-TAT was higher than that of HPRP-A1. This result suggests that TAT protects HPRP-A1 against degradation, likely due to its high number of positively charged amino acids or the further release of peptides into cancer cells from endocytotic vesicles. We believe that this TAT modification approach may provide an effective new strategy for improving the therapeutic index and anticancer activity of ACPs for clinical use.	[Hao, Xueyu; Yan, Qiuyan; Zhao, Jing; Huang, Yibing; Chen, Yuxin] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China; [Hao, Xueyu; Yan, Qiuyan; Zhao, Jing; Huang, Yibing; Chen, Yuxin] Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China; [Huang, Yibing; Chen, Yuxin] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China; [Wang, Wenren] Changchun ProteLight Pharmaceut & Biotechnol Co L, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University	Huang, YB (corresponding author), Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China.	huangyibing@jlu.edu.cn; chen_yuxin@jlu.edu.cn	Huang, Yibing/M-9462-2018	Huang, Yibing/0000-0002-2655-535X	National Natural Science Foundation of China [81373445, 21442001]; Natural Science Foundation of Jilin Province [20150101189JC, 20140101042JC]; Changchun ProteLight Pharmaceutical & Biotechnology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province; Changchun ProteLight Pharmaceutical & Biotechnology Co., Ltd	Funding: This study was supported by the National Natural Science Foundation of China (No. 81373445, YC and No. 21442001, YH) and the Natural Science Foundation of Jilin Province (No. 20150101189JC, YC and No. 20140101042JC, YH). The funders provided support in the form of salaries for authors [XH, QY, JZ], and Changchun ProteLight Pharmaceutical & Biotechnology Co., Ltd provided support in the form of salaries for author [WW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anand T, 2014, CYTOTECHNOLOGY, V66, P823, DOI 10.1007/s10616-013-9634-7; Acero FRB, 2014, MOL PHARMACEUT, V11, P1798, DOI 10.1021/mp4006062; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Constance JE, 2012, THER DELIV, V3, P961, DOI 10.4155/TDE.12.75; Dennison SR, 2006, CURR PROTEIN PEPT SC, V7, P487, DOI 10.2174/138920306779025611; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08029; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Gupta S, 2009, J CELL MOL MED, V13, P1004, DOI 10.1111/j.1582-4934.2009.00697.x; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Holm T, 2011, BBA-BIOMEMBRANES, V1808, P1544, DOI 10.1016/j.bbamem.2010.10.019; Huang Y, 2014, MINIREVIEWS MED CHEM; Huang Y, 2014, PROTEIN CELL, V5, P194, DOI 10.1007/s13238-014-0028-1; Huang YB, 2011, MOL CANCER THER, V10, P416, DOI 10.1158/1535-7163.MCT-10-0811; Jo J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04378; Kerkis A, 2006, IUBMB LIFE, V58, P7, DOI 10.1080/15216540500494508; Lim KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066084; MacEwan SR, 2013, WIRES NANOMED NANOBI, V5, P31, DOI 10.1002/wnan.1197; Martin I, 2010, PHARMACEUTICALS, V3, P1456, DOI 10.3390/ph3051456; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Pushpanathan Muthuirulan, 2013, Int J Pept, V2013, P675391, DOI 10.1155/2013/675391; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Sawant RR, 2009, INT J PHARMACEUT, V374, P114, DOI 10.1016/j.ijpharm.2009.02.022; Song JJ, 2015, PEPTIDES, V63, P143, DOI 10.1016/j.peptides.2014.12.001; Straser A, 2013, MAR DRUGS, V11, P3077, DOI 10.3390/md11083077; Tan JJ, 2014, MOLECULES, V19, P10803, DOI 10.3390/molecules190810803; Tints K, 2014, INT J MOL SCI, V15, P5680, DOI 10.3390/ijms15045680; Trabulo S, 2010, PHARMACEUTICALS, V3, P961, DOI 10.3390/ph3040961; van Bracht E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110813; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vives E, 2003, J MOL RECOGNIT, V16, P265, DOI 10.1002/jmr.636; Yang H, 2010, J BIOL CHEM, V285, P25666, DOI 10.1074/jbc.M109.089417; Yesylevskyy S, 2009, BIOPHYS J, V97, P40, DOI 10.1016/j.bpj.2009.03.059; Zhang XP, 2009, MOL PHARMACEUT, V6, P836, DOI 10.1021/mp800121f; Zhao J, 2015, ONCOTARGET, V6, P1769, DOI 10.18632/oncotarget.2754; Zhao LJ, 2013, SCI CHINA CHEM, V56, P1307, DOI 10.1007/s11426-013-4884-y	38	28	32	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138911	10.1371/journal.pone.0138911	http://dx.doi.org/10.1371/journal.pone.0138911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405806	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700117
J	Langereis, EJ; Wagemans, T; Kulik, W; Lefeber, DJ; van Lenthe, H; Oussoren, E; van der Ploeg, AT; Ruijter, GJ; Wevers, RA; Wijburg, FA; van Vlies, N				Langereis, Eveline J.; Wagemans, Tom; Kulik, Wim; Lefeber, Dirk J.; van Lenthe, Henk; Oussoren, Esmee; van der Ploeg, Ans T.; Ruijter, George J.; Wevers, Ron A.; Wijburg, Frits A.; van Vlies, Naomi			A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses	PLOS ONE			English	Article							SCREENING-PROCEDURE; KERATAN SULFATE; HEPARAN-SULFATE; URINARY GLYCOSAMINOGLYCANS; MASS-SPECTROMETRY; DERMATAN SULFATE; PLASMA; DISACCHARIDES; BIOMARKER; MORQUIO	Introduction Diagnosis of the mucopolysaccharidoses (MPSs) generally relies on an initial analysis of total glycosaminoglycan (GAG) excretion in urine. Often the dimethylmethylene blue dye-binding (DMB) assay is used, although false-negative results have been reported. We report a multiplexed diagnostic test with a high sensitivity for all MPSs and with the potential to identify patients with I-cell disease (ML II) and mucolipidosis III (ML III). Methods Urine samples of 100 treatment naive MPS patients were collected and analyzed by the conventional DMB assay and a multiplex assay based on enzymatic digestion of heparan sulfate (HS), dermatan sulfate (DS) and keratan sulfate (KS) followed by quantification by LC-MS/MS. Specificity was calculated by analyzing urine samples from a cohort of 39 patients suspected for an inborn error of metabolism, including MPSs. Results The MPS cohort consisted of 18 MPS I, 16 MPS II, 34 MPS III, 10 MPS IVA, 3 MPS IVB, 17 MPS VI and 2 MPS VII patients. All 100 patients were identified by the LC-MS/MS assay with typical patterns of elevation of HS, DS and KS, respectively (sensitivity 100%). DMB analysis of the urine was found to be in the normal range in 10 of the 100 patients (sensitivity 90%). Three out of the 39 patients were identified as false-positive, resulting in a specificity of the LS-MS/MS assay of 92%. For the DMB this was 97%. All three patients with MLII/MLIII had elevated GAGs in the LC-MS/MS assay while the DMB test was normal in 2 of them. Conclusion The multiplex LC-MS/MS assay provides a robust and very sensitive assay for the diagnosis of the complete spectrum of MPSs and has the potential to identify MPS related disorders such as MLII/MLIII. Its performance is superior to that of the conventional DMB assay.	[Langereis, Eveline J.; Wagemans, Tom; Wijburg, Frits A.; van Vlies, Naomi] Univ Amsterdam, Dept Pediat Metab Dis, Emma Childrens Hosp, Amsterdam, Netherlands; [Langereis, Eveline J.; Wagemans, Tom; Wijburg, Frits A.; van Vlies, Naomi] Univ Amsterdam, Acad Med Ctr, Amsterdam Lysosome Ctr Sphinx, NL-1105 AZ Amsterdam, Netherlands; [Wagemans, Tom; Kulik, Wim; van Lenthe, Henk; van Vlies, Naomi] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Lefeber, Dirk J.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol & Lab Med, Translat Metab Lab, NL-6525 ED Nijmegen, Netherlands; [Oussoren, Esmee; van der Ploeg, Ans T.] Erasmus MC, Ctr Lysosomal & Metab Dis, Dept Pediat, Rotterdam, Netherlands; [Ruijter, George J.] Erasmus MC, Ctr Lysosomal & Metab Dis, Dept Clin Genet, Rotterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Wijburg, FA (corresponding author), Univ Amsterdam, Dept Pediat Metab Dis, Emma Childrens Hosp, Amsterdam, Netherlands.	f.a.wijburg@amc.uva.nl	Lefeber, Dirk DJ/A-2146-2014; Wevers, Ron A./H-8116-2014	Wevers, Ron A./0000-0003-2278-9746; Wijburg, Frits/0000-0002-0950-1368	Biomarin pharmaceutical inc	Biomarin pharmaceutical inc	Biomarin pharmaceutical inc financially supported development of the assay. Validation of the diagnostic accuracy was not funded by this sponsor. The authors received no other funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auray-Blais C, 2011, MOL GENET METAB, V102, P49, DOI 10.1016/j.ymgme.2010.09.003; Bodamer OA, 2014, MOL GENET METAB, V113, P34, DOI 10.1016/j.ymgme.2014.07.013; Braulke T, 2014, METABOLIC MOL BASIS, P3469; Chuang CK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0135-3; de Ru MH, 2013, J INHERIT METAB DIS, V36, P247, DOI 10.1007/s10545-012-9538-2; DEJONG JGN, 1992, CLIN CHEM, V38, P803; DEJONG JGN, 1991, CLIN CHEM, V37, P572; DEJONG JGN, 1989, CLIN CHEM, V35, P1472; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Fuller M, 2004, PEDIATR RES, V56, P733, DOI 10.1203/01.PDR.0000141987.69757.DD; Hieber V, 1975, Birth Defects Orig Artic Ser, V11, P307; Hintze JP, 2011, BIOMARK INSIGHTS, V6, P69, DOI 10.4137/BMI.S7451; Jura-Poltorak A, 2014, CLIN CHIM ACTA, V433, P20, DOI 10.1016/j.cca.2014.02.027; Lamanna WC, 2011, J BIOL CHEM, V286, P6955, DOI 10.1074/jbc.M110.192062; Langereis EJ, 2015, MOL GENET METAB, V114, P129, DOI 10.1016/j.ymgme.2014.10.012; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Martell LA, 2011, BIOANALYSIS, V3, P1855, DOI [10.4155/BIO.11.172, 10.4155/bio.11.172]; Nelson A, 2008, SHOCK, V30, P623, DOI 10.1097/SHK.0b013e3181777da3; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Oguma T, 2007, ANAL BIOCHEM, V368, P79, DOI 10.1016/j.ab.2007.05.016; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Tomatsu S, 2005, J INHERIT METAB DIS, V28, P743, DOI 10.1007/s10545-005-0069-y; Tomatsu S, 2004, PEDIATR RES, V55, P592, DOI 10.1203/01.PDR.0000113767.60140.E9; Tomatsu S, 2014, METABOLITES, V4, P655, DOI 10.3390/metabo4030655; Valstar MJ, 2010, J INHERIT METAB DIS, V33, P759, DOI 10.1007/s10545-010-9199-y; VANDERHORST GTJ, 1983, AM J MED GENET, V16, P261, DOI 10.1002/ajmg.1320160215; Zhang HY, 2015, MOL GENET METAB, V114, P123, DOI 10.1016/j.ymgme.2014.09.009	27	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138622	10.1371/journal.pone.0138622	http://dx.doi.org/10.1371/journal.pone.0138622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406883	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700062
J	Ruff, M; Leyme, A; Le Cann, F; Bonnier, D; Le Seyec, J; Chesnel, F; Fattet, L; Rimokh, R; Baffet, G; Theret, N				Ruff, Michael; Leyme, Anthony; Le Cann, Fabienne; Bonnier, Dominique; Le Seyec, Jacques; Chesnel, Franck; Fattet, Laurent; Rimokh, Ruth; Baffet, Georges; Theret, Nathalie			The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-beta-Induced Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							CELL LUNG CARCINOMAS; HUMAN BREAST-CANCER; MELTRIN-ALPHA; TUMOR PROGRESSION; EXPRESSION; GENE; PROLIFERATION; SMAD3; INDUCTION; SIGNATURE	The increased expression of the Disintegrin and Metalloprotease ADAM12 has been associated with human cancers, however its role remain unclear. We have previously reported that ADAM12 expression is induced by the transforming growth factor, TGF-beta and promotes TGF-beta-dependent signaling through interaction with the type II receptor of TGF-beta. Here we explore the implication of ADAM12 in TGF-beta-mediated epithelial to mesenchymal transition (EMT), a key process in cancer progression. We show that ADAM12 expression is correlated with EMT markers in human breast cancer cell lines and biopsies. Using a non-malignant breast epithelial cell line (MCF10A), we demonstrate that TGF-beta-induced EMT increases expression of the membrane-anchored ADAM12L long form. Importantly, ADAM12L overexpression in MCF10A is sufficient to induce loss of cell-cell contact, reorganization of actin cytoskeleton, up-regulation of EMT markers and chemoresistance. These effects are independent of the proteolytic activity but require the cytoplasmic tail and are specific of ADAM12L since overexpression of ADAM12S failed to induce similar changes. We further demonstrate that ADAM12L-dependent EMT is associated with increased phosphorylation of Smad3, Akt and ERK proteins. Conversely, inhibition of TGF-beta receptors or ERK activities reverses ADAM12L-induced mesenchymal phenotype. Together our data demonstrate that ADAM12L is associated with EMT and contributes to TGF-beta-dependent EMT by favoring both Smad-dependent and Smad-independent pathways.	[Ruff, Michael; Leyme, Anthony; Le Cann, Fabienne; Bonnier, Dominique; Le Seyec, Jacques; Baffet, Georges; Theret, Nathalie] Univ Rennes 1, IRSET, INSERM U1085, Rennes, France; [Chesnel, Franck] Univ Rennes 1, CNRS IGDR UMR6290, Rennes, France; [Fattet, Laurent; Rimokh, Ruth] Ctr Rech Cancerol Lyon, INSERM U1052, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Theret, N (corresponding author), Univ Rennes 1, IRSET, INSERM U1085, Rennes, France.	nathalie.theret@univ-rennes1.fr	theret, nathalie/ABG-6780-2020; Fattet, Laurent/ABH-5434-2020; LI, HUI/G-1227-2011; Baffet, Georges/I-2574-2015; FATTET, Laurent/W-8392-2019; Theret, Nathalie/I-2871-2015; Le Seyec, Jacques/J-5680-2015; Baffet, Georges/M-1583-2016; Rimokh, Ruth/G-7506-2014; Le Seyec, Jacques/GLU-3933-2022	theret, nathalie/0000-0002-5857-7828; Fattet, Laurent/0000-0001-5152-4937; LI, HUI/0000-0002-4114-8349; Theret, Nathalie/0000-0002-5857-7828; Le Seyec, Jacques/0000-0002-1118-3311	Institut National de la Sante et de la Recherche Medicale, the Ligue Nationale Contre le Cancer	Institut National de la Sante et de la Recherche Medicale, the Ligue Nationale Contre le Cancer	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Bourd-Boittin K, 2008, J BIOL CHEM, V283, P26000, DOI 10.1074/jbc.M709829200; Cao Y, 2003, MOL CELL BIOL, V23, P6725, DOI 10.1128/MCB.23.19.6725-6738.2003; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; DeMaio L, 2012, J PATHOL, V226, P633, DOI 10.1002/path.3016; Dzwonek J, 2009, MOL CANCER RES, V7, P1342, DOI 10.1158/1541-7786.MCR-08-0558; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Frohlich C, 2011, MOL CANCER RES, V9, P1449, DOI 10.1158/1541-7786.MCR-11-0100; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Gruel Jeremy, 2009, BMC Res Notes, V2, P193, DOI 10.1186/1756-0500-2-193; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Inoue D, 1998, J BIOL CHEM, V273, P4180, DOI 10.1074/jbc.273.7.4180; Joshi A, 2010, FRONT BIOSCI-LANDMRK, V15, P180, DOI 10.2741/3614; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim JJ, 2014, STEM CELLS, V32, P1468, DOI 10.1002/stem.1675; Kim YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040820; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Kornberg LJ, 2005, LARYNGOSCOPE, V115, P690, DOI 10.1097/01.mlg.0000161333.67977.93; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Leyme A, 2012, MOL BIOL CELL, V23, P3461, DOI 10.1091/mbc.E11-11-0918; Li H, 2013, BREAST CANCER RES TR, V139, P691, DOI 10.1007/s10549-013-2602-2; Li H, 2012, BREAST CANCER RES TR, V135, P759, DOI 10.1007/s10549-012-2220-4; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Masaki M, 2005, ENDOCRINOLOGY, V146, P1752, DOI 10.1210/en.2004-1082; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Narita D, 2010, ROM J MORPHOL EMBRYO, V51, P669; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohtsuka T, 2006, INT J CANCER, V118, P263, DOI 10.1002/ijc.21324; Okada A, 2008, ARTHRITIS RHEUM-US, V58, P778, DOI 10.1002/art.23262; Okano K, 2006, J BIOL CHEM, V281, P26196, DOI 10.1074/jbc.M606710200; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Qi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092536; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Rocks N, 2008, CELL PROLIFERAT, V41, P988, DOI 10.1111/j.1365-2184.2008.00557.x; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Roy R, 2011, J BIOL CHEM, V286, P20758, DOI 10.1074/jbc.M110.216036; Serrano I, 2013, ONCOGENE, V32, P50, DOI 10.1038/onc.2012.30; Shao SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085936; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Stautz D, 2010, EXP CELL RES, V316, P55, DOI 10.1016/j.yexcr.2009.09.017; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thodeti CK, 2005, FEBS LETT, V579, P5589, DOI 10.1016/j.febslet.2005.09.024; Tian BL, 2002, J CLIN PATHOL-MOL PA, V55, P394, DOI 10.1136/mp.55.6.394; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	62	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139179	10.1371/journal.pone.0139179	http://dx.doi.org/10.1371/journal.pone.0139179			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407179	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700185
J	Henriksen, RE; Thuen, F				Henriksen, Roger Ekeberg; Thuen, Frode			Marital Quality and Stress in Pregnancy Predict the Risk of Infectious Disease in the Offspring: The Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							MATERNAL STRESS; PRENATAL STRESS; SOCIAL SUPPORT; HEALTH; SATISFACTION; CORTISOL; OUTCOMES; ANXIETY; IMPACT	Objectives The aim of this study was to explore the degree to which couples' relationship dissatisfaction and stressful life events during pregnancy predict the risk of infectious disease in the offspring during their first year of life. Methods Data were obtained from the Norwegian Mother and Child Cohort Study, conducted by the Norwegian Institute of Public Health. Pregnant women completed questionnaires in week 30 of pregnancy concerning the couples' relationship satisfaction and stressful life events. In follow-up questionnaires, the women reported whether their children (n = 74,801) had been subject to various categories of infectious disease: the common cold, throat infection, bronchitis, RS virus, pneumonia, pseudocroup, gastric flu, ear infection, conjunctivitis and urinary tract infection. Reports from two age groups of infants were used. Associations between the predictor and outcome variables were assessed via logistic regression and linear regression analyses. Results Separate logistic regression analyses for each disease and age group showed that prenatal relationship dissatisfaction and stressful life events were significantly associated with all reported categories of infectious disease. After controlling for socioeconomic factors, social support, smoking, breastfeeding, maternal depression, the sex of the offspring, and use of child care, 29 out of 32 tested associations were statistically significant. Finally, multivariate linear regression analyses showed that prenatal relationship dissatisfaction and stressful life events were significantly associated with the frequency, as well as the variety, of infectious disease in the offspring.	[Henriksen, Roger Ekeberg; Thuen, Frode] Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway	Western Norway University of Applied Sciences	Henriksen, RE (corresponding author), Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway.	roger.ekeberg.henriksen@hib.no			Norwegian Ministry of Health; Ministry of Education and Research (NIH/NIEHS) [NO1-ES-75558]; Ministry of Education and Research (NIH/NINDS) [1 UO1 NS 047537-01, 2 UO1 NS047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Ministry of Health; Ministry of Education and Research (NIH/NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ministry of Education and Research (NIH/NINDS); Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research (NIH/NIEHS contract no. NO1-ES-75558, NIH/NINDS grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS047537-06A1) and the Norwegian Research Council/FUGE (grant no. 151918/S10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and the authors received no specific funding for this work.	Aiken, 2003, APPL MULTIPLE REGRES, P703, DOI DOI 10.2307/2064799; Beigelman A, 2013, CURR OPIN ALLERGY CL, V13, P211, DOI 10.1097/ACI.0b013e32835eb6ef; Beijers R, 2014, EUR CHILD ADOLES PSY, V23, P943, DOI 10.1007/s00787-014-0566-3; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Blum JS, 1999, J PERS, V67, P93, DOI 10.1111/1467-6494.00049; Bookwala J, 2005, J AGING HEALTH, V17, P85, DOI 10.1177/0898264304272794; Bradbury TN, 2000, J MARRIAGE FAM, V62, P964, DOI 10.1111/j.1741-3737.2000.00964.x; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; CODDINGTON RD, 1972, J PSYCHOSOM RES, V16, P205, DOI 10.1016/0022-3999(72)90045-1; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Cote SM, 2010, ARCH PEDIAT ADOL MED, V164, P1132, DOI 10.1001/archpediatrics.2010.216; de Weerth C, 2005, NEUROSCI BIOBEHAV R, V29, P295, DOI 10.1016/j.neubiorev.2004.10.005; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Giesbrecht GF, 2013, PSYCHOSOM MED, V75, P856, DOI 10.1097/PSY.0000000000000004; Graham JE, 2009, HEALTH PSYCHOL, V28, P621, DOI 10.1037/a0015208; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; Hennessy MB, 2009, FRONT NEUROENDOCRIN, V30, P470, DOI 10.1016/j.yfrne.2009.06.001; Henriksen RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116796; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Howerton CL, 2012, HORM BEHAV, V62, P237, DOI 10.1016/j.yhbeh.2012.03.007; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; Kern S, 2008, PSYCHONEUROENDOCRINO, V33, P517, DOI 10.1016/j.psyneuen.2008.01.010; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377; Kinsella MT, 2009, CLIN OBSTET GYNECOL, V52, P425, DOI 10.1097/GRF.0b013e3181b52df1; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lindstrom M, 2012, PUBLIC HEALTH, V126, P790, DOI 10.1016/j.puhe.2012.06.001; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Marques AH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00120; Merlot E, 2008, BRAIN BEHAV IMMUN, V22, P42, DOI 10.1016/j.bbi.2007.05.007; Metzger MJ, 2013, PEDIAT INFECT DIS J, V32; Mortensen O, 2012, FAM PROCESS, V51, P122, DOI 10.1111/j.1545-5300.2012.01384.x; Nielsen NM, 2011, AM J EPIDEMIOL, V173, P990, DOI 10.1093/aje/kwq492; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; O'Connor TG, 2013, BRAIN BEHAV IMMUN, V32, P21, DOI 10.1016/j.bbi.2013.02.002; Obel C, 2005, PSYCHONEUROENDOCRINO, V30, P647, DOI 10.1016/j.psyneuen.2004.11.006; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pfuntner A., 2013, MOST FREQUENT CONDIT; Rosand GMB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-66; Rosand GMB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-161; Snyder D. K, 1997, MARITAL SATISFACTION; Stapleton LRT, 2012, J FAM PSYCHOL, V26, P453, DOI 10.1037/a0028332; Suglia SF, 2010, PSYCHOL TRAUMA-US, V2, P326, DOI 10.1037/a0018953; Tegethoff M, 2011, ENVIRON HEALTH PERSP, V119, P1647, DOI 10.1289/ehp.1003253; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; van den Berg JP, 2011, EARLY HUM DEV, V87, P67, DOI 10.1016/j.earlhumdev.2010.11.003; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; Zijlmans MAC, 2015, NEUROSCI BIOBEHAV R, V53, P1, DOI 10.1016/j.neubiorev.2015.02.015	52	20	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137304	10.1371/journal.pone.0137304	http://dx.doi.org/10.1371/journal.pone.0137304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422017	Green Published, gold			2022-12-27	WOS:000362175700013
J	Biggs, SN; Walter, LM; Jackman, AR; Nisbet, LC; Weichard, AJ; Hollis, SL; Davey, MJ; Anderson, V; Nixon, GM; Horne, RSC				Biggs, Sarah N.; Walter, Lisa M.; Jackman, Angela R.; Nisbet, Lauren C.; Weichard, Aidan J.; Hollis, Samantha L.; Davey, Margot J.; Anderson, Vicki; Nixon, Gillian M.; Horne, Rosemary S. C.			Long-Term Cognitive and Behavioral Outcomes following Resolution of Sleep Disordered Breathing in Preschool Children	PLOS ONE			English	Article							QUALITY-OF-LIFE; APNEA SYNDROME; BLOOD-PRESSURE; ADENOTONSILLECTOMY; TONSILLECTOMY; MANAGEMENT; REGRESSION; DIAGNOSIS; DEFICITS; GROWTH	This study aimed to determine the long term effects of resolution of SDB in preschool children, either following treatment or spontaneous recovery, on cognition and behavior. Children diagnosed with SDB at 3-5y (N = 35) and non-snoring controls (N = 25), underwent repeat polysomnography (PSG) and cognitive and behavioral assessment 3 years following a baseline study. At follow-up, children with SDB were grouped into Resolved and Unresolved. Resolution was defined as: obstructive apnea hypopnea index (OAHI) <= 1 event/h; no snoring detected on PSG; and no parental report of habitual snoring. 57% (20/35) of children with SDB received treatment, with SDB resolving in 60% (12/20). 43% (15/35) were untreated, of whom 40% (6/15) had spontaneous resolution of SDB. Cognitive reduced between baseline and follow-up, however this was not related to persistent disease, with no difference in cognitive outcomes between Resolved, Unresolved or Control groups. Behavioral functioning remained significantly worse in children originally diagnosed with SDB compared to control children, regardless of resolution. Change in OAHI did not predict cognitive or behavioral outcomes, however a reduction in nocturnal arousals, irrespective of full resolution, was associated with improvement in attention and aggressive behavior. These results suggest that resolution of SDB in preschool children has little effect on cognitive or behavioral outcomes over the long term. The association between sleep fragmentation and behavior appears independent of SDB, however may be moderated by concomitant SDB. This challenges the assumption that treatment of SDB will ameliorate associated cognitive and behavioural deficits and supports the possibility of a SDB phenotype.	[Biggs, Sarah N.; Walter, Lisa M.; Nisbet, Lauren C.; Weichard, Aidan J.; Hollis, Samantha L.; Davey, Margot J.; Nixon, Gillian M.; Horne, Rosemary S. C.] Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia; [Biggs, Sarah N.; Walter, Lisa M.; Davey, Margot J.; Nixon, Gillian M.; Horne, Rosemary S. C.] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia; [Davey, Margot J.; Nixon, Gillian M.] Monash Med Ctr, Monash Childrens, Melbourne Childrens Sleep Ctr, Melbourne, Vic, Australia; [Jackman, Angela R.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci Res, Melbourne, Vic, Australia	Hudson Institute of Medical Research; Monash University; Monash University; University of Melbourne; Murdoch Children's Research Institute	Biggs, SN (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia.	sarah.biggs@monash.edu		Walter, Lisa/0000-0003-1158-493X; Biggs, Sarah/0000-0002-1144-2694; Horne, Rosemary/0000-0003-3575-0461	National Health and Medical Research Council of Australia [APP1008919]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This research was funded by the National Health and Medical Research Council of Australia (APP1008919). The Hudson Institute of Medical Research is supported by the Victorian Government's Operational Infrastructure Support Program.	Achenbach T. M., 2001, MANUAL ASEBA PRESCHO; Achenbach TM, 2001, MANUAL ASEBA SCH BAS; Ali NJ, 1996, EUR J PEDIATR, V155, P56, DOI 10.1007/BF02115629; Biggs SN, 2014, SLEEP, V37, P77, DOI 10.5665/sleep.3312; Biggs SN, 2014, SLEEP MED R IN PRESS; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Bourke R, 2011, SLEEP MED, V12, P489, DOI 10.1016/j.sleep.2010.11.010; Chervin RD, 2006, PEDIATRICS, V117, pE769, DOI 10.1542/peds.2005-1837; Chervin RD, 2014, J CLIN SLEEP MED, V10, P903, DOI 10.5664/jcsm.3968; Chervin RD, 2012, CHEST, V142, P101, DOI 10.1378/chest.11-2456; Constantin E, 2007, J PEDIATR-US, V150, P540, DOI 10.1016/j.jpeds.2007.01.026; Curtis JL, 2015, OTOLARYNG HEAD NECK, V152, P691, DOI 10.1177/0194599815572123; Dillon JE, 2007, J AM ACAD CHILD PSY, V46, P1425, DOI 10.1097/chi.0b013e31814b8eb2; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Friedman BC, 2003, SLEEP, V26, P999, DOI 10.1093/sleep/26.8.999; Gioia G. A., 2002, BEHAV RATING INVENTO; Gioia GA, 2000, BEHAV RATING EXECUTI; Giordani B, 2008, J INT NEUROPSYCH SOC, V14, P571, DOI 10.1017/S1355617708080776; Giordani B, 2012, J INT NEUROPSYCH SOC, V18, P212, DOI 10.1017/S1355617711001743; Gozal D, 2006, SLEEP MED REV, V10, P83, DOI 10.1016/j.smrv.2005.07.005; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; GUILLEMINAULT C, 1982, EUR J PEDIATR, V139, P165, DOI 10.1007/BF01377349; Guilleminault C, 2007, OTOLARYNG HEAD NECK, V136, P169, DOI 10.1016/j.otohns.2006.09.021; Harvey JMM, 1999, J PAEDIATR CHILD H, V35, P136, DOI 10.1046/j.1440-1754.1999.t01-1-00336.x; Huang YS, 2014, SLEEP, V37, P71, DOI 10.5665/sleep.3310; Iber C., 2007, AASM MANUAL SCORING; Jackman AR, 2013, SLEEP, V36, P1639, DOI 10.5665/sleep.3116; Jackman AR, 2012, SLEEP MED, V13, P621, DOI 10.1016/j.sleep.2012.01.013; JEANS WD, 1981, BRIT J RADIOL, V54, P117, DOI 10.1259/0007-1285-54-638-117; Joosten Simon A, 2014, Ann Am Thorac Soc, V11, P761, DOI 10.1513/AnnalsATS.201309-306OC; Katz Eliot S, 2008, Proc Am Thorac Soc, V5, P253, DOI 10.1513/pats.200707-111MG; Katz ES, 2002, J PEDIATR-US, V140, P589, DOI 10.1067/mpd.2002.123290; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kohler MJ, 2010, NAT SCI SLEEP, V2, P159, DOI 10.2147/NSS.S6934; Kohler MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007343; Korkman M., 2007, NEPSY 2 DEVELOPMENTA; Korkman M., 2007, NEPSY 2, V2nd; Li HY, 2006, LARYNGOSCOPE, V116, P1142, DOI 10.1097/01.mlg.0000217542.84013.b5; Loughlin GM, 1996, AM J RESP CRIT CARE, V153, P866; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Marcus CL, 2013, NEW ENGL J MED, V368, P2366, DOI 10.1056/NEJMoa1215881; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; Marcus CL, 2002, PEDIATRICS, V109, P704; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Mindell JA, 2013, SLEEP MED, V14, P1283, DOI 10.1016/j.sleep.2013.09.002; Mitchell RB, 2006, OTOLARYNG HEAD NECK, V134, P374, DOI 10.1016/j.otohns.2005.11.035; Montgomery-Downs HE, 2005, EUR RESPIR J, V25, P336, DOI 10.1183/09031936.05.00082904; Nisbet LC, 2013, SLEEP MED, V14, P1310, DOI 10.1016/j.sleep.2013.07.010; Nisbet LC, 2013, SLEEP MED, V14, P1123, DOI 10.1016/j.sleep.2013.06.010; Nisbet LC, 2013, SLEEP, V36, P1219, DOI 10.5665/sleep.2890; Nixon GM, 2014, J CLIN SLEEP MED; O'Brien LM, 2003, PEDIATRICS, V111, P554, DOI 10.1542/peds.111.3.554; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Owens Judith, 2000, Sleep Breath, V4, P67, DOI 10.1055/s-2000-19814; Rapoport JL, 2008, NEUROPSYCHOPHARMACOL, V33, P181, DOI 10.1038/sj.npp.1301553; Roberts G, 2008, J PAEDIATR CHILD H, V44, P276, DOI 10.1111/j.1440-1754.2007.01251.x; Roid GH., 2003, STANFORD BINET INTEL, V5th; Tabachnick B. G., 2001, USING MULTIVARIATE S; Van Dongen HPA, 2004, METHOD ENZYMOL, V384, P139; Vlahandonis A, 2013, SLEEP MED, V14, P1295, DOI 10.1016/j.sleep.2013.07.014; Wei JL, 2007, ARCH OTOLARYNGOL, V133, P974, DOI 10.1001/archotol.133.10.974; Wei JL, 2009, ARCH OTOLARYNGOL, V135, P642, DOI 10.1001/archoto.2009.74; WITTIG RM, 1984, AM REV RESPIR DIS, V129, P244; ZACHARY RA, 1985, J CLIN PSYCHOL, V41, P86, DOI 10.1002/1097-4679(198501)41:1<86::AID-JCLP2270410115>3.0.CO;2-W	64	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139142	10.1371/journal.pone.0139142	http://dx.doi.org/10.1371/journal.pone.0139142			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418065	Green Published, gold			2022-12-27	WOS:000362171400053
J	Rebe, K; Lewis, D; Myer, L; de Swardt, G; Struthers, H; Kamkuemah, M; McIntyre, J				Rebe, Kevin; Lewis, David; Myer, Landon; de Swardt, Glenn; Struthers, Helen; Kamkuemah, Monika; McIntyre, James			A Cross Sectional Analysis of Gonococcal and Chlamydial Infections among Men-Who-Have-Sex-with-Men in Cape Town, South Africa	PLOS ONE			English	Article							RECTAL GONORRHEA; HIV; RISK; PREVALENCE; TRANSMISSION	Background Men-who-have-sex-with-men (MSM) are at high risk of HIV and sexually transmitted infection (STI) transmission. Asymptomatic STIs are common in MSM and remain undiagnosed and untreated where syndromic management is advocated. Untreated STIs could be contributing to high HIV rates. This study investigated symptomatic (SSTI) and asymptomatic STIs (ASTIs) in MSM in Cape Town. Methods MSM, 18 years and above, were enrolled into this study. Participants underwent clinical and microbiological screening for STIs. Urine, oro-pharyngeal and anal swab specimens were collected for STI analysis, and blood for HIV and syphilis screening. A psychosocial and sexual questionnaire was completed. STI specimens were analysed for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) infection. Results 200 MSM were recruited with a median age of 32 years (IQR 26-39.5). Their median number of sex partners within the last year was 5 (IQR 2-20). 155/200 (78%) reported only male sex partners while 45/200 (23%) reported sex with men and women. 77/200 (39%) reported transactional sex. At enrolment, 88/200 (44%) were HIV positive and 8/112 (7%) initially HIV-negative participants seroconverted during the study. Overall, 47/200 (24%) screened positive for either NG or CT. There were 32 MSM (16%) infected with NG and 7 (3.5%) of these men had NG infections at two anatomical sites (39 NG positive results in total). Like-wise, there were 23 MSM (12%) infected with CT and all these men had infections at only one site. Eight of the 47 men (17%) were infected with both NG and CT. ASTI was more common than SSTI irrespective of anatomical site, 38 /200 (19%) versus 9/200 (5%) respectively (p<0.001). The anus was most commonly affected, followed by the oro-pharynx and then urethra. Asymptomatic infection was associated with transgender identity (OR 4.09 CI 1.60-5.62), >= 5 male sex partners in the last year (OR 2.50 CI 1.16-5.62) and transactional sex (OR 2.33 CI 1.13-4.79) but not with HIV infection. Conclusions Asymptomatic STI was common and would not have been detected using a syndromic management approach. Although molecular screening for NG/CT is costly, in our study only four MSM needed to be screened to detect one case. This supports dual NG/CT molecular screening for MSM, which, in the case of confirmed NG infections, may trigger further culture-based investigations to determine gonococcal antimicrobial susceptibility in the current era of multi-drug resistant gonorrhoea.	[Rebe, Kevin; de Swardt, Glenn; Struthers, Helen; McIntyre, James] Anova Hlth Inst, Johannesburg, South Africa; [Rebe, Kevin; de Swardt, Glenn; Struthers, Helen; McIntyre, James] Anova Hlth Inst, Cape Town, South Africa; [Rebe, Kevin; Struthers, Helen] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Lewis, David] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr HIV & Sexually Transmitted Infect, Johannesburg, South Africa; [Lewis, David] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Lewis, David] Western Sydney Sexual Hlth Ctr, Parramatta, Australia; [Lewis, David] Univ Sydney, Westmead Clin Sch, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia; [Lewis, David] Univ Sydney, Westmead Clin Sch, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Myer, Landon; Kamkuemah, Monika; McIntyre, James] Univ Cape Town, Sch Publ & Family Med, Div Epidemiol & Biostat, ZA-7925 Cape Town, South Africa	University of Cape Town; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Cape Town; University of Sydney; University of Sydney; University of Cape Town	Rebe, K (corresponding author), Anova Hlth Inst, Johannesburg, South Africa.	rebe@anovhealth.co.za	McIntyre, James/V-7115-2019; Kamkuemah, Monika/GRY-4837-2022	Lewis, David/0000-0002-5534-8392; Kamkuemah, Monika/0000-0002-7603-2792	Presidents Emergency Fund for AIDS Relief / United States Agency for International Development [AID-674-A-12-00015]	Presidents Emergency Fund for AIDS Relief / United States Agency for International Development(United States Agency for International Development (USAID))	Funded by Presidents Emergency Fund for AIDS Relief / United States Agency for International Development Cooperative Agreement No. AID-674-A-12-00015 (www.pepfar.gov). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Beck EC, 2015, J AQUIR IMMUNE DEFIC; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Burrell E, 2010, SEX HEALTH, V7, P149, DOI 10.1071/SH09090; Carpenter RJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002775; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Council SANA, 2012, NAT STRAT PLAN HIV S; De Swardt G, 2010, MSM IN YOUR POCKET; De Swardt G, 2010, TOP BOTTOM SEX POSIT; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Kelley CF, 2011, J INFECT DIS, V204, P761, DOI 10.1093/infdis/jir400; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Lewis DA, 2013, J ANTIMICROB CHEMOTH, V68, P1267, DOI 10.1093/jac/dkt034; Lewis DA, 2010, SEX TRANSM INFECT, V86, P415, DOI 10.1136/sti.2010.042648; Rebe KB, 2013, S AFR J HIV MED, V14, P52, DOI [10.7196/SAJHIVMED.841, 10.7196/sajhivmed.841]; Rebe KB, 2010, INT AIDS SOC C VIENN; Rieg G, 2008, AIDS PATIENT CARE ST, V22, P947, DOI 10.1089/apc.2007.0240; Rispel LC, 2011, JAIDS-J ACQ IMM DEF, V57, P69, DOI 10.1097/QAI.0b013e318211b40a; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Sanders EJ, 2014, SEX TRANSM INFECT, V90, P94, DOI 10.1136/sextrans-2013-051078; Sanders EJ, 2010, SEX TRANSM INFECT, V86, P440, DOI 10.1136/sti.2010.043224; Sheibe A, 2014, EY POPULATIONS KEY S; South African Department of Health, 2003, 1 LIN COMPR MAN CONT; Turner AN, 2013, SEX TRANSM DIS, V40, P433, DOI 10.1097/OLQ.0b013e31828fd163; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Wand Handan, 2015, J Int AIDS Soc, V18, P19866, DOI 10.7448/IAS.18.1.19866; World Health Organisation, 2011, CONS GUID US ANT DRU	30	38	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138315	10.1371/journal.pone.0138315	http://dx.doi.org/10.1371/journal.pone.0138315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418464	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400013
J	Tang, X; Sun, B; Yang, YH; Tong, ZH				Tang, Xiao; Sun, Bing; Yang, Yuanhua; Tong, Zhaohui			A Survey of the Knowledge of Venous Thromboembolism Prophylaxis among the Medical Staff of Intensive Care Units in North China	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PATIENTS ANTITHROMBOTIC THERAPY; CLINICAL-PRACTICE GUIDELINES; ED AMERICAN-COLLEGE; THROMBOPROPHYLAXIS; PREVENTION; VTE; THROMBOSIS	Background Guideline concordance for venous thromboembolism (VTE) prophylaxis in critically ill patients in intensive care units (ICUs) varies across different countries. Objective To explore how the medical staff of ICUs in China comprehend and practice VTE prophylaxis. Method Questionnaires comprising 39 questions and including 4 dimensions of thromboprophylaxis were administered in ICUs in North China. Results In all, 52 ICUs at 23 tertiary hospitals in 7 Chinese provinces and municipalities were surveyed. A total of 2500 questionnaires were sent, and 1861 were returned, corresponding to a response rate of approximately 74.4%. Of all surveyed medical staff, 36.5% of physicians and 22.2% of nurses were aware of the guidelines in China, and 19.0% of physicians and 9.5% of nurses comprehended the 9th edition of the guidelines of the American College of Chest Physicians (ACCP). Additionally, 37.6% of the medical staff chose a prophylaxis method based on the related guidelines, and 10.3% could demonstrate the exact indication for mechanical pattern application. Worries about skin injury, difficulty with removal and discomfort during mechanical thromboprophylaxis were cited by more than 30% of nurses, which was significantly more frequent than for physicians (graduated compression stockings: 54.3% VS 34.1%, 60.7% VS 49%, and 59.4% VS 54%, p = 0.000; intermittent pneumatic compression: 31% VS 22.2%, 19.2% VS 13.9%, and 37.8% VS 27.2%, p = 0.000). Conclusions and Relevance The knowledge of VTE prophylaxis among the medical staff of ICUs in North China remains limited, which may lead to a lack of standardization of VTE prophylaxis. Strengthened, standardized training may help medical staff to improve their comprehension of the relevant guidelines and may finally reduce the occurrence of VTE in ICUs and improve the prognosis of critically ill patients with VTE.	[Tang, Xiao; Sun, Bing; Yang, Yuanhua; Tong, Zhaohui] Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Tang, Xiao; Sun, Bing; Yang, Yuanhua; Tong, Zhaohui] Beijing Inst Resp Med, Beijing, Peoples R China	Capital Medical University	Sun, B (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China.	ricusunbing@126.com			Beijing Municipal Administration of Hospitals of China;  [ZYLX201312]	Beijing Municipal Administration of Hospitals of China; 	This study was funded by Beijing Municipal Administration of Hospitals of China. ZHT is the recipient of the funding (ZYLX201312). ZHT drafted the manuscript and gave final approval of the version to be published.	Arabi YM, 2013, CHEST, V144, P152, DOI 10.1378/chest.12-2028; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Geerts W, 2002, J CRIT CARE, V17, P95, DOI 10.1053/jcrc.2002.33941; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; group OBFARBIBSPMSSSCTCZaV-Ns, 2014, MAEDICA J CLIN MED, V9, P6; Ho KM, 2011, CHEST, V140, P1436, DOI 10.1378/chest.11-1444; Jose A., 2014, EUROPEAN J INTERNAL, V25, P717, DOI [10.1016/j.ejim.2014.07.005, DOI 10.1016/J.EJIM.2014.07.005]; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kim H, 2015, J CLIN NURS, V24, P308, DOI 10.1111/jocn.12610; Lauzier F, 2014, CRIT CARE, V18, DOI 10.1186/cc13844; Medicine CSoCC, 2009, CHINESE J INTERNAL M, V48, P788; Ribic C, 2009, J CRIT CARE, V24, P197, DOI 10.1016/j.jcrc.2008.11.002; Schaden E, 2012, INTENS CARE MED, V38, P984, DOI 10.1007/s00134-012-2533-0	14	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139162	10.1371/journal.pone.0139162	http://dx.doi.org/10.1371/journal.pone.0139162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418162	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400054
J	Badhwar, R; Bagler, G				Badhwar, Rahul; Bagler, Ganesh			Control of Neuronal Network in Caenorhabditis elegans	PLOS ONE			English	Article							NERVOUS-SYSTEM; PLUGIN	Caenorhabditis elegans, a soil dwelling nematode, is evolutionarily rudimentary and contains only similar to 300 neurons which are connected to each other via chemical synapses and gap junctions. This structural connectivity can be perceived as nodes and edges of a graph. Controlling complex networked systems (such as nervous system) has been an area of excitement for mankind. Various methods have been developed to identify specific brain regions, which when controlled by external input can lead to achievement of control over the state of the system. But in case of neuronal connectivity network the properties of neurons identified as driver nodes is of much importance because nervous system can produce a variety of states (behaviour of the animal). Hence to gain insight on the type of control achieved in nervous system we implemented the notion of structural control from graph theory to C. elegans neuronal network. We identified 'driver neurons' which can provide full control over the network. We studied phenotypic properties of these neurons which are referred to as 'phenoframe' as well as the 'genoframe' which represents their genetic correlates. We find that the driver neurons are primarily motor neurons located in the ventral nerve cord and contribute to biological reproduction of the animal. Identification of driver neurons and its characterization adds a new dimension in controllability of C. elegans neuronal network. This study suggests the importance of driver neurons and their utility to control the behaviour of the organism.	[Badhwar, Rahul; Bagler, Ganesh] Indian Inst Technol Jodhpur, Ctr Biol Inspired Syst Sci, Jodhpur, Rajasthan, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Jodhpur	Bagler, G (corresponding author), Indian Inst Technol Jodhpur, Ctr Biol Inspired Syst Sci, Jodhpur, Rajasthan, India.	bagler@iitj.ac.in; ganesh.bagler@gmail.com	; Bagler, Ganesh/A-1102-2009	Badhwar, Rahul/0000-0002-1985-6162; Bagler, Ganesh/0000-0003-1924-6070				Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Dinitz Y, 1970, DOKL AKAD NAUK SSSR, V11, P1277; Duff IS, 2011, ACM T MATH SOFTWARE, V38, DOI 10.1145/2049673.2049677; HALL DH, 1991, J NEUROSCI, V11, P1; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Luenberger DG, 2002, IEEE T AUTOMATIC CON, P440; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Micali S., 1980, 21st Annual Symposium on Foundations of Computer Science, P17; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Mucha M, 2004, ANN IEEE SYMP FOUND, P248, DOI 10.1109/FOCS.2004.40; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Tang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048013; Von Stetina SE, 2005, INT REV NEUROBIOL, V69, P125, DOI 10.1016/S0074-7742(05)69005-8; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Zhang XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112039	23	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139204	10.1371/journal.pone.0139204	http://dx.doi.org/10.1371/journal.pone.0139204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413834	gold, Green Submitted, Green Published			2022-12-27	WOS:000362170700049
J	Liljeroos, M; Agren, S; Jaarsma, T; Arestedt, K; Stromberg, A				Liljeroos, Maria; Agren, Susanna; Jaarsma, Tiny; Arestedt, Kristofer; Stromberg, Anna			Long Term Follow-Up after a Randomized Integrated Educational and Psychosocial Intervention in Patient-Partner Dyads Affected by Heart Failure	PLOS ONE			English	Article							QUALITY-OF-LIFE; SELF-CARE; COGNITIVE IMPAIRMENT; CAREGIVER BURDEN; SOCIAL SUPPORT; TRIAL; METAANALYSIS; DEPRESSION; GUIDELINES; MANAGEMENT	Background To date, contemporary heart failure care remains patient-focused, but awareness of the partners' and families' situation is increasing. Randomized studies have mainly evaluated the short-term effects of dyadic interventions. Therefore, the aim of this study was to determine the 24-month effects of an intervention with psych-educational support in dyads of heart failure patients and their partners. Methods This study used a randomized study design and 155 patient-partner dyads were enrolled. The intervention included a nurse-led program of three sessions addressing psychoeducational support. Results The intervention did not have any effect on health, depressive symptoms or perceived control among the patient-partner dyads after 24 months. Furthermore, time to first event did not differ significantly between the intervention group and the control patients. Conclusion This study may be regarded as a first step in trying to understand dyads' need for supportive care. Individualized and more targeted interventions seem necessary to achieve a higher impact on dyad outcomes.	[Liljeroos, Maria; Agren, Susanna; Arestedt, Kristofer; Stromberg, Anna] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Liljeroos, Maria] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Agren, Susanna] Cty Council Ostergotland, Dept Cardiothorac Surg, Linkoping, Sweden; [Jaarsma, Tiny] Linkoping Univ, Dept Social & Welf Studies, Linkoping, Sweden; [Arestedt, Kristofer] Linnaeus Univ, Fac Hlth Social Work & Behav Sci, Sch Hlth & Caring Sci, Kalmar, Sweden; [Arestedt, Kristofer] Ersta Skondal Univ Collage, Palliat Res Ctr, Stockholm, Sweden; [Arestedt, Kristofer] Ersta Hosp, Stockholm, Sweden; [Stromberg, Anna] Cty Council Ostergotland, Dept Cardiol, Linkoping, Sweden	Linkoping University; Uppsala University; City Council Ostergotland; Linkoping University; Linnaeus University; Ersta Sjukhus; City Council Ostergotland	Liljeroos, M (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	maria.liljeroos@dll.se	Liljeroos, Maria/S-6410-2019; Liljeroos, Maria/K-6942-2019	Liljeroos, Maria/0000-0002-7957-8600; Jaarsma, Tiny/0000-0002-4197-4026	Centre for Clinical Research Sormland; Linkoping University; Swedish Research Council; Swedish Institute for Health Sciences	Centre for Clinical Research Sormland; Linkoping University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute for Health Sciences	The study was financially supported by grants from the Centre for Clinical Research Sormland, Linkoping University, the Swedish Research Council and the Swedish Institute for Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren S., 2010, J CARDIOVASC NURS; Agren S, 2012, J CARD FAIL, V18, P359, DOI 10.1016/j.cardfail.2012.01.014; Altman D.G., 1991, PRACTICAL STATISTIC; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Birnie K, 2010, PSYCHO-ONCOLOGY, V19, P1004, DOI 10.1002/pon.1651; Buck H.G., 2014, EUR J CARDIOVASC NUR; Cheng HY, 2014, PATIENT ED COUNS; Clark AP, 2006, DIMENS CRIT CARE NUR, V25, P93, DOI 10.1097/00003465-200605000-00001; Cohen J., 2003, APPL MULTIPLE REGRES; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dunbar SB, 2013, J CARD FAIL, V19, P829, DOI 10.1016/j.cardfail.2013.10.007; Dunbar SB, 2005, NURS RES, V54, P158; Ekman I, 2012, EUR HEART J, V33, P1112, DOI 10.1093/eurheartj/ehr306; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; Gallagher R, 2011, J CARDIOVASC NURS, V26, P439, DOI 10.1097/JCN.0b013e31820984e1; Jaarsma T, 1999, EUR HEART J, V20, P673, DOI 10.1053/euhj.1998.1341; Johansson P, 2010, EUR J CARDIOVASC NUR, V9, P108, DOI 10.1016/j.ejcnurse.2009.11.005; Liljeroos M, 2014, J CLIN NURS; Lofvenmark C, 2013, J CLIN NURS, V22, P115, DOI 10.1111/j.1365-2702.2012.04201.x; Luttik Marie Louise, 2005, Eur J Cardiovasc Nurs, V4, P11, DOI 10.1016/j.ejcnurse.2004.12.002; Martensson J, 2003, J HEART LUNG TRANSPL, V22, P460, DOI 10.1016/S1053-2498(02)00818-5; Martire LM, 2004, HEALTH PSYCHOL, V23, P599, DOI 10.1037/0278-6133.23.6.599; Martire Lynn M, 2008, Fam Syst Health, V26, P185; Martire LM, 2010, ANN BEHAV MED, V40, P325, DOI 10.1007/s12160-010-9216-2; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Molloy GJ, 2005, EUR J HEART FAIL, V7, P592, DOI 10.1016/j.ejheart.2004.07.008; Moser DK, 2012, CURR CARDIOL REP, V14, P265, DOI 10.1007/s11886-012-0267-9; Moser DK, 2009, NURS RES, V58, P42, DOI 10.1097/NNR.0b013e3181900ca0; MOSER DK, 1995, HEART LUNG, V24, P273, DOI 10.1016/S0147-9563(05)80070-6; Peters-Klimm F, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-56; Pitteri F, 2013, GERIATR PSYCHOL NEUR, V11, P443, DOI 10.1684/pnv.2013.0426; Pressler SJ, 2010, J CARDIOVASC NURS, V25, P189, DOI 10.1097/JCN.0b013e3181ca36fe; Quinn Christina, 2010, Appl Nurs Res, V23, pe15, DOI 10.1016/j.apnr.2008.10.001; Reid J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073459; Riegel B, 2002, AM J CRIT CARE, V11, P520, DOI 10.4037/ajcc2002.11.6.520; Riegel B, 2009, CIRCULATION, V120, P1141, DOI 10.1161/CIRCULATIONAHA.109.192628; Rigby H, 2009, INT J STROKE, V4, P285, DOI 10.1111/j.1747-4949.2009.00289.x; Rosland AM, 2010, CHRONIC ILLN, V6, P7, DOI 10.1177/1742395309352254; Saunders Mitzi M, 2003, Holist Nurs Pract, V17, P136; Sayers SL, 2008, ANN BEHAV MED, V35, P70, DOI 10.1007/s12160-007-9003-x; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Sebern M, 2009, EUR J CARDIOVASC NUR, V8, P97, DOI 10.1016/j.ejcnurse.2008.07.004; Sebern MD, 2012, WESTERN J NURS RES, V34, P289, DOI 10.1177/0193945911399088; Stromberg A, 2003, EUR HEART J, V24, P1014, DOI 10.1016/S0195-668X(03)00112-X; Stromberg A, 2006, PATIENT EDUC COUNS, V64, P128, DOI 10.1016/j.pec.2005.12.007; Stuifbergen A, 1999, J Neurosci Nurs, V31, P73; Stuijbergen AK, 2003, ARCH PHYS MED REHAB, V84, P467, DOI 10.1053/apmr.2003.50028; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; van der Wal MHL, 2010, EUR HEART J, V31, P1486, DOI 10.1093/eurheartj/ehq091; Ware J., 1993, SF 36 HLTH SURVEY MA; Woltz PC, 2012, HEART LUNG, V41, P469, DOI 10.1016/j.hrtlng.2012.06.002	52	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138058	10.1371/journal.pone.0138058	http://dx.doi.org/10.1371/journal.pone.0138058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406475	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700030
J	Maselou, DA; Perdikis, DC; Sabelis, MW; Fantinou, AA				Maselou, Dionyssia A.; Perdikis, Dionyssios Ch.; Sabelis, Maurice W.; Fantinou, Argyro A.			Plant Resources as a Factor Altering Emergent Multi-Predator Effects	PLOS ONE			English	Article							GENERALIST PREDATORS; MACROLOPHUS-PYGMAEUS; BIOLOGICAL-CONTROL; TUTA-ABSOLUTA; INTRAGUILD PREDATION; ENEMY BIODIVERSITY; NATURAL ENEMIES; POTENTIAL USE; HOST PLANTS; PREY	Multiple predator effects (MPEs) can modify the strength of pest regulation, causing positive or negative deviations from those that are predicted from independent effects of isolated predators. Despite increasing evidence that omnivory can shape predator-prey interactions, few studies have examined the impact of alternative plant food on interactions between multiple predators. In the present study, we examined the effects and interactions of two omnivorous mirids, Macrolophus pygmaeus and Nesidiocoris tenuis, on different densities of their aphid prey, Myzus persicae. Prey were offered to the to single or pairs of mirid predator individuals, either conspecific or heterospecific on a leaf, while simultaneously adding or excluding a flower as an alternative food resource. Data were compared with calculated expected values using the multiplicative risk model and the substitutive model. We showed that predation of aphids was reduced in the presence of the alternative flower resource in treatments with single M. pygmaeus individuals, but not with single N. tenuis individuals. When the predators had access only to prey, the effects of multiple predation, either conspecific or heterospecific, were additive. The addition of an alternative plant resource differently affected MPEs depending on the nature of predator pairings. Predation risk was increased in conspecific M. pygmaeus treatments at intermediate prey densities, whereas it was reduced in conspecific N. tenuis treatments at high prey densities. Observations of foraging behaviour concerning the location of conspecific pairings revealed that M. pygmaeus individuals showed a clear tendency to reside mainly in the flower, whereas N. tenuis individuals were found to reside at different posts in the dish. We suggest that the competition between omnivorous predators may be mediated through the diversity of their plant feeding preferences, which directly affects the strength of MPEs. Consequently, the preferences of the interacting predators for different plant resources should be considered in studies evaluating the outcomes of MPEs.	[Maselou, Dionyssia A.; Fantinou, Argyro A.] Agr Univ Athens, Lab Ecol & Environm Sci, GR-11855 Athens, Greece; [Perdikis, Dionyssios Ch.] Agr Univ Athens, Lab Agr Zool & Entomol, GR-11855 Athens, Greece; [Sabelis, Maurice W.] Univ Amsterdam, IBED, Amsterdam, Netherlands	Agricultural University of Athens; Agricultural University of Athens; University of Amsterdam	Fantinou, AA (corresponding author), Agr Univ Athens, Lab Ecol & Environm Sci, GR-11855 Athens, Greece.	argyr@aua.gr		FANTINOU, ARGYRO/0000-0002-6122-9170	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund.	Agrawal AA, 2000, J ANIM ECOL, V69, P525, DOI 10.1046/j.1365-2656.2000.00416.x; Albajes R, 1999, DEV PLANT PATHOL, P265; Ameixa OMCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062530; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; Byers JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093969; Cardinale BJ, 2003, ECOL LETT, V6, P857, DOI 10.1046/j.1461-0248.2003.00508.x; Carey MP, 2010, OECOLOGIA, V162, P443, DOI 10.1007/s00442-009-1461-3; Casula Paolo, 2013, ISRN Ecology, P1; Chailleux A, 2014, NATURWISSENSCHAFTEN, V101, P1075, DOI 10.1007/s00114-014-1246-3; Chailleux A, 2013, J PEST SCI, V86, P533, DOI 10.1007/s10340-013-0498-6; Chang GC, 1996, ENVIRON ENTOMOL, V25, P207, DOI 10.1093/ee/25.1.207; Coll M., 2009, RELATIONSHIPS NATURA; Crowder DW, 2014, BIOL CONTROL, V75, P8, DOI 10.1016/j.biocontrol.2013.10.010; De Puysseleyr V, 2013, BIOCONTROL, V58, P205, DOI 10.1007/s10526-012-9486-7; Eubanks MD, 2000, ECOLOGY, V81, P936, DOI 10.2307/177168; EVANS EW, 1991, OECOLOGIA, V87, P401, DOI 10.1007/BF00634598; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Finke DL, 2005, ECOL LETT, V8, P1299, DOI 10.1111/j.1461-0248.2005.00832.x; Gillespie DR, 2006, PROG BIOL CONTROL, V3, P71; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Griffen BD, 2006, OECOLOGIA, V148, P702, DOI 10.1007/s00442-006-0414-3; Hamdi F, 2013, J INSECT BEHAV, V26, P614, DOI 10.1007/s10905-013-9379-3; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Jakobsen L, 2004, BIOCONTROL SCI TECHN, V14, P17, DOI 10.1080/09583150310001606561; Kehrli Patrik, 2011, ISRN Ecology, V2011, P1, DOI 10.5402/2011/480195; Koss AM, 2005, BIOL CONTROL, V32, P243, DOI 10.1016/j.biocontrol.2004.10.002; Lampropoulos PD, 2013, BASIC APPL ECOL, V14, P605, DOI 10.1016/j.baae.2013.08.004; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; Lykouressis D.P., 2000, Entomologia Hellenica, V13, P35; Lykouressis D, 2014, PHYTOPARASITICA, V42, P303, DOI 10.1007/s12600-013-0360-7; Maleki F, 2006, Commun Agric Appl Biol Sci, V71, P393; Maselou DA, 2014, BIOL CONTROL, V79, P92, DOI 10.1016/j.biocontrol.2014.09.002; Molla O, 2014, BIOCONTROL, V59, P175, DOI 10.1007/s10526-013-9553-8; Moreno-Ripoll R, 2012, BIOL CONTROL, V62, DOI 10.1016/j.biocontrol.2012.04.005; Nakaishi K, 2011, JPN J APPL ENTOMOL Z, V55, P199, DOI 10.1303/jjaez.2011.199; Nilsson E, 2006, FRESHWATER BIOL, V51, P1507, DOI 10.1111/j.1365-2427.2006.01581.x; Northfield T. D., 2012, TRAIT MEDIATED INDIR, P450; Perdikis D, 2014, BIOL CONTROL, V70, P35, DOI 10.1016/j.biocontrol.2013.12.003; Perdikis D, 2000, BIOL CONTROL, V17, P55, DOI 10.1006/bcon.1999.0774; Perdikis DC, 2004, J ECON ENTOMOL, V97, P1291, DOI 10.1603/0022-0493-97.4.1291; Perez-Hedo M, 2015, J PEST SCI, V88, P543, DOI 10.1007/s10340-014-0640-0; Prasad RP, 2010, OECOLOGIA, V162, P747, DOI 10.1007/s00442-009-1486-7; Provost C, 2006, J INSECT BEHAV, V19, P265, DOI 10.1007/s10905-006-9023-6; Sabelis Maurice W., 2006, IOBC-WPRS Bulletin, V29, P195; SAS Institute, 2012, JMP VERS 10 0 0; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Snyder WE, 2001, ECOLOGY, V82, P705, DOI 10.1890/0012-9658(2001)082[0705:GPDBCB]2.0.CO;2; SOLUK DA, 1988, OIKOS, V52, P94, DOI 10.2307/3565987; SOLUK DA, 1993, ECOLOGY, V74, P219, DOI 10.2307/1939516; Straub CS, 2008, ECOLOGY, V89, P1605, DOI 10.1890/07-0657.1; Urbaneja A, 2005, BIOCONTROL SCI TECHN, V15, P513, DOI 10.1080/09583150500088777; Urbaneja A, 2009, J APPL ENTOMOL, V133, P292, DOI 10.1111/j.1439-0418.2008.01319.x; Urbaneja A, 2012, PEST MANAG SCI, V68, P1215, DOI 10.1002/ps.3344; van Lenteren JC, 2012, BIOCONTROL, V57, P1, DOI 10.1007/s10526-011-9395-1; Vance-Chalcraft HD, 2005, OECOLOGIA, V146, P452, DOI 10.1007/s00442-005-0201-6; Vandekerkhove B, 2010, BIOL CONTROL, V53, P238, DOI 10.1016/j.biocontrol.2010.01.005; Venzon Madelaine, 2001, Neotropical Entomology, V30, P1, DOI 10.1590/S1519-566X2001000100002; Wackers F. L., 2005, PLANT PROVIDED FOOD; Werling BP, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.3001; Wilby A, 2005, ECOL ENTOMOL, V30, P497, DOI 10.1111/j.0307-6946.2005.00717.x; Wilby A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070258; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9	64	8	8	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138764	10.1371/journal.pone.0138764	http://dx.doi.org/10.1371/journal.pone.0138764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406443	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700090
J	Schwaberger, B; Pichler, G; Avian, A; Binder-Heschl, C; Baik, N; Urlesberger, B				Schwaberger, Bernhard; Pichler, Gerhard; Avian, Alexander; Binder-Heschl, Corinna; Baik, Nariae; Urlesberger, Berndt			Do Sustained Lung Inflations during Neonatal Resuscitation Affect Cerebral Blood Volume in Preterm Infants? A Randomized Controlled Pilot Study	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; FUNCTIONAL RESIDUAL CAPACITY; REGIONAL OXYGEN-SATURATION; BIRTH-WEIGHT INFANTS; CARDIOPULMONARY-RESUSCITATION; PREMATURE-INFANTS; DELIVERY ROOM; TRANSITION; VENTILATION; HEMORRHAGE	Background Sustained lung inflations (SLI) during neonatal resuscitation may promote alveolar recruitment in preterm infants. While most of the studies focus on respiratory outcome, the impact of SLI on the brain hasn't been investigated yet. Objective Do SLI affect cerebral blood volume (CBV) in preterm infants? Methods Preterm infants of gestation 28 weeks 0 days to 33 weeks 6 days with requirement for respiratory support (RS) were included in this randomized controlled pilot trial. Within the first 15 minutes after birth near-infrared spectroscopy (NIRS) measurements using 'NIRO-200-NX' (Hamamatsu, Japan) were performed to evaluate changes in CBV and cerebral tissue oxygenation. Two groups were compared based on RS: In SLI group RS was given by applying 1-3 SLI (30 cmH(2)O for 15 s) continued by respiratory standard care. Control group received respiratory standard care only. Results 40 infants (20 in each group) with mean gestational age of 32 weeks one day (+/- 2 days) and birth weight of 1707 (+/- 470) g were included. In the control group Delta CBV was significantly decreasing, whereas in SLI group Delta CBV showed similar values during the whole period of 15 minutes. Comparing both groups within the first 15 minutes Delta CBV showed a tendency toward different overall courses (p = 0.051). Conclusion This is the first study demonstrating an impact of SLI on CBV. Further studies are warranted including reconfirmation of the present findings in infants with lower gestational age. Future investigations on SLI should not only focus on respiratory outcome but also on the consequences on the developing brain.	[Schwaberger, Bernhard; Pichler, Gerhard; Binder-Heschl, Corinna; Baik, Nariae; Urlesberger, Berndt] Med Univ Graz, Res Unit Cerebral Dev & Oximetry, Graz, Austria; [Schwaberger, Bernhard; Pichler, Gerhard; Binder-Heschl, Corinna; Baik, Nariae; Urlesberger, Berndt] Med Univ Graz, Res Unit Neonatal Micro & Macrocirculat, Graz, Austria; [Schwaberger, Bernhard; Pichler, Gerhard; Binder-Heschl, Corinna; Baik, Nariae; Urlesberger, Berndt] Med Univ Graz, Dept Pediat, Div Neonatol, Graz, Austria; [Avian, Alexander] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Urlesberger, B (corresponding author), Med Univ Graz, Res Unit Cerebral Dev & Oximetry, Graz, Austria.	berndt.urlesberger@medunigraz.at	Schwaberger, Bernhard/M-7929-2019	Schwaberger, Bernhard/0000-0001-5499-3712; Urlesberger, Berndt/0000-0003-0648-5785; Avian, Alexander/0000-0003-1084-5763; Pichler, Gerhard/0000-0003-2405-7143	Jubilaeumsfond, Oesterreichische Nationalbank [14312]	Jubilaeumsfond, Oesterreichische Nationalbank	Funding: Funding provided by Jubilaeumsfond, Oesterreichische Nationalbank (Grant No. 14312), BU received the funding. http://www.oenb.at/en/About-Us/Research-Promotion/The-OeNB-Anniversary-Fund.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder C, 2013, J PEDIATR-US, V163, P394, DOI 10.1016/j.jpeds.2013.01.026; BIONDI JW, 1988, ANESTH ANALG, V67, P144; Bjorklund LJ, 1997, PEDIATR RES, V42, P348; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; du Plessis AJ, 2008, CLIN PERINATOL, V35, P609, DOI 10.1016/j.clp.2008.07.010; Duldink J, 2008, ARCH DIS CHILD-FETAL, V93, pF201, DOI 10.1136/adc.2007.118067; Fuchs H, 2012, J PERINATOL, V32, P356, DOI 10.1038/jp.2011.110; Fuchs H, 2011, PEDIATR RES, V70, P176, DOI 10.1203/PDR.0b013e318220c1e0; GhaziBirry HS, 1997, AM J NEURORADIOL, V18, P219; HAUSDORF G, 1987, CRIT CARE MED, V15, P661, DOI 10.1097/00003246-198707000-00007; Hillman NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113473; Jobe AH, 2008, NEONATOLOGY, V94, P190, DOI 10.1159/000143721; Kattwinkel J, 2010, CIRCULATION, V122, pS909, DOI 10.1161/CIRCULATIONAHA.110.971119; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF188, DOI 10.1136/fn.82.3.F188; Lindner W, 2005, ACTA PAEDIATR, V94, P303, DOI 10.1080/08035250410023647; Lindner W, 1999, PEDIATRICS, V103, P961, DOI 10.1542/peds.103.5.961; Lista G, 2015, PEDIATRICS, V135, pE457, DOI 10.1542/peds.2014-1692; MIRRO R, 1987, J PEDIATR-US, V111, P101, DOI 10.1016/S0022-3476(87)80354-2; Patterson SW, 1914, J PHYSIOL-LONDON, V48, P357; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Pichler G, 2013, J PEDIATR-US, V163, P1558, DOI 10.1016/j.jpeds.2013.07.007; Pocivalnik M, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3575647; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Schmolzer GM, 2015, ARCH DIS CHILD-FETAL, V100, pF361, DOI 10.1136/archdischild-2014-306836; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schwaberger B, 2015, NEONATOLOGY, V108, P253, DOI 10.1159/000437347; Schwaberger B, 2014, PHYSIOL MEAS, V35, P2085, DOI 10.1088/0967-3334/35/10/2085; Skiold B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095804; Sweet DG, 2010, NEONATOLOGY, V97, P402, DOI 10.1159/000297773; Pas ABT, 2007, PEDIATRICS, V120, P322, DOI 10.1542/peds.2007-0114; te Pas AB, 2009, PEDIATR RES, V66, P295, DOI 10.1203/PDR.0b013e3181b1bca4; te Pas AB, 2009, PEDIATR RES, V65, P537, DOI 10.1203/PDR.0b013e31819da21b; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Urlesberger B, 2011, J PEDIATR-US, V159, P404, DOI 10.1016/j.jpeds.2011.02.030; van Vonderen JJ, 2014, J PEDIATR-US, V165, P903, DOI 10.1016/j.jpeds.2014.06.007; VANDERZEE P, 1992, ADV EXP MED BIOL, V316, P143; WYATT JS, 1991, PEDIATR RES, V29, P553, DOI 10.1203/00006450-199106010-00007	37	32	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138964	10.1371/journal.pone.0138964	http://dx.doi.org/10.1371/journal.pone.0138964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406467	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700130
J	Tomioka, K; Kurumatani, N; Hosoi, H				Tomioka, Kimiko; Kurumatani, Norio; Hosoi, Hiroshi			Social Participation and the Prevention of Decline in Effectance among Community-Dwelling Elderly: A Population-Based Cohort Study	PLOS ONE			English	Article							SELF-RATED HEALTH; LEVEL FUNCTIONAL-CAPACITY; OLDER-ADULTS; INCIDENT DISABILITY; GENDER-DIFFERENCES; DEPRESSION; ONSET; ASSOCIATION; INVOLVEMENT; PREDICTORS	Background We examined the association between a decline in effectance and social participation (SP) from the perspective of the number and the type of SP in a prospective cohort study. Methods Included in this analysis were community-dwelling elderly aged >= 65 without dependency on the basic activities of daily living and reporting a perfect baseline effectance score (n = 4,588; mean age 72.8 +/- 5.7). SP was categorized into 5 types: neighborhood associations, hobby groups, local event groups, senior citizen clubs, and volunteer groups. Effectance was evaluated using the Tokyo Metropolitan Institute of Gerontology Index of Competence. Using logistic regression analysis, odds ratio (OR) and a 95% confidence interval (CI) for a decline in effectance were calculated. Age, family, BMI, pensions, medical history, medications, alcohol, smoking, cognitive function, depression, social support, ADL, and IADL were used as covariates. Results During the 3-year follow-up, 17.8% of eligible participants reported a decline in effectance. After adjustment for covariates, participation in various groups was associated with the preservation of effectance for both genders. Regarding the type of SP, among females, participation in neighborhood associations (OR: 0.62, 95% CI: 0.48-0.81), hobby groups (0.58, 0.430.77), local event groups (0.63, 0.47-0.86), and volunteer groups (0.53, 0.35-0.82) was inversely associated with a decline in effectance. Among males, the beneficial effect was more likely limited to hobby groups (0.59, 0.43-0.81) and volunteer groups (0.57, 0.39-0.83). Conclusions Our results suggest that participation in a variety of social groups is effective for maintenance of older people's effectance, while the beneficial effect of each type of SP on effectance is stronger for females than for males. Recommending community-dwelling elderly to participate in social groups appropriate for their gender may be effective for successful aging.	[Tomioka, Kimiko; Kurumatani, Norio; Hosoi, Hiroshi] Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara 634, Japan	Nara Medical University	Tomioka, K (corresponding author), Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara 634, Japan.	tkimiko@naramed-u.ac.jp			Nara Medical University	Nara Medical University	This work was supported by center administrative expense from Nara Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rayya HM, 2005, INTERNET J HLTH, V5, P2; Aida J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-499; Antonucci T.C., 1994, WOMEN GROWING OLDER, P239; Avlund K, 2004, ARCH GERONTOL GERIAT, V38, P85, DOI 10.1016/j.archger.2003.08.003; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Cabinet Office Government of Japan, 2014, ANN REP AG SOC 2014; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013; de Leon CFM, 2003, AM J EPIDEMIOL, V157, P633, DOI 10.1093/aje/kwg028; Desrosiers J, 2004, AGING CLIN EXP RES, V16, P406; Desrosiers J, 2009, ARCH GERONTOL GERIAT, V49, P397, DOI 10.1016/j.archger.2008.12.006; Fujiwara Y, 2003, ARCH GERONTOL GERIAT, V36, P141, DOI 10.1016/S0167-4943(02)00081-X; Fujiwara Y., 2002, GERIATR GERONTOL INT, V2, P57; Fujiwara Y, 2016, GERIATR GERONTOL INT, V16, P126, DOI 10.1111/ggi.12441; GRAND A, 1988, SOC SCI MED, V27, P1337, DOI 10.1016/0277-9536(88)90198-0; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Herzog AR, 1998, PSYCHOL AGING, V13, P179, DOI 10.1037/0882-7974.13.2.179; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hoyl MT, 1999, J AM GERIATR SOC, V47, P873, DOI 10.1111/j.1532-5415.1999.tb03848.x; Hsu HC, 2007, AGING MENT HEALTH, V11, P699, DOI 10.1080/13607860701366335; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424, DOI 10.1111/j.1532-5415.2000.tb02632.x; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Kishimoto Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1189; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Koyano W., 1987, JPN J PUBLIC HLTH, V34, P109; Lachman ME, 1998, PSYCHOL AGING, V13, P553, DOI 10.1037/0882-7974.13.4.553; Lawton MP, 1972, RES PLANNING ACTION, P122; Levasseur M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1824-0; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Lindstrom M, 2006, SOC SCI MED, V62, P280, DOI 10.1016/j.socscimed.2005.06.005; Lund R, 2010, AGE AGEING, V39, P319, DOI 10.1093/ageing/afq020; MAHONEY F I, 1965, Md State Med J, V14, P61; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Nilsson CJ, 2008, J AGING HEALTH, V20, P235, DOI 10.1177/0898264307310474; Norton MC, 2006, J GERONTOL B-PSYCHOL, V61, pP129, DOI 10.1093/geronb/61.3.P129; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; STRAWBRIDGE WJ, 1993, GERONTOLOGIST, V33, P603, DOI 10.1093/geront/33.5.603; Sun W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-297; Takagi D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-701; Takeuchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061741; Tsubota-Utsugi M, 2011, J AM GERIATR SOC, V59, P1993, DOI 10.1111/j.1532-5415.2011.03633.x; Unger JB, 1997, ANN BEHAV MED, V19, P152, DOI 10.1007/BF02883332; Wilson RS, 2015, NEUROPSYCHOLOGY, V29, P561, DOI 10.1037/neu0000154; World Health Organization, 2002, ACT AG POL FRAM; World Health Organization (WHO) Scientific Group on the Epidemiology of Aging, 1984, TECHNICAL REPORT SER, V706; Zunzunegui M V, 2005, Eur J Ageing, V2, P40, DOI 10.1007/s10433-005-0021-x	50	38	38	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139065	10.1371/journal.pone.0139065	http://dx.doi.org/10.1371/journal.pone.0139065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26406326	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700159
J	Witte, K; Koch, E; Volk, HD; Wolk, K; Sabat, R				Witte, Katrin; Koch, Egon; Volk, Hans-Dieter; Wolk, Kerstin; Sabat, Robert			The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GROUP A-STREPTOCOCCI; DOUBLE-BLIND; IN-VITRO; IL-22; CELLS; KERATINOCYTES; EFFICACY; DIFFERENTIATION; EXPRESSION	Pelargonium sidoides is a medical herb and respective extracts are used very frequently for the treatment of respiratory tract infections. However, the effects of Pelargonium sidoides and a special extract prepared from its roots (EPs 7630) on human immune cells are not fully understood. Here we demonstrate that EPs 7630 induced a rapid and dose-dependent production of TNF-alpha, IL-6, and IL-10 by human blood immune cells. This EPs 7630-induced cytokine profile was more pro-inflammatory in comparison with the profile induced by viral or bacterial infection-mimicking agents. The search for EPs 7630 target cells revealed that T-cells did not respond to EPs 7630 stimulation by production of TNF-alpha, IL-6, or IL-10. Furthermore, pretreatment of T-cells with EPs 7630 did not modulate their TNF-alpha, IL-6, and IL-10 secretion during subsequent activation. In contrast to lymphocytes, monocytes showed clear intracellular TNF-alpha staining after EPs 7630 treatment. Accordingly, EPs 7630 predominantly provoked activation of MAP kinases and inhibition of p38 strongly reduced the monocyte TNF-alpha production. The pretreatment of blood immune cells with EPs 7630 lowered their secretion of TNF-alpha and IL-10 and caused an IL-6 dominant response during second stimulation with viral or bacterial infection-mimicking agents. In summary, we demonstrate that EPs 7630 activates human monocytes, induces MAP kinase-dependent pro-inflammatory cytokines in these cells, and specifically modulates their production capacity of mediators known to lead to an increase of acute phase protein production in the liver, neutrophil generation in the bone marrow, and the generation of adaptive Th17 and Th22 cells.	[Witte, Katrin; Wolk, Kerstin; Sabat, Robert] Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol Dermatol M, Berlin, Germany; [Witte, Katrin; Volk, Hans-Dieter; Wolk, Kerstin] Univ Hosp Charite, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Koch, Egon] Dr Willmar Schwabe GmbH & Co KG, Preclin Res, Karlsruhe, Germany; [Volk, Hans-Dieter] Univ Hosp Charite, Inst Med Immunol, Berlin, Germany; [Wolk, Kerstin; Sabat, Robert] Univ Hosp Charite, Psoriasis Res & Treatment Ctr, Berlin, Germany; [Sabat, Robert] Univ Hosp Charite, Res Ctr Immunosci, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Dr. Willmar Schwabe GmbH & Co. KG; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sabat, R (corresponding author), Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol Dermatol M, Berlin, Germany.	robert.sabat@charite.de	volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668; Wolk, Kerstin/0000-0002-7689-4130	Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany	Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany	RS received a research grant from Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany. Additionally, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany provided support in the form of research material (EPs 7630) and salaries for author EK. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agbabiaka TB, 2008, PHYTOMEDICINE, V15, P378, DOI 10.1016/j.phymed.2007.11.023; Bachert C, 2009, RHINOLOGY, V47, P51; BEIL W, 2007, PHYTOMEDICINE S1, V14, P5, DOI DOI 10.1016/J.PHYMED.2006.11.024]; Bereznoy VV, 2003, ALTERN THER HEALTH M, V9, P68; Brendler T, 2008, J ETHNOPHARMACOL, V119, P420, DOI 10.1016/j.jep.2008.07.037; Conrad A, 2007, PHYTOMEDICINE, V14, P46, DOI 10.1016/j.phymed.2006.11.016; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Helfer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087487; Janecki A, 2011, J ETHNOPHARMACOL, V133, P147, DOI 10.1016/j.jep.2010.09.018; Janecki A, 2010, MOLECULES, V15, P7139, DOI 10.3390/molecules15107139; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Kolodziej H, 2005, BIOORGAN MED CHEM, V13, P6470, DOI 10.1016/j.bmc.2005.07.012; Kolodziej H, 2003, PHYTOMEDICINE, V10, P18, DOI 10.1078/1433-187X-00307; Kolodziej H, 2007, PHYTOMEDICINE, V14, P9, DOI 10.1016/j.phymed.2006.11.021; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Lizogub VG, 2007, EXPLORE-NY, V3, P573, DOI 10.1016/j.explore.2007.09.004; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Matthys H, 2013, RESP MED, V107, P691, DOI 10.1016/j.rmed.2013.02.011; Michaelis M, 2011, PHYTOMEDICINE, V18, P384, DOI 10.1016/j.phymed.2010.09.008; Neugebauer P, 2005, PHYTOMEDICINE, V12, P46, DOI 10.1016/j.phymed.2003.11.005; Pugh ND, 2008, INT IMMUNOPHARMACOL, V8, P1023, DOI 10.1016/j.intimp.2008.03.007; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Schnitzler P, 2008, PHYTOMEDICINE, V15, P1108, DOI 10.1016/j.phymed.2008.06.009; Schoetz K, 2008, PLANTA MED, V74, P667, DOI 10.1055/s-2008-1074515; Thale C, 2011, PLANTA MED, V77, P718, DOI 10.1055/s-0030-1250567; Theisen LL, 2012, ANTIVIR RES, V94, P147, DOI 10.1016/j.antiviral.2012.03.006; Trun W, 2006, PHYTOMEDICINE, V13, P570, DOI 10.1016/j.phymed.2005.07.004; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; Wittschier N, 2007, PHYTOMEDICINE, V14, P285, DOI 10.1016/j.phymed.2006.12.008; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006245; Wolk K, 2011, J IMMUNOL, V186, P1228, DOI 10.4049/jimmunol.0903907; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0	37	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138075	10.1371/journal.pone.0138075	http://dx.doi.org/10.1371/journal.pone.0138075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406906	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700032
J	Kopp, CW; Cleland, EE				Kopp, Christopher W.; Cleland, Elsa E.			A Range-Expanding Shrub Species Alters Plant Phenological Response to Experimental Warming	PLOS ONE			English	Article							CLIMATE-CHANGE; BIOTIC INTERACTIONS; COMMUNITY RESPONSES; LEAF PHENOLOGY; SHIFTS; ABUNDANCE; TREES	Shifts in plant species phenology (the timing of life-history events such as flowering) have been observed worldwide in concert with rising global temperatures. While most species display earlier phenology with warming, there is large variation among, and even within, species in phenological sensitivity to rising temperatures. Other indirect effects of climate change, such as shifting species composition and altered species interactions, may also be contributing to shifting plant phenology. Here, we describe how experimental warming and the presence of a range-expanding species, sagebrush (Artemisia rothrockii), interact to influence the flowering phenology (day of first and peak flowering) and production (number of flowers) of an alpine cushion plant, Trifolium andersonii, in California's White Mountains. Both first flowering and peak flowering were strongly accelerated by warming, but not when sagebrush was present. Warming significantly increased flower production of T. andersonii, but less so in the presence of sagebrush. A shading treatment delayed phenology and lowered flower production, suggesting that shading may be the mechanism by which sagebrush presence delayed flowering of the understory species. This study demonstrates that species interactions can modify phenological responses to climate change, and suggests that indirect effects of rising temperatures arising from shifting species ranges and altered species interactions may even exceed the direct effects of rising temperatures on phenology.	[Kopp, Christopher W.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Cleland, Elsa E.] Univ Calif San Diego, Div Biol Sci, Ecol Behav & Evolut Sect, San Diego, CA 92103 USA	University of British Columbia; University of California System; University of California San Diego	Kopp, CW (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada.	ckopp@biodiversity.ubc.ca		Cleland, Elsa/0000-0003-3920-0029	University of California, San Diego Division of Biological Sciences; Jean Marie Messier Memorial Endowment; White Mountain Research Center; UC Natural Reserve System; California Native Plant Society; Bristlecone Chapter of the California Native Plant Society; American Alpine Club; Nevada Native Plant Society; ARCS (Achievement Rewards for College Scientists) Foundation; National Science Foundation Graduate STEM Fellows in K-12 Education (GK-12) Program [DGE-1007911]	University of California, San Diego Division of Biological Sciences; Jean Marie Messier Memorial Endowment; White Mountain Research Center; UC Natural Reserve System; California Native Plant Society; Bristlecone Chapter of the California Native Plant Society; American Alpine Club; Nevada Native Plant Society; ARCS (Achievement Rewards for College Scientists) Foundation; National Science Foundation Graduate STEM Fellows in K-12 Education (GK-12) Program	Support was provided by the University of California, San Diego Division of Biological Sciences (http://biology.ucsd.edu); Jean Marie Messier Memorial Endowment; White Mountain Research Center (http://www.wmrc.edu); UC Natural Reserve System (http://nrs.ucop.edu); California Native Plant Society (http://www.cnps.org); Bristlecone Chapter of the California Native Plant Society (http://bristleconecnps.org); American Alpine Club (http://www.americanalpineclub.org); Nevada Native Plant Society (https://nvnps.org); ARCS (Achievement Rewards for College Scientists) Foundation (https://www.arcsfoundation.org/san_diego/); and the National Science Foundation Graduate STEM Fellows in K-12 Education (GK-12) Program (DGE-1007911) (http://www.gk12.org).	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Augspurger CK, 2003, TREE PHYSIOL, V23, P517, DOI 10.1093/treephys/23.8.517; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres LA, 2014, ECOL LETT, V17, P193, DOI 10.1111/ele.12217; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Cramer W, 2014, PART A GLOBAL AND SE, P979; Delzon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080443; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Galloway LF, 2009, NEW PHYTOL, V182, P1003, DOI 10.1111/j.1469-8137.2009.02803.x; Gould AMA, 2000, AM MIDL NAT, V144, P36, DOI 10.1674/0003-0031(2000)144[0036:EOTEIS]2.0.CO;2; Hall C, 1991, NATURAL HISTORY OF T; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; Kopp CW, 2014, J VEG SCI, V25, P135, DOI 10.1111/jvs.12072; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Kudo G, 2013, ECOLOGY, V94, P2311, DOI 10.1890/12-2003.1; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Molau U, 1996, INTERNATIONAL TUNDRA; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Saccone P, 2009, J VEG SCI, V20, P403, DOI 10.1111/j.1654-1103.2009.01012.x; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Vitasse Y, 2009, AGR FOREST METEOROL, V149, P735, DOI 10.1016/j.agrformet.2008.10.019; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wipf S, 2006, GLOBAL CHANGE BIOL, V12, P1496, DOI 10.1111/j.1365-2486.2006.01185.x; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x	38	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139029	10.1371/journal.pone.0139029	http://dx.doi.org/10.1371/journal.pone.0139029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402617	Green Submitted, gold, Green Published			2022-12-27	WOS:000361798100053
J	Wang, W; He, Y; Yu, GD; Li, BL; Sexton, DW; Wileman, T; Roberts, AA; Hamilton, CJ; Liu, RX; Chao, YM; Shan, YJ; Bao, YP				Wang, Wei; He, Yan; Yu, Guodong; Li, Baolong; Sexton, Darren W.; Wileman, Thomas; Roberts, Alexandra A.; Hamilton, Chris J.; Liu, Ruoxi; Chao, Yimin; Shan, Yujuan; Bao, Yongping			Sulforaphane Protects the Liver against CdSe Quantum Dot-Induced Cytotoxicity	PLOS ONE			English	Article							MOUSE EMBRYONIC FIBROBLASTS; PROSTATE-CANCER CELLS; OXIDATIVE STRESS; CACO-2 CELLS; CHEMOPREVENTIVE AGENT; SIGNALING PATHWAYS; GENE-EXPRESSION; HUMAN HEPG2; GLUTATHIONE; AUTOPHAGY	The potential cytotoxicity of cadmium selenide (CdSe) quantum dots (QDs) presents a barrier to their use in biomedical imaging or as diagnostic and therapeutic agents. Sulforaphane (SFN) is a chemoprotective compound derived from cruciferous vegetables which can up-regulate antioxidant enzymes and induce apoptosis and autophagy. This study reports the effects of SFN on CdSe QD-induced cytotoxicity in immortalised human hepatocytes and in the livers of mice. CdSe QDs induced dose-dependent cell death in hepatocytes with an IC50 = 20.4 mu M. Pre-treatment with SFN (5 mu M) increased cell viability in response to CdSe QDs (20 mu M) from 49.5 to 89.3%. SFN induced a pro-oxidant effect characterized by depletion of intracellular reduced glutathione during short term exposure (3-6 h), followed by up-regulation of antioxidant enzymes and glutathione levels at 24 h. SFN also caused Nrf2 translocation into the nucleus, up-regulation of antioxidant enzymes and autophagy. siRNA knockdown of Nrf2 suggests that the Nrf2 pathway plays a role in the protection against CdSe QD-induced cell death. Wortmannin inhibition of SFN-induced autophagy significantly suppressed the protective effect of SFN on CdSe QD-induced cell death. Moreover, the role of autophagy in SFN protection against CdSe QD-induced cell death was confirmed using mouse embryonic fibroblasts lacking ATG5. CdSe QDs caused significant liver damage in mice, and this was decreased by SFN treatment. In conclusion, SFN attenuated the cytotoxicity of CdSe QDs in both human hepatocytes and in the mouse liver, and this protection was associated with the induction of Nrf2 pathway and autophagy.	[Wang, Wei; Yu, Guodong; Sexton, Darren W.; Wileman, Thomas; Bao, Yongping] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [He, Yan] Harbin Inst Technol, Dept Pathol, Harbin 150006, Heilongjiang, Peoples R China; [Li, Baolong] Heilongjiang Univ Chinese Med, Ctr Safety Evaluat Drugs, Harbin, Heilongjiang, Peoples R China; [Roberts, Alexandra A.; Hamilton, Chris J.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Liu, Ruoxi; Chao, Yimin] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; [Shan, Yujuan] Harbin Inst Technol, Sch Food Sci & Engn, Harbin 150006, Heilongjiang, Peoples R China	University of East Anglia; Harbin Institute of Technology; Heilongjiang University of Chinese Medicine; University of East Anglia; University of East Anglia; Harbin Institute of Technology	Shan, YJ (corresponding author), Harbin Inst Technol, Sch Food Sci & Engn, Harbin 150006, Heilongjiang, Peoples R China.	shanyujuan@hit.edu.cn; y.bao@uea.ac.uk	Chao, Yimin/A-4054-2008; Sexton, Darren/AAF-3171-2020; hamilton, chris/C-5651-2009; Bao, Yongping/A-6951-2010	Chao, Yimin/0000-0002-8488-2690; Bao, Yongping/0000-0002-6425-0370; Roberts, Alexandra/0000-0002-0705-1615; Sexton, Darren/0000-0003-3344-3150	Cancer Prevention Research Trust, UK; BBSRC, UK [BB/H013504/1]; National Natural Science Foundation, China [81101735]; Biotechnology and Biological Sciences Research Council [BB/H013504/1] Funding Source: researchfish; BBSRC [BB/H013504/1] Funding Source: UKRI	Cancer Prevention Research Trust, UK; BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was, in part, supported by awards from the Cancer Prevention Research Trust, UK, the BBSRC (BB/H013504/1), UK, and the National Natural Science Foundation, China (No 81101735).	Akhtar MJ, 2012, J TOXICOL SCI, V37, P139, DOI 10.2131/jts.37.139; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bacon JR, 2007, J AGR FOOD CHEM, V55, P1170, DOI 10.1021/jf062398+; Bacon JR, 2003, CARCINOGENESIS, V24, P1903, DOI 10.1093/carcin/bgg157; Bao YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114764; Barrera LN, 2012, BBA-MOL CELL RES, V1823, P1914, DOI 10.1016/j.bbamcr.2012.07.007; Basten GP, 2002, CARCINOGENESIS, V23, P1399, DOI 10.1093/carcin/23.8.1399; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Chiang HS, 2011, FREE RADICAL BIO MED, V51, P688, DOI 10.1016/j.freeradbiomed.2011.05.015; Chu MQ, 2012, BIOMATERIALS, V33, P7071, DOI 10.1016/j.biomaterials.2012.06.062; Clayton RF, 2005, LIVER INT, V25, P389, DOI 10.1111/j.1478-3231.2005.01017.x; Dashwood RH, 2006, CARCINOGENESIS, V27, P344, DOI 10.1093/carcin/bgi253; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Emmert SW, 2010, BIOORG MED CHEM LETT, V20, P2675, DOI 10.1016/j.bmcl.2010.01.044; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123, DOI 10.1080/10408398209527361; Gaona-Gaona L, 2011, TOXICOLOGY, V286, P20, DOI 10.1016/j.tox.2011.04.014; Gasper AV, 2005, AM J CLIN NUTR, V82, P1283, DOI 10.1093/ajcn/82.6.1283; Gibbs A, 2009, P NATL ACAD SCI USA, V106, P16663, DOI 10.1073/pnas.0908908106; Harris KE, 2008, J NUTR BIOCHEM, V19, P246, DOI 10.1016/j.jnutbio.2007.02.014; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hu R, 2004, J PHARMACOL EXP THER, V310, P263, DOI 10.1124/jpet.103.064261; Huber WW, 2007, CURR OPIN PHARMACOL, V7, P404, DOI 10.1016/j.coph.2007.05.005; Jackson SJT, 2004, CARCINOGENESIS, V25, P219, DOI 10.1093/carcin/bgg192; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanematsu S, 2010, ANTICANCER RES, V30, P3381; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Keum YS, 2005, DRUG NEWS PERSPECT, V18, P445, DOI 10.1358/dnp.2005.18.7.939350; Kim BR, 2003, CANCER RES, V63, P7520; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Li D, 2012, FOOD CHEM, V133, P300, DOI 10.1016/j.foodchem.2012.01.026; Li J., 2014, J ENG SCI TECHNOL, V7, P9, DOI DOI 10.1371/J0URNAL.P0NE.0100685; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035122; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; Lu YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093013; Mastrangelo L, 2008, CANCER RES, V68, P5487, DOI 10.1158/0008-5472.CAN-07-6171; McConnachie LA, 2013, NANOTOXICOLOGY, V7, P181, DOI 10.3109/17435390.2011.648224; Nagy A, 2012, ACS NANO, V6, P4748, DOI 10.1021/nn204886b; NEWTON GL, 1995, METHOD ENZYMOL, V251, P148, DOI 10.1016/0076-6879(95)51118-0; Ni T, 2002, J AM CHEM SOC, V124, P3980, DOI 10.1021/ja017149a; Nishikawa T, 2010, ANGIOGENESIS, V13, P227, DOI 10.1007/s10456-010-9180-2; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; OCHI T, 1988, CHEM-BIOL INTERACT, V65, P1, DOI 10.1016/0009-2797(88)90026-9; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Pelley JL, 2009, TOXICOL SCI, V112, P276, DOI 10.1093/toxsci/kfp188; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Ramirez MC, 2009, J NUTR BIOCHEM, V20, P195, DOI 10.1016/j.jnutbio.2008.02.002; Rikans LE, 2000, J BIOCHEM MOL TOXIC, V14, P110, DOI 10.1002/(SICI)1099-0461(2000)14:2<110::AID-JBT7>3.0.CO;2-J; Speciale A, 2011, CURR MOL MED, V11, P770, DOI 10.2174/156652411798062395; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Techapiesancharoenkij N, 2015, TOXICOL APPL PHARM, V282, P52, DOI 10.1016/j.taap.2014.11.004; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Wang FQ, 2012, NUTR RES, V32, P374, DOI 10.1016/j.nutres.2012.03.014; Wang Lin, 2008, Journal of Nanobiotechnology, V6, P11, DOI 10.1186/1477-3155-6-11; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 2005, FREE RADICAL BIO MED, V38, P70, DOI 10.1016/j.freeradbiomed.2004.09.033; Zhao JJ, 2013, ONCOTARGETS THER, V6, P303, DOI 10.2147/OTT.S38453	67	23	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138771	10.1371/journal.pone.0138771	http://dx.doi.org/10.1371/journal.pone.0138771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402917	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000361798100036
J	Bace, R; Svoboda, M; Janda, P; Morrissey, RC; Wild, J; Clear, JL; Cada, V; Donato, DC				Bace, Radek; Svoboda, Miroslav; Janda, Pavel; Morrissey, Robert C.; Wild, Jan; Clear, Jennifer L.; Cada, Vojtech; Donato, Daniel C.			Legacy of Pre-Disturbance Spatial Pattern Determines Early Structural Diversity following Severe Disturbance in Montane Spruce Forests	PLOS ONE			English	Article							MOUNTAIN NORWAY SPRUCE; SORBUS-AUCUPARIA L.; TREE-SEEDLING BANK; INTERSPECIFIC VARIATION; HEIGHT STRUCTURE; BOHEMIAN FOREST; ABIES FOREST; FIR FORESTS; REGENERATION; MORTALITY	Background Severe canopy-removing disturbances are native to many temperate forests and radically alter stand structure, but biotic legacies (surviving elements or patterns) can lend continuity to ecosystem function after such events. Poorly understood is the degree to which the structural complexity of an old-growth forest carries over to the next stand. We asked how pre-disturbance spatial pattern acts as a legacy to influence post-disturbance stand structure, and how this legacy influences the structural diversity within the early-seral stand. Methods Two stem-mapped one-hectare forest plots in the Czech Republic experienced a severe bark beetle outbreak, thus providing before-and-after data on spatial patterns in live and dead trees, crown projections, down logs, and herb cover. Results Post-disturbance stands were dominated by an advanced regeneration layer present before the disturbance. Both major species, Norway spruce (Picea abies) and rowan (Sorbus aucuparia), were strongly self-aggregated and also clustered to former canopy trees, pre-disturbance snags, stumps and logs, suggesting positive overstory to understory neighbourhood effects. Thus, although the disturbance dramatically reduced the stand's height profile with similar to 100% mortality of the canopy layer, the spatial structure of post-disturbance stands still closely reflected the pre-disturbance structure. The former upper tree layer influenced advanced regeneration through microsite and light limitation. Under formerly dense canopies, regeneration density was high but relatively homogeneous in height; while in former small gaps with greater herb cover, regeneration density was lower but with greater heterogeneity in heights. Conclusion These findings suggest that pre-disturbance spatial patterns of forests can persist through severe canopy-removing disturbance, and determine the spatial structure of the succeeding stand. Such patterns constitute a subtle but key legacy effect, promoting structural complexity in early-seral forests as well as variable successional pathways and rates. This influence suggests a continuity in spatial ecosystem structure that may well persist through multiple forest generations.	[Bace, Radek; Svoboda, Miroslav; Janda, Pavel; Morrissey, Robert C.; Clear, Jennifer L.; Cada, Vojtech; Donato, Daniel C.] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Ecol, Prague, Czech Republic; [Wild, Jan] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Wild, Jan] Czech Univ Life Sci, Fac Environm Sci, Dept Appl Geoinformat & Spatial Planning, Prague, Czech Republic; [Donato, Daniel C.] Washington State Dept Nat Resources, Olympia, WA USA	Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Bace, R (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Ecol, Prague, Czech Republic.	bace@fld.czu.cz	Wild, Jan/G-2380-2010; Bace, Radek/N-2228-2014; Chen, Han YH/A-1359-2008; Svoboda, Miroslav/E-6860-2010; Janda, Pavel/F-1190-2017; Bače, Radek/AAI-2200-2021; Čada, Vojtěch/J-4726-2019	Wild, Jan/0000-0003-3007-4070; Chen, Han YH/0000-0001-9477-5541; Svoboda, Miroslav/0000-0003-4050-3422; Janda, Pavel/0000-0003-4732-6908; Bače, Radek/0000-0001-6872-1355; Čada, Vojtěch/0000-0002-3922-2108; Clear, Jennifer/0000-0002-7588-2576	project Czech Science Foundation (GACR) [P504/12/1218]; Ministry of Finance of the Czech Republic, Norway [EHP-CZ02-OV-1-019-2014]; ESF [CZ.1.07/2.3.00/30.0040]; long-term research development project [RVO67985939]; Czech University of Life Sciences, Prague [20154309]	project Czech Science Foundation (GACR); Ministry of Finance of the Czech Republic, Norway; ESF(European Commission); long-term research development project; Czech University of Life Sciences, Prague	This work was supported by project Czech Science Foundation (GACR) number P504/12/1218. RB, PJ and RCM were supported by Ministry of Finance of the Czech Republic, Norway grant "Frameworks and possibilities of forest adaptation measures and strategies connected with climate change" No. EHP-CZ02-OV-1-019-2014. RB and MS were supported also by ESF a MSMT number CZ.1.07/2.3.00/30.0040. JW was supported by long-term research development project no. RVO67985939. JLC and VC were supported by the Czech University of Life Sciences, Prague (Project CIGA No. 20154309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos JA, 2000, AM MIDL NAT, V143, P342, DOI 10.1674/0003-0031(2000)143[0342:ASAGOT]2.0.CO;2; Asselin H, 2001, FOREST ECOL MANAG, V140, P29, DOI 10.1016/S0378-1127(00)00273-5; Bace R., 2009, SILVA GABRETA, V15, P67; Bace R, 2014, REP FOR RES, V59, P140; Bace R, 2011, SILVA FENN, V45, P1065, DOI 10.14214/sf.87; Baddeley A, 2012, STAT INTERFACE, V5, P221; Baddeley AJ, 2004, SPATSTAT R PACKAGE A; Bassler C, 2010, FUNGAL BIOL-UK, V114, P129, DOI 10.1016/j.funbio.2009.11.001; Boggs K, 2008, FOREST ECOL MANAG, V255, P3571, DOI 10.1016/j.foreco.2008.02.039; Cada V, 2013, FOREST ECOL MANAG, V295, P59, DOI 10.1016/j.foreco.2012.12.037; Canham CD, 2001, CAN J FOREST RES, V31, P1, DOI 10.1139/cjfr-31-1-1; DeRose RJ, 2010, J VEG SCI, V21, P377, DOI 10.1111/j.1654-1103.2009.01150.x; Diggle P., 2003, STAT ANAL SPATIAL PO; Donato DC, 2012, J VEG SCI, V23, P576, DOI 10.1111/j.1654-1103.2011.01362.x; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Frelich LE, 1999, ECOSYSTEMS, V2, P151, DOI 10.1007/s100219900066; George Lisa O., 2003, P265; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Holeksa J, 2005, EKOL BRATISLAVA, V24, P263; Holeksa J, 2003, PLANT ECOL, V168, P57, DOI 10.1023/A:1024457303815; Ilisson T, 2009, J VEG SCI, V20, P735, DOI 10.1111/j.1654-1103.2009.01066.x; Janda P, 2014, FOREST ECOL MANAG, V330, P304, DOI 10.1016/j.foreco.2014.06.041; Kane VR, 2013, REMOTE SENS ENV; Kashian DM, 2011, CAN J FOREST RES, V41, P2403, DOI [10.1139/X11-142, 10.1139/x11-142]; Kashian DM, 2005, ECOLOGY, V86, P643, DOI 10.1890/03-0828; Kayes LJ, 2012, FOREST ECOL MANAG, V263, P57, DOI 10.1016/j.foreco.2011.09.035; Kobe RK, 1997, CAN J FOREST RES, V27, P227, DOI 10.1139/cjfr-27-2-227; Kopacek J, 2002, SILVA GABRETA, V8, P43, DOI DOI 10.1111/J.1469-8137.2007.02342.X; Krasowski MJ, 1996, NEW FOREST, V12, P261; Kwit C, 2003, ECOLOGY, V84, P2575, DOI 10.1890/02-3130; Lausch A, 2011, FOREST ECOL MANAG, V261, P233, DOI 10.1016/j.foreco.2010.10.012; Lehnert LW, 2013, J NAT CONSERV, V21, P97, DOI 10.1016/j.jnc.2012.11.003; Lorente M, 2013, PLANT SOIL, V364, P39, DOI 10.1007/s11104-012-1331-3; Lutz JA, 2014, ECOLOGY, V95, P2047, DOI 10.1890/14-0157.1; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; Mezei P, 2014, FOREST ECOL MANAG, V331, P196, DOI 10.1016/j.foreco.2014.07.031; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Motta R, 2003, FOREST ECOL MANAG, V181, P139, DOI 10.1016/S0378-1127(03)00128-2; Nagel TA, 2006, FOREST ECOL MANAG, V226, P268, DOI 10.1016/j.foreco.2006.01.039; Neuhaslova Z, 2003, SILVA GABRETA, V9, P81; Novakova MH, 2015, FOREST ECOL MANAG, V344, P120, DOI 10.1016/j.foreco.2015.02.010; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Panayotov M, 2011, FOREST ECOL MANAG, V262, P470, DOI 10.1016/j.foreco.2011.04.013; Rich RL, 2007, J ECOL, V95, P1261, DOI 10.1111/j.1365-2745.2007.01301.x; Romme WH, 1998, ECOSYSTEMS, V1, P524, DOI 10.1007/s100219900048; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Seidl R, 2007, ECOL MODEL, V206, P383, DOI 10.1016/j.ecolmodel.2007.04.002; Seidl R, 2011, GLOBAL CHANGE BIOL, V17, P2842, DOI 10.1111/j.1365-2486.2011.02452.x; Sherriff RL, 2011, ECOLOGY, V92, P1459, DOI 10.1890/10-1118.1; Suzuki SN, 2013, J FOREST RES-JPN, V18, P139, DOI 10.1007/s10310-011-0331-0; Svoboda M, 2014, J VEG SCI, V25, P386, DOI 10.1111/jvs.12109; Svoboda M, 2012, J VEG SCI, V23, P86, DOI 10.1111/j.1654-1103.2011.01329.x; Svoboda M, 2010, FOREST ECOL MANAG, V260, P707, DOI 10.1016/j.foreco.2010.05.027; Swanson ME, 2014, FOREST ECOL MANAG, V324, P160, DOI 10.1016/j.foreco.2014.03.046; Trotsiuk V, 2014, FOREST ECOL MANAG, V334, P144, DOI 10.1016/j.foreco.2014.09.005; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; White PS, 2011, MANAG FOR ECOSYST, V21, P27, DOI 10.1007/978-94-007-1620-9_3; Wiegand T., 2013, HDB SPATIAL POINT PA; Wild J, 2014, J VEG SCI, V25, P1327, DOI 10.1111/jvs.12189; Winter MB, 2015, FOREST ECOL MANAG, V338, P32, DOI 10.1016/j.foreco.2014.11.019; Zywiec M, 2008, PLANT ECOL, V194, P283, DOI 10.1007/s11258-007-9291-z; Zywiec M, 2013, OECOLOGIA, V172, P461, DOI 10.1007/s00442-012-2502-x	62	29	30	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139214	10.1371/journal.pone.0139214	http://dx.doi.org/10.1371/journal.pone.0139214			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421726	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700080
J	Lemma, MT; Zenebe, Y; Tulu, B; Mekonnen, D; Mekonnen, Z				Lemma, Martha Tibebu; Zenebe, Yohannes; Tulu, Begna; Mekonnen, Daniel; Mekonnen, Zewdie			Methicillin Resistant Staphylococcus aureus among HIV Infected Pediatric Patients in Northwest Ethiopia: Carriage Rates and Antibiotic Co-Resistance Profiles	PLOS ONE			English	Article							NASOPHARYNGEAL BACTERIAL-COLONIZATION; SOFT-TISSUE INFECTION; NASAL CARRIAGE; STREPTOCOCCUS-PNEUMONIAE; PREVIOUS HOSPITALIZATION; POSITIVE CHILDREN; HIGH PREVALENCE; RISK-FACTORS; EPIDEMIOLOGY; BACTEREMIA	Background MRSA infections are becoming more prevalent throughout the HIV community. MRSA infections are a challenge to both physicians and patients due to limited choice of therapeutic options and increased cost of care. Objectives This study was aimed to determine the prevalence of colonization and co-resistance patterns of MRSA species among HIV positive pediatric patients in the Amhara National Regional State, Northwest Ethiopia. Methods Culture swabs were collected from the anterior nares, the skin and the perineum of 400 participants. In vitro antimicrobial susceptibility testing was done on Muller Hinton Agar by the Kirby-Bauer disk diffusion method, using 30 mu g cefoxitin (OXOID, ENGLAND) according to the recommendations of the Clinical and Laboratory Standards Institute. Methicillin sensitivity/resistance was tested using cefoxitin. Data was analyzed by descriptive statistics and logistic regression model using Epi Info 7. Results S. aureus was detected in 206 participants (51.5%). The prevalence of MRSA colonization in this study was 16.8%. Colonization by S. aureus was associated with male gender (OR = 0.5869; 95% CI: 0.3812-0.9036; p-value = 0.0155), history of antibiotic use over the previous 3 months (OR = 2.3126; 95% CI: 1.0707-4.9948; p-value = 0.0329) and having CD4 T-cell counts of more than 350 x 10(6) cells / L (OR = 0.5739; 95% CI = 0.3343-0.9851; p-value = 0.0440). Colonization by MRSA was not associated with any one of the variables. Concomitant resistance of the MRSA to clindamycin, chloramphenicol, co-trimoxazole, ceftriaxone, erythromycin and tetracycline was 7.6%, 6%, 5.25%, 20.9%, 23.9% and 72.1%, respectively. Conclusion High rates of colonization by pathogenic MRSA strains is observed among HIV positive pediatric patients in the Amhara National Regional state.	[Lemma, Martha Tibebu; Zenebe, Yohannes; Tulu, Begna; Mekonnen, Daniel] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Microbiol Immunol & Parasitol, Bahir Dar, Ethiopia; [Mekonnen, Zewdie] Bahir Dar Univ, Dept Biochem, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Tulu, Begna; Mekonnen, Daniel; Mekonnen, Zewdie] Bahir Dar Univ, Biotechnol Res Inst, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University; Bahir Dar University	Lemma, MT (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Microbiol Immunol & Parasitol, Bahir Dar, Ethiopia.	marthatib@hotmail.com	Tulu, Begna/R-6762-2019	Tulu, Begna/0000-0003-1341-9559; chekol, yohannes zenebe/0000-0003-4522-4481	Research and Community Service Office of Bahir Dar University	Research and Community Service Office of Bahir Dar University	This study was granted by the Research and Community Service Office of Bahir Dar University (http://www.bdu.edu.et/) under the watchful eye of the "Biotechnology Research Institute" of Bahir Dar University. MTL and YZC received the funding and submitted progress reports to the Biotechnology Institute as per the agreement.	Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Chen AE, 2006, PEDIATR EMERG CARE, V22, P717, DOI 10.1097/01.pec.0000236832.23947.a0; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; D'Avila NEM, 2008, J TROP PEDIATRICS, V54, P410, DOI 10.1093/tropej/fmn051; Das Bhattacharya S, 2012, INDIAN J PEDIATR, V79, P1447, DOI 10.1007/s12098-012-0762-4; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Dietrich DW, 2004, PEDIATRICS, V113, pE347, DOI 10.1542/peds.113.4.e347; Drapeau CMJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-36; Federal Ministry of Health of Ethiopia, 2007, ETH 4 NAT HLTH ACC; Fergie JE, 2001, PEDIATR INFECT DIS J, V20, P860, DOI 10.1097/00006454-200109000-00007; Groome MJ, 2012, PAEDIATR INT CHILD H, V32, P140, DOI 10.1179/1465328111Y.0000000044; HERWALDT LA, 1999, AM J MED, V106, P11, DOI DOI 10.1016/S0002-9343(98)00350-7; Joore IKCW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002505; Kinabo GD, 2013, TROP MED INT HEALTH, V18, P286, DOI 10.1111/tmi.12057; Klevens RM, 2006, EMERG INFECT DIS, V12, P1991; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Krcmery V, 2013, TROP MED INT HEALTH, V18, P1267, DOI 10.1111/tmi.12178; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; McNally LM, 2006, J INFECT DIS, V194, P385, DOI 10.1086/505076; McNeil JC, 2012, PEDIATR INFECT DIS J, V31, P284, DOI 10.1097/INF.0b013e318239c1fe; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nguyen MH, 1999, ANN INTERN MED, V130, P221, DOI 10.7326/0003-4819-130-3-199902020-00026; Onorato M, 1999, INFECT CONT HOSP EP, V20, P26, DOI 10.1086/501556; Parras F, 1991, Enferm Infecc Microbiol Clin, V9, P200; Popovich KJ, 2010, CLIN INFECT DIS, V50, P979, DOI 10.1086/651076; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Santoro-Lopes G, 2005, LIVER TRANSPLANT, V11, P203, DOI 10.1002/lt.20338; Shet A, 2009, J INFECT DIS, V200, P88, DOI 10.1086/599315; Srinivasan A, 2009, AIDS RES HUM RETROV, V25, P1219, DOI 10.1089/aid.2009.0040; Szumowski JD, 2009, CLIN INFECT DIS, V49, P118, DOI 10.1086/599608; Warshawsky B, 2000, INFECT CONT HOSP EP, V21, P724, DOI 10.1086/501718; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	34	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137254	10.1371/journal.pone.0137254	http://dx.doi.org/10.1371/journal.pone.0137254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421927	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700012
J	Marlow, CA; Viskontas, IV; Matlin, A; Boydston, C; Boxer, A; Taylor, RP				Marlow, Colleen A.; Viskontas, Indre V.; Matlin, Alisa; Boydston, Cooper; Boxer, Adam; Taylor, Richard P.			Temporal Structure of Human Gaze Dynamics Is Invariant During Free Viewing	PLOS ONE			English	Article							NATURAL IMAGES; SPECTRA; STATISTICS	We investigate the dynamic structure of human gaze and present an experimental study of the frequency components of the change in gaze position over time during free viewing of computer-generated fractal images. We show that changes in gaze position are scale-invariant in time with statistical properties that are characteristic of a random walk process. We quantify and track changes in the temporal structure using a well-defined scaling parameter called the Hurst exponent, H. We find H is robust regardless of the spatial complexity generated by the fractal images. In addition, we find the Hurst exponent is invariant across all participants, including those with distinct changes to higher order visual processes due to neural degeneration. The value we find for H of 0.57 shows that the gaze dynamics during free viewing of fractal images are consistent with a random walk process with persistent movements. Our research suggests the human visual system may have a common strategy that drives the dynamics of human gaze during exploration.	[Marlow, Colleen A.] Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Marlow, Colleen A.] Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93407 USA; [Viskontas, Indre V.; Matlin, Alisa; Boxer, Adam] Univ Calif San Francisco, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Boydston, Cooper; Taylor, Richard P.] Univ Oregon, Dept Phys, Eugene, OR 97403 USA	University of California System; University of California San Francisco; California State University System; California Polytechnic State University San Luis Obispo; University of California System; University of California San Francisco; University of Oregon	Marlow, CA (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	camarlow@calpoly.edu	Malo, Jesus/K-9235-2017; Taylor, Richard P/P-9908-2016	Malo, Jesus/0000-0002-5684-8591; Taylor, Richard/0000-0002-5248-4524	National Institutes of Health [5 P20 GM103430-13]; A. Boxer's National Institutes of Health [R01AG038791, R01AG031278, P01AG019724]; Tau Research Consortium; Institutional Development Award (IDeA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS092089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031278, P01AG019724, R01AG038791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A. Boxer's National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tau Research Consortium; Institutional Development Award (IDeA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	C. A. Marlow was funded as a Sloan-Swartz Fellow during the data collection phase of this work and during the analysis phase by the Institutional Development Award (IDeA) from the National Institutes of Health under grant number 5 P20 GM103430-13. The experiment was funded through A. Boxer's National Institutes of Health grants, R01AG038791, R01AG031278, P01AG019724 and the Tau Research Consortium. Swartz Foundation: http://www.theswartzfoundation.org/research_a.asp, Institutional Development Award (IDeA) from the National Institutes of Health: http://web.uri.edu/inbre/ri-inbre/about-ri-inbre/, National Institutes of Health: http://www.nih.gov/, and Tau Research Consortium: http://tauconsortium.org/research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aks D.J., 1996, EMPIR STUD ARTS, V14, P1, DOI [10.2190/6V31-7M9R-T9L5-CDG9, DOI 10.2190/6V31-7M9R-T9L5-CDG9, 10.2190/6v31-7m9r-t9l5-cdg9]; Avnir D, 1998, SCIENCE, V279, P39, DOI 10.1126/science.279.5347.39; Billock VA, 2000, PHYSICA D, V137, P379, DOI 10.1016/S0167-2789(99)00197-9; Billock VA, 2001, PHYSICA D, V148, P136, DOI 10.1016/S0167-2789(00)00174-3; Boccignone G, 2004, PHYSICA A, V331, P207, DOI 10.1016/j.physa.2003.09.011; Boccignone G, 2014, IEEE T CYBERNETICS, V44, P266, DOI 10.1109/TCYB.2013.2253460; Boxer AL, 2012, ARCH NEUROL-CHICAGO, V69, P509, DOI 10.1001/archneurol.2011.1021; Brockmann D, 2000, NEUROCOMPUTING, V32, P643, DOI 10.1016/S0925-2312(00)00227-7; Credidio HF, 2012, SCI REP-UK, V2, DOI 10.1038/srep00920; CUTTING JE, 1987, PERCEPT PSYCHOPHYS, V42, P365, DOI 10.3758/BF03203093; DUBUC B, 1989, PHYS REV A, V39, P1500, DOI 10.1103/PhysRevA.39.1500; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; Engbert R, 2011, P NATL ACAD SCI USA, V108, pE765, DOI 10.1073/pnas.1102730108; Fairbanks M., 2011, NONLINEAR DYNAMICAL, P341, DOI [10.1201/9781439820025, DOI 10.1201/9781439820025]; Field DJ, 1997, VISION RES, V37, P3367, DOI 10.1016/S0042-6989(97)00181-8; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Hagerhall CM, 2015, NONLIN DYNAM PSYCHOL, V19, P1; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Ko PC, 2011, CLIN SPECTRUM ALZHEI; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Liang JR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031909; Mergenthaler K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.138104; Otero-Millan J, 2013, P NATL ACAD SCI USA, V110, P6175, DOI 10.1073/pnas.1222715110; Redies C, 2008, SPATIAL VISION, V21, P97, DOI 10.1163/156856808782713780; Rizzo M, 2000, NEUROPSYCHOLOGIA, V38, P1157, DOI 10.1016/S0028-3932(00)00023-3; Rogowitz B. E., 1990, P SPIE, V1249; Rucci M, 2015, TRENDS NEUROSCI, V38, P195, DOI 10.1016/j.tins.2015.01.005; Shinde DP, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/68001; Spehar B, 2003, COMPUT GRAPH-UK, V27, P813, DOI 10.1016/S0097-8493(03)00154-7; Stephen DG, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056114; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Taylor R. P., 2005, NONLINEAR DYNAMICS P, V12, P89; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Viskontas IV, 2011, NEUROPSYCHOLOGIA, V49, P468, DOI 10.1016/j.neuropsychologia.2010.12.039; Viskontas IV, 2009, BEHAV NEUROLOGY DEME, P45; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139379	10.1371/journal.pone.0139379	http://dx.doi.org/10.1371/journal.pone.0139379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421613	Green Published, gold			2022-12-27	WOS:000362175700107
J	Riessen, R; Behmenburg, M; Blumenstock, G; Guenon, D; Enkel, S; Schafer, R; Haap, M				Riessen, Reimer; Behmenburg, Melanie; Blumenstock, Gunnar; Guenon, Doris; Enkel, Sigrid; Schaefer, Richard; Haap, Michael			A Simple "Blood-Saving Bundle" Reduces Diagnostic Blood Loss and the Transfusion Rate in Mechanically Ventilated Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; CONSERVATION DEVICE; CELL TRANSFUSION; ANEMIA; REQUIREMENTS; SYSTEM; LINE	Introduction Aim of this study was to reduce blood loss caused by diagnostic blood sampling and to minimize the development of anemia in a high-risk group of mechanically ventilated medical intensive care patients. We therefore implemented a "blood-saving bundle" (BSB) combining a closed-loop arterial blood sampling system, smaller sampling tubes, reduced frequency of blood drawings, and reduced sample numbers. Methods The study included all patients from our medical ICU who were ventilated for more than 72 hours. Exclusion criteria were: acute or chronic anemia on admission, bleeding episode(s) during the ICU stay, or end-of-life therapy. The BSB was introduced in 2009 with training and educational support. Patients treated in 2008, before the introduction of the BSB, served as a control group (n = 41, 617 observation days), and were compared with patients treated in 2010 after the introduction of the BSB (BSB group, n = 50, 559 observation days). Primary endpoints were blood loss per day, and development of anemia. Secondary endpoints were numbers of blood transfusions, number of days on mechanical ventilation, and length of the ICU stay. Results Mean blood loss per ICU day was decreased from 43.3 ml (95% CI: 41.2 to 45.3 ml) in the controls to 15.0 ml (14.3 to 15.7 ml) in the BSB group (P < 0.001). The introduction of a closed-loop arterial blood sampling system was the major contributor to this effect. Mean hemoglobin concentrations showed no significant differences in both groups during the ICU stay. Hemoglobin values < 9 g/dl, however, were recorded in 21.2% of observation days in the controls versus 15.4% in the BSB group (P = 0.01). Units of transfused red blood cells per 100 observation days decreased from 7 to 2.3 (P < 0.001). The mean number of ventilation days was 7.1 days (6.1 to 8.3 days) in the controls and 7.5 days (6.6 to 8.5 days) in the BSB group (P = NS). In total, patients in the BSB group stayed in ICU for a mean of 9.9 days (8.6 to 11.3 days), compared to a mean ICU stay of 13.0 days (10.9 to 15.4 days) in the control group (P = 0.014). Due to the longitudinal study design, however, we cannot exclude uncontrolled confounders affecting the transfusion frequency and mean ICU stay. Conclusion Our BSB could be easily implemented and was able to reduce diagnostic blood loss.	[Riessen, Reimer; Behmenburg, Melanie; Haap, Michael] Univ Tubingen, Dept Internal Med, Med Intens Care Unit, Tubingen, Germany; [Blumenstock, Gunnar; Guenon, Doris] Univ Tubingen, Dept Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Enkel, Sigrid] Univ Tubingen, Clin Transfus Med, Tubingen, Germany; [Schaefer, Richard] German Red Cross Blood Donor Serv Baden Wurttembe, Johann Wolfgang Goethe Univ Hosp, Inst Transfus Med & Immunohaematol, Frankfurt, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Riessen, R (corresponding author), Univ Tubingen, Dept Internal Med, Med Intens Care Unit, Tubingen, Germany.	reimer.riessen@med.uni-tuebingen.de	Riessen, Reimer/AFR-0686-2022					Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Fowler RA, 2003, CRIT CARE MED, V31, pS715, DOI 10.1097/01.CCM.0000099350.50651.46; Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9; Hendrickson JE, 2009, ANESTH ANALG, V108, P759, DOI 10.1213/ane.0b013e3181930a6e; Leal-Noval SR, 2013, INTENS CARE MED, V39, P445, DOI 10.1007/s00134-012-2757-z; Lelubre C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-43; MacIsaac CM, 2003, ANAESTH INTENS CARE, V31, P653, DOI 10.1177/0310057X0303100607; Mahdy Saad, 2009, Middle East Journal of Anesthesiology, V20, P219; Mudumbai SC, 2011, TRANSFUSION, V51, P2148, DOI 10.1111/j.1537-2995.2011.03134.x; Mukhopadhyay A, 2011, ANAESTH INTENS CARE, V39, P426, DOI 10.1177/0310057X1103900313; Mukhopadhyay A, 2010, CRIT CARE, V14, DOI 10.1186/cc8859; Page C, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-14; PERUZZI WT, 1993, CRIT CARE MED, V21, P501, DOI 10.1097/00003246-199304000-00007; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Shander A, 2004, CRIT CARE CLIN, V20, P159, DOI 10.1016/j.ccc.2004.01.002; SILVER MJ, 1993, CHEST, V104, P1711, DOI 10.1378/chest.104.6.1711; SMOLLER BR, 1989, AM J CLIN PATHOL, V91, P701, DOI 10.1093/ajcp/91.6.701; Thorpe S, 2000, ANAESTHESIA, V55, P27, DOI 10.1046/j.1365-2044.2000.01129.x; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; von Ahsen N, 1999, CRIT CARE MED, V27, P2630, DOI 10.1097/00003246-199912000-00005; Walsh TS, 2004, TRANSFUSION, V44, P1405, DOI 10.1111/j.1537-2995.2004.04085.x	22	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138879	10.1371/journal.pone.0138879	http://dx.doi.org/10.1371/journal.pone.0138879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421920	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700054
J	Saleem, S; Teal, PD; Kleijn, WB; O'Donnell, T; Witter, T; Tzeng, YC				Saleem, Saqib; Teal, Paul D.; Kleijn, W. Bastiaan; O'Donnell, Terrence; Witter, Trevor; Tzeng, Yu-Chieh			Non-Linear Characterisation of Cerebral Pressure-Flow Dynamics in Humans	PLOS ONE			English	Article							BLOOD-PRESSURE; SPONTANEOUS FLUCTUATIONS; AUTOREGULATION; RESPONSES; INSIGHTS; VELOCITY; SYSTEMS	Cerebral metabolism is critically dependent on the regulation of cerebral blood flow (CBF), so it would be expected that vascular mechanisms that play a critical role in CBF regulation would be tightly conserved across individuals. However, the relationships between blood pressure (BP) and cerebral blood velocity fluctuations exhibit inter-individual variations consistent with heterogeneity in the integrity of CBF regulating systems. Here we sought to determine the nature and consistency of dynamic cerebral autoregulation (dCA) during the application of oscillatory lower body negative pressure (OLBNP). In 18 volunteers we recorded BP and middle cerebral artery blood flow velocity (MCAv) and examined the relationships between BP and MCAv fluctuations during 0.03, 0.05 and 0.07Hz OLBNP. dCA was characterised using project pursuit regression (PPR) and locally weighted scatterplot smoother (LOWESS) plots. Additionally, we proposed a piecewise regression method to statistically determine the presence of a dCA curve, which was defined as the presence of a restricted autoregulatory plateau shouldered by pressure-passive regions. Results show that LOWESS has similar explanatory power to that of PPR. However, we observed heterogeneous patterns of dynamic BP-MCAv relations with few individuals demonstrating clear evidence of a dCA central plateau. Thus, although BP explains a significant proportion of variance, dCA does not manifest as any single characteristic BP-MCAv function.	[Saleem, Saqib; Teal, Paul D.; Kleijn, W. Bastiaan] Victoria Univ Wellington, Sch Engn & Comp Sci, Wellington, New Zealand; [Saleem, Saqib; O'Donnell, Terrence; Witter, Trevor; Tzeng, Yu-Chieh] Univ Otago, Ctr Translat Physiol, Cardiovasc Syst Lab, Wellington, New Zealand	Victoria University Wellington; University of Otago	Tzeng, YC (corresponding author), Univ Otago, Ctr Translat Physiol, Cardiovasc Syst Lab, Wellington, New Zealand.	shieak.tzeng@otago.ac.nz	Saleem, Saqib/M-4377-2016	Kleijn, W./0000-0002-1973-3920; Teal, Paul/0000-0002-6111-6280	Wellington Medical Research Foundation [2013/227]	Wellington Medical Research Foundation	YT holds the New Zealand Health Research Council Sir Charles Hercus Fellowship (Ref 09/186). This study was supported by funds from Wellington Medical Research Foundation (Ref 2013/227) awarded to YT.	Angarita-Jaimes N, 2011, BIOSIGNALS 2011, P251; Bashtannyk DM, 2001, COMPUT STAT DATA AN, V36, P279, DOI 10.1016/S0167-9473(00)00046-3; Baumert M, 2005, FLUCT NOISE LETT, V5, pL549, DOI 10.1142/S0219477505003002; Clarke D., 1999, BASIC NEUROCHEMISTRY; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; FRIEDMAN JH, 1974, IEEE T COMPUT, VC 23, P881, DOI 10.1109/T-C.1974.224051; FRIEDMAN JH, 1981, J AM STAT ASSOC, V76, P817, DOI 10.2307/2287576; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hamner JW, 2010, STROKE, V41, P102, DOI 10.1161/STROKEAHA.109.557132; Hamner JW, 2004, J PHYSIOL-LONDON, V559, P965, DOI 10.1113/jphysiol.2004.066969; HOLLENBERG NK, 1984, HYPERTENSION, V6, P579, DOI 10.1161/01.HYP.6.4.579; Hu K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002601; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; Maggio P, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.280; Marmarelis VZ, 2013, ANN BIOMED ENG, V41, P1029, DOI 10.1007/s10439-012-0736-8; MARMARELIS VZ, 1993, ANN BIOMED ENG, V21, P573, DOI 10.1007/BF02368639; Marmarelis VZ, 2004, NONLINEAR DYNAMIC MO; Martinez WL., 2002, COMPUTATIONAL STAT H; Mitsis GD, 2002, ANN BIOMED ENG, V30, P555, DOI 10.1114/1.1477448; Navidi W.C, 2008, STAT ENG SCI; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; OMBONI S, 1993, HYPERTENSION, V22, P26, DOI 10.1161/01.HYP.22.1.26; Panerai RB, 2010, J APPL PHYSIOL, V109, P1860, DOI 10.1152/japplphysiol.00857.2010; Panerai RB, 1998, MED BIOL ENG COMPUT, V36, P315, DOI 10.1007/BF02522477; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Salinet ASM, 2015, J APPL PHYSIOL, V118, P170, DOI 10.1152/japplphysiol.00620.2014; SCHWETLICK H, 1995, BIT, V35, P361, DOI 10.1007/BF01732610; Simpson DM, 2008, P 4 IET INT C ADV ME; Tan CO, 2013, J PHYSIOL-LONDON, V591, P5095, DOI 10.1113/jphysiol.2013.259747; Tan CO, 2012, J APPL PHYSIOL, V113, P1194, DOI 10.1152/japplphysiol.00783.2012; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tzeng YC, 2014, J APPL PHYSIOL, V117, P1037, DOI 10.1152/japplphysiol.00366.2014; Tzeng YC, 2012, AM J PHYSIOL-HEART C, V303, pH658, DOI 10.1152/ajpheart.00328.2012; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; Tzeng YC, 2011, J PHYSIOL-LONDON, V589, P3263, DOI 10.1113/jphysiol.2011.206953; Zhang R, 1998, J APPL PHYSIOL, V85, P1113, DOI 10.1152/jappl.1998.85.3.1113; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhang R, 2009, J PHYSIOL-LONDON, V587, P2567, DOI 10.1113/jphysiol.2008.168302	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139470	10.1371/journal.pone.0139470	http://dx.doi.org/10.1371/journal.pone.0139470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421429	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700120
J	Alleva, JM; Sheeran, P; Webb, TL; Martijn, C; Miles, E				Alleva, Jessica M.; Sheeran, Paschal; Webb, Thomas L.; Martijn, Carolien; Miles, Eleanor			A Meta-Analytic Review of Stand-Alone Interventions to Improve Body Image	PLOS ONE			English	Article							PHYSICAL SELF-PERCEPTIONS; PUBLICATION BIAS; SOCIOCULTURAL ATTITUDES; CONTROLLED-TRIALS; ADOLESCENT GIRLS; ESTEEM SCALE; VALIDATION; APPEARANCE; DISSATISFACTION; QUESTIONNAIRE	Objective Numerous stand-alone interventions to improve body image have been developed. The present review used meta-analysis to estimate the effectiveness of such interventions, and to identify the specific change techniques that lead to improvement in body image. Methods The inclusion criteria were that (a) the intervention was stand-alone (i.e., solely focused on improving body image), (b) a control group was used, (c) participants were randomly assigned to conditions, and (d) at least one pretest and one posttest measure of body image was taken. Effect sizes were meta-analysed and moderator analyses were conducted. A taxonomy of 48 change techniques used in interventions targeted at body image was developed; all interventions were coded using this taxonomy. Results The literature search identified 62 tests of interventions (N = 3,846). Interventions produced a small-to-medium improvement in body image (d(+) = 0.38), a small-to-medium reduction in beauty ideal internalisation (d(+) = -0.37), and a large reduction in social comparison tendencies (d(+) = -0.72). However, the effect size for body image was inflated by bias both within and across studies, and was reliable but of small magnitude once corrections for bias were applied. Effect sizes for the other outcomes were no longer reliable once corrections for bias were applied. Several features of the sample, intervention, and methodology moderated intervention effects. Twelve change techniques were associated with improvements in body image, and three techniques were contra-indicated. Conclusions The findings show that interventions engender only small improvements in body image, and underline the need for large-scale, high-quality trials in this area. The review identifies effective techniques that could be deployed in future interventions.	[Alleva, Jessica M.; Martijn, Carolien] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands; [Sheeran, Paschal] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC USA; [Webb, Thomas L.] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Miles, Eleanor] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	Maastricht University; University of North Carolina; University of North Carolina Chapel Hill; University of Sheffield; University of Sussex	Alleva, JM (corresponding author), Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands.	Jessica.alleva@maastrichtuniversity.nl	Sheeran, Paschal/Y-3370-2019; Webb, Thomas/E-8946-2010	Webb, Thomas/0000-0001-9320-0068; Miles, Eleanor/0000-0002-8375-4638	NWO (The Netherlands Organisation for Scientific Research) [404-10-118]	NWO (The Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	The contribution of JMA was supported by NWO (The Netherlands Organisation for Scientific Research; www.nwo.nl) grant 404-10-118: Novel strategies to enhance body satisfaction, awarded to CM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Albertson ER, 2015, MINDFULNESS, V6, P444, DOI 10.1007/s12671-014-0277-3; Alleva JM, 2016, J BEHAV THER EXP PSY, V50, P33, DOI 10.1016/j.jbtep.2015.04.012; [Anonymous], HDB RES METHODS SOCI; Arroyo A, 2012, J APPL COMMUN RES, V40, P167, DOI 10.1080/00909882.2012.654500; Aspen V, 2015, BEHAV RES THER, V69, P93, DOI 10.1016/j.brat.2015.04.003; Avalos Laura, 2005, Body Image, V2, P285, DOI 10.1016/j.bodyim.2005.06.002; BARNARD PJ, 1991, COGNITION EMOTION, V5, P1, DOI 10.1080/02699939108411021; Bennett-Levy J, 2003, BEHAV COGN PSYCHOTH, V31, P261, DOI 10.1017/S1352465803003035; BENTOVIM DI, 1991, PSYCHOL MED, V21, P775, DOI 10.1017/S0033291700022406; BERSCHEID E, 1973, PSYCHOL TODAY, V7, P119; Blashill AJ, 2015, HEALTH PSYCHOL, V34, P93, DOI 10.1037/hea0000100; BROWN TA, 1990, J PERS ASSESS, V55, P135, DOI 10.1207/s15327752jpa5501&2_13; BUTTERS JW, 1987, J CONSULT CLIN PSYCH, V55, P889, DOI 10.1037/0022-006X.55.6.889; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Cafri G, 2005, CLIN PSYCHOL-SCI PR, V12, P421, DOI 10.1093/clipsy/bpi053; Campbell A, 2009, J HEALTH PSYCHOL, V14, P780, DOI 10.1177/1359105309338977; CAMPBELL DT, 1957, PSYCHOL BULL, V54, P297, DOI 10.1037/h0040950; Cash T. F., 2011, BODY IMAGE HDB SCI P, V2nd; Cash TF, 2002, INT J EAT DISORDER, V32, P362, DOI 10.1002/eat.10100; Cash TF, 2002, BODY IMAGE: A HANDBOOK OF THEORY, RESEARCH, AND CLINICAL PRACTICE, P277; Cash TF, 2002, INT J EAT DISORDER, V31, P455, DOI 10.1002/eat.10033; Cash TF., 2004, BODY IMAGE, V1, P363, DOI [10.1016/j.bodyim.2004.10.001, DOI 10.1016/J.B0DYIM.2004.10.001, DOI 10.1016/J.BODYIM.2004.10.001]; Cash TF, 1990, BODY IMAGES DEV DEVI; Cash Thomas F, 2002, Eat Disord, V10, P103, DOI 10.1080/10640260290081678; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooley E, 2001, INT J EAT DISORDER, V30, P28, DOI 10.1002/eat.1051; Cooper H.M., 1989, INTEGRATING RES GUID; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Corning AF, 2010, BODY IMAGE, V7, P289, DOI 10.1016/j.bodyim.2010.08.001; Coyne JC, 2010, HEALTH PSYCHOL, V29, P107, DOI 10.1037/a0017633; Deeks AA, 2001, PSYCHOL HEALTH, V16, P367, DOI 10.1080/08870440108405513; Dohnt HK, 2008, EUR EAT DISORD REV, V16, P222, DOI 10.1002/erv.814; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EVANS C, 1993, INT J EAT DISORDER, V13, P315, DOI 10.1002/1098-108X(199304)13:3&lt;315::AID-EAT2260130310&gt;3.0.CO;2-3; FAIRBURN CG, 1986, INT J EAT DISORDER, V5, P403, DOI 10.1002/1098-108X(198603)5:3<403::AID-EAT2260050302>3.0.CO;2-Z; Farrell C, 2006, EUR EAT DISORD REV, V14, P289, DOI 10.1002/erv.693; Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445; Field AP, 2010, BRIT J MATH STAT PSY, V63, P665, DOI 10.1348/000711010X502733; Fisher E, 2002, J SOC CLIN PSYCHOL, V21, P566, DOI 10.1521/jscp.21.5.566.22618; FOX KR, 1989, J SPORT EXERCISE PSY, V11, P408, DOI 10.1123/jsep.11.4.408; FRANZOI SL, 1984, J PERS ASSESS, V48, P173, DOI 10.1207/s15327752jpa4802_12; FURNHAM A, 1983, PSYCHOL MED, V13, P829, DOI 10.1017/S0033291700051540; Garner D., 1997, PSYCHOL TODAY NEW YO, V30, P30; Garner D.M., 1991, EATING DISORDER INVE; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; Grogan S, 2004, J GENDER STUD, V13, P49, DOI 10.1080/0958923032000184970; Grogan S., 2011, BODY IMAGE HDB SCI P, V2nd, P93; Grogan S, 2006, J HEALTH PSYCHOL, V11, P523, DOI 10.1177/1359105306065013; HART EA, 1989, J SPORT EXERCISE PSY, V11, P94, DOI 10.1123/jsep.11.1.94; Harter S, 1985, MANUAL SELF PERCEPTI; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Hefner V, 2014, MEDIA PSYCHOL, V17, P185, DOI 10.1080/15213269.2013.838903; HEINBERG LJ, 1995, INT J EAT DISORDER, V17, P81, DOI 10.1002/1098-108X(199501)17:1<81::AID-EAT2260170111>3.0.CO;2-Y; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Horowitz JL, 2006, J CONSULT CLIN PSYCH, V74, P401, DOI 10.1037/0022-006X.74.3.401; Howard GS, 2009, REV GEN PSYCHOL, V13, P146, DOI 10.1037/a0015319; Hunter J. E., 2004, METHODS METAANALYSIS; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010; Irving LM, 2001, PSYCHOL WOMEN QUART, V25, P103, DOI 10.1111/1471-6402.00012; Jakatdar Tejal A, 2006, Body Image, V3, P325, DOI 10.1016/j.bodyim.2006.09.001; Jarry J. L., 2011, BODY IMAGE HDB SCI P, P415; Jarry Josee L, 2005, Body Image, V2, P317, DOI 10.1016/j.bodyim.2005.10.001; Jarry Josee L, 2004, Body Image, V1, P319, DOI 10.1016/j.bodyim.2004.10.005; Jones D. C., 2011, BODY IMAGE HDB SCI P, P110; KARASU TB, 1986, AM J PSYCHIAT, V143, P687; Klar Y, 2012, SELF CHANGE SOCIAL P; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Larimer ME, 2002, J STUD ALCOHOL, P148, DOI 10.15288/jsas.2002.s14.148; Levine Michael P, 2004, Body Image, V1, P57, DOI 10.1016/S1740-1445(03)00006-8; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Light R.J., 1984, SUMMING SCI REV RES; Lindwall M, 2005, PSYCHOL SPORT EXERC, V6, P643, DOI 10.1016/j.psychsport.2005.03.003; Littleton Heather, 2005, Body Image, V2, P193, DOI 10.1016/j.bodyim.2005.02.003; MARSH HW, 1994, J SPORT EXERCISE PSY, V16, P270, DOI 10.1123/jsep.16.3.270; Martijn C, 2013, HEALTH PSYCHOL, V32, P433, DOI 10.1037/a0028592; Martijn C, 2010, HEALTH PSYCHOL, V29, P514, DOI 10.1037/a0020770; Martin Ginis K. A., 2011, BODY IMAGE HDB SCI P, P378; Martin KA, 2002, BODY IMAGE: A HANDBOOK OF THEORY, RESEARCH, AND CLINICAL PRACTICE, P414; McCabe MP, 2006, J HEALTH PSYCHOL, V11, P589, DOI 10.1177/1359105306065019; McCabe MP, 2003, HEALTH PSYCHOL, V22, P39, DOI 10.1037/0278-6133.22.1.39; Mendelson BK, 2001, J PERS ASSESS, V76, P90, DOI 10.1207/S15327752JPA7601_6; MENDELSON BK, 1982, PERCEPT MOTOR SKILL, V54, P899, DOI 10.2466/pms.1982.54.3.899; Menzel JE, 2011, BODY IMAGE HDB SCI P, P3; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Myers TA, 2009, J ABNORM PSYCHOL, V118, P683, DOI 10.1037/a0016763; Niemeyer H, 2012, SCHIZOPHR RES, V138, P103, DOI 10.1016/j.schres.2012.03.023; O'Connor D, 2008, COCHRANE HDB SYSTEMA, P81, DOI DOI 10.1002/9780470712184.CH5; O'Dea J. A., 2011, BODY IMAGE A HANDBOO, P434; O'Dea Jennifer A, 2004, Eat Disord, V12, P225, DOI 10.1080/10640260490481438; Pais-Ribeiro José L., 2003, Aná. Psicológica, V21, P431; Patrick D. L., 2008, COCHRANE HDB SYSTEMA, P531; Paxton SJ, 2006, J CLIN CHILD ADOLESC, V35, P539, DOI 10.1207/s15374424jccp3504_5; Peters GJY, 2015, HEALTH PSYCHOL REV, V9, P1, DOI 10.1080/17437199.2013.848409; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014; Reas DL, 2002, INT J EAT DISORDER, V31, P324, DOI 10.1002/eat.10012; Reboussin BA, 2000, PSYCHOL HEALTH, V15, P239, DOI 10.1080/08870440008400304; REED DL, 1991, J ANXIETY DISORD, V5, P323, DOI 10.1016/0887-6185(91)90032-O; Ricciardelli Lina A, 2002, Eat Behav, V3, P45, DOI 10.1016/S1471-0153(01)00044-7; Rosen J., 1991, PSYCHOL ASSESSMENT J, V3, P32, DOI [https://doi.org/10.1037/1040-3590.3.1.32, DOI 10.1037/1040-3590.3.1.32]; ROSEN JC, 1989, BEHAV THER, V20, P393, DOI 10.1016/S0005-7894(89)80058-9; ROSEN JC, 1995, BEHAV THER, V26, P25, DOI 10.1016/S0005-7894(05)80081-4; ROSEN JC, 1995, J CONSULT CLIN PSYCH, V63, P263, DOI 10.1037/0022-006X.63.2.263; Rosen JC, 1996, INT J EAT DISORDER, V20, P331, DOI 10.1002/(SICI)1098-108X(199612)20:4<331::AID-EAT1>3.0.CO;2-O; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Salk RH, 2011, PSYCHOL WOMEN QUART, V35, P18, DOI 10.1177/0361684310384107; Schilder, 1999, IMAGE APPEARANCE HUM; Schooler D, 2013, SEX RES SOC POLICY, V10, P52, DOI 10.1007/s13178-012-0099-9; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Skinner EA, 2003, PSYCHOL BULL, V129, P216, DOI 10.1037/0033-2909.129.2.216; Slevec JH, 2011, CLIN PSYCHOL REV, V31, P515, DOI 10.1016/j.cpr.2010.12.002; Smolak L, 2001, BODY IMAGE, EATING DISORDERS, AND OBESITY IN YOUTH: ASSESSMENT, PREVENTION, AND TREATMENT, P41, DOI 10.1037/10404-002; Smolak L., 2011, BODY IMAGE HDB SCI P; Stice E, 2007, ANNU REV CLIN PSYCHO, V3, P207, DOI 10.1146/annurev.clinpsy.3.022806.091447; Thompson J. K., 1991, BEHAV THERAPIST, V14, DOI DOI 10.1107/S0108768190010898; Thompson JK, 2004, INT J EAT DISORDER, V35, P293, DOI 10.1002/eat.10257; THOMPSON MA, 1995, J PERS ASSESS, V64, P258, DOI 10.1207/s15327752jpa6402_6; Tiggemann Marika, 2004, Body Image, V1, P29, DOI 10.1016/S1740-1445(03)00002-0; Tschacher W, 2014, CLIN PSYCHOL PSYCHOT, V21, P82, DOI 10.1002/cpp.1822; van den Berg P, 2007, J ADOLESCENT HEALTH, V41, P415, DOI 10.1016/j.jadohealth.2007.06.001; Weaver AD, 2006, PSYCHOL WOMEN QUART, V30, P333, DOI 10.1111/j.1471-6402.2006.00308.x; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Whitehead J. R., 1995, PEDIATR EXERC SCI, V7, P132; Williamson DA, 2004, BEHAV MODIF, V28, P711, DOI 10.1177/0145445503259853; Winstead BA, 1984, M SE PSYCH ASS NEW O; Wiseman CV, 1998, INT J EAT DISORDER, V24, P429, DOI 10.1002/(SICI)1098-108X(199812)24:4&lt;429::AID-EAT10&gt;3.0.CO;2-D; Wood KC, 1996, J APPL DEV PSYCHOL, V17, P85, DOI 10.1016/S0193-3973(96)90007-6; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yager Z, 2013, BODY IMAGE, V10, P271, DOI 10.1016/j.bodyim.2013.04.001	137	133	136	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139177	10.1371/journal.pone.0139177	http://dx.doi.org/10.1371/journal.pone.0139177			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418470	gold, Green Accepted, Green Published			2022-12-27	WOS:000362171400057
J	Cabieses, B; Cookson, R; Espinoza, M; Santorelli, G; Delgado, I				Cabieses, Baltica; Cookson, Richard; Espinoza, Manuel; Santorelli, Gillian; Delgado, Iris			Did Socioeconomic Inequality in Self-Reported Health in Chile Fall after the Equity-Based Healthcare Reform of 2005? A Concentration Index Decomposition Analysis	PLOS ONE			English	Article							INCOME-RELATED INEQUALITY; EDUCATIONAL-LEVEL; RELATIVE POVERTY; PROSPECTIVE COHORT; MORTALITY; ABSOLUTE; ASSOCIATION; PREDICTORS; EUROPE; CANCER	Objective Chile, a South American country recently defined as a high-income nation, carried out a major healthcare system reform from 2005 onwards that aimed at reducing socioeconomic inequality in health. This study aimed to estimate income-related inequality in self-reported health status (SRHS) in 2000 and 2013, before and after the reform, for the entire adult Chilean population. Methods Using data on equivalized household income and adult SRHS from the 2000 and 2013 CASEN surveys (independent samples of 101 046 and 172 330 adult participants, respectively) we estimated Erreygers concentration indices (CIs) for above average SRHS for both years. We also decomposed the contribution of both "legitimate" standardizing variables (age and sex) and "illegitimate" variables (income, education, occupation, ethnicity, urban/rural, marital status, number of people living in the household, and healthcare entitlement). Results There was a significant concentration of above average SRHS favoring richer people in Chile in both years, which was less pronounced in 2013 than 2000 (Erreygers corrected CI 0.165 [Standard Error, SE 0.007] in 2000 and 0.047 [SE 0.008] in 2013). To help interpret the magnitude of this decline, adults in the richest fifth of households were 33% more likely than those in the poorest fifth to report above-average health in 2000, falling to 11% in 2013. In 2013, the contribution of illegitimate factors to income-related inequality in SRHS remained higher than the contribution of legitimate factors. Conclusions Income-related inequality in SRHS in Chile has fallen after the equity-based healthcare reform. Further research is needed to ascertain how far this fall in health inequality can be attributed to the 2005 healthcare reform as opposed to economic growth and other determinants of health that changed during the period.	[Cabieses, Baltica] Univ Desarrollo, Fac Med, Clin Alemana, Santiago, Chile; [Cabieses, Baltica] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Cookson, Richard] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Espinoza, Manuel] Pontificia Univ Catolica Chile, Dept Publ Hlth, Santiago, Chile; [Santorelli, Gillian] Univ Leeds, Leeds Inst Clin Trials Res, Leeds LS2 9JT, W Yorkshire, England; [Delgado, Iris] Univ Desarrollo, Fac Med, Clin Alemana, CEPS, Santiago, Chile	Clinica Alemana; Universidad del Desarrollo; University of York - UK; University of York - UK; Pontificia Universidad Catolica de Chile; University of Leeds; Clinica Alemana; Universidad del Desarrollo	Cabieses, B (corresponding author), Univ Desarrollo, Fac Med, Clin Alemana, Ave La Plaza 680, Santiago, Chile.	bcabieses@udd.cl	Cabieses, Baltica/V-5024-2017; Espinoza, Manuel/AAU-5178-2020	Cabieses, Baltica/0000-0003-0756-1954; Espinoza, Manuel/0000-0001-9564-9512	Fondo Nacional de Desarrollo Cientifico y Tecnologico [11130042]; Fondecyt; Fondo Interno de Investigacion Universidad del Desarrollo; National Institute for Health Research [SRF-2013-06-015] Funding Source: researchfish	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo Interno de Investigacion Universidad del Desarrollo; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico Number 11130042, Fondecyt http://www.conicyt.cl/fondecyt/ and Fondo Interno de Investigacion Universidad del Desarrollo 2012 (no number), http://fondosconcursables.udd.cl/fondos-internos-udd/.	[Anonymous], 2008, ANAL HLTH EQUITY USI; Arrau F, 2002, CONCEPTUALIZACION PL; Arteaga Oscar, 2002, Cad. Saúde Pública, V18, P1053, DOI 10.1590/S0102-311X2002000400011; Arteaga Óscar, 2002, Rev Panam Salud Publica, V11, P374, DOI 10.1590/S1020-49892002000500012; Balaev M, 2014, SOC SCI RES, V46, P169, DOI 10.1016/j.ssresearch.2014.03.004; Belov V B, 2003, Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med, P14; Brennan DS, 2012, J NUTR HEALTH AGING, V16, P437, DOI 10.1007/s12603-012-0006-3; Burrows J, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.022715; Caviedes R, 1995, HLTH 21 CENTURY NECE, P19; CHARLTON BG, 1994, LANCET, V344, P755, DOI 10.1016/S0140-6736(94)92245-4; Chilean Ministry of Planning, 2013, CASEN 2013 DOC MET; Chilean Ministry of Social Development, 2000, CASEN 2000 DOC MET; Dardanoni V., 1999, ECONOMETRICS J, V2, P49, DOI DOI 10.1111/1368-423X.00020; DEAN M, 1994, LANCET, V344, P463; Elstad JI, 2012, INT J ENV RES PUB HE, V9, P4715, DOI 10.3390/ijerph9124715; Erreygers G, 2012, J HEALTH ECON, V31, P257, DOI 10.1016/j.jhealeco.2011.10.009; Erreygers G, 2011, J HEALTH ECON, V30, P685, DOI 10.1016/j.jhealeco.2011.04.004; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Fleurbaey M, 2009, J HEALTH ECON, V28, P73, DOI 10.1016/j.jhealeco.2008.07.016; Fritzell J, 2015, INT J PUBLIC HEALTH, V60, P101, DOI 10.1007/s00038-014-0614-2; Genovese Cristina, 2004, Krankenpfl Soins Infirm, V97, P65; GHANMA M A, 1984, Genus, V40, P107; Gravelle H, 2003, HEALTH ECON, V12, P803, DOI 10.1002/hec.813; Gray L, 2012, EUR J PUBLIC HEALTH, V22, P40, DOI 10.1093/eurpub/ckq170; Green DA, 2000, PUBLIC HEALTH, V114, P495; Hagenaars A., 1994, POVERTY STAT LATE 19; Harding R, 2012, AIDS CARE, V24, P963, DOI 10.1080/09540121.2012.668175; Hays RD, 2015, J GEN INTERN MED; Riquelme CAH, 2015, REV PANAM SALUD PUBL, V37, P44; Hillemeier MM, 2003, AM J PUBLIC HEALTH, V93, P652, DOI 10.2105/AJPH.93.4.652; Hong E, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-41; Instituto Nacional de Estadistica, 2009, SINT GEOGR NAC COMP; Instituto Nacional de Estadistica de Chile, 2008, CHILE PROYECC EST PR; Joung IMA, 2000, J CLIN EPIDEMIOL, V53, P955, DOI 10.1016/S0895-4356(99)00232-2; Karlsson M, 2010, SOC SCI MED, V70, P875, DOI 10.1016/j.socscimed.2009.10.056; Kohler Lennart, 2007, Lakartidningen, V104, P1989; Koolman X, 2004, HEALTH ECON, V13, P649, DOI 10.1002/hec.884; KUNST AE, 1995, J EPIDEMIOL COMMUN H, V49, P117, DOI 10.1136/jech.49.2.117; Lagos R, 2000, COMMUNICATION; Morris S, 2003, CHE TECHNICAL PAPER, V27; Noronha KVMD, 2005, REV PANAM SALUD PUBL, V17, P410, DOI 10.1590/S1020-49892005000500013; OECD, 2010, CHIL ACC OECD; Phillips AC, 2010, BRIT J HEALTH PSYCH, V15, P337, DOI 10.1348/135910709X466180; Ram R, 2006, SOC SCI MED, V62, P779, DOI 10.1016/j.socscimed.2005.06.034; RAO VM, 1969, J R STAT SOC SER A-G, V132, P418, DOI 10.2307/2344120; Saito M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111169; Salinero-Fort MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038462; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Shelley D, 2011, J URBAN HEALTH, V88, P651, DOI 10.1007/s11524-011-9555-8; Steele L, 2007, CAN J PSYCHIAT, V52, P201, DOI 10.1177/070674370705200312; Subramanian SV, 2003, J EPIDEMIOL COMMUN H, V57, P844, DOI 10.1136/jech.57.11.844; Subramanian V, 2003, REV MED CHILE, V131, P321; Sundquist J, 1997, J EPIDEMIOL COMMUN H, V51, P35, DOI 10.1136/jech.51.1.35; Tai E, 2012, CANCER-AM CANCER SOC, V118, P4884, DOI 10.1002/cncr.27445; van Doorslaer E, 2004, HEALTH ECON, V13, P629, DOI 10.1002/hec.919; Vasquez F, 2013, REV PANAM SALUD PUBL, V33, P98, DOI 10.1590/S1020-49892013000200004; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A, 2004, HEALTH ECON, V13, P297, DOI 10.1002/hec.822; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wagstaff A, 2003, HEALTH ECON, V12, P885, DOI 10.1002/hec.805; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; Wilkinson RG, 2008, AM J PUBLIC HEALTH, V98, P699, DOI 10.2105/AJPH.2007.109637; Wu B, 2011, ASIA PAC J PUBLIC HL; Yamamoto T, 2012, PSYCHOSOM MED, V74, P241, DOI 10.1097/PSY.0b013e318246dffb; Yu HJ, 1996, AM STAT ASS 1996 P S, VI, P468	65	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138227	10.1371/journal.pone.0138227	http://dx.doi.org/10.1371/journal.pone.0138227			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418354	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400012
J	Kantola, K; Hedman, L; Tanner, L; Simell, V; Makinen, M; Partanen, J; Sadeghi, M; Veijola, R; Knip, M; Ilonen, J; Hyoty, H; Toppari, J; Simell, O; Hedman, K; Soderlund-Venermo, M				Kantola, Kalle; Hedman, Lea; Tanner, Laura; Simell, Ville; Makinen, Marjaana; Partanen, Juulia; Sadeghi, Mohammadreza; Veijola, Riitta; Knip, Mikael; Ilonen, Jorma; Hyoty, Heikki; Toppari, Jorma; Simell, Olli; Hedman, Klaus; Soderlund-Venermo, Maria			B-Cell Responses to Human Bocaviruses 1-4: New Insights from a Childhood Follow-Up Study	PLOS ONE			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; ORIGINAL ANTIGENIC SIN; DENGUE VIRUS-INFECTION; INFLUENZA-A VIRUSES; ACUTE GASTROENTERITIS; LINE U937; CHILDREN; DISEASE; RISK; ASSOCIATION	Human bocaviruses (HBoVs) 1-4 are recently discovered, antigenically similar parvoviruses. We examined the hypothesis that the antigenic similarity of these viruses could give rise to clinically and diagnostically important immunological interactions. IgG and IgM EIAs as well as qPCR were used to study similar to 2000 sera collected from infancy to early adolescence at 3-6-month intervals from 109 children whose symptoms were recorded. We found that HBoV1-4-specific seroprevalences at age 6 years were 80%, 48%, 10%, and 0%, respectively. HBoV1 infections resulted in significantly weaker IgG responses among children who had pre-existing HBoV2 IgG, and vice versa. Furthermore, we documented a complete absence of virus type-specific immune responses in six viremic children who had pre-existing IgG for another bocavirus, indicating that not all HBoV infections can be diagnosed serologically. Our results strongly indicate that interactions between consecutive HBoV infections affect HBoV immunity via a phenomenon called "original antigenic sin", cross-protection, or both; however, without evident clinical consequences but with important ramifications for the serodiagnosis of HBoV infections. Serological data is likely to underestimate human exposure to these viruses.	[Kantola, Kalle; Hedman, Lea; Partanen, Juulia; Sadeghi, Mohammadreza; Hedman, Klaus; Soderlund-Venermo, Maria] Univ Helsinki, Dept Virol, Helsinki, Finland; [Hedman, Lea; Hedman, Klaus] Helsinki Univ Hosp, Lab Serv, Helsinki, Finland; [Tanner, Laura; Ilonen, Jorma; Toppari, Jorma] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Simell, Ville; Makinen, Marjaana; Ilonen, Jorma; Toppari, Jorma; Simell, Olli] Univ Turku, Medicity, Turku, Finland; [Veijola, Riitta] Univ Oulu, Dept Paediat, Oulu, Finland; [Knip, Mikael] Univ Helsinki, Helsinki, Finland; [Knip, Mikael] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Knip, Mikael] Res Programs Unit, Diabet & Obes, Helsinki, Finland; [Knip, Mikael] Folkhalsan Res Ctr, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Tampere Ctr Child Hlth Res, Tampere, Finland; [Ilonen, Jorma] Univ Eastern Finland, Dept Clin Microbiol, Kuopio, Finland; [Ilonen, Jorma] Univ Turku, Immunogenet Lab, Turku, Finland; [Hyoty, Heikki] Univ Tampere, Dept Virol, FIN-33101 Tampere, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Tampere University; Tampere University Hospital; University of Eastern Finland; University of Turku; Tampere University	Kantola, K (corresponding author), Univ Helsinki, Dept Virol, Helsinki, Finland.	kalle.kantola@helsinki.fi	Söderlund-Venermo, Maria/AAX-2112-2020; Mäkinen, Marjaana/H-8065-2019; Knip, Mikael/AAL-3773-2020; Hedman, Klaus/D-5379-2009	Mäkinen, Marjaana/0000-0003-1319-0707; sadeghi, mohammad reza/0000-0002-2725-6407; Hyoty, Heikki/0000-0003-0370-4145; Ilonen, Jorma/0000-0002-9973-2062; Hedman, Klaus/0000-0003-1779-7960; Knip, Mikael/0000-0003-0474-0033	Academy of Finland [1257964]; Helsinki Biomedical Graduate School; Helsinki University Hospital Research Education; Research & Development Funds; Medical Society of Finland; University of Helsinki; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Helsinki Biomedical Graduate School; Helsinki University Hospital Research Education; Research & Development Funds; Medical Society of Finland; University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Financial support was provided by The Academy of Finland (www.aka.fi/en) project 1257964) to KH and MSV, The Helsinki Biomedical Graduate School (www.helsinki.fi/dpbm) to KK, Helsinki University Hospital Research & Education, and Research & Development Funds (www.hus.fi/en) to KH, The Medical Society of Finland (www.fls.fi/sallskapet/) to KK, KH and MSV, The Research Funds of the University of Helsinki (www.helsinki.fi/en) to MSV, and The Sigrid Juselius Foundation (www.sigridjuselius.fi/foundation) to KH, MSV, and OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Blessing K, 2009, PEDIATR INFECT DIS J, V28, P1018, DOI 10.1097/INF.0b013e3181a854ae; Bloom ME, 2001, J VIROL, V75, P11116, DOI 10.1128/JVI.75.22.11116-11127.2001; Chieochansin T, 2009, EMERG INFECT DIS, V15, P1503, DOI 10.3201/eid1509.090394; Christensen A, 2013, EMERG INFECT DIS, V19, P574, DOI 10.3201/eid1904.121775; Christensen A, 2010, J CLIN VIROL, V49, P158, DOI 10.1016/j.jcv.2010.07.016; DAVENPORT FM, 1956, J EXP MED, V104, P85, DOI 10.1084/jem.104.1.85; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Guo LN, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-636; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; Ilonen J, 2002, AM J MED GENET, V115, P30, DOI 10.1002/ajmg.10341; JENSEN KE, 1956, J EXP MED, V104, P199, DOI 10.1084/jem.104.2.199; Jin Y, 2011, J CLIN VIROL, V52, P251, DOI 10.1016/j.jcv.2011.07.012; KANNO H, 1993, J VIROL, V67, P7017, DOI 10.1128/JVI.67.12.7017-7024.1993; Kantola K, 2008, CLIN INFECT DIS, V46, P540, DOI 10.1086/526532; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Lehtoranta L, 2012, INT J PEDIATR OTORHI, V76, P206, DOI 10.1016/j.ijporl.2011.10.025; Li XM, 2015, J GEN VIROL, V96, P3099, DOI 10.1099/jgv.0.000253; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Martin ET, 2015, J INFECT DIS; Meriluoto M, 2012, EMERG INFECT DIS, V18, P264, DOI 10.3201/eid1802.111293; Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Munakata Y, 2006, VIROLOGY, V345, P251, DOI 10.1016/j.virol.2005.09.040; Nawaz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041346; Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x; Paloniemi M, 2014, EUR J PEDIATR, V173, P1051, DOI 10.1007/s00431-014-2290-x; Proenca-Modena JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021083; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; TAMURA M, 1991, VIROLOGY, V182, P211, DOI 10.1016/0042-6822(91)90664-W; TAMURA M, 1994, J VIROL, V68, P3499, DOI 10.1128/JVI.68.6.3499-3504.1994; van Panhuis WG, 2010, J INFECT DIS, V202, P1002, DOI 10.1086/656141; von Kietzell K, 2014, J VIROL, V88, P8102, DOI 10.1128/JVI.00649-14; von Linstow ML, 2008, PEDIATR INFECT DIS J, V27, P897, DOI 10.1097/INF.0b013e3181757b16	41	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139096	10.1371/journal.pone.0139096	http://dx.doi.org/10.1371/journal.pone.0139096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418064	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400042
J	Saito, S; Hirata, Y; Sasahara, K; Suzuki, H				Saito, Shota; Hirata, Yoshito; Sasahara, Kazutoshi; Suzuki, Hideyuki			Tracking Time Evolution of Collective Attention Clusters in Twitter: Time Evolving Nonnegative Matrix Factorisation	PLOS ONE			English	Article								Micro-blogging services, such as Twitter, offer opportunities to analyse user behaviour. Discovering and distinguishing behavioural patterns in micro-blogging services is valuable. However, it is difficult and challenging to distinguish users, and to track the temporal development of collective attention within distinct user groups in Twitter. In this paper, we formulate this problem as tracking matrices decomposed by Nonnegative Matrix Factorisation for time-sequential matrix data, and propose a novel extension of Nonnegative Matrix Factorisation, which we refer to as Time Evolving Nonnegative Matrix Factorisation (TENMF). In our method, we describe users and words posted in some time interval by a matrix, and use several matrices as time-sequential data. Subsequently, we apply Time Evolving Nonnegative Matrix Factorisation to these time-sequential matrices. TENMF can decompose time-sequential matrices, and can track the connection among decomposed matrices, whereas previous NMF decomposes a matrix into two lower dimension matrices arbitrarily, which might lose the time-sequential connection. Our proposed method has an adequately good performance on artificial data. Moreover, we present several results and insights from experiments using real data from Twitter.	[Saito, Shota; Hirata, Yoshito; Suzuki, Hideyuki] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Tokyo, Japan; [Hirata, Yoshito; Suzuki, Hideyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Sasahara, Kazutoshi] Nagoya Univ, Grad Sch Informat Sci, Dept Complex Syst Sci, Nagoya, Aichi 4648601, Japan	University of Tokyo; University of Tokyo; Nagoya University	Saito, S (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Tokyo, Japan.	ssaito@sat.t.u-tokyo.ac.jp	Hirata, Yoshito/L-9297-2018; Suzuki, Hideyuki/A-4161-2013	Hirata, Yoshito/0000-0002-9245-2543; Suzuki, Hideyuki/0000-0002-8150-140X; Sasahara, Kazutoshi/0000-0003-2572-0648	Aihara Innovative Mathematical Modelling Project; Japanese Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP)	Aihara Innovative Mathematical Modelling Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This research was supported by the Aihara Innovative Mathematical Modelling Project, the Japanese Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139085	10.1371/journal.pone.0139085	http://dx.doi.org/10.1371/journal.pone.0139085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417999	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400039
J	Liu, F; Zhao, YL; Wang, XL; Hu, HB; Peng, HS; Wang, W; Wang, JF; Zhang, XH				Liu, Fei; Zhao, Yi-Lei; Wang, Xiaolei; Hu, Hongbo; Peng, Huasong; Wang, Wei; Wang, Jing-Fang; Zhang, Xuehong			Elucidation of Enzymatic Mechanism of Phenazine Biosynthetic Protein PhzF Using QM/MM and MD Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PSEUDOMONAS-FLUORESCENS 2-79; PARTICLE MESH EWALD; TRANSITION-STATE; PK(A) VALUES; FORCE-FIELD; AERUGINOSA; PYOCYANIN; BACTERIA; DENSITY	The phenazine biosynthetic pathway is of considerable importance for the pharmaceutical industry. The pathway produces two products: phenazine-1,6-dicarboxylic acid and phenazine-1-carboxylic acid. PhzF is an isomerase that catalyzes trans-2,3-dihydro-3-hydroxyanthranilic acid isomerization and plays an essential role in the phenazine biosynthetic pathway. Although the PhzF crystal structure has been determined recently, an understanding of the detailed catalytic mechanism and the roles of key catalytic residues are still lacking. In this study, a computational strategy using a combination of molecular modeling, molecular dynamics simulations, and quantum mechanics/molecular mechanics simulations was used to elucidate these important issues. The Apo enzyme, enzyme-substrate complexes with negatively charged Glu45, enzyme-transition state analog inhibitor complexes with neutral Glu45, and enzyme-product complexes with negatively charged Glu45 structures were optimized and modeled using a 200 ns molecular dynamics simulation. Residues such as Gly73, His74, Asp208, Gly212, Ser213, and water, which play important roles in ligand binding and the isomerization reaction, were comprehensively investigated. Our results suggest that the Glu45 residue at the active site of PhzF acts as a general base/acid catalyst during proton transfer. This study provides new insights into the detailed catalytic mechanism of PhzF and the results have important implications for PhzF modification.	[Liu, Fei; Zhao, Yi-Lei; Wang, Xiaolei; Hu, Hongbo; Peng, Huasong; Wang, Wei; Zhang, Xuehong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Wang, Jing-Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xuehzhang@sjtu.edu.cn	Wang, Jingfang/Q-2597-2018; wang, xiao/HGB-7081-2022	Wang, Jingfang/0000-0002-1355-5481; wang, xiao/0000-0002-4088-3341	National Key Basic Research Program of China [2012CB721005]; National Natural Science Foundation of China [31270084]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (No. 2012CB721005), and the National Natural Science Foundation of China (No. 31270084). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abken HJ, 1998, J BACTERIOL, V180, P2027, DOI 10.1128/JB.180.8.2027-2032.1998; [Anonymous], 2014, INT ENCY STAT SCI; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; Beifuss U, 2005, NATURAL PRODUCTS SYN; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; Blankenfeldt W, 2013, MICROBIAL PHENAZINES; Blankenfeldt W, 2014, CURR OPIN STRUC BIOL, V29, P26, DOI 10.1016/j.sbi.2014.08.013; Campos SRR, 2009, J PHYS CHEM B, V113, P15989, DOI 10.1021/jp902991u; CASEWIT CJ, 1992, J AM CHEM SOC, V114, P10035, DOI 10.1021/ja00051a041; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; Chin-A-Woeng TFC, 2003, NEW PHYTOL, V157, P503, DOI 10.1046/j.1469-8137.2003.00686.x; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P969, DOI 10.1094/MPMI.2001.14.8.969; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Frisch G. W., 2013, GAUSSIAN 09; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kohn W, 1996, J PHYS CHEM-US, V100, P12974, DOI 10.1021/jp960669l; Kondratyuk TP, 2012, MAR DRUGS, V10, P451, DOI 10.3390/md10020451; Kozuch S, 2006, J AM CHEM SOC, V128, P3355, DOI 10.1021/ja0559146; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liger D, 2005, PROTEINS, V60, P778, DOI 10.1002/prot.20548; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2004, ACTA CRYSTALLOGR D, V60, P184, DOI [10.1107/S090744490302571X, 10.1107/S0907444903025]; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; McDonald M, 2001, J AM CHEM SOC, V123, P9459, DOI 10.1021/ja011243+; Mentel M, 2009, CHEMBIOCHEM, V10, P2295, DOI 10.1002/cbic.200900323; Mitomo D, 2006, PROTEINS, V64, P883, DOI 10.1002/prot.21069; Ohfuji K, 2004, BIOSENS BIOELECTRON, V19, P1237, DOI 10.1016/j.bios.2003.11.010; Parsons JF, 2004, BIOCHEMISTRY-US, V43, P12427, DOI 10.1021/bi049059z; Parsons JF, 2004, ACTA CRYSTALLOGR D, V60, P2110, DOI 10.1107/S0907444904022474; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; PIERSON LS, 1992, MOL PLANT MICROBE IN, V5, P330, DOI 10.1094/MPMI-5-330; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santos AS, 2005, ELECTROANAL, V17, P1103, DOI 10.1002/elan.200403222; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schoental R, 1941, BRIT J EXP PATHOL, V22, P137; Schramm VL, 2011, ANNU REV BIOCHEM, V80, P703, DOI 10.1146/annurev-biochem-061809-100742; Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Torres CI, 2010, FEMS MICROBIOL REV, V34, P3, DOI 10.1111/j.1574-6976.2009.00191.x; TURNER JM, 1986, ADV MICROB PHYSIOL, V27, P211, DOI 10.1016/S0065-2911(08)60306-9; van der Kamp MW, 2013, BIOCHEMISTRY-US, V52, P2708, DOI 10.1021/bi400215w; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varnai C, 2013, J PHYS CHEM B, V117, P12202, DOI 10.1021/jp405974b; Vreven T, 2003, J COMPUT CHEM, V24, P760, DOI 10.1002/jcc.10156; Vreven T, 2006, J CHEM THEORY COMPUT, V2, P815, DOI 10.1021/ct050289g; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09	63	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139081	10.1371/journal.pone.0139081	http://dx.doi.org/10.1371/journal.pone.0139081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414009	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700040
J	Luo, YG; Wang, DF; Liu, K; Weng, J; Guan, YF; Chan, KCC; Chu, WCW; Shi, L				Luo, Yun-gang; Wang, Defeng; Liu, Kai; Weng, Jian; Guan, Yuefeng; Chan, Kate C. C.; Chu, Winnie C. W.; Shi, Lin			Brain Structure Network Analysis in Patients with Obstructive Sleep Apnea	PLOS ONE			English	Article							WORKING-MEMORY; ANATOMICAL NETWORKS; CORTICAL THICKNESS; CHINESE CHILDREN; ORGANIZATION; PRESSURE; DYSFUNCTION; ACTIVATION; HEALTH	Childhood obstructive sleep apnea (OSA) is a sleeping disorder commonly affecting school-aged children and is characterized by repeated episodes of blockage of the upper airway during sleep. In this study, we performed a graph theoretical analysis on the brain morphometric correlation network in 25 OSA patients (OSA group; 5 female; mean age, 10.1 +/- 1.8 years) and investigated the topological alterations in global and regional properties compared with 20 healthy control individuals (CON group; 6 females; mean age, 10.4 +/- 1.8 years). A structural correlation network based on regional gray matter volume was constructed respectively for each group. Our results revealed a significantly decreased mean local efficiency in the OSA group over the density range of 0.32-0.44 (p < 0.05). Regionally, the OSAs showed a tendency of decreased betweenness centrality in the left angular gyrus, and a tendency of decreased degree in the right lingual and inferior frontal (orbital part) gyrus (p < 0.005, uncorrected). We also found that the network hubs in OSA and controls were distributed differently. To the best of our knowledge, this is the first study that characterizes the brain structure network in OSA patients and invests the alteration of topological properties of gray matter volume structural network. This study may help to provide new evidence for understanding the neuropathophysiology of OSA from a topological perspective.	[Luo, Yun-gang; Guan, Yuefeng] Jilin Univ, Hosp 2, Dept Stomatol, Changchun 130041, Jilin Province, Peoples R China; [Wang, Defeng; Liu, Kai; Weng, Jian; Chu, Winnie C. W.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Res Ctr Med Image Comp, Shatin, Hong Kong, Peoples R China; [Wang, Defeng; Guan, Yuefeng; Chu, Winnie C. W.] CUHK Shenzhen Res Inst, Shenzhen, Peoples R China; [Wang, Defeng; Liu, Kai] Chinese Univ Hong Kong, Dept Biomed Engn, Shatin, Hong Kong, Peoples R China; [Wang, Defeng; Liu, Kai] Chinese Univ Hong Kong, Inst Adv Engn, Shatin, Hong Kong, Peoples R China; [Chan, Kate C. C.] Chinese Univ Hong Kong, Dept Paediat, Shatin, Hong Kong, Peoples R China; [Shi, Lin] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Jilin University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Luo, YG (corresponding author), Jilin Univ, Hosp 2, Dept Stomatol, Changchun 130041, Jilin Province, Peoples R China.	luoyungang@sohu.com; shilin@cuhk.edu.hk	Chu, Winnie CW/F-8449-2014; Shi, Lin/K-5241-2014; Chan, Kate Ching-ching/P-2947-2018	Chu, Winnie CW/0000-0003-4962-4132; Shi, Lin/0000-0003-2318-4669; Chan, Kate Ching-ching/0000-0001-7272-8285	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 475711, CUHK 416712, CUHK 411811, CUHK 473012, CUHK 14113214]; Shenzhen Science and Technology Innovation Committee [CXZZ20140606164105361]; National Natural Science Foundation of China [81271653, 81201157]; Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong [BME-p2-13/BME-CUHK]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Shenzhen Science and Technology Innovation Committee; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong(Chinese University of Hong Kong)	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CUHK 475711, CUHK 416712, CUHK 411811, CUHK 473012, CUHK 14113214), a grant from Shenzhen Science and Technology Innovation Committee (Project No. CXZZ20140606164105361), grants from the National Natural Science Foundation of China (Project No. 81271653 and 81201157), and a grant from the Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong (Project No. BME-p2-13/BME-CUHK).	Antczak J, 2007, J PHYSIOL PHARMACOL, V58, P25; Avants BB, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.3; Ayalon L, 2006, NEUROIMAGE, V31, P1817, DOI 10.1016/j.neuroimage.2006.02.042; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bennett LS, 1999, AM J RESP CRIT CARE, V159, P1884, DOI 10.1164/ajrccm.159.6.9808107; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bischof M, 2004, ANN NEUROL, V56, P583, DOI 10.1002/ana.20246; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Carroll JL, 2003, CLIN CHEST MED, V24, P261, DOI 10.1016/S0272-5231(03)00024-8; Castronovo V, 2009, SLEEP, V32, P1161, DOI 10.1093/sleep/32.9.1161; Chan KC, 2014, SLEEP MED, V15, P1055, DOI 10.1016/j.sleep.2014.04.011; Decary A, 2000, SLEEP, V23, P369; Dominguez D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021909; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Gale SD, 2004, J INT NEUROPSYCH SOC, V10, P60; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Huynh NT, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00058; Joo EY, 2007, SLEEP, V30, P1515, DOI 10.1093/sleep/30.11.1515; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li AM, 2008, THORAX, V63, P803, DOI 10.1136/thx.2007.091132; Li AM, 2006, PEDIATR PULM, V41, P1153, DOI 10.1002/ppul.20505; Li AM, 2010, THORAX, V65, P991, DOI 10.1136/thx.2010.134858; Liu K, 2015, NEUROSCI LETT, V589, P169, DOI 10.1016/j.neulet.2015.01.037; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Marcus CL, 2008, CHEST, V134, P1114, DOI 10.1378/chest.08-2011; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; Pagel JF, 2003, SLEEP MED, V4, P235, DOI 10.1016/S1389-9457(02)00255-1; Peng DC, 2014, NEUROPSYCH DIS TREAT, V10, P1819, DOI 10.2147/NDT.S67805; Prilipko O, 2011, SLEEP, V34, P293, DOI 10.1093/sleep/34.3.293; Psychological Corporation, 1981, HONG KONG WECHSL INT; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Santarnecchi E, 2013, J SLEEP RES, V22, P337, DOI 10.1111/jsr.12006; Simmons MS, 2009, J AM DENT ASSOC, V140, P536, DOI 10.14219/jada.archive.2009.0221; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Sweet LH, 2010, BRAIN IMAGING BEHAV, V4, P155, DOI 10.1007/s11682-010-9095-y; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Tsang CSL, 2006, EYE, V20, P38, DOI 10.1038/sj.eye.6701785; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x; Zhang Q, 2013, SLEEP, V36, P651, DOI 10.5665/sleep.2620	54	15	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139055	10.1371/journal.pone.0139055	http://dx.doi.org/10.1371/journal.pone.0139055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413809	gold, Green Published, Green Submitted			2022-12-27	WOS:000362170700036
J	Crouzevialle, M; Smeding, A; Butera, F				Crouzevialle, Marie; Smeding, Annique; Butera, Fabrizio			Striving for Excellence Sometimes Hinders High Achievers: Performance-Approach Goals Deplete Arithmetical Performance in Students with High Working Memory Capacity	PLOS ONE			English	Article							INTRINSIC MOTIVATION; AVOIDANCE GOALS; OPERATION SPAN; TASK; PRESSURE; CHOKING; IMPACT; GRADES; INFORMATION; COMPETENCE	We tested whether the goal to attain normative superiority over other students, referred to as performance-approach goals, is particularly distractive for high-Working Memory Capacity (WMC) students-that is, those who are used to being high achievers. Indeed, WMC is positively related to high-order cognitive performance and academic success, a record of success that confers benefits on high-WMC as compared to low-WMC students. We tested whether such benefits may turn out to be a burden under performance-approach goal pursuit. Indeed, for high achievers, aiming to rise above others may represent an opportunity to reaffirm their positive status-a stake susceptible to trigger disruptive outcome concerns that interfere with task processing. Results revealed that with performance-approach goals -as compared to goals with no emphasis on social comparison-the higher the students' WMC, the lower their performance at a complex arithmetic task (Experiment 1). Crucially, this pattern appeared to be driven by uncertainty regarding the chances to outclass others (Experiment 2). Moreover, an accessibility measure suggested the mediational role played by status-related concerns in the observed disruption of performance. We discuss why high-stake situations can paradoxically lead high-achievers to sub-optimally perform when high-order cognitive performance is at play.	[Crouzevialle, Marie; Smeding, Annique; Butera, Fabrizio] Univ Lausanne, Lausanne, Switzerland; [Smeding, Annique] Univ Savoie, Chambery, France	University of Lausanne; Universite de Savoie	Butera, F (corresponding author), Univ Lausanne, Lausanne, Switzerland.	Fabrizio.Butera@unil.ch		Butera, Fabrizio/0000-0002-8856-4374	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; Ashcraft MH, 2007, PSYCHON B REV, V14, P243, DOI 10.3758/BF03194059; Barron K.E., 2003, INT J EDUC RES, V39, P357, DOI [DOI 10.1016/J.IJER.2004.06.004, 10.1016/j.ijer.2004.06.004]; BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610; Beilock SL, 2007, J EXP PSYCHOL LEARN, V33, P983, DOI 10.1037/0278-7393.33.6.983; Beilock SL, 2005, PSYCHOL SCI, V16, P101, DOI 10.1111/j.0956-7976.2005.00789.x; Beilock SL, 2004, J EXP PSYCHOL GEN, V133, P584, DOI 10.1037/0096-3445.133.4.584; BUTLER R, 1987, J EDUC PSYCHOL, V79, P474, DOI 10.1037/0022-0663.79.4.474; BUTLER R, 1986, J EDUC PSYCHOL, V78, P210, DOI 10.1037/0022-0663.78.3.210; BUTLER R, 1989, J EDUC PSYCHOL, V81, P269, DOI 10.1037/0022-0663.81.2.269; BUTLER R, 1988, BRIT J EDUC PSYCHOL, V58, P1, DOI 10.1111/j.2044-8279.1988.tb00874.x; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Conner J, 2009, EDUC LEADERSHIP, V67, P54; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Crouzevialle M, 2013, J EXP PSYCHOL GEN, V142, P666, DOI 10.1037/a0029632; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Darnon C, 2007, PERS SOC PSYCHOL B, V33, P813, DOI 10.1177/0146167207301022; Darnon C, 2009, EUR J PSYCHOL EDUC, V24, P423, DOI 10.1007/BF03178759; Darnon C, 2009, J PERS SOC PSYCHOL, V96, P119, DOI 10.1037/a0012824; DEUTSCH M, 1979, AM PSYCHOL, V34, P391, DOI 10.1037/0003-066X.34.5.391; Elliot A.J., 2003, INT J EDUC RES, V39, P339, DOI [10.1016/j.ijer.2004.06.003, DOI 10.1016/J.IJER.2004.06.003]; Elliot AJ, 1999, EDUC PSYCHOL-US, V34, P169, DOI 10.1207/s15326985ep3403_3; Elliot AJ, 1996, J PERS SOC PSYCHOL, V70, P461, DOI 10.1037/0022-3514.70.3.461; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Forster J, 2005, J EXP SOC PSYCHOL, V41, P220, DOI 10.1016/j.jesp.2004.06.009; Galloway M, 2013, J EXP EDUC, V81, P490, DOI 10.1080/00220973.2012.745469; Gimmig D, 2006, PSYCHON B REV, V13, P1005, DOI 10.3758/BF03213916; Hambrick D. Z., 2003, PSYCHOL PROBLEM SOLV, P176, DOI DOI 10.1017/CB09780511615771.007; Harackiewicz JM, 2000, J EDUC PSYCHOL, V92, P316, DOI 10.1037//0022-0663.92.2.316; Harackiewicz JM, 2002, J EDUC PSYCHOL, V94, P638, DOI 10.1037//0022-0663.94.3.638; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; JAGACINSKI CM, 1987, J EDUC PSYCHOL, V79, P107, DOI 10.1037/0022-0663.79.2.107; Judd C. M., 2011, DATA ANAL MODEL COMP; Kane MJ, 2008, VARIATION WORKING ME, P21; Koole SL, 1999, J PERS SOC PSYCHOL, V77, P111, DOI 10.1037/0022-3514.77.1.111; Lewin Tamar, 2011, NY TIMES; Matlack C., 2013, BUSINESSWEEK; McGregor HA, 2002, J EDUC PSYCHOL, V94, P381, DOI 10.1037//0022-0663.94.2.381; Midgley C, 2001, J EDUC PSYCHOL, V93, P77, DOI 10.1037//0022-0663.93.1.77; Murayama K, 2012, PSYCHOL BULL, V138, P1035, DOI 10.1037/a0028324; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Osborne J, 2011, EDUC PSYCHOL REV, V23, P131, DOI 10.1007/s10648-011-9151-1; Pope D. C., 2001, DOING SCH WE ARE CRE; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pryor JohnH., 2010, AM FRESHMAN NATL NOR; Pulfrey C, 2013, PSYCHOL SCI, V24, P2153, DOI 10.1177/0956797613487221; Pulfrey C, 2013, J EDUC PSYCHOL, V105, P39, DOI 10.1037/a0029376; Pulfrey C, 2011, J EDUC PSYCHOL, V103, P683, DOI 10.1037/a0023911; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; REDICK TS, 2007, INHIBITION COGNITION, P125, DOI DOI 10.1037/11587-007; Senko C, 2011, EDUC PSYCHOL-US, V46, P26, DOI 10.1080/00461520.2011.538646; Smeding A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071678; Sommet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084178; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2005, INTELLIGENCE, V33, P67, DOI 10.1016/j.intell.2004.08.003; Van Yperen NW, 2011, BRIT J MANAGE, V22, pS5, DOI 10.1111/j.1467-8551.2010.00702.x; Yzerbyt VY, 2004, J EXP SOC PSYCHOL, V40, P424, DOI 10.1016/j.jesp.2003.10.001	58	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137629	10.1371/journal.pone.0137629	http://dx.doi.org/10.1371/journal.pone.0137629			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26407097	Green Published, gold			2022-12-27	WOS:000361800700024
J	Dao, T; Hong, XM; Wang, XB; Tang, WY				Dao, Tyna; Hong, Xiumei; Wang, Xiaobin; Tang, Wan-Yee			Aberrant 5 '-CpG Methylation of Cord Blood TNF alpha Associated with Maternal Exposure to Polybrominated Diphenyl Ethers	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; PERSISTENT ORGANIC POLLUTANTS; DNA METHYLATION; GENE-EXPRESSION; BDE-47; PROMOTER; CELLS; BIRTH; HYPOMETHYLATION	Growing evidence suggests that maternal exposures to endocrine disrupting chemicals during pregnancy may lead to poor pregnancy outcomes and increased fetal susceptibility to adult diseases. Polybrominated diphenyl ethers (PBDEs), which are ubiquitously used flame-retardants, could leach into the environment; and become persistent organic pollutants via bioaccumulation. In the United States, blood PBDE levels in adults range from 30100 ng/g-lipid but the alarming health concern revolves around children who have reported blood PBDE levels 3 to 9-fold higher than adults. PBDEs disrupt endocrine, immune, reproductive and nervous systems. However, the mechanism underlying its adverse health effect is not fully understood. Epigenetics is a possible biological mechanism underlying maternal exposure-child health outcomes by regulating gene expression without changes in the DNA sequence. We sought to examine the relationship between maternal exposure to environmental PBDEs and promoter methylation of a proinflammatory gene, tumor necrosis factor alpha (TNF alpha). We measured the maternal blood PBDE levels and cord blood TNF alpha promoter methylation levels on 46 paired samples of maternal and cord blood from the Boston Birth Cohort (BBC). We showed that decreased cord blood TNF alpha methylation associated with high maternal PBDE47 exposure. CpG site-specific methylation showed significantly hypomethylation in the girl whose mother has a high blood PBDE47 level. Consistently, decreased TNF alpha methylation associated with an increase in TNF alpha protein level in cord blood. In conclusion, our finding provided evidence that in utero exposure to PBDEs may epigenetically reprogram the offspring's immunological response through promoter methylation of a proinflammatory gene.	[Dao, Tyna; Tang, Wan-Yee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Hong, Xiumei; Wang, Xiaobin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Human Populat & Reprod Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tang, WY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA.	wtang@jhsph.edu		Tang, Wan-Yee/0000-0002-0663-9820	National Institutes of Health [R00ES016817, R21HD066471]; Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016817, T32ES007141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This work was in part supported by National Institutes of Health grants R00ES016817 (WYT) and R21HD066471 (XBW). Other supports were come Discretionary Fund (WYT) from Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MA, 2014, ENVIRON INT, V63, P130, DOI 10.1016/j.envint.2013.11.009; Almasry SM, 2012, J MOL HISTOL, V43, P253, DOI 10.1007/s10735-012-9410-6; BARKER DJP, 1993, BRIT MED J, V306, P422, DOI 10.1136/bmj.306.6875.422; Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Blandizzi C, 2014, INT J IMMUNOPATH PH, V27, P1, DOI 10.1177/03946320140270S101; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Byun HM, 2015, TOXICOLOGY, V328, P152, DOI 10.1016/j.tox.2014.12.019; Costa LG, 2007, NEUROTOXICOLOGY, V28, P1047, DOI 10.1016/j.neuro.2007.08.007; Costa LG, 2014, TOXICOL LETT, V230, P282, DOI 10.1016/j.toxlet.2013.11.011; Du P, 2015, INT J DEV NEUROSCI; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; Emond C, 2013, TOXICOL APPL PHARM, V273, P335, DOI 10.1016/j.taap.2013.09.007; Eskenazi B, 2013, ENVIRON HEALTH PERSP, V121, P257, DOI 10.1289/ehp.1205597; EVANS HL, 1995, CLIN CHEM, V41, P1874; Falvo JV, 2013, ADV IMMUNOL, V118, P37, DOI 10.1016/B978-0-12-407708-9.00002-9; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Geyer H.J., 2004, ORGANOHALOGEN COMP, V66, P3820; GOLDFELD AE, 1994, J EXP MED, V180, P763, DOI 10.1084/jem.180.2.763; Golikova EA, 2013, J ASTHMA, V50, P705, DOI 10.3109/02770903.2013.796972; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Herbstman JB, 2010, ENVIRON HEALTH PERSP, V118, P712, DOI 10.1289/ehp.0901340; Hermsdorff HH, 2013, CYTOKINE, V64, P265, DOI 10.1016/j.cyto.2013.05.028; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Hong XM, 2012, SEMIN IMMUNOPATHOL, V34, P655, DOI 10.1007/s00281-012-0323-y; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huen K, 2014, ENVIRON MOL MUTAGEN, V55, P209, DOI 10.1002/em.21845; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koenig CM, 2012, NEUROTOXICOL TERATOL, V34, P571, DOI 10.1016/j.ntt.2012.09.005; Koh TW, 2010, INT J HYG ENVIR HEAL, V213, P59, DOI 10.1016/j.ijheh.2009.09.004; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Liu XB, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/692467; Liu X, 2014, ENVIRON MOL MUTAGEN, V55, P223, DOI 10.1002/em.21827; Liu X, 2012, HUM GENET, V131, P341, DOI 10.1007/s00439-011-1079-5; Martin PA, 2007, ENVIRON TOXICOL CHEM, V26, P988, DOI 10.1897/06-246R.1; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Nasiri R, 2013, J INVEST ALLERG CLIN, V23, P455; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Ranjbar S, 2006, J IMMUNOL, V176, P4182, DOI 10.4049/jimmunol.176.7.4182; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Rusiecki JA, 2008, ENVIRON HEALTH PERSP, V116, P1547, DOI 10.1289/ehp.11338; Sanders JM, 2006, XENOBIOTICA, V36, P824, DOI 10.1080/00498250600815906; Singh AK, 2015, MOL NEUROBIOL; Sjodin A, 2004, ANAL CHEM, V76, P4508, DOI 10.1021/ac0495384; Staskal DF, 2006, TOXICOL SCI, V94, P28, DOI 10.1093/toxsci/kfl091; Staskal DF, 2005, TOXICOL SCI, V83, P215, DOI 10.1093/toxsci/kfi018; Stock W, 2000, LANCET, V355, P1351, DOI 10.1016/S0140-6736(00)02125-5; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Sullivan KE, 2007, CLIN IMMUNOL, V123, P74, DOI 10.1016/j.clim.2006.12.008; Suvorov A, 2011, J APPL TOXICOL, V31, P179, DOI 10.1002/jat.1580; Suvorov A, 2011, J APPL TOXICOL, V31, P477, DOI 10.1002/jat.1667; Suvorov A, 2009, NEONATOLOGY, V95, P203, DOI 10.1159/000155651; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; Tang WY, 2012, ENVIRON HEALTH PERSP, V120, P1195, DOI 10.1289/ehp.1103744; Tang WY, 2008, ENDOCRINOLOGY, V149, P5922, DOI 10.1210/en.2008-0682; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Ta TA, 2011, NEUROTOXICOL TERATOL, V33, P393, DOI 10.1016/j.ntt.2011.02.003; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Tsytsykova AV, 2007, J BIOL CHEM, V282, P11629, DOI 10.1074/jbc.M611418200; US-EPA, 2010, EXP ASS POL DIPH ETH; Viviani B, 2014, NEUROTOXICOLOGY, V43, P10, DOI 10.1016/j.neuro.2014.03.004; Wang DL, 2012, EPIGENETICS-US, V7, P594, DOI 10.4161/epi.20117; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; Woods R, 2012, HUM MOL GENET, V21, P2399, DOI 10.1093/hmg/dds046	65	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138815	10.1371/journal.pone.0138815	http://dx.doi.org/10.1371/journal.pone.0138815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406892	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700102
J	Godfrey, J; Jeanguenin, L; Castro, N; Olney, JJ; Dudley, J; Pipkin, J; Walls, SM; Wang, W; Herr, DR; Harris, GL; Brasser, SM				Godfrey, Jessica; Jeanguenin, Lisa; Castro, Norma; Olney, Jeffrey J.; Dudley, Jason; Pipkin, Joseph; Walls, Stanley M.; Wang, Wei; Herr, Deron R.; Harris, Greg L.; Brasser, Susan M.			Chronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats	PLOS ONE			English	Article							INDUCED APOPTOTIC NEURODEGENERATION; MODERATE ALCOHOL; INSULIN-RESISTANCE; BRAIN-DAMAGE; CARDIOVASCULAR PROTECTION; RISK-FACTORS; DRINKING; SPHINGOSINE; MODEL; EXPOSURE	Heavy alcohol consumption has detrimental neurologic effects, inducing widespread neuronal loss in both fetuses and adults. One proposed mechanism of ethanol-induced cell loss with sufficient exposure is an elevation in concentrations of bioactive lipids that mediate apoptosis, including the membrane sphingolipid metabolites ceramide and sphingosine. While these naturally-occurring lipids serve as important modulators of normal neuronal development, elevated levels resulting from various extracellular insults have been implicated in pathological apoptosis of neurons and oligodendrocytes in several neuroinflammatory and neurodegenerative disorders. Prior work has shown that acute administration of ethanol to developing mice increases levels of ceramide in multiple brain regions, hypothesized to be a mediator of fetal alcohol-induced neuronal loss. Elevated ceramide levels have also been implicated in ethanol-mediated neurodegeneration in adult animals and humans. Here, we determined the effect of chronic voluntary ethanol consumption on lipid profiles in brain and peripheral tissues from adult alcohol-preferring (P) rats to further examine alterations in lipid composition as a potential contributor to ethanol-induced cellular damage. P rats were exposed for 13 weeks to a 20% ethanol intermittent-access drinking paradigm (45 ethanol sessions total) or were given access only to water (control). Following the final session, tissues were collected for subsequent chromatographic analysis of lipid content and enzymatic gene expression. Contrary to expectations, ethanol-exposed rats displayed substantial reductions in concentrations of ceramides in forebrain and heart relative to non-exposed controls, and modest but significant decreases in liver cholesterol. qRT-PCR analysis showed a reduction in the expression of sphingolipid delta(4)-desaturase (Degs2), an enzyme involved in de novo ceramide synthesis. These findings indicate that ethanol intake levels achieved by alcohol-preferring P rats as a result of chronic voluntary exposure may have favorable vs. detrimental effects on lipid profiles in this genetic line, consistent with data supporting beneficial cardioprotective and neuroprotective effects of moderate ethanol consumption.	[Godfrey, Jessica; Castro, Norma; Olney, Jeffrey J.; Dudley, Jason; Pipkin, Joseph; Brasser, Susan M.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Jeanguenin, Lisa; Walls, Stanley M.; Herr, Deron R.; Harris, Greg L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Wang, Wei; Herr, Deron R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	California State University System; San Diego State University; California State University System; San Diego State University; National University of Singapore	Harris, GL (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	gharris@mail.sdsu.edu; sbrasser@mail.sdsu.edu	Herr, Deron/AAB-7380-2020	Herr, Deron/0000-0001-5755-0896	National Institutes of Health [AA015741, AA023291, AA015512]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015741, R21AA023291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by National Institutes of Health grants AA015741 and AA023291(SMB) and AA015512 (Indiana Alcohol Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Agag LH, 2005, FREE RADICAL BIO MED, V39, P540, DOI 10.1016/j.freeradbiomed.2005.04.007; Bae M, 2014, J NEUROCHEM, V131, P645, DOI 10.1111/jnc.12834; BARNES DE, 1981, DEV BRAIN RES, V1, P333, DOI 10.1016/0165-3806(81)90071-7; Beresewicz A, 2002, J PHYSIOL PHARMACOL, V53, P371; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Brasser SM, 2004, ALCOHOL CLIN EXP RES, V28, P1074, DOI 10.1097/01.ALC.0000130802.07692.29; Cargiulo T, 2007, AM J HEALTH-SYST PH, V64, pS5, DOI 10.2146/ajhp060647; Carnicella S, 2014, ALCOHOL, V48, P243, DOI 10.1016/j.alcohol.2014.01.006; Chakraborty G, 2012, J NEUROCHEM, V121, P806, DOI 10.1111/j.1471-4159.2012.07723.x; Chen CH, 1999, P NATL ACAD SCI USA, V96, P12784, DOI 10.1073/pnas.96.22.12784; Chen WJA, 1996, PHARM TOXIC, P343; Chen YH, 2003, ALCOHOL ALCOHOLISM, V38, P18, DOI 10.1093/alcalc/agg014; Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007; Cohen AC, 2007, ALCOHOL CLIN EXP RES, V31, P1558, DOI 10.1111/j.1530-0277.2007.00450.x; Collins MA, 2010, MOL NEUROBIOL, V41, P420, DOI 10.1007/s12035-010-8138-0; Collins MA, 2009, ALCOHOL CLIN EXP RES, V33, P206, DOI 10.1111/j.1530-0277.2008.00828.x; Dasgupta S, 2007, NEUROCHEM RES, V32, P2217, DOI 10.1007/s11064-007-9445-3; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; de la Monte SM, 2008, J GASTROEN HEPATOL, V23, pE477, DOI 10.1111/j.1440-1746.2008.05339.x; de la Monte SM, 2009, INT J ENV RES PUB HE, V6, P2055, DOI 10.3390/ijerph6072055; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; DELAMONTE SM, 1988, ARCH NEUROL-CHICAGO, V45, P990, DOI 10.1001/archneur.1988.00520330076013; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Getz GS, 2008, J LIPID RES, V49, P2077, DOI 10.1194/jlr.E800015-JLR200; Goswami R, 2000, J NEUROSCI RES, V60, P141, DOI 10.1002/(SICI)1097-4547(20000415)60:2<141::AID-JNR2>3.0.CO;2-5; Gunzerath L, 2004, ALCOHOL CLIN EXP RES, V28, P829, DOI 10.1097/01.ALC.0000128382.79375.B6; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Harper C, 1998, J NEUROPATH EXP NEUR, V57, P101, DOI 10.1097/00005072-199802000-00001; Herr DR, 2004, J BIOL CHEM, V279, P12685, DOI 10.1074/jbc.M310647200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Ichi I, 2006, LIPIDS, V41, P859, DOI 10.1007/s11745-006-5041-6; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Kamada Kazuma, 2004, Pathophysiology, V10, P131, DOI 10.1016/j.pathophys.2003.10.010; KORTHIUS RJ, 2006, MICROVASCULAR RES BI, P777; Krenz M, 2012, J MOL CELL CARDIOL, V52, P93, DOI 10.1016/j.yjmcc.2011.10.011; Lucas DL, 2005, J AM COLL CARDIOL, V45, P1916, DOI 10.1016/j.jacc.2005.02.075; Lumeng L., 1977, ALC ALDEHYDE MET SYS, VIII, P537; Mitchell RM, 2009, J NEUROCHEM, V111, P580, DOI 10.1111/j.1471-4159.2009.06351.x; Miyamae Masami, 2010, Curr Drug Abuse Rev, V3, P39; O'Keefe JH, 2014, MAYO CLIN PROC, V89, P382, DOI 10.1016/j.mayocp.2013.11.005; Pang MY, 2009, J HEPATOL, V50, P1192, DOI 10.1016/j.jhep.2009.01.021; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Ping PP, 2001, CIRC RES, V88, P59, DOI 10.1161/01.RES.88.1.59; Poli A, 2013, NUTR METAB CARDIOVAS, V23, P487, DOI 10.1016/j.numecd.2013.02.007; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Roux A, 2015, ACS CHEM NEUROSCI, V6, P247, DOI 10.1021/cn500174c; Saito M, 2005, ALCOHOL CLIN EXP RES, V29, P1374, DOI 10.1097/01.alc.0000175011.22307.61; Saito M, 2010, J NEUROCHEM, V115, P168, DOI 10.1111/j.1471-4159.2010.06913.x; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Singh AK, 2007, ALCOHOL ALCOHOLISM, V42, P385, DOI 10.1093/alcalc/agl120; Sivaswamy S, 2010, EUR J NEUROSCI, V32, P1800, DOI 10.1111/j.1460-9568.2010.07451.x; SPIEGEL S, 1993, ADV LIPID RES, V25, P105; Sprow GM, 2012, PHYSIOL BEHAV, V106, P325, DOI 10.1016/j.physbeh.2011.12.026; Standridge JB, 2004, SOUTH MED J, V97, P664, DOI 10.1097/00007611-200407000-00012; Thiele TE, 2014, ALCOHOL, V48, P235, DOI 10.1016/j.alcohol.2013.08.005; Thompson PL, 2013, MED J AUSTRALIA, V198, P419, DOI 10.5694/mja12.10922; Ussher JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037703; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Walls SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003970; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Yamaguchi T, 2002, AM J PHYSIOL-HEART C, V283, pH1019, DOI 10.1152/ajpheart.00173.2002; Yamaguchi T, 2007, AM J PHYSIOL-HEART C, V292, pH1435, DOI 10.1152/ajpheart.00282.2006; Zhou HZ, 2002, AM J PHYSIOL-HEART C, V283, pH165, DOI 10.1152/ajpheart.00408.2001	70	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139012	10.1371/journal.pone.0139012	http://dx.doi.org/10.1371/journal.pone.0139012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405804	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700147
J	Gouveia-Figueira, S; Karlsson, J; Deplano, A; Hashemian, S; Svensson, M; Sundbom, MF; Congiu, C; Onnis, V; Fowler, CJ				Gouveia-Figueira, Sandra; Karlsson, Jessica; Deplano, Alessandro; Hashemian, Sanaz; Svensson, Mona; Sundbom, Marcus Fredriksson; Congiu, Cenzo; Onnis, Valentina; Fowler, Christopher J.			Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor	PLOS ONE			English	Article							ANTIINFLAMMATORY DRUGS; LINEAR-MODELS; ANANDAMIDE; IBUPROFEN; FLURBIPROFEN; OXYGENATION; ENZYME; COX-2; ENDOCANNABINOIDS; INDOMETHACIN	Background Increased endocannabinoid tonus by dual-action fatty acid amide hydrolase (FAAH) and substrate selective cyclooxygenase (COX-2) inhibitors is a promising approach for pain-relief. One such compound with this profile is 2-(2-fluorobiphenyl-4-yl)-N-(3-methylpyridin-2-yl)propanamide (Flu-AM1). These activities are shown by Flu-AM1 racemate, but it is not known whether its two single enantiomers behave differently, as is the case towards COX-2 for the parent flurbiprofen enantiomers. Further, the effects of the compound upon COX-2-derived lipids in intact cells are not known. Methodology/Principal Findings COX inhibition was determined using an oxygraphic method with arachidonic acid and 2-arachidonoylglycerol (2-AG) as substrates. FAAH was assayed in mouse brain homogenates using anandamide (AEA) as substrate. Lipidomic analysis was conducted in unstimulated and lipopolysaccharide + interferon gamma-stimulated RAW 264.7 macrophage cells. Both enantiomers inhibited COX-2 in a substrate-selective and time-dependent manner, with IC50 values in the absence of a preincubation phase of: (R)-Flu-AM1, COX-1 (arachidonic acid) 6 mu M; COX-2 (arachidonic acid) 20 mu M; COX-2 (2-AG) 1 mu M; (S)-Flu-AM1, COX-1 (arachidonic acid) 3 mu M; COX-2 (arachidonic acid) 10 mu M; COX-2 (2-AG) 0.7 mu M. The compounds showed no enantiomeric selectivity in their FAAH inhibitory properties. (R)-Flu-AM1 (10 mu M) greatly inhibited the production of prostaglandin D2 and E2 in both unstimulated and lipopolysaccharide + interferon.-stimulated RAW 264.7 macrophage cells. Levels of 2-AG were not affected either by (R)-Flu-AM1 or by 10 mu M flurbiprofen, either alone or in combination with the FAAH inhibitor URB597 (1 mu M). Conclusions/Significance Both enantiomers of Flu-AM1 are more potent inhibitors of 2-AG compared to arachidonic acid oxygenation by COX-2. Inhibition of COX in lipopolysaccharide + interferon.-stimulated RAW 264.7 cells is insufficient to affect 2-AG levels despite the large induction of COX-2 produced by this treatment.	[Gouveia-Figueira, Sandra; Karlsson, Jessica; Hashemian, Sanaz; Svensson, Mona; Sundbom, Marcus Fredriksson; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Pharmacol Unit, Umea, Sweden; [Gouveia-Figueira, Sandra] Umea Univ, Dept Chem, Umea, Sweden; [Deplano, Alessandro; Congiu, Cenzo; Onnis, Valentina] Univ Cagliari, Dept Life & Environm Sci, Unit Pharmaceut Pharmacol & Nutraceut Sci, Cagliari, Italy	Umea University; Umea University; University of Cagliari	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Pharmacol Unit, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019; Onnis, Valentina/B-1649-2008; Deplano, Alessandro/T-8589-2018	Fowler, Christopher J./0000-0002-6658-7874; Onnis, Valentina/0000-0002-2438-725X; Deplano, Alessandro/0000-0002-8451-5831; Karlsson, Jessica/0000-0001-8572-5841	Swedish Medical Research Council [12158]; Umea University Medical Faculty; Italian Ministero dell'Istruzione, Universita e della Ricerca [20105YY2HL_002]; Regione Autonoma della Sardegna [L.R. 7/2007, 2012_CRP-59473]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Umea University Medical Faculty; Italian Ministero dell'Istruzione, Universita e della Ricerca; Regione Autonoma della Sardegna(Regione Sardegna)	This work was supported by grants from the Swedish Medical Research Council (Grant no. 12158, medicine, to CJF), the Research Funds of Umea University Medical Faculty (to CJF), the Italian Ministero dell'Istruzione, Universita e della Ricerca (PRIN 2010-2011, Prot. no. 20105YY2HL_002, to VO) and from the Regione Autonoma della Sardegna (Project L.R. 7/2007, Prot. no. 2012_CRP-59473, to VO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Bjorklund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087542; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cipriano M, 2013, EUR J PHARMACOL, V720, P383, DOI 10.1016/j.ejphar.2013.09.065; Cocco MT, 2003, EUR J MED CHEM, V38, P513, DOI 10.1016/S0223-5234(03)00074-6; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Favia AD, 2012, J MED CHEM, V55, P8807, DOI 10.1021/jm3011146; Fowler CJ, 2009, BRIT J PHARMACOL, V156, P412, DOI 10.1111/j.1476-5381.2008.00029.x; Fowler CJ, 2013, J ENZYM INHIB MED CH, V28, P172, DOI 10.3109/14756366.2011.643304; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P468, DOI 10.1016/j.tips.2012.05.003; Fowler CJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P191, DOI 10.1006/abbi.1998.1025; Geisslinger G, 1996, J CLIN PHARMACOL, V36, P513, DOI 10.1002/j.1552-4604.1996.tb05041.x; Gouveia-Figueira S, 2015, PROSTAGLAND IN PRESS, DOI [10. 1016/ j. prostaglandins. 2015. 06. 003, DOI 10.1016/J.PROSTAGLANDINS.2015.06.003]; Guhring H, 2002, EUR J PHARMACOL, V454, P153, DOI 10.1016/S0014-2999(02)02485-8; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Holt S, 2007, EUR J PHARMACOL, V565, P26, DOI 10.1016/j.ejphar.2007.02.051; Hwang D, 1996, BIOCHEM BIOPH RES CO, V226, P810, DOI 10.1006/bbrc.1996.1433; Kloke JD, 2012, R J, V4, P57, DOI 10.32614/rj-2012-014; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043023; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; McKean JW, 2004, STAT SCI, V19, P562, DOI 10.1214/088342304000000549; MEADE EA, 1993, J BIOL CHEM, V268, P6610; Murakami T, 2007, FEBS LETT, V581, P140, DOI 10.1016/j.febslet.2006.12.017; Naidu PS, 2009, J PHARMACOL EXP THER, V329, P48, DOI 10.1124/jpet.108.143487; Norris PC, 2011, J LEUKOCYTE BIOL, V90, P563, DOI 10.1189/jlb.0311153; Onnis V, 2010, J MED CHEM, V53, P2286, DOI 10.1021/jm901891p; Pestonjamasp VK, 1998, BBA-LIPID LIPID MET, V1394, P249, DOI 10.1016/S0005-2760(98)00110-6; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; R Core TeamR, LANG ENV STAT COMP; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; Sasso O, 2015, FASEB J, V29, P2616, DOI 10.1096/fj.15-270637; Tsuboi K, 2007, BBA-MOL CELL BIOL L, V1771, P623, DOI 10.1016/j.bbalip.2007.03.005; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139212	10.1371/journal.pone.0139212	http://dx.doi.org/10.1371/journal.pone.0139212			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406890	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700192
J	Hsieh, IC; Chen, CC; Hsieh, MJ; Yang, CH; Chen, DY; Chang, SH; Wang, CY; Lee, CH; Tsai, ML				Hsieh, I-Chang; Chen, Chun-Chi; Hsieh, Ming-Jer; Yang, Chia-Hung; Chen, Dong-Yi; Chang, Shang-Hung; Wang, Chao-Yung; Lee, Cheng-Hung; Tsai, Ming-Lung			Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation	PLOS ONE			English	Article							PLASMA-LEVELS; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; EVENTS; INTERLEUKIN-6; INFLAMMATION; MORTALITY; DISEASE; MARKERS	Introduction The level of 9-month high-sensitivity C-reactive protein (hsCRP) in predicting cardiovascular outcomes is scanty in patients at 9 months after receiving drug-eluting stent (DES) implantations. This study aims to evaluate the relationship between 9-month follow-up hsCRP levels and long-term clinical outcomes in patients at 9 months after receiving DES. Methods A total of 1,763 patients who received 9-month follow-up angiography were enrolled and grouped according to hsCRP level 9 months after the DES implantation: group I (718 patients, hsCRP<1.0 mg/L), group II (639 patients, 1.0 <= hsCRP <= 3.0 mg/L), and group III (406 patients, hsCRP>3.0 mg/L). Results Group III patients had a lower cardiovascular event-free survival rate than group I or II patients during a follow-up of 64 +/- 45 months (64.5% vs. 71.6% vs. 72.8%, respectively, p = 0.012). Multivariate analysis showed that a follow-up hsCRP level <3.0 mg/L was an independent predictor of a major adverse cardiovascular event (cardiac death, reinfarction, target lesion revascularization, stenting in a new lesion, or coronary bypass surgery). Group III patients had a higher restenosis rate (11.3% vs. 5.8% vs. 6.6%, respectively, p = 0.002) and loss index (0.21 +/- 0.32 vs. 0.16 +/- 0.24 vs. 0.18 +/- 0.28, respectively, p = 0.001) than group I or II patients in 9-month follow-up angiography. Conclusions A high 9-month follow-up hsCRP level is an independent predictor of long-term clinical cardiovascular outcomes in patients at 9 months after DES implantation. It is also associated with a higher restenosis rate, larger late loss and loss index at 9 months after DES implantation.	[Hsieh, I-Chang; Chen, Chun-Chi; Hsieh, Ming-Jer; Yang, Chia-Hung; Chen, Dong-Yi; Chang, Shang-Hung; Wang, Chao-Yung; Lee, Cheng-Hung; Tsai, Ming-Lung] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Cardiol,Percutaneous Coronary Intervent Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hsieh, IC (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Cardiol,Percutaneous Coronary Intervent Ctr, Taoyuan, Taiwan.	hsiehic@gmail.com	Wang, Chao-Yung/ABA-6757-2021; Hsieh, Ming-Jer/M-1340-2013; Lee, Cheng-Hung/ABA-8070-2021	Wang, Chao-Yung/0000-0003-1546-7298; Hsieh, Ming-Jer/0000-0002-0148-8357; Chang, Shang-hung/0000-0003-0462-2344				Delhaye C, 2009, CARDIOVASC REVASCULA, V10, P144, DOI 10.1016/j.carrev.2009.01.005; Dibra A, 2003, AM J MED, V114, P715, DOI 10.1016/S0002-9343(03)00183-9; Gaspardone A, 2006, AM J CARDIOL, V97, P1311, DOI 10.1016/j.amjcard.2005.11.060; Gomma AH, 2004, AM HEART J, V147, P1071, DOI 10.1016/j.ahj.2003.10.050; Gottsauner-Wolf M, 2000, EUR HEART J, V21, P1152, DOI 10.1053/euhj.1999.1987; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Herrmann J, 2012, CIRC-CARDIOVASC INTE, V5, P783, DOI 10.1161/CIRCINTERVENTIONS.112.972182; Hong SJ, 2006, HEART, V92, P1119, DOI 10.1136/hrt.2005.075960; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; LE JM, 1989, LAB INVEST, V61, P588; Li JJ, 2010, TEX HEART I J, V37, P49; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Palmerini T, 2005, CIRCULATION, V112, P2332, DOI 10.1161/CIRCULATIONAHA.105.551648; Park DW, 2007, HEART, V93, P1087, DOI 10.1136/hrt.2006.099762; PIETILA K, 1991, ANN MED, V23, P529, DOI 10.3109/07853899109150513; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Segev A, 2004, EUR HEART J, V25, P1029, DOI 10.1016/j.ehj.2004.04.027; Versaci F, 2000, AM J CARDIOL, V85, P92, DOI 10.1016/S0002-9149(99)00612-8; Walter DH, 2001, J AM COLL CARDIOL, V37, P839, DOI 10.1016/S0735-1097(00)01193-1; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Xu YL, 2011, CHINESE MED J-PEKING, V124, P845, DOI 10.3760/cma.j.issn.0366-6999.2011.06.008; Yip HK, 2005, CIRC J, V69, P1202, DOI 10.1253/circj.69.1202; Zairis MN, 2002, J AM COLL CARDIOL, V40, P1375, DOI 10.1016/S0735-1097(02)02267-2	24	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138512	10.1371/journal.pone.0138512	http://dx.doi.org/10.1371/journal.pone.0138512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406989	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700053
J	Ishizaki, K; Nishihama, R; Ueda, M; Inoue, K; Ishida, S; Nishimura, Y; Shikanai, T; Kohchi, T				Ishizaki, Kimitsune; Nishihama, Ryuichi; Ueda, Minoru; Inoue, Keisuke; Ishida, Sakiko; Nishimura, Yoshiki; Shikanai, Toshiharu; Kohchi, Takayuki			Development of Gateway Binary Vector Series with Four Different Selection Markers for the Liverwort Marchantia polymorpha	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GENE ORGANIZATION; COMPLETE SEQUENCE; CELL FATE; ARABIDOPSIS; L.; VISUALIZATION; EXPRESSION; EVOLUTION; AGARTRAP	We previously reported Agrobacterium-mediated transformation methods for the liverwort Marchantia polymorpha using the hygromycin phosphotransferase gene as a marker for selection with hygromycin. In this study, we developed three additional markers for M. polymorpha transformation: the gentamicin 3'-acetyltransferase gene for selection with gentamicin; a mutated acetolactate synthase gene for selection with chlorsulfuron; and the neomycin phosphotransferase II gene for selection with G418. Based on these four marker genes, we have constructed a series of Gateway binary vectors designed for transgenic experiments on M. polymorpha. The 35S promoter from cauliflower mosaic virus and endogenous promoters for constitutive and heat-inducible expression were used to create these vectors. The reporters and tags used were Citrine, 3xCitrine, Citrine-NLS, TagRFP, tdTomato, tdTomato-NLS, GR, SRDX, SRDX-GR, GUS, ELuc(PEST), and 3xFLAG. These vectors, designated as the pMpGWB series, will facilitate molecular genetic analyses of the emerging model plant M. polymorpha.	[Ishizaki, Kimitsune; Nishihama, Ryuichi; Inoue, Keisuke; Ishida, Sakiko; Kohchi, Takayuki] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Ishizaki, Kimitsune] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 657, Japan; [Ueda, Minoru; Nishimura, Yoshiki; Shikanai, Toshiharu] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto, Japan	Kyoto University; Kobe University; Kyoto University	Kohchi, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.	tkohchi@lif.kyoto-u.ac.jp	Nishihama, Ryuichi/X-8623-2019; Shikanai, Toshiharu/AAK-9112-2020; Ishizaki, Kimitsune/L-4480-2019; Ueda, Minoru/AAF-1885-2019	Nishihama, Ryuichi/0000-0002-7032-732X; Ishizaki, Kimitsune/0000-0003-0504-8196; Ueda, Minoru/0000-0002-7750-6056; Nishimura, Yoshiki/0000-0001-8686-9206; Kohchi, Takayuki/0000-0002-9712-4872	MEXT KAKENHI [23012025, 25113009, 25119711, 15H01233]; JSPS KAKENHI [24580140, 24570048, 26650095]; JSPS [21-764, 24-7049]; Asahi Glass Foundation; SUNTORY Foundation for Life Sciences; Grants-in-Aid for Scientific Research [26650111, 15H04391] Funding Source: KAKEN	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asahi Glass Foundation; SUNTORY Foundation for Life Sciences(Suntory Foundation for Life Sciences); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: MEXT KAKENHI Grants-in-Aid for Scientific Research on Priority Areas (23012025 to T. K.) and for Scientific Research on Innovative Areas (25113009 to T. K., 25119711 and 15H01233 to K.Is.); by JSPS KAKENHI Grants-in-Aid for Scientific Research (C) (24580140 to K. Is., 24570048 to R.N.) and for Challenging Exploratory Research (26650095 to T.K.); by a research fellowship from the JSPS for young scientists (21-764 to M.U., 24-7049 to K.In). URL for Kakenhi: http://www.jsps.go.jp/english/e-grants/index.html. This work was also funded by the Asahi Glass Foundation (http://www.af-info.or.jp/en/index.html) and the SUNTORY Foundation for Life Sciences (http://www.sunbor.or.jp/egs/index.html) to K.Is. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; AOYAMA T, 1995, PLANT CELL, V7, P1773, DOI 10.1105/tpc.7.11.1773; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; CARRER H, 1991, PLANT MOL BIOL, V17, P301, DOI 10.1007/BF00039510; Chiyoda S, 2008, PLANT CELL REP, V27, P1467, DOI 10.1007/s00299-008-0570-5; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Era A, 2009, PLANT CELL PHYSIOL, V50, P1041, DOI 10.1093/pcp/pcp055; Flores-Sandoval E, 2016, PLANT CELL PHYSIOL, V57, P281, DOI 10.1093/pcp/pcv068; Flores-Sandoval E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005207; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Ishizaki K, 2016, PLANT CELL PHYSIOL, V57, P262, DOI 10.1093/pcp/pcv097; Ishizaki K, 2013, PLANT CELL, V25, P4075, DOI 10.1105/tpc.113.117051; Ishizaki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01532; Ishizaki K, 2012, J PLANT RES, V125, P643, DOI 10.1007/s10265-012-0477-7; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kanazawa T, 2016, PLANT CELL PHYSIOL, V57, P307, DOI 10.1093/pcp/pcv076; Kanazawa T, 2013, PLANT CELL PHYSIOL, V54, P1736, DOI 10.1093/pcp/pct119; Kato H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005084; Kawai K, 2008, J PESTIC SCI, V33, P128, DOI 10.1584/jpestics.G07-29; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; Komatsu A, 2014, PLANT PHYSIOL, V166, P411, DOI 10.1104/pp.114.245100; Kubota A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4668; Kubota A, 2013, BIOSCI BIOTECH BIOCH, V77, P167, DOI 10.1271/bbb.120700; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mitsuda N, 2011, METHODS MOL BIOL, V754, P87, DOI 10.1007/978-1-61779-154-3_5; Mitsuhashi N, 2000, PLANT CELL PHYSIOL, V41, P993, DOI 10.1093/pcp/pcd040; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nishihama R, 2016, PLANT CELL PHYSIOL, V57, P271, DOI 10.1093/pcp/pcv102; Nishihama R, 2015, J PLANT RES, V128, P407, DOI 10.1007/s10265-015-0724-9; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; TIMMERMANS MCP, 1990, J BIOTECHNOL, V14, P333, DOI 10.1016/0168-1656(90)90117-T; Tsuboyama S, 2014, PLANT CELL PHYSIOL, V55, P229, DOI 10.1093/pcp/pct168; Tsuboyama-Tanaka S, 2015, J PLANT RES, V128, P337, DOI 10.1007/s10265-014-0695-2; Ueda M, 2013, GENOME BIOL EVOL, V5, P1836, DOI 10.1093/gbe/evt137; Viviani VR, 1999, PHOTOCHEM PHOTOBIOL, V70, P254, DOI 10.1111/j.1751-1097.1999.tb07997.x; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104	50	117	117	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138876	10.1371/journal.pone.0138876	http://dx.doi.org/10.1371/journal.pone.0138876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406247	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700108
J	Kanatani, S; Uhlen, P; Barragan, A				Kanatani, Sachie; Uhlen, Per; Barragan, Antonio			Infection by Toxoplasma gondii Induces Amoeboid-Like Migration of Dendritic Cells in a Three-Dimensional Collagen Matrix	PLOS ONE			English	Article							LEUKOCYTE MIGRATION; LIGANDS; DISSEMINATION; RESISTANCE; INDUCTION; ANTIGEN; EDGE; 3D	Toxoplasma gondii, an obligate intracellular parasite of humans and other warm-blooded vertebrates, invades a variety of cell types in the organism, including immune cells. Notably, dendritic cells (DCs) infected by T. gondii acquire a hypermigratory phenotype that potentiates parasite dissemination by a 'Trojan horse' type of mechanism in mice. Previous studies have demonstrated that, shortly after parasite invasion, infected DCs exhibit hypermotility in 2-dimensional confinements in vitro and enhanced transmigration in transwell systems. However, interstitial migration in vivo involves interactions with the extracellular matrix in a 3-dimensional (3D) space. We have developed a collagen matrix-based assay in a 96-well plate format that allows quantitative locomotion analyses of infected DCs in a 3D confinement over time. We report that active invasion of DCs by T. gondii tachyzoites induces enhanced migration of infected DCs in the collagen matrix. Parasites of genotype II induced superior DC migratory distances than type I parasites. Moreover, Toxoplasma-induced hypermigration of DCs was further potentiated in the presence of the CCR7 chemotactic cue CCL19. Blocking antibodies to integrins (CD11a, CD11b, CD18, CD29, CD49b) insignificantly affected migration of infected DCs in the 3D matrix, contrasting with their inhibitory effects on adhesion in 2D assays. Morphological analyses of infected DCs in the matrix were consistent with the acquisition of an amoeboid-like migratory phenotype. Altogether, the present data show that the Toxoplasma-induced hypermigratory phenotype in a 3D matrix is consistent with integrin-independent amoeboid DC migration with maintained responsiveness to chemotactic and chemokinetic cues. The data support the hypothesis that induction of amoeboid hypermigration and chemotaxis/chemokinesis in infected DCs potentiates the dissemination of T. gondii.	[Kanatani, Sachie; Barragan, Antonio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Kanatani, Sachie; Barragan, Antonio] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Uhlen, Per] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Karolinska Institutet	Barragan, A (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	antonio.barragan@su.se	Barragan, Antonio/AAL-8618-2020; Barragan, Antonio/P-6278-2015	Barragan, Antonio/0000-0001-7746-9964; Barragan, Antonio/0000-0001-7746-9964; kanatani, sachie/0000-0002-7072-0447; Uhlen, Per/0000-0003-1446-1062	Vetenskapsradet (Swedish Research Council)	Vetenskapsradet (Swedish Research Council)(Swedish Research Council)	Funding was provided by Vetenskapsradet (Swedish Research Council), http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Collantes-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032123; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; de Vries IJM, 2003, CANCER RES, V63, P12; DEBRUYN PPH, 1946, ANAT REC, V95, P177, DOI 10.1002/ar.1090950209; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Hitziger N, 2005, CELL MICROBIOL, V7, P837, DOI 10.1111/j.1462-5822.2005.00517.x; John B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002246; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lambert H, 2011, MICROBES INFECT, V13, P96, DOI 10.1016/j.micinf.2010.10.002; Lambert H, 2009, INFECT IMMUN, V77, P1679, DOI 10.1128/IAI.01289-08; LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Mason BN, 2013, ACTA BIOMATER, V9, P4635, DOI 10.1016/j.actbio.2012.08.007; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Ricart BG, 2011, J IMMUNOL, V186, P53, DOI 10.4049/jimmunol.1002358; Shutt DC, 2000, CELL MOTIL CYTOSKEL, V46, P200, DOI 10.1002/1097-0169(200007)46:3<200::AID-CM5>3.0.CO;2-M; Sixt M, 2011, METHODS MOL BIOL, V769, P149, DOI 10.1007/978-1-61779-207-6_11; Stachowiak AN, 2006, J IMMUNOL, V177, P2340, DOI 10.4049/jimmunol.177.4.2340; Ueno N, 2014, CELL MICROBIOL, V16, P580, DOI 10.1111/cmi.12239; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; van Helden SFG, 2010, J IMMUNOL, V184, P1280, DOI 10.4049/jimmunol.0900764; Weidner JM, 2014, INT J PARASITOL, V44, P85, DOI 10.1016/j.ijpara.2013.09.006; Weidner JM, 2013, CELL MICROBIOL, V15, P1735, DOI 10.1111/cmi.12145	36	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139104	10.1371/journal.pone.0139104	http://dx.doi.org/10.1371/journal.pone.0139104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406763	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700171
J	Lagzi, F; Rotter, S				Lagzi, Fereshteh; Rotter, Stefan			Dynamics of Competition between Subnetworks of Spiking Neuronal Networks in the Balanced State	PLOS ONE			English	Article							PERSISTENT ACTIVITY; SYNAPTIC ACTIVITY; DECISION-MAKING; NEURAL BASIS; MODEL; CORTEX; OSCILLATIONS; VARIABILITY; INTEGRATION; PERCEPTION	We explore and analyze the nonlinear switching dynamics of neuronal networks with non-homogeneous connectivity. The general significance of such transient dynamics for brain function is unclear; however, for instance decision-making processes in perception and cognition have been implicated with it. The network under study here is comprised of three subnetworks of either excitatory or inhibitory leaky integrate-and-fire neurons, of which two are of the same type. The synaptic weights are arranged to establish and maintain a balance between excitation and inhibition in case of a constant external drive. Each subnetwork is randomly connected, where all neurons belonging to a particular population have the same in-degree and the same out-degree. Neurons in different subnetworks are also randomly connected with the same probability; however, depending on the type of the pre-synaptic neuron, the synaptic weight is scaled by a factor. We observed that for a certain range of the "within" versus "between" connection weights (bifurcation parameter), the network activation spontaneously switches between the two sub-networks of the same type. This kind of dynamics has been termed "winnerless competition", which also has a random component here. In our model, this phenomenon is well described by a set of coupled stochastic differential equations of Lotka-Volterra type that imply a competition between the subnetworks. The associated mean-field model shows the same dynamical behavior as observed in simulations of large networks comprising thousands of spiking neurons. The deterministic phase portrait is characterized by two attractors and a saddle node, its stochastic component is essentially given by the multiplicative inherent noise of the system. We find that the dwell time distribution of the active states is exponential, indicating that the noise drives the system randomly from one attractor to the other. A similar model for a larger number of populations might suggest a general approach to study the dynamics of interacting populations of spiking networks.	[Lagzi, Fereshteh] Bernstein Ctr Freiburg, Freiburg, Germany; Fac Biol, Freiburg, Germany		Lagzi, F (corresponding author), Bernstein Ctr Freiburg, Freiburg, Germany.	fereshteh.lagzi@bcf.uni-freiburg.de			German Ministry of Education and Research (BMBF) [BFNT 01GQ0830]; German Research Foundation (DFG) [EXC 1086]; INTERREG IV Rhin Superieur program; European Funds for Regional Development (FEDER) [A31]; Ministry of Science, Research and Arts and the Universities of the State of Baden-Wurttemberg, Germany	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); INTERREG IV Rhin Superieur program; European Funds for Regional Development (FEDER)(European Commission); Ministry of Science, Research and Arts and the Universities of the State of Baden-Wurttemberg, Germany	Funding: Funding by the German Ministry of Education and Research (BMBF, grant BFNT 01GQ0830) and the German Research Foundation (DFG, grant EXC 1086) is gratefully acknowledged. The authors also thank the TIGER project funded by INTERREG IV Rhin Superieur program and European Funds for Regional Development (FEDER, #A31). This work was performed on the computational resource bwUniCluster funded by the Ministry of Science, Research and Arts and the Universities of the State of Baden-Wurttemberg, Germany, within the framework program bwHPC. The article processing charge was covered by the open access publication fund of the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Afraimovich V, 2008, CHAOS, V18, DOI 10.1063/1.2991108; Albantakis L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002086; Amari S, 1977, SYSTEMS NEUROSCIENCE, V119, P165, DOI [DOI 10.1016/B978-0-12-491850-4.50009-X, 10.1007/978-3-642-46466-9]; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Bick C, 2010, DYNAM SYST, V25, P97, DOI 10.1080/14689360903322227; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Braun J, 2010, NEUROIMAGE, V52, P740, DOI 10.1016/j.neuroimage.2009.12.126; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 1998, NETWORK-COMP NEURAL, V9, P123, DOI 10.1088/0954-898X/9/1/007; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; COHEN MA, 1983, IEEE T SYST MAN CYB, V13, P815, DOI 10.1109/TSMC.1983.6313075; Colliaux D, 2009, COGN NEURODYNAMICS, V3, P141, DOI 10.1007/s11571-009-9078-0; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; DALE HENRY, 1935, PROC ROY SOC MED, V28, P319; Dayan P, 1998, NEURAL COMPUT, V10, P1119, DOI 10.1162/089976698300017377; Dayan P, 2001, COMPUTATIONAL NEUROS; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Doiron B, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00056; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Flannery B. P., 1992, NUMERICAL RECIPES IN; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; Fukai T, 1997, NEURAL COMPUT, V9, P77, DOI 10.1162/neco.1997.9.1.77; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; GERSTNER W, 1995, PHYS REV E, V51, P738, DOI 10.1103/PhysRevE.51.738; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI DOI 10.4249/SCH0LARPEDIA.1430; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; Hahnloser RHR, 2003, NEURAL COMPUT, V15, P621, DOI 10.1162/089976603321192103; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; HernandezBermejo B, 1997, MATH BIOSCI, V140, P1, DOI 10.1016/S0025-5564(96)00131-9; Jones E., 2001, SCIPY OPEN SOURCE SC; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lagzi F, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00142; Laing CR, 2002, J COMPUT NEUROSCI, V12, P39, DOI 10.1023/A:1014942129705; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; Litwin-Kumar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6319; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Lotka AJ, 1919, P N A S, P410; Lotka AJ, 1926, AM MATH MONTHLY, V33, P426, DOI [10.2307/2298330, DOI 10.2307/2298330]; Marti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002534; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; McCormick DA, 2005, CURR BIOL, V15, pR294, DOI 10.1016/j.cub.2005.04.009; McDonnell MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088254; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Neves FS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.018701; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Polk A, 2012, P NATL ACAD SCI USA, V109, P6295, DOI 10.1073/pnas.1121274109; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; PRAJNESHU, 1987, J THEOR BIOL, V125, P61, DOI 10.1016/S0022-5193(87)80179-0; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Rabinovich MI, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00024; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roxin A, 2011, J NEUROSCI, V31, P16217, DOI 10.1523/JNEUROSCI.1677-11.2011; Salinas E, 2003, NEURAL COMPUT, V15, P1439, DOI 10.1162/089976603321891756; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; SIEGERT AJF, 1951, PHYS REV, V81, P617, DOI 10.1103/PhysRev.81.617; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Steriade M., 2005, BRAINSTEM CONTROL WA; Tetzlaff T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002596; Tiesinga PHE, 2001, HIPPOCAMPUS, V11, P251, DOI 10.1002/hipo.1041; van der Hofstad R., 2014, RANDOM GRAPHS VOMPLE, V1; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Volterra V., 1931, VARIATIONS FLUCTUATI; WALKER P, 1975, PERCEPT PSYCHOPHYS, V18, P467, DOI 10.3758/BF03204122; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	80	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138947	10.1371/journal.pone.0138947	http://dx.doi.org/10.1371/journal.pone.0138947			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407178	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700125
J	Lin, XL; Stur, E; Ekrem, T				Lin, Xiaolong; Stur, Elisabeth; Ekrem, Torbjorn			Exploring Genetic Divergence in a Species-Rich Insect Genus Using 2790 DNA Barcodes	PLOS ONE			English	Article							NON-BITING MIDGES; DIPTERA CHIRONOMIDAE; MITOCHONDRIAL-DNA; IMMATURE STAGES; WULP DIPTERA; IDENTIFICATION; DELIMITATION; TAXONOMY; SEQUENCE; PATTERNS	DNA barcoding using a fragment of the mitochondrial cytochrome c oxidase subunit 1 gene (COI) has proven to be successful for species-level identification in many animal groups. However, most studies have been focused on relatively small datasets or on large datasets of taxonomically high-ranked groups. We explore the quality of DNA barcodes to delimit species in the diverse chironomid genus Tanytarsus (Diptera: Chironomidae) by using different analytical tools. The genus Tanytarsus is the most species-rich taxon of tribe Tanytarsini (Diptera: Chironomidae) with more than 400 species worldwide, some of which can be notoriously difficult to identify to species-level using morphology. Our dataset, based on sequences generated from own material and publicly available data in BOLD, consist of 2790 DNA barcodes with a fragment length of at least 500 base pairs. A neighbor joining tree of this dataset comprises 131 well separated clusters representing 121 morphological species of Tanytarsus: 77 named, 16 unnamed and 28 unidentified theoretical species. For our geographically widespread dataset, DNA barcodes unambiguously discriminate 94.6% of the Tanytarsus species recognized through prior morphological study. Deep intraspecific divergences exist in some species complexes, and need further taxonomic studies using appropriate nuclear markers as well as morphological and ecological data to be resolved. The DNA barcodes cluster into 120-242 molecular operational taxonomic units (OTUs) depending on whether Objective Clustering, Automatic Barcode Gap Discovery (ABGD), Generalized Mixed Yule Coalescent model (GMYC), Poisson Tree Process (PTP), subjective evaluation of the neighbor joining tree or Barcode Index Numbers (BINs) are used. We suggest that a 4-5% threshold is appropriate to delineate species of Tanytarsus non-biting midges.	[Lin, Xiaolong; Stur, Elisabeth; Ekrem, Torbjorn] Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Lin, XL (corresponding author), Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, N-7034 Trondheim, Norway.	xiaolong.lin@ntnu.no	Ekrem, Torbjørn/AAC-4087-2021	Ekrem, Torbjørn/0000-0003-3469-9211; Lin, Xiao-Long/0000-0001-6544-6204	Research Council of Norway [226134/F50]; Norwegian Biodiversity Information Centre [14-14, 70184209]	Research Council of Norway(Research Council of Norway); Norwegian Biodiversity Information Centre	Part of the DNA barcode data in this publication was generated in collaboration with the Norwegian Barcode of Life Network (NorBOL) funded by the Research Council of Norway (226134/F50) and the Norwegian Biodiversity Information Centre (14-14, 70184209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1985, J AM MOSQUITO CONTR, V1, P63; [Anonymous], 2014, TRACER V1 6; Armitage PD, 1995, CHIRONOMIDAE BIOL EC, VXII; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Brodin Y, 2013, MOL ECOL RESOUR, V13, P996, DOI 10.1111/1755-0998.12053; Carew ME, 2005, ANN ENTOMOL SOC AM, V98, P587, DOI 10.1603/0013-8746(2005)098[0587:TUODMI]2.0.CO;2; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Cranston PS, 2013, RAFFLES B ZOOL, V61, P779; Da Silva FL, 2014, ZOOTAXA, V3769, P1, DOI 10.11646/zootaxa.3769.1.1; Demin AG, 2011, RUSS J GENET+, V47, P1168, DOI 10.1134/S1022795411100061; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Ekrem T, 2004, DEUT ENTOMOL Z, V51, P97; Ekrem T, 2003, ANN ENTOMOL SOC AM, V96, P265, DOI 10.1603/0013-8746(2003)096[0265:NATIDA]2.0.CO;2; Ekrem T, 2001, AUST J ENTOMOL, V40, P312, DOI 10.1046/j.1440-6055.2001.00246.x; Ekrem T, 2002, HYDROBIOLOGIA, V474, P1, DOI 10.1023/A:1016527603086; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Ekrem T, 2010, ORG DIVERS EVOL, V10, P397, DOI 10.1007/s13127-010-0034-y; Ekrem Torbjorn, 2001, Tijdschrift voor Entomologie, V144, P5; Ekrem Torbjorn, 2007, P87; Epler J., 2013, INSECT SYSTEMATICS E, P387; Ezard T, 2009, PACKAGE SPLITS SPECI; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gay L, 2007, MOL ECOL, V16, P3215, DOI 10.1111/j.1365-294X.2007.03363.x; Gilka W, 2008, ENTOMOL FENNICA, V19, P41, DOI 10.33338/ef.84412; Gilka W, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2197.1.3; GLOVER B, 1973, Australian Journal of Zoology Supplementary Series, P403; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hawlitschek O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073368; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heckman KL, 2007, MOL PHYLOGENET EVOL, V43, P353, DOI 10.1016/j.ympev.2007.03.005; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Huemer P, 2014, ZOOKEYS, P91, DOI 10.3897/zookeys.404.7234; Hunter SJ, 2008, MOL ECOL RESOUR, V8, P56, DOI 10.1111/j.1471-8286.2007.01879.x; Ilmonen J, 2009, ZOOL J LINN SOC-LOND, V156, P847, DOI 10.1111/j.1096-3642.2009.00500.x; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Langton PH, 1998, J KANSAS ENTOMOL SOC, V71, P208; LINDEBERG BERNHARD, 1963, ANN ENTOMOL FENN, V29, P118; LINDEBERG BERNHARD, 1967, ANN ZOOL FENN, V4, P45; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Maddison WP., 2008, EVOLUTION, V62, P1103; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; McKie BG, 2005, CAN J ZOOL, V83, P553, DOI 10.1139/Z05-051; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; MOUBAYED Z, 1990, HYDROBIOLOGIA, V203, P29, DOI 10.1007/BF00005610; Nzelu CO, 2015, ACTA TROP, V145, P45, DOI 10.1016/j.actatropica.2015.02.003; Oba Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116612; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Ree Han-Il, 2010, Korean Journal of Systematic Zoology, V26, P115; Reiss F, 1971, ARCH HYDROBIOL S, V40, P75; Renaud AK, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-24; Resch MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090653; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rosenberg D.M., 1992, NETHERLANDS J AQUATI, V26, P101, DOI DOI 10.1007/BF02255231; Saether OA, 1969, SOME NEARCTIC PONDON; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanseverino AM, 2006, THESIS LMU MUNICH MU; Sari A, 2015, BIOCHEM SYST ECOL, V59, P229, DOI 10.1016/j.bse.2015.01.005; Sasa M, 1987, STUDIES CHIRONOMID M; Sasa Manabu, 2000, Tropical Medicine, V42, P1; Sasa Manabu, 1998, Tropical Medicine, V40, P47; Schmidt S, 2015, MOL ECOL RESOUR; Silva FL, 2014, B ENTOMOL RES, V104, P65, DOI 10.1017/S0007485313000515; Silva FL, 2015, ZOOL SCR, V44, P59, DOI 10.1111/zsc.12089; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sinclair CS, 2008, B ENTOMOL RES, V98, P555, DOI 10.1017/S0007485308005865; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Smith PJ, 2005, J FISH BIOL, V67, P1178, DOI 10.1111/j.0022-1112.2005.00804.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stur E, 2011, ZOOTAXA, P27, DOI 10.11646/zootaxa.2743.1.2; Sublette JE, 1994, SPIXIANA S, P20; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Team RC, 2012, LANG ENV STAT COMP, DOI DOI 10.1093/MOLBEV/MSH110; Turney S, 2015, PEERJ, V3, DOI 10.7717/peerj.1168; Webb JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038063; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Wulp F. M., 1874, TIJDSCHRIFT ENTOMOLO, V17, P109; Xu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115168; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1	105	72	76	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138993	10.1371/journal.pone.0138993	http://dx.doi.org/10.1371/journal.pone.0138993			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406595	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700141
J	Majid, L; Zagorodnyaya, T; Plant, EP; Petrovskaya, S; Bidzhieva, B; Ye, ZP; Simonyan, V; Chumakov, K				Majid, Laassri; Zagorodnyaya, Tatiana; Plant, Ewan P.; Petrovskaya, Svetlana; Bidzhieva, Bella; Ye, Zhiping; Simonyan, Vahan; Chumakov, Konstantin			Deep Sequencing for Evaluation of Genetic Stability of Influenza A/California/07/2009 (H1N1) Vaccine Viruses	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; LIVE VIRAL VACCINES; A VIRUS; GEL-ELECTROPHORESIS; SIALIC-ACID; HEMAGGLUTININ; NEURAMINIDASE; RNA; SPECIFICITY; POPULATIONS	Virus growth during influenza vaccine manufacture can lead to mutations that alter antigenic properties of the virus, and thus may affect protective potency of the vaccine. Different reassortants of pandemic "swine" H1N1 influenza A vaccine (121XP, X-179A and X-181) viruses as well as wild type A/California/07/2009(H1N1) and A/PR/8/34 strains were propagated in embryonated eggs and used for DNA/RNA Illumina HiSeq and MiSeq sequencing. The RNA sequences of these viruses published in NCBI were used as references for alignment of the sequencing reads generated in this study. Consensus sequences of these viruses differed from the NCBI-deposited sequences at several nucleotides. 121XP stock derived by reverse genetics was more heterogeneous than X-179A and X-181 stocks prepared by conventional reassortant technology. Passaged 121XP virus contained four non-synonymous mutations in the HA gene. One of these mutations (Lys(226)Glu) was located in the Ca antigenic site of HA (present in 18% of the population). Two non-synonymous mutations were present in HA of viruses derived from X-179A: Pro(314)Gln (18%) and Asn(146)Asp (78%). The latter mutation located in the Sa antigenic site was also detected at a low level (11%) in the wild-type A/California/07/2009(H1N1) virus, and was present as a complete substitution in X-181 viruses derived from X-179A virus. In the passaged X-181 viruses, two mutations emerged in HA: a silent mutation A(1398)G (31%) in one batch and G(756)T (Glu(252)Asp, 47%) in another batch. The latter mutation was located in the conservative region of the antigenic site Ca. The protocol for RNA sequencing was found to be robust, reproducible, and suitable for monitoring genetic consistency of influenza vaccine seed stocks.	[Majid, Laassri; Zagorodnyaya, Tatiana; Plant, Ewan P.; Petrovskaya, Svetlana; Bidzhieva, Bella; Ye, Zhiping; Simonyan, Vahan; Chumakov, Konstantin] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Majid, L (corresponding author), US FDA, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	majid.laassri@fda.hhs.gov	Plant, Ewan/AAB-1911-2020	Plant, Ewan/0000-0003-0166-5939				Amexis G, 2001, P NATL ACAD SCI USA, V98, P12097, DOI 10.1073/pnas.211423298; Bidzhieva B, 2014, J VIROL METHODS, V201, P86, DOI 10.1016/j.jviromet.2014.02.012; Bidzhieva B, 2014, J VIROL METHODS, V199, P68, DOI 10.1016/j.jviromet.2013.12.018; Cherkasova E, 2003, P NATL ACAD SCI USA, V100, P9398, DOI 10.1073/pnas.1633511100; Chumakov K M, 1999, Dev Biol Stand, V100, P67; CHUMAKOV KM, 1991, P NATL ACAD SCI USA, V88, P199, DOI 10.1073/pnas.88.1.199; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Das SR, 2013, CELL HOST MICROBE, V13, P314, DOI 10.1016/j.chom.2013.02.008; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; DOMINGO E, 1985, GENE, V40, P1, DOI 10.1016/0378-1119(85)90017-4; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Girard MP, 2006, VACCINE, V24, P2732, DOI 10.1016/j.vaccine.2005.10.014; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hughes MT, 2001, J VIROL, V75, P3766, DOI 10.1128/JVI.75.8.3766-3770.2001; Jing XH, 2012, VACCINE, V30, P4144, DOI 10.1016/j.vaccine.2012.04.073; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Laassri M, 2003, J VIROL METHODS, V112, P67, DOI 10.1016/S0166-0934(03)00193-9; Laassri M, 2012, VIRAL GENOMES - MOLECULAR STRUCTURE, DIVERSITY, GENE EXPRESSION MECHANISMS AND HOST-VIRUS INTERACTIONS, P181; Lamb RA, 2007, ORTHOMYXOVIRIDAE VIR; MAASSAB HF, 1985, VACCINE, V3, P355, DOI 10.1016/0264-410X(85)90124-0; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; McCarthy MW, 2004, ANN PHARMACOTHER, V38, P2086, DOI 10.1345/aph.1E191; Monto AS, 2011, VACCINE, V29, P6427, DOI 10.1016/j.vaccine.2011.06.113; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neverov A, 2010, P NATL ACAD SCI USA, V107, P20063, DOI 10.1073/pnas.1012537107; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAYMOND FL, 1986, VIROLOGY, V148, P275, DOI 10.1016/0042-6822(86)90325-9; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; Rogers YH, 2005, NATURE, V437, P326, DOI 10.1038/437326a; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; WEBSTER RG, 1975, INFLUENZA VIRUSES IN, P269; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; World Health Organization, 2009, CHAR EM INFL A H1N1; Zambon M, 2001, ANTIVIR RES, V49, P147, DOI 10.1016/S0166-3542(01)00124-3	42	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138650	10.1371/journal.pone.0138650	http://dx.doi.org/10.1371/journal.pone.0138650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407068	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700064
J	Mugita, Y; Minematsu, T; Huang, LJ; Nakagami, G; Kishi, C; Ichikawa, Y; Nagase, T; Oe, M; Noguchi, H; Mori, T; Abe, M; Sugama, J; Sanada, H				Mugita, Yuko; Minematsu, Takeo; Huang, Lijuan; Nakagami, Gojiro; Kishi, Chihiro; Ichikawa, Yoshie; Nagase, Takashi; Oe, Makoto; Noguchi, Hiroshi; Mori, Taketoshi; Abe, Masatoshi; Sugama, Junko; Sanada, Hiromi			Histopathology of Incontinence-Associated Skin Lesions: Inner Tissue Damage Due to Invasion of Proteolytic Enzymes and Bacteria in Macerated Rat Skin	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; TRANSDERMAL DELIVERY; PERINEAL DERMATITIS; TRYPSIN	A common complication in patients with incontinence is perineal skin lesions, which are recognized as a form of dermatitis. In these patients, perineal skin is exposed to digestive enzymes and intestinal bacterial flora, as well as excessive water. The relative contributions of digestive enzymes and intestinal bacterial flora to skin lesion formation have not been fully shown. This study was conducted to reveal the process of histopathological changes caused by proteases and bacterial inoculation in skin maceration. For skin maceration, agarose gel containing proteases was applied to the dorsal skin of male Sprague-Dawley rats for 4 h, followed by Pseudomonas aeruginosa inoculation for 30 min. Macroscopic changes, histological changes, bacterial distribution, inflammatory response, and keratinocyte proliferation and differentiation were examined. Proteases induced digestion in the prickle cell layer of the epidermis, and slight bleeding in the papillary dermis and around hair follicles in the macerated skin without macroscopic evidence of erosion. Bacterial inoculation of the skin macerated by proteolytic solution resulted in the formation of bacteria-rich clusters comprising numerous microorganisms and inflammatory cells within the papillary dermis, with remarkable tissue damage around the clusters. Tissue damage expanded by day 2. On day 3, the proliferative keratinocyte layer was elongated from the bulge region of the hair follicles. Application of proteases and P. aeruginosa induced skin lesion formation internally without macroscopic erosion of the overhydrated area, suggesting that the histopathology might be different from regular dermatitis. The healing process of this lesion is similar to transepidermal elimination.	[Mugita, Yuko; Minematsu, Takeo; Huang, Lijuan; Nakagami, Gojiro; Kishi, Chihiro; Nagase, Takashi; Abe, Masatoshi; Sanada, Hiromi] Univ Tokyo, Dept Gerontol Nursing Wound Care Management, Grad Sch Med, Tokyo, Japan; [Mugita, Yuko] Japan Soc Promot Sci, Tokyo, Japan; [Huang, Lijuan] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan; [Ichikawa, Yoshie] Univ Shizuoka, Sch Nursing, Shizuoka 4228526, Japan; [Oe, Makoto] Univ Tokyo, Grad Sch Med, Dept Adv Nursing Technol, Tokyo, Japan; [Noguchi, Hiroshi; Mori, Taketoshi] Univ Tokyo, Grad Sch Med, Dept Life Support Technol Molten, Tokyo, Japan; [Abe, Masatoshi] Sapporo Skin Clin, Sapporo, Hokkaido, Japan; [Sugama, Junko] Kanazawa Univ, Grad Sch Med Sci, Dept Clin Nursing, Kanazawa, Ishikawa 9201192, Japan	University of Tokyo; Japan Society for the Promotion of Science; Tokyo University of Science; University of Shizuoka; University of Tokyo; University of Tokyo; Kanazawa University	Sanada, H (corresponding author), Univ Tokyo, Dept Gerontol Nursing Wound Care Management, Grad Sch Med, Tokyo, Japan.	hsanada-tky@umin.ac.jp	Nakagami, Gojiro/V-9093-2019; Noguchi, Hiroshi/GQI-0676-2022; Mori, Taketoshi/E-3849-2016	Nakagami, Gojiro/0000-0002-9650-2464; Noguchi, Hiroshi/0000-0002-5303-5210; Mugita, Yuko/0000-0003-4964-7107; Mori, Taketoshi/0000-0002-7208-6435; Minematsu, Takeo/0000-0001-5859-7290	Japan Society for the Promotion of Science [24-3913]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by a Grant-in-Aid for Fellows of Japan Society for the Promotion of Science (#24-3913, http://www.jsps.go.jp/english/e-grants/). Japan Society for the Promotion of Science had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALM RA, 1995, MOL MICROBIOL, V16, P485, DOI 10.1111/j.1365-2958.1995.tb02413.x; BAYOUMI AHM, 1978, BRIT J DERMATOL, V99, P611, DOI 10.1111/j.1365-2133.1978.tb07054.x; Berardesca E, 1997, Skin Res Technol, V3, P126, DOI 10.1111/j.1600-0846.1997.tb00174.x; BERG RW, 1994, PEDIATR DERMATOL, V11, P18, DOI 10.1111/j.1525-1470.1994.tb00066.x; Bliss DZ, 2006, NURS RES, V55, P243, DOI 10.1097/00006199-200607000-00004; Bouwstra JA, 2008, J INVEST DERMATOL, V128, P378, DOI 10.1038/sj.jid.5700994; Buckingham K W, 1986, Pediatr Dermatol, V3, P107, DOI 10.1111/j.1525-1470.1986.tb00499.x; Driver DS, 2007, CRIT CARE NURSE, V27, P42; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Gray M, 2007, J WOUND OSTOMY CONT, V34, P45, DOI 10.1097/00152192-200701000-00008; KHARAZMI A, 1991, IMMUNOL LETT, V30, P201, DOI 10.1016/0165-2478(91)90026-7; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Kudo A., 2003, JUNTENDO MED COLL NU, V14, P202; Langemo D, 2011, ADV SKIN WOUND CARE, V24, P126, DOI 10.1097/01.ASW.0000395037.28398.6c; Li YZ, 2008, BIOL PHARM BULL, V31, P1574, DOI 10.1248/bpb.31.1574; Li Y, 2009, J PHARM PHARMACOL, V61, P1005, DOI 10.1211/jpp/61.08.0003; Meyer-Hoffert U, 2004, EXP DERMATOL, V13, P234, DOI 10.1111/j.0906-6705.2004.00159.x; Minematsu T, 2011, J JPN WOCM, V15, P278; Minematsu T, 2011, J DERMATOL SCI, V62, P160, DOI 10.1016/j.jdermsci.2011.03.005; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Nakagami G, 2006, DERMATOLOGY, V213, P293, DOI 10.1159/000096192; Nakagami G, 2011, WOUND REPAIR REGEN, V19, P214, DOI 10.1111/j.1524-475X.2010.00653.x; Onunkwo CC, 2010, ARCH DERMATOL RES, V302, P375, DOI 10.1007/s00403-010-1030-y; Rogiers V, 2001, SKIN PHARMACOL APPL, V14, P117, DOI 10.1159/000056341; Shigeta Y, 2009, J CLIN NURS, V18, P1607, DOI 10.1111/j.1365-2702.2008.02606.x; SMITH JS, 1971, CAN MED ASSOC J, V104, P691; Tan G, 2010, J PHARM SCI-US, V99, P730, DOI 10.1002/jps.21863; Taylor R M, 1986, Clin Dermatol, V4, P18, DOI 10.1016/0738-081X(86)90059-3; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Warner RR, 1999, J INVEST DERMATOL, V113, P960, DOI 10.1046/j.1523-1747.1999.00774.x; Wilson D, 2005, OSTOMY WOUND MANAG, V51, P52	31	24	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138117	10.1371/journal.pone.0138117	http://dx.doi.org/10.1371/journal.pone.0138117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407180	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700035
J	Murphy, MSQ; Seaborn, GEJ; Redfearn, DP; Smith, GN				Murphy, Malia S. Q.; Seaborn, Geoffrey E. J.; Redfearn, Damian P.; Smith, Graeme N.			Reduced Heart Rate Variability and Altered Cardiac Conduction after Pre-Eclampsia	PLOS ONE			English	Article							P-WAVE DURATION; BLOOD-PRESSURE; DISEASE RISK; PREGNANCY; WOMEN; PARAMETERS; FAILURE; HEALTH	Pre-eclampsia is a hypertensive disorder of pregnancy that is associated with elevated maternal risk for cardiovascular disease. The aims of this study were to determine the effect of normal pregnancy on postpartum parameters of the electrocardiogram, and furthermore to determine how a history of pre-eclampsia may affect these parameters. Ten-minute high-resolution (1000 Hz) orthogonal Holter electrocardiogram (ECG) recordings were used to measure heart rate variability (HRV). Signal-averaged P-wave and QRS complex durations were determined. Participants included non-pregnant controls, normotensive parous controls and women with a recent history of PE. While reductions in HRV induced by uncomplicated pregnancy returned to non-pregnant levels by 6-8 months postpartum HRV remained reduced in women with a history of PE compared to control groups. In addition, P-Wave and QRS complex durations were prolonged in PE subjects at 6-8 months postpartum compared to control groups. Only QRS duration was independent of differences in blood pressure. These results suggest increased sympathetic cardiac activity, and delayed myocardial conduction in women after PE; alterations consistent with cardiac remodeling and increased risk for arrhythmia. In examining the association between PE and cardiovascular disease, identification of ECG abnormalities soon after pregnancy in women with a history of PE highlights a unique opportunity for early identification and screening in this population before other risk factors become apparent.	[Murphy, Malia S. Q.; Seaborn, Geoffrey E. J.; Redfearn, Damian P.; Smith, Graeme N.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Seaborn, Geoffrey E. J.] Queens Univ, Sch Comp, Kingston, ON, Canada; [Redfearn, Damian P.] Kingston Gen Hosp, Dept Cardiol, Kingston, ON K7L 2V7, Canada; [Smith, Graeme N.] Kingston Gen Hosp, Dept Obstet & Gynecol, Kingston, ON K7L 2V7, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada	Smith, GN (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	gns@queensu.ca	Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; Murphy, Malia/0000-0002-4566-4957	Canadian Institute of Health Research [299823]; Ontario Graduate Scholarship	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	Funding was provided by the Canadian Institute of Health Research (#299823; GNS, DPR), and an Ontario Graduate Scholarship was awarded to MSQM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Chamchad D, 2007, INT J OBSTET ANESTH, V16, P106, DOI 10.1016/j.ijoa.2006.08.008; Dhingra R, 2006, HYPERTENSION, V47, P861, DOI 10.1161/01.HYP.0000217141.20163.23; Drost JT, 2012, MATURITAS, V73, P148, DOI 10.1016/j.maturitas.2012.06.006; Ekholm EMK, 1997, AM J OBSTET GYNECOL, V177, P1208, DOI 10.1016/S0002-9378(97)70041-3; Eneroth E, 1999, HYPERTENS PREGNANCY, V18, P1, DOI 10.3109/10641959909009606; Eneroth E, 1998, GYNECOL OBSTET INVES, V45, P170, DOI 10.1159/000009949; ENEROTHGRIMFORS E, 1994, ACTA OBSTET GYN SCAN, V73, P680, DOI 10.3109/00016349409029402; Faber R, 2004, J HUM HYPERTENS, V18, P707, DOI 10.1038/sj.jhh.1001730; Kirbas O, 2014, EUR J OBSTET GYN R B, V183, P141, DOI 10.1016/j.ejogrb.2014.10.042; Magee LA, 2014, PREGNANCY HYPERTENS, V4, P105, DOI 10.1016/j.preghy.2014.01.003; Magnani JW, 2011, HEART RHYTHM, V8, P93, DOI 10.1016/j.hrthm.2010.09.020; Melchiorre K, 2011, HYPERTENSION, V58, P709, DOI 10.1161/HYPERTENSIONAHA.111.176537; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Raffaelli R, 2014, HYPERTENS RES, V37, P984, DOI 10.1038/hr.2014.102; Ray JG, 2012, HEART, V98, P1136, DOI 10.1136/heartjnl-2011-301548; Redfearn DP, 2006, PACE, V29, P1089, DOI 10.1111/j.1540-8159.2006.00469.x; Redfearn DP, 2006, ANN NONINVAS ELECTRO, V11, P12, DOI 10.1111/j.1542-474X.2006.00058.x; Scholten RR, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.025; Scholten RR, 2014, AM J PHYSIOL-HEART C, V307, pH418, DOI 10.1152/ajpheart.00128.2014; Smith GN, 2013, J OBSTET GYNAECOL CA, V35, P831, DOI 10.1016/S1701-2163(15)30841-0; Spaan J, 2012, HYPERTENSION, V60, P1368, DOI 10.1161/HYPERTENSIONAHA.112.198812; Stein PK, 1999, AM J OBSTET GYNECOL, V180, P978, DOI 10.1016/S0002-9378(99)70670-8; Strobl I, 2011, BJOG-INT J OBSTET GY, V118, P76, DOI 10.1111/j.1471-0528.2010.02780.x; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Walther T, 2014, HYPERTENS PREGNANCY, V33, P1, DOI 10.3109/10641955.2013.821481; Whitsel EA, 2001, EUR HEART J, V22, P165, DOI 10.1053/euhj.2000.2262; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang CCH, 2000, AM J PHYSIOL-HEART C, V278, pH1269, DOI 10.1152/ajpheart.2000.278.4.H1269	30	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138664	10.1371/journal.pone.0138664	http://dx.doi.org/10.1371/journal.pone.0138664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407294	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700066
J	Peery, AF; Sandler, RS; Galanko, JA; Bresalier, RS; Figueiredo, JC; Ahnen, DJ; Barry, EL; Baron, JA				Peery, Anne F.; Sandler, Robert S.; Galanko, Joseph A.; Bresalier, Robert S.; Figueiredo, Jane C.; Ahnen, Dennis J.; Barry, Elizabeth L.; Baron, John A.			Risk Factors for Hemorrhoids on Screening Colonoscopy	PLOS ONE			English	Article							CONSTIPATION; PREVALENCE	Background Constipation, a low fiber diet, sedentary lifestyle and gravidity are commonly assumed to increase the risk of hemorrhoids. However, evidence regarding these factors is limited. We examined the association between commonly cited risk factors and the prevalence of hemorrhoids. Methods We performed a cross sectional study of participants who underwent a colonoscopy in a colorectal adenoma prevention trial and who had a detailed assessment of bowel habits, diet and activity. The presence of hemorrhoids was extracted from the subjects' colonoscopy reports. We used logistic regression to estimate odds ratios and 95% confidence intervals while adjusting for age and sex. Results The study included 2,813 participants. Of these, 1,074 had hemorrhoids recorded. Constipation was associated with an increased prevalence of hemorrhoids (OR 1.43, 95% CI 1.11, 1.86). Of the fiber subtypes, high grain fiber intake was associated with a reduced risk (OR for quartile 4 versus quartile 1 = 0.78, 95% CI 0.62, 0.98). We found no association when comparing gravid and nulligravida women (OR 0.93, 95% CI 0.62-1.40). Sedentary behavior was associated with a reduced risk (OR 0.80, 95% CI 0.65-0.98), but not physical activity (OR 0.83, 95% CI 0.66-1.03). Neither being overweight nor obese was associated with the presence of hemorrhoids (OR 0.89, 95% CI 0.72-1.09 and OR 0.86, 95% CI 0.70-1.06). Conclusions Constipation is associated with an increased risk of hemorrhoids. Gravidity and physical activity do not appear to be associated. High grain fiber intake and sedentary behavior are associated with a decreased risk of hemorrhoids.	[Peery, Anne F.; Sandler, Robert S.; Galanko, Joseph A.; Baron, John A.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Bresalier, Robert S.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Figueiredo, Jane C.] Univ Calif Los Angeles, Keck Sch Med, Los Angeles, CA USA; [Ahnen, Dennis J.] Univ Colorado, Denver, CO 80202 USA; [Barry, Elizabeth L.; Baron, John A.] Geisel Sch Med Dartmouth, Hanover, NH USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Denver; Dartmouth College	Peery, AF (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA.	Anne_Peery@med.unc.edu	Barry, Elizabeth/AAB-7916-2019	Bresalier, Robert/0000-0002-9740-281X	National Institutes of Health [R01 CA098286]; National Center for Advancing Translational Sciences, National Institutes of Health [1KL2TR001109]; NATIONAL CANCER INSTITUTE [R01CA098286, P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by grants from the National Institutes of Health (R01 CA098286) and by the National Center for Advancing Translational Sciences, National Institutes of Health, Grant 1KL2TR001109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Coello P, 2006, AM J GASTROENTEROL, V101, P181, DOI 10.1111/j.1572-0241.2005.00359.x; Avsar AF, 2010, J OBSTET GYNAECOL, V30, P231, DOI 10.3109/01443610903439242; Bharucha AE, 2013, GASTROENTEROLOGY, V144, P218, DOI 10.1053/j.gastro.2012.10.028; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Delco F, 1998, DIS COLON RECTUM, V41, P1534, DOI 10.1007/BF02237302; Drossman DA, 1994, FUNCTIONAL GASTROINT; Everhart JE, 2009, GASTROENTEROLOGY, V136, P741, DOI 10.1053/j.gastro.2009.01.015; Ganz RA, 2013, CLIN GASTROENTEROL H, V11, P593, DOI 10.1016/j.cgh.2012.12.020; Johannsson HO, 2005, AM J GASTROENTEROL, V100, P401, DOI 10.1111/j.1572-0241.2005.40195.x; JOHANSON JF, 1994, AM J GASTROENTEROL, V89, P1981; JOHANSON JF, 1990, GASTROENTEROLOGY, V98, P380, DOI 10.1016/0016-5085(90)90828-O; Riss S, 2011, COLORECTAL DIS, V13, pE227, DOI 10.1111/j.1463-1318.2011.02632.x; Riss S, 2012, INT J COLORECTAL DIS, V27, P215, DOI 10.1007/s00384-011-1316-3; Saad RJ, 2010, AM J GASTROENTEROL, V105, P403, DOI 10.1038/ajg.2009.612; Waye JD, 1999, AM J GASTROENTEROL, V94, P1429, DOI 10.1111/j.1572-0241.1999.1429_a.x; Whitehead W. E., 1991, GASTROENTEROLOGY INT, V4, P99; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	18	36	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139100	10.1371/journal.pone.0139100	http://dx.doi.org/10.1371/journal.pone.0139100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406337	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700169
J	White, MJV; Gomer, RH				White, Michael J. V.; Gomer, Richard H.			Trypsin, Tryptase, and Thrombin Polarize Macrophages towards a Pro-Fibrotic M2a Phenotype	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; MAST-CELL TRYPTASE; UP-REGULATION; FIBROCYTE DIFFERENTIATION; ACTIVATED MACROPHAGES; EXPRESSION; FIBROSIS; INJURY; ORCHESTRATE; SECRETION	For both wound healing and the formation of a fibrotic lesion, circulating monocytes enter the tissue and differentiate into fibroblast-like cells called fibrocytes and pro-fibrotic M2a macrophages, which together with fibroblasts form scar tissue. Monocytes can also differentiate into classically activated M1 macrophages and alternatively activated M2 macrophages. The proteases thrombin, which is activated during blood clotting, and tryptase, which is released by activated mast cells, potentiate fibroblast proliferation and fibrocyte differentiation, but their effect on macrophages is unknown. Here we report that thrombin, tryptase, and the protease trypsin bias human macrophage differentiation towards a pro-fibrotic M2a phenotype expressing high levels of galectin-3 from unpolarized monocytes, or from M1 and M2 macrophages, and that these effects appear to operate through protease-activated receptors. These results suggest that proteases can initiate scar tissue formation by affecting fibroblasts, fibrocytes, and macrophages.	[White, Michael J. V.; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgomer@tamu.edu		Gomer, Richard/0000-0003-2361-4307; White, Michael/0000-0002-9615-2249	National Institutes of Health (NIH) [HL118507]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grant HL118507, "Pentraxin regulation of macrophage differentiation". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CK, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-139; Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; DAWES KE, 1993, EUR J CELL BIOL, V61, P126; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Devouassoux G, 1999, J ALLERGY CLIN IMMUN, V104, P811, DOI 10.1016/S0091-6749(99)70292-7; Drew Philip, 2007, Int Wound J, V4, P149, DOI 10.1111/j.1742-481X.2007.00337.x; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Duitman J, 2014, MOL MED, V20, P410, DOI 10.2119/molmed.2014.00027; EKLUND A, 1993, SARCOIDOSIS, V10, P12; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Gilpin SE, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-48; Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x; Gudbrandsdottir S, 2013, J IMMUNOL, V191, P4059, DOI 10.4049/jimmunol.1201103; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; Hermes B, 2000, J INVEST DERMATOL, V114, P51, DOI 10.1046/j.1523-1747.2000.00837.x; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McGaha TL, 2003, ARTHRITIS RHEUM-US, V48, P2275, DOI 10.1002/art.11089; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naldini A, 2005, J LEUKOCYTE BIOL, V78, P736, DOI 10.1189/jlb.0205082; Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Pesci A, 1996, CHEST, V110, P383, DOI 10.1378/chest.110.2.383; PILCHER BK, 1994, EXP CELL RES, V211, P368, DOI 10.1006/excr.1994.1100; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Undas A, 2001, BLOOD, V98, P2423, DOI 10.1182/blood.V98.8.2423; Vowden Kathryn R, 2009, J Tissue Viability, V18, P7, DOI 10.1016/j.jtv.2008.11.004; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WALLS AF, 1991, CLIN SCI, V81, P183, DOI 10.1042/cs0810183; Weiclenbusch M, 2012, J INNATE IMMUN, V4, P463, DOI 10.1159/000336717; White MJV, 2015, J IMMUNOL, V195, P1858, DOI 10.4049/jimmunol.1500365; White MJV, 2015, J IMMUNOL, V194, P142, DOI 10.4049/jimmunol.1401777; White MJV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070795; White MJ, 2014, J IMMUNOLOGY; Wygrecka M, 2013, AM J PATHOL, V182, P2094, DOI 10.1016/j.ajpath.2013.02.013; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412	64	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138748	10.1371/journal.pone.0138748	http://dx.doi.org/10.1371/journal.pone.0138748			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407067	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700084
J	Varasteh, S; Braber, S; Akbari, P; Garssen, J; Fink-Gremmels, J				Varasteh, Soheil; Braber, Saskia; Akbari, Peyman; Garssen, Johan; Fink-Gremmels, Johanna			Differences in Susceptibility to Heat Stress along the Chicken Intestine and the Protective Effects of Galacto-Oligosaccharides	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTORS; BROILER-CHICKENS; GROWTH-PERFORMANCE; MANNAN-OLIGOSACCHARIDES; IMPAIRS PERFORMANCE; LIPID-PEROXIDATION; PROBIOTIC MIXTURE; OXIDATIVE STRESS; EPITHELIAL-CELLS; LIPOIC ACID	High ambient temperatures negatively affect the human well-being as well as animal welfare and production. The gastrointestinal tract is predominantly responsive to heat stress. The currently available information about the multifaceted response to heat stress within different parts of the intestine is limited, especially in avian species. Hence, this study aims to evaluate the heat stress-induced sequence of events in the intestines of chickens. Furthermore, the gut health-promoting effect of dietary galacto-oligosaccharides (GOS) was investigated in these heat stress-exposed chickens. Chickens were fed a control diet or diet supplemented with 1% or 2.5% GOS (6 days) prior to and during a temperature challenge for 5 days (38-39 degrees C, 8h per day). The parameters measured in different parts of the intestines included the genes (qPCR) HSF1, HSF3, HSP70, HSP90, E-cadherin, claudin-1, claudin-5, ZO-1, occludin, TLR-2, TLR-4, IL-6, IL-8, HO-1, HIF-1 alpha) and their associated proteins HSP70, HSP90 and pan-cadherin (western blots). In addition, IL-6 and IL-8 plasma concentrations were measured by ELISA. In the jejunum, HSF3, HSP70, HSP90, E-cadherin, claudin-5, ZO-1, TLR-4, IL-6 and IL-8 mRNA expression and HSP70 protein expression were increased after heat stress exposure and a more pronounced increase in gene expression was observed in ileum after heat stress exposure, and in addition HSF1, claudin-1 and HIF1a mRNA levels were upregulated. Furthermore, the IL-8 plasma levels were decreased in chickens exposed to heat stress. Interestingly, the heat stress-related effects in the jejunum were prevented in chickens fed a GOS diet, while dietary GOS did not alter these effects in ileum. In conclusion, our results demonstrate the differences in susceptibility to heat stress along the intestine, where the most obvious modification in gene expression is observed in ileum, while dietary GOS only prevent the heat stress-related changes in jejunum.	[Varasteh, Soheil; Braber, Saskia; Akbari, Peyman; Fink-Gremmels, Johanna] Univ Utrecht, Div Vet Pharm Pharmacol & Toxicol, Utrecht, Netherlands; [Varasteh, Soheil; Akbari, Peyman; Garssen, Johan] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Garssen, Johan] Nutricia Res, Utrecht, Netherlands	Utrecht University; Utrecht University; Danone Nutricia	Braber, S (corresponding author), Univ Utrecht, Div Vet Pharm Pharmacol & Toxicol, Utrecht, Netherlands.	S.Braber@uu.nl	Fink-Gremmels, Johanna/G-3707-2012; garssen, johan/I-7159-2016; Begaud, Xavier/H-7141-2016	Begaud, Xavier/0000-0002-0731-1384				Akbari P, 2015, J NUTR, V145, P1604, DOI 10.3945/jn.114.209486; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Al-Sheraji SH, 2013, J FUNCT FOODS, V5, P1542, DOI 10.1016/j.jff.2013.08.009; Altan O, 2003, BRIT POULTRY SCI, V44, P545, DOI 10.1080/00071660310001618334; BAILEY JS, 1991, POULTRY SCI, V70, P2433, DOI 10.3382/ps.0702433; Baurhoo B, 2007, POULTRY SCI, V86, P1070, DOI 10.1093/ps/86.6.1070; Bruno-Barcena JM, 2015, J FUNCT FOODS, V12, P92, DOI 10.1016/j.jff.2014.10.029; Chausse AM, 2011, INFECT IMMUN, V79, P3445, DOI 10.1128/IAI.00025-11; Chen WS, 2013, J BIOL CHEM, V288, P9001, DOI 10.1074/jbc.M112.437897; Cray JA, 2013, ENVIRON MICROBIOL, V15, P287, DOI 10.1111/1462-2920.12018; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Deeb N, 2002, J HERED, V93, P107, DOI 10.1093/jhered/93.2.107; Gribar SC, 2008, MOL MED, V14, P645, DOI 10.2119/2008-00035.Gribar; Gu XH, 2012, POULTRY SCI, V91, P790, DOI 10.3382/ps.2011-01628; Habibian M, 2016, BIOL TRACE ELEM RES, V169, P142, DOI 10.1007/s12011-015-0404-6; Hamano Y, 2014, BRIT POULTRY SCI, V55, P343, DOI 10.1080/00071668.2014.903559; Hao Y, 2012, POULTRY SCI, V91, P781, DOI 10.3382/ps.2011-01627; Imik H, 2012, BRIT POULTRY SCI, V53, P800, DOI 10.1080/00071668.2012.740615; Jeurink PV, 2013, AM J CLIN NUTR, V98, p572S, DOI 10.3945/ajcn.112.038596; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Jung SJ, 2008, POULTRY SCI, V87, P1694, DOI 10.3382/ps.2007-00489; Lambert GP, 2002, J APPL PHYSIOL, V92, P1750, DOI 10.1152/japplphysiol.00787.2001; Lang BJ, 2012, CELL STRESS CHAPERON, V17, P765, DOI 10.1007/s12192-012-0349-z; Lara Lucas J, 2013, Animals (Basel), V3, P356, DOI 10.3390/ani3020356; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Luo XJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2399; Maloyan A, 2005, PHYSIOL GENOMICS, V23, P79, DOI 10.1152/physiolgenomics.00279.2004; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Naito Y, 2011, J CLIN BIOCHEM NUTR, V48, P126, DOI 10.3164/jcbn.10-61; Ortega-Gonzalez M, 2014, MOL NUTR FOOD RES, V58, P384, DOI 10.1002/mnfr.201300296; Osselaere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069014; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Peterson CY, 2010, SURG INFECT, V11, P137, DOI 10.1089/sur.2009.053; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Quinteiro WM, 2012, AVIAN PATHOL, V41, P421, DOI 10.1080/03079457.2012.709315; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Santos RR, 2015, AVIAN PATHOL, V44, P19, DOI 10.1080/03079457.2014.988122; Settar P, 1999, POULTRY SCI, V78, P1353, DOI 10.1093/ps/78.10.1353; Sohail MU, 2012, POULTRY SCI, V91, P2235, DOI 10.3382/ps.2012-02182; Song J, 2014, POULTRY SCI, V93, P581, DOI 10.3382/ps.2013-03455; Spring P, 2000, POULTRY SCI, V79, P205, DOI 10.1093/ps/79.2.205; Stacchiotti A, 2004, HISTOL HISTOPATHOL, V19, P1209, DOI 10.14670/HH-19.1209; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Stocki P, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/617213; Syafwan S, 2011, WORLD POULTRY SCI J, V67, P653, DOI 10.1017/S0043933911000742; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Tanabe M, 1997, J BIOL CHEM, V272, P15389, DOI 10.1074/jbc.272.24.15389; Tomasello G, 2011, EUR J HISTOCHEM, V55, P210, DOI 10.4081/ejh.2011.e38; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; van der Hoeven-Hangoor E, 2013, POULTRY SCI, V92, P2713, DOI 10.3382/ps.2013-03017; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; van Eden W, 2015, ENDOCR METAB IMMUNE, V15, P31, DOI 10.2174/1871530314666140922145333; Varasteh S, 2015, J FUNCT FOODS, V16, P265, DOI 10.1016/j.jff.2015.04.045; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Vos AP, 2007, CRIT REV IMMUNOL, V27, P97, DOI 10.1615/CritRevImmunol.v27.i2.10; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wyatt TT, 2015, ENVIRON MICROBIOL, V17, P395, DOI 10.1111/1462-2920.12558; Xie JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102204; Xu DN, 2015, BIOL TRACE ELEM RES, V168, P235, DOI 10.1007/s12011-015-0351-2; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176; Zhang WW, 2014, GENET MOL RES, V13, P9787, DOI 10.4238/2014.November.27.6; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771; Zhong Y, 2009, CLIN NUTR, V28, P575, DOI 10.1016/j.clnu.2009.04.026	68	132	137	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138975	10.1371/journal.pone.0138975	http://dx.doi.org/10.1371/journal.pone.0138975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402906	Green Published, Green Submitted, gold			2022-12-27	WOS:000361798100046
J	Mancino, ME; Recchioni, MC				Mancino, Maria Elvira; Recchioni, Maria Cristina			Fourier Spot Volatility Estimator: Asymptotic Normality and Efficiency with Liquid and Illiquid High-Frequency Data	PLOS ONE			English	Article							STOCHASTIC VOLATILITY; INTEGRATED VOLATILITY; VARIANCE; OPTIONS; PRICES	The recent availability of high frequency data has permitted more efficient ways of computing volatility. However, estimation of volatility from asset price observations is challenging because observed high frequency data are generally affected by noise-microstructure effects. We address this issue by using the Fourier estimator of instantaneous volatility introduced in Malliavin and Mancino 2002. We prove a central limit theorem for this estimator with optimal rate and asymptotic variance. An extensive simulation study shows the accuracy of the spot volatility estimates obtained using the Fourier estimator and its robustness even in the presence of different microstructure noise specifications. An empirical analysis on high frequency data (U.S. S&P500 and FIB 30 indices) illustrates how the Fourier spot volatility estimates can be successfully used to study intraday variations of volatility and to predict intraday Value at Risk.	[Mancino, Maria Elvira] Univ Florence, Dept Econ & Management, Florence, Italy; [Recchioni, Maria Cristina] Polytech Univ Marche, Dept Management, Ancona, Italy	University of Florence; Marche Polytechnic University	Recchioni, MC (corresponding author), Polytech Univ Marche, Dept Management, Ancona, Italy.	m.c.recchioni@univpm.it	Mancino, Maria Elvira/AAF-7860-2020		European 543 Union, Seventh Framework Programme FP7 [612955]	European 543 Union, Seventh Framework Programme FP7	The research leading to these results has been partially supported by the European 543 Union, Seventh Framework Programme FP7, under grant agreement FinMaP no. 612955.	Alfarano S., 2005, Computational Economics, V26, P19, DOI 10.1007/s10614-005-6415-1; Andersen TG, 2001, J AM STAT ASSOC, V96, P42, DOI 10.1198/016214501750332965; Andersen TG, 2010, HANDB FINANC, P67, DOI 10.1016/B978-0-444-50897-3.50005-5; Bandi FM, 2006, J FINANC ECON, V79, P655, DOI 10.1016/j.jfineco.2005.01.005; Barndorff-Nielsen OE, 2009, ECONOMET J, V12, pC1, DOI 10.1111/j.1368-423X.2008.00275.x; Barndorff-Nielsen OE, 2002, J R STAT SOC B, V64, P253, DOI 10.1111/1467-9868.00336; Barndorff-Nielsen OE, 2008, ECONOMETRICA, V76, P1481, DOI 10.3982/ECTA6495; Barucci E., 2001, J INT FINANC MARK I, V12, P183, DOI DOI 10.1016/S1042-4431(02); Barucci E, 2010, INT J THEOR APPL FIN, V13, P767, DOI 10.1142/S0219024910005991; Bibinger M, 2015, J ECONOMETRICS, V184, P361, DOI 10.1016/j.jeconom.2014.10.004; Brock WA, 1997, ECONOMETRICA, V65, P1059, DOI 10.2307/2171879; Clement E, 2011, STOCH PROC APPL, V121, P1097, DOI 10.1016/j.spa.2010.11.016; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; Cuchiero C, 2015, STOCH PROC APPL, V125, P116, DOI 10.1016/j.spa.2014.07.023; Curato IV, 2014, SPOT VOLATILITY ESTI; Delattre S, 1997, BERNOULLI, V3, P1, DOI 10.2307/3318650; EPPS TW, 1979, J AM STAT ASSOC, V74, P291, DOI 10.2307/2286325; Fan JQ, 2008, STAT INTERFACE, V1, P279; Foster DP, 1996, ECONOMETRICA, V64, P139, DOI 10.2307/2171927; Gontis V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102201; Griffin JE, 2011, J ECONOMETRICS, V160, P58, DOI 10.1016/j.jeconom.2010.03.015; Hansen PR, 2006, J BUS ECON STAT, V24, P127, DOI 10.1198/073500106000000071; HESTON SL, 1993, REV FINANC STUD, V6, P327, DOI 10.1093/rfs/6.2.327; HULL J, 1987, J FINANC, V42, P281, DOI 10.1111/j.1540-6261.1987.tb02568.x; Jacod J., 1997, SEMINAIRE PROBABILIT, P232, DOI [10.1007/BFb0119308, DOI 10.1007/BFB0119308]; Jacod J, 1994, LIMIT RANDOM MEASURE; KIRMAN A, 1993, Q J ECON, V108, P137, DOI 10.2307/2118498; Kristensen D, 2010, ECONOMET THEOR, V26, P60, DOI 10.1017/S0266466609090616; Li YY, 2015, J FINANC ECONOMET, V13, P478, DOI 10.1093/jjfinec/nbu005; Malliavin P, 2002, FINANC STOCH, V6, P49, DOI 10.1007/s780-002-8400-6; Malliavin P, 2009, ANN STAT, V37, P1983, DOI 10.1214/08-AOS633; Mancini C, 2015, FINANC STOCH, V19, P261, DOI 10.1007/s00780-015-0255-1; Mancino ME, 2008, COMPUT STAT DATA AN, V52, P2966, DOI 10.1016/j.csda.2007.07.014; Nielsen MO, 2008, J EMPIR FINANC, V15, P265, DOI 10.1016/j.jempfin.2006.12.005; Park S, ESTIMATING QUADRATIC; Precup OV, 2004, PHYSICA A, V344, P252, DOI 10.1016/j.physa.2004.06.127; STEIN EM, 1991, REV FINANC STUD, V4, P727, DOI 10.1093/rfs/4.4.727; Tedeschi G, 2009, EUR PHYS J B, V71, P489, DOI 10.1140/epjb/e2009-00337-6; Tedeschi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052749; Tedeschi G, 2012, J ECON BEHAV ORGAN, V81, P82, DOI 10.1016/j.jebo.2011.09.006; Toth B, 2009, PHYSICA A, V388, P1696, DOI 10.1016/j.physa.2008.12.062; Voss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118308; Zhang L, 2005, J AM STAT ASSOC, V100, P1394, DOI 10.1198/016214505000000169; Zheng ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102940; Zu Y, 2014, J ECONOMETRICS, V181, P117, DOI 10.1016/j.jeconom.2014.04.001	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139041	10.1371/journal.pone.0139041	http://dx.doi.org/10.1371/journal.pone.0139041			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26421617	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700065
J	Schenberg, EE; Alexandre, JFM; Filev, R; Cravo, AM; Sato, JR; Muthukumaraswamy, SD; Yonamine, M; Waguespack, M; Lomnicka, I; Barker, SA; da Silveira, DX				Schenberg, Eduardo Ekman; Morel Alexandre, Joao Felipe; Filev, Renato; Cravo, Andre Mascioli; Sato, Joao Ricardo; Muthukumaraswamy, Suresh D.; Yonamine, Mauricio; Waguespack, Marian; Lomnicka, Izabela; Barker, Steven A.; da Silveira, Dartiu Xavier			Acute Biphasic Effects of Ayahuasca	PLOS ONE			English	Article							PSYCHOACTIVE BEVERAGE AYAHUASCA; AMERICAN HALLUCINOGENIC PLANTS; MONOAMINE-OXIDASE INHIBITORS; BETA-CARBOLINES; BANISTERIOPSIS-CAAPI; HARMALA ALKALOIDS; SELF-LOCATION; EEG; N,N-DIMETHYLTRYPTAMINE; BINDING	Ritual use of ayahuasca, an amazonian Amerindian medicine turned sacrament in syncretic religions in Brazil, is rapidly growing around the world. Because of this internationalization, a comprehensive understanding of the pharmacological mechanisms of action of the brew and the neural correlates of the modified states of consciousness it induces is important. Employing a combination of electroencephalogram (EEG) recordings and quantification of ayahuasca's compounds and their metabolites in the systemic circulation we found ayahuasca to induce a biphasic effect in the brain. This effect was composed of reduced power in the alpha band (8-13 Hz) after 50 minutes from ingestion of the brew and increased slow- and fast-gamma power (30-50 and 50-100 Hz, respectively) between 75 and 125 minutes. Alpha power reductions were mostly located at left parieto-occipital cortex, slow-gamma power increase was observed at left centro-parieto-occipital, left fronto-temporal and right frontal cortices while fast-gamma increases were significant at left centro-parieto-occipital, left fronto-temporal, right frontal and right parieto-occipital cortices. These effects were significantly associated with circulating levels of ayahuasca's chemical compounds, mostly N, N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine and some of their metabolites. An interpretation based on a cognitive and emotional framework relevant to the ritual use of ayahuasca, as well as it's potential therapeutic effects is offered.	[Schenberg, Eduardo Ekman; Filev, Renato; da Silveira, Dartiu Xavier] Univ Fed Sao Paulo, Dept Psiquiatria, Sao Paulo, Brazil; [Morel Alexandre, Joao Felipe; Cravo, Andre Mascioli; Sato, Joao Ricardo] Univ Fed ABC, Ctr Matemat Comp & Cognicao, Santo Andre, Brazil; [Muthukumaraswamy, Suresh D.] Univ Auckland, Sch Pharm, Auckland 1, New Zealand; [Muthukumaraswamy, Suresh D.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Yonamine, Mauricio] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Waguespack, Marian; Lomnicka, Izabela; Barker, Steven A.] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC); University of Auckland; University of Auckland; Universidade de Sao Paulo; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Schenberg, EE (corresponding author), Inst Plantando Consciencia, Sao Paulo, Brazil.	eduardoschenberg@gmail.com	Cravo, Andre M/B-8874-2014; Yonamine, Mauricio/C-6316-2012; Cravo, Andre/C-7966-2013	Cravo, Andre M/0000-0002-8580-5697; Yonamine, Mauricio/0000-0002-4615-1088; Cravo, Andre/0000-0002-8580-5697; Schenberg, Eduardo/0000-0001-7111-9891; Sato, Joao Ricardo/0000-0002-7503-9781; Muthukumaraswamy, Suresh/0000-0001-7042-3920	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/11341-8, 2012/07699-7, 2014/07540-3, 2015/13536-1]; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) grants 2011/11341-8 (EES), 2012/07699-7 (DXS), 2014/07540-3 (EES) and 2015/13536-1 (DXS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN MM, 1981, MED BIOL, V59, P190; Berntson GG, 2003, EUR J NEUROSCI, V18, P2103, DOI 10.1046/j.1460-9568.2003.02967.x; Brierley DI, 2012, PROG NEURO-PSYCHOPH, V39, P263, DOI 10.1016/j.pnpbp.2012.06.001; Callaway JC, 2005, J PSYCHOACTIVE DRUGS, V37, P151, DOI 10.1080/02791072.2005.10399796; Callaway JC, 1999, J ETHNOPHARMACOL, V65, P243, DOI 10.1016/S0378-8741(98)00168-8; Callaway JC, 2005, J PSYCHOACTIVE DRUGS, V37, P145, DOI 10.1080/02791072.2005.10399795; Callaway JC, 2005, J PSYCHOACTIVE DRUGS, V37, P157, DOI 10.1080/02791072.2005.10399797; Callaway JC, 1996, J ANAL TOXICOL, V20, P492, DOI 10.1093/jat/20.6.492; Castellano M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00064; Cozzi NV, 2009, J NEURAL TRANSM, V116, P1591, DOI 10.1007/s00702-009-0308-8; DAVIDSON RJ, 1988, INT J NEUROSCI, V39, P71, DOI 10.3109/00207458808985694; Davis W., 2014, ONE RIVER; de Araujo DB, 2012, HUM BRAIN MAPP, V33, P2550, DOI 10.1002/hbm.21381; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Don NS, 1998, PHYTOMEDICINE, V5, P87, DOI 10.1016/S0944-7113(98)80003-2; dos Santos RG, 2012, PSYCHOPHARMACOLOGY, V219, P1039, DOI 10.1007/s00213-011-2434-x; Erritzoe D, 2009, NEUROIMAGE, V46, P23, DOI 10.1016/j.neuroimage.2009.01.050; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Frecska E, 2013, J NEURAL TRANSM, V120, P1295, DOI 10.1007/s00702-013-1024-y; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gatch MB, 2009, PSYCHOPHARMACOLOGY, V204, P715, DOI 10.1007/s00213-009-1501-z; Ginovart N, 2006, J CEREBR BLOOD F MET, V26, P330, DOI 10.1038/sj.jcbfm.9600197; Glennon RA, 2000, DRUG ALCOHOL DEPEN, V60, P121, DOI 10.1016/S0376-8716(99)00148-9; Glennon RA, 2004, BIOORG MED CHEM LETT, V14, P999, DOI 10.1016/j.bmcl.2003.11.078; Grella B, 2003, BIOORG MED CHEM LETT, V13, P4421, DOI 10.1016/j.bmcl.2003.09.027; Grella B, 1998, DRUG ALCOHOL DEPEN, V50, P99, DOI 10.1016/S0376-8716(97)00163-4; Grob CS, 1996, J NERV MENT DIS, V184, P86, DOI 10.1097/00005053-199602000-00004; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Herraiz T, 2010, FOOD CHEM TOXICOL, V48, P839, DOI 10.1016/j.fct.2009.12.019; Herraiz T, 2014, BIOCHEM BIOPH RES CO, V451, P42, DOI 10.1016/j.bbrc.2014.07.047; Hoffmann E, 2001, MAPS B, V11, P25; Holmstedt B, 1967, Psychopharmacol Bull, V4, P16; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jiang XL, 2013, DRUG METAB DISPOS, V41, P975, DOI 10.1124/dmd.112.050724; Johnson MW, 2008, J PSYCHOPHARMACOL, V22, P603, DOI 10.1177/0269881108093587; Keeley PW, 2011, NAUSEA AND VOMITING; Kometer M, 2013, J NEUROSCI, V33, P10544, DOI 10.1523/JNEUROSCI.3007-12.2013; Labate BC, 2012, INT J DRUG POLICY, V23, P154, DOI 10.1016/j.drugpo.2011.06.006; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; McIlhenny EH, 2012, BIOMED CHROMATOGR, V26, P301, DOI 10.1002/bmc.1657; McIlhenny EH, 2009, J CHROMATOGR A, V1216, P8960, DOI 10.1016/j.chroma.2009.10.088; MCKENNA DJ, 1984, J ETHNOPHARMACOL, V10, P195, DOI 10.1016/0378-8741(84)90003-5; MCKENNA DJ, 1984, J ETHNOPHARMACOL, V12, P179, DOI 10.1016/0378-8741(84)90048-5; Metzner R, 1998, J PSYCHOACTIVE DRUGS, V30, P333; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Mizumoto S, 2011, REV PSIQ CLIN-BRAZIL, V38, P231; Morillas-Romero A, 2013, CLIN EEG NEUROSCI, V44, P188, DOI 10.1177/1550059412465871; Muthukumaraswamy SD, 2013, J NEUROSCI, V33, P15171, DOI 10.1523/JNEUROSCI.2063-13.2013; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Napadow V, 2013, CEREB CORTEX, V23, P806, DOI 10.1093/cercor/bhs073; Naranjo C, 1967, Psychopharmacol Bull, V4, P16; Naranjo C., 1967, ETHNOPHARMACOLOGIC S; Naranjo C., 1987, J MENTAL IMAGERY, V11, P131; Naranjo P., 1959, REV CONFEDERACION ME, V6, P1; Nelson SM, 2013, NEUROSCIENTIST, V19, P578, DOI 10.1177/1073858413492389; Nexus D., ENTHEOGENIC EFFECTS; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ott J, 1999, J PSYCHOACTIVE DRUGS, V31, P171, DOI 10.1080/02791072.1999.10471741; PENNES HH, 1957, AM J PSYCHIAT, V113, P887, DOI 10.1176/ajp.113.10.887; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pharmahuasca Ott J., 1997, YB ETHNOMEDICINE, P1; Popov T, 2012, PSYCHOPHYSIOLOGY, V49, P1545, DOI 10.1111/j.1469-8986.2012.01484.x; Riba J, 2006, PSYCHOPHARMACOLOGY, V186, P93, DOI 10.1007/s00213-006-0358-7; Riba J, 2005, J PSYCHOACTIVE DRUGS, V37, P219, DOI 10.1080/02791072.2005.10399804; Riba J, 2004, NEUROPSYCHOBIOLOGY, V50, P89, DOI 10.1159/000077946; Riba J, 2002, BRIT J CLIN PHARMACO, V53, P613, DOI 10.1046/j.1365-2125.2002.01609.x; Riba J, 2012, DRUG TEST ANAL, V4, P610, DOI 10.1002/dta.1344; RIVIER L, 1972, ECON BOT, V26, P101, DOI 10.1007/BF02860772; Rodd R, 2008, J PSYCHOACTIVE DRUGS, V40, P301, DOI 10.1080/02791072.2008.10400645; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sacher J, 2012, J CEREBR BLOOD F MET, V32, P443, DOI 10.1038/jcbfm.2011.184; Samoylenko V, 2010, J ETHNOPHARMACOL, V127, P357, DOI 10.1016/j.jep.2009.10.030; Sandkuhler S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001459; Schmid JT, 2014, HEALING AYAHUASCA NO, P77; Schultes R. E, 1973, BOT CHEM HALLUCINOGE; SCHULTES RE, 1969, SCIENCE, V163, P245, DOI 10.1126/science.163.3864.245; Serino A, 2013, CONSCIOUS COGN, V22, P1239, DOI 10.1016/j.concog.2013.08.013; Shanon B., 2013, THERAPEUTIC USE AYAH, P59; Shen HW, 2010, CURR DRUG METAB, V11, P659, DOI 10.2174/138920010794233495; Shepard GH, 1998, J PSYCHOACTIVE DRUGS, V30, P321; SHULGIN AT, 1977, J PSYCHEDEL DRUG, V9, P79, DOI 10.1080/02791072.1977.10472029; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Smith RL, 1998, PHARMACOL BIOCHEM BE, V61, P323, DOI 10.1016/S0091-3057(98)00110-5; Stuckey DE, 2005, J PSYCHOACTIVE DRUGS, V37, P163, DOI 10.1080/02791072.2005.10399798; Szara Stephen, 2007, Neuropsychopharmacol Hung, V9, P201; Tupper KW, 2014, CURRENT DRUG ABUSE R, P1; Vitale AA, 2011, J NUCL MED, V52, P970, DOI 10.2967/jnumed.110.083246; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Voss U, 2014, NAT NEUROSCI, V17, P810, DOI 10.1038/nn.3719; Voss U, 2009, SLEEP, V32, P1191, DOI 10.1093/sleep/32.9.1191; Wallach JV, 2009, MED HYPOTHESES, V72, P91, DOI 10.1016/j.mehy.2008.07.052; Zhao T, 2012, FOOD CHEM, V134, P1096, DOI 10.1016/j.foodchem.2012.03.024	97	55	56	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137202	10.1371/journal.pone.0137202	http://dx.doi.org/10.1371/journal.pone.0137202			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421727	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700010
J	Sobey, CG; Judkins, CP; Sundararajan, V; Phan, TG; Drummond, GR; Srikanth, VK				Sobey, Christopher G.; Judkins, Courtney P.; Sundararajan, Vijaya; Phan, Thanh G.; Drummond, Grant R.; Srikanth, Velandai K.			Risk of Major Cardiovascular Events in People with Down Syndrome	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; INTELLECTUAL DISABILITY; UNITED-STATES; OLDER-PEOPLE; STROKE; SURVIVAL; MOYAMOYA	Background Improved medical care over more than five decades has markedly increased life expectancy, from 12 years to approximately 60 years, in people with Down syndrome (DS). With increased survival into late adulthood, there is now a greater need for the medical care of people with DS to prevent and treat aging-related disorders. In the wider population, acquired cardiovascular diseases such as stroke and coronary heart disease are common with increasing age, but the risks of these diseases in people with DS are unknown. There are no population-level data on the incidence of acquired major cerebrovascular and coronary diseases in DS, and no data examining how cardiovascular comorbidities or risk factors in DS might impact on cardiovascular event incidence. Such data would be also valuable to inform health care planning for people with DS. Our objective was therefore to conduct a population-level matched cohort study to quantify the risk of incident major cardiovascular events in DS. Methods and Findings A population-level matched cohort study compared the risk of incident cardiovascular events between hospitalized patients with and without DS, adjusting for sex, and vascular risk factors. The sample was derived from hospitalization data within the Australian state of Victoria from 1993-2010. For each DS admission, 4 exact age-matched non-DS admissions were randomly selected from all hospitalizations within a week of the relevant DS admission to form the comparison cohort. There were 4,081 people with DS and 16,324 without DS, with a total of 212,539 person-years of observation. Compared to the group without DS, there was a higher prevalence in the DS group of congenital heart disease, cardiac arrhythmia, dementia, pulmonary hypertension, diabetes and sleep apnea, and a lower prevalence of ever-smoking. DS was associated with a greater risk of incident cerebrovascular events (Risk Ratio, RR 2.70, 95% CI 2.08, 3.53) especially among females (RR 3.31, 95% CI 2.21, 4.94) and patients aged <= 50 years old. The association of DS with ischemic strokes was substantially attenuated on adjustment for cardioembolic risk (RR 1.93, 95% CI 1.04, 3.20), but unaffected by adjustment for atherosclerotic risk. DS was associated with a 40-70% reduced risk of any coronary event in males (RR 0.58, 95% CI 0.40, 0.84) but not in females (RR 1.14, 95% CI 0.73, 1.77). Conclusions DS is associated with a high risk of stroke, expressed across all ages. Ischemic stroke risk in DS appears mostly driven by cardioembolic risk. The greater risk of hemorrhagic stroke and lower risk of coronary events (in males) in DS remain unexplained.	[Sobey, Christopher G.; Judkins, Courtney P.; Drummond, Grant R.] Monash Univ, Biomed Discovery Inst, Cardiovac Dis Program, Clayton, Vic, Australia; [Sobey, Christopher G.; Drummond, Grant R.] Monash Univ, Southern Clin Sch, Dept Surg, Monash Med Ctr, Clayton, Vic, Australia; [Sundararajan, Vijaya; Phan, Thanh G.; Srikanth, Velandai K.] Monash Univ, Monash Hlth, Sch Clin Sci, Stroke & Ageing Res Grp,Dept Med, Clayton, Vic, Australia; [Sundararajan, Vijaya] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Phan, Thanh G.; Srikanth, Velandai K.] Monash Hlth, Stroke Unit, Melbourne, Vic, Australia; [Srikanth, Velandai K.] Menzies Res Inst, Hobart, Tas, Australia	Monash University; Monash University; Monash University; St Vincent's Hospital Melbourne; University of Melbourne; University of Tasmania; Menzies Institute for Medical Research	Sobey, CG (corresponding author), Monash Univ, Biomed Discovery Inst, Cardiovac Dis Program, Clayton, Vic, Australia.	chris.sobey@monash.edu	Sobey, Christopher G/A-2786-2008	Sobey, Christopher G/0000-0001-6525-9097; Drummond, Grant/0000-0001-8556-9738; Srikanth, Velandai/0000-0002-8442-8981	National Health and Medical Research Council of Australia (NHMRC) [APP1079467, APP1006017]; NHMRC Career Development Fellowship [APP1061457]; Heart Foundation Future Leader Fellowship [100089]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation Future Leader Fellowship	CGS and GRD are supported by Senior Research Fellowships from the National Health and Medical Research Council of Australia (NHMRC; ID Nos. APP1079467 and APP1006017, respectively). VKS is supported by an NHMRC Career Development Fellowship (APP1061457) and a Heart Foundation Future Leader Fellowship (ID 100089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, VICT REG BIRTHS DEAT; Baraona F, 2013, AM J CARDIOL, V111, P1046, DOI 10.1016/j.amjcard.2012.12.025; Barnhart RC, 2007, PHYS THER, V87, P1399, DOI 10.2522/ptj.20060334; BRATTSTROM L, 1987, LANCET, V1, P391; Cramer SC, 1996, STROKE, V27, P2131, DOI 10.1161/01.STR.27.11.2131; de Graaf G, 2015, AM J MED GENET A, V167, P756, DOI 10.1002/ajmg.a.37001; de Winter CF, 2012, RES DEV DISABIL, V33, P1722, DOI 10.1016/j.ridd.2012.04.010; de Winter CF, 2012, RES DEV DISABIL, V33, P398, DOI 10.1016/j.ridd.2011.09.022; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; Haesebaert J, 2013, STROKE, V44, P1770, DOI 10.1161/STROKEAHA.113.001300; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Irving CA, 2012, ARCH DIS CHILD, V97, P326, DOI 10.1136/adc.2010.210534; Kainth DS, 2013, NEUROSURGERY, V72, P210, DOI 10.1227/NEU.0b013e31827b9beb; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; MIETTINEN OS, 1969, BIOMETRICS, V25, P339, DOI 10.2307/2528794; MURDOCH JC, 1977, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.6081.226; PENROSE LS, 1949, J MENT SCI, V95, P685, DOI 10.1192/bjp.95.400.685; Rodan L, 2012, ANN NEUROL, V72, P103, DOI 10.1002/ana.23574; Sacco S, 2013, STROKE, V44, P1766, DOI 10.1161/STROKEAHA.113.001742; Tyrrell J, 2001, INT J GERIATR PSYCH, V16, P1168, DOI 10.1002/gps.502; Vis JC, 2009, J INTELL DISABIL RES, V53, P419, DOI 10.1111/j.1365-2788.2009.01158.x; YLAHERTTUALA S, 1989, ATHEROSCLEROSIS, V76, P269, DOI 10.1016/0021-9150(89)90110-X	22	71	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137093	10.1371/journal.pone.0137093	http://dx.doi.org/10.1371/journal.pone.0137093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421620	gold, Green Published			2022-12-27	WOS:000362175700009
J	Mikulska, JE				Mikulska, Joanna E.			Analysis of Response Elements Involved in the Regulation of the Human Neonatal Fc Receptor Gene (FCGRT) (vol 10, e0135141, 2015)	PLOS ONE			English	Correction														Mikulska, Joanna/0000-0002-5953-7473				Mikulska JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135141	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139744	10.1371/journal.pone.0139744	http://dx.doi.org/10.1371/journal.pone.0139744			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418416	gold, Green Published			2022-12-27	WOS:000362171400098
J	Rodriguez-Sickert, C; Cosmelli, D; Claro, F; Fuentes, MA				Rodriguez-Sickert, Carlos; Cosmelli, Diego; Claro, Francisco; Angel Fuentes, Miguel			The Underlying Social Dynamics of Paradigm Shifts	PLOS ONE			English	Article							EVOLUTION; MODEL	We develop here a multi-agent model of the creation of knowledge (scientific progress or technological evolution) within a community of researchers devoted to such endeavors. In the proposed model, agents learn in a physical-technological landscape, and weight is attached to both individual search and social influence. We find that the combination of these two forces together with random experimentation can account for both i) marginal change, that is, periods of normal science or refinements on the performance of a given technology (and in which the community stays in the neighborhood of the current paradigm); and ii) radical change, which takes the form of scientific paradigm shifts (or discontinuities in the structure of performance of a technology) that is observed as a swift migration of the knowledge community towards the new and superior paradigm. The efficiency of the search process is heavily dependent on the weight that agents posit on social influence. The occurrence of a paradigm shift becomes more likely when each member of the community attaches a small but positive weight to the experience of his/her peers. For this parameter region, nevertheless, a conservative force is exerted by the representatives of the current paradigm. However, social influence is not strong enough to seriously hamper individual discovery, and can act so as to empower successful individual pioneers who have conquered the new and superior paradigm.	[Rodriguez-Sickert, Carlos] UDD, Ctr Invest Complejidad Social, Fac Gobierno, Santiago, Chile; [Cosmelli, Diego] Pontificia Univ Catolica Chile, Escuela Psicol, Fac Ciencias Sociales, Santiago, Chile; [Cosmelli, Diego] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencias, Santiago, Chile; [Claro, Francisco] Pontificia Univ Catolica Chile, Fac Fis, Santiago, Chile; [Angel Fuentes, Miguel] Santa Fe Inst, Santa Fe, NM 87501 USA; [Angel Fuentes, Miguel] Inst Invest Filosof, RA-1428 Buenos Aires, DF, Argentina; [Angel Fuentes, Miguel] Univ San Sebastian, Santiago 7510157, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; The Santa Fe Institute; Universidad San Sebastian	Rodriguez-Sickert, C (corresponding author), UDD, Ctr Invest Complejidad Social, Fac Gobierno, Santiago, Chile.	carodsic@gmail.com	Rodriguez-Sickert, Carlos/AAM-8128-2021; Fuentes, Miguel Angel/GYQ-5828-2022	Rodriguez-Sickert, Carlos/0000-0001-5102-7914; Fuentes, Miguel Angel/0000-0003-0833-1245	Universidad del Desarrollo: Proyecto Interfacultades; Fund for Innovation and Competitiveness (FIC) of the Chilean Ministry of Economy, Development and Tourism, through the Millennium Scientific Initiative [IS 130005-MIDAP]	Universidad del Desarrollo: Proyecto Interfacultades; Fund for Innovation and Competitiveness (FIC) of the Chilean Ministry of Economy, Development and Tourism, through the Millennium Scientific Initiative	CR-S and MAF thank grant from Universidad del Desarrollo: Proyecto Interfacultades. CR-S, DC and MAF thank CONICYT: Anillo en Complejidad Social SOC-1101. DC acknowledges financial support by the Fund for Innovation and Competitiveness (FIC) of the Chilean Ministry of Economy, Development and Tourism, through the Millennium Scientific Initiative, Grant number IS 130005-MIDAP. MAF thanks CONICYT: FONDECYT 1140278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GROUP GENIUS CREATIV; Bonabeau E., 2002, P NATL ACAD SCI USA, V99; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Eppstein MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049901; Feldman MW, 1996, ANTHROPOL SCI, V104, P209, DOI 10.1537/ase.104.209; Feldman R, 2006, PHILOS GOD; Foster R. N., 1986, INNOVATION ATTACKERS; Fuller S., 1998, SOCIAL EPISTEMOLOGY; Gouldman AI, 1999, KNOWLEDGE SOCIAL WOR; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hempel C., 1965, ASPECTS SCI EXPLANAT; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Kauffman S, 2000, J ECON BEHAV ORGAN, V43, P141, DOI 10.1016/S0167-2681(00)00114-1; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kuhn T., 1977, ESSENTIAL TENSION SE, DOI DOI 10.1086/AHR/83.5.1231; KUHN TS, 1962, SCIENCE, V136, P760, DOI 10.1126/science.136.3518.760; Lakatos I., 1978, METHODOLOGY SCI RES, DOI 10.1017/CBO9780511621123; Latour B., 2013, LAB LIFE CONSTRUCTIO; Mitroff II, 1976, METHOD OUTLINE ANARC; Molleman L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068153; Nabel GJ, 2009, SCIENCE, V326, P53, DOI 10.1126/science.1177637; Nelson K, 2003, MEMORY, V11, P125, DOI 10.1080/741938203; Perreault C, 2012, EVOL HUM BEHAV, V33, P449, DOI 10.1016/j.evolhumbehav.2011.12.007; Richerson P. J., 2004, NOT GENES ALONE CULT; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Servia-Rodriguez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114302; Silverberg G, 2005, J ECON DYN CONTROL, V29, P225, DOI 10.1016/j.jedc.2003.05.005; Smith ER, 2007, PERS SOC PSYCHOL REV, V11, P87, DOI 10.1177/1088868306294789; Thagard P., 1992, CONCEPTUAL REVOLUTIO; Utterback J., 1994, MASTERING DYNAMICS I	30	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138172	10.1371/journal.pone.0138172	http://dx.doi.org/10.1371/journal.pone.0138172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418255	gold, Green Submitted, Green Published			2022-12-27	WOS:000362171400011
J	Suzuki, K; Miyamoto, M; Miyamoto, T; Inoue, Y; Matsui, K; Nishida, S; Hayashida, K; Usui, A; Ueki, Y; Nakamura, M; Murata, M; Numao, A; Watanabe, Y; Suzuki, S; Hirata, K				Suzuki, Keisuke; Miyamoto, Masayuki; Miyamoto, Tomoyuki; Inoue, Yuichi; Matsui, Kentaro; Nishida, Shingo; Hayashida, Kenichi; Usui, Akira; Ueki, Yoichiro; Nakamura, Masaki; Murata, Momoyo; Numao, Ayaka; Watanabe, Yuji; Suzuki, Shiho; Hirata, Koichi			The Prevalence and Characteristics of Primary Headache and Dream-Enacting Behaviour in Japanese Patients with Narcolepsy or Idiopathic Hypersomnia: A Multi-Centre Cross-Sectional Study	PLOS ONE			English	Article							INCREASED FREQUENCY; DAYTIME SLEEPINESS; CHRONIC MIGRAINE; HALLUCINATIONS; QUESTIONNAIRE; MECHANISMS; DISORDERS; HISTAMINE; OBESITY; AURA	Background Because the prevalence and characteristics of primary headache have yet to be thoroughly studied in patients with hypersomnia disorders, including narcolepsy and idiopathic hypersomnia, we examined these parameters in the Japanese population. Methods In a multicentre cross-sectional survey, among 576 consecutive outpatients with sleep disorders, 68 narcolepsy patients and 35 idiopathic hypersomnia patients were included. Additionally, 61 healthy control subjects participated. Semi-structured headache questionnaires were administered to all participants. Results The patients with narcolepsy (52.9%) and idiopathic hypersomnia (77.1%) more frequently experienced headache than the healthy controls (24.6%; p<0.0001). The prevalence rates were 23.5%, 41.2% and 4.9% for migraine (p<0.0001) and 16.2%, 23.5% and 14.8% (p = 0.58) for tension-type headache among the narcolepsy patients, the idiopathic hypersomnia patients and the control subjects, respectively. Those who experienced migraine more frequently experienced excessive daytime sleepiness, defined as an Epworth Sleepiness Scale score of >= 10, than those who did not experience headache among the patients with narcolepsy (93.8% vs. 65.6%, p = 0.040) and idiopathic hypersomnia (86.7% vs. 37.5%, p = 0.026). Dream-enacting behaviour (DEB), as evaluated by the rapid eye movement sleep disorders questionnaire, was more frequently observed in the narcolepsy patients than in the idiopathic hypersomnia patients and the control subjects. An increased DEB frequency was observed in the narcolepsy patients with migraines compared to those without headache. Conclusions Migraines were frequently observed in patients with narcolepsy and idiopathic hypersomnia. DEB is a characteristic of narcolepsy patients. Further studies are required to assess the factors that contribute to migraines in narcolepsy and idiopathic hypersomnia patients.	[Suzuki, Keisuke; Numao, Ayaka; Watanabe, Yuji; Suzuki, Shiho; Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Shimotsuga, Tochigi, Japan; [Miyamoto, Masayuki] Dokkyo Med Univ, Sch Nursing, Shimotsuga, Tochigi, Japan; [Miyamoto, Tomoyuki] Dokkyo Med Univ, Dept Neurol, Koshigaya Hosp, Saitama, Japan; [Inoue, Yuichi; Matsui, Kentaro; Nishida, Shingo; Usui, Akira; Nakamura, Masaki] Yoyogi Sleep Disorder Ctr, Tokyo, Japan; [Hayashida, Kenichi; Ueki, Yoichiro] Sleep & Stress Clin, Tokyo, Japan; [Murata, Momoyo] Kokubunji Sakura Clin, Shimotsuga, Tochigi, Japan	Dokkyo Medical University; Dokkyo Medical University; Dokkyo Medical University	Suzuki, K (corresponding author), Dokkyo Med Univ, Dept Neurol, Shimotsuga, Tochigi, Japan.	keisuke@dokkyomed.ac.jp	Suzuki, Keisuke/I-5464-2014	Suzuki, Keisuke/0000-0003-0320-8993; Matsui, Kentaro/0000-0003-4538-5381	Japanese Society of Sleep Medicine; Sleep Stress Clinic; Kokubunji Sakura Clinic	Japanese Society of Sleep Medicine; Sleep Stress Clinic; Kokubunji Sakura Clinic	This study was supported by a grant from the Japanese Society of Sleep Medicine (Dr. K Suzuki was the recipient of a Young Investigator Award from the Japanese Society of Sleep Medicine in 2012). Sleep & Stress Clinic and Kokubunji Sakura Clinic provided support in the form of salaries for authors K Hayashida and YU and M Murata respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aiba S, 2010, CEPHALALGIA, V30, P962, DOI 10.1177/0333102409361213; Alberti A, 2006, SLEEP MED REV, V10, P431, DOI 10.1016/j.smrv.2006.03.003; Alstadhaug KB, 2014, HEADACHE, V54, P246, DOI 10.1111/head.12293; Barbanti P, 2013, SLEEP MED, V14, P278, DOI 10.1016/j.sleep.2012.10.022; Beck AT, 1996, PSYCHOL ASSESS; Bigal ME, 2007, NEUROLOGY, V68, P1851, DOI 10.1212/01.wnl.0000262045.11646.b1; Billiard M, 2007, SLEEP MED REV, V11, P377, DOI 10.1016/j.smrv.2007.04.001; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Dahmen N, 1999, NEUROLOGY, V52, P1291, DOI 10.1212/WNL.52.6.1291; Dahmen N, 2003, CEPHALALGIA, V23, P14, DOI 10.1046/j.1468-2982.2003.00343.x; DRAKE ME, 1990, HEADACHE, V30, P600, DOI 10.1111/j.1526-4610.1990.hed3009600.x; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, DOI 10.2147/NDT.S42182; Evers S, 2003, CEPHALALGIA, V23, P786, DOI 10.1046/j.1468-2982.2003.00594.x; Gori Sara, 2005, J Headache Pain, V6, P258; Heier MS, 2007, SLEEP, V30, P969, DOI 10.1093/sleep/30.8.969; Hoffmann J, 2015, NEUROBIOL DIS, V74, P137, DOI 10.1016/j.nbd.2014.10.022; Holland PR, 2014, CEPHALALGIA, V34, P725, DOI 10.1177/0333102414541687; Jennum P, 2002, SLEEP MED REV, V6, P471, DOI 10.1053/smrv.2001.0223; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kanbayashi T, 2009, SLEEP, V32, P181, DOI 10.1093/sleep/32.2.181; LEVITAN H, 1984, PSYCHOTHER PSYCHOSOM, V41, P161, DOI 10.1159/000287805; LIPPMAN CW, 1954, J NERV MENT DIS, V120, P273, DOI 10.1097/00005053-195412030-00014; LIPPMAN CW, 1951, AM J PSYCHIAT, V107, P856, DOI 10.1176/ajp.107.11.856; LIPPMAN CW, 1953, J NERV MENT DIS, V117, P345, DOI 10.1097/00005053-195304000-00008; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Maniyar FH, 2014, BRAIN, V137, P232, DOI 10.1093/brain/awt320; Miyamoto T, 2009, SLEEP MED, V10, P1151, DOI 10.1016/j.sleep.2009.05.007; Nishino S, 2010, ACTA PHYSIOL, V198, P209, DOI 10.1111/j.1748-1716.2009.02012.x; Ozaki A, 2012, SLEEP MED, V13, P200, DOI 10.1016/j.sleep.2011.07.014; Peterlin BL, 2010, HEADACHE, V50, P631, DOI 10.1111/j.1526-4610.2009.01554.x; Rainero I, 2011, J HEADACHE PAIN, V12, P193, DOI 10.1007/s10194-011-0314-8; Rains JC, 2006, HEADACHE, V46, P1344, DOI 10.1111/j.1526-4610.2006.00578.x; Sachdev A, 2012, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00161; Sakai F, 1997, CEPHALALGIA, V17, P15, DOI 10.1046/j.1468-2982.1997.1701015.x; Sarchielli P, 2008, CEPHALALGIA, V28, P714, DOI 10.1111/j.1468-2982.2008.01566.x; Schwedt TJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1416; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Suzuki K, 2013, CEPHALALGIA, V33, P868, DOI 10.1177/0333102413477742; Suzuki S, 2011, J NEUROL, V258, P2026, DOI 10.1007/s00415-011-6064-3	40	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139229	10.1371/journal.pone.0139229	http://dx.doi.org/10.1371/journal.pone.0139229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418536	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400065
J	Wallace, HM; Leonhardt, SD				Wallace, Helen Margaret; Leonhardt, Sara Diana			Do Hybrid Trees Inherit Invasive Characteristics? Fruits of Corymbia torelliana X C. citriodora Hybrids and Potential for Seed Dispersal by Bees	PLOS ONE			English	Article							AUSTRALIAN STINGLESS BEES; LONG-DISTANCE DISPERSAL; CUTICULAR PROFILES; HYBRIDIZATION; RESIN; PLANTATIONS; HYMENOPTERA; POPULATIONS; CARBONARIA; EUCALYPTUS	Tree invasions have substantial impacts on biodiversity and ecosystem functioning, and trees that are dispersed by animals are more likely to become invasive. In addition, hybridisation between plants is well documented as a source of new weeds, as hybrids gain new characteristics that allow them to become invasive. Corymbia torelliana is an invasive tree with an unusual animal dispersal mechanism: seed dispersal by stingless bees, that hybridizes readily with other species. We examined hybrids between C. torelliana and C. citriodora subsp. citriodora to determine whether hybrids have inherited the seed dispersal characteristics of C. torelliana that allow bee dispersal. Some hybrid fruits displayed the characteristic hollowness, resin production and resin chemistry associated with seed dispersal by bees. However, we did not observe bees foraging on any hybrid fruits until they had been damaged. We conclude that C. torelliana and C. citriodora subsp. citriodora hybrids can inherit some fruit characters that are associated with dispersal by bees, but we did not find a hybrid with the complete set of characters that would enable bee dispersal. However, around 20,000 hybrids have been planted in Australia, and ongoing monitoring is necessary to identify any hybrids that may become invasive.	[Wallace, Helen Margaret] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, DC 4558, Australia; [Leonhardt, Sara Diana] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany	University of the Sunshine Coast; University of Wurzburg	Wallace, HM (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, DC 4558, Australia.	hwallace@usc.edu.au	Wallace, Helen/AAB-3162-2019; Leonhardt, Sara/AAI-6901-2020	Wallace, Helen/0000-0002-8801-4401; Leonhardt, Sara/0000-0002-8154-9569	Australian Research Council Linkage Grant [LP0218877]; Queensland Government Smart State Program via the Smart Forests Alliance Queensland; Deutsche Forschungs-Gemeinschaft (DFG) [LE 2750/1-1]; German Excellence Initiative	Australian Research Council Linkage Grant(Australian Research Council); Queensland Government Smart State Program via the Smart Forests Alliance Queensland; Deutsche Forschungs-Gemeinschaft (DFG)(German Research Foundation (DFG)); German Excellence Initiative	This work was funded in part by an Australian Research Council Linkage Grant LP0218877 to HMW and the Queensland Government Smart State Program via the Smart Forests Alliance Queensland to HMW. Funding for SDL was provided by the Deutsche Forschungs-Gemeinschaft (DFG project: LE 2750/1-1) and by a grant of the German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacelar-Lima Christinny Giselly, 2006, Acta Amaz., V36, P343, DOI 10.1590/S0044-59672006000300009; Barbour RC, 2008, FOREST ECOL MANAG, V256, P1, DOI 10.1016/j.foreco.2008.03.028; Boland D, 1976, AUST SEED SCI NEWS, V2, P11; Caplat P, 2014, BIOL INVASIONS, V16, P677, DOI 10.1007/s10530-013-0608-7; Carr D, 1987, EUCALYPTUS; Dickinson GR, 2010, SILVAE GENET, V59, P233, DOI 10.1515/sg-2010-0028; Dickinson GR, 2013, ANN FOREST SCI, V70, P1, DOI 10.1007/s13595-012-0231-2; Dickinson GR, 2012, ANN BOT-LONDON, V109, P1215, DOI 10.1093/aob/mcs050; Drescher N, 2014, OECOLOGIA, V176, P943, DOI 10.1007/s00442-014-3070-z; Hayes RA, 2013, AUST J BOT, V61, P52, DOI 10.1071/BT12224; Hill K. D., 1995, Telopea, V6, P185; Klumpp J., 2007, AUSTR STINGLESS BEES; Langenheim J.H., 2003, PLANT RESINS CHEM EV; Lee D. J., 2007, Australian Forestry, V70, P11; Leonhardt SD, 2009, INSECT SOC, V56, P157, DOI 10.1007/s00040-009-0007-3; Leonhardt SD, 2015, CHEMOECOLOGY, V25, P159, DOI 10.1007/s00049-015-0185-6; Leonhardt SD, 2014, ANIM BEHAV, V98, P41, DOI 10.1016/j.anbehav.2014.09.024; Leonhardt SD, 2014, APIDOLOGIE, V45, P514, DOI 10.1007/s13592-013-0266-x; Leonhardt SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023445; Leonhardt SD, 2011, AUSTRAL ECOL, V36, P537, DOI 10.1111/j.1442-9993.2010.02184.x; Leonhardt SD, 2009, BIOTROPICA, V41, P730, DOI 10.1111/j.1744-7429.2009.00535.x; Lesser MR, 2013, ECOL LETT, V16, P380, DOI 10.1111/ele.12053; Massaro CF, 2015, PHYTOTHER RES, V29, P48, DOI 10.1002/ptr.5225; Massaro FC, 2011, NATURWISSENSCHAFTEN, V98, P329, DOI 10.1007/s00114-011-0770-7; Nahrung HF, 2009, J CHEM ECOL, V35, P1043, DOI 10.1007/s10886-009-9682-9; Nobakht M, 2014, MOLECULES, V19, P17862, DOI 10.3390/molecules191117862; Nunez CV, 2008, APIDOLOGIE, V39, P618, DOI 10.1051/apido:2008047; Potts BM, 2004, NEW FOREST, V27, P115, DOI 10.1023/A:1025021324564; R Core Team, 2020, R LANG ENV STAT COMP; Richardson DM, 2011, DIVERS DISTRIB, V17, P788, DOI 10.1111/j.1472-4642.2011.00782.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Roubik DW, 2006, APIDOLOGIE, V37, P124, DOI 10.1051/apido:2006026; Schierenbeck KA, 2009, BIOL INVASIONS, V11, P1093, DOI 10.1007/s10530-008-9388-x; Vigueira CC, 2013, HEREDITY, V110, P303, DOI 10.1038/hdy.2012.104; Wallace HM, 2008, DIVERS DISTRIB, V14, P87, DOI 10.1111/j.1472-4642.2007.00427.x; Wallace HM, 2010, APIDOLOGIE, V41, P428, DOI 10.1051/apido/2009074; WALLACE HM, 1995, OECOLOGIA, V104, P12, DOI 10.1007/BF00365556; Wu W, 2013, BIOL INVASIONS, V15, P75, DOI 10.1007/s10530-012-0269-y	38	4	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138868	10.1371/journal.pone.0138868	http://dx.doi.org/10.1371/journal.pone.0138868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418155	Green Published, gold			2022-12-27	WOS:000362171400023
J	Woodhall-Melnik, J; Misir, V; Kaufman-Shriqui, V; O'Campo, P; Stergiopoulos, V; Hwang, S				Woodhall-Melnik, Julia; Misir, Vachan; Kaufman-Shriqui, Vered; O'Campo, Patricia; Stergiopoulos, Vicky; Hwang, Stephen			The Impact of a 24 Month Housing First Intervention on Participants' Body Mass Index and Waist Circumference: Results from the At Home/Chez Soi Toronto Site Randomized Controlled Trial	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; HOMELESS INDIVIDUALS; FOOD INSECURITY; MENTAL-ILLNESS; HARM REDUCTION; LIFE-STYLE; OBESITY; HEALTH; DIET; NUTRITION	Research suggests that individuals experiencing homelessness have high rates of overweight and obesity. Unhealthy weights and homelessness are both associated with increased risk of poor health and mortality. Using longitudinal data from 575 participants at the Toronto site of the At Home/Chez Soi randomized controlled trial, we investigate the impact of receiving a Housing First intervention on the Body Mass Index (BMI) and waist circumference of participants with moderate and high needs for mental health support services. The ANCOVA results indicate that the intervention resulted in no significant change in BMI or waist circumference from baseline to 24 months. The findings suggest a need for a better understanding of factors contributing to overweight, obesity, and high waist circumference in populations who have histories of housing precarity and experience low-income in tandem with other concerns such as mental illness and addictions.	[Woodhall-Melnik, Julia; Misir, Vachan; Kaufman-Shriqui, Vered; O'Campo, Patricia; Stergiopoulos, Vicky; Hwang, Stephen] St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [O'Campo, Patricia; Stergiopoulos, Vicky] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hwang, Stephen] Univ Toronto, Div Gen Internal Med, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Woodhall-Melnik, J (corresponding author), St Michaels Hosp, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	woodhallmelj@smh.ca	Hwang, Stephen W./GVR-7773-2022; Shriqui, Vered Kaufman/R-8657-2019	Shriqui, Vered Kaufman/0000-0003-3190-4187	Mental Health Commission of Canada; Canadian Institutes of Health Research through the ACHIEVE post-doctoral fellowship program	Mental Health Commission of Canada; Canadian Institutes of Health Research through the ACHIEVE post-doctoral fellowship program(Canadian Institutes of Health Research (CIHR))	This trial was funded by the Mental Health Commission of Canada [http://www.mentalhealthcommission.ca/]. The Lead Author is funded by the Canadian Institutes of Health Research through the ACHIEVE post-doctoral fellowship program [http://cihr-irsc.gc.ca/e/193.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggett TP, 2011, J GEN INTERN MED, V26, P627, DOI 10.1007/s11606-011-1638-4; Barry D, 2009, ADDICT BEHAV, V34, P51, DOI 10.1016/j.addbeh.2008.08.008; Denoth F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027358; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Eyre H, 2004, DIABETES CARE, V27, P1812, DOI 10.2337/diacare.27.7.1812; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Fontaine KR, 2001, PSYCHIAT RES, V101, P277, DOI 10.1016/S0165-1781(01)00234-7; Frankish CJ, 2005, CAN J PUBLIC HEALTH, V96, pS23, DOI 10.1007/BF03403700; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Hawk M, 2012, AIDS CARE, V24, P577, DOI 10.1080/09540121.2011.630352; Health Canada, 2003, CANADIAN GUIDELINES; Hwang SW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-787; Jenkins Maxine, 2014, Community Pract, V87, P24; Kirst M, 2015, DRUG ALCOHOL DEPEN, V146, P24, DOI 10.1016/j.drugalcdep.2014.10.019; Koh KA, 2012, J URBAN HEALTH, V89, P952, DOI 10.1007/s11524-012-9708-4; Krieger J, 2002, AM J PUBLIC HEALTH, V92, P758, DOI 10.2105/AJPH.92.5.758; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Ledoux TA, 2011, OBES REV, V12, pe143, DOI 10.1111/j.1467-789X.2010.00786.x; McKenzie M, 1999, J HEALTH CARE POOR U, V10, P409; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; O'Connell JJ, 2005, J GEN INTERN MED, V20, P127; Olson CM, 1999, J NUTR, V129, p521S, DOI 10.1093/jn/129.2.521S; Padgett DK, 2007, SOC SCI MED, V64, P1925, DOI 10.1016/j.socscimed.2007.02.011; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Schwarz Kathleen B, 2007, MedGenMed, V9, P48; Smith C, 2010, AGR HUM VALUES, V27, P141, DOI 10.1007/s10460-009-9191-z; Solomon CG, 1997, AM J CLIN NUTR, V66, P1044, DOI 10.1093/ajcn/66.4.1044S; Stergiopoulos V., 2014, HOME CHEZ SOI PROJEC; Tanumihardjo SA, 2007, J AM DIET ASSOC, V107, P1966, DOI 10.1016/j.jada.2007.08.007; Tsai J, 2013, PUBLIC HEALTH REP, V128, P29, DOI 10.1177/003335491312800105; Tse C, 2008, PUBLIC HEALTH NUTR, V11, P1296, DOI 10.1017/S1368980008002577; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; Tsemberis S, 2010, HOW TO HOUSE THE HOMELESS, P37; Victor C, 1993, HLTH ED J, V5, P79; Wicks R, 2006, J AM DIET ASSOC, V106, P921, DOI 10.1016/j.jada.2006.03.006; Wu RR, 2008, JAMA-J AM MED ASSOC, V299, P185, DOI 10.1001/jama.2007.56-b; Zerger S, 2004, AM J ORTHOPSYCHIAT, V84, P431	37	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0137069	10.1371/journal.pone.0137069	http://dx.doi.org/10.1371/journal.pone.0137069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418677	Green Submitted, gold, Green Published			2022-12-27	WOS:000362171400005
J	Pender, A; Garcia-Murillas, I; Rana, S; Cutts, RJ; Kelly, G; Fenwick, K; Kozarewa, I; de Castro, DG; Bhosle, J; O'Brien, M; Turner, NC; Popat, S; Downward, J				Pender, Alexandra; Garcia-Murillas, Isaac; Rana, Sareena; Cutts, Rosalind J.; Kelly, Gavin; Fenwick, Kerry; Kozarewa, Iwanka; de Castro, David Gonzalez; Bhosle, Jaishree; O'Brien, Mary; Turner, Nicholas C.; Popat, Sanjay; Downward, Julian			Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach	PLOS ONE			English	Article							DNA; MUTATIONS; AFATINIB	Droplet digital PCR (ddPCR) can be used to detect low frequency mutations in oncogene-driven lung cancer. The range of KRAS point mutations observed in NSCLC necessitates a multiplex approach to efficient mutation detection in circulating DNA. Here we report the design and optimisation of three discriminatory ddPCR multiplex assays investigating nine different KRAS mutations using PrimePCR (TM) ddPCR (TM) Mutation Assays and the Bio-Rad QX100 system. Together these mutations account for 95% of the nucleotide changes found in KRAS in human cancer. Multiplex reactions were optimised on genomic DNA extracted from KRAS mutant cell lines and tested on DNA extracted from fixed tumour tissue from a cohort of lung cancer patients without prior knowledge of the specific KRAS genotype. The multiplex ddPCR assays had a limit of detection of better than 1 mutant KRAS molecule in 2,000 wild-type KRAS molecules, which compared favourably with a limit of detection of 1 in 50 for next generation sequencing and 1 in 10 for Sanger sequencing. Multiplex ddPCR assays thus provide a highly efficient methodology to identify KRAS mutations in lung adenocarcinoma.	[Pender, Alexandra; Rana, Sareena; Downward, Julian] Inst Canc Res, Div Mol Pathol, Lung Canc Grp, London SW3 6JB, England; [Pender, Alexandra; Bhosle, Jaishree; O'Brien, Mary; Turner, Nicholas C.; Popat, Sanjay] Royal Marsden NHS Fdn Trust, Dept Med, London, England; [Pender, Alexandra; Kelly, Gavin; Downward, Julian] Francis Crick Inst, London, England; [Garcia-Murillas, Isaac; Cutts, Rosalind J.; Fenwick, Kerry; Kozarewa, Iwanka; Turner, Nicholas C.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [de Castro, David Gonzalez] Inst Canc Res, Ctr Mol Pathol, Sutton, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London; Royal Marsden NHS Foundation Trust; Francis Crick Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK	Downward, J (corresponding author), Inst Canc Res, Div Mol Pathol, Lung Canc Grp, London SW3 6JB, England.	julian.downward@crick.ac.uk	Popat, Sanjay/AAO-1634-2021; Kelly, Gavin/ABG-2715-2021	Popat, Sanjay/0000-0003-2087-4963; Kelly, Gavin/0000-0001-7219-560X; garcia-murillas, isaac/0000-0001-8183-7969; Downward, Julian/0000-0002-2331-4729; Pender, Alexandra/0000-0001-5912-2457; Turner, Nicholas/0000-0001-8937-0873	National Health Service (England); Institute of Cancer Research; Cancer Research UK, Stratified Medicine Programme; Revere Charitable Trust; Pierre-Fabre Ltd.; European Research Council; Wellcome Trust [103799/Z/14/Z]; Cancer Research UK [15680] Funding Source: researchfish; National Institute for Health Research [ACF-2011-22-003] Funding Source: researchfish; Wellcome Trust [103799/A/14/Z] Funding Source: researchfish; The Francis Crick Institute [10071, 10074, 10002, 10070] Funding Source: researchfish	National Health Service (England); Institute of Cancer Research; Cancer Research UK, Stratified Medicine Programme; Revere Charitable Trust; Pierre-Fabre Ltd.; European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	The authors gratefully acknowledge the support of this work by the National Health Service (England), through funding to the National Institute for Health Research Biomedical Research Centre at The Royal Marsden Hospital. They also gratefully acknowledge funding from the Institute of Cancer Research and Cancer Research UK, Stratified Medicine Programme. This research was also supported in part by the Revere Charitable Trust, an unrestricted educational grant from Pierre-Fabre Ltd., the European Research Council Advanced Grant RASTARGET and the Wellcome Trust Senior Investigator Award, 103799/Z/14/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Health and Social Care Information Centre, 2013, NAT LUNG CANC AUD RE; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Leary AF, 2012, EUR J CANCER, V48, P61, DOI 10.1016/j.ejca.2011.09.022; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MT, 2014, AM J CLIN PATHOL, V141, P856, DOI 10.1309/AJCPMWGWGO34EGOD; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Popat S, 2014, LUNG CANCER, V85, P230, DOI 10.1016/j.lungcan.2014.05.007; Ruiz MIG, 2007, CELL ONCOL, V29, P257; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359	16	48	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139074	10.1371/journal.pone.0139074	http://dx.doi.org/10.1371/journal.pone.0139074			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413866	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700038
J	Almenning, I; Rieber-Mohn, A; Lundgren, KM; Lovvik, TS; Garnaes, KK; Moholdt, T				Almenning, Ida; Rieber-Mohn, Astrid; Lundgren, Kari Margrethe; Lovvik, Tone Shetelig; Garnaes, Kirsti Krohn; Moholdt, Trine			Effects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot Study	PLOS ONE			English	Article							AND/OR PHYSICAL-EXERCISE; ANTI-MULLERIAN HORMONE; FLOW-MEDIATED DILATION; INSULIN-RESISTANCE; OBESE WOMEN; BODY-COMPOSITION; FOLLOW-UP; ENDOTHELIAL FUNCTION; HYPOCALORIC DIET; OVERWEIGHT WOMEN	Background Polycystic ovary syndrome is a common endocrinopathy in reproductive-age women, and associates with insulin resistance. Exercise is advocated in this disorder, but little knowledge exists on the optimal exercise regimes. We assessed the effects of high intensity interval training and strength training on metabolic, cardiovascular, and hormonal outcomes in women with polycystic ovary syndrome. Materials and Methods Three-arm parallel randomized controlled trial. Thirty-one women with polycystic ovary syndrome (age 27.2 +/- 5.5 years; body mass index 26.7 +/- 6.0 kg/m(2)) were randomly assigned to high intensity interval training, strength training, or a control group. The exercise groups exercised three times weekly for 10 weeks. Results The main outcome measure was change in homeostatic assessment of insulin resistance (HOMA-IR). HOMA-IR improved significantly only after high intensity interval training, by -0.83 (95% confidence interval [CI], -1.45, -0.20), equal to 17%, with between-group difference (p = 0.014). After high intensity interval training, high-density lipoprotein cholesterol increased by 0.2 (95% CI, 0.02, 0.5) mmol/L, with between group difference (p = 0.04). Endothelial function, measured as flow-mediated dilatation of the brachial artery, increased significantly after high intensity interval training, by 2.0 (95% CI, 0.1, 4.0) %, between-group difference (p = 0.08). Fat percentage decreased significantly after both exercise regimes, without changes in body weight. After strength training, anti-Muallariahhormone was significantly reduc, by -14.8 (95% CI, -21.2, -8.4) pmol/L, between-group difference (p = 0.04). There were no significant changes in high-sensitivity C-reactive protein, adiponectin or leptin in any group. Conclusions High intensity interval training for ten weeks improved insulin resistance, without weight loss, in women with polycystic ovary syndrome. Body composition improved significantly after both strength training and high intensity interval training. This pilot study indicates that exercise training can improve the cardiometabolic profile in polycystic ovary syndrome in the absence of weight loss.	[Almenning, Ida; Rieber-Mohn, Astrid; Lundgren, Kari Margrethe; Garnaes, Kirsti Krohn; Moholdt, Trine] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Lovvik, Tone Shetelig; Moholdt, Trine] St Olavs Hosp, Dept Obstet & Gynecol, Trondheim, Norway; [Lovvik, Tone Shetelig] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moholdt, T (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway.	trine.moholdt@ntnu.no	Moholdt, Trine/ABC-8674-2021; Moholdt, Trine/J-5884-2014	Moholdt, Trine/0000-0003-1024-8088; 	Norwegian Fund for Research in Sports Medicine	Norwegian Fund for Research in Sports Medicine	Funding: The Norwegian Fund for Research in Sports Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Kindi Manal K, 2012, Oman Med J, V27, P471, DOI 10.5001/omj.2012.112; Alvarez-Blasco F, 2006, ARCH INTERN MED, V166, P2081, DOI 10.1001/archinte.166.19.2081; Brown AJ, 2009, MED SCI SPORT EXER, V41, P497, DOI 10.1249/MSS.0b013e31818c6c0c; Costello MF, 2007, HUM REPROD, V22, P1200, DOI 10.1093/humrep/dem005; Croymans DM, 2013, J APPL PHYSIOL, V115, P1245, DOI 10.1152/japplphysiol.00485.2013; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Dunaif A, 1999, ENDOCRIN METAB CLIN, V28, P341, DOI 10.1016/S0889-8529(05)70073-6; Earnest CP, 2013, INT J SPORTS MED, V34, P355, DOI 10.1055/s-0032-1311594; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Froelicher VF, 2006, EXERCISE HEART, VXI; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gibala M, 2009, APPL PHYSIOL NUTR ME, V34, P428, DOI 10.1139/H09-046; Harrison CL, 2012, CLIN ENDOCRINOL, V76, P351, DOI 10.1111/j.1365-2265.2011.04160.x; Harrison CL, 2011, HUM REPROD UPDATE, V17, P171, DOI 10.1093/humupd/dmq045; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hutchison SK, 2011, J CLIN ENDOCR METAB, V96, pE48, DOI 10.1210/jc.2010-0828; Kim Jin Ju, 2013, Obstet Gynecol Sci, V56, P137, DOI 10.5468/ogs.2013.56.3.137; Kirchengast S, 2001, HUM REPROD, V16, P1255, DOI 10.1093/humrep/16.6.1255; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moran LJ, 2011, HORM METAB RES, V43, P977, DOI 10.1055/s-0031-1291208; Moran LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007506.pub3; Moran LJ, 2009, FERTIL STERIL, V92, P1966, DOI 10.1016/j.fertnstert.2008.09.018; Nybacka A, 2013, FERTIL STERIL, V100, P1096, DOI 10.1016/j.fertnstert.2013.06.030; Nybacka A, 2011, FERTIL STERIL, V96, P1508, DOI 10.1016/j.fertnstert.2011.09.006; Palomba S, 2010, HUM REPROD, V25, P2783, DOI 10.1093/humrep/deq254; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146/annurev.me.44.020193.001005; Repaci A, 2011, MOL CELL ENDOCRINOL, V335, P30, DOI 10.1016/j.mce.2010.08.002; Schmidt J, 2011, J CLIN ENDOCR METAB, V96, P3794, DOI 10.1210/jc.2011-1677; Skaug EA, 2013, EUR J PREV CARDIOL, V20, P531, DOI 10.1177/2047487312444234; Sprung VS, 2013, MED SCI SPORT EXER, V45, P2234, DOI 10.1249/MSS.0b013e31829ba9a1; Sprung VS, 2013, CLIN ENDOCRINOL, V78, P438, DOI 10.1111/j.1365-2265.2012.04490.x; Stener-Victorin E, 2009, AM J PHYSIOL-REG I, V297, pR387, DOI 10.1152/ajpregu.00197.2009; Stepto NK, 2013, HUM REPROD, V28, P777, DOI 10.1093/humrep/des463; Thomson RL, 2009, HUM REPROD, V24, P1976, DOI 10.1093/humrep/dep101; Thomson RL, 2008, J CLIN ENDOCR METAB, V93, P3373, DOI 10.1210/jc.2008-0751; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Vigorito C, 2007, J CLIN ENDOCR METAB, V92, P1379, DOI 10.1210/jc.2006-2794; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; WILD RA, 1983, AM J OBSTET GYNECOL, V146, P602, DOI 10.1016/0002-9378(83)90998-5; Wild S, 2000, CLIN ENDOCRINOL, V52, P595, DOI 10.1046/j.1365-2265.2000.01000.x	42	66	66	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138793	10.1371/journal.pone.0138793	http://dx.doi.org/10.1371/journal.pone.0138793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406234	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000361800700098
J	Buccellato, E; Melis, M; Biagi, C; Donati, M; Motola, D; Vaccheri, A				Buccellato, Elena; Melis, Mauro; Biagi, Chiara; Donati, Monia; Motola, Domenico; Vaccheri, Alberto			Use of Antibiotics in Pediatrics: 8-Years Survey in Italian Hospitals	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; CARDIOVASCULAR RISKS; AZITHROMYCIN; PRESCRIPTIONS; POPULATION; ASSOCIATION; CHILDREN; PROFILE; DEATH	Objectives To evaluate antibiotic consumption in the pediatric wards of Emilia-Romagna Region, from 2004 to 2011, with a focus on the antibiotics reserved to the most serious infections, and to analyse the ADRs reported for antibiotics by the pediatric wards of Emilia-Romagna hospitals. Methods Reference population was represented by all the patients (0-14 years old) admitted to the pediatric wards of all the hospitals of Emilia-Romagna Region. Drug consumption was expressed as number of DDDs per 100 Bed-Days (BD) and data were analysed by active substance, by therapeutic subgroups or by ward type. The time trends of antibiotic consumption were statistically analysed by linear regression. All the suspected ADR reports associated with antibiotics, reported between January 2004 and December 2011 were drawn by the Italian Spontaneous Reporting Database. Results Overall antibiotic consumption showed only a slight increase (p = 0.224). Among the pediatric wards, pediatric surgery showed the highest increase from 2004 to 2011 (p = 0.011). Penicillins and beta-lactamase inhibitors was the first therapeutic group with a statistically significant increase over years (p = 0.038), whereas penicillins with extended spectrum presented a statistically significant reduction (p = 0.008). Moreover, only 5 drugs out of the 8 antibiotics reserved to the most serious infections were used. Pharmacovigilance data showed 27 spontaneous ADR reports associated to ATC J01 drugs. Amoxicillin/clavulanic acid had the highest number of ADR reports (n = 7). Conclusions The steadily increasing consumption in penicillins and a-lactamase inhibitors, in association with a considerable decrease of plain penicillins, raises a serious concern. Pharmacovigilance reports seem to suggest a safe use of antibiotics in the hospital setting of Emilia-Romagna. Further studies to investigate the reason for prescribing antibiotics in children inpatients are needed.	[Buccellato, Elena; Melis, Mauro; Biagi, Chiara; Donati, Monia; Motola, Domenico; Vaccheri, Alberto] Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, I-40126 Bologna, Italy	University of Bologna	Vaccheri, A (corresponding author), Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, Via Irnerio 48, I-40126 Bologna, Italy.	alberto.vaccheri@unibo.it			Emilia-Romagna Region Health Authority	Emilia-Romagna Region Health Authority	This research was supported by an institutional grant from the Emilia-Romagna Region Health Authority.	AIFA. Italian Medicines Agency, 2012, IT MED AG ANT US SOL; AIFA. Italian Medicines Agency, 2010, IT MED AG ANT DIF TU; AIFA. Italian Medicines Agency, 2008, IT MED AG ANT SI MA; AIFA. Italian Medicines Agency, 2009, IT MED AG ANT US CON; [Anonymous], 2012, USO MED ITALIA RAPPO; Biagi C, 2013, EUR J CLIN PHARMACOL, V69, P237, DOI 10.1007/s00228-012-1321-7; Blix HS, 2007, J ANTIMICROB CHEMOTH, V59, P971, DOI 10.1093/jac/dkm032; Brass EP, 2013, NEW ENGL J MED, V369, P580, DOI 10.1056/NEJMc1306999; Buccellato E, 2014, EXPERT REV ANTI-INFE, V12, P383, DOI 10.1586/14787210.2014.884459; Chiappini E, 2011, CLIN THER, V33, P48, DOI 10.1016/j.clinthera.2011.02.001; Ciofi DAM, 2008, EURO SURVEILLANCE BU, V13, P541; Clavenna A, 2009, EUR J PEDIATR, V168, P173, DOI 10.1007/s00431-008-0725-y; Clavenna A, 2011, ARCH DIS CHILD, V96, P590, DOI 10.1136/adc.2010.183541; Clavenna A, 2009, EUR J CLIN PHARMACOL, V65, P749, DOI 10.1007/s00228-009-0679-7; Control EC, 2011, ECDC SURV REP SURV A; Di Mario S, 2008, QUADERNI ACP, V15, P76; ESAC-Net, 2011, TOT ANT US 2011 EXPR; Gagliotti C, 2005, ACTA PAEDIATR, V94, P1502, DOI 10.1080/08035250510036714; Hoffman-Terry ML, 1999, AM J MED, V106, P44, DOI 10.1016/S0002-9343(98)00362-3; Iannini Paul B, 2002, Expert Opin Drug Saf, V1, P121, DOI 10.1517/14740338.1.2.121; ISTAT TN, 2011, IT CENS STRUTT DEM P; Khosropour CM, 2014, NEW ENGL J MED, V370, P1961, DOI 10.1056/NEJMc1401831; KRAMER MS, 1985, J PEDIATR-US, V106, P305, DOI 10.1016/S0022-3476(85)80314-0; Maria Luisa Moro A. P, 2010, USO ANTIBIOTICI RESI; McMurray JJV, 2013, NEW ENGL J MED, V369, P579, DOI 10.1056/NEJMc1306999; Mori F, 2014, INT J IMMUNOPATH PH, V27, P121, DOI 10.1177/039463201402700116; Mosholder AD, 2013, NEW ENGL J MED, V368, P1665, DOI 10.1056/NEJMp1302726; NICE, 2008, NAT I HLTH CAR EXC P; Otters HBM, 2004, J ANTIMICROB CHEMOTH, V53, P361, DOI 10.1093/jac/dkh062; Piovani D, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-46; Piovani D, 2012, EUR J CLIN PHARMACOL, V68, P997, DOI 10.1007/s00228-011-1204-3; Region Sa, 2014, RAPP SORV ANT US ANT; Regoli M, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-10; Resi D, 2003, J ANTIMICROB CHEMOTH, V52, P282, DOI 10.1093/jac/dkg302; Rossignoli A, 2007, EUR J CLIN PHARMACOL, V63, P1099, DOI 10.1007/s00228-007-0376-3; Salvo F, 2007, J ANTIMICROB CHEMOTH, V60, P121, DOI 10.1093/jac/dkm111; Shea K., WONDER DRUGS DONT WO; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Thrane N, 1999, PEDIATR INFECT DIS J, V18, P333, DOI 10.1097/00006454-199904000-00004; Vaccheri A, 2002, J ANTIMICROB CHEMOTH, V50, P989, DOI 10.1093/jac/dkf239; van Houten MA, 1998, INT J ANTIMICROB AG, V10, P161, DOI 10.1016/S0924-8579(98)00022-3; VanderStichele RH, 2006, J ANTIMICROB CHEMOTH, V58, P159, DOI 10.1093/jac/dkl147; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST	43	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139097	10.1371/journal.pone.0139097	http://dx.doi.org/10.1371/journal.pone.0139097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405817	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700167
J	Guwatudde, D; Mutungi, G; Wesonga, R; Kajjura, R; Kasule, H; Muwonge, J; Ssenono, V; Bahendeka, SK				Guwatudde, David; Mutungi, Gerald; Wesonga, Ronald; Kajjura, Richard; Kasule, Hafisa; Muwonge, James; Ssenono, Vincent; Bahendeka, Silver K.			The Epidemiology of Hypertension in Uganda: Findings from the National Non-Communicable Diseases Risk Factor Survey	PLOS ONE			English	Article							POISSON REGRESSION APPROACH; BLOOD-PRESSURE; PREVALENCE; COMMUNITY; DISTRICT; URBAN	Background Hypertension is an important contributor to global burden of disease and mortality, and is a growing public health problem in sub-Saharan Africa. However, most sub-Saharan African countries lack detailed countrywide data on hypertension and other non-communicable diseases (NCD) risk factors that would provide benchmark information for design of appropriate interventions. We analyzed blood pressure data from Uganda's nationwide NCD risk factor survey conducted in 2014, to describe the prevalence and distribution of hypertension in the Ugandan population, and to identify the associated factors. Methods The NCD risk factor survey drew a countrywide sample stratified by the four regions of the country, and with separate estimates for rural and urban areas. The World Health Organization's STEPs tool was used to collect data on demographic and behavioral characteristics, and physical and biochemical measurements. Prevalence rate ratios (PRR) using modified Poison regression modelling was used to identify factors associated with hypertension. Results Of the 3906 participants, 1033 were classified as hypertensive, giving an overall prevalence of 26.4%. Prevalence was highest in the central region at 28.5%, followed by the eastern region at 26.4%, western region at 26.3%, and northern region at 23.3%. Prevalence in urban areas was 28.9%, and 25.8% in rural areas. The differences between regions, and between rural-urban areas were not statistically significant. Only 7.7% of participants with hypertension were aware of their high blood pressure. The prevalence of pre-hypertension was also high at 36.9%. The only modifiable factor found to be associated with hypertension was higher body mass index (BMI). Compared to participants with BMI less than 25 kg/m(2), prevalence was significantly higher among participants with BMI between 25 to 29.9 kg/m(2) with an adjusted PRR = 1.46 [95% CI = 1.25-1.71], and even higher among obese participants (BMI >= 30 kg/m(2)) with an adjusted PRR = 1.60 [95% CI = 1.29-1.99]. The un-modifiable factor found to be associated with hypertension was older age with an adjusted PRR of 1.02 [95% CI = 1.02-1.03] per yearly increase in age. Conclusions The prevalence of hypertension in Uganda is high, with no significant differences in distribution by geographical location. Only 7.7% of persons with hypertension were aware of their hypertension, indicating a high burden of undiagnosed and un-controlled high blood pressure. Thus a big percentage of persons with hypertension are at high risk of hypertension-related cardiovascular NCDs.	[Guwatudde, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Mutungi, Gerald] Minist Hlth, Control Noncommunicable Dis Desk, Kampala, Uganda; [Wesonga, Ronald] Makerere Univ, Coll Business & Management Sci, Sch Stat & Planning, Kampala, Uganda; [Kajjura, Richard] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Kasule, Hafisa] WHO, Uganda Country Off, Kampala, Uganda; [Muwonge, James; Ssenono, Vincent] Uganda Bur Stat, Div Socioecon Surveys, Kampala, Uganda; [Bahendeka, Silver K.] Nsambya Hosp, Dept Internal Med, Kampala, Uganda	Makerere University; Makerere University; Makerere University; World Health Organization	Guwatudde, D (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.	dguwatudde@musph.ac.ug	PAN, ZEQIANG/X-6341-2018; Wesonga, Ronald/E-9373-2016	Wesonga, Ronald/0000-0003-4887-9088; Silver, Bahendeka/0000-0001-8080-7872	Uganda government; World Health Organization; World Diabetes Foundation; United Nations Development Program	Uganda government; World Health Organization(World Health Organization); World Diabetes Foundation; United Nations Development Program	The conduct of the survey was supported by funding from the Uganda government, the World Health Organization, the World Diabetes Foundation, and the United Nations Development Program.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Bromfield S, 2013, CURR HYPERTENS REP, V15, P134, DOI 10.1007/s11906-013-0340-9; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; Mendis Shanthi, 2003, Ethn Dis, V13, pS67; Mondo CK, 2013, CARDIOVASC J AFR, V24, P52, DOI 10.5830/CVJA-2012-081; Musinguzi G, 2015, J CLIN HYPERTENS, V17, P63, DOI 10.1111/jch.12371; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Rehm J, 2004, COMP QUANTIFICATION, V102, P959, DOI [10.1542/peds.102.5.e54, DOI 10.1542/PEDS.102.5.E54]; Sit JWH, 2010, J CARDIOVASC NURS, V25, P461, DOI 10.1097/JCN.0b013e3181dcb551; Suri MFK, 2006, J CARDIOVASC NURS, V21, P478, DOI 10.1097/00005082-200611000-00012; UBOS, 2015, NAT POP HOUS CENS 20; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Wamala JF, 2009, AFR HEALTH SCI, V9, P153; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2009, WHO STEPWISE APPR SU; WHO, 2013, WHO HLTH PEOPL WHAT; World Health Organization, 2004, GLOB STAT REP ALC 20, DOI [10.1016/j.revpalbo.2010.09.001, DOI 10.1016/J.REVPALBO.2010.09.001, 10. 1016/j. revpalbo. 2010. 09. 001]; World Health Organization, 2013, WORLD WHO 2000 2025; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	106	106	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138991	10.1371/journal.pone.0138991	http://dx.doi.org/10.1371/journal.pone.0138991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406462	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700140
J	Hsu, HY; Chen, SH; Cha, YR; Tsukamoto, K; Lin, CY; Han, YS				Hsu, Hsiang-Yi; Chen, Shu-Hwa; Cha, Yuh-Ru; Tsukamoto, Katsumi; Lin, Chung-Yen; Han, Yu-San			De Novo Assembly of the Whole Transcriptome of the Wild Embryo, Preleptocephalus, Leptocephalus, and Glass Eel of Anguilla japonica and Deciphering the Digestive and Absorptive Capacities during Early Development	PLOS ONE			English	Article							RNA-SEQ DATA; JAPANESE EEL; PROVIDES INSIGHTS; FINE-STRUCTURE; PROTEIN; EXPRESSION; GENOME; QUANTIFICATION; GENERATION; ADAPTATION	Natural stocks of Japanese eel (Anguilla japonica) have decreased drastically because of overfishing, habitat destruction, and changes in the ocean environment over the past few decades. However, to date, artificial mass production of glass eels is far from reality because of the lack of appropriate feed for the eel larvae. In this study, wild glass eel, leptocephali, preleptocephali, and embryos were collected to conduct RNA-seq. Approximately 279 million reads were generated and assembled into 224,043 transcripts. The transcript levels of genes coding for digestive enzymes and nutrient transporters were investigated to estimate the capacities for nutrient digestion and absorption during early development. The results showed that the transcript levels of protein digestion enzymes were higher than those of carbohydrate and lipid digestion enzymes in the preleptocephali and leptocephali, and the transcript levels of amino acid transporters were also higher than those of glucose and fructose transporters and the cholesterol transporter. In addition, the transcript levels of glucose and fructose transporters were significantly raising in the leptocephali. Moreover, the transcript levels of protein, carbohydrate, and lipid digestion enzymes were balanced in the glass eel, but the transcript levels of amino acid transporters were higher than those of glucose and cholesterol transporters. These findings implied that preleptocephali and leptocephali prefer high-protein food, and the nutritional requirements of monosaccharides and lipids for the eel larvae vary with growth. An online database (http://molas.iis.sinica.edu.tw/jpeel/) that will provide the sequences and the annotated results of assembled transcripts was established for the eel research community.	[Hsu, Hsiang-Yi; Cha, Yuh-Ru; Han, Yu-San] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei 10764, Taiwan; [Chen, Shu-Hwa; Lin, Chung-Yen] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Tsukamoto, Katsumi] Nihon Univ, Coll Bioresource Sci, Dept Marine Sci & Resources, Fujisawa, Kanagawa, Japan	National Taiwan University; Academia Sinica - Taiwan; Nihon University	Lin, CY (corresponding author), Acad Sinica, Inst Informat Sci, Taipei, Taiwan.	cylin@iis.sinica.edu.tw; yshan@ntu.edu.tw	Lin, Chung-Yen/AAQ-3833-2021	Lin, Chung-Yen/0000-0002-4733-9488; Hsu, Hsiang-yi/0000-0001-7177-6816	Ministry of Science and Technology, Executive Yuan, Taiwan [NSC 99-2313-B-002-021-MY3, NSC 102-2628-B-002 -023 -MY3]; Council of Agriculture, Executive Yuan, Taiwan [103AS-11.3.4-FA-F1]	Ministry of Science and Technology, Executive Yuan, Taiwan; Council of Agriculture, Executive Yuan, Taiwan	YSH thanks the Ministry of Science and Technology, Executive Yuan, Taiwan (NSC 99-2313-B-002-021-MY3, NSC 102-2628-B-002 -023 -MY3), and the Council of Agriculture, Executive Yuan, Taiwan (103AS-11.3.4-FA-F1) for the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baillon L, 2015, ECOTOXICOLOGY, V24, P71, DOI 10.1007/s10646-014-1356-x; BERNBACK S, 1990, J CLIN INVEST, V85, P1221, DOI 10.1172/JCI114556; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Chen JZ, 2014, ESTUAR COAST SHELF S, V151, P361, DOI 10.1016/j.ecss.2014.06.004; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Churcher AM, 2015, MOL ECOL, V24, P822, DOI 10.1111/mec.13065; Dirks RP, 2014, GEN COMP ENDOCR, V204, P267, DOI 10.1016/j.ygcen.2014.06.023; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Furuita H, 2014, FISHERIES SCI, V80, P581, DOI 10.1007/s12562-014-0713-2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Holt J., 2011, LARVAL FISH NUTR; Ijiri S., 2011, AQUACULT EUR, V36, P13; Ishikawa S, 2001, FISHERIES SCI, V67, P1097, DOI 10.1046/j.1444-2906.2001.00366.x; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kleppe L, 2014, MOL REPROD DEV, V81, P619, DOI 10.1002/mrd.22328; Kurokawa T, 2002, FISHERIES SCI, V68, P736, DOI 10.1046/j.1444-2906.2002.00487.x; Kurokawa T, 2003, EEL BIOL, P435; Kuroki M, 2009, J FISH BIOL, V74, P1853, DOI 10.1111/j.1095-8649.2009.02299.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Masuda Yoshitsugu, 2012, Bulletin of Fisheries Research Agency, P111; Michael D, 2014, GASTROINTESTINAL SYS, P159; Miller Michael J., 2012, Coastal Marine Science, V35, P277; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Mochioka N, 1996, MAR BIOL, V125, P447; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murashita K, 2013, FISH PHYSIOL BIOCHEM, V39, P895, DOI 10.1007/s10695-012-9749-3; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Ohta H, 1997, FISH PHYSIOL BIOCHEM, V17, P163, DOI 10.1023/A:1007720600588; Okamura A, 2014, ECOL FRESHW FISH, V23, P95, DOI 10.1111/eff.12086; OTAKE T, 1993, MAR ECOL PROG SER, V92, P27, DOI 10.3354/meps092027; Otake T, 1996, FISHERIES SCI, V62, P28, DOI 10.2331/fishsci.62.28; Ozaki Y, 2006, FISHERIES SCI, V72, P13, DOI 10.1111/j.1444-2906.2006.01110.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PFEILER E, 1991, J FISH BIOL, V38, P533, DOI 10.1111/j.1095-8649.1991.tb03140.x; Pujolar JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-507; RATH J, 1994, APPL ENVIRON MICROB, V60, P807, DOI 10.1128/AEM.60.3.807-813.1994; Satoh H., 1979, IDEN, V33, P23; Schartl M, 2013, NAT GENET, V45, P567, DOI 10.1038/ng.2604; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sonnhammer ELL, 1998, ISMB 98 P; Sudo R, 2013, COMP BIOCHEM PHYS A, V164, P10, DOI 10.1016/j.cbpa.2012.09.019; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; TANAKA H, 1995, FISHERIES SCI, V61, P171, DOI 10.2331/fishsci.61.171; Tanaka H, 2001, AQUACULTURE, V201, P51, DOI 10.1016/S0044-8486(01)00553-1; Tanaka H., 1998, FARMING JAPAN, V32, P22; Tatsukawa K., 2003, EEL BIOL, P293; Tesch F-W., 2003, EEL, DOI [10.1002/9780470995389, DOI 10.1002/9780470995389]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tse WKF, 2013, J PROTEOMICS, V89, P81, DOI 10.1016/j.jprot.2013.05.026; Tsukamoto K., 2014, 144 ANN M AM FISH SO; Tsukamoto Katsumi, 2009, P21; Wang Y, 1980, J FISH CHINA, V4, P147; YAMAMOTO K, 1974, NATURE, V251, P220, DOI 10.1038/251220a0; Yu TC, 1993, J TAIWAN FISH RES, V1, P27	63	17	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139105	10.1371/journal.pone.0139105	http://dx.doi.org/10.1371/journal.pone.0139105			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406914	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700172
J	Huang, J; Yang, XT; Zhang, CM; Yin, X; Liu, SP; Li, XG				Huang, Jian; Yang, Xiaoting; Zhang, Chunmei; Yin, Xiao; Liu, Shipeng; Li, Xingang			Development of Chloroplast Microsatellite Markers and Analysis of Chloroplast Diversity in Chinese Jujube (Ziziphus jujuba Mill.) and Wild Jujube (Ziziphus acidojujuba Mill.)	PLOS ONE			English	Article							SEQUENCE REPEATS; GENE FLOW; DNA; POLYMORPHISM	Ziziphus is an important genus within the family Rhamnaceae. This genus includes several important fruit tree species that are widely planted in China and India, such as the Chinese jujube (Ziziphus jujuba Mill.), the wild jujube (Z. acidojujuba), and the Indian jujube (Z. mauritiana). However, information about their domestication based on the chlorotype diversity of Chinese jujube population is lacking. In this study, chloroplast microsatellite (cpSSR) markers were developed and used to investigate the genetic relationships between and domestication of jujube cultivars and wild jujube populations. Primer sets flanking each of the 46 cpSSR loci in non-coding regions of the chloroplast genome sequence of Z. jujuba Mill. cv. 'Junzao' were designed. In total, 10 markers showed polymorphisms from 15 samples (9 jujube cultivars and 6 wild jujube individuals), of which 8 loci were due to variations in the number of mononucleotide (A/T) repeats and 2 were due to indels. Six cpSSR markers were used in further analyses of 81 additional samples (63 jujube cultivars, 17 wild jujube samples, and 1 Indian jujube). Using these cpSSR markers, the number of alleles per locus ranged from two to four. In general, the Shannon Index (I) for each cpSSR ranged from 0.159 to 0.1747, and the diversity indices (h) and uh were 0.061 to 0.435 and 0.062 to 0.439, respectively. Seven chlorotypes were found; the Indian jujube showed distinct chlorotypes, and both the Chinese and wild jujube had four chlorotypes and shared two chlorotypes. A dominant chlorotype (G) accounted for 53 of 72 jujube cultivars and 13 of 23 wild jujube individuals. All chlorotypes were highly localized along the Yellow River, from the mid-to the lower reaches, suggesting a wide origin of jujube. These cpSSR markers can be applied to population and evolution studies of Chinese jujube and wild jujube.	[Huang, Jian; Li, Xingang] Northwest A&F Univ, Coll Forestry, Res Ctr Jujube Engn & Technol, State Forestry Adm, Yangling, Peoples R China; [Huang, Jian; Liu, Shipeng] Yanan Univ, Coll Life Sci, Key Lab Jujube Shaanxi Prov, Yanan, Peoples R China; [Yang, Xiaoting; Zhang, Chunmei; Yin, Xiao] Northwest A&F Univ, Coll Forestry, Key Comprehens Lab Forest Shaanxi Prov, Yangling, Peoples R China	Northwest A&F University - China; Yanan University; Northwest A&F University - China	Li, XG (corresponding author), Northwest A&F Univ, Coll Forestry, Res Ctr Jujube Engn & Technol, State Forestry Adm, Yangling, Peoples R China.	xingangle@nwsuaf.edu.cn			Ministry of Science and Technology of P.R. China [2013BAD14B03, 2013BAD20B03]; Natural Science Foundation of Shaanxi Province [2013JQ3001]; Key Laboratory Project on jujube of Shaanxi Province [14JS114]	Ministry of Science and Technology of P.R. China(Ministry of Science and Technology, China); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Key Laboratory Project on jujube of Shaanxi Province	This work was supported by the Projects in the National Science & Technology Pillar Program (grant no. 2013BAD14B03 and 2013BAD20B03) from the Ministry of Science and Technology of P.R. China (www.most.gov.cn/) to XL; Natural Science Foundation of Shaanxi Province for young scientist (grant No: 2013JQ3001) to JH (http://www.sninfo.gov.cn); and Key Laboratory Project on jujube of Shaanxi Province (14JS114) (http://www.snedu.gov.cn) to SL & JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cheng YJ, 2005, TREE PHYSIOL, V25, P661, DOI 10.1093/treephys/25.6.661; Delplancke M, 2012, EVOL APPL, V5, P317, DOI 10.1111/j.1752-4571.2011.00223.x; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Deng ZN, 2007, SCI HORTIC-AMSTERDAM, V111, P186, DOI 10.1016/j.scienta.2006.10.004; Ebert D, 2009, MOL ECOL RESOUR, V9, P673, DOI 10.1111/j.1755-0998.2008.02319.x; Guichoux E, 2011, MOL ECOL RESOUR, V11; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Islam MB, 2006, SYST BOT, V31, P826, DOI 10.1600/036364406779695997; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Li Li, 2009, Scientia Agricultura Sinica, V42, P1713; Li RuiHuan, 2012, Journal of Fruit Science, V29, P366; Liu MJ, 1995, ACTA HORTIC, P161, DOI 10.17660/ActaHortic.1995.390.23; Liu Ping, 2005, Scientia Silvae Sinicae, V41, P182; Liu W, 2013, TREE GENET GENOMES, V9, P975, DOI 10.1007/s11295-013-0610-3; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peng JianYing, 2000, Acta Horticulturae Sinica, V27, P171; POWELL W, 1995, CURR BIOL, V5, P1023, DOI 10.1016/S0960-9822(95)00206-5; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Qu Z, 1993, FRUIT TREE RECORDS C; Wang SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099842; Wang YongKang, 2007, Journal of Fruit Science, V24, P146; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zeinalabedini M, 2010, SCI HORTIC-AMSTERDAM, V125, P593, DOI 10.1016/j.scienta.2010.05.007; Zhang CM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0809-y; Zhao Jin, 2003, Scientia Agricultura Sinica, V36, P590	31	32	34	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0134519	10.1371/journal.pone.0134519	http://dx.doi.org/10.1371/journal.pone.0134519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406601	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700001
J	Ker, DFE; Sharma, R; Wang, ETH; Yang, YP				Ker, Dai Fei Elmer; Sharma, Rashmi; Wang, Evelyna Tsi Hsin; Yang, Yunzhi Peter			Development of mRuby2-Transfected C3H10T1/2 Fibroblasts for Musculoskeletal Tissue Engineering	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BONE-MARROW; POSTCONFLUENCE INHIBITION; SIGNALING PATHWAY; SKELETAL-MUSCLE; ADIPOSE-TISSUE; DIFFERENTIATION; ADULT; MULTIPLE	Mouse C3H10T1/2 fibroblasts are multipotent, mesenchymal stemcell (MSC)-like progenitor cells that are widely used in musculoskeletal research. In this study, we have established a clonal population of C3H10T1/2 cells stably-transfected with mRuby2, an orange-red fluorescence reporter gene. Flow cytometry analysis and fluorescence imaging confirmed successful transfection of these cells. Cell counting studies showed that untransfected C3H10T1/2 cells and mRuby2-transfected C3H10T1/2 cells proliferated at similar rates. Adipogenic differentiation experiments demonstrated that untransfected C3H10T1/2 cells and mRuby2-transfected C3H10T1/2 cells stained positive for Oil Red O and showed increased expression of adipogenic genes including adiponectin and lipoprotein lipase. Chondrogenic differentiation experiments demonstrated that untransfected C3H10T1/2 cells and mRuby2-transfected C3H10T1/2 cells stained positive for Alcian Blue and showed increased expression of chondrogenic genes including aggrecan. Osteogenic differentiation experiments demonstrated that untransfected C3H10T1/2 cells and mRuby2-transfected C3H10T1/2 cells stained positive for alkaline phosphatase (ALP) as well as Alizarin Red and showed increased expression of osteogenic genes including alp, ocn and osf-1. When seeded on calcium phosphate-based ceramic scaffolds, mRuby2-transfected C3H10T1/2 cells maintained even fluorescence labeling and osteogenic differentiation. In summary, mRuby2-transfected C3H10T1/2 cells exhibitmRuby2 fluorescence and showed little-to-no difference in terms of cell proliferation and differentiation as untransfected C3H10T1/2 cells. These cells will be available from American Type Culture Collection (ATCC; CRL-3268) and may be a valuable tool for preclinical studies.	[Ker, Dai Fei Elmer; Yang, Yunzhi Peter] Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Sharma, Rashmi; Yang, Yunzhi Peter] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Wang, Evelyna Tsi Hsin; Yang, Yunzhi Peter] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Yang, YP (corresponding author), Stanford Univ, Dept Orthopaed Surg, Stanford, CA 94305 USA.	ypyang@stanford.edu	Ker, Dai Fei Elmer/R-5959-2018	Ker, Dai Fei Elmer/0000-0003-3434-8390; Wang, Evelyna/0000-0002-5697-474X	NIH S10 Shared Instrument Grant [S10RR027431-01]; NIH [R01AR057837, R01DE021468]; Department of Defense [W81XWH-10-1-0966]; Stanford Startup Funding; AO Startup Grant [S-13-134K]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021468] Funding Source: NIH RePORTER	NIH S10 Shared Instrument Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Stanford Startup Funding; AO Startup Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Flow cytometry sorting and analysis was performed on an instrument in the Stanford Shared FACS Facility obtained using NIH S10 Shared Instrument Grant S10RR027431-01. This work was supported by NIH grants R01AR057837 (YPY) and R01DE021468 (YPY), Department of Defense (W81XWH-10-1-0966; YPY), Stanford Startup Funding (YPY) and AO Startup Grant (Project S-13-134K; DFEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir J, 2014, PM&R, V6, P61, DOI 10.1016/j.pmrj.2013.05.007; Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carlson S, 2011, CARDIOVASC RES, V91, P99, DOI 10.1093/cvr/cvr061; Chen WCW, 2014, JOVE-J VIS EXP, DOI 10.3791/51195; Cho YC, 2004, J CELL BIOCHEM, V91, P336, DOI 10.1002/jcb.10743; COLONTEICHER L, 1993, NUCLEIC ACIDS RES, V21, P2223, DOI 10.1093/nar/21.9.2223; Cooper GM, 2011, PLAST RECONSTR SURG, V127, P88, DOI 10.1097/PRS.0b013e3181fad311; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gordeladze JO, 2008, EXP CELL RES, V314, P1495, DOI 10.1016/j.yexcr.2007.12.023; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Ju WJ, 2000, J BONE MINER RES, V15, P1889, DOI 10.1359/jbmr.2000.15.10.1889; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Kaukua N, 2014, NATURE, V513, P551, DOI 10.1038/nature13536; Ker EDF, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025; Ker EDF, 2011, BIOMATERIALS, V32, P3413, DOI 10.1016/j.biomaterials.2011.01.036; Kinnaird T, 2004, CIRCULATION, V109; Krawiec JT, 2015, TISSUE ENG PT A, V21, P426, DOI [10.1089/ten.tea.2014.0208, 10.1089/ten.TEA.2014.0208]; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Laschke MW, 2014, EUR CELLS MATER, V28, P287, DOI 10.22203/eCM.v028a20; Lin CS, 2013, HISTOL HISTOPATHOL, V28, P1109, DOI 10.14670/HH-28.1109; Liu YX, 2010, J BIOMED MATER RES A, V92A, P997, DOI 10.1002/jbm.a.32443; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mendicino M, 2014, CELL STEM CELL, V14, P141, DOI 10.1016/j.stem.2014.01.013; Nakajima R, 2014, J DENT RES, V93, P1133, DOI 10.1177/0022034514549377; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Ovchinnikov Dmitry, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5170; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PRENTICE AI, 1967, J CLIN PATHOL, V20, P717, DOI 10.1136/jcp.20.5.717; Qin YH, 2014, POSTGRAD MED J, V90, P643, DOI 10.1136/postgradmedj-2013-132387; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; Roy R, 2010, DIFFERENTIATION, V79, P211, DOI 10.1016/j.diff.2010.03.003; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tille JC, 2002, EXP CELL RES, V280, P179, DOI 10.1006/excr.2002.5635; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128; Zhao L, 2009, CALCIFIED TISSUE INT, V84, P56, DOI 10.1007/s00223-008-9189-3; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	55	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139054	10.1371/journal.pone.0139054	http://dx.doi.org/10.1371/journal.pone.0139054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407291	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700156
J	Kunutsor, SK; Whitehouse, MR; Blom, AW; Beswick, AD				Kunutsor, Setor K.; Whitehouse, Michael R.; Blom, Ashley W.; Beswick, Andrew D.		INFORM Team	Re-Infection Outcomes following One-and Two-Stage Surgical Revision of Infected Hip Prosthesis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ARTHROPLASTY; SINGLE; PROPORTION; MANAGEMENT	Background The two-stage revision strategy has been claimed as being the "gold standard" for treating prosthetic joint infection. The one-stage revision strategy remains an attractive alternative option; however, its effectiveness in comparison to the two-stage strategy remains uncertain. Objective To compare the effectiveness of one-and two-stage revision strategies in treating prosthetic hip infection, using re-infection as an outcome. Design Systematic review and meta-analysis. Data Sources MEDLINE, EMBASE, Web of Science, Cochrane Library, manual search of bibliographies to March 2015, and email contact with investigators. Study Selection Cohort studies (prospective or retrospective) conducted in generally unselected patients with prosthetic hip infection treated exclusively by one-or two-stage revision and with reinfection outcomes reported within two years of revision. No clinical trials were identified. Review Methods Data were extracted by two independent investigators and a consensus was reached with involvement of a third. Rates of re-infection from 38 one-stage studies (2,536 participants) and 60 two-stage studies (3,288 participants) were aggregated using random-effect models after arcsine transformation, and were grouped by study and population level characteristics. Results In one-stage studies, the rate (95% confidence intervals) of re-infection was 8.2% (6.0-10.8). The corresponding re-infection rate after two-stage revision was 7.9% (6.2-9.7). Reinfection rates remained generally similar when grouped by several study and population level characteristics. There was no strong evidence of publication bias among contributing studies. Conclusion Evidence from aggregate published data suggest similar re-infection rates after one-or two-stage revision among unselected patients. More detailed analyses under a broader range of circumstances and exploration of other sources of heterogeneity will require collaborative pooling of individual participant data.	[Kunutsor, Setor K.; Whitehouse, Michael R.; Blom, Ashley W.; Beswick, Andrew D.; INFORM Team] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Southmead Hosp, Bristol BS10 5NB, Avon, England	Southmead Hospital; University of Bristol	Kunutsor, SK (corresponding author), Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Southmead Hosp, Learning & Res Bldg Level 1,Southmead Rd, Bristol BS10 5NB, Avon, England.	skk31@cantab.net	Kunutsor, Setor K/H-9807-2019; Whitehouse, Michael/AAR-3898-2020	Kunutsor, Setor K/0000-0002-2625-0273; Whitehouse, Michael/0000-0003-2436-9024; Beswick, Andrew/0000-0002-7032-7514; MacGowan, Alasdair/0000-0002-6720-5268; Blom, Ashley/0000-0002-9940-1095	National Institute for Health Research (NIHR) [RP-PG-1210-12005]; Medical Research Council [MR/K025643/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10114, RP-PG-1210-12005] Funding Source: researchfish; MRC [MR/K025643/1] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research program (RP-PG-1210-12005). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AE, 2010, AM J INFECT CONTROL, V38, P711, DOI 10.1016/j.ajic.2010.03.017; Beswick AD, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-18; Blom AW, 2003, J BONE JOINT SURG BR, V85B, P956, DOI 10.1302/0301-620X.85B7.14095; Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937; BUCHHOLZ HW, 1981, J BONE JOINT SURG BR, V63, P342, DOI 10.1302/0301-620X.63B3.7021561; Cahill J L, 2008, J Orthop Surg (Hong Kong), V16, P58; Dale H, 2012, ACTA ORTHOP, V83, P449, DOI 10.3109/17453674.2012.733918; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freeman MF, 1950, TRANSFORMATIONS RELA, P607, DOI DOI 10.1214/AOMS/1177729756; Gallo J, 2009, ACTA CHIR ORTHOP TR, V76, P302; Gehrke T, 2012, HIP INT, V22, pS40, DOI 10.5301/HIP.2012.9569; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsieh PH, 2004, J BONE JOINT SURG AM, V86A, P1989, DOI 10.2106/00004623-200409000-00018; HUNTER G, 1977, J BONE JOINT SURG BR, V59, P293, DOI 10.1302/0301-620X.59B3.893507; Hunter JP, 2014, J CLIN EPIDEMIOL, V67, P897, DOI 10.1016/j.jclinepi.2014.03.003; Klouche S, 2012, ORTHOP TRAUMATOL-SUR, V98, P144, DOI 10.1016/j.otsr.2011.08.018; Klouche S, 2010, ORTHOP TRAUMATOL-SUR, V96, P124, DOI [10.1016/j.rcot.2010.02.005, 10.1016/j.otsr.2009.11.004]; Kunutsor SK, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0044-0; Laffer RR, 2006, CLIN MICROBIOL INFEC, V12, P433, DOI 10.1111/j.1469-0691.2006.01378.x; Lange Jeppe, 2012, Clin Epidemiol, V4, P57, DOI 10.2147/CLEP.S29025; Leonard HAC, 2014, CLIN ORTHOP RELAT R, V472, P1036, DOI 10.1007/s11999-013-3294-y; Matthews PC, 2009, BMJ-BRIT MED J, V338, pb1773, DOI DOI 10.1136/BMJ.B1773; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Ong KL, 2009, J ARTHROPLASTY, V24, P105, DOI 10.1016/j.arth.2009.04.027; Schafroth M, 2003, TOTAL HIP REPLACEMENT: IMPLANTATION TECHNIQUE AND LOCAL COMPLICATIONS, P65; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Vanhegan IS, 2012, J BONE JOINT SURG BR, V94B, P619, DOI 10.1302/0301-620X.94B5.27073; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Winkler H, 2009, INT J MED SCI, V6, P247; Wolf CF, 2011, J BONE JOINT SURG AM, V93A, P631, DOI 10.2106/JBJS.I.01256; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	38	88	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139166	10.1371/journal.pone.0139166	http://dx.doi.org/10.1371/journal.pone.0139166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407003	Green Published, gold			2022-12-27	WOS:000361800700183
J	Morello, E; Mallet, A; Konto-Ghiorghi, Y; Chaze, T; Mistou, MY; Oliva, G; Oliveira, L; Di Guilmi, AM; Trieu-Cuot, P; Dramsi, S				Morello, Eric; Mallet, Adeline; Konto-Ghiorghi, Yoan; Chaze, Thibault; Mistou, Michel-Yves; Oliva, Giulia; Oliveira, Liliana; Di Guilmi, Anne-Marie; Trieu-Cuot, Patrick; Dramsi, Shaynoor			Evidence for the Sialylation of PilA, the PI-2a Pilus-Associated Adhesin of Streptococcus agalactiae Strain NEM316	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; LINKED PROTEIN GLYCOSYLATION; CELL-SHAPE; DISEASE; BIOSYNTHESIS; PATHOGENS; SRR1	Streptococcus agalactiae (or Group B Streptococcus, GBS) is a commensal bacterium present in the intestinal and urinary tracts of approximately 30% of humans. We and others previously showed that the PI-2a pilus polymers, made of the backbone pilin PilB, the tip adhesin PilA and the cell wall anchor protein PilC, promote adhesion to host epithelia and biofilm formation. Affinity-purified PI-2a pili from GBS strain NEM316 were recognized by N-acetylneuraminic acid (NeuNAc, also known as sialic acid) specific lectins such as Elderberry Bark Lectin (EBL) suggesting that pili are sialylated. Glycan profiling with twenty different lectins combined with monosaccharide composition by HPLC suggested that affinity-purified PI-2a pili are modified by N-glycosylation and decorated with sialic acid attached to terminal galactose. Analysis of various relevant mutants in the PI-2a pilus operon by flow-cytometry and electron microscopy analyses pointed to PilA as the pilus subunit modified by glycosylation. Double labeling using PilB antibody and EBL lectin, which specifically recognizes N-acetylneuraminic acid attached to galactose in alpha-2, 6, revealed a characteristic binding of EBL at the tip of the pilus structures, highly reminiscent of PilA localization. Expression of a secreted form of PilA using an inducible promoter showed that this recombinant PilA binds specifically to EBL lectin when produced in the native GBS context. In silico search for potentially glycosylated asparagine residues in PilA sequence pointed to N427 and N597, which appear conserved and exposed in the close homolog RrgA from S. pneumoniae, as likely candidates. Conversion of these two asparagyl residues to glutamyl resulted in a higher instability of PilA. Our results provide the first evidence that the tip PilA adhesin can be glycosylated, and suggest that this modification is critical for PilA stability and may potentially influence interactions with the host.	[Morello, Eric; Konto-Ghiorghi, Yoan; Oliva, Giulia; Oliveira, Liliana; Trieu-Cuot, Patrick; Dramsi, Shaynoor] Inst Pasteur, Unite Bacteries Pathogenes Gram Positif, Paris, France; [Morello, Eric; Konto-Ghiorghi, Yoan; Oliva, Giulia; Oliveira, Liliana; Trieu-Cuot, Patrick; Dramsi, Shaynoor] CNRS, ERL 3526, Paris, France; [Mallet, Adeline] Inst Pasteur, Imagopole, Ultrastruct Microscopy Platform, Paris, France; [Chaze, Thibault] Inst Pasteur, Spectrometrie Masse Struct & Prote, Paris, France; [Chaze, Thibault; Mistou, Michel-Yves] INRA, UMR 1319, MICALIS, Jouy En Josas, France; [Di Guilmi, Anne-Marie] Univ Grenoble Alpes, IBS, Grenoble, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Dramsi, S (corresponding author), INSERM, U1100, Fac Med Francois Rabelais Tours, Ctr Etud Pathol Resp, Tours, France.	shaynoor.dramsi@pasteur.fr	Mistou, Michel-Yves/AAY-2688-2021; Oliveira, Liliana/K-5859-2013; Oliveira, Liliana/AAX-9115-2021; MORELLO, Eric/P-8087-2016	Oliveira, Liliana/0000-0001-5222-7600; Oliveira, Liliana/0000-0001-5222-7600; MORELLO, Eric/0000-0002-2009-4919; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Mistou, Michel-Yves/0000-0001-9732-3970; Di Guilmi, Anne Marie/0000-0001-7335-3470	French National Research Agency [ANR-10-BLANC-1314 Glyco-Path]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	French National Research Agency(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	This study has received funding from the French National Research Agency (ANR-10-BLANC-1314 Glyco-Path) attributed to SD; and from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID) to PTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Chang YC, 2014, GLYCOBIOLOGY, V24, P818, DOI 10.1093/glycob/cwu067; Chaze T, 2014, MOL CELL PROTEOMICS, V13, P2168, DOI 10.1074/mcp.M114.038075; Chia JS, 2001, INFECT IMMUN, V69, P6987, DOI 10.1128/IAI.69.11.6987-6998.2001; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Dramsi S, 2012, MICROB DRUG RESIST, V18, P286, DOI 10.1089/mdr.2012.0005; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Landemarre L, 2013, GLYCOCONJUGATE J, V30, P195, DOI 10.1007/s10719-012-9433-y; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Nothaft H, 2010, METHODS MOL BIOL, V600, P227, DOI 10.1007/978-1-60761-454-8_16; Nouaille S, 2006, APPL ENVIRON MICROB, V72, P2272, DOI 10.1128/AEM.72.3.2272-2279.2006; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Reinscheid DJ, 2002, MICROBIOL-SGM, V148, P3245, DOI 10.1099/00221287-148-10-3245; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Seo HW, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-194; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Sutcliffe IC, 2008, MICROBIOL-SGM, V154, P1354, DOI 10.1099/mic.0.2007/014522-0; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; VANASSELDONK M, 1990, GENE, V95, P155, DOI 10.1016/0378-1119(90)90428-T; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1	28	5	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138103	10.1371/journal.pone.0138103	http://dx.doi.org/10.1371/journal.pone.0138103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407005	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700033
J	Petit, NY; Lambert-Niclot, S; Marcelin, AG; Garcia, S; Marodon, G				Petit, Nicolas Y.; Lambert-Niclot, Sidonie; Marcelin, Anne-Genevieve; Garcia, Sylvie; Marodon, Gilles			HIV Replication Is Not Controlled by CD8(+) T Cells during the Acute Phase of the Infection in Humanized Mice	PLOS ONE			English	Article							DEPLETION; PATHOGENESIS; RESPONSES; VIREMIA; MOUSE; MODEL	HIV replication follows a well-defined pattern during the acute phase of the infection in humans. After reaching a peak during the first few weeks after infection, viral replication resolves to a set-point thereafter. There are still uncertainties regarding the contribution of CD8(+) T cells in establishing this set-point. An alternative explanation, supported by in silico modeling, would imply that viral replication is limited by the number of available targets for infection, i.e. CD4(+) CCR5(+) T cells. Here, we used NOD. SCID. gc(-/-) mice bearing human CD4(+) CCR5(+) and CD8(+) T cells derived from CD34(+) progenitors to investigate the relative contribution of both in viral control after the peak. Using low dose of a CCR5-tropic HIV virus, we observed an increase in viral replication followed by "spontaneous" resolution of the peak, similar to humans. To rule out any possible role for CD8(+) T cells in viral control, we infected mice in which CD8(+) T cells had been removed by a depleting antibody. Globally, viral replication was not affected by the absence of CD8(+) T cells. Strikingly, resolution of the viral peak was equally observed in mice with or without CD8(+) T cells, showing that CD8(+) T cells were not involved in viral control in the early phase of the infection. In contrast, a marked and specific loss of CCR5-expressing CD4(+) T cells was observed in the spleen and in the bone marrow, but not in the blood, of infected animals. Our results strongly suggest that viral replication during the acute phase of the infection in humanized mice is mainly constrained by the number of available targets in lymphoid tissues rather than by CD8(+) T cells.	[Petit, Nicolas Y.; Marodon, Gilles] Univ Paris 06, INSERM, Sorbonne Univ, CNRS,CIMI, Paris, France; [Lambert-Niclot, Sidonie; Marcelin, Anne-Genevieve] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Garcia, Sylvie] Inst Pasteur, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Marodon, G (corresponding author), Univ Paris 06, INSERM, Sorbonne Univ, CNRS,CIMI, Paris, France.	gilles.marodon@upmc.fr	marodon, gilles/E-7202-2017; Marcelin, Anne-Genevieve/D-8272-2014	marodon, gilles/0000-0003-4889-6785; Marcelin, Anne-Genevieve/0000-0003-4808-8999; Garcia, Sylvie/0000-0002-7655-8911	Agence Nationale de la Recherche contre le SIDA et les Hepatites (ANRS); SIDAction; ANRS	Agence Nationale de la Recherche contre le SIDA et les Hepatites (ANRS); SIDAction; ANRS(ANRSFrench National Research Agency (ANR))	This work was funded by grants to GM and AGM form the Agence Nationale de la Recherche contre le SIDA et les Hepatites (ANRS). NP was supported by grant from SIDAction and ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mohsen M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-106; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Bruel T, 2015, J VIROL, V89, P3542, DOI 10.1128/JVI.03723-14; Buzon MJ, 2011, J VIROL, V85, P9646, DOI 10.1128/JVI.05327-11; Centlivre M, 2007, AIDS, V21, P1, DOI 10.1097/QAD.0b013e3280117f7f; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Davenport MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000728; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dudek TE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003984; Gorantla S, 2010, J IMMUNOL, V184, P7082, DOI 10.4049/jimmunol.1000438; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Marodon G, 2009, EUR J IMMUNOL, V39, P2136, DOI 10.1002/eji.200939480; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mueller YM, 2009, J IMMUNOL, V183, P5006, DOI 10.4049/jimmunol.0900141; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Nie CY, 2009, VIROLOGY, V394, P64, DOI 10.1016/j.virol.2009.08.011; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Perelson AS, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-96; Phillips AN, 1996, SCIENCE, V271, P497, DOI 10.1126/science.271.5248.497; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138420	10.1371/journal.pone.0138420	http://dx.doi.org/10.1371/journal.pone.0138420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407077	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700044
J	Sjolund, BM; Wimo, A; Engstrom, M; von Strauss, E				Sjolund, Britt-Marie; Wimo, Anders; Engstrom, Maria; von Strauss, Eva			Incidence of ADL Disability in Older Persons, Physical Activities as a Protective Factor and the Need for Informal and Formal Care - Results from the SNAC-N Project	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEMENTED ELDERLY PERSONS; RESOURCE UTILIZATION; FUNCTIONAL STATUS; RISK-FACTORS; POPULATION; ADULTS; HOME; EXERCISE; HEALTH	Background The aim of the study was to examine 1) the incidence of disability in Activities of Daily Living (ADL), in persons 78 years and older 2) explore whether being physical active earlier is a significant predictor of being disability free at follow-up and 3) describe the amount of informal and formal care in relation to ADL-disability. Methods Data were used from a longitudinal community-based study in Nordanstig (SNAC-N), a part of the Swedish National Study on Aging and Care (SNAC). To study objectives 1) and 2) all ADL-independent participants at baseline (N = 307) were included; for objective 3) all participants 78 years and older were included (N = 316). Data were collected at baseline and at 3- and 6-year follow-ups. ADL-disability was defined as a need for assistance in one or more activities. Informal and formal care were measured using the Resource utilization in Dementia (RUD)-instrument. Results The incidence rates for men were similar in the age groups 78-81and 84 years and older, 42.3 vs. 42.5/1000 person-years. For women the incidence rate for ADL-disability increased significantly from the age group 78-81 to the age group 84 years and older, 20.8 vs. 118.3/ 1000 person-years. In the age group 78-81 years, being physically active earlier (aOR 6.2) and during the past 12 month (aOR 2.9) were both significant preventive factors for ADLdisability. Both informal and formal care increased with ADL-disability and the amount of informal care was greater than formal care. The incidence rate for ADL-disability increases with age for women and being physically active is a protective factor for ADL-disability. Conclusion The incidence rate for ADL-disability increases with age for women, and being physical active is a protective factor for ADL-disability.	[Sjolund, Britt-Marie; Wimo, Anders; von Strauss, Eva] Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Sjolund, Britt-Marie; Wimo, Anders; von Strauss, Eva] Stockholm Univ, S-10691 Stockholm, Sweden; [Sjolund, Britt-Marie; Engstrom, Maria] Univ Gavle, Dept Hlth & Caring Sci, Fac Hlth & Occupat Studies, Gavle, Sweden; [Wimo, Anders] Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Engstrom, Maria] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [von Strauss, Eva] Swedish Red Cross Univ Coll, Stockholm, Sweden	Karolinska Institutet; Stockholm University; University of Gavle; Karolinska Institutet; Uppsala University	Sjolund, BM (corresponding author), Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.	britt-marie.sjolund@hig.se	Engström, Maria/R-3969-2016; Wimo, Anders/ABA-2678-2021	Engström, Maria/0000-0002-9912-5350; von Strauss, Eva/0000-0001-5800-6454	Swedish Brain Power; Center for Gender Medicine at Karolinska Institutet; Alzheimer Foundation Sweden; Karolinska Institutet Foundations	Swedish Brain Power; Center for Gender Medicine at Karolinska Institutet(Karolinska Institutet); Alzheimer Foundation Sweden; Karolinska Institutet Foundations(Karolinska Institutet)	Funding: This study was supported by grants from the Swedish Brain Power, Center for Gender Medicine at Karolinska Institutet, the Alzheimer Foundation Sweden, and Karolinska Institutet Foundations. The sponsors had no role in the design, methods, participant recruitment, data collection, analysis, or preparation of the manuscript.	Alexandre TD, 2012, ARCH GERONTOL GERIAT, V55, P431, DOI 10.1016/j.archger.2012.04.001; Andel R, 2008, J GERONTOL A-BIOL, V63, P62, DOI 10.1093/gerona/63.1.62; Andren S, 2008, J CLIN NURS, V17, P790, DOI 10.1111/j.1365-2702.2007.02066.x; Balzi D, 2010, AGE AGEING, V39, P92, DOI 10.1093/ageing/afp209; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Chou CH, 2012, ARCH PHYS MED REHAB, V93, P237, DOI 10.1016/j.apmr.2011.08.042; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Di Bari M, 2008, AGING CLIN EXP RES, V20, P31, DOI 10.1007/BF03324745; Feng QS, 2013, J GERONTOL B-PSYCHOL, V68, P476, DOI 10.1093/geronb/gbt012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fries JF, 2002, B WORLD HEALTH ORGAN, V80, P245; Gill TM, 2013, AM J EPIDEMIOL, V178, P418, DOI 10.1093/aje/kws554; Gschwind YJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-105; Guralnik J M, 1997, J Am Med Womens Assoc (1972), V52, P113; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hardy SE, 2008, GERONTOLOGY, V54, P79, DOI 10.1159/000115004; Hellstrom Y, 2004, HEALTH SOC CARE COMM, V12, P504, DOI 10.1111/j.1365-2524.2004.00519.x; JOHANSSON L, 1991, HEALTH POLICY, V18, P231, DOI 10.1016/0168-8510(91)90024-R; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; King J, 2012, J AM GERIATR SOC, V60, P569, DOI 10.1111/j.1532-5415.2011.03844.x; Lagergren M, 2004, AGING CLIN EXP RES, V16, P158; Lin SF, 2012, AM J PUBLIC HEALTH, V102, P2157, DOI 10.2105/AJPH.2011.300602; Lindholm C, 2013, INT J GERIATR PSYCH, V28, P454, DOI 10.1002/gps.3844; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; MANTON KG, 1995, J GERONTOL B-PSYCHOL, V50, pS194, DOI 10.1093/geronb/50B.4.S194; Nordberg G, 2005, INT J GERIATR PSYCH, V20, P862, DOI 10.1002/gps.1371; Olshansky S.J., 1991, J AGING HEALTH, V3, P194, DOI DOI 10.1177/089826439100300205; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Paillard-Borg S, 2012, J ALZHEIMERS DIS, V31, P835, DOI 10.3233/JAD-2012-120724; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Perez LG, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130032; Pinkhasov RM, 2010, INT J CLIN PRACT, V64, P465, DOI 10.1111/j.1742-1241.2009.02289.x; Rejeski WJ, 2008, J GERONTOL B-PSYCHOL, V63, pP19, DOI 10.1093/geronb/63.1.P19; Shah RC, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-63; Tas U, 2007, PREV MED, V44, P272, DOI 10.1016/j.ypmed.2006.11.007; von Stauss E, 2000, J AM GERIATR SOC, V48, P1462, DOI 10.1111/j.1532-5415.2000.tb02638.x; Wimo A, 2011, INT J GERIATR PSYCH, V26, P56, DOI 10.1002/gps.2488; Wimo A, 2010, J NUTR HEALTH AGING, V14, P685, DOI 10.1007/s12603-010-0316-2; Wimo A, 2007, ARCH GERONTOL GERIAT, V44, P71, DOI 10.1016/j.archger.2006.03.001	42	24	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138901	10.1371/journal.pone.0138901	http://dx.doi.org/10.1371/journal.pone.0138901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26407207	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700115
J	Anderson, JL; Park, A; Akiyama, R; Tap, WD; Denny, CT; Federman, N				Anderson, Jennifer L.; Park, Ann; Akiyama, Ryan; Tap, William D.; Denny, Christopher T.; Federman, Noah			Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; REFRACTORY EWING SARCOMA; ADVANCED SOLID TUMORS; ANTIBODY CIXUTUMUMAB; MONOCLONAL-ANTIBODY; RECEPTOR ANTIBODY; DOSE-ESCALATION; PHASE-2 TRIAL; FAMILY TUMORS; OPEN-LABEL	Pediatric bone and soft tissue sarcomas often display increased Akt phosphorylation through up regulation of insulin-like growth factor (IGF1) signaling. Additionally, Akt signaling has been linked to resistance to IGF1 receptor (IGF1R) and mTOR (mammalian target of rapamycin) inhibitors in sarcoma, further demonstrating the role of Akt in tumor survival. This suggests targeting components of the PI3K/Akt pathway may be an effective therapeutic strategy. Here, we investigated the in vitro activity of the pan-class I PI3K inhibitor buparlisib (BKM120) in pediatric bone and soft tissue sarcomas. Buparlisib inhibited activation of Akt and signaling molecules downstream of mTORC1 (mTOR complex 1) in Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma cell lines. Anti-proliferative effects were observed in both anchorage dependent and independent conditions and apoptosis was induced within 24 hours of drug treatment. Buparlisib demonstrated cytotoxicity as a single agent, but was found to be more effective when used in combination. Synergy was observed when buparlisib was combined with the IGF1R inhibitor NVP-AEW541 and the mTORC1 inhibitor rapamycin. The addition of NVP-AEW541 also further reduced phospho-Akt levels and more potently induced apoptosis compared to buparlisib treatment alone. Additionally, the combination of buparlisib with the MEK1/2 inhibitor trametinib resulted in synergy in sarcoma cell lines possessing MAPK pathway mutations. Taken together, these data indicate buparlisib could be a novel therapy for the treatment of pediatric bone and soft tissue sarcomas.	[Anderson, Jennifer L.; Park, Ann; Akiyama, Ryan; Denny, Christopher T.; Federman, Noah] Univ Calif Los Angeles, Dept Pediat, Div Hematol Oncol, Gwynne Hazen Cherry Mem Labs, Los Angeles, CA 90024 USA; [Tap, William D.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumors, Sarcoma Med Oncol Serv, New York, NY 10021 USA; [Tap, William D.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Denny, Christopher T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Denny, Christopher T.; Federman, Noah] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Denny, Christopher T.; Federman, Noah] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Federman, N (corresponding author), Univ Calif Los Angeles, Dept Pediat, Div Hematol Oncol, Gwynne Hazen Cherry Mem Labs, Los Angeles, CA 90024 USA.	nfederman@mednet.ucla.edu			Kurelt Foundation; St. Baldrick's Foundation; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant [UL1TR000124]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Kurelt Foundation; St. Baldrick's Foundation; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research funding was provided by a grant from the Kurelt Foundation (www.kureit.org). Dr. Federman is supported by a St. Baldrick's Foundation (www.stbaldricks.org) career development award. The research described was supported by NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR000124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2014, MOL CANCER RES, V12, P1740, DOI 10.1158/1541-7786.MCR-14-0159; Anderson JL, 2012, PEDIATR RES, V72, P112, DOI 10.1038/pr.2012.54; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Brachmann SM, 2012, MOL CANCER THER, V11, P1747, DOI 10.1158/1535-7163.MCT-11-1021; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Garofalo C, 2011, ONCOGENE, V30, P2730, DOI 10.1038/onc.2010.640; Gobin B, 2015, INT J CANCER, V136, P784, DOI 10.1002/ijc.29040; Gobin B, 2014, CANCER LETT, V344, P291, DOI 10.1016/j.canlet.2013.11.017; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Juergens H, 2011, J CLIN ONCOL, V29, P4534, DOI 10.1200/JCO.2010.33.0670; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Massacesi C, 2013, ANN NY ACAD SCI, V1280, P19, DOI 10.1111/nyas.12060; Naing A, 2012, CLIN CANCER RES, V18, P2625, DOI 10.1158/1078-0432.CCR-12-0061; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pappo AS, 2014, CANCER-AM CANCER SOC, V120, P2448, DOI 10.1002/cncr.28728; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Perry JA, 2014, P NATL ACAD SCI USA, V111, pE5564, DOI 10.1073/pnas.1419260111; Reynolds CP, 2013, PEDIATR BLOOD CANCER, V60, P791, DOI 10.1002/pbc.24301; Rodon J, 2014, INVEST NEW DRUG, V32, P670, DOI 10.1007/s10637-014-0082-9; Schoffski P, 2013, EUR J CANCER, V49, P3219, DOI 10.1016/j.ejca.2013.06.010; Schwartz GK, 2013, LANCET ONCOL, V14, P371, DOI 10.1016/S1470-2045(13)70049-4; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Subbiah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018424; Tap WD, 2012, J CLIN ONCOL, V30, P1849, DOI 10.1200/JCO.2011.37.2359; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990	35	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0133610	10.1371/journal.pone.0133610	http://dx.doi.org/10.1371/journal.pone.0133610			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402468	Green Published, Green Submitted, gold			2022-12-27	WOS:000361798100002
J	Badger, M; Ortega-Jimenez, VM; von Rabenau, L; Smiley, A; Dudley, R				Badger, Marc; Ortega-Jimenez, Victor Manuel; von Rabenau, Lisa; Smiley, Ashley; Dudley, Robert			Electrostatic Charge on Flying Hummingbirds and Its Potential Role in Pollination	PLOS ONE			English	Article							FORCES	Electrostatic phenomena are known to enhance both wind-and insect-mediated pollination, but have not yet been described for nectar-feeding vertebrates. Here we demonstrate that wild Anna's Hummingbirds (Calypte anna) can carry positive charges up to 800 pC while in flight (mean +/- s.d.: 66 +/- 129 pC). Triboelectric charging obtained by rubbing an isolated hummingbird wing against various plant structures generated charges up to 700 pC. A metal hummingbird model charged to 400 pC induced bending of floral stamens in four plants (Nicotiana, Hemerocallis, Penstemon, and Aloe spp.), and also attracted falling Lycopodium spores at distances of < 2 mm. Electrostatic forces may therefore influence pollen transfer onto nectar-feeding birds.	[Badger, Marc; Ortega-Jimenez, Victor Manuel; Dudley, Robert] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [von Rabenau, Lisa] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Smiley, Ashley] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Dudley, Robert] Smithsonian Trop Res Inst, Balboa, Panama	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of New Mexico; Smithsonian Institution; Smithsonian Tropical Research Institute	Ortega-Jimenez, VM (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	vortega@berkeley.edu	Gruverman, Alexei/P-3537-2014	Gruverman, Alexei/0000-0003-0492-2750; Ortega-Jimenez, Victor Manuel/0000-0003-0024-5086	John and Mary Gompertz Chair in Integrative Biology, University of California, Berkeley	John and Mary Gompertz Chair in Integrative Biology, University of California, Berkeley	This work was funded by the John and Mary Gompertz Chair in Integrative Biology, University of California, Berkeley (RD).	Bowker GE, 2007, ATMOS ENVIRON, V41, P1596, DOI 10.1016/j.atmosenv.2006.10.048; CHAUZY S, 1980, J ATMOS SCI, V37, P1619, DOI 10.1175/1520-0469(1980)037<1619:RRAECA>2.0.CO;2; Clarke D, 2013, SCIENCE, V340, P66, DOI 10.1126/science.1230883; COLIN ME, 1991, J BIOELECTRICITY, V10, P17, DOI 10.3109/15368379109031397; CORBET SA, 1982, PLANT CELL ENVIRON, V5, P125, DOI 10.1111/1365-3040.ep11571488; Eguchi M, 1925, PHILOS MAG, V49, P178, DOI 10.1080/14786442508634594; Gallot-Lavallee O., 2013, DIELECTRIC MAT ELECT, DOI [10.1002/9781118753491, DOI 10.1002/9781118753491]; Hu SS, 2008, P NATL ACAD SCI USA, V105, P240, DOI 10.1073/pnas.0707989105; Jetter R, 2006, ANNU PLANT REV, V23, P145; McGonigle DF, 2002, J ELECTROSTAT, V54, P167, DOI 10.1016/S0304-3886(01)00177-2; Ortega-Jimenez VM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02108; Ortega-Jimenez VM, 2012, P ROY SOC B-BIOL SCI, V279, P3996, DOI 10.1098/rspb.2012.1285; Pinillos V, 2008, HORTICULTURAL REV, V34, DOI [10.1002/9780470380147, DOI 10.1002/9780470380147]; Proctor M, 1996, NATURAL HIST POLLINA, DOI [10.3366/anh.1997.24.2.307, DOI 10.3366/ANH.1997.24.2.307]; Vaknin Y, 2000, PLANT SYST EVOL, V222, P133, DOI 10.1007/BF00984099; WALKER JA, 1997, QUICKSAND QUICK SMOO	16	9	9	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138003	10.1371/journal.pone.0138003	http://dx.doi.org/10.1371/journal.pone.0138003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421845	gold, Green Published			2022-12-27	WOS:000362175700025
J	Hendlisz, A; Deleporte, A; Delaunoit, T; Marechal, R; Peeters, M; Holbrechts, S; Van den Eynde, M; Houbiers, G; Filleul, B; Van Laethem, JL; Ceyssens, S; Barbuto, AM; Lhommel, R; Demolin, G; Garcia, C; El Mansy, H; Ameye, L; Moreau, M; Guiot, T; Paesmans, M; Piccart, M; Flamen, P				Hendlisz, Alain; Deleporte, Amelie; Delaunoit, Thierry; Marechal, Raphael; Peeters, Marc; Holbrechts, Stephane; Van den Eynde, Marc; Houbiers, Ghislain; Filleul, Bertrand; Van Laethem, Jean-Luc; Ceyssens, Sarah; Barbuto, Anna-Maria; Lhommel, Renaud; Demolin, Gauthier; Garcia, Camilo; El Mansy, Hazem; Ameye, Lieveke; Moreau, Michel; Guiot, Thomas; Paesmans, Marianne; Piccart, Martine; Flamen, Patrick			The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; 1ST-LINE CHEMOTHERAPY; EARLY PREDICTION; BREAST-CANCER; FDG-PET/CT; SORAFENIB; CAPECITABINE; COMBINATION; SURVIVAL; PROTOCOL	Background Tumoral heterogeneity is a major determinant of resistance in solid tumors. FDG-PET/CT can identify early during chemotherapy non-responsive lesions within the whole body tumor load. This prospective multicentric proof-of-concept study explores intra-individual metabolic response (mR) heterogeneity as a treatment efficacy biomarker in chemorefractory metastatic colorectal cancer (mCRC). Methods Standardized FDG-PET/CT was performed at baseline and after the first cycle of combined sorafenib (600mg/day for 21 days, then 800mg/day) and capecitabine (1700 mg/m(2)/day administered D1-14 every 21 days). MR assessment was categorized according to the proportion of metabolically non-responding (non-mR) lesions (stable FDG uptake with SUV-max decrease < 15%) among all measurable lesions. Results Ninety-two patients were included. The median overall survival (OS) and progression-free survival (PFS) were 8.2 months (95% CI: 6.8-10.5) and 4.2 months (95% CI: 3.4-4.8) respectively. In the 79 assessable patients, early PET-CT showed no metabolically refractory lesion in 47%, a heterogeneous mR with at least one non-mR lesion in 32%, and a consistent non-mR or early disease progression in 21%. On exploratory analysis, patients without any non-mR lesion showed a significantly longer PFS (HR 0.34; 95% CI: 0.21-0.56, P-value <0.001) and OS (HR 0.58; 95% CI: 0.36-0.92, P-value 0.02) compared to the other patients. The proportion of non-mR lesions within the tumor load did not impact PFS/OS. Conclusion The presence of at least one metabolically refractory lesion is associated with a poorer outcome in advanced mCRC patients treated with combined sorafenib-capecitabine. Early detection of treatment-induced mR heterogeneity may represent an important predictive efficacy biomarker in mCRC.	[Hendlisz, Alain; Deleporte, Amelie; El Mansy, Hazem; Piccart, Martine] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med Oncol, Brussels, Belgium; [Delaunoit, Thierry; Filleul, Bertrand; El Mansy, Hazem] Jolimont Hosp, Dept Oncol, Haine St Paul, Belgium; [Marechal, Raphael; Van Laethem, Jean-Luc; El Mansy, Hazem] Univ Libre Bruxelles, Erasme Univ Hosp, Gastroenterol Medicosurg Dept, Brussels, Belgium; [Peeters, Marc; El Mansy, Hazem] Univ Antwerp, Univ Antwerp Hosp, Dept Oncol, Edegem, Belgium; [Ceyssens, Sarah; El Mansy, Hazem] Univ Hosp, Dept Nucl Med, Edegem, Belgium; [Holbrechts, Stephane; El Mansy, Hazem] CHU Ambroise Pare, Dept Oncol, Mons, Belgium; [Van den Eynde, Marc; El Mansy, Hazem] Catholic Univ Louvain, Clin Univ St Luc, Dept Oncol, B-1200 Brussels, Belgium; [Lhommel, Renaud; El Mansy, Hazem] Catholic Univ Louvain, Clin Univ St Luc, Dept Nucl Med, B-1200 Brussels, Belgium; [Houbiers, Ghislain; Demolin, Gauthier; El Mansy, Hazem] CHC ST Joseph, Dept Gastroenterol, Liege, Belgium; [Garcia, Camilo; El Mansy, Hazem; Guiot, Thomas; Flamen, Patrick] Univ Libre Bruxelles, Inst Jules Bordet, Dept Nucl Med, Brussels, Belgium; [Ameye, Lieveke; Moreau, Michel; Paesmans, Marianne] Univ Libre Bruxelles, Inst Jules Bordet, Ctr Data, Brussels, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; Groupe Jolimont; Universite Libre de Bruxelles; University of Antwerp; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut Jules Bordet; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut Jules Bordet; Universite Libre de Bruxelles	Hendlisz, A (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Dept Med Oncol, Brussels, Belgium.	alain.hendlisz@bordet.be	Peeters, Marc/C-5525-2013	Peeters, Marc/0000-0003-4969-2303; hendlisz, alain/0000-0003-2122-1948; Guiot, Thomas/0000-0001-7041-598X; Lhommel, Renaud/0000-0003-0668-6122	Institut Jules Bordet; Bayer Healthcare AG	Institut Jules Bordet; Bayer Healthcare AG(Bayer AGBayer Healthcare Pharmaceuticals)	Institut Jules Bordet sponsored this study. Bayer Healthcare AG furnished both a grant and sorafenib but played no further role. AH, PF, M. Paesmans, LA, MM had access to the raw data. The corresponding author had the final responsibility to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Awada A, 2011, J CLIN PHARMACOL, V51, P1674, DOI 10.1177/0091270010386226; Barrington SF, 2014, J CLIN ONCOL; Baselga J, 2012, J CLIN ONCOL, V30, P1484, DOI 10.1200/JCO.2011.36.7771; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Buvat I, 2012, EUR J NUCL MED MOL I, V39, P1628, DOI 10.1007/s00259-012-2172-2; Bystrom P, 2009, ANN ONCOL, V20, P1057, DOI 10.1093/annonc/mdn744; Cheson BD, 2014, J CLIN ONCOL; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; de Geus-Oei LF, 2008, ANN ONCOL, V19, P348, DOI 10.1093/annonc/mdm470; de Geus-Oei LF, 2009, J NUCL MED, V50, p43S, DOI 10.2967/jnumed.108.057224; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Gebhart G, 2013, J NUCL MED, V54, P1862, DOI 10.2967/jnumed.112.119271; Giobbie-Hurder A, 2013, J CLIN ONCOL, V31, P2963, DOI 10.1200/JCO.2013.49.5283; Grothey A, 2008, J CLIN ONCOL, V26, P183, DOI 10.1200/JCO.2007.13.8099; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hendlisz A, 2012, ANN ONCOL, V23, P1687, DOI 10.1093/annonc/mdr554; Hendlisz A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-190; Hoekstra CJ, 2005, J CLIN ONCOL, V23, P8362, DOI 10.1200/JCO.2005.01.1189; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Kobe C, 2008, BLOOD, V112, P3989, DOI 10.1182/blood-2008-06-155820; Kupsch Petra, 2005, Clin Colorectal Cancer, V5, P188, DOI 10.3816/CCC.2005.n.030; Lastoria S, 2013, J NUCL MED, V54, P2062, DOI 10.2967/jnumed.113.119909; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; MARUBINI E, 1995, ANALYSING SURVIVAL D; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Novello S, 2013, CLIN LUNG CANCER, V14, P230, DOI 10.1016/j.cllc.2012.10.004; Ott K, 2006, J CLIN ONCOL, V24, P4692, DOI 10.1200/JCO.2006.06.7801; Patel MR, 2012, J CLIN ONCOL, V30; Rousseau C, 2006, J CLIN ONCOL, V24, P5366, DOI 10.1200/JCO.2006.05.7406; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Ueno D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-162; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4	37	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138341	10.1371/journal.pone.0138341	http://dx.doi.org/10.1371/journal.pone.0138341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421426	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700036
J	Wang, FW; Deng, Y; Zhou, YG; Dong, JY; Chen, H; Dong, YY; Wang, N; Li, XW; Li, HY				Wang, Fawei; Deng, Yu; Zhou, Yonggang; Dong, Jinye; Chen, Huan; Dong, Yuanyuan; Wang, Nan; Li, Xiaowei; Li, Haiyan			Genome-Wide Analysis and Expression Profiling of the Phospholipase C Gene Family in Soybean (Glycine max)	PLOS ONE			English	Article							PLASMA-MEMBRANE; ABSCISIC-ACID; MEDICAGO-TRUNCATULA; ARABIDOPSIS; CALCIUM; DIACYLGLYCEROL; IDENTIFICATION; PURIFICATION; CELLS; NPC4	Phosphatidylinositol-specific phospholipase C (PI-PLC) hydrolyses phosphatidylinositol-4,5-bisphosphate to produce diacylglycerol and inositol 1,4,5-trisphosphate. It plays an important role in plant development and abiotic stress responses. However, systematic analysis and expression profiling of the phospholipase C (PLC) gene family in soybean have not been reported. In this study, 12 putative PLC genes were identified in the soybean genome. Soybean PLCs were found on chromosomes 2, 11, 14 and 18 and encoded 58.8-70.06 kD proteins. Expression pattern analysis by RT-PCR demonstrated that expression of the GmPLCs was induced by PEG, NaCl and saline-alkali treatments in roots and leaves. GmPLC transcripts accumulated specifically in roots after ABA treatment. Furthermore, GmPLC transcripts were analyzed in various tissues. The results showed that GmPLC7 was highly expressed in most tissues, whereas GmPLC12 was expressed in early pods specifically. In addition, subcellular localization analysis was carried out and confirmed that GmPLC10 was localized in the plasma membrane in Nicotiana benthamiana. Our genomic analysis of the soybean PLC family provides an insight into the regulation of abiotic stress responses and development. It also provides a solid foundation for the functional characterization of the soybean PLC gene family.	[Wang, Fawei; Deng, Yu; Zhou, Yonggang; Dong, Jinye; Chen, Huan; Dong, Yuanyuan; Wang, Nan; Li, Xiaowei; Li, Haiyan] Jilin Agr Univ, Coll Life Sci, Engn Res Ctr, Chinese Minist Educ Bioreactor & Pharmaceut Dev, Changchun 130122, Peoples R China	Jilin Agricultural University	Li, HY (corresponding author), Jilin Agr Univ, Coll Life Sci, Engn Res Ctr, Chinese Minist Educ Bioreactor & Pharmaceut Dev, Changchun 130122, Peoples R China.	hyli99@163.com			National Natural Science Foundation of China [31201144, 31271746, 31401403, 31101091]; Special Program for Research of Transgenic Plants [2014ZX08010-002]; Ministry of Education doctoral program funding: Young Teacher Funding Project of China [20122223120003]; National Training Programs of Innovation and Entrepreneurship for Undergraduates [201410193036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Research of Transgenic Plants; Ministry of Education doctoral program funding: Young Teacher Funding Project of China; National Training Programs of Innovation and Entrepreneurship for Undergraduates	This research was supported by the National Natural Science Foundation of China (31201144, 31271746, 31401403, 31101091), the Special Program for Research of Transgenic Plants (2014ZX08010-002), The Ministry of Education doctoral program funding: Young Teacher Funding Project of China (20122223120003) and the National Training Programs of Innovation and Entrepreneurship for Undergraduates (201410193036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Charron D, 2004, PLANT PHYSIOL, V136, P3582, DOI 10.1104/pp.104.051110; Chou WM, 2004, PLANT BIOLOGY, V6, P664, DOI 10.1055/s-2004-830351; Coursol S, 2000, BIOCHEM SOC T, V28, P821, DOI 10.1042/BST0280821; Engstrom EM, 2002, PLANT PHYSIOL, V128, P1390, DOI 10.1104/pp.010691; Hunt L, 2004, NEW PHYTOL, V162, P643, DOI 10.1111/j.1469-8137.2004.01069.x; KAMADA Y, 1991, BIOCHIM BIOPHYS ACTA, V1093, P72, DOI 10.1016/0167-4889(91)90140-S; Katagiri T, 1996, PLANT MOL BIOL, V30, P647, DOI 10.1007/BF00049339; Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8; KIM SY, 1990, NUCLEIC ACIDS RES, V18, P6845, DOI 10.1093/nar/18.23.6845; Kocourkova D, 2011, J EXP BOT, V62, P3753, DOI 10.1093/jxb/err039; Komis G, 2008, NEW PHYTOL, V178, P267, DOI 10.1111/j.1469-8137.2007.02363.x; Lemtiri-Chlieh F, 2003, P NATL ACAD SCI USA, V100, P10091, DOI 10.1073/pnas.1133289100; Liu HT, 2006, J EXP BOT, V57, P3337, DOI 10.1093/jxb/erl098; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; McLoughlin F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00525; McMurry WC, 1987, BIOCHEM J, V249, P877; MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y; MELIN PM, 1987, FEBS LETT, V223, P87, DOI 10.1016/0014-5793(87)80515-X; Mills LN, 2004, J EXP BOT, V55, P199, DOI 10.1093/jxb/erh027; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Park SK, 2002, MOL CELLS, V13, P377; Park S, 2015, PLANT J, V82, P193, DOI 10.1111/tpj.12796; Pejchar P, 2010, NEW PHYTOL, V188, P150, DOI 10.1111/j.1469-8137.2010.03349.x; Peters C, 2010, PLANT CELL, V22, P2642, DOI 10.1105/tpc.109.071720; PFAFFMANN H, 1987, PLANT PHYSIOL, V85, P1151, DOI 10.1104/pp.85.4.1151; Pokotylo I, 2014, BIOCHIMIE, V96, P144, DOI 10.1016/j.biochi.2013.07.004; Pokotylo I, 2013, PROG LIPID RES, V52, P62, DOI 10.1016/j.plipres.2012.09.001; Ravel C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00621; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SHI JR, 1995, PLANT J, V8, P381, DOI 10.1046/j.1365-313X.1995.08030381.x; Singh A, 2015, CELL CALCIUM, V58, P139, DOI 10.1016/j.ceca.2015.04.003; Singh Amarjeet, 2015, Methods Mol Biol, V1275, P153, DOI 10.1007/978-1-4939-2365-6_11; Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062494; TAKAIWA F, 1991, PLANT MOL BIOL, V16, P49, DOI 10.1007/BF00017916; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tasma IM, 2008, PLANT PHYSIOL BIOCH, V46, P627, DOI 10.1016/j.plaphy.2008.04.015; TATE BF, 1989, PLANT PHYSIOL, V91, P1275, DOI 10.1104/pp.91.4.1275; Vedel V, 2011, PLANT SCI, V180, P182, DOI 10.1016/j.plantsci.2010.09.009; Vossen JH, 2010, PLANT J, V62, P224, DOI 10.1111/j.1365-313X.2010.04136.x; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wimalasekera R, 2010, MOL PLANT, V3, P610, DOI 10.1093/mp/ssq005; YOTSUSHIMA K, 1992, BIOSCI BIOTECH BIOCH, V56, P1247, DOI 10.1271/bbb.56.1247; YOTSUSHIMA K, 1993, PLANT PHYSIOL, V102, P165, DOI 10.1104/pp.102.1.165; Zhang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105061; Zhao JZ, 2012, J PLANT RES, V125, P569, DOI 10.1007/s10265-011-0468-0; Zheng L, 2000, J BIOL CHEM, V275, P19700, DOI 10.1074/jbc.M001945200; Zheng SZ, 2012, PLANT J, V69, P689, DOI 10.1111/j.1365-313X.2011.04823.x	55	17	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138467	10.1371/journal.pone.0138467	http://dx.doi.org/10.1371/journal.pone.0138467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421918	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700040
J	Leibowitz, AA; Garcia-Aguilar, AT; Farrell, K				Leibowitz, Arleen A.; Garcia-Aguilar, Agustin T.; Farrell, Kevin			Initial Health Assessments and HIV Screening under the Affordable Care Act	PLOS ONE			English	Article							UNITED-STATES; TRANSMISSION; PREVENTION; UNAWARE; AWARE	Background The Centers for Disease Control and Prevention (CDC) estimates that 156,300 (95% CI 144,100-165,900) Americans living with HIV in 2012 were unaware of their infection. To increase knowledge of HIV status, CDC guidelines seek to make HIV screening a routine part of medical care. This paper examines how routinely California primary care providers test for HIV and how providers' knowledge of California's streamlined testing requirements, use of sexual histories, and having an electronic medical record prompt for HIV testing, relate to test offers. Methods We surveyed all ten California health plans offered under health reform's Insurance Exchange (response rate = 50%) and 322 primary care providers to those plans (response rate = 19%) to assess use of HIV screening and risk assessments. Results Only 31.7% of 60 responding providers reported offering HIV tests to all or most new enrollees and only 8.8% offered an HIV test of blood samples all or most of the time despite the California law requiring that providers offer HIV testing of blood samples in primary care settings. Twenty-eight of the 60 providers (46.6%) were unaware that California had reduced barriers to HIV screening by eliminating the requirement for written informed consent and pre-test counseling. HIV screening of new enrollees all or most of the time was reported by 53.1% of the well-informed providers, but only 7.1% of the less informed providers, a difference of 46 percentage points (95% CI: 21.0%-66.5%). Providers who routinely obtained sexual histories were 29 percentage points (95% CI: 0.2%-54.9%) more likely to screen for HIV all or most of the time than those who did not ask sexual histories. Conclusion Changing HIV screening requirements is important, but not sufficient to make HIV testing a routine part of medical care. Provider education to increase knowledge about the changed HIV testing requirements could positively impact testing rates.	[Leibowitz, Arleen A.; Garcia-Aguilar, Agustin T.; Farrell, Kevin] Univ Calif Los Angeles, Luskin Sch Publ Affairs, Dept Publ Policy, Los Angeles, CA 90095 USA; [Garcia-Aguilar, Agustin T.; Farrell, Kevin] AIDS Project Los Angeles, Los Angeles, CA 90005 USA	University of California System; University of California Los Angeles	Leibowitz, AA (corresponding author), Univ Calif Los Angeles, Luskin Sch Publ Affairs, Dept Publ Policy, Box 951656, Los Angeles, CA 90095 USA.	leibowia@luskin.ucla.edu			California HIV/AIDS Research Program [RP11-LA-020]; Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH [MH58107]; UCLA Center for AIDS Research (CFAR) grant [5P30AI028697]; National Center for Advancing Translational Sciences through UCLA CTSI [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	California HIV/AIDS Research Program; Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH; UCLA Center for AIDS Research (CFAR) grant; National Center for Advancing Translational Sciences through UCLA CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by California HIV/AIDS Research Program, grant RP11-LA-020, www.californiaaidsresearch.org; The Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) NIMH grant MH58107, www.nimh.nih.gov; the UCLA Center for AIDS Research (CFAR) grant 5P30AI028697, www.niaid.nih.gov; and The National Center for Advancing Translational Sciences through UCLA CTSI Grant UL1TR000124, www.ncats.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of California HIV/AIDS Research Program or of NIH.	Arya Monisha, 2014, J Int Assoc Provid AIDS Care, V13, P296, DOI 10.1177/2325957413517140; Berkenblit GV, 2012, J GEN INTERN MED, V27, P839, DOI 10.1007/s11606-012-1985-9; Branson BM, 2013, JAIDS-J ACQ IMM DEF, V63, pS117, DOI 10.1097/QAI.0b013e3182986f25; Cahill S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107104; *CDCP, 2006, REV REC HIV TEST AD; Centers for Disease Control and Prevention, 2015, HIV SURVEILLANCE S, V20; Centers for Disease Control and Prevention, 1998, NO HLTH INS AG 65 US; Centers for Disease Control and Prevention, 2012, HIV SURV REP DIAGN H, V24; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Department of Managed Health Care Division of Plan Surveys, 2012, 1115 WAIV CONT CAR C; Duffus W., 2006, Morbidity and Mortality Weekly Report, V55, P1269; Edelstein ZR, 2015, JAIDS-J ACQ IMM DEF, V68, pS45, DOI 10.1097/QAI.0000000000000390; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hallmark CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110010; Hamel L, HIV AIDS LIVES GAY B; Korthuis PT, 2011, AIDS EDUC PREV, V23, P70, DOI 10.1521/aeap.2011.23.3_supp.70; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McNaghten AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051231; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Sanchez TH, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3378; SANTNER TJ, 1980, J AM STAT ASSOC, V75, P386, DOI 10.2307/2287464; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; U.S. Preventive Services Task Force, 2014, GRAD DEF JUL 2012; Wagner Z, 2014, HEALTH AFFAIR, V33, P378, DOI 10.1377/hlthaff.2013.0996; Zielinski M, 2015, JAIDS-J ACQ IMM DEF, V68, pS21, DOI 10.1097/QAI.0000000000000392	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139361	10.1371/journal.pone.0139361	http://dx.doi.org/10.1371/journal.pone.0139361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418260	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400084
J	von Spiczak, J; Crelier, G; Giese, D; Kozerke, S; Maintz, D; Bunck, AC				von Spiczak, Jochen; Crelier, Gerard; Giese, Daniel; Kozerke, Sebastian; Maintz, David; Bunck, Alexander Christian			Quantitative Analysis of Vortical Blood Flow in the Thoracic Aorta Using 4D Phase Contrast MRI	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; WALL SHEAR-STRESS; PATTERNS; VISUALIZATION; VOLUNTEERS; ANEURYSMS; ARTERY; FIELD	Introduction Phase contrast MRI allows for the examination of complex hemodynamics in the heart and adjacent great vessels. Vortex flow patterns seem to play an important role in certain vascular pathologies. We propose two-and three-dimensional metrics for the objective quantification of aortic vortex blood flow in 4D phase contrast MRI. Materials and Methods For two-dimensional vorticity assessment, a standardized set of 6 regions-of-interest (ROIs) was defined throughout the course of the aorta. For each ROI, a heatmap of time-resolved vorticity values (omega) over right arrow = del(nu) over right arrow was computed. Evolution of minimum, maximum, and average values as well as opposing rotational flow components were analyzed. For three-dimensional analysis, vortex core detection was implemented combining the predictor-corrector method with lambda(2) correction. Strength, elongation, and radial expansion of the detected vortex core were recorded over time. All methods were applied to 4D flow MRI datasets of 9 healthy subjects, 2 patients with mildly dilated aorta, and 1 patient with aortic aneurysm. Results Vorticity quantification in the 6 standardized ROIs enabled the description of physiological vortex flow in the healthy aorta. Helical flow developed early in the ascending aorta (absolute vorticity = 166.4 +/- 86.4 s(-1) at 12% of cardiac cycle) followed by maximum values inmid-systole in the aortic arch (240.1 +/- 45.2 s(-1) at 16%). Strength, elongation, and radial expansion of 3D vortex cores escalated in early systole, reaching a peak inmid systole (strength = 241.2 +/- 30.7 s(-1) at 17%, elongation = 65.1 +/- 34.6 mm at 18%, expansion = 80.1 +/- 48.8 mm(2) at 20%), before all three parameters similarly decreased to overall low values in diastole. Flow patterns were considerably altered in patient data: Vortex flow developed late inmid/end-systole close to the aortic bulb and no physiological helix was found in the aortic arch. Conclusions We have introduced objective measures for quantification of vortical flow in 4D phase contrast MRI. Vortex blood flow in the thoracic aorta could be consistently described in all healthy volunteers. In patient data, pathologically altered vortex flow was observed.	[von Spiczak, Jochen; Giese, Daniel; Maintz, David; Bunck, Alexander Christian] Univ Hosp Cologne, Dept Radiol & Neuroradiol, Cologne, Germany; [Crelier, Gerard; Kozerke, Sebastian] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Crelier, Gerard; Kozerke, Sebastian] ETH, Zurich, Switzerland	University of Cologne; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	von Spiczak, J (corresponding author), Univ Hosp Cologne, Dept Radiol & Neuroradiol, Cologne, Germany.	jochen.v.s@gmx.net	Giese, Daniel/I-1779-2013; Maintz, David/ABG-3220-2020; Bunck, Alexander C/M-6389-2014; Giese, Daniel/ABD-8524-2021; Kozerke, Sebastian/J-3209-2015	Giese, Daniel/0000-0002-3925-4441; Bunck, Alexander C/0000-0003-0986-0042; Kozerke, Sebastian/0000-0003-3725-8884				Bachler P, 2013, MAGN RESON IMAGING, V31, P178, DOI 10.1016/j.mri.2012.06.036; Banks D. C., 1994, Proceedings. Visualization '94 (Cat. No.94CH35707), P132, DOI 10.1109/VISUAL.1994.346327; Bissell MM, 2013, CIRC-CARDIOVASC IMAG, V6, P499, DOI 10.1161/CIRCIMAGING.113.000528; BOGREN HG, 1995, J THORAC CARDIOV SUR, V110, P704, DOI 10.1016/S0022-5223(95)70102-8; Bogren HG, 1997, JMRI-J MAGN RESON IM, V7, P784, DOI 10.1002/jmri.1880070504; Bogren HG, 1999, J MAGN RESON IMAGING, V10, P861, DOI 10.1002/(SICI)1522-2586(199911)10:5<861::AID-JMRI35>3.3.CO;2-5; Born S, 2012, IEEE PAC VIS SYMP, P105, DOI 10.1109/PacificVis.2012.6183580; Born S, 2013, IEEE T VIS COMPUT GR, V19, P900, DOI 10.1109/TVCG.2012.318; Burk J, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-84; Buonocore MH, 1998, MAGN RESON MED, V40, P210, DOI 10.1002/mrm.1910400207; Chapra S.C., 2010, NUMERICAL METHOD ENG; Dolan ED, 2003, SIAM J OPTIMIZ, V14, P567, DOI 10.1137/S1052623400374495; Elbaz MSM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0078-9; Fouras A, 1998, EXP FLUIDS, V25, P409, DOI 10.1007/s003480050248; Frydrychowicz A, 2008, J THORAC CARDIOV SUR, V136, P400, DOI 10.1016/j.jtcvs.2008.02.062; Frydrychowicz A, 2007, J COMPUT ASSIST TOMO, V31, P9, DOI 10.1097/01.rct.0000232918.45158.c9; Frydrychowicz A, 2012, EUR RADIOL, V22, P1122, DOI 10.1007/s00330-011-2353-6; Haimes R, 1999, VELOCITY GRADIENT TE; Heiberg E, 2003, IEEE T VIS COMPUT GR, V9, P313, DOI 10.1109/TVCG.2003.1207439; Hess AT, 2013, J CARDIOVASC MAGN R, V15, pE36, DOI [DOI 10.1186/1532-429X-15-S1-E36, 10.1186/1532-429X-15-S1-E36]; Hiratzka LF, 2010, J AM COLL CARDIOL, V55, pE27, DOI 10.1016/j.jacc.2010.02.015; Hope MD, 2010, RADIOLOGY, V255, P53, DOI 10.1148/radiol.09091437; Hope TA, 2007, J MAGN RESON IMAGING, V26, P1471, DOI 10.1002/jmri.21082; Hope TA, 2008, SEMIN THORAC CARDIOV, V20, P358, DOI 10.1053/j.semtcvs.2008.11.013; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Jiang M, 2005, VISUALIZATION HDB, P295, DOI DOI 10.1016/B978-012387582-2/50016-2; KILNER PJ, 1993, CIRCULATION, V88, P2235, DOI 10.1161/01.CIR.88.5.2235; Kohler B, 2013, IEEE T VIS COMPUT GR, V19, P2773, DOI 10.1109/TVCG.2013.189; Liu X, 2009, AM J PHYSIOL-HEART C, V297, pH163, DOI 10.1152/ajpheart.00266.2009; Lorenz R, 2014, MAGN RESON MED, V71, P1542, DOI 10.1002/mrm.24802; Luff JD, 1999, EXP FLUIDS, V26, P36, DOI 10.1007/s003480050263; Majda A., 2002, VORTICITY INCOMPRESS; Markl M, 2004, J COMPUT ASSIST TOMO, V28, P459, DOI 10.1097/00004728-200407000-00005; Markl M, 2012, J MAGN RESON IMAGING, V36, P1015, DOI 10.1002/jmri.23632; Markl M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-7; Meckel S, 2008, NEURORADIOLOGY, V50, P473, DOI 10.1007/s00234-008-0367-9; Morbiducci U, 2009, ANN BIOMED ENG, V37, P516, DOI 10.1007/s10439-008-9609-6; Reiter G, 2008, CIRC-CARDIOVASC IMAG, V1, P23, DOI 10.1161/CIRCIMAGING.108.780247; Rogers D.F., 1992, LAMINAR FLOW ANAL; Ruan X, 2001, EXP FLUIDS, V30, P696, DOI 10.1007/s003480000249; Sahner J, 2005, GALILEAN INVARIANT E; Schafhitzel T, 2008, COMPUT GRAPH FORUM, V27, P1023, DOI 10.1111/j.1467-8659.2008.01238.x; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; Stalder A, 2010, P 18 SCI M STOCKH; Stegmaier S, 2005, OPENING CAN WORMS EX, P59, DOI [10.1109/VIS.2005.74, DOI 10.1109/VIS.2005.74]; Weigang E, 2008, EUR J CARDIO-THORAC, V34, P11, DOI 10.1016/j.ejcts.2008.03.047; Wigstrom L, 1996, MAGNET RESON MED, V36, P800, DOI 10.1002/mrm.1910360521; Wigstrom L, 1999, MAGNET RESON MED, V41, P793, DOI 10.1002/(SICI)1522-2594(199904)41:4<793::AID-MRM19>3.0.CO;2-2; Wong KKL, 2010, MED ENG PHYS, V32, P174, DOI 10.1016/j.medengphy.2009.11.007; Wong KKL, 2009, ANN BIOMED ENG, V37, P1495, DOI 10.1007/s10439-009-9709-y	50	39	40	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139025	10.1371/journal.pone.0139025	http://dx.doi.org/10.1371/journal.pone.0139025			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418327	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000362171400034
J	Shukla, AM; Bose, C; Karaduta, OK; Apostolov, EO; Kaushal, GP; Fahmi, T; Segal, MS; Shah, SV				Shukla, Ashutosh M.; Bose, Chhanda; Karaduta, Oleg K.; Apostolov, Eugene O.; Kaushal, Gur P.; Fahmi, Tariq; Segal, Mark S.; Shah, Sudhir V.			Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; DIABETES-MELLITUS; AUTOPHAGY; MICE; HEMODIALYSIS; LIPOPROTEIN; SURVIVAL; THERAPY; ALPHA; MOUSE	Cardiovascular disease is the largest cause of morbidity and mortality among patients with chronic kidney disease (CKD) and end-stage kidney disease, with nearly half of all deaths attributed to cardiovascular disease. Hydroxychloroquine (HCQ), an anti-inflammatory drug, has been shown to have multiple pleiotropic actions relevant to atherosclerosis. We conducted a proof-of-efficacy study to evaluate the effects of hydroxychloroquine in an animal model of atherosclerosis in ApoE knockout mice with and without chronic kidney disease. Forty male, 6-week-old mice were divided into four groups in a 2 x 2 design: sham placebo group; sham treatment group; CKD placebo group; and CKD treatment group. CKD was induced by a two-step surgical procedure. All mice received a high-fat diet through the study duration and were sacrificed after 16 weeks of therapy. Mice were monitored with ante-mortem ultrasonic echography (AUE) for atherosclerosis and vascular stiffness and with post-mortem histology studies for atherosclerosis. Therapy with HCQ significantly reduced the severity of atherosclerosis in CKD mice and sham treated mice. HCQ reduced the area of aortic atherosclerosis on en face examination by approximately 60% in HCQ treated groups compared to the non-treated groups. Additionally, therapy with HCQ resulted in significant reduction in vascular endothelial dysfunction with improvement in vascular elasticity and flow patterns and better-preserved vascular wall thickness across multiple vascular beds. More importantly, we found that presence of CKD had no mitigating effect on HCQ's anti-atherosclerotic and vasculoprotective effects. These beneficial effects were not due to any significant effect of HCQ on inflammation, renal function, or lipid profile at the end of 16 weeks of therapy. This study, which demonstrates structural and functional protection against atherosclerosis by HCQ, provides a rationale to evaluate its use in CKD patients. Further studies are needed to define the exact mechanisms through which HCQ confers these benefits.	[Shukla, Ashutosh M.; Segal, Mark S.] North Florida South Georgia Vet Healthcare Syst, Gainesville, FL 32608 USA; [Shukla, Ashutosh M.; Segal, Mark S.] Univ Florida, Gainesville, FL USA; [Bose, Chhanda; Karaduta, Oleg K.; Apostolov, Eugene O.; Kaushal, Gur P.; Fahmi, Tariq; Shah, Sudhir V.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Bose, Chhanda; Karaduta, Oleg K.; Apostolov, Eugene O.; Kaushal, Gur P.; Fahmi, Tariq; Shah, Sudhir V.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	State University System of Florida; University of Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Shukla, AM (corresponding author), North Florida South Georgia Vet Healthcare Syst, Gainesville, FL 32608 USA.	ashutosh.shukla@medicine.ufl.edu		KARADUTA, OLEG/0000-0003-3873-052X	South Central Veterans Administration Healthcare Network pilot project [VISN-16]; Gatorade research fund, University of Florida, DoM	South Central Veterans Administration Healthcare Network pilot project; Gatorade research fund, University of Florida, DoM	This work was supported by South Central Veterans Administration Healthcare Network pilot project grant (VISN-16); and Gatorade research fund, University of Florida, DoM.	[Anonymous], 2012, US REN DAT SYST 2012; Apostolov EO, 2010, J AM SOC NEPHROL, V21, P1852, DOI 10.1681/ASN.2010040365; Aronoff GR, 2007, DRUG PRESCRIBING REN, V5th; Bengtsson C, 2010, BASIC CLIN PHARMACOL, V107, P919, DOI 10.1111/j.1742-7843.2010.00604.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Borba EF, 2001, J RHEUMATOL, V28, P780; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Filiopoulos Vasilis, 2009, Inflammation & Allergy Drug Targets, V8, P369; GAGNON RF, 1990, NEPHRON, V54, P70, DOI 10.1159/000185812; Gan LM, 2007, ATHEROSCLEROSIS, V190, P313, DOI 10.1016/j.atherosclerosis.2006.03.035; Ghigo D, 1998, J CLIN INVEST, V102, P595, DOI 10.1172/JCI1052; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gomez-Guzman M, 2014, HYPERTENSION, V64, P330, DOI 10.1161/HYPERTENSIONAHA.114.03587; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Ivanovski O, 2008, J UROLOGY, V179, P1631, DOI 10.1016/j.juro.2007.11.042; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Lavandero S, 2013, AUTOPHAGY, V9, P1455, DOI 10.4161/auto.25969; Lesiak A, 2010, LUPUS, V19, P683, DOI 10.1177/0961203309356455; Leung N, 2010, AM J TRANSPLANT, V10, P558, DOI 10.1111/j.1600-6143.2009.02959.x; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; LORBER M, 1985, BRIT J RHEUMATOL, V24, P250; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; McCullough PA, 2008, CLIN J AM SOC NEPHRO, V3, P1585, DOI 10.2215/CJN.01930408; Mei Y, 2015, BBA-MOL BASIS DIS, V1852, P243, DOI 10.1016/j.bbadis.2014.05.005; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; PICOT S, 1991, J INFECT DIS, V164, P830, DOI 10.1093/infdis/164.4.830; Razani B, 2010, J LIPID RES, V51, P1738, DOI 10.1194/jlr.M003681; Ruiz-Irastorza G, 2006, LUPUS, V15, P577, DOI 10.1177/0961203306071872; Ruiz-Irastorza G, 2010, ANN RHEUM DIS, V69, P20, DOI 10.1136/ard.2008.101766; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Selzer F, 2001, HYPERTENSION, V37, P1075, DOI 10.1161/01.HYP.37.4.1075; Siso A, 2008, LUPUS, V17, P281, DOI 10.1177/0961203307086503; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Tawakol A, 2003, J AM COLL CARDIOL, V42, P687, DOI 10.1016/S0735-1097(03)00771-X; Tawakol A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186039; Todorovic Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092673; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wikstrom J, 2005, J AM COLL CARDIOL, V46, P720, DOI 10.1016/j.jacc.2005.04.053; Williams ME, 2010, CLIN J AM SOC NEPHRO, V5, P1595, DOI 10.2215/CJN.09301209	45	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139226	10.1371/journal.pone.0139226	http://dx.doi.org/10.1371/journal.pone.0139226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414017	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700051
J	Brunkhorst, LC; Fichtner, A; Hocker, B; Burmeister, G; Ahlenstiel-Grunow, T; Krupka, K; Bald, M; Zapf, A; Tonshoff, B; Pape, L				Brunkhorst, Lena Caroline; Fichtner, Alexander; Hoecker, Britta; Burmeister, Greta; Ahlenstiel-Grunow, Thurid; Krupka, Kai; Bald, Martin; Zapf, Antonia; Toenshoff, Burkhard; Pape, Lars			Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients	PLOS ONE			English	Article							SOLID-ORGAN TRANSPLANTATION; LOW-DOSE CYCLOSPORINE; DE-NOVO THERAPY; KIDNEY-TRANSPLANTATION; STEROID ELIMINATION; MTOR INHIBITORS; 3-YEAR; MULTICENTER; TRIAL	Introduction Data on the efficacy and safety of everolimus in pediatric renal transplantation compared to other immunosuppressive regimens are scarce. Patients/Methods We therefore performed a multicenter, observational, matched cohort study over 4 years post-transplant in 35 patients on everolimus plus low-dose cyclosporine, who were matched (1: 2) with a control group of 70 children receiving a standard-dose calcineurin-inhibitor-and mycophenolate mofetil-based regimen. Results Corticosteroids were withdrawn in 83% in the everolimus vs. 39% in the control group (p<0.001). Patient and graft survival were comparable. The rate of biopsy-proven acute rejection episodes Banff score >= IA during the first year post-transplant was 6% in the everolimus vs. 13% in the control group (p = 0.23). The rate of de novo donor-specific HLA antibodies (11% in everolimus, 18% in controls) was comparable (p = 0.55). At 4 years post-transplant, mean eGFR in the everolimus group was 56 +/- 33 ml/min per 1.73 m(2) vs. 63 +/- 22 ml/min per 1.73 m(2) in the control group (p = 0.14). Everolimus therapy was associated with less BK polyomavirus replication (3% vs. 17% in controls; p = 0.04), but with a higher percentage of arterial hypertension and more hyperlipidemia (p<0.001). Conclusion In pediatric renal transplantation, an everolimus-based regimen with low-dose cyclosporine yields comparable four year results as a standard regimen, but with a different side effect profile.	[Brunkhorst, Lena Caroline; Burmeister, Greta; Ahlenstiel-Grunow, Thurid; Pape, Lars] Hannover Med Sch, Dept Pediat Nephrol, Hannover, Germany; [Fichtner, Alexander; Hoecker, Britta; Krupka, Kai; Toenshoff, Burkhard] Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany; [Bald, Martin] Olga Hosp, Dept Pediat Nephrol, Stuttgart, Germany; [Burmeister, Greta] Univ Hosp Schleswig Holstein, Dept Visceral & Transplant Surg, Kiel, Germany; [Zapf, Antonia] Univ Clin Gottingen, Dept Biostat, Gottingen, Germany	Hannover Medical School; Ruprecht Karls University Heidelberg; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart; University of Kiel; Schleswig Holstein University Hospital; University of Gottingen	Pape, L (corresponding author), Hannover Med Sch, Dept Pediat Nephrol, Hannover, Germany.	Pape.Lars@mh-hannover.de	Pape, Lars/AAF-1477-2021	Pape, Lars/0000-0002-3635-6418	Novartis Germany, Nuremberg, Germany	Novartis Germany, Nuremberg, Germany	This investigator-initiated trial was supported by an unrestricted grant from Novartis Germany, Nuremberg, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billing H, 2013, TRANSPL INT, V26, P903, DOI 10.1111/tri.12148; Brennan D C, 2011, Am J Transplant, V11, P2453, DOI 10.1111/j.1600-6143.2011.03674.x; Chapman JR, 2007, TRANSPL P, V39, P2937, DOI 10.1016/j.transproceed.2007.09.008; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Ettenger R, 2008, PEDIATR TRANSPLANT, V12, P456, DOI 10.1111/j.1399-3046.2007.00832.x; Ferraresso M, 2014, PEDIATR TRANSPLANT, V18, P350, DOI 10.1111/petr.12261; Flechner SM, 2007, TRANSPLANTATION, V83, P883, DOI 10.1097/01.tp.0000258586.52777.4c; Ganschow R, 2013, PEDIATR TRANSPLANT, V17, P694, DOI 10.1111/petr.12147; Hirsch HH, 2014, CLIN MICROBIOL INFEC, V20, P74, DOI 10.1111/1469-0691.12538; Hirsch HH, 2005, TRANSPLANTATION, V79, P1277, DOI 10.1097/01.TP.0000156165.83160.09; Hirsch HH, 2003, LANCET INFECT DIS, V3, P611, DOI 10.1016/S1473-3099(03)00770-9; Lorber MI, 2005, TRANSPLANTATION, V80, P244, DOI 10.1097/01.TP.0000164352.65613.24; Murakami N, 2014, AM J TRANSPLANT, V14, P2317, DOI 10.1111/ajt.12852; Nashan B, 2012, TRANSPLANTATION, V93, P1075, DOI 10.1097/TP.0b013e31824810e6; Pape L, 2010, AM J TRANSPLANT, V10, P2349, DOI 10.1111/j.1600-6143.2010.03266.x; Pape L, 2014, PEDIATR NEPHROL, V29, P1119, DOI 10.1007/s00467-013-2505-9; Pape L, 2011, TRANSPLANTATION, V92, P658, DOI 10.1097/TP.0b013e3182295bed; Plotnicki L, 2013, TRANSPL P, V45, P1414, DOI 10.1016/j.transproceed.2013.01.007; Robert Koch Institut, 2011, REF ANTHR MASSZ BLUT; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Silva HT, 2010, AM J TRANSPLANT, V10, P1401, DOI 10.1111/j.1600-6143.2010.03129.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Tonshoff B, 2014, PEDIATR TRANSPLANT, V18, P323, DOI 10.1111/petr.12268; Tonshoff B, 2012, 24 INT C TRANSPL SOC	24	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0135439	10.1371/journal.pone.0135439	http://dx.doi.org/10.1371/journal.pone.0135439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407177	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700005
J	Dang, W; McInnes, MDF; Kielar, AZ; Hong, JH				Dang, Wilfred; McInnes, Matthew D. F.; Kielar, Ania Z.; Hong, Jiho			A Comprehensive Analysis of Authorship in Radiology Journals	PLOS ONE			English	Article							RESEARCH ARTICLES; RESEARCHER CONTRIBUTIONS; HONORARY	Objectives The purpose of our study was to investigate authorship trends in radiology journals, and whether International Committee of Medical Journal Editors (ICMJE) recommendations have had an impact on these trends. A secondary objective was to explore other variables associated with authorship trends. Methods A retrospective, bibliometric analysis of 49 clinical radiology journals published from 19462013 was conducted. The following data was exported from MEDLINE (1946 to May 2014) for each article: authors' full name, year of publication, primary author institution information, language of publication and publication type. Microsoft Excel Visual Basics for Applications scripts were programmed to categorize extracted data. Statistical analysis was performed to determine the overall mean number of authors per article over time, impact of ICMJE guidelines, authorship frequency per journal, country of origin, article type and language of publication. Results 216,271 articles from 1946-2013 were included. A univariate analysis of the mean authorship frequency per year of all articles yielded a linear relationship between time and authorship frequency. The mean number of authors per article in 1946 (1.42) was found to have increased consistently by 0.07 authors/article per year (R-2 = 0.9728, P<0.001) to 5.79 authors/article in 2013. ICMJE guideline dissemination did not have an impact on this rise in authorship frequency. There was considerable variability in mean authors per article and change over time between journals, country of origin, language of publication and article type. Conclusion Overall authorship for 49 radiology journals across 68 years has increased markedly with no demonstrated impact from ICMJE guidelines. A higher number of authors per article was seen in articles from: higher impact journals, European and Asian countries, original research type, and those journals who explicitly endorse the ICMJE guidelines.	[Dang, Wilfred] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [McInnes, Matthew D. F.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Kielar, Ania Z.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada; [McInnes, Matthew D. F.; Kielar, Ania Z.] Univ Ottawa, Dept Radiol, Ottawa, ON, Canada; [Hong, Jiho] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Western University (University of Western Ontario)	McInnes, MDF (corresponding author), Ottawa Hosp, Dept Radiol, C-1,1053 Carling Ave, Ottawa, ON K1R 4E9, Canada.	mmcinnes@toh.on.ca	McInnes, Matthew/D-4532-2013	McInnes, Matthew/0000-0001-8404-4075	University of Ottawa Department of Radiology Research Stipend Program	University of Ottawa Department of Radiology Research Stipend Program	This research is supported by the University of Ottawa Department of Radiology Research Stipend Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J CITATION REPORTS; Baerlocher MO, 2009, J CLIN EPIDEMIOL, V62, P875, DOI 10.1016/j.jclinepi.2009.03.010; Baethge C, 2008, DTSCH ARZTEBL INT, V105, P380, DOI 10.3238/arztebl.2008.0380; Barbour V, 2010, HAEMATOL-HEMATOL J, V95, P1, DOI 10.3324/haematol.2009.017426; Bennett Dianne M, 2003, Emerg Med (Fremantle), V15, P263, DOI 10.1046/j.1442-2026.2003.00432.x; Bonekamp S, 2012, AM J ROENTGENOL, V198, P1247, DOI 10.2214/AJR.11.8253; Borry P, 2006, BIOETHICS, V20, P213, DOI 10.1111/j.1467-8519.2006.00496.x; CHEW FS, 1988, AM J ROENTGENOL, V150, P23, DOI 10.2214/ajr.150.1.23; Chow DS, 2015, AM J ROENTGENOL, V204, pW52, DOI 10.2214/AJR.14.12852; Davidoff F., 2000, SCI EDITOR, V23, P111; Eisenberg RL, 2014, RADIOLOGY, V271, P472, DOI 10.1148/radiol.13131710; Eisenberg RL, 2011, RADIOLOGY, V259, P479, DOI 10.1148/radiol.11101500; Flanagin A, 2008, JAMA-J AM MED ASSOC, V288, P3166; Gaeta TJ, 1999, ACAD EMERG MED, V6, P297, DOI 10.1111/j.1553-2712.1999.tb00393.x; Hricak H, 2013, RADIOLOGY, V266, P14, DOI 10.1148/radiol.12124052; Hwang SS, 2003, RADIOLOGY, V226, P16, DOI 10.1148/radiol.2261011255; International Committee of Medical Journal Editors, 2013, NEW ICMJE REC; Levsky ME, 2007, SOUTH MED J, V100, P371, DOI 10.1097/01.smj.0000257537.51929.4b; McDonald RJ, 2010, MAYO CLIN PROC, V85, P920, DOI 10.4065/mcp.2010.0291; Moffatt B, 2007, PERSPECT BIOL MED, V50, P18, DOI 10.1353/pbm.2007.0009; Pearson H, 2006, NATURE, V440, P591, DOI 10.1038/440591a; Pitkin RM, 1999, JAMA-J AM MED ASSOC, V281, P1110, DOI 10.1001/jama.281.12.1110; Rennie D, 2000, JAMA-J AM MED ASSOC, V284, P89, DOI 10.1001/jama.284.1.89; Reynolds TM, 2004, J CLIN PATHOL, V57, P426, DOI 10.1136/jcp.2003.012351; Slone RM, 1996, AM J ROENTGENOL, V167, P571, DOI 10.2214/ajr.167.3.8751654; Smith E, 2012, SCI ENG ETHICS, V18, P199, DOI 10.1007/s11948-011-9263-5; Strange K, 2008, AM J PHYSIOL-CELL PH, V295, pC567, DOI 10.1152/ajpcell.00208.2008; Weeks WB, 2004, SOC SCI MED, V59, P1949, DOI 10.1016/j.socscimed.2004.02.029; Weijer C, 2003, CAMB Q HEALTHC ETHIC, V12, P124; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Yank V, 1999, ANN INTERN MED, V130, P661, DOI 10.7326/0003-4819-130-8-199904200-00013; Yukawa Y, 2014, INT J JPN SOCIOL, V23, P80, DOI 10.1111/ijjs.12016	33	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139005	10.1371/journal.pone.0139005	http://dx.doi.org/10.1371/journal.pone.0139005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407072	Green Published, gold			2022-12-27	WOS:000361800700144
J	Fisch, AS; Yerges-Armstrong, LM; Backman, JD; Wang, H; Donnelly, P; Ryan, KA; Parihar, A; Pavlovich, MA; Mitchell, BD; O'Connell, JR; Herzog, W; Harman, CR; Wren, JD; Lewis, JP				Fisch, Adam S.; Yerges-Armstrong, Laura M.; Backman, Joshua D.; Wang, Hong; Donnelly, Patrick; Ryan, Kathleen A.; Parihar, Ankita; Pavlovich, Mary A.; Mitchell, Braxton D.; O'Connell, Jeffrey R.; Herzog, William; Harman, Christopher R.; Wren, Jonathan D.; Lewis, Joshua P.			Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial Dysfunction	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; PEAR1; IDENTIFICATION; EXPRESSION; PHENOTYPE; ENDOGLIN; REVEALS; VARIANT; PLAYS; CELLS	Platelet Endothelial Aggregation Receptor 1 (PEAR1) is a newly identified membrane protein reported to be involved in multiple vascular and thrombotic processes. While most studies to date have focused on the effects of this receptor in platelets, PEAR1 is located in multiple tissues including the endothelium, where it is most highly expressed. Our first objective was to evaluate the role of PEAR1 in endothelial function by examining flow-mediated dilation of the brachial artery in 641 participants from the Heredity and Phenotype Intervention Heart Study. Our second objective was to further define the impact of PEAR1 on cardiovascular disease computationally through meta-analysis of 75,000 microarrays, yielding insights regarding PEAR1 function, and predictions of phenotypes and diseases affected by PEAR1 dysregulation. Based on the results of this meta-analysis we examined whether genetic variation in PEAR1 influences endothelial function using an ex vivo assay of endothelial cell migration. We observed a significant association between rs12041331 and flow-mediated dilation in participants of the Heredity and Phenotype Intervention Heart Study (P = 0.02). Meta-analysis results revealed that PEAR1 expression is highly correlated with several genes (e.g. ANG2, ACVRL1, ENG) and phenotypes (e.g. endothelial cell migration, angiogenesis) that are integral to endothelial function. Functional validation of these results revealed that PEAR1 rs12041331 is significantly associated with endothelial migration (P = 0.04). Our results suggest for the first time that genetic variation of PEAR1 is a significant determinant of endothelial function through pathways implicated in cardiovascular disease.	[Fisch, Adam S.; Yerges-Armstrong, Laura M.; Backman, Joshua D.; Wang, Hong; Donnelly, Patrick; Ryan, Kathleen A.; Parihar, Ankita; Pavlovich, Mary A.; Mitchell, Braxton D.; O'Connell, Jeffrey R.; Lewis, Joshua P.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Fisch, Adam S.; Yerges-Armstrong, Laura M.; Backman, Joshua D.; Wang, Hong; Donnelly, Patrick; Ryan, Kathleen A.; Parihar, Ankita; Pavlovich, Mary A.; Mitchell, Braxton D.; O'Connell, Jeffrey R.; Lewis, Joshua P.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Herzog, William] Johns Hopkins Univ, Sch Med, Div Cardiol, Dept Med, Baltimore, MD USA; [Harman, Christopher R.] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA; [Wren, Jonathan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Wren, Jonathan D.] Oklahoma Med Res Fdn, Program Arthrit & Clin Immunol Res, Oklahoma City, OK 73104 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Lewis, JP (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	jlewis2@medicine.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Vandenbriele, Christophe/ABF-7540-2020; Wren, Jonathan D/E-5611-2011	Vandenbriele, Christophe/0000-0001-5151-6400; Wren, Jonathan D/0000-0003-2776-3545; Lewis, Joshua/0000-0002-4107-6066; Mitchell, Braxton/0000-0003-4920-4744	National Institute of General Medical Sciences [U01GM074518, P20GM103636, U54GM104938, K23GM102678]; National Heart, Lung, and Blood Institute [U01HL072515, K01HL116770, T32HL072751]; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK072488]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072751, U01HL072515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518, K23GM102678, P20GM103636, U54GM104938] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Support was provided by: U01GM074518 National Institute of General Medical Sciences [http://www.nigms.nih.gov/Pages/default.aspx]; U01HL072515 National Heart, Lung, and Blood Institute [http://www.nhlbi.nih.gov/] to author BDM; P20GM103636 National Institute of General Medical Sciences [http://www.nigms.nih.gov/Pages/default.aspx] to author JDW; U54GM104938 National Institute of General Medical Sciences [http://www.nigms.nih.gov/Pages/default.aspx] to author JDW; K01HL116770 National Heart, Lung, and Blood Institute [http://www.nhlbi.nih.gov/] to author LMYA; K23GM102678 National Institute of General Medical Sciences [http://www.nigms.nih.gov/Pages/default.aspx] to author JPL; P30DK072488 National Institute of Diabetes and Digestive and Kidney Diseases [http://www.niddk.nih.gov/Pages/default.aspx] to author BDM; T32HL072751 National Heart, Lung, and Blood Institute [http://www.nhlbi.nih.gov/] to author ASF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 1999, AM J MED GENET, V86, P156, DOI 10.1002/(SICI)1096-8628(19990910)86:2<156::AID-AJMG13>3.0.CO;2-5; Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Atkinson G, 2014, INT J CARDIOL, V172, P261, DOI 10.1016/j.ijcard.2013.12.264; Atkinson G, 2013, ATHEROSCLEROSIS, V226, P425, DOI 10.1016/j.atherosclerosis.2012.11.027; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Berg J, 2003, J MED GENET, V40, P585, DOI 10.1136/jmg.40.8.585; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Cheung Ambrose L, 2007, Curr Protoc Microbiol, VAppendix 4, p4B, DOI 10.1002/9780471729259.mca04bs4; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Dozmorov MG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S2; Faraday N, 2011, BLOOD, V118, P3367, DOI 10.1182/blood-2010-11-320788; Gandhapudi SK, 2015, J IMMUNOL, V194, P3820, DOI 10.4049/jimmunol.1301542; Gillis Jesse, 2013, BMC Bioinformatics, V14 Suppl 3, pS15; Gu Y, 2006, BLOOD, V107, P1951, DOI 10.1182/blood-2005-05-1834; Herrera-Galeano JE, 2008, ARTERIOSCL THROM VAS, V28, P1484, DOI 10.1161/ATVBAHA.108.168971; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Kauskot A, 2013, BLOOD, V121, P5208, DOI 10.1182/blood-2012-10-462887; Kauskot A, 2012, BLOOD, V119, P4056, DOI 10.1182/blood-2011-11-392787; Kim Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064179; Leszczynska K, 2011, BIOCHEM SOC T, V39, P1606, DOI 10.1042/BST20110702; Lewis JP, 2013, CIRC-CARDIOVASC GENE, V6, P184, DOI 10.1161/CIRCGENETICS.111.964627; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lupu C, 2011, BLOOD, V118, P4463, DOI 10.1182/blood-2011-05-355370; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Mancini ML, 2009, DEV DYNAM, V238, P2479, DOI 10.1002/dvdy.22066; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Nanda N, 2005, J BIOL CHEM, V280, P24680, DOI 10.1074/jbc.M413411200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Suzuki K, 2008, ATHEROSCLEROSIS, V197, P212, DOI 10.1016/j.atherosclerosis.2007.03.023; Towner RA, 2013, NEURO-ONCOLOGY, V15, P1625, DOI 10.1093/neuonc/not124; Towner RA, 2013, NEUROSURGERY, V72, P77, DOI 10.1227/NEU.0b013e318276b29d; Vandenbriele C, 2015, CARDIOVASC RES, V108, P124, DOI 10.1093/cvr/cvv193; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Wren JD, 2009, BIOINFORMATICS, V25, P1694, DOI 10.1093/bioinformatics/btp290; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Xiang Q, 2013, PHARMACOGENOMICS, V14, P1179, DOI [10.2217/pgs.13.108, 10.2217/PGS.13.108]; Yan LF, 2014, EXP TOXICOL PATHOL, V66, P61, DOI 10.1016/j.etp.2013.08.004	40	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138795	10.1371/journal.pone.0138795	http://dx.doi.org/10.1371/journal.pone.0138795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406321	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700099
J	Liu, YZ; Li, X				Liu, Yazhi; Li, Xiong			Heterogeneous Participant Recruitment for Comprehensive Vehicle Sensing	PLOS ONE			English	Article							MOBILE; SYSTEMS	Widely distributed mobile vehicles wherein various sensing devices and wireless communication interfaces are installed bring vehicular participatory sensing into practice. However, the heterogeneity of vehicles in terms of sensing capability and mobility, and the participants' expectations on the incentives blackmake the collection of comprehensive sensing data a challenging task. A sensing data quality-oriented optimal heterogeneous participant recruitment strategy is proposed in this paper for vehicular participatory sensing. In the proposed strategy, the differences between the sensing data requirements and the collected sensing data are modeled. An optimization formula is established to model the optimal participant recruitment problem, and a participant utility analysis scheme is built based on the sensing and mobility features of vehicles. Besides, a greedy algorithm is then designed according to the utility of vehicles to recruit the most efficient vehicles with a limited total incentive budget. Real trace-driven simulations show that the proposed strategy can collect 85.4% of available sensing data with 34% incentive budget.	[Liu, Yazhi] North China Univ Sci & Technol, Coll Informat, Tangshan 063009, Peoples R China; [Li, Xiong] Hunan Univ Sci & Technol, Sch Comp Sci & Engn, Xiangtan 411201, Peoples R China	North China University of Science & Technology; Hunan University of Science & Technology	Li, X (corresponding author), Hunan Univ Sci & Technol, Sch Comp Sci & Engn, Xiangtan 411201, Peoples R China.	lixiongzhq@163.com	Li, Xiong/K-7233-2012	Li, Xiong/0000-0001-6619-554X	National Natural Science Foundation of China [61370197, 61300220]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by National Natural Science Foundation of China under Grant No. 61370197, http://www.nsfc.gov.cn/, Y L (responsible for the overall design), and National Natural Science Foundation of China under Grant No. 61300220, http://www.nsfc.gov.cn/, X L (responsible for the overall design).	Banerjee R., 2013, P 28 ANN ACM S APPL, P567; Boutsis I, 2013, 2013 IEEE 14TH INTERNATIONAL CONFERENCE ON MOBILE DATA MANAGEMENT (MDM 2013), VOL 1, P227, DOI 10.1109/MDM.2013.32; Burke J., 2006, WORKSH WORLD SENS WE, P117; Chon Y, 2013, UBICOMP'13: PROCEEDINGS OF THE 2013 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P3, DOI 10.1145/2493432.2493498; Cortez RA, 2010, IEEE INT CONF ROBOT, P3052, DOI 10.1109/ROBOT.2010.5509294; Devarakonda S., 2013, P 2 ACM SIGKDD INT W, P1, DOI [10.1145/2505821.2505834, DOI 10.1145/2505821.2505834]; Ganti RK, 2011, IEEE COMMUN MAG, V49, P32, DOI 10.1109/MCOM.2011.6069707; Gormer S, 2009, IEEE INT VEH SYM, P279, DOI 10.1109/IVS.2009.5164291; Grossklags J, 2007, INT DAT ENG APPL S 2, P206; Guo B, 2014, INT CONF PERVAS COMP, P593, DOI 10.1109/PerComW.2014.6815273; Ho C.J., 2012, P AAAI C ART INT TOR, P45, DOI DOI 10.1007/JHEP06(2012)045; Hu S., 2009, P IEEE VTS AS PAC WI, P168; Huang HY, 2012, J UNIVERS COMPUT SCI, V18, P1072; Hull B., 2006, P 4 INT C EMB NETW S, P125, DOI DOI 10.1145/1182807.1182821; Hyyppa J., 2009, PROC IEEE JOINT URBA, P1; Jaimes LG, 2012, INT CONF PERVAS COMP, P103, DOI 10.1109/PerCom.2012.6199855; Jang J, 2012, INT C WINT MAINT SUR, P54; Jayaraman PP, 2013, 9 IEEE INT C COLL CO, P1; Juong-Sik Lee, 2010, 2010 IEEE International Conference on Pervasive Computing and Communications (PerCom 2010), P60, DOI 10.1109/PERCOM.2010.5466993; Khan WZ, 2013, IEEE COMMUN SURV TUT, V15, P402, DOI 10.1109/SURV.2012.031412.00077; Lane ND, 2010, IEEE COMMUN MAG, V48, P140, DOI 10.1109/MCOM.2010.5560598; Liu B., 2012, P 10 ACM C EMB NETW, P57, DOI [DOI 10.1145/2426656.2426663, 10.1145/2426656.2426663]; Liu X, 2006, COMPUT ENVIRON URBAN, V30, P741, DOI 10.1016/j.compenvurbsys.2006.02.007; Ra M. -R., 2012, ACM MOBISYS 12, P481; Reddy S, 2010, LECT NOTES COMPUT SC, V6030, P138, DOI 10.1007/978-3-642-12654-3_9; Shen J, 2015, J INTERNET TECHNOL, V16, P171; Sheng X, 2012, IEEE INFOCOM SER, P1916, DOI 10.1109/INFCOM.2012.6195568; Tuncay GS, 2012, MOBICOM 12: PROCEEDINGS OF THE 18TH ANNUAL INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P407; Wang XL, 2014, IEEE T MOBILE COMPUT, V13, P2777, DOI 10.1109/TMC.2013.150; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Xie SD, 2014, WIRELESS PERS COMMUN, V78, P231, DOI 10.1007/s11277-014-1748-5; Yuan J., 2011, P 17 ACM SIGKDD INT, P316, DOI [DOI 10.1145/2020408.2020462, DOI 10.1109/ICDM.2016.0061]; Yuan J., 2010, P 18 SIGSPATIAL INT, P99, DOI 10.1145/1869790.1869807; Zhou P, 2013, P 11 ACM C EMB NETW, P1; Zhu YM, 2013, IEEE T MOBILE COMPUT, V12, P2289, DOI 10.1109/TMC.2012.205	35	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138898	10.1371/journal.pone.0138898	http://dx.doi.org/10.1371/journal.pone.0138898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407102	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700114
J	Lu, ZD; Du, R; Du, PR; Qin, SS; Liang, ZM; Li, ZM; Wang, YL; Wang, YF				Lu, Zedong; Du, Rui; Du, Pengrui; Qin, Saisai; Liang, Zongmin; Li, Ziming; Wang, Yaling; Wang, Yanfen			Influences of Land Use/Cover Types on Nitrous Oxide Emissions during Freeze-Thaw Periods from Waterlogged Soils in Inner Mongolia	PLOS ONE			English	Article							BEECH FOREST ECOSYSTEM; N-SATURATED SPRUCE; N2O EMISSIONS; INTERANNUAL VARIABILITY; GRASSLAND ECOSYSTEMS; SPATIAL VARIABILITY; METHANE EMISSIONS; CONTINUOUS RECORD; CARBON-DIOXIDE; LIMED SOIL	Nitrous oxide emissions during freeze/thaw periods contribute significantly to annual soil N2O emissions budgets in middle-and high-latitude areas; however, the freeze/thaw-related N2O emissions from waterlogged soils have hardly been studied in the Hulunber Grassland, Inner Mongolia. For this study, the effects of changes in land use/cover types on N2O emissions during freeze-thaw cycles were investigated to more accurately quantify the annual N2O emissions from grasslands. Soil cores from six sites were incubated at varying temperature (ranging from -15 to 10 degrees C) to simulate freeze-thaw cycles. N2O production rates were low in all soil cores during freezing periods, but increased markedly after soil thawed. Mean rates of N2O production differed by vegetation type, and followed the sequence: Leymus chinensis (LC) and Artemisia tanacetifolia (AT) steppes > LC steppes >= Stipa baicalensis (SB) steppes. Land use types (mowing and grazing) had differing effects on freeze/thaw-related N2O production. Grazing significantly reduced N2O production by 36.8%, while mowing enhanced production. The production of N2O was related to the rate at which grassland was mowed, in the order: triennially (M3) > once annually (M1) >= unmown (UM). Compared with the UM control plot, the M3 and M1 mowing regimes enhanced N2O production by 57.9% and 13.0% respectively. The results of in situ year-round measurements showed that large amounts of N2O were emitted during the freeze-thaw period, and that annual mean fluxes of N2O were 9.21 mu g N2O-N m(-2) h(-1) (ungrazed steppe) and 6.54 mu g N2O-N m(-2) h(-1) (grazed steppe). Our results further the understanding of freeze/thaw events as enhancing N2O production, and confirm that different land use/cover types should be differentiated rather than presumed to be equivalent, regarding nitrous oxide emission. Even so, further research involving multi-year and intensive measurements of N2O emission is still needed.	[Lu, Zedong; Du, Rui; Du, Pengrui; Qin, Saisai; Liang, Zongmin; Li, Ziming; Wang, Yaling; Wang, Yanfen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Du, R (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	ruidu@ucas.ac.cn		wang, yan fen/0000-0001-5666-9289	Chinese Academy of Sciences [XDA0520402]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the Chinese Academy of Sciences (Program No.: XDA0520402) http://people.ucas.ac.cn/similar to ruidu?language=cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Ball BC, 1997, J ENVIRON QUAL, V26, P1399, DOI 10.2134/jeq1997.00472425002600050029x; BOUWMAN AF, 1995, J GEOPHYS RES-ATMOS, V100, P2785, DOI 10.1029/94JD02946; BREMNER JM, 1980, GEOPHYS RES LETT, V7, P641, DOI 10.1029/GL007i009p00641; BREMNER JM, 1978, SCIENCE, V199, P295, DOI 10.1126/science.199.4326.295; BREMNER JM, 1975, SOIL BIOL BIOCHEM, V7, P383, DOI 10.1016/0038-0717(75)90054-1; Butterbach-Bahl K, 2002, PLANT SOIL, V240, P77, DOI 10.1023/A:1015856617553; CHEN Y, 1995, AGR ECOSYST ENVIRON, V55, P123, DOI 10.1016/0167-8809(95)00611-U; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; CHRISTENSEN S, 1991, J SOIL SCI, V42, P637, DOI 10.1111/j.1365-2389.1991.tb00110.x; CHRISTENSEN S, 1990, J SOIL SCI, V41, P1, DOI 10.1111/j.1365-2389.1990.tb00039.x; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; Corre MD, 1996, SOIL SCI SOC AM J, V60, P1806, DOI 10.2136/sssaj1996.03615995006000060028x; Davidson E. A., 1991, Microbial production and consumption of greenhouse gases: methane, nitrogen oxides, and halomethanes., P219; DENMEAD OT, 1979, SOIL SCI SOC AM J, V43, P726, DOI 10.2136/sssaj1979.03615995004300040020x; Du R, 2006, SOIL BIOL BIOCHEM, V38, P3474, DOI 10.1016/j.soilbio.2006.06.012; Du Rui, 2004, Huanjing Kexue, V25, P12; EDWARDS AC, 1986, SOIL USE MANAGE, V2, P86, DOI 10.1111/j.1475-2743.1986.tb00688.x; FLESSA H, 1995, J GEOPHYS RES-ATMOS, V100, P23115, DOI 10.1029/95JD02270; Garcia-Salamanca A, 2013, MICROB BIOTECHNOL, V6, P36, DOI 10.1111/j.1751-7915.2012.00358.x; GOODROAD LL, 1984, CAN J SOIL SCI, V64, P187, DOI 10.4141/cjss84-020; Groffman PM, 2006, GLOBAL CHANGE BIOL, V12, P1748, DOI 10.1111/j.1365-2486.2006.01194.x; GROFFMAN PM, 1989, SOIL BIOL BIOCHEM, V21, P613, DOI 10.1016/0038-0717(89)90053-9; HEANEY DJ, 1988, SOIL SCI SOC AM J, V52, P667, DOI 10.2136/sssaj1988.03615995005200030013x; Hiernaux P, 1998, PLANT ECOL, V138, P191, DOI 10.1023/A:1009752606688; Holst J, 2008, PLANT SOIL, V308, P105, DOI 10.1007/s11104-008-9610-8; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Hyde BP, 2006, NUTR CYCL AGROECOSYS, V75, P187, DOI 10.1007/s10705-006-9026-x; Jin HJ, 1999, CHINESE SCI BULL, V44, P2282, DOI 10.1007/BF02885940; Kaiser EA, 1996, PLANT SOIL, V181, P57, DOI 10.1007/BF00011292; Katayanagi N, 2012, SOIL SCI PLANT NUTR, V58, P261, DOI 10.1080/00380768.2012.670810; Klemedtsson L, 2005, GLOBAL CHANGE BIOL, V11, P1142, DOI 10.1111/j.1365-2486.2005.00973.x; Laverman AM, 2001, SOIL BIOL BIOCHEM, V33, P683, DOI 10.1016/S0038-0717(00)00180-2; Le Roux X, 2008, ISME J, V2, P221, DOI 10.1038/ismej.2007.109; Li X Z, 1999, THESIS CHINESE ACAD; [刘光生 Liu Guangsheng], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P555; Liu XR, 2010, NUTR CYCL AGROECOSYS, V86, P231, DOI 10.1007/s10705-009-9287-2; Lu ZD, 2015, FRONT EARTH SCI-PRC, V9, P473, DOI 10.1007/s11707-014-0486-z; Ludwig B, 2006, SOIL BIOL BIOCHEM, V38, P3516, DOI 10.1016/j.soilbio.2006.06.006; Ludwig B, 2004, J PLANT NUTR SOIL SC, V167, P678, DOI 10.1002/jpln.200421462; Malla G, 2005, CHEMOSPHERE, V58, P141, DOI 10.1016/j.chemosphere.2004.09.003; Marschner H., 1998, Soil chemistry and ecosystem health., P191; MATSON PA, 1991, BIOGEOCHEMISTRY, V14, P1; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Muller C, 2002, SOIL BIOL BIOCHEM, V34, P1325, DOI 10.1016/S0038-0717(02)00076-7; NAETH MA, 1991, CAN J SOIL SCI, V71, P313, DOI 10.4141/cjss91-031; NAGELE W, 1990, BIOL FERT SOILS, V10, P139; Neilson CB, 2001, SOIL SCI SOC AM J, V65, P1723, DOI 10.2136/sssaj2001.1723; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; NORMAN M. J. T., 1960, JOUR BRIT GRASSLAND SOC, V15, P145, DOI 10.1111/j.1365-2494.1960.tb00170.x; Nyborg M, 1997, CAN J SOIL SCI, V77, P153, DOI 10.4141/S96-105; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Paniagua A, 1999, AGR ECOSYST ENVIRON, V72, P215, DOI 10.1016/S0167-8809(98)00183-2; Papen H, 1999, J GEOPHYS RES-ATMOS, V104, P18487, DOI 10.1029/1999JD900293; Pei Z Y, 2003, THESIS CHINESE ACAD; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Rosen CJ, 2007, HORTTECHNOLOGY, V17, P422, DOI 10.21273/HORTTECH.17.4.422; Saggar S, 2004, NEW ZEAL J AGR RES, V47, P513, DOI 10.1080/00288233.2004.9513618; SKOGLAND T, 1988, SOIL BIOL BIOCHEM, V20, P851, DOI 10.1016/0038-0717(88)90092-2; Song CC, 2006, ATMOS ENVIRON, V40, P6879, DOI 10.1016/j.atmosenv.2005.08.028; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Stevens RJ, 1998, SOIL BIOL BIOCHEM, V30, P1119, DOI 10.1016/S0038-0717(97)00227-7; Teepe R, 2000, SOIL BIOL BIOCHEM, V32, P1807, DOI 10.1016/S0038-0717(00)00078-X; Teepe R, 2001, SOIL BIOL BIOCHEM, V33, P1269, DOI 10.1016/S0038-0717(01)00084-0; Vaario LM, 2011, APPL ENVIRON MICROB, V77, P8523, DOI 10.1128/AEM.05839-11; Vestgarden LS, 2009, GLOBAL CHANGE BIOL, V15, P876, DOI 10.1111/j.1365-2486.2008.01722.x; Wagner-Riddle C, 2007, GLOBAL CHANGE BIOL, V13, P1722, DOI 10.1111/j.1365-2486.2007.01388.x; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wang YS, 2005, CHEMOSPHERE, V58, P205, DOI 10.1016/j.chemosphere.2004.04.043; Wang YS, 2003, ADV ATMOS SCI, V20, P842, DOI 10.1007/BF02915410; Weintraub MN, 2005, BIOSCIENCE, V55, P408, DOI 10.1641/0006-3568(2005)055[0408:NCATSO]2.0.CO;2; Wolf B, 2010, NATURE, V464, P881, DOI 10.1038/nature08931; Wu X, 2014, BIOL FERT SOILS, V50, P295, DOI 10.1007/s00374-013-0853-z; Xu R, 2004, THESIS CHINESE ACAD; Yan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081466; Yanai J, 2003, J ENVIRON QUAL, V32, P1965, DOI 10.2134/jeq2003.1965; Yanai Y, 2004, SOIL SCI PLANT NUTR, V50, P821, DOI 10.1080/00380768.2004.10408542; Yao Z, 2010, J GEOPHYS RES, V115; Zancarini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047096; Zhang L, 2012, CHINA PLOS ONE, V7, DOI [10.1371/journal.pone.0035952, DOI 10.1371/J0URNAL.P0NE.0035952]; Zhong L, 2014, SOIL BIOL BIOCHEM, V69, P1, DOI 10.1016/j.soilbio.2013.10.028; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x; Zhu X, 2013, P NATL ACAD SCI USA, V110, P6328, DOI 10.1073/pnas.1219993110; Zou Y, 2011, ACTA ECOL SIN, V31, P150, DOI [10.1016/j.chnaes.2011.03.004, DOI 10.1016/J.CHNAES.2011.03.004]	84	8	8	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139316	10.1371/journal.pone.0139316	http://dx.doi.org/10.1371/journal.pone.0139316			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407303	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700206
J	Masconi, KL; Matsha, TE; Erasmus, RT; Kengne, AP				Masconi, Katya L.; Matsha, Tandi E.; Erasmus, Rajiv T.; Kengne, Andre P.			Effects of Different Missing Data Imputation Techniques on the Performance of Undiagnosed Diabetes Risk Prediction Models in a Mixed-Ancestry Population of South Africa	PLOS ONE			English	Article							MULTIPLE IMPUTATION; SCORE; REGRESSION; VALUES	Background Imputation techniques used to handle missing data are based on the principle of replacement. It is widely advocated that multiple imputation is superior to other imputation methods, however studies have suggested that simple methods for filling missing data can be just as accurate as complex methods. The objective of this study was to implement a number of simple and more complex imputation methods, and assess the effect of these techniques on the performance of undiagnosed diabetes risk prediction models during external validation. Methods Data from the Cape Town Bellville-South cohort served as the basis for this study. Imputation methods and models were identified via recent systematic reviews. Models' discrimination was assessed and compared using C-statistic and non-parametric methods, before and after recalibration through simple intercept adjustment. Results The study sample consisted of 1256 individuals, of whom 173 were excluded due to previously diagnosed diabetes. Of the final 1083 individuals, 329 (30.4%) had missing data. Family history had the highest proportion of missing data (25%). Imputation of the outcome, undiagnosed diabetes, was highest in stochastic regression imputation (163 individuals). Overall, deletion resulted in the lowest model performances while simple imputation yielded the highest C-statistic for the Cambridge Diabetes Risk model, Kuwaiti Risk model, Omani Diabetes Risk model and Rotterdam Predictive model. Multiple imputation only yielded the highest C-statistic for the Rotterdam Predictive model, which were matched by simpler imputation methods. Conclusions Deletion was confirmed as a poor technique for handling missing data. However, despite the emphasized disadvantages of simpler imputation methods, this study showed that implementing these methods results in similar predictive utility for undiagnosed diabetes when compared to multiple imputation.	[Masconi, Katya L.; Erasmus, Rajiv T.] NHLS, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa; [Masconi, Katya L.; Erasmus, Rajiv T.] Univ Stellenbosch, Cape Town, South Africa; [Masconi, Katya L.; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Matsha, Tandi E.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Technol, Cape Town, South Africa; [Kengne, Andre P.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa	Stellenbosch University; South African Medical Research Council; Cape Peninsula University of Technology; University of Cape Town	Kengne, AP (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.	andre.kengne@mrc.ac.za	Kengne, Andre Pascal/ABB-3696-2020	Matsha, Tandi/0000-0001-5251-030X; Kengne, Andre Pascal/0000-0002-5183-131X	South African National Research Foundation; Carl & Emily Fuchs Foundation	South African National Research Foundation(National Research Foundation - South Africa); Carl & Emily Fuchs Foundation	KLM was supported by a scholarship from the South African National Research Foundation and the Carl & Emily Fuchs Foundation. The authors received no other specific funding for this work.	Al Khalaf M. M., 2010, Eastern Mediterranean Health Journal, V16, P725; Al-Lawati JA, 2007, DIABETES RES CLIN PR, V77, P438, DOI 10.1016/j.diabres.2007.01.013; Alzola C., 2006, INTRO S HMISC DESIGN, P310; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Baker J, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-47; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302; Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; Buuren S., 2011, J STAT SOFTWARE, V45; City of Cape Town, 2013, CITY CAPE TOWN 2011; City of Cape Town, 2006, CITY CAPE TOWN CENSU; CRAWFORD SL, 1995, J CLIN EPIDEMIOL, V48, P209, DOI 10.1016/0895-4356(94)00124-9; DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Graham JW, 1996, MULTIVAR BEHAV RES, V31, P197, DOI 10.1207/s15327906mbr3102_3; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Harrell FE, 2001, REGRESSION MODELING, Vxxii; Kengne AP, 2014, CRIT REV CL LAB SCI, V51, P1, DOI 10.3109/10408363.2013.853025; Little R.J.A., 2002, STAT ANAL MISSING DA; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Masconi K, 2015, DIABETOLOGY METABOLI; Masconi KL, 2015, EPMA J, V6, DOI 10.1186/s13167-015-0028-0; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; Rubin D. B., 2004, MULTIPLE IMPUTATION; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Steyerberg E., 2009, CLIN PREDICTION MODE; The R Foundation, 2015, R PROJECT STAT COMPU; Vach W, 1997, STAT MED, V16, P57; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; World Health Organization, 2003, WHONMHMNC031	37	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139210	10.1371/journal.pone.0139210	http://dx.doi.org/10.1371/journal.pone.0139210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406594	Green Published, gold			2022-12-27	WOS:000361800700191
J	Miller, AL; Leach, MC				Miller, Amy L.; Leach, Matthew C.			The Mouse Grimace Scale: A Clinically Useful Tool?	PLOS ONE			English	Article							LABORATORY MICE; CHRONIC PAIN; RATS; STRAINS	Medical research has a heavy and continuing demand for rodent models across a range of disciplines. Behavioural assessment of pain in such models is highly time consuming, thus limiting the number of models and analgesics that can be studied. Facial expressions are widely used to assess pain in human infants. Recently the mouse grimace scale (MGS) has been developed and shown to be accurate and reliable, requiring only a short amount of training for the observer. This system therefore has the potential to become a highly useful tool both in pain research and clinical assessment of mouse pain. To date, the MGS has only been used as a research tool, however there is increasing interest in its use in cage-side clinical assessment. It is often wrongly assumed that MGS scores of animals not in pain (i.e. at baseline) are zero. Here, we aimed to assess the variability in baseline MGS scores between cohorts, sexes and strains of mice. Establishing the presence of a consistent baseline MGS score could lead to a valuable clinical pain assessment tool for mice when baseline information from the individual mouse may not be available as a comparator. Results demonstrated a significant difference in baseline MGS scores between both sexes (males > females) and strains of mice. The method used to score the facial action units (Live vs. retrospectively from still images) demonstrated significant differences in scores with live scores being significantly lower than retrospective scoring from images. The level of variation shown demonstrates the need for further research to be undertaken with regard to establishing baseline MGS scores for specific strains and sexes of mice, taking into account the method of scoring, prior to considering clinical implementation of this method in pain assessment.	[Miller, Amy L.; Leach, Matthew C.] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Miller, AL (corresponding author), Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	amy.miller@ncl.ac.uk			UK National centre for 3Rs (NC3Rs) [G1100563/1]; National Centre for the Replacement [G1100563/1] Funding Source: researchfish	UK National centre for 3Rs (NC3Rs); National Centre for the Replacement	Funded by the UK National centre for the 3Rs (NC3Rs), grant number G1100563/1 (Website: https://www.nc3rs.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colpaert FC, 2001, PAIN, V91, P33, DOI 10.1016/S0304-3959(00)00413-9; Dennis Melvin B Jr, 2002, ILAR J, V43, P100; Endo T, 2008, PAIN, V138, P292, DOI 10.1016/j.pain.2007.12.017; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Home Office, 2013, ANN STAT SCI PROC LI; Jennings M, 1998, LAB ANIM-UK, V32, P233, DOI 10.1258/002367798780559301; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kest B, 2002, PHARMACOL BIOCHEM BE, V73, P821, DOI 10.1016/S0091-3057(02)00908-5; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Matsumiya LC, 2012, J AM ASSOC LAB ANIM, V51, P42; Miller AL, 2012, LAB ANIM-UK, V46, P304, DOI 10.1258/la.2012.012078; Minett MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104458; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; SUFKA KJ, 1994, PAIN, V58, P355, DOI 10.1016/0304-3959(94)90130-9; Whittaker AL, 2014, APPL ANIM BEHAV SCI, V151, P1, DOI 10.1016/j.applanim.2013.11.001; Williams WO, 2008, J AM ASSOC LAB ANIM, V47, P8	21	69	70	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136000	10.1371/journal.pone.0136000	http://dx.doi.org/10.1371/journal.pone.0136000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406227	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700008
J	Mustafa, T; Horton, DR; Cooper, WR; Swisher, KD; Zack, RS; Pappu, HR; Munyaneza, JE				Mustafa, Tariq; Horton, David R.; Cooper, W. Rodney; Swisher, Kylie D.; Zack, Richard S.; Pappu, Hanu R.; Munyaneza, Joseph E.			Use of Electrical Penetration Graph Technology to Examine Transmission of 'Candidatus Liberibacter solanacearum' to Potato by Three Haplotypes of Potato Psyllid (Bactericera cockerelli; Hemiptera: Triozidae)	PLOS ONE			English	Article							ZEBRA CHIP DISEASE; STYLET PENETRATION; 1ST REPORT; INOCULATION; ACQUISITION; BEHAVIOR; PLANT; ASSOCIATION; BIOLOGY; APHIDS	The potato psyllid, Bactericera cockerelli (Sulc) (Hemiptera: Triozidae), is a vector of the phloem-limited bacterium 'Candidatus Liberibacter solanacearum' (Lso), the putative causal agent of zebra chip disease of potato. Little is known about how potato psyllid transmits Lso to potato. We used electrical penetration graph (EPG) technology to compare stylet probing behaviors and efficiency of Lso transmission of three haplotypes of potato psyllid (Central, Western, Northwestern). All haplotypes exhibited the full suite of stylet behaviors identified in previous studies with this psyllid, including intercellular penetration and secretion of the stylet pathway, xylem ingestion, and phloem activities, the latter comprising salivation and ingestion. The three haplotypes exhibited similar frequency and duration of probing behaviors, with the exception of salivation into phloem, which was of higher duration by psyllids of the Western haplotype. We manipulated how long psyllids were allowed access to potato ("inoculation access period", or IAP) to examine the relationship between phloem activities and Lso transmission. Between 25 and 30% of psyllids reached and salivated into phloem at an IAP of 1 hr, increasing to almost 80% of psyllids as IAP was increased to 24 h. Probability of Lso-transmission was lower across all IAP levels than probability of phloem salivation, indicating that a percentage of infected psyllids which salivated into the phloem failed to transmit Lso. Logistic regression showed that probability of transmission increased as a function of time spent salivating into the phloem; transmission occurred as quickly as 5 min following onset of salivation. A small percentage of infected psyllids showed extremely long salivation events but nonetheless failed to transmit Lso, for unknown reasons. Information from these studies increases our understanding of Lso transmission by potato psyllid, and demonstrates the value of EPG technology in exploring questions of vector efficiency.	[Mustafa, Tariq; Horton, David R.; Cooper, W. Rodney; Swisher, Kylie D.; Munyaneza, Joseph E.] USDA ARS, Yakima Agr Res Lab, Wapato, WA 98951 USA; [Mustafa, Tariq; Zack, Richard S.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Pappu, Hanu R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University; Washington State University	Munyaneza, JE (corresponding author), USDA ARS, Yakima Agr Res Lab, Wapato, WA 98951 USA.	Joseph.Munyaneza@ars.usda.gov	Cooper, William/ABB-1389-2020; Mustafa, Tariq/AAU-4194-2021	Cooper, William/0000-0001-7983-3627; Mustafa, Tariq/0000-0002-6083-5806	Northwest Potato Research Consortium, Washington State Potato Commission; United States Department of Agriculture, Agricultural Research Service State Cooperative Potato Research Program; United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative [2009-51181-20176]	Northwest Potato Research Consortium, Washington State Potato Commission; United States Department of Agriculture, Agricultural Research Service State Cooperative Potato Research Program; United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative	Funding: Financial support for this research was partially provided by the Northwest Potato Research Consortium, Washington State Potato Commission; United States Department of Agriculture, Agricultural Research Service State Cooperative Potato Research Program; and United States Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative (Project #2009-51181-20176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PD, 2006, LOGISTIC REGRESSION; Arp A, 2014, ENVIRON ENTOMOL, V43, P344, DOI 10.1603/EN13256; Backus EA, 2009, J INSECT PHYSIOL, V55, P869, DOI 10.1016/j.jinsphys.2009.05.007; Buchman JL, 2011, J ECON ENTOMOL, V104, P1486, DOI 10.1603/EC11123; Butler CD, 2012, ENTOMOL EXP APPL, V142, P247, DOI 10.1111/j.1570-7458.2012.01219.x; Cooper WR, 2015, ANN ENTOMOL SOC AM, V108, P137, DOI 10.1093/aesa/sau048; Cooper WR, 2014, ANN ENTOMOL SOC AM, V107, P204, DOI 10.1603/AN13087; Crosslin JM, 2012, PLANT DIS, V96, P453, DOI 10.1094/PDIS-10-11-0853; Crosslin JM, 2012, PLANT DIS, V96, P452, DOI 10.1094/PDIS-10-11-0894; Fereres A, 2001, VIRUS INSECT PLANT I; Gbur EE, 2012, ACSESS PUBL, P1, DOI 10.2134/2012.generalized-linear-mixed-models; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Liu D, 2007, ENTOMOL EXP APPL, V123, P35, DOI 10.1111/j.1570-7458.2007.00521.x; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; MCLEAN DL, 1964, NATURE, V202, P1358, DOI 10.1038/2021358a0; Moreno A, 2012, J GEN VIROL, V93, P662, DOI 10.1099/vir.0.037887-0; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza J. E., 2007, PLANT SCI, V59, P30; Munyaneza JE., 2008, SUBPLANT SCI, V60, P27; Munyaneza JE, 2015, AM J POTATO RES, V92, P230, DOI 10.1007/s12230-015-9448-6; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Mustafa T, 2015, ENVIRON ENTOMOL, V44, P593, DOI 10.1093/ee/nvv018; Mustafa T, 2015, ENVIRON ENTOMOL, V44, P300, DOI 10.1093/ee/nvu029; Nischwitz C., 2015, UTAH PESTS NEWS, V9, P1; Pastrik KH, 2000, J PHYTOPATHOL, V148, P619, DOI 10.1046/j.1439-0434.2000.00567.x; Pearson CC, 2014, ANN ENTOMOL SOC AM, V107, P650, DOI 10.1603/AN13178; POWELL G, 1991, ANN APPL BIOL, V119, P313, DOI 10.1111/j.1744-7348.1991.tb04870.x; Prager SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094047; Sandanayaka WRM, 2014, ENTOMOL EXP APPL, V151, P170, DOI 10.1111/eea.12179; Sandanayaka WRM, 2013, ARTHROPOD-PLANT INTE, V7, P137, DOI 10.1007/s11829-012-9238-8; SAS Institute, 2012, SAS REL 9 3 ED; Sengoda VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093475; Sengoda VG, 2013, J ECON ENTOMOL, V106, P1964, DOI 10.1603/EC13129; Stafford CA, 2009, ENTOMOL EXP APPL, V130, P130, DOI 10.1111/j.1570-7458.2008.00813.x; Swisher KD, 2014, AM J POTATO RES, V91, P485, DOI 10.1007/s12230-014-9378-8; Swisher KD, 2013, AM J POTATO RES, V90, P570, DOI 10.1007/s12230-013-9330-3; Swisher KD, 2013, ENVIRON ENTOMOL, V42, P381, DOI 10.1603/EN12261; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Symmes EJ, 2008, ENTOMOL EXP APPL, V129, P258, DOI 10.1111/j.1570-7458.2008.00784.x; Thinakaran J, 2015, ANN ENTOMOL SOC AM, V108, P459, DOI 10.1093/aesa/sav030; Thomas K. L., 2011, New Zealand Plant Protection, V64, P259; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P177, DOI 10.1007/BF00361930; Tjallingii WF, 2001, VIRUS INSECT PLANT I; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0	46	34	34	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138946	10.1371/journal.pone.0138946	http://dx.doi.org/10.1371/journal.pone.0138946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407093	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700124
J	Nagel, S; Ehrentraut, S; Meyer, C; Kaufmann, M; Drexler, HG; MacLeod, RAF				Nagel, Stefan; Ehrentraut, Stefan; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.			Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma	PLOS ONE			English	Article							REED-STERNBERG CELLS; ZINC-FINGERS; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEIN; GROWTH; AMPLIFICATION; INHIBITION; INDUCTION; RECURRENT; EVOLUTION	In Hodgkin lymphoma (HL) we recently reported that deregulated homeobox gene MSX1 mediates repression of the B-cell specific transcription factor ZHX2. In this study we investigated regulation of MSX1 in this B-cell malignancy. Accordingly, we analyzed expression and function of OTX homeobox genes which activate MSX1 transcription during embryonal development in the neural plate border region. Our data demonstrate that OTX1 and OTX2 are aberrantly expressed in both HL patients and cell lines. Moreover, both OTX loci are targeted by genomic gains in overexpressing cell lines. Comparative expression profiling and subsequent pathway modulations in HL cell lines indicated that aberrantly enhanced FGF2-signalling activates the expression of OTX2. Downstream analyses of OTX2 demonstrated transcriptional activation of genes encoding transcription factors MSX1, FOXC1 and ZHX1. Interestingly, examination of the physiological expression profile of ZHX1 in normal hematopoietic cells revealed elevated levels in T-cells and reduced expression in B-cells, indicating a discriminatory role in lymphopoiesis. Furthermore, two OTX-negative HL cell lines overexpressed ZHX1 in correlation with genomic amplification of its locus at chromosomal band 8q24, supporting the oncogenic potential of this gene in HL. Taken together, our data demonstrate that deregulated homeobox genes MSX1 and OTX2 respectively impact transcriptional inhibition of (B-cell specific) ZHX2 and activation of (T-cell specific) ZHX1. Thus, we show how reactivation of a specific embryonal gene regulatory network promotes disturbed B-cell differentiation in HL.	[Nagel, Stefan; Ehrentraut, Stefan; Meyer, Corinna; Kaufmann, Maren; Drexler, Hans G.; MacLeod, Roderick A. F.] German Collect Microorganisms & Cell Cultures, Dept Human & Anim Cell Lines, Leibniz Inst DSMZ, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Nagel, S (corresponding author), German Collect Microorganisms & Cell Cultures, Dept Human & Anim Cell Lines, Leibniz Inst DSMZ, Braunschweig, Germany.	sna@dsmz.de						Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Agoston Z, 2009, DEVELOPMENT, V136, P3311, DOI 10.1242/dev.037770; Aldinucci D, 2010, J PATHOL, V221, P248, DOI 10.1002/path.2711; Atayar C, 2005, AM J PATHOL, V166, P127, DOI 10.1016/S0002-9440(10)62238-9; Barthelemy I, 1996, BIOCHEM BIOPH RES CO, V224, P870, DOI 10.1006/bbrc.1996.1114; Bayarsaihan D, 2003, P NATL ACAD SCI USA, V100, P10358, DOI 10.1073/pnas.1834010100; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Binato R, 2007, BIOCHEM BIOPH RES CO, V358, P655, DOI 10.1016/j.bbrc.2007.04.190; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Bohle V, 2013, LEUKEMIA, V27, P671, DOI 10.1038/leu.2012.280; Boon K, 2005, CANCER RES, V65, P703; Briata P, 1999, FEBS LETT, V445, P160, DOI 10.1016/S0014-5793(99)00113-1; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Bunt J, 2012, INT J CANCER, V131, pE21, DOI 10.1002/ijc.26474; Butler AB, 2000, ANAT REC, V261, P111, DOI 10.1002/1097-0185(20000615)261:3<111::AID-AR6>3.0.CO;2-F; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Chen JY, 2009, INT J DEV BIOL, V53, P733, DOI 10.1387/ijdb.072513cj; Chen SL, 2013, J CELL BIOCHEM, V114, P2323, DOI 10.1002/jcb.24579; Dimitrova L, 2014, LEUKEMIA, V28, P213, DOI 10.1038/leu.2013.211; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Fazi B, 2009, ONCOGENE, V28, P3814, DOI 10.1038/onc.2009.233; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Gan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039770; Gharbaran R, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-62; Giefing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084928; Grimmer MR, 2006, CURR OPIN PEDIATR, V18, P634, DOI 10.1097/MOP.0b013e32801080fe; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Hertel CB, 2002, ONCOGENE, V21, P4908, DOI 10.1038/sj.onc.1205629; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Joos S, 2000, CANCER RES, V60, P549; Joos S, 2002, BLOOD, V99, P1381, DOI 10.1182/blood.V99.4.1381; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; Khnykin D, 2006, J PATHOL, V208, P431, DOI 10.1002/path.1900; Koshida S, 2002, DEV BIOL, V244, P9, DOI 10.1006/dbio.2002.0581; Krenacs L, 1998, BLOOD, V92, P1308, DOI 10.1182/blood.V92.4.1308.416k32_1308_1316; Kube D, 2001, BLOOD, V98, P762, DOI 10.1182/blood.V98.3.762; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; Kwiecinska A, 2014, GENE CHROMOSOME CANC, V53, P750, DOI 10.1002/gcc.22184; MacLeod RAF, 2000, LEUKEMIA, V14, P1803, DOI 10.1038/sj.leu.2401894; MacLeod RAF, 2011, METHODS MOL BIOL, V731, P57, DOI 10.1007/978-1-61779-080-5_6; Martin-Subero JI, 2002, BLOOD, V99, P1474, DOI 10.1182/blood.V99.4.1474; Martin-Subero JI, 2006, CANCER RES, V66, P10332, DOI 10.1158/0008-5472.CAN-06-1992; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; Murphy D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-14; Nagel S, 2005, LEUKEMIA, V19, P841, DOI 10.1038/sj.leu.2403716; Nagel S, 2007, BLOOD, V109, P3015, DOI 10.1182/blood-2006-08-044347; Nagel S, 2015, LEUKEMIA LYMPHOMA, V56, P480, DOI 10.3109/10428194.2014.924119; Nagel S, 2014, GENE CHROMOSOME CANC, V53, P917, DOI 10.1002/gcc.22204; Nagel S, 2014, LEUKEMIA LYMPHOMA, V55, P1893, DOI 10.3109/10428194.2013.864762; Nagel S, 2013, GENE CHROMOSOME CANC, V52, P741, DOI 10.1002/gcc.22069; Nagel S, 2012, LEUKEMIA RES, V36, P646, DOI 10.1016/j.leukres.2011.10.019; Nagel S, 2011, GENE CHROMOSOME CANC, V50, P996, DOI 10.1002/gcc.20920; Nelms B.L., 2010, TRANSCRIPTIONAL CONT; Ogata-Kawata H, 2007, FRONT BIOSCI-LANDMRK, V12, P1911, DOI 10.2741/2197; Omodei D, 2009, AM J PATHOL, V175, P2609, DOI 10.2353/ajpath.2009.090542; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Re D, 2001, CANCER RES, V61, P2080; Renne C, 2006, AM J PATHOL, V169, P655, DOI 10.2353/ajpath.2006.060020; Robel L, 1995, J NEUROSCI, V15, P7879; Sakurai Y, 2010, DEV BIOL, V347, P392, DOI 10.1016/j.ydbio.2010.08.028; Samuel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089110; SCHLEGELBERGER B, 1994, LEUKEMIA, V8, P72; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; Schmidt A, 2010, GENE CHROMOSOME CANC, V49, P803, DOI 10.1002/gcc.20789; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; Shou ZF, 2004, BIOCHEM BIOPH RES CO, V314, P885, DOI 10.1016/j.bbrc.2003.12.162; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Singh N, 2013, DEV BIOL, V377, P333, DOI 10.1016/j.ydbio.2013.03.008; Sohlbach K, 2012, LEUKEMIA LYMPHOMA, V53, P996, DOI 10.3109/10428194.2011.634046; Stanelle J, 2010, BLOOD, V116, P4202, DOI 10.1182/blood-2010-01-265827; Stein H, 2001, BLOOD, V97, P496, DOI 10.1182/blood.V97.2.496; Tomsa JM, 1999, DEV BIOL, V207, P26, DOI 10.1006/dbio.1998.9163; Yamada K, 2002, BIOCHEM BIOPH RES CO, V297, P368, DOI 10.1016/S0006-291X(02)02203-9; Zheng B, 2003, BLOOD, V102, P1019, DOI 10.1182/blood-2002-11-3507	80	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138416	10.1371/journal.pone.0138416	http://dx.doi.org/10.1371/journal.pone.0138416			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406991	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700043
J	Qu, SJ; Ji, Y; Goh, M				Qu, Shaojian; Ji, Ying; Goh, Mark			The Robust Weighted Multi-Objective Game	PLOS ONE			English	Article							MODELS	This paper studies a class of multi-objective n-person non-zero sum games through a robust weighted approach where each player has more than one competing objective. This robust weighted multi-objective game model assumes that each player attaches a set of weights to its objectives instead of accessing accurate weights. Each player wishes to minimize its maximum weighted sum objective where the maximization is pointing to the set of weights. To address this new model, a new equilibrium concept-robust weighted Nash equilibrium is obtained. The existence of this new concept is proven on suitable assumptions about the multi-objective payoffs.	[Qu, Shaojian] Shanghai Univ Sci & Technol, Sch Business, Shanghai, Peoples R China; [Qu, Shaojian; Ji, Ying; Goh, Mark] Natl Univ Singapore, Logist Inst Asia Pacific, Singapore 117548, Singapore; [Ji, Ying] Harbin Inst Technol, Ctr Nat Sci, Harbin 150006, Peoples R China; [Goh, Mark] Natl Univ Singapore, NUS Business Sch, Singapore 117548, Singapore	University of Shanghai for Science & Technology; National University of Singapore; Harbin Institute of Technology; National University of Singapore	Qu, SJ (corresponding author), Shanghai Univ Sci & Technol, Sch Business, Shanghai, Peoples R China.	qushaojian@163.com	goh, mark/GQO-8860-2022; goh, mark/AAC-4268-2022	goh, mark/0000-0002-3620-7658; goh, mark/0000-0002-3620-7658	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [TP2014043]; Science and Engineering Research Council (SERC), A*STAR [1121790043]; Natural Scientific Foundation of China [71201040, 11201099]	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Engineering Research Council (SERC), A*STAR(Agency for Science Technology & Research (A*STAR)); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: The work is supported by The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (No. TP2014043). The work is also supported by a research Grant from Science and Engineering Research Council (SERC), A*STAR (Title of Supported Project: Master Facilitative Control Tower for Risk Management of Complex Supply Chains and Ref Number: 1121790043) and by Natural Scientific Foundation of China (No. 71201040, No. 11201099).	Blackwell David, 1956, PAC J MATH, V6, P1, DOI [10.2140/pjm.1956.6.1, DOI 10.2140/PJM.1956.6.1]; Hu J, 2012, OPER RES, V60, P936, DOI 10.1287/opre.1120.1071; Kakutani S., 1941, DUKE MATH J, P457, DOI DOI 10.1215/S0012-7094-41-00838-4; Lozovanu D., 2005, B ACAD STIINTE REPUB, V3, P115; Peng JW, 2011, J OPTIMIZ THEORY APP, V150, P416, DOI 10.1007/s10957-011-9839-x; WANG SY, 1993, J OPTIMIZ THEORY APP, V79, P373, DOI 10.1007/BF00940586; WEBER M, 1993, EUR J OPER RES, V67, P1, DOI 10.1016/0377-2217(93)90318-H; Yu J, 1998, COMPUT MATH APPL, V35, P17, DOI 10.1016/S0898-1221(98)00053-4	9	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138970	10.1371/journal.pone.0138970	http://dx.doi.org/10.1371/journal.pone.0138970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406986	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700133
J	Yang, Y; Yao, KH; Ma, X; Shi, W; Yuan, L; Yang, YH				Yang, Ying; Yao, Kaihu; Ma, Xiang; Shi, Wei; Yuan, Lin; Yang, Yonghong			Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014)	PLOS ONE			English	Article							SEQUENCE VARIATION; RESISTANCE; STRAINS; PERIOD; TOXIN; IMMUNIZATION; SURVEILLANCE; POLYMORPHISM; NETHERLANDS; VACCINATION	Objectives To investigate changes in virulence-related genotypes and in the antimicrobial susceptibility of Bordetella pertussis isolates collected from the 1970s to 2014 in the northern part of China. Methods A total of 124 B. pertussis isolates from three periods, the 1970s, 2000-2008, and May 2013-Sept 2014, were typed by multilocus sequence typing (MLST) and tested for antimicrobial susceptibility and virulence-related genes. A fragment of the 23S rRNA gene from each of the 99 isolates from 2013-2014 was amplified and sequenced. Results All isolates from 2000-2008 and 2013-2014 were identified as ST2, whereas isolates from the 1970s were ST1. PtxA2/ptxC1/ptxP1/prn1/fim2-1/fim3-1/tcfA2, which was the same as the vaccine strain, was the only type in the 1970s. During the 2000s and 2013-2014, the virulence type ptxA1/ptxC1/ptxP1/prn1/fim2-1/fim3-1/tcfA2 was dominant, with frequencies of 68.4% and 91.9%, respectively. Nine ptxP3 strains, which were more virulent, were detected after 2000. All 124 isolates were susceptible to levofloxacin, sulphamethoxazole/trimethoprim and tetracycline. The isolates from the 1970s and 2000-2008 were susceptible to all tested macrolides, whereas 91.9% of the 2013-2014 isolates were highly resistant (minimal inhibitory concentration, MIC >256 mu g/ml). No ptxP3 strain was resistant to macrolides. All erythromycin-resistant strains except for one had the A2047G mutation in the 23S rRNA gene. Conclusions Macrolide resistance of the B. pertussis population has been a serious problem in the northern part of China. Because most of the epidemic clone of the pathogen expresses the same antigen profiles as the vaccine strain, except ptxA, improvements in immunization strategies may prevent the spread of infection and drug resistance.	[Yang, Ying; Yao, Kaihu; Shi, Wei; Yuan, Lin; Yang, Yonghong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst,Minist Educ,Key Lab Major, Beijing Key Lab Pediat Resp Infect Dis,Natl Clin, Beijing, Peoples R China; [Yang, Ying; Yao, Kaihu; Shi, Wei; Yuan, Lin; Yang, Yonghong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst,Minist Educ,Natl Key Disc, Beijing Key Lab Pediat Resp Infect Dis,Natl Clin, Beijing, Peoples R China; [Ma, Xiang] Shandong Univ, Qilu Childrens Hosp, Resp Dept, Jinan 250100, Peoples R China	Capital Medical University; Capital Medical University; Shandong University	Yang, YH (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst,Minist Educ,Key Lab Major, Beijing Key Lab Pediat Resp Infect Dis,Natl Clin, Beijing, Peoples R China.	yyh628628@sina.com	ma, xiang/GSE-2438-2022	ma, xiang/0000-0001-6139-4355	Beijing Municipal Science and Technology Commission [2014-bjsekyjs-3]; National Clinical Center Project from the Ministry of Science and Technology of the People's Republic of China [2013BAI09B11]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Clinical Center Project from the Ministry of Science and Technology of the People's Republic of China	Funding: This study was financially supported by the Research Funds of Profession Quota Budget from Beijing Municipal Science and Technology Commission (2014-bjsekyjs-3) and the National Clinical Center Project from the Ministry of Science and Technology of the People's Republic of China (Grant No. 2013BAI09B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 1997, Commun Dis Intell, V21, P145; [Anonymous], 2010, IMM PROF CHIN, P12; Baron S, 1998, PEDIATR INFECT DIS J, V17, P412, DOI 10.1097/00006454-199805000-00013; Bartkus JM, 2003, J CLIN MICROBIOL, V41, P1167, DOI 10.1128/JCM.41.3.1167-1172.2003; BASS JW, 1994, PEDIATR INFECT DIS J, V13, P343, DOI 10.1097/00006454-199405000-00002; deMelker HE, 1997, EMERG INFECT DIS, V3, P175, DOI 10.3201/eid0302.970211; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Fry NK, 2010, EUR J CLIN MICROBIOL, V29, P1183, DOI 10.1007/s10096-010-0976-1; Godfroid F, 2005, EXPERT REV VACCINES, V4, P757, DOI 10.1586/14760584.4.5.757; Gordon KA, 2001, ANTIMICROB AGENTS CH, V45, P3599, DOI 10.1128/AAC.45.12.3599-3600.2001; Guillot S, 2012, EMERG INFECT DIS, V18, P966, DOI 10.3201/eid1806.120091; Hill BC, 2000, J CLIN MICROBIOL, V38, P1151, DOI 10.1128/JCM.38.3.1151-1155.2000; Horiba K, 2014, JPN J INFECT DIS, V67, P345, DOI 10.7883/yoken.67.345; Jung Sang-Oun, 2011, Osong Public Health Res Perspect, V2, P115, DOI 10.1016/j.phrp.2011.08.003; Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052; LEWIS K, 1995, PEDIATR INFECT DIS J, V14, P388, DOI 10.1097/00006454-199505000-00010; Li YR, 2015, APMIS, V123, P361, DOI 10.1111/apm.12357; Liang XF., 2007, NATL IMMUNIZATION PR, V13, P245, DOI DOI 10.3969/J.ISSN.1006-916X.2007.03.015; Miyaji Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077165; Mooi FR, 2014, EPIDEMIOL INFECT, V142, P685, DOI 10.1017/S0950268813000071; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Mosiej E, 2015, EUR J CLIN MICROBIOL, V34, P147, DOI 10.1007/s10096-014-2216-6; Packard ER, 2004, J MED MICROBIOL, V53, P355, DOI 10.1099/jmm.0.05515-0; Shahcheraghi F, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.10880; Simmonds K, 2014, INT J INFECT DIS, V29, P223, DOI 10.1016/j.ijid.2014.10.028; Sintchenko V, 2007, J ANTIMICROB CHEMOTH, V60, P1178, DOI 10.1093/jac/dkm343; Tsang RSW, 2004, J CLIN MICROBIOL, V42, P5364, DOI 10.1128/JCM.42.11.5364-5367.2004; van Gent M, 2015, EUR J CLIN MICROBIOL, V34, P821, DOI 10.1007/s10096-014-2297-2; Wang JM, 2002, EMERG INFECT DIS, V8, P859, DOI 10.3201/eid0808.010442; Wang Z, 2014, CLIN MICROBIOL INFEC, V20, pO825, DOI 10.1111/1469-0691.12671; World Health Organization, 2004, LAB MAN DIAGN WHOOP; Xu YH, 2015, HUM VACC IMMUNOTHER, V11, P421, DOI 10.4161/21645515.2014.988549; Yao SM, 2008, J MED MICROBIOL, V57, P1577, DOI 10.1099/jmm.0.2008/002857-0; Zhang L, 2010, EMERG INFECT DIS, V16, P1695, DOI 10.3201/eid1611.100401; Zhang Q, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-138; Zhang WS, 2008, EUR J CLIN PHARMACOL, V64, P821, DOI 10.1007/s00228-008-0489-3; Zhang XL, 2000, CHIN J VAC IMMUN, V6, P93	39	36	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138941	10.1371/journal.pone.0138941	http://dx.doi.org/10.1371/journal.pone.0138941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406905	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700122
J	Zeng, SY; Gong, Y; Zhang, YP; Chen, SB; Chen, JY; Lin, CQ; Peng, JH; Hou, ZD; Zhong, JQ; Liang, HJ; Huang, GH; Wang, DM; Lai, HY; Li, LP; Zeng, QY				Zeng, Shao-ying; Gong, Yao; Zhang, Yu-ping; Chen, Su-biao; Chen, Jun-yang; Lin, Chu-qing; Peng, Jian-hua; Hou, Zhi-duo; Zhong, Jian-qiu; Liang, Hong-jin; Huang, Guo-hai; Wang, Dan-min; Lai, Huai-yuan; Li, Li-ping; Zeng, Qing Yu			Changes in the Prevalence of Rheumatic Diseases in Shantou, China, in the Past Three Decades: A COPCORD Study	PLOS ONE			English	Article							RISK-FACTORS; ANKYLOSING-SPONDYLITIS; KNEE OSTEOARTHRITIS; AMERICAN-COLLEGE; CRITERIA; GOUT; CLASSIFICATION; EPIDEMIOLOGY; POPULATION; ARTHRITIS	This study aimed to clarify changes in the prevalence of rheumatic diseases in Shantou, China, in the past 3 decades and validate whether stair-climbing is a risk factor for knee pain and knee osteoarthritis (KOA). The World Health Organization-International League Against Rheumatism Community Oriented Program for Control of Rheumatic Diseases (COPCORD) protocol was implemented. In all, 2337 adults living in buildings without elevators and 1719 adults living in buildings with elevators were surveyed. The prevalence of rheumatic pain at any site and in the knee was 15.7% and 10.2%, respectively; both types of pain had a significantly higher incidence in residents of buildings without elevators than was reported by people who lived in buildings with elevators (14.9% vs. 10.6% and 11.32% vs. 8.82%, respectively) (both P < 0.0001). The prevalence of rheumatic pain in the neck, lumbar spine, shoulder, elbow, and foot was 5.6%, 4.5%, 3.1%, 1.4%, and 1.8%, respectively; these findings were similar to the data from the 1987 rural survey, but were somewhat lower than data reported in the urban and suburban surveys of the 1990s, with the exception of neck and lumbar pain. The prevalence of KOA, gout, and fibromyalgia was 7.10%, 1.08%, and 0.07%, respectively, and their prevalence increased significantly compared with those in previous studies from the 20th century. There were no significant differences in the prevalence of rheumatoid arthritis (RA) (0.35%) or ankylosing spondylitis (AS) (0.31%) compared to that reported in prior surveys. The prevalence of KOA was higher in for residents of buildings without elevators than that in those who had access to elevators (16-64 years, 5.89% vs. 3.95%, P = 0.004; 16-> 85 years, 7.64% vs. 6.26%, P = 0.162). The prevalence of RA and AS remained stable, whereas that of KOA, gout, and fibromyalgia has increased significantly in Shantou, China, during the past 3 decades. Stair-climbing might be an important risk factor for knee pain and KOA.	[Zeng, Shao-ying; Li, Li-ping] Shantou Univ, Coll Med, Ctr Injury Prevent Res, Shantou, Peoples R China; [Gong, Yao; Zhang, Yu-ping; Chen, Su-biao; Peng, Jian-hua; Huang, Guo-hai; Wang, Dan-min; Zeng, Qing Yu] Shantou Univ, Coll Med, Dept Rheumatol, Shantou, Peoples R China; [Chen, Jun-yang] Third Shantou Municipal Hosp, Shantou, Peoples R China; [Lin, Chu-qing; Lai, Huai-yuan] Fourth Shantou Municipal Hosp, Shantou, Peoples R China; [Hou, Zhi-duo; Zhong, Jian-qiu; Liang, Hong-jin] Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou, Peoples R China	Shantou University; Shantou University; Shantou University	Li, LP (corresponding author), Shantou Univ, Coll Med, Ctr Injury Prevent Res, Shantou, Peoples R China.	lpli@stu.edu.cn; qyzeng@stu.edu.cn	Hou, Zhiduo/AAA-8076-2022	Hou, Zhi-duo/0000-0001-7734-001X	Asia Pacific League of Association for Rheumatology (APLAR) Community Oriented program for Control of Rheumatic Diseases (COPCORD); Shantou University Medical College [LDo30601]	Asia Pacific League of Association for Rheumatology (APLAR) Community Oriented program for Control of Rheumatic Diseases (COPCORD); Shantou University Medical College	This work was supported by Asia Pacific League of Association for Rheumatology (APLAR) Community Oriented program for Control of Rheumatic Diseases (COPCORD), Grant 2012, and partly supported by a grant from Shantou University Medical College (NO.LDo30601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Caughey D, 1988, SEAPAL B, V7, P11; Chen R, 2000, CHIN J RHEUMATOL, V4, P240; Chen R, 1993, J SHANTOU U MED COLL, V2, P54; Chen SL, 1998, CHINESE MED J-PEKING, V111, P228; Chen SL, 1996, 8 AS PAC LEAG ASS RH, ps182; Chen SL, 1991, APLAR RHEUMATOLOGY S, V18, p10S; Chopra A, 2001, J Assoc Physicians India, V49, P240; Chopra A, 2015, J INDIAN J RHEUMATOL, V10, P70, DOI DOI 10.1016/J.INJR.2015.04.002; CHOU CT, 1994, J RHEUMATOL, V21, P302; Chuang SY, 2011, ASIA PAC J CLIN NUTR, V20, P301; Dai SM, 2003, J RHEUMATOL, V30, P2245; Darmawan J, 2007, CLIN RHEUMATOL, V26, P853, DOI 10.1007/s10067-007-0553-x; Du H, 2005, RHEUMATOL INT, V25, P585, DOI 10.1007/s00296-004-0492-7; [方卫纲 FANG Weigang], 2006, [基础医学与临床, Basic Medical Sciences and Clinics], V26, P781; Haq SA, 2005, J RHEUMATOL, V32, P348; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Li R, 2012, RHEUMATOLOGY, V51, P721, DOI 10.1093/rheumatology/ker370; Lin L., 2007, SHANXI MED J, V8, P678; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; NISHIKAI M, 1992, J RHEUMATOL, V19, P110; Pelaez-Ballestas I, 2011, J RHEUMATOL, V38, P3, DOI 10.3899/jrheum.100951; Shi Fang, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P1136; Silman AJ, 1993, OSTEOARTHRITIS, P257; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WIGLEY RD, 1994, J RHEUMATOL, V21, P1484; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Yang X Y, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P10; Zang CH., 2007, CHIN REMEDIES CLIN, V8, P597; Zeng QY, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2368; Zeng QY, 2006, CHINESE MED J-PEKING, V119, P1522, DOI 10.1097/00029330-200609020-00004; Zeng QY, 2005, J RHEUMATOL, V32, P920; Zeng QY, 2004, J RHEUMATOL, V31, P2439; Zeng QY, 2003, CHINESE MED J-PEKING, V116, P66; Zeng QY, 1987, CHINESE J INTERN MED, V26, P387; Zeng QY, 1995, APLAR B, V13, P74; Zeng QY, 1993, J SHANTOU U MED COLL, V6, P46; Zhang NZ, 1985, S 2 NAT C RHEUM CHIN, P99; Zhang NZ, 1988, S 3 NAT C RHEUM CHIN, P1; Zhang NZ, 1994, CHINESE J INTERN MED, V34, P84	42	24	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138492	10.1371/journal.pone.0138492	http://dx.doi.org/10.1371/journal.pone.0138492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406469	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700050
J	Guitet, S; Herault, B; Molto, Q; Brunaux, O; Couteron, P				Guitet, Stephane; Herault, Bruno; Molto, Quentin; Brunaux, Olivier; Couteron, Pierre			Spatial Structure of Above-Ground Biomass Limits Accuracy of Carbon Mapping in Rainforest but Large Scale Forest Inventories Can Help to Overcome	PLOS ONE			English	Article							TROPICAL FOREST; LIVE BIOMASS; REGIONAL-VARIATION; NATIONAL FOREST; TREE DIVERSITY; UNCERTAINTY; AMAZON; EMISSIONS; BALANCE; DENSITY	Precise mapping of above-ground biomass (AGB) is a major challenge for the success of REDD+ processes in tropical rainforest. The usual mapping methods are based on two hypotheses: a large and long-ranged spatial autocorrelation and a strong environment influence at the regional scale. However, there are no studies of the spatial structure of AGB at the landscapes scale to support these assumptions. We studied spatial variation in AGB at various scales using two large forest inventories conducted in French Guiana. The dataset comprised 2507 plots (0.4 to 0.5 ha) of undisturbed rainforest distributed over the whole region. After checking the uncertainties of estimates obtained from these data, we used half of the dataset to develop explicit predictive models including spatial and environmental effects and tested the accuracy of the resulting maps according to their resolution using the rest of the data. Forest inventories provided accurate AGB estimates at the plot scale, for a mean of 325 Mg. ha(-1). They revealed high local variability combined with a weak autocorrelation up to distances of no more than 10 km. Environmental variables accounted for a minor part of spatial variation. Accuracy of the best model including spatial effects was 90 Mg. ha(-1) at plot scale but coarse graining up to 2-km resolution allowed mapping AGB with accuracy lower than 50 Mg. ha(-1). Whatever the resolution, no agreement was found with available pan-tropical reference maps at all resolutions. We concluded that the combined weak autocorrelation and weak environmental effect limit AGB maps accuracy in rainforest, and that a trade-off has to be found between spatial resolution and effective accuracy until adequate "wall-to-wall" remote sensing signals provide reliable AGB predictions. Waiting for this, using large forest inventories with low sampling rate (< 0.5%) may be an efficient way to increase the global coverage of AGB maps with acceptable accuracy at kilometric resolution.	[Guitet, Stephane; Brunaux, Olivier] ONF, R&D Dept, Cayenne, French Guiana; [Guitet, Stephane] INRA, UMR Amap, F-34060 Montpellier, France; [Herault, Bruno] Ctr Cooperat Int Rech Agronom Dev CIRAD, UMR EcoFoG, Kourou, French Guiana; [Molto, Quentin] CIRAD, UR BSEF, Montpellier, France; [Guitet, Stephane; Couteron, Pierre] IRD, UMR Amap, Montpellier, France	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; CIRAD; CIRAD; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Guitet, S (corresponding author), ONF, R&D Dept, Cayenne, French Guiana.	stephane.guitet@cirad.fr	Hérault, Bruno/B-2765-2011; Guitet, Stéphane/F-5616-2016	Hérault, Bruno/0000-0002-6950-7286; Guitet, Stéphane/0000-0003-2374-4240	Office National des Forets (ONF); Parc Amazonien de Guyane (PAG); French Ministry of the Environment (MEDD); European Union (UE) [FEDER 30453]; project Observatoire du Carbone (Region Guyane)	Office National des Forets (ONF); Parc Amazonien de Guyane (PAG); French Ministry of the Environment (MEDD); European Union (UE)(European Commission); project Observatoire du Carbone (Region Guyane)	Office National des Forets (ONF), Parc Amazonien de Guyane (PAG), the ECOTROP and BGF programs of the French Ministry of the Environment (MEDD), and the PO-FEDER program of the European Union (UE, ref. FEDER 30453-28/10/2009) provided funding for part of the data collection. Funding for publication came from the project Observatoire du Carbone (European structural fundings, Region Guyane). BH benefited from an 'Investissement d'Avenir' grant managed by the Agence Nationale de la recherche (CEBA, ref ANR-10-LABX-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2012, BIOGEOSCIENCES DISCU, V9, P2445, DOI DOI 10.5194/BGD-9-2445-2012; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Baccini A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045011; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Baker DJ, 2010, ENVIRON SCI POLICY, V13, P249, DOI 10.1016/j.envsci.2010.03.004; Baraloto C, 2013, BIOTROPICA, V45, P288, DOI 10.1111/btp.12006; Baraloto C, 2011, GLOBAL CHANGE BIOL, V17, P2677, DOI 10.1111/j.1365-2486.2011.02432.x; Bastin JF, 2014, ECOL APPL, V24, P1984, DOI 10.1890/13-1574.1; Basuki TM, 2012, GEOCARTO INT, V27, P329, DOI 10.1080/10106049.2011.634928; Calcagno V, 2010, J STAT SOFTW, V34, P1; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chen Q, 2015, REMOTE SENS ENVIRON, V160, P134, DOI 10.1016/j.rse.2015.01.009; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Clark ML, 2011, REMOTE SENS ENVIRON, V115, P2931, DOI 10.1016/j.rse.2010.08.029; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; Deblauwe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048766; Espirito-Santo FDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4434; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Glenday J, 2006, FOREST ECOL MANAG, V235, P72, DOI 10.1016/j.foreco.2006.08.014; Gond V, 2011, INT J APPL EARTH OBS, V13, P357, DOI 10.1016/j.jag.2011.01.004; Guitet S, 2015, BIODIVERS CONSERV, V24, P1215, DOI 10.1007/s10531-014-0854-8; Guitet S, 2014, FOREST ECOL MANAG, V328, P270, DOI 10.1016/j.foreco.2014.05.045; Guitet S, 2013, J MAPS, V9, P325, DOI 10.1080/17445647.2013.785371; Hawes JE, 2012, FOREST ECOL MANAG, V281, P163, DOI 10.1016/j.foreco.2012.06.023; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Huffman GJ, 2007, JOURNAL OF HYDROMETE, V8; Ioki K, 2014, FOREST ECOL MANAG, V328, P335, DOI 10.1016/j.foreco.2014.06.003; Kasischke ES, 1997, REMOTE SENS ENVIRON, V59, P141, DOI 10.1016/S0034-4257(96)00148-4; Keller M, 2001, FOREST ECOL MANAG, V154, P371, DOI 10.1016/S0378-1127(01)00509-6; Laumonier Y, 2010, FOREST ECOL MANAG, V259, P505, DOI 10.1016/j.foreco.2009.11.007; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Maniatis D., 2011, International Journal of Forestry Research, V2011, P134526, DOI 10.1155/2011/134526; Marvin DC, 2014, P NATL ACAD SCI USA, V111, pE5224, DOI 10.1073/pnas.1412999111; Mascaro Joseph, 2014, Carbon Balance Manag, V9, P7, DOI 10.1186/s13021-014-0007-0; Mascaro J, 2011, REMOTE SENS ENVIRON, V115, P3770, DOI 10.1016/j.rse.2011.07.019; McRoberts RE, 2014, FOREST SCI, V60, P34, DOI 10.5849/forsci.12-141; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Molto Q, 2014, BIOGEOSCIENCES, V11, P3121, DOI 10.5194/bg-11-3121-2014; Molto Q, 2013, METHODS ECOL EVOL, V4, P175, DOI 10.1111/j.2041-210x.2012.00266.x; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P1853, DOI 10.1016/j.foreco.2008.07.022; Oldeman RAA, 1972, LARCHITECTURE DE LA; Ollier S, 2003, REMOTE SENS ENVIRON, V85, P453, DOI 10.1016/S0034-4257(03)00038-5; Ploton P, 2012, ECOL APPL, V22, P993, DOI 10.1890/11-1606.1; Proisy C, 2007, REMOTE SENS ENVIRON, V109, P379, DOI 10.1016/j.rse.2007.01.009; Propastin P, 2013, GISCI REMOTE SENS, V50, P633, DOI 10.1080/15481603.2013.850305; Qureshi A, 2012, ENVIRON SCI POLICY, V16, P81, DOI 10.1016/j.envsci.2011.11.001; Rejou-Mechain M, 2014, BIOGEOSCIENCES DISCU, V11, P5711, DOI DOI 10.5194/BGD-11-5711-2014; Rejou-Mechain M, 2008, J TROP ECOL, V24, P663, DOI 10.1017/S0266467408005506; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; Ribeiro Jr P. J., 2001, R NEWS, V1, P14; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Rutishauser E, 2010, J VEG SCI, V21, P672, DOI 10.1111/j.1654-1103.2010.01175.x; Saatchi S., 2009, BIOGEO SCI DISCUSS, V6, P5461, DOI [10.5194/bgd-6-5461-2009, DOI 10.5194/BGD-6-5461-2009]; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sales MH, 2007, ECOL MODEL, V205, P221, DOI 10.1016/j.ecolmodel.2007.02.033; Traissac S, 2014, J VEG SCI, V25, P491, DOI 10.1111/jvs.12080; Truffet C., 2003, GEOL FR, P5; Valeix J., 1989, BOIS FOR TROP, V219, P13; Vincent G, 2014, OECOLOGIA, V175, P439, DOI 10.1007/s00442-014-2913-y; Wagner F, 2010, BIOTROPICA, V42, P664, DOI 10.1111/j.1744-7429.2010.00644.x; Zanne A.E., 2009, DRYAD IDENTIFIER HTT, P235	67	25	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138456	10.1371/journal.pone.0138456	http://dx.doi.org/10.1371/journal.pone.0138456			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402522	Green Published, gold, Green Submitted			2022-12-27	WOS:000361798100024
J	Zhou, XY; Zhu, FM; Li, JP; Mao, W; Zhang, DM; Liu, ML; Hei, AL; Dai, DP; Jiang, P; Shan, XY; Zhang, BW; Zhu, CF; Shen, J; Deng, ZH; Wang, ZL; Yu, WJ; Chen, Q; Qiao, YH; Zhu, XM; Lv, R; Li, GY; Li, GL; Li, HC; Zhang, X; Pei, B; Jiao, LX; Shen, G; Liu, Y; Feng, ZH; Su, YP; Xu, ZX; Di, WY; Jiang, YQ; Fu, HL; Liu, XJ; Liu, X; Zhou, MZ; Du, D; Liu, Q; Han, Y; Zhang, ZX; Cai, JP				Zhou, Xiao-Yang; Zhu, Fa-Ming; Li, Jian-Ping; Mao, Wei; Zhang, De-Mei; Liu, Meng-Li; Hei, Ai-Lian; Dai, Da-Peng; Jiang, Ping; Shan, Xiao-Yan; Zhang, Bo-Wei; Zhu, Chuan-Fu; Shen, Jie; Deng, Zhi-Hui; Wang, Zheng-Lei; Yu, Wei-Jian; Chen, Qiang; Qiao, Yan-Hui; Zhu, Xiang-Ming; Lv, Rong; Li, Guo-Ying; Li, Guo-Liang; Li, Heng-Cong; Zhang, Xu; Pei, Bin; Jiao, Li-Xin; Shen, Gang; Liu, Ying; Feng, Zhi-Hui; Su, Yu-Ping; Xu, Zhao-Xia; Di, Wen-Ying; Jiang, Yao-Qin; Fu, Hong-Lei; Liu, Xiang-Jun; Liu, Xiang; Zhou, Mei-Zhen; Du, Dan; Liu, Qi; Han, Ying; Zhang, Zhi-Xin; Cai, Jian-Ping			High-Resolution Analyses of Human Leukocyte Antigens Allele and Haplotype Frequencies Based on 169,995 Volunteers from the China Bone Marrow Donor Registry Program	PLOS ONE			English	Article							HLA CLASS-I; HAN POPULATION; AND-DRB1 POLYMORPHISM; CELL TRANSPLANTATION; GENETIC LINK; HLA-DRB1; COMMON; DISTRIBUTIONS; YUNNAN; ASSOCIATION	Allogeneic hematopoietic stem cell transplantation is a widely used and effective therapy for hematopoietic malignant diseases and numerous other disorders. High-resolution human leukocyte antigen (HLA) haplotype frequency distributions not only facilitate individual donor searches but also determine the probability with which a particular patient can find HLA-matched donors in a registry. The frequencies of the HLA-A, -B, -C, -DRB1, and -DQB1 alleles and haplotypes were estimated among 169,995 Chinese volunteers using the sequencing-based typing (SBT) method. Totals of 191 HLA-A, 244 HLA-B, 146 HLA-C, 143 HLA-DRB1 and 47 HLA-DQB1 alleles were observed, which accounted for 6.98%, 7.06%, 6.46%, 9.11% and 7.91%, respectively, of the alleles in each locus in the world (IMGT 3.16 Release, Apr. 2014). Among the 100 most common haplotypes from the 169,995 individuals, nine distinct haplotypes displayed significant regionally specific distributions. Among these, three were predominant in the South China region (i.e., the 20th, 31st, and 81sthaplotypes), another three were predominant in the Southwest China region (i.e., the 68th, 79th, and 95th haplotypes), one was predominant in the South and Southwest China regions (the 18th haplotype), one was relatively common in the Northeast and North China regions (the 94th haplotype), and one was common in the Northeast, North and Northwest China (the 40th haplotype). In conclusion, this is the first to analyze high-resolution HLA diversities across the entire country of China, based on a detailed and complete data set that covered 31 provinces, autonomous regions, and municipalities. Specifically, we also evaluated the HLA matching probabilities within and between geographic regions and analyzed the regional differences in the HLA diversities in China. We believe that the data presented in this study might be useful for unrelated HLA-matched donor searches, donor registry planning, population genetic studies, and anthropogenesis studies.	[Zhou, Xiao-Yang; Hei, Ai-Lian; Dai, Da-Peng; Jiang, Ping; Zhang, Zhi-Xin; Cai, Jian-Ping] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Zhou, Xiao-Yang; Hei, Ai-Lian; Dai, Da-Peng; Jiang, Ping; Zhang, Zhi-Xin; Cai, Jian-Ping] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Zhou, Xiao-Yang; Hei, Ai-Lian; Dai, Da-Peng; Jiang, Ping; Zhang, Zhi-Xin; Cai, Jian-Ping] China Bone Marrow Program, Qual Control Lab, Beijing, Peoples R China; [Zhu, Fa-Ming] Zhejiang Blood Ctr, HLA Lab, Hangzhou, Zhejiang, Peoples R China; [Li, Jian-Ping; Zhang, Xu] Liaoning Blood Ctr, HLA Lab, Shenyang, Liaoning, Peoples R China; [Mao, Wei] Chongqing Blood Ctr, HLA Lab, Chongqing, Peoples R China; [Zhang, De-Mei] Taiyuan Red Cross Blood Ctr, HLA Lab, Taiyuan, Shanxi, Peoples R China; [Liu, Meng-Li] Shaanxi Blood Ctr, HLA Lab, Xian, Shaanxi, Peoples R China; [Shan, Xiao-Yan] Beijing Red Cross Blood Ctr, HLA Lab, Beijing, Peoples R China; [Zhang, Bo-Wei] Henan Blood Ctr, HLA Lab, Zhengzhou, Henan, Peoples R China; [Zhu, Chuan-Fu] Shandong Blood Ctr, HLA Lab, Jinan, Shandong, Peoples R China; [Shen, Jie] Nanjing Med Univ, Affiliated Hosp 1, HLA Lab, Nanjing, Jiangsu, Peoples R China; [Deng, Zhi-Hui] Shenzhen Blood Ctr, Key Lab Histocompatibil & Immunogenet, Shenzhen, Guangdong, Peoples R China; [Wang, Zheng-Lei] Hebei Blood Ctr, HLA Lab, Shijiazhuang, Hebei, Peoples R China; [Yu, Wei-Jian] Dalian Red Cross Blood Ctr, HLA Lab, Dalian, Liaoning, Peoples R China; [Chen, Qiang] Chinese Acad Med Sci, Inst Blood Transfus, HLA Lab, Chengdu, Sichuan, Peoples R China; [Chen, Qiang] Peking Union Med Coll, Chengdu, Sichuan, Peoples R China; [Qiao, Yan-Hui] Xinjiang Blood Ctr, HLA Lab, Urumqi, Xinjiang, Peoples R China; [Zhu, Xiang-Ming] Kunming Blood Ctr, HLA Lab, Kunming, Yunnan, Peoples R China; [Lv, Rong] Hefei Red Cross Blood Ctr, HLA Lab, Hefei, Anhui, Peoples R China; [Li, Guo-Ying] Gansu Red Cross Blood Ctr, HLA Lab, Lanzhou, Gansu, Peoples R China; [Li, Guo-Liang] Jiangxi Blood Ctr, HLA Lab, Nanchang, Jiangxi, Peoples R China; [Li, Heng-Cong] Nanning Blood Ctr, HLA Lab, Nanning, Guangxi, Peoples R China; [Pei, Bin] Xiamen Blood Ctr, HLA Lab, Xiamen, Fujian, Peoples R China; [Jiao, Li-Xin] Changchun Blood Ctr, HLA Lab, Changchun, Jilin, Peoples R China; [Shen, Gang] Wuhan Blood Ctr, HLA Lab, Wuhan, Hubei, Peoples R China; [Liu, Ying] Harbin Red Cross Blood Ctr, HLA Lab, Harbin, Heilongjiang, Peoples R China; [Feng, Zhi-Hui] Qingdao Blood Ctr, HLA Lab, Qingdao, Shandong, Peoples R China; [Su, Yu-Ping] Yueyang Red Cross Blood Ctr, HLA Lab, Yueyang, Hunan, Peoples R China; [Xu, Zhao-Xia] Changsha Blood Ctr, HLA Lab, Changsha, Hunan, Peoples R China; [Di, Wen-Ying] Soochow Red Cross Blood Ctr, HLA Lab, Suzhou, Jiangsu, Peoples R China; [Jiang, Yao-Qin] Shanghai Blood Ctr, HLA Lab, Shanghai, Peoples R China; [Fu, Hong-Lei; Liu, Xiang-Jun] BFR Transplant Diagnost Serv Ctr, HLA Lab, Beijing, Peoples R China; [Liu, Xiang] CapitalBio Corp, HLA Lab, Beijing, Peoples R China; [Zhou, Mei-Zhen] Beijing Genom Inst, HLA Lab, Shenzhen, Guangdong, Peoples R China; [Du, Dan; Liu, Qi; Han, Ying] China Bone Marrow Program, Dept HLA Technol, Beijing, Peoples R China	Beijing Hospital; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Genomics Institute (BGI)	Zhang, ZX (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	zzxhla@yahoo.com.cn; caijp61@vip.sina.com		deng, zhihui/0000-0002-2046-1467; Li, Jianping/0000-0002-5392-0471; Zhou, Xiao-yang/0000-0003-3320-570X	Red Cross Society of China	Red Cross Society of China	This work was funded by the Red Cross Society of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Ayala E, 2011, CANCER CONTROL, V18, P246, DOI 10.1177/107327481101800405; Boquett Juliano, 2015, Biol Blood Marrow Transplant, V21, P1140, DOI 10.1016/j.bbmt.2015.02.019; Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014; Cao HZ, 2013, HUM MUTAT, V34, P1715, DOI 10.1002/humu.22439; Chen R, 1993, Yi Chuan Xue Bao, V20, P389; Chen SW, 2007, HUM IMMUNOL, V68, P550, DOI 10.1016/j.humimm.2007.02.006; China NBOSo, 2011, CHINA WIND POWER INS, P19; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gao Su-qing, 2009, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V26, P228, DOI 10.3760/cma.j.issn.1003-9406.2009.02.025; [Gao Su-qing 高素青], 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P983; Ge ML, 2010, J GEOGR SCI, V20, P628, DOI 10.1007/s11442-010-0628-5; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; He J, 2012, HUM IMMUNOL, V73, P61, DOI 10.1016/j.humimm.2011.06.005; Hei AL, 2009, INT J IMMUNOGENET, V36, P275, DOI 10.1111/j.1744-313X.2009.00866.x; [黑爱莲 HEI Ailian], 2009, [中国输血杂志, Chinese Journal of Blood Transfusion], V22, P363; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hong W, 2005, TISSUE ANTIGENS, V66, P297, DOI 10.1111/j.1399-0039.2005.00474.x; Horn PA, 2007, TISSUE ANTIGENS, V70, P335, DOI 10.1111/j.1399-0039.2007.00918.x; Huh JY, 2013, INT J IMMUNOGENET, V40, P515, DOI 10.1111/iji.12067; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Jinam TA, 2010, TISSUE ANTIGENS, V75, P151, DOI 10.1111/j.1399-0039.2009.01417.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kollman C, 2004, TRANSPLANTATION, V78, P89, DOI 10.1097/01.TP.0000132327.40702.97; Lai MJ, 2010, HUM IMMUNOL, V71, P777, DOI 10.1016/j.humimm.2010.05.013; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Li Yang, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P92, DOI 10.3760/cma.j.issn.1003-9406.2011.01.021; Lucarelli G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011825; Mack SJ, 2013, TISSUE ANTIGENS, V81, P194, DOI 10.1111/tan.12093; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Marrack P, 1986, Adv Immunol, V38, P1, DOI 10.1016/S0065-2776(08)60005-X; Marrack P, 2001, J IMMUNOL, V167, P617, DOI 10.4049/jimmunol.167.2.617; Ogata S, 2007, TISSUE ANTIGENS, V69, P154, DOI 10.1111/j.1399-0039.2006.00698.x; Pan Meng, 2012, Zhonghua Xue Ye Xue Za Zhi, V33, P94; Pan QQ, 2011, HUM IMMUNOL, V72, P872, DOI 10.1016/j.humimm.2011.06.006; Pingel J, 2013, HUM IMMUNOL, V74, P330, DOI 10.1016/j.humimm.2012.10.029; Rendine S, 2012, HUM IMMUNOL, V73, P399, DOI 10.1016/j.humimm.2012.01.005; Romphruk AV, 2010, TISSUE ANTIGENS, V75, P701, DOI 10.1111/j.1399-0039.2010.01448.x; Schmidt AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086605; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Shi L, 2006, TISSUE ANTIGENS, V67, P38, DOI 10.1111/j.1399-0039.2005.00526.x; Shi L, 2010, INT J IMMUNOGENET, V37, P467, DOI 10.1111/j.1744-313X.2010.00949.x; Shi L, 2010, TISSUE ANTIGENS, V75, P159, DOI 10.1111/j.1399-0039.2009.01407.x; Shi L, 2008, HUM IMMUNOL, V69, P58, DOI 10.1016/j.humimm.2007.11.007; Shi L, 2011, J ZHEJIANG UNIV-SC B, V12, P428, DOI 10.1631/jzus.B1000285; Tokunaga K, 2001, HUM IMMUNOL, V62, P1001, DOI 10.1016/S0198-8859(01)00301-9; Trachtenberg E, 2007, TISSUE ANTIGENS, V70, P455, DOI 10.1111/j.1399-0039.2007.00932.x; Yan Chunxia, 2003, Genomics Proteomics & Bioinformatics, V1, P304; Yang G, 2006, TISSUE ANTIGENS, V67, P146, DOI 10.1111/j.1399-0039.2006.00529.x; Yao Y, 2012, TISSUE ANTIGENS, V80, P452, DOI 10.1111/tan.12007; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x; Yuliwulandari R, 2010, HUM IMMUNOL, V71, P697, DOI 10.1016/j.humimm.2010.04.005; Zhao T M, 1991, Yi Chuan Xue Bao, V18, P97; Zhu BF, 2010, J ZHEJIANG UNIV-SC B, V11, P127, DOI 10.1631/jzus.B0900232; Zou HY JS, 2010, INT J BLOOD TRANSFUS, V33, P103	61	66	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139485	10.1371/journal.pone.0139485	http://dx.doi.org/10.1371/journal.pone.0139485			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421847	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700123
J	Han, SS; Wang, G; Jin, Y; Ma, ZL; Jia, WJ; Wu, X; Wang, XY; He, MY; Cheng, X; Li, WJ; Yang, XS; Liu, GS				Han, Sha-sha; Wang, Guang; Jin, Ya; Ma, Zheng-lai; Jia, Wei-jing; Wu, Xia; Wang, Xiao-yu; He, Mei-yao; Cheng, Xin; Li, Wei-jing; Yang, Xuesong; Liu, Guo-sheng			Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; OXIDATIVE STRESS; DIASTOLIC DYSFUNCTION; CARDIOMYOPATHY; EXPRESSION; CHICK; APOPTOSIS; INSIGHTS; NKX2-5; EMBRYO	Hyperglycemia in diabetic mothers enhances the risk of fetal cardiac hypertrophy during gestation. However, the mechanism of high-glucose-induced cardiac hypertrophy is not largely understood. In this study, we first demonstrated that the incidence rate of cardiac hypertrophy dramatically increased in fetuses of diabetic mothers using color ultrasound examination. In addition, human fetal cardiac hypertrophy was successfully mimicked in a streptozotocin (STZ)-induced diabetes mouse model, in which mouse cardiac hypertrophy was diagnosed using type-M ultrasound and a histological assay. PH3 immunofluorescent staining of mouse fetal hearts and in vitro-cultured H9c2 cells indicated that cell proliferation decreased in E18.5, E15.5 and E13.5 mice, and cell apoptosis in H9c2 cells increased in the presence of high glucose in a dose-dependent manner. Next, we found that the individual cardiomyocyte size increased in pre-gestational diabetes mellitus mice and in response to high glucose exposure. Meanwhile, the expression of beta-MHC and BMP-10 was up-regulated. Nkx2.5 immunofluorescent staining showed that the expression of Nkx2.5, a crucial cardiac transcription factor, was suppressed in the ventricular septum, left ventricular wall and right ventricular wall of E18.5, E15.5 and E13.5 mouse hearts. However, cardiac hypertrophy did not morphologically occur in E13.5 mouse hearts. In cultured H9c2 cells exposed to high glucose, Nkx2.5 expression decreased, as detected by both immunostaining and western blotting, and the expression of KCNE1 and Cx43 was also restricted. Taken together, alterations in cell size rather than cell proliferation or apoptosis are responsible for hyperglycemia-induced fetal cardiac hypertrophy. The aberrant expression of Nkx2.5 and its regulatory target genes in the presence of high glucose could be a principal component of pathogenesis in the development of fetal cardiac hypertrophy.	[Han, Sha-sha; Jin, Ya; Jia, Wei-jing; Wu, Xia; He, Mei-yao; Liu, Guo-sheng] Jinan Univ, Affiliated Hosp 1, Inst Fetal Preterm Labor Med, Dept Pediat & Neonatol, Guangzhou 510630, Guangdong, Peoples R China; [Wang, Guang; Ma, Zheng-lai; Wang, Xiao-yu; Cheng, Xin; Yang, Xuesong] Jinan Univ, Coll Med, Div Histol & Embryol, Key Lab Regenerat Med,Minist Educ, Guangzhou 510632, Guangdong, Peoples R China; [Li, Wei-jing] Jinan Univ, Affiliated Hosp 1, Dept Fetal Med, Guangzhou 510630, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Yang, XS (corresponding author), Jinan Univ, Coll Med, Div Histol & Embryol, Key Lab Regenerat Med,Minist Educ, Guangzhou 510632, Guangdong, Peoples R China.	yang_xuesong@126.com; tlgs@jnu.edu.cn	Wang, Guang/AAC-4624-2019		NSFC [81571436, 31401230]; Science and Technology Program of Guangzhou [201510010073]; Science and Technology Planning Project of Guangdong Province [2014A020213008]; China Postdoctoral Science Foundation [2015T80940, 2014M560694]; Fundamental Research Funds for the Central Universities [21614319, 21615421]; Funds for Young Creative Talents of Higher Education in Guangdong Province [2014KQNCX026]	NSFC(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou; Science and Technology Planning Project of Guangdong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Funds for Young Creative Talents of Higher Education in Guangdong Province	This study was supported by NSFC grant (81571436, 31401230); Science and Technology Program of Guangzhou (201510010073); Science and Technology Planning Project of Guangdong Province (2014A020213008); China Postdoctoral Science Foundation (2015T80940, 2014M560694); the Fundamental Research Funds for the Central Universities (21614319, 21615421); and The Funds for Young Creative Talents of Higher Education in Guangdong Province (2014KQNCX026).	Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Aman J, 2011, NEONATOLOGY, V100, P147, DOI 10.1159/000323741; Azakie A, 2006, J THORAC CARDIOV SUR, V132, P1262, DOI 10.1016/j.jtcvs.2006.08.005; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Corrigan N, 2013, REPROD SCI, V20, P781, DOI 10.1177/1933719112466298; Corrigan N, 2009, BIRTH DEFECTS RES A, V85, P523, DOI 10.1002/bdra.20567; Ding F, 2013, AMINO ACIDS, V45, P339, DOI 10.1007/s00726-013-1504-2; Ejdesjo A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1198, DOI 10.1152/ajpendo.00661.2011; Gheorman L, 2011, ROM J MORPHOL EMBRYO, V52, P1127; Huang JH, 2012, J CLIN INVEST, V122, P3678, DOI 10.1172/JCI63635; Huynh K, 2012, DIABETOLOGIA, V55, P1544, DOI 10.1007/s00125-012-2495-3; Jaiswal A, 2010, MOL CELL BIOCHEM, V345, P231, DOI 10.1007/s11010-010-0577-4; Jin YM, 2013, EXP CLIN ENDOCR DIAB, V121, P448, DOI 10.1055/s-0033-1349080; Kobylinska J, 2013, POSTEP HIG MED DOSW, V67, P950, DOI 10.5604/17322693.1066060; Kumar SD, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-34; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li XZ, 2012, DIABETES, V61, P2084, DOI 10.2337/db11-1624; Li Y, 2014, INT J CARDIOL, V176, P62, DOI 10.1016/j.ijcard.2014.06.044; Maron BJ, 2010, CIRCULATION, V121, P445, DOI 10.1161/CIRCULATIONAHA.109.878579; Maron BJ, 2004, AM J MED, V116, P63, DOI 10.1016/j.amjmed.2003.10.012; Martinsen BJ, 2005, DEV DYNAM, V233, P1217, DOI 10.1002/dvdy.20468; MORKIN E, 1972, CIRC RES, V30, P690, DOI 10.1161/01.RES.30.6.690; Munshi NV, 2012, CIRC RES, V110, P1525, DOI 10.1161/CIRCRESAHA.111.260026; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Qin RJ, 1981, ZHONGHUA ER KE ZA ZH, V19, P92; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Simeone RM, 2015, AM J PREV MED, V48, P195, DOI 10.1016/j.amepre.2014.09.002; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Terada R, 2011, CARDIOVASC RES, V91, P289, DOI 10.1093/cvr/cvr037; Xu JJ, 2014, CRIT CARE MED, V42, pE583, DOI 10.1097/CCM.0000000000000415; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zangen Sarah W, 2002, Int J Exp Diabetes Res, V3, P247, DOI 10.1080/15604280214933; Zhang L, 2014, DEV BIOL, V390, P68, DOI 10.1016/j.ydbio.2014.02.023	37	28	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139141	10.1371/journal.pone.0139141	http://dx.doi.org/10.1371/journal.pone.0139141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418041	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400052
J	Kagesten, A; Tuncalp, O; Ali, M; Chandra-Mouli, V; Tran, N; Gulmezoglu, AM				Kagesten, Anna; Tuncalp, Oezge; Ali, Moazzam; Chandra-Mouli, Venkatraman; Tran, Nhan; Guelmezoglu, A. Metin			A Systematic Review of Reporting Tools Applicable to Sexual and Reproductive Health Programmes: Step 1 in Developing Programme Reporting Standards	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; COMPLEX INTERVENTIONS; CLINICAL-TRIALS; PUBLICATION GUIDELINES; QUALITATIVE RESEARCH; DIAGNOSTIC-ACCURACY; CONSORT STATEMENT; STARE-HI; IMPLEMENTATION; CHECKLIST	Background Complete and accurate reporting of programme preparation, implementation and evaluation processes in the field of sexual and reproductive health (SRH) is essential to understand the impact of SRH programmes, as well as to guide their replication and scale-up. Objectives To provide an overview of existing reporting tools and identify core items used in programme reporting with a focus on programme preparation, implementation and evaluation processes. Methods A systematic review was completed for the period 2000-2014. Reporting guidelines, checklists and tools, irrespective of study design, applicable for reporting on programmes targeting SRH outcomes, were included. Two independent reviewers screened the title and abstract of all records. Full texts were assessed in duplicate, followed by data extraction on the focus, content area, year of publication, validation and description of reporting items. Data was synthesized using an iterative thematic approach, where items related to programme preparation, implementation and evaluation in each tool were extracted and aggregated into a consolidated list. Results Out of the 3,656 records screened for title and abstracts, full texts were retrieved for 182 articles, out of which 108 were excluded. Seventy-four full text articles corresponding to 45 reporting tools were retained for synthesis. The majority of tools were developed for reporting on intervention research (n = 15), randomized controlled trials (n = 8) and systematic reviews (n = 7). We identified a total of 50 reporting items, across three main domains and corresponding sub-domains: programme preparation (objective/focus, design, piloting); programme implementation (content, timing/duration/location, providers/staff, participants, delivery, implementation outcomes), and programme evaluation (process evaluation, implementation barriers/facilitators, outcome/impact evaluation). Conclusions Over the past decade a wide range of tools have been developed to improve the reporting of health research. Development of Programme Reporting Standards (PRS) for SRH can fill a significant gap in existing reporting tools. This systematic review is the first step in the development of such standards. In the next steps, we will draft a preliminary version of the PRS based on the aggregate list of identified items, and finalize the tool using a consensus process among experts and user-testing.	[Kagesten, Anna] Johns Hopkins Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Tuncalp, Oezge; Ali, Moazzam; Chandra-Mouli, Venkatraman; Guelmezoglu, A. Metin] WHO, WHO Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, CH-1211 Geneva, Switzerland; [Tran, Nhan] WHO, Alliance Hlth Policy & Syst Res, Implementat Res Platform, CH-1211 Geneva, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; The World Bank; United Nations Population Fund; World Health Organization; World Health Organization	Kagesten, A (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	akaagesten@jhu.edu	Tunçalp, Ӧzge/Y-2724-2018	Tunçalp, Ӧzge/0000-0002-5370-682X; Ali, Moazzam/0000-0001-6949-8976	Alliance for Health Policy and Systems Research (AHPSR)	Alliance for Health Policy and Systems Research (AHPSR)	The current study was funded by the Alliance for Health Policy and Systems Research (AHPSR), hosted by the WHO (http://www.who.int/alliance-hpsr/about/en/). Nhan Tran at AHPSR contributed with materials and preparation of the manuscript.	Abraham C, 2014, JAIDS-J ACQ IMM DEF, V66, pS293, DOI 10.1097/QAI.0000000000000231; Albrecht L, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-52; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Altman DG, 2012, STAT MED, V31, P2985, DOI 10.1002/sim.5402; Armstrong R, 2008, J PUBLIC HEALTH-UK, V30, P103, DOI 10.1093/pubmed/fdm082; Baker TB, 2010, PATIENT EDUC COUNS, V81, pS77, DOI 10.1016/j.pec.2010.07.040; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Bird VJ, 2014, BRIT J PSYCHIAT, V204, P316, DOI 10.1192/bjp.bp.113.128314; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Boutron I, 2005, J CLIN EPIDEMIOL, V58, P1233, DOI 10.1016/j.jclinepi.2005.05.004; Boutron I, 2008, ANN INTERN MED, V148, pW60, DOI 10.7326/0003-4819-148-4-200802190-00008-w1; Burford BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075122; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Conn VS, 2011, NURS OUTLOOK, V59, P318, DOI 10.1016/j.outlook.2011.06.003; Davidoff F, 2008, QUAL SAF HEALTH CARE, V17, P3, DOI 10.1136/qshc.2008.029066; Davidson KW, 2003, ANN BEHAV MED, V26, P161, DOI 10.1207/S15324796ABM2603_01; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Eysenbach G, 2011, J MED INTERNET RES, V13, P25; Fernald D, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120004; Flores SA, 2004, AIDS EDUC PREV, V16, P341, DOI 10.1521/aeap.16.4.341.40396; Flottorp SA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-35; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Harrington NG, 2012, HEALTH EDUC RES, V27, P331, DOI 10.1093/her/cyr108; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Kogesten A, 2014, AM J PUBLIC HEALTH, V104, pE23, DOI 10.2105/AJPH.2014.302246; Kavanagh J, 2008, REFLECTIONS DEV USIN; Last J.M., 2000, DICT EPIDEMIOLOGY, Vthird; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Little J, 2009, J CLIN EPIDEMIOL, V62, P597, DOI 10.1016/j.jclinepi.2008.12.004; MacPherson Hugh, 2002, Acupunct Med, V20, P22; MacPherson H, 2010, J ALTERN COMPLEM MED, V16, P929, DOI 10.1089/acm.2010.0558; MacPherson H, 2010, ACUPUNCT MED, V28, P83, DOI 10.1136/aim.2009.001370; Matsumoto M, 2012, RURAL REMOTE HEALTH, V12; Mayo-Wilson E, 2007, AM J PUBLIC HEALTH, V97, P630, DOI 10.2105/AJPH.2006.094169; Mayo-Wilson E, 2013, TRIALS, V14, DOI [10.1192/bjp.bp.112.123745, 10.1186/1745-6215-14-242, 10.1007/s11292-013-9180-5]; Michie S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-40; Mohler R, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-125; Mohler R, 2012, INT J NURS STUD, V49, P40, DOI 10.1016/j.ijnurstu.2011.08.003; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Montgomery P, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-99; Montgomery P, 2013, J CLIN EPIDEMIOL, V66, P874, DOI 10.1016/j.jclinepi.2013.03.006; Niazkhani Z, 2011, STUD HEALTH TECHNOL, V169, P877, DOI 10.3233/978-1-60750-806-9-877; O'Neill J, 2014, J CLIN EPIDEMIOL, V67, P56, DOI 10.1016/j.jclinepi.2013.08.005; Ogrinc G, 2008, QUAL SAF HEALTH CARE, V17, P13, DOI 10.1136/qshc.2008.029058; Peters DH, 2013, INPLEMENTATION RESEARCH IN HEALTH: A PRACTICAL GUIDE, pCOVER1; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Phillips A, 2014, TURNING THE PAGE: THE EVOLUTION OF THE BOOK, P1; Phillips AC, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-159; Phillips AC, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-9; Pinnock H, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0235-z; Proudfoot Judith, 2011, Cognitive Behaviour Therapy, V40, P82, DOI 10.1080/16506073.2011.573807; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Rigby M, 2009, STUD HEALTH TECHNOL, V150, P66, DOI 10.3233/978-1-60750-044-5-66; Roen K, 2006, SOC SCI MED, V63, P1060, DOI 10.1016/j.socscimed.2006.02.013; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Simel DL, 2008, J GEN INTERN MED, V23, P768, DOI 10.1007/s11606-008-0583-3; Smidt Nynke, 2006, BMC Med Res Methodol, V6, P12, DOI 10.1186/1471-2288-6-12; Stein KF, 2010, J AM PSYCHIAT NURSES, V16, P337; Talmon J, 2009, INT J MED INFORM, V78, P1, DOI 10.1016/j.ijmedinf.2008.09.002; The SURE collaboration, 2011, SUR GUID PREP US EV; Thomas CW, 2006, AIDS EDUC PREV, V18, P74, DOI 10.1521/aeap.2006.18.supp.74; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Tooth L, 2005, AM J EPIDEMIOL, V161, P280, DOI 10.1093/aje/kwi042; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Welch V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001333; Welch V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031360; Welch VA, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-43; Wells GA, 2013, RES SYNTH METHODS, V4, P63, DOI 10.1002/jrsm.1077; Wells M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-95; WHO Sexual and Reproductive Health, WHO SEX REPR HLTH; World Health Organization [WHO] ExpandNet., 2011, BEG END MIND PLANN P; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	85	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138647	10.1371/journal.pone.0138647	http://dx.doi.org/10.1371/journal.pone.0138647			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418859	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400018
J	Brown, AN; Vied, C; Dennis, JH; Bhide, PG				Brown, Amber N.; Vied, Cynthia; Dennis, Jonathan H.; Bhide, Pradeep G.			Nucleosome Repositioning: A Novel Mechanism for Nicotine- and Cocaine-Induced Epigenetic Changes	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; SH-SY5Y CELLS; TRANSCRIPTIONAL REGULATION; ACETYLCHOLINE-RECEPTOR; DNA ELEMENTS; COMPLEX-I; EXPRESSION; DOPAMINE; GENOME; EXPOSURE	Drugs of abuse modify behavior by altering gene expression in the brain. Gene expression can be regulated by changes in DNA methylation as well as by histone modifications, which alter chromatin structure, DNA compaction and DNA accessibility. In order to better understand the molecular mechanisms directing drug-induced changes in chromatin structure, we examined DNA-nucleosome interactions within promoter regions of 858 genes in human neuroblastoma cells (SH-SY5Y) exposed to nicotine or cocaine. Widespread, drug- and time-resolved repositioning of nucleosomes was identified at the transcription start site and promoter region of multiple genes. Nicotine and cocaine produced unique and shared changes in terms of the numbers and types of genes affected, as well as repositioning of nucleosomes at sites which could increase or decrease the probability of gene expression based on DNA accessibility. Half of the drug-induced nucleosome positions approximated a theoretical model of nucleosome occupancy based on physical and chemical characteristics of the DNA sequence, whereas the basal or drug naive positions were generally DNA sequence independent. Thus we suggest that nucleosome repositioning represents an initial dynamic genome-wide alteration of the transcriptional landscape preceding more selective downstream transcriptional reprogramming, which ultimately characterizes the cell-and tissue-specific responses to drugs of abuse.	[Brown, Amber N.; Vied, Cynthia; Bhide, Pradeep G.] Florida State Univ, Coll Med, Dept Biomed Sci, Ctr Brain Repair, Tallahassee, FL 32306 USA; [Dennis, Jonathan H.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bhide, PG (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Ctr Brain Repair, Tallahassee, FL 32306 USA.	pradeep.bhide@med.fsu.edu	Brown, Amber N/G-4543-2012	Vied, Cynthia/0000-0003-3941-3614; Bhide, Pradeep/0000-0003-4236-9415	Jim and Betty Ann Rodgers Chair Funds at the FSU College of Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033775] Funding Source: NIH RePORTER	Jim and Betty Ann Rodgers Chair Funds at the FSU College of Medicine; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Jim and Betty Ann Rodgers Chair Funds at the FSU College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang E, 2001, J NEUROCHEM, V79, P221, DOI 10.1046/j.1471-4159.2001.00563.x; Arredondo J, 2001, LAB INVEST, V81, P1653, DOI 10.1038/labinvest.3780379; Ballare C, 2013, NUCLEUS-AUSTIN, V4, P189, DOI 10.4161/nucl.25108; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Bellucci A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027959; Ben-Shachar D, 2004, BIOCHEM PHARMACOL, V67, P1965, DOI 10.1016/j.bcp.2004.02.015; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Bhide PG, 1996, J COMP NEUROL, V374, P506; Biederman J, 2006, BIOL PSYCHIAT, V59, P258, DOI 10.1016/j.biopsych.2005.07.009; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Brenner-Lavie H, 2008, BBA-BIOENERGETICS, V1777, P173, DOI 10.1016/j.bbabio.2007.10.006; Dajas-Bailador FA, 2002, J NEUROCHEM, V80, P520, DOI 10.1046/j.0022-3042.2001.00725.x; Dorofeeva NA, 2013, J EVOL BIOCHEM PHYS+, V49, P175, DOI 10.1134/S0022093013020060; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Druliner BR, 2013, CELL CYCLE, V12, P1536, DOI 10.4161/cc.24664; Dunckley T, 2003, J BIOL CHEM, V278, P15633, DOI 10.1074/jbc.M210389200; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066629; Feng J, 2013, CURR OPIN NEUROBIOL, V23, P521, DOI 10.1016/j.conb.2013.01.001; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; Holloway AC, 2014, AM J PHYSIOL-ENDOC M, V306, pE443, DOI 10.1152/ajpendo.00478.2013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUGHES P, 1995, PHARMACOL REV, V47, P133; JAEGER AW, 1982, EMBO J, V1, P811, DOI 10.1002/j.1460-2075.1982.tb01252.x; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jouvert P, 2004, J NEUROSCI, V24, P10716, DOI 10.1523/JNEUROSCI.1398-04.2004; Koranda JL, 2014, J NEUROPHYSIOL, V111, P103, DOI 10.1152/jn.00269.2013; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Lyn-Cook L, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-15; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; McCarthy DM, 2014, PROG BRAIN RES, V211, P277, DOI 10.1016/B978-0-444-63425-2.00012-X; McCarthy DM, 2012, DEV NEUROSCI-BASEL, V34, P174, DOI 10.1159/000337172; Mychasiuk R, 2013, BEHAV BRAIN RES, V256, P655, DOI 10.1016/j.bbr.2013.09.006; Ohtani N, 2003, J NEUROSCI, V23, P2840; Osborne JK, 2014, MOL BIOL CELL, V25, P1782, DOI 10.1091/mbc.E13-06-0316; Perisic O, 2010, J MOL BIOL, V403, P777, DOI 10.1016/j.jmb.2010.07.057; Popolo M, 2004, DEV NEUROSCI-BASEL, V26, P229, DOI 10.1159/000082140; Ridley DL, 2002, BRIT J PHARMACOL, V135, P1051, DOI 10.1038/sj.bjp.0704508; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rodrigues AC, 2011, BIOPHARM DRUG DISPOS, V32, P355, DOI 10.1002/bdd.764; Sexton BS, 2014, GENOME RES, V24, P251, DOI 10.1101/gr.160150.113; Skene PJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02042; Tanaka Yoshiaki, 2009, Genome Inform, V23, P169; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Trauth JA, 2000, BRAIN RES, V867, P29, DOI 10.1016/S0006-8993(00)02208-3; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Veljkovic E, 2011, TOXICOL IN VITRO, V25, P446, DOI 10.1016/j.tiv.2010.11.011; Vera DL, 2014, PLANT CELL, V26, P3883, DOI 10.1105/tpc.114.130609; Vierstra J, 2014, NAT METHODS, V11, P66, DOI [10.1038/NMETH.2713, 10.1038/nmeth.2713]; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Wang L, 2010, NEUROPSYCHOPHARMACOL, V35, P913, DOI 10.1038/npp.2009.193; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	61	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139103	10.1371/journal.pone.0139103	http://dx.doi.org/10.1371/journal.pone.0139103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414157	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700043
J	Neto, PSGD; Cavalcanti, GDC; Madeiro, F; Ferreira, TAE				de Mattos Neto, Paulo S. G.; Cavalcanti, George D. C.; Madeiro, Francisco; Ferreira, Tiago A. E.			An Approach to Improve the Performance of PM Forecasters	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; PARTICULATE MATTER; PREDICTION MODEL; HYBRID ARIMA; REGRESSION; POLLUTION; SYSTEM; PM2.5; MORTALITY; EXPOSURE	The particulate matter (PM) concentration has been one of the most relevant environmental concerns in recent decades due to its prejudicial effects on living beings and the earth's atmosphere. High PM concentration affects the human health in several ways leading to short and long term diseases. Thus, forecasting systems have been developed to support decisions of the organizations and governments to alert the population. Forecasting systems based on Artificial Neural Networks (ANNs) have been highlighted in the literature due to their performances. In general, three ANN-based approaches have been found for this task: ANN trained via learning algorithms, hybrid systems that combine search algorithms with ANNs, and hybrid systems that combine ANN with other forecasters. Independent of the approach, it is common to suppose that the residuals (error series), obtained from the difference between actual series and forecasting, have a white noise behavior. However, it is possible that this assumption is infringed due to: misspecification of the forecasting model, complexity of the time series or temporal patterns of the phenomenon not captured by the forecaster. This paper proposes an approach to improve the performance of PM forecasters from residuals modeling. The approach analyzes the remaining residuals recursively in search of temporal patterns. At each iteration, if there are temporal patterns in the residuals, the approach generates the forecasting of the residuals in order to improve the forecasting of the PM time series. The proposed approach can be used with either only one forecaster or by combining two or more forecasting models. In this study, the approach is used to improve the performance of a hybrid system (HS) composed by genetic algorithm (GA) and ANN from residuals modeling performed by two methods, namely, ANN and own hybrid system. Experiments were performed for PM2.5 and PM10 concentration series in Kallio and Vallila stations in Helsinki and evaluated from six metrics. Experimental results show that the proposed approach improves the accuracy of the forecasting method in terms of fitness function for all cases, when compared with the method without correction. The correction via HS obtained a superior performance, reaching the best results in terms of fitness function and in five out of six metrics. These results also were found when a sensitivity analysis was performed varying the proportions of the sets of training, validation and test. The proposed approach reached consistent results when compared with the forecasting method without correction, showing that it can be an interesting tool for correction of PM forecasters.	[de Mattos Neto, Paulo S. G.; Cavalcanti, George D. C.] Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil; [Madeiro, Francisco] Univ Catolica Pernambuco, Recife, PE, Brazil; [Ferreira, Tiago A. E.] Univ Fed Rural Pernambuco, Dept Estat & Informat, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Catolica de Pernambuco; Universidade Federal Rural de Pernambuco (UFRPE)	Neto, PSGD (corresponding author), Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil.	psgmn@cin.ufpe.br	Cavalcanti, George DC/C-2364-2017; Ferreira, Tiago A E/A-7448-2016; Madeiro, Francisco/B-4866-2019	Cavalcanti, George DC/0000-0001-7714-2283; Ferreira, Tiago A E/0000-0002-2131-9825; Madeiro, Francisco/0000-0002-6123-0390; de Mattos Neto, Paulo/0000-0002-2396-7973	CNPq; Facepe	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Facepe(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was partially supported by Brazilian agencies: CNPq and Facepe.	Al-Alawi SM, 2008, ENVIRON MODELL SOFTW, V23, P396, DOI 10.1016/j.envsoft.2006.08.007; Antanasijevic DZ, 2013, SCI TOTAL ENVIRON, V443, P511, DOI 10.1016/j.scitotenv.2012.10.110; Bank W., 2008, GLOB MON REP 2008 MD; Sanchez AB, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/238259; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Box G.E.P., 2008, WILEY SER PROBAB ST; Brody H, 2014, NATURE, V513, pS1, DOI 10.1038/513S1a; Caselli M, 2009, WATER AIR SOIL POLL, V201, P365, DOI 10.1007/s11270-008-9950-2; Csavina J, 2014, SCI TOTAL ENVIRON, V487, P82, DOI 10.1016/j.scitotenv.2014.03.138; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P367, DOI 10.1289/ehp.1205575; de Gennaro G, 2013, SCI TOTAL ENVIRON, V463, P875, DOI 10.1016/j.scitotenv.2013.06.093; Neto PSGD, 2014, ENG APPL ARTIF INTEL, V32, P185, DOI 10.1016/j.engappai.2014.03.010; de Mattos Neto PSG, 2010, IEEE WORLD C COMP IN, P1; Diaz-Robles LA, 2008, ATMOS ENVIRON, V42, P8331, DOI 10.1016/j.atmosenv.2008.07.020; Englert N, 2004, TOXICOL LETT, V149, P235, DOI 10.1016/j.toxlet.2003.12.035; Ettouney RS, 2009, MANAG ENVIRON QUAL, V20, P668, DOI 10.1108/14777830910990843; European Environment Agency, 2014, AIR QUAL EUR REP 201; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033385; Ferreira TAE, 2008, NEURAL PROCESS LETT, V28, P113, DOI 10.1007/s11063-008-9085-x; Firmino PRA, 2015, NEUROCOMPUTING, V153, P242, DOI 10.1016/j.neucom.2014.11.030; Firmino PRA, 2014, NEURAL NETWORKS, V50, P1, DOI 10.1016/j.neunet.2013.10.008; Genc S, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/782462; Harrison RM, 2000, SCI TOTAL ENVIRON, V249, P85, DOI 10.1016/S0048-9697(99)00513-6; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; Kim JW, 2014, TOX RESEARCH, V30, P65, DOI 10.5487/TR.2014.30.2.065; Kleinman Michael T., 2014, CENTRAL NERVOUS SYST; Kukkonen J, 2003, ATMOS ENVIRON, V37, P4539, DOI 10.1016/S1352-2310(03)00583-1; Kurt A, 2010, EXPERT SYST APPL, V37, P7986, DOI 10.1016/j.eswa.2010.05.093; Lima AR, 2010, GECCO-2010 COMPANION PUBLICATION: PROCEEDINGS OF THE 12TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P2015; Mishra D, 2015, ATMOS ENVIRON, V102, P239, DOI 10.1016/j.atmosenv.2014.11.050; Niska H, 2005, ATMOS ENVIRON, V39, P6524, DOI 10.1016/j.atmosenv.2005.07.035; Ordieres JB, 2005, ENVIRON MODELL SOFTW, V20, P547, DOI 10.1016/j.envsoft.2004.03.010; Pascal M, 2014, ATMOS ENVIRON, V95, P175, DOI 10.1016/j.atmosenv.2014.06.030; Perez P, 2006, ATMOS ENVIRON, V40, P2845, DOI 10.1016/j.atmosenv.2006.01.010; Perez P, 2012, ATMOS ENVIRON, V60, P271, DOI 10.1016/j.atmosenv.2012.06.024; Qin SS, 2014, ATMOS ENVIRON, V98, P665, DOI 10.1016/j.atmosenv.2014.09.046; Shang Y, 2013, ENVIRON INT, V54, P100, DOI 10.1016/j.envint.2013.01.010; Sharma S, 2003, INT J ENVIRON POLLUT, V19, P442, DOI 10.1504/IJEP.2003.004327; Silva DA, 2014, EXPERT SYST APPL, V41, P7147, DOI 10.1016/j.eswa.2014.06.001; Siwek K, 2012, ENG APPL ARTIF INTEL, V25, P1246, DOI 10.1016/j.engappai.2011.10.013; Slini T, 2006, ENVIRON MODELL SOFTW, V21, P559, DOI 10.1016/j.envsoft.2004.06.011; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3951, DOI 10.3748/wjg.v19.i25.3951; Tong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108076; Ul-Saufie AZ, 2013, ATMOS ENVIRON, V77, P621, DOI 10.1016/j.atmosenv.2013.05.017; Vlachogianni A, 2011, SCI TOTAL ENVIRON, V409, P1559, DOI 10.1016/j.scitotenv.2010.12.040; Voukantsis D, 2011, SCI TOTAL ENVIRON, V409, P1266, DOI 10.1016/j.scitotenv.2010.12.039; Wang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075220; Westerlund J, 2014, ATMOS ENVIRON, V89, P22, DOI 10.1016/j.atmosenv.2014.02.015; Wong MS, 2015, ATMOS RES, V158, P89, DOI 10.1016/j.atmosres.2015.02.006; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhou Lei, 2014, Biomed Res Int, V2014, P748068, DOI 10.1155/2014/748068	53	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138507	10.1371/journal.pone.0138507	http://dx.doi.org/10.1371/journal.pone.0138507			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414182	gold, Green Published, Green Submitted			2022-12-27	WOS:000362170700018
J	Corzo-Martinez, M; Luscher, A; de las Rivas, B; Munoz, R; Moreno, J				Corzo-Martinez, Marta; Luscher, Alice; de las Rivas, Blanca; Munoz, Rosario; Moreno, Javier			Valorization of Cheese and Tofu Whey through Enzymatic Synthesis of Lactosucrose	PLOS ONE			English	Article							NONDIGESTIBLE OLIGOSACCHARIDES; LEVANSUCRASE; SUCROSE; TRIMETHYLSILYL; TRISACCHARIDES; MICROFLORA; MODULATION; PROBIOTICS; MICROBIOTA; PERMEATE	This work deals with the development of a new bioprocess for the efficient synthesis of lactosucrose, a potential prebiotic oligosaccharide with a high value-added, from two important and inexpensive agro-industrial by-products such as tofu whey and cheese whey permeate. The bioconversion is driven by the ability of the enzyme levansucrase SacB from Bacillus subtilis CECT 39 to transfructosylate lactose contained in the cheese whey permeate by using not only sucrose but also raffinose and stachyose, which are present in considerable amounts in the tofu whey, as suitable donors of fructosyl moieties. The maximum lactosucrose concentration obtained from both by-products was 80.1 g L-1 after a short reaction time 120 min at 37 degrees C, leading to productivity and specific productivity values of 40.1 g lactosucrose L-1 h(-1) and 80.1 mg lactosucrose U enzyme(-1) h(-1), respectively. Findings contained in this work could provide a new strategy to valorize agro-industrial by-products as cheese whey permeate and, specially, tofu whey by means of their use as renewable resources in the enzymatic synthesis of bioactive oligosaccharides.	[Corzo-Martinez, Marta; Luscher, Alice; Moreno, Javier] CEI UAM CSIC, CIAL CSIC UAM, Inst Invest Ciencias Alimentac, Madrid 28049, Spain; [de las Rivas, Blanca; Munoz, Rosario] ICTAN CSIC, Inst Ciencia & Tecnol Alimentos Nutr, Madrid 28006, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN)	Moreno, J (corresponding author), CEI UAM CSIC, CIAL CSIC UAM, Inst Invest Ciencias Alimentac, C Nicolas Cabrera 9, Madrid 28049, Spain.	javier.moreno@csic.es	Moreno, F. Javier/B-1817-2008; Muñoz, Rosario/H-8597-2012; MARTINEZ, MARTA CORZO/D-2146-2015; de las Rivas, Blanca/K-3899-2014	Moreno, F. Javier/0000-0002-7637-9542; Muñoz, Rosario/0000-0003-4170-9713; MARTINEZ, MARTA CORZO/0000-0002-6284-3236; de las Rivas, Blanca/0000-0002-8357-5226	Ministerio de Economia y Competitividad [AGL2011-27884]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad(Spanish Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been financed by project AGL2011-27884 from Ministerio de Economia y Competitividad.	Aachary AA, 2011, COMPR REV FOOD SCI F, V10, P2, DOI 10.1111/j.1541-4337.2010.00135.x; Andersone I, 2004, ENG LIFE SCI, V4, P56, DOI 10.1002/elsc.200400006; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Arakawa K., 2002, Journal of Applied Glycoscience, V49, P63; Ben Ounis W, 2008, DESALINATION, P229; Brokl M, 2009, J CHROMATOGR A, V1216, P4689, DOI 10.1016/j.chroma.2009.03.069; Choi HJ, 2004, BIOTECHNOL PROGR, V20, P1876, DOI 10.1021/bp049770v; Corzo-Martinez M, 2013, J SCI FOOD AGR, V93, P1591, DOI 10.1002/jsfa.5929; Diez-Municio M, 2015, THESIS AUTONOMOUS U, P127; Diez-Municio M, 2012, J AGR FOOD CHEM, V60, P1945, DOI 10.1021/jf204956v; Foda MI, 2000, PROCESS BIOCHEM, V35, P581, DOI 10.1016/S0032-9592(99)00108-9; Fuzfai Z, 2008, J CHROMATOGR A, V1177, P183, DOI 10.1016/j.chroma.2007.11.023; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Han WC, 2007, J BIOTECHNOL, V131, pS113, DOI 10.1016/j.jbiotec.2007.07.195; Han WC, 2009, J MICROBIOL BIOTECHN, V19, P1153, DOI 10.4014/jmb.0901.045; Kanauchi O, 2003, CURR PHARM DESIGN, V9, P333, DOI 10.2174/1381612033391883; KANEKO T, 1994, BIOSCI BIOTECH BIOCH, V58, P2288, DOI 10.1271/bbb.58.2288; Kimura Y, 2002, J NUTR, V132, P80, DOI 10.1093/jn/132.1.80; Kitahata S, 1993, OLIGOSACCHARIDES PRO, P158; LEIVA MHL, 1995, PROCESS BIOCHEM, V30, P757, DOI 10.1016/0032-9592(95)00006-H; Madsen KL, 2001, CAN J GASTROENTEROL, V15, P817, DOI 10.1155/2001/690741; Montilla A, 2009, J AGR FOOD CHEM, V57, P5007, DOI 10.1021/jf900309x; Mountzouris KC, 2002, BRIT J NUTR, V87, P405, DOI 10.1079/BJN2002563; Mu WM, 2013, APPL MICROBIOL BIOT, V97, P1821, DOI 10.1007/s00253-013-4687-2; Mussatto SI, 2007, CARBOHYD POLYM, V68, P587, DOI 10.1016/j.carbpol.2006.12.011; OHKUSA T, 1995, DIGESTION, V56, P415, DOI 10.1159/000201269; Park HE, 2003, ENZYME MICROB TECH, V32, P820, DOI 10.1016/S0141-0229(03)00062-0; Park NH, 2005, BIOTECHNOL LETT, V27, P495, DOI 10.1007/s10529-005-2539-6; PETERSSON G, 1974, CARBOHYD RES, V33, P47, DOI 10.1016/S0008-6215(00)82939-0; Playne MJ, 2009, ADV DAIRY CHEM, V3, P121, DOI DOI 10.1007/978-0-387-84865-5; Rastall RA, 2010, ANNU REV FOOD SCI T, V1, P305, DOI 10.1146/annurev.food.080708.100746; Sako T, 1999, INT DAIRY J, V9, P69, DOI 10.1016/S0958-6946(99)00046-1; Sanz ML, 2004, J CHROMATOGR A, V1059, P143, DOI 10.1016/j.chroma.2004.09.095; Seibel J, 2006, CARBOHYD RES, V341, P2335, DOI 10.1016/j.carres.2006.07.001; Steer T, 2000, NUTR RES REV, V13, P229, DOI 10.1079/095442200108729089; Sudyani Y, 2007, ANN INT C CHEM SCI, P47; Teramoto F, 1996, J GASTROENTEROL, V31, P33, DOI 10.1007/BF01211184; Thi LN, 2003, INT J FOOD MICROBIOL, V89, P67, DOI 10.1016/S0168-1605(03)00109-0; van Hijum SAFT, 2004, MICROBIOL-SGM, V150, P621, DOI 10.1099/mic.0.26671-0; Visnapuu T, 2009, RAPID COMMUN MASS SP, V23, P1337, DOI 10.1002/rcm.4007; Zuluaga J, 2011, BIOL TRACE ELEM RES, V144, P1302, DOI 10.1007/s12011-011-9140-8	41	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139035	10.1371/journal.pone.0139035	http://dx.doi.org/10.1371/journal.pone.0139035			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406885	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700152
J	Glenn, JD; Smith, MD; Kirby, LA; Baxi, EG; Whartenby, KA				Glenn, Justin D.; Smith, Matthew D.; Kirby, Leslie A.; Baxi, Emily G.; Whartenby, Katharine A.			Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; IN-VITRO; T-CELLS; ENCEPHALITOGENIC ANTIGENS; IMMUNE DEVIATION; MYELIN ANTIGENS; MODEL; TH17; REMYELINATION	Mesenchymal stem cells (MSCs) are pleiotropic cells with potential therapeutic benefits for a wide range of diseases. Because of their immunomodulatory properties they have been utilized to treat autoimmune diseases such as multiple sclerosis (MS), which is characterized by demyelination. The microenvironment surrounding MSCs is thought to affect their differentiation and phenotype, which could in turn affect the efficacy. We thus sought to dissect the potential for differential impact of MSCs on central nervous system (CNS) disease in T cell mediated and non-T cell mediated settings using the MOG(35-55) experimental autoimmune encephalomyelitis (EAE) and cuprizone-mediated demyelination models, respectively. As the pathogeneses of MS and EAE are thought to be mediated by IFN gamma-producing (T(H)1) and IL-17A-producing (T(H)17) effector CD4+ T cells, we investigated the effect of MSCs on the development of these two key pathogenic cell groups. Although MSCs suppressed the activation and effector function of T(H)17 cells, they did not affect T(H)1 activation, but enhanced T(H)1 effector function and ultimately produced no effect on EAE. In the non-T cell mediated cuprizone model of demyelination, MSC administration had a positive effect, with an overall increase in myelin abundance in the brain of MSC-treated mice compared to controls. These results highlight the potential variability of MSCs as a biologic therapeutic tool in the treatment of autoimmune disease and the need for further investigation into the multifaceted functions of MSCs in diverse microenvironments and the mechanisms behind the diversity.	[Glenn, Justin D.; Smith, Matthew D.; Kirby, Leslie A.; Baxi, Emily G.; Whartenby, Katharine A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Whartenby, Katharine A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Whartenby, KA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	whartenby@jhmi.edu		Smith, Matthew/0000-0001-6614-569X; Glenn, Justin/0000-0002-3567-6233; Kirby, Leslie/0000-0003-4467-2661	nmss.org; Silverman foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	nmss.org; Silverman foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by nmss.org and Silverman foundation (no website). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton SM, 2015, BIOMED J, V38, P206, DOI 10.4103/2319-4170.158510; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bruck W, 2005, J NEUROL, V252, pV10, DOI 10.1007/s00415-005-5003-6; Buckland Jenny, 2014, Nat Rev Rheumatol, V10, P699, DOI 10.1038/nrrheum.2014.183; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duffy MM, 2011, EUR J IMMUNOL, V41, P2840, DOI 10.1002/eji.201141499; Farooq SM, 2014, BRAIN BEHAV IMMUN, V42, P118, DOI 10.1016/j.bbi.2014.06.010; Farooq SM, 2014, BRAIN BEHAV IMMUN, V35, P64, DOI 10.1016/j.bbi.2013.09.016; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Faunce DE, 2004, J IMMUNOL, V172, P1991, DOI 10.4049/jimmunol.172.4.1991; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Glenn JD, 2014, STEM CELLS, V32, P2744, DOI 10.1002/stem.1755; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gran B, 2010, TRENDS MOL MED, V17, P119; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; Hedayatpour A, 2013, CELL J, V15, P142; Jaramillo-Merchan J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.304; Kang ZZ, 2012, J NEUROSCI, V32, P8284, DOI 10.1523/JNEUROSCI.0841-12.2012; Kasarello K, 2015, MED SCI MONITOR, V21, P1587, DOI 10.12659/MSM.892764; Lanza C, 2009, J NEUROCHEM, V110, P1674, DOI 10.1111/j.1471-4159.2009.06268.x; Leech MD, 2007, EUR J IMMUNOL, V37, P3576, DOI 10.1002/eji.200737148; Li QC, 2014, INT IMMUNOPHARMACOL, V21, P119, DOI 10.1016/j.intimp.2014.04.018; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069795; Pender MP, 2007, CURR ALLERGY ASTHM R, V7, P285, DOI 10.1007/s11882-007-0043-x; Peron JPS, 2010, J NEUROIMMUNOL, V227, P10, DOI 10.1016/j.jneuroim.2010.06.002; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Rivera FJ, 2012, BIOL RES, V45, P257, DOI 10.4067/S0716-97602012000300007; Robinson AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107649; Sajic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030708; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Skarica M, 2009, J IMMUNOL, V182, P4192, DOI 10.4049/jimmunol.0803631; Steinman L, 2005, TRENDS IMMUNOL, V26, P565, DOI 10.1016/j.it.2005.08.014; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Sun B, 2010, J NEUROIMMUNOL, V226, P116, DOI 10.1016/j.jneuroim.2010.05.042; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tatara R, 2011, CYTOTHERAPY, V13, P686, DOI 10.3109/14653249.2010.542456; Thiruppathi M, 2014, J AUTOIMMUN, V52, P64, DOI 10.1016/j.jaut.2013.12.014; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962	53	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139008	10.1371/journal.pone.0139008	http://dx.doi.org/10.1371/journal.pone.0139008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407166	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700145
J	Kitterer, D; Latus, J; Pohlmann, C; Alscher, MD; Kimmel, M				Kitterer, Daniel; Latus, Joerg; Poehlmann, Christoph; Alscher, M. Dominik; Kimmel, Martin			Microbiological Surveillance of Peritoneal Dialysis Associated Peritonitis: Antimicrobial Susceptibility Profiles of a Referral Center in GERMANY over 32 Years	PLOS ONE			English	Article							CAPD PERITONITIS; INFECTIONS; EXPERIENCE; ORGANISMS; CEFAZOLIN; UPDATE; TRENDS	Objectives Peritonitis is one of the most important causes of treatment failure in peritoneal dialysis (PD) patients. This study describes changes in characteristics of causative organisms in PD-related peritonitis and antimicrobial susceptibility. Methods In this single center study we analyzed retrospective 487 susceptibility profiles of the peritoneal fluid cultures of 351 adult patients with peritonitis from 1979 to 2014 (divided into three time periods, P1-P3). Results Staphylococcus aureus decreased from P1 compared to P2 and P3 (P<0.05 and P<0.01, respectively). Methicillin-resistant S. aureus (MRSA) occurred only in P3. Methicillin-resistant Staphylococcus epidermidis (MRSE) increased in P3 over P1 and P2 (P<0.0001, respectively). In P2 and P3, vancomycin resistant enterococci were detected. The percentage of gram-negative organisms remained unchanged. Third generation cephalosporin resistant gram-negative rods (3GCR-GN) were found exclusively in P3. Cefazolin-susceptible gram-positive organisms decreased over the three decades (93% in P1, 75% in P2 and 58% in P3, P<0.01, P<0.05 and P<0.0001, respectively). Vancomycin susceptibility decreased and gentamicin susceptibility in gram-negatives was 94% in P1, 82% in P2 and 90% in P3. Ceftazidim susceptibility was 84% in P2 and 93% in P3. Conclusions Peritonitis caused by MSSA decreased, but peritonitis caused by MRSE increased. MRSA peritonitis is still rare. Peritonitis caused by 3GCR-GN is increasing. An initial antibiotic treatment protocol should be adopted for PD patients to provide continuous surveillance.	[Kitterer, Daniel; Latus, Joerg; Alscher, M. Dominik; Kimmel, Martin] Robert Bosch Krankenhaus, Dept Internal Med, Div Nephrol, Stuttgart, Germany; [Poehlmann, Christoph] Robert Bosch Krankenhaus, Dept Diagnost & Lab Med, Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus; Bosch; Robert Bosch Krankenhaus	Kimmel, M (corresponding author), Robert Bosch Krankenhaus, Dept Internal Med, Div Nephrol, Stuttgart, Germany.	martin.kimmel@rbk.de	Kimmel, Martin/AAM-2514-2021					BAZZATO G, 1984, T AM SOC ART INT ORG, V30, P690; Bending M, 1996, J AM SOC NEPHROL, V7, P2403; Boeschoten EW, 2006, NEPHROL DIAL TRANSPL, V21, pii31; Boudville N, 2012, J AM SOC NEPHROL, V23, P1398, DOI 10.1681/ASN.2011121135; Chao CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110315; Daly C, 2001, COCHRANE DB SYST REV; Friedman O, 2008, PERITON DIALYSIS INT, V28, P195; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; HOLLEY JL, 1990, AM J KIDNEY DIS, V16, P142, DOI 10.1016/S0272-6386(12)80569-5; Institute CaLS, 2014, PERF STAND ANT SUSC; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Kavanagh D, 2004, NEPHROL DIAL TRANSPL, V19, P2584, DOI 10.1093/ndt/gfh386; KEANE WF, 1993, PERITON DIALYSIS INT, V13, P14; Kim DK, 2004, PERITON DIALYSIS INT, V24, P424; Leung CB, 2004, PERITON DIALYSIS INT, V24, P440; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Piraino B, 2011, PERITON DIALYSIS INT, V31, P614, DOI 10.3747/pdi.2011.00057; Strippoli GFM, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004679.PUB2; Szeto CC, 2007, CLIN J AM SOC NEPHRO, V2, P245, DOI 10.2215/CJN.03180906; Troidle Laura, 2006, Ann Clin Microbiol Antimicrob, V5, P6, DOI 10.1186/1476-0711-5-6; van Esch S, 2014, PERITON DIALYSIS INT, V34, P162, DOI 10.3747/pdi.2013.00275; Vlaar PJ, 2013, PERITON DIALYSIS INT, V33, P708, DOI 10.3747/pdi.2012.00155; WEBER J, 1989, PERITON DIALYSIS INT, V9, P191; Yip T, 2006, PERITON DIALYSIS INT, V26, P191	25	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0135969	10.1371/journal.pone.0135969	http://dx.doi.org/10.1371/journal.pone.0135969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405797	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700007
J	Liu, HC; Ding, TT; Zhan, Y; Feng, HL				Liu, Haochen; Ding, Tingting; Zhan, Yuan; Feng, Hailan			A Novel AXIN2 Missense Mutation Is Associated with Non-Syndromic Oligodontia	PLOS ONE			English	Article							TOOTH AGENESIS; ECTODERMAL DYSPLASIA; NONSENSE MUTATION; WNT10A; MSX1; PAX9; POLYMORPHISMS; HYPODONTIA; EDARADD; ACCOUNT	Oligodontia is defined as the congenital absence of six or more permanent teeth, excluding the third molars. Oligodontia may contribute to masticatory dysfunction, speech alteration, aesthetic problems and malocclusion. Numerous gene mutations have been association with oligodontia. In the present study, we identified a de novo AXIN2 missense mutation (c.314T>G) in a Chinese individual with non-syndromic oligodontia. This mutation results in the substitution of Val at residue 105 for Gly (p.Val105Gly); residue 105 is located in the highly conserved regulator of G protein signaling (RGS) domain of the AXIN2 protein. This is the first report indicating that a mutation in the RGS domain of AXIN2 is responsible for non-syndromic oligodontia. Our study supports the relationship between AXIN2 mutation and non-syndromic oligodontia and extends the mutation spectrum of the AXIN2 gene.	[Liu, Haochen; Ding, Tingting; Feng, Hailan] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China; [Zhan, Yuan] Peking Univ, Sch & Hosp Stomatol, Dent Ctr 3, Beijing 100871, Peoples R China	Peking University; Peking University	Feng, HL (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China.	kqfenghl@bjmu.edu.cn			National Natural Science Foundation of China [81100725]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81100725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073705; Arzoo PS, 2014, AM J MED GENET A, V164, P353, DOI 10.1002/ajmg.a.36243; Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Callahan N, 2009, ARCH ORAL BIOL, V54, P45, DOI 10.1016/j.archoralbio.2008.08.002; Chhabra N, 2014, MED ORAL PATOL ORAL, V19, pE112, DOI 10.4317/medoral.19158; Chishti MS, 2006, J HUM GENET, V51, P872, DOI 10.1007/s10038-006-0037-x; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Han D, 2008, EUR J MED GENET, V51, P536, DOI 10.1016/j.ejmg.2008.06.002; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klein OD, 2013, AM J MED GENET C, V163, P318, DOI 10.1002/ajmg.c.31382; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lan Y, 2014, SEMIN CELL DEV BIOL, V25, P61, DOI 10.1016/j.semcdb.2013.12.003; Marvin ML, 2011, AM J MED GENET A, V155A, P898, DOI 10.1002/ajmg.a.33927; Mostowska A, 2006, J HUM GENET, V51, P262, DOI 10.1007/s10038-005-0353-6; Mu YD, 2013, GENET MOL RES, V12, P4446, DOI 10.4238/2013.October.10.10; Nagy N, 2010, J DERMATOL SCI, V58, P220, DOI 10.1016/j.jdermsci.2010.03.012; Nawaz S, 2009, EUR J HUM GENET, V17, P1600, DOI 10.1038/ejhg.2009.81; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Nikopensius T, 2013, J DENT RES, V92, P507, DOI 10.1177/0022034513487210; Pan YC, 2008, EUR J ORAL SCI, V116, P98, DOI 10.1111/j.1600-0722.2007.00517.x; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Petrof G, 2011, AUSTRALAS J DERMATOL, V52, P224, DOI 10.1111/j.1440-0960.2011.00788.x; Ruf S, 2013, J OROFAC ORTHOP, V74, P295, DOI 10.1007/s00056-013-0138-z; Sadier A, 2014, TRENDS GENET, V30, P24, DOI 10.1016/j.tig.2013.08.006; Silva Elisangela R, 2009, J Oral Sci, V51, P341; Song S, 2009, J DENT RES, V88, P126, DOI 10.1177/0022034508328627; Song SJ, 2014, HUM GENET, V133, P117, DOI 10.1007/s00439-013-1360-x; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Wang Y, 2009, CELLS TISSUES ORGANS, V189, P80, DOI 10.1159/000151448; Wong SW, 2014, MUTAGENESIS, V29, P319, DOI 10.1093/mutage/geu019; Wong SW, 2014, ARCH ORAL BIOL, V59, P349, DOI 10.1016/j.archoralbio.2013.12.009; Yang Y, 2013, J DENT RES, V92, P500, DOI 10.1177/0022034513487557	37	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138221	10.1371/journal.pone.0138221	http://dx.doi.org/10.1371/journal.pone.0138221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406231	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700038
J	Liu, L; Zhang, J; Yang, XM; Fang, C; Xu, HL; Xi, XW				Liu, Lei; Zhang, Jing; Yang, Xiaoming; Fang, Chi; Xu, Huali; Xi, Xiaowei			SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer	PLOS ONE			English	Article							CASSETTE TRANSPORTER GENES; EXPRESSION; ONCOGENE; CELLS; APOPTOSIS; NUCLEAR	SALL4 plays important roles in the development and progression of many cancers. However, the role and molecular mechanism of SALL4 in endometrial cancer remain elusive. In the present research, we have demonstrated that the expression of SALL4 was upregulated in endometrial cancer and correlated positively with tumor stage, metastases and poor survival of patients. The overexpression of SALL4 promoted the invasiveness in endometrial cancer cells, as indicated by the upregulation of mesenchymal cell marker N-cadherin and downregulation of the epithelial marker E-cadherin, and invasion assays in vitro. Additionally, there was also an increase in drug resistance in these cell models due to the upregulation of ATP-binding cassette multidrug transporter ABCB1 expression. Moreover, we also found that ABCB1 was critical for SALL4-induced drug resistance. In contrast, SALL4 knockdown restored drug sensitivity, reversed EMT, diminished cell metastasis and suppressed the downregulation of E-cadherin and the upregulation of N-cadherin and ABCB1. Furthermore, we showed that SALL4 upregulated c-Myc expression and c-Myc was a direct target for SALL4 by ChIP assay, depletion of c-Myc with siRNA abolished the SALL4-induced downregulation of E-cadherin, upregulation of N-cadherin and ABCB1, suggesting that c-Myc was a downstream target for SALL4 and required for SALL4-induced EMT, invasion and drugs resistance in endometrial cancer cells. These results indicated that SALL4 could induce EMT and resistance to antineoplastic drugs through the regulation of c-Myc. SALL4 and c-Myc may be novel therapeutic targets for endometrial cancer.	[Zhang, Jing; Yang, Xiaoming; Fang, Chi; Xu, Huali; Xi, Xiaowei] Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xi, XW (corresponding author), Shanghai Jiao Tong Univ, Dept Obstet & Gynecol, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China.	xixiaoweix66@126.com			National Natural Science Foundation of China (NSFC) [81172478]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundation of China (NSFC No. 81172478). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Bahng AY, 2012, J GYNECOL ONCOL, V23, P257, DOI 10.3802/jgo.2012.23.4.257; BAI MK, 1994, ONCOLOGY, V51, P314; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Cao DF, 2009, CANCER-AM CANCER SOC, V115, P2640, DOI 10.1002/cncr.24308; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Forghanifard MM, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-6; Geisler JP, 2004, INT J GYNECOL CANCER, V14, P133, DOI 10.1111/j.1048-891x.2004.14027.x; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hermeking H, 2003, CURR CANCER DRUG TAR, V3, P163, DOI 10.2174/1568009033481949; Hupfeld T, 2013, BRIT J HAEMATOL, V161, P204, DOI 10.1111/bjh.12246; Itou J, 2013, FEBS LETT, V587, P3115, DOI 10.1016/j.febslet.2013.07.049; Jeong HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018372; Kobayashi D, 2011, INT J ONCOL, V38, P933, DOI 10.3892/ijo.2011.929; Li A, 2015, ONCOGENE, V34, P63, DOI 10.1038/onc.2013.529; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Oikawa T, 2013, HEPATOLOGY, V57, P1469, DOI 10.1002/hep.26159; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Porro A, 2011, MOL CANCER RES, V9, P1054, DOI 10.1158/1541-7786.MCR-10-0510; Porro A, 2010, J BIOL CHEM, V285, P19532, DOI 10.1074/jbc.M109.078584; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Saito T, 2003, CANCER-AM CANCER SOC, V97, P1002, DOI 10.1002/cncr.11157; Smith RA, 2003, CA-CANCER J CLIN, V53, P27, DOI 10.3322/canjclin.53.1.27; Strizzi L, 2009, CANCER RES, V69, P7131, DOI 10.1158/0008-5472.CAN-09-1199; Tanaka Y, 2013, CANCER BIOL THER, V14, P13, DOI 10.4161/cbt.22625; Terek MC, 2003, INT J GYNECOL CANCER, V13, P673, DOI 10.1046/j.1525-1438.2003.13324.x; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vale CL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003915.pub4; Wei YA, 2012, ONCOL REP, V27, P504, DOI 10.3892/or.2011.1536; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yong KJ, 2013, NEW ENGL J MED, V368, P2266, DOI 10.1056/NEJMoa1300297; You JS, 2009, CANCER RES, V69, P5716, DOI 10.1158/0008-5472.CAN-08-4953; Yuan Y, 2014, BIORESOURCE TECHNOL, V174, P1, DOI 10.1016/j.biortech.2014.07.104; Zhang L, 2014, ONCOGENE, V33, P5491, DOI 10.1038/onc.2013.495; Zhang ZB, 2013, INT J ONCOL, V43, P1194, DOI 10.3892/ijo.2013.2054	41	48	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138515	10.1371/journal.pone.0138515	http://dx.doi.org/10.1371/journal.pone.0138515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407074	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700054
J	Nguyen, KP; McGilvray, KC; Puttlitz, CM; Mukhopadhyay, S; Chabasse, C; Sarkar, R				Nguyen, Khanh P.; McGilvray, Kirk C.; Puttlitz, Christian M.; Mukhopadhyay, Subhradip; Chabasse, Christine; Sarkar, Rajabrata			Matrix Metalloproteinase 9 (MMP-9) Regulates Vein Wall Biomechanics in Murine Thrombus Resolution	PLOS ONE			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; VENOUS THROMBOSIS; MATRIX-METALLOPROTEINASE; EXPRESSION; MIGRATION; MODEL; CYTOKINES; DELETION; BEHAVIOR; INJURY	Objective Deep venous thrombosis is a common vascular problem with long-term complications including post-thrombotic syndrome. Post-thrombotic syndrome consists of leg pain, swelling and ulceration that is related to incomplete or maladaptive resolution of the venous thrombus as well as loss of compliance of the vein wall. We examine the role of metalloproteinase-9 (MMP-9), a gene important in extracellular remodeling in other vascular diseases, in mediating thrombus resolution and biomechanical changes of the vein wall. Methods and Results The effects of targeted deletion of MMP-9 were studied in an in vivo murine model of thrombus resolution using the FVB strain of mice. MMP-9 expression and activity significantly increased on day 3 after DVT. The lack of MMP-9 impaired thrombus resolution by 27% and this phenotype was rescued by the transplantation of wildtype bone marrow cells. Using novel biomechanical techniques, we demonstrated that the lack of MMP-9 significantly decreased thrombus-induced loss of vein wall compliance. Biomechanical analysis of the contribution of individual structural components showed that MMP-9 affected the elasticity of the extracellular matrix and collagen-elastin fibers. Biochemical and histological analyses correlated with these biomechanical effects as thrombi of mice lacking MMP-9 had significantly fewer macrophages and collagen as compared to those of wildtype mice. Conclusions MMP-9 mediates thrombus-induced loss of vein wall compliance by increasing stiffness of the extracellular matrix and collagen-elastin fibers during thrombus resolution. MMP-9 also mediates macrophage and collagen content of the resolving thrombus and bone-marrow derived MMP-9 plays a role in resolution of thrombus mass. These disparate effects of MMP-9 on various aspects of thrombus illustrate the complexity of individual protease function on biomechanical and morphometric aspects of thrombus resolution.	[Nguyen, Khanh P.] Oregon Hlth & Sci Univ, Div Vasc Surg, Portland, OR 97201 USA; [McGilvray, Kirk C.; Puttlitz, Christian M.] Colorado State Univ, Dept Mech Engn, Orthopaed Bioengn Res Lab, Ft Collins, CO 80523 USA; [McGilvray, Kirk C.; Puttlitz, Christian M.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA; [Mukhopadhyay, Subhradip; Chabasse, Christine; Sarkar, Rajabrata] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Mukhopadhyay, Subhradip; Chabasse, Christine; Sarkar, Rajabrata] Univ Maryland, Div Vasc Surg, Baltimore, MD 21201 USA	Oregon Health & Science University; Colorado State University; Colorado State University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Sarkar, R (corresponding author), Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	rsarkar@smail.umaryland.edu	mcgilvray, kirk/AAG-8307-2019		NIH [1F32HL091643-01, R01 HL083917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL091643, R01HL083917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH F32 Grant: 1F32HL091643-01 (KN) and RO1 Grant: R01 HL083917 (RS).	Ali T, 2006, J VASC SURG, V43, P601, DOI 10.1016/j.jvs.2005.10.073; Ashrani AA, 2009, J THROMB THROMBOLYS, V28, P465, DOI 10.1007/s11239-009-0309-3; Baldwin JF, 2012, J VASC SURG, V56, P1089, DOI 10.1016/j.jvs.2012.02.054; Dahi S, 2005, J VASC SURG, V42, P539, DOI 10.1016/j.jvs.2005.04.051; Deatrick KB, 2005, J VASC SURG, V42, P140, DOI 10.1016/j.jvs.2005.04.014; Deatrick KB, 2013, J VASC SURG, V58, P1375, DOI 10.1016/j.jvs.2012.11.088; Deatrick KB, 2013, THROMB RES, V132, P360, DOI 10.1016/j.thromres.2013.06.027; Deatrick KB, 2011, J VASC SURG, V53, P139, DOI 10.1016/j.jvs.2010.07.043; Dewyer NA, 2007, J SURG RES, V142, P357, DOI 10.1016/j.jss.2007.03.064; FUNG YC, 1993, J BIOMECH ENG-T ASME, V115, P453, DOI 10.1115/1.2895523; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Gossage JA, 2006, J VASC SURG, V44, P1085, DOI 10.1016/j.jvs.2006.07.020; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Hao Q, 2011, STROKE, V42, P453, DOI 10.1161/STROKEAHA.110.596452; Henke PK, 2007, THROMB HAEMOSTASIS, V98, P1045, DOI 10.1160/TH07-03-0190; Henke PK, 2006, J IMMUNOL, V177, P3388, DOI 10.4049/jimmunol.177.5.3388; Henke PK, 2011, ARTERIOSCL THROM VAS, V31, P43, DOI 10.1161/ATVBAHA.110.216317; Henke PK, 2006, THROMB HAEMOSTASIS, V95, P272, DOI 10.1160/Th05-02-0099; Henke PK, 2004, ARTERIOSCL THROM VAS, V24, P1130, DOI 10.1161/01.ATV.0000129537.72553.73; Holzapfel GA, 2007, INT J CARDIOL, V116, P78, DOI 10.1016/j.ijcard.2006.03.033; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Janowska-Wieczorek A, 1999, BLOOD, V93, P3379, DOI 10.1182/blood.V93.10.3379.410k09_3379_3390; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; McGilvray KC, 2010, J BIOMECH, V43, P2941, DOI 10.1016/j.jbiomech.2010.07.012; Modarai B, 2005, CIRCULATION, V111, P2645, DOI 10.1161/CIRCULATIONAHA.104.492678; Myers DD, 2006, J VASC SURG, V44, P625, DOI 10.1016/j.jvs.2006.05.021; NEGLEN P, 1995, J CARDIOVASC SURG, V36, P225; Nosaka M, 2011, J CLIN INVEST, V121, P2911, DOI 10.1172/JCI40782; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Sacks MS, 2003, ANNU REV BIOMED ENG, V5, P251, DOI 10.1146/annurev.bioeng.5.011303.120714; Singh I, 2003, CIRCULATION, V107, P869, DOI 10.1161/01.CIR.0000050149.22928.39; Sood V, 2010, THROMB HAEMOSTASIS, V104, P1174, DOI 10.1160/TH10-03-0184; Sood V, 2010, ANN VASC SURG, V24, P233, DOI 10.1016/j.avsg.2009.11.002; Vande Geest JP, 2004, J BIOMECH ENG-T ASME, V126, P815, DOI 10.1115/1.1824121; Varma MR, 2003, J VASC SURG, V38, P1090, DOI 10.1016/S0741-5214(03)00431-2; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WAKEFIELD TW, 1993, THROMB HAEMOSTASIS, V69, P164; WAKEFIELD TW, 1995, ARTERIOSCL THROM VAS, V15, P258, DOI 10.1161/01.ATV.15.2.258; Xia MH, 1996, J IMMUNOL, V156, P160; XIE JP, 1991, J BIOMECH ENG-T ASME, V113, P36, DOI 10.1115/1.2894083; Zhang HQ, 2011, J NEUROSCI, V31, P15894, DOI 10.1523/JNEUROSCI.3943-11.2011	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139145	10.1371/journal.pone.0139145	http://dx.doi.org/10.1371/journal.pone.0139145			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406902	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700182
J	Lopes-Marques, M; Delgado, ILS; Ruivo, R; Torres, Y; Sainath, SB; Rocha, E; Cunha, I; Santos, MM; Castro, LFC				Lopes-Marques, Mnica; Delgado, Ines L. S.; Ruivo, Raquel; Torres, Yan; Sainath, Sri Bhashyam; Rocha, Eduardo; Cunha, Isabel; Santos, Miguel M.; Castro, L. Filipe C.			The Origin and Diversity of Cpt1 Genes in Vertebrate Species	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; GENOME DUPLICATION; BODY-WEIGHT; BRAIN; METABOLISM; REVEALS; LIVER; FISH; EXPRESSION; RETENTION	The Carnitine palmitoyltransferase I (Cpt1) gene family plays a crucial role in energy homeostasis since it is required for the occurrence of fatty acid beta-oxidation in the mitochondria. The exact gene repertoire in different vertebrate lineages is variable. Presently, four genes are documented: Cpt1a, also known as Cpt1a1, Cpt1a2; Cpt1b and Cpt1c. The later is considered a mammalian innovation resulting from a gene duplication event in the ancestor of mammals, after the divergence of sauropsids. In contrast, Cpt1a2 has been found exclusively in teleosts. Here, we reassess the overall evolutionary relationships of Cpt1 genes using a combination of approaches, including the survey of the gene repertoire in basal gnathostome lineages. Through molecular phylogenetics and synteny studies, we find that Cpt1c is most likely a rapidly evolving orthologue of Cpt1a2. Thus, Cpt1c is present in other lineages such as cartilaginous fish, reptiles, amphibians and the coelacanth. We show that genome duplications (2R) and variable rates of sequence evolution contribute to the history of Cpt1 genes in vertebrates. Finally, we propose that loss of Cpt1b is the likely cause for the unusual energy metabolism of elasmobranch.	[Lopes-Marques, Mnica; Delgado, Ines L. S.; Ruivo, Raquel; Torres, Yan; Sainath, Sri Bhashyam; Rocha, Eduardo; Cunha, Isabel; Santos, Miguel M.; Castro, L. Filipe C.] Univ Porto, CIMAR Associate Lab, Interdisciplinary Ctr Marine & Environm Res, CIIMAR, P-4100 Oporto, Portugal; [Lopes-Marques, Mnica; Torres, Yan; Rocha, Eduardo] Univ Porto, Abel Salazar Biomed Sci Inst, ICBAS, P-4100 Oporto, Portugal; [Santos, Miguel M.; Castro, L. Filipe C.] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Castro, LFC (corresponding author), Univ Porto, CIMAR Associate Lab, Interdisciplinary Ctr Marine & Environm Res, CIIMAR, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	filipe.castro@ciimar.up.pt	Ruivo, Raquel/B-2511-2013; Rocha, Eduardo/H-6786-2019; Ruivo, Raquel/ABB-3175-2020; Castro, Filipe/AAA-2197-2022; Santos, Miguel M./AAD-9267-2021; Quality, Aquaculture Seafood/AAD-7718-2019; Lopes-Marques, Monica/F-9930-2011	Ruivo, Raquel/0000-0003-2412-8730; Rocha, Eduardo/0000-0001-9813-4389; Ruivo, Raquel/0000-0003-2412-8730; Castro, Filipe/0000-0001-7697-386X; Lopes-Marques, Monica/0000-0002-8597-4730; Torres, Yan/0000-0001-5520-4092; Santos, Miguel/0000-0001-7347-0546; Cunha, Isabel/0000-0002-6149-9840; Delgado, Ines/0000-0002-7369-2883				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Boukouvala E, 2010, COMP BIOCHEM PHYS B, V157, P189, DOI 10.1016/j.cbpb.2010.06.004; BRITTON CH, 1995, P NATL ACAD SCI USA, V92, P1984, DOI 10.1073/pnas.92.6.1984; Castro LFC, 2012, GENE, V497, P249, DOI 10.1016/j.gene.2012.01.013; Cohen I, 2001, J BIOL CHEM, V276, P5403, DOI 10.1074/jbc.M009555200; Esser V, 1996, J BIOL CHEM, V271, P6972, DOI 10.1074/jbc.271.12.6972; Feiner N, 2014, GENOME BIOL EVOL, V6, P1635, DOI 10.1093/gbe/evu135; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Ka S, 2013, PHYSIOL GENOMICS, V45, P367, DOI 10.1152/physiolgenomics.00078.2012; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lee J, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-23; Lovell PV, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0565-1; Lundin Lars-Gustav, 2003, Journal of Structural and Functional Genomics, V3, P53, DOI 10.1023/A:1022600813840; Morash AJ, 2010, AM J PHYSIOL-REG I, V299, pR579, DOI 10.1152/ajpregu.00088.2010; Mulley JF, 2010, MOL BIOL EVOL, V27, P2386, DOI 10.1093/molbev/msq121; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Ravi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003177; Rozen S, 2000, Methods Mol Biol, V132, P365; Samanta S, 2014, BIOPOLYMERS, V101, P398, DOI 10.1002/bip.22396; Schonfeld P, 2013, J CEREBR BLOOD F MET, V33, P1493, DOI 10.1038/jcbfm.2013.128; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Skiba-Cassy S, 2007, COMP BIOCHEM PHYS B, V147, P278, DOI 10.1016/j.cbpb.2007.01.007; Speers-Roesch B, 2010, COMP BIOCHEM PHYS A, V155, P417, DOI 10.1016/j.cbpa.2009.09.031; van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055; Wang Q, 2012, DATABASE, V2012; Wang Z, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-2; Wolfgang MJ, 2008, J NEUROCHEM, V105, P1550, DOI 10.1111/j.1471-4159.2008.05255.x; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103	33	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138447	10.1371/journal.pone.0138447	http://dx.doi.org/10.1371/journal.pone.0138447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421611	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700037
J	Fariss, CJ; Linder, FJ; Jones, ZM; Crabtree, CD; Biek, MA; Ross, ASM; Kaur, T; Tsai, M				Fariss, Christopher J.; Linder, Fridolin J.; Jones, Zachary M.; Crabtree, Charles D.; Biek, Megan A.; Ross, Ana-Sophia M.; Kaur, Taranamol; Tsai, Michael			Human Rights Texts: Converting Human Rights Primary Source Documents into Data	PLOS ONE			English	Article							GOVERNMENT RESPECT; POLITICAL-SCIENCE; INFORMATION; REPRESSION; INTEGRITY; SELECTION; TREATIES; AID	We introduce and make publicly available a large corpus of digitized primary source human rights documents which are published annually by monitoring agencies that include Amnesty International, Human Rights Watch, the Lawyers Committee for Human Rights, and the United States Department of State. In addition to the digitized text, we also make available and describe document-term matrices, which are datasets that systematically organize the word counts from each unique document by each unique term within the corpus of human rights documents. To contextualize the importance of this corpus, we describe the development of coding procedures in the human rights community and several existing categorical indicators that have been created by human coding of the human rights documents contained in the corpus. We then discuss how the new human rights corpus and the existing human rights datasets can be used with a variety of statistical analyses and machine learning algorithms to help scholars understand how human rights practices and reporting have evolved over time. We close with a discussion of our plans for dataset maintenance, updating, and availability.	[Fariss, Christopher J.; Linder, Fridolin J.; Jones, Zachary M.; Crabtree, Charles D.; Biek, Megan A.; Ross, Ana-Sophia M.] Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA; [Kaur, Taranamol; Tsai, Michael] Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California San Diego	Fariss, CJ (corresponding author), Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA.	cjf20@psu.edu	Fariss, Christopher J/AAG-9477-2021; Fariss, Christopher/AAN-9494-2020	Fariss, Christopher J/0000-0001-9837-186X; Linder, Fridolin/0000-0002-0499-0676; Crabtree, Charles/0000-0001-5144-8671	McCourtney Institute for Democracy Innovation Grant at Pennsylvania State University; College of Liberal Arts at Pennsylvania State University; National Science Foundation under IGERT [DGE-1144860]	McCourtney Institute for Democracy Innovation Grant at Pennsylvania State University; College of Liberal Arts at Pennsylvania State University; National Science Foundation under IGERT(National Science Foundation (NSF))	CJF acknowledges research funding from The McCourtney Institute for Democracy Innovation Grant, and the College of Liberal Arts, both at Pennsylvania State University. FJL acknowledges support by the National Science Foundation under IGERT Grant DGE-1144860, Big Data Social Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A., 2011, P WORKSH LANG SOC ME; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; BRYSK A, 1994, HUM RIGHTS QUART, V16, P676, DOI 10.2307/762564; Carey S. C., 2010, POLITICS HUMAN RIGHT; CARLETON D, 1985, HUM RIGHTS QUART, V7, P205, DOI 10.2307/762080; Cingranelli DL, 1999, INT STUD QUART, V43, P407, DOI 10.1111/0020-8833.00126; Cingranelli DL, 2015, CINGRANELLI RICHARDS; Conrad CR, 2013, INT STUD PERSPECT, V14, P199, DOI 10.1111/j.1528-3585.2012.00471.x; CONRAD COURTENAY R., 2011, ILL TREATMENT TORTUR; Conrad CR, 2015, AM POLITICA IN PRESS; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; Crabtree CD, 2015, RES POLITICS, V2, DOI 10.1177/2053168015605343; D'Orazio V, 2014, POLITICAL ANAL; Dancy G, 2014, HUMAN RIGHTS FUTURES; Davenport C., 2010, MEDIA BIAS PERSPECTI; Davenport C, 2007, ANNU REV POLIT SCI, V10, P1, DOI 10.1146/annurev.polisci.10.101405.143216; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Fariss CJ, 2014, J CONFLICT RESOLUT, V58, P1003, DOI 10.1177/0022002713487314; Fariss CJ, 2014, AM POLIT SCI REV, V108, P297, DOI 10.1017/S0003055414000070; Fariss CJ., 2015, BRIT J POLI IN PRESS; Gastil Raymond, 1980, FREEDOM WORLD POLITI; Gibney, 1996, POLICY STUDIES DEV N, V4, P73; Gibney M., 2015, POLITICAL TERROR SCA; Gibney Mark, 1988, OPEN BORDERS CLOSED, P151; Goldstein Robert Justin, 1978, POLITICAL REPRESSION; Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028; Hastie T., 2008, ELEMENTS STAT LEARNI; Hathaway OA, 2002, YALE LAW J, V111, P1935, DOI 10.2307/797642; Hill DW, 2014, AM POLIT SCI REV, V108, P661, DOI 10.1017/S0003055414000306; Hill DW, 2013, INT STUD QUART, V57, P219, DOI 10.1111/isqu.12022; Hill DW, 2010, J POLIT, V72, P1161, DOI 10.1017/S0022381610000599; Hopkins DJ, 2010, AM J POLIT SCI, V54, P229, DOI 10.1111/j.1540-5907.2009.00428.x; Innes JE, 1992, HUMAN RIGHTS STAT GE; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055760; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052168; Keith LC, 2012, PA STUD HUM RIGHTS, P1; King G, 2014, SCIENCE, V345, P891, DOI 10.1126/science.1251722; King G, 2013, AM POLIT SCI REV, V107, P326, DOI 10.1017/S0003055413000014; Landman T, 2005, BRIT J POLIT SCI, V35, P549, DOI 10.1017/S0007123405000293; Landman T, 2004, HUM RIGHTS QUART, V26, P906, DOI 10.1353/hrq.2004.0049; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lucas C, 2015, POLIT ANAL, V23, P254, DOI 10.1093/pan/mpu019; Lupu Y, 2013, AM J POLIT SCI, V57, P912, DOI 10.1111/ajps.12033; Lupu Y, 2013, INT ORGAN, V67, P469, DOI 10.1017/S002081831300012X; Lustick IS, 1996, AM POLIT SCI REV, V90, P605, DOI 10.2307/2082612; Monroe BL, 2011, POLITICAL ANAL; Monroe BL, 2015, PS-POLIT SCI POLIT, V48, P71, DOI 10.1017/S1049096514001760; Monroe BL, 2008, POLIT ANAL, V16, P372, DOI 10.1093/pan/mpn018; Poe S., 2019, UNDERSTANDING HUMAN, P16; POE SC, 1993, INT INTERACT, V18, P309, DOI 10.1080/03050629308434811; POE SC, 1994, AM POLIT SCI REV, V88, P853, DOI 10.2307/2082712; POE SC, 1990, HUM RIGHTS QUART, V12, P499, DOI 10.2307/762497; Poe SC, 2001, HUM RIGHTS QUART, V23, P650, DOI 10.1353/hrq.2001.0041; Poe Steven C., 1991, INT INTERACT, V16, P295, DOI DOI 10.1080/03050629108434763; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Richards DL, 2001, INT STUD QUART, V45, P219, DOI 10.1111/0020-8833.00189; Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103; Schnakenberg KE, 2014, POLIT SCI RES METH, V2, P1, DOI 10.1017/psrm.2013.15; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Settle JE, 2016, POLIT SCI RES METH, V4, P361, DOI 10.1017/psrm.2015.1; Sikkink Kathryn, 2012, JUSTICE CASCADE HUMA; Wood RM, 2010, HUM RIGHTS QUART, V32, P367, DOI 10.1353/hrq.0.0152	65	22	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138935	10.1371/journal.pone.0138935	http://dx.doi.org/10.1371/journal.pone.0138935			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418817	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400028
J	Geduhn, A; Jacob, J; Schenke, D; Keller, B; Kleinschmidt, S; Esther, A				Geduhn, Anke; Jacob, Jens; Schenke, Detlef; Keller, Barbara; Kleinschmidt, Sven; Esther, Alexandra			Relation between Intensity of Biocide Practice and Residues of Anticoagulant Rodenticides in Red Foxes (Vulpes vulpes)	PLOS ONE			English	Article							NONTARGET SMALL MAMMALS; RATTUS-NORVEGICUS; EXPOSURE; WILDLIFE; DIET; BROMADIOLONE; BRODIFACOUM; POPULATIONS; RESISTANCE; RISK	Anticoagulant rodenticides (ARs) are commonly used to control rodent infestations for biocidal and plant protection purposes. This can lead to AR exposure of non-target small mammals and their predators, which is known from several regions of the world. However, drivers of exposure variation are usually not known. To identify environmental drivers of AR exposure in non-targets we analyzed 331 liver samples of red foxes (Vulpes vulpes) for residues of eight ARs and used local parameters (percentage of urban area and livestock density) to test for associations to residue occurrence. 59.8% of samples collected across Germany contained at least one rodenticide, in 20.2% of cases at levels at which biological effects are suspected. Second generation anticoagulants (mainly brodifacoum and bromadiolone) occurred more often than first generation anticoagulants. Local livestock density and the percentage of urban area were good indicators for AR residue occurrence. There was a positive association between pooled ARs and brodifacoum occurrence with livestock density as well as of pooled ARs, brodifacoum and difenacoum occurrence with the percentage of urban area on administrative district level. Pig holding drove associations of livestock density to AR residue occurrence in foxes. Therefore, risk mitigation strategies should focus on areas of high pig density and on highly urbanized areas to minimize non-target risk.	[Geduhn, Anke; Jacob, Jens; Esther, Alexandra] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Plant Protect Hort & Forests, Vertebrate Res, Munster, North Rhine Wes, Germany; [Geduhn, Anke] Univ Munster, Inst Landscape Ecol, D-48149 Munster, North Rhine Wes, Germany; [Schenke, Detlef] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Ecol Chem Plant Anal & Stored Product Protec, Berlin, Germany; [Keller, Barbara; Kleinschmidt, Sven] Food & Vet Inst Braunschweig Hannover, Lower Saxony State Off Consumer Protect & Food Sa, Hannover, Lower Saxony, Germany	Julius Kuhn-Institut; University of Munster; Julius Kuhn-Institut	Geduhn, A (corresponding author), Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Plant Protect Hort & Forests, Vertebrate Res, Munster, North Rhine Wes, Germany.	Anke.Geduhn@jki.bund.de	Jacob, Jens/C-2189-2013; Jacob, Jens/AAZ-7850-2020	Jacob, Jens/0000-0002-5136-6606	Federal Environment Agency within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety [3710 63 401]	Federal Environment Agency within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety	This study was funded by the Federal Environment Agency (http://www.umweltbundesamt.de/en) within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (grant number 3710 63 401). The funders had no role in study design, data collection and analysis, or decision to publish. An employee of the Federal Environment Agency provided comments and authorised the manuscript.	Albert CA, 2010, ARCH ENVIRON CON TOX, V58, P451, DOI 10.1007/s00244-009-9402-z; Alterio N, 1997, J ZOOL, V243, P863, DOI 10.1111/j.1469-7998.1997.tb01986.x; [Anonymous], 2013, R LANG ENV STAT COMP; Bates D., 2007, LME4 PACKAGE R PACKA, P74; Battersby S., 2008, COMMENSAL RODENTS PU, P387; BAuA, 2014, LIST BIOZ PROD 14 RO; Berny PJ, 1997, CHEMOSPHERE, V35, P1817, DOI 10.1016/S0045-6535(97)00242-7; Bontzorlos VA, 2005, FOLIA ZOOL, V54, P99; Borner K, 2014, VERSCHIEDENEN ANTHR; Brakes CR, 2005, J APPL ECOL, V42, P118, DOI 10.1111/j.1365-2664.2005.00997.x; Braun M, 2005, DIE SAUGETIERE; Buckle A, 2013, PEST MANAG SCI, V69, P233, DOI 10.1002/ps.3373; Buckle AP, 1994, RODENT PESTS THEIR C; Coeurdassier M, 2014, CONSERV BIOL; Coeurdassier M, 2012, IBIS, V154, P136, DOI 10.1111/j.1474-919X.2011.01193.x; Contesse P, 2004, MAMM BIOL, V69, P81, DOI 10.1078/1616-5047-00123; Daniels MJ, 2003, EPIDEMIOL INFECT, V130, P561, DOI 10.1017/S0950268803008483; Deplazes P, 2004, TRENDS PARASITOL, V20, P77, DOI 10.1016/j.pt.2003.11.011; Eason CT, 2002, ECOTOXICOLOGY, V11, P35, DOI 10.1023/A:1013793029831; EPA, 1998, EPA738R98007; Erickson W., 2004, POTENTIAL RISKS 9 RO, P1; Fisher P, 2003, PERSISTENCE 4 ANTICO, V139, P5; Geduhn A, 2014, SCI TOTAL ENVIRON, V496, P328, DOI 10.1016/j.scitotenv.2014.07.049; Giraudoux P, 2006, ENVIRON RES, V102, P291, DOI 10.1016/j.envres.2006.02.008; Goldyn B, 2003, Z JAGDWISS, V49, P191, DOI 10.1007/BF02189737; Hosea RC, 2000, PROC VERTEBR PEST C, P236; Hughes J, 2013, ECOTOXICOLOGY, V22, P974, DOI 10.1007/s10646-013-1074-9; Jacquot M, 2013, J APPL ECOL, V50, P1406, DOI 10.1111/1365-2664.12151; Laakso S, 2010, LIT REV RESIDUES ANT; Lambert O, 2007, B ENVIRON CONTAM TOX, V79, P91, DOI 10.1007/s00128-007-9134-6; Lopez-Perea JJ, 2015, SCI TOTAL ENVIRON, V511, P259, DOI 10.1016/j.scitotenv.2014.12.042; LUND M, 1964, NATURE, V203, P778, DOI 10.1038/203778a0; Maroni Marco, 2000, Toxicology, V143, P91; McDonald RA, 1998, ENVIRON POLLUT, V103, P17, DOI 10.1016/S0269-7491(98)00141-9; McMillin SC, 2008, P VERTEBR PEST C, V23, P163; Meerburg BG, 2004, NJAS-WAGEN J LIFE SC, V52, P195, DOI 10.1016/S1573-5214(04)80014-9; Meisner K, 2014, ACTA THERIOL WARSZ, P1; MENDENHALL V M, 1980, Wildlife Society Bulletin, V8, P311; Murray M, 2011, J ZOO WILDLIFE MED, V42, P88, DOI 10.1638/2010-0188.1; Pelz HJ, 2007, INT J PEST MANAGE, V53, P299, DOI 10.1080/09670870701245223; Proulx G, 2012, INTEGR ZOOL, V7, P41, DOI [10.1111/j.1749-4877.2012.00274.x, 10.1111/j.1749-4877.2011.00276.x]; Raoul F, 2003, INT J PARASITOL, V33, P945, DOI 10.1016/S0020-7519(03)00127-9; Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n; Riley SPD, 2007, J WILDLIFE MANAGE, V71, P1874, DOI 10.2193/2005-615; Sage M, 2010, ENVIRON RES, V110, P664, DOI 10.1016/j.envres.2010.07.009; Sanchez-Barbudo IS, 2012, SCI TOTAL ENVIRON, V420, P280, DOI 10.1016/j.scitotenv.2012.01.028; Shore RF, 2003, ENVIRON POLLUT, V122, P183, DOI 10.1016/S0269-7491(02)00297-X; Statistische Amter des Bundes und der Lander, 2014, STAT AMT BUND LAND; Stone WB, 1999, J WILDLIFE DIS, V35, P187, DOI 10.7589/0090-3558-35.2.187; Tosh DG, 2011, ENVIRON POLLUT, V159, P3106, DOI 10.1016/j.envpol.2011.03.028; Tosh DG, 2012, ECOTOXICOLOGY, V21, P1325, DOI 10.1007/s10646-012-0886-3; Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z; Valchev I, 2008, TURK J VET ANIM SCI, V32, P237; Vandenbroucke V, 2008, J VET PHARMACOL THER, V31, P437, DOI 10.1111/j.1365-2885.2008.00979.x; Walker LA, 2008, SCI TOTAL ENVIRON, V392, P93, DOI 10.1016/j.scitotenv.2007.10.061; Zuur Alain F., 2009, P1	56	36	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139191	10.1371/journal.pone.0139191	http://dx.doi.org/10.1371/journal.pone.0139191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418154	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400061
J	Pichardo, S; Silva, RRC; Rubel, O; Curiel, L				Pichardo, Samuel; Silva, Rafael R. C.; Rubel, Oleg; Curiel, Laura			Efficient Driving of Piezoelectric Transducers Using a Biaxial Driving Technique	PLOS ONE			English	Article							POLARIZATION ROTATION; LOSSES	Efficient driving of piezoelectric materials is desirable when operating transducers for biomedical applications such as high intensity focused ultrasound (HIFU) or ultrasound imaging. More efficient operation reduces the electric power required to produce the desired bioeffect or contrast. Our preliminary work [Cole et al. Journal of Physics: Condensed Matter. 2014; 26(13): 135901.] suggested that driving transducers by applying orthogonal electric fields can significantly reduce the coercivity that opposes ferroelectric switching. We present here the experimental validation of this biaxial driving technique using piezoelectric ceramics typically used in HIFU. A set of narrow-band transducers was fabricated with two sets of electrodes placed in an orthogonal configuration (following the propagation and the lateral mode). The geometry of the ceramic was chosen to have a resonance frequency similar for the propagation and the lateral mode. The average (+/- s.d.) resonance frequency of the samples was 465.1 (+/- 1.5) kHz. Experiments were conducted in which each pair of electrodes was driven independently and measurements of effective acoustic power were obtained using the radiation force method. The efficiency (acoustic/electric power) of the biaxial driving method was compared to the results obtained when driving the ceramic using electrodes placed only in the pole direction. Our results indicate that the biaxial method increases efficiency from 50% to 125% relative to the using a single electric field.	[Pichardo, Samuel; Curiel, Laura] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada; [Pichardo, Samuel; Silva, Rafael R. C.; Curiel, Laura] Lakehead Univ, Elect Engn, Thunder Bay, ON P7B 5E1, Canada; [Rubel, Oleg] McMaster Univ, Mat Sci & Engn, Hamilton, ON, Canada	Northern Ontario School of Medicine; Lakehead University; McMaster University	Pichardo, S (corresponding author), 980 Oliver Rd, Thunder Bay, ON P7B 6V4, Canada.	spichard@lakeheadu.ca	Rubel, Oleg/H-7521-2017	Rubel, Oleg/0000-0001-5104-5602	Natural Sciences and Engineering Research Council of Canada [386715, 386265]; MaRS Innovation Proof of Principle Grant	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MaRS Innovation Proof of Principle Grant	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grant (386715), http://www.nserc-crsng.gc.ca (SP); Natural Sciences and Engineering Research Council of Canada Discovery Grant (386265), http://www.nserc-crsng.gc.ca (LC); and MaRS Innovation Proof of Principle Grant, http://marsinnovation.com (OR, LC, SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SJ, 2014, MODEL SIMUL MATER SC, V22, DOI 10.1088/0965-0393/22/5/055014; Ahmed SJ, 2013, COMPUT PHYS COMMUN, V184, P647, DOI 10.1016/j.cpc.2012.10.028; Birer A, 2004, SYSTEMS MAN CYBERN A, V51, P878, DOI [10.1109/TUFFC.2004.1320748, DOI 10.1109/TUFFC.2004.1320748]; Budimir M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.064107; Cole J, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/13/135901; Fu HX, 2000, NATURE, V403, P281, DOI 10.1038/35002022; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hong JW, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115107; International electrotechnical commission, 2013, 61161 IEC; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Lin SY, 2000, ULTRASONICS, V37, P549, DOI 10.1016/S0041-624X(99)00076-1; Mezheritsky AV, 2004, IEEE T ULTRASON FERR, V51, P695, DOI 10.1109/TUFFC.2004.1304268; Noheda B, 2001, PHYS REV LETT, V86, P3891, DOI 10.1103/PhysRevLett.86.3891; Taherinejad M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.155138; Uchino K, 2001, IEEE T ULTRASON FERR, V48, P307, DOI 10.1109/58.896144; Uchino K., 2007, FRONTIERS FERROELECT, P217	16	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139178	10.1371/journal.pone.0139178	http://dx.doi.org/10.1371/journal.pone.0139178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418550	gold, Green Submitted, Green Published			2022-12-27	WOS:000362171400058
J	Yang, HK; Kim, MJ; Hwang, JM				Yang, Hee Kyung; Kim, Mi-Jin; Hwang, Jeong-Min			Predictive Factors Affecting Long-Term Outcome of Unilateral Lateral Rectus Recession	PLOS ONE			English	Article							STRABISMUS SURGERY; CONSECUTIVE ESOTROPIA; PRISMATIC CORRECTION; SURGICAL OUTCOMES; EXOTROPIA; ANGLE; CHILDREN; ALIGNMENT	Background There are few long-term outcome reports of unilateral lateral rectus (LR) recession for exotropia including a large number of subjects. Previous reports on unilateral LR recession commonly show extremely low rates of initial overcorrection and large exodrifts after surgery suggesting that the surgical dose may be increased. However, little is known of the long-term outcome of a large unilateral LR recession for exotropia. Objectives To determine long-term outcomes and predictive factors of recurrence after a large unilateral LR recession in patients with exotropia. Data Extraction Retrospective analysis was performed on 92 patients aged 3 to 17 years who underwent 10 mm unilateral LR recession for exotropia of <= 25 prism diopters (Delta) with prism and alternate cover testing and were followed up for more than 2 years after surgery. Final success rates within 10 Delta of exophoria/tropia and 5. of esophoria/tropia at distance in the primary position, improvement in stereopsis and the predictive factors for recurrence were evaluated. Results At 24 months after surgery, 54% of patients had ocular alignment meeting the defined criteria of success, 45% had recurrence and 1% had overcorrection. After a mean follow-up of 39 months, 36% showed success, 63% showed recurrence and 1% resulted in overcorrection. The average time of recurrence was 23.4 +/- 14.7 months (range, 1-60 months) and the rate of recurrence per person-year was 23% after unilateral LR recession. Predictive factors of recurrence were a larger preoperative near angle of deviation (>16 Delta) and larger initial postoperative exodeviation (> 5 Delta) at distance. Conclusions Long-term outcome of unilateral LR recession for exotropia showed low success rates with high recurrence, thus should be reserved for patients with a small preoperative near angle of exodeviation.	[Yang, Hee Kyung; Kim, Mi-Jin; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea.	hjm@snu.ac.kr	Kim, Mi Jin/GXH-9639-2022		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2013R1A1A2010606]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (2013R1A1A2010606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; Choi J, 2011, J AAPOS, V15, P224, DOI 10.1016/j.jaapos.2010.12.019; Dadeya S, 2003, J PEDIAT OPHTH STRAB, V40, P283, DOI 10.3928/0191-3913-20030901-09; Deacon BS, 2014, J AAPOS, V18, P572, DOI 10.1016/j.jaapos.2014.08.010; DEUTSCH JA, 1992, ANN OPHTHALMOL, V24, P111; Feretis D, 1990, J Pediatr Ophthalmol Strabismus, V27, P315; Jeoung JW, 2006, AM J OPHTHALMOL, V141, P683, DOI 10.1016/j.ajo.2005.11.021; Kim C, 2005, EYE, V19, P637, DOI 10.1038/sj.eye.6701604; Kim HJ, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-46; Kim KE, 2014, AM J OPHTHALMOL, V157, P1214, DOI 10.1016/j.ajo.2014.02.038; Kim SH, 2006, EYE, V20, P785, DOI 10.1038/sj.eye.6702002; Lee EK, 2015, BRIT J OPHTHALMOL, V99, P342, DOI 10.1136/bjophthalmol-2014-305861; Lee EK, 2013, OPHTHALMOLOGY, V120, P504, DOI 10.1016/j.ophtha.2012.08.026; Lee Kyoungsook, 2011, Korean J Ophthalmol, V25, P329, DOI 10.3341/kjo.2011.25.5.329; Leow PL, 2010, J PEDIAT OPHTH STRAB, V47, P12, DOI 10.3928/01913913-20100106-04; Livir-Rallatos G, 2002, J AAPOS, V6, P77, DOI 10.1067/mpa.2002.122059; Menon V, 2010, J PEDIAT OPHTH STRAB, V47, P288, DOI 10.3928/01913913-20091118-07; Nelson LB, 1998, J PEDIAT OPHTH STRAB, V35, P132; NELSON LB, 1992, J PEDIATR OPHTHALMOL, V29, P357; Oh JY, 2006, EYE, V20, P1268, DOI 10.1038/sj.eye.6702091; Olitsky SE, 1998, J PEDIAT OPHTH STRAB, V35, P146; SCHWARTZ RL, 1980, J PEDIAT OPHTH STRAB, V17, P359; Spierer A, 2005, OPHTHAL SURG LAS IM, V36, P114, DOI 10.3928/1542-8877-20050301-06; Tibrewal S, 2015, J AAPOS, V19, P293, DOI 10.1016/j.jaapos.2015.03.010; Wang LH, 2010, CURR OPIN OPHTHALMOL, V21, P335, DOI 10.1097/ICU.0b013e32833bd953; Wang LH, 2010, J PEDIAT OPHTH STRAB, V47, P242, DOI 10.3928/01913913-20091019-12; WEAKLEY DR, 1993, OPHTHALMIC SURG LAS, V24, P458; Wright KW., 2007, COLOR ATLAS STRABISM, P13648; Yang HK, 2011, OPHTHALMOLOGY, V118, P1512, DOI 10.1016/j.ophtha.2011.01.004	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0137687	10.1371/journal.pone.0137687	http://dx.doi.org/10.1371/journal.pone.0137687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418819	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400007
J	Ali, A; Ali, I				Ali, Akhtar; Ali, Ijaz			The Complete Genome Phylogeny of Geographically Distinct Dengue Virus Serotype 2 Isolates (1944-2013) Supports Further Groupings within the Cosmopolitan Genotype	PLOS ONE			English	Article							MOLECULAR EVOLUTION; NUCLEOTIDE-SEQUENCE; HEMORRHAGIC-FEVER; PUERTO-RICO; AMINO-ACID; TYPE-2; REEMERGENCE; EPIDEMIC; CIRCULATION; EMERGENCE	Dengue virus serotype 2 (DENV-2) isolates have been implicated in deadly outbreaks of dengue fever (DF) and dengue hemorrhagic fever (DHF) in several regions of the world. Phylogenetic analysis of DENV-2 isolates collected from particular countries has been performed using partial or individual genes but only a few studies have examined complete whole-genome sequences collected worldwide. Herein, 50 complete genome sequences of DENV-2 isolates, reported over the past 70 years from 19 different countries, were downloaded from GenBank. Phylogenetic analysis was conducted and evolutionary distances of the 50 DENV-2 isolates were determined using maximum likelihood (ML) trees or Bayesian phylogenetic analysis created from complete genome nucleotide (nt) and amino acid (aa) sequences or individual gene sequences. The results showed that all DENV-2 isolates fell into seven main groups containing five previously defined genotypes. A Cosmopolitan genotype showed further division into three groups (C-I, C-II, and C-III) with the C-I group containing two subgroups (C-IA and C-IB). Comparison of the aa sequences showed specific mutations among the various groups of DENV-2 isolates. A maximum number of aa mutations was observed in the NS5 gene, followed by the NS2A, NS3 and NS1 genes, while the smallest number of aa substitutions was recorded in the capsid gene, followed by the PrM/M, NS4A, and NS4B genes. Maximum evolutionary distances were found in the NS2A gene, followed by the NS4A and NS4B genes. Based on these results, we propose that genotyping of DENV-2 isolates in future studies should be performed on entire genome sequences in order to gain a complete understanding of the evolution of various isolates reported from different geographical locations around the world.	[Ali, Akhtar; Ali, Ijaz] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	University of Tulsa	Ali, A (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	akhtar-ali@utulsa.edu	Ali, Akhtar/AAA-7582-2021; ALI, IJAZ/AAC-2691-2019	Ali, Akhtar/0000-0003-3474-0253; ALI, IJAZ/0000-0003-2163-8874	Department of Biological Science; Office of Research and Sponsored Programs	Department of Biological Science; Office of Research and Sponsored Programs	Department of Biological Science and Office of Research and Sponsored Programs.	Ali A, 2013, BIOHELIKON IMMUN DIS, V1, P1, DOI DOI 10.1186/S12985-016-0603-6; Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; Chan YC, 1995, T ROY SOC TROP MED H, V89, P619, DOI 10.1016/0035-9203(95)90412-3; Chen HL, 2008, AM J TROP MED HYG, V79, P495, DOI 10.4269/ajtmh.2008.79.495; Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013; Faria NRD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002095; Dash PK, 2013, BIOCHEM BIOPH RES CO, V436, P478, DOI 10.1016/j.bbrc.2013.05.130; Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004; Fatima Z, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-200; Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020; Franco L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001251; Grant D, 2011, J VIROL, V85, P7775, DOI 10.1128/JVI.00665-11; GRUENBERG A, 1988, J GEN VIROL, V69, P1391, DOI 10.1099/0022-1317-69-6-1391; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Idrees M., 2012, AM J BIOMED SCI, V4, P307, DOI [10.5099/aj120400307, DOI 10.5099/AJ120400307]; Khan MA, 2011, PLOS ONE, V8; Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021; Koo C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-275; Kurosu T, 2014, JPN J INFECT DIS, V67, P132, DOI 10.7883/yoken.67.132; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; Ma XZ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-56; McBride W. J. H., 1995, Communicable Diseases Intelligence, V19, P522; McElroy KL, 2011, EMERG INFECT DIS, V17, P64, DOI 10.3201/eid1701.100961; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022; NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788; Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Osman O, 2008, VIRUS RES, V135, P48, DOI 10.1016/j.virusres.2008.02.006; Pickett BE, 2013, VIROLOGY, V447, P45, DOI 10.1016/j.virol.2013.08.021; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011811; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; Sotomayor-Bonilla J, 2014, AM J TROP MED HYG, V91, P129, DOI 10.4269/ajtmh.13-0524; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7, DOI 10.1590/S0102-311X2009001300002; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447; Vasilakis N, 2008, VIROLOGY, V377, P296, DOI 10.1016/j.virol.2008.04.044; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Williams M, 2014, AM J TROP MED HYG, V91, P611, DOI 10.4269/ajtmh.13-0600; Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322; Yamashita A, 2013, FUTURE VIROL, V8, P1061, DOI 10.2217/fvl.13.99; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087630	56	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138900	10.1371/journal.pone.0138900	http://dx.doi.org/10.1371/journal.pone.0138900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414178	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700026
J	Bologna, A; Detrain, C				Bologna, Audrey; Detrain, Claire			Steep Decline and Cessation in Seed Dispersal by Myrmica rubra Ants	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; LEAF-CUTTING ANTS; MULTIVARIATE DATA-ANALYSIS; MYRMECOCHOROUS PLANTS; FORAGING ACTIVITY; DECIDUOUS FOREST; COLONY GROWTH; REMOVAL RATES; HYMENOPTERA; ELAIOSOMES	Myrmecochorous diaspores bear a nutrient-rich appendage, the elaiosome, attractive to ant workers that retrieve them into the nest, detach the elaiosome and reject the seed intact. While this interaction is beneficial for the plant partner by ensuring its seed dispersal, elaiosome consumption has various effects -positive, negative or none - on ants' demography and survival, depending on both the ant/plant species involved. In this context, the contribution of ants to seed dispersal strongly varies according to the ant/plant pairs considered. In this paper, we investigate whether the dynamics of myrmecochory also vary on a temporal scale, for a given pair of partners: Myrmica rubra ants and Viola odorata seeds. During their first encounter with seeds, ants collect all the diaspores and eat the majority of elaiosomes. Both the harvesting effort and the elaiosome consumption decline when seeds are offered on the next week and completely cease for the following weeks. This is related to a decrease in the number of foragers reaching the food source, as well as to a reduced probability for an ant contacting a seed to retrieve it. Seed retrieval is not reactivated after seven weeks without any encounter with V. odorata seeds. By contrast, naive ant colonies only fed with fruit flies do not show a decline of prey harvesting of which the speed of retrieval even increases over the successive weeks. Myrmecochory may thus be labile at the scale of a fruiting season due to the ability of ants to steeply tune and cease for several months the harvesting of these seemingly poorly rewarding items and to maintain cessation of seed exploitation. The present study emphasizes the importance of a long-lasting follow up of the myrmecochory process, to assess the stability of this ant-plant partnership and to identify mechanisms of adaptive harvesting in ants.	[Bologna, Audrey; Detrain, Claire] Univ Libre Bruxelles, Serv Ecol Sociale, Brussels, Belgium	Universite Libre de Bruxelles	Bologna, A (corresponding author), Univ Libre Bruxelles, Serv Ecol Sociale, Brussels, Belgium.	aubologn@ulb.ac.be			FRIA (Fonds pour la formation a la recherche dans l'Industrie et dans l'Agriculture) Ph.D. grant; FRFC from FRS-FNRS [2.4579.12]	FRIA (Fonds pour la formation a la recherche dans l'Industrie et dans l'Agriculture) Ph.D. grant(Fonds de la Recherche Scientifique - FNRS); FRFC from FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	This study was funded by a FRIA (Fonds pour la formation a la recherche dans l'Industrie et dans l'Agriculture) Ph.D. grant attributed to Audrey Bologna, as well by an FRFC grant (2.4579.12) from FRS-FNRS.	Barroso A, 2013, INSECT SOC, V60, P75, DOI 10.1007/s00040-012-0268-0; Bas JM, 2009, ACTA OECOL, V35, P380, DOI 10.1016/j.actao.2009.02.003; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Berg RY, 1981, ROLE ANTS SEED DISPE, P383; BERNSTEIN RA, 1975, ECOLOGY, V56, P213, DOI 10.2307/1935314; Bono JM, 2002, INSECT SOC, V49, P320, DOI 10.1007/PL00012655; Boulay R, 2007, P ROY SOC B-BIOL SCI, V274, P2515, DOI 10.1098/rspb.2007.0594; Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; BREW CR, 1989, OECOLOGIA, V80, P490, DOI 10.1007/BF00380071; BULOWOLSEN A, 1984, AM MIDL NAT, V112, P251, DOI 10.2307/2425432; BURROWS FM, 1975, NEW PHYTOL, V75, P405, DOI 10.1111/j.1469-8137.1975.tb01404.x; Caut S, 2013, ECOL ENTOMOL, V38, P390, DOI 10.1111/een.12028; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Champagne D, 1991, PYSIOLOGICAL ENTOMOL, V15, P105; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; COX DR, 1972, J R STAT SOC B, V34, P187; DEBISEAU JC, 1994, J INSECT BEHAV, V7, P767, DOI 10.1007/BF01997125; Detrain C, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P331; Detrain C, 2000, INSECT SOC, V47, P56, DOI 10.1007/s000400050009; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Dupuy F, 2006, ANIM BEHAV, V72, P1081, DOI 10.1016/j.anbehav.2006.03.011; Dussutour A, 2008, J EXP BIOL, V211, P2224, DOI 10.1242/jeb.017509; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; ELMES GW, 1991, INSECT SOC, V38, P51, DOI 10.1007/BF01242713; ELMES GW, 1973, J ANIM ECOL, V42, P761, DOI 10.2307/3136; Elmes GW, 1975, POPULATION STUDIES G; FEWELL JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P401, DOI 10.1007/BF00294977; Fischer RC, 2005, INSECT SOC, V52, P55, DOI 10.1007/s00040-004-0773-x; Fokuhl G, 2007, ECOL RES, V22, P845, DOI 10.1007/s11284-006-0331-2; Gammans N, 2005, OECOLOGIA, V146, P43, DOI 10.1007/s00442-005-0154-9; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Gorb E, 2000, ECOL RES, V15, P187, DOI 10.1046/j.1440-1703.2000.00338.x; GORB SN, 1995, OIKOS, V73, P367, DOI 10.2307/3545960; Gorb SN, 1999, OIKOS, V84, P110, DOI 10.2307/3546871; Gorb SN, 2000, ACTA OECOL, V21, P293, DOI 10.1016/S1146-609X(00)01081-X; Gove AD, 2007, OECOLOGIA, V153, P687, DOI 10.1007/s00442-007-0756-5; Guitian J, 2006, PLANT SPEC BIOL, V21, P165, DOI 10.1111/j.1442-1984.2006.00162.x; GUNTHER RW, 1989, AM MIDL NAT, V122, P321, DOI 10.2307/2425919; HADLEY M, 1972, Ekologia polska, V20, P173; HANZAWA FM, 1985, AM J BOT, V72, P1707, DOI 10.2307/2443727; Heithaus ER, 2005, J INSECT BEHAV, V18, P827, DOI 10.1007/s10905-005-8743-3; Herz H, 2008, BEHAV ECOL, V19, P575, DOI 10.1093/beheco/arn016; HIGASHI S, 1989, OIKOS, V54, P389, DOI 10.2307/3565300; HORVITZ CC, 1981, OECOLOGIA, V51, P47, DOI 10.1007/BF00344651; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; HUGHES L, 1992, ECOLOGY, V73, P1300, DOI 10.2307/1940677; JENSEN TF, 1978, OIKOS, V31, P207, DOI 10.2307/3543564; Kay A, 2004, BEHAV ECOL, V15, P63, DOI 10.1093/beheco/arg106; KJELLSSON G, 1985, OECOLOGIA, V67, P416, DOI 10.1007/BF00384949; Lambinon J., 2012, NOUVELLE FLORE BELGI, V6; Le Roux AM, 2002, J CHEM ECOL, V28, P2307, DOI 10.1023/A:1021009618298; LEE JC, 1988, PHYSIOL ENTOMOL, V13, P291, DOI 10.1111/j.1365-3032.1988.tb00481.x; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mark S, 1996, OECOLOGIA, V107, P95, DOI 10.1007/BF00582239; Marussich WA, 2006, INSECT SOC, V53, P403, DOI 10.1007/s00040-005-0888-3; Morales MA, 1998, ECOLOGY, V79, P734, DOI 10.1890/0012-9658(1998)079[0734:FFSDMS]2.0.CO;2; NAKANISHI H, 1994, ECOL RES, V9, P1, DOI 10.1007/BF02347236; Oberrath R, 2002, ECOLOGY, V83, P1412, DOI 10.1890/0012-9658(2002)083[1412:PAOADP]2.0.CO;2; Ohkawara K, 2005, PLANT SPEC BIOL, V20, P145, DOI 10.1111/j.1442-1984.2005.00133.x; OHKAWARA K, 1994, OECOLOGIA, V100, P135, DOI 10.1007/BF00317140; OOSTERMEIJER JGB, 1989, OECOLOGIA, V78, P302, DOI 10.1007/BF00379102; Orians G.H., 1979, P155; Passera L., 2005, FOURMIS COMPORTEMENT; Pfeiffer M, 2010, FUNCT ECOL, V24, P545, DOI 10.1111/j.1365-2435.2009.01661.x; RAHBE Y, 1988, B ENTOMOL RES, V78, P329, DOI 10.1017/S0007485300013092; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Ridley P, 1996, EXPERIENTIA, V52, P631, DOI 10.1007/BF01969745; Saverschek N, 2011, ANIM BEHAV, V82, P453, DOI 10.1016/j.anbehav.2011.05.015; Saverschek N, 2010, ANIM BEHAV, V79, P689, DOI 10.1016/j.anbehav.2009.12.021; Schmidt A., 1938, Zeitschrift fuer Vergleichende Physiologie Berlin, V25, P351; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; SEIFERT B, 1996, AMEISEN BEOBACHTEN B; Sernander R., 1906, K SVEN VETENSKAPSAKA, V41, P410; Servigne P, 2008, INSECT SOC, V55, P220, DOI 10.1007/s00040-008-0991-8; Sheridan SL, 1996, J INSECT PHYSIOL, V42, P149, DOI 10.1016/0022-1910(95)00087-9; Sousa-Souto L, 2008, SOCIOBIOLOGY, V52, P645; Souza JM, 2012, AN ACAD BRAS CIENC, V84, P43, DOI 10.1590/S0001-37652012000100006; Tedjakumala SR, 2013, J EXP BIOL, V216, P2985, DOI 10.1242/jeb.086629; Thiele T, 2014, J CHEM ECOL, V40, P617, DOI 10.1007/s10886-014-0460-y; THOMPSON JN, 1981, AM NAT, V117, P104, DOI 10.1086/283691; Turner KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071871; Vander Wall SB, 2004, TRENDS ECOL EVOL, V19, P155, DOI 10.1016/j.tree.2003.12.004; von Beeren C, 2014, ANIM BEHAV, V89, P71, DOI 10.1016/j.anbehav.2013.12.006; Walin L, 2001, ECOL ENTOMOL, V26, P537, DOI 10.1046/j.1365-2311.2001.00350.x; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; Willson M. F., 2000, Seeds: the ecology of regeneration in plant communities, P85, DOI 10.1079/9780851994321.0085	90	9	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139365	10.1371/journal.pone.0139365	http://dx.doi.org/10.1371/journal.pone.0139365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414161	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700054
J	Shi, C; Huang, X; Zhang, B; Zhu, D; Luo, HQ; Lu, QQ; Xiong, WC; Mei, L; Luo, SW				Shi, Chao; Huang, Xuan; Zhang, Bin; Zhu, Dan; Luo, Huqiao; Lu, Quqin; Xiong, Wen-Cheng; Mei, Lin; Luo, Shiwen			The Inhibition of Heat Shock Protein 90 Facilitates the Degradation of Poly-Alanine Expanded Poly (A) Binding Protein Nuclear 1 via the Carboxyl Terminus of Heat Shock Protein 70-Interacting Protein	PLOS ONE			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; POLYALANINE EXPANSION MUTANT; UBIQUITIN-PROTEASOME SYSTEM; REDUCE AGGREGATE FORMATION; MOLECULAR CHAPERONES; CELL-DEATH; TRANSGENIC MICE; QUALITY-CONTROL; HSP90; CHIP	Background Since the identification of poly-alanine expanded poly(A) binding protein nuclear 1 (PABPN1) as the genetic cause of oculopharyngeal muscular dystrophy (OPMD), considerable progress has beenmade in our understanding of the pathogenesis of the disease. However, the molecular mechanisms that regulate the onset and progression of the disease remain unclear. Results In this study, we show that PABPN1 interacts with and is stabilized by heat shock protein 90 (HSP90). Treatment with the HSP90 inhibitor 17-AAG disrupted the interaction of mutant PABPN1 with HSP90 and reduced the formation of intranuclear inclusions (INIs). Furthermore, mutant PABPN1 was preferentially degraded in the presence of 17-AAG compared with wild-type PABPN1 in vitro and in vivo. The effect of 17-AAG was mediated through an increase in the interaction of PABPN1 with the carboxyl terminus of heat shock protein 70-interacting protein (CHIP). The overexpression of CHIP suppressed the aggregation of mutant PABPN1 in transfected cells. Conclusions Our results demonstrate that the HSP90 molecular chaperone system plays a crucial role in the selective elimination of abnormal PABPN1 proteins and also suggest a potential therapeutic application of the HSP90 inhibitor 17-AAG for the treatment of OPMD.	[Shi, Chao; Huang, Xuan; Luo, Shiwen] Nanchang Univ, Ctr Med Expt, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Zhang, Bin] Huazhong Univ Sci & Technol, Sch Basic Med, Tongji Med Coll, Dept Physiol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Bin; Zhu, Dan; Xiong, Wen-Cheng; Mei, Lin] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Zhang, Bin; Zhu, Dan; Xiong, Wen-Cheng; Mei, Lin] Georgia Regents Univ, Dept Neurol, Augusta, GA USA; [Luo, Huqiao] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Lu, Quqin] Nanchang Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanchang, Jiangxi, Peoples R China	Nanchang University; Huazhong University of Science & Technology; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Shanghai Jiao Tong University; Nanchang University	Mei, L (corresponding author), Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA.	lmei@gru.edu; shiwenluo@ncu.edu.cn		Shi, Chao/0000-0003-2347-6127; ZHU, DAN/0000-0003-2735-8996; Zhang, Bin/0000-0003-1323-8678	China National Basic Research Program [2010CB535001]; National Natural Science Foundation of China [81060095]; Science & Technology Support Plan of Jiangxi Province [2010BSA12700]	China National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Support Plan of Jiangxi Province	This work was supported in part by grants from the China National Basic Research Program (2010CB535001 to S.L.), the National Natural Science Foundation of China (81060095 to S.L.) and the Science & Technology Support Plan of Jiangxi Province (2010BSA12700 to S.L.).	Abu-Baker A, 2005, TRAFFIC, V6, P766, DOI 10.1111/j.1600-0854.2005.00315.x; Abu-Baker A, 2003, HUM MOL GENET, V12, P2609, DOI 10.1093/hmg/ddg293; Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Anvar SY, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-15; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bao YP, 2004, J MED GENET, V41, P47, DOI 10.1136/jmg.2003.014548; Bao YP, 2002, J BIOL CHEM, V277, P12263, DOI 10.1074/jbc.M109633200; Bengoechea R, 2012, NEUROBIOL DIS, V46, P118, DOI 10.1016/j.nbd.2011.12.052; Bhattacharjee RB, 2012, CELL BIOL INT, V36, P697, DOI 10.1042/CBI20110348; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brais B, 2003, CYTOGENET GENOME RES, V100, P252, DOI 10.1159/000072861; Brais Bernard, 2011, Handb Clin Neurol, V101, P181, DOI 10.1016/B978-0-08-045031-5.00014-1; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Chen L, 2009, CELL IMMUNOL, V258, P38, DOI 10.1016/j.cellimm.2009.03.009; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088386; Chiosis G, 2004, DRUG DISCOV TODAY, V9, P881, DOI 10.1016/S1359-6446(04)03245-3; Chiosis G, 2003, MOL CANCER THER, V2, P123; Clare DK, 2013, BIOPOLYMERS, V99, P846, DOI 10.1002/bip.22361; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dion P, 2005, NEUROBIOL DIS, V18, P528, DOI 10.1016/j.nbd.2004.09.021; Fan XP, 2003, CAN J NEUROL SCI, V30, P8, DOI 10.1017/S0317167100002365; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Fujikake N, 2008, J BIOL CHEM, V283, P26188, DOI 10.1074/jbc.M710521200; Hino H, 2004, HUM MOL GENET, V13, P181, DOI 10.1093/hmg/ddh017; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Laederich MB, 2011, J BIOL CHEM, V286, P19597, DOI 10.1074/jbc.M110.206151; Luo SW, 2008, NEURON, V60, P97, DOI 10.1016/j.neuron.2008.08.013; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Neckers L, 2002, CLIN CANCER RES, V8, P962; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; TOME FMS, 1980, ACTA NEUROPATHOL, V49, P85, DOI 10.1007/BF00692226; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Wang QS, 2005, HUM MOL GENET, V14, P3673, DOI 10.1093/hmg/ddi395; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138936	10.1371/journal.pone.0138936	http://dx.doi.org/10.1371/journal.pone.0138936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414348	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700030
J	Chiu, HY; Huang, HL; Li, CH; Chen, HA; Yeh, CL; Chiu, SH; Lin, WC; Cheng, YP; Tsai, TF; Ho, SY				Chiu, Hsien-Yi; Huang, Hui-Ling; Li, Chien-Hsun; Chen, Hung-An; Yeh, Chia-Lun; Chiu, Shih-Hsiang; Lin, Wei-Chun; Cheng, Yu-Pin; Tsai, Tsen-Fang; Ho, Shinn-Ying			Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study	PLOS ONE			English	Article							SUBCLINICAL RENAL DYSFUNCTION; INSURANCE RESEARCH DATABASE; ISCHEMIC-STROKE; FOLLOW-UP; EVENTS; CYCLOSPORINE; PROGRESSION; PREVALENCE; VALIDATION; PREDICTOR	Background and Objectives There have been few large population-based studies of the association between rheumatoid arthritis (RA) and chronic kidney disease (CKD) and glomerulonephritis. This nationwide cohort study investigated the risks of developing CKD and glomerulonephritis in patients with RA, and the associated risks for cardiovascular complications. Methods From the Taiwan National Health Insurance Research Database, we identified a study cohort of 12,579 patients with RA and randomly selected 37,737 subjects without RA as a control cohort. Each subject was individually followed for up for 5 years, and the risk of CKD was analyzed using Cox proportional hazards regression models. Results During the follow-up period, after adjusting for traditional cardiovascular risk factors RA was independently associated with a significantly increased risk of CKD (adjusted hazard ratio [aHR] 1.31; 95% confidence interval [CI] 1.23-1.40) and glomerulonephritis (aHR 1.55; 95% CI 1.37-1.76). Increased risk of CKD was also associated with the use of non-steroidal anti-inflammatory drugs, cyclosporine, glucocorticoids, mycophenolate mofetil, and cyclophosphamide. Patients with comorbidities had even greater increased risk of CKD. Moreover, RA patients with concurrent CKD had significantly higher likelihood of developing ischemic heart disease and stroke. Conclusions RA patients had higher risk of developing CKD and glomerulonephritis, independent of traditional cardiovascular risk factors. Their increased risk of CKD may be attributed to glomerulonephritis, chronic inflammation, comorbidities, and renal toxicity of antirheumatic drugs. Careful monitoring of renal function in RA patients and tight control of their comorbid diseases and cardiovascular risk factors are warranted.	[Chiu, Hsien-Yi] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Dept Dermatol, Hsin Chu Branch, Hsinchu, Taiwan; [Chiu, Hsien-Yi; Tsai, Tsen-Fang] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Chiu, Hsien-Yi; Tsai, Tsen-Fang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chiu, Hsien-Yi] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Li, Chien-Hsun; Chen, Hung-An; Yeh, Chia-Lun; Chiu, Shih-Hsiang; Lin, Wei-Chun; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Huang, Hui-Ling; Ho, Shinn-Ying] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Li, Chien-Hsun] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Hsin Chu Branch, Hsinchu, Taiwan; [Cheng, Yu-Pin] Cathay Gen Hosp, Dept Dermatol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Fu Jen Catholic University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Cathay General Hospital	Tsai, TF (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.	tftsai@yahoo.com; syho@mail.nctu.edu.tw		Ho, Shinn-Ying/0000-0002-1901-8353; TSAI, TSEN-FANG/0000-0002-1498-1474; LI, CHIEN-HSUN/0000-0001-7671-9618; Chiu, Hsien-Yi/0000-0002-0493-9707	Cathay General Hospital [MR-A10324]; National Science Council of Taiwan [MOST-103-2221-E-009-117-]; Center forBioinformatics Research of Aiming for the Top University Program of the National Chiao Tung University; Center forBioinformatics Research of Aiming for the Top University Program of Ministry of Education, Taiwan, R.O.C. [104W962]; UST-UCSD International Center of Excellence in Advanced Bioengineering - Ministry of Science and Technology with I-RiCE Program [MOST 103-2911-I-009-101. 2]	Cathay General Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Center forBioinformatics Research of Aiming for the Top University Program of the National Chiao Tung University; Center forBioinformatics Research of Aiming for the Top University Program of Ministry of Education, Taiwan, R.O.C.; UST-UCSD International Center of Excellence in Advanced Bioengineering - Ministry of Science and Technology with I-RiCE Program	This work was funded by the Cathay General Hospital (Grant number: MR-A10324; http://www.cgh.org.tw/index.html), the National Science Council of Taiwan under contract number MOST-103-2221-E-009-117-, and the Center forBioinformatics Research of Aiming for the Top University Program of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. for the project 104W962. This work was also supported in part by UST-UCSD International Center of Excellence in Advanced Bioengineering, sponsored by the Ministry of Science and Technology with I-RiCE Program under Grant Number: MOST 103-2911-I-009-101. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2011, CHEMOTHERAPY, V57, P327, DOI 10.1159/000330463; BOERS M, 1987, ANN RHEUM DIS, V46, P658, DOI 10.1136/ard.46.9.658; BOERS M, 1990, ARTHRITIS RHEUM, V33, P95, DOI 10.1002/art.1780330113; Chen YC, 2014, KIDNEY INT, V85, P1200, DOI 10.1038/ki.2013.455; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiu HY, 2015, BRIT J DERMATOL, V173, P146, DOI 10.1111/bjd.13599; Chiu HY, 2012, DERMATOL SIN, V30, P136, DOI 10.1016/j.dsi.2012.08.002; Daoussis D, 2010, ANN RHEUM DIS, V69, P517, DOI 10.1136/ard.2008.105049; Daoussis D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2775; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Dessein PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121693; DIJKMANS BAC, 1992, SEMIN ARTHRITIS RHEU, V22, P30, DOI 10.1016/0049-0172(92)90046-G; Fried L, 2004, J AM SOC NEPHROL, V15, P3184, DOI 10.1097/01.ASN.0000146422.45434.35; Goicoechea M, 2012, J NEPHROL, V25, P969, DOI 10.5301/jn.5000077; Haroon M, 2011, INT J RHEUM DIS, V14, P255, DOI 10.1111/j.1756-185X.2011.01594.x; HELIN HJ, 1995, ARTHRITIS RHEUM, V38, P242, DOI 10.1002/art.1780380213; Hickson LJ, 2014, AM J KIDNEY DIS, V63, P206, DOI 10.1053/j.ajkd.2013.08.010; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Huang HL, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-80; Karie S, 2008, RHEUMATOLOGY, V47, P350, DOI 10.1093/rheumatology/kem370; Karstila K, 2007, CLIN RHEUMATOL, V26, P2089, DOI 10.1007/s10067-007-0625-y; Kawada T, 2012, ANN RHEUM DIS, V71, pE3, DOI 10.1136/annrheumdis-2012-202595; Kim HW, 2015, RHEUMATOL INT, V35, P727, DOI 10.1007/s00296-014-3146-4; Koseki Y, 2001, ANN RHEUM DIS, V60, P327, DOI 10.1136/ard.60.4.327; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Lai MN, 2010, AM J KIDNEY DIS, V55, P507, DOI 10.1053/j.ajkd.2009.10.055; Levy AR, 2014, ARTHRIT CARE RES, V66, P440, DOI 10.1002/acr.22176; Moller B, 2015, ANN RHEUM DIS, V74, P718, DOI 10.1136/annrheumdis-2013-204078; Nakano M, 1998, CLIN NEPHROL, V50, P154; National Health Insurance Database, 2014, LHID 2005; Sihvonen S, 2004, NEPHRON CLIN PRACT, V96, pC107, DOI 10.1159/000077372; Stuveling EM, 2003, KIDNEY INT, V63, P654, DOI 10.1046/j.1523-1755.2003.00762.x; Sugumar E, 2007, CLIN CHIM ACTA, V376, P244, DOI 10.1016/j.cca.2006.04.006; Thomas E, 2003, J RHEUMATOL, V30, P958; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; van Sijl AM, 2012, ANN RHEUM DIS, V71, P341, DOI 10.1136/annrheumdis-2011-200051; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; YOCUM DE, 1988, ANN INTERN MED, V109, P863, DOI 10.7326/0003-4819-109-11-863; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	40	65	76	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136508	10.1371/journal.pone.0136508	http://dx.doi.org/10.1371/journal.pone.0136508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406879	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700012
J	Farley, D; Zheng, H; Rousi, E; Leotsakos, A				Farley, Donna; Zheng, Hao; Rousi, Eirini; Leotsakos, Agnes			Field Test of the World Health Organization Multi-Professional Patient Safety Curriculum Guide	PLOS ONE			English	Article								Introduction Although the importance of training in patient safety has been acknowledged for over a decade, it remains under-utilized and under-valued in most countries. WHO developed the Multi-professional Patient Safety Curriculum Guide to provide schools with the requirements and tools for incorporating patient safety in education. It was field tested with 12 participating schools across the six WHO regions, to assess its effectiveness for teaching patient safety to undergraduate and graduate students in a global variety of settings. Methods The evaluation used a combined prospective/retrospective design to generate formative information on the experiences of working with the Guide and summative information on the impacts of the Guide. Using stakeholder interviews and student surveys, data were gathered from each participating school at three times: the start of the field test (baseline), soon after each school started teaching, and soon after each school finished teaching. Results Stakeholders interviewed were strongly positive about the Guide, noting that it emphasized universally important patient safety topics, was culturally appropriate for their countries, and gave credibility and created a focus on patient safety at their schools. Student perceptions and attitudes regarding patient safety improved substantially during the field test, and their knowledge of the topics they were taught doubled, from 10.7% to 20.8% of correct answers on the student survey. Discussion This evaluation documented the effectiveness of the Curriculum Guide, for both ease of use by schools and its impacts on improving the patient safety knowledge of healthcare students. WHO should be well positioned to refine the contents of the Guide and move forward in encouraging broader use of the Guide globally for teaching patient safety.	[Farley, Donna; Zheng, Hao; Rousi, Eirini; Leotsakos, Agnes] WHO, Serv Delivery & Safety Dept, CH-1211 Geneva, Switzerland; [Zheng, Hao] Tongji Univ, Sch Med, Div Med Humanities & Behav Sci, Shanghai 200092, Peoples R China	World Health Organization; Tongji University	Zheng, H (corresponding author), WHO, Serv Delivery & Safety Dept, CH-1211 Geneva, Switzerland.	hzheng@iomba.ch; leotsakosagnes@gmail.com			World Health Organization	World Health Organization(World Health Organization)	This work is a part of the Patient Safety Education Project supported by the World Health Organization: www.who.int. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker, 2000, EVALUATING IMPACT DE; Berg BL, 2004, INTRO CONTENT ANAL Q, V5; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Guskey TR., 2007, EDUC MEAS-ISSUES PRA, V26, P19, DOI [DOI 10.1111/J.1745-3992.2007.00085.X, 10.1111/j.1745-3992.2007.00085.x]; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Patey R, 2007, QUAL SAF HEALTH CARE, V16, P256, DOI 10.1136/qshc.2006.021014; Pearson P., 2009, PATIENT SAFETY HLTH, P1; Walton Merrilyn M, 2009, J Evid Based Med, V2, P136, DOI 10.1111/j.1756-5391.2009.01030.x; Weber R. P, 1990, BASIC CONTENT ANAL; WHO, 2011, PAT SAF CURR GUID MU; World Health Organization, 2011, WHO PAT SAF CURR GUI	12	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138510	10.1371/journal.pone.0138510	http://dx.doi.org/10.1371/journal.pone.0138510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406893	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700052
J	Fogen, D; Wu, SC; Ng, KKS; Wong, SL				Fogen, Dawson; Wu, Sau-Ching; Ng, Kenneth Kai-Sing; Wong, Sui-Lam			Engineering Streptavidin and a Streptavidin-Binding Peptide with Infinite Binding Affinity and Reversible Binding Capability: Purification of a Tagged Recombinant Protein to High Purity via Affinity-Driven Thiol Coupling	PLOS ONE			English	Article							ONE-STEP PURIFICATION; MONOMERIC STREPTAVIDIN; BIOTIN DISSOCIATION; BACILLUS-SUBTILIS; STREP-TAG; DISULFIDE; SYSTEM; LIGAND; MODEL; DNA	To extend and improve the utility of the streptavidin-binding peptide tag (SBP-tag) in applications ranging from affinity purification to the reversible immobilization of recombinant proteins, a cysteine residue was introduced to the streptavidin mutein SAVSBPM18 and the SBP-tag to generate SAVSBPM32 and SBP(A18C), respectively. This pair of derivatives is capable of forming a disulfide bond through the newly introduced cysteine residues. SAVSBPM32 binds SBP-tag and biotin with binding affinities (K-d similar to 10(-8)M) that are similar to SAVSBPM18. Although SBP(A18C) binds to SAVSBPM32 more weakly than SBP-tag, the binding affinity is sufficient to bring the two binding partners together efficiently before they are locked together via disulfide bond formation-a phenomenon we have named affinity-driven thiol coupling. Under the condition with SBP(A18C) tags in excess, two SBP(A18C) tags can be captured by a tetrameric SAVSBPM32. The stoichiometry of the disulfide-bonded SAVSBPM32-SBP(A18C) complex was determined using a novel two-dimensional electrophoresis method which has general applications for analyzing the composition of disulfide-bonded protein complexes. To illustrate the application of this reversible immobilization technology, optimized conditions were established to use the SAVSBPM32-affinity matrix for the purification of a SBP(A18C)-tagged reporter protein to high purity. Furthermore, we show that the SAVSBPM32-affinity matrix can also be applied to purify a biotinylated protein and a reporter protein tagged with the unmodified SBP-tag. The dual (covalent and non-covalent) binding modes possible in this system offer great flexibility to many different applications which need reversible immobilization capability.	[Fogen, Dawson; Wu, Sau-Ching; Ng, Kenneth Kai-Sing; Wong, Sui-Lam] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Wong, SL (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	slwong@ucalgary.ca		Ng, Kenneth K.S./0000-0001-7280-8445	Discovery grant from Natural Sciences and Engineering Research Council of Canada (NSERC) [690573, 262089]	Discovery grant from Natural Sciences and Engineering Research Council of Canada (NSERC)	This study was supported by Discovery grant (690573) from The Natural Sciences and Engineering Research Council of Canada (NSERC) to SLW,http://www.nserc-crsng.gc.ca/; Discovery grant (262089) from The Natural Sciences and Engineering Research Council of Canada (NSERC) to KKSN, http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Barrette-Ng IH, 2013, ACTA CRYSTALLOGR D, V69, P879, DOI 10.1107/S0907444913002576; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/nmeth.1450, 10.1038/NMETH.1450]; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Creus M, 2007, ORG BIOMOL CHEM, V5, P1835, DOI 10.1039/b702068f; DeMonte D, 2013, PROTEINS, V81, P1621, DOI 10.1002/prot.24320; Dombkowski AA, 2014, FEBS LETT, V588, P206, DOI 10.1016/j.febslet.2013.11.024; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Fairhead M, 2014, J MOL BIOL, V426, P199, DOI 10.1016/j.jmb.2013.09.016; Funabashi H, 2007, BIOTECHNOL LETT, V29, P785, DOI 10.1007/s10529-006-9301-6; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; HALLING SM, 1977, BIOCHEMISTRY-US, V16, P2880, DOI 10.1021/bi00632a012; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Huang SC, 1996, ANAL BIOCHEM, V237, P115, DOI 10.1006/abio.1996.0208; HUTCHENS TW, 1987, BIOCHEMISTRY-US, V26, P7199, DOI 10.1021/bi00396a049; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kim DM, 2011, SMALL, V7, P656, DOI 10.1002/smll.201002114; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; Los GV, 2007, METH MOL B, V356, P195; Maraveyas A, 1998, INT J CANCER, V78, P610, DOI 10.1002/(SICI)1097-0215(19981123)78:5<610::AID-IJC14>3.3.CO;2-K; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Ovsejevi K, 2013, METHODS MOL BIOL, V1051, P89, DOI 10.1007/978-1-62703-550-7_7; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Qureshi MH, 2001, J BIOL CHEM, V276, P46422, DOI 10.1074/jbc.M107398200; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Sun X, 2014, BIOCONJUGATE CHEM, V25, P1375, DOI 10.1021/bc500296p; Swift JL, 2006, BIOPHYS J, V90, P1396, DOI 10.1529/biophysj.105.069526; Valadon P, 2010, J BIOL CHEM, V285, P713, DOI 10.1074/jbc.M109.061838; Wilchek M, 2006, IMMUNOL LETT, V103, P27, DOI 10.1016/j.imlet.2005.10.022; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; Wilson JL, 2010, BIOCHEM MOL BIOL EDU, V38, P400, DOI 10.1002/bmb.20442; Wu SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069530; Wu SC, 2009, PROTEINS, V77, P404, DOI 10.1002/prot.22446; Wu SC, 2006, PROTEIN EXPRES PURIF, V46, P268, DOI 10.1016/j.pep.2005.10.006; Wu SC, 2005, J BIOL CHEM, V280, P23225, DOI 10.1074/jbc.M501733200; Wu SC, 2002, APPL ENVIRON MICROB, V68, P3261, DOI 10.1128/AEM.68.7.3261-3269.2002; Wu SC, 2002, PROTEIN EXPRES PURIF, V24, P348, DOI 10.1006/prep.2001.1582; Wu SC, 2002, PROTEIN EXPRES PURIF, V24, P357, DOI 10.1006/prep.2001.1583; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zhang XB, 2014, AICHE J, V60, P1245, DOI 10.1002/aic.14348	51	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139137	10.1371/journal.pone.0139137	http://dx.doi.org/10.1371/journal.pone.0139137			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406477	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700180
J	Haq, I; Anwar, S; Shah, K; Khan, MT; Shah, SA				Haq, Izhar; Anwar, Shahzad; Shah, Kamran; Khan, Muhammad Tahir; Shah, Shaukat All			Fuzzy Logic Based Edge Detection in Smooth and Noisy Clinical Images	PLOS ONE			English	Article								Edge detection has beneficial applications in the fields such as machine vision, pattern recognition and biomedical imaging etc. Edge detection highlights high frequency components in the image. Edge detection is a challenging task. It becomes more arduous when it comes to noisy images. This study focuses on fuzzy logic based edge detection in smooth and noisy clinical images. The proposed method (in noisy images) employs a 3x3 mask guided by fuzzy rule set. Moreover, in case of smooth clinical images, an extra mask of contrast adjustment is integrated with edge detection mask to intensify the smooth images. The developed method was tested on noise-free, smooth and noisy images. The results were compared with other established edge detection techniques like Sobel, Prewitt, Laplacian of Gaussian (LOG), Roberts and Canny. When the developed edge detection technique was applied to a smooth clinical image of size 270x290 pixels having 24 dB 'salt and pepper' noise, it detected very few (22) false edge pixels, compared to Sobel (1931), Prewitt (2741), LOG (3102), Roberts (1451) and Canny (1045) false edge pixels. Therefore it is evident that the developed method offers improved solution to the edge detection problem in smooth and noisy clinical images.	[Haq, Izhar; Anwar, Shahzad; Shah, Kamran; Khan, Muhammad Tahir] Univ Engn & Technol, Inst Mechatron Engn, Peshawar, Pakistan; [Shah, Shaukat All] Univ Engn & Technol, Dept Mech Engn, Peshawar, Pakistan	University of Engineering & Technology Peshawar; University of Engineering & Technology Peshawar	Haq, I (corresponding author), Univ Engn & Technol, Inst Mechatron Engn, Peshawar, Pakistan.	izhar@uetpeshawar.edu.pk	Shah, Kamran/AAF-3675-2019					Banerjee S., 2012, TURKISH J FUZZY SYST, P16; Botzheim J, 2001, LECT NOTES COMPUT SC, V2206, P218; Bruno S, 2008, ROBOTICS MODELLING P; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chen SM, 2013, IEEE T FUZZY SYST, V21, P412, DOI 10.1109/TFUZZ.2012.2226942; CHUCHERD S, 2014, COMP SCI SOFTW ENG J, P58; El-Khamy SE, 2000, RAD SCI C 17 NRSC 20, pC32/1; Genming C., 1989, J ELECT CHINA, V6, P314; Goshtasby AA, 2005, 2-D AND 3-D IMAGE REGISTRATION FOR MEDICAL, REMOTE SENSING, AND INDUSTRIAL APPLICATIONS, P1; Hsu CH, 2013, IEEE T FUZZY SYST, V21, P100, DOI 10.1109/TFUZZ.2012.2202665; Jiang XY, 1999, COMPUT VIS IMAGE UND, V73, P183, DOI 10.1006/cviu.1998.0715; Kaur EK., 2010, INT J COMPUT APPL, V1, P55, DOI [10.5120/442-675, DOI 10.5120/442-675]; Kim DS, 2004, PATTERN RECOGN LETT, V25, P101, DOI 10.1016/j.patrec.2003.09.010; KIRSCH RA, 1971, COMPUT BIOMED RES, V4, P315, DOI 10.1016/0010-4809(71)90034-6; Kuo YH, 1997, PROCEEDINGS OF THE SIXTH IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOLS I - III, P1069, DOI 10.1109/FUZZY.1997.622858; Lei Y, 2011, IM SIGN PROC CISP 20, P1197; Lin H, 2004, CHINESE GEOGR SCI, V14, P263, DOI 10.1007/s11769-003-0057-9; Liu J, 2011, J VIS COMMUN IMAGE R, V22, P263, DOI 10.1016/j.jvcir.2010.12.009; Loft A, 2013, CASE REP MED, V2013, DOI 10.1155/2013/791078; Luisier F, 2011, IEEE T IMAGE PROCESS, V20, P696, DOI 10.1109/TIP.2010.2073477; Monicka JG., 2011, INT J COMPUTER APPL, V13, P8; Naumenko A, 2012, 2012 INTERNATIONAL CONFERENCE ON MATHEMATICAL METHODS IN ELECTROMAGNETIC THEORY (MMET), P508, DOI 10.1109/MMET.2012.6331257; ROSENFELD A, 1981, IEEE T PATTERN ANAL, V3, P101, DOI 10.1109/TPAMI.1981.4767056; Rulaningtyas R., 2009, INT C INSTRUMENTATIO, P1, DOI [10.1109/ICICI-BME.2009.5417299, DOI 10.1109/ICICI-BME.2009.5417299]; Satyananda Reddy Ch, 2009, Journal of Software, V4, P452; Setayesh M., 2012, P IEEE C EV COMP, P1, DOI DOI 10.1109/CEC.2012.6256104; Subbaram Naidu D., 2006, INT J ROBUST NONLIN, V16, P548; TORRE V, 1986, IEEE T PATTERN ANAL, V8, P147, DOI 10.1109/TPAMI.1986.4767769; ULUPINAR F, 1990, COMPUT VISION GRAPH, V51, P275, DOI 10.1016/0734-189X(90)90004-F; Van Leekwijck W, 1999, FUZZY SET SYST, V108, P159, DOI 10.1016/S0165-0114(97)00337-0; Verma O. P., 2011, Proceedings of the 2011 World Congress on Information and Communication Technologies (WICT), P507, DOI 10.1109/WICT.2011.6141297; Zhang Jin-Yu, 2009, IM AN SIGN PROC 2009, P31, DOI DOI 10.1109/IASP.2009.5054605; Zhou HB, 2013, IEEE T FUZZY SYST, V21, P447, DOI 10.1109/TFUZZ.2012.2226891	33	24	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138712	10.1371/journal.pone.0138712	http://dx.doi.org/10.1371/journal.pone.0138712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407133	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700074
J	Ihwagi, FW; Wang, T; Wittemyer, G; Skidmore, AK; Toxopeus, AG; Ngene, S; King, J; Worden, J; Omondi, P; Douglas-Hamilton, I				Ihwagi, Festus W.; Wang, Tiejun; Wittemyer, George; Skidmore, Andrew K.; Toxopeus, Albertus G.; Ngene, Shadrack; King, Juliet; Worden, Jeffrey; Omondi, Patrick; Douglas-Hamilton, Iain			Using Poaching Levels and Elephant Distribution to Assess the Conservation Efficacy of Private, Communal and Government Land in Northern Kenya	PLOS ONE			English	Article							AFRICAN ELEPHANTS; WILDLIFE; LANDSCAPE; ATTITUDES; MOVEMENTS; LIVESTOCK; DYNAMICS; LAIKIPIA	Efforts to curb elephant poaching have focused on reducing demand, confiscating ivory and boosting security patrols in elephant range. Where land is under multiple uses and ownership, determining the local poaching dynamics is important for identifying successful conservation models. Using 2,403 verified elephant, Loxodonta africana, mortality records collected from 2002 to 2012 and the results of aerial total counts of elephants conducted in 2002, 2008 and 2012 for the Laikipia-Samburu ecosystem of northern Kenya, we sought to determine the influence of land ownership and use on diurnal elephant distribution and on poaching levels. We show that the annual proportions of illegally killed (i.e., poached) elephants increased over the 11 years of the study, peaking at 70% of all recorded deaths in 2012. The type of land use was more strongly related to levels of poaching than was the type of ownership. Private ranches, comprising only 13% of land area, hosted almost half of the elephant population and had significantly lower levels of poaching than other land use types except for the officially designated national reserves (covering only 1.6% of elephant range in the ecosystem). Communal grazing lands hosted significantly fewer elephants than expected, but community areas set aside for wildlife demonstrated significantly higher numbers of elephants and lower illegal killing levels relative to non-designated community lands. While private lands had lower illegal killing levels than community conservancies, the success of the latter relative to other community-held lands shows the importance of this model of land use for conservation. This work highlights the relationship between illegal killing and various land ownership and use models, which can help focus anti-poaching activities.	[Ihwagi, Festus W.; Wang, Tiejun; Skidmore, Andrew K.; Toxopeus, Albertus G.] Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Ihwagi, Festus W.; Wittemyer, George; Douglas-Hamilton, Iain] Save Elephants, Nairobi, Kenya; [Wittemyer, George] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Ngene, Shadrack; Omondi, Patrick] Kenya Wildlife Serv, Nairobi, Kenya; [King, Juliet; Worden, Jeffrey] No Rangelands Trust, Isiolo, Kenya	University of Twente; Colorado State University	Ihwagi, FW (corresponding author), Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands.	f.w.ihwagi@utwente.nl	Toxopeus, Albertus/A-3650-2010; Wang, Tiejun/A-4671-2010; Skidmore, Andrew K/C-7441-2011; Wittemyer, George/AFQ-1840-2022	Wang, Tiejun/0000-0002-1138-8464; Skidmore, Andrew K/0000-0002-7446-8429; 	Nature Conservancy; Barrett Bateman Foundation; NUFFIC [NFP-PhD.14/44]	Nature Conservancy; Barrett Bateman Foundation; NUFFIC	Support for the study was provided by the Nature Conservancy, the Barrett Bateman Foundation and NUFFIC (NFP-PhD.14/44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekure S, 1990, STRUGGLE LAND INDIGE; Blom A, 2005, ORYX, V39, P381, DOI 10.1017/S0030605305001080; Burn RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024165; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caro T, 2011, TRENDS ECOL EVOL, V26, P111, DOI 10.1016/j.tree.2010.12.008; COLDHAM SFR, 1979, J MOD AFR STUD, V17, P615, DOI 10.1017/S0022278X00007473; Craig G. C., 2004, MONITORING ILLEGAL K; DIAMOND JM, 1984, EXTINCTIONS; Didier KA, 2009, BIODIVERS CONSERV, V18, P1979, DOI 10.1007/s10531-008-9568-0; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Douglas-Hamilton I, 1991, AFR WILDL RES MAN P; Douglas-Hamilton I., 2009, PACHYDERM, V45, P154; Douglas-Hamilton I, 2010, REPORT LEVELS ILLEGA, P1; Douglas-Hamilton Iain, 1996, P28; Fitzsimons JA, 2007, J ENVIRON MANAGE, V84, P38, DOI 10.1016/j.jenvman.2006.05.009; Gadd ME, 2005, ENVIRON CONSERV, V32, P50, DOI 10.1017/S0376892905001918; Gardner TA, 2007, CONSERV BIOL, V21, P1516, DOI 10.1111/j.1523-1739.2007.00794.x; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Georgiadis NJ, 2011, INTRO CONSERVING WIL; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Greiner C, 2012, HUM ECOL, V40, P415, DOI 10.1007/s10745-012-9491-6; Hedges S, 2005, BIOL CONSERV, V124, P35, DOI 10.1016/j.biocon.2005.01.004; Jachmann H, 2013, PACHYDERM, V52, P72; Kahindi O, 2010, AFR J ECOL, V48, P972, DOI 10.1111/j.1365-2028.2009.01200.x; Maingi JK, 2012, WILDLIFE RES, V39, P234, DOI 10.1071/WR11017; Milliken T, 2012, 16 M C PART CITES CI; Murwira A, 2005, LANDSCAPE ECOL, V20, P217, DOI 10.1007/s10980-004-3159-6; Newmark WD, 2000, BIOSCIENCE, V50, P585, DOI 10.1641/0006-3568(2000)050[0585:CWIAIC]2.0.CO;2; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; Ogutu JO, 2014, BIODIVERS CONSERV, V23, P573, DOI 10.1007/s10531-013-0617-y; Omondi P., 2012, GEORG WRIGHT FORUM, V29, P90; Ottichilo WK, 2000, AFR J ECOL, V38, P202, DOI 10.1046/j.1365-2028.2000.00242.x; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Petrzelka P, 2011, AGR HUM VALUES, V28, P549, DOI 10.1007/s10460-011-9307-0; Pia MV, 2013, J ARID ENVIRON, V91, P31, DOI 10.1016/j.jaridenv.2012.11.004; R Core Team, 2012, LANG ENV STAT COMP; Raizman EA, 2013, PREV VET MED, V111, P76, DOI 10.1016/j.prevetmed.2013.04.007; Thouless CR, 1995, AFR J ECOL, V33, P321, DOI 10.1111/j.1365-2028.1995.tb01042.x; Thouless CR, 2008, REPORT STATUS KENYAS; UNEP CITES IUCN TRAFFIC, 2013, EL DUST AFR EL CRIS; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Waltert M, 2009, AFR J ECOL, V47, P737, DOI 10.1111/j.1365-2028.2009.01080.x; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Wiederholt R, 2010, ECOL MODEL, V221, P2482, DOI 10.1016/j.ecolmodel.2010.06.026; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111; Wittemyer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053726; Woodroffe R., 2005, CONSERV BIOL	47	31	31	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139079	10.1371/journal.pone.0139079	http://dx.doi.org/10.1371/journal.pone.0139079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407001	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700163
J	Kim, HS; Seung, J; Lee, JH; Chung, BH; Yang, CW				Kim, Hyun Seon; Seung, Jaeho; Lee, Ju Hyun; Chung, Byung Ha; Yang, Chul Woo			Clinical Significance of Pre-Transplant Arterial Stiffness and the Impact of Kidney Transplantation on Arterial Stiffness	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; POSTTRANSPLANT RENAL-FUNCTION; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; SUBCLINICAL ATHEROSCLEROSIS; STRONG PREDICTOR; RISK-FACTOR; PROGRESSION; PRESSURE; DIALYSIS	Background Arterial stiffness is closely associated with cardiovascular disease (CVD) in end stage renal disease (ESRD) patients. However, the clinical significance of pre-transplant arterial stiffness and the impact of kidney transplantation (KT) on arterial stiffness have not yet been determined. Method We measured the brachial-ankle pulse wave velocity (baPWV) before KT and one year after KT. We evaluated the potential utility of pre-transplant baPWV as a screening test to predict CVD. The impact of KT on progression of arterial stiffness was evaluated according to changes in baPWV after KT. The factors that influence the change of baPWV after KT were also examined. Result The mean value of pre-transplant baPWV was 1508 +/- 300 cm/s in ESRD patients; 93.4% had a higher baPWV value than healthy controls. Pre-transplant baPWV was higher in patients with CVD than in those without CVD (1800 +/- 440 vs. 1491 +/- 265 cm/s, p<0.05), and was a strong predictive factor of CVD (OR 1.003, p<0.05). The optimal cut-off value of baPWV for the detection of CVD was 1591 cm/s, and this value was an independent predictor of CVD in KT recipients (OR 6.3, p<0.05). The post-transplant baPWV was significantly decreased compared to that of pre-transplant rates (1418 +/- 235 vs. 1517 +/- 293 cm/s, p<0.05), and progression of arterial stiffness was not observed in 86.9% patients. Logistic regression analysis revealed that higher body mass index and the degree of increase in calcium levels were independent risk factors that affected baPWV after KT. Conclusions Evaluation of arterial stiffness with baPWV is a useful screening test for predicting CVD after KT, and KT is effective in preventing the progression of arterial stiffness in ESRD patients.	[Kim, Hyun Seon; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea; [Kim, Hyun Seon; Seung, Jaeho; Lee, Ju Hyun; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med,Div Nephrol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Transplant Res Ctr, Seoul, South Korea.	yangch@catholic.ac.kr			Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI14C3417]	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C3417).	Adamidis KN, 2013, RENAL FAILURE, V35, P1075, DOI 10.3109/0886022X.2013.815090; Adragao T, 2012, NEPHROL DIAL TRANSPL, V27, P318, DOI 10.1093/ndt/gfr233; Ai ZS, 2011, BRAZ J MED BIOL RES, V44, P1000; Avramovski P, 2014, RENAL FAILURE, V36, P176, DOI 10.3109/0886022X.2013.843359; Avramovski P, 2013, KOREAN J INTERN MED, V28, P464, DOI 10.3904/kjim.2013.28.4.464; Bachelet-Rousseau C, 2011, NEPHROL DIAL TRANSPL, V26, P3386, DOI 10.1093/ndt/gfr058; Brunner EJ, 2015, HYPERTENSION, V66, P294, DOI 10.1161/HYPERTENSIONAHA.115.05494; Chen NX, 2012, CURR HYPERTENS REP, V14, P228, DOI 10.1007/s11906-012-0265-8; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Claes KJ, 2013, TRANSPL INT, V26, P973, DOI 10.1111/tri.12151; Clemente G, 2015, INT J FOOD SCI NUTR, V66, P466, DOI 10.3109/09637486.2015.1042845; Covic A, 2005, AM J KIDNEY DIS, V45, P965, DOI 10.1053/j.ajkd.2005.02.026; Dahle DO, 2015, TRANSPLANTATION, V99, P1730, DOI 10.1097/TP.0000000000000660; Deng XR, 2014, BIOMED ENVIRON SCI, V27, P594, DOI 10.3967/bes2014.091; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Elewa U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123903; Fernandez-Fresnedo G, 2003, TRANSPLANT P, V35, P1730, DOI 10.1016/S0041-1345(03)00605-5; Garcia-Donaire JA, 2010, CURR HYPERTENS REP, V12, P307, DOI 10.1007/s11906-010-0129-z; Gast KB, 2015, ATHEROSCLEROSIS, V241, P547, DOI 10.1016/j.atherosclerosis.2015.05.026; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Hirai T, 2010, TRANSPL P, V42, P4061, DOI 10.1016/j.transproceed.2010.09.083; Hotta K, 2012, TRANSPL P, V44, P684, DOI 10.1016/j.transproceed.2011.11.016; Kovacs D, 2013, TRANSPL P, V45, P3682, DOI 10.1016/j.transproceed.2013.10.010; Ma YX, 2015, INT UROL NEPHROL, V47, P1157, DOI 10.1007/s11255-015-1009-x; Mansell H, 2014, SCI WORLD J, DOI 10.1155/2014/750579; Marechal C, 2012, AM J KIDNEY DIS, V59, P258, DOI 10.1053/j.ajkd.2011.07.019; McEniery CM, 2006, HYPERTENSION, V48, P602, DOI 10.1161/01.HYP.0000239206.64270.5f; Moe SM, 2004, NEPHROL DIAL TRANSPL, V19, P2387, DOI 10.1093/ndt/gfh303; Nitta K, 2015, CONTRIB NEPHROL, V185, P156, DOI 10.1159/000380980; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Salvadori M, 2003, TRANSPL P, V35, P2863, DOI 10.1016/j.transproceed.2003.10.070; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Verbeke F, 2011, HYPERTENSION, V58, P833, DOI 10.1161/HYPERTENSIONAHA.111.176594	35	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139138	10.1371/journal.pone.0139138	http://dx.doi.org/10.1371/journal.pone.0139138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406607	Green Submitted, gold, Green Published			2022-12-27	WOS:000361800700181
J	Nguyen, KH; Smith, AC; Armfield, NR; Bensink, M; Scuffham, PA				Kim-Huong Nguyen; Smith, Anthony C.; Armfield, Nigel R.; Bensink, Mark; Scuffham, Paul A.			Cost-Effectiveness Analysis of a Mobile Ear Screening and Surveillance Service versus an Outreach Screening, Surveillance and Surgical Service for Indigenous Children in Australia	PLOS ONE			English	Article							ABORIGINAL CHILDREN; QUEENSLAND; OUTCOMES; DISEASE	Indigenous Australians experience a high rate of ear disease and hearing loss, yet they have a lower rate of service access and utilisation compared to their non-Indigenous counterparts. Screening, surveillance and timely access to specialist ear, nose and throat (ENT) services are key components in detecting and preventing the recurrence of ear diseases. To address the low access and utilisation rate by Indigenous Australians, a collaborative, community-based mobile telemedicine-enabled screening and surveillance (MTESS) service was trialled in Cherbourg, the third largest Indigenous community in Queensland, Australia. This paper aims to evaluate the cost-effectiveness of the MTESS service using a lifetime Markov model that compares two options: (i) the Deadly Ears Program alone (current practice involving an outreach ENT surgical service and screening program), and (ii) the Deadly Ears Program supplemented with the MTESS service. Data were obtained from the Deadly Ears Program, a feasibility study of the MTESS service and the literature. Incremental cost-utility ratios were calculated from a societal perspective with both costs (in 2013-14 Australian dollars) and quality-adjusted life years (QALYs) discounted at 5% annually. The model showed that compared with the Deadly Ears Program, the probability of an acceptable cost-utility ratio at a willingness-to-pay threshold of $ 50,000/QALY was 98% for the MTESS service. This cost effectiveness arises from preventing hearing loss in the Indigenous population and the subsequent reduction in associated costs. Deterministic and probability sensitivity analyses indicated that the model was robust to parameter changes. We concluded that the MTESS service is a cost-effective strategy. It presents an opportunity to resolve major issues confronting Australia's health system such as the inequitable provision and access to quality healthcare for rural and remotes communities, and for Indigenous Australians. Additionally, it may encourage effective health service delivery at a time when the healthcare funding and workforce capacity are limited.	[Kim-Huong Nguyen; Bensink, Mark; Scuffham, Paul A.] Griffith Univ, Ctr Appl Hlth Econ, Menzies Hlth Inst, Meadowbrook, Qld 4131, Australia; [Smith, Anthony C.; Armfield, Nigel R.; Bensink, Mark] Univ Queensland, Ctr Online Hlth, Brisbane, Qld, Australia; [Smith, Anthony C.; Armfield, Nigel R.; Bensink, Mark] Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; University of Queensland	Nguyen, KH (corresponding author), Griffith Univ, Ctr Appl Hlth Econ, Menzies Hlth Inst, Meadowbrook, Qld 4131, Australia.	kim.nguyen@griffith.edu.au	Scuffham, Paul/AAS-8084-2021; Scuffham, Paul/B-3066-2014; Armfield, Nigel R./B-4896-2010; Smith, Anthony Carl/E-9538-2010; Nguyen, Kim-Huong/ABA-5902-2020; Nguyen, Kim-Huong/C-7260-2017	Scuffham, Paul/0000-0001-5931-642X; Scuffham, Paul/0000-0001-5931-642X; Armfield, Nigel R./0000-0003-4218-0030; Smith, Anthony Carl/0000-0002-7756-5136; Nguyen, Kim-Huong/0000-0002-2592-9372; Nguyen, Kim-Huong/0000-0002-2592-9372	Children's Hospital Foundation, Queensland; Centre of Research Excellence in Telehealth - National Health and Medical Research Council [APP1061183]; Darling Downs Hospital and Health Service (Queensland Department of Health)	Children's Hospital Foundation, Queensland; Centre of Research Excellence in Telehealth - National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Darling Downs Hospital and Health Service (Queensland Department of Health)	Start-up funding for this project was provided through the Children's Hospital Foundation, Queensland, by corporate and community sponsors. This research was conducted with the support of the Centre of Research Excellence in Telehealth funded by the National Health and Medical Research Council (grant ID: APP1061183). This service was funded by the Darling Downs Hospital and Health Service (Queensland Department of Health).	[ABS Australia Bureau of Statistics], 2012, AUSTR AB TORR STRAT; [ABS Australia Bureau of Statistics], 2013, LIF EXP MORT AUSTR; Access Economics, 2006, LIST HEAR EC IMPACT; [Anonymous], 2014, XE WORLDS FAVOURITE; Bamford J., 2007, CURRENT PRACTICE ACC; Barton Garry R, 2004, Appl Health Econ Health Policy, V3, P103, DOI 10.2165/00148365-200403020-00006; Barton GR, 2006, EAR HEARING, V27, P575, DOI 10.1097/01.aud.0000233967.11072.24; Burn J, 2013, REV EAR HLTH HEARING; Clemens S, 2014, QUAL LIFE RES, V23, P2375, DOI 10.1007/s11136-014-0676-x; Closing the Gap Clearinghouse (AIHW & AIFS ), 2014, EAR DIS AB TORR STRA; Eikelboom RH, 2005, INT J PEDIATR OTORHI, V69, P739, DOI 10.1016/j.ijporl.2004.12.008; Elliott G, 2010, TELEMED J E-HEALTH, V16, P250, DOI 10.1089/tmj.2010.0045; Howard D, 1993, ABORIG ISLANDER HEAL, V3, P1993; Howard D, 2004, AUST J TEACH ED, V29; Independent Hospital Pricing Authority (IHPA), 2014, NAT HOSP COST DAT CO; Kaplan RM, 1995, VALUING HLTH CARE CO, P31; Leach AJ, 1999, INT J PEDIATR OTORHI, V49, pS173; Mak D, 2004, CLIN OTOLARYNGOL, V29, P606, DOI 10.1111/j.1365-2273.2004.00896.x; Mak D, 2000, J LARYNGOL OTOL, V114, P26, DOI 10.1258/0022215001903843; Mbao MN, 2003, TELEMED J E-HEALTH, V9, P325, DOI 10.1089/153056203772744644; Morris P, 2010, REC CLIN CARE GUIDEL; Morris Peter, 2012, BMJ Clin Evid, V2012; Morris Peter S, 2005, BMC Pediatr, V5, P27, DOI 10.1186/1471-2431-5-27; Smith AC, 2003, J TELEMED TELECARE, V9, pS58; Smith AC, 2006, J TELEMED TELECARE, V12, P76, DOI 10.1258/135763306779380138; Smith AC, 2013, J TELEMED TELECARE, V19, P397, DOI 10.1177/1357633X13506526; Smith AC, 2012, J TELEMED TELECARE, V18, P485, DOI [10.1258/jtt.2012.GTH114, 10.1258/jtt.2012.CTH114]; Thorne J, 2004, CONTEMP NURSE, V16, P145, DOI DOI 10.5172/C0NU.16.1-2.145; World Health Organization, 2004, CHRON SUPP OT MED CS; World Health Organization, 1996, PREV HEAR IMP CHRON; Zubrick S., 2004, W AUSTR ABORIGINAL C	31	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138369	10.1371/journal.pone.0138369	http://dx.doi.org/10.1371/journal.pone.0138369			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406592	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700041
J	Li, JY; Flick, F; Verheugd, P; Carloni, P; Lusher, B; Rossetti, G				Li, Jinyu; Flick, Franziska; Verheugd, Patricia; Carloni, Paolo; Luesher, Bernhard; Rossetti, Giulia			Insight into the Mechanism of Intramolecular Inhibition of the Catalytic Activity of Sirtuin 2 (SIRT2)	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; FORCE-FIELD; ADP-RIBOSE; DYNAMICS; NICOTINAMIDE; DEACETYLASE; NAD(+); DEGENERATION	Sirtuin 2 (SIRT2) is a NAD(+)-dependent deacetylase that has been associated with neurodegeneration and cancer. SIRT2 is composed of a central catalytic domain, the structure of which has been solved, and N- and C-terminal extensions that are thought to control SIRT2 function. However structural information of these N- and C-terminal regions is missing. Here, we provide the first full-length molecular models of SIRT2 in the absence and presence of NAD+. We also predict the structural alterations associated with phosphorylation of SIRT2 at S331, a modification that inhibits catalytic activity. Bioinformatics tools and molecular dynamics simulations, complemented by in vitro deacetylation assays, provide a consistent picture based on which the C-terminal region of SIRT2 is suggested to function as an autoinhibitory region. This has the capacity to partially occlude the NAD(+) binding pocket or stabilize the NAD(+) in a non-productive state. Furthermore, our simulations suggest that the phosphorylation at S331 causes large conformational changes in the C-terminal region that enhance the autoinhibitory activity, consistent with our previous findings that phosphorylation of S331 by cyclin-dependent kinases inhibits SIRT2 catalytic activity. The molecular insight into the role of the C-terminal region in controlling SIRT2 function described in this study may be useful for future design of selective inhibitors targeting SIRT2 for therapeutic applications.	[Li, Jinyu; Carloni, Paolo; Rossetti, Giulia] Forschungszentrum Julich, Computat Biomed, Inst Adv Simulat IAS 5, D-52425 Julich, Germany; [Li, Jinyu; Carloni, Paolo; Rossetti, Giulia] Forschungszentrum Julich, Inst Neurosci & Med INM 9, D-52425 Julich, Germany; [Li, Jinyu; Flick, Franziska; Verheugd, Patricia; Luesher, Bernhard] Rhein Westfal TH Aachen, Inst Biochem & Mol Biol, D-52057 Aachen, Germany; [Carloni, Paolo] Forschungszentrum Julich, German Res Sch Simulat Sci, Computat Biophys, D-52425 Julich, Germany; [Rossetti, Giulia] Forschungszentrum Julich, Julich Supercomp Ctr, D-52425 Julich, Germany; [Rossetti, Giulia] Rhein Westfal TH Aachen, Dept Oncol Hematol & Stem Cell Transplantat, Aachen, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; RWTH Aachen University; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; RWTH Aachen University	Rossetti, G (corresponding author), Forschungszentrum Julich, Computat Biomed, Inst Adv Simulat IAS 5, D-52425 Julich, Germany.	g.rossetti@fz-juelich.de	Rossetti, Giulia/U-2448-2019; Rossetti, Giulia/G-3473-2018; Korn, Patricia/AGZ-7000-2022; Luscher, Bernhard/A-7330-2011	Rossetti, Giulia/0000-0002-2032-4630; Rossetti, Giulia/0000-0002-2032-4630; Korn, Patricia/0000-0002-2434-1550; Carloni, Paolo/0000-0002-9010-0149; Luscher, Bernhard/0000-0002-9622-8709	Interdisciplinary Center for Clinical Research IZKF Aachen [N5-2]; Julich Supercomputing Centre	Interdisciplinary Center for Clinical Research IZKF Aachen; Julich Supercomputing Centre	This work was supported by funds from the Interdisciplinary Center for Clinical Research IZKF Aachen (http://www.rwth-aachen.de/cms/root/Forschung/Forschen-an-der-RWTH/Profilbereiche/Medical-Science-Technology-MedST-/similar to eerv/IZKF/lidx/1/) to BL (fund number: N5-2). The authors gratefully acknowledge the computing time granted by the JARA-HPC Vergabegremium (http://www.jara.org/en/research/jara-hpc/partition/details/details-useallocation/) to PC (jara0016) and provided on the JARA-HPC Partition part of the supercomputer RWTH Compute Cluster (RCC) at RWTH Aachen University. Julich Supercomputing Centre (http://www.fz-juelich.de/ias/jsc/EN/Home/home_node.html) provided support in the form of a salary for GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2004, MOL CELL, V13, P639, DOI 10.1016/S1097-2765(04)00082-6; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOWIE JU, 1994, P NATL ACAD SCI USA, V91, P4436, DOI 10.1073/pnas.91.10.4436; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cobucci-Ponzano B, 2009, CHEM BIOL, V16, P1097, DOI 10.1016/j.chembiol.2009.09.013; Craft JW, 2005, J BIOMOL NMR, V33, P15, DOI 10.1007/s10858-005-1199-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Jong RM, 2003, EMBO J, V22, P4933, DOI 10.1093/emboj/cdg479; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dong XS, 2005, J BACTERIOL, V187, P2483, DOI 10.1128/JB.187.7.2483-2490.2005; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hasegawa T, 2010, NEUROCHEM INT, V57, P857, DOI 10.1016/j.neuint.2010.09.002; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hu L, 2011, J CHEM THEORY COMPUT, V7, P12; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ingvarsson H, 2010, FEBS J, V277, P3947, DOI 10.1111/j.1742-4658.2010.07784.x; Jacobsen DM, 2012, J AM CHEM SOC, V134, P15357, DOI 10.1021/ja304419t; James TW, 2011, P NATL ACAD SCI USA, V108, P2222, DOI 10.1073/pnas.1013388108; Jeyakanthan J, CRYSTAL STRUCTURE UR; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kunishima N., CRYSTAL STRUCTURE SO; Lahr SJ, 2005, J MOL BIOL, V346, P1441, DOI 10.1016/j.jmb.2004.12.016; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; McMahon SA, 2005, NAT STRUCT MOL BIOL, V12, P886, DOI 10.1038/nsmb992; Mermershtain I, 2011, PROTEIN SCI, V20, P160, DOI 10.1002/pro.549; Micheletti C, 2000, PROTEINS, V40, P662, DOI 10.1002/1097-0134(20000901)40:4<662::AID-PROT90>3.0.CO;2-F; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Murayama K, CRYSTAL STRUCTURE RI; Nair UB, CRYSTAL STRUCTURE RY; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oganesyan V, 2007, ACTA CRYSTALLOGR F, V63, P369, DOI 10.1107/S1744309107018945; Ohnishi S, SOLUTION STRUCTURE 3; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pavelites JJ, 1997, J COMPUT CHEM, V18, P221, DOI 10.1002/(SICI)1096-987X(19970130)18:2<221::AID-JCC7>3.0.CO;2-X; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Ragunathan P, 2009, ACTA CRYSTALLOGR D, V65, P1262, DOI 10.1107/S0907444909038359; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rehse PH, 2004, ACTA CRYSTALLOGR D, V60, P1997, DOI 10.1107/S0907444904021146; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Shrestha L, CRYSTAL STRUCTURE HU, V1; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Suzuki K, 2007, NEUROSCIENCE, V147, P599, DOI 10.1016/j.neuroscience.2007.04.059; Trapp J, 2007, CHEMMEDCHEM, V2, P1419, DOI 10.1002/cmdc.200700003; Walker RC, 2002, J PHYS CHEM B, V106, P11658, DOI 10.1021/jp0261814; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Yajima S, 2006, NUCLEIC ACIDS RES, V34, P6074, DOI 10.1093/nar/gkl729; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001; Yuan H, 2012, J BIOL CHEM, V287, P42428, DOI 10.1074/jbc.R112.372300; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao KH, 2003, STRUCTURE, V11, P1403, DOI 10.1016/j.str.2003.09.016; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	84	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139095	10.1371/journal.pone.0139095	http://dx.doi.org/10.1371/journal.pone.0139095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407304	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700166
J	Liao, XH; Hu, ZB; Liu, WK; Lu, Y; Chen, DH; Chen, MX; Qiu, SY; Zeng, ZQ; Tian, XG; Cui, H; Zhou, R				Liao, Xiaohong; Hu, Zhengbo; Liu, Wenkuan; Lu, Yan; Chen, Dehui; Chen, Meixin; Qiu, Shuyan; Zeng, Zhiqi; Tian, Xingui; Cui, Hong; Zhou, Rong			New Epidemiological and Clinical Signatures of 18 Pathogens from Respiratory Tract Infections Based on a 5-Year Study	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS INFECTION; HUMAN BOCAVIRUS; STEM-CELL; TRANSPLANT RECIPIENTS; VIRUS-INFECTIONS; CHILDREN; POPULATION; GUANGZHOU; ETIOLOGY; ANTIBODY	Background Respiratory tract infections (RTIs) are a heavy burden on society. However, due to the complex etiology of RTIs, the clinical diagnosis, treatment, and prevention of these infections remain challenging, especially in developing countries. Methods To determine the epidemiological and clinical characteristics of 18 respiratory pathogens, we analyzed 12,502 patients with acute respiratory infections (ARIs) by performing polymerase chain reaction (PCR) on patient pharyngeal swabs. Results Samples positive for at least 1 pathogen were obtained from 48.42% of the total patients. Of these pathogen-positive patients, 17.99% were infected with more than 1 pathogen. Of the 18 pathogens analyzed, four were detected with a positive detection rate (PDR) > 5%: influenza A virus (IAV) > respiratory syncytial virus (RSV) > Mycoplasma pneumoniae (MP) > human coronavirus (HCoV). The pathogens with the 4 highest co-infection rates (CIRs) were as follows: HCoV > human bocavirus (HBoV) > enterovirus (EV) > parainfluenza virus (PIV). The overall positive detection rate (PDR) varied significantly according to patient age, the season and year of detection, and the disease subgroup, but not according to patient sex. The individual PDRs of the pathogens followed 3 types of distributions for patient sex, 4 types of distributions for patient age, 4 types of seasonal distributions, 2 types of seasonal epidemic trends, 4 types of yearly epidemic trends, and different susceptibility distributions in the disease subgroups. Additionally, the overall CIR showed significantly different distributions according to patient sex, patient age, and the disease subgroup, whereas the CIRs of individual pathogens suggested significant preference characteristics. Conclusion IAV remains the most common pathogen among the pathogens analyzed. More effort should be directed toward the prevention and control of pathogens that show a trend of increasing incidence such as HCoV, human adenovirus (ADV), and RSV. Although clinically distinguishing specific pathogens responsible for RTIs is difficult, the epidemiological and clinical characteristics of the various RTI-causing agents could provide clues for clinicians, thereby informing decisions regarding prevention and medication and guiding appropriate public health strategies.	[Liao, Xiaohong; Liu, Wenkuan; Lu, Yan; Chen, Meixin; Qiu, Shuyan; Zeng, Zhiqi; Tian, Xingui; Cui, Hong; Zhou, Rong] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Liao, Xiaohong; Liu, Wenkuan; Lu, Yan; Chen, Dehui; Chen, Meixin; Qiu, Shuyan; Zeng, Zhiqi; Tian, Xingui; Cui, Hong; Zhou, Rong] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Hu, Zhengbo] Southern Med Univ, Zhujiang Hosp, Dept Orthoped, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Southern Medical University - China	Zhou, R (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	zhourong_gird@163.com	Tian, Xingui/AAC-3957-2021; Tian, Xingui/AAF-5709-2020	Tian, Xingui/0000-0001-9761-6677; Liu, Wen-Kuan/0000-0003-3020-9158	China Central Government [2012ZX10004-213]; National Science and Technology Support Program [2012BAI05B01]	China Central Government; National Science and Technology Support Program	This study was supported by The State Major Infectious Disease Research Program (China Central Government, 2012ZX10004-213), National Science and Technology Support Program (2012BAI05B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Ampuero JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046898; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Boeckh M, 2008, BRIT J HAEMATOL, V143, P455, DOI 10.1111/j.1365-2141.2008.07295.x; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; de Almeida MB, 2010, EMERG INFECT DIS, V16, P996, DOI 10.3201/eid1606.100063; Dominguez SR, 2009, J MED VIROL, V81, P1597, DOI 10.1002/jmv.21541; Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137; Esposito S, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/j.1750-2659.2012.00340.x; Everitt DE, 1996, J INFECT DIS, V174, P463, DOI 10.1093/infdis/174.3.463; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Ison MG, 2003, CLIN INFECT DIS, V36, P1139, DOI 10.1086/374340; Jokinen C, 2001, CLIN INFECT DIS, V32, P1141, DOI 10.1086/319746; Kahn J, 2008, CURR OPIN PEDIATR, V20, P62, DOI 10.1097/MOP.0b013e3282f3f518; Kamboj M, 2008, J INFECTION, V57, P464, DOI 10.1016/j.jinf.2008.10.003; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Kim YJ, 2007, SEMIN RESP CRIT CARE, V28, P222, DOI 10.1055/s-2007-976494; Lee MKP, 2013, J MED VIROL, V85, P1811, DOI 10.1002/jmv.23663; Lee MS, 2001, J INFECT DIS, V183, P1281, DOI 10.1086/319690; Liu WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096674; Liu WK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-28; Liu WK, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-345; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Nascimento MS, 2010, CLINICS, V65, P1133, DOI 10.1590/S1807-59322010001100014; Reimer LG, 1998, CLIN INFECT DIS, V26, P742, DOI 10.1086/514583; Rojas LJ, 2012, EPIDEMIOL INFECT, V140, P818, DOI 10.1017/S0950268811001269; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Ryan MAK, 2002, CLIN INFECT DIS, V34, P577, DOI 10.1086/338471; Schmidt AC, 2011, EXPERT REV RESP MED, V5, P515, DOI [10.1586/ers.11.32, 10.1586/ERS.11.32]; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Signorelli SS, 2010, J CHEMOTHERAPY, V22, P392, DOI 10.1179/joc.2010.22.6.392; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; Tran DN, 2015, EPIDEMIOL INFECT, V144, P1; Williams JV, 2010, J INFECT DIS, V201, P1890, DOI 10.1086/652782; Wu PS, 2008, EUR J PEDIATR, V167, P75, DOI 10.1007/s00431-007-0429-8; Yeung R, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-11; Zou LR, 2012, APMIS, V120, P683, DOI 10.1111/j.1600-0463.2012.02890.x	42	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138684	10.1371/journal.pone.0138684	http://dx.doi.org/10.1371/journal.pone.0138684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406339	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700069
J	Ojha, D; Das, R; Sobia, P; Dwivedi, V; Ghosh, S; Samanta, A; Chattopadhyay, D				Ojha, Durbadal; Das, Rashmi; Sobia, Parveen; Dwivedi, Vedprakash; Ghosh, Soma; Samanta, Amalesh; Chattopadhyay, Debprasad			Pedilanthus tithymaloides Inhibits HSV Infection by Modulating NF-kappa B Signaling	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; PROTEIN-KINASE; NUCLEAR TRANSLOCATION; ANTIVIRAL ACTIVITY; GENE-EXPRESSION; ACTIVATION; PATHWAYS; APOPTOSIS; ETHNOMEDICINE; FLAVONOIDS	Pedilanthus tithymaloides (PT), a widely used ethnomedicinal plant, has been employed to treat a number of skin conditions. To extend its utility and to fully exploit its medicinal potential, we have evaluated the in vitro antiviral activity of a methanolic extract of PT leaves and its isolated compounds against Herpes Simplex Virus type 2 (HSV-2). Bioactivity-guided studies revealed that the extract and one of its constituents, luteolin, had potent antiviral activity against wild-type and clinical isolates of HSV-2 (EC50 48.5-52.6 and 22.4-27.5 mu g/ml, respectively), with nearly complete inhibition at 86.5-101.8 and 40.2-49.6 mu g/ml, respectively. The inhibitory effect was significant (p<0.001) when the drug was added 2 h prior to infection, and was effective up to 4 h post-infection. As viral replication requires NF-kappa B activation, we examined whether the observed extract-induced inhibition of HSV-2 was related to NF-kappa B inhibition. Interestingly, we observed that treatment of HSV-2-infected cells with extract or luteolin suppressed NF-kappa B activation. Although NF-kappa B, JNK and MAPK activation was compromised during HSV replication, neither the extract nor luteolin affected HSV-2-induced JNK1/2 and MAPK activation. Moreover, the PT leaf extract and luteolin potently down-regulated the expression of tumor necrosis factor (TNF)-alpha, Interleukin (IL)-1 beta, IL-6, NO and iNOS and the production of gamma interferon (IFN-gamma), which are directly involved in controlling the NF-kappa B signaling pathway. Thus, our results indicate that both PT leaf extract and luteolin modulate the NF-kappa B signaling pathway, resulting in the inhibition of HSV-2 replication.	[Ojha, Durbadal; Das, Rashmi; Ghosh, Soma; Chattopadhyay, Debprasad] ID & BG Hosp, ICMR Virus Unit, Kolkata 700010, India; [Sobia, Parveen; Dwivedi, Vedprakash] Univ KwaZulu Natal, Dept Microbiol, Coll Cell Sci, ZA-4001 Durban, South Africa; [Ghosh, Soma; Samanta, Amalesh] Jadavpur Univ, Dept Pharmaceut Technol, Kolkata 700032, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; University of Kwazulu Natal; Jadavpur University	Chattopadhyay, D (corresponding author), ID & BG Hosp, ICMR Virus Unit, Gen Block 4,57 Dr Suresh Chandra Banerjee Rd, Kolkata 700010, India.	debprasadc@gmail.com		Dwivedi, Ved Prakash/0000-0003-4321-2567; CHATTOPADHYAY, Dr DEBPRASAD/0000-0002-7999-329X	Science and Engineering Research Board, Department of Science and Technology, Govt. of India, New Delhi [SB/SO/HS-025/2013]	Science and Engineering Research Board, Department of Science and Technology, Govt. of India, New Delhi	The authors acknowledge financial support from the Science and Engineering Research Board, Department of Science and Technology, Govt. of India, New Delhi (SB/SO/HS-025/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici C, 2006, J BIOL CHEM, V281, P7110, DOI 10.1074/jbc.M512366200; Amici C, 2001, J BIOL CHEM, V276, P28759, DOI 10.1074/jbc.M103408200; Baba M, 2006, ANTIVIR RES, V71, P301, DOI 10.1016/j.antiviral.2006.01.002; Bag P, 2014, ANTIVIR RES, V105, P126, DOI 10.1016/j.antiviral.2014.02.007; Bag P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077937; Bag P, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-98; Behbahani M, 2013, ANTIVIR RES, V97, P376, DOI 10.1016/j.antiviral.2013.01.001; Bhattacharjee S, 2009, J ANTIMICROB CHEMOTH, V63, P317, DOI 10.1093/jac/dkn479; Bunyapraphatsara N, 2000, MED PLANTS INDIGENOU, P691; Chattopadhyay D, 2008, BIOTECHNOL ANN REV, V14, P297, DOI 10.1016/S1387-2656(08)00012-4; Chen XQ, 2011, ANTIVIR RES, V92, P341, DOI 10.1016/j.antiviral.2011.09.005; Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Dai X, 2008, INT IMMUNOL, V20, P901, DOI 10.1093/intimm/dxn048; Dai XJ, 2006, J INVEST DERMATOL, V126, P1574, DOI 10.1038/sj.jid.5700294; Du T, 2013, P NATL ACAD SCI USA, V110, pE2621, DOI 10.1073/pnas.1309906110; Faith SA, 2006, ANTIVIR RES, V72, P242, DOI 10.1016/j.antiviral.2006.06.011; Ghosh S, 2013, MED CHEM RES, V22, P4347, DOI 10.1007/s00044-012-0449-4; Ghosh S, 2012, J ETHNOPHARMACOL, V142, P714, DOI 10.1016/j.jep.2012.05.048; Gregory D, 2004, J VIROL, V78, P13582, DOI 10.1128/JVI.78.24.13582-13590.2004; Hargett D, 2005, J VIROL, V79, P8348, DOI 10.1128/JVI.79.13.8348-8360.2005; Hirobe C, 1997, PHYTOCHEMISTRY, V46, P521, DOI 10.1016/S0031-9422(97)00127-1; Huang WJ, 2012, J IMMUNOL, V188, P6247, DOI 10.4049/jimmunol.1103706; Karaca G, 2004, VIROLOGY, V329, P142, DOI 10.1016/j.virol.2004.08.020; Khan MTH, 2005, ANTIVIR RES, V67, P107, DOI 10.1016/j.antiviral.2005.05.002; Krylova N. V., 2011, Antibiotiki i Khimioterapiya, V56, P7; Kumar G.P., 2010, ETHNOBOT LEAFL, V2010, P4; Kutluay SB, 2008, VIROLOGY, V373, P239, DOI 10.1016/j.virol.2007.11.028; Lee JK, 2009, BIOCHEM PHARMACOL, V77, P1391, DOI 10.1016/j.bcp.2009.01.009; Liu AL, 2008, PLANTA MED, V74, P847, DOI 10.1055/s-2008-1074558; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; McLean TI, 1999, J VIROL, V73, P8415, DOI 10.1128/JVI.73.10.8415-8426.1999; Mehla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027915; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Mukherjee H, 2013, MICROBIOL RES, V168, P238, DOI 10.1016/j.micres.2012.11.002; Patel A, 1998, VIROLOGY, V247, P212, DOI 10.1006/viro.1998.9243; Perkins D, 2002, J VIROL, V76, P1435, DOI 10.1128/JVI.76.3.1435-1449.2002; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Smith CC, 2000, J VIROL, V74, P10417, DOI 10.1128/JVI.74.22.10417-10429.2000; Song SW, 2014, ANTIMICROB AGENTS CH, V58, P5068, DOI 10.1128/AAC.02427-14; Swiecki M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003728; VRIJSEN R, 1988, J GEN VIROL, V69, P1749, DOI 10.1099/0022-1317-69-7-1749; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Xu L, 2014, VIRUSES-BASEL, V6, P2778, DOI 10.3390/v6072778; Yedowitz JC, 2005, VIROLOGY, V342, P297, DOI 10.1016/j.virol.2005.07.036; Zachos G, 1999, J BIOL CHEM, V274, P5097, DOI 10.1074/jbc.274.8.5097	47	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139338	10.1371/journal.pone.0139338	http://dx.doi.org/10.1371/journal.pone.0139338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405764	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700207
J	Davila, MP; Munoz, PM; Tapia, JA; Ferrusola, CO; da Silva, CB; Pena, FJ				Plaza Davila, Maria; Martin Munoz, Patricia; Tapia, Jose A.; Ortega Ferrusola, Cristina; da Silva C, Carolina Balao; Pena, Fernando J.			Inhibition of Mitochondrial Complex I Leads to Decreased Motility and Membrane Integrity Related to Increased Hydrogen Peroxide and Reduced ATP Production, while the Inhibition of Glycolysis Has Less Impact on Sperm Motility	PLOS ONE			English	Article							STALLION SPERMATOZOA; OXIDATIVE STRESS; CRYOPRESERVATION; APOPTOSIS; PHOSPHORYLATION; IDENTIFICATION; PRESERVATION; GENERATION; FORECAST; FROZEN	Mitochondria have been proposed as the major source of reactive oxygen species in somatic cells and human spermatozoa. However, no data regarding the role of mitochondrial ROS production in stallion spermatozoa are available. To shed light on the role of the mitochondrial electron transport chain in the origin of oxidative stress in stallion spermatozoa, specific inhibitors of complex I (rotenone) and III (antimycin-A) were used. Ejaculates from seven Andalusian stallions were collected and incubated in BWW media at 37 degrees C in the presence of rotenone, antimycin-A or control vehicle. Incubation in the presence of these inhibitors reduced sperm motility and velocity (CASA analysis) (p<0.01), but the effect was more evident in the presence of rotenone (a complex I inhibitor). These inhibitors also decreased ATP content. The inhibition of complexes I and III decreased the production of reactive oxygen species (p<0.01) as assessed by flow cytometry after staining with CellRox deep red. This observation suggests that the CellRox probe mainly identifies superoxide and that superoxide production may reflect intense mitochondrial activity rather than oxidative stress. The inhibition of complex I resulted in increased hydrogen peroxide production (p<0.01). The inhibition of glycolysis resulted in reduced sperm velocities (p<0.01) without an effect on the percentage of total motile sperm. Weak and moderate (but statistically significant) positive correlations were observed between sperm motility, velocity and membrane integrity and the production of reactive oxygen species. These results indicate that stallion sperm rely heavily on oxidative phosphorylation (OXPHOS) for the production of ATP for motility but also require glycolysis to maintain high velocities. These data also indicate that increased hydrogen peroxide originating in the mitochondria is a mechanism involved in stallion sperm senescence.	[Plaza Davila, Maria; Martin Munoz, Patricia; Ortega Ferrusola, Cristina; da Silva C, Carolina Balao; Pena, Fernando J.] Univ Extremadura, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain; [Tapia, Jose A.] Univ Extremadura, Dept Physiol, Fac Vet Med, Caceres, Spain	Universidad de Extremadura; Universidad de Extremadura	Davila, MP (corresponding author), Univ Extremadura, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain.	fjuanpvega@unex.es	Tapia, Jose A./C-5181-2008; Ortega-Ferrusola, Cristina/AGI-8478-2022; Peña, Fernando J/D-8450-2012	Tapia, Jose A./0000-0002-3614-6867; Ortega-Ferrusola, Cristina/0000-0002-7698-8735; Peña, Fernando J/0000-0002-1311-2947; Balao da Silva, Carolina Maria/0000-0002-9230-3919; PLAZA DAVILA, MARIA/0000-0002-8522-5879	Ministerio de Economia y Competitividad-FEDER in Madrid, Spain [AGL2013-43211-R]; Junta de Extremadura-FEDER [GR 10010, PCE1002]	Ministerio de Economia y Competitividad-FEDER in Madrid, Spain; Junta de Extremadura-FEDER(European Commission)	The authors received financial support for this study from Ministerio de Economia y Competitividad-FEDER in Madrid, Spain, grants AGL2013-43211-R and Junta de Extremadura-FEDER (GR 10010 and PCE1002).	Aitken RJ, 2014, ASIAN J ANDROL, V16, P31, DOI 10.4103/1008-682X.122203; Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; da Silva CMB, 2013, ANIM REPROD SCI, V141, P68, DOI 10.1016/j.anireprosci.2013.07.008; Ball BA, 2001, AM J VET RES, V62, P508, DOI 10.2460/ajvr.2001.62.508; Ball BA, 2001, THERIOGENOLOGY, V56, P577, DOI 10.1016/S0093-691X(01)00590-8; Ball BA, 2000, AM J VET RES, V61, P1026, DOI 10.2460/ajvr.2000.61.1026; Ball BA, 2008, ANIM REPROD SCI, V107, P257, DOI 10.1016/j.anireprosci.2008.04.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caselles AB, 2014, REPROD DOMEST ANIM, V49, P254, DOI 10.1111/rda.12264; Bolanos JMG, 2014, REPROD DOMEST ANIM, V49, P657, DOI 10.1111/rda.12343; Bolanos JMG, 2014, REPRODUCTION, V148, P221, DOI 10.1530/REP-13-0191; Bolanos JMG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030688; Gibb Z, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118539; Gonzalez-Fernandez L, 2009, BIOL REPROD, V80, P1239, DOI 10.1095/biolreprod.108.073486; Gravance CG, 2000, THERIOGENOLOGY, V53, P1691, DOI 10.1016/S0093-691X(00)00308-3; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Koppers AJ, 2011, BIOCHEM J, V436, P687, DOI 10.1042/BJ20110114; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Garcia BM, 2011, REPROD DOMEST ANIM, V46, P141, DOI 10.1111/j.1439-0531.2010.01609.x; Garcia BM, 2011, J ANDROL, V33, P105, DOI 10.2164/jandrol.110.011957; Macias-Garcia B, 2012, ANIM REPROD SCI, V132, P74, DOI 10.1016/j.anireprosci.2012.03.017; Morillo-Rodriguez A, 2012, ANDROLOGIA, V44, P688, DOI 10.1111/j.1439-0272.2011.01251.x; Neagu VR, 2010, THERIOGENOLOGY, V73, P645, DOI 10.1016/j.theriogenology.2009.10.021; Nunez-Martinez I, 2007, INT J ANDROL, V30, P182, DOI 10.1111/j.1365-2605.2007.00743.x; O'Flaherty C, 2006, FREE RADICAL BIO MED, V41, P528, DOI 10.1016/j.freeradbiomed.2006.04.027; Ferrusola CO, 2010, THERIOGENOLOGY, V74, P458, DOI 10.1016/j.theriogenology.2010.02.029; Ferrusola CO, 2009, BIOL REPROD, V81, P1106, DOI 10.1095/biolreprod.109.078220; Ferrusola CO, 2009, REPRODUCTION, V138, P55, DOI [10.1530/REP-08-0484, 10.1530/RFP-08-0484]; Ortega-Ferrusola C, 2008, J ANDROL, V29, P213, DOI 10.2164/jandrol.107.003640; Ortega-Ferrusola C, 2009, ANIM REPROD SCI, V114, P393, DOI 10.1016/j.anireprosci.2008.10.005; Pena FJ, 2015, REPROD DOMEST ANIM, V50, P529, DOI 10.1111/rda.12551; Pena FJ, 2011, THERIOGENOLOGY, V76, P1177, DOI 10.1016/j.theriogenology.2011.06.023; Pena FJ, 2009, REPROD DOMEST ANIM, V44, P345, DOI 10.1111/j.1439-0531.2008.01211.x; Pena FJ, 2005, INT J ANDROL, V28, P107, DOI 10.1111/j.1365-2605.2005.00512.x; Pena FJ, 2003, ANIM REPROD SCI, V78, P85, DOI 10.1016/S0378-4320(03)00049-6; Roca J, 2005, J ANDROL, V26, P15; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Xi Q, 2005, CIRC RES, V97, P354, DOI 10.1161/01.RES.0000177669.29525.78; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	42	82	83	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138777	10.1371/journal.pone.0138777	http://dx.doi.org/10.1371/journal.pone.0138777			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407142	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700095
J	Ruggeri, C; Drinkwater, N; Sivaraman, KK; Bamert, RS; McGowan, S; Paiardini, A				Ruggeri, Chiara; Drinkwater, Nyssa; Sivaraman, Komagal Kannan; Bamert, Rebecca S.; McGowan, Sheena; Paiardini, Alessandro			Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MOLECULAR DOCKING; LIGANDS; DESIGN; INTERFACE; DATABASE; MODEL; ZINC	The Plasmodium falciparum PfA-M1 and PfA-M17 metalloaminopeptidases are validated drug targets for the discovery of antimalarial agents. In order to identify dual inhibitors of both proteins, we developed a hierarchical virtual screening approach, followed by in vitro evaluation of the highest scoring hits. Starting from the ZINC database of purchasable compounds, sequential 3D-pharmacophore and molecular docking steps were applied to filter the virtual 'hits'. At the end of virtual screening, 12 compounds were chosen and tested against the in vitro aminopeptidase activity of both PfA-M1 and PfA-M17. Two molecules showed significant inhibitory activity (low micromolar/nanomolar range) against both proteins. Finally, the crystal structure of the most potent compound in complex with both PfA-M1 and PfA-M17 was solved, revealing the binding mode and validating our computational approach.	[Ruggeri, Chiara] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Drinkwater, Nyssa; Sivaraman, Komagal Kannan; Bamert, Rebecca S.; McGowan, Sheena] Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia; [Drinkwater, Nyssa; Sivaraman, Komagal Kannan; Bamert, Rebecca S.; McGowan, Sheena] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Paiardini, Alessandro] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy	Sapienza University Rome; Monash University; Monash University; Sapienza University Rome	McGowan, S (corresponding author), Monash Univ, Dept Microbiol, Clayton Campus, Melbourne, Vic 3800, Australia.	sheena.mcgowan@monash.edu; alessandro.paiardini@uniroma1.it	McGowan, Sheena/C-4797-2014	McGowan, Sheena/0000-0001-6863-1106; Drinkwater, Nyssa/0000-0001-9165-7806; Paiardini, Alessandro/0000-0001-9078-7545	Australian Research Council [FT100100690]; Australia Endeavour Research Fellowship [4100-2014]; Sapienza University of Rome [C26A149EC4]; National Health and Medical Research [1063786]	Australian Research Council(Australian Research Council); Australia Endeavour Research Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science); Sapienza University of Rome; National Health and Medical Research	Funding: SM acknowledges Future Fellowship support from the Australian Research Council (Grant FT100100690). CR was an Australia Endeavour Research Fellowship recipient (Grant 4100-2014). AP acknowledges Sapienza University of Rome (Grant C26A149EC4) for funding. This work was supported by the National Health and Medical Research (Grant 1063786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Borbulevych OY, 2014, ACTA CRYSTALLOGR D, V70, P1233, DOI 10.1107/S1399004714002260; Chen YC, 2015, TRENDS PHARMACOL SCI, V36, P78, DOI 10.1016/j.tips.2014.12.001; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; Drinkwater N, 2015, PROTEINS, V83, P789, DOI 10.1002/prot.24771; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Flannery EL, 2013, NAT REV MICROBIOL, V11, P849, DOI 10.1038/nrmicro3138; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; John S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S28; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; Krishnamoorthy M, 2013, BIOINFORMATION, V9, P293, DOI 10.6026/97320630009293; Kroon-Batenburg LMJ, 2014, ACTA CRYSTALLOGR D, V70, P2502, DOI 10.1107/S1399004713029817; Lahana R, 1999, DRUG DISCOV TODAY, V4, P447, DOI 10.1016/S1359-6446(99)01393-8; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mistry SN, 2014, J MED CHEM, V57, P9168, DOI 10.1021/jm501323a; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Paiardini A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115859; Poreba M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031938; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schneider N, 2013, J COMPUT AID MOL DES, V27, P15, DOI 10.1007/s10822-012-9626-2; Seebeck B, 2008, PROTEINS, V71, P1237, DOI 10.1002/prot.21818; Sivaraman KK, 2013, J MED CHEM, V56, P5213, DOI 10.1021/jm4005972; Skinner-Adams TS, 2010, TRENDS BIOCHEM SCI, V35, P53, DOI 10.1016/j.tibs.2009.08.004; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; Steffen A, 2006, J CHEM INF MODEL, V46, P1695, DOI 10.1021/ci060072v; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e	34	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138957	10.1371/journal.pone.0138957	http://dx.doi.org/10.1371/journal.pone.0138957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406322	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700129
J	Shu, JS; Liu, YM; Li, ZS; Zhang, LL; Fang, ZY; Yang, LM; Zhuang, M; Zhang, YY; Lv, HH				Shu, Jinshuai; Liu, Yumei; Li, Zhansheng; Zhang, Lili; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong; Lv, Honghao			Organelle Simple Sequence Repeat Markers Help to Distinguish Carpelloid Stamen and Normal Cytoplasmic Male Sterile Sources in Broccoli	PLOS ONE			English	Article							BRASSICA-NAPUS L.; MADS-BOX GENES; MITOCHONDRIAL GENOME; MATERNAL INHERITANCE; CHLOROPLAST GENOME; OLERACEA L.; DNA; NUCLEAR; RAPESEED; CMS	We previously discovered carpelloid stamens when breeding cytoplasmic male sterile lines in broccoli (Brassica oleracea var. italica). In this study, hybrids and multiple backcrosses were produced from different cytoplasmic male sterile carpelloid stamen sources and maintainer lines. Carpelloid stamens caused dysplasia of the flower structure and led to hooked or coiled siliques with poor seed setting, which were inherited in a maternal fashion. Using four distinct carpelloid stamens and twelve distinct normal stamens from cytoplasmic male sterile sources and one maintainer, we used 21 mitochondrial simple sequence repeat (mtSSR) primers and 32 chloroplast SSR primers to identify a mitochondrial marker, mtSSR2, that can differentiate between the cytoplasm of carpelloid and normal stamens. Thereafter, mtSSR2 was used to identify another 34 broccoli accessions, with an accuracy rate of 100%. Analysis of the polymorphic sequences revealed that the mtSSR2 open reading frame of carpelloid stamen sterile sources had a deletion of 51 bases (encoding 18 amino acids) compared with normal stamen materials. The open reading frame is located in the coding region of orf125 and orf108 of the mitochondrial genomes in Brassica crops and had the highest similarity with Raphanus sativus and Brassica carinata. The current study has not only identified a useful molecular marker to detect the cytoplasm of carpelloid stamens during broccoli breeding, but it also provides evidence that the mitochondrial genome is maternally inherited and provides a basis for studying the effect of the cytoplasm on flower organ development in plants.	[Shu, Jinshuai; Liu, Yumei; Li, Zhansheng; Zhang, Lili; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong; Lv, Honghao] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Liu, YM (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr, 12 Zhongguancun Nandajie St, Beijing 100081, Peoples R China.	liuyumei@caas.cn	Li, Zhansheng/M-9593-2019; Li, Zhansheng/L-8017-2019; Lv, Honghao/AFS-6332-2022	Li, Zhansheng/0000-0003-0132-2741; Shu, Jinshuai/0000-0001-8270-1879; Lv, Honghao/0000-0003-2635-3042; fang, zhi yuan/0000-0003-1664-759X	China Agriculture Research System [CARS-25-A]; National Natural Science Foundation of China [31372067]; National High Technology Research and Development Program (863 Program) of China [2012AA100105]; Key Projects in the National Science and Technology Pillar Program of China [2013BAD01B04]; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, P. R. China; Chinese Academy of Agricultural Sciences [CAAS-ASTIP-IVFCAAS]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Key Projects in the National Science and Technology Pillar Program of China; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, P. R. China; Chinese Academy of Agricultural Sciences	This work was supported by China Agriculture Research System (Grant No. CARS-25-A), National Natural Science Foundation of China (Grant No. 31372067), the National High Technology Research and Development Program (863 Program) of China (Grant No. 2012AA100105), the Key Projects in the National Science and Technology Pillar Program of China (Grant No. 2013BAD01B04), the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, P. R. China, and the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (Grant No. CAAS-ASTIP-IVFCAAS). YML received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender CJ, 2007, THEOR APPL GENET, V114, P609, DOI 10.1007/s00122-006-0461-5; Allender CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-54; Ashutosh, 2005, PLANT SCI, V168, P1083, DOI 10.1016/j.plantsci.2004.12.005; Avise John C., 1994, pi; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Canene-Adams K, 2007, CANCER RES, V67, P836, DOI 10.1158/0008-5472.CAN-06-3462; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017662; Chen Z. J., 1993, Acta Agriculturae Zhejiangensis, V5, P172; Cheng YJ, 2003, ACTA BOT SIN, V45, P906; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Department for Environment Food and Rural Affairs (DEFRA), 2010, BAS HORT STAT UK; Dinkova-Kostova AT, 2007, CANCER EPIDEM BIOMAR, V16, P847, DOI 10.1158/1055-9965.EPI-06-0934; Fang Z. Y., 2001, WATER RESOURCES PROT, V1, P1; Fang ZhiYuan, 2004, Scientia Agricultura Sinica, V37, P717; Finley JW, 2003, NUTR REV, V61, P250, DOI [10.1301/nr.2003.jul.250-254, 10.1031/nr.2003.jul.250-254]; Flannery ML, 2006, THEOR APPL GENET, V113, P1221, DOI 10.1007/s00122-006-0377-0; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Handa H, 2007, GENOME, V50, P234, DOI 10.1139/G06-150; Hansen AK, 2007, AM J BOT, V94, P42, DOI 10.3732/ajb.94.1.42; Hu JB, 2009, ACTA PHYSIOL PLANT, V31, P1085, DOI 10.1007/s11738-009-0325-0; Hu ZY, 2011, GENET RESOUR CROP EV, V58, P875, DOI 10.1007/s10722-010-9626-9; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Jeffery EH, 2009, PHYTOCHEM REV, V8, P283, DOI 10.1007/s11101-008-9106-4; Kaundun SS, 2002, GENOME, V45, P1041, DOI 10.1139/G02-070; Keck AS, 2003, J AGR FOOD CHEM, V51, P3320, DOI 10.1021/jf026189a; Kensler TW, 2005, CANCER EPIDEM BIOMAR, V14, P2605, DOI 10.1158/1055-9965.EPI-05-0368; Lamb RS, 2003, P NATL ACAD SCI USA, V100, P6558, DOI 10.1073/pnas.0631708100; Lampe JW, 2002, J NUTR, V132, P2991, DOI 10.1093/jn/131.10.2991; Lanner C, 1998, CAN J BOT, V76, P228, DOI 10.1139/cjb-76-2-228; Lehnebach CA, 2007, PLANT SYST EVOL, V264, P109, DOI 10.1007/s00606-006-0488-8; Leino M, 2003, THEOR APPL GENET, V106, P1156, DOI 10.1007/s00122-002-1167-y; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Linke B, 2003, PLANT J, V34, P27, DOI 10.1046/j.1365-313X.2003.01703.x; [陆光远 Liu Guangyuan], 2005, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V27, P28; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Malik M, 1999, PLANT BREEDING, V118, P75, DOI 10.1046/j.1439-0523.1999.118001075.x; Murashima M, 2004, BIOFACTORS, V22, P271, DOI 10.1002/biof.5520220154; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nishiyama T, 2004, MOL BIOL EVOL, V21, P1813, DOI 10.1093/molbev/msh203; PALMER JD, 1983, NATURE, V301, P725, DOI 10.1038/301725a0; PALMER JD, 1983, THEOR APPL GENET, V65, P181, DOI 10.1007/BF00308062; Panda S, 2003, THEOR APPL GENET, V106, P1122, DOI 10.1007/s00122-002-1134-7; Pinheiro F, 2009, CONSERV GENET RESOUR, V1, P505, DOI 10.1007/s12686-009-9121-9; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Skuza L, 2013, USE ORGANELLE MARKET, DOI [10.5772/52028, DOI 10.5772/52028]; Soltis ED, 2000, PLANT MOL BIOL, V42, P45, DOI 10.1023/A:1006371803911; Soranzo N, 1999, GENOME, V42, P158, DOI 10.1139/gen-42-1-158; Sun Bo, 2010, Acta Horticulturae Sinica, V37, P59; Testolin R, 1997, THEOR APPL GENET, V94, P897, DOI 10.1007/s001220050493; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Walley PG, 2012, THEOR APPL GENET, V124, P467, DOI 10.1007/s00122-011-1721-6; [王道杰 Wang Daojie], 2014, [植物生理学报, Plant Physiology Journal], V50, P290; Wang QB, 2012, MOL BREEDING, V30, P709, DOI 10.1007/s11032-011-9656-9; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Worth JRP, 2014, J PLANT RES, V127, P617, DOI 10.1007/s10265-014-0646-y; Zhang RJ, 2013, GENET RESOUR CROP EV, V60, P967, DOI 10.1007/s10722-012-9892-9; Zhang Y., 2011, THESIS BEIJING CHINE; Zhang Yan, 2010, Acta Horticulturae Sinica, V37, P915; Zhang YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020930; [张彦锋 Zhang Yanfeng], 2005, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V14, P164; Zhang YY, 2012, J HERED, V103, P606, DOI 10.1093/jhered/ess006; Zhang YangYong, 2011, Scientia Agricultura Sinica, V44, P2959; Zhao HX, 2010, THEOR APPL GENET, V121, P643, DOI 10.1007/s00122-010-1336-3; Zhu YuYing, 1998, Acta Agriculturae Shanghai, V14, P19	72	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138750	10.1371/journal.pone.0138750	http://dx.doi.org/10.1371/journal.pone.0138750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407159	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700085
J	Wu, JQ; Kohno, N; Mano, S; Fukumoto, Y; Tanabe, H; Hasegawa, M; Yonezawa, T				Wu, Jiaqi; Kohno, Naoki; Mano, Shuhei; Fukumoto, Yukio; Tanabe, Hideyuki; Hasegawa, Masami; Yonezawa, Takahiro			Phylogeographic and Demographic Analysis of the Asian Black Bear (Ursus thibetanus) Based on Mitochondrial DNA	PLOS ONE			English	Article							COMPREHENSIVE ANALYSIS; GENETIC-STRUCTURE; PHYLOGENY; ORIGIN; DIVERGENCE; SEQUENCES; GENOMES; FAMILY; SUBSTITUTION; POLYMORPHISM	The Asian black bear Ursus thibetanus is widely distributed in Asia and is adapted to broad-leaved deciduous forests, playing an important ecological role in the natural environment. Several subspecies of U. thibetanus have been recognized, one of which, the Japanese black bear, is distributed in the Japanese archipelago. Recent molecular phylogeographic studies clarified that this subspecies is genetically distantly related to continental subspecies, suggesting an earlier origin. However, the evolutionary relationship between the Japanese and continental subspecies remained unclear. To understand the evolution of the Asian black bear in relation to geological events such as climatic and transgression-regression cycles, a reliable time estimation is also essential. To address these issues, we determined and analyzed the mt-genome of the Japanese subspecies. This indicates that the Japanese subspecies initially diverged from other Asian black bears in around 1.46Ma. The Northern continental population (northeast China, Russia, Korean peninsula) subsequently evolved, relatively recently, from the Southern continental population (southern China and Southeast Asia). While the Japanese black bear has an early origin, the tMRCAs and the dynamics of population sizes suggest that it dispersed relatively recently in the main Japanese islands: during the late Middle and Late Pleistocene, probably during or soon after the extinction of the brown bear in Honshu in the same period. Our estimation that the population size of the Japanese subspecies increased rapidly during the Late Pleistocene is the first evidential signal of a niche exchange between brown bears and black bears in the Japanese main islands. This interpretation seems plausible but was not corroborated by paleontological evidence that fossil record of the Japanese subspecies limited after the Late Pleistocene. We also report here a new fossil record of the oldest Japanese black bear from the Middle Pleistocene, and it supports our new evolutionary hypothesis of the Japanese black bear.	[Wu, Jiaqi; Hasegawa, Masami; Yonezawa, Takahiro] Fudan Univ, Sch Life Sci, Shanghai 200438, Peoples R China; [Kohno, Naoki] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan; [Kohno, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Mano, Shuhei; Hasegawa, Masami; Yonezawa, Takahiro] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan; [Fukumoto, Yukio] Hiroshima City Asa Zool Pk, Asakita Ku, Hiroshima 7313355, Japan; [Tanabe, Hideyuki; Yonezawa, Takahiro] Grad Univ Adv Studies, Sch Adv Sci, Hayama, Kanagawa 2400193, Japan	Fudan University; National Museum of Nature and Science; University of Tsukuba; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Graduate University for Advanced Studies - Japan	Kohno, N (corresponding author), Natl Museum Nat & Sci, Dept Geol & Paleontol, Amakubo 4-1-1, Tsukuba, Ibaraki 3050005, Japan.	kohno@kahaku.go.jp; cyclotis@gmail.com		Yonezawa, Takahiro/0000-0002-0012-1887	National Natural Foundation for the Foreign Young Scientist; Fudan University [EZH6281304/001/029]; JSPS [C25440219]; Grants-in-Aid for Scientific Research [25440219] Funding Source: KAKEN	National Natural Foundation for the Foreign Young Scientist; Fudan University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by National Natural Foundation for the Foreign Young Scientist to T.Y., Graduate innovation fund EZH6281304/001/029 of Fudan University to J.W., and a Grant in Aid for Scientific Research (C25440219) from JSPS to M.H.	Abella J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048985; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Baryshnikov G. F., 2013, Trudy Zoologicheskogo Instituta, V317, P3; Baryshnikov G.F., 2010, Trudy Zoologicheskogo Instituta, V314, P67; Choi EH, 2010, MITOCHONDR DNA, V21, P105, DOI 10.3109/19401736.2010.491864; Davis CS, 2004, MOL PHYLOGENET EVOL, V33, P363, DOI 10.1016/j.ympev.2004.06.006; Dobson Mike, 1998, Quaternary Research (Tokyo), V37, P385; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Ginsburg Leonard, 1998, Annales de Paleontologie, V84, P71, DOI 10.1016/S0753-3969(98)80003-7; Griffiths RC, 1999, ANN APPL PROBAB, V9, P567; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Hasegawa Y, 1979, HONYURUI KAGAKU, V38, P23; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Hou WR, 2007, INT J BIOL SCI, V3, P85; Hwang DS, 2008, MITOCHONDR DNA, V19, P418, DOI 10.1080/19401730802389525; IUCN, 2012, IUCN RED LIST THREAT; Kawamura Y., 2000, ACTA ANTHR SINICA S, V19, P264; Kawamura Y., 1982, HONYURUI KAGAKU, V43/44, P99; Kim YK, 2011, J HERED, V102, P165, DOI 10.1093/jhered/esq121; Kohno Naoki, 2005, Fossils (Tokyo), V77, P34; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Kurten B, 1980, PLEISTOCENE MAMMALS, P182; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; McLellan B, 1994, BEARS THEIR BIOL MAN, P85; Nakagome S, 2008, MOL BIOL EVOL, V25, P1344, DOI 10.1093/molbev/msn086; Nakagome S, 2013, SCIENCE, V339, DOI 10.1126/science.1227339; Nikaido M, 2001, J MOL EVOL, V53, P508, DOI 10.1007/s002390010241; OHDACHI S. D., 2009, WILD MAMMALS JAPAN; Ohnishi N, 2009, HEREDITY, V102, P579, DOI 10.1038/hdy.2009.28; QIU Z, 2003, B AM MUS NAT HIST, V279, P18; Qiu Zhan-Xiang, 2014, Vertebrata Palasiatica, V52, P265; Qiu Zhanxiang, 1989, Vertebrata Palasiatica, V27, P153; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinmetz R, 2008, J WILDLIFE MANAGE, V72, P814, DOI 10.2193/2007-098; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi K, 2007, KYUSEKKI KENKYU, V3, P5; Takakuwa Yuji, 2007, Bulletin of Gunma Museum of Natural History, V11, P63; Taruno H, 2010, DAIYONKI KENKYU, V49, P315; Waits LP, 1999, MOL PHYLOGENET EVOL, V13, P82, DOI 10.1006/mpev.1999.0637; Walker EP., 1975, MAMMALS WORLD; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Woodburne MO, 2004, GLOBAL EVENTS N AM M, P331; Wu JQ, 2014, GENES GENET SYST, V89, P237, DOI 10.1266/ggs.89.237; Yamazaki H., 2001, ATLAS QUATERNARY MAR, P26; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yasukochi Y, 2009, J HERED, V100, P297, DOI 10.1093/jhered/esn097; Yoneda Masaaki, 2011, Honyurui Kagaku, V51, P79; Yonezawa T, 2007, GENE, V396, P1, DOI 10.1016/j.gene.2006.12.040; Yonezawa T, 2009, GENE, V441, P89, DOI 10.1016/j.gene.2009.01.022; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZHANG YP, 1993, P NATL ACAD SCI USA, V90, P9557, DOI 10.1073/pnas.90.20.9557	68	14	15	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0136398	10.1371/journal.pone.0136398	http://dx.doi.org/10.1371/journal.pone.0136398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406587	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700011
J	Munoz, A; Bertuzzi, M; Bettgenhaeuser, J; Iakobachvili, N; Bignell, EM; Read, ND				Munoz, Alberto; Bertuzzi, Margherita; Bettgenhaeuser, Jan; Iakobachvili, Nino; Bignell, Elaine M.; Read, Nick D.			Different Stress-Induced Calcium Signatures Are Reported by Aequorin-Mediated Calcium Measurements in Living Cells of Aspergillus fumigatus	PLOS ONE			English	Article							CHRONIC PULMONARY ASPERGILLOSIS; COMPARATIVE GENOMIC ANALYSIS; INVASIVE FUNGAL-INFECTIONS; TRANSPLANT RECIPIENTS; ANTIFUNGAL ACTIVITY; WALL INTEGRITY; GLOBAL BURDEN; HYPHAL GROWTH; CALCINEURIN; HOMEOSTASIS	Aspergillus fumigatus is an inhaled fungal pathogen of human lungs, the developmental growth of which is reliant upon Ca2+-mediated signalling. Ca2+ signalling has regulatory significance in all eukaryotic cells but how A. fumigatus uses intracellular Ca2+ signals to respond to stresses imposed by the mammalian lung is poorly understood. In this work, A. fumigatus strains derived from the clinical isolate CEA10, and a non-homologous recombination mutant Delta akuB(KU80), were engineered to express the bioluminescent Ca2+-reporter aequorin. An aequorin-mediated method for routine Ca2+ measurements during the early stages of colony initiation was successfully developed and dynamic changes in cytosolic free calcium ([Ca2+](c)) in response to extracellular stimuli were measured. The response to extracellular challenges (hypo- and hyper-osmotic shock, mechanical perturbation, high extracellular Ca2+, oxidative stress or exposure to human serum) that the fungus might be exposed to during infection, were analysed in living conidial germlings. The 'signatures' of the transient [Ca2+](c) responses to extracellular stimuli were found to be dose-and age-dependent. Moreover, Ca2+-signatures associated with each physico-chemical treatment were found to be unique, suggesting the involvement of heterogeneous combinations of Ca2+-signalling components in each stress response. Concordant with the involvement of Ca2+-calmodulin complexes in these Ca2+-mediated responses, the calmodulin inhibitor trifluoperazine (TFP) induced changes in the Ca2+-signatures to all the challenges. The Ca2+-chelator BAPTA potently inhibited the initial responses to most stressors in accordance with a critical role for extracellular Ca2+ in initiating the stress responses.	[Munoz, Alberto; Bertuzzi, Margherita; Bignell, Elaine M.; Read, Nick D.] Univ Manchester, Inst Inflammat & Repair, Manchester Fungal Infect Grp, Manchester, Lancs, England; [Munoz, Alberto; Bettgenhaeuser, Jan; Read, Nick D.] Univ Edinburgh, Inst Cell Biol, Fungal Cell Biol Grp, Edinburgh, Midlothian, Scotland; [Bertuzzi, Margherita; Iakobachvili, Nino; Bignell, Elaine M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Mol Bacteriol & Infect, London, England	University of Manchester; University of Edinburgh; Imperial College London	Bignell, EM (corresponding author), Univ Manchester, Inst Inflammat & Repair, Manchester Fungal Infect Grp, Manchester, Lancs, England.	Elaine.Bignell@manchester.ac.uk; Nick.Read@manchester.ac.uk	Bettgenhaeuser, Jan/I-2282-2019	Bettgenhaeuser, Jan/0000-0002-6901-1774; Bignell, Elaine/0000-0001-7748-1920; Bertuzzi, Margherita/0000-0002-5900-591X; Munoz, Alberto/0000-0002-1622-5074	Wellcome Trust [WT093596/A/10/Z, WT093596/C/10/Z]; Medical Research Council [G0501164]; BBSRC [BB/G009619/1]; MRC [MR/L000822/1, G0501164, MR/M02010X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G009619/1] Funding Source: researchfish; Medical Research Council [MR/M02010X/1, MR/L000822/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants to EMB and NDR from the Wellcome Trust (WT093596/A/10/Z and WT093596/C/10/Z, respectively), and in part by grants to EMB from the Medical Research Council (G0501164) and the BBSRC (BB/G009619/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Baddley JW, 2010, CLIN INFECT DIS, V50, P1559, DOI 10.1086/652768; Bagar T, 2012, FUNGAL GENET BIOL, V49, P779, DOI 10.1016/j.fgb.2012.07.007; Bains SN, 2012, CLIN CHEST MED, V33, P265, DOI 10.1016/j.ccm.2012.02.003; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Bencina M, 2005, MOL MICROBIOL, V56, P268, DOI 10.1111/j.1365-2958.2005.04541.x; Bencina M, 2009, FUNGAL GENET BIOL, V46, pS93, DOI 10.1016/j.fgb.2008.07.019; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Binder U, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-209; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; Binder U, 2010, MOL MICROBIOL, V75, P294, DOI 10.1111/j.1365-2958.2009.06936.x; Bonora M, 2013, NAT PROTOC, V8, P2105, DOI 10.1038/nprot.2013.127; Bowman BJ, 2011, EUKARYOT CELL, V10, P654, DOI 10.1128/EC.00239-10; Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Cavinder B, 2012, EUKARYOT CELL, V11, P978, DOI 10.1128/EC.00007-12; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cramer RA, 2008, EUKARYOT CELL, V7, P1085, DOI 10.1128/EC.00086-08; Ferreira MED, 2007, FUNGAL GENET BIOL, V44, P219, DOI 10.1016/j.fgb.2006.08.004; de Carvalho MJA, 2003, FUNGAL GENET BIOL, V39, P204, DOI 10.1016/S1087-1845(03)00044-6; Castro PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103957; Denning DW, 2013, EUR RESPIR J, V41, P621, DOI 10.1183/09031936.00226911; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; Denning DW, 2011, B WORLD HEALTH ORGAN, V89, P864, DOI 10.2471/BLT.11.089441; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; Ding XH, 2014, BIOCHEM BIOPH RES CO, V446, P1073, DOI 10.1016/j.bbrc.2014.03.059; Fernandez-Martinez J, 2003, J MOL BIOL, V334, P667, DOI 10.1016/j.jmb.2003.09.072; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Goncalves AP, 2014, J CELL SCI; Greene V, 2002, CELL SIGNAL, V14, P437, DOI 10.1016/S0898-6568(01)00266-2; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Juvvadi PR, 2014, FUNGAL BIOL REV, V28, P56, DOI 10.1016/j.fbr.2014.02.004; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Kim HS, 2012, FUNGAL GENET BIOL, V49, P589, DOI 10.1016/j.fgb.2012.05.011; Kim YK, 1998, J BACTERIOL, V180, P5144, DOI 10.1128/JB.180.19.5144-5150.1998; Kleinkauf N, 2013, RISK ASSESSMENT ON T; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Kubodera T, 2000, BIOSCI BIOTECH BIOCH, V64, P1416, DOI 10.1271/bbb.64.1416; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Liu SY, 2015, EUKARYOT CELL, V14, P324, DOI 10.1128/EC.00271-14; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; Meyer V, 2009, EUKARYOT CELL, V8, P1677, DOI 10.1128/EC.00050-09; MONOD M, 1993, FEMS MICROBIOL LETT, V106, P39, DOI 10.1111/j.1574-6968.1993.tb05932.x; Munoz A, 2014, MOL MICROBIOL, V92, P1357, DOI 10.1111/mmi.12634; Munoz A, 2012, MOL MICROBIOL, V85, P89, DOI 10.1111/j.1365-2958.2012.08091.x; Nelson G, 2004, MOL MICROBIOL, V52, P1437, DOI 10.1111/j.1365-2958.2004.04066.x; Ohba R, 2013, ANN HEMATOL, V92, P1, DOI 10.1007/s00277-012-1564-5; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Sanchez-Piris M, 2002, J BIOL CHEM, V277, P17722, DOI 10.1074/jbc.M200104200; Soriani FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-12; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Steinbach WJ, 2007, ANTIMICROB AGENTS CH, V51, P2979, DOI 10.1128/AAC.01394-06; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Teng JF, 2008, MICROBIOL-SGM, V154, P3775, DOI 10.1099/mic.0.2008/021089-0; Troppens DM, 2013, FUNGAL GENET BIOL, V56, P135, DOI 10.1016/j.fgb.2013.04.006; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Wagener J, 2008, EUKARYOT CELL, V7, P1661, DOI 10.1128/EC.00221-08; Warwar V, 1996, APPL ENVIRON MICROB, V62, P74, DOI 10.1128/AEM.62.1.74-79.1996; Yu QL, 2014, MYCOPATHOLOGIA, V177, P167, DOI 10.1007/s11046-014-9735-7; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001	64	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138008	10.1371/journal.pone.0138008	http://dx.doi.org/10.1371/journal.pone.0138008			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402916	Green Published, gold, Green Submitted			2022-12-27	WOS:000361798100016
J	El-Shitany, NA; Shaala, LA; Abbas, AT; Abdel-dayem, UA; Azhar, EI; Ali, SS; van Soest, RWM; Youssef, DTA				El-Shitany, Nagla A.; Shaala, Lamiaa A.; Abbas, Aymn T.; Abdel-dayem, Umama A.; Azhar, Esam I.; Ali, Soad S.; van Soest, Rob W. M.; Youssef, Diaa T. A.			Evaluation of the Anti-Inflammatory, Antioxidant and Immunomodulatory Effects of the Organic Extract of the Red Sea Marine Sponge Xestospongia testudinaria against Carrageenan Induced Rat Paw Inflammation	PLOS ONE			English	Article							IN-VITRO; STEROLS; EDEMA; ACID; METABOLITES; RADICALS	Marine sponges are found to be a rich source of bioactive compounds which show a wide range of biological activities including antiviral, antibacterial, and anti-inflammatory activities. This study aimed to investigate the possible anti-inflammatory, antioxidant and immunomodulator effects of the methanolic extract of the Red Sea marine sponge Xestospongia testudinaria. The chemical composition of the Xestospongia testudinaria methanolic extract was determined using Gas chromatography-mass spectroscopy (GC-MS) analysis. DPPH (2, 2-diphenyl-1-picryl-hydrazyl) was measured to assess the antioxidant activity of the sponge extract. Carrageenan-induced rat hind paw edema was adopted in this study. Six groups of rats were used: group1: Control, group 2: Carrageenan, group 3: indomethacin (10mg/kg), group 4-6: Xestospongia testudinaria methanolic extract (25, 50, and 100 mg/kg). Evaluation of the anti-inflammatory activity was performed by both calculating the percentage increase in paw weight and hisopathologically. Assessment of the antioxidant and immunomodulatory activity was performed. GC-MS analysis revealed that there were 41 different compounds present in the methanolic extract. Sponge extract exhibited antioxidant activity against DPPH free radicals. Xestospongia testudinaria methanolic extract (100 mg/kg) significantly decreased % increase in pawweightmeasured at 1, 2, 3 and 4 h after carrageenan injection. Histopathologically, the extract caused a marked decrease in the capillary congestion and inflammatory cells infiltrate. The extract decreased paw malondialdehyde (MDA) and nitric oxide (NO) and increased the reduced glutathione (GSH), glutathione peroxidase (GPx), and catalase (CAT) activity. It also decreased the inflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta(IL-1 beta) and IL-6. The results of this study demonstrated the antiinflammatory, antioxidant, and immunomodulatory effects of the methanolic extract of the Red Sea sponge Xestospongia testudinaria (100 mg/kg).	[El-Shitany, Nagla A.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah 21413, Saudi Arabia; [El-Shitany, Nagla A.] Tanta Univ, Fac Pharm, Dept Pharmacol & Toxicol, Tanta, Egypt; [Shaala, Lamiaa A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Nat Prod Unit, Jeddah 21413, Saudi Arabia; [Abbas, Aymn T.; Azhar, Esam I.] King Abdulaziz Univ, King Fahd Med Res Ctr, Special Infect Agents Unit, Jeddah 21413, Saudi Arabia; [Abbas, Aymn T.] Mansoura Univ, Gastroenterol Surg Ctr, Biotechnol Res Labs, Mansoura, Egypt; [Abdel-dayem, Umama A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Anim Facil Unit, Jeddah 21413, Saudi Arabia; [Azhar, Esam I.] King Abdulaziz Univ, Fac Appl Med Sci, Med Lab Technol Dept, Jeddah 21413, Saudi Arabia; [Ali, Soad S.] King Abdulaziz Univ, Fac Med, Anat Dept Cytol & Histol, Jeddah 21413, Saudi Arabia; [van Soest, Rob W. M.] Nat Biodivers Ctr, Deptartment Marine Zool, NL-2300 RA Leiden, Netherlands; [Youssef, Diaa T. A.] King Abdulaziz Univ, Fac Pharm, Dept Nat Prod, Jeddah 21413, Saudi Arabia	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Tanta University; King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Mansoura University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; Naturalis Biodiversity Center; King Abdulaziz University	Youssef, DTA (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Nat Prod, Jeddah 21413, Saudi Arabia.	diaa22@yahoo.com	Azhar, Esam/ABI-1044-2020; Youssef, Diaa/ADU-7200-2022; Ali, Soad/J-7708-2012; Abbas, Ayman Tallat/J-2247-2012; shaala, lamiaa/AAD-9815-2019; El-Shitany, Nagla A/J-3359-2012; Youssef, Diaa TA/H-9813-2012; Shaala, Lamiaa A/H-9827-2012	Youssef, Diaa/0000-0003-2217-4039; Ali, Soad/0000-0002-2434-2027; Abbas, Ayman Tallat/0000-0001-7372-370X; Shaala, Lamiaa A/0000-0002-1866-8258; Azhar, Esam/0000-0002-1736-181X				Abbas AT, 2014, EVID-BASED COMPL ALT, V2014, P1; Aebi H, 1984, Methods Enzymol, V105, P121; Aknin M, 2010, MAR DRUGS, V8, P2961, DOI 10.3390/md8122961; Amir M., 2007, Indian Journal of Pharmaceutical Sciences, V69, P337; Azevedo LG, 2008, FUND CLIN PHARMACOL, V22, P549, DOI 10.1111/j.1472-8206.2008.00624.x; Bendary E., 2013, Annals of Agricultural Science (Cairo), V58, P173, DOI 10.1016/j.aoas.2013.07.002; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cai C, 2014, PLOS ONE, V2; Chang Ching-Wen, 2012, Evid Based Complement Alternat Med, V2012, P135379; D'Orazio N, 2012, MAR DRUGS, V10, P812, DOI 10.3390/md10040812; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Garbacki Nancy, 2004, BMC Pharmacology, V4, P25, DOI 10.1186/1471-2210-4-25; GLASER KB, 1989, MOL PHARMACOL, V36, P782; Grosser N, 2004, BIOCHEM BIOPH RES CO, V314, P351, DOI 10.1016/j.bbrc.2003.12.089; Gualillo O, 2001, J ETHNOPHARMACOL, V75, P213; Handy RLC, 1998, BRIT J PHARMACOL, V123, P1119, DOI 10.1038/sj.bjp.0701735; Harada H, 2002, ANTICANCER RES, V22, P2587; Inotai A, 2010, PHARMACOEPIDEM DR S, V19, P183, DOI 10.1002/pds.1893; JAIN P, 1981, AGENTS ACTIONS, V11, P243, DOI 10.1007/BF01967621; Keyzers RA, 2005, CHEM SOC REV, V34, P355, DOI 10.1039/b408600g; Kumar PP, 2009, IMMUNOPHARM IMMUNOT, V31, P94, DOI 10.1080/08923970802438391; Kumaran A, 2007, FOOD CHEM, V100, P356, DOI 10.1016/j.foodchem.2005.09.051; KUSHNER I, 1993, PERSPECT BIOL MED, V36, P611; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Li JL, 2011, CHEM PHARM BULL, V59, P120, DOI 10.1248/cpb.59.120; Liolios CC, 2009, PLANT FOOD HUM NUTR, V64, P52, DOI 10.1007/s11130-008-0100-1; Mannix D, 1999, PHYSICA B, V262, P125, DOI 10.1016/S0921-4526(98)00477-3; Marxen K, 2007, SENSORS-BASEL, V7, P2080, DOI 10.3390/s7102080; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PASSI S, 1991, FREE RADICAL RES COM, V11, P329, DOI 10.3109/10715769109088931; Pereira DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088341; Qin HY, 2011, J GASTROENTEROL, V46, P164, DOI 10.1007/s00535-010-0321-6; Rajagopal Gobalakrishnan, 2014, Journal of Medicinal Plants Research, V8, P454; Robert AK, 2005, CHEM SOC REV, V34, P355; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Senthilkumar K, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/572859; Sharma V, 2004, J MED CHEM, V47, P3700, DOI 10.1021/jm040013d; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; VANESCH A, 1995, ARCH PEDIAT ADOL MED, V149, P632, DOI 10.1001/archpedi.1995.02170190042007; Wang R, 2014, BIOORG MED CHEM LETT, V24, P3944, DOI 10.1016/j.bmcl.2014.06.039; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Wu X., 2013, ABSTR APPL ANAL, V2013, P1, DOI DOI 10.1109/ISSCC.2013.6487667; Youssef DTA, 2010, NAT PROD COMMUN, V5, P27; Zhou XF, 2011, CHEM PHYS LIPIDS, V164, P703, DOI 10.1016/j.chemphyslip.2011.08.002	48	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138917	10.1371/journal.pone.0138917	http://dx.doi.org/10.1371/journal.pone.0138917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422010	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700055
J	Slapsinskaite, A; Razon, S; Serre, NB; Hristovski, R; Tenenbaum, G				Slapsinskaite, Agne; Razon, Selen; Balague Serre, Natalia; Hristovski, Robert; Tenenbaum, Gershon			Local Pain Dynamics during Constant Exhaustive Exercise	PLOS ONE			English	Article							PERCEIVED EXERTION; MUSCLE PAIN; INTENSITY; SCALE; ATTENTION; THRESHOLD; WOMEN	The purpose of this study was to delineate the topological dynamics of pain and discomfort during constant exercise performed until volitional exhaustion. Eleven physical education students were tested while cycling and running at a "hard" intensity level (e.g., corresponding to Borg's RPE (6-20) = 15). During the tests, participants reported their discomfort and pain on a body map every 15s. "Time on task" for each participant was divided into five equal non-overlapping temporal windows within which their ratings were considered for analysis. The analyses revealed that the number of body locations with perceived pain and discomfort increased throughout the five temporal windows until reaching the mean (+/- SE) values of 4.2 +/- 0.7 and 4.1 +/- 0.6 in cycling and running, respectively. The dominant locations included the quadriceps and hamstrings during cycling and quadriceps and chest during running. In conclusion, pain seemed to spread throughout the body during constant cycling and running performed up to volitional exhaustion with differences between cycling and running in the upper body but not in the lower body dynamics.	[Slapsinskaite, Agne; Balague Serre, Natalia] INEFC Univ Barcelona, Dept Hlth & Appl Sci, Barcelona, Spain; [Razon, Selen] Ball State Univ, Dept Phys Educ, Muncie, IN 47306 USA; [Hristovski, Robert] Ss Cyril & Methodius Univ, Dept Phys Educ Sport & Hlth, Skopje, Macedonia; [Tenenbaum, Gershon] Florida State Univ, Dept Educ Psychol & Learning Syst, Tallahassee, FL 32306 USA	University of Barcelona; Ball State University; Saints Cyril & Methodius University of Skopje; State University System of Florida; Florida State University	Slapsinskaite, A (corresponding author), INEFC Univ Barcelona, Dept Hlth & Appl Sci, Barcelona, Spain.	agneslapsinskaite@gmail.com	Slapšinskaitė, Agnė/ABG-4911-2021; Hristovski, Robert/L-4116-2015	Slapšinskaitė, Agnė/0000-0003-0845-9978; Hristovski, Robert/0000-0001-6805-2833; Balague, Natalia/0000-0001-5076-9166	Institut Nacional d'Educacio Fisica de Catalunya (INEFC); Generalitat de Catalunya; Secretaria General de l'Esport i Departament d'Innovacio Universitats i Empresa; Agency for the Management of University and Research Grants (AGAUR)	Institut Nacional d'Educacio Fisica de Catalunya (INEFC); Generalitat de Catalunya(Generalitat de Catalunya); Secretaria General de l'Esport i Departament d'Innovacio Universitats i Empresa; Agency for the Management of University and Research Grants (AGAUR)	This study was supported by the Institut Nacional d'Educacio Fisica de Catalunya (INEFC), the Generalitat de Catalunya and Secretaria General de l'Esport i Departament d'Innovacio Universitats i Empresa. Agne Slapsinskaite is the recipient of a predoctoral fellowship from the Agency for the Management of University and Research Grants (AGAUR). We would like to thank TECNO SPORT for the technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones D, 2013, PSYCHOL SPORT EXERC, V14, P796, DOI 10.1016/j.psychsport.2013.05.009; Balague N, 2015, J SPORT SCI, V33, P48, DOI 10.1080/02640414.2014.921833; Balague N, 2012, PSYCHOL SPORT EXERC, V13, P591, DOI 10.1016/j.psychsport.2012.02.013; Borg E, 2010, SCAND J MED SCI SPOR, V20, P644, DOI 10.1111/j.1600-0838.2009.00985.x; Borg G., 1998, BORGS PERCEIVED EXER; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Cook DB, 1997, MED SCI SPORT EXER, V29, P999, DOI 10.1097/00005768-199708000-00004; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Graven-Nielsen T, 2010, NAT REV RHEUMATOL, V6, P599, DOI 10.1038/nrrheum.2010.107; Haile L, 2015, EXERCISE INDUCED MUS, P21; Hristovski R, 2010, HUM MOVEMENT SCI, V29, P483, DOI 10.1016/j.humov.2010.05.004; Koltyn KF, 2002, SPORTS MED, V32, P477, DOI 10.2165/00007256-200232080-00001; Kress J.L., 2007, J SPORT BEHAV, V30, P428; Lau WY, 2013, J MUSCULOSKELET PAIN, V21, P320, DOI 10.3109/10582452.2013.848967; Marcora SM, 2010, EUR J APPL PHYSIOL, V109, P763, DOI 10.1007/s00421-010-1418-6; MARGOLIS RB, 1986, PAIN, V24, P57, DOI 10.1016/0304-3959(86)90026-6; Mauger A., 2012, J SPORTS MED DOPING, V2, P1; Mauger AR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00104; Micalos PS, 2004, J SPORT SCI MED, V3, P70; Morton DP, 2005, J SCI MED SPORT, V8, P152, DOI 10.1016/S1440-2440(05)80006-4; Motl RW, 2003, J PAIN, V4, P316, DOI 10.1016/S1526-5900(03)00635-7; Nielsen CS, 2009, J PAIN, V10, P231, DOI 10.1016/j.jpain.2008.09.010; Racine M, 2012, PAIN, V153, P619, DOI 10.1016/j.pain.2011.11.026; Richard LG, 1980, HUMAN FACTORS TRANSP, P356; Robertson RJ, 2004, MED SCI SPORT EXER, V36, P102, DOI 10.1249/01.MSS.0000106169.35222.8B; Robinson ME, 2013, J PAIN, V14, P323, DOI 10.1016/j.jpain.2012.05.007; Stendardi L, 2005, RESP MED, V99, P933, DOI 10.1016/j.rmed.2005.02.005; Tenenbaum G, 1999, J SPORT SCI, V17, P183, DOI 10.1080/026404199366082; UEDA T, 1993, EUR J APPL PHYSIOL, V66, P196, DOI 10.1007/BF00235093; Villemure C, 2002, PAIN, V95, P195, DOI 10.1016/S0304-3959(02)00007-6; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Zamuner AR, 2011, J SPORT SCI MED, V10, P130	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137895	10.1371/journal.pone.0137895	http://dx.doi.org/10.1371/journal.pone.0137895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421436	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700022
J	Lineman, M; Do, Y; Kim, JY; Joo, GJ				Lineman, Maurice; Do, Yuno; Kim, Ji Yoon; Joo, Gea-Jae			Talking about Climate Change and Global Warming	PLOS ONE			English	Article							SEARCH BEHAVIOR; TRENDS	The increasing prevalence of social networks provides researchers greater opportunities to evaluate and assess changes in public opinion and public sentiment towards issues of social consequence. Using trend and sentiment analysis is one method whereby researchers can identify changes in public perception that can be used to enhance the development of a social consciousness towards a specific public interest. The following study assessed Relative search volume (RSV) patterns for global warming (GW) and Climate change (CC) to determine public knowledge and awareness of these terms. In conjunction with this, the researchers looked at the sentiment connected to these terms in social media networks. It was found that there was a relationship between the awareness of the information and the amount of publicity generated around the terminology. Furthermore, the primary driver for the increase in awareness was an increase in publicity in either a positive or a negative light. Sentiment analysis further confirmed that the primary emotive connections to the words were derived from the original context in which the word was framed. Thus having awareness or knowledge of a topic is strongly related to its public exposure in the media, and the emotional context of this relationship is dependent on the context in which the relationship was originally established. This has value in fields like conservation, law enforcement, or other fields where the practice can and often does have two very strong emotive responses based on the context of the problems being examined.	[Lineman, Maurice; Do, Yuno; Kim, Ji Yoon; Joo, Gea-Jae] Pusan Natl Univ, Dept Biol Sci, Coll Nat Sci, Busan, South Korea	Pusan National University	Joo, GJ (corresponding author), Pusan Natl Univ, Dept Biol Sci, Coll Nat Sci, Busan, South Korea.	gjjoo@pusan.ac.kr		Kim, Ji Yoon/0000-0001-5228-4939	Post-Doc Development Program of Pusan National University	Post-Doc Development Program of Pusan National University	This study was financially supported by the 2015 Post-Doc Development Program of Pusan National University.	Abeywardena IS., 2014, PUBLIC OPINION OER M; Aston N., 2014, J COMPUT COMMUN, V2, P11, DOI DOI 10.4236/JCC.2014.23002; Bollen J, 2011, P INT AAAI C WEB SOC, V5; Bossomaier T, 2003, ADV COMPLEX SYST, V6, P313, DOI 10.1142/S0219525903000992; BOSTROM A, 1994, RISK ANAL, V14, P959, DOI 10.1111/j.1539-6924.1994.tb00065.x; Bruns A, 2011, AUSVOTES TWITTER COV; Castle NG, 2005, HEALTH SERV RES, V40, P1996, DOI 10.1111/j.1475-6773.2005.00475.x; Cavnar W.B., 1994, P SDAIR 94 3 ANN S D, VVolume 161175, DOI DOI 10.1.1.53.9367; Chadwick A, 2011, INT J PRESS/POLIT, V16, P3, DOI 10.1177/1940161210384730; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Choi Yejin, 2008, P C EMP METH NAT LAN; Conway M, 2009, INT J MED INFORM, V78, pE47, DOI 10.1016/j.ijmedinf.2009.03.010; De Longueville Bertrand, 2009, P 2009 INT WORKSH LO; Do Y, 2015, CONSERV BIOL, V29, P271, DOI 10.1111/cobi.12419; Doherty TJ, 2011, PSYCHOL IMPACTS GLOB; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Fayyad U, 1996, AI MAG, V17, P37; Fayyad U, 1996, KNOWLEDGE DISCOVERY; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Fredrickson BL, 1998, REV GEN PSYCHOL, V2, P300, DOI DOI 10.1037/1089-2680.2.3.300; GIDDENS A., 2009, POLITICS CLIMATE CHA; Granka L. A., 2009, UIIR SIGIR, P28; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Holscher C, 2000, COMPUT NETW, V33, P337, DOI 10.1016/S1389-1286(00)00031-1; Kim J. G., 2014, T MAT PROCESSING, V23, P23; Kouloumpis E, 2011, ICWSM, V11, P164; Lawrence L, 2014, RELIABILITY SENTIMEN; Lazarus R.S., 1991, EMOTION ADAPTATION; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; McCright AM, 2000, SOC PROBL, V47, P499, DOI 10.1525/sp.2000.47.4.03x0305s; Miksza P, 2010, J RES MUSIC EDUC, V57, P364, DOI 10.1177/0022429409351655; Mobley C, 2009, ENV BEHAV; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Motteux NMG., EVALUATING PEOPLE EN; Nasukawa T., 2003, SENTIMENT ANAL CAPTU, P1, DOI [10.1145/945645.945658, DOI 10.1145/945645.945658]; Neverla I, 2008, ICA C GLOB COMM SOC; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; Pettitt A. N., 1979, Applied Statistics, V28, P126, DOI 10.2307/2346729; Phelan O, 2009, P 3 ACM C REC SYST A; Pinkerton B., 1994, P 2 WWW C CHIC IL US; Proulx R, 2014, CONSERV BIOL, V28, P44, DOI 10.1111/cobi.12131; Rigg R, 2011, ORYX, V45, P272, DOI 10.1017/S0030605310000074; Ripberger JT, 2011, POLICY STUD J, V39, P239, DOI 10.1111/j.1541-0072.2011.00406.x; ROBERTS ML, 1994, PUBLIC OPIN QUART, V58, P165, DOI 10.1086/269417; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Wang Xiaolong, 2011, P 20 ACM INT C INF K; Weingart P, 2000, PUBLIC UNDERST SCI, V9, P261, DOI 10.1088/0963-6625/9/3/304; Welch DD, 1997, SO CALIFORNIA INTERD, V6, P55; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003; Wiegand M., 2010, P WORKSH NEG SPEC NA; Zhao D., 2009, P ACM 2009 INT C SUP	52	50	50	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138996	10.1371/journal.pone.0138996	http://dx.doi.org/10.1371/journal.pone.0138996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418127	Green Submitted, gold, Green Published			2022-12-27	WOS:000362171400032
J	Pellegrini, B; Peyre-Tartaruga, LA; Zoppirolli, C; Bortolan, L; Bacchi, E; Figard-Fabre, H; Schena, F				Pellegrini, Barbara; Peyre-Tartaruga, Leonardo Alexandre; Zoppirolli, Chiara; Bortolan, Lorenzo; Bacchi, Elisabetta; Figard-Fabre, Helene; Schena, Federico			Exploring Muscle Activation during Nordic Walking: A Comparison between Conventional and Uphill Walking	PLOS ONE			English	Article							CROSS-COUNTRY SKIERS; PHYSIOLOGICAL-RESPONSES; HIKING POLES; ENERGY-COST; ADAPTATION; LOCOMOTION; TREADMILL; EXERTION; SURFACES; LEVEL	Nordic Walking (NW) owes much of its popularity to the benefits of greater energy expenditure and upper body engagement than found in conventional walking (W). Muscle activation during NW is still understudied, however. The aim of the present study was to assess differences in muscle activation and physiological responses between NW and W in level and uphill walking conditions. Nine expert Nordic Walkers (mean age 36.8 +/- 11.9 years; BMI 24.2 +/- 1.8 kg/m(2)) performed 5-minute treadmill trials of W and NW at 4 km/h on inclines of 0% and 15%. The electromyographic activity of seven upper body and five leg muscles and oxygen consumption (VO2) were recorded and pole force during NW was measured. VO2 during NW was 22.3% higher at 0% and only 6.9% higher at 15% than during W, while upper body muscle activation was 2- to 15-fold higher under both conditions. Lower body muscle activation was similarly increased during NW and Win the uphill condition, whereas the increase in erector spinae muscle activity was lower during NW than W. The lack of a significant increase in pole force during uphill walking may explain the lower extra energy expenditure of NW, indicating less upper body muscle activation to lift the body against gravity. NW seemed to reduce lower back muscle contraction in the uphill condition, suggesting that walking with poles may reduce effort to control trunk oscillations and could contribute to work production during NW. Although the difference in extra energy expenditure between NW and W was smaller in the uphill walking condition, the increased upper body muscle involvement during exercising with NW may confer additional benefit compared to conventional walking also on uphill terrains. Furthermore, people with low back pain may gain benefit from pole use when walking uphill.	[Pellegrini, Barbara; Zoppirolli, Chiara; Bortolan, Lorenzo; Figard-Fabre, Helene; Schena, Federico] Univ Verona, CeRiSM Res Ctr Mt Sport & Hlth, Rovereto, Italy; [Pellegrini, Barbara; Zoppirolli, Chiara; Bortolan, Lorenzo; Schena, Federico] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Peyre-Tartaruga, Leonardo Alexandre] Univ Fed Rio Grande do Sul, Sch Phys Educ, Porto Alegre, RS, Brazil; [Bacchi, Elisabetta] Univ Verona, Dept Med, I-37100 Verona, Italy; [Figard-Fabre, Helene] Gen Council High Pyrenees, Dept Off Sports, Tarbes, France	University of Verona; Universidade Federal do Rio Grande do Sul; University of Verona	Pellegrini, B (corresponding author), Univ Verona, CeRiSM Res Ctr Mt Sport & Hlth, Rovereto, Italy.	barbara.pellegrini@univr.it	Pellegrini, Barbara/AFV-5894-2022; Peyré-Tartaruga, Leonardo Alexandre/C-7103-2013	Peyré-Tartaruga, Leonardo Alexandre/0000-0003-1742-5016; Schena, Federico/0000-0002-2052-5117; Bortolan, Lorenzo/0000-0002-1591-8565; PELLEGRINI, Barbara/0000-0002-9626-2632				[Anonymous], 2013, ACSMS GUIDELINES EXE; Benedetti M. G, 2012, MUSCLE ACTIVATION PA; CARLSON H, 1988, ACTA PHYSIOL SCAND, V133, P343, DOI 10.1111/j.1748-1716.1988.tb08416.x; Church TS, 2002, RES Q EXERCISE SPORT, V73, P296, DOI 10.1080/02701367.2002.10609023; Figard-Fabre H, 2010, EUR J APPL PHYSIOL, V108, P1141, DOI 10.1007/s00421-009-1315-z; Foissac MJ, 2008, MED SCI SPORT EXER, V40, P1117, DOI 10.1249/MSS.0b013e318167228a; Franz JR, 2012, GAIT POSTURE, V35, P143, DOI 10.1016/j.gaitpost.2011.08.025; Gottschall JS, 2003, J APPL PHYSIOL, V94, P1766, DOI 10.1152/japplphysiol.00670.2002; Hansen EA, 2009, J STRENGTH COND RES, V23, P1187, DOI 10.1519/JSC.0b013e31819f1e2b; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hermens HJ., 1999, ROESSINGH RES DEV, V8, P13; Holmberg HC, 2006, MED SCI SPORT EXER, V38, P1853, DOI 10.1249/01.mss.0000230121.83641.d1; Holmberg HC, 2005, MED SCI SPORT EXER, V37, P807, DOI 10.1249/01.MSS.0000162615.47763.C8; Knight CA, 2000, MED SCI SPORT EXER, V32, P2093, DOI 10.1097/00005768-200012000-00020; Lay AN, 2007, J BIOMECH, V40, P1276, DOI 10.1016/j.jbiomech.2006.05.023; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Leroux A, 1999, EXP BRAIN RES, V126, P359, DOI 10.1007/s002210050743; Lindinger SJ, 2009, EUR J APPL PHYSIOL, V106, P353, DOI 10.1007/s00421-009-1018-5; McGill SM, 2000, ERGONOMICS, V43, P486, DOI 10.1080/001401300184369; Nilsson J, 2013, EUR J APPL PHYSIOL, V113, P1385, DOI 10.1007/s00421-012-2568-5; OWENS SG, 1989, J SPORT MED PHYS FIT, V29, P384; Pellegrini B, 2011, SCAND J MED SCI SPOR, V21, P589, DOI 10.1111/j.1600-0838.2009.01071.x; Pellegrini B, 2013, HUM MOVEMENT SCI, V32, P1415, DOI 10.1016/j.humov.2013.07.010; Perrey S, 2008, J SPORT SCI MED, V7, P32; Porcari JP, 1997, RES Q EXERCISE SPORT, V68, P161, DOI 10.1080/02701367.1997.10607992; Rainoldi A, 2000, J ELECTROMYOGR KINES, V10, P327, DOI 10.1016/S1050-6411(00)00024-9; Schiffer T, 2006, EUR J APPL PHYSIOL, V98, P56, DOI 10.1007/s00421-006-0242-5; Schiffer T, 2011, EUR J APPL PHYSIOL, V111, P1121, DOI 10.1007/s00421-010-1739-5; Schiffer T, 2009, MED SCI SPORT EXER, V41, P663, DOI 10.1249/MSS.0b013e31818b9321; Schilling N, 2009, J EXP BIOL, V212, P1053, DOI 10.1242/jeb.020248; Shim JM, 2013, J PHYS THER SCI, V25, P1553, DOI 10.1589/jpts.25.1553; Sugiyama K, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-2; Umberger BR, 2008, J BIOMECH, V41, P2575, DOI 10.1016/j.jbiomech.2008.05.024; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; YANG JF, 1984, ARCH PHYS MED REHAB, V65, P517	35	52	53	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138906	10.1371/journal.pone.0138906	http://dx.doi.org/10.1371/journal.pone.0138906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418339	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400025
J	Pereira, JMC; Oom, D; Pereira, P; Turkman, AA; Turkman, KF				Pereira, Jose M. C.; Oom, Duarte; Pereira, Paula; Turkman, Antonia A.; Feridun Turkman, K.			Religious Affiliation Modulates Weekly Cycles of Cropland Burning in Sub-Saharan Africa	PLOS ONE			English	Article							FIRE; SAVANNA; AEROSOL; CLIMATE; IMPACT	Vegetation burning is a common land management practice in Africa, where fire is used for hunting, livestock husbandry, pest control, food gathering, cropland fertilization, and wildfire prevention. Given such strong anthropogenic control of fire, we tested the hypotheses that fire activity displays weekly cycles, and that the week day with the fewest fires depends on regionally predominant religious affiliation. We also analyzed the effect of land use (anthrome) on weekly fire cycle significance. Fire density (fire counts.km(-2)) observed per week day in each region was modeled using a negative binomial regression model, with fire counts as response variable, region area as offset and a structured random effect to account for spatial dependence. Anthrome (settled, cropland, natural, rangeland), religion (Christian, Muslim, mixed) week day, and their 2-way and 3-way interactions were used as independent variables. Models were also built separately for each anthrome, relating regional fire density with week day and religious affiliation. Analysis revealed a significant interaction between religion and week day, i.e. regions with different religious affiliation (Christian, Muslim) display distinct weekly cycles of burning. However, the religion vs. week day interaction only is significant for croplands, i.e. fire activity in African croplands is significantly lower on Sunday in Christian regions and on Friday in Muslim regions. Magnitude of fire activity does not differ significantly among week days in rangelands and in natural areas, where fire use is under less strict control than in croplands. These findings can contribute towards improved specification of ignition patterns in regional/global vegetation fire models, and may lead to more accurate meteorological and chemical weather forecasting.	[Pereira, Jose M. C.; Oom, Duarte] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal; [Pereira, Paula] Escola Super Tecnol Setubal, Inst Politecn Setubal, Setubal, Portugal; [Turkman, Antonia A.; Feridun Turkman, K.] Univ Lisbon, Fac Ciencias, Ctr Estat & Aplicacoes, Lisbon, Portugal	Universidade de Lisboa; Instituto Politecnico de Setubal; Universidade de Lisboa	Pereira, JMC (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal.	jmocpereira@gmail.com	Turkman, Maria Antónia Amaral/M-6010-2013; Oom, Duarte/B-5290-2008; Pereira, José/N-2829-2019; Pereira, Jose MC/I-1283-2014; Turkman, Kamil Feridun/M-3484-2015	Turkman, Maria Antónia Amaral/0000-0002-7564-7154; Oom, Duarte/0000-0002-9244-3487; Pereira, José/0000-0003-2583-3669; Pereira, Jose MC/0000-0003-2583-3669; Pereira, Paula/0000-0002-9326-1466; Turkman, Kamil Feridun/0000-0002-6864-8773	Fundacao para a Ciencia e a Tecnologia [PEst-OE/AGR/UI0239/2014, PEst-OE/MAT/UI0006/2014, PTDC/MAT/118335/2010, SFRH/BD/4752/2008]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding for this research was provided by Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/) research projects PEst-OE/AGR/UI0239/2014 (JMCP and DO), PEst-OE/MAT/UI0006/2014 (KFT, AT and PP), PTDC/MAT/118335/2010 (KFT, AT, PP and JMCP) and doctoral grant SFRH/BD/4752/2008 (DO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald S, 2010, INT J WILDLAND FIRE, V19, P774, DOI [10.1071/WF08207, 10.1071/WF10008]; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Balzter H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022526; Banerjee S., 2014, HIERARCHICAL MODELIN; Beirle S, 2003, ATMOS CHEM PHYS, V3, P2225, DOI 10.5194/acp-3-2225-2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird MI, 1998, NATURE, V394, P767, DOI 10.1038/29507; Bond W. J., 1997, P421; Box GE, 1992, BAYESIAN INFERENCE S; CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669; Dwyer E, 2000, J BIOGEOGR, V27, P57, DOI 10.1046/j.1365-2699.2000.00339.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Giglio L, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000142; Goitein SD, 1959, MUSLIM WORLD, V49, P183; Hackett C., 2012, GLOBAL RELIG LANDSCA; Held L, 2004, J COMPUT GRAPH STAT, V13, P20, DOI 10.1198/1061860043083; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Johnson TM, 2012, WORLD RELIG DATABASE; Johnston FH, 2012, ENVIRON HEALTH PERSP, V120, P695, DOI 10.1289/ehp.1104422; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P3, DOI 10.1016/S0034-4257(02)00084-6; Kaiser JW, 2012, BIOGEOSCIENCES, V9, P527, DOI 10.5194/bg-9-527-2012; Kull Christian A., 2009, P171, DOI 10.1007/978-3-540-77381-8_7; Lamarque JF, 2010, ATMOS CHEM PHYS, V10, P7017, DOI 10.5194/acp-10-7017-2010; Laris P, 2002, HUM ECOL, V30, P155, DOI 10.1023/A:1015685529180; Le Page Y, 2008, ATMOS CHEM PHYS, V8, P1911, DOI 10.5194/acp-8-1911-2008; Le Page Y, 2010, GLOBAL ECOL BIOGEOGR, V19, P575, DOI 10.1111/j.1466-8238.2010.00525.x; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Oom D, 2013, INT J APPL EARTH OBS, V21, P326, DOI 10.1016/j.jag.2012.07.018; PENNER JE, 1992, SCIENCE, V256, P1432, DOI 10.1126/science.256.5062.1432; Quaas J, 2009, ATMOS CHEM PHYS, V9, P8493, DOI 10.5194/acp-9-8493-2009; Ringwald CD, 2007, DAY APART JEWS CHRIS; Roberts G, 2009, BIOGEOSCIENCES, V6, P849, DOI 10.5194/bg-6-849-2009; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sanchez-Lorenzo A, 2012, ATMOS CHEM PHYS, V12, P5755, DOI 10.5194/acp-12-5755-2012; Schultz MG, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003031; Shaffer LJ, 2010, FIRE ECOL, V6, P43, DOI 10.4996/fireecology.0602043; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Wooster MJ, 2012, BIOGEOSCIENCES, V9, P317, DOI 10.5194/bg-9-317-2012; Xia XG, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009604	41	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139189	10.1371/journal.pone.0139189	http://dx.doi.org/10.1371/journal.pone.0139189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418002	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400060
J	Rios, L; Rosas, A; Estalrrich, A; Garcia-Tabernero, A; Bastir, M; Huguet, R; Pastor, F; Sanchis-Gimeno, JA; de la Rasilla, M				Rios, Luis; Rosas, Antonio; Estalrrich, Almudena; Garcia-Tabernero, Antonio; Bastir, Markus; Huguet, Rosa; Pastor, Francisco; Sanchis-Gimeno, Juan Alberto; de la Rasilla, Marco			Possible Further Evidence of Low Genetic Diversity in the El Sidron (Asturias, Spain) Neandertal Group: Congenital Clefts of the Atlas	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; KLIPPEL-FEIL-SYNDROME; POSTERIOR ARCH; ANTERIOR ARCH; BIPARTITE ATLAS; ANTEROPOSTERIOR SPONDYLOSCHISIS; OSSIFICATION PATTERNS; DEVELOPMENTAL ANATOMY; BRIEF COMMUNICATION; CERVICAL-VERTEBRAE	We present here the first cases in Neandertals of congenital clefts of the arch of the atlas. Two atlases from El Sidron, northern Spain, present respectively a defect of the posterior (frequency in extant modern human populations ranging from 0.73% to 3.84%), and anterior (frequency in extant modern human populations ranging from 0.087% to 0.1%) arch, a condition in most cases not associated with any clinical manifestation. The fact that two out of three observable atlases present a low frequency congenital condition, together with previously reported evidence of retained deciduous mandibular canine in two out of ten dentitions from El Sidron, supports the previous observation based on genetic evidence that these Neandertals constituted a group with close genetic relations. Some have proposed for humans and other species that the presence of skeletal congenital conditions, although without clinical significance, could be used as a signal of endogamy or inbreeding. In the present case this interpretation would fit the general scenario of high incidence of rare conditions among Pleistocene humans and the specific scenariothat emerges from Neandertal paleogenetics, which points to long-term small and decreasing population size with reduced and isolated groups. Adverse environmental factors affecting early pregnancies would constitute an alternative, non-exclusive, explanation for a high incidence of congenital conditions. Further support or rejection of these interpretations will come from new genetic and skeletal evidence from Neandertal remains.	[Rios, Luis; Rosas, Antonio; Estalrrich, Almudena; Garcia-Tabernero, Antonio; Bastir, Markus] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Grp Paleoanthropol, E-28006 Madrid, Spain; [Rios, Luis] Aranzadi Soc Sci, Dept Phys Anthropol, Donostia San Sebastian, Basque Country, Spain; [Huguet, Rosa] Univ Rovira & Virgili, Area Prehist, Inst Catala Palecol Humana & Evolucio Social IPHE, Unidad Asociada,CSIC, E-43007 Tarragona, Spain; [Pastor, Francisco] Univ Valladolid, Fac Med, Dept Anat & Radiol, Museo Anat, Valladolid, Spain; [Sanchis-Gimeno, Juan Alberto] Univ Valencia, Fac Med, Dept Anat & Human Embriol, Valencia, Spain; [de la Rasilla, Marco] Univ Oviedo, Dept Hist, Area Prehist, Oviedo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Rovira i Virgili; Universidad de Valladolid; University of Valencia; University of Oviedo	Rios, L (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Grp Paleoanthropol, E-28006 Madrid, Spain.	mertibea@yahoo.com; arosas@mncn.csic.es	Huguet, Rosa/H-5713-2015; García-Tabernero, Antonio/AAQ-8382-2020; Rios, Luis/G-3533-2015; Sanchis-Gimeno, Juan A/G-9976-2015; Rosas, Antonio/D-9742-2016; Estalrrich, Almudena/ABF-1891-2020; Bastir, Markus/G-8987-2013	García-Tabernero, Antonio/0000-0001-5400-5630; Rios, Luis/0000-0002-6720-2534; Sanchis-Gimeno, Juan A/0000-0002-2599-8474; Rosas, Antonio/0000-0002-5829-9952; Estalrrich, Almudena/0000-0003-2295-5396; Bastir, Markus/0000-0002-3141-3401	Ministerio de Economia y Competitividad, Spain [CGL2012-36682, CGL2012-37279]	Ministerio de Economia y Competitividad, Spain	Funding was provided by Ministerio de Economia y Competitividad, Spain, projects CGL2012-36682 and CGL2012-37279. Convenio Principado de Asturias-Universidad de Oviedo CN-09-084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Kaissi A, 2007, EUR SPINE J, V16, pS265, DOI 10.1007/s00586-006-0297-3; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Alt KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065649; Alt KW, 1997, AM J PHYS ANTHROPOL, V102, P123, DOI 10.1002/(SICI)1096-8644(199701)102:1<123::AID-AJPA10>3.0.CO;2-2; [Anonymous], 1912, TRAITE VARIATIONS CO; [Anonymous], 2005, NEW METHOD IDENIFYIN; Atasoy C, 2002, NEURORADIOLOGY, V44, P253, DOI 10.1007/s00234-001-0740-4; Barrett CK, 2012, AM J PHYS ANTHROPOL, V149, P193, DOI 10.1002/ajpa.22107; Bastir M, 2015, J HUM EVOL, V80, P64, DOI 10.1016/j.jhevol.2014.10.008; Bastir M, 2010, J HUM EVOL, V58, P68, DOI 10.1016/j.jhevol.2009.08.006; Bittles AH, 2010, ANNU REV ANTHROPOL, V39, P193, DOI 10.1146/annurev.anthro.012809.105051; Blanco-Perez E, 2015, SPINE J, V15, P198, DOI 10.1016/j.spinee.2014.08.450; Bocquet-Appel JP, 2013, CURR ANTHROPOL, V54, pS202, DOI 10.1086/673725; CALVY TM, 1987, AM J NEURORADIOL, V8, P489; Cardoso HFV, 2011, AM J PHYS ANTHROPOL, V144, P238, DOI 10.1002/ajpa.21394; Cardoso HFV, 2009, AM J PHYS ANTHROPOL, V138, P136, DOI 10.1002/ajpa.20910; Carmichael SL, 2007, J NUTR, V137, P2087, DOI 10.1093/jn/137.9.2087; Carmichael SL, 2012, ARCH PEDIAT ADOL MED, V166, P121, DOI 10.1001/archpediatrics.2011.185; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; CHALMERS AG, 1985, BRIT J RADIOL, V58, P761, DOI 10.1259/0007-1285-58-692-761; Chernoff N, 2004, J TOXICOL ENV HEAL B, V7, P437, DOI 10.1080/10937400490512447; CHILDERS JC, 1971, J BONE JOINT SURG AM, VA 53, P578, DOI 10.2106/00004623-197153030-00015; CURRARINO G, 1994, AM J NEURORADIOL, V15, P249; de la Rasilla M RA, 2011, UNA INVESTIGACION IN; Dean MC, 2013, J HUM EVOL, V64, P678, DOI 10.1016/j.jhevol.2013.03.004; Desgrez H, 1965, J Radiol Electrol Med Nucl, V46, P819; Dilettoso S, 2012, SPINE J, V12, P449, DOI 10.1016/j.spinee.2012.03.031; Eaves-Johnson KL, 2010, FASEB J, V24; Estalrrich A, 2015, J HUM EVOL, V80, P51, DOI 10.1016/j.jhevol.2014.07.007; Estalrrich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062797; Fabre V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005151; FARMAN AG, 1979, J ANAT, V128, P595; Galis F, 2006, EVOLUTION, V60, P2643; Ganau Mario, 2013, J Emerg Trauma Shock, V6, P47, DOI 10.4103/0974-2700.106325; Garg A, 2004, SPINE, V29, pE35, DOI 10.1097/01.BRS.0000106487.89648.88; GEHWEILER JA, 1976, SKELETAL RADIOL, V1, P97, DOI 10.1007/BF00347414; GEIPEL P, 1955, Zentralbl Allg Pathol, V94, P19; Gomez-Olivencia A., 2013, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V25, P19, DOI 10.1007/s13219-012-0064-4; Gomez-Olivencia A, 2007, J HUM EVOL, V53, P6, DOI 10.1016/j.jhevol.2006.12.006; Gomez-Olivencia A, 2013, J HUM EVOL, V64, P582, DOI 10.1016/j.jhevol.2013.02.006; Gomez-Olivencia A, 2013, J HUM EVOL, V64, P608, DOI 10.1016/j.jhevol.2013.02.008; Gonzalez-Reimers E, 2001, ANN RHEUM DIS, V60, P174; Guatelli-Steinberg D, 2004, J HUM EVOL, V47, P65, DOI 10.1016/j.jhevol.2004.05.004; Guenkel S, 2013, RADIOL RES PRACT, V2013, DOI 10.1155/2013/957280; HAAKONSEN M, 1995, ACTA ORTHOP SCAND, V66, P369, DOI 10.3109/17453679508995564; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Holliday TW, 2014, CURR ANTHROPOL, V55, P696, DOI 10.1086/679068; Hu Y, 2014, J SPINAL DISORD TECH, V27, pE219, DOI 10.1097/BSD.0b013e31829a36c5; Hu Y, 2009, SPINE, V34, pE418, DOI 10.1097/BRS.0b013e3181a0ff2f; Hummel E, 2013, SPINE J, V13, pE1, DOI 10.1016/j.spinee.2013.01.024; Jans Christophe, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.04.2009.1824; Jefferson G, 1920, BRIT J SURG, V7, P407; Jin M, 2014, SPINE J, V14, P1155, DOI 10.1016/j.spinee.2013.07.482; Junewick JJ, 2011, AM J ROENTGENOL, V197, P1229, DOI 10.2214/AJR.10.5403; Karwacki GM, 2012, AM J NEURORADIOL, V33, P1882, DOI 10.3174/ajnr.A3105; Klimo P, 2003, SPINE, V28, pE224, DOI 10.1097/00007632-200306150-00023; Kwon JK, 2009, J KOREAN NEUROSURG S, V46, P522, DOI 10.3340/jkns.2009.46.6.522; Lalueza-Fox C, 2012, QUATERN INT, V247, P10, DOI 10.1016/j.quaint.2010.10.012; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; LANDELLS CD, 1988, SPINE, V13, P450, DOI 10.1097/00007632-198805000-00002; Le Minor J. M., 1991, Archives d'Anatomie d'Histologie et d'Embryologie, V74, P11; LEE C, 1991, AM J NEURORADIOL, V12, P1105; Leonardi R, 2009, ANGLE ORTHOD, V79, P727, DOI 10.2319/082408-448.1; LEVINE AM, 1991, J BONE JOINT SURG AM, V73A, P680, DOI 10.2106/00004623-199173050-00006; LIPSON SJ, 1978, J BONE JOINT SURG AM, V60, P1104, DOI 10.2106/00004623-197860080-00016; MARTICH V, 1992, RADIOLOGY, V183, P125, DOI 10.1148/radiology.183.1.1532260; Martirosyan NL, 2011, NEUROSURGERY, V69, pE1317, DOI 10.1227/NEU.0b013e31822a9ab1; Menezes AH, 2008, CHILD NERV SYST, V24, P1109, DOI 10.1007/s00381-008-0600-1; Merbs CF, 2004, AM J PHYS ANTHROPOL, V123, P236, DOI 10.1002/ajpa.10264; Muthu SK, 2007, EMERG RADIOL, V13, P337, DOI 10.1007/s10140-006-0565-x; OGDEN JA, 1984, SKELETAL RADIOL, V12, P12, DOI 10.1007/BF00373169; Ogilvie MD, 1998, J HUM EVOL, V35, P597, DOI 10.1006/jhev.1998.0249; OGILVIE MD, 1989, AM J PHYS ANTHROPOL, V79, P25, DOI 10.1002/ajpa.1330790104; Osher SJ, 2004, BRIT J ORAL MAX SURG, V42, P270, DOI 10.1016/j.bjoms.2004.01.006; Osti Michael, 2006, Eur Spine J, V15 Suppl 5, P564, DOI 10.1007/s00586-005-0017-4; PALMA A, 1990, Archivio Italiano di Anatomia e di Embriologia, V95, P11; Pang D, 2014, PEDIATRIC CRANIOVERT, P19; Park JS, 2011, SPINE, V36, pE144, DOI 10.1097/BRS.0b013e3181efa320; Pascual-Gallego M, 2014, NEUROCIRUGIA, V25, P29, DOI 10.1016/j.neucir.2012.10.002; Pena-Melian A, 2011, ANAT REC, V294, P1370, DOI 10.1002/ar.21427; Petraglia Anthony L, 2012, Surg Neurol Int, V3, P126, DOI 10.4103/2152-7806.102351; Petre BM, 2012, ORTHOPEDICS, V35, pE1449, DOI 10.3928/01477447-20120822-39; Piatt JH, 2011, J NEUROSURG-PEDIATR, V8, P235, DOI 10.3171/2011.6.PEDS11187; Popat H, 2008, BRIT DENT J, V204, P303, DOI 10.1038/bdj.2008.199; Prempeh RC, 2002, SPINAL CORD, V40, P92, DOI 10.1038/sj.sc.3101230; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Radov~ci J., 1988, KRAPINA HOMINIDS ILL; Raikkonen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067218; Rao RD, 2013, J BONE JOINT SURG AM, V95A, P1605, DOI 10.2106/JBJS.L.01035; Reumer JWF, 2014, PEERJ, V2, DOI 10.7717/peerj.318; Rios L, 2007, JORNADES ANTROPOLOGI, P12; Rios L, 2010, FORENSIC SCI INT, V199, pE27, DOI 10.1016/j.forsciint.2010.02.023; Rogers SA, 2011, ANGLE ORTHOD, V81, P350, DOI 10.2319/032210-165.1; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Rosas A, 2015, J HUM EVOL, V82, P51, DOI 10.1016/j.jhevol.2015.02.018; Rosas A, 2013, CR PALEVOL, V12, P279, DOI 10.1016/j.crpv.2013.06.003; Rosas A, 2012, ANTHROPOLOGIE, V116, P57, DOI 10.1016/j.anthro.2011.12.003; Sanchez-Quinto F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0374; Sanchis-Gimeno JA, 2014, FORENSIC SCI INT, V242, pE1, DOI 10.1016/j.forsciint.2014.06.016; Sanchis-Gimeno JA, 2011, EUR SPINE J, V20, P1574, DOI 10.1007/s00586-011-1715-8; SANDHAM A, 1986, CLEFT PALATE J, V23, P206; Sasaka KK, 2006, EMERG RADIOL, V12, P130, DOI 10.1007/s10140-005-0455-7; SAUNDERS SR, 1978, AM J PHYS ANTHROPOL, V49, P193, DOI 10.1002/ajpa.1330490207; Scheuer L., 2000, DEV JUVENIL OSTEOLOG; Schrodel MH, 2005, EMERG MED J, V22, P526, DOI 10.1136/emj.2003.006759; SEGAL LS, 1987, J BONE JOINT SURG AM, V69A, P1423; Selby S, 1955, AM J PHYS ANTHROP-NE, V13, P129, DOI 10.1002/ajpa.1330130110; Senoglu M, 2007, J NEUROSURG-SPINE, V7, P399, DOI 10.3171/SPI-07/10/399; Sholts SB, 2010, AM J PHYS ANTHROPOL, V143, P155, DOI 10.1002/ajpa.21343; Trinkaus E, 2011, P NATL ACAD SCI USA, V108, P1267, DOI 10.1073/pnas.1018700108; Tyrrell AJ, 2004, INT J OSTEOARCHAEOL, V14, P52, DOI 10.1002/oa.712; Ugar DA, 2001, CLEFT PALATE-CRAN J, V38, P498, DOI 10.1597/1545-1569_2001_038_0498_tpoaot_2.0.co_2; WALKER J, 1995, ACTA RADIOL, V36, P152; Wang SL, 2010, EUR SPINE J, V19, P361, DOI 10.1007/s00586-009-1208-1; Wasterlain SN, 2016, INT J OSTEOARCHAEOL, V26, P621, DOI 10.1002/oa.2453; Wolf RFE, 1997, SURG RADIOL ANAT, V19, P339, DOI 10.1007/BF01637605; Wood RE, 2013, ARCHAEOMETRY, V55, P148, DOI 10.1111/j.1475-4754.2012.00671.x; Wu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059587; Yang J, 2008, AM J EPIDEMIOL, V167, P145, DOI 10.1093/aje/kwm283	119	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0136550	10.1371/journal.pone.0136550	http://dx.doi.org/10.1371/journal.pone.0136550			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418427	gold, Green Submitted, Green Published			2022-12-27	WOS:000362171400003
J	Welge, WA; Barton, JK				Welge, Weston A.; Barton, Jennifer K.			Expanding Functionality of Commercial Optical Coherence Tomography Systems by Integrating a Custom Endoscope	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; ULTRAHIGH-RESOLUTION; DISPERSION COMPENSATION; NEEDLE PROBE; HIGH-SPEED; ENDOMICROSCOPY; CATHETER; BIOPSY; CANCER; COLON	Optical coherence tomography (OCT) is a useful imaging modality for detecting and monitoring diseases of the gastrointestinal tract and other tubular structures. The non-destructiveness of OCT enables time-serial studies in animal models. While turnkey commercial research OCT systems are plenty, researchers often require custom imaging probes. We describe the integration of a custom endoscope with a commercial swept-source OCT system and generalize this description to any imaging probe and OCT system. A numerical dispersion compensation method is also described. Example images demonstrate that OCT can visualize the mouse colon crypt structure and detect adenoma in vivo.	[Welge, Weston A.; Barton, Jennifer K.] Univ Arizona, Ctr Opt Sci, Tucson, AZ 85721 USA; [Barton, Jennifer K.] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA	University of Arizona; University of Arizona	Welge, WA (corresponding author), Univ Arizona, Ctr Opt Sci, Tucson, AZ 85721 USA.	wwelge@email.arizona.edu; barton@email.arizona.edu			National Cancer Institute [R01CA109385]; National Heart, Lung, and Blood Institute of the National Institutes of Health [T32HL007955]; American Society for Laser Medicine and Surgery Student Research Grant; NATIONAL CANCER INSTITUTE [R01CA109385] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007955] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Society for Laser Medicine and Surgery Student Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Cancer Institute (cancer.gov) and the National Heart, Lung, and Blood Institute (nhlbi.nih.gov) of the National Institutes of Health under award numbers R01CA109385 (JKB) and T32HL007955 (WAW), respectively, and the American Society for Laser Medicine and Surgery (aslms.org) Student Research Grant (WAW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DC, 2007, NAT PHOTONICS, V1, P709, DOI 10.1038/nphoton.2007.228; Alrawi SJ, 2006, ANTICANCER RES, V26, P107; Bonnema GT, 2009, J BIOPHOTONICS, V2, P353, DOI 10.1002/jbio.200910024; Cense B, 2004, OPT EXPRESS, V12, P2435, DOI 10.1364/OPEX.12.002435; Choi HY, 2008, OPT LETT, V33, P34, DOI 10.1364/OL.33.000034; Drexler W, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.071412; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; Fercher AF, 2002, OPT COMMUN, V204, P67, DOI 10.1016/S0030-4018(02)01137-9; Hadri LP, 2007, CANCER BIOL THER, V6, P1753, DOI 10.4161/cbt.6.11.4852; Hatta W, 2012, GASTROINTEST ENDOSC, V76, P548, DOI 10.1016/j.gie.2012.05.012; Herz PR, 2004, OPT EXPRESS, V12, P3532, DOI 10.1364/OPEX.12.003532; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Keenan MR, 2015, LASER SURG MED, V47, P30, DOI 10.1002/lsm.22307; Lorenser D, 2011, OPT LETT, V36, P3894, DOI 10.1364/OL.36.003894; Marks DL, 2003, APPL OPTICS, V42, P204, DOI 10.1364/AO.42.000204; Quirk BC, 2014, OPT LETT, V39, P2888, DOI 10.1364/OL.39.002888; Reed WA, 2002, OPT LETT, V27, P1794, DOI 10.1364/OL.27.001794; Suter MJ, 2014, GASTROINTEST ENDOSC, V79, P886, DOI 10.1016/j.gie.2013.11.016; Swanson E, 2014, P SOC PHOTO-OPT INS, V8934, DOI [10.1117/12.2064185, DOI 10.1117/12.2064185]; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Tearney GJ, 1996, OPT LETT, V21, P543, DOI 10.1364/OL.21.000543; Tsai TH, 2014, BIOMED OPT EXPRESS, V5, P4387, DOI 10.1364/BOE.5.004387; Tsai TH, 2013, BIOMED OPT EXPRESS, V4, P1119, DOI 10.1364/BOE.4.001119; Tumlinson AR, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2399454; Welge WA, 2013, PROC SPIE, V8575, DOI 10.1117/12.2002655; Winkler AM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3446674; Wojtkowski M, 2004, OPT EXPRESS, V12, P2404, DOI 10.1364/OPEX.12.002404; Xie Yijing, 2014, Front Neuroeng, V7, P34, DOI 10.3389/fneng.2014.00034; Zhang N, 2014, OPT LETT, V39, P186, DOI 10.1364/OL.39.000186; Zhao MT, 2012, OPT LETT, V37, P4835, DOI 10.1364/OL.37.004835; Zhou C, 2012, GASTROINTEST ENDOSC, V76, P32, DOI 10.1016/j.gie.2012.02.003	31	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139396	10.1371/journal.pone.0139396	http://dx.doi.org/10.1371/journal.pone.0139396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418811	gold, Green Submitted, Green Published			2022-12-27	WOS:000362171400087
J	Johnston, S; Kendall, C; Hogel, M; McLaren, M; Liddy, C				Johnston, Sharon; Kendall, Claire; Hogel, Matthew; McLaren, Meaghan; Liddy, Clare			Measures of Quality of Care for People with HIV: A Scoping Review of Performance Indicators for Primary Care	PLOS ONE			English	Review							HEALTH-CARE; SYSTEM	The healthcare of people with HIV is transitioning from specialty care to the primary healthcare (PHC) system. However, many of the performance indicators used to measure the quality of HIV care pre-date this transition. The goal of this work was to examine how existing HIV care performance indicators measure the comprehensive and longitudinal care offered in a PHC setting. A scoping review consisting of peer-reviewed and grey literature searches was performed. Two reviewers evaluated study eligibility and indicators in documents meeting inclusion criteria were extracted into a database. Indicators were matched to a PHC performance measurement framework to determine their applicability for evaluating quality of care in the PHC setting. The literature search identified 221 publications, of which 47 met inclusion criteria. 1184 indicators were extracted and removal of duplicates left 558 unique indicators. A majority of the 558 indicators fell under the 'secondary prevention' (12%) and 'care of chronic conditions' (33%) domains when indicators were matched to the PHC performance framework. Despite the imbalance, nearly all performance domains in the PHC framework were populated by at least one indicator with significant concentrations in domains such as patient-provider relationship, patient satisfaction, population and community characteristics, and access to care. Existing performance frameworks for the care of people with HIV provide a comprehensive set of indicators that align well with a PHC performance framework. Nonetheless, some important elements of care, such as patient-reported outcomes, are poorly covered by existing indicators. Advancing our understanding of how the experience of care for people with HIV is impacted by changes in health services delivery, specifically more care within the PHC system, will require performance indicators to capture this aspect of HIV care.	[Johnston, Sharon; Kendall, Claire; McLaren, Meaghan; Liddy, Clare] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Johnston, Sharon; Kendall, Claire; Hogel, Matthew; McLaren, Meaghan; Liddy, Clare] Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Johnston, S (corresponding author), Univ Ottawa, Dept Family Med, Ottawa, ON, Canada.	sjohnston@bruyere.org		Hogel, Matthew/0000-0002-1193-1746	Canadian Institutes of Health Research [TT5-128270]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) Grant number TT5-128270. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Best A, 2012, MILBANK Q, V90, P421, DOI 10.1111/j.1468-0009.2012.00670.x; Calkins E, 1999, NEW WAYS CARE OLDER; Canadian Institute for Health Information, 2012, PAN CAN PRIM HLTH CA; Chu C, 2011, J URBAN HEALTH, V88, P556, DOI 10.1007/s11524-011-9552-y; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg W, 2008, INT J QUAL HEALTH C, V20, P308, DOI 10.1093/intqhc/mzm054; HRSA HIV/AIDS Bureau, 2012, HLTH RES SERV ADM HI; Kerr CA, 2012, AM J MED QUAL, V27, P321, DOI 10.1177/1062860611425714; Liddy C, 2013, ADV PRIMARY HEALTHCA; McKee M, 2009, PERFORMANCE MEASUREM, P406; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; New York Department of Health AIDS Institute, 2002, PAT SAT SURV HIV AMB; New York Department of Health AIDS Institute, 2004, HIV CLIN RES; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Schoen C, 2008, HLTH AFFAIRS MILLWOO, V28, pw1, DOI DOI 10.1377/HLTHAFF.28.1.W1; Smith P. C., 2009, PERFORMANCE MEASUREM, P3; The Primary Care Performance Measurement Steering Committee, 2014, PRIM CAR PERF MEAS F	20	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0136757	10.1371/journal.pone.0136757	http://dx.doi.org/10.1371/journal.pone.0136757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EO	26414994	gold, Green Published, Green Submitted			2022-12-27	WOS:000362170700005
J	Wallen, MC; Gaj, T; Barbas, CF				Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III			Redesigning Recombinase Specificity for Safe Harbor Sites in the Human Genome	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; DNA-SEQUENCE SPECIFICITY; GAMMA-DELTA-RESOLVASE; HUMAN-CELLS; DIRECTED EVOLUTION; SERINE RECOMBINASE; STAPHYLOCOCCUS-AUREUS; CHIMERIC NUCLEASES; MAMMALIAN GENOMES; CRYSTAL-STRUCTURE	Site-specific recombinases (SSRs) are valuable tools for genetic engineering due to their ability to manipulate DNA in a highly specific manner. Engineered zinc-finger and TAL effector recombinases, in particular, are two classes of SSRs composed of custom-designed DNA-binding domains fused to a catalytic domain derived from the resolvase/invertase family of serine recombinases. While TAL effector and zinc-finger proteins can be assembled to recognize a wide range of possible DNA sequences, recombinase catalytic specificity has been constrained by inherent base requirements present within each enzyme. In order to further expand the targeted recombinase repertoire, we used a genetic screen to isolate enhanced mutants of the Bin and Tn21 recombinases that recognize target sites outside the scope of other engineered recombinases. We determined the specific base requirements for recombination by these enzymes and demonstrate their potential for genome engineering by selecting for variants capable of specifically recombining target sites present in the human CCR5 gene and the AAVS1 safe harbor locus. Taken together, these findings demonstrate that complementing functional characterization with protein engineering is a potentially powerful approach for generating recombinases with expanded targeting capabilities.	[Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Wallen, Mark C.; Gaj, Thomas; Barbas, Carlos F., III] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wallen, MC (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	mcwallen@scripps.edu			National Institutes of Health [DP1 CA174426]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [DP1CA174426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (Pioneer Award DP1 CA174426 to C.F.B.) and The Skaggs Institute for Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian A, 2003, P NATL ACAD SCI USA, V100, P8688, DOI 10.1073/pnas.1533177100; Arnold PH, 1999, EMBO J, V18, P1407, DOI 10.1093/emboj/18.5.1407; Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolusani S, 2006, NUCLEIC ACIDS RES, V34, P5259, DOI 10.1093/nar/gkl548; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gaj T, 2014, METHOD ENZYMOL, V546, P79, DOI 10.1016/B978-0-12-801185-0.00004-0; Gaj T, 2014, J AM CHEM SOC, V136, P5047, DOI 10.1021/ja4130059; Gaj T, 2014, BIOTECHNOL BIOENG, V111, P1, DOI 10.1002/bit.25096; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2013, NUCLEIC ACIDS RES, V41, P3937, DOI 10.1093/nar/gkt071; Gaj T, 2011, P NATL ACAD SCI USA, V108, P498, DOI 10.1073/pnas.1014214108; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; Gersbach CA, 2010, NUCLEIC ACIDS RES, V38, P4198, DOI 10.1093/nar/gkq125; GLASGOW AC, 1989, J BIOL CHEM, V264, P10072; Gordley RM, 2007, J MOL BIOL, V367, P802, DOI 10.1016/j.jmb.2007.01.017; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAHMANN R, 1985, CELL, V41, P771, DOI 10.1016/S0092-8674(85)80058-1; Keenholtz RA, 2011, STRUCTURE, V19, P799, DOI 10.1016/j.str.2011.03.017; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; KLIPPEL A, 1988, EMBO J, V7, P3983, DOI 10.1002/j.1460-2075.1988.tb03286.x; Kolb AF, 2005, TRENDS BIOTECHNOL, V23, P399, DOI 10.1016/j.tibtech.2005.06.005; KRASNOW MA, 1983, CELL, V32, P1313, DOI 10.1016/0092-8674(83)90312-4; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; NEWMAN BJ, 1984, CELL, V38, P463, DOI 10.1016/0092-8674(84)90501-4; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Proudfoot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019537; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ritacco CJ, 2013, NUCLEIC ACIDS RES, V41, P2673, DOI 10.1093/nar/gks1303; ROGOWSKY P, 1985, EMBO J, V4, P2135, DOI 10.1002/j.1460-2075.1985.tb03904.x; ROJO F, 1995, NUCLEIC ACIDS RES, V23, P3181, DOI 10.1093/nar/23.16.3181; Rowland SJ, 2009, MOL MICROBIOL, V74, P282, DOI 10.1111/j.1365-2958.2009.06756.x; ROWLAND SJ, 1990, MOL MICROBIOL, V4, P961, DOI 10.1111/j.1365-2958.1990.tb00669.x; Rowland SJ, 2002, MOL MICROBIOL, V44, P607, DOI 10.1046/j.1365-2958.2002.02897.x; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Schneider F, 2000, J MOL BIOL, V295, P767, DOI 10.1006/jmbi.1999.3412; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Segal DJ, 2004, J BIOL CHEM, V279, P14509, DOI 10.1074/jbc.M400349200; Sirk SJ, 2014, NUCLEIC ACIDS RES, V42, P4755, DOI 10.1093/nar/gkt1389; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; WELLS RG, 1984, J MOL BIOL, V179, P667, DOI 10.1016/0022-2836(84)90161-X; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0	67	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139123	10.1371/journal.pone.0139123	http://dx.doi.org/10.1371/journal.pone.0139123			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414179	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700044
J	Yakimovich, A; Andriasyan, V; Witte, R; Wang, IH; Prasad, V; Suomalainen, M; Greber, UF				Yakimovich, Artur; Andriasyan, Vardan; Witte, Robert; Wang, I-Hsuan; Prasad, Vibhu; Suomalainen, Maarit; Greber, Urs F.			Plaque2.0-A High-Throughput Analysis Framework to Score Virus-Cell Transmission and Clonal Cell Expansion	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN ADENOVIRUS; HUMAN RHINOVIRUS; IN-VITRO; RECEPTOR; SPREAD; ENTRY; INTEGRINS; MECHANISM; VIVO	Classical plaque assay measures the propagation of infectious agents across a monolayer of cells. It is dependent on cell lysis, and limited by user-specific settings and low throughput. Here, we developed Plaque2.0, a broadly applicable, fluorescence microscopy-based high-throughput method to mine patho-biological clonal cell features. Plaque2.0 is an open source framework to extract information from chemically fixed cells by immuno-histochemistry or RNA in situ hybridization, or from live cells expressing GFP transgene. Multi-parametric measurements include infection density, intensity, area, shape or location information at single plaque or population levels. Plaque2.0 distinguishes lytic and non-lytic spread of a variety of DNA and RNA viruses, including vaccinia virus, adenovirus and rhinovirus, and can be used to visualize simultaneous plaque formation from co-infecting viruses. Plaque2.0 also analyzes clonal growth of cancer cells, which is relevant for cell migration and metastatic invasion studies. Plaque2.0 is suitable to quantitatively analyze virus infections, vector properties, or cancer cell phenotypes.	[Yakimovich, Artur; Andriasyan, Vardan; Witte, Robert; Wang, I-Hsuan; Prasad, Vibhu; Suomalainen, Maarit; Greber, Urs F.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Greber, UF (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	urs.greber@imls.uzh.ch	Prasad, Vibhu/AAG-8493-2020; Prasad, Vibhu Ranjan/E-6107-2011; Wang, I-Hsuan/AAC-1200-2019; Yakimovich, Artur/AAA-5565-2020; Greber, Urs/G-9458-2015	Prasad, Vibhu/0000-0001-7450-607X; Wang, I-Hsuan/0000-0003-2159-7347; Yakimovich, Artur/0000-0003-2458-4904; Greber, Urs/0000-0003-2278-120X	Swiss National Science Foundation [31003A_141222/1, 310030B_160316]; Medical Research and Development project VirX from SystemsX.ch; Novartis Foundation; Kanton Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research and Development project VirX from SystemsX.ch; Novartis Foundation(Novartis); Kanton Zurich	Funding was obtained from the Swiss National Science Foundation (31003A_141222/1 and 310030B_160316 to UFG), the Medical Research and Development project VirX from SystemsX.ch (to UFG), the Novartis Foundation, and the Kanton Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigas M, 2006, MICROELECTRON J, V37, P433, DOI 10.1016/j.mejo.2005.07.002; Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111; Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Burckhardt CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000621; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cordeiro JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008506; D'Herelle F., 1926, NATURE, V118, P183, DOI [10.1038/118183a0, DOI 10.1038/118183A0]; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Doronin K, 2003, VIROLOGY, V305, P378, DOI 10.1006/viro.2002.1772; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; Dziedzic K, 2014, SEMIN CELL DEV BIOL, V36, P57, DOI 10.1016/j.semcdb.2014.08.003; Edlmayr J, 2011, EUR RESPIR J, V37, P44, DOI 10.1183/09031936.00149109; Flatt JW, 2015, CELLS-BASEL, V4, P277, DOI 10.3390/cells4030277; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Greber UF, 2007, CELL HOST MICROBE, V2, P143, DOI 10.1016/j.chom.2007.08.004; Helmuth JA, 2009, J STRUCT BIOL, V167, P1, DOI 10.1016/j.jsb.2009.03.017; Helmuth JA, 2007, J STRUCT BIOL, V159, P347, DOI 10.1016/j.jsb.2007.04.003; Hendrickx R, 2014, HUM GENE THER, V25, P265, DOI 10.1089/hum.2014.001; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976; Jurgeit A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-264; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; LAUTER CB, 1974, ANTIMICROB AGENTS CH, V6, P598, DOI 10.1128/AAC.6.5.598; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Lutschg V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1391; Luisoni S, 2015, CELL HOST MICROBE, V18, P75, DOI 10.1016/j.chom.2015.06.006; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Mercer J, 2003, J VIROL, V77, P8857, DOI 10.1128/JVI.77.16.8857-8871.2003; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107; Merilahti P, 2012, ADV VIROL, V2012, DOI 10.1155/2012/547530; Moss B, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010199; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nagel H, 2003, GENE THER, V10, P1643, DOI 10.1038/sj.gt.3302058; Nichol PF, 1996, J VIROL, V70, P5476, DOI 10.1128/JVI.70.8.5476-5486.1996; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PAYNE LG, 1980, J GEN VIROL, V50, P89, DOI 10.1099/0022-1317-50-1-89; Prasad V, 2014, J VIROL, V88, P13086, DOI 10.1128/JVI.02156-14; Puntener D, 2011, J VIROL, V85, P481, DOI 10.1128/JVI.01571-10; Reddy VS, 2010, SCIENCE, V329, P1071, DOI 10.1126/science.1187292; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Roulin PS, 2014, CELL HOST MICROBE, V16, P677, DOI 10.1016/j.chom.2014.10.003; Sanderson CM, 1998, J GEN VIROL, V79, P1415, DOI 10.1099/0022-1317-79-6-1415; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schumann M, 2006, CANCER RES, V66, P1282, DOI 10.1158/0008-5472.CAN-05-1484; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Suomalainen M, 2013, CURR OPIN VIROL, V3, P27, DOI 10.1016/j.coviro.2012.12.004; Wang XM, 2006, J IMMUNOL, V177, P6859, DOI 10.4049/jimmunol.177.10.6859; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Wolfrum N, 2013, CELL MICROBIOL, V15, P53, DOI 10.1111/cmi.12053; Yakimovich A, 2012, J VIROL, V86, P10123, DOI 10.1128/JVI.01102-12; Yoon M, 2002, J VIROL, V76, P7203, DOI 10.1128/JVI.76.14.7203-7208.2002; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu YZ, 2014, WORLD J GASTROENTERO, V20, P3457, DOI 10.3748/wjg.v20.i13.3457	62	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138760	10.1371/journal.pone.0138760	http://dx.doi.org/10.1371/journal.pone.0138760			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413745	gold, Green Published, Green Accepted			2022-12-27	WOS:000362170700021
J	Cha, SB; Jeon, BY; Kim, WS; Kim, JS; Kim, HM; Kwon, KW; Cho, SN; Shin, SJ; Koh, WJ				Cha, Seung Bin; Jeon, Bo Young; Kim, Woo Sik; Kim, Jong-Seok; Kim, Hong Min; Kwon, Kee Woong; Cho, Sang-Nae; Shin, Sung Jae; Koh, Won-Jung			Experimental Reactivation of Pulmonary Mycobacterium avium Complex Infection in a Modified Cornell-Like Murine Model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LATENT TUBERCULOSIS; TUBERCLE-BACILLI; THERAPY; DISEASE; DIFFERENTIATION; SUSCEPTIBILITY; PERSISTENCE; DIAGNOSIS; RISK	The latency and reactivation of Mycobacterium tuberculosis infection has been well studied. However, there have been few studies of the latency and reactivation of Mycobacterium avium complex (MAC), the most common etiological non-tuberculous Mycobacterium species next to M. tuberculosis in humans worldwide. We hypothesized that latent MAC infections can be reactivated following immunosuppression after combination chemotherapy with clarithromycin and rifampicin under experimental conditions. To this end, we employed a modified Cornell-like murine model of tuberculosis and investigated six strains consisting of two type strains and four clinical isolates of M. avium and M. intracellulare. After aerosol infection of each MAC strain, five to six mice per group were euthanized at 2, 4, 10, 18, 28 and 35 weeks post-infection, and lungs were sampled to analyze bacterial burden and histopathology. One strain of each species maintained a culture-negative state for 10 weeks after completion of 6 weeks of chemotherapy, but was reactivated after 5 weeks of immunosuppression in the lungs with dexamethasone (three out of six mice in M. avium infection) or sulfasalazine (four out of six mice in both M. avium and M. intracellulare infection). The four remaining MAC strains exhibited decreased bacterial loads in response to chemotherapy; however, they remained at detectable levels and underwent regrowth after immunosuppression. In addition, the exacerbated lung pathology demonstrated a correlation with bacterial burden after reactivation. In conclusion, our results suggest the possibility of MAC reactivation in an experimental mouse model, and experimentally demonstrate that a compromised immune status can induce reactivation and/or regrowth of MAC infection.	[Cha, Seung Bin; Kim, Woo Sik; Kim, Jong-Seok; Kim, Hong Min; Kwon, Kee Woong; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol,Inst Immunol & Immunol Dis, Seoul, South Korea; [Jeon, Bo Young] Yonsei Univ, Coll Hlth Sci, Dept Biomed Lab Sci, Wonju, South Korea; [Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Sungkyunkwan University (SKKU); Samsung Medical Center	Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol,Inst Immunol & Immunol Dis, Seoul, South Korea.	sjshin@yuhs.ac; wjkoh@skku.edu	Koh, Won-Jung/D-9586-2018; Koh, Won Jung/C-9595-2011	Koh, Won-Jung/0000-0002-4756-3527; Shin, Sung Jae/0000-0003-0854-4582	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A120647]; Basic Science Research Program through the Ministry of Science, ICT, and Future Planning [NRF-2013R1A2A1A01009932]; Samsung Medical Center	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea; Basic Science Research Program through the Ministry of Science, ICT, and Future Planning; Samsung Medical Center(Samsung)	This work was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A120647) and the Basic Science Research Program through the Ministry of Science, ICT, and Future Planning (NRF-2013R1A2A1A01009932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Samsung Medical Center provided support in the form of salary for the author Won-Jung Koh, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Bussone G, 2012, J INFECTION, V64, P613, DOI 10.1016/j.jinf.2011.12.020; Cardona PJ, 1999, SCAND J IMMUNOL, V49, P362; CLSI, 2011, CONTRACT NO CLSI DOC; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Fukunaga H, 2002, AM J RESP CRIT CARE, V166, P994, DOI 10.1164/rccm.2111028; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Guide SV, 2002, INFECT DIS CLIN N AM, V16, P163, DOI 10.1016/S0891-5520(03)00051-5; Jeon BY, 2011, MICROBES INFECT, V13, P284, DOI 10.1016/j.micinf.2010.11.002; Jeong BH, 2015, AM J RESP CRIT CARE, V191, P96, DOI 10.1164/rccm.201408-1545OC; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kendall BA, 2013, SEMIN RESP CRIT CARE, V34, P87, DOI 10.1055/s-0033-1333567; Khan K, 2007, AM J RESP CRIT CARE, V176, P306, DOI 10.1164/rccm.200702-201OC; Koh WJ, 2012, CHEST, V142, P1482, DOI 10.1378/chest.12-0494; LAMBRECHT RS, 1988, APPL ENVIRON MICROB, V54, P910, DOI 10.1128/AEM.54.4.910-916.1988; Lee SK, 2013, LUNG, V191, P565, DOI 10.1007/s00408-013-9481-5; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Maslow JN, 2003, J INFECT DIS, V187, P1748, DOI 10.1086/374985; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; Reed C, 2006, AM J EPIDEMIOL, V164, P32, DOI 10.1093/aje/kwj159; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Scanga CA, 1999, INFECT IMMUN, V67, P4531, DOI 10.1128/IAI.67.9.4531-4538.1999; Sexton P, 2008, EUR RESPIR J, V31, P1322, DOI 10.1183/09031936.00140007; Shin SJ, 2010, J CLIN MICROBIOL, V48, P4057, DOI 10.1128/JCM.00904-10; Taga S., 2014, JMM CASE REP, V1, P1, DOI [10.1099/jmmcr.0.000935, DOI 10.1099/JMMCR.0.000935]; Torrelles JB, 2002, TUBERCULOSIS, V82, P293, DOI 10.1054/tube.2002.0373; Turenne CY, 2006, J CLIN MICROBIOL, V44, P433, DOI 10.1128/JCM.44.2.433-440.2006; van Ingen J, 2012, AM J RESP CRIT CARE, V186, P559, DOI 10.1164/rccm.201204-0682OC; Wallace RJ, 2014, CHEST, V146, P276, DOI 10.1378/chest.13-2538; Winthrop KL, 2013, ANN RHEUM DIS, V72, P37, DOI 10.1136/annrheumdis-2011-200690; Yoo JW, 2014, EUR RESPIR J, V44, P1289, DOI 10.1183/09031936.00063514	35	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139251	10.1371/journal.pone.0139251	http://dx.doi.org/10.1371/journal.pone.0139251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406237	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700198
J	Cheng, C; MacIntyre, L; Abdelmohsen, UR; Horn, H; Polymenakou, PN; Edrada-Ebel, R; Hentschel, U				Cheng, Cheng; MacIntyre, Lynsey; Abdelmohsen, Usama Ramadan; Horn, Hannes; Polymenakou, Paraskevi N.; Edrada-Ebel, RuAngelie; Hentschel, Ute			Biodiversity, Anti-Trypanosomal Activity Screening, and Metabolomic Profiling of Actinomycetes Isolated from Mediterranean Sponges	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; MASS-SPECTROMETRY; NATURAL-PRODUCTS; POLY(ADP-RIBOSE) SYNTHETASE; ANTIMYCOBACTERIAL PEPTIDES; DEREPLICATION STRATEGIES; ANTIMICROBIAL ACTIVITIES; EPOXYDON GROUP; TERREIC ACID	Marine sponge-associated actinomycetes are considered as promising sources for the discovery of novel biologically active compounds. In the present study, a total of 64 actinomycetes were isolated from 12 different marine sponge species that had been collected offshore the islands of Milos and Crete, Greece, eastern Mediterranean. The isolates were affiliated to 23 genera representing 8 different suborders based on nearly full length 16S rRNA gene sequencing. Four putatively novel species belonging to genera Geodermatophilus, Microlunatus, Rhodococcus and Actinomycetospora were identified based on a 16S rRNA gene sequence similarity of < 98.5% to currently described strains. Eight actinomycete isolates showed bioactivities against Trypanosma brucei brucei TC221 with half maximal inhibitory concentration (IC50) values <20 mu g/mL. Thirty four isolates from the Milos collection and 12 isolates from the Crete collection were subjected to metabolomic analysis using high resolution LC-MS and NMR for dereplication purposes. Two isolates belonging to the genera Streptomyces (SBT348) and Micromonospora (SBT687) were prioritized based on their distinct chemistry profiles as well as their anti-trypanosomal activities. These findings demonstrated the feasibility and efficacy of utilizing metabolomics tools to prioritize chemically unique strains from microorganism collections and further highlight sponges as rich source for novel and bioactive actinomycetes.	[Cheng, Cheng; Abdelmohsen, Usama Ramadan; Horn, Hannes; Hentschel, Ute] Univ Wurzburg, Dept Bot 2, Julius von Sachs Inst Biol Sci, D-97070 Wurzburg, Germany; [MacIntyre, Lynsey; Edrada-Ebel, RuAngelie] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Polymenakou, Paraskevi N.] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Crete, Greece	University of Wurzburg; University of Strathclyde; Hellenic Centre for Marine Research	Edrada-Ebel, R (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	ruangelie.edrada-ebel@strath.ac.uk; ute.hentschel@uni-wuerzburg.de	Polymenakou, Paraskevi/AAW-5313-2020; Abdelmohsen, Usama Ramadan/AAX-9874-2020; Hentschel, Ute/H-8343-2013; Hentschel, Ute/ABD-6624-2021; Edrada-Ebel, RuAngelie/G-6127-2015	Abdelmohsen, Usama Ramadan/0000-0002-1014-6922; Hentschel, Ute/0000-0003-0596-790X; Hentschel, Ute/0000-0003-0596-790X; Edrada-Ebel, RuAngelie/0000-0003-2420-1117; Horn, Hannes/0000-0003-0324-5241	SeaBioTech - European Commission [KBBE.2012.3.2-01, 311932]	SeaBioTech - European Commission	This work was supported by SeaBioTech, funded by the European Commission within its FP7 Programme, under the thematic area KBBE.2012.3.2-01 with Grant Number 311932 (http://spider.science.strath.ac.uk/seabiotech/).	Abdelmohsen UR, 2014, MAR DRUGS, V12, P1220, DOI 10.3390/md12031220; Abdelmohsen UR, 2014, NAT PROD REP, V31, P381, DOI 10.1039/c3np70111e; Abdelmohsen UR, 2012, MAR DRUGS, V10, P2208, DOI 10.3390/md10102208; Abdelmohsen UR, 2012, TETRAHEDRON LETT, V53, P23, DOI 10.1016/j.tetlet.2011.10.051; Abdelmohsen UR, 2010, MAR DRUGS, V8, P399, DOI 10.3390/md8030399; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AOYAGI T, 1988, J ANTIBIOT, V41, P1009, DOI 10.7164/antibiotics.41.1009; Balskus EP, 2014, NAT CHEM BIOL, V10, P611, DOI 10.1038/nchembio.1588; Cain R B, 1968, Antonie Van Leeuwenhoek, V34, P17; Chagas-Paula DA, 2015, METABOLITES, V5, P404, DOI 10.3390/metabo5030404; DANDO PR, 1995, CONT SHELF RES, V15, P913, DOI 10.1016/0278-4343(95)80002-U; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELSTNER EF, 1973, BIOCHEMISTRY-US, V12, P4992, DOI 10.1021/bi00748a027; Eltamany EE, 2014, BIOORG MED CHEM LETT, V24, P4939, DOI 10.1016/j.bmcl.2014.09.040; Forner D, 2013, ANAL CHIM ACTA, V805, P70, DOI 10.1016/j.aca.2013.10.029; Gao SS, 2011, MAR DRUGS, V9, P59, DOI 10.3390/md9010059; GHIRINGHELLI D, 1981, BIOMED MASS SPECTROM, V8, P155, DOI 10.1002/bms.1200080405; Grkovic T, 2014, BIOORG MED CHEM LETT, V24, P5089, DOI 10.1016/j.bmcl.2014.08.068; Guo CJ, 2014, ORG LETT, V16, P5250, DOI 10.1021/ol502242a; Gutierrez-Lugo MT, 2005, NAT PROD RES, V19, P645, DOI 10.1080/14786410412331272040; Han HJ, 2010, BIOCHEMISTRY-US, V49, P4276, DOI 10.1021/bi100365b; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; HUBER W, 1993, ACTA TROP, V55, P257, DOI 10.1016/0001-706X(93)90083-N; HURLEY LH, 1979, ANTIMICROB AGENTS CH, V15, P42, DOI 10.1128/AAC.15.1.42; Igarashi Y, 2009, J NAT PROD, V72, P980, DOI 10.1021/np9000575; Iwatsuki M, 2007, J ANTIBIOT, V60, P357, DOI 10.1038/ja.2007.48; Iwatsuki M, 2006, J AM CHEM SOC, V128, P7486, DOI 10.1021/ja056780z; Kampfer P, 2015, INT J SYST EVOL MICR, V65, P879, DOI 10.1099/ijs.0.000031; Kampfer P, 2014, INT J SYST EVOL MICR, V64, P705, DOI 10.1099/ijs.0.055152-0; Kawakami Y, 1999, P NATL ACAD SCI USA, V96, P2227, DOI 10.1073/pnas.96.5.2227; Kunz AL, 2014, MAR DRUGS, V12, P1699, DOI 10.3390/md12041699; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li CS, 2013, MAR DRUGS, V11, P3068, DOI 10.3390/md11083068; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li K, 2011, MAR DRUGS, V9, P690, DOI 10.3390/md9050690; Li YF, 2000, TETRAHEDRON LETT, V41, P5181, DOI 10.1016/S0040-4039(00)00772-3; Macintyre L, 2014, MAR DRUGS, V12, P3416, DOI 10.3390/md12063416; Martens T, 2007, MICROB ECOL, V54, P31, DOI 10.1007/s00248-006-9165-2; Martinez-Luis S, 2012, MOLECULES, V17, P11146, DOI 10.3390/molecules170911146; Mincer TJ, 2005, APPL ENVIRON MICROB, V71, P7019, DOI 10.1128/AEM.71.11.7019-7028.2005; NOBLE M, 1977, J ANTIBIOT, V30, P455, DOI 10.7164/antibiotics.30.455; Olson JB, 2000, MICROBIAL ECOL, V40, P139; ORLOVA TI, 1973, ANTIBIOT MED BIOTEK, V18, P500; Pabel CT, 2003, MAR BIOTECHNOL, V5, P424, DOI 10.1007/s10126-002-0088-8; Polymenakou PN, 2009, SYST APPL MICROBIOL, V32, P17, DOI 10.1016/j.syapm.2008.09.006; Proksch P, 2002, APPL MICROBIOL BIOT, V59, P125, DOI 10.1007/s00253-002-1006-8; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; READ G, 1969, CAN J BIOCHEM CELL B, V47, P1071, DOI 10.1139/o69-171; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; REDDY GCS, 1984, J ANTIBIOT, V37, P1596, DOI 10.7164/antibiotics.37.1596; Roue M, 2012, NAT PROD REP, V29, P739, DOI 10.1039/c2np20040f; Santos-Gandelman JF, 2014, CURR PHARM BIOTECHNO, V15, P143, DOI 10.2174/1389201015666140711115033; SEKIGUCHI J, 1978, BIOCHEMISTRY-US, V17, P1785, DOI 10.1021/bi00602a033; SEKIGUCHI J, 1979, CAN J MICROBIOL, V25, P881, DOI 10.1139/m79-131; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stinchi S, 2003, FEMS MICROBIOL LETT, V225, P53, DOI 10.1016/S0378-1097(03)00490-7; Sugiyama Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2731, DOI 10.1271/bbb.90636; Tawfike AF, 2013, METHODS MOL BIOL, V1055, P227, DOI 10.1007/978-1-62703-577-4_17; Terui Y, 2008, BIOORG MED CHEM LETT, V18, P6321, DOI 10.1016/j.bmcl.2008.10.104; Thomas TRA, 2010, MAR DRUGS, V8, P1417, DOI 10.3390/md8041417; Viegelmann C, 2014, MAR DRUGS, V12, P3323, DOI 10.3390/md12063323; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; YOSHIDA S, 1988, J ANTIBIOT, V41, P1015, DOI 10.7164/antibiotics.41.1015; Yuliana ND, 2011, PHYTOTHER RES, V25, P157, DOI 10.1002/ptr.3258; Zhang HT, 2006, INT J SYST EVOL MICR, V56, P2309, DOI 10.1099/ijs.0.64217-0; Zhang HT, 2006, ANTON LEEUW INT J G, V90, P159, DOI 10.1007/s10482-006-9070-1	72	33	37	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138528	10.1371/journal.pone.0138528	http://dx.doi.org/10.1371/journal.pone.0138528			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407167	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000361800700055
J	Chi, PC; Bulage, P; Urdal, H; Sundby, J				Chi, Primus Che; Bulage, Patience; Urdal, Henrik; Sundby, Johanne			Barriers in the Delivery of Emergency Obstetric and Neonatal Care in Post-Conflict Africa: Qualitative Case Studies of Burundi and Northern Uganda	PLOS ONE			English	Article							MATERNAL MORTALITY; HEALTH-SERVICES; ARMED CONFLICT; AVAILABILITY; IMPACT; DISTRICT; ACCESS; WOMEN; KENYA; WAR	Objectives Maternal and neonatal mortality and morbidity rates are particularly grim in conflict, post-conflict and other crisis settings, a situation partly blamed on non-availability and/or poor quality of emergency obstetric and neonatal care (EmONC) services. The aim of this study was to explore the barriers to effective delivery of EmONC services in post-conflict Burundi and Northern Uganda, in order to provide policy makers and other relevant stakeholders context-relevant data on improving the delivery of these lifesaving services. Methods This was a qualitative comparative case study that used 42 face-to-face semi-structured in-depth interviews and 4 focus group discussions for data collection. Participants were 32 local health providers and 37 staff of NGOs working in the area of maternal health. Data was analysed using the framework approach. Results The availability, quality and distribution of EmONC services were major challenges across the sites. The barriers in the delivery of quality EmONC services were categorised into two major themes; human resources-related challenges, and systemic and institutional failures. While some of the barriers were similar, others were unique to specific sites. The common barriers included shortage of qualified staff; lack of essential installations, supplies and medications; increasing workload, burn-out and turnover; and poor data collection and monitoring systems. Barriers unique to Northern Uganda were demoralised personnel and lack of recognition; poor referral system; inefficient drug supply system; staff absenteeism in rural areas; and poor coordination among key personnel. In Burundi, weak curriculum; poor harmonisation and coordination of training; and inefficient allocation of resources were the unique challenges. To improve the situation across the sites, efforts are ongoing to improve the training and recruitment of more staff; harmonise and strengthen the curriculum and training; increase the number of EmONC facilities; and improve staff supervision, monitoring and support. Conclusions Post-conflict health systems face different challenges in the delivery of EmONC services and as such require context-specific interventions to improve the delivery of these services.	[Chi, Primus Che; Urdal, Henrik] PRIO, Oslo, Norway; [Chi, Primus Che; Sundby, Johanne] Univ Oslo, Inst Hlth Soc, Oslo, Norway; [Bulage, Patience] Int Org Migrat, Kampala, Uganda	Peace Research Institute Oslo (PRIO); University of Oslo; International Organization for Migration	Chi, PC (corresponding author), PRIO, POB 9229, Oslo, Norway.	prichi@prio.org		Chi, Primus Che/0000-0002-2727-2693	Folke Bernadotte Academy, Sweden; Institute of Health and Society, University of Oslo, Norway; EU 7th Framework Marie Curie ITN 'Training and Mobility Network for Economic Analysis of Conflict' TAMNEAC [263905]; Peace Research Institute Oslo (PRIO)	Folke Bernadotte Academy, Sweden; Institute of Health and Society, University of Oslo, Norway; EU 7th Framework Marie Curie ITN 'Training and Mobility Network for Economic Analysis of Conflict' TAMNEAC; Peace Research Institute Oslo (PRIO)	This fieldwork received funding from Folke Bernadotte Academy, Sweden, and the Institute of Health and Society, University of Oslo, Norway. The entire work has been supported by the EU 7th Framework Marie Curie ITN 'Training and Mobility Network for the Economic Analysis of Conflict' TAMNEAC (Grant agreement 263905) and the Peace Research Institute Oslo (PRIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh C, 2012, INT J GYNECOL OBSTET, V117, P283, DOI 10.1016/j.ijgo.2012.01.015; Ameh CA, 2011, MATERN CHILD HLTH J, V15, P4, DOI 10.1007/s10995-009-0545-3; [Anonymous], 2011, MIN IN SERV PACK MIS; Apuuli Kasaija Phillip, 2006, J INT CRIM JUSTICE, V4, P179; Apuuli KP, 2003, WAR NO UGANDA WORLDS; Averting Maternal Death and Disability, 2013, EM OBST NEWB CAR LIF; Bundervoet T, 2009, J HUM RESOUR, V44, P536; Cabinet of the President Republic of Burundi, 2010, REP BUR TROIS REC GE; Chi PC, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0449-8; Cho H, 2012, MONITORING MATERNAL; Chynoweth SK, 2008, REPROD HEALTH MATTER, V16, P93, DOI 10.1016/S0968-8080(08)31348-2; Devkota Bhimsen, 2010, Confl Health, V4, P20, DOI 10.1186/1752-1505-4-20; Echoka E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-113; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Inter-agency Working Group on Reproductive Health in Crisis, 2010, INT FIELD MAN REPR H; Jamieson DJ, 2000, JAMA-J AM MED ASSOC, V283, P397, DOI 10.1001/jama.283.3.397; Kim YM, 2012, INT J GYNECOL OBSTET, V116, P192, DOI 10.1016/j.ijgo.2011.10.017; Kongnyuy EJ, 2009, BJOG-INT J OBSTET GY, V116, P41, DOI 10.1111/j.1471-0528.2009.02332.x; Krause S K, 2006, Glob Public Health, V1, P205, DOI 10.1080/17441690600679939; Kruk ME, 2010, B WORLD HEALTH ORGAN, V88, P527, DOI 10.2471/BLT.09.071068; Kyotalengerire A, 2014, NEW VISION NEWS 1115; Lam Jennifer O, 2012, Confl Health, V6, P2, DOI 10.1186/1752-1505-6-2; Lee RB, 2008, REPROD HEALTH MATTER, V16, P65, DOI 10.1016/S0968-8080(08)31346-9; Mbonye AK, 2007, INT J GYNECOL OBSTET, V98, P285, DOI 10.1016/j.ijgo.2007.05.019; Medecins Sans Frontieres, 2012, SAF DEL RED MAT MORT; Mezie-Okoye Margaret M, 2012, Afr J Reprod Health, V16, P171; Ministry of Health Republic of Uganda, 2005, HLTH MORT SURV INT D; Morof Diane F, 2014, Confl Health, V8, P8, DOI 10.1186/1752-1505-8-8; New Deal for Building Peaceful States, NEW DEAL ENG FRAG ST; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; Ocowun C, 2010, GULU NEEDS 316 HLTH; Orinda V, 2005, INT J GYNECOL OBSTET, V91, P285, DOI 10.1016/j.ijgo.2005.07.023; Otunnu O, 2002, CAUSES CONSEQUENCES; Oyerinde K, 2011, INT J GYNECOL OBSTET, V114, P168, DOI 10.1016/j.ijgo.2011.05.006; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Pearson L, 2005, INT J GYNECOL OBSTET, V88, P208, DOI 10.1016/j.ijgo.2004.09.027; Population Reference Bureau, 2014, 2014 WORLD POP SHEET; Reproductive Health Response in Conflict Consortium, 2004, EM OBST CAR CRIT NEE; Roberts B, 2008, REPROD HEALTH MATTER, V16, P57, DOI 10.1016/S0968-8080(08)31347-0; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P993, DOI 10.1111/tmi.12121; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P166, DOI 10.1111/tmi.12022; Turkmani S, 2013, MIDWIFERY, V29, P1166, DOI 10.1016/j.midw.2013.06.015; Uganda Medical & Dental Practitioners Council, REG; Uganda National Bureau of Statistics, 2010, UG NAT HOUS SURV 200; Uganda Nurses and Midwives Council, REG NURS MIDW HLTH W; UNFPA, 2012, WOM AR FABR REPR HLT; UNICEF, 2014, TRANSMONEE 2014 GUID; UNICEF WHO UN Population Fund, 1997, GUID MON AV US OBST; Urdal H, 2013, INT INTERACT, V39, P489, DOI 10.1080/03050629.2013.805133; Voors MJ, 2012, AM ECON REV, V102, P941, DOI 10.1257/aer.102.2.941; Wick L, 2012, REPROD HEALTH MATTER, V20, P7, DOI 10.1016/S0968-8080(12)40648-6; Women's Refugee Commission, 2009, REPR HLTH NO UG REP; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2011, BUR NAT PERF BAS FIN; World Health Organization, 2009, HLTH WORKF INFR ESS; World Health Organization: Burundi, 2014, COUNTR COOP STRAT; World Health Organization: Uganda, 2014, COUNTR COOP STRAT; World Health Organization (WHO), 2005, TECHNICAL REPORT; Zotti ME, 2013, MATERN CHILD HLTH J, V17, P783, DOI 10.1007/s10995-012-1068-x; Zuniga I, 2013, PUBLIC HEALTH ACTION, V3, P276, DOI 10.5588/pha.13.0050	62	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139120	10.1371/journal.pone.0139120	http://dx.doi.org/10.1371/journal.pone.0139120			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1CR	26405800	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700177
J	Shepherd, SO; Wilson, OJ; Taylor, AS; Thogersen-Ntoumani, C; Adlan, AM; Wagenmakers, AJM; Shaw, CS				Shepherd, Sam O.; Wilson, Oliver J.; Taylor, Alexandra S.; Thogersen-Ntoumani, Cecilie; Adlan, Ahmed M.; Wagenmakers, Anton J. M.; Shaw, Christopher S.			Low-Volume High-Intensity Interval Training in a Gym Setting Improves Cardio-Metabolic and Psychological Health	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SPRINT INTERVAL; INSULIN SENSITIVITY; SUBJECTIVE VITALITY; AEROBIC EXERCISE; DISEASE; ADULTS; LIFE; METAANALYSIS; ADAPTATIONS	Background Within a controlled laboratory environment, high-intensity interval training (HIT) elicits similar cardiovascular and metabolic benefits as traditional moderate-intensity continuous training (MICT). It is currently unclear how HIT can be applied effectively in a real-world environment. Purpose To investigate the hypothesis that 10 weeks of HIT, performed in an instructor-led, group-based gym setting, elicits improvements in aerobic capacity (VO2max), cardio-metabolic risk and psychological health which are comparable to MICT. Methods Ninety physically inactive volunteers (42 +/- 11 y, 27.7 +/- 4.8 kg.m(-2)) were randomly assigned to HIT or MICT group exercise classes. HIT consisted of repeated sprints (15-60 seconds, >90% HRmax) interspersed with periods of recovery cycling (<= 25 min.session(-1), 3 sessions.week(-1)). MICT participants performed continuous cycling (similar to 70% HRmax, 30-45 min.session(-1) , 5 sessions.week(-1)). VO2max, markers of cardio-metabolic risk, and psychological health were assessed pre and post-intervention. Results Mean weekly training time was 55 +/- 10 (HIT) and 128 +/- 44 min (MICT) (p<0.05), with greater adherence to HIT (83 +/- 14% vs. 61 +/- 15% prescribed sessions attended, respectively; p<0.05). HIT improved VO2max, insulin sensitivity, reduced abdominal fat mass, and induced favourable changes in blood lipids (p<0.05). HIT also induced beneficial effects on health perceptions, positive and negative affect, and subjective vitality (p<0.05). No difference between HIT and MICT was seen for any of these variables. Conclusions HIT performed in a real-world gym setting improves cardio-metabolic risk factors and psychological health in physically inactive adults. With a reduced time commitment and greater adherence than MICT, HIT offers a viable and effective exercise strategy to target the growing incidence of metabolic disease and psychological ill-being associated with physical inactivity.	[Shepherd, Sam O.; Wagenmakers, Anton J. M.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Wilson, Oliver J.] Leeds Beckett Univ, Carnegie Fac, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Taylor, Alexandra S.] Univ Birmingham, UBSport Hi Performance Ctr, Birmingham, W Midlands, England; [Thogersen-Ntoumani, Cecilie] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia; [Adlan, Ahmed M.] Heartlands Hosp, Dept Cardiol, Birmingham, W Midlands, England; [Shaw, Christopher S.] Deakin Univ, Sch Exercise & Nutr Sci, Geelong, Vic 3217, Australia	Liverpool John Moores University; Leeds Beckett University; University of Birmingham; Curtin University; Heart of England NHS Foundation Trust; Deakin University	Shaw, CS (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Geelong, Vic 3217, Australia.	chris.shaw@deakin.edu.au	Wagenmakers, Anton/H-7625-2014	Wagenmakers, Anton/0000-0003-1916-3822; Thogersen-Ntoumani, Cecilie/0000-0003-0255-1263; Adlan, Ahmed/0000-0002-3661-2776; Shaw, Christopher/0000-0003-1499-0220	BUPA Foundation	BUPA Foundation	This work was supported by a medical research grant from the BUPA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Berger B.G., 2015, FDN EXERCISE PSYCHOL, V3rd; Bostic TJ, 2000, SOC INDIC RES, V52, P313, DOI 10.1023/A:1007136110218; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566; Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Currie KD, 2013, MED SCI SPORT EXER, V45, P1436, DOI 10.1249/MSS.0b013e31828bbbd4; Currie KD, 2013, APPL PHYSIOL NUTR ME, V38, P644, DOI 10.1139/apnm-2012-0354; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Duda JL, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-10; Edmunds J, 2008, EUR J SOC PSYCHOL, V38, P375, DOI 10.1002/ejsp.463; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GAUVIN L, 1993, J SPORT EXERCISE PSY, V15, P403, DOI 10.1123/jsep.15.4.403; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Gillen JB, 2014, APPL PHYSIOL NUTR ME, V39, P409, DOI 10.1139/apnm-2013-0187; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hardcastle SJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01505; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Lunt H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083256, 10.1371/journal.pone.0105360]; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Metcalfe RS, 2012, EUR J APPL PHYSIOL, V112, P2767, DOI 10.1007/s00421-011-2254-z; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Netz Y, 2005, PSYCHOL AGING, V20, P272, DOI 10.1037/0882-7974.20.2.272; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Oliveira BRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079965; PAFFENBARGER RS, 1993, MED SCI SPORT EXER, V25, P60, DOI 10.1249/00005768-199301000-00010; Puetz TW, 2006, PSYCHOL BULL, V132, P866, DOI 10.1037/0033-2909.132.6.866; Reed J, 2006, PSYCHOL SPORT EXERC, V7, P477, DOI 10.1016/j.psychsport.2005.11.003; Ryan RM, 1997, J PERS, V65, P529, DOI 10.1111/j.1467-6494.1997.tb00326.x; Sandvei M, 2012, ARCH PHYSIOL BIOCHEM, V118, P139, DOI 10.3109/13813455.2012.677454; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Shepherd SO, 2013, J PHYSIOL-LONDON, V591, P657, DOI 10.1113/jphysiol.2012.240952; Sloth M, 2013, SCAND J MED SCI SPOR, V23, pE341, DOI 10.1111/sms.12092; Stutts Wanda C, 2002, AAOHN J, V50, P499; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002	46	66	67	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139056	10.1371/journal.pone.0139056	http://dx.doi.org/10.1371/journal.pone.0139056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS1BS	26402859	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000361798100055
J	Kinnula, H; Mappes, J; Valkonen, JK; Sundberg, LR				Kinnula, Hanna; Mappes, Johanna; Valkonen, Janne K.; Sundberg, Lotta-Riina			The Influence of Infective Dose on the Virulence of a Generalist Pathogen in Rainbow Trout (Oncorhynchus mykiss) and Zebra Fish (Danio rerio)	PLOS ONE			English	Article							COLUMNARE FLEXIBACTER-COLUMNARIS; MIXED-GENOTYPE INFECTIONS; FLAVOBACTERIUM-COLUMNARE; MULTIPLE INFECTIONS; EVOLUTION; DISEASE; SUSCEPTIBILITY; PARASITE; ENVIRONMENT; PLASTICITY	Pathogen density and genetic diversity fluctuate in the outside-host environment during and between epidemics, affecting disease emergence and the severity and probability of infections. Although the importance of these factors for pathogen virulence and infection probability has been acknowledged, their interactive effects are not well understood. We studied how an infective dose in an environmentally transmitted opportunistic fish pathogen, Flavobacterium columnare, affects its virulence both in rainbow trout, which are frequently infected at fish farms, and in zebra fish, a host that is not naturally infected by F. columnare. We used previously isolated strains of confirmed high and low virulence in a single infection and in a co-infection. Infection success (measured as host morbidity) correlated positively with dose when the hosts were exposed to the high-virulence strain, but no response for the dose increase was found when the hosts were exposed to the low-virulence strain. Interestingly, the co-infection resulted in poorer infection success than the single infection with the high-virulence strain. The rainbow trout were more susceptible to the infection than the zebra fish but, in both species, the effects of the doses and the strains were qualitatively similar. We suggest that as an increase in dose can lead to increased host morbidity, both the interstrain interactions and differences in infectivity in different hosts may influence the severity and consequently the evolution of disease. Our results also confirm that the zebra fish is a good laboratory model to study F. columnare infection.	[Kinnula, Hanna; Mappes, Johanna; Valkonen, Janne K.; Sundberg, Lotta-Riina] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, SF-40351 Jyvaskyla, Finland	University of Jyvaskyla	Kinnula, H (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, SF-40351 Jyvaskyla, Finland.	hanna.kinnula@jyu.fi	Sundberg, Lotta-Riina/AAW-3125-2020; Sundberg, Lotta-Riina/N-1551-2014; Mappes, Johanna/AAZ-3627-2021	Sundberg, Lotta-Riina/0000-0003-3510-4398; Sundberg, Lotta-Riina/0000-0003-3510-4398; Kinnula, Hanna/0000-0002-7320-9054; Mappes, Johanna/0000-0002-1117-5629; Valkonen, Janne/0000-0002-2177-6612	Centre of Excellence in Biological Interactions [252411]; Academy of Finland [272995]	Centre of Excellence in Biological Interactions; Academy of Finland(Academy of Finland)	This work was supported by the Centre of Excellence in Biological Interactions, grant #252411 (https://www.jyu.fi/bioenv/en/divisions/coeinteractions), and the Academy of Finland, grant #272995 (http://www.aka.fi/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; ANACKER RL, 1959, J BACTERIOL, V78, P33, DOI 10.1128/JB.78.1.33-40.1959; Bandilla M, 2006, INT J PARASITOL, V36, P987, DOI 10.1016/j.ijpara.2006.05.001; Ben-Ami F, 2008, EVOLUTION, V62, P1700, DOI 10.1111/j.1558-5646.2008.00391.x; Benmayor R, 2009, CURR BIOL, V19, P764, DOI 10.1016/j.cub.2009.03.023; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Cai WL, 2013, APPL ENVIRON MICROB, V79, P5633, DOI 10.1128/AEM.01192-13; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Declercq AM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-27; Decostere A, 1998, VET MICROBIOL, V62, P35, DOI 10.1016/S0378-1135(98)00196-5; Decostere A, 1997, J CLIN MICROBIOL, V35, P322, DOI 10.1128/JCM.35.1.322-324.1997; Ebert D, 2000, OECOLOGIA, V122, P200, DOI 10.1007/PL00008847; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Fellous S, 2010, OECOLOGIA, V162, P935, DOI 10.1007/s00442-009-1535-2; Finnish Game and Fisheries Research Institute, 2009, RAINB TROUT ONC MYK; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gower CM, 2005, EVOLUTION, V59, P544, DOI 10.1111/j.0014-3820.2005.tb01014.x; Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005; Jokela J, 2000, OIKOS, V89, P267, DOI 10.1034/j.1600-0706.2000.890207.x; Karvonen A, 2012, P ROY SOC B-BIOL SCI, V279, P171, DOI 10.1098/rspb.2011.0879; Karvonen A, 2010, INT J PARASITOL, V40, P1483, DOI 10.1016/j.ijpara.2010.04.015; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kunttu HMT, 2012, ENV MICROBIOL REP, V4, P398, DOI 10.1111/j.1758-2229.2012.00342.x; Kunttu HMT, 2009, EPIDEMICS-NETH, V1, P96, DOI 10.1016/j.epidem.2009.04.003; Laanto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053157; Laanto E, 2011, APPL ENVIRON MICROB, V77, P7868, DOI 10.1128/AEM.05574-11; LaFrentz BR, 2012, DIS AQUAT ORGAN, V101, P115, DOI 10.3354/dao02522; Lass S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0588; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Leggett HC, 2013, TRENDS ECOL EVOL, V28, P592, DOI 10.1016/j.tree.2013.07.002; Leggett HC, 2013, CURR BIOL, V23, P139, DOI 10.1016/j.cub.2012.11.045; Leggett HC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002512; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Li Y, 2014, J THEOR BIOL, V347, P63, DOI 10.1016/j.jtbi.2014.01.008; Moyer TR, 2007, DIS AQUAT ORGAN, V76, P39, DOI 10.3354/dao076039; Olivares-Fuster O, 2007, SYST APPL MICROBIOL, V30, P624, DOI 10.1016/j.syapm.2007.07.003; Olivares-Fuster O, 2011, DIS AQUAT ORGAN, V96, P221, DOI 10.3354/dao02371; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Read AF, 1999, EVOLUTION IN HEALTH AND DISEASE, P205; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Regoes RR, 2002, P ROY SOC B-BIOL SCI, V269, P271, DOI 10.1098/rspb.2001.1816; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Scott SJ, 2014, J VET DIAGN INVEST, V26, P832, DOI 10.1177/1040638714553591; Shoemaker CA, 2008, VET MICROBIOL, V127, P353, DOI 10.1016/j.vetmic.2007.09.003; SONG YL, 1988, FISH PATHOL, V23, P91, DOI 10.3147/jsfp.23.91; Sundberg LR, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-67; Suomalainen LR, 2006, DIS AQUAT ORGAN, V70, P55, DOI 10.3354/dao070055; Suomalainen LR, 2005, J FISH DIS, V28, P271, DOI 10.1111/j.1365-2761.2005.00631.x; Susi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6975; Taylor LH, 1997, PARASITOLOGY, V115, P121, DOI 10.1017/S0031182097001145; United States Department of Agriculture, 2000, RAINB TROUT ONC MYK, V13; Wagner BA, 2002, J AQUAT ANIM HEALTH, V14, P263, DOI 10.1577/1548-8667(2002)014&lt;0263:TEOBDI&gt;2.0.CO;2; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; Xu DH, 2014, AQUACULTURE, V430, P44, DOI 10.1016/j.aquaculture.2014.03.041; Zuur Alain F., 2009, P1	57	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139378	10.1371/journal.pone.0139378	http://dx.doi.org/10.1371/journal.pone.0139378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421435	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700106
J	Laine, JE; Ray, P; Bodnar, W; Cable, PH; Boggess, K; Offenbacher, S; Fry, RC				Laine, Jessica E.; Ray, Paul; Bodnar, Wanda; Cable, Peter H.; Boggess, Kim; Offenbacher, Steven; Fry, Rebecca C.			Placental Cadmium Levels Are Associated with Increased Preeclampsia Risk	PLOS ONE			English	Article							PREGNANCY; SELENIUM; ZINC; FETAL	Environmental exposure to heavy metals is a potentially modifiable risk factor for preeclampsia (PE). Toxicologically, there are known interactions between the toxic metal cadmium (Cd) and essential metals such as selenium (Se) and zinc (Zn), as these metals can protect against the toxicity of Cd. As they relate to preeclampsia, the interaction between Cd and these essential metals is unknown. The aims of the present study were to measure placental levels of Cd, Se, and Zn in a cohort of 172 pregnant women from across the southeast US and to examine associations of metals levels with the odds of PE in a nested case-control design. Logistic regressions were performed to assess odds ratios (OR) for PE with exposure to Cd controlling for confounders, as well as interactive models with Se or Zn. The mean placental Cd level was 3.6 ng/g, ranging from 0.52 to 14.5 ng/g. There was an increased odds ratio for PE in relationship to placental levels of Cd (OR = 1.5; 95% CI: 1.1-2.2). The Cd-associated OR for PE increased when analyzed in relationship to lower placental Se levels (OR = 2.0; 95% CI: 1.1-3.5) and decreased with higher placental Se levels (OR = 0.98; 95% CI: 0.5-1.9). Similarly, under conditions of lower placental Zn, the Cd-associated OR for PE was elevated (OR = 1.8; 95% CI: 0.8-3.9), whereas with higher placental Zn it was reduced (OR = 1.3; 95% CI: 0.8-2.0). Data from this pilot study suggest that essential metals may play an important role in reducing the odds of Cd-associated preeclampsia and that replication in a larger cohort is warranted.	[Laine, Jessica E.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Ray, Paul; Bodnar, Wanda; Cable, Peter H.; Fry, Rebecca C.] Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Boggess, Kim] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Offenbacher, Steven] Univ N Carolina, Sch Dent, Dept Periodontol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Fry, RC (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	rfry@email.unc.edu	Bodnar, Wanda/AAV-5362-2021	Laine, Jessica/0000-0003-3497-2812; Fry, Rebecca/0000-0003-0899-9018; Bodnar, Wanda/0000-0001-7554-8140	National Institutes of Health [R01 ES019315, P42 ES005948, 5U01DE014577]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE014577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019315, T32ES007126, P42ES005948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by grants from the National Institutes of Health (http://www.nih.gov): R01 ES019315, P42 ES005948, and 5U01DE014577. The funders of this study had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159; [Anonymous], 1989, World Health Organ Tech Rep Ser, V776, P1; Banni M, 2011, BIOMETALS, V24, P981, DOI 10.1007/s10534-011-9456-z; Durska Grazyna, 2002, Ginekol Pol, V73, P43; GOYER RA, 1991, FUND APPL TOXICOL, V16, P22, DOI 10.1016/0272-0590(91)90130-V; Iyengar GV, 2001, SCI TOTAL ENVIRON, V280, P221, DOI 10.1016/S0048-9697(01)00827-0; Jain S, 2010, BIOL TRACE ELEM RES, V133, P162, DOI 10.1007/s12011-009-8423-9; Jin L, 2013, REPROD TOXICOL, V35, P25, DOI 10.1016/j.reprotox.2012.10.015; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Kippler M, 2012, ENVIRON HEALTH PERSP, V120, P1462, DOI 10.1289/ehp.1104431; Kippler M, 2010, TOXICOL LETT, V192, P162, DOI 10.1016/j.toxlet.2009.10.018; Kolusari A, 2008, J INT MED RES, V36, P1335, DOI 10.1177/147323000803600622; Maleki A, 2011, HYPERTENS PREGNANCY, V30, P180, DOI 10.3109/10641950903322931; Donangelo CM, 2012, NUTRIENTS, V4, P782, DOI 10.3390/nu4070782; Min J, 2009, PLACENTA, V30, P418, DOI 10.1016/j.placenta.2009.02.007; Mistry HD, 2008, HYPERTENSION, V52, P881, DOI 10.1161/HYPERTENSIONAHA.108.116103; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Offenbacher S, 2009, OBSTET GYNECOL, V114, P551, DOI 10.1097/AOG.0b013e3181b1341f; Rayman MP, 2003, AM J OBSTET GYNECOL, V189, P1343, DOI 10.1067/S0002-9378(03)00723-3; Reeves PG, 2008, SCI TOTAL ENVIRON, V398, P13, DOI 10.1016/j.scitotenv.2008.03.009; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Semczuk M, 2001, MED SCI MONITOR, V7, P332; Szuster-Ciesielska A, 2000, TOXICOLOGY, V145, P159, DOI 10.1016/S0300-483X(00)00144-X; Vanderlelie J, 2005, PLACENTA, V26, P53, DOI 10.1016/j.placenta.2004.04.002; Vanderlelie J, 2011, PREGNANCY HYPERTENS, V1, P213, DOI 10.1016/j.preghy.2011.07.001; Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011; Zadrozna M, 2009, J TRACE ELEM MED BIO, V23, P144, DOI 10.1016/j.jtemb.2009.02.005	28	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139341	10.1371/journal.pone.0139341	http://dx.doi.org/10.1371/journal.pone.0139341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422011	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700097
J	Striberny, A; Ravuri, CS; Jobling, M; Jorgensen, EH				Striberny, Anja; Ravuri, Chandra Sekhar; Jobling, Malcolm; Jorgensen, Even Hjalmar			Seasonal Differences in Relative Gene Expression of Putative Central Appetite Regulators in Arctic Charr (Salvelinus alpinus) Do Not Reflect Its Annual Feeding Cycle	PLOS ONE			English	Article							NEUROPEPTIDE-Y NPY; LEPTIN RECEPTOR EXPRESSION; STIMULATES FOOD-INTAKE; ATLANTIC SALMON; PLASMA LEPTIN; TISSUE DISTRIBUTION; TRANSCRIPT CART; CHOLECYSTOKININ CCK; NUTRITIONAL-STATUS; MOLECULAR-CLONING	The highly seasonal anadromous Arctic charr (Salvelinus alpinus) was used to investigate the possible involvement of altered gene expression of brain neuropeptides in seasonal appetite regulation. Pro-opiomelanocortin (POMCA1, POMCA2), Cocaine and amphetamine regulated transcript (CART), Agouti related Peptide (AgRP), Neuropeptide Y (NPY) and Melanocortin Receptor 4 (MC4-R) genes were examined. The function of centrally expressed Leptin (Lep) in fish remains unclear, so Lep (LepA1, LepA2) and Leptin Receptor (LepR) genes were included in the investigation. In a ten months study gene expression was analysed in hypothalamus, mesencephalon and telencephalon of immature charr held under natural photoperiod (69 degrees 38'N) and ambient temperature and given excess feed. From April to the beginning of June the charr did not feed and lost weight, during July and August they were feeding and had a marked increase in weight and condition factor, and from November until the end of the study the charr lost appetite and decreased in weight and condition factor. Brain compartments were sampled from non-feeding charr (May), feeding charr (July), and non-feeding charr (January). Reverse transcription real-time quantitative PCR revealed temporal patterns of gene expression that differed across brain compartments. The non-feeding charr (May, January) had a lower expression of the anorexigenic LepA1, MC4-R and LepR in hypothalamus and a higher expression of the orexigenic NPY and AgRP in mesencephalon, than the feeding charr (July). In the telencephalon, LepR was more highly expressed in January and May than in July. These results do not indicate that changes in central gene expression of the neuropeptides investigated here directly induce seasonal changes in feeding in Arctic charr.	[Striberny, Anja; Ravuri, Chandra Sekhar; Jobling, Malcolm; Jorgensen, Even Hjalmar] UiT, Dept Arctic & Marine Biol, Tromso, Norway	UiT The Arctic University of Tromso	Jorgensen, EH (corresponding author), UiT, Dept Arctic & Marine Biol, Tromso, Norway.	even.jorgensen@uit.no		Striberny, Anja/0000-0003-0385-6018	Tromso Research Foundation, UiT-The Arctic University of Norway	Tromso Research Foundation, UiT-The Arctic University of Norway	This work was supported by Tromso Research Foundation, UiT-The Arctic University of Norway.	Aarseth JJ, 2010, POLAR BIOL, V33, P379, DOI 10.1007/s00300-009-0715-1; Aas-Hansen O, 2005, CAN J FISH AQUAT SCI, V62, P195, DOI 10.1139/F04-186; Adam CL, 2004, P NUTR SOC, V63, P413, DOI 10.1079/PNS2004367; Aldegunde M, 2006, PEPTIDES, V27, P719, DOI 10.1016/j.peptides.2005.09.014; Babichuk NA, 2013, PHYSIOL BEHAV, V120, P54, DOI 10.1016/j.physbeh.2013.06.022; Baltzegar DA, 2014, J ENDOCRINOL, V220, P61, DOI 10.1530/JOE-13-0292; Tinoco AB, 2012, PEPTIDES, V34, P329, DOI 10.1016/j.peptides.2012.02.001; Bernier NJ, 2012, J EXP BIOL, V215, P2273, DOI 10.1242/jeb.066183; Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904; BOIVIN TG, 1990, CAN J ZOOL, V68, P2284, DOI 10.1139/z90-319; Bottengard L, 2008, COMP BIOCHEM PHYS A, V151, P596, DOI 10.1016/j.cbpa.2008.07.019; Carpio Y, 2006, PEPTIDES, V27, P710, DOI 10.1016/j.peptides.2005.08.013; Carpio Y, 2007, AQUACULTURE, V272, P649, DOI 10.1016/j.aquaculture.2007.08.024; Ebling FJP, 2015, FRONT NEUROENDOCRIN, V37, P97, DOI 10.1016/j.yfrne.2014.10.003; Frantzen M, 2004, J FISH BIOL, V65, P1526, DOI 10.1111/j.0022-1112.2004.00564.x; Froiland E, 2012, GEN COMP ENDOCR, V178, P330, DOI 10.1016/j.ygcen.2012.06.017; Froiland E, 2010, GEN COMP ENDOCR, V165, P136, DOI 10.1016/j.ygcen.2009.06.010; Fuentes EN, 2012, GEN COMP ENDOCR, V177, P120, DOI 10.1016/j.ygcen.2012.02.019; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Hosomi N, 2014, FISHERIES SCI, V80, P483, DOI 10.1007/s12562-014-0711-4; Jobling M., 1994, FISH BIOENERGETICS; Johnson L., 1980, CHARRS SALMONID FISH, P15; Jorgensen EH, 1997, J FISH BIOL, V51, P312, DOI 10.1006/jfbi.1997.0436; Jorgensen EH, 2007, AQUACULTURE, V273, P227, DOI 10.1016/j.aquaculture.2007.10.004; Jorgensen EH, 2013, J EXP BIOL, V216, P3222, DOI 10.1242/jeb.088344; Klemetsen A, 2003, J FISH BIOL, V62, P1082, DOI 10.1046/j.1095-8649.2003.00101.x; Kling P, 2009, GEN COMP ENDOCR, V162, P307, DOI 10.1016/j.ygcen.2009.04.003; Kurokawa T, 2009, GEN COMP ENDOCR, V161, P229, DOI 10.1016/j.ygcen.2009.01.008; Li GG, 2010, GEN COMP ENDOCR, V166, P117, DOI 10.1016/j.ygcen.2009.10.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Londraville RL, 2014, GEN COMP ENDOCR, V203, P146, DOI 10.1016/j.ygcen.2014.02.002; Lopez-Patino MA, 1999, EUR J PHARMACOL, V377, P147, DOI 10.1016/S0014-2999(99)00408-2; MacDonald E, 2009, HORM BEHAV, V56, P58, DOI 10.1016/j.yhbeh.2009.03.002; MacDonald E, 2009, GEN COMP ENDOCR, V161, P252, DOI 10.1016/j.ygcen.2009.01.021; Mathisen OA, 1968, I FRESHWATER RES DRO, V48, P177; Murashita K, 2008, COMP BIOCHEM PHYS B, V150, P377, DOI 10.1016/j.cbpb.2008.04.007; Murashita K, 2011, COMP BIOCHEM PHYS A, V158, P79, DOI 10.1016/j.cbpa.2010.09.001; Murashita K, 2009, GEN COMP ENDOCR, V162, P160, DOI 10.1016/j.ygcen.2009.03.015; Narnaware YK, 2000, AM J PHYSIOL-REG I, V279, pR1025, DOI 10.1152/ajpregu.2000.279.3.R1025; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Reddy AB, 1999, EUR J NEUROSCI, V11, P3255, DOI 10.1046/j.1460-9568.1999.00746.x; RICKER W E, 1975, P382; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Ronnestad I, 2010, GEN COMP ENDOCR, V168, P55, DOI 10.1016/j.ygcen.2010.04.010; Saether BS, 1996, J FISH BIOL, V48, P1113, DOI 10.1111/j.1095-8649.1996.tb01808.x; Salmeron C, 2015, GEN COMP ENDOCR, V210, P114, DOI 10.1016/j.ygcen.2014.10.016; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Silverstein JT, 1998, GEN COMP ENDOCR, V110, P157, DOI 10.1006/gcen.1998.7058; Silverstein JT, 2000, AM ZOOL, V40, P296, DOI 10.1668/0003-1569(2000)040[0296:TEONAI]2.0.CO;2; Swanson HK, 2011, CAN J FISH AQUAT SCI, V68, P2020, DOI 10.1139/F2011-111; Tang ZG, 2013, MOL CELL ENDOCRINOL, V376, P114, DOI 10.1016/j.mce.2013.06.020; Tinoco AB, 2014, GEN COMP ENDOCR, V204, P239, DOI 10.1016/j.ygcen.2014.06.006; Trombley S, 2014, GEN COMP ENDOCR, V204, P60, DOI 10.1016/j.ygcen.2014.04.033; Trombley S, 2012, GEN COMP ENDOCR, V175, P92, DOI 10.1016/j.ygcen.2011.10.001; Tveiten H, 1996, J FISH BIOL, V48, P910, DOI 10.1111/j.1095-8649.1996.tb01486.x; Volkoff H, 2001, REGUL PEPTIDES, V101, P59, DOI 10.1016/S0167-0115(01)00261-0; Volkoff H, 2009, FISH PHYSIOL, V28, P421, DOI 10.1016/S1546-5098(09)28009-5; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yokobori E, 2012, J NEUROENDOCRINOL, V24, P766, DOI 10.1111/j.1365-2826.2012.02281.x; Zhang HX, 2013, GEN COMP ENDOCR, V181, P295, DOI 10.1016/j.ygcen.2012.09.008; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou Y, 2013, AQUACULTURE, V380, P52, DOI 10.1016/j.aquaculture.2012.11.033	62	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138857	10.1371/journal.pone.0138857	http://dx.doi.org/10.1371/journal.pone.0138857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421838	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700053
J	Filiponi, TC; Requiao-Moura, LR; Tonato, EJ; de Matos, ACC; Silva, APE; Durao, MD				Filiponi, Thiago Corsi; Requiao-Moura, Lucio Roberto; Tonato, Eduardo Jose; Carvalho de Matos, Ana Cristina; Pacheco e Silva-Filho, Alvaro; Durao Junior, Marcelino de Souza			Hospital Admission following Acute Kidney Injury in Kidney Transplant Recipients Is Associated with a Negative Impact on Graft Function after 1-Year	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; HIGH-RISK; OUTCOMES; DISEASE; FAILURE	The incidence and outcomes of acute kidney injury (AKI) in kidney transplantation are poorly known. Retrospective cohort analysis was performed on the data of all patients (3 months after transplantation and >= 16 years of age) admitted to the hospital due to medical or surgical complications from 2007 to 2010. We analyzed 458 kidney transplant recipients, 55.2% men, median age 49 (IQR, 36-58) years, median of 12.5 (IQR, 3-35) months after kidney transplantation; admitted to the hospital due to medical or surgical complications. Most of the patients received a kidney from a deceased donor (62.2%), the primary cause for hospital admission was infection (60.7%) and 57 (12.4%) individuals were diagnosed with acute rejection (AR). The incidence of AKI was 82.3%: 31.9% stage 1, 29.3% stage 2 and 21.2% stage 3. Intensive care unit (ICU) admission (OR 8.90, 95% CI: 1.77-44.56 p = 0.008), infection (OR 5.73, 95% CI: 2.61-12.56, p<0.001) and the use of contrast media (OR 9.34, 95% CI: 2.04-42.70, p = 0.004) were the independent risk factors for AKI development. The mortality rate was 2.1% and all patients who died were diagnosed with AKI. Even after the exclusion of AR cases, at the end of 12 months, the individuals with AKI exhibited higher percent changes in creatinine values when compared with individuals without AKI (9.1% vs. -4.3%; p<0.001). According to KDIGO system, we found a high incidence of AKI among the complications of renal transplantation. As in other scenarios, AKI was associated with renal function loss at 1-year after the hospital discharge.	[Filiponi, Thiago Corsi; Requiao-Moura, Lucio Roberto; Tonato, Eduardo Jose; Carvalho de Matos, Ana Cristina; Pacheco e Silva-Filho, Alvaro; Durao Junior, Marcelino de Souza] Hosp Israelita Albert Einstein, Kidney Transplant Unit, Sao Paulo, Brazil; [Filiponi, Thiago Corsi; Pacheco e Silva-Filho, Alvaro; Durao Junior, Marcelino de Souza] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP)	Durao, MD (corresponding author), Hosp Israelita Albert Einstein, Kidney Transplant Unit, Sao Paulo, Brazil.	marcelino@einstein.br	silva, alvaro/HDO-6977-2022; Requião-Moura, Lúcio/X-1613-2019	Requião-Moura, Lúcio/0000-0001-8751-9048				Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P402, DOI 10.1053/j.ajkd.2006.06.002; Bastin AJ, 2013, J CRIT CARE, V28, P389, DOI 10.1016/j.jcrc.2012.12.008; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Campbell GA, 2014, ADV CHRONIC KIDNEY D, V21, P64, DOI 10.1053/j.ackd.2013.08.002; Cannon CP, 2013, CIRCULATION, V127, P1052, DOI 10.1161/CIR.0b013e3182831a11; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Cooper JE, 2013, CURR OPIN NEPHROL HY, V22, P698, DOI 10.1097/MNH.0b013e328365b388; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Durao MS, 2008, CRIT CARE MED, V36, P3024, DOI 10.1097/CCM.0b013e31818b9100; Elyasi S, EUR J CLINPHARMACOL, V68, P1243; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Golshahi Jafar, 2014, J Nephropathol, V3, P51, DOI 10.12860/jnp.2014.12; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Issa N, 2013, AM J NEPHROL, V37, P602, DOI 10.1159/000351648; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kotton CN, 2010, TRANSPLANTATION, V89, P779, DOI 10.1097/TP.0b013e3181cee42f; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Mohammed Nazar M A, 2013, Heart Views, V14, P106, DOI 10.4103/1995-705X.125926; Nakamura M, 2012, CLIN TRANSPLANT, V26, P520, DOI 10.1111/j.1399-0012.2011.01546.x; Requiao-Moura LR, 2012, TRANSPL P, V44, P2428, DOI 10.1016/j.transproceed.2012.07.013; Salahudeen AK, 2013, CLIN J AM SOC NEPHRO, V8, P347, DOI 10.2215/CJN.03530412; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Uchino S, 2007, INT J ARTIF ORGANS, V30, P281, DOI 10.1177/039139880703000402; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2010, NEPHROL DIAL TRANSPL, V25, P1833, DOI 10.1093/ndt/gfp624; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138944	10.1371/journal.pone.0138944	http://dx.doi.org/10.1371/journal.pone.0138944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417949	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400029
J	Gabrielova, E; Zholobenko, AV; Bartosikova, L; Necas, J; Modriansky, M				Gabrielova, Eva; Zholobenko, Aleksey Vladimirovich; Bartosikova, Lenka; Necas, Jiri; Modriansky, Martin			Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart	PLOS ONE			English	Article							KINASE-C-EPSILON; INDUCED CARDIOTOXICITY; FCCP; OXIDATION; SILYBIN; ROS	2,3-dehydrosilybin (DHS) is a minor flavonolignan component of Silybum marianum seed extract known for its hepatoprotective activity. Recently we identified DHS as a potentially cardioprotective substance during hypoxia/reoxygenation in isolated neonatal rat cardiomyocytes. This is the first report of positive inotropic effect of DHS on perfused adult rat heart. When applied to perfused adult rat heart, DHS caused a dose-dependent inotropic effect resembling that of catecholamines. The effect was apparent with DHS concentration as low as 10 nM. Suspecting direct interaction with beta-adrenergic receptors, we tested whether DHS can trigger beta agonist-dependent gene transcription in a model cell line. While DHS alone was unable to trigger beta agonist-dependent gene transcription, it enhanced the effect of isoproterenol, a known unspecific beta agonist. Further tests confirmed that DHS could not induce cAMP accumulation in isolated neonatal rat cardiomyocytes even though high concentrations (>= 10 mu M) of DHS were capable of decreasing phosphodiesterase activity. Pre-treatment of rats with reserpine, an indole alkaloid which depletes catecholamines from peripheral sympathetic nerve endings, abolished the DHS inotropic effect in perfused hearts. Our data suggest that DHS causes the inotropic effect without acting as a beta agonist. Hence we identify DHS as a novel inotropic agent.	[Gabrielova, Eva; Zholobenko, Aleksey Vladimirovich; Modriansky, Martin] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, CR-77147 Olomouc, Czech Republic; [Bartosikova, Lenka; Necas, Jiri] Palacky Univ, Fac Med & Dent, Dept Physiol, CR-77147 Olomouc, Czech Republic; [Gabrielova, Eva; Modriansky, Martin] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Modriansky, M (corresponding author), Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, CR-77147 Olomouc, Czech Republic.	martin.modriansky@upol.cz	GABRIELOVÁ, Eva/ABE-5387-2021; Modriansky, Martin/A-6338-2008; Gabrielová, Eva/E-2137-2018	Modriansky, Martin/0000-0001-7692-0338; Gabrielová, Eva/0000-0003-1460-0915	Ministry of Education, Youth and Sports (Czech Republic) [LO1403, CZ.1.07/2.3.00/30.0041]	Ministry of Education, Youth and Sports (Czech Republic)(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government)	This work was supported by grants LO1403 and CZ.1.07/2.3.00/30.0041 from the Ministry of Education, Youth and Sports (Czech Republic, www.msmt.cz). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete P, 2010, AGEING RES REV, V9, P153, DOI 10.1016/j.arr.2009.07.001; Bartosikova L, 2008, BIOMED PAP, V152, P79, DOI 10.5507/bp.2008.012; Bors W, 2002, ANN NY ACAD SCI, V957, P57, DOI 10.1111/j.1749-6632.2002.tb02905.x; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; Chlopcikova A, 2004, PHYTOTHER RES, V18, P107, DOI 10.1002/ptr.1415; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; Comelli MC, 2007, INTEGR CANCER THER, V6, P120, DOI 10.1177/1534735407302349; El-Awady EE, 2011, EUR J PHARMACOL, V650, P335, DOI 10.1016/j.ejphar.2010.09.085; El-Shitany NA, 2008, FOOD CHEM TOXICOL, V46, P2422, DOI 10.1016/j.fct.2008.03.033; Fraga CG, 2010, MOL ASPECTS MED, V31, P435, DOI 10.1016/j.mam.2010.09.006; Frances C, 2003, J CARDIOVASC PHARM, V41, P396, DOI 10.1097/00005344-200303000-00008; FRIEL DD, 1994, J NEUROSCI, V14, P4007; Gabrielova E, 2015, PHYSIOL RES, V64, P79, DOI 10.33549/physiolres.932703; Gabrielova E, 2010, J BIOENERG BIOMEMBR, V42, P499, DOI 10.1007/s10863-010-9319-2; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; Gazak R, 2013, TETRAHEDRON LETT, V54, P315, DOI 10.1016/j.tetlet.2012.11.049; Gazak R, 2011, J MED CHEM, V54, P7397, DOI 10.1021/jm201034h; Hou DX, 2010, ANTIOXID REDOX SIGN, V13, P691, DOI 10.1089/ars.2009.2816; Kozlovski VI, 2004, POL J PHARMACOL, V56, P767; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; Nabavi SM, 2012, AN ACAD BRAS CIENC, V84, P1121, DOI 10.1590/S0001-37652012005000056; Philipp S, 2006, CARDIOVASC RES, V70, P308, DOI 10.1016/j.cardiores.2006.02.014; Rambaldi A, 2005, AM J GASTROENTEROL, V100, P2583, DOI 10.1111/j.1572-0241.2005.00262.x; Rao Pragada Rajeswara, 2007, Exp Clin Cardiol, V12, P179; Raskovic A, 2011, MOLECULES, V16, P8601, DOI 10.3390/molecules16108601; Slim HB, 2011, AM J CARDIOL, V108, P308, DOI 10.1016/j.amjcard.2011.03.041; Taghiabadi E, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/352091; Tang XL, 2014, J PHARMACOL SCI, V125, P176, DOI 10.1254/jphs.13247FP; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Xu TR, 2007, CELL SIGNAL, V19, P1986, DOI 10.1016/j.cellsig.2007.05.009; Zatta AJ, 2006, CARDIOVASC RES, V70, P315, DOI 10.1016/j.cardiores.2005.11.030; Zholobenko A, 2014, FITOTERAPIA, V97, P122, DOI 10.1016/j.fitote.2014.05.016; Zhou JJ, 2002, BRIT J PHARMACOL, V135, P1675, DOI 10.1038/sj.bjp.0704640	36	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139208	10.1371/journal.pone.0139208	http://dx.doi.org/10.1371/journal.pone.0139208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418338	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400063
J	Sugiyama, A; Fukuda, S; Takanashi, K; Yoshioka, M; Yoshioka, H; Narusaka, Y; Narusaka, M; Kojima, M; Sakakibara, H; Shitan, N; Sato, S; Tabata, S; Kawaguchi, M; Yazaki, K				Sugiyama, Akifumi; Fukuda, Shoju; Takanashi, Kojiro; Yoshioka, Miki; Yoshioka, Hirofumi; Narusaka, Yoshihiro; Narusaka, Mari; Kojima, Mikiko; Sakakibara, Hitoshi; Shitan, Nobukazu; Sato, Shusei; Tabata, Satoshi; Kawaguchi, Masayoshi; Yazaki, Kazufumi			Molecular Characterization of LjABCG1, an ATP-Binding Cassette Protein in Lotus japonicus	PLOS ONE			English	Article							MEMBRANE ABC TRANSPORTER; ARABIDOPSIS-THALIANA; MODEL LEGUME; CONFERS RESISTANCE; NONHOST RESISTANCE; PLANT; GENE; EXPRESSION; PATHOGEN; NODULATION	LjABCG1, a full-size ABCG subfamily of ATP-binding cassette proteins of a model legume, Lotus japonicus, was reported as a gene highly expressed during the early stages of nodulation, but have not been characterized in detail. In this study we showed that the induction of LjABCG1 expression was remarkable by methyl jasmonate treatment, and reporter gene experiments indicated that LjABCG1 was strongly expressed in the nodule parenchyma and cell layers adjacent to the root vascular tissue toward the nodule. LjABCG1 was suggested to be localized at the plasma membrane based on the fractionation of microsomal membranes as well as separation via aqueous two-phase partitioning. The physiological functions of LjABCG1 in symbiosis and pathogenesis were analyzed in homologous and heterologous systems. LjABCG1 knock-down L. japonicus plants did not show clear phenotypic differences in nodule formation, and not in defense against Pseudomonas syringae, either. In contrast, when LjABCG1 was expressed in the Arabidopsis pdr8-1 mutant, the penetration frequency of Phytophthora infestans, a potato late blight pathogen, was significantly reduced in LjABCG1/pdr8-1 than in pdr8-1 plants. This finding indicated that LjABCG1, at least partially, complemented the phenotype of pdr8 in Arabidopsis, suggesting the multiple roles of this protein in plant-microbe interactions.	[Sugiyama, Akifumi; Fukuda, Shoju; Takanashi, Kojiro; Yazaki, Kazufumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Uji, Kyoto 6110011, Japan; [Yoshioka, Miki; Yoshioka, Hirofumi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Def Plant Pathogen Interact, Nagoya, Aichi 4648601, Japan; [Narusaka, Yoshihiro; Narusaka, Mari] Res Inst Biol Sci, Yoshikawa, Okayama 7161241, Japan; [Kojima, Mikiko; Sakakibara, Hitoshi] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Shitan, Nobukazu] Kobe Pharmaceut Univ, Lab Nat Med Chem, Kobe, Hyogo 6588558, Japan; [Sato, Shusei] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Sato, Shusei; Tabata, Satoshi] Kazusa DNA Res Inst, Chiba 2920812, Japan; [Kawaguchi, Masayoshi] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	Kyoto University; Nagoya University; RIKEN; Kobe Pharmaceutical University; Tohoku University; Kazusa DNA Research Institute; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Yazaki, K (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Lab Plant Gene Express, Uji, Kyoto 6110011, Japan.	yazaki@rish.kyoto-u.ac.jp	Kojima, Mikiko/D-1459-2017; Sakakibara, Hitoshi/A-6040-2010; Sato, Shusei/A-3616-2015	Sakakibara, Hitoshi/0000-0001-5449-6492; Sato, Shusei/0000-0002-0293-5366; Sugiyama, Akifumi/0000-0002-9643-6639; Shitan, Nobukazu/0000-0001-7760-2745; Kawaguchi, Masayoshi/0000-0002-1032-6261	Japan Society for the Promotion of Science [183051];  [20053009];  [23012024];  [23780066];  [26712013]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; 	This work was supported in part by Grants-in-Aid for Scientific Research (No. 20053009 and No. 23012024 to K.Y., No. 23780066 and 26712013 to A.S.); and by Research Fellowships for Young Scientists from the Japan Society for the Promotion of Science (No. 183051 to A.S.).	Akashi R, 2003, PLANT SOIL, V255, P27, DOI 10.1023/A:1026143606752; Banasiak J, 2013, J EXP BOT; BHUVANESWARI TV, 1980, PLANT PHYSIOL, V66, P1027, DOI 10.1104/pp.66.6.1027; Bordenave CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083199; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Carvalhais LC, 2015, MOL PLANT MICROBE IN, V28, P1049, DOI 10.1094/MPMI-01-15-0016-R; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; DeMichelis MI, 1996, PLANT PHYSIOL, V110, P957, DOI 10.1104/pp.110.3.957; Ding YL, 2008, PLANT CELL, V20, P2681, DOI 10.1105/tpc.108.061739; Eichhorn H, 2006, J EXP BOT, V57, P2193, DOI 10.1093/jxb/erj179; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Giovannetti M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00480; Hawes C., 2003, CURR PROTOC CELL BIO, V19, P1, DOI [DOI 10.1002/0471143030.CB0107S19, 10.1002/0471143030.cb0107s19]; Hirayama T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3247; Huitema E, 2003, MOL PLANT PATHOL, V4, P487, DOI [10.1046/j.1364-3703.2003.00195.x, 10.1046/J.1364-3703.2003.00195.X]; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Kamimoto Y, 2012, PLANT CELL PHYSIOL, V53, P2090, DOI 10.1093/pcp/pcs149; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kato T, 2005, J BIOSCI BIOENG, V99, P165, DOI 10.1263/jbb.99.165; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Kobayashi M, 2012, NEW PHYTOL, V196, P223, DOI 10.1111/j.1469-8137.2012.04226.x; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Kumagai H, 2003, MOL PLANT MICROBE IN, V16, P663, DOI 10.1094/MPMI.2003.16.8.663; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Masai M, 2013, BIOSCI BIOTECH BIOCH, V77, P1773, DOI 10.1271/bbb.130209; Nagata M, 2008, MOL PLANT MICROBE IN, V21, P1175, DOI 10.1094/MPMI-21-9-1175; Nakagawa T, 2006, PLANT CELL PHYSIOL, V47, P176, DOI 10.1093/pcp/pci222; Narusaka M, 2011, J GEN PLANT PATHOL, V77, P75, DOI 10.1007/s10327-011-0298-x; Niwa S, 2001, MOL PLANT MICROBE IN, V14, P848, DOI 10.1094/MPMI.2001.14.7.848; Sasabe M, 2002, FEBS LETT, V518, P164, DOI 10.1016/S0014-5793(02)02697-2; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; Shitan N, 2013, INT REV CEL MOL BIO, V305, P383, DOI 10.1016/B978-0-12-407695-2.00009-3; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Sugiyama A, 2007, PLANT PHYSIOL, V144, P2000, DOI 10.1104/pp.107.096727; Sugiyama A, 2006, DNA RES, V13, P205, DOI 10.1093/dnares/dsl013; Suzuki A, 2011, P NATL ACAD SCI USA, V108, P16837, DOI 10.1073/pnas.1105892108; Takanashi K, 2012, MOL PLANT MICROBE IN, V25, P869, DOI 10.1094/MPMI-01-12-0011-R; Takanashi K, 2012, J PLANT PHYSIOL, V169, P322, DOI 10.1016/j.jplph.2011.11.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; van den Brule S, 2002, PLANTA, V216, P95, DOI 10.1007/s00425-002-0889-z; van den Brule S, 2002, PLANT J, V30, P649, DOI 10.1046/j.1365-313X.2002.01321.x; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680	53	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139127	10.1371/journal.pone.0139127	http://dx.doi.org/10.1371/journal.pone.0139127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418593	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400047
J	Yamaguchi, M; Murakami, S; Yoneda, T; Nakamura, M; Zhang, L; Uezumi, A; Fukuda, S; Kokubo, H; Tsujikawa, K; Fukada, S				Yamaguchi, Masahiko; Murakami, Satoshi; Yoneda, Tomohiro; Nakamura, Miki; Zhang, Lidan; Uezumi, Akiyoshi; Fukuda, Sumiaki; Kokubo, Hiroki; Tsujikawa, Kazutake; Fukada, So-ichiro			Evidence of Notch-Hesr-Nrf2 Axis in Muscle Stem Cells, but Absence of Nrf2 Has No Effect on Their Quiescent and Undifferentiated State	PLOS ONE			English	Article							SKELETAL-MUSCLE; REDOX REGULATION; SATELLITE CELLS; REGENERATION; MAINTENANCE; DIFFERENTIATION; PROLIFERATION; EXPRESSION; MYOGENESIS; PATHWAYS	Nrf2 is a master regulator of oxidative stresses through the induction of anti-oxidative genes. Nrf2 plays roles in maintaining murine hematopoietic stem cells and fly intestinal stem cells. The canonical Notch signaling pathway is also crucial for maintaining several types of adult stem cells including muscle stem cells (satellite cells). Here, we show that Dll1 induced Nrf2 expression in myogenic cells. In addition, primary targets of Notch signaling, Hesr1 and Hesr3, were involved in the up-regulation of Nrf2 mRNA and expression of its target genes. In vitro, Nrf2 had anti-myogenic and anti-proliferative effects on primary myoblasts. In vivo, although Nrf2-knockout mice showed decreased expression of its target genes in muscle stem cells, adult muscle stem cells of Nrf2-knockout mice did not exhibit the phenotype. Taken together, in muscle stem cells, the Notch-Hesr-Nrf2 axis is a pathway potentially inducing anti-oxidative genes, but muscle stem cells either do not require Nrf2-mediated anti-oxidative gene expression or they have a complementary system compensating for the loss of Nrf2.	[Yamaguchi, Masahiko; Murakami, Satoshi; Yoneda, Tomohiro; Nakamura, Miki; Zhang, Lidan; Fukuda, Sumiaki; Tsujikawa, Kazutake; Fukada, So-ichiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Suita, Osaka 5650871, Japan; [Uezumi, Akiyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Toyoake, Aichi 4701192, Japan; [Kokubo, Hiroki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Minami Ku, Hiroshima 7348551, Japan	Osaka University; Fujita Health University; Hiroshima University	Fukada, S (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	fukada@phs.osaka-u.ac.jp	Uezumi, Akiyoshi/ABF-7359-2020; Fukada, So-ichiro/AAI-9151-2020	Uezumi, Akiyoshi/0000-0003-4294-0116; Fukada, So-ichiro/0000-0003-4051-5108	JSPS KAKENHI grant [25702044, 22-5, 25-5]; Nakatomi Foundation; Grants-in-Aid for Scientific Research [15K12675] Funding Source: KAKEN	JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakatomi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS KAKENHI grant, Grant-in Aid for Young Scientists (A) (25702044 to So-ichiro F), Intramural Research Grant (22-5 to So-ichiro F, 25-5 to So-ichiro F) for Neurological and Psychiatric Disorders of NCNP (NationalCenter of Neurology and Psychiatry), and The Nakatomi Foundation (to So-ichiro F).	Al-Sawaf O, 2014, J PATHOL, V234, P538, DOI 10.1002/path.4418; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00317; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Gopinath SD, 2014, STEM CELL REP, V2, P414, DOI 10.1016/j.stemcr.2014.02.002; Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Kombairaju P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00057; L'honore A, 2014, DEV CELL, V29, P392, DOI 10.1016/j.devcel.2014.04.006; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Merchant AA, 2011, BLOOD, V118, P6572, DOI 10.1182/blood-2011-05-355362; Miller CJ, 2012, BBA-MOL BASIS DIS, V1822, P1038, DOI 10.1016/j.bbadis.2012.02.007; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Satow T, 2001, J NEUROSCI, V21, P1265; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Wakabayashi N, 2014, MOL CELL BIOL, V34, P653, DOI 10.1128/MCB.01408-13; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Yamaguchi M., 2013, TUMOR DORMANCY QUIES, V1, P107; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200	36	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138517	10.1371/journal.pone.0138517	http://dx.doi.org/10.1371/journal.pone.0138517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418810	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400017
J	Gomez, GB; Foster, N; Brals, D; Nelissen, HE; Bolarinwa, OA; Hendriks, ME; Boers, AC; van Eck, D; Rosendaal, N; Adenusi, P; Agbede, K; Akande, TM; van Hensbroek, MB; Wit, FW; Hankins, CA; Schultsz, C				Gomez, Gabriela B.; Foster, Nicola; Brals, Daniella; Nelissen, Heleen E.; Bolarinwa, Oladimeji A.; Hendriks, Marleen E.; Boers, Alexander C.; van Eck, Diederik; Rosendaal, Nicole; Adenusi, Peju; Agbede, Kayode; Akande, Tanimola M.; van Hensbroek, Michael Boele; Wit, Ferdinand W.; Hankins, Catherine A.; Schultsz, Constance			Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; ECONOMIC-EVALUATION; NORTHERN NIGERIA; MORTALITY; INTERVENTIONS; PREVENTION; PREGNANCY; SERVICES; BURDEN	Background While the Nigerian government has made progress towards the Millennium Development Goals, further investments are needed to achieve the targets of post-2015 Sustainable Development Goals, including Universal Health Coverage. Economic evaluations of innovative interventions can help inform investment decisions in resource-constrained settings. We aim to assess the cost and cost-effectiveness of maternal care provided within the new Kwara State Health Insurance program (KSHI) in rural Nigeria. Methods and Findings We used a decision analytic model to simulate a cohort of pregnant women. The primary outcome is the incremental cost effectiveness ratio (ICER) of the KSHI scenario compared to the current standard of care. Intervention cost from a healthcare provider perspective included service delivery costs and above-service level costs; these were evaluated in a participating hospital and using financial records from the managing organisations, respectively. Standard of care costs from a provider perspective were derived from the literature using an ingredient approach. We generated 95% credibility intervals around the primary outcome through probabilistic sensitivity analysis (PSA) based on a Monte Carlo simulation. We conducted one-way sensitivity analyses across key model parameters and assessed the sensitivity of our results to the performance of the base case separately through a scenario analysis. Finally, we assessed the sustainability and feasibility of this program's scale up within the State's healthcare financing structure through a budget impact analysis. The KSHI scenario results in a health benefit to patients at a higher cost compared to the base case. The mean ICER (US$46.4/disability-adjusted life year averted) is considered very cost-effective compared to a willingness-to-pay threshold of one gross domestic product per capita (Nigeria, US$2012, 2,730). Our conclusion was robust to uncertainty in parameters estimates (PSA: median US$49.1, 95% credible interval 21.9-152.3), during one-way sensitivity analyses, and when cost, quality, cost and utilization parameters of the base case scenario were changed. The sustainability of this program's scale up by the State is dependent on further investments in healthcare. Conclusions This study provides evidence that the investment made by the KSHI program in rural Nigeria is likely to have been cost-effective; however, further healthcare investments are needed for this program to be successfully expanded within Kwara State. Policy makers should consider supporting financial initiatives to reduce maternal mortality tackling both supply and demand issues in the access to care.	[Gomez, Gabriela B.; Brals, Daniella; Nelissen, Heleen E.; Hendriks, Marleen E.; Boers, Alexander C.; Rosendaal, Nicole; Wit, Ferdinand W.; Hankins, Catherine A.; Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Gomez, Gabriela B.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Foster, Nicola] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, ZA-7925 Cape Town, South Africa; [Bolarinwa, Oladimeji A.; Akande, Tanimola M.] Univ Ilorin, Teaching Hosp, Dept Epidemiol & Community Hlth, Ilorin, Nigeria; [van Eck, Diederik] Pharmaccess Fdn, Amsterdam, Netherlands; [Adenusi, Peju] Hygeia Nigeria Ltd, Lagos, Nigeria; [Agbede, Kayode] Ogo Oluwa Hosp, Bacita, Kwara State, Nigeria; [van Hensbroek, Michael Boele] AMC, Emma Childrens Hosp, Global Child Hlth Grp, Amsterdam, Netherlands; [Hankins, Catherine A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of Ilorin; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine	Gomez, GB (corresponding author), Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	g.gomez@aighd.org	Wit, Ferdinand/AAC-3803-2019; Foster, Nicola/AAA-9040-2020; Akande, Tanimola Makanjuola/U-1362-2019	Foster, Nicola/0000-0003-4630-6243; Hankins, Catherine/0000-0002-1642-8592; Nelissen, Heleen Elise/0000-0001-7489-1297; Boele van Hensbroek, Michael/0000-0003-1907-5427	Health Insurance Fund; Hygeia Nigeria Ltd.	Health Insurance Fund; Hygeia Nigeria Ltd.	This study was funded by the Health Insurance Fund (www.hifund.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hygeia Nigeria Ltd. provided support in the form of a salary for author PA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Abimbola S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001211; AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Adinma Echendu D, 2010, Nig Q J Hosp Med, V20, P86; Ashir Garba Mohammed, 2013, Glob J Health Sci, V5, P34, DOI 10.5539/gjhs.v5n3p34; Begley CM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub2; Bonfrer I, 2015, 201501 ER U ROTT; Brals D, IMPACT HLTH IN UNPUB; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Calvert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041114; Doctor HV, 2013, J HEALTH CARE POOR U, V24, P152, DOI 10.1353/hpu.2013.0032; Dolea C, GLOBAL BURDEN OBSTRU; Dolea C, GLOBAL BURDEN MATERN; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2; Emmanuel NK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-53; Erim DO, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-786; Erim DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039555; Ezegwui HU, 2013, ANN MED HEALTH SCI R, V3, P75, DOI 10.4103/2141-9248.109511; Ezugwu EC, 2011, J OBSTET GYNAECOL, V31, P409, DOI 10.3109/01443615.2011.578227; Federal Ministry of Health [Nigeria], 2013, NAT HIV AIDS REPR HL; Federal Republic of Nigeria, POP HOUS CENS 2006 P; Findley SE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1034; Fistula Care, 2012, EST COSTS PROV FIST; Galadanci H, 2011, INT J GYNECOL OBSTET, V114, P23, DOI 10.1016/j.ijgo.2011.02.005; Garattini L, 2011, EUR J HEALTH ECON, V12, P499, DOI 10.1007/s10198-011-0348-5; Guerrier G, 2013, INT J WOMENS HEALTH, V5, P495, DOI 10.2147/IJWH.S48179; Gustafsson-Wright E, 2013, ACHIEVING UNIVERSAL; Hendriks ME, 2014, JAMA INTERN MED, V174, P555, DOI 10.1001/jamainternmed.2013.14458; Hendriks ME, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23573; HIFUND, HLTH INS FUND FUND I; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Igwegbe AO, 2012, INT J GYNECOL OBSTET, V116, P197, DOI 10.1016/j.ijgo.2011.10.023; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; Kaye DK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-65; Kramer B., 2014, INTRA HOUSEHOLD ALLO; Kruk ME, 2007, HEALTH POLICY PLANN, V22, P303, DOI 10.1093/heapol/czm027; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Lawanson AO, 2014, ASIAN J HUMANIT SOC, V2; Leduc D, 2009, J OBSTET GYNAECOL CA, V31, P980, DOI 10.1016/S1701-2163(16)34329-8; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Nwosu B O, 2012, Niger J Med, V21, P196; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Obiechina NJ, 2013, INT J WOMENS HEALTH, V5, P431, DOI 10.2147/IJWH.S46988; Okafor I I, 2011, Niger J Med, V20, P441; Onwujekwe O, 2009, HEALTH POLICY, V92, P96, DOI 10.1016/j.healthpol.2009.02.007; Prata N, 2012, SOC SCI MED, V74, P1288, DOI 10.1016/j.socscimed.2011.11.035; Rai RK, 2012, WOMEN HEALTH ISS, V22, pE407, DOI 10.1016/j.whi.2012.05.001; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Saidu Rakiya, 2013, Afr J Reprod Health, V17, P41; Seale AC, 2009, LANCET INFECT DIS, V9, P428, DOI 10.1016/S1473-3099(09)70172-0; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; The World Bank, OFF EXCH RAT LCU PER; The World Bank, IND DAT; The World Bank, GDP PER CAP CURR USS; United Nations, MILL DEV GOALS 2015; United Nations, INTR PROP GOALS TARG; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; WHO UNICEF UNFPA, 1997, GUID MON AV US OBST; World Bank, RAT NAT INCR; World Health Organization, 2014, COST EFF STRAT PLANN; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	64	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139048	10.1371/journal.pone.0139048	http://dx.doi.org/10.1371/journal.pone.0139048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EO	26413788	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000362170700035
J	Aziz, A; Ali, Y; Aziz, T; Siddique, JI				Aziz, Asim; Ali, Yasir; Aziz, Taha; Siddique, J. I.			Heat Transfer Analysis for Stationary Boundary Layer Slip Flow of a Power-Law Fluid in a Darcy Porous Medium with Plate Suction/Injection	PLOS ONE			English	Article							FLAT-PLATE; FORCED-CONVECTION; MASS-TRANSFER; THERMAL-CONDUCTIVITY; STRETCHING SHEET; SURFACE	In this paper, we investigate the slip effects on the boundary layer flow and heat transfer characteristics of a power-law fluid past a porous flat plate embedded in the Darcy type porous medium. The nonlinear coupled system of partial differential equations governing the flow and heat transfer of a power-law fluid is transformed into a system of nonlinear coupled ordinary differential equations by applying a suitable similarity transformation. The resulting system of ordinary differential equations is solved numerically using Matlab bvp4c solver. Numerical results are presented in the form of graphs and the effects of the power-law index, velocity and thermal slip parameters, permeability parameter, suction/injection parameter on the velocity and temperature profiles are examined.	[Aziz, Asim; Ali, Yasir] Natl Univ Sci & Technol, Coll Elect & Mech Engn, Rawalpindi 46000, Pakistan; [Aziz, Taha] Univ Witwatersrand, DST NRF Ctr Excellence Math & Stat Sci, ZA-2050 Johannesburg, South Africa; [Siddique, J. I.] Penn State Univ, Dept Math, York, PA 17403 USA	National University of Sciences & Technology - Pakistan; University of Witwatersrand; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Aziz, A (corresponding author), Natl Univ Sci & Technol, Coll Elect & Mech Engn, Rawalpindi 46000, Pakistan.	aaziz@ceme.nust.edu.pk	Aziz, Taha/AAD-5198-2020	Aziz, Taha/0000-0003-0519-1320; Aziz, Asim/0000-0002-2798-5191				ABUSITTA AMM, 1994, APPL MATH COMPUT, V64, P73, DOI 10.1016/0096-3003(94)90140-6; ACRIVOS A, 1960, AICHE J, V6, P312, DOI 10.1002/aic.690060227; ANDERSSON HI, 1992, INT J NONLINEAR MECH, V27, P929, DOI 10.1016/0020-7462(92)90045-9; Andersson HI, 2002, ACTA MECH, V158, P121, DOI 10.1007/BF01463174; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; Aziz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114544; Baoku IG, 2013, INT J HEAT FLUID FL, V40, P81, DOI 10.1016/j.ijheatfluidflow.2013.01.016; BEAVERS GS, 1967, J FLUID MECH, V30, P197, DOI 10.1017/S0022112067001375; Bhattacharyya K, 2011, J PETROL SCI ENG, V78, P304, DOI 10.1016/j.petrol.2011.06.009; Blasius H., 1908, GRENZSCHICHTEN FLUSS, V1256; Cheng CY, 2011, INT COMMUN HEAT MASS, V38, P615, DOI 10.1016/j.icheatmasstransfer.2010.12.034; Cheng CY, 2009, INT COMMUN HEAT MASS, V36, P351, DOI 10.1016/j.icheatmasstransfer.2009.01.003; Farhad A., 2011, EUR J SCI RES, V57, P293; GEBHART B, 1971, INT J HEAT MASS TRAN, V14, P2025, DOI 10.1016/0017-9310(71)90026-3; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hajmohammadi MR, 2014, HEAT TRANSFER ENG, V35, P863, DOI 10.1080/01457632.2014.852896; Hayat T, 2015, J APPL FLUID MECH, V8, P273; Howarth L, 1938, PROC R SOC LON SER-A, V164, P0547, DOI 10.1098/rspa.1938.0037; Ibrahim W, 2013, COMPUT FLUIDS, V75, P1, DOI 10.1016/j.compfluid.2013.01.014; Ingham D. B., 1998, TRANSPORT PHENOMENA; Ishak A, 2010, APPL MATH COMPUT, V217, P837, DOI 10.1016/j.amc.2010.06.026; Khan ZH, 2009, HT2008: PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE, VOL 1, P301, DOI 10.1115/HT2008-56448; KUMARI M, 1990, ACTA MECH, V84, P201, DOI 10.1007/BF01176098; LEE SY, 1966, AICHE J, V12, P700, DOI 10.1002/aic.690120415; Loureiro JBR, 2013, J NON-NEWTON FLUID, V199, P20, DOI 10.1016/j.jnnfm.2013.05.003; Luna N, 2005, INT J THERM SCI, V44, P656, DOI 10.1016/j.ijthermalsci.2004.12.008; Magyari E, 2011, COMMUN NONLINEAR SCI, V16, P599, DOI 10.1016/j.cnsns.2010.03.020; Mahmoud MAA, 2006, ACTA MECH, V181, P83, DOI 10.1007/s00707-005-0268-5; Megahed AM, 2015, MECCANICA, V50, P1693, DOI 10.1007/s11012-015-0114-3; Mukhopadhyay S, 2009, MECCANICA, V44, P587, DOI 10.1007/s11012-009-9211-5; Nield D.A., 1998, CONVECTION POROUS ME; Noghrehabadi A, 2012, INT J THERM SCI, V54, P253, DOI 10.1016/j.ijthermalsci.2011.11.017; Pakdemirli M, 1996, INT J NONLINEAR MECH, V31, P267, DOI 10.1016/0020-7462(95)00071-2; Pal D, 2013, APPL MATH COMPUT, V219, P7556, DOI 10.1016/j.amc.2012.10.119; Pal D, 2010, COMMUN NONLINEAR SCI, V15, P1813, DOI 10.1016/j.cnsns.2009.07.011; Qasim M., 2014, PLOS ONE, V9; Sahoo B, 2010, CENT EUR J PHYS, V8, P498, DOI 10.2478/s11534-009-0105-x; SCHOWALTER WR, 1960, AICHE J, V6, P24, DOI 10.1002/aic.690060105; Shyam R, 2013, INT J HEAT MASS TRAN, V64, P1127, DOI 10.1016/j.ijheatmasstransfer.2013.05.052; Vafai K., 2000, HDB POROUS MEDIA, V1st; Wang CY, 2002, CHEM ENG SCI, V57, P3745, DOI 10.1016/S0009-2509(02)00267-1; WANG TY, 1995, INT J HEAT FLUID FL, V16, P56, DOI 10.1016/0142-727X(94)00008-Z; Xu H, 2006, J NON-NEWTON FLUID, V139, P31, DOI 10.1016/j.jnnfm.2006.06.003; Xu H, 2009, COMPUT MATH APPL, V57, P1425, DOI 10.1016/j.camwa.2009.01.029; Yazdi MH, 2014, INT REV MODELLING SI, V7	45	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138855	10.1371/journal.pone.0138855	http://dx.doi.org/10.1371/journal.pone.0138855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407162	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700105
J	Boyapalle, S; Xu, WD; Raulji, P; Mohapatra, S; Mohapatra, SS				Boyapalle, Sandhya; Xu, Weidong; Raulji, Payal; Mohapatra, Subhra; Mohapatra, Shyam S.			A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models	PLOS ONE			English	Article							VIRUS TYPE-1 REPLICATION; SMALL INTERFERING RNA; CHITOSAN NANOPARTICLES; VAGINAL MICROBICIDES; HIV-1 INFECTION; GENE DELIVERY; T-CELLS; INHIBITION; TRANSMISSION; EXPRESSION	Human immunodeficiency virus (HIV) types 1 and 2 (HIV-1 and HIV-2) are the etiologic agents of AIDS. Most HIV-1 infected individuals worldwide are women, who acquire HIV infections during sexual contact. Blocking HIV mucosal transmission and local spread in the female lower genital tract is important in preventing infection and ultimately eliminating the pandemic. Microbicides work by destroying the microbes or preventing them from establishing an infection. Thus, a number of different types of microbicides are under investigation, however, the lack of their solubility and bioavailability, and toxicity has been major hurdles. Herein, we report the development of multifunctional chitosan-lipid nanocomplexes that can effectively deliver plasmids encoding siRNA(s) as microbicides without adverse effects and provide significant protection against HIV in both in vitro and in vivo models. Chitosan or chitosan-lipid (chlipid) was complexed with a cocktail of plasmids encoding HIV-1-specific siRNAs (psiRNAs) and evaluated for their efficacy in HEK-293 cells, PBMCs derived from nonhuman primates, 3-dimensional human vaginal ectocervical tissue (3D-VEC) model and also in non-human primate model. Moreover, prophylactic administration of the chlipid to deliver a psiRNA cocktail intravaginally with a cream formulation in a non-human primate model showed substantial reduction of SHIV (simian/human immunodeficiency virus SF162) viral titers. Taken together, these studies demonstrate the potential of chlipid-siRNA nanocomplexes as a potential genetic microbicide against HIV infections.	[Boyapalle, Sandhya; Xu, Weidong; Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Div Translat Med, Tampa, FL 33612 USA; [Boyapalle, Sandhya; Xu, Weidong; Mohapatra, Shyam S.] Univ S Florida, Nanomed Res Ctr, Tampa, FL USA; [Raulji, Payal; Mohapatra, Subhra] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL USA; [Mohapatra, Subhra; Mohapatra, Shyam S.] James A Haley VA Hosp, Tampa, FL USA; [Boyapalle, Sandhya; Xu, Weidong; Raulji, Payal] Transgenex Nanobiotech Inc, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Mohapatra, SS (corresponding author), Univ S Florida, Dept Internal Med, Div Translat Med, Tampa, FL 33612 USA.	smohapat@health.usf.edu			National Institutes of Health [R43 AI080431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI080431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, R43 AI080431 awarded to Weidong Xu and Shyam S. Mohapatra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2013, CURR OPIN IMMUNOL, V25, P403, DOI 10.1016/j.coi.2013.03.009; Arrighi JF, 2004, J VIROL, V78, P10848, DOI 10.1128/JVI.78.20.10848-10855.2004; Artan M, 2010, CARBOHYD RES, V345, P656, DOI 10.1016/j.carres.2009.12.017; Arteaga HJ, 2003, NAT BIOTECHNOL, V21, P230, DOI 10.1038/nbt0303-230; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3; Boyapalle S, 2012, J GLOB INFECT DIS, V4, P62, DOI 10.4103/0974-777X.93764; Brehm MA, 2014, J IMMUNOL METHODS, V410, P3, DOI 10.1016/j.jim.2014.02.011; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Capodici J, 2002, J IMMUNOL, V169, P5196, DOI 10.4049/jimmunol.169.9.5196; Coburn GA, 2002, J VIROL, V76, P9225, DOI 10.1128/JVI.76.18.9225-9231.2002; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Dudek TE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003984; Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Karagozlu MZ, 2014, INT J BIOL MACROMOL, V66, P260, DOI 10.1016/j.ijbiomac.2014.02.020; Khan AB, 2014, CURR DRUG DELIV, V11, P112, DOI 10.2174/156720181000131028120709; Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012; Lavender KJ, 2013, BLOOD, V122, P4013, DOI 10.1182/blood-2013-06-506949; Lee MTM, 2003, J VIROL, V77, P11964, DOI 10.1128/JVI.77.22.11964-11972.2003; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6; Librelotto CS, 2015, REV SOC BRAS MED TRO, V48, P249, DOI 10.1590/0037-8682-0083-2015; Liu SK, 2004, NUCLEIC ACIDS RES, V32, P3752, DOI 10.1093/nar/gkh715; Malhotra M, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S43683; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meng JN, 2014, NANOMEDICINE-UK, V9, P1595, DOI [10.2217/NNM.13.136, 10.2217/nnm.13.136]; Meng JN, 2011, EUR J PHARM SCI, V44, P57, DOI 10.1016/j.ejps.2011.06.007; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Nakagawa F, 2014, CURR HIV-AIDS REP, V11, P177, DOI 10.1007/s11904-014-0198-8; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Obiero J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-289; Oshima K, 2003, CANCER RES, V63, P6809; Park SC, 2015, INT J MOL SCI, V16, P7995, DOI 10.3390/ijms16047995; Park S, 2013, CARBOHYD POLYM, V92, P57, DOI 10.1016/j.carbpol.2012.08.116; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Salgado M, 2014, J VIROL, V88, P3340, DOI 10.1128/JVI.03380-13; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Tager AM, 2013, J INFECT DIS, V208, pS121, DOI 10.1093/infdis/jit451; UNAIDS, 2013, REP GLOB AIDS EP; Unwalla HJ, 2004, NAT BIOTECHNOL, V22, P1573, DOI 10.1038/nbt1040; Veselinovic M, 2012, VIROLOGY, V432, P505, DOI 10.1016/j.virol.2012.06.025; Walker PR, 2003, NATURE, V422, P679, DOI 10.1038/422679a; Wilkinson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109296; Wu CJ, 2005, ANTIVIR RES, V65, P45, DOI 10.1016/j.antiviral.2004.09.005; Zhang Weidong, 2004, Genet Vaccines Ther, V2, P8, DOI 10.1186/1479-0556-2-8; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	56	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0135288	10.1371/journal.pone.0135288	http://dx.doi.org/10.1371/journal.pone.0135288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407080	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700004
J	Cheroni, C; Donnici, L; Aghemo, A; Balistreri, F; Bianco, A; Zanoni, V; Pagani, M; Soffredini, R; D'Ambrosio, R; Rumi, MG; Colombo, M; Abrignani, S; Neddermann, P; De Francesco, R				Cheroni, Cristina; Donnici, Lorena; Aghemo, Alessio; Balistreri, Francesca; Bianco, Annalisa; Zanoni, Valeria; Pagani, Massimiliano; Soffredini, Roberta; D'Ambrosio, Roberta; Rumi, Maria Grazia; Colombo, Massimo; Abrignani, Sergio; Neddermann, Petra; De Francesco, Raffaele			Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity	PLOS ONE			English	Article							DEFECTIVE INTERFERING PARTICLES; B-VIRUS; TRANSPLANT RECIPIENTS; PERSISTENT INFECTION; ENCEPHALITIS-VIRUS; VERO CELLS; IN-VITRO; RNA; IDENTIFICATION; DISEASE	Hepatitis C virus (HCV) variants characterized by genomic deletions in the structural protein region have been sporadically detected in liver and serum of hepatitis C patients. These defective genomes are capable of autonomous RNA replication and are packaged into infectious viral particles in cells co-infected with the wild-type virus. The prevalence of such forms in the chronically HCV-infected population and the impact on the severity of liver disease or treatment outcome are currently unknown. In order to determine the prevalence of HCV defective variants and to study their association with clinical characteristics, a screening campaign was performed on pre-therapy serum samples from a well-characterized cohort of previously untreated genotype 1 HCV-infected patients who received treatment with PEG-IFN alpha and RBV. 132 subjects were successfully analyzed for the presence of defective species exploiting a long-distance nested PCR assay. HCV forms with deletions predominantly affecting E1, E2 and p7 proteins were found in a surprising high fraction of the subjects (25/132, 19%). Their presence was associated with patient older age, higher viral load and increased necroinflammatory activity in the liver. While the presence of circulating HCV carrying deletions in the E1-p7 region did not appear to significantly influence sustained virological response rates to PEG-IFN alpha/RBV, our study indicates that the presence of these subgenomic HCV mutants could be associated with virological relapse in patients who did not have detectable viremia at the end of the treatment.	[Cheroni, Cristina; Donnici, Lorena; Balistreri, Francesca; Bianco, Annalisa; Zanoni, Valeria; Pagani, Massimiliano; Abrignani, Sergio; Neddermann, Petra; De Francesco, Raffaele] Ist Nazl Genet Mol Romeo & Enrica Invernizzi, INGM, Milan, Italy; [Aghemo, Alessio; Soffredini, Roberta; D'Ambrosio, Roberta; Colombo, Massimo] Univ Milan, AM Migliavacca Ctr Liver Dis, Div Gastroenterol 1, Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Milan, Italy; [Rumi, Maria Grazia] Univ Milan, Div Hepatol, Osped San Giuseppe IRCCS Multimed, Milan, Italy; [Abrignani, Sergio] Univ Milan, DISCCO, Dept Clin Sci & Community Hlth, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; University of Milan	De Francesco, R (corresponding author), Ist Nazl Genet Mol Romeo & Enrica Invernizzi, INGM, Milan, Italy.	defrancesco@ingm.org	Aghemo, Alessio/ABE-5976-2021; D'Ambrosio, Roberta/K-3078-2016; Balistreri, Francesca/AAL-5608-2021; Cheroni, Cristina/AAO-2316-2020; De Francesco, Raffaele/J-6003-2012	Aghemo, Alessio/0000-0003-0941-3226; D'Ambrosio, Roberta/0000-0003-0019-1153; Balistreri, Francesca/0000-0001-9886-1228; De Francesco, Raffaele/0000-0001-8754-5123; RUMI, MARIAGRAZIA/0000-0002-5876-8528; Abrignani, Sergio/0000-0002-0794-3285; Cheroni, Cristina/0000-0002-0832-2333; Pagani, Massimiliano/0000-0002-7017-9304	Italian Ministry of Education, University and Research (MIUR) [RBAP10TPXK]; Italian Foundation for Research in Hepatology (FIRE, Fondazione Italiana per la Ricerca in Epatologia)	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Foundation for Research in Hepatology (FIRE, Fondazione Italiana per la Ricerca in Epatologia)	This study was supported by a research grant from the Italian Ministry of Education, University and Research (MIUR; grant number RBAP10TPXK to INGM). Francesca Balistreri is the recipient of an annual fellowship of the Italian Foundation for Research in Hepatology (FIRE, Fondazione Italiana per la Ricerca in Epatologia). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Aghemo A, 2013, HEPATOLOGY, V58, P428, DOI 10.1002/hep.26371; Aghemo A, 2009, ANTIVIR THER, V14, P577; Aoki H, 2001, J VET MED SCI, V63, P751, DOI 10.1292/jvms.63.751; Asselah T, 2010, J PATHOL, V221, P264, DOI 10.1002/path.2703; Bernardin F, 2007, VIROLOGY, V365, P446, DOI 10.1016/j.virol.2007.04.003; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; DELATORRE JC, 1990, J VIROL, V64, P6278, DOI 10.1128/JVI.64.12.6278-6281.1990; Farinati F, 2007, J VIRAL HEPATITIS, V14, P821, DOI 10.1111/1365-2893.2007.00878.x; FERNHOLZ D, 1993, VIROLOGY, V194, P137, DOI 10.1006/viro.1993.1243; Fimia GM, 2003, CELL DEATH DIFFER, V10, pS16, DOI 10.1038/sj.cdd.4401114; Fricke J, 2001, VIROLOGY, V291, P77, DOI 10.1006/viro.2001.1170; Goossens N, 2014, HEPATOLOGY, V59, P2403, DOI 10.1002/hep.26905; Iwai A, 2006, J VIRAL HEPATITIS, V13, P523, DOI 10.1111/j.1365-2893.2006.00760.x; Kupfermann H, 1996, J VIROL, V70, P8175, DOI 10.1128/JVI.70.11.8175-8181.1996; Lancaster MU, 1998, J VIROL, V72, P2474, DOI 10.1128/JVI.72.3.2474-2482.1998; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; MELEGARI M, 1994, VIROLOGY, V199, P292, DOI 10.1006/viro.1994.1127; MEYERS G, 1995, J VIROL, V69, P3683, DOI 10.1128/JVI.69.6.3683-3689.1995; Noppornpanth S, 2007, J VIROL, V81, P12496, DOI 10.1128/JVI.01059-07; Ohtsuru S, 2013, J CLIN MICROBIOL, V51, P3645, DOI 10.1128/JCM.00676-13; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; R Development Core Team, R LANG ENV STAT COMP; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08; Venables WN., 2002, MODERN APPL STAT S 4; Yagi S, 2005, J MED VIROL, V77, P399, DOI 10.1002/jmv.20469; Yoon SW, 2006, MOL CELLS, V21, P112; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33	32	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138546	10.1371/journal.pone.0138546	http://dx.doi.org/10.1371/journal.pone.0138546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405760	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700057
J	Lemic, D; Mikac, KM; Ivkosic, SA; Bazok, R				Lemic, Darija; Mikac, Katarina M.; Ivkosic, Stephanie A.; Bazok, Renata			The Temporal and Spatial Invasion Genetics of the Western Corn Rootworm (Coleoptera: Chrysomelidae) in Southern Europe	PLOS ONE			English	Article							DIABROTICA-VIRGIFERA-VIRGIFERA; MULTIPLE TRANSATLANTIC INTRODUCTIONS; POPULATION-STRUCTURE; MICROSATELLITE LOCI; REDUCTIONS; INFERENCE; AMERICAN; PROGRAM	This study describes the genetics of the western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte in southern Europe during the introduction (1996-2001) and establishment/spread (2002-2011) phases of its invasion. The Diabrotica microsatellite core-set was used to perform traditional population genetics analyses. Our results indicated that during the introduction phase genetic diversity and population genetic structure were lower overall as compared to the establishment/spread phase. Unusually high genetic differentiation was found between the Italy and southern Europe comparisons, including high differentiation between Italian populations separated by a short distance during the establishment/ spread phase. STRUCTURE analysis revealed two genetic clusters during the introduction phase and two genetic clusters during the establishment/spread phase. However, bottlenecked populations were only detected during the invasion phase. A small but significant isolation by distance effect was noted in both phases. Serbia was the geographic source of WCR to Croatia and Hungary in the introduction phase, while the United States of America was the possible source of WCR to Italy in 2001. These introductory populations were the subsequent source of individuals sampled during the establishment/spread phase. Repeated introductions and admixture events in southern Europe may have resulted in genetically diverse WCR populations that have attained 83% of all known alleles worldwide.	[Lemic, Darija; Bazok, Renata] Univ Zagreb, Fac Agr, Dept Agr Zool, Zagreb 41000, Croatia; [Mikac, Katarina M.; Ivkosic, Stephanie A.] Univ Wollongong, Ctr Sustainable Ecosyst Solut, Wollongong, NSW, Australia	University of Zagreb; University of Wollongong	Lemic, D (corresponding author), Univ Zagreb, Fac Agr, Dept Agr Zool, Zagreb 41000, Croatia.	dlemic@agr.hr	Bazok, Renata/G-8225-2012	Bazok, Renata/0000-0003-1655-8140; Mikac, Katarina/0000-0002-5779-7351	Ministry of Science, Education and Sports of the Republic of Croatia [178-1782066-2064, 178-1782066-2065]	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	Funding: This research was supported by the Ministry of Science, Education and Sports of the Republic of Croatia by projects: Risk estimation system-the basis for integrated control of corn pests, principal investigator: prof.dr.sc. Renata Bazok 178-1782066-2064. The spatial distribution of economically important pests with the use of GIS, Principal investigator: prof.dr.sc. Jasminka Igrc Barcic 178-1782066-2065.	Baca F, 1994, PFLANZENSCHUTZ, V1-2, P9; Barcic J. I., 2003, Entomologia Croatica, V7, P63; Baufeld P, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P285, DOI 10.1079/9780851998176.0285; Bermond G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050129; Boriani M., 2006, Bulletin OEPP, V36, P531; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Ciosi M, 2011, EVOL APPL, V4, P54, DOI 10.1111/j.1752-4571.2010.00133.x; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; (DEEDI) Department of Employment Economic Development and Innovation, 2011, AUSTR NAT RED IMP FI; Dobrincic Renata, 2002, Agriculturae Conspectus Scientificus, V67, P1; Earl DA, 2011, CONSERVATION GENETIC; (EPPO) European and Mediterranean Plant Protection Organisation, 2011, PRES SIT DIABR VIRG; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Frausin C, 2004, IWGO NEWSLETTER, V2, P8; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ivkosic SA, 2014, ENVIRON ENTOMOL, V43, P804, DOI 10.1603/EN13264; Johannesen J, 2013, ENTOMOL EXP APPL, V147, P61, DOI 10.1111/eea.12041; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kim KS, 2005, ENVIRON ENTOMOL, V34, P494, DOI 10.1603/0046-225X-34.2.494; Kim KS, 2005, MOL ECOL NOTES, V5, P115, DOI 10.1111/j.1471-8286.2004.00853.x; Kim KS, 2008, ENVIRON ENTOMOL, V37, P293, DOI 10.1603/0046-225X(2008)37[293:ACSOMM]2.0.CO;2; Kim KS, 2013, J ASIA-PAC ENTOMOL, V16, P87, DOI 10.1016/j.aspen.2012.11.004; Kiritani Keizi, 2003, P44; Kiss J, 2005, W CORN ROOTWORM ECOL, P285; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Krysan J.L., 1986, METHODS STUDY PEST D, P260; Lemic D, 2013, ENVIRON ENTOMOL, V42, P811, DOI 10.1603/EN12351; Lemic D, 2016, PEST MANAG SCI, V72, P405, DOI 10.1002/ps.4072; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Miller NJ, 2007, J APPL ENTOMOL, V131, P378, DOI 10.1111/j.1439-0418.2007.01190.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Park M, 2013, B ENTOMOL RES, V103, P414, DOI 10.1017/S0007485313000011; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sappington Thomas W., 2006, American Entomologist, V52, P90; Sivcev I, 2000, P 5 FAO TCP M 6 EPPO; SLATKIN M, 1995, GENETICS, V139, P457; Szalai M, 2011, J PEST SCI, V84, P133, DOI 10.1007/s10340-010-0336-z; Venette R. C., 1998, California Agriculture, V52, P13, DOI 10.3733/ca.v052n02p13; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034567	53	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138796	10.1371/journal.pone.0138796	http://dx.doi.org/10.1371/journal.pone.0138796			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406466	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700100
J	Safia; Kamil, M; Jadiya, P; Sheikh, S; Haque, E; Nazir, A; Lakshmi, V; Mir, SS				Safia; Kamil, Mohd; Jadiya, Pooja; Sheikh, Saba; Haque, Ejazul; Nazir, Aamir; Lakshmi, Vijai; Mir, Snober S.			The Chromone Alkaloid, Rohitukine, Affords Anti-Cancer Activity via Modulating Apoptosis Pathways in A549 Cell Line and Yeast Mitogen Activated Protein Kinase (MAPK) Pathway	PLOS ONE			English	Article							DYSOXYLUM-BINECTARIFERUM; SACCHAROMYCES-CEREVISIAE; CASPASE ACTIVATION; FLAVOPIRIDOL; STRESS; PROLIFERATION; INHIBITOR; CYCLIN; REPRESSION; PRODUCTS	The field of cancer research and treatment has made significant progress, yet we are far from having completely safe, efficient and specific therapies that target cancer cells and spare the healthy tissues. Natural compounds may reduce the problems related to cancer treatment. Currently, many plant products are being used to treat cancer. In this study, Rohitukine, a natural occurring chromone alkaloid extracted from Dysoxylum binectariferum, was investigated for cytotoxic properties against budding yeast as well as against lung cancer (A549) cells. We endeavored to specifically study Rohitukine in S. cerevisiae in the context of MAPK pathways as yeast probably represents the experimental model where the organization and regulation of MAPK pathways are best understood. MAPK are evolutionarily conserved protein kinases that transfer extracellular signals to the machinery controlling essential cellular processes like growth, migration, differentiation, cell division and apoptosis. We aimed at carrying out hypothesis driven studies towards targeting the important network of cellular communication, a critical process that gets awry in cancer. Employing mutant strains of genetic model system Saccharomyces cerevisiae. S. cerevisiae encodes five MAPKs involved in control of distinct cellular responses such as growth, differentiation, migration and apoptosis. Our study involves gene knockouts of Slt2 and Hog1 which are functional homologs of human ERK5 and mammalian p38 MAPK, respectively. We performed cytotoxicity assay to evaluate the effect of Rohitukine on cell viability and also determined the effects of drug on generation of reactive oxygen species, induction of apoptosis and expression of Slt2 and Hog1 gene at mRNA level in the presence of drug. The results of this study show a differential effect in the activity of drug between the WT, Slt2 and Hog1 gene deletion strain indicating involvement of MAPK pathway. Further, we investigated Rohitukine induced cytotoxic effects in lung cancer cells and stimulated the productions of ROS after exposure for 24 hrs. Results from western blotting suggest that Rohitukine triggered apoptosis in A549 cell line through upregulation of p53, caspase9 and down regulation of Bcl-2 protein. The scope of this study is to understand the mechanism of anticancer activity of Rohitukine to increase the repertoire of anticancer drugs, so that problem created by emergence of resistance towards standard anticancer compounds can be alleviated.	[Safia; Kamil, Mohd; Sheikh, Saba; Haque, Ejazul; Mir, Snober S.] Integral Univ, Dept Bioengn & Biosci, Lucknow, Uttar Pradesh, India; [Jadiya, Pooja; Nazir, Aamir] CSIR Cent Drug Res Inst, Lab Funct Genom & Mol Toxicol, Div Toxicol, Lucknow, Uttar Pradesh, India; [Lakshmi, Vijai] King Georges Med Univ, Dept Biochem, Lucknow, Uttar Pradesh, India	Integral University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University	Mir, SS (corresponding author), Integral Univ, Dept Bioengn & Biosci, Lucknow, Uttar Pradesh, India.	smir@iul.ac.in	Haque, Ejazul/AAS-9597-2020; Safia/AAU-4182-2020	Safia/0000-0002-5562-6460; Kamil, Mohd/0000-0001-9429-2662; Nazir, Aamir/0000-0002-2503-1335; Jadiya, Pooja/0000-0003-4807-9304	Integral University; University Grant Commission India; University Grants Commission (UGC), Government of India [F1-17.1/2011/MANF-MUS-UTT-5405]	Integral University; University Grant Commission India(University Grants Commission, India); University Grants Commission (UGC), Government of India(University Grants Commission, India)	The authors are funded by Integral University and University Grant Commission India. Ms. Safia is grateful to University Grants Commission (UGC), Government of India for Maulana Azad National Fellowship, (F1-17.1/2011/MANF-MUS-UTT-5405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almenara J, 2002, LEUKEMIA, V16, P1331, DOI 10.1038/sj.leu.2402535; Azad GK, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0317-0; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Carlson B, 1999, CANCER RES, V59, P4634; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Cui YX, 2012, MOL BIOL CELL, V23, P4373, DOI 10.1091/mbc.E12-04-0281; Decker RH, 2001, CELL DEATH DIFFER, V8, P715, DOI 10.1038/sj.cdd.4400868; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Harrison JC, 2004, J BIOL CHEM, V279, P2616, DOI 10.1074/jbc.M306110200; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hsuuw YD, 2005, J CELL PHYSIOL, V205, P379, DOI 10.1002/jcp.20408; Jadiya P, 2012, CNS NEUROL DISORD-DR, V11, P976; Jiang SY, 2007, J EXP MICROBIOL IMMU, V11, P112; Kaba HEJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-16; Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769; Karathia H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016015; Keshri G, 2007, CONTRACEPTION, V76, P400, DOI 10.1016/j.contraception.2007.07.009; Kitada S, 2000, BLOOD, V96, P393; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kumara PM, 2013, ANTON LEEUW INT J G, V101, P323; Lakshmi V, 2007, PHYTOMEDICINE, V14, P36, DOI 10.1016/j.phymed.2005.10.002; Lane N, 2006, NATURE, V440, P600, DOI 10.1038/440600a; Lawrence CL, 2004, MOL CELL BIOL, V24, P3307, DOI 10.1128/MCB.24.8.3307-3323.2004; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Matuo R, 2012, CANCER CHEMOTH PHARM, V70, P491, DOI 10.1007/s00280-012-1937-4; Mitsui K, 2005, FEBS LETT, V579, P723, DOI 10.1016/j.febslet.2004.12.051; Mohanakumara P, 2010, FITOTERAPIA, V81, P145, DOI 10.1016/j.fitote.2009.08.010; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moye-Rowley WS, 2003, PROG NUCLEIC ACID RE, V73, P251, DOI 10.1016/S0079-6603(03)01008-0; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Queralt E, 2005, GENETICS, V171, P1485, DOI 10.1534/genetics.105.045005; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Sedlacek HH, 1996, INT J ONCOL, V9, P1143, DOI 10.3892/ijo.9.6.1143; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Soriano-Carot M, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-1; Stepanov A, 2008, MOL PHARMACOL, V74, P423, DOI 10.1124/mol.107.044651; Stevens SK, 2013, MOL PHARMACOL, V83, P225, DOI 10.1124/mol.112.079657; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Takada Y, 2008, MOL PHARMACOL, V73, P1549, DOI 10.1124/mol.107.041350; Tong NN, 2012, ONCOL LETT, V3, P1263, DOI 10.3892/ol.2012.644; Tsuchiya T, 2008, HEPATO-GASTROENTEROL, V55, P930; Verma M, 2013, PLOS ONE, V7, DOI 10.1371-journal.pone.0042923; WAN CP, 1993, J IMMUNOL METHODS, V159, P131, DOI 10.1016/0022-1759(93)90150-6; WATTS C, 2009, MOL ENDOCRINOL, V9, P1804; Wen J, 2008, J HEALTH SCI, V54, P129, DOI 10.1248/jhs.54.129; Westfall PJ, 2004, SCIENCE, V306, P1511, DOI 10.1126/science.1104879; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yu CR, 2002, CLIN CANCER RES, V8, P2976; Yuan L, 2013, FOOD CHEM TOXICOL, V53, P62, DOI [10.1016/j.fct.2013.02.003, 10.1016/j.fct.2012.11.048]; Zheng F, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-36	58	24	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137991	10.1371/journal.pone.0137991	http://dx.doi.org/10.1371/journal.pone.0137991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405812	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700027
J	van Driel, J; Sligte, IG; Linders, J; Elport, D; Cohen, MX				van Driel, Joram; Sligte, Ilja G.; Linders, Jara; Elport, Daniel; Cohen, Michael X.			Frequency Band-Specific Electrical Brain Stimulation Modulates Cognitive Control Processes	PLOS ONE			English	Article							ALTERNATING-CURRENT STIMULATION; ANTERIOR CINGULATE CORTEX; INCREASES THETA ENERGY; MEDIAL-FRONTAL-CORTEX; HIGHER RESPONSE-TIME; INDIVIDUAL-DIFFERENCES; DYNAMICS; OSCILLATIONS; MECHANISMS; ADAPTATION	A large body of findings has tied midfrontal theta-band (4-8 Hz) oscillatory activity to adaptive control mechanisms during response conflict. Thus far, this evidence has been correlational. To evaluate whether theta oscillations are causally involved in conflict processing, we applied transcranial alternating current stimulation (tACS) in the theta band to a midfrontal scalp region, while human subjects performed a spatial response conflict task. Conflict was introduced by incongruency between the location of the target stimulus and the required response hand. As a control condition, we used alpha-band (8-12 Hz) tACS over the same location. The exact stimulation frequencies were determined empirically for each subject based on a pre-stimulation EEG session. Behavioral results showed general conflict effects of slower response times (RT) and lower accuracy for high conflict trials compared to low conflict trials. Importantly, this conflict effect was reduced specifically during theta tACS, which was driven by slower response times on low conflict trials. These results show how theta tACS can modulate adaptive cognitive control processes, which is in accordance with the view of midfrontal theta oscillations as an active mechanism for cognitive control.	[van Driel, Joram] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [van Driel, Joram; Sligte, Ilja G.; Linders, Jara; Elport, Daniel] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Sligte, Ilja G.] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Sligte, Ilja G.] Univ Birmingham, Dept Psychol, Visual Experience Lab, Birmingham, W Midlands, England; [Cohen, Michael X.] Radboud Univ Nijmegen, Fac Sci, NL-6525 ED Nijmegen, Netherlands; [Cohen, Michael X.] Radboud Univ Nijmegen, Univ Med Ctr, NL-6525 ED Nijmegen, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; University of Birmingham; Radboud University Nijmegen; Radboud University Nijmegen	van Driel, J (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	joramvandriel@gmail.com	Cohen, Michael/A-3092-2016	Cohen, Michael/0000-0002-1879-3593; van Driel, Joram/0000-0002-6950-2901	ERC StG [638589]; Netherlands Organization for Scientific Research; Newton International Fellowship from the Royal Academy	ERC StG; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Newton International Fellowship from the Royal Academy	This work was made possible by an ERC StG (project 638589) and a Vidi grant from the Netherlands Organization for Scientific Research (nwo.nl) awarded to MXC, and a Newton International Fellowship from the Royal Academy (raeng.org.uk) awarded to IGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2011, P NATL ACAD SCI USA, V108, P17556, DOI 10.1073/pnas.1103475108; Bestmann S, 2015, TRENDS COGN SCI, V19, P13, DOI 10.1016/j.tics.2014.10.003; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brignani D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056589; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cohen MX, 2014, TRENDS NEUROSCI, V37, P480, DOI 10.1016/j.tins.2014.06.004; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Cohen MX, 2013, CLIN NEUROPHYSIOL, V124, P1479, DOI 10.1016/j.clinph.2013.03.013; Cohen MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057293; Cohen MX, 2013, CEREB CORTEX, V23, P1061, DOI 10.1093/cercor/bhs069; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Cohen MX, 2011, NEUROIMAGE, V55, P1373, DOI 10.1016/j.neuroimage.2010.12.072; Compton RJ, 2012, PSYCHOPHYSIOLOGY, V49, P583, DOI 10.1111/j.1469-8986.2012.01354.x; Compton RJ, 2011, PSYCHOPHYSIOLOGY, V48, P583, DOI 10.1111/j.1469-8986.2010.01124.x; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Duthoo W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110462; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Egner T, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00154; Filmer HL, 2014, TRENDS NEUROSCI, V37, P742, DOI 10.1016/j.tins.2014.08.003; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Gulbinaite R, 2014, NEUROIMAGE, V99, P197, DOI 10.1016/j.neuroimage.2014.05.060; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Huster RJ, 2014, BRAIN STRUCT FUNCT, V219, P49, DOI 10.1007/s00429-012-0483-5; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Krause B, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00025; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Meiron O, 2014, CLIN NEUROPHYSIOL, V125, P77, DOI 10.1016/j.clinph.2013.06.013; Neuling T, 2015, NEUROIMAGE, V118, P406, DOI 10.1016/j.neuroimage.2015.06.026; Nigbur R, 2012, J COGNITIVE NEUROSCI, V24, P1264, DOI 10.1162/jocn_a_00128; Nigbur R, 2011, CLIN NEUROPHYSIOL, V122, P2185, DOI 10.1016/j.clinph.2011.03.030; Pahor A, 2014, INT J PSYCHOPHYSIOL, V93, P322, DOI 10.1016/j.ijpsycho.2014.06.015; Parkin BL, 2015, NEURON, V87, P932, DOI 10.1016/j.neuron.2015.07.032; Pastotter B, 2013, J COGNITIVE NEUROSCI, V25, P2167, DOI 10.1162/jocn_a_00474; Polania R, 2012, CURR BIOL, V22, P1314, DOI 10.1016/j.cub.2012.05.021; Reato D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00687; Reinhart RMG, 2015, P NATL ACAD SCI USA, V112, P9448, DOI 10.1073/pnas.1504196112; Reinhart RMG, 2014, J NEUROSCI, V34, P4214, DOI 10.1523/JNEUROSCI.5421-13.2014; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; Scherbaum S, 2013, CLIN NEUROPHYSIOL, V124, P1477, DOI 10.1016/j.clinph.2012.12.007; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Townsend J. T., 1983, STOCHASTIC MODELING; van den Wildenberg WPM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00222; van Driel J, 2015, COGN AFFECT BEHAV NE; van Driel J, 2012, J NEUROSCI, V32, P16795, DOI 10.1523/JNEUROSCI.0802-12.2012; Vosskuhl J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00257; Weissman DH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00587	53	34	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138984	10.1371/journal.pone.0138984	http://dx.doi.org/10.1371/journal.pone.0138984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405801	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700137
J	Yeung, CY; Chan, WT; Jiang, CB; Cheng, ML; Liu, CY; Chang, SW; Chiau, JSC; Lee, HC				Yeung, Chun-Yan; Chan, Wai-Tao; Jiang, Chun-Bin; Cheng, Mei-Lien; Liu, Chia-Yuan; Chang, Szu-Wen; Chiau, Jen-Shiu Chiang; Lee, Hung-Chang			Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model	PLOS ONE			English	Article							LACTOBACILLUS-FERMENTUM BR11; CLINICAL-PRACTICE GUIDELINES; RECOMMENDED GUIDELINES; RAT MODEL; PREVENTION; 5-FLUOROURACIL; INFLAMMATION; MANAGEMENT; BACTERIA; SAFETY	Background and Aims Intestinal mucositis is a frequently encountered side effect in oncology patients undergoing chemotherapy. No well-established or up to date therapeutic strategies are available. To study a novel way to alleviate mucositis, we investigate the effects and safety of probiotic supplementation in ameliorating 5-FU-induced intestinal mucositis in a mouse model. Methods Seventy-two mice were injected saline or 5-Fluorouracil (5-FU) intraperitoneally daily. Mice were either orally administrated daily saline, probiotic suspension of Lactobacillus casei variety rhamnosus (Lcr35) or Lactobacillus acidophilus and Bifidobacterium bifidum (LaBi). Diarrhea score, pro-inflammatory cytokines serum levels, intestinal villus height and crypt depth and total RNA from tissue were assessed. Samples of blood, liver and spleen tissues were assessed for translocation. Results Marked diarrhea developed in the 5-FU groups but was attenuated after oral Lcr35 and LaBi administrations. Diarrhea scores decreased significantly from 2.64 to 1.45 and 0.80, respectively (P<0.001). Those mice in 5-FU groups had significantly higher proinflammatory cytokine levels (TNF-alpha: 234.80 vs. 29.10, P<0.001, IL-6: 25.13 vs. 7.43, P<0.001, IFN-.: 22.07 vs. 17.06, P = 0.137). A repairing of damage in jejunal villi was observed following probiotics administration. We also found TNF-alpha, IL-1 beta and IL-6 mRNA expressions were up-regulated in intestinal mucositis tissues following 5-FU treatment (TNF-alpha: 4.35 vs. 1.18, IL-1 beta: 2.29 vs. 1.07, IL-6: 1.49 vs. 1.02) and that probiotics treatment suppressed this up-regulation (P<0.05). No bacterial translocation was found in this study. Conclusions In conclusion, our results show that oral administration of probiotics Lcr35 and LaBi can ameliorate chemotherapy-induced intestinal mucositis in a mouse model. This suggests probiotics may serve as an alternative therapeutic strategy for the prevention or management of chemotherapy-induced mucositis in the future.	[Yeung, Chun-Yan; Chan, Wai-Tao; Jiang, Chun-Bin; Chang, Szu-Wen] MacKay Mem Hosp, Dept Pediat, Div Gastroenterol & Nutr, Taipei, Taiwan; [Yeung, Chun-Yan] MacKay Med Coll, Dept Med, New Taipei City, Taiwan; [Yeung, Chun-Yan] MacKay Junior Coll Med Nursing & Management, Taipei, Taiwan; [Yeung, Chun-Yan; Cheng, Mei-Lien; Liu, Chia-Yuan; Chiau, Jen-Shiu Chiang] MacKay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Liu, Chia-Yuan] MacKay Mem Hosp, Dept Hepatol & Gastroenterol, Taipei, Taiwan; [Lee, Hung-Chang] Hsinchu MacKay Mem Hosp, Dept Pediat, Div Gastroenterol & Nutr, Hsinchu, Taiwan; [Lee, Hung-Chang] Taipei Med Univ, Dept Pediat, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Taipei Medical University	Lee, HC (corresponding author), Hsinchu MacKay Mem Hosp, Dept Pediat, Div Gastroenterol & Nutr, Hsinchu, Taiwan.	8231boss@gmail.com			Hsinchu MacKay Memorial Hospital [MMH-10206]; Taipei MacKay Memorial Hospital [MMH-TT-9905]	Hsinchu MacKay Memorial Hospital; Taipei MacKay Memorial Hospital	The authors declare here that this research was supported by research grants from the Hsinchu MacKay Memorial Hospital (MMH-10206) and the Taipei MacKay Memorial Hospital (MMH-TT-9905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimosleh SM, 2012, DIGEST DIS SCI, V57, P887, DOI 10.1007/s10620-011-1979-1; Arnold Renee J Goldberg, 2005, J Support Oncol, V3, P227; Bellavia M, 2014, J BIOL REG HOMEOS AG, V28, P251; Benson AB, 2004, J CLIN ONCOL, V22, P2918, DOI 10.1200/jco.2004.04.132; Bhatt Valkal, 2010, J Oncol Pharm Pract, V16, P195, DOI 10.1177/1078155209348721; Bowen JM, 2007, CANCER BIOL THER, V6, P1449, DOI 10.4161/cbt.6.9.4622; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Carasi P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/208974; Casey PG, 2007, APPL ENVIRON MICROB, V73, P1858, DOI 10.1128/AEM.01840-06; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fang HW, 2010, J MED MICROBIOL, V59, P573, DOI 10.1099/jmm.0.009662-0; Geier MS, 2007, INT J FOOD MICROBIOL, V114, P267, DOI 10.1016/j.ijfoodmicro.2006.09.018; Gibson RJ, 2013, SUPPORT CARE CANCER, V21, P313, DOI 10.1007/s00520-012-1644-z; Gosselink MP, 2004, DIS COLON RECTUM, V47, P1519, DOI 10.1007/s10350-004-0623-y; Grem JL, 2000, INVEST NEW DRUG, V18, P299, DOI 10.1023/A:1006416410198; Haisan A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/286902; Honeycutt TCB, 2007, PEDIATR CRIT CARE ME, V8, P452, DOI 10.1097/01.PCC.0000282176.41134.E6; Huang TY, 2009, BIOCHEM BIOPH RES CO, V389, P634, DOI 10.1016/j.bbrc.2009.09.041; Joint FAO/WHO Expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, 2001, FAO FOOD NUTR PAPER, P1; Keefe DM, 2007, CANCER-AM CANCER SOC, V109, P820, DOI 10.1002/cncr.22484; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Lalla RV, 2006, CANCER J, V12, P348, DOI 10.1097/00130404-200609000-00004; Leiper K, 2001, CLIN SCI, V101, P395, DOI 10.1042/CS20010078; Liong MT, 2008, NUTR REV, V66, P192, DOI 10.1111/j.1753-4887.2008.00024.x; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Maioli TU, 2014, J NEGAT RESULTS BIOM, V13, DOI 10.1186/1477-5751-13-6; Galdeano CM, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-64; Mauger CA, 2007, DIGEST DIS SCI, V52, P612, DOI 10.1007/s10620-006-9464-y; Llana MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082588; Prisciandaro LD, 2012, SUPPORT CARE CANCER, V20, P3205, DOI 10.1007/s00520-012-1446-3; Prisciandaro LD, 2011, CRIT REV FOOD SCI, V51, P239, DOI 10.1080/10408390903551747; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Rubenstein EB, 2004, CANCER-AM CANCER SOC, V100, P2026, DOI 10.1002/cncr.20163; Smith CL, 2008, NUTR CANCER, V60, P757, DOI 10.1080/01635580802192841; Soares PMG, 2008, CANCER CHEMOTH PHARM, V63, P91, DOI 10.1007/s00280-008-0715-9; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Stringer AM, 2009, EXP BIOL MED, V234, P430, DOI 10.3181/0810-RM-301; Takiue S, 2013, ANAT REC, V296, P443, DOI 10.1002/ar.22652; Tazuke Y, 2011, PEDIATR SURG INT, V27, P151, DOI 10.1007/s00383-010-2798-8; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Wadler S, 1998, J CLIN ONCOL, V16, P3169, DOI 10.1200/JCO.1998.16.9.3169; Wagner AE, 2012, J CELL MOL MED, V16, P836, DOI 10.1111/j.1582-4934.2011.01367.x; Wang S, 2013, NUTR RES, V33, P1072, DOI 10.1016/j.nutres.2013.09.002; Wassenaar TM, 2008, J FOOD PROTECT, V71, P1734, DOI 10.4315/0362-028X-71.8.1734; Whitford EJ, 2009, CANCER BIOL THER, V8, P505, DOI 10.4161/cbt.8.6.7594; Yeung CY, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/973209	47	93	99	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138746	10.1371/journal.pone.0138746	http://dx.doi.org/10.1371/journal.pone.0138746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406888	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700082
J	Frederiksen, J; Buggert, M; Noyan, K; Nowak, P; Sonnerborg, A; Lund, O; Karlsson, AC				Frederiksen, Juliet; Buggert, Marcus; Noyan, Kajsa; Nowak, Piotr; Sonnerborg, Anders; Lund, Ole; Karlsson, Annika C.			Multidimensional Clusters of CD4+T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection	PLOS ONE			English	Article							FLOW-CYTOMETRY DATA; IMMUNE ACTIVATION; T-LYMPHOCYTES; ANTIRETROVIRAL THERAPY; GASTROINTESTINAL-TRACT; DISEASE PROGRESSION; LYMPH-NODES; VIRAL LOAD; IDENTIFICATION; POPULATION	HIV infection provokes a myriad of pathological effects on the immune system where many markers of CD4+ T cell dysfunction have been identified. However, most studies to date have focused on single/double measurements of immune dysfunction, while the identification of pathological CD4+ T cell clusters that is highly associated to a specific biomarker for HIV disease remain less studied. Here, multi-parametric flow cytometry was used to investigate immune activation, exhaustion, and senescence of diverse maturation phenotypes of CD4+ T cells. The traditional method of manual data analysis was compared to a multidimensional clustering tool, FLOw Clustering with K (FLOCK) in two cohorts of 47 untreated HIV-infected individuals and 21 age and sex matched healthy controls. In order to reduce the subjectivity of FLOCK, we developed an "artificial reference", using 2% of all CD4+ gated T cells from each of the HIV-infected individuals. Principle component analyses demonstrated that using an artificial reference lead to a better separation of the HIV-infected individuals from the healthy controls as compared to using a single HIV-infected subject as a reference or analyzing data manually. Multiple correlation analyses between laboratory parameters and pathological CD4+ clusters revealed that the CD4/CD8 ratio was the preeminent surrogate marker of CD4+ T cells dysfunction using all three methods. Increased frequencies of an early-differentiated CD4+ T cell cluster with high CD38, HLA-DR and PD-1 expression were best correlated (Rho = -0.80, P value = 1.96x10(-11)) with HIV disease progression as measured by the CD4/CD8 ratio. The novel approach described here can be used to identify cell clusters that distinguish healthy from HIV infected subjects and is biologically relevant for HIV disease progression. These results further emphasize that a simple measurement of the CD4/CD8 ratio is a useful biomarker for assessment of combined CD4+ T cell dysfunction in chronic HIV disease.	[Frederiksen, Juliet; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Buggert, Marcus; Noyan, Kajsa; Nowak, Piotr; Sonnerborg, Anders; Karlsson, Annika C.] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Buggert, Marcus] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Nowak, Piotr; Sonnerborg, Anders] Karolinska Univ Hosp Huddinge, Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, Stockholm, Sweden	Technical University of Denmark; Karolinska Institutet; University of Pennsylvania; Karolinska Institutet; Karolinska University Hospital	Buggert, M (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	marcus.buggert@ki.se	Buggert, Marcus/F-4663-2018; Lund, Ole/F-4437-2014; Sönnerborg, Anders/W-2011-2019; Karlsson, Annika/R-2255-2016	Buggert, Marcus/0000-0003-0633-1719; Lund, Ole/0000-0003-1108-0491; Sönnerborg, Anders/0000-0001-8928-3374; Karlsson, Annika/0000-0002-2028-8393; Noyan, Kajsa/0000-0002-1053-6832; Nowak, Piotr/0000-0003-2747-0734	Swedish Research Council [K2010-56X-20345-04-3, K2014-57X-22451-01-5]; Swedish Physicians Against AIDS Research Foundation [Fob2013-0008]; Magnus Bergvalls foundation; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Physicians Against AIDS Research Foundation; Magnus Bergvalls foundation; Karolinska Institutet(Karolinska Institutet)	This work was supported by The Swedish Research Council (Grants K2010-56X-20345-04-3 and K2014-57X-22451-01-5), http://www.vr.se/; The Swedish Physicians Against AIDS Research Foundation (Fob2013-0008), http://www.aidsfond.se/; Magnus Bergvalls foundation (2013), http://www.magnbergvallsstiftelse.nu/; Karolinska Institutet (Partial funding of new postgraduate student at Karolinska Institutet 2010-2013), https://internwebben.ki.se/en/grants-office.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Aghaeepour N, 2012, BIOINFORMATICS, V28, P1009, DOI 10.1093/bioinformatics/bts082; Aghaeepour N, 2011, CYTOM PART A, V79A, P6, DOI 10.1002/cyto.a.21007; Amadori A, 1996, IMMUNOL TODAY, V17, P414, DOI 10.1016/0167-5699(96)10049-9; Anglaret X, 1997, J ACQ IMMUN DEF SYND, V14, P361, DOI 10.1097/00042560-199704010-00009; Anglaret X, 1998, INT J EPIDEMIOL, V27, P928, DOI 10.1093/ije/27.5.928; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buggert M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004251; Buggert M, 2014, J IMMUNOL, V192, P2099, DOI 10.4049/jimmunol.1302596; Chattopadhyay PK, 2012, METHODS, V57, P251, DOI 10.1016/j.ymeth.2012.02.009; Chattopadhyay PK, 2010, CYTOM PART A, V77A, P614, DOI 10.1002/cyto.a.20905; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; Cossarizza A, 2013, CYTOM PART A, V83A, P680, DOI 10.1002/cyto.a.22318; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Eller MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018779; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Freer G, 2013, METHODS, V61, P30, DOI 10.1016/j.ymeth.2013.03.035; GIORGI JV, 1989, CLIN IMMUNOL IMMUNOP, V52, P10, DOI 10.1016/0090-1229(89)90188-8; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Henn AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02327; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lelic A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003076; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; McArthur MA, 2013, CLIN IMMUNOL, V146, P140, DOI 10.1016/j.clim.2012.12.003; McArthur MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038408; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Norstrom MM, 2012, J VIROL, V86, P9802, DOI 10.1128/JVI.01165-12; O'Donnell Erika A, 2013, Immune Netw, V13, P43, DOI 10.4110/in.2013.13.2.43; O'Neill K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003365; Pedreira CE, 2013, TRENDS BIOTECHNOL, V31, P415, DOI 10.1016/j.tibtech.2013.04.008; Qian Y, 2010, CYTOM PART B-CLIN CY, V78B, pS69, DOI 10.1002/cyto.b.20554; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; R RDCT, 2011, R FDN STAT COMPUT, V1, P409; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Strindhall J, 2007, EXP GERONTOL, V42, P753, DOI 10.1016/j.exger.2007.05.001; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; WIKBY A, 1994, EXP GERONTOL, V29, P531, DOI 10.1016/0531-5565(94)90036-1; Zare H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-403	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0137635	10.1371/journal.pone.0137635	http://dx.doi.org/10.1371/journal.pone.0137635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402620	gold, Green Published, Green Submitted			2022-12-27	WOS:000361798100013
J	Buchmann, N; Kassner, U; Norman, K; Goldeck, D; Eckardt, R; Pawelec, G; Steinhagen-Thiessen, E; Demuth, I				Buchmann, Nikolaus; Kassner, Ursula; Norman, Kristina; Goldeck, David; Eckardt, Rahel; Pawelec, Graham; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja			Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People - Data from the Berlin Aging Study II	PLOS ONE			English	Article							REDUCED LUNG-FUNCTION; C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATION; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK; DECLINE; POPULATION; MORTALITY; PLASMA	Reduced pulmonary function and elevated serum cholesterol levels are recognized risk factors for cardiovascular disease. Currently, there is some controversy concerning relationships between cholesterol, LDL-cholesterol, HDL-cholesterol, serum triglycerides and lung function. However, most previous studies compared patients suffering from chronic obstructive pulmonary disease (COPD) with healthy controls, and only a small number examined this relationship in population-based cohorts. Moreover, lipoprotein a [Lp(a)], another lipid parameter independently associated with cardiovascular diseases, appears not to have been addressed at all in studies of lung function at the population level. Here, we determined relationships between lung function and several lipid parameters including Lp(a) in 606 older community-dwelling participants (55.1% women, 68 +/- 4 years old) from the Berlin Aging Study II (BASE-II). We found a significantly lower forced expiration volume in 1 second (FEV1) in men with low Lp(a) concentrations (t-test). This finding was further substantiated by linear regression models adjusting for known covariates, showing that these associations are statistically significant in both men and women. According to the highest adjusted model, men and women with Lp(a) levels below the 20th percentile had 217.3ml and 124.2ml less FEV1 and 239.0ml and 135.2ml less FVC, respectively, compared to participants with higher Lp(a) levels. The adjusted models also suggest that the known strong correlation between pro-inflammatory parameters and lung function has only a marginal impact on the Lp(a)-pulmonary function association. Our results do not support the hypothesis that higher Lp(a) levels are responsible for the increased CVD risk in people with reduced lung function, at least not in the group of community-dwelling older people studied here.	[Buchmann, Nikolaus; Norman, Kristina; Eckardt, Rahel; Steinhagen-Thiessen, Elisabeth; Demuth, Ilja] Charite, Res Grp Geriatr, D-13347 Berlin, Germany; [Kassner, Ursula; Steinhagen-Thiessen, Elisabeth] Charite, Lipid Clin, Interdisciplinary Metab Ctr, D-13353 Berlin, Germany; [Goldeck, David; Pawelec, Graham] Univ Tubingen, Med Res Ctr, Dept Internal Med 2, Tubingen, Germany; [Demuth, Ilja] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Buchmann, N (corresponding author), Charite, Res Grp Geriatr, Reinickendorfer Str 61, D-13347 Berlin, Germany.	nikolaus.buchmann@charite.de; ilja.demuth@charite.de	Demuth, Ilja/ABD-5352-2021; Pawelec, Graham/H-2713-2019	Demuth, Ilja/0000-0002-4340-2523; Pawelec, Graham/0000-0002-3600-0163; Norman, Kristina/0000-0003-2029-9102; Kassner, ursula/0000-0002-4536-7063; Buchmann, Nikolaus/0000-0002-4345-3515	German Federal Ministry of Education and Research [16SV5536K]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The work was supported by the German Federal Ministry of Education and Research (grant number #16SV5536K, EST). URL: http://www.bmbf.de/en/.	Albers JJ, 2007, KIDNEY INT, V71, P961, DOI 10.1038/sj.ki.5002240; Anuurad E, 2008, J CLIN ENDOCR METAB, V93, P1482, DOI 10.1210/jc.2007-2416; Arcari A, 2012, EUR J PREV CARDIOL; Badimon L, 2012, EUROPEAN HEART J ACU; Basili S, 1999, ATHEROSCLEROSIS, V147, P249, DOI 10.1016/S0021-9150(99)00192-6; Bertram L, 2013, INT J EPIDEMIOL; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Cirillo DJ, 2002, AM J EPIDEMIOL, V155, P842, DOI 10.1093/aje/155.9.842; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Danesh J, 2009, NAT REV CARDIOL, V6, P565, DOI 10.1038/nrcardio.2009.138; Eickhoff P, 2008, AM J RESP CRIT CARE, V178, P1211, DOI 10.1164/rccm.200709-1412OC; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Engstrom G, 2000, J CARDIOVASC RISK, V7, P267; Erqou S, 2010, J AM COLL CARDIOL, V55, P2160, DOI 10.1016/j.jacc.2009.10.080; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582; Gunnell D, 2003, J EPIDEMIOL COMMUN H, V57, P141, DOI 10.1136/jech.57.2.141; Hancox RJ, 2007, THORAX, V62, P1064, DOI 10.1136/thx.2006.076877; Jakicic JM, 2013, 2013 AHA ACC GUIDELI; Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174; KANNEL WB, 1983, AM HEART J, V105, P311, DOI 10.1016/0002-8703(83)90532-X; Klein OL, 2010, DIABETIC MED, V27, P977, DOI 10.1111/j.1464-5491.2010.03073.x; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Lam KBH, 2010, EUR RESPIR J, V35, P317, DOI 10.1183/09031936.00024709; Lamon-Fava S, 2011, J LIPID RES, V52, P1181, DOI 10.1194/jlr.M012526; Li X, 2013, AM J RESP CRIT CARE, V187; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mannino DM, 1997, AM J RESP CRIT CARE, V156, P814, DOI 10.1164/ajrccm.156.3.9702026; Marquis Karine, 2005, J Cardiopulm Rehabil, V25, P226, DOI 10.1097/00008483-200507000-00010; Melbye Hasse, 2006, Prim Care Respir J, V15, P294, DOI 10.1016/j.pcrj.2006.07.002; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rasmussen F, 2009, EUR RESPIR J, V33, P382, DOI 10.1183/09031936.00040708; Ryan G, 1999, J EPIDEMIOL COMMUN H, V53, P230, DOI 10.1136/jech.53.4.230; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sethi S, 2012, AM J MED, V125, P1162, DOI 10.1016/j.amjmed.2012.06.024; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Sniderman AD, 2011, CIRC-CARDIOVASC QUAL, V4, P337, DOI 10.1161/CIRCOUTCOMES.110.959247; Ulubas B, 2003, TURKISH RESP J, V4, P120; UTERMANN G, 1983, FEBS LETT, V154, P357, DOI 10.1016/0014-5793(83)80182-3; van Diepen JA, 2013, ATHEROSCLEROSIS, V228, P306, DOI 10.1016/j.atherosclerosis.2013.02.028; Yeh F, 2011, DIABETES CARE, V34, P2306, DOI 10.2337/dc11-0682	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139040	10.1371/journal.pone.0139040	http://dx.doi.org/10.1371/journal.pone.0139040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421427	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700064
J	Jutla, A; Aldaach, H; Billian, H; Akanda, A; Huq, A; Colwell, R				Jutla, Antarpreet; Aldaach, Haidar; Billian, Hannah; Akanda, Ali; Huq, Anwar; Colwell, Rita			Satellite Based Assessment of Hydroclimatic Conditions Related to Cholera in Zimbabwe	PLOS ONE			English	Article							CLIMATE-CHANGE; ENVIRONMENTAL-FACTORS; VIBRIO-CHOLERAE; OUTBREAKS; AFRICA; DISEASE; HEALTH	Introduction Cholera, an infectious diarrheal disease, has been shown to be associated with large scale hydroclimatic processes. The sudden and sporadic occurrence of epidemic cholera is linked with high mortality rates, in part, due to uncertainty in timing and location of outbreaks. Improved understanding of the relationship between pathogenic abundance and climatic processes allows prediction of disease outbreak to be an achievable goal. In this study, we show association of large scale hydroclimatic processes with the cholera epidemic in Zimbabwe reported to have begun in Chitungwiza, a city in Mashonaland East province, in August, 2008. Principal Findings Climatic factors in the region were found to be associated with triggering cholera outbreak and are shown to be related to anomalies of temperature and precipitation, validating the hypothesis that poor conditions of sanitation, coupled with elevated temperatures, and followed by heavy rainfall can initiate outbreaks of cholera. Spatial estimation by satellite of precipitation and global gridded air temperature captured sensitivities in hydroclimatic conditions that permitted identification of the location in the region where the disease outbreak began. Discussion Satellite derived hydroclimatic processes can be used to capture environmental conditions related to epidemic cholera, as occurred in Zimbabwe, thereby providing an early warning system. Since cholera cannot be eradicated because the causative agent, Vibrio cholerae, is autochthonous to the aquatic environment, prediction of conditions favorable for its growth and estimation of risks of triggering the disease in a given population can be used to alert responders, potentially decreasing infection and saving lives.	[Jutla, Antarpreet; Aldaach, Haidar; Billian, Hannah] W Virginia Univ, Dept Civil & Environm Engn, Morgantown, WV 26506 USA; [Akanda, Ali] Univ Rhode Isl, Dept Civil & Environm Engn, Kingston, RI 02881 USA; [Huq, Anwar; Colwell, Rita] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Colwell, Rita] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Colwell, Rita] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	West Virginia University; University of Rhode Island; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jutla, A (corresponding author), W Virginia Univ, Dept Civil & Environm Engn, Morgantown, WV 26506 USA.	asjutla@mail.wvu.edu; rcolwell@mail.wvu.edu		Jutla, Antarpreet/0000-0002-8191-2348	NASA [NNX15AF71G]; WV NASA space grant	NASA(National Aeronautics & Space Administration (NASA)); WV NASA space grant	This research is funded in part from a NASA grant (NNX15AF71G) and WV NASA space grant.	Akanda AS, 2012, B WORLD HEALTH ORGAN, V90, P243, DOI 10.2471/BLT.11.092189; Akanda AS, 2014, LANCET GLOB HEALTH, V2, pE69, DOI 10.1016/S2214-109X(13)70155-4; Alexander KA, 2013, INT J ENV RES PUB HE, V10, P1202, DOI 10.3390/ijerph10041202; Bompangue D, 2008, EMERG INFECT DIS, V14, P798, DOI 10.3201/eid1405.071260; Bompangue Didier, 2012, PLoS Curr, V4, pRRN1310; CDC Foundation, CHOL OUTBR INV CENTR, P20; Central African Republic, CENTR AFR REP SEV LO; Enserink M, 2010, NATURE, V330, P738, DOI [10.1126/science.330.6005.738, DOI 10.1126/SCIENCE.330.6005.738]; Fernandez MAL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-442; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; Hosmer DW, 1997, STAT MED, V16, P965; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; ISLAM MS, 1995, T ROY SOC TROP MED H, V89, P506, DOI 10.1016/0035-9203(95)90086-1; Jutla A, 2013, AM J TROP MED HYG, V89, P597, DOI 10.4269/ajtmh.12-0721; Jutla AS, 2011, AM J TROP MED HYG, V85, P303, DOI 10.4269/ajtmh.2011.11-0181; Jutla AS, 2010, J AM WATER RESOUR AS, V46, P651, DOI 10.1111/j.1752-1688.2010.00448.x; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Mendelsohn J, 2008, INT J HYG ENVIR HEAL, V211, P156, DOI 10.1016/j.ijheh.2006.12.002; MIH R, 2012, CHOL OUTBR KIN BIR H, P5; Mukandavire Z, 2011, P NATL ACAD SCI USA, V108, P8767, DOI 10.1073/pnas.1019712108; Rebaudet S, 2013, J INFECT DIS, V208, pS46, DOI 10.1093/infdis/jit195; Relief Web, 2013, 6 REL WEB; Reyburn R, 2011, AM J TROP MED HYG, V84, P862, DOI 10.4269/ajtmh.2011.10-0277; Thompson AA, 2012, INT J ENV RES PUB HE, V9, P831, DOI 10.3390/ijerph9030831; Traerup SLM, 2011, INT J ENV RES PUB HE, V8, P4386, DOI 10.3390/ijerph8124386; Turton A, 2008, CSIRNREWREXP20080160, P28; WHO, WHO RESP HLTH CRIS F; WHO, 2014, CHOL OUTBR JUB; WHO, CHOL ZIMB UPD; World Health Organization, GLOB TASK FORC CHOL, V2; World Health Organization, GLOB TASK FORC CHOL, P2	32	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0137828	10.1371/journal.pone.0137828	http://dx.doi.org/10.1371/journal.pone.0137828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417994	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400009
J	Occhipinti, S; Chambers, SK; Lepore, S; Aitken, J; Dunn, J				Occhipinti, Stefano; Chambers, Suzanne K.; Lepore, Stephen; Aitken, Joanne; Dunn, Jeff			A Longitudinal Study of Post-Traumatic Growth and Psychological Distress in Colorectal Cancer Survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; BREAST-CANCER; PHYSICAL-ACTIVITY; DIAGNOSIS; ADJUSTMENT; PREVALENCE; BENEFITS; MODEL	The stability of post-traumatic growth over time and the relationship between post-traumatic growth and traditional distress outcomes remains unclear. We tracked post-traumatic growth in a population-based sample of colorectal cancer patients from soon after diagnosis to five years subsequently to assess the heterogeneity of a post-traumatic growth response to cancer over time and describe the simultaneous and longitudinal relationships between post-traumatic growth and psychological distress. 1966 colorectal patients who were five months post diagnosis were assessed six times over a five year period. There was considerable heterogeneity associated with both psychological distress and benefit finding scores over time. However, both for benefit finding and psychological distress, the variation in individual scores suggested an underlying positive linear trend and both lagged and lagged change components. Specifically, benefit finding and psychological distress are mutual leading indicators of each other. First, benefit finding served as a leading indicator of distress, in that increases in reported benefit finding from year to year predicted higher future increases in psychological distress. As well, in an inverse relationship, psychological distress served as a leading indicator of benefit finding, such that increases in reported distress from year to year predicted lower future increases in benefit finding. Post-traumatic growth may reflect patients coping efforts to enhance perceptions of wellbeing in response to escalating cancer-related threats, acting as harbinger of increasing trajectories of psychological distress. This explanation is consistent with a cognitive dissonance response in which threats to the integrity of the self then lead to a tendency to accentuate positive aspects of the self.	[Occhipinti, Stefano; Chambers, Suzanne K.; Aitken, Joanne; Dunn, Jeff] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia; [Chambers, Suzanne K.; Aitken, Joanne; Dunn, Jeff] Canc Council Queensland, Ctr Canc Res, Brisbane, Qld, Australia; [Chambers, Suzanne K.] Edith Cowan Univ, Hlth & Wellness Inst, Perth, WA, Australia; [Chambers, Suzanne K.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Lepore, Stephen] Temple Univ, Coll Publ Hlth, Dept Social & Behav Sci, Philadelphia, PA 19122 USA; [Aitken, Joanne] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Aitken, Joanne; Dunn, Jeff] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Cancer Council Queensland; Edith Cowan University; University of Queensland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Queensland University of Technology (QUT); University of Queensland	Chambers, SK (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia.	suzanne.chambers@griffith.edu.au	Lepore, Stephen/AAE-3485-2020; Occhipinti, Stefano/G-3361-2015; Chambers, Suzanne K/H-5957-2012	Lepore, Stephen/0000-0001-7370-6280; Occhipinti, Stefano/0000-0002-2558-0609; Chambers, Suzanne K/0000-0003-2369-6111; Aitken, Joanne Frances/0000-0001-6859-2186; Dunn, Jeff/0000-0002-1180-3381	Cancer Council Queensland	Cancer Council Queensland(Cancer Council Queensland)	The original study was funded by Cancer Council Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck G, 1996, J PERS, V64, P899, DOI 10.1111/j.1467-6494.1996.tb00948.x; Chambers SK, 2012, QUAL LIFE RES, V21, P1551, DOI 10.1007/s11136-011-0067-5; Coyne JC, 2010, ANN BEHAV MED, V39, P16, DOI 10.1007/s12160-009-9154-z; Derogatis L.R, 1993, BRIEF SYMPTOM INVENT; Engelhard I. M., 2014, CLIN PSYCHOL SCI; Festinger L, 1956, PROPHECY FAILS, DOI 10.1037/10030-000; Frazier P, 2014, EUR J PERSONALITY, V28, P337; Frazier P, 2009, PSYCHOL SCI, V20, P912, DOI 10.1111/j.1467-9280.2009.02381.x; Grimm KJ, 2012, STRUCT EQU MODELING, V19, P268, DOI 10.1080/10705511.2012.659627; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Helgeson VS, 2004, HEALTH PSYCHOL, V23, P3, DOI 10.1037/0278-6133.23.1.3; Jansen L, 2011, BRIT J CANCER, V105, P1158, DOI 10.1038/bjc.2011.335; Jayawickreme E, 2014, EUR J PERSONALITY, V28, P312, DOI 10.1002/per.1963; Kernan WD, 2009, SOC SCI MED, V68, P1176, DOI 10.1016/j.socscimed.2008.12.038; Lynch BM, 2007, MED J AUSTRALIA, V186, P288, DOI 10.5694/j.1326-5377.2007.tb00902.x; McArdle JJ, 2009, ANNU REV PSYCHOL, V60, P577, DOI 10.1146/annurev.psych.60.110707.163612; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Park CL, 2009, MED ILLNESS POSITIVE; Rinaldis M, 2010, BRIT J PSYCHOL, V101, P259, DOI 10.1348/000712609X448676; Stone J, 2001, J EXP SOC PSYCHOL, V37, P228, DOI 10.1006/jesp.2000.1446; Sumalla EC, 2009, CLIN PSYCHOL REV, V29, P24, DOI 10.1016/j.cpr.2008.09.006; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tennen H., 2009, MEDICAL ILLNESS POSI, P31, DOI DOI 10.1037/11854-002; Tomich PL, 2004, HEALTH PSYCHOL, V23, P16, DOI 10.1037/0278-6133.23.1.16; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	29	26	27	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139119	10.1371/journal.pone.0139119	http://dx.doi.org/10.1371/journal.pone.0139119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418357	Green Published, Green Accepted, gold			2022-12-27	WOS:000362171400045
J	Yang, SY; Huh, IS; Baek, JH; Cho, EY; Choi, MJ; Ryu, S; Kim, JS; Park, T; Ha, K; Hong, KS				Yang, So Yung; Huh, Ik Soo; Baek, Ji Hyun; Cho, Eun-Young; Choi, Mi Ji; Ryu, Seunghyong; Kim, Ji Sun; Park, Taesung; Ha, Kyooseob; Hong, Kyung Sue			Association between ST8SIA2 and the Risk of Schizophrenia and Bipolar I Disorder across Diagnostic Boundaries	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; POLYSIALIC ACID; OLFACTORY-BULB; PSA-NCAM; LINKAGE; SCAN; GENE; PSYCHOSIS; FAMILIES; SPECTRUM	Background Findings from family studies and recent genome-wide association studies have indicated overlap in the risk genes between schizophrenia and bipolar disorder (BD). After finding a linkage between the ST8SIA2 (ST8 alpha-N-acetyl-neuraminide alpha-2, 8-sicalyltransferase 2 gene) locus (15q26) and mixed families with schizophrenia and BD, several studies have reported a significant association between this gene and schizophrenia or BD. We investigated the genetic association between ST8SIA2 and both schizophrenia and BD in the Korean population. Methods A total of 582 patients with schizophrenia, 339 patients with BD, and 502 healthy controls were included. Thirty-one tag single nucleotide polymorphisms (SNPs) across the ST8SIA2 region and three other SNPs showing significant associations in previous studies were genotyped. The associations were evaluated by logistic regression analysis using additive, dominant, and recessive genetic models. Results Fourteen of 34 SNPs showed a nominally significant association (p < 0.05) with at least one diagnostic group. These association trends were strongest for the schizophrenia and combined schizophrenia and bipolar I disorder (BD-I) groups. The strongest association was observed in rs11637898 for schizophrenia (p = 0.0033) and BD-I (p = 0.0050) under the dominant model. The association between rs11637898 and the combined schizophrenia and BD-I group (p = 0.0006, under the dominant model) remained significant after correcting for multiple testing. Discussion We identified a possible role of ST8SIA2 in the common susceptibility of schizophrenia and BD-I. However, no association trend was observed for bipolar II disorder. Further efforts are needed to identify a specific phenotype associated with this gene crossing the current diagnostic categories.	[Yang, So Yung; Baek, Ji Hyun; Ryu, Seunghyong; Kim, Ji Sun; Hong, Kyung Sue] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, Seoul, South Korea; [Huh, Ik Soo; Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Cho, Eun-Young; Choi, Mi Ji; Hong, Kyung Sue] Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea; [Ha, Kyooseob] Seoul Natl Hosp, Seoul, South Korea; [Ha, Kyooseob] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neuropsychiat, Kyunggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU)	Hong, KS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, Seoul, South Korea.	hongks@skku.edu		Ha, Kyooseob/0000-0001-5035-2950	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120887]; National Research Foundation (NRF) of Korea grant - Korea government (MSIP) [2012R1A3A2026438]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation (NRF) of Korea grant - Korea government (MSIP)	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120887). The work of T Park and IS H was supported by National Research Foundation (NRF) of Korea grant funded by the Korea government (MSIP) (No. 2012R1A3A2026438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDREASEN NC, 1987, ARCH GEN PSYCHIAT, V44, P461; ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Gomez-Climent MA, 2011, CEREB CORTEX, V21, P1028, DOI 10.1093/cercor/bhq177; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; Baek JH, 2011, J AFFECT DISORDERS, V131, P59, DOI 10.1016/j.jad.2010.11.020; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; Clayton D., 2014, SNPSTATS SNPMATRIX X; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; Gilabert-Juan J, 2013, PSYCHIAT RES, V210, P1293, DOI 10.1016/j.psychres.2013.09.001; Gonzalez-Pinto A, 1998, J AFFECT DISORDERS, V50, P41, DOI 10.1016/S0165-0327(98)00032-9; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Holmans P, 2004, AM J HUM GENET, V74, P1154, DOI 10.1086/421333; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Keshavan MS, 2011, SCHIZOPHR RES, V133, P250, DOI 10.1016/j.schres.2011.09.005; Krabbendam L, 2005, SCHIZOPHR RES, V80, P137, DOI 10.1016/j.schres.2005.08.004; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; McAuley EZ, 2009, MOL PSYCHIATR, V14, P492, DOI 10.1038/sj.mp.4002146; McAuley EZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038172; Merikangas KR, 2014, MOL PSYCHIATR, V19, P214, DOI 10.1038/mp.2013.116; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Ryu S, 2013, PSYCHIAT RES, V210, P756, DOI 10.1016/j.psychres.2013.08.015; Sadock BJ, 2014, SYNOPSIS PSYCHIAT BE, P23; Sanches M, 2008, PROG NEURO-PSYCHOPH, V32, P1617, DOI 10.1016/j.pnpbp.2008.04.017; Seki T, 1998, J NEUROSCI, V18, P3757; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Shaw AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092556; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Tamminga CA, 2013, AM J PSYCHIAT, V170, P1263, DOI 10.1176/appi.ajp.2013.12101339; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Valles V, 2000, SCHIZOPHR RES, V42, P83, DOI 10.1016/S0920-9964(99)00117-6; Verma R, 2008, BIOL PSYCHIAT, V63, P1185, DOI 10.1016/j.biopsych.2008.02.005; Vieta E, 1997, COMPR PSYCHIAT, V38, P98, DOI 10.1016/S0010-440X(97)90088-2	46	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139413	10.1371/journal.pone.0139413	http://dx.doi.org/10.1371/journal.pone.0139413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418860	Green Published, gold, Green Submitted			2022-12-27	WOS:000362171400088
J	Nyri, K; Kohegyi, B; Micsonai, A; Kardos, J; Vertessy, BG				Nyri, Kinga; Kohegyi, Bianka; Micsonai, Andras; Kardos, Jozsef; Vertessy, Beata G.			Evidence-Based Structural Model of the Staphylococcal Repressor Protein: Separation of Functions into Different Domains	PLOS ONE			English	Article							PHOSPHATE ESTER HYDROLYSIS; CRYSTAL-STRUCTURE; LAMBDA-REPRESSOR; SECONDARY STRUCTURE; CATALYTIC MECHANISM; C1 REPRESSOR; STRUCTURE PREDICTION; ACTIVE-SITE; DUTPASE; OPERATOR	Horizontal transfer of mobile genetic elements within Staphylococci is of high biomedical significance as such elements are frequently responsible for virulence and toxic effects. Staphylococcus-encoded repressor proteins regulate the replication of these mobile genetic elements that are located within the so-called pathogenicity islands. Here, we report structural and functional characterization of one such repressor protein, namely the Stl protein encoded by the pathogenicity island SaPIbov1. We create a 3D structural model and based on this prediction, we investigate the different functionalities of truncated and point mutant constructs. Results suggest that a helix-turn-helix motif governs the interaction of the Stl protein with its cognate DNA site: point mutations within this motif drastically decrease DNA-binding ability, whereas the interaction with the Stl-binding partner protein dUTPase is unperturbed by these point mutations. The 3D model also suggested the potential independent folding of a carboxy-terminal domain. This suggestion was fully verified by independent experiments revealing that the carboxy-terminal domain does not bind to DNA but is still capable of binding to and inhibiting dUTPase. A general model is proposed, which suggests that among the several structurally different repressor superfamilies Stl-like Staphylococcal repressor proteins belong to the helix-turn-helix transcription factor group and the HTH motif is suggested to reside within N-terminal segment.	[Nyri, Kinga; Kohegyi, Bianka; Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1111 Budapest, Hungary; [Nyri, Kinga; Kohegyi, Bianka; Vertessy, Beata G.] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1117 Budapest, Hungary; [Micsonai, Andras; Kardos, Jozsef] Eotvos Lorand Univ, Inst Biol, Dept Biochem, H-1117 Budapest, Hungary; [Micsonai, Andras; Kardos, Jozsef] Eotvos Lorand Univ, Inst Biol, MTA ELTE NAP B Neuroimmunol Res Grp, H-1117 Budapest, Hungary	Budapest University of Technology & Economics; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Eotvos Lorand University	Nyri, K (corresponding author), Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1111 Budapest, Hungary.	nyiri.kinga@ttk.mta.hu; vertessy@mail.bme.hu	Kardos, József/J-1035-2017; Vertessy, Beata G/H-6202-2012	Kardos, József/0000-0002-2135-2932; Vertessy, Beata G./0000-0002-1288-2982	Hungarian Scientific Research Fund OTKA [NK 84008, K109486]; Baross Program of the New Hungary Development Plan [3DSTRUCT] [OMFB-00266/2010 REG-KM- 09-1-2009-0050]; Hungarian Academy of Sciences [TTK IF-28/2012]; Hungarian Academy of Sciences (MedinProt program); ICGEB Research Grant [CRP/HUN14-01]; European Commission FP7 Biostruct-X project [283570]; Hungarian Academy of Sciences;  [KTIA_NAP_13-2-2014-0017]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Baross Program of the New Hungary Development Plan [3DSTRUCT]; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Academy of Sciences (MedinProt program); ICGEB Research Grant(Department of Biotechnology (DBT) India); European Commission FP7 Biostruct-X project; Hungarian Academy of Sciences(Hungarian Academy of Sciences); 	This study was supported by the Hungarian Scientific Research Fund OTKA [NK 84008, K109486]; Baross Program of the New Hungary Development Plan [3DSTRUCT, OMFB-00266/2010 REG-KM- 09-1-2009-0050]; Hungarian Academy of Sciences ([TTK IF-28/2012]; MedinProt program); CRP/HUN14-01 ICGEB Research Grant to BGV and the European Commission FP7 Biostruct-X project [contract No. 283570]. Funding for open access charge: Hungarian Academy of Sciences. A. M. and J.K. were supported by the KTIA_NAP_13-2-2014-0017 program. SRCD experiments were supported by SOLEIL (Proposal No. 20140646).	AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Albright RA, 1998, J MOL BIOL, V280, P137, DOI 10.1006/jmbi.1998.1848; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; Bell CE, 2001, J MOL BIOL, V314, P1127, DOI 10.1006/jmbi.2000.5196; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; CARLSON PA, 1994, J BACTERIOL, V176, P6907, DOI 10.1128/JB.176.22.6907-6914.1994; CEDERGRENZEPPEZAUER ES, 1992, NATURE, V355, P740, DOI 10.1038/355740a0; CHEN GC, 1977, ANAL LETT, V10, P1195, DOI 10.1080/00032717708067855; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Donner AL, 1997, J BACTERIOL, V179, P1253, DOI 10.1128/jb.179.4.1253-1261.1997; HEINZEL T, 1990, J BIOL CHEM, V265, P17928; HEINZEL T, 1992, J BIOL CHEM, V267, P4183; Hemsworth GR, 2013, BIOCHEM J, V456, P81, DOI 10.1042/BJ20130796; Hirmondo R, 2015, DNA REPAIR, V30, P21, DOI 10.1016/j.dnarep.2015.03.005; Hochschild A, 2009, CURR OPIN STRUC BIOL, V19, P79, DOI 10.1016/j.sbi.2008.12.008; Horvati K, 2015, TUBERCULOSIS, V95, pS207, DOI 10.1016/j.tube.2015.02.026; ISACKSON PJ, 1985, P NATL ACAD SCI USA, V82, P6226, DOI 10.1073/pnas.82.18.6226; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Leveles I, 2013, ACTA CRYSTALLOGR D, V69, P2298, DOI 10.1107/S0907444913021136; Leveles I, 2011, ACTA CRYSTALLOGR F, V67, P1411, DOI 10.1107/S1744309111034580; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mir-Sanchis I, 2012, MOL MICROBIOL, V85, P833, DOI 10.1111/j.1365-2958.2012.08145.x; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; Nagy GN, 2014, FEBS J, V281, P4207, DOI 10.1111/febs.12941; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Orosz F, 1997, BRIT J PHARMACOL, V121, P947, DOI 10.1038/sj.bjp.0701189; Pecsi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037461; Pecsi I, 2010, NUCLEIC ACIDS RES, V38, P7179, DOI 10.1093/nar/gkq584; Pedersen M, 2008, J MOL BIOL, V376, P983, DOI 10.1016/j.jmb.2007.12.022; Persson R, 2001, CURR PROTEIN PEPT SC, V2, P287, DOI 10.2174/1389203013381035; Pinkett HW, 2006, MOL CELL, V21, P605, DOI 10.1016/j.molcel.2006.01.019; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Revet B, 1999, CURR BIOL, V9, P151, DOI 10.1016/S0960-9822(99)80069-4; RIEDEL HD, 1993, FEBS LETT, V334, P165, DOI 10.1016/0014-5793(93)81705-5; ROBERTS JW, 1975, P NATL ACAD SCI USA, V72, P147, DOI 10.1073/pnas.72.1.147; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Shearwin KE, 1998, J BIOL CHEM, V273, P5708, DOI 10.1074/jbc.273.10.5708; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sreerama N, 1999, PROTEIN SCI, V8, P370; Stayrook S, 2008, NATURE, V452, P1022, DOI 10.1038/nature06831; Szabo JE, 2014, NUCLEIC ACIDS RES, V42, P11912, DOI 10.1093/nar/gku882; Takacs E, 2004, FEBS LETT, V566, P48, DOI 10.1016/j.febslet.2004.04.039; Takacs E, 2009, FEBS LETT, V583, P865, DOI 10.1016/j.febslet.2009.02.011; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; VERTESSY BG, 1994, BBA-PROTEIN STRUCT M, V1205, P146, DOI 10.1016/0167-4838(94)90103-1; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Wang YL, 2007, NUCLEIC ACIDS RES, V35, pD298, DOI 10.1093/nar/gkl952; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wojciak JM, 2001, NAT STRUCT BIOL, V8, P84	64	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139086	10.1371/journal.pone.0139086	http://dx.doi.org/10.1371/journal.pone.0139086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414067	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000362170700041
J	Smith, M; Wilson, R; O'Brien, S; Tufarelli, C; Anderson, SI; O'Sullivan, SE				Smith, Marie; Wilson, Richard; O'Brien, Sally; Tufarelli, Cristina; Anderson, Susan I.; O'Sullivan, Saoirse Elizabeth			The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation	PLOS ONE			English	Article							TYPE-2 CANNABINOID RECEPTOR; MARROW STROMAL CELLS; REGULATES BONE MASS; FUNCTION IN-VITRO; OSTEOCLAST FUNCTION; KINASE; MICE; OSTEOPOROSIS; INVOLVEMENT; SYSTEM	The endocannabinoid system is expressed in bone, although its role in the regulation of bone growth is controversial. Many studies have examined the effect of endocannabinoids directly on osteoclast function, but few have examined their role in human osteoblast function, which was the aim of the present study. Human osteoblasts were treated from seeding with increasing concentrations of anandamide or 2-arachidonoylglycerol for between 1 and 21 days. Cell proliferation (DNA content) and differentiation (alkaline phosphatase (ALP), collagen and osteocalcin secretion and calcium deposition) were measured. Anandamide and 2-arachidonoylglycerol significantly decreased osteoblast proliferation after 4 days, associated with a concentration-dependent increase in ALP. Inhibition of endocannabinoid degradation enzymes to increase endocannabinoid tone resulted in similar increases in ALP production. 2-arachidonoylglycerol also decreased osteocalcin secretion. After prolonged (21 day) treatment with 2-arachidonoylglycerol, there was a decrease in collagen content, but no change in calcium deposition. Anandamide did not affect collagen or osteocalcin, but reduced calcium deposition. Anandamide increased levels of phosphorylated CREB, ERK 1/2 and JNK, while 2-arachidonoylglycerol increased phosphorylated CREB and Akt. RT-PCR demonstrated the expression of CB2 and TRPV1, but not CB1 in HOBs. Anandamide-induced changes in HOB differentiation were CB1 and CB2-independent and partially reduced by TRPV1 antagonism, and reduced by inhibition of ERK 1/2 and JNK. Our results have demonstrated a clear involvement of anandamide and 2-arachidonoylglycerol in modulating the activity of human osteoblasts, with anandamide increasing early cell differentiation and 2-AG increasing early, but decreasing late osteoblast-specific markers of differentiation.	[Smith, Marie; Wilson, Richard; O'Brien, Sally; Tufarelli, Cristina; Anderson, Susan I.; O'Sullivan, Saoirse Elizabeth] Univ Nottingham, Royal Derby Hosp, Sch Med, Div Med Sci & Grad Entry Med, Derby DE22 3DT, England	University of Nottingham	O'Sullivan, SE (corresponding author), Univ Nottingham, Royal Derby Hosp, Sch Med, Div Med Sci & Grad Entry Med, Derby DE22 3DT, England.	saoirse.osullivan@nottingham.ac.uk	Tufarelli, Cristina/AAD-3265-2019	Tufarelli, Cristina/0000-0002-1053-4618; O'Sullivan, Saoirse Elizabeth/0000-0002-1672-6610; O'Brien, Sally/0000-0003-1269-8648; Kokolski, Marie/0000-0002-7779-4887; Smith, Marie/0000-0002-0874-4624				Anderson SI, 1998, J MATER SCI-MATER M, V9, P731, DOI 10.1023/A:1008955002955; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Bab I, 2008, J NEUROENDOCRINOL, V20, P69, DOI 10.1111/j.1365-2826.2008.01675.x; Bab I, 2009, ANN MED, V41, P560, DOI 10.1080/07853890903121025; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Di Marzo V, 2011, P NATL ACAD SCI USA, V108, P12567, DOI 10.1073/pnas.1109567108; Di Silvio L, 1995, NOVEL APPL 2 BIOMATE; Doan TKP, 2012, TISSUE ENG REGEN MED, V9, P283, DOI 10.1007/s13770-012-0352-6; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Fratzl-Zelman N, 1998, BONE, V23, P511, DOI 10.1016/S8756-3282(98)00139-2; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ghilardi JR, 2005, J NEUROSCI, V25, P3126, DOI 10.1523/JNEUROSCI.3815-04.2005; Gui H, 2015, INT IMMUNOPHARMACOL, V26, P86, DOI 10.1016/j.intimp.2015.03.006; Henstock JR, 2014, J MATER SCI-MATER M, V25, P1087, DOI 10.1007/s10856-014-5140-5; Henstock JR, 2009, POROUS SILICON POLYC; Hind W.H., 2015, BR J PHARM; Hind WH, 2015, BRIT J PHARMACOL, V172, P3015, DOI 10.1111/bph.13106; Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604; Huang YF, 2012, J BONE MINER RES, V27, P1093, DOI 10.1002/jbmr.1548; Hutchins HL, 2011, J NUTR BIOCHEM, V22, P195, DOI 10.1016/j.jnutbio.2010.06.001; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Idris AI, 2008, ENDOCRINOLOGY, V149, P5619, DOI 10.1210/en.2008-0150; Idris AI, 2010, BONE, V46, P1089, DOI 10.1016/j.bone.2010.01.368; Idris AI, 2009, CELL METAB, V10, P139, DOI 10.1016/j.cmet.2009.07.006; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Karsak M, 2005, HUM MOL GENET, V14, P3389, DOI 10.1093/hmg/ddi370; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.95; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Rossi F, 2009, BONE, V44, P476, DOI 10.1016/j.bone.2008.10.056; Rossi F, 2011, BONE, V48, P997, DOI 10.1016/j.bone.2011.01.001; Scutt A, 2007, CALCIFIED TISSUE INT, V80, P50, DOI 10.1007/s00223-006-0171-7; Sophocleous A, 2011, ENDOCRINOLOGY, V152, P2141, DOI 10.1210/en.2010-0930; Tam J, 2008, FASEB J, V22, P285, DOI 10.1096/fj.06-7957com; Tam J, 2006, MOL PHARMACOL, V70, P786, DOI 10.1124/mol.106.026435; Whyte LS, 2012, BRIT J PHARMACOL, V165, P2584, DOI 10.1111/j.1476-5381.2011.01519.x; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Yamanouchi K, 1997, J BONE MINER METAB, V15, P23, DOI DOI 10.1007/BF02439451; Yang L, 2003, CHINESE MED J-PEKING, V116, P1357; Zhang RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020780; Zhang X, 2015, MOL CELL BIOCH; Zhao M, 2009, BONE, V44, pS27, DOI 10.1016/j.bone.2009.01.062; ZHOU H, 1994, J BONE MINER RES, V9, P1489	49	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0136546	10.1371/journal.pone.0136546	http://dx.doi.org/10.1371/journal.pone.0136546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414859	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700003
J	Aubry, F; Nougairede, A; de Fabritus, L; Piorkowski, G; Gould, EA; de Lamballerie, X				Aubry, Fabien; Nougairede, Antoine; de Fabritus, Lauriane; Piorkowski, Geraldine; Gould, Ernest A.; de Lamballerie, Xavier			"ISA-Lation" of Single-Stranded Positive-Sense RNA Viruses from Non-Infectious Clinical/Animal Samples	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; INFECTIOUS MOLECULAR CLONES; REAL-TIME PCR; DIAGNOSTIC VIROLOGY; AMPLIFICATION; CHIKUNGUNYA; GENERATION; SEQUENCES; GENOME	Isolation of viral pathogens from clinical and/or animal samples has traditionally relied on either cell cultures or laboratory animal model systems. However, virus viability is notoriously susceptible to adverse conditions that may include inappropriate procedures for sample collection, storage temperature, support media and transportation. Using our recently described ISA method, we have developed a novel procedure to isolate infectious single-stranded positive-sense RNA viruses from clinical or animal samples. This approach, that we have now called "ISA-lation", exploits the capacity of viral cDNA subgenomic fragments to re-assemble and produce infectious viral RNA in susceptible cells. Here, it was successfully used to rescue enterovirus, Chikungunya and Tick-borne encephalitis viruses from a variety of inactivated animal and human samples. ISA-lation represents an effective option to rescue infectious virus from clinical and/or animal samples that may have deteriorated during the collection and storage period, but also potentially overcomes logistic and administrative difficulties generated when complying with current health and safety and biosecurity guidelines associated with shipment of infectious viral material.	[Aubry, Fabien; Nougairede, Antoine; de Fabritus, Lauriane; Piorkowski, Geraldine; Gould, Ernest A.; de Lamballerie, Xavier] Aix Marseille Univ, EHESP French Sch Publ Hlth, IRD French Inst Res Dev, EPV UMR D 190 Emergence Pathol Virales, F-13385 Marseille, France; [Nougairede, Antoine; de Lamballerie, Xavier] Univ Mediterranee Infect, Inst Hosp, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Aubry, F (corresponding author), Aix Marseille Univ, EHESP French Sch Publ Hlth, IRD French Inst Res Dev, EPV UMR D 190 Emergence Pathol Virales, F-13385 Marseille, France.	fab1.aubry@gmail.com		Piorkowski, Geraldine/0000-0001-5023-855X; de Fabritus, Lauriane/0000-0003-0668-4629; Aubry, Fabien/0000-0002-7733-7694	European Union [278433, 653316]; Agence Nationale de la Recherche [ANR-14-CE14-0001 RNA Vacci-Code]	European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the project Predemics, http://predemics.biomedtrain.eu/cms/default.aspx (European Union Seventh Framework Programme under grant no. 278433); the European Virus Archive goes Global, http://global.european-virus-archive.com/ (European Union's Horizon 2020 research and innovation programme under grant agreement no. 653316); and the Agence Nationale de la Recherche, http://www.agence-nationale-recherche.fr/ (grant ANR-14-CE14-0001 RNA Vacci-Code). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007; Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0; Blow JA, 2004, J VIROL METHODS, V119, P195, DOI 10.1016/j.jviromet.2004.03.015; de Fabritus L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004738; Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Gunson RN, 2006, J CLIN VIROL, V35, P355, DOI 10.1016/j.jcv.2005.12.006; HSIUNG GD, 1984, YALE J BIOL MED, V57, P727; Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Nougairede A, 2014, J CLIN VIROL, V61, P118, DOI 10.1016/j.jcv.2014.05.022; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Paul JR, 1940, J EXP MED, V71, P765, DOI 10.1084/jem.71.6.765; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6; Santiago ML, 2003, J VIROL, V77, P2233, DOI 10.1128/JVI.77.3.2233-2242.2003; Schnepp BC, 2009, J VIROL, V83, P1456, DOI 10.1128/JVI.01686-08; Storch GA, 2000, CLIN INFECT DIS, V31, P739, DOI 10.1086/314015; Takehisa J, 2007, J VIROL, V81, P7463, DOI 10.1128/JVI.00551-07; Tapparel C, 2009, J CLIN MICROBIOL, V47, P1742, DOI 10.1128/JCM.02339-08	23	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138703	10.1371/journal.pone.0138703	http://dx.doi.org/10.1371/journal.pone.0138703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407018	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700073
J	Beltrame, CO; Cortes, MF; Bonelli, RR; Correa, ABD; Botelho, AMN; Americo, MA; Fracalanzza, SEL; Figueiredo, AMS				Beltrame, Cristiana Ossaille; Cortes, Marina Farrel; Bonelli, Raquel Regina; de Almeida Correa, Ana Beatriz; Nunes Botelho, Ana Maria; Americo, Marco Antonio; Longo Fracalanzza, Sergio Eduardo; Sa Figueiredo, Agnes Marie			Inactivation of the Autolysis-Related Genes lrgB and yycI in Staphylococcus aureus Increases Cell Lysis-Dependent eDNA Release and Enhances Biofilm Development In Vitro and In Vivo	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; MUREIN HYDROLASE ACTIVITY; EXTRACELLULAR DNA; BACTERIAL DEATH; RESISTANCE; PENICILLIN; EXPRESSION; REGULATOR; SYSTEM; SARA	Staphylococcus aureus ica-independent biofilms are multifactorial in nature, and various bacterial proteins have been associated with biofilm development, including fibronectin-binding proteins A and B, protein A, surface protein SasG, proteases, and some autolysins. The role of extracellular DNA (eDNA) has also been demonstrated in some S. aureus biofilms. Here, we constructed a Tn551 library, and the screening identified two genes that affected biofilm formation, lrgB and yycI. The repressive effect of both genes on the development of biofilm was also confirmed in knockout strains constructed by allelic recombination. In contrast, the superexpression of either lrgB or yycI by a cadmium-inducible promoter led to a decrease in biofilm accumulation. Indeed, a significant increase in the cell-lysis dependent eDNA release was detected when lrgB or yycI were inactivated, explaining the enhanced biofilm formed by these mutants. In fact, lrgB and yycI genes belong to distinct operons that repress bacterial autolysis through very different mechanisms. LrgB is associated with the synthesis of phage holin/anti-holin analogues, while YycI participates in the activation/repression of the two-component system YycGF (WalKR). Our in vivo data suggest that autolysins activation lead to increased bacterial virulence in the foreign body animal model since a higher number of attached cells was recovered from the implanted catheters inoculated with lrgB or yycI knockout mutants.	[Beltrame, Cristiana Ossaille; Cortes, Marina Farrel; Bonelli, Raquel Regina; de Almeida Correa, Ana Beatriz; Nunes Botelho, Ana Maria; Americo, Marco Antonio; Longo Fracalanzza, Sergio Eduardo; Sa Figueiredo, Agnes Marie] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Med, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Figueiredo, AMS (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Microbiol Med, Rio De Janeiro, RJ, Brazil.	agnes@micro.ufrj.br	Figueiredo, Agnes/N-6836-2013; Bonelli, Raquel Regina/G-2494-2017; Figueiredo, Agnes Marie Sá/AAH-2084-2020; Côrtes, Marina Farrel/H-5255-2018	Bonelli, Raquel Regina/0000-0003-4537-5458; Figueiredo, Agnes Marie Sá/0000-0001-8229-6957; Ossaille Beltrame, Cristiana/0000-0002-5939-2585	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) [302290/2011-7, 470534/2010-9]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR) [E-26/111.663/2013]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR)	Funding: Funding was provided by: 1. AMSF, Grant Funder: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR). Grant Number 302290/2011-7. URL: www.cnpq.br; 2. AMSF, Grant Funder: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR). Grant Number 470534/2010-9. URL: www.cnpq.br; 3. AMSF, Grant Funder: Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR). Grant Number: E-26/111.663/2013. URL: www.faperj.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MM, 2005, J INFECT DIS, V192, P801, DOI 10.1086/432515; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Baek KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077122; Bayles KW, 2014, NAT REV MICROBIOL, V12, P63, DOI 10.1038/nrmicro3136; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bose JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042244; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chu XM, 2013, RES MICROBIOL, V164, P695, DOI 10.1016/j.resmic.2013.06.001; Cockfield JD, 2007, J MED MICROBIOL, V56, P614, DOI 10.1099/jmm.0.47074-0; Coelho LR, 2008, MICROBIOL-SGM, V154, P3480, DOI 10.1099/mic.0.2007/016014-0; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Cortes MF, 2015, INT J MED MICROBIOL, V305, P140, DOI 10.1016/j.ijmm.2014.11.011; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Das T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091935; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; Dewey JS, 2010, P NATL ACAD SCI USA, V107, P2219, DOI 10.1073/pnas.0914030107; Dubrac S, 2008, ADV EXP MED BIOL, V631, P214, DOI 10.1007/978-0-387-78885-2_15; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Ferreira FA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-93; Ferreira FA, 2012, J MICROBIOL METH, V88, P393, DOI 10.1016/j.mimet.2012.01.007; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Hsueh PR, 1999, J CLIN MICROBIOL, V37, P504, DOI 10.1128/JCM.37.3.504-509.1999; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; Ingavale SS, 2003, MOL MICROBIOL, V48, P1451, DOI 10.1046/j.1365-2958.2003.03503.x; JONES CL, 1986, J BACTERIOL, V166, P29, DOI 10.1128/jb.166.1.29-33.1986; KORNBLUM J, 1986, EUR J CLIN MICROBIOL, V5, P714, DOI 10.1007/BF02013311; Korol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083743; MANI N, 1993, J BACTERIOL, V175, P1493, DOI 10.1128/JB.175.5.1493-1499.1993; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Manna AC, 2004, J BACTERIOL, V186, P5267, DOI 10.1128/JB.186.16.5267-5280.2004; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; MOREILLON P, 1990, ANTIMICROB AGENTS CH, V34, P33, DOI 10.1128/AAC.34.1.33; Morkel G, 2014, PAEDIATR INT CHILD H, V34, P108, DOI 10.1179/2046905513Y.0000000082; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Santelli E, 2007, J BACTERIOL, V189, P3290, DOI 10.1128/JB.01937-06; Savva CG, 2008, MOL MICROBIOL, V69, P784, DOI 10.1111/j.1365-2958.2008.06298.x; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Verhasselt P, 1992, DNA Seq, V2, P281, DOI 10.3109/10425179209030960; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yamaguchi M, 2012, PLANT CELL PHYSIOL, V53, P125, DOI 10.1093/pcp/pcr180; Yang YJ, 2012, NEW PHYTOL, V193, P81, DOI 10.1111/j.1469-8137.2011.03867.x; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4; Zielinska AK, 2012, MOL MICROBIOL, V86, P1183, DOI 10.1111/mmi.12048	60	22	22	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138924	10.1371/journal.pone.0138924	http://dx.doi.org/10.1371/journal.pone.0138924			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406329	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700119
J	Magnuszewski, P; Ostasiewicz, K; Chazdon, R; Salk, C; Pajak, M; Sendzimir, J; Andersson, K				Magnuszewski, Piotr; Ostasiewicz, Katarzyna; Chazdon, Robin; Salk, Carl; Pajak, Michal; Sendzimir, Jan; Andersson, Krister			Resilience and Alternative Stable States of Tropical Forest Landscapes under Shifting Cultivation Regimes	PLOS ONE			English	Article							SLASH-AND-BURN; AGRICULTURAL INTENSIFICATION; SOUTHEAST-ASIA; LINKING THEORY; LAND-USE; FIRE; DEFORESTATION; BIODIVERSITY; DEGRADATION; MANAGEMENT	Shifting cultivation is a traditional agricultural practice in most tropical regions of the world and has the potential to provide for human livelihoods while hosting substantial biodiversity. Little is known about the resilience of shifting cultivation to increasing agricultural demands on the landscape or to unexpected disturbances. To investigate these issues, we develop a simple social-ecological model and implement it with literature-derived ecological parameters for six shifting cultivation landscapes from three continents. Analyzing the model with the tools of dynamical systems analysis, we show that such landscapes exhibit two stable states, one characterized by high forest cover and agricultural productivity, and another with much lower values of these traits. For some combinations of agricultural pressure and ecological parameters both of these states can potentially exist, and the actual state of the forest depends critically on its historic state. In many cases, the landscapes' 'ecological resilience', or amount of forest that could be destroyed without shifting out of the forested stability domain, declined substantially at lower levels of agricultural pressure than would lead to maximum productivity. A measure of 'engineering resilience', the recovery time from standardized disturbances, was independent of ecological resilience. These findings suggest that maximization of short-term agricultural output may have counterproductive impacts on the long-term productivity of shifting cultivation landscapes and the persistence of forested areas.	[Magnuszewski, Piotr; Ostasiewicz, Katarzyna; Pajak, Michal; Sendzimir, Jan] Int Inst Appl Syst Anal, Risk Policy & Vulnerabil Program, A-2361 Laxenburg, Austria; [Magnuszewski, Piotr; Pajak, Michal] Ctr Syst Solut, Wroclaw, Poland; [Ostasiewicz, Katarzyna] Wroclaw Univ Econ, Dept Stat, Wroclaw, Poland; [Chazdon, Robin] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Salk, Carl; Andersson, Krister] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Salk, Carl] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria; [Salk, Carl] Swedish Univ Agr Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden; [Pajak, Michal] Wroclaw Univ Econ, Dept Math Econ, Wroclaw, Poland	International Institute for Applied Systems Analysis (IIASA); Wroclaw University of Economics & Business; University of Connecticut; University of Colorado System; University of Colorado Boulder; International Institute for Applied Systems Analysis (IIASA); Swedish University of Agricultural Sciences; Wroclaw University of Economics & Business	Magnuszewski, P (corresponding author), Int Inst Appl Syst Anal, Risk Policy & Vulnerabil Program, A-2361 Laxenburg, Austria.	piotr.magnuszewski@crs.org.pl	Pająk, Michał/AAH-4923-2019; andersson, krister/R-7554-2019; Chazdon, Robin/O-9766-2018	Pająk, Michał/0000-0002-4328-7123; andersson, krister/0000-0002-9320-8155; Magnuszewski, Piotr/0000-0003-1211-0672; Salk, Carl/0000-0003-2833-8292; Chazdon, Robin/0000-0002-7349-5687; Ostasiewicz, Katarzyna/0000-0002-0115-3696	National Science Foundation [DEB-1114984]	National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by the National Science Foundation (http://www.nsf.gov/), grant number: DEB-1114984, KA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoellah O, 1993, 3 U CAL CTR SE AS ST; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Barrera-Bassols N, 2005, J LAT AM GEOGR, V4, P9, DOI 10.1353/lag.2005.0021; Baumol W., 1996, ENVIRON DEV ECON, V3, P221, DOI 10.1017/S1355770X98240125; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Cairns M, 1999, AGROFOREST SYST, V47, P37, DOI 10.1023/A:1006248104991; Chazdon RL., 2013, J SUSTAIN FOREST, V32, P649, DOI DOI 10.1080/10549811.2013.817340; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Colfer Carol J. Pierce, 1997, ADV EC BOT, V11; CONKLIN HC, 1961, CURR ANTHROPOL, V2, P27, DOI 10.1086/200160; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; DUFOUR DL, 1990, BIOSCIENCE, V40, P652, DOI 10.2307/1311432; EHUI SK, 1989, AM J AGR ECON, V71, P703, DOI 10.2307/1242026; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fox J, 2000, BIOSCIENCE, V50, P521, DOI 10.1641/0006-3568(2000)050[0521:SCANOP]2.0.CO;2; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gilroy JJ, 2014, J APPL ECOL, V51, P1337, DOI 10.1111/1365-2664.12284; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Holling C. S, 1996, ENG ECOLOGICAL CONST, P31, DOI DOI 10.17226/4919; Jakovac CC, 2015, J ECOL, V103, P67, DOI 10.1111/1365-2745.12298; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Lawrence D, 2004, ECOL APPL, V14, P1855, DOI 10.1890/03-5321; Lawrence D, 2007, P NATL ACAD SCI USA, V104, P20696, DOI 10.1073/pnas.0705005104; Lawrence D, 2010, BIOTROPICA, V42, P21, DOI 10.1111/j.1744-7429.2009.00599.x; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Mertz O, 2009, HUM ECOL, V37, P259, DOI 10.1007/s10745-009-9245-2; Minang PA, 2014, PARTNERSHIP TROPICAL, P241; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nobre CA, 2009, CURR OPIN ENV SUST, V1, P28, DOI 10.1016/j.cosust.2009.07.003; NYE P. H., 1960, The Soil under Shifting Cultivation.; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Pace ML, 2013, LIMNOL OCEANOGR, V58, P525, DOI 10.4319/lo.2013.58.2.0525; Padoch C, 2007, GEOGR TIDSSKR-DEN, V107, P29, DOI 10.1080/00167223.2007.10801373; Padoch C, 2010, BIOTROPICA, V42, P550, DOI 10.1111/j.1744-7429.2010.00681.x; Palm CA, 2005, SLASH AND BURN AGR S; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Phelps J, 2013, P NATL ACAD SCI USA, V110, P7601, DOI 10.1073/pnas.1220070110; Richards PW, 1952, TROPICAL RAIN FOREST; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Schmidt-Vogt D, 2009, HUM ECOL, V37, P269, DOI 10.1007/s10745-009-9239-0; Schooler SS, 2011, NATURE, V470, P86, DOI 10.1038/nature09735; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Seekell DA, 2013, THEOR ECOL-NETH, V6, P385, DOI 10.1007/s12080-013-0183-7; Styger E, 2007, AGR ECOSYST ENVIRON, V119, P257, DOI 10.1016/j.agee.2006.07.012; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; van Nes EH, 2014, GLOBAL CHANGE BIOL, V20, P1016, DOI 10.1111/gcb.12398; van Vliet N, 2012, GLOBAL ENVIRON CHANG, V22, P418, DOI 10.1016/j.gloenvcha.2011.10.009; vandeKoppel J, 1997, TRENDS ECOL EVOL, V12, P352, DOI 10.1016/S0169-5347(97)01133-6; Veldman JW, 2011, BIOL CONSERV, V144, P1419, DOI 10.1016/j.biocon.2011.01.011	56	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137497	10.1371/journal.pone.0137497	http://dx.doi.org/10.1371/journal.pone.0137497			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406907	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700022
J	Netikul, T; Kiratisin, P				Netikul, Thidarat; Kiratisin, Pattarachai			Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MODIFIED HODGE TEST; MOLECULAR EPIDEMIOLOGY; ESCHERICHIA-COLI; SEQUENCE TYPES; K.-PNEUMONIAE; EMERGENCE; PORIN; INFECTIONS; LACTAMASES	Carbapenem-resistant Enterobacteriaceae (CRE) has increasingly spread worldwide in the past decade. The prevalence and characteristics of CRE in Thailand are unknown. In this study, we conducted a 2-year surveillance of CRE among 12,741 clinical isolates of Enterobacteriaceae at the largest university hospital in Thailand with molecular characterization of beta-lactamase (bla) genes, including carbapenemase genes. The CRE prevalence was 1.4%. bla(KPC-13) and bla(IMP-14a) were the only carbapenemase genes detected among these CRE isolates. bla(KPC-13) gene was found in a single isolate of Escherichia coli, Enterobacter cloacae and Citrobacter freundii, and bla(IMP-14a) was found in four isolates of Klebsiella pneumoniae. Carbapenem-resistant K. pneumoniae (CRKP) isolates were resistant to multiple carbapenems at a higher ratio than other CRE species, and thus were further characterized for resistance phenotypes, bla genotypes and molecular epidemiology. Most CRKP isolates harboured multiple bla genes, especially those related to extended-spectrum beta-lactamases. Seven CRKP isolates were resistant to all tested carbapenems, and showed decreased ompK35 and/or ompK36 porin gene expression. Molecular typing of CRKP based on pulsed-field gel electrophoresis (PFGE) demonstrated several unrelated clones. Multilocus sequence typing (MLST) was partially concordant with PFGE results and revealed that ST340, a member of drug-resistant K. pneumoniae clonal complex 258, was the most predominant clone, followed by ST48, ST11 and ST273. The novel ST1645 was identified from this study. ST340 has neither been shown to be predominated among CRKP from other studies, nor been reported in Thailand. Therefore, it emphases a critical concern to monitor and control the spread of CRKP.	[Netikul, Thidarat; Kiratisin, Pattarachai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand	Mahidol University	Kiratisin, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.	pattarachai.kir@mahidol.ac.th			Thailand Research Fund through Royal Golden Jubilee Ph. D. Program [PHD/0232/2552]; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital	Thailand Research Fund through Royal Golden Jubilee Ph. D. Program; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital	This study was supported by the Thailand Research Fund through the Royal Golden Jubilee Ph. D. Program (Grant No. PHD/0232/2552 to PK and TN) (URL http://rgj.trf.or.th/eng/rgje11.asp) . PK was also supported by the Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital (URL http://www.si.mahidol.ac.th/en/) during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageevets VA, 2014, INT J ANTIMICROB AG, V44, P152, DOI 10.1016/j.ijantimicag.2014.05.004; Bushnell G, 2013, INT J INFECT DIS, V17, pE325, DOI 10.1016/j.ijid.2012.11.025; Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431; Chen L, 2014, TRENDS MICROBIOL, V22, P686, DOI 10.1016/j.tim.2014.09.003; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Correa L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-80; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Domenech-Sanchez A, 2003, ANTIMICROB AGENTS CH, V47, P3332, DOI 10.1128/AAC.47.10.3332-3335.2003; Donati V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090564; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; European Committee on Antimicrobial Susceptibility Testing, 2014, BREAKP TABL INT MICS; Falagas ME, 2014, EMERG INFECT DIS, V20, P1170, DOI 10.3201/eid2007.121004; Geffen Y, 2013, J ANTIMICROB CHEMOTH, V68, P719, DOI 10.1093/jac/dks443; Giakkoupi P, 2011, J ANTIMICROB CHEMOTH, V66, P1510, DOI 10.1093/jac/dkr166; Girlich D, 2012, J CLIN MICROBIOL, V50, P477, DOI 10.1128/JCM.05247-11; Giske CG, 2012, ANTIMICROB AGENTS CH, V56, P2735, DOI 10.1128/AAC.06142-11; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Haeggman S, 2004, ANTIMICROB AGENTS CH, V48, P2400, DOI 10.1128/AAC.48.7.2400-2408.2004; Hernandez-Alles S, 2000, J ANTIMICROB CHEMOTH, V46, P273, DOI 10.1093/jac/46.2.273; Hsueah PR, 2010, INT J ANTIMICROB AG, V36, P408, DOI 10.1016/j.ijantimicag.2010.07.002; Kim SY, 2013, DIAGN MICR INFEC DIS, V76, P486, DOI 10.1016/j.diagmicrobio.2013.04.006; Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08; Kiratisin P, 2012, INT J ANTIMICROB AG, V39, P311, DOI 10.1016/j.ijantimicag.2012.01.002; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Leavitt A, 2010, ANTIMICROB AGENTS CH, V54, P3002, DOI 10.1128/AAC.01818-09; Lubbert C, 2014, LIVER TRANSPLANT, V20, P736, DOI 10.1002/lt.23858; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Netikul T, 2014, INT J ANTIMICROB AG, V44, P568, DOI 10.1016/j.ijantimicag.2014.08.005; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Novais A, 2012, EUR J CLIN MICROBIOL, V31, P3057, DOI 10.1007/s10096-012-1665-z; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Pereira PS, 2013, J ANTIMICROB CHEMOTH, V68, P312, DOI 10.1093/jac/dks396; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poirel L, 2010, LANCET INFECT DIS, V10, P832, DOI 10.1016/S1473-3099(10)70279-6; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rimrang B, 2012, J ANTIMICROB CHEMOTH, V67, P2626, DOI 10.1093/jac/dks267; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Vourli S, 2004, FEMS MICROBIOL LETT, V234, P209, DOI 10.1016/j.femsle.2004.03.028; Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11; Zhang Y, 2014, ANTIMICROB AGENTS CH, V58, P1214, DOI 10.1128/AAC.02045-12	46	44	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139116	10.1371/journal.pone.0139116	http://dx.doi.org/10.1371/journal.pone.0139116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407326	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700176
J	Ruby, A; Knight, A; Perel, P; Blanchet, K; Roberts, B				Ruby, Alexander; Knight, Abigail; Perel, Pablo; Blanchet, Karl; Roberts, Bayard			The Effectiveness of Interventions for Non-Communicable Diseases in Humanitarian Crises: A Systematic Review	PLOS ONE			English	Article							NEWCASTLE-OTTAWA SCALE; PALESTINE REFUGEES; DIABETES-MELLITUS; HEALTH; COHORT; QUALITY	Background Non-communicable diseases (NCDs) are of increasing concern in low-and middle-income countries (LMICs) affected humanitarian crises. Humanitarian agencies and governments are increasingly challenged with how to effectively tackle NCDs. Reviewing the evidence of interventions for NCDs in humanitarian crises can help guide future policies and research by identifying effective interventions and evidence gaps. The aim of this paper is to systematically review evidence on the effectiveness of interventions targeting NCDs during humanitarian crises in LMICs. Methods A systematic review methodology was followed using PRISMA standards. Studies were selected on NCD interventions with civilian populations affected by humanitarian crises in low-and middle-income countries. Five bibliographic databases and a range of grey literature sources were searched. Descriptive analysis was applied and a quality assessment conducted using the Newcastle-Ottawa Quality Assessment Scale for observational studies and the Cochrane Risk of Bias Tool for experimental studies. Results The search yielded 4919 references of which 8 studies met inclusion criteria. Seven of the 8 studies were observational, and one study was a non-blinded randomised-controlled trial. Diseases examined included hypertension, heart failure, diabetes mellitus, chronic kidney disease, thalassaemia, and arthritis. Study settings included locations in the Middle East, Eastern Europe, and South Asia. Interventions featuring disease-management protocols and/or cohort monitoring demonstrated the strongest evidence of effectiveness. No studies examined intervention costs. The quality of studies was limited, with a reliance on observational study designs, limited use of control groups, biases associated with missing data and inadequate patient-follow-up, and confounding was poorly addressed. Conclusions The review highlights the extremely limited quantity and quality of evidence on this topic. Interventions that incorporate standardisation and facilitate patient follow-up appear beneficial. However, substantially more research is needed, including data on costs.	[Ruby, Alexander; Roberts, Bayard] London Sch Hyg & Trop Med, ECOHOST, London WC1, England; [Knight, Abigail; Blanchet, Karl] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1, England; [Perel, Pablo] London Sch Hyg & Trop Med, Ctr Global Non Communicable Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Roberts, B (corresponding author), London Sch Hyg & Trop Med, ECOHOST, London WC1, England.	Bayard.Roberts@lshtm.ac.uk		/0000-0002-2342-301X; Blanchet, Karl/0000-0003-0498-8020; Roberts, Bayard/0000-0003-4482-5859	Research for Health in Humanitarian Crises (R2HC) Programme; Wellcome Trust; DFID	Research for Health in Humanitarian Crises (R2HC) Programme; Wellcome Trust(Wellcome Trust); DFID	The work for this systematic review was funded by the Research for Health in Humanitarian Crises (R2HC) Programme. The R2HC programme is funded equally by the Wellcome Trust and DFID, and managed by the Enhancing Learning and Research for Humanitarian Assistance (ELRHA).	Allain TJ, 2011, TROP MED INT HEALTH, V16, P1077, DOI 10.1111/j.1365-3156.2011.02808.x; Amara AH, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-24; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Blanchet VS K, 2014, EVIDENCE REV RES HLT; Bolt Jason D, 2010, AANA J, V78, P129; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Culbert H, 2007, PLOS MED, V4, P794, DOI 10.1371/journal.pmed.0040129; Deeks J J, 2003, Health Technol Assess, V7, piii; Demaio Alessandro, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.53e08b951d59ff913ab8b9bb51c4d0de; ELHRA, 2015, R2HC RES HLTH HUM CR; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Harries AD, 2009, JAIDS-J ACQ IMM DEF, V52, pS14, DOI 10.1097/QAI.0b013e3181bbc99e; Harries AD, 2009, T ROY SOC TROP MED H, V103, P537, DOI 10.1016/j.trstmh.2008.12.008; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P982, DOI 10.1016/j.jclinepi.2013.03.003; Haskew C, 2010, B WORLD HEALTH ORGAN, V88, P792, DOI 10.2471/BLT.09.074096; Hebert K, 2011, CIRC-HEART FAIL, V4, P763, DOI 10.1161/CIRCHEARTFAILURE.111.962431; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holmes MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000244; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Kayabu Bonnix, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.ed42382881b3bf79478ad503be4693ea; Khader A, 2013, PUBLIC HEALTH ACTION, V3, P259, DOI 10.5588/pha.13.0083; Khader A, 2014, TROP MED INT HEALTH, V19, P219, DOI 10.1111/tmi.12241; Khader A, 2012, TROP MED INT HEALTH, V17, P1569, DOI 10.1111/j.1365-3156.2012.03097.x; Khader A, 2012, TROP MED INT HEALTH, V17, P1163, DOI 10.1111/j.1365-3156.2012.03048.x; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Roberts B, 2012, B WORLD HEALTH ORGAN, V90, P2, DOI 10.2471/BLT.11.098863; Ryan M, 1997, SOC SCI MED, V44, P535, DOI 10.1016/S0277-9536(96)00165-7; Sever MS, 2004, J AM SOC NEPHROL, V15, P1071, DOI 10.1097/01.ASN.0000119145.40232.67; Spiegel P, 2014, LANCET ONCOL, V15, pE290, DOI 10.1016/S1470-2045(14)70067-1; Spiegel PB, 2010, LANCET, V375, P341, DOI 10.1016/S0140-6736(09)61873-0; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tol WA, 2011, LANCET, V378, P1581, DOI 10.1016/S0140-6736(11)61094-5; United Nations High Commissioner for Refugees, 2014, UNHCR GLOB TRENDS 20; United Nations High Commissioner for Refugees, 2014, GLOB STRAT PUBL HLTH; Wells G., 2014, S SYST REV BAS; World Health Organization, 2013, GLOB ACT PLAN PREV C	40	42	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138303	10.1371/journal.pone.0138303	http://dx.doi.org/10.1371/journal.pone.0138303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406317	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700039
J	Stros, M; Polanska, E; Kucirek, M; Pospisilova, S				Stros, Michal; Polanska, Eva; Kucirek, Martin; Pospisilova, Sarka			Histone H1 Differentially Inhibits DNA Bending by Reduced and Oxidized HMGB1 Protein	PLOS ONE			English	Article							GROUP BOX DOMAINS; LINKER HISTONES; CHROMATIN INTERACTIONS; 2 MUTATIONS; A-DOMAIN; BINDING; ASSOCIATION; HMG-1; LIGATION; TERMINUS	HMGB1 protein and linker histone H1 have overlapping binding sites in the nucleosome. HMGB1 has been implicated in many DNA-dependent processes in chromatin involving binding of specific proteins, including transcription factors, to DNA sites pre-bent by HMGB1. HMGB1 can also act as an extracellular signaling molecule by promoting inflammation, tumor growth a metastasis. Many of the intra-and extracellular functions of HMGB1 depend on redox-sensitive cysteine residues of the protein. Here we report that mild oxidization of HMGB1 (and much less mutation of cysteines involved in disulphide bond formation) can severely compromise the functioning of the protein as a DNA chaperone by inhibiting its ability to unwind or bend DNA. Histone H1 (via the highly basic C-terminal domain) significantly inhibits DNA bending by the full-length HMGB1, and the inhibition is further enhanced upon oxidization of HMGB1. Interestingly, DNA bending by HMGB1 lacking the acidic C-tail (HMGB1 Delta C) is much less affected by histone H1, but oxidization rendered DNA bending by HMGB1 Delta C and HMGB1 equally prone for inhibition by histone H1. Possible consequences of histone H1-mediated inhibition of DNA bending by HMGB1 of different redox state for the functioning of chromatin are discussed.	[Stros, Michal; Polanska, Eva; Kucirek, Martin] Acad Sci Czech Republ, Inst Biophys, Lab Anal Chromosomal Proteins, Brno, Czech Republic; [Pospisilova, Sarka] Masaryk Univ, CEITEC, Ctr Mol Med, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno	Stros, M (corresponding author), Acad Sci Czech Republ, Inst Biophys, Lab Anal Chromosomal Proteins, Brno, Czech Republic.	michal.stros@email.cz	Pospisilova, Sarka/D-7200-2012	Pospisilova, Sarka/0000-0001-7136-2680; Kucirek, Martin/0000-0003-1297-8631	Grant Agency of the Czech Republic [P305/12/2475, P305-15-01354S]; CEITEC [MSMT CR CZ.1.05/1.1.00/02.0068]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); CEITEC	This work was supported by the Grant Agency of the Czech Republic (grants P305/12/2475 and P305-15-01354S awarded to MS). SP was also supported by research project MSMT CR CZ.1.05/1.1.00/02.0068 (CEITEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgrano FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079572; BILLINGS PC, 1992, BIOCHEM BIOPH RES CO, V188, P1286, DOI 10.1016/0006-291X(92)91371-V; Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; JACKSON JB, 1979, BIOCHEMISTRY-US, V18, P3739, DOI 10.1021/bi00584a015; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; KOHLSTAEDT LA, 1994, BIOCHEMISTRY-US, V33, P570, DOI 10.1021/bi00168a023; Lu X, 2004, J BIOL CHEM, V279, P8701, DOI 10.1074/jbc.M311348200; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Park S, 2011, BIOCHEMISTRY-US, V50, P2567, DOI 10.1021/bi2000214; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; Polanska E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089070; Sanchez-Giraldo R, 2015, ACTA CRYSTALLOGR D, V71, P1423, DOI 10.1107/S1399004715007452; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; SOBCZAK J, 1988, EUR J BIOCHEM, V175, P379, DOI 10.1111/j.1432-1033.1988.tb14207.x; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; STROS M, 1990, INT J BIOL MACROMOL, V12, P282, DOI 10.1016/0141-8130(90)90014-2; Stros M, 1998, J BIOL CHEM, V273, P10355; STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044; Stros M, 2001, BIOCHEMISTRY-US, V40, P4769, DOI 10.1021/bi002741i; Stros M, 2000, EUR J BIOCHEM, V267, P4088, DOI 10.1046/j.1432-1327.2000.01450.x; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tang DL, 2012, MOL MED, V18, P1360, DOI 10.2119/molmed.2012.00314; TEO SH, 1995, EUR J BIOCHEM, V230, P943, DOI 10.1111/j.1432-1033.1995.tb20640.x; TEO SH, 1995, EMBO J, V14, P3844, DOI 10.1002/j.1460-2075.1995.tb00054.x; Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Travers A, 2000, CURR OPIN STRUC BIOL, V10, P102, DOI 10.1016/S0959-440X(99)00056-1; Ueda T, 2010, BBA-GENE REGUL MECH, V1799, P114, DOI 10.1016/j.bbagrm.2009.11.005; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang J, 2013, BIOCHEM BIOPH RES CO, V441, P701, DOI 10.1016/j.bbrc.2013.10.085; Yamanaka S, 2002, BIOCHEM BIOPH RES CO, V292, P268, DOI 10.1006/bbrc.2002.6647; Zlatanova J, 1998, BIOESSAYS, V20, P584, DOI 10.1002/(SICI)1521-1878(199807)20:7<584::AID-BIES10>3.0.CO;2-W	41	14	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138774	10.1371/journal.pone.0138774	http://dx.doi.org/10.1371/journal.pone.0138774			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406975	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700093
J	El Sadik, AO; El Ghamrawy, TA; El-Galil, TIA				El Sadik, Abir O.; El Ghamrawy, Tarek A.; El-Galil, Tarek I. Abd			The Effect of Mesenchymal Stem Cells and Chitosan Gel on Full Thickness Skin Wound Healing in Albino Rats: Histological, Immunohistochemical and Fluorescent Study	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; BONE-MARROW; IN-VIVO; STROMAL CELLS; GROWTH-FACTOR; ANIMAL-MODEL; REPAIR; DIFFERENTIATION; TISSUE; DEFECT	Background Wound healing involves the integration of complex biological processes. Several studies examined numerous approaches to enhance wound healing and to minimize its related morbidity. Both chitosan and mesenchymal stem cells (MSCs) were used in treating skin wounds. The aim of the current work was to compare MSCs versus chitosan in wound healing, evaluate the most efficient route of administration of MSCs, either intradermal or systemic injection, and elicit the mechanisms inducing epidermal and dermal cell regeneration using histological, immunohistochemical and fluorescent techniques. Material and Methods Forty adult male Sprague Dawley albino rats were divided into four equal groups (ten rats in each group): control group (Group I); full thickness surgical skin wound model, Group II: Wound and chitosan gel. Group III: Wound treated with systemic injection of MSCs and Group IV: Wound treated with intradermal injection of MSCs. The healing ulcer was examined on day 3, 5, 10 and 15 for gross morphological evaluation and on day 10 and 15 for histological, immunohistochemical and fluorescent studies. Results Chitosan was proved to promote wound healing more than the control group but none of their wound reached complete closure. Better and faster healing of wounds in MSCs treated groups were manifested more than the control or chitosan treated groups. It was found that the intradermal route of administration of stem cells enhanced the rate of healing of skin wounds better than the systemic administration to the extent that, by the end of the fifteenth day of the experiment, the wounds were completely healed in all rats of this group. Histologically, the wound areas of group IV were hardly demarcated from the adjacent normal skin and showed complete regeneration of the epidermis, dermis, hypodermis and underlying muscle fibers. Collagen fibers were arranged in many directions, with significant increase in their area percent, surrounding fully regenerated hair follicles and sebaceous glands in the dermis of the healed areas more than in other groups. Conclusion MSCs enhanced the healing process of wound closure more than chitosan gel treatment. Furthermore, MSCs injected intradermally, were more efficient in accelerating wound healing than any other mode of treatment.	[El Sadik, Abir O.; El Ghamrawy, Tarek A.; El-Galil, Tarek I. Abd] Cairo Univ, Fac Med, Dept Anat & Embryol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University	El Ghamrawy, TA (corresponding author), Cairo Univ, Fac Med, Dept Anat & Embryol, Cairo, Egypt.	tarekabdelmoniem@gmail.com	Abd El-Galil, tarek Ibrahim/AGZ-3058-2022; Sadik, Abir El/AAE-4726-2021	Abd El-Galil, tarek Ibrahim/0000-0003-2217-7045; El Sadik, Abir/0000-0003-2098-2155				Akela A, 2012, INT WOUND J, V9, P505, DOI 10.1111/j.1742-481X.2011.00909.x; Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015; Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Alsarra IA, 2009, INT J BIOL MACROMOL, V45, P16, DOI 10.1016/j.ijbiomac.2009.03.010; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; [Anonymous], 2006, SCI PHARM; Augello A, 2010, EUR CELLS MATER, V20, P121; Bancroft J., 1994, MANUAL HISTOLOGICAL, P263; Bancroft JD, 2008, THEORY PRACTICE HIST, P150; Bohling MW, 2004, VET SURG, V33, P579, DOI 10.1111/j.1532-950X.2004.04081.x; Brissett Anthony E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P245, DOI 10.1097/00020840-200308000-00005; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cha JS, 2007, CLIN DERMATOL, V25, P73, DOI 10.1016/j.clindermatol.2006.10.002; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen Ming, 2009, Critical Reviews in Biomedical Engineering, V37, P399, DOI 10.1615/CritRevBiomedEng.v37.i4-5.50; Choi YS, 2001, J MATER SCI-MATER M, V12, P67, DOI 10.1023/A:1026765321117; Dai YC, 2007, BURNS, V33, P418, DOI 10.1016/j.burns.2006.08.028; Efron PA, 2004, J BURN CARE REHABIL, V25, P149, DOI 10.1097/01.BCR.0000111766.97335.34; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fu XB, 2006, WOUND REPAIR REGEN, V14, P325, DOI 10.1111/j.1743-6109.2006.00128.x; Fukuoka H, 2015, EPLASTY, V15, P65; Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012; Hattori H, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0052-y; Hengartner NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116772; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Hsu SH, 2015, WOUND REPAIR REGEN, V23, P57, DOI 10.1111/wrr.12239; Huang SP, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-51; Huang SP, 2012, ANN PLAS SURG, V69, P656, DOI 10.1097/SAP.0b013e318273f909; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Ji KH, 2009, J DERMATOL, V36, P403, DOI 10.1111/j.1346-8138.2009.00666.x; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kawaguchi K, 2010, ARCH HISTOL CYTOL, V73, P65, DOI 10.1679/aohc.73.65; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Li HH, 2006, CELL TISSUE RES, V326, P725, DOI 10.1007/s00441-006-0270-9; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Luo GX, 2010, WOUND REPAIR REGEN, V18, P506, DOI 10.1111/j.1524-475X.2010.00616.x; Nishino Y, 2011, J CRANIOFAC SURG, V22, P438, DOI 10.1097/SCS.0b013e318207b507; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Park IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122776; Petrie A, 2005, MED STAT GLANCE, P55; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Raza K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109034; Sabapathy V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093726; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Svensjo T, 2000, PLAST RECONSTR SURG, V106, P602, DOI 10.1097/00006534-200009030-00012; Tario JD, 2011, METHODS MOL BIOL, V699, P119, DOI 10.1007/978-1-61737-950-5_7; Tark KC, 2010, ANN PLAS SURG, V65, P565, DOI 10.1097/SAP.0b013e3181d9aae2; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2; Wu Y, 2012, INT WOUND J, V9, P586, DOI 10.1111/j.1742-481X.2012.01076.x; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yamaguchi Y, 2005, BRIT J DERMATOL, V152, P616, DOI 10.1111/j.1365-2133.2005.06402.x; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhao FJ, 2011, HUM VACCINES, V7, P1083, DOI 10.4161/hv.7.10.16541; Zhao JJ, 2015, TISSUE ENG PT A, V21, P982, DOI [10.1089/ten.tea.2013.0726, 10.1089/ten.TEA.2013.0726]; Zohdi RM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/843025	59	17	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0137544	10.1371/journal.pone.0137544	http://dx.doi.org/10.1371/journal.pone.0137544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402454	gold, Green Published			2022-12-27	WOS:000361798100012
J	Min, YW; Min, BH; Kim, S; Choi, D; Rhee, PL				Min, Yang Won; Min, Byung-Hoon; Kim, Seonwoo; Choi, Dongil; Rhee, Poong-Lyul			Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial	PLOS ONE			English	Article							PROKINETIC AGENT; SENSORIMOTOR FUNCTION; CORYDALIS TUBER; DYSPEPSIA; MEAL; BAROSTAT; HUMANS; ACCOMMODATION; VOLUME; ITOPRIDE	Background Improving gastric accommodation and gastric emptying is an attractive physiological treatment target in patients with functional dyspepsia (FD). We evaluated the effect of DA-9701, a new drug for FD, on gastric motor function after a meal in healthy volunteers using magnetic resonance imaging (MRI). Methods Forty healthy volunteers were randomly allocated to receive either DA-9701 or placebo. After 5 days of treatment, subjects underwent gastric MRI (60 min before and 15, 30, 45, 60, 90, and 120 min after a liquid test meal). Gastric volume was measured through 3-dimensional reconstruction from MRI data. We analyzed 4 outcome variables including changes in total gastric volume (TGV), proximal TGV, and proximal to distal TGV ratio after a meal and gastric emptying rates after adjusting values at the pre-test meal. Results Changes in TGV and proximal TGV after a meal did not differ between the DA-9701 and placebo groups (difference between groups -25.9 mL, 95% confidence interval [CI] -54.0 to 2.3 mL, P = 0.070 and -2.9 mL, 95% CI -30.3 to 24.5 mL, P = 0.832, respectively). However, pre-treatment with DA-9701 increased postprandial proximal to distal TGV ratio more than placebo (difference between groups 0.93, 95% CI 0.08 to 1.79, P = 0.034). In addition, pretreatment with DA-9701 significantly increased gastric emptying as compared with placebo (mean difference between groups 3.41%, 95% CI 0.54% to 6.29%, P = 0.021, by mixed model for repeated measures). Conclusion Our results suggested that DA-9701 enhances gastric emptying and does not significantly affect gastric accommodation in healthy volunteers. Further studies to confirm whether DA-9701 enhances these gastric motor functions in patients with FD are warranted.	[Min, Yang Won; Min, Byung-Hoon; Rhee, Poong-Lyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Kim, Seonwoo] Samsung Biomed Res Inst, Biostat Team, Seoul, South Korea; [Choi, Dongil] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Radiol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Rhee, PL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	plrhee@skku.edu		Rhee, Poong-Lyul/0000-0003-0495-5296	Global Leading Technology Program of the Office of Strategic R&D Planning (OSP) - Ministry of Knowledge Economy, Republic of Korea [10039303]	Global Leading Technology Program of the Office of Strategic R&D Planning (OSP) - Ministry of Knowledge Economy, Republic of Korea	This work was supported by the Global Leading Technology Program of the Office of Strategic R&D Planning (OSP), funded by the Ministry of Knowledge Economy, Republic of Korea (10039303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZPIROZ F, 1987, GASTROENTEROLOGY, V92, P934, DOI 10.1016/0016-5085(87)90967-X; AZPIROZ F, 1985, AM J PHYSIOL, V248, P229; Azpiroz F, 2014, J GASTROENTEROL, V49, P206, DOI 10.1007/s00535-013-0917-8; Boulby P, 1997, NEUROGASTROENT MOTIL, V9, P41, DOI 10.1046/j.1365-2982.1997.d01-6.x; Bouras EP, 2002, GUT, V51, P781, DOI 10.1136/gut.51.6.781; Breen M, 2011, NEUROGASTROENT MOTIL, V23, P308, DOI 10.1111/j.1365-2982.2010.01660.x; CHAUDHURI TK, 1991, AM J GASTROENTEROL, V86, P533; Choi MG, 2015, J NEUROGASTROENTEROL, V21, P414, DOI 10.5056/jnm14117; Doran S, 1998, AM J PHYSIOL-REG I, V275, pR1712, DOI 10.1152/ajpregu.1998.275.5.R1712; Feinle C, 1999, GUT, V44, P106, DOI 10.1136/gut.44.1.106; Fruehauf H, 2009, NEUROGASTROENT MOTIL, V21, P697, DOI 10.1111/j.1365-2982.2009.01267.x; Haans JJL, 2011, J MAGN RESON IMAGING, V34, P685, DOI 10.1002/jmri.22619; Hallerback BI, 2002, ALIMENT PHARM THER, V16, P959, DOI 10.1046/j.1365-2036.2002.01236.x; Holtmann G, 2006, NEW ENGL J MED, V354, P832, DOI 10.1056/NEJMoa052639; Holtmann G, 2008, DIGEST DIS, V26, P218, DOI 10.1159/000121350; JAHNBERG T, 1975, SCAND J GASTROENTERO, V10, P593; Jung YS, 2013, NEUROGASTROENT MOTIL, V25, P254, DOI 10.1111/nmo.12053; Kim ER, 2012, J GASTROEN HEPATOL, V27, P766, DOI 10.1111/j.1440-1746.2011.06924.x; Komada T, 2007, BIOL PHARM BULL, V30, P508, DOI 10.1248/bpb.30.508; Kuiken SD, 1999, AM J PHYSIOL-GASTR L, V277, pG1217, DOI 10.1152/ajpgi.1999.277.6.G1217; Kunz P, 1999, JMRI-J MAGN RESON IM, V9, P75, DOI 10.1002/(SICI)1522-2586(199901)9:1<75::AID-JMRI10>3.0.CO;2-I; Kwon YS, 2013, BIOMOL THER, V21, P181, DOI 10.4062/biomolther.2012.096; Lacy BE, 2012, AM J GASTROENTEROL, V107, P1615, DOI 10.1038/ajg.2012.104; Lee TH, 2008, PHYTOMEDICINE, V15, P836, DOI 10.1016/j.phymed.2008.02.019; Lee TH, 2011, J PHARMACOL EXP THER, V338, P917, DOI 10.1124/jpet.111.182048; Marciani L, 2001, AM J PHYSIOL-GASTR L, V280, pG1227, DOI 10.1152/ajpgi.2001.280.6.G1227; Matsueda K, 2012, GUT, V61, P821, DOI 10.1136/gutjnl-2011-301454; Matsumoto Y, 2009, J GASTROENTEROL, V44, P1118, DOI 10.1007/s00535-009-0113-z; MORAGAS G, 1993, AM J PHYSIOL, V264, pG1112, DOI 10.1152/ajpgi.1993.264.6.G1112; Mundt MW, 2002, AM J PHYSIOL-GASTR L, V283, pG681, DOI 10.1152/ajpgi.00499.2001; Pohl D, 2008, DIGESTION, V77, P184, DOI 10.1159/000142726; Rosch W, 2006, PHYTOMEDICINE, V13, P114, DOI 10.1016/j.phymed.2006.03.022; Sarnelli G, 2004, AM J PHYSIOL-GASTR L, V287, pG988, DOI 10.1152/ajpgi.00419.2003; Sarnelli G, 2001, AM J GASTROENTEROL, V96, P1047; Stanghellini V, 1996, GASTROENTEROLOGY, V110, P1036, DOI 10.1053/gast.1996.v110.pm8612991; Tack J, 2001, Curr Gastroenterol Rep, V3, P503, DOI 10.1007/s11894-001-0071-y; Tack J, 2004, GASTROENTEROLOGY, V127, P1058, DOI 10.1053/j.gastro.2004.07.005; Tack J, 2003, ALIMENT PHARM THER, V17, P603, DOI 10.1046/j.1365-2036.2003.01469.x; Tack J, 1998, GASTROENTEROLOGY, V115, P1346, DOI 10.1016/S0016-5085(98)70012-5; Talley NJ, 2008, GUT, V57, P740, DOI 10.1136/gut.2007.132449; Talley NJ, 1999, GUT, V45, P37; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x; THOMFORDE GM, 1995, J NUCL MED, V36, P93; Treier R, 2006, J MAGN RESON IMAGING, V23, P331, DOI 10.1002/jmri.20507; Vakil N, 2008, AM J GASTROENTEROL, V103, P1906, DOI 10.1111/j.1572-0241.2008.01953.x	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138927	10.1371/journal.pone.0138927	http://dx.doi.org/10.1371/journal.pone.0138927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402448	gold, Green Published, Green Submitted			2022-12-27	WOS:000361798100043
J	Lin, Z; Mao, GY; Vasudevan, B; Jin, ZB; Ciuffreda, KJ; Jhanji, V; Zhou, HJ; Wang, NL; Liang, YB				Lin, Zhong; Mao, Guang Yun; Vasudevan, Balamurali; Jin, Zi Bing; Ciuffreda, Kenneth J.; Jhanji, Vishal; Zhou, Hong Jia; Wang, Ning Li; Liang, Yuan Bo			The Association between Maternal Reproductive Age and Progression of Refractive Error in Urban Students in Beijing	PLOS ONE			English	Article							SCHOOL-CHILDREN; GENERATIONAL-DIFFERENCE; FAMILIAL AGGREGATION; SINGAPOREAN CHILDREN; VISUAL IMPAIRMENT; OUTDOOR ACTIVITY; GESTATIONAL-AGE; SOUTHERN CHINA; BIRTH-WEIGHT; MYOPIA	Purpose To investigate the association between maternal reproductive age and their children' refractive error progression in Chinese urban students. Methods The Beijing Myopia Progression Study was a three-year cohort investigation. Cycloplegic refraction of these students at both baseline and follow-up vision examinations, as well as non-cycloplegic refraction of their parents at baseline, were performed. Student's refractive change was defined as the cycloplegic spherical equivalent (SE) of the right eye at the final follow-up minus the cycloplegic SE of the right eye at baseline. Results At the final follow-up, 241 students (62.4%) were reexamined. 226 students (58.5%) with completed refractive data, as well as completed parental reproductive age data, were enrolled. The average paternal and maternal age increased from 29.4 years and 27.5 years in 1993-1994 to 32.6 years and 29.2 years in 2003-2004, respectively. In the multivariate analysis, students who were younger (beta = 0.08 diopter/year/year, P < 0.001), with more myopic refraction at baseline (beta = 0.02 diopter/year/diopter, P = 0.01), and with older maternal reproductive age (beta = -0.18 diopter/year/decade, P = 0.01), had more myopic refractive change. After stratifying the parental reproductive age into quartile groups, children with older maternal reproductive age (trend test: P = 0.04) had more myopic refractive change, after adjusting for the children's age, baseline refraction, maternal refraction, and near work time. However, no significant association between myopic refractive change and paternal reproductive age was found. Conclusions In this cohort, children with older maternal reproductive age had more myopic refractive change. This new risk factor for myopia progression may partially explain the faster myopic progression found in the Chinese population in recent decades.	[Lin, Zhong; Mao, Guang Yun; Jin, Zi Bing; Zhou, Hong Jia; Liang, Yuan Bo] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Mao, Guang Yun] Wenzhou Med Univ, Sch Environm Sci & Publ Hlth, Wenzhou, Zhejiang, Peoples R China; [Vasudevan, Balamurali] Mid Western Univ, Coll Optometry, Glendale, AZ USA; [Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA; [Jhanji, Vishal] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Ning Li] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Wang, Ning Li] Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Midwestern University; Midwestern University - Arizona College of Optometry; State University of New York (SUNY) System; SUNY Optometry; Chinese University of Hong Kong; Capital Medical University	Liang, YB (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.	yuanboliang@126.com	Jin, Zi-Bing/J-6810-2014; Jhanji, Vishal/I-5676-2014; Jin, Zi-Bing/AAE-4106-2019; Virgili, Gianni/P-6607-2014	Jin, Zi-Bing/0000-0003-0515-698X; Jin, Zi-Bing/0000-0003-0515-698X; Virgili, Gianni/0000-0002-9960-2989; liang, Yuanbo/0000-0001-9685-7356	Eye Hospital of Wenzhou Medical University [YNCX201308, KYQD131101]; Wenzhou Medical University [89213008]; Beijing Science & Technology Novel Star Program [2009B44]	Eye Hospital of Wenzhou Medical University; Wenzhou Medical University; Beijing Science & Technology Novel Star Program	The study was supported by the Innovation Research Project of the Eye Hospital of Wenzhou Medical University (YNCX201308), the Research Startup Project for doctors of the Eye Hospital of Wenzhou Medical University (KYQD131101), the Research Startup Project of Wenzhou Medical University (89213008), and the Beijing Science & Technology Novel Star Program (2009B44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornish KS, 2013, AM J OPHTHALMOL, V156, P190, DOI 10.1016/j.ajo.2013.02.004; Csermely G, 2015, J MATERN-FETAL NEO M, V28, P436, DOI 10.3109/14767058.2014.918946; Dirani M, 2009, OPHTHALMIC RES, V41, P154, DOI 10.1159/000209669; Fotouhi A, 2007, BRIT J OPHTHALMOL, V91, P1440, DOI 10.1136/bjo.2007.120162; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Hsieh TT, 2010, EUR J OBSTET GYN R B, V148, P21, DOI 10.1016/j.ejogrb.2009.08.022; Huynh SC, 2006, BRIT J OPHTHALMOL, V90, P597, DOI 10.1136/bjo.2005.083154; Lam CSY, 2004, OPTOMETRY VISION SCI, V81, P317, DOI 10.1097/01.opx.0000134905.98403.18; Lam DSC, 2008, INVEST OPHTH VIS SCI, V49, P873, DOI 10.1167/iovs.06-1097; Lee KE, 2001, ARCH OPHTHALMOL-CHIC, V119, P1679; Liang YB, 2013, BRIT J OPHTHALMOL, V97, P765, DOI 10.1136/bjophthalmol-2012-302468; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lim HT, 2012, JPN J OPHTHALMOL, V56, P76, DOI 10.1007/s10384-011-0090-7; Lin Z, 2014, INVEST OPHTH VIS SCI, V55, P5711, DOI 10.1167/iovs.13-13693; Lin Z, 2014, OPTOMETRY VISION SCI, V91, P376, DOI 10.1097/OPX.0000000000000219; Lin Z, 2012, OPTOMETRY VISION SCI, V89, P1725, DOI 10.1097/OPX.0b013e3182775e05; Mandel Y, 2008, OPHTHALMOLOGY, V115, P686, DOI 10.1016/j.ophtha.2007.05.040; Miller A, 2011, AM J MED GENET A, V155A, P2137, DOI 10.1002/ajmg.a.34130; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI DOI 10.1016/J.OPHTHA.2010.09.025; Saw S M, 2001, Ophthalmic Epidemiol, V8, P227, DOI 10.1076/opep.8.4.227.1609; Saw SM, 2000, OPTOMETRY VISION SCI, V77, P549, DOI 10.1097/00006324-200010000-00009; Saw SM, 2006, INVEST OPHTH VIS SCI, V47, P1839, DOI 10.1167/iovs.05-1081; Saw SM, 2005, BRIT J OPHTHALMOL, V89, P1489, DOI 10.1136/bjo.2005.071118; Saw SM, 2005, INVEST OPHTH VIS SCI, V46, P51, DOI 10.1167/iovs.04-0565; Saw SM, 2004, BRIT J OPHTHALMOL, V88, P538, DOI 10.1136/bjo.2003.025411; Saw SM, 1997, ACTA OPHTHALMOL SCAN, V75, P548; Seoud MAF, 2002, AM J PERINAT, V19, P1, DOI 10.1055/s-2002-20175; Varghese RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004469; Varughese S, 2005, CURR EYE RES, V30, P423, DOI 10.1080/02713680590959295; Wojciechowski R, 2005, INVEST OPHTH VIS SCI, V46, P1588, DOI 10.1167/iovs.04-0740; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3; Zile I, 2013, MEDICINA-LITHUANIA, V49, P29, DOI 10.3390/medicina49010006	35	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139383	10.1371/journal.pone.0139383	http://dx.doi.org/10.1371/journal.pone.0139383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421841	gold, Green Published			2022-12-27	WOS:000362175700109
J	Moore, TG; Garzon, MH; Deaton, RJ				Moore, Tyler G.; Garzon, Max H.; Deaton, Russell J.			Probabilistic Analysis of Pattern Formation in Monotonic Self-Assembly	PLOS ONE			English	Article							TILE COMPLEXITY; DNA; SHAPES	Inspired by biological systems, self-assembly aims to construct complex structures. It functions through piece-wise, local interactions among component parts and has the potential to produce novel materials and devices at the nanoscale. Algorithmic self-assembly models the product of self-assembly as the output of some computational process, and attempts to control the process of assembly algorithmically. Though providing fundamental insights, these computational models have yet to fully account for the randomness that is inherent in experimental realizations, which tend to be based on trial and error methods. In order to develop a method of analysis that addresses experimental parameters, such as error and yield, this work focuses on the capability of assembly systems to produce a pre-determined set of target patterns, either accurately or perhaps only approximately. Self-assembly systems that assemble patterns that are similar to the targets in a significant percentage are "strong" assemblers. In addition, assemblers should predominantly produce target patterns, with a small percentage of errors or junk. These definitions approximate notions of yield and purity in chemistry and manufacturing. By combining these definitions, a criterion for efficient assembly is developed that can be used to compare the ability of different assembly systems to produce a given target set. Efficiency is a composite measure of the accuracy and purity of an assembler. Typical examples in algorithmic assembly are assessed in the context of these metrics. In addition to validating the method, they also provide some insight that might be used to guide experimentation. Finally, some general results are established that, for efficient assembly, imply that every target pattern is guaranteed to be assembled with a minimum common positive probability, regardless of its size, and that a trichotomy exists to characterize the global behavior of typical efficient, monotonic self-assembly systems in the literature.	[Moore, Tyler G.; Garzon, Max H.] Univ Memphis, Dept Comp Sci, Memphis, TN 38152 USA; [Deaton, Russell J.] Univ Memphis, Dept Elect Engn & Comp Engn, Memphis, TN 38152 USA	University of Memphis; University of Memphis	Moore, TG (corresponding author), Univ Memphis, Dept Comp Sci, Memphis, TN 38152 USA.	tgmoore@memphis.edu			National Science Foundation [CCF-1049719, CMMI-1235100]; Directorate For Engineering [1235100] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation at www.nsf.gov through "EAGER: Self-Assembly of Complex Systems" (CCF-1049719) and "Engineering Nano-Building Block Toolboxes for Programmable Self-Assembly of Nanostructures with Arbitrary Shapes and Functions" (CMMI-1235100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryans N, 2011, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P590; Cannon S, 2012, ARXIV120116520; Chandran H, 2012, SIAM J COMPUT, V41, P1051, DOI 10.1137/110822487; Cook M, 2011, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P570; DOMANY E, 1984, PHYS REV LETT, V53, P311, DOI 10.1103/PhysRevLett.53.311; Doty D, 2012, ANN IEEE SYMP FOUND, P302, DOI 10.1109/FOCS.2012.76; Doty D, 2010, SIAM J COMPUT, V39, P3521, DOI 10.1137/090779152; Doty D, 2010, ANN IEEE SYMP FOUND, P417, DOI 10.1109/FOCS.2010.47; Doty D, 2009, LECT NOTES COMPUT SC, V5877, P35, DOI 10.1007/978-3-642-10604-0_4; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Garzon M., 1995, MODELS MASSIVE PARAL; Hu HQ, 2014, SOFT MATTER, V10, P3867, DOI 10.1039/c3sm52607k; Huang M.D, 2001, P 33 ANN ACM S THEOR, P740, DOI DOI 10.1145/380752.380881; Kao MY, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P571, DOI 10.1145/1109557.1109620; Kim JW, 2011, ANGEW CHEM INT EDIT, V50, P9185, DOI 10.1002/anie.201102342; Lathrop JI, 2009, THEOR COMPUT SCI, V410, P384, DOI 10.1016/j.tcs.2008.09.062; Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/nnano.2010.107, 10.1038/NNANO.2010.107]; Maune HT, 2010, NAT NANOTECHNOL, V5, P61, DOI [10.1038/nnano.2009.311, 10.1038/NNANO.2009.311]; Meunier PE, 2014, ARXIV14066889; Padilla JE, 2013, LECT NOTES COMPUT SC, V7956, P174, DOI 10.1007/978-3-642-39074-6_17; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Patitz Matthew J., 2012, Unconventional Computation and Natural Computation. Proceedings of the 11th International Conference, UCNC 2012, P34, DOI 10.1007/978-3-642-32894-7_6; Patitz MJ, 2011, LECT NOTES COMPUT SC, V6937, P175, DOI 10.1007/978-3-642-23638-9_15; Patitz MJ, 2014, ABSTRACT TILE ASSEMB; Pei RJ, 2010, NAT NANOTECHNOL, V5, P773, DOI [10.1038/nnano.2010.194, 10.1038/NNANO.2010.194]; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Rothemund P. W. K., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P459, DOI 10.1145/335305.335358; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Summers SM, 2012, ALGORITHMICA, V63, P117, DOI 10.1007/s00453-011-9522-5; Tikhomirov G, 2011, NAT NANOTECHNOL, V6, P485, DOI [10.1038/nnano.2011.100, 10.1038/NNANO.2011.100]; VALIANT LG, 1984, COMMUN ACM, V27, P1134, DOI 10.1145/1968.1972; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E, 2004, LECT NOTES COMPUT SC, V2943, P126; Winfree E, 1998, ALGORITHMIC SELF ASS; Wolfram S., 1986, THEORY APPL CELLULAR, V1; Woods D., 2014, P 25 ANN ACM SIAM S, P752, DOI DOI 10.1137/1.9781611973402.56; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zhao Z, 2011, NANO LETT, V11, P2997, DOI 10.1021/nl201603a	40	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137982	10.1371/journal.pone.0137982	http://dx.doi.org/10.1371/journal.pone.0137982			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421616	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700023
J	Tacharoenmuang, R; Komoto, S; Guntapong, R; Ide, T; Haga, K; Katayama, K; Kato, T; Ouchi, Y; Kurahashi, H; Tsuji, T; Sangkitporn, S; Taniguchi, K				Tacharoenmuang, Ratana; Komoto, Satoshi; Guntapong, Ratigorn; Ide, Tomihiko; Haga, Kei; Katayama, Kazuhiko; Kato, Takema; Ouchi, Yuya; Kurahashi, Hiroki; Tsuji, Takao; Sangkitporn, Somchai; Taniguchi, Koki			Whole Genomic Analysis of an Unusual Human G6P[14] Rotavirus Strain Isolated from a Child with Diarrhea in Thailand: Evidence for Bovine-To-Human Interspecies Transmission and Reassortment Events	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; SEROTYPE G6; GENETIC-CHARACTERIZATION; PROVIDES EVIDENCE; SEQUENCE ANALYSES; MONO-REASSORTANT; IDENTIFICATION; PORCINE; VP4; GENOTYPES	An unusual rotavirus strain, SKT-27, with the G6P[14] genotypes (RVA/Human-wt/THA/SKT-27/2012/G6P[14]), was identified in a stool specimen from a hospitalized child aged eight months with severe diarrhea. In this study, we sequenced and characterized the complete genome of strain SKT-27. On whole genomic analysis, strain SKT-27 was found to have a unique genotype constellation: G6-P[14]-I2-R2-C2-M2-A3-N2-T6-E2-H3. The non-G/P genotype constellation of this strain (I2-R2-C2-M2-A3-N2-T6-E2-H3) is commonly shared with rotavirus strains from artiodactyls such as cattle. Phylogenetic analysis indicated that nine of the 11 genes of strain SKT-27 (VP7, VP4, VP6, VP2-3, NSP1, NSP3-5) appeared to be of artiodactyl (likely bovine) origin, while the remaining VP1 and NSP2 genes were assumed to be of human origin. Thus, strain SKT-27 was found to have a bovine rotavirus genetic backbone, and thus is likely to be of bovine origin. Furthermore, strain SKT-27 appeared to be derived through interspecies transmission and reassortment events involving bovine and human rotavirus strains. Of note is that the VP7 gene of strain SKT-27 was located in G6 lineage-5 together with those of bovine rotavirus strains, away from the clusters comprising other G6P[14] strains in G6 lineages-2/6, suggesting the occurrence of independent bovine-to-human interspecies transmission events. To our knowledge, this is the first report on full genome-based characterization of human G6P[14] strains that have emerged in Southeast Asia. Our observations will provide important insights into the origin of G6P[14] strains, and into dynamic interactions between human and bovine rotavirus strains.	[Tacharoenmuang, Ratana; Guntapong, Ratigorn; Sangkitporn, Somchai] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Komoto, Satoshi; Ide, Tomihiko; Taniguchi, Koki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan; [Haga, Kei; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Kato, Takema; Kurahashi, Hiroki] Fujita Hlth Univ, Div Mol Genet, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Ouchi, Yuya; Kurahashi, Hiroki] Fujita Hlth Univ, Genome & Transcriptome Anal Ctr, Toyoake, Aichi, Japan; [Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan	Ministry of Public Health - Thailand; Fujita Health University; National Institute of Infectious Diseases (NIID); Fujita Health University; Fujita Health University; Fujita Health University	Komoto, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi 47011, Japan.	satoshik@fujita-hu.ac.jp		Katayama, Kazuhiko/0000-0002-7692-1151	MEXT; Ministry of Health, Labor, and Welfare of Japan; Original Rotavirus Vaccine Effectiveness Study Program from the Ministry of Public Health of Thailand	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Original Rotavirus Vaccine Effectiveness Study Program from the Ministry of Public Health of Thailand	This study was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2010-2014 (KT), Grants-in-Aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor, and Welfare of Japan (KT), and the Original Rotavirus Vaccine Effectiveness Study Program from the Ministry of Public Health of Thailand (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrad MH, 2013, INFECT GENET EVOL, V19, P120, DOI 10.1016/j.meegid.2013.06.030; Arista S, 1999, J CLIN MICROBIOL, V37, P2706, DOI 10.1128/JCM.37.8.2706-2708.1999; Banyai K, 2004, J CLIN MICROBIOL, V42, P393, DOI 10.1128/JCM.42.1.393-397.2004; Banyai K, 2003, EPIDEMIOL INFECT, V130, P107, DOI 10.1017/S0950268802007975; Banyai K, 2009, J MED VIROL, V81, P362, DOI 10.1002/jmv.21375; BROWNING GF, 1992, ARCH VIROL, V125, P121, DOI 10.1007/BF01309632; Cashman O, 2010, VET MICROBIOL, V146, P238, DOI 10.1016/j.vetmic.2010.05.012; Chen YD, 2008, VIROLOGY, V375, P361, DOI 10.1016/j.virol.2008.01.003; Cilla G, 2010, EUR J CLIN MICROBIOL, V29, P955, DOI 10.1007/s10096-010-0951-x; Cooney MA, 2001, J MED MICROBIOL, V50, P462, DOI 10.1099/0022-1317-50-5-462; De Grazia S, 2011, INFECT GENET EVOL, V11, P1449, DOI 10.1016/j.meegid.2011.05.015; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Diwakarla S, 2002, MICROBIOL IMMUNOL, V46, P499, DOI 10.1111/j.1348-0421.2002.tb02726.x; Doan YH, 2012, INFECT GENET EVOL, V12, P1202, DOI 10.1016/j.meegid.2012.04.023; El Sherif M, 2011, INFECT GENET EVOL, V11, P1436, DOI 10.1016/j.meegid.2011.05.012; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GERNA G, 1994, J GEN VIROL, V75, P1781, DOI 10.1099/0022-1317-75-7-1781; GERNA G, 1992, J CLIN MICROBIOL, V30, P9, DOI 10.1128/JCM.30.1.9-16.1992; GERNA G, 1994, VIROLOGY, V200, P66, DOI 10.1006/viro.1994.1163; Ghosh S, 2013, INFECT GENET EVOL, V16, P165, DOI 10.1016/j.meegid.2012.12.019; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Ghosh S, 2011, J MED VIROL, V83, P367, DOI 10.1002/jmv.21974; Ghosh S, 2010, J GEN VIROL, V91, P2367, DOI 10.1099/vir.0.022244-0; Hassine-Zaafrane M, 2014, J APPL MICROBIOL, V116, P1387, DOI 10.1111/jam.12469; Ide T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124965; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; Jere KC, 2012, VET MICROBIOL, V159, P245, DOI 10.1016/j.vetmic.2012.03.040; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Komoto S, 2014, VET MICROBIOL, V174, P577, DOI 10.1016/j.vetmic.2014.09.033; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Komoto S, 2013, J GEN VIROL, V94, P1568, DOI 10.1099/vir.0.051011-0; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Matthijnssens J, 2009, J VIROL, V83, P2917, DOI 10.1128/JVI.02246-08; Midgley SE, 2012, EPIDEMIOL INFECT, V140, P1013, DOI 10.1017/S0950268811001981; Mullick S, 2013, INFECT GENET EVOL, V14, P15, DOI 10.1016/j.meegid.2012.11.010; Nyaga MM, 2015, INFECT GENET EVOL, V31, P321, DOI 10.1016/j.meegid.2015.02.011; O'Shea H, 2014, VET MICROBIOL, V170, P151, DOI 10.1016/j.vetmic.2014.01.012; PALOMBO EA, 1995, J MED VIROL, V47, P348, DOI 10.1002/jmv.1890470410; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Rahman M, 2003, J CLIN MICROBIOL, V41, P2088, DOI 10.1128/JCM.41.5.2088-2095.2003; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Schoondermark-van de Ven E, 2013, VET MICROBIOL, V166, P154, DOI 10.1016/j.vetmic.2013.05.028; Solberg OD, 2009, VIROLOGY, V385, P58, DOI 10.1016/j.virol.2008.11.026; Steyer A, 2013, INFECT GENET EVOL, V13, P89, DOI 10.1016/j.meegid.2012.09.004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; URASAWA S, 1982, INFECT IMMUN, V38, P781, DOI 10.1128/IAI.38.2.781-784.1982; URASAWA S, 1984, ARCH VIROL, V81, P1, DOI 10.1007/BF01309292; Wu FT, 2012, JPN J INFECT DIS, V65, P455, DOI 10.7883/yoken.65.455; WYATT RG, 1983, J CLIN MICROBIOL, V18, P310, DOI 10.1128/JCM.18.2.310-317.1983	60	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139381	10.1371/journal.pone.0139381	http://dx.doi.org/10.1371/journal.pone.0139381			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421718	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700108
J	Fabianek, F; Simard, MA; Desrochers, A				Fabianek, Francois; Simard, Marie Anouk; Desrochers, Andre			Exploring Regional Variation in Roost Selection by Bats: Evidence from a Meta-Analysis	PLOS ONE			English	Article							LONG-LEGGED MYOTIS; BIG BROWN BATS; SITE SELECTION; CHALINOLOBUS-TUBERCULATUS; PACIFIC-NORTHWEST; MATERNITY ROOSTS; MODEL SELECTION; TREE SELECTION; FEMALE BATS; TAILED BATS	Background and Aims Tree diameter, tree height and canopy closure have been described by previous meta-analyses as being important characteristics in roost selection by cavity-roosting bats. However, size and direction of effects for these characteristics varied greatly among studies, also referred to as heterogeneity. Potential sources of heterogeneity have not been investigated in previous meta-analyses, which are explored by correlating additional covariates (moderator variables). We tested whether effect sizes from 34 studies were consistent enough to reject the null hypothesis that trees selected by bats did not significantly differ in their characteristics from randomly selected trees. We also examined whether heterogeneity in tree diameter effect sizes was correlated to moderator variables such as sex, bat species, habitat type, elevation and mean summer temperature. Methods We used Hedges' g standardized mean difference as the effect size for the most common characteristics that were encountered in the literature. We estimated heterogeneity indices, potential publication bias, and spatial autocorrelation of our meta-data. We relied upon meta-regression and multi-model inference approaches to evaluate the effects of moderator variables on heterogeneity in tree diameter effect sizes. Results Tree diameter, tree height, snag density, elevation, and canopy closure were significant characteristics of roost selection by cavity-roosting bats. Size and direction of effects varied greatly among studies with respect to distance to water, tree density, slope, and bark remaining on trunks. Inclusion of mean summer temperature and sex in meta-regressions further explained heterogeneity in tree diameter effect sizes. Conclusions Regional differences in roost selection for tree diameter were related to mean summer temperature. Large diameter trees play a central role in roost selection by bats, especially in colder regions, where they are likely to provide a warm and stable microclimate for reproductive females. Records of summer temperature fluctuations inside and outside tree cavities that are used by bats should be included in future research.	[Fabianek, Francois; Desrochers, Andre] Univ Laval, CEF, Quebec City, PQ, Canada; [Fabianek, Francois; Simard, Marie Anouk; Desrochers, Andre] Univ Laval, Fac Foresterie Geog & Geomat, Quebec City, PQ, Canada; [Simard, Marie Anouk] Minist Forets Faune & Parcs, Quebec City, PQ, Canada; [Simard, Marie Anouk] Univ Laval, Ctr Sci Biodivers Quebec, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Fabianek, F (corresponding author), Univ Laval, CEF, Quebec City, PQ, Canada.	fabianekfrancois@gmail.com	Desrochers, André/B-6248-2008	Desrochers, André/0000-0002-5676-964X	Fonds de Recherche du Quebec - Nature et Technologies (FQRNT)	Fonds de Recherche du Quebec - Nature et Technologies (FQRNT)	This research was funded by the Fonds de Recherche du Quebec - Nature et Technologies (FQRNT). The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; Angers VA, 2010, FOREST ECOL MANAG, V259, P246, DOI 10.1016/j.foreco.2009.09.026; Anzures-Cabrera J, 2010, RES SYNTH METHODS, V1, P66, DOI 10.1002/jrsm.6; Arnett EB, 2009, J WILDLIFE MANAGE, V73, P214, DOI 10.2193/2007-532; Arnold BD, 2007, AM MIDL NAT, V157, P374, DOI 10.1674/0003-0031(2007)157[374:PSASDI]2.0.CO;2; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baker MD, 2006, J WILDLIFE MANAGE, V70, P207, DOI 10.2193/0022-541X(2006)70[207:DHOFLM]2.0.CO;2; Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x; Barclay Robert M.R., 2007, P17; Bivand R, 2015, J STAT SOFTW, V63, P1; Boland JL, 2009, J MAMMAL, V90, P222, DOI 10.1644/07-MAMM-A-369.1; Borenstein M., 2009, INTRO METAANALYSIS, DOI [10. 1002/9780470743386, DOI 10.1002/9780470743386]; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Boyles JG, 2007, ACTA CHIROPTEROL, V9, P297, DOI 10.3161/1733-5329(2007)9[297:DRUBFB]2.0.CO;2; Brigham RM, 1997, J MAMMAL, V78, P1231, DOI 10.2307/1383066; Britzke ER, 2006, AM MIDL NAT, V155, P181, DOI 10.1674/0003-0031(2006)155[0181:DOSRTU]2.0.CO;2; Britzke ER, 2003, SOUTHEAST NAT, V2, P235, DOI 10.1656/1528-7092(2003)002[0235:IBMSMR]2.0.CO;2; Broders HG, 2004, J WILDLIFE MANAGE, V68, P602, DOI 10.2193/0022-541X(2004)068[0602:IAIVIR]2.0.CO;2; Broders HG, 2003, SUMMER ROOSTING FORA; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carter TC, 2003, SUMMER HABITAT USE R; Clement MJ, 2013, ACTA CHIROPTEROL, V15, P133, DOI 10.3161/150811013X667939; Coombs AB, 2010, J WILDLIFE MANAGE, V74, P1875, DOI 10.2193/2009-560; Cryan PM, 2000, J MAMMAL, V81, P719, DOI 10.1644/1545-1542(2000)081<0719:EOEODO>2.3.CO;2; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dzal YA, 2013, J COMP PHYSIOL B, V183, P279, DOI 10.1007/s00360-012-0705-4; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fabianek F, 2015, CAN J ZOOL, V93, P539, DOI 10.1139/cjz-2014-0294; Fan ZF, 2003, CAN J FOREST RES, V33, P1481, DOI [10.1139/x03-068, 10.1139/X03-068]; Fleming HL, 2013, AM MIDL NAT, V169, P43, DOI 10.1674/0003-0031-169.1.43; Fukui D, 2006, J ANIM ECOL, V75, P1252, DOI 10.1111/j.1365-2656.2006.01146.x; Geiser F, 2004, LIF COLD EV MECH AD; Grindal SD, 1999, CAN J ZOOL, V77, P972, DOI 10.1139/cjz-77-6-972; Grindal SD, 1996, BC MIN FOR RES PROGR, V23, P260; Gruebler MU, 2014, INT J BIOMETEOROL, V58, P629, DOI 10.1007/s00484-013-0643-1; HAMILTON IM, 1994, CAN J ZOOL, V72, P744, DOI 10.1139/z94-100; Hein CD, 2008, J MAMMAL, V89, P964, DOI 10.1644/07-MAMM-A-335.1; Herder MJ, 2000, TRANSACTIONS OF THE WESTERN SECTION OF THE WILDLIFE SOCIETY, P1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holloway GL, 2000, ECOSCIENCE, V7, P115, DOI 10.1080/11956860.2000.11682579; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; Johnson JS, 2014, ECOL EVOL, V4, P157, DOI 10.1002/ece3.913; Johnson JB, 2012, FOREST ECOL MANAG, V266, P223, DOI 10.1016/j.foreco.2011.11.032; Johnson JB, 2010, J FISH WILDL MANAG, V1, P111, DOI 10.3996/042010-JFWM-007; Jung TS, 2004, FOREST ECOL MANAG, V202, P325, DOI 10.1016/j.foreco.2004.07.043; Kalcounis-Ruppell MC, 2005, WILDLIFE SOC B, V33, P1123, DOI 10.2193/0091-7648(2005)33[1123:TRSBBA]2.0.CO;2; Kerth G, 2001, OECOLOGIA, V126, P1, DOI 10.1007/s004420000489; Krusic RA, 1996, J WILDLIFE MANAGE, V60, P625, DOI 10.2307/3802081; Kunz TH, 2003, BAT ECOLOGY, P3; Kurta A, 2001, BAT CONSERVATION AND MINING: A TECHNICAL INTERACTIVE FORUM, PROCEEDINGS, P197; KURTA A, 1989, CAN J ZOOL, V67, P2468, DOI 10.1139/z89-348; Lacki M.J., 2007, BATS IN FORESTS; Lacki MJ, 2013, ACTA CHIROPTEROL, V15, P143, DOI 10.3161/150811013X667948; Lacki MJ, 2012, J WILDLIFE MANAGE, V76, P1310, DOI 10.1002/jwmg.376; Lacki MJ, 2010, J WILDLIFE MANAGE, V74, P1218, DOI 10.2193/2009-274; Lacki MJ, 2009, AM MIDL NAT, V162, P318, DOI 10.1674/0003-0031-162.2.318; Lacki MJ, 2003, ACTA CHIROPTEROL, V5, P199, DOI 10.3161/001.005.0211; Lacki MJ, 2001, J WILDLIFE MANAGE, V65, P482, DOI 10.2307/3803101; Leak WB, 1985, RELATIONSHIPS TREE A; Lee P, 1998, FOREST ECOL MANAG, V105, P263, DOI 10.1016/S0378-1127(97)00286-7; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; MACKEY RL, 1989, CAN J ZOOL, V67, P1167, DOI 10.1139/z89-168; McCarthy John, 2001, Environmental Reviews, V9, P1, DOI 10.1139/a00-012; Menzel MA, 2002, FOREST ECOL MANAG, V155, P107, DOI 10.1016/S0378-1127(01)00551-5; Miller DA, 2003, WILDLIFE SOC B, V31, P30; Moroni MT, 2010, FORESTRY, V83, P229, DOI 10.1093/forestry/cpp027; O'Donnell M.S., 2012, US GEOLOGICAL SURVEY, V691, P10, DOI DOI 10.3133/DS691; Ormsbee PC, 1998, J WILDLIFE MANAGE, V62, P596, DOI 10.2307/3802335; Paclik M, 2007, INT J BIOMETEOROL, V51, P287, DOI 10.1007/s00484-006-0067-2; Park AC, 2012, NORTHEAST NAT, V19, P165, DOI 10.1656/045.019.0203; Parsons S, 2003, FOREST ECOL MANAG, V177, P559, DOI 10.1016/S0378-1127(02)00448-6; Perry RW, 2007, FOREST ECOL MANAG, V247, P220, DOI 10.1016/j.foreco.2007.04.041; Quinn GM, 2007, UNPUBLISHED REPORT T; Rabe MJ, 1998, J WILDLIFE MANAGE, V62, P612, DOI 10.2307/3802337; Randall Lea A., 2014, Northwestern Naturalist, V95, P312; Ruczynski I, 2006, CAN J ZOOL, V84, P900, DOI 10.1139/Z06-060; RUDOLPH DC, 1991, WILSON BULL, V103, P458; Russo D, 2002, MAMMALIA, V66, P543, DOI 10.1515/mamm.2002.66.4.543; Schwarzer G., 2014; Sedgeley JA, 2004, NEW ZEAL J ECOL, V28, P1; Sedgeley JA, 2003, NEW ZEAL J ZOOL, V30, P227, DOI 10.1080/03014223.2003.9518341; Sedgeley JA, 2001, J APPL ECOL, V38, P425, DOI 10.1046/j.1365-2664.2001.00607.x; Seibold S, 2013, J ZOOL, V290, P302, DOI 10.1111/jzo.12041; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Siemers BM, 2001, J EXP BIOL, V204, P3843; Song FJ, 1999, J CLIN EPIDEMIOL, V52, P725, DOI 10.1016/S0895-4356(99)00066-9; Stawski C, 2014, J ZOOL, V292, P86, DOI 10.1111/jzo.12105; Syme DM, 2001, ECOSCIENCE, V8, P18, DOI 10.1080/11956860.2001.11682626; TYRRELL LE, 1994, ECOLOGY, V75, P370, DOI 10.2307/1939541; Vanclay JK, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009063; Veilleux JP, 2004, AM MIDL NAT, V152, P196, DOI 10.1674/0003-0031(2004)152[0196:IAIFTS]2.0.CO;2; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vonhof MJ, 1996, CAN J ZOOL, V74, P1797, DOI 10.1139/z96-200; Warren RD, 2000, BIOL CONSERV, V92, P85, DOI 10.1016/S0006-3207(99)00062-2; Weller TJ, 2001, J WILDLIFE MANAGE, V65, P489, DOI 10.2307/3803102; Whitaker DM, 2000, CAN J ZOOL, V78, P740, DOI 10.1139/cjz-78-5-740; Wiebe KL, 2001, AUK, V118, P412, DOI 10.1642/0004-8038(2001)118[0412:MOTCNI]2.0.CO;2; Wilde CJ, 1999, J EXP ZOOL, V284, P35, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;35::AID-JEZ6&gt;3.0.CO;2-Z; Willis CKR, 2004, ANIM BEHAV, V68, P495, DOI 10.1016/j.anbehav.2003.08.028; Willis CKR, 2006, J MAMMAL, V87, P345, DOI 10.1644/05-MAMM-A-118R1.1; Willis CKR, 2003, ACTA CHIROPTEROL, V5, P85, DOI 10.3161/001.005.0107; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y; Zahn A, 1997, Z SAUGETIERKD, V62, P1	107	6	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139126	10.1371/journal.pone.0139126	http://dx.doi.org/10.1371/journal.pone.0139126			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418465	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400046
J	Shi, P; Goodson, JM; Hartman, ML; Hasturk, H; Yaskell, T; Vargas, J; Cugini, M; Barake, R; Alsmadi, O; Al-Mutawa, S; Ariga, J; Soparkar, P; Behbehani, J; Behbehani, K; Welty, F				Shi, Ping; Goodson, J. Max; Hartman, Mor-Li; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Cugini, Maryann; Barake, Roula; Alsmadi, Osama; Al-Mutawa, Sabiha; Ariga, Jitendra; Soparkar, Pramod; Behbehani, Jawad; Behbehani, Kazem; Welty, Francine			Continuous Metabolic Syndrome Scores for Children Using Salivary Biomarkers	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; NORMAL-WEIGHT; RISK SCORE; ADIPONECTIN; LEPTIN; YOUTH; ADOLESCENTS; PREVALENCE; PREDICTORS; OVERWEIGHT	Background Binary definitions of the metabolic syndrome based on the presence of a particular number of individual risk factors are limited, particularly in the pediatric population. To address this limitation, we aimed at constructing composite and continuous metabolic syndrome scores (cmetS) to represent an overall measure of metabolic syndrome (MetS) in a large cohort of metabolically at-risk children, focusing on the use of the usual clinical parameters (waist circumference (WC) and systolic blood pressure (SBP), supplemented with two salivary surrogate variables (glucose and high density lipoprotein cholesterol (HDLC). Two different approaches used to create the scores were evaluated in comparison. Methods Data from 8,112 Kuwaiti children (10.00 +/- 0.67 years) were used to construct two cmetS for each subject. The first cmetS (cmetS-Z) was created by summing standardized residuals of each variable regressed on age and gender; and the second cmetS (cmetS-PCA) was defined as the first principal component from gender-specific principal component analysis based on the four variables. Results There was a graded relationship between both scores and the number of adverse risk factors. The areas under the curve using cmetS-Z and cmetS-PCA as predictors for severe metabolic syndrome (defined as the presence of >= 3 metabolic risk factors) were 0.935 and 0.912, respectively. cmetS-Z was positively associated with WC, SBP, and glucose, but inversely associated with HDLC. Except for the lack of association with glucose, cmetS-PCA was similar to cmetS-Z in boys, but had minimum loading on HDLC in girls. Analysis using quantile regression showed an inverse association of fitness level with cmetS-PCA (p = 0.001 for boys; p = 0.002 for girls), and comparison of cmetS-Z and cmetS-PCA suggested that WC and SBP were main contributory components. Significant alterations in the relationship between cmetS and salivary adipocytokines were demonstrated in overweight and obese children as compared to underweight and normal-weight children. Conclusion We have derived continuous summary scores for MetS from a large-scale pediatric study using two different approaches, incorporating salivary measures as surrogate for plasma measures. The derived scores were viable expressions of metabolic risk, and can be utilized to study the relationships of MetS with various aspects of the metabolic disease process.	[Shi, Ping; Goodson, J. Max; Hartman, Mor-Li; Hasturk, Hatice; Yaskell, Tina; Vargas, Jorel; Cugini, Maryann; Soparkar, Pramod] Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA; [Barake, Roula; Alsmadi, Osama; Behbehani, Kazem] Dasman Diabet Inst, Kuwait, Kuwait; [Al-Mutawa, Sabiha; Ariga, Jitendra] Minist Hlth, Kuwait, Kuwait; [Behbehani, Jawad] Kuwait Univ, Fac Dent, Kuwait, Kuwait; [Welty, Francine] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA	Harvard University; Forsyth Institute; Kuwait University; Harvard University; Beth Israel Deaconess Medical Center	Shi, P (corresponding author), Forsyth Res Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA.	pscshi@gmail.com; mgoodson@forsyth.org		Barake, Roula/0000-0002-9461-2897	Dasman Diabetes Institute in Kuwait;  [P30 DK46200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER	Dasman Diabetes Institute in Kuwait; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by a grant from the Dasman Diabetes Institute in Kuwait. The authors also received a consultation service from Boston Nutrition and Obesity Research Center, supported by grant P30 DK46200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/919425; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Bacha F, 2004, DIABETES CARE, V27, P547, DOI 10.2337/diacare.27.2.547; Batey LS, 1997, CIRCULATION, V96, P4319; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Brewer HB, 1999, AM J CARDIOL, V83, p3F; Chilibeck PD, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/597162; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DuBose KD, 2007, PEDIATRICS, V120, pE1262, DOI 10.1542/peds.2007-0443; Dubose KD, 2006, ACTA PAEDIATR, V95, P1005, DOI 10.1080/08035250600570553; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Gonzalez M, 2012, EUR J CLIN NUTR, V66, P1141, DOI 10.1038/ejcn.2012.112; Goodson J.M., 2014, DIABETES MANAGE, V4, P463; Goodson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098799; Goodson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074461; Hartman ML, 2015, DIABET METAB SYND OB, V8, P9, DOI 10.2147/DMSO.S72744; Hillier TA, 2006, DIABETOLOGIA, V49, P1528, DOI 10.1007/s00125-006-0266-8; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Korner A, 2007, PEDIATR RES, V61, P640, DOI 10.1203/01.pdr.0000262638.48304.ef; Martinez-Vizcaino V, 2010, DIABETES CARE, V33, P1370, DOI 10.2337/dc09-2049; Mascarenhas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101706; Miller M, 2007, INT J CARDIOL, V119, P192, DOI 10.1016/j.ijcard.2006.07.132; Mochizuki K, 2013, EUR J NUTR, V52, P67, DOI 10.1007/s00394-011-0287-z; Okosun IS, 2010, ANN EPIDEMIOL, V20, P843, DOI 10.1016/j.annepidem.2010.08.001; Pandit D, 2011, INT J OBESITY, V35, P1318, DOI 10.1038/ijo.2011.138; Peterson MD, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-146; Rizzo ACB, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-19; Singh S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/215748; Sovio U, 2013, J OBES, V2013, DOI 10.1155/2013/684782; Suriano K, 2010, J PEDIATR-US, V157, P552, DOI 10.1016/j.jpeds.2010.04.042; Thanakun S, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-19; Venner AA, 2006, CLIN BIOCHEM, V39, P1047, DOI 10.1016/j.clinbiochem.2006.07.010; Wijndaele K, 2006, DIABETES CARE, V29, P2329, DOI 10.2337/dc06-1341; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	40	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138979	10.1371/journal.pone.0138979	http://dx.doi.org/10.1371/journal.pone.0138979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418011	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400030
J	Hernandez-Camacho, CJ; Bakker, VJ; Aurioles-Gamboa, D; Laake, J; Gerber, LR				Hernandez-Camacho, Claudia J.; Bakker, Victoria. J.; Aurioles-Gamboa, David; Laake, Jeff; Gerber, Leah R.			The Use of Surrogate Data in Demographic Population Viability Analysis: A Case Study of California Sea Lions	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; ZALOPHUS-CALIFORNIANUS; TEMPORAL VARIATION; SURVIVAL; CONSERVATION; MANAGEMENT; MODELS; RATES; AGE; ACCURACY	Reliable data necessary to parameterize population models are seldom available for imperiled species. As an alternative, data from populations of the same species or from ecologically similar species have been used to construct models. In this study, we evaluated the use of demographic data collected at one California sea lion colony (Los Islotes) to predict the population dynamics of the same species from two other colonies (San Jorge and Granito) in the Gulf of California, Mexico, for which demographic data are lacking. To do so, we developed a stochastic demographic age-structured matrix model and conducted a population viability analysis for each colony. For the Los Islotes colony we used site-specific pup, juvenile, and adult survival probabilities, as well as birth rates for older females. For the other colonies, we used site-specific pup and juvenile survival probabilities, but used surrogate data from Los Islotes for adult survival probabilities and birth rates. We assessed these models by comparing simulated retrospective population trajectories to observed population trends based on count data. The projected population trajectories approximated the observed trends when surrogate data were used for one colony but failed to match for a second colony. Our results indicate that species-specific and even region-specific surrogate data may lead to erroneous conservation decisions. These results highlight the importance of using population-specific demographic data in assessing extinction risk. When vital rates are not available and immediate management actions must be taken, in particular for imperiled species, we recommend the use of surrogate data only when the populations appear to have similar population trends.	[Hernandez-Camacho, Claudia J.; Gerber, Leah R.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Bakker, Victoria. J.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Aurioles-Gamboa, David] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Pinnipedos Burney J Le Boeuf, La Paz, Baja California, Mexico; [Laake, Jeff] NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA USA	Arizona State University; Arizona State University-Tempe; Montana State University System; Montana State University Bozeman; Instituto Politecnico Nacional - Mexico; National Oceanic Atmospheric Admin (NOAA) - USA	Hernandez-Camacho, CJ (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Pinnipedos Burney J Le Boeuf, La Paz, Baja California, Mexico.	jcamacho@ipn.mx	Camacho, Claudia J. Hernández/Q-8914-2018	Camacho, Claudia J. Hernández/0000-0002-6309-9728	Instituto Politecnico Nacional [SIP 20100911]; Consejo Nacional de Ciencia y Tecnologia [132415]; National Science Foundation [0347960]	Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation(National Science Foundation (NSF))	This work was funded by Instituto Politecnico Nacional (SIP 20100911) (http://www.sip.ipn.mx/Paginas/Principal.aspx) to CJHC, Consejo Nacional de Ciencia y Tecnologia (# 132415) (http://www.conacyt.mx/) to CJHC, and National Science Foundation (# 0347960) to LRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi F, 2010, ECOLOGY, V91, P7, DOI 10.1890/08-2235.1; Aurioles D., 1991, ECOL STUD, V88, P112; Bakker VJ, 2009, FRONT ECOL ENVIRON, V7, P158, DOI 10.1890/070220; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; CANCINO Jorge, 2010, Acta Zool. Mex, V26, P173; Caro T, 2005, CONSERV BIOL, V19, P1821, DOI 10.1111/j.1523-1739.2005.00251.x; Chilvers BL, 2010, J MAMMAL, V91, P758, DOI 10.1644/09-MAMM-A-285.1; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; Ellner SP, 2002, CONSERV BIOL, V16, P258, DOI 10.1046/j.1523-1739.2002.00553.x; Etterson MA, 2006, HUM ECOL RISK ASSESS, V12, P1074, DOI 10.1080/10807030600977277; Finkelstein ME, 2010, BIOL CONSERV, V143, P321, DOI 10.1016/j.biocon.2009.10.013; Fowler C.W., 1987, Current Mammalogy, V1, P401; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Garcia-Aguilar MC, CIENCIAS MARINAS, V29, P573; Githiru M, 2007, ORYX, V41, P239, DOI 10.1017/S0030605307001810; Gonzalez-Suarez M, 2009, MOL ECOL, V18, P1088, DOI 10.1111/j.1365-294X.2009.04093.x; Heath CB, 1989, THESIS U SAN CRUZ, P255; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hernandez-Camacho CJ, 2008, J MAMMAL, V89, P1059, DOI 10.1644/07-MAMM-A-404.1; Hernandez-Camacho CJ, 2008, MAR MAMMAL SCI, V24, P664, DOI 10.1111/j.1748-7692.2008.00199.x; Johnson HE, 2010, ECOL APPL, V20, P1753, DOI 10.1890/09-1107.1; Laake J., 2022, MARK, P109; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Melin SR, 2012, MAR MAMMAL SCI, V28, P751, DOI 10.1111/j.1748-7692.2011.00538.x; Melin SR, 2000, MAR MAMMAL SCI, V16, P169, DOI 10.1111/j.1748-7692.2000.tb00911.x; Miller DH, 2002, ECOL MODEL, V151, P271, DOI 10.1016/S0304-3800(01)00493-8; Morris W. F., 2002, QUANTITATIVE CONSERV; Nilsen EB, 2009, J ANIM ECOL, V78, P585, DOI 10.1111/j.1365-2656.2009.01523.x; Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Pistorius PA, 2001, POLAR BIOL, V24, P343, DOI 10.1007/s003000000217; Ralls K., 1980, REPORT INT WHALING C, V2, P233; Schaub M, 2011, J ORNITHOL, V152, P227, DOI 10.1007/s10336-010-0632-7; Schramm Y, 2009, MAR BIOL, V156, P1375, DOI 10.1007/s00227-009-1178-1; Schtickzelle N, 2005, OIKOS, V109, P89, DOI 10.1111/j.0030-1299.2005.13745.x; Schulz TM, 2005, ECOL MONOGR, V75, P159, DOI 10.1890/04-0319; Servanty S, 2011, J APPL ECOL, V48, P835, DOI 10.1111/j.1365-2664.2011.02017.x; Sinclair ARE, 1996, FRONTIERS OF POPULATION ECOLOGY, P127; Soule M., 1987, VIABLE POPULATIONS C; Szteren D, 2011, CIENC MAR, V37, P349, DOI 10.7773/cm.v37i3.1818; Szteren D, 2006, LOW WAKE FI, P369; Underwood JG, 2008, CONSERV BIOL, V22, P701, DOI 10.1111/j.1523-1739.2008.00919.x; Ward EJ, 2010, J APPL ECOL, V47, P47, DOI 10.1111/j.1365-2664.2009.01745.x; White G. C., 2001, WILDLIFE LAND PEOPLE, P368; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 2000, METH C CONS, P288; Wielgus J, 2008, ECOL APPL, V18, P1287, DOI 10.1890/07-0892.1; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Young JK, 2007, MAR MAMMAL SCI, V23, P926, DOI 10.1111/j.1748-7692.2007.00138.x; ZavalaGonzalez A, 1997, FISH B-NOAA, V95, P180	54	11	11	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139158	10.1371/journal.pone.0139158	http://dx.doi.org/10.1371/journal.pone.0139158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413746	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700047
J	Lee, Y; Lee, M; Choi, SI				Lee, Yonggeol; Lee, Minsik; Choi, Sang-Il			Image Generation Using Bidirectional Integral Features for Face Recognition with a Single Sample per Person	PLOS ONE			English	Article							ONE TRAINING IMAGE; ILLUMINATION; CLASSIFICATION; EXTRACTION; SELECTION; VECTORS	In face recognition, most appearance-based methods require several images of each person to construct the feature space for recognition. However, in the real world it is difficult to collect multiple images per person, and in many cases there is only a single sample per person (SSPP). In this paper, we propose a method to generate new images with various illuminations from a single image taken under frontal illumination. Motivated by the integral image, which was developed for face detection, we extract the bidirectional integral feature (BIF) to obtain the characteristics of the illumination condition at the time of the picture being taken. The experimental results for various face databases show that the proposed method results in improved recognition performance under illumination variation.	[Lee, Yonggeol; Choi, Sang-Il] Dankook Univ, Dept Comp Sci & Engn, Yongin 448701, Gyeonggi Do, South Korea; [Lee, Minsik] Hanyang Univ, Div Elect Engn, Ansan 426791, Gyeonggi Do, South Korea	Dankook University; Hanyang University	Choi, SI (corresponding author), Dankook Univ, Dept Comp Sci & Engn, 126 Jukjeon Dong, Yongin 448701, Gyeonggi Do, South Korea.	choisi@dankook.ac.kr	Lee, Minsik/S-7959-2017	Lee, Minsik/0000-0003-4941-4311	Dankook University	Dankook University	The present research was conducted by the research fund of Dankook University in 2013.	[Anonymous], YALE FACE DATABASE; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Cevikalp H, 2005, IEEE T PATTERN ANAL, V27, P4, DOI 10.1109/TPAMI.2005.9; Chen SC, 2004, PATTERN RECOGN LETT, V25, P1173, DOI 10.1016/j.patrec.2004.03.012; Choi S.-I., 2010, FACE RECOGNITION BAS; Choi SI, 2012, SENSORS-BASEL, V12, P16182, DOI 10.3390/s121216182; Choi SI, 2012, PATTERN RECOGN LETT, V33, P1083, DOI 10.1016/j.patrec.2012.01.005; Choi SI, 2012, SIGNAL PROCESS, V92, P636, DOI 10.1016/j.sigpro.2011.08.023; De la Torre F, 2005, PROC CVPR IEEE, P266; Fukunaga K., 2013, INTRO STAT PATTERN R; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Jiang XD, 2008, IEEE T PATTERN ANAL, V30, P383, DOI 10.1109/TPAMI.2007.70708; Jung HC, 2004, SIXTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P272; Kim C, 2007, PATTERN RECOGN, V40, P1592, DOI 10.1016/j.patcog.2006.09.010; Kim C, 2012, IEEE T SYST MAN CY B, V42, P1095, DOI 10.1109/TSMCB.2012.2186798; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; Lu JW, 2013, IEEE T PATTERN ANAL, V35, P39, DOI 10.1109/TPAMI.2012.70; Martinez AM, 2002, IEEE T PATTERN ANAL, V24, P748, DOI 10.1109/TPAMI.2002.1008382; Mian Ajmal S., 2009, 2009 IEEE 12th International Conference on Computer Vision Workshops, ICCV Workshops, P1833, DOI 10.1109/ICCVW.2009.5457505; Mian A, 2011, OPT EXPRESS, V19, P7491, DOI 10.1364/OE.19.007491; Oh J, 2013, PATTERN RECOGN LETT, V34, P1540, DOI 10.1016/j.patrec.2013.06.009; Sim T, 2003, IEEE T PATTERN ANAL, V25, P1615, DOI 10.1109/TPAMI.2003.1251154; Tan XY, 2006, PATTERN RECOGN, V39, P1725, DOI 10.1016/j.patcog.2006.03.013; Turk M. A., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P586, DOI 10.1109/CVPR.1991.139758; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wu JX, 2002, PATTERN RECOGN LETT, V23, P1711, DOI 10.1016/S0167-8655(02)00134-4; Xu Y, 2013, PATTERN RECOGN, V46, P1151, DOI 10.1016/j.patcog.2012.11.003; Yan SC, 2007, IEEE T INF FOREN SEC, V2, P69, DOI 10.1109/TIFS.2006.890313; Yang Q, 2002, 2002 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P97; Yu H, 2001, PATTERN RECOGN, V34, P2067, DOI 10.1016/S0031-3203(00)00162-X; Zhang DQ, 2005, APPL MATH COMPUT, V163, P895, DOI 10.1016/j.amc.2004.04.016; Zhang T, 2014, OPTIK, V125, P5017, DOI 10.1016/j.ijleo.2014.01.171	32	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138859	10.1371/journal.pone.0138859	http://dx.doi.org/10.1371/journal.pone.0138859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414018	Green Submitted, gold, Green Published			2022-12-27	WOS:000362170700025
J	Qiu, X; Wu, S; Hilchey, SP; Thakar, J; Liu, ZP; Welle, SL; Henn, AD; Wu, HL; Zand, MS				Qiu, Xing; Wu, Shuang; Hilchey, Shannon P.; Thakar, Juilee; Liu, Zhi-Ping; Welle, Stephen L.; Henn, Alicia D.; Wu, Hulin; Zand, Martin S.			Diversity in Compartmental Dynamics of Gene Regulatory Networks: The Immune Response in Primary Influenza A Infection in Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; DIFFERENTIAL-EQUATION MODELS; TOLL-LIKE RECEPTOR; VIRUS-INFECTION; MEASUREMENT ERROR; EXPRESSION; IDENTIFICATION; ACTIVATION; MIGRATION; CD4(+)	Current approaches to study transcriptional profiles post influenza infection typically rely on tissue sampling from one or two sites at a few time points, such as spleen and lung in murine models. In this study, we infected female C57/BL6 mice intranasally with mouse-adapted H3N2/Hong Kong/X31 avian influenza A virus, and then analyzed the gene expression profiles in four different compartments (blood, lung, mediastinal lymph nodes, and spleen) over 11 consecutive days post infection. These data were analyzed by an advanced statistical procedure based on ordinary differential equation (ODE) modeling. Vastly different lists of significant genes were identified by the same statistical procedure in each compartment. Only 11 of them are significant in all four compartments. We classified significant genes in each compartment into co-expressed modules based on temporal expression patterns. We then performed functional enrichment analysis on these co-expression modules and identified significant pathway and functional motifs. Finally, we used an ODE based model to reconstruct gene regulatory network (GRN) for each compartment and studied their network properties.	[Qiu, Xing; Wu, Shuang; Thakar, Juilee; Liu, Zhi-Ping] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Hilchey, Shannon P.; Henn, Alicia D.; Zand, Martin S.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Thakar, Juilee; Henn, Alicia D.] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Liu, Zhi-Ping] Shandong Univ, Dept Biomed Engn, Jinan 250100, Shandong, Peoples R China; [Welle, Stephen L.] Univ Rochester, Funct Genom Ctr, Rochester, NY 14642 USA; [Wu, Hulin] Univ Texas Hlth Sci Ctr Houston, Dept Biostat, Sch Publ Hlth, Houston, TX 77030 USA	University of Rochester; University of Rochester; University of Rochester; Shandong University; University of Rochester; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Wu, HL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biostat, Sch Publ Hlth, Houston, TX 77030 USA.	Hulin.Wu@uth.tmc.edu; martin_zand@urmc.rochester.edu	Liu, Zhi-Ping/C-9846-2010	Liu, Zhi-Ping/0000-0001-7742-9161; Ye, Guoyou/0000-0002-9943-4815; Zand, Martin/0000-0002-7095-8682	National Institutes of Health [NIH HHSN272201000055C, 5 R01 AI087135, R01-AI091461, R01-AI069351, 2 R01 HL062826-09A2]; University of Rochester CTSI pilot award from the National Center For Research Resources [UL1RR024160]; National Center for Advancing Translational Sciences of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069351, R01AI087135, R01AI098112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester CTSI pilot award from the National Center For Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is partially supported by NIH HHSN272201000055C, 5 R01 AI087135, R01-AI091461, R01-AI069351 and 2 R01 HL062826-09A2 from the National Institutes of Health; and the University of Rochester CTSI pilot award (UL1RR024160) from the National Center For Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almudevar A, 2010, EURASIP J BIOINFORM, DOI 10.1155/2010/947564; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; Doherty PC, 2009, REV SCI TECH OIE, V28, P175, DOI 10.20506/rst.28.1.1857; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Girard MP, 2005, VACCINE, V23, P5708, DOI 10.1016/j.vaccine.2005.07.046; Gossner A, 2011, VET MICROBIOL, V153, P218, DOI 10.1016/j.vetmic.2011.05.036; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Henderson SC, 2002, J IMMUNOL, V168, P118, DOI 10.4049/jimmunol.168.1.118; Henn AD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00345; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; KILBOURNE ED, 1968, SCIENCE, V160, P74, DOI 10.1126/science.160.3823.74; Klamp T, 2003, J IMMUNOL, V171, P1255, DOI 10.4049/jimmunol.171.3.1255; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Leaman DW, 2002, J BIOL CHEM, V277, P28504, DOI 10.1074/jbc.M204851200; Lee HY, 2009, J VIROL, V83, P7151, DOI 10.1128/JVI.00098-09; Liang H, 2008, J AM STAT ASSOC, V103, P1570, DOI 10.1198/016214508000000797; Lines JL, 2010, J IMMUNOL, V185, P2980, DOI 10.4049/jimmunol.0903075; Lu T, 2011, J AM STAT ASSOC, V106, P1242, DOI 10.1198/jasa.2011.ap10194; Ludtke THW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003189; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Mount AM, 2010, METHODS MOL BIOL, V595, P299, DOI 10.1007/978-1-60761-421-0_20; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Olson MR, 2010, FUTURE VIROL, V5, P175, DOI 10.2217/FVL.10.3; Pommerenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041169; Rahman N, 2010, IMMUNOL CELL BIOL, V88, P817, DOI 10.1038/icb.2010.57; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Sandford EE, 2012, AVIAN DIS, V56, P732, DOI 10.1637/10261-060512-Reg.1; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Topham DJ, 1996, J VIROL, V70, P1288, DOI 10.1128/JVI.70.2.1288-1291.1996; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; Voit EO, 2004, BIOINFORMATICS, V20, P1670, DOI 10.1093/bioinformatics/bth140; Walters KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062412; Wu HL, 2011, J IMMUNOL, V187, P4474, DOI 10.4049/jimmunol.1101443; Wu S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-6; Xu H, 2006, BLOOD, V107, P2400, DOI 10.1182/blood-2005-08-3340; Xue HQ, 2010, ANN STAT, V38, P2351, DOI 10.1214/09-AOS784; Yao F, 2005, J AM STAT ASSOC, V100, P577, DOI 10.1198/016214504000001745; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; Zaslavsky E, 2010, J IMMUNOL, V184, P2908, DOI 10.4049/jimmunol.0903453	52	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138110	10.1371/journal.pone.0138110	http://dx.doi.org/10.1371/journal.pone.0138110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413862	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700013
J	Liao, S; Yang, WQ; Tan, Y; Peng, Y; Li, J; Tan, B; Wu, FZ				Liao, Shu; Yang, Wanqin; Tan, Yu; Peng, Yan; Li, Jun; Tan, Bo; Wu, Fuzhong			Soil Fauna Affects Dissolved Carbon and Nitrogen in Foliar Litter in Alpine Forest and Alpine Meadow	PLOS ONE			English	Article							CLIMATE-CHANGE; FIELD DECOMPOSITION; ORGANIC NITROGEN; LEAF-LITTER; WINTER; MANIPULATION; MACROFAUNA; DIVERSITY; NUTRIENT; IMPACTS	Dissolved organic carbon (DOC) and total dissolved nitrogen (TDN) are generally considered important active biogeochemical pools of total carbon and nitrogen. Many studies have documented the contributions of soil fauna to litter decomposition, but the effects of the soil fauna on labile substances (i.e., DOC and TDN) in litter during early decomposition are not completely clear. Therefore, a field litterbag experiment was carried out from 13th November 2013 to 23rd October 2014 in an alpine forest and an alpine meadow located on the eastern Tibetan Plateau. Litterbags with different mesh sizes were used to provide access to or prohibit the access of the soil fauna, and the concentrations of DOC and TDN in the foliar litter were measured during the winter (the onset of freezing, deep freezing and thawing stage) and the growing season (early and late). After one year of field incubation, the concentration of DOC in the litter significantly decreased, whereas the TDN concentration in the litter increased. Similar dynamic patterns were detected under the effects of the soil fauna on both DOC and TDN in the litter between the alpine forest and the alpine meadow. The soil fauna showed greater positive effects on decreasing DOC concentration in the litter in the winter than in the growing season. In contrast, the dynamics of TND in the litter were related to seasonal changes in environmental factors, rather than the soil fauna. In addition, the soil fauna promoted a decrease in litter DOC/TDN ratio in both the alpine forest and the alpine meadow throughout the first year of decomposition, except for in the late growing season. These results suggest that the soil fauna can promote decreases in DOC and TDN concentrations in litter, contributing to early litter decomposition in these cold biomes.	[Liao, Shu; Yang, Wanqin; Tan, Yu; Peng, Yan; Li, Jun; Tan, Bo; Wu, Fuzhong] Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Key Lab Ecol Forestry Engn Upper Reaches Yangtze, Inst Ecol & Forestry, Chengdu, Peoples R China; [Liao, Shu; Yang, Wanqin; Tan, Yu; Peng, Yan; Li, Jun; Tan, Bo; Wu, Fuzhong] Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu, Peoples R China	Sichuan Agricultural University	Wu, FZ (corresponding author), Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Key Lab Ecol Forestry Engn Upper Reaches Yangtze, Inst Ecol & Forestry, Chengdu, Peoples R China.	wufzchina@163.com	Li, Jun/GWR-0996-2022	Li, Jun/0000-0001-6459-4117	National Natural Science Foundation of China [31270498, 31170423]; Doctoral Scientific Fund Project of the Ministry of Education of China [20135103110002]; Postdoctoral Foundation of China [2012T50782]; Sichuan Youth Science & Technology Foundation [2012JQ0008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Scientific Fund Project of the Ministry of Education of China; Postdoctoral Foundation of China(China Postdoctoral Science Foundation); Sichuan Youth Science & Technology Foundation	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) Grants 31270498 to FW, 31170423 to WY; the Doctoral Scientific Fund Project of the Ministry of Education of China (http://www.cutech.edu.cn) Grants 20135103110002 to FW; the Postdoctoral Foundation of China (http://res.chinapostdoctor.org.cn) Grants 2012T50782 to FW; and the Sichuan Youth Science & Technology Foundation (http://www.qnjj.sc.cn) Grants 2012JQ0008 to FW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert M, 2010, FOREST ECOL MANAG, V259, P563, DOI 10.1016/j.foreco.2009.11.014; Berg B, 2014, SOIL BIOL BIOCHEM, V78, P222, DOI 10.1016/j.soilbio.2014.08.005; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Berglund SL, 2012, OIKOS, V121, P1112, DOI 10.1111/j.1600-0706.2011.19787.x; Bo Tan, 2012, Biodiversity Science, V20, P215; Bo Tan, 2010, Acta Ecologica Sinica, V30, P93; Bokhorst S, 2012, GLOBAL CHANGE BIOL, V18, P1152, DOI 10.1111/j.1365-2486.2011.02565.x; Brussaard L, 2007, PEDOBIOLOGIA, V50, P447, DOI 10.1016/j.pedobi.2006.10.007; Chanpin FS, 2002, PRINCIPLES TERRESTRI; Chen H, 2013, GLOBAL CHANGE BIOL, V19, P2940, DOI 10.1111/gcb.12277; Coleman DC, 2005, PEDOBIOLOGIA, V49, P479, DOI 10.1016/j.pedobi.2005.05.006; Cornelissen JHC, 2014, ECOL RES, V29, P517, DOI 10.1007/s11284-013-1106-1; Cotrufo MF, 1998, SOIL BIOL BIOCHEM, V30, P1565, DOI 10.1016/S0038-0717(98)00032-7; Crutsinger GM, 2009, BASIC APPL ECOL, V10, P535, DOI 10.1016/j.baae.2008.10.011; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; FAO, 2020, SOILS PORTAL WORLD R; Frouz J, 2006, APPL SOIL ECOL, V33, P308, DOI 10.1016/j.apsoil.2005.11.001; Frouz J, 2015, EUR J SOIL BIOL, V68, P18, DOI 10.1016/j.ejsobi.2015.03.002; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P135, DOI 10.1023/A:1013039830323; Hafner SD, 2005, BIOGEOCHEMISTRY, V74, P257, DOI 10.1007/s10533-004-4722-6; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Hawes TC, 2008, POLAR BIOL, V31, P681, DOI 10.1007/s00300-008-0406-3; Hawes TC, 2006, ECOL ENTOMOL, V31, P450, DOI 10.1111/j.1365-2311.2006.00796.x; Liu Ruilong, 2014, Chinese Journal of Applied and Environmental Biology, V20, P499, DOI 10.3724/SP.J.1145.2014.09045; McCay TS, 2013, FOREST ECOL MANAG, V304, P254, DOI 10.1016/j.foreco.2013.05.010; Megonigal JP., 2014, ANAEROBIC METABOLISM, V10; Ni XY, 2015, GEODERMA, V241, P136, DOI 10.1016/j.geoderma.2014.11.018; Ni XY, 2014, CAN J SOIL SCI, V94, P453, DOI 10.4141/CJSS2013-121; Sanchez FG, 2001, FOREST ECOL MANAG, V152, P85, DOI 10.1016/S0378-1127(00)00592-2; Scheu S, 2000, OECOLOGIA, V123, P285, DOI 10.1007/s004420051015; Silva JO, 2015, BASIC APPL ECOL, V16, P210, DOI 10.1016/j.baae.2015.02.005; Sinclair BJ, 2005, FUNCT ECOL, V19, P214, DOI 10.1111/j.1365-2435.2005.00962.x; Slade EM, 2012, BASIC APPL ECOL, V13, P423, DOI 10.1016/j.baae.2012.06.008; Tan B., 2013, ACTA ECOLOGICA SINIC, V33, P12, DOI 10.1016/j.chnaes.2012.12.003; Ullah S, 2006, BIOGEOCHEMISTRY, V81, P253, DOI 10.1007/s10533-006-9040-8; Versini A, 2014, GEODERMA, V232, P426, DOI 10.1016/j.geoderma.2014.05.018; Vestergard M, 2015, APPL SOIL ECOL, V92, P54, DOI 10.1016/j.apsoil.2015.03.002; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Wu QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097112; Xu ZF, 2015, GEODERMA, V239, P223, DOI 10.1016/j.geoderma.2014.10.018; Zwahlen C, 2007, PLANT SOIL, V300, P245, DOI 10.1007/s11104-007-9410-6	43	6	8	7	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139099	10.1371/journal.pone.0139099	http://dx.doi.org/10.1371/journal.pone.0139099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406249	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700168
J	Liu, YJ; Cotillard, A; Vatier, C; Bastard, JP; Fellahi, S; Stevant, M; Allatif, O; Langlosis, C; Bieuvelet, S; Brochot, A; Guilbot, A; Clement, K; Rizkalla, SW				Liu, Yuejun; Cotillard, Aurelie; Vatier, Camille; Bastard, Jean-Philippe; Fellahi, Soraya; Stevant, Marie; Allatif, Omran; Langlosis, Clotilde; Bieuvelet, Severine; Brochot, Amandine; Guilbot, Angele; Clement, Karine; Rizkalla, Salwa W.			A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; BLOOD-GLUCOSE; BODY-COMPOSITION; LIFE-STYLE; GLYCATED HEMOGLOBIN; PREVENTION; EXTRACT; MANAGEMENT; WEIGHT	Background Preventing or slowing the progression of prediabetes to diabetes is a major therapeutic issue. Objectives Our aim was to evaluate the effects of 4-month treatment with a dietary supplement containing cinnamon, chromium and carnosine in moderately obese or overweight pre-diabetic subjects, the primary outcome being change in fasting plasma glucose (FPG) level. Other parameters of plasma glucose homeostasis, lipid profile, adiposity and inflammatory markers were also assessed. Methods In a randomized, double-blind, placebo-controlled study, 62 subjects with a FPG level ranging from 5.55 to 7 mmol/L and a body mass index >= 25 kg/m(2), unwilling to change their dietary and physical activity habits, were allocated to receive a 4-month treatment with either 1.2 g/day of the dietary supplement or placebo. Patients were followed up until 6 months post-randomization. Results Four-month treatment with the dietary supplement decreased FPG compared to placebo (-0.24 +/- 0.50 vs + 0.12 +/- 0.59 mmol/L, respectively, p = 0.02), without detectable significant changes in HbA1c. Insulin sensitivity markers, plasma insulin, plasma lipids and inflammatory markers did not differ between the treatment groups. Although there were no significant differences in changes in body weight and energy or macronutrient intakes between the two groups, fat-free mass (%) increased with the dietary supplement compared to placebo (p = 0.02). Subjects with a higher FPG level and a milder inflammatory state at baseline benefited most from the dietary supplement. Conclusions Four-month treatment with a dietary supplement containing cinnamon, chromium and carnosine decreased FPG and increased fat-free mass in overweight or obese pre-diabetic subjects. These beneficial effects might open up new avenues in the prevention of diabetes.	[Liu, Yuejun; Cotillard, Aurelie; Vatier, Camille; Bastard, Jean-Philippe; Fellahi, Soraya; Allatif, Omran; Clement, Karine; Rizkalla, Salwa W.] Hop La Pitie Salpetriere, Heart & Nutr Dept, AP HP, Inst Cardiometab & Nutr,ICAN, F-75013 Paris, France; [Liu, Yuejun; Cotillard, Aurelie; Vatier, Camille; Bastard, Jean-Philippe; Fellahi, Soraya; Allatif, Omran; Clement, Karine; Rizkalla, Salwa W.] Human Nutr Res Center Ile France, F-75013 Paris, France; [Liu, Yuejun; Cotillard, Aurelie; Vatier, Camille; Allatif, Omran; Clement, Karine; Rizkalla, Salwa W.] INSERM, U1166, UMR S, Nutri, F-75013 Paris, France; [Liu, Yuejun; Cotillard, Aurelie; Clement, Karine; Rizkalla, Salwa W.] Univ Paris 06, Sorbonne Univ, UMR S 1166 I, Nutri Team, Paris, France; [Bastard, Jean-Philippe; Fellahi, Soraya] Hop Tenon, Biochem & Hormonol Dept, AP HP, F-75970 Paris, France; [Stevant, Marie; Bieuvelet, Severine] AdipoPhYt, F-75013 Paris, France; [Langlosis, Clotilde; Brochot, Amandine; Guilbot, Angele] Grp PiLeJe, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Rizkalla, SW (corresponding author), Hop La Pitie Salpetriere, Heart & Nutr Dept, AP HP, Inst Cardiometab & Nutr,ICAN, F-75013 Paris, France.	salwa.rizkalla@psl.aphp.fr	Clément, karine/R-1120-2017	ALLATIF, Omran/0000-0002-2539-972X	PileJe (Saint-Laurent-des-Autels, France); INSERM; Pierre and Marie Curie University (Paris, France)	PileJe (Saint-Laurent-des-Autels, France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Pierre and Marie Curie University (Paris, France)	This work was supported by PileJe (Saint-Laurent-des-Autels, France), the study sponsor, as well as by INSERM and Pierre and Marie Curie University (Paris, France). The funders participated in the design and monitoring of the study, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Akilen R, 2010, DIABETIC MED, V27, P1159, DOI 10.1111/j.1464-5491.2010.03079.x; Akilen R, 2012, CLIN NUTR, V31, P609, DOI 10.1016/j.clnu.2012.04.003; Allen RW, 2013, ANN FAM MED, V11, P452, DOI 10.1370/afm.1517; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; Anderson RA, 1998, NUTR REV, V56, P266, DOI 10.1111/j.1753-4887.1998.tb01763.x; Antuna-Puente B, 2009, EUR J ENDOCRINOL, V161, P51, DOI 10.1530/EJE-09-0091; Atlantis E, 2009, METABOLISM, V58, P1013, DOI 10.1016/j.metabol.2009.02.027; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bailey CH, 2014, BIOL TRACE ELEM RES, V157, P1, DOI 10.1007/s12011-013-9863-9; Balk EM, 2007, DIABETES CARE, V30, P2154, DOI 10.2337/dc06-0996; Bragg F, 2014, DIABETIC MED, V31, P540, DOI 10.1111/dme.12392; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Crawford P, 2009, J AM BOARD FAM MED, V22, P507, DOI 10.3122/jabfm.2009.05.080093; Crawford V, 1999, DIABETES OBES METAB, V1, P331, DOI 10.1046/j.1463-1326.1999.00055.x; Davis PA, 2011, J MED FOOD, V14, P884, DOI 10.1089/jmf.2010.0180; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Dominguez Ligia J, 2007, J Cardiometab Syndr, V2, P183, DOI 10.1111/j.1559-4564.2007.06673.x; European Food Safety Authority (EFSA), 2008, 793 EFSA; Evert AB, 2014, DIABETES CARE, V37, pS120, DOI 10.2337/dc14-S120; Farshchi A, 2013, J PHARM PHARM SCI, V16, P99, DOI 10.18433/J3G022; Festa A, 2003, CIRCULATION, V108, P1822, DOI 10.1161/01.CIR.0000091339.70120.53; Garber AJ, 2013, ENDOCR PRACT, V19, P536, DOI 10.4158/EP13176.CS; Garber Alan J, 2008, Endocr Pract, V14, P933; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2009, DYSGLYCEMIA RISK CAR, P179; Haffner SM, 2003, AM J CARDIOL, V92, p18J, DOI 10.1016/S0002-9149(03)00612-X; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Heine RJ, 2006, BMJ-BRIT MED J, V333, P1200, DOI 10.1136/bmj.39022.462546.80; Incani M, 2015, J DIABETES INVEST, V6, P44, DOI 10.1111/jdi.12241; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215; Kim CW, 2011, J NUTR BIOCHEM, V22, P1030, DOI 10.1016/j.jnutbio.2010.10.001; Kleefstra N, 2007, DIABETES CARE, V30, P1092, DOI 10.2337/dc06-2192; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Leach MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007170.pub2; Lemon J., 2006, R R NEWS; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lu QG, 2009, DIABETES RES CLIN PR, V84, P319, DOI 10.1016/j.diabres.2009.03.002; Mang B, 2006, EUR J CLIN INVEST, V36, P340, DOI 10.1111/j.1365-2362.2006.01629.x; Martin J, 2006, DIABETES CARE, V29, P1826, DOI 10.2337/dc06-0254; Martins AR, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-30; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medagama AB, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-374; Miller CS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056018, 10.1371/journal.pone.0081692]; Moutzouri E, 2011, EUR J PHARMACOL, V672, P9, DOI 10.1016/j.ejphar.2011.10.007; Nagai K, 2003, EXP BIOL MED, V228, P1138, DOI 10.1177/153537020322801007; Nagai K, 2012, AMINO ACIDS, V43, P97, DOI 10.1007/s00726-012-1251-9; Onakpoya I, 2013, OBES REV, V14, P496, DOI 10.1111/obr.12026; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Pellegrinelli V, 2014, DIABETES, V63, P535, DOI 10.2337/db13-0537; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Pittler MH, 2003, INT J OBESITY, V27, P522, DOI 10.1038/sj.ijo.0802262; McLellan KCP, 2014, THER CLIN RISK MANAG, V10, P173, DOI 10.2147/TCRM.S39564; Qin B, 2004, HORM METAB RES, V36, P119, DOI 10.1055/s-2004-814223; Qin B, 2009, HORM METAB RES, V41, P516, DOI 10.1055/s-0029-1202813; Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6; Rafehi H, 2012, DIABETES OBES METAB, V14, P493, DOI 10.1111/j.1463-1326.2011.01538.x; Ranasinghe P, 2012, DIABETIC MED, V29, P1480, DOI 10.1111/j.1464-5491.2012.03718.x; Ranasinghe P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-275; Ranasinghe P, 2012, PHARMACOGN RES, V4, P73, DOI 10.4103/0974-8490.94719; Reddy V Prakash, 2005, Sci Aging Knowledge Environ, V2005, ppe12, DOI 10.1126/sageke.2005.18.pe12; Ribiere C, 2002, BIOCHEM BIOPH RES CO, V291, P394, DOI 10.1006/bbrc.2002.6444; Rizkalla SW, 2012, AM J CLIN NUTR, V95, P49, DOI 10.3945/ajcn.111.017277; Roussel AM, 2009, J AM COLL NUTR, V28, P16, DOI 10.1080/07315724.2009.10719756; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sheng XY, 2008, PPAR RES, V2008, DOI 10.1155/2008/581348; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Suksomboon N, 2014, J CLIN PHARM THER, V39, P292, DOI 10.1111/jcpt.12147; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Theuma P, 2004, METAB SYNDR RELAT D, V2, P105, DOI 10.1089/met.2004.2.105; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vafa M, 2012, INT J PREVENTIVE MED, V3, P531; Ziegenfuss TN, 2006, J INT SOC SPORT NUTR, V3, DOI 10.1186/1550-2783-3-2-45	78	29	29	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138646	10.1371/journal.pone.0138646	http://dx.doi.org/10.1371/journal.pone.0138646			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406981	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700063
J	McCarthy, MK; Procario, MC; Wilke, CA; Moore, BB; Weinberg, JB				McCarthy, Mary K.; Procario, Megan C.; Wilke, Carol A.; Moore, Bethany B.; Weinberg, Jason B.			Prostaglandin E-2 Production and T Cell Function in Mouse Adenovirus Type 1 Infection following Allogeneic Bone Marrow Transplantation	PLOS ONE			English	Article							EXTENSIVE CROSS-REACTIVITY; RESPIRATORY-INFECTION; SELECTIVE INHIBITOR; ANTIVIRAL IMMUNITY; EARLY REGION-1; DNA-SEQUENCE; RESPONSES; CD4(+); CD8(+); IMMUNOSUPPRESSION	Adenovirus infections are important complications of bone marrow transplantation (BMT). We demonstrate delayed clearance of mouse adenovirus type 1 (MAV-1) from lungs of mice following allogeneic BMT. Virus-induced prostaglandin E-2 (PGE(2)) production was greater in BMT mice than in untransplanted controls, but BMT using PGE(2)-deficient donors or recipients failed to improve viral clearance, and treatment of untransplanted mice with the PGE(2) analog misoprostol did not affect virus clearance. Lymphocyte recruitment to the lungs was not significantly affected by BMT. Intracellular cytokine staining of lung lymphocytes demonstrated impaired production of INF-gamma and granzyme B by cells from BMT mice, and production of IFN-gamma, IL-2, IL-4, and IL-17 following ex vivo stimulation was impaired in lymphocytes obtained from lungs of BMT mice. Viral clearance was not delayed in untransplanted INF-gamma-deficient mice, suggesting that delayed viral clearance in BMT mice was not a direct consequence of impaired IFN-gamma production. However, lung viral loads were higher in untransplanted CD8-deficient mice than in controls, suggesting that delayed MAV-1 clearance in BMT mice is due to defective CD8 T cell function. We did not detect significant induction of IFN-beta expression in lungs of BMT mice or untransplanted controls, and viral clearance was not delayed in untransplanted type I IFN-unresponsive mice. We conclude that PGE(2) overproduction in BMT mice is not directly responsible for delayed viral clearance. PGE(2)-independent effects on CD8 T cell function likely contribute to the inability of BMT mice to clear MAV-1 from the lungs.	[McCarthy, Mary K.; Moore, Bethany B.; Weinberg, Jason B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Procario, Megan C.; Weinberg, Jason B.] Univ Michigan, Dept Pediat & Communicable Dis, Div Infect Dis, Ann Arbor, MI 48109 USA; [Wilke, Carol A.; Moore, Bethany B.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weinberg, JB (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	jbwein@umich.edu		Moore, Bethany/0000-0003-3051-745X; Weinberg, Jason/0000-0002-4768-4361	National Institutes of Health [R01 AI083334, R01 HL115618]; University of Michigan Nancy Newton Loeb Pediatric Cancer Award; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117229, R01AI083334, T32AI007528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Nancy Newton Loeb Pediatric Cancer Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (www.nih.gov; R01 AI083334 to JBW and R01 HL115618 to BBM). This work was also supported by a University of Michigan Nancy Newton Loeb Pediatric Cancer Award (to JBW; http://www.med.umich.edu/pediatrics/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VE, 2009, VIROLOGY, V391, P25, DOI 10.1016/j.virol.2009.06.009; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Auner HW, 2002, ANN HEMATOL, V81, P374, DOI 10.1007/s00277-002-0484-1; Baldwin A, 2000, BONE MARROW TRANSPL, V26, P1333, DOI 10.1038/sj.bmt.1702716; BALL AO, 1991, VIROLOGY, V180, P257, DOI 10.1016/0042-6822(91)90030-F; BALL AO, 1988, J VIROL, V62, P3947, DOI 10.1128/JVI.62.11.3947-3957.1988; BALL AO, 1989, VIROLOGY, V170, P523, DOI 10.1016/0042-6822(89)90444-3; Ballinger MN, 2006, J IMMUNOL, V177, P5499, DOI 10.4049/jimmunol.177.8.5499; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; BETZ M, 1991, J IMMUNOL, V146, P108; Boulet L, 2004, J BIOL CHEM, V279, P23229, DOI 10.1074/jbc.M400443200; Cauthen AN, 1996, GENE, V168, P183, DOI 10.1016/0378-1119(95)00715-6; Cauthen Angela N, 2007, Methods Mol Med, V130, P41; CAYEUX SJ, 1993, BONE MARROW TRANSPL, V12, P603; Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377; Chakupurakal G, 2013, J IMMUNOTHER, V36, P423, DOI 10.1097/CJI.0b013e3182a8029e; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Coomes SM, 2010, TRANSPLANTATION, V90, P1139, DOI 10.1097/TP.0b013e3181efd018; Coomes SM, 2010, J IMMUNOL, V184, P5130, DOI 10.4049/jimmunol.0901871; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Domingo-Gonzalez R, 2013, J IMMUNOL, V190, P5809, DOI 10.4049/jimmunol.1203274; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Feuchtinger T, 2004, EXP HEMATOL, V32, P282, DOI 10.1016/j.exphem.2003.12.009; FLOMENBERG P, 1994, J INFECT DIS, V169, P775, DOI 10.1093/infdis/169.4.775; Geyeregger R, 2014, J IMMUNOTHER, V37, P245, DOI 10.1097/CJI.0000000000000034; Gil L, 2007, INFECTION, V35, P421, DOI 10.1007/s15010-007-6350-2; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; Gowdy KM, 2015, TRANSPL IMMUNOL, V32, P51, DOI 10.1016/j.trim.2014.10.005; Heemskerk B, 2005, J INFECT DIS, V191, P520, DOI 10.1086/427513; Heemskerk B, 2003, J VIROL, V77, P6562, DOI 10.1128/JVI.77.11.6562-6566.2003; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; Howard DS, 1999, CLIN INFECT DIS, V29, P1494, DOI 10.1086/313514; Hubbard LLN, 2008, EXP LUNG RES, V34, P263, DOI 10.1080/01902140802022518; Hubbard LLN, 2010, J IMMUNOL, V184, P6299, DOI 10.4049/jimmunol.0902828; Kajon AE, 2003, J MED VIROL, V71, P233, DOI 10.1002/jmv.10475; Kapoor M, 2006, FASEB J, V20, P2387, DOI 10.1096/fj.06-6366fje; KLINGEMANN HG, 1986, BLOOD, V68, P102; Kojaoghlanian T, 2003, REV MED VIROL, V13, P155, DOI 10.1002/rmv.386; KRING SC, 1990, NUCLEIC ACIDS RES, V18, P4003, DOI 10.1093/nar/18.13.4003; KRING SC, 1992, VIROLOGY, V190, P248, DOI 10.1016/0042-6822(92)91211-C; Leen AA, 2006, BIOL BLOOD MARROW TR, V12, P243, DOI 10.1016/j.bbmt.2005.10.024; Leen AM, 2004, BLOOD, V103, P1011, DOI 10.1182/blood-2003-07-2449; Leen AM, 2009, BLOOD, V114, P4283, DOI 10.1182/blood-2009-07-232454; Li J, 2011, FASEB J, V25, P883, DOI 10.1096/fj.10-160895; Martin-Pena A, 2011, CLIN TRANSPLANT, V25, P468, DOI 10.1111/j.1399-0012.2010.01286.x; McCarthy MK, 2014, VIROLOGY, V456, P259, DOI 10.1016/j.virol.2014.04.008; McCarthy MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077628; Meissner JD, 1997, VIRUS RES, V51, P53, DOI 10.1016/S0168-1702(97)00079-8; Nagayama Y, 2012, CLIN EXP IMMUNOL, V168, P268, DOI 10.1111/j.1365-2249.2012.04578.x; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Nguyen Y, 2011, VIRUS RES, V160, P351, DOI 10.1016/j.virusres.2011.07.012; Nguyen YN, 2008, VIROLOGY, V380, P182, DOI 10.1016/j.virol.2008.07.031; Procario MC, 2012, J VIROL, V86, P4194, DOI 10.1128/JVI.06967-11; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2; Runde V, 2001, BONE MARROW TRANSPL, V28, P51, DOI 10.1038/sj.bmt.1703083; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; SHIELDS AF, 1985, NEW ENGL J MED, V312, P529, DOI 10.1056/NEJM198502283120901; Smith CA, 1998, HUM GENE THER, V9, P1419, DOI 10.1089/hum.1998.9.10-1419; Smith CA, 1996, J VIROL, V70, P6733, DOI 10.1128/JVI.70.10.6733-6740.1996; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; van Tol MJD, 2005, BONE MARROW TRANSPL, V35, pS73, DOI 10.1038/sj.bmt.1704852; Walls T, 2003, LANCET INFECT DIS, V3, P79, DOI 10.1016/S1473-3099(03)00515-2; Weinberg JB, 2007, VIROLOGY, V357, P54, DOI 10.1016/j.virol.2006.08.013; Weinberg JB, 2005, VIROLOGY, V340, P245, DOI 10.1016/j.virol.2005.06.021; WIGAND R, 1977, ARCH VIROL, V54, P131, DOI 10.1007/BF01314385; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zandvliet ML, 2010, HAEMATOL-HEMATOL J, V95, P1943, DOI 10.3324/haematol.2010.022947	71	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139235	10.1371/journal.pone.0139235	http://dx.doi.org/10.1371/journal.pone.0139235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407316	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700196
J	Cecchetti, S; Bortolomai, I; Ferri, R; Mercurio, L; Canevari, S; Podo, F; Miotti, S; Iorio, E				Cecchetti, Serena; Bortolomai, Ileana; Ferri, Renata; Mercurio, Laura; Canevari, Silvana; Podo, Franca; Miotti, Silvia; Iorio, Egidio			Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; SPHINGOMYELIN SYNTHASE; DRUG-RESISTANCE; FUNCTIONAL-ROLE; GROWTH-FACTOR; IDENTIFICATION; ACTIVATION; EGFR; EXPRESSION; HEAD	Purpose The role of phosphatidylcholine-specific phospholipase C (PC-PLC), the enzyme involved in cell differentiation and proliferation, has not yet been explored in tumor initiating cells (TICs). We investigated PC-PLC expression and effects of PC-PLC inhibition in two adherent (AD) squamous carcinoma cell lines (A431 and CaSki), with different proliferative and stemness potential, and in TIC-enriched floating spheres (SPH) originated from them. Results Compared with immortalized non-tumoral keratinocytes (HaCaT) A431-AD cells showed 2.5-fold higher PC-PLC activity, nuclear localization of a 66-kDa PC-PLC isoform, but a similar distribution of the enzyme on plasma membrane and in cytoplasmic compartments. Compared with A431-AD, A431-SPH cells showed about 2.8-fold lower PC-PLC protein and activity levels, but similar nuclear content. Exposure of adherent cells to the PC-PLC inhibitor D609 (48h) induced a 50% reduction of cell proliferation at doses comprised between 33 and 50 mu g/ml, without inducing any relevant cytotoxic effect (cell viability 95 +/- 5%). In A431-SPH and CaSki-SPH D609 induced both cytostatic and cytotoxic effects at about 20 to 30-fold lower doses (IC50 ranging between 1.2 and 1.6 mu g/ml). Furthermore, D609 treatment of A431-AD and CaSki-AD cells affected the sphere-forming efficiency, which dropped in both cells, and induced down-modulation of stem-related markers mRNA levels (Oct4, Nestin, Nanog and ALDH1 in A431; Nestin and ALDH1 in CaSki cells). Conclusions These data suggest that the inhibition of PC-PLC activity may represent a new therapeutic approach to selectively target the most aggressive and tumor promoting sub-population of floating spheres originated from squamous cancer cells possessing different proliferative and stemness potential.	[Cecchetti, Serena; Mercurio, Laura; Podo, Franca; Iorio, Egidio] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Bortolomai, Ileana; Ferri, Renata; Canevari, Silvana; Miotti, Silvia] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy	Istituto Superiore di Sanita (ISS); Fondazione IRCCS Istituto Nazionale Tumori Milan	Canevari, S (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	silvana.canevari@istitutotumori.mi.it; franca.podo@alice.it	Iorio, Egidio/M-7077-2017; Mercurio, Laura/K-2750-2018; Cecchetti, Serena/N-1061-2015	Iorio, Egidio/0000-0001-6673-3838; Mercurio, Laura/0000-0003-0629-1729; Cecchetti, Serena/0000-0002-3601-176X; Ileana, Bortolomai/0000-0002-2592-1274	Fondazione CARIPLO [2007.5376]; AIRC; Italian Health Ministry-Progetto Oncologico di Medicina Molecolare: I Tumori Femminili; ISS Onco-Technology Program	Fondazione CARIPLO(Fondazione Cariplo); AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Health Ministry-Progetto Oncologico di Medicina Molecolare: I Tumori Femminili; ISS Onco-Technology Program	This work was partially supported by Fondazione CARIPLO 2007.5376, AIRC IG to Dr. Podo and Dr. Canevari, Italian Health Ministry-Progetto Oncologico di Medicina Molecolare: I Tumori Femminili to Dr. Canevari, ISS Onco-Technology Program to Dr. Iorio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalsamo L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3151; Abe M, 2006, BRIT J PHARMACOL, V147, P402, DOI 10.1038/sj.bjp.0706634; AMTMANN E, 1990, INT J CANCER, V45, P1113, DOI 10.1002/ijc.2910450621; Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Bortolomai I, 2010, CELL CYCLE, V9, P1194, DOI 10.4161/cc.9.6.11108; Cascianelli G, 2008, MOL BIOL CELL, V19, P5289, DOI 10.1091/mbc.E08-05-0517; Cecchetti S, 2007, EUR J IMMUNOL, V37, P2912, DOI 10.1002/eji.200737266; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen D, 2015, MOL MED REP, V11, P4309, DOI 10.3892/mmr.2015.3279; Cichocki M, 2014, MOL CELL BIOCHEM, V396, P221, DOI 10.1007/s11010-014-2157-5; CLARK MA, 1986, BIOCHEM BIOPH RES CO, V140, P114, DOI 10.1016/0006-291X(86)91065-X; Cojoc M, 2015, SEMIN CANCER BIOL, V31, P16, DOI 10.1016/j.semcancer.2014.06.004; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Conesa-Zamora P, 2013, EXP MOL PATHOL, V95, P151, DOI 10.1016/j.yexmp.2013.06.011; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Desiderio V, 2015, ONCOTARGET, V6, P71, DOI 10.18632/oncotarget.2698; Duggal Rohit, 2013, J Stem Cells, V8, P135, DOI jsc.2014.8.3/4.135; Fantuzzi L, 2008, BLOOD, V111, P3355, DOI 10.1182/blood-2007-08-104901; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hashimoto N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-722; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jansen JFA, 2006, MAGN RESON MED, V56, P666, DOI 10.1002/mrm.20968; Kalluri HSG, 2013, MOL NEUROBIOL, V47, P782, DOI 10.1007/s12035-012-8390-6; Kalluri HSG, 2010, NEUROREPORT, V21, P700, DOI 10.1097/WNR.0b013e32833b46f6; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; Liu SY, 2013, ONCOTARGET, V4, P2462, DOI 10.18632/oncotarget.1578; Liu X, 2006, ENDOTHELIUM-J ENDOTH, V13, P205, DOI 10.1080/10623320600760423; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; Mao XG, 2010, CELL MOL NEUROBIOL, V30, P775, DOI 10.1007/s10571-010-9505-0; Mateos MV, 2010, BBA-BIOMEMBRANES, V1798, P624, DOI 10.1016/j.bbamem.2009.12.008; Mawn TM, 2011, BIOCONJUGATE CHEM, V22, P2434, DOI 10.1021/bc200242v; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Menendez JA, 2013, CELL CYCLE, V12, P1166, DOI 10.4161/cc.24479; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Paris L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2575; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pectasides D, 2008, CANCER TREAT REV, V34, P603, DOI 10.1016/j.ctrv.2008.05.006; Podo F, 1996, ANTICANCER RES, V16, P1399; Podo F, 2011, NMR BIOMED, V24, P648, DOI 10.1002/nbm.1658; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ramoni C, 2004, EXP CELL RES, V299, P370, DOI 10.1016/j.yexcr.2004.05.037; Ramoni C, 2001, J IMMUNOL, V167, P2642, DOI 10.4049/jimmunol.167.5.2642; Romanska HM, 2009, NEOPLASIA, V11, P1301, DOI 10.1593/neo.09850; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sebastian Carlos, 2014, Critical Reviews in Oncogenesis, V19, P363; Smith KM, 2010, EMBO MOL MED, V2, P371, DOI 10.1002/emmm.201000093; Spadaro F, 2008, CANCER RES, V68, P6541, DOI 10.1158/0008-5472.CAN-07-6763; Spadaro F, 2006, EUR J IMMUNOL, V36, P3277, DOI 10.1002/eji.200635927; Spadaro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059705; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Tomas A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8324; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang K, 2013, INT J NANOMED, V8, P899, DOI 10.2147/IJN.S38641; Wang N, 2008, INT J BIOCHEM CELL B, V40, P294, DOI 10.1016/j.biocel.2007.08.003; Wang N, 2006, BIOORG MED CHEM LETT, V16, P4780, DOI 10.1016/j.bmcl.2006.06.080; Wu JH, 2013, CURR CANCER DRUG TAR, V13, P143, DOI 10.2174/1568009611313020004; Zhao M, 2011, CLIN CANCER RES, V17, P7248, DOI 10.1158/1078-0432.CCR-11-0690; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	64	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0136120	10.1371/journal.pone.0136120	http://dx.doi.org/10.1371/journal.pone.0136120			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402860	Green Submitted, gold, Green Published			2022-12-27	WOS:000361798100005
J	Kaur, G; Singh, HP; Batish, DR; Mahajan, P; Kohli, RK; Rishi, V				Kaur, Gurpreet; Singh, Harminder Pal; Batish, Daizy R.; Mahajan, Priyanka; Kohli, Ravinder Kumar; Rishi, Valbha			Exogenous Nitric Oxide (NO) Interferes with Lead (Pb)-Induced Toxicity by Detoxifying Reactive Oxygen Species in Hydroponically Grown Wheat (Triticum aestivum) Roots	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; OXIDATIVE STRESS; CROSS-TALK; ACCUMULATION; ANTIOXIDANT; SENESCENCE; LEAVES; COUNTERACTS; GERMINATION; METABOLISM	Nitric Oxide (NO) is a bioactive signaling molecule that mediates a variety of biotic and abiotic stresses. The present study investigated the role of NO (as SNP [sodium nitroprusside]) in ameliorating lead (Pb)-toxicity in Triticum aestivum (wheat) roots. Pb (50 and 250 mu M) alone and in combination with SNP (100 mu M) was given to hydroponically grown wheat roots for a period of 0-8 h. NO supplementation reduced the accumulation of oxidative stress markers (malondialdehyde, conjugated dienes, hydroxyl ions and superoxide anion) and decreased the antioxidant enzyme activity in wheat roots particularly up to 6 h, thereby suggesting its role as an antioxidant. NO ameliorated Pb-induced membrane damage in wheat roots as evidenced by decreased ion-leakage and in situ histochemical localization. Pb-exposure significantly decreased in vivo NO level. The study concludes that exogenous NO partially ameliorates Pb-toxicity, but could not restore the plant growth on prolonged Pb-exposure.	[Kaur, Gurpreet; Singh, Harminder Pal] Panjab Univ, Dept Environm Studies, Chandigarh 160014, India; [Batish, Daizy R.; Mahajan, Priyanka; Kohli, Ravinder Kumar] Panjab Univ, Dept Bot, Chandigarh 160014, India; [Rishi, Valbha] Chandigarh Coll Engn & Technol, Chandigarh 160019, India	Panjab University; Panjab University	Singh, HP (corresponding author), Panjab Univ, Dept Environm Studies, Chandigarh 160014, India.	hpsingh_01@yahoo.com	Kohli, Ravinder/S-4061-2016; Singh, Harminder/E-1848-2012; Kohli, Ravinder/AAB-2281-2019	Kohli, Ravinder/0000-0002-4375-3390; Singh, Harminder/0000-0002-0024-5855; Kohli, Ravinder/0000-0002-4375-3390	University Grants Commission (UGC), India; Council for Scientific and Industrial Research (CSIR), India	University Grants Commission (UGC), India(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Gurpreet Kaur and Priyanka Mahajan received funding from University Grants Commission (UGC), India, and Council for Scientific and Industrial Research (CSIR), India, respectively.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Bajji M, 2002, CAN J BOT, V80, P297, DOI [10.1139/B02-008, 10.1139/b02-008]; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Beligni MV, 2002, PLANT PHYSIOL, V129, P1642, DOI 10.1104/pp.002337; Beligni MV, 2002, PLANT CELL ENVIRON, V25, P737, DOI 10.1046/j.1365-3040.2002.00857.x; BOVERIS A, 1980, PHOTOBIOCH PHOTOBIOP, V1, P175; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buet A, 2015, ANN NY ACAD SCI, V1340, P39, DOI 10.1111/nyas.12644; Correa-Aragunde N, 2015, J EXP BOT, V66, P2913, DOI 10.1093/jxb/erv073; Domingos P, 2015, MOL PLANT, V8, P506, DOI 10.1016/j.molp.2014.12.010; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gross F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00419; Guillas I, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00341, 10.3389/fpls.2013.00553]; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hermes VS, 2013, BIOL PLANTARUM, V57, P620, DOI 10.1007/s10535-013-0353-x; Hsu YT, 2004, PLANT GROWTH REGUL, V42, P227, DOI 10.1023/B:GROW.0000026514.98385.5c; Hung KT, 2005, BOT BULL ACAD SINICA, V46, P21; Kaur G, 2015, BIOLOGIA, V70, P190, DOI 10.1515/biolog-2015-0023; Kopyra M, 2003, PLANT PHYSIOL BIOCH, V41, P1011, DOI 10.1016/j.plaphy.2003.09.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007; Mishina TE, 2007, PLANT CELL ENVIRON, V30, P39, DOI 10.1111/j.1365-3040.2006.01604.x; MISRA HP, 1972, J BIOL CHEM, V247, P188; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Niu YH, 2012, J INTEGR PLANT BIOL, V54, P516, DOI 10.1111/j.1744-7909.2012.01140.x; Nriagu JO, 1996, SCIENCE, V272, P223, DOI 10.1126/science.272.5259.223; Phang IC, 2011, ECOTOX ENVIRON SAFE, V74, P1310, DOI 10.1016/j.ecoenv.2011.02.006; Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x; Rubbo H, 2000, J BIOL CHEM, V275, P10812, DOI 10.1074/jbc.275.15.10812; Sang JR, 2008, J INTEGR PLANT BIOL, V50, P231, DOI 10.1111/j.1744-7909.2007.00594.x; Sanz L, 2015, J EXP BOT, V66, P2857, DOI 10.1093/jxb/erv213; Serrano I, 2015, J EXP BOT, V66, P2869, DOI 10.1093/jxb/erv083; Shi SY, 2005, NITRIC OXIDE-BIOL CH, V13, P1, DOI 10.1016/j.niox.2005.04.006; Singh HP, 2009, NITRIC OXIDE-BIOL CH, V20, P289, DOI 10.1016/j.niox.2009.02.004; Singh HP, 2008, ENVIRON EXP BOT, V63, P158, DOI 10.1016/j.envexpbot.2007.12.005; Singh HP, 2007, PLANT GROWTH REGUL, V53, P65, DOI 10.1007/s10725-007-9205-z; Sun BT, 2007, J PLANT PHYSIOL, V164, P536, DOI 10.1016/j.jplph.2006.02.011; Wang YQ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00314; Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; WOODBURY W, 1971, ANAL BIOCHEM, V44, P301, DOI 10.1016/0003-2697(71)90375-7; Xiong J, 2010, ARCH BIOCHEM BIOPHYS, V497, P13, DOI 10.1016/j.abb.2010.02.014; Yu CC, 2005, J PLANT PHYSIOL, V162, P1319, DOI 10.1016/j.jplph.2005.02.003; Yu MD, 2014, NEW PHYTOL, V202, P1142, DOI 10.1111/nph.12739; Zaninotto F, 2006, PLANT PHYSIOL, V141, P379, DOI 10.1104/pp.106.078857; Zhang H, 2008, RUSS J PLANT PHYSL+, V55, P469, DOI 10.1134/S1021443708040067	48	52	52	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0138713	10.1371/journal.pone.0138713	http://dx.doi.org/10.1371/journal.pone.0138713			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402793	Green Submitted, gold, Green Published			2022-12-27	WOS:000361798100034
J	Bao, JL; Huang, BR; Zou, LD; Chen, SH; Zhang, C; Zhang, YL; Chen, MW; Wan, JB; Su, HX; Wang, YT; He, CW				Bao, Jiaolin; Huang, Borong; Zou, Lidi; Chen, Shenghui; Zhang, Chao; Zhang, Yulin; Chen, Meiwan; Wan, Jian-Bo; Su, Huanxing; Wang, Yitao; He, Chengwei			Hormetic Effect of Berberine Attenuates the Anticancer Activity of Chemotherapeutic Agents	PLOS ONE			English	Article							RADIATION HORMESIS; STRESS; CELLS; PATHWAYS; GROWTH; CANCER; RESVERATROL; EXPRESSION; INDUCTION	Hormesis is a phenomenon of biphasic dose response characterized by exhibiting stimulatory or beneficial effects at low doses and inhibitory or toxic effects at high doses. Increasing numbers of chemicals of various types have been shown to induce apparent hormetic effect on cancer cells. However, the underlying significance and mechanisms remain to be elucidated. Berberine, one of the major active components of Rhizoma coptidis, has been manifested with notable anticancer activities. This study aims to investigate the hormetic effect of berberine and its influence on the anticancer activities of chemotherapeutic agents. Our results demonstrated that berberine at low dose range (1.25 similar to 5 mu M) promoted cell proliferation to 112% similar to 170% of the untreated control in various cancer cells, while berberine at high dose rage (10 similar to 80 mu M) inhibited cell proliferation. Further, we observed that co-treatment with low dose berberine could significantly attenuate the anticancer activity of chemotherapeutic agents, including fluorouracil (5-FU), camptothecin (CPT), and paclitaxel (TAX). The hormetic effect and thereby the attenuated anticancer activity of chemotherapeutic drugs by berberine may attributable to the activated protective stress response in cancer cells triggered by berberine, as evidenced by up-regulated MAPK/ERK1/2 and PI3K/AKT signaling pathways. These results provided important information to understand the potential side effects of hormesis, and suggested cautious application of natural compounds and relevant herbs in adjuvant treatment of cancer.	[Bao, Jiaolin; Huang, Borong; Chen, Shenghui; Zhang, Chao; Zhang, Yulin; Chen, Meiwan; Wan, Jian-Bo; Su, Huanxing; Wang, Yitao; He, Chengwei] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Zou, Lidi] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	University of Macau; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	He, CW (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China.	chengweihe@umac.mo	Su, Huanxing/X-3980-2019; Su, Huanxing/X-3954-2019; Bao, Jiaolin/GRJ-8416-2022; Wang, Yitao/O-5184-2016; Wan, Jian-Bo/D-8368-2014	Su, Huanxing/0000-0002-0513-4943; Su, Huanxing/0000-0003-3254-825X; He, Chengwei/0000-0003-4701-2984; Wan, Jian-Bo/0000-0002-6750-2617; Bao, Jiaolin/0000-0003-0630-071X	Macao Science and Technology Development Fund [074/2013/A]; Research Fund of the University of Macau [MYRG107(Y1-L3)-ICMS13-HCW, MYRG2015-00081-ICMS-QRCM, MRG013/HCW/2014/ICMS]; Institute of Chinese Materia Medica at China Academy of Chinese Medical Sciences	Macao Science and Technology Development Fund; Research Fund of the University of Macau; Institute of Chinese Materia Medica at China Academy of Chinese Medical Sciences	This study was supported by the Macao Science and Technology Development Fund (code: 074/2013/A to CH) (http://www.fdct.gov.mo/) and the Research Fund of the University of Macau (code: MYRG107(Y1-L3)-ICMS13-HCW to CH, MYRG2015-00081-ICMS-QRCM to CH, and MRG013/HCW/2014/ICMS to CH) (www.umac.mo) in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Lidi Zou is employed by Institute of Chinese Materia Medica at China Academy of Chinese Medical Sciences, where provided support in the form of salary for author LZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALLEY MC, 1991, CANCER RES, V51, P1247; Berna MJ, 2009, CELL SIGNAL, V21, P622, DOI 10.1016/j.cellsig.2009.01.003; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burotto M, 2014, CANCER-AM CANCER SOC, V120, P3446, DOI 10.1002/cncr.28864; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Calabrese E, 2008, INT J TOXICOL, V27, P369, DOI 10.1080/10915810802503735; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; Calabrese EJ, 2003, CRIT REV TOXICOL, V33, P305, DOI 10.1080/713611041; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Demirovic D, 2011, BIOGERONTOLOGY, V12, P437, DOI 10.1007/s10522-011-9326-7; Gomez-Pinilla F, 2008, AGEING RES REV, V7, P49, DOI 10.1016/j.arr.2007.04.003; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Juan SH, 2005, BIOCHEM PHARMACOL, V69, P41, DOI 10.1016/j.bcp.2004.09.015; Kaboli PJ, 2014, EUR J PHARMACOL, V740, P584, DOI 10.1016/j.ejphar.2014.06.025; Lee WK, 2012, BBA-MOL CELL RES, V1823, P1864, DOI 10.1016/j.bbamcr.2012.06.003; Li F, 2002, AM J PHYSIOL-CELL PH, V283, pC917, DOI 10.1152/ajpcell.00517.2001; Lu JJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/485042; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; Mizoguchi M, 1996, BUNSEKI KAGAKU, V45, P111; Ortiz LMG, 2014, MOLECULES, V19, P12349, DOI 10.3390/molecules190812349; Pallas M, 2013, CURR PHARM DESIGN, V19, P6726, DOI 10.2174/1381612811319380005; Qi HY, 2012, NEUROPHARMACOLOGY, V62, P1659, DOI 10.1016/j.neuropharm.2011.11.012; Ranzato E, 2010, J CELL BIOCHEM, V110, P783, DOI 10.1002/jcb.22591; Ranzato E, 2009, MOL CELL BIOCHEM, V332, P199, DOI 10.1007/s11010-009-0192-4; Rithidech KN, 2008, DOSE-RESPONSE, V6, P252, DOI 10.2203/dose-response.07-024.Rithidech; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Szumiel I, 2012, INT J RADIAT BIOL, V88, P619, DOI 10.3109/09553002.2012.699698; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Tong NN, 2012, ONCOL LETT, V3, P1263, DOI 10.3892/ol.2012.644; Vezmar M, 2000, BIOCHEM PHARMACOL, V59, P1245, DOI 10.1016/S0006-2952(00)00270-7; VICHI P, 1989, CANCER RES, V49, P2679; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yu ML, 2014, MOL MED REP, V9, P249, DOI 10.3892/mmr.2013.1762; Zhang Q, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-98; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	38	41	41	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139298	10.1371/journal.pone.0139298	http://dx.doi.org/10.1371/journal.pone.0139298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421434	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700092
J	Gutfraind, A; Boodram, B; Prachand, N; Hailegiorgis, A; Dahari, H; Major, ME				Gutfraind, Alexander; Boodram, Basmattee; Prachand, Nikhil; Hailegiorgis, Atesmachew; Dahari, Harel; Major, Marian E.			Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; HUMAN IMMUNODEFICIENCY; VIRAL-HEPATITIS; SOCIAL NETWORK; RISK BEHAVIOR; HEROIN USERS; YOUNG; TRANSMISSION; MORTALITY	People who inject drugs (PWID) are at high risk for blood-borne pathogens transmitted during the sharing of contaminated injection equipment, particularly hepatitis C virus (HCV). HCV prevalence is influenced by a complex interplay of drug-use behaviors, social networks, and geography, as well as the availability of interventions, such as needle exchange programs. To adequately address this complexity in HCV epidemic forecasting, we have developed a computational model, the Agent-based Pathogen Kinetics model (APK). APK simulates the PWID population in metropolitan Chicago, including the social interactions that result in HCV infection. We used multiple empirical data sources on Chicago PWID to build a spatial distribution of an in silico PWID population and modeled networks among the PWID by considering the geography of the city and its suburbs. APK was validated against 2012 empirical data (the latest available) and shown to agree with network and epidemiological surveys to within 1%. For the period 2010-2020, APK forecasts a decline in HCV prevalence of 0.8% per year from 44(+/- 2)% to 36(+/- 5)%, although some sub-populations would continue to have relatively high prevalence, including Non-Hispanic Blacks, 48(+/- 5)%. The rate of decline will be lowest in Non-Hispanic Whites and we find, in a reversal of historical trends, that incidence among non-Hispanic Whites would exceed incidence among Non-Hispanic Blacks (0.66 per 100 per years vs 0.17 per 100 person years). APK also forecasts an increase in PWID mean age from 35(+/- 1) to 40(+/- 2) with a corresponding increase from 59 (+/- 2)% to 80(+/- 6)% in the proportion of the population >30 years old. Our studies highlight the importance of analyzing subpopulations in disease predictions, the utility of computer simulation for analyzing demographic and health trends among PWID and serve as a tool for guiding intervention and prevention strategies in Chicago, and other major cities.	[Gutfraind, Alexander; Boodram, Basmattee] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60064 USA; [Gutfraind, Alexander; Dahari, Harel] Loyola Univ, Med Ctr, Dept Med, Program Expt & Theoret Modeling, Maywood, IL 60153 USA; [Gutfraind, Alexander; Major, Marian E.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Prachand, Nikhil] Chicago Dept Publ Hlth, STI HIV Surveillance, Chicago, IL USA; [Hailegiorgis, Atesmachew] George Mason Univ, Dept Computat Social Sci, Fairfax, VA 22030 USA; [Dahari, Harel] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Loyola University Chicago; US Food & Drug Administration (FDA); Chicago Department of Public Health; George Mason University; United States Department of Energy (DOE); Los Alamos National Laboratory	Gutfraind, A (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60064 USA.	agutfrai@uic.edu; marian.major@fda.hhs.gov			National Institutes of Health [P20-GM103452, R01-AI078881]; Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER); University of Illinois at Chicago (UIC) Areas of Excellence Award; National Science Foundation [OCI-1053575]; U.S. Department of Energy [DE-AC52-06NA25396]; TACC at the University of Texas at Austin; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452, P30GM110907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER); University of Illinois at Chicago (UIC) Areas of Excellence Award; National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); TACC at the University of Texas at Austin; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by National Institutes of Health [http://www.nih.gov/] grant P20-GM103452 and R01-AI078881 to HD, Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) intramural research funds [http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CBER/default.htm] to MM, University of Illinois at Chicago (UIC) Areas of Excellence Award [http://www.uic.edu/uic/] to BB. Computational experiments were supported through the National Science Foundation's [www.nsf.gov] XSEDE supercomputing system through grant number OCI-1053575 to AG. Portion of this work were done under the auspices of the U.S. Department of Energy under contract DE-AC52-06NA25396. Additional computing training and resources were awarded by TACC at the University of Texas at Austin to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Amon JJ, 2008, CLIN INFECT DIS, V46, P1852, DOI 10.1086/588297; ANDERSON R M, 1991; Armstrong GL, 2007, ARCH INTERN MED, V167, P166, DOI 10.1001/archinte.167.2.166; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Boodram B, 2010, DRUG ALCOHOL DEPEN, V111, P136, DOI 10.1016/j.drugalcdep.2010.04.003; Boodram B, 2011, DRUG ALCOHOL DEPEN, V119, P166, DOI 10.1016/j.drugalcdep.2011.06.005; Brewer DD, 2006, J INFECT DIS, V194, P764, DOI 10.1086/505585; Broz D, 2008, DRUG ALCOHOL DEPEN, V94, P221, DOI 10.1016/j.drugalcdep.2007.11.020; Broz D, 2014, AIDS BEHAV, V18, pS284, DOI 10.1007/s10461-013-0660-4; CDC, 2008, JAMA-J AM MED ASSOC, V300, P34; CDC, 2011, JAMA-J AM MED ASSOC, V306, P2448; CDC. Centers for Disease Control and Prevention, 2012, VIR HEP DRUG US; CDC. Centers for Disease Control and Prevention, 2014, HCV STAT; Cousien A, 2015, J VIRAL HEPATITIS, V22, P213, DOI 10.1111/jvh.12337; Dahari H, 2005, GASTROENTEROLOGY, V128, P1056, DOI 10.1053/j.gastro.2005.01.049; Dahari H, 2010, GASTROENTEROLOGY, V139, P965, DOI 10.1053/j.gastro.2010.05.077; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Del Valle S. Y., 2013, MODELING INTERPLAY H, P59; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Feinstone SM, 2012, CLIN INFECT DIS, V55, pS25, DOI 10.1093/cid/cis362; Garfein RS, 2007, DRUG ALCOHOL DEPEN, V91, pS4, DOI 10.1016/j.drugalcdep.2007.05.007; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grebely J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097726; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Hagan H, 2007, INT J DRUG POLICY, V18, P341, DOI 10.1016/j.drugpo.2007.01.016; Hahn JA, 2009, EPIDEMICS-NETH, V1, P47, DOI 10.1016/j.epidem.2008.10.002; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hickman M, 2003, J URBAN HEALTH, V80, P274, DOI 10.1093/jurban/jtg030; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Huo DZ, 2007, JAIDS-J ACQ IMM DEF, V45, P108, DOI 10.1097/QAI.0b013e318050d260; Hutchinson SJ, 2006, INT J DRUG POLICY, V17, P211, DOI 10.1016/j.drugpo.2006.02.008; Iman R.L., 2008, ENCY QUANTITATIVE RI, DOI DOI 10.1002/9780470061596.RISK0299; Kane A, 1999, B WORLD HEALTH ORGAN, V77, P801; Lansky A, 2007, PUBLIC HEALTH REP, V122, P48, DOI 10.1177/00333549071220S108; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mackesy-Amiti ME, 2013, AIDS BEHAV, V17, P2459, DOI 10.1007/s10461-012-0335-6; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Mather D, 1999, EUR J EPIDEMIOL, V15, P5, DOI 10.1023/A:1007548307196; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Mniszewski SM, 2014, INTEL SYST REF LIBR, V52, P97, DOI 10.1007/978-3-642-39149-1_8; National Institute of Drug Abuse, 2011, EP TRENDS DRUG AB P, VII; National Institute of Drug Abuse, 2010, EPIDEMIOLOGIC TRENDS, VII; Neaigus A, 2006, JAIDS-J ACQ IMM DEF, V41, P493, DOI 10.1097/01.qai.0000186391.49205.3b; Neaigus A, 2007, J INFECT DIS, V195, P1052, DOI 10.1086/512081; North M.J., 2007, MANAGING BUSINESS CO; North MJ, 2006, ACM T MODEL COMPUT S, V16, P1, DOI 10.1145/1122012.1122013; Onofrey S, 2011, JAMA-J AM MED ASSOC, V305, P2511; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Rolls DA, 2012, J THEOR BIOL, V297, P73, DOI 10.1016/j.jtbi.2011.12.008; Strickland GT, 2008, LANCET INFECT DIS, V8, P379, DOI 10.1016/S1473-3099(08)70126-9; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Thorpe LE, 2001, J ACQ IMMUN DEF SYND, V27, P71, DOI 10.1097/00126334-200105010-00012; Tsui JI, 2014, JAMA INTERN MED, V174, P1974, DOI 10.1001/jamainternmed.2014.5416; VANDENHOEK JAR, 1990, J INFECT DIS, V162, P823, DOI 10.1093/infdis/162.4.823; Vickerman P, 2007, INT J EPIDEMIOL, V36, P396, DOI 10.1093/ije/dyl276; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wylie JL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-229; Youm Y, 2009, J URBAN HEALTH, V86, pS107, DOI 10.1007/s11524-009-9371-6	67	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137993	10.1371/journal.pone.0137993	http://dx.doi.org/10.1371/journal.pone.0137993			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421722	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700024
J	Jacobs, CE; Main, MB				Jacobs, Caitlin E.; Main, Martin B.			A Conservation-Based Approach to Compensation for Livestock Depredation: The Florida Panther Case Study	PLOS ONE			English	Article							LARGE CARNIVORE DEPREDATION; SELECTION; MODELS; PUMAS; PERFORMANCE; LANDSCAPE; CONFLICT; HABITAT; RISK; DISTRIBUTIONS	Calf (Bos taurus) depredation by the federally endangered Florida panther (Puma concolor coryi) on ranches in southwest Florida is an important issue because ranches represent mixed landscapes that provide habitat critical to panther recovery. The objectives of this study were to (1) quantify calf depredation by panthers on two ranches in southwest Florida, and (2) develop a habitat suitability model to evaluate the quality of panther hunting habitat on ranchlands, assess whether the model could predict predation risk to calves, and discuss its potential to be incorporated into an incentive-based compensation program. We ear-tagged 409 calves with VHF transmitters on two ranches during 2011-2013 to document calf mortality. We developed a model to evaluate the quality of panther hunting habitat on private lands in southwest Florida using environmental variables obtained from the Florida Natural Areas Inventory (FNAI) Cooperative Landcover Database and nocturnal GPS locations of panthers provided by the Florida Fish and Wildlife Conservation Commission (FWC). We then tested whether the model could predict the location of calf depredation sites. Tagged calf loss to panthers varied between the two ranches (0.5%/yr to 5.3%/yr) and may have been influenced by the amount of panther hunting habitat on each ranch as the ranch that experienced higher depredation rates contained a significantly higher probability of panther presence. Depredation sites of tagged calves had a significantly greater probability of panther presence than depredation sites of untagged calves that were found by ranchers in open pastures. This suggests that there may be more calves killed in high risk environments than are being found and reported by ranchers and that panthers can hunt effectively in open environments. It also suggests that the model may provide a means for evaluating the quality of panther hunting habitat and the corresponding risk of depredation to livestock across the landscape. We suggest that our approach could be applied to prioritize and categorize private lands for participation in a Payment for Ecosystem Services program that compensates landowners for livestock loss and incentivizes conserving high quality habitat for large carnivores where livestock depredation is a concern.	[Jacobs, Caitlin E.; Main, Martin B.] Univ Florida, Inst Food & Agr Sci, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Jacobs, CE (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	caitlin.jacobs@gmail.com; mmain@ufl.edu	Main, Martin/AAT-1536-2020		U.S. Fish and Wildlife Service [F11AP00120]; University of Florida Institute of Food and Agricultural Sciences; Florida Defenders of Wildlife; Florida Fish and Wildlife Conservation Commission	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); University of Florida Institute of Food and Agricultural Sciences(University of Florida); Florida Defenders of Wildlife; Florida Fish and Wildlife Conservation Commission	Funding and support was provided by the U.S. Fish and Wildlife Service (Grant Agreement No. F11AP00120), the University of Florida Institute of Food and Agricultural Sciences (internal funding), Florida Defenders of Wildlife (loan of trail cameras), and Florida Fish and Wildlife Conservation Commission (technical support confirming panther kills and conducting necropsies).	Abade L, 2014, BIOL CONSERV, V180, P241, DOI 10.1016/j.biocon.2014.10.005; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barnes M., 2013, KEYSTONES RANGELAND; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Breck SW, 2011, BIOL CONSERV, V144, P930, DOI 10.1016/j.biocon.2010.12.014; Chen E., 1990, ECOSYSTEMS FLORIDA, P11; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; Elbroch LM, 2013, J MAMMAL, V94, P259, DOI 10.1644/12-MAMM-A-041.1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Florida Fish and Wildlife Conservation Commission, 2014, FWCS QUICK MAPS; Florida Fish and Wildlife Conservation Commission (FWC), 2014, ANN REP RES MAN FLOR; Garrison E, 2006, ECOLOGY MANAGEMENT W; Gehring TM, 2010, BIOSCIENCE, V60, P299, DOI 10.1525/bio.2010.60.4.8; Gervasi V, 2013, ECOL APPL, V23, P1722, DOI 10.1890/12-1615.1; Giuliano WM., WILD HOGS FLORIDA EC; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jacobs CE, 2014, THESIS U FLORIDA; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Kissling WD, 2009, ECOGRAPHY, V32, P807, DOI 10.1111/j.1600-0587.2009.05781.x; Laundre JW, 2003, WILDLIFE BIOL, V9, P123, DOI 10.2981/wlb.2003.034; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Leyhausen P., 1979, CAT BEHAV PREDATOR S; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Logan K.A., 2001, DESERT PUMA EVOLUTIO; MAEHR DS, 1990, J WILDLIFE MANAGE, V54, P420, DOI 10.2307/3809651; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McBride RT, 2008, SOUTHEAST NAT, V7, P381, DOI 10.1656/1528-7092-7.3.381; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Michalski F, 2006, ANIM CONSERV, V9, P179, DOI 10.1111/j.1469-1795.2006.00025.x; MONTAG J, 2003, CARNIVORE DAMAGE PRE, V6, P2; Nelson Fred, 2009, Human Dimensions of Wildlife, V14, P381, DOI 10.1080/10871200903045228; Nyhus PJ, 2005, CONSERV BIOL SER, V9, P107; Olden JD, 2002, T AM FISH SOC, V131, P329, DOI 10.1577/1548-8659(2002)131<0329:PMOFSD>2.0.CO;2; Onorato DP, 2011, ANIM CONSERV, V14, P196, DOI 10.1111/j.1469-1795.2010.00415.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; Poor EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049390; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Rosas-Rosas OC, 2008, HUMAN WILDLIFE INTER, V4, P103; Ross PI, 1997, CAN J ZOOL, V75, P771, DOI 10.1139/z97-098; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Swenson JE, 2005, CONSERV BIOL SER, V9, P323; Thurfjell H, 2009, EUR J WILDLIFE RES, V55, P517, DOI 10.1007/s10344-009-0268-1; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; US Fish and Wildlife Service (USFWS), 2008, FLOR PANTH REC PLAN; Waller DM, 1999, WILDLIFE SOC B, V25, P217; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zabel A, 2008, CONSERV BIOL, V22, P247, DOI 10.1111/j.1523-1739.2008.00898.x; Zarco-Gonzalez MM, 2013, BIOL CONSERV, V159, P80, DOI 10.1016/j.biocon.2012.11.007	57	8	8	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139203	10.1371/journal.pone.0139203	http://dx.doi.org/10.1371/journal.pone.0139203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421433	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700078
J	Westergard, T; Salari, R; Martin, JV; Brannigan, G				Westergard, Thomas; Salari, Reza; Martin, Joseph V.; Brannigan, Grace			Interactions of L-3,5,4 '-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABA(A) Receptor: Evidence for Overlapping Intersubunit Binding Modes	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GENERAL ANESTHETIC ACTIONS; ADULT MALE RATS; THYROID-HORMONES; ACUTE MICROINJECTIONS; MOLECULAR-MECHANISMS; L-TRIIODOTHYRONINE; CHLORIDE CURRENTS; PREOPTIC REGION; FORCE-FIELD	Structural mechanisms of modulation of gamma-aminobutyric acid (GABA) type A receptors by neurosteroids and hormones remain unclear. The thyroid hormone L-3,5,3'-triiodothyronine (T3) inhibits GABA(A) receptors at micromolar concentrations and has common features with neurosteroids such as allopregnanolone (ALLOP). Here we use functional experiments on alpha(2)beta(1)gamma(2) GABA(A) receptors expressed in Xenopus oocytes to detect competitive interactions between T3 and an agonist (ivermectin, IVM) with a crystallographically determined binding site at subunit interfaces in the transmembrane domain of a homologous receptor (glutamate-gated chloride channel, GluCl). T3 and ALLOP also show competitive effects, supporting the presence of both a T3 and ALLOP binding site at one or more subunit interfaces. Molecular dynamics (MD) simulations over 200 ns are used to investigate the dynamics and energetics of T3 in the identified intersubunit sites. In these simulations, T3 molecules occupying all intersubunit sites (with the exception of the alpha-beta interface) display numerous energetically favorable conformations with multiple hydrogen bonding partners, including previously implicated polar/acidic sidechains and a structurally conserved deformation in the M1 backbone.	[Westergard, Thomas] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [Westergard, Thomas; Salari, Reza; Martin, Joseph V.; Brannigan, Grace] Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA; [Salari, Reza; Brannigan, Grace] Rutgers State Univ, Dept Phys, Camden, NJ 08102 USA; [Martin, Joseph V.] Rutgers State Univ, Dept Biol, Camden, NJ 08102 USA	Jefferson University; Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick	Brannigan, G (corresponding author), Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA.	grace.brannigan@rutgers.edu	Brannigan, Grace/ABA-2750-2021; Martin, Joseph/M-9744-2019	Brannigan, Grace/0000-0001-8949-2694; Martin, Joseph/0000-0003-3757-3091	National Science Foundation [MCB1330728, DBI1126052]; National Science Foundation XSEDE program [MCB110149]; Div Of Biological Infrastructure [1126052] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Science Foundation XSEDE program; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation [MCB1330728], 'http://www.nsf.gov/div/index.jsp?div=MCB, JM, GB; National Science Foundation [DBI1126052], http://www.nsf.gov/div/index.jsp?div=DBI, TW, RS, GB; and National Science Foundation XSEDE program [MCB110149], https://www.xsede.org/, TW, GB.	Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Belelli D, 1999, NEUROCHEM INT, V34, P447, DOI 10.1016/S0197-0186(99)00037-6; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Chapell R, 1998, EUR J PHARMACOL, V349, P115, DOI 10.1016/S0014-2999(98)00182-4; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Chisari M, 2010, TRENDS NEUROSCI, V33, P299, DOI 10.1016/j.tins.2010.03.005; Colquhoun D, 2007, TRENDS PHARMACOL SCI, V28, P608, DOI 10.1016/j.tips.2007.09.011; Covey DF, 2001, BRAIN RES REV, V37, P91, DOI 10.1016/S0165-0173(01)00126-6; Dawson GR, 2000, J PHARMACOL EXP THER, V295, P1051; DEESCOBAR GM, 1994, ENDOCRINOLOGY, V134, P2410; Dratman MB, 1996, THYROID, V6, P639, DOI 10.1089/thy.1996.6.639; DRATMAN MB, 1978, AM J PHYSIOL, V235, pE638, DOI 10.1152/ajpendo.1978.235.6.E638; DRATMAN MB, 1982, SCIENCE, V215, P309, DOI 10.1126/science.7053582; DRATMAN MB, 1976, P NATL ACAD SCI USA, V73, P941, DOI 10.1073/pnas.73.3.941; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Henin J, 2014, BIOPHYS J, V106, P1938, DOI 10.1016/j.bpj.2014.03.024; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hosie AM, 2007, PHARMACOL THERAPEUT, V116, P7, DOI 10.1016/j.pharmthera.2007.03.011; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Hu LY, 2013, PLOS ONE, V8, pe7305; HU YF, 1993, J MED CHEM, V36, P3956, DOI 10.1021/jm00076a025; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; KRUSEK J, 1994, EUR J PHARMACOL, V259, P121, DOI 10.1016/0014-2999(94)90500-2; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; Lynagh T, 2012, TRENDS PHARMACOL SCI, V33, P432, DOI 10.1016/j.tips.2012.05.002; Lynagh T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00060; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martin JV, 2013, BRAIN RES, V1516, P45, DOI 10.1016/j.brainres.2013.01.032; Martin JV, 1996, NEUROSCIENCE, V73, P705, DOI 10.1016/0306-4522(96)00052-8; Martin JV, 2004, BRAIN RES, V1004, P98, DOI 10.1016/j.brainres.2003.12.043; MASON GA, 1993, NEUROPSYCHOPHARMACOL, V8, P253, DOI 10.1038/npp.1993.28; Miller KW, 2002, BRIT J ANAESTH, V89, P17, DOI 10.1093/bja/aef167; Miller PS, 2014, CRYSTAL STRUCTURE HU; Mitchell EA, 2008, NEUROCHEM INT, V52, P588, DOI 10.1016/j.neuint.2007.10.007; Moffett SX, 2013, BRAIN RES, V1516, P55, DOI 10.1016/j.brainres.2013.04.017; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murail S, 2011, BIOPHYS J, V100, P1642, DOI 10.1016/j.bpj.2011.02.032; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; OBREGON MJ, 1978, ENDOCRINOLOGY, V103, P2145, DOI 10.1210/endo-103-6-2145; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Sarkar PK, 1998, NEUROREPORT, V9, P1149, DOI 10.1097/00001756-199804200-00035; Shen WX, 1999, NEUROPHARMACOLOGY, V38, P267, DOI 10.1016/S0028-3908(98)00172-5; Stewart DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111470; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yoluk O, 2013, BIOPHYS J, V105, P640, DOI 10.1016/j.bpj.2013.06.037	62	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139072	10.1371/journal.pone.0139072	http://dx.doi.org/10.1371/journal.pone.0139072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421724	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700066
J	Schonrock-Adema, J; Visscher, M; Raat, ANJ; Brand, PLP				Schonrock-Adema, Johanna; Visscher, Maartje; Raat, A. N. Janet; Brand, Paul L. P.			Development and Validation of the Scan of Postgraduate Educational Environment Domains (SPEED): A Brief Instrument to Assess the Educational Environment in Postgraduate Medical Education	PLOS ONE			English	Article							LEARNING-ENVIRONMENT; HEALTH-PROFESSIONS; OPERATING-THEATER; CONSENSUS METHODS; STUDENTS LEARN; QUALITY	Introduction Current instruments to evaluate the postgraduate medical educational environment lack theoretical frameworks and are relatively long, which may reduce response rates. We aimed to develop and validate a brief instrument that, based on a solid theoretical framework for educational environments, solicits resident feedback to screen the postgraduate medical educational environment quality. Methods Stepwise, we developed a screening instrument, using existing instruments to assess educational environment quality and adopting a theoretical framework that defines three educational environment domains: content, atmosphere and organization. First, items from relevant existing instruments were collected and, after deleting duplicates and items not specifically addressing educational environment, grouped into the three domains. In a Delphi procedure, the item list was reduced to a set of items considered most important and comprehensively covering the three domains. These items were triangulated against the results of semi-structured interviews with 26 residents from three teaching hospitals to achieve face validity. This draft version of the Scan of Postgraduate Educational Environment Domains (SPEED) was administered to residents in a general and university hospital and further reduced and validated based on the data collected. Results Two hundred twenty-three residents completed the 43-item draft SPEED. We used half of the dataset for item reduction, and the other half for validating the resulting SPEED (15 items, 5 per domain). Internal consistencies were high. Correlations between domain scores in the draft and brief versions of SPEED were high (>0.85) and highly significant (p<0.001). Domain score variance of the draft instrument was explained for >= 80% by the items representing the domains in the final SPEED. Conclusions The SPEED comprehensively covers the three educational environment domains defined in the theoretical framework. Because of its validity and brevity, the SPEED is promising as useful and easily applicable tool to regularly screen educational environment quality in postgraduate medical education.	[Schonrock-Adema, Johanna; Raat, A. N. Janet; Brand, Paul L. P.] Univ Groningen, Univ Med Ctr Groningen, Inst Med Educ, Ctr Educ Dev & Res Hlth Sci, Groningen, Netherlands; [Visscher, Maartje; Brand, Paul L. P.] Univ Groningen, Univ Med Ctr Groningen, Postgrad Sch Med, Groningen, Netherlands; [Brand, Paul L. P.] Isala Hosp, Princess Amalia Childrens Ctr, Zwolle, Netherlands	University of Groningen; University of Groningen	Schonrock-Adema, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Inst Med Educ, Ctr Educ Dev & Res Hlth Sci, Groningen, Netherlands.	j.schonrock-adema@umcg.nl; p.l.p.brand@isala.nl	Brand, Paul/ABB-3693-2021; Schönrock-Adema, Johanna/P-2397-2019	Schönrock-Adema, Johanna/0000-0002-9844-339X				Boor K, 2011, MED TEACH, V33, P820, DOI 10.3109/0142159X.2010.541533; Bordage G, 2009, MED EDUC, V43, P312, DOI 10.1111/j.1365-2923.2009.03295.x; Cassar K, 2004, MED TEACH, V26, P260, DOI 10.1080/0142159042000191975; Dornan T, 2005, MED EDUC, V39, P356, DOI 10.1111/j.1365-2929.2005.02112.x; Dornan T, 2014, ADV HEALTH SCI EDUC, V19, P721, DOI 10.1007/s10459-014-9501-0; Edwards P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Eva KW, 2008, MED EDUC, V42, P752, DOI 10.1111/j.1365-2923.2008.03135.x; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Fluit C, 2012, MED TEACH, V34, P893, DOI 10.3109/0142159X.2012.699114; Fluit CRMG, 2010, J GEN INTERN MED, V25, P1337, DOI 10.1007/s11606-010-1458-y; Hagg-Martinell A, 2014, EDUC HEALTH, V27, P15, DOI 10.4103/1357-6283.134296; Holt MC, 2004, MED TEACH, V26, P553, DOI 10.1080/01421590410001711599; INSEL PM, 1974, AM PSYCHOL, V29, P179, DOI 10.1037/h0035994; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kaphagawani NC, 2013, STUD ETHNO-MED, V7, P181, DOI 10.1080/09735070.2013.11886459; Lombarts KMJMH, 2009, ANESTHESIOLOGY, V111, P709, DOI 10.1097/ALN.0b013e3181b76516; Lyon PMA, 2003, MED EDUC, V37, P680, DOI 10.1046/j.1365-2923.2003.01583.x; Moos R. H., 1974, SOCIAL CLIMATE SCALE; MOOS RH, 1973, AM PSYCHOL, V28, P652, DOI 10.1037/h0035722; Mulrooney A, 2005, MED TEACH, V27, P338, DOI 10.1080/01421590500150809; Porter S.R., 2004, NEW DIRECT INSTITUTI, V2004, P63, DOI [DOI 10.1002/IR.101, 10.1002/ir.101]; Prideaux D, 2002, MED EDUC, V36, P1114, DOI 10.1046/j.1365-2923.2002.01411.x; Ramani S, 2008, MED TEACH, V30, P347, DOI 10.1080/01421590802061613; Rees CE, 2010, MED EDUC, V44, P334, DOI 10.1111/j.1365-2923.2009.03615.x; Roff S, 2005, MED TEACH, V27, P353, DOI 10.1080/01421590500151039; Roff S, 2005, MED TEACH, V27, P322, DOI 10.1080/01421590500151054; Roff S, 2005, MED TEACH, V27, P326, DOI 10.1080/01421590500150874; Roszkowski M.J., 1990, J BUSINESS PSYCHOL, V4, P495, DOI [10.1007/BF01013611, DOI 10.1007/BF01013611]; Sahlqvist S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-62; Schonrock-Adema J, 2012, ADV HEALTH SCI EDUC, V17, P727, DOI 10.1007/s10459-011-9346-8; Snell L, 2000, MED EDUC, V34, P862, DOI 10.1046/j.1365-2923.2000.00754.x; Soemantri D, 2010, MED TEACH, V32, P947, DOI 10.3109/01421591003686229; Stanton JM, 2002, PERS PSYCHOL, V55, P167, DOI 10.1111/j.1744-6570.2002.tb00108.x; van Vendeloo SN, 2014, BONE JOINT J, V96B, P1133, DOI [10.1302/0301-620X.9668, 10.1302/0301-620X.96B8.33609]	35	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137872	10.1371/journal.pone.0137872	http://dx.doi.org/10.1371/journal.pone.0137872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EO	26413836	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700012
J	Capaldo, BJ; Roller, D; Axelrod, MJ; Koeppel, AF; Petricoin, EF; Slingluff, CL; Weber, MJ; Mackey, AJ; Gioeli, D; Bekiranov, S				Capaldo, Brian J.; Roller, Devin; Axelrod, Mark J.; Koeppel, Alex F.; Petricoin, Emanuel F.; Slingluff, Craig L., Jr.; Weber, Michael J.; Mackey, Aaron J.; Gioeli, Daniel; Bekiranov, Stefan			Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma	PLOS ONE			English	Article							IMPROVED SURVIVAL; RAF INHIBITION; IMMUNE ESCAPE; UP-REGULATION; CELL LINES; ACTIVATION; RESISTANCE; CANCER; GENE; PROLIFERATION	Fifty percent of cutaneous melanomas are driven by activated BRAF(V600E), but tumors treated with RAF inhibitors, even when they respond dramatically, rapidly adapt and develop resistance. Thus, there is a pressing need to identify the major mechanisms of intrinsic and adaptive resistance and develop drug combinations that target these resistance mechanisms. In a combinatorial drug screen on a panel of 12 treatment-naive BRAFV600E mutant melanoma cell lines of varying levels of resistance to mitogen-activated protein kinase (MAPK) pathway inhibition, we identified the combination of PLX4720, a targeted inhibitor of mutated BRaf, and lapatinib, an inhibitor of the ErbB family of receptor tyrosine kinases, as synergistically cytotoxic in the subset of cell lines that displayed the most resistance to PLX4720. To identify potential mechanisms of resistance to PLX4720 treatment and synergy with lapatinib treatment, we performed a multi-platform functional genomics analysis to profile the genome as well as the transcriptional and proteomic responses of these cell lines to treatment with PLX4720. We found modest levels of resistance correlated with the zygosity of the BRAF V600E allele and receptor tyrosine kinase (RTK) mutational status. Layered over base-line resistance was substantial upregulation of many ErbB pathway genes in response to BRaf inhibition, thus generating the vulnerability to combination with lapatinib. The transcriptional responses of ErbB pathway genes are associated with a number of transcription factors, including ETS2 and its associated cofactors that represent a convergent regulatory mechanism conferring synergistic drug susceptibility in the context of diverse mutational landscapes.	[Capaldo, Brian J.; Bekiranov, Stefan] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Roller, Devin; Axelrod, Mark J.; Weber, Michael J.; Gioeli, Daniel] Univ Virginia, Dept Microbiol Immunol & Canc, Charlottesville, VA USA; [Koeppel, Alex F.] Univ Virginia, Bioinfomat Core Facil, Charlottesville, VA USA; [Petricoin, Emanuel F.] George Mason Univ, Ctr Appl Prote & Mol Med, Sch Syst Biol, Coll Sci, Manassas, VA USA; [Slingluff, Craig L., Jr.] Univ Virginia, Dept Surg, Charlottesville, VA USA; [Mackey, Aaron J.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; George Mason University; University of Virginia; University of Virginia	Bekiranov, S (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	sb3de@virginia.edu		Capaldo, Brian/0000-0003-1244-8884	Melanoma Research Alliance; UVA Cancer Center [DR01510 113573]; National Cancer Institute [R01 CA178338]; NATIONAL CANCER INSTITUTE [P30CA044579, R01CA178338] Funding Source: NIH RePORTER	Melanoma Research Alliance; UVA Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Young Investigator Award from the Melanoma Research Alliance (www.curemelanoma.org) to AJM, a UVA Cancer Center (http://cancer.uvahealth.com) Farrow Fellowship (DR01510 113573) to BJC, and R01 grant support: National Cancer Institute (R01 CA178338, DG).	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; DARROW TL, 1989, J IMMUNOL, V142, P3329; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Federici G, 2013, MOL CANCER RES, V11, P676, DOI 10.1158/1541-7786.MCR-12-0690; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Held MA, 2013, CANCER DISCOV, V3, P52, DOI 10.1158/2159-8290.CD-12-0408; Hertzman Johansson C, 2013, MELANOMA RES; Holderfield M, 2014, BRIT J CANCER, V111, P640, DOI 10.1038/bjc.2014.139; Improta G, 2011, J PROTEOME RES, V10, P3089, DOI 10.1021/pr200065t; Ji ZY, 2015, J INVEST DERMATOL, V135, P1863, DOI 10.1038/jid.2015.105; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kugel CH, 2014, CANCER RES, V74, P4122, DOI 10.1158/0008-5472.CAN-14-0464; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Levin-Gromiko U, 2014, CARCINOGENESIS, V35, P2555, DOI 10.1093/carcin/bgu178; Li QL, 2014, ONCOTARGET, V5, P6387, DOI 10.18632/oncotarget.2201; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Molhoek KR, 2011, MELANOMA RES, V21, P274, DOI 10.1097/CMR.0b013e328343a1d6; Molhoek KR, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-39; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Oike T, 2013, JPN J CLIN ONCOL, V43, P849, DOI 10.1093/jjco/hyt101; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sapkota B, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22890; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shtivelman E, 2014, ONCOTARGET, V5, P1701, DOI 10.18632/oncotarget.1892; Slingluff CL, 2000, CANCER IMMUNOL IMMUN, V48, P661, DOI 10.1007/s002620050015; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Teven CM, 2014, GENES DIS, V1, P199, DOI 10.1016/j.gendis.2014.09.005; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Xu SX, 2015, DNA CELL BIOL, V34, P69, DOI 10.1089/dna.2014.2590; Yamshchikov GV, 2005, J IMMUNOL, V174, P6863, DOI 10.4049/jimmunol.174.11.6863; Zhang KM, 2013, PIGM CELL MELANOMA R, V26, P408, DOI 10.1111/pcmr.12089	66	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138210	10.1371/journal.pone.0138210	http://dx.doi.org/10.1371/journal.pone.0138210			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405815	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700037
J	Ho, NF; Chong, JSX; Koh, HL; Koukouna, E; Lee, TS; Fung, D; Lim, CG; Zhou, J				Ho, New-Fei; Chong, Joanna S. X.; Koh, Hui Li; Koukouna, Eleni; Lee, Tih-Shih; Fung, Daniel; Lim, Choon Guan; Zhou, Juan			Intrinsic Affective Network Is Impaired in Children with Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; FUNCTIONAL CONNECTIVITY MRI; AUTISM SPECTRUM DISORDERS; MEDICATION-NAIVE CHILDREN; EMOTIONAL SELF-REGULATION; PREFRONTAL CORTEX; BEHAVIOR CHECKLIST; HUMAN AMYGDALA; HUMAN BRAIN; FOLLOW-UP	Deficits in impulsivity and affect dysregulation are key features of attention-deficit/hyperactivity disorder (ADHD) besides impairing levels of hyperactivity and/or inattention. However, the neural substrates underlying these traits are relatively under-investigated. In this study, we use resting-state functional magnetic resonance imaging to test the hypothesis of diminished functional integration within the affective/limbic network (which includes the amygdala, hippocampus, subgenual cingulate cortex, orbitofrontal cortex and nucleus accumbens) of children with ADHD, which is associated with their behavioral measures of emotional control deficits. Resting state-fMRI data were obtained from 12 healthy control subjects and 15 children with ADHD, all who had a minimum one-month washout period for medications and supplements. Children with ADHD demonstrated less integrated affective network, evidenced by increased bilateral amygdalar and decreased left orbitofrontal connectivity within the affective network compared to healthy controls. The hyper-connectivity at the left amygdalar within the affective network was associated with increased aggressiveness and conduct problems, as well as decline in functioning in children with ADHD. Similar findings in affective network dysconnectivity were replicated in a subset of children with ADHD three months later. Our findings of divergent changes in amygdala and orbitofrontal intrinsic connectivity support the hypothesis of an impaired functional integration within the affective network in childhood ADHD. Larger prospective studies of the intrinsic affective network in ADHD are required, which may provide further insight on the biological mechanisms of emotional control deficits observed in ADHD.	[Ho, New-Fei; Chong, Joanna S. X.; Koh, Hui Li; Lee, Tih-Shih; Zhou, Juan] Duke Natl Univ Singapore, Grad Sch Med, Ctr Cognit Neurosci, Neurosci & Behav Disorders Program, Singapore, Singapore; [Ho, New-Fei] Inst Mental Hlth, Div Res, Singapore, Singapore; [Koh, Hui Li; Koukouna, Eleni; Fung, Daniel; Lim, Choon Guan] Inst Mental Hlth, Dept Child & Adolescent Psychiat, Singapore, Singapore; [Zhou, Juan] Natl Univ Singapore, Agcy Sci Technol & Research, Clin Imaging Res Ctr, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); National University of Singapore	Zhou, J (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Ctr Cognit Neurosci, Neurosci & Behav Disorders Program, Singapore, Singapore.	helen.zhou@duke-nus.edu.sg	Fung, Daniel S S/W-6915-2019; Ho, NF/R-1144-2019; Sheng, Daniel Fung Shuen/AAN-9385-2021; Fung, Daniel/AAF-4775-2020	Sheng, Daniel Fung Shuen/0000-0003-0718-9363; , newfei/0000-0002-0456-3391; Zhou, Juan/0000-0002-0180-8648	National Medical Research Council (NMRC) [NIG11may025]; Duke-NUS Graduate Medical School Signature Research Program - Ministry of Health, Singapore	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Duke-NUS Graduate Medical School Signature Research Program - Ministry of Health, Singapore(Ministry of Health-SingaporeNational University of Singapore)	This research was supported by the National Medical Research Council (NMRC) Centre Grant (Institute of Mental Health [New-Fei Ho] and the NMRC New Investigator Grant NIG11may025 [Choon Guan Lim]). This research was also supported by Duke-NUS Graduate Medical School Signature Research Program funded by Ministry of Health, Singapore awarded to Juan Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Achenbach TM, 2014, ASEBA CHILD BEHAV CH; Althoff RR, 2010, J AM ACAD CHILD PSY, V49, P1105, DOI 10.1016/j.jaac.2010.08.006; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J., 2010, SPM8 MANUAL; Barkley RA, 2010, J AM ACAD CHILD PSY, V49, P503, DOI 10.1016/j.jaac.2010.01.019; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Biederman J, 2012, NEUROPSYCH DIS TREAT, V8, P267, DOI 10.2147/NDT.S29670; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brotman MA, 2010, AM J PSYCHIAT, V167, P61, DOI 10.1176/appi.ajp.2009.09010043; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Castellanos FX, 2009, CAN J PSYCHIAT, V54, P665, DOI 10.1177/070674370905401003; Cha J, 2015, NEUROPSYCHOPHARMACOL, V40, P1717, DOI 10.1038/npp.2015.18; Chabernaud C, 2012, BIOL PSYCHIAT, V71, P434, DOI 10.1016/j.biopsych.2011.08.013; Choi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083516; CLEMENTS SD, 1966, J LANCET, V86, P121; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cortese S, 2013, BIOL PSYCHIAT, V74, P591, DOI 10.1016/j.biopsych.2013.02.025; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dolan RJ, 2007, PHILOS T R SOC B, V362, P787, DOI 10.1098/rstb.2007.2088; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Gotham K, 2015, J AM ACAD CHILD PSY, V54, P369, DOI 10.1016/j.jaac.2015.02.005; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hulvershorn LA, 2014, J AM ACAD CHILD PSY, V53, P351, DOI 10.1016/j.jaac.2013.11.012; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Kucyi A, 2015, HUM BRAIN MAPP; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li F, 2014, RADIOLOGY, V272, P514, DOI 10.1148/radiol.14131622; MACLEAN PD, 1955, ARCH NEURO PSYCHIATR, V73, P130, DOI 10.1001/archneurpsyc.1955.02330080008004; Mazzone L, 2013, RES DEV DISABIL, V34, P3699, DOI 10.1016/j.ridd.2013.07.034; McCarthy H, 2013, JAMA PSYCHIAT, V70, P1329, DOI 10.1001/jamapsychiatry.2013.2174; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Mueller S, 2014, HUM BRAIN MAPP, V35, P5379, DOI 10.1002/hbm.22557; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Posner J, 2013, PSYCHIAT RES-NEUROIM, V213, P24, DOI 10.1016/j.pscychresns.2013.01.004; Posner J, 2011, J AM ACAD CHILD PSY, V50, P828, DOI 10.1016/j.jaac.2011.05.010; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ray S, 2014, HUM BRAIN MAPP, V35, P6032, DOI 10.1002/hbm.22603; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Schulz KP, 2014, NEUROIMAGE-CLIN, V5, P1, DOI 10.1016/j.nicl.2014.05.016; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Spencer TJ, 2011, POSTGRAD MED, V123, P50, DOI 10.3810/pgm.2011.09.2459; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Surman CBH, 2013, ADHD-ATTEND DEFICIT, V5, P273, DOI 10.1007/s12402-012-0100-8; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vanderwal T, 2013, J AM ACAD CHILD PSY, V52, P562, DOI 10.1016/j.jaac.2013.03.004; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wehmeier PM, 2010, J ADOLESCENT HEALTH, V46, P209, DOI 10.1016/j.jadohealth.2009.09.009; WIMBERGER HC, 1968, J AMER ACAD CHILD PS, V7, P677, DOI 10.1016/S0002-7138(09)62187-7; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	77	11	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139018	10.1371/journal.pone.0139018	http://dx.doi.org/10.1371/journal.pone.0139018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406311	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700149
J	Kaur, G; Leslie, EM; Tillman, H; Lee, WM; Swanlund, DP; Karvellas, CJ				Kaur, Gurnit; Leslie, Elaine M.; Tillman, Holly; Lee, William M.; Swanlund, Diane P.; Karvellas, Constantine J.		US Acute Liver Failure Study Grp	Detection of Ophthalmic Acid in Serum from Acetaminophen-Induced Acute Liver Failure Patients Is More Frequent in Non-Survivors	PLOS ONE			English	Article							GLUTATHIONE; ACETYLCYSTEINE	Background/Aim Acetaminophen (APAP) hepatotoxicity is related to the formation of N-acetyl-p-benzoquinone imine (NAPQI), which is detoxified through conjugation with reduced glutathione (GSH). Ophthalmic acid (OA) is an analogue of GSH in which cysteine is replaced with 2-aminobutyrate. Metabolomics studies of mice with APAP-induced acute liver failure (APAP-ALF) identified OA as a marker of oxidative stress and hepatic GSH consumption. The aim of the current study was to determine whether OA is detectable in APAP-ALF human patients either early (day 2) or late (day 4) and whether OA levels were associated with in-hospital survival in the absence of liver transplant. Methods Serum samples from 130 APAP-ALF patients (82 survivors, 48 non-survivors) were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and correlated with clinical data from the United States Acute Liver Failure Study Group (US ALFSG) Registry (2004-2011). Results Survivors had significantly lower admission bilirubin (4.2 vs. 5.7 mg/dl) and lactate levels (3.3 vs. 6.5 mu mol/l, p<0.05 for all). During the first 7 days of the study, survivors were less likely to require mechanical ventilation (55% vs. 88%), vasopressor support (9.8% vs. 67%) or renal replacement therapy (26% vs. 63%, p<0.001 for all). Non-survivors were more likely to have detectable OA levels early (31% vs. 15%, p = 0.034) and late (27% vs. 11%, p = 0.02). However there were no significant differences in mean OA levels between non-survivors and survivors (early 0.48 vs. 0.36, late 0.43 vs. 0.37, P > 0.5 for all). Conclusion OA was detectable more frequently in APAP-ALF non-survivors but mean OA levels were not associated with survival. The routine clinical administration of N-acetyl cysteine could replenish GSH levels and prevent OA production.	[Kaur, Gurnit; Leslie, Elaine M.] Univ Alberta, Dept Lab Med, Pathol, Edmonton, AB, Canada; [Leslie, Elaine M.; Swanlund, Diane P.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Tillman, Holly] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Lee, William M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Karvellas, Constantine J.] Univ Alberta, Div Hepatol, Edmonton, AB, Canada; [Karvellas, Constantine J.] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; Medical University of South Carolina; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alberta; University of Alberta	Karvellas, CJ (corresponding author), Univ Alberta, Div Hepatol, Edmonton, AB, Canada.	dean.karvellas@ualberta.ca		Hynan, Linda/0000-0002-4642-7769; Karvellas, Constantine/0000-0002-1555-1089; Leslie, Elaine/0000-0003-1825-348X	NIH from NIDDK [U01 58369]; Transplant Fund Value Added; Canadian Institutes of Health Research [MOP-272075]	NIH from NIDDK; Transplant Fund Value Added; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was sponsored by NIH grant U01 58369 (from NIDDK). It was also supported by a grant from the Transplant Fund Value Added and the Canadian Institutes of Health Research [Grant MOP-272075]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, HEPATIC COMA SYNDROM; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; BERNUAU J, 1986, HEPATOLOGY, V6, P648, DOI 10.1002/hep.1840060417; Carretero A, 2014, ANAL BIOANAL CHEM, V406, P5465, DOI 10.1007/s00216-014-7983-5; DONALDSON BW, 1993, HEPATOLOGY, V18, P1370, DOI 10.1016/0270-9139(93)90226-D; Fagan E, 1996, BRIT MED J, V313, P1417, DOI 10.1136/bmj.313.7070.1417; Geenen S, 2011, J PHARMACEUT BIOMED, V54, P1128, DOI 10.1016/j.jpba.2010.11.038; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; KEAYS R, 1991, BRIT MED J, V303, P1026, DOI 10.1136/bmj.303.6809.1026; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; New LS, 2008, J CHROMATOGR SCI, V46, P209, DOI 10.1093/chromsci/46.3.209; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1993, LANCET, V342, P743, DOI 10.1016/0140-6736(93)91736-6; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	17	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139299	10.1371/journal.pone.0139299	http://dx.doi.org/10.1371/journal.pone.0139299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407170	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700205
J	Leblond, AL; Klinkert, K; Martin, K; Turner, EC; Kumar, AH; Browne, T; Caplice, NM				Leblond, Anne-Laure; Klinkert, Kerstin; Martin, Kenneth; Turner, Elizebeth C.; Kumar, Arun H.; Browne, Tara; Caplice, Noel M.			Systemic and Cardiac Depletion of M2 Macrophage through CSF-1R Signaling Inhibition Alters Cardiac Function Post Myocardial Infarction	PLOS ONE			English	Article							MONOCYTE SUBSETS; IN-VIVO; MICE; POLARIZATION; INFLAMMATION; IMPROVES; RUPTURE; GW2580; INJURY; REPAIR	The heart hosts tissue resident macrophages which are capable of modulating cardiac inflammation and function by multiple mechanisms. At present, the consequences of phenotypic diversity in macrophages in the heart are incompletely understood. The contribution of cardiac M2-polarized macrophages to the resolution of inflammation and repair response following myocardial infarction remains to be fully defined. In this study, the role of M2 macrophages was investigated utilising a specific CSF-1 receptor signalling inhibition strategy to achieve their depletion. In mice, oral administration of GW2580, a CSF-1R kinase inhibitor, induced significant decreases in Gr1(lo) and F4/80(hi) monocyte populations in the circulation and the spleen. GW2580 administration also induced a significant depletion of M2 macrophages in the heart after 1 week treatment as well as a reduction of cardiac arginase1 and CD206 gene expression indicative of M2 macrophage activity. In a murine myocardial infarction model, reduced M2 macrophage content was associated with increased M1-related gene expression (IL-6 and IL-1 beta), and decreased M2-related gene expression (Arginase1 and CD206) in the heart of GW2580-treated animals versus vehicle-treated controls. M2 depletion was also associated with a loss in left ventricular contractile function, infarct enlargement, decreased collagen staining and increased inflammatory cell infiltration into the infarct zone, specifically neutrophils and M1 macrophages. Taken together, these data indicate that CSF-1R signalling is critical for maintaining cardiac tissue resident M2-polarized macrophage population, which is required for the resolution of inflammation post myocardial infarction and, in turn, for preservation of ventricular function.	[Leblond, Anne-Laure; Klinkert, Kerstin; Martin, Kenneth; Turner, Elizebeth C.; Kumar, Arun H.; Browne, Tara; Caplice, Noel M.] Natl Univ Ireland Univ Coll Cork, Vasc Biol Res Ctr, Biosci Inst, Cork, Ireland	University College Cork	Caplice, NM (corresponding author), Natl Univ Ireland Univ Coll Cork, Vasc Biol Res Ctr, Biosci Inst, Coll Rd, Cork, Ireland.	n.caplice@ucc.ie	Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219; Leblond, Anne-Laure/0000-0003-4080-3126; Caplice, Noel/0000-0001-5445-1016; Klinkert, Kerstin/0000-0001-5268-3710	Science Foundation Ireland [09/SRC/B1794, 07/RFP/BIMF816, 10/IN.1/B3034]; Health Research Board, Dublin, Ireland [R11831-NMC]; National Biophotonics and Imaging Platform, Ireland; Irish Government's Programme for Research in Third Level Institutions, Cycle 4; Ireland's EU Structural Funds Programmes [RCSI/NBIP/CEMP11]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board, Dublin, Ireland; National Biophotonics and Imaging Platform, Ireland; Irish Government's Programme for Research in Third Level Institutions, Cycle 4; Ireland's EU Structural Funds Programmes	Grants were provided by Science Foundation Ireland (09/SRC/B1794,07/RFP/BIMF816, 10/IN.1/B3034), and Health Research Board, Dublin, Ireland (R11831-NMC); National Biophotonics and Imaging Platform, Ireland; the Irish Government's Programme for Research in Third Level Institutions, Cycle 4, and Ireland's EU Structural Funds Programmes 2007 to 2013 (RCSI/NBIP/CEMP11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2008, CARDIOVASC RES, V79, P395, DOI 10.1093/cvr/cvn097; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9; Conway JG, 2008, J PHARMACOL EXP THER, V326, P41, DOI 10.1124/jpet.107.129429; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Frangogiannis NG, 2006, ANTIOXID REDOX SIGN, V8, P1907, DOI 10.1089/ars.2006.8.1907; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Martin K, 2014, CURR PHARM DESIGN, V20, P1930, DOI 10.2174/13816128113199990450; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Priceman SJ, 2010, BLOOD, V115, P1461, DOI 10.1182/blood-2009-08-237412; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Sane DC, 2009, CARDIOL REV, V17, P293, DOI 10.1097/CRD.0b013e3181bf4ab4; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363	26	61	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0137515	10.1371/journal.pone.0137515	http://dx.doi.org/10.1371/journal.pone.0137515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407006	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700023
J	Paziewska, A; Cukrowska, B; Dabrowska, M; Goryca, K; Piatkowska, M; Kluska, A; Mikula, M; Karczmarski, J; Oralewska, B; Rybak, A; Socha, J; Balabas, A; Zeber-Lubecka, N; Ambrozkiewicz, F; Konopka, E; Trojanowska, I; Zagroba, M; Szperl, M; Ostrowski, J				Paziewska, Agnieszka; Cukrowska, Bozena; Dabrowska, Michalina; Goryca, Krzysztof; Piatkowska, Magdalena; Kluska, Anna; Mikula, Michal; Karczmarski, Jakub; Oralewska, Beata; Rybak, Anna; Socha, Jerzy; Balabas, Aneta; Zeber-Lubecka, Natalia; Ambrozkiewicz, Filip; Konopka, Ewa; Trojanowska, Ilona; Zagroba, Malgorzata; Szperl, Malgorzata; Ostrowski, Jerzy			Combination Testing Using a Single MSH5 Variant alongside HLA Haplotypes Improves the Sensitivity of Predicting Coeliac Disease Risk in the Polish Population	PLOS ONE			English	Article							EUROPEAN GENETICS CLUSTER; DQ; PREVALENCE; DIAGNOSIS; HMSH5	Assessment of non-HLA variants alongside standard HLA testing was previously shown to improve the identification of potential coeliac disease (CD) patients. We intended to identify new genetic variants associated with CD in the Polish population that would improve CD risk prediction when used alongside HLA haplotype analysis. DNA samples of 336 CD and 264 unrelated healthy controls were used to create DNA pools for a genome wide association study (GWAS). GWAS findings were validated with individual HLA tag single nucleotide polymorphism (SNP) typing of 473 patients and 714 healthy controls. Association analysis using four HLA-tagging SNPs showed that, as was found in other populations, positive predicting genotypes (HLA-DQ2.5/DQ2.5, HLA-DQ2.5/DQ2.2, and HLA-DQ2.5/DQ8) were found at higher frequencies in CD patients than in healthy control individuals in the Polish population. Both CD-associated SNPs discovered by GWAS were found in the CD susceptibility region, confirming the previously-determined association of the major histocompatibility (MHC) region with CD pathogenesis. The two most significant SNPs from the GWAS were rs9272346 (HLA-dependent; localized within 1 Kb of DQA1) and rs3130484 (HLA-independent; mapped to MSH5). Specificity of CD prediction using the four HLA-tagging SNPs achieved 92.9%, but sensitivity was only 45.5%. However, when a testing combination of the HLA-tagging SNPs and the MSH5 SNP was used, specificity decreased to 80%, and sensitivity increased to 74%. This study confirmed that improvement of CD risk prediction sensitivity could be achieved by including non-HLA SNPs alongside HLA SNPs in genetic testing.	[Paziewska, Agnieszka; Zeber-Lubecka, Natalia; Ambrozkiewicz, Filip; Ostrowski, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland; [Cukrowska, Bozena; Konopka, Ewa; Trojanowska, Ilona] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Dabrowska, Michalina; Goryca, Krzysztof; Piatkowska, Magdalena; Kluska, Anna; Mikula, Michal; Karczmarski, Jakub; Balabas, Aneta] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Genet, Warsaw, Poland; [Oralewska, Beata; Rybak, Anna; Socha, Jerzy] Childrens Mem Hlth Inst, Dept Gastroenerol Hepatol Nutr Disorders & Pediat, Warsaw, Poland; [Zagroba, Malgorzata] State Higher Sch Vocat Educ, Fac Hlth Protect & Human Sci, Ciechanow, Poland; [Szperl, Malgorzata] Cardinal Stefan Wyszynski Inst Cardiol, Dept Mol Biol, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Children's Memorial Health Institute; Maria Sklodowska-Curie National Research Institute of Oncology; Children's Memorial Health Institute	Ostrowski, J (corresponding author), Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland.	jostrow@warman.com.pl	Rybak, Anna/HGB-1849-2022; Mikula, Michal/G-8276-2011; Żeber-Lubecka, Natalia/AAL-8834-2020	Mikula, Michal/0000-0003-3447-7328; Żeber-Lubecka, Natalia/0000-0003-4036-3191; Piatkowska, Magdalena/0000-0001-8372-8002; Kluska, Anna/0000-0002-5087-6575; Balabas, Aneta/0000-0001-6078-9232; Konopka, Ewa/0000-0002-5686-1112; Karczmarski, Jakub/0000-0002-7976-0365; Dabrowska, Michalina/0000-0002-7585-4946; Aneta, Balabas/0000-0003-0228-7650; Ambrozkiewicz, Filip/0000-0001-6850-780X; Cukrowska, Bozena/0000-0001-6887-0094; Ostrowski, Jerzy/0000-0003-1363-3766; Paziewska, Agnieszka/0000-0002-6644-1509	National Science Centre [2011/02/A/NZ5/00339]; Children's Memorial Health Institute [Z221/2012, S135/2013]	National Science Centre(National Science Centre, Poland); Children's Memorial Health Institute	Supported by 2011/02/A/NZ5/00339 grant from the National Science Centre (JO), and Z221/2012 and S135/2013 grants from the Children's Memorial Health Institute (BC).	Bao F, 2012, ARCH PATHOL LAB MED, V136, P735, DOI 10.5858/arpa.2011-0572-RA; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clark N, 2013, CURR GENOMICS, V14, P81, DOI 10.2174/1389202911314020002; Developer TJA, 2012, EP EP TOOLS; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Fernando MMA, 2012, ANN RHEUM DIS, V71, P777, DOI 10.1136/annrheumdis-2011-200808; Gaj P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035307; Garampazzi A, 2007, J PEDIATR GASTR NUTR, V45, P611, DOI 10.1097/MPG.0b013e31814c3d79; Godfrey JD, 2010, GASTROENTEROLOGY, V139, P763, DOI 10.1053/j.gastro.2010.05.041; Hadithi M, 2007, ANN INTERN MED, V147, P294, DOI 10.7326/0003-4819-147-5-200709040-00003; Her C, 1998, GENOMICS, V52, P50, DOI 10.1006/geno.1998.5374; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Juyal G, 2014, GUT; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Lasky-Su J, 2012, CLIN EXP ALLERGY, V42, P1724, DOI 10.1111/cea.12000; Liu E, 2014, NEW ENGL J MED, V371, P42, DOI 10.1056/NEJMoa1313977; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; Megiorni F, 2008, AM J GASTROENTEROL, V103, P997, DOI 10.1111/j.1572-0241.2007.01716.x; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Pallav K, 2014, DIGEST DIS SCI, V59, P2199, DOI 10.1007/s10620-014-3143-1; Rampertab SD, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.044; Romanos J, 2014, GUT, V63, P415, DOI 10.1136/gutjnl-2012-304110; Salardi S, 2008, J PEDIATR GASTR NUTR, V46, P612, DOI 10.1097/MPG.0b013e31815d697e; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Turner SD, 2014, BIORXIV, DOI 10. 1101/005165 , 2014 .; Uenishi RH, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-36; Ventura A, 2002, GUT, V51, P897, DOI 10.1136/gut.51.6.897; Wroblova K, 2014, ACTA BIOCHIM POL, V61, P191; Yi W, 2005, BIOCHEM BIOPH RES CO, V332, P524, DOI 10.1016/j.bbrc.2005.04.154	31	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139197	10.1371/journal.pone.0139197	http://dx.doi.org/10.1371/journal.pone.0139197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406233	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700188
J	Su, YB; Liu, YM; Li, ZS; Fang, ZY; Yang, LM; Zhuang, M; Zhang, YY				Su, Yanbin; Liu, Yumei; Li, Zhansheng; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong			QTL Analysis of Head Splitting Resistance in Cabbage (Brassica oleracea L. var. capitata) Using SSR and InDel Makers Based on Whole-Genome Re-Sequencing	PLOS ONE			English	Article							LINKAGE MAP; GENETIC-MAP; PLASMODIOPHORA-BRASSICAE; FLOWERING TIME; RFLP MARKERS; INHERITANCE; TRAITS; CONSTRUCTION; POPULATION; LOCI	Head splitting resistance (HSR) in cabbage is an important trait closely related to both quality and yield of head. However, the genetic control of this trait remains unclear. In this study, a doubled haploid (DH) population derived from an intra-cross between head splitting-susceptible inbred cabbage line 79-156 and resistant line 96-100 was obtained and used to analyze inheritance and detect quantitative trait loci (QTLs) for HSR using a mixed major gene/polygene inheritance analysis and QTL mapping. HSR can be attributed to additive-epistatic effects of three major gene pairs combined with those of polygenes. Negative and significant correlations were also detected between head Hsr and head vertical diameter (Hvd), head transverse diameter (Htd) and head weight (Hw). Using the DH population, a genetic map was constructed with simple sequence repeat (SSR) and insertion-deletion (InDel) markers, with a total length of 1065.9 cM and average interval length of 4.4 cM between adjacent markers. Nine QTLs for HSR were located on chromosomes C3, C4, C7, and C9 based on 2 years of phenotypic data using both multiple-QTL mapping and inclusive composite interval mapping. The identified QTLs collectively explained 39.4 to 59.1% of phenotypic variation. Three major QTLs (Hsr 3.2, 4.2, 9.2) showing a relatively larger effect were robustly detected in different years or with different mapping methods. The HSR trait was shown to have complex genetic mechanisms. Results from QTL mapping and classical genetic analysis were consistent. The QTLs obtained in this study should be useful for molecular marker-assisted selection in cabbage breeding and provide a foundation for further research on HSR genetic regulation.	[Su, Yanbin; Liu, Yumei; Li, Zhansheng; Fang, Zhiyuan; Yang, Limei; Zhuang, Mu; Zhang, Yangyong] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China; [Su, Yanbin] Beijing Zhongnong Futong Hort Corp Ltd, Beijing 100083, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Liu, YM (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China.	liuyumei@caas.cn	Li, Zhansheng/L-8017-2019; Li, Zhansheng/M-9593-2019	Li, Zhansheng/0000-0003-0132-2741; fang, zhi yuan/0000-0003-1664-759X	National High Technology Research and Development Program (863 Program) of China [2012AA100104, 2012AA100105]; Key Projects in the National Science and Technology Pillar Program of China [2013BAD01B04]; China Agriculture Research System [CARS-25-A]; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences [CAAS-ASTIP-IVFCAAS]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Key Projects in the National Science and Technology Pillar Program of China; China Agriculture Research System; Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences	This work was supported by the National High Technology Research and Development Program (863 Program) of China (2012AA100104, 2012AA100105), the Key Projects in the National Science and Technology Pillar Program of China (2013BAD01B04), the China Agriculture Research System (CARS-25-A), the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, People's Republic of China, the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (Grant no. CAAS-ASTIP-IVFCAAS). YML received all the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, P S APPL STAT AMST N, P27; Anbessa Y, 2006, J HERED, V97, P55, DOI 10.1093/jhered/esj009; Brown AF, 2014, THEOR APPL GENET, V127, P2051, DOI 10.1007/s00122-014-2360-5; Budan S., 1999, EUR S FRUIT BREED GE, V538, P123; Camargo LEA, 1996, THEOR APPL GENET, V92, P610, DOI 10.1007/BF00224565; Chen Chen, 2010, Acta Horticulturae Sinica, V37, P221; Chen X, 2010, GENETICS, V186, P1053, DOI 10.1534/genetics.110.120311; Cheng LR, 2011, THEOR APPL GENET, V123, P421, DOI 10.1007/s00122-011-1594-8; CHIANG MS, 1972, EUPHYTICA, V21, P507, DOI 10.1007/BF00039347; CORTES C, 1983, SCI HORTIC-AMSTERDAM, V21, P323, DOI 10.1016/0304-4238(83)90122-X; Fahey JW, 1995, CUR TOP PL, V15, P87; Farinho M, 2004, THEOR APPL GENET, V109, P1392, DOI 10.1007/s00122-004-1747-0; Foisset N, 1996, THEOR APPL GENET, V93, P1017, DOI 10.1007/BF00230119; Gai J., 2003, GENETIC SYSTEM QUANT; Gai JY, 2000, EXPT METHOD; Gai JY, FRONT AGR CHINA, V1, P1; Gao MQ, 2007, THEOR APPL GENET, V115, P277, DOI 10.1007/s00122-007-0568-3; Hao JJ, 2008, PLANT BREEDING, V127, P383, DOI 10.1111/j.1439-0523.2007.01474.x; HOLT JE, 1983, J TEXTURE STUD, V14, P99, DOI 10.1111/j.1745-4603.1983.tb00337.x; Junyi G, 2006, FRONT BIOL CHINA, V1, P85, DOI [10.1007/s11515-005-0001-8, DOI 10.1007/S11515-005-0001-8]; Kifuji Y, 2013, EUPHYTICA, V190, P289, DOI 10.1007/s10681-012-0847-1; Lan TH, 2001, THEOR APPL GENET, V103, P383, DOI 10.1007/s001220100615; LANDRY BS, 1992, GENOME, V35, P409, DOI 10.1139/g92-061; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li XX, 2007, DESCRIPTORS DATA STA; Liang HZ, 2014, THEOR APPL GENET, V127, P2127, DOI 10.1007/s00122-014-2366-z; Liu B, 2013, THEOR APPL GENET, V126, P231, DOI 10.1007/s00122-012-1976-6; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Iniguez-Luy FL, 2009, THEOR APPL GENET, V120, P31, DOI 10.1007/s00122-009-1157-4; Lv HH, 2014, MOL BREEDING, V34, P87, DOI 10.1007/s11032-014-0019-1; Masarirambi M. T., 2011, African Journal of Plant Science, V5, P8; Mei JQ, 2013, THEOR APPL GENET, V126, P549, DOI 10.1007/s00122-012-2000-x; Moriguchi K, 1999, BREEDING SCI, V49, P257, DOI 10.1270/jsbbs.49.257; Nagaoka T, 2010, THEOR APPL GENET, V120, P1335, DOI 10.1007/s00122-010-1259-z; Okazaki K, 2007, THEOR APPL GENET, V114, P595, DOI 10.1007/s00122-006-0460-6; Pang W, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0318-1; Piepho HP, 2005, THEOR APPL GENET, V110, P561, DOI 10.1007/s00122-004-1872-9; Pink D, 2008, EUPHYTICA, V164, P509, DOI 10.1007/s10681-008-9742-1; Pu ZJ, 2012, MOL BREEDING, V30, P809, DOI 10.1007/s11032-011-9665-8; Qin Z. W., 1994, J NE AGR U, V25, P344; Rudolf K, 1999, PLANT BREEDING, V118, P237, DOI 10.1046/j.1439-0523.1999.118003237.x; Sabouri H, 2009, J GENET, V88, P81, DOI 10.1007/s12041-009-0011-4; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sebastian RL, 2000, THEOR APPL GENET, V100, P75, DOI 10.1007/s001220050011; SLOCUM MK, 1990, THEOR APPL GENET, V80, P57, DOI 10.1007/BF00224016; SOLLER M, 1990, THEOR APPL GENET, V80, P205, DOI 10.1007/BF00224388; Sotelo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091428; [苏成付 Su Chengfu], 2010, [作物学报, Acta Agronomica Sinica], V36, P1100; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; UZUNOVA M, 1995, THEOR APPL GENET, V90, P194, DOI 10.1007/BF00222202; Vali U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-8; van Eeuwijk FA, 2010, CURR OPIN PLANT BIOL, V13, P193, DOI 10.1016/j.pbi.2010.01.001; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; VANOOIJEN JW, 2002, MAP QTL 4 0 SOFTWARE; Voorrips RE, 1997, THEOR APPL GENET, V94, P75, DOI 10.1007/s001220050384; Walley PG, 2012, THEOR APPL GENET, V124, P467, DOI 10.1007/s00122-011-1721-6; Wang WX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-523; Wang WY, 2012, SCI HORTIC-AMSTERDAM, V147, P29, DOI 10.1016/j.scienta.2012.08.033; Xing GN, 2012, THEOR APPL GENET, V125, P859, DOI 10.1007/s00122-012-1878-7; Yuan SX, 2011, PLANT BREEDING, V130, P80, DOI 10.1111/j.1439-0523.2009.01754.x; Yuan SX, 2012, PLANT CELL TISS ORG, V110, P69, DOI 10.1007/s11240-012-0131-z; Zeng A. S., 2009, ACTA AGR BOREALI S S, VS2, P41; Zhang F, 2011, EUPHYTICA, V177, P15, DOI 10.1007/s10681-010-0239-3; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]; Zhang YM, 2003, GENET RES, V81, P157, DOI 10.1017/S0016672303006141; Zhuang M, 2009, CHINA VEG, V1, P12	66	11	16	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138073	10.1371/journal.pone.0138073	http://dx.doi.org/10.1371/journal.pone.0138073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406606	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700031
J	Zhang, TJ; Yu, LX; Zheng, P; Li, YJ; Rivera, M; Main, D; Greene, SL				Zhang, Tiejun; Yu, Long-Xi; Zheng, Ping; Li, Yajun; Rivera, Martha; Main, Dorrie; Greene, Stephanie L.			Identification of Loci Associated with Drought Resistance Traits in Heterozygous Autotetraploid Alfalfa (Medicago sativa L.) Using Genome-Wide Association Studies with Genotyping by Sequencing	PLOS ONE			English	Article							ENVIRONMENTAL-STRESS; ENHANCED TOLERANCE; GENETIC DIVERSITY; ARABIDOPSIS; YIELD; TRANSCRIPTION; POPULATIONS; CULTIVARS; FAMILY; WHEAT	Drought resistance is an important breeding target for enhancing alfalfa productivity in arid and semi-arid regions. Identification of genes involved in drought tolerance will facilitate breeding for improving drought resistance and water use efficiency in alfalfa. Our objective was to use a diversity panel of alfalfa accessions comprised of 198 cultivars and landraces to identify genes involved in drought tolerance. The panel was selected from the USDA-ARS National Plant Germplasm System alfalfa collection and genotyped using genotyping by sequencing. A greenhouse procedure was used for phenotyping two important traits associated with drought tolerance: drought resistance index (DRI) and relative leaf water content (RWC). Marker-trait association identified nineteen and fifteen loci associated with DRI and RWC, respectively. Alignments of target sequences flanking to the resistance loci against the reference genome of M. truncatula revealed multiple chromosomal locations. Markers associated with DRI are located on all chromosomes while markers associated with RWC are located on chromosomes 1, 2, 3, 4, 5, 6 and 7. Co-localizations of significant markers between DRI and RWC were found on chromosomes 3, 5 and 7. Most loci associated with DRI in this work overlap with the reported QTLs associated with biomass under drought in alfalfa. Additional significant markers were targeted to several contigs with unknown chromosomal locations. BLAST search using their flanking sequences revealed homology to several annotated genes with functions in stress tolerance. With further validation, these markers may be used for marker-assisted breeding new alfalfa varieties with drought resistance and enhanced water use efficiency.	[Zhang, Tiejun; Yu, Long-Xi; Li, Yajun; Rivera, Martha] ARS, Plant & Germplasm Intro & Testing Res, USDA, Prosser, WA USA; [Zheng, Ping; Main, Dorrie] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Greene, Stephanie L.] ARS, Natl Ctr Genet Resource Preservat, USDA, Ft Collins, CO USA	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA)	Yu, LX (corresponding author), ARS, Plant & Germplasm Intro & Testing Res, USDA, Prosser, WA USA.	longxi.yu@ars.usda.gov	Zhang, Tiejun/HDM-7091-2022	Greene, Stephanie/0000-0002-3624-5021	USDA-ARS National Program Project [5354-21000-015-00D]; National Alfalfa and Forage Alliance; ARS [ARS-0425169] Funding Source: Federal RePORTER	USDA-ARS National Program Project; National Alfalfa and Forage Alliance; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding: This work was supported by USDA-ARS National Program Project No. 5354-21000-015-00D and by a partial grant from the National Alfalfa and Forage Alliance to L-X Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Ariss JJ, 2007, CROP SCI, V47, P2274, DOI 10.2135/cropsci2006.12.0782; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger D, 2000, GENE DEV, V14, P1119; Bouton J, 2007, EUPHYTICA, V154, P263, DOI 10.1007/s10681-006-9220-6; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chen D, 2008, ACTA PHYSIOL PLANT, V30, P183, DOI 10.1007/s11738-007-0107-5; de Vasconcelos ES, 2008, ACTA SCI-AGRON, V30, P339, DOI 10.4025/actasciagron.v30i3.3511; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; FUERST PA, 1977, GENETICS, V86, P455; Garrison E, 2012, 12073907 ARXIV, V1207, P3907; GUERRERO FD, 1990, PLANT MOL BIOL, V15, P11, DOI 10.1007/BF00017720; Hamdy A, 2003, IRRIG DRAIN, V52, P3, DOI 10.1002/ird.73; Han SK, 2014, J EXP BOT, V65, P2785, DOI 10.1093/jxb/ert403; Kang Y, 2011, PLANT J, V68, P871, DOI 10.1111/j.1365-313X.2011.04738.x; LABERGE S, 1993, PLANT PHYSIOL, V101, P1411, DOI 10.1104/pp.101.4.1411; LENSSEN AW, 1991, CROP SCI, V31, P293, DOI 10.2135/cropsci1991.0011183X003100020012x; Li GD, 2010, CROP PASTURE SCI, V61, P645, DOI 10.1071/CP09360; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LUO M, 1992, J BIOL CHEM, V267, P15367; LUO M, 1991, PLANT MOL BIOL, V17, P1267, DOI 10.1007/BF00028745; Manabe Y, 2008, PLANT PHYSIOL, V146, P612, DOI 10.1104/pp.107.109009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKersie BD, 1996, PLANT PHYSIOL, V111, P1177, DOI 10.1104/pp.111.4.1177; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray IM, 2015, CROP SCI, V55, P2012, DOI 10.2135/cropsci2014.12.0840; Ray IM, 2004, CROP SCI, V44, P1970, DOI 10.2135/cropsci2004.1970; Ray IM, 1998, CROP SCI, V38, P1386, DOI 10.2135/cropsci1998.0011183X003800050038x; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; SCHONFELD MA, 1988, CROP SCI, V28, P526, DOI 10.2135/cropsci1988.0011183X002800030021x; Segovia-Lerma A, 2003, GENOME, V46, P51, DOI 10.1139/G02-100; Sledge MK, 2005, THEOR APPL GENET, V111, P980, DOI 10.1007/s00122-005-0038-8; SPOMER LA, 1985, HORTSCIENCE, V20, P1021; Suarez R, 2009, CROP SCI, V49, P1791, DOI 10.2135/cropsci2008.09.0573; Tan JJ, 2014, MOL PLANT, V7, P1329, DOI 10.1093/mp/ssu054; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219	41	47	53	8	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138931	10.1371/journal.pone.0138931	http://dx.doi.org/10.1371/journal.pone.0138931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406473	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700120
J	Zulliger, R; Conley, SM; Mwoyosvi, ML; Stuck, MW; Azadi, S; Naash, MI				Zulliger, Rahel; Conley, Shannon M.; Mwoyosvi, Maggie L.; Stuck, Michael W.; Azadi, Seifollah; Naash, Muna I.			SNAREs Interact with Retinal Degeneration Slow and Rod Outer Segment Membrane Protein-1 during Conventional and Unconventional Outer Segment Targeting	PLOS ONE			English	Article							R172W MUTATION; INTRAFAMILIAL VARIABILITY; STATISTICAL-MODEL; CYSTEINE RESIDUES; SYNTAXIN 3B; PERIPHERIN/RDS; CONE; PHOTORECEPTORS; DYSTROPHY; FUSION	Mutations in the photoreceptor protein peripherin-2 (also known as RDS) cause severe retinal degeneration. RDS and its homolog ROM-1 (rod outer segment protein 1) are synthesized in the inner segment and then trafficked into the outer segment where they function in tetramers and covalently linked larger complexes. Our goal is to identify binding partners of RDS and ROM-1 that may be involved in their biosynthetic pathway or in their function in the photoreceptor outer segment (OS). Here we utilize several methods including mass spectrometry after affinity purification, in vitro co-expression followed by pull-down, in vivo pull-down from mouse retinas, and proximity ligation assay to identify and confirm the SNARE proteins Syntaxin 3B and SNAP-25 as novel binding partners of RDS and ROM-1. We show that both covalently linked and non-covalently linked RDS complexes interact with Syntaxin 3B. RDS in the mouse is trafficked from the inner segment to the outer segment by both conventional (i.e., Golgi dependent) and unconventional secretory pathways, and RDS from both pathways interacts with Syntaxin3B. Syntaxin 3B and SNAP-25 are enriched in the inner segment (compared to the outer segment) suggesting that the interaction with RDS/ROM-1 occurs in the inner segment. Syntaxin 3B and SNAP-25 are involved in mediating fusion of vesicles carrying other outer segment proteins during outer segment targeting, so could be involved in the trafficking of RDS/ROM-1.	[Zulliger, Rahel; Conley, Shannon M.; Mwoyosvi, Maggie L.; Stuck, Michael W.; Azadi, Seifollah; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77204 USA.	mnaash@central.uh.edu			National Eye Institute at the National Institutes of Health [R01EY10609]; Foundation Fighting Blindness; Oklahoma Center for the Advancement of Science and Technology [HR14-150]; NATIONAL EYE INSTITUTE [R01EY010609] Funding Source: NIH RePORTER	National Eye Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Oklahoma Center for the Advancement of Science and Technology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute at the National Institutes of Health (R01EY10609, MIN, https://www.nei.nih.gov), the Foundation Fighting Blindness (MIN), and the Oklahoma Center for the Advancement of Science and Technology (HR14-150, SMC, http://www.ok.gov/ocast/).	ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Bachnoff N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01620; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boesze-Battaglia K, 2002, EXP EYE RES, V75, P227, DOI 10.1006/exer.2002.2004; Boesze-Battaglia K, 2007, BIOCHEMISTRY-US, V46, P1256, DOI 10.1021/bi061466i; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098939; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Conley SM, 2014, HUM MOL GENET, V23, P3102, DOI 10.1093/hmg/ddu014; Conley SM, 2012, CELL MOL LIFE SCI, V69, P1035, DOI 10.1007/s00018-011-0736-0; Conley SM, 2010, BIOCHEMISTRY-US, V49, P905, DOI 10.1021/bi901622w; Curtis LB, 2008, J COMP NEUROL, V510, P550, DOI 10.1002/cne.21806; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Edrington TCV, 2007, BIOCHEMISTRY-US, V46, P3862, DOI 10.1021/bi061999r; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khattree N, 2013, J CELL SCI, V126, P4659, DOI 10.1242/jcs.126888; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Liu XQ, 2014, MOL CELL NEUROSCI, V60, P53, DOI 10.1016/j.mcn.2014.03.002; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1592, DOI 10.1016/j.ophtha.2005.04.004; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Ritter LM, 2011, J NEUROSCI, V31, P11231, DOI 10.1523/JNEUROSCI.2875-11.2011; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; Sherry DM, 2003, MOL VIS, V9, P673; Stuck MW, 2014, HUM MOL GENET, V23, P6260, DOI 10.1093/hmg/ddu345; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Teng FYH, 2001, GENOME BIOL, V2; Tian G, 2014, J NEUROSCI, V34, P992, DOI 10.1523/JNEUROSCI.3437-13.2014; Vaclavik V, 2012, RETINA-J RET VIT DIS, V32, P1942, DOI 10.1097/IAE.0b013e31824b32e4; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10	47	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138508	10.1371/journal.pone.0138508	http://dx.doi.org/10.1371/journal.pone.0138508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406599	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700051
J	Kuzuya, T; Ishigami, M; Ishizu, Y; Honda, T; Hayashi, K; Katano, Y; Hirooka, Y; Ishikawa, T; Nakano, I; Goto, H				Kuzuya, Teiji; Ishigami, Masatoshi; Ishizu, Yoji; Honda, Takashi; Hayashi, Kazuhiko; Katano, Yoshiaki; Hirooka, Yoshiki; Ishikawa, Tetsuya; Nakano, Isao; Goto, Hidemi			Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma	PLOS ONE			English	Article							ALPHA-FETOPROTEIN RESPONSE; MODIFIED RECIST; ADVERSE EVENTS; CHILD-PUGH; EFFICACY; SAFETY; SURVIVAL; MRECIST	Background & Aims We evaluated the relationship between the early clinical response after 2 weeks of sorafenib therapy and the outcomes and anti-tumor response in patients with advanced hepatocellular carcinoma. Methods Fifty-seven patients who had intrahepatic hypervascular hepatocellular carcinoma and Child-Pugh (CP) class A disease at baseline were enrolled in this prospective, multicenter, observational, non-interventional study. As an early clinical response after 2 weeks of sorafenib therapy, changes in intra-tumor blood flow on contrast-enhanced computed tomography (CE-CT), alpha-fetoprotein (AFP) levels, and remnant liver function were investigated. Results After 2 weeks of sorafenib therapy, there were 26 patients (45.6%) without disappearance of arterial tumor enhancement on CE-CT, 15 patients (26.3%) with an AFP ratio of >1.2, and seven patients (12.3%) with two or more increments in the CP score. Multivariate analysis showed that the absence of disappearance of arterial tumor enhancement on CE-CT, AFP ratio of >1.2, and two or more increments in the CP score after 2 weeks of sorafenib therapy were significant and independent predictors of worse survival. Upon scoring these three variables as "poor prognostic factors", patients with poor prognostic score 4, 3 or 2 (n = 17) had significantly worse outcomes and a significantly higher progressive disease (PD) rate based onmodified Response Evaluation Criteria in Solid Tumors at 6 weeks after sorafenib therapy than those with poor prognostic score 1 or 0 (n = 40) (median overall survival: 194 days vs. 378 days; p = 0.0010, PD rate: 70.6% vs. 20.0%; p = 0.0003, respectively). Conclusions Changes in intra-tumor blood flow on CE-CT, AFP levels, and remnant liver function after 2 weeks of sorafenib therapy may be useful for predicting the outcomes and anti-tumor response to sorafenib in patients with advanced hepatocellular carcinoma.	[Kuzuya, Teiji; Ishigami, Masatoshi; Ishizu, Yoji; Honda, Takashi; Hayashi, Kazuhiko; Hirooka, Yoshiki; Ishikawa, Tetsuya; Nakano, Isao; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Katano, Yoshiaki] Fujita Hlth Univ, Sch Med, Banbuntane Hotokukai Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan	Nagoya University; Fujita Health University	Ishigami, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan.	masaishi@med.nagoya-u.ac.jp	Kuzuya, Teiji/ABG-8786-2021; Honda, Takashi/I-7268-2014; Hayashi, Kazuhiko/J-7932-2019; ishizu, yoji/I-7484-2014; Hayashi, Kazuhiko/I-7382-2014; Hirooka, Yoshiki/I-7351-2014	Hayashi, Kazuhiko/0000-0002-7919-6071; ishizu, yoji/0000-0002-1255-5201; Hayashi, Kazuhiko/0000-0002-7919-6071; Hirooka, Yoshiki/0000-0001-9639-7425	Bayer Yakuhin, Ltd.	Bayer Yakuhin, Ltd.	This study was supported by Bayer Yakuhin, Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizumi T, 2014, J GASTROENTEROL, V49, P1578, DOI 10.1007/s00535-014-0936-0; Arizumi T, 2014, DIGEST DIS, V32, P733, DOI 10.1159/000368013; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Camma C, 2013, HEPATOLOGY, V57, P1046, DOI 10.1002/hep.26221; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Colombo M, 2015, LIVER INT, V35, P129, DOI 10.1111/liv.12713; Edeline J, 2012, CANCER-AM CANCER SOC, V118, P147, DOI 10.1002/cncr.26255; Kaneko S, 2012, HEPATOL RES, V42, P523, DOI 10.1111/j.1872-034X.2012.00981.x; Kawaoka T, 2012, ONCOLOGY-BASEL, V83, P192, DOI 10.1159/000341347; Kim HY, 2013, J GASTROEN HEPATOL, V28, P1756, DOI 10.1111/jgh.12310; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Kuzuya T, 2013, KANZO, V54, P505; Kuzuya T, 2011, ONCOLOGY-BASEL, V81, P251, DOI 10.1159/000334454; Lee S, 2014, J GASTROEN HEPATOL, V29, P1463, DOI 10.1111/jgh.12542; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Miyahara K, 2011, J GASTROEN HEPATOL, V26, P1604, DOI 10.1111/j.1440-1746.2011.06887.x; Nakazawa T, 2013, EUR J GASTROEN HEPAT, V25, P683, DOI 10.1097/MEG.0b013e32835d913b; Ogasawara S, 2015, INVEST NEW DRUG, V33, P729, DOI 10.1007/s10637-015-0237-3; Okuyama H, 2015, ONCOLOGY-BASEL, V88, P241, DOI 10.1159/000369351; Personeni N, 2012, J HEPATOL, V57, P101, DOI 10.1016/j.jhep.2012.02.016; Reig M, 2014, J HEPATOL, V61, P318, DOI 10.1016/j.jhep.2014.03.030; Shao YY, 2013, LIVER CANCER, V2, P93, DOI 10.1159/000343845; Shao YY, 2010, CANCER-AM CANCER SOC, V116, P4590, DOI 10.1002/cncr.25257; Sugimoto K, 2013, LIVER INT, V33, P605, DOI 10.1111/liv.12098; Takeda H, 2015, LIVER INT, V35, P1581, DOI 10.1111/liv.12591; Tsuchiya K, 2014, CANCER-AM CANCER SOC, V120, P229, DOI 10.1002/cncr.28384; Zocco MA, 2013, J HEPATOL, V59, P1014, DOI 10.1016/j.jhep.2013.06.011	33	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138776	10.1371/journal.pone.0138776	http://dx.doi.org/10.1371/journal.pone.0138776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421430	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700050
J	Mallhi, TH; Khan, AH; Adnan, AS; Sarriff, A; Khan, YH; Jummaat, F				Mallhi, Tauqeer Hussain; Khan, Amer Hayat; Adnan, Azreen Syazril; Sarriff, Azmi; Khan, Yusra Habib; Jummaat, Fauziah			Incidence, Characteristics and Risk Factors of Acute Kidney Injury among Dengue Patients: A Retrospective Analysis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; HEMORRHAGIC-FEVER; RHABDOMYOLYSIS; INFECTION; OUTCOMES; NETWORK; ADULTS	Background Dengue induced acute kidney injury (AKI) imposes heavy burden of illness in terms of morbidity and mortality. A retrospective study was conducted to investigate incidence, characteristics, risk factors and clinical outcomes of AKI among dengue patients. Methodology A total 667 dengue patients (2008-2013) were retrospectively evaluated and were stratified into AKI and non-AKI groups by using AKIN criteria. Two groups were compared by using appropriate statistical methods. Results There were 95 patients (14.2%) who had AKI, with AKIN-I, AKIN-II and AKIN-III in 76.8%, 16.8% and 6.4% patients, respectively. Significant differences (P<0.05) in demographics and clinico-laboratory characteristics were observed between patients with and without AKI. Presence of dengue hemorrhagic fever [OR (95% CI): 8.0 (3.64-17.59), P<0.001], rhabdomyolysis [OR (95% CI): 7.9 (3.04-20.49)], multiple organ dysfunction [OR (95% CI): 34.6 (14.14-84.73), P<0.001], diabetes mellitus [OR (95% CI): 4.7 (1.12-19.86), P = 0.034], late hospitalization [OR (95% CI): 2.1 (1.12-19.86), P = 0.033] and use of nephrotoxic drugs [OR (95% CI): 2.9 (1.12-19.86), P = 0.006] were associated with AKI. Longer hospital stay (>3 days) was also observed among AKI patients (OR = 1.3, P = 0.044). Additionally, 48.4% AKI patients had renal insufficiencies at discharge that were signicantly associated with severe dengue, secondary infection and diabetes mellitus. Overall mortality was 1.2% and all fatal cases had AKI. Conclusions The incidence of AKI is high at 14.2% among dengue patients, and those with AKI portended significant morbidity, mortality, longer hospital stay and poor renal outcomes. Our findings suggest that AKI in dengue is likely to increase healthcare burden that underscores the need of clinicians' alertness to this highly morbid and potentially fatal complication for optimal prevention and management.	[Mallhi, Tauqeer Hussain; Khan, Amer Hayat; Sarriff, Azmi; Khan, Yusra Habib] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Mallhi, Tauqeer Hussain; Khan, Amer Hayat; Adnan, Azreen Syazril; Khan, Yusra Habib] Univ Sains Malaysia, Chron Kidney Dis Resource Ctr, Sch Med Sci, Kubang Kerain, Kelantan, Malaysia; [Jummaat, Fauziah] Univ Sains Malaysia, Sch Med Sci, Dept Obstet & Gynecol, Kubang Kerain, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Mallhi, TH (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.	tauqeer.hussain.mallhi@hotmail.com	Khan, Amer Hayat/O-5310-2018; Aftab, Raja Ahsan/J-1261-2014; Mallhi, Tauqeer Hussain/W-5155-2017; Khan, Yusra Habib/AFK-9024-2022	Khan, Amer Hayat/0000-0003-4802-6181; Mallhi, Tauqeer Hussain/0000-0001-9957-5362; Khan, Yusra Habib/0000-0002-9479-6147	Institute of Postgraduate Studies (IPS) of University Sains Malaysia (USM) [P-FD0010/149(R)]	Institute of Postgraduate Studies (IPS) of University Sains Malaysia (USM)	The authors are thankful to Institute of Postgraduate Studies (IPS) of University Sains Malaysia (USM) for fellowship support [Ref. no. P-FD0010/149(R).	Acharya S, 2010, ANN INDIAN ACAD NEUR, V13, P221, DOI 10.4103/0972-2327.70882; Avasthi G, 2012, J CLIN CASE REP, V2, P2; Bhaskar ME, 2010, INDIAN J MED RES, V132, P738; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Davis JS, 2004, CLIN INFECT DIS, V38, pE109, DOI 10.1086/392510; Funahara Y, 1982, BIBL HAEMATOL, P201; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Guzman M G, 1999, Int J Infect Dis, V3, P130, DOI 10.1016/S1201-9712(99)90033-4; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hoste EAJ, 2006, CURR OPIN CRIT CARE, V12, P531, DOI 10.1097/MCC.0b013e3280102af7; Humayoun MA, 2010, INT J INFECT DIS, V14, pE54, DOI 10.1016/j.ijid.2009.10.008; Khalil MAM, 2012, CLIN KIDNEY J, V5, P390, DOI 10.1093/ckj/sfs117; Khan Y, 2014, VALUE HEALTH, V17, pA811, DOI 10.1016/j.jval.2014.08.551; Kohli HS, 2000, NEPHROL DIAL TRANSPL, V15, P212, DOI 10.1093/ndt/15.2.212; Kularatne S. A. M., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P686; Kuo MC, 2008, CLIN J AM SOC NEPHRO, V3, P1350, DOI 10.2215/CJN.00020108; Laoprasopwattana K, 2010, J PEDIATR-US, V157, P303, DOI 10.1016/j.jpeds.2010.02.008; Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149; Lee IK, 2009, AM J TROP MED HYG, V80, P651, DOI 10.4269/ajtmh.2009.80.651; Lima EQ, 2008, SEMIN NEPHROL, V28, P409, DOI 10.1016/j.semnephrol.2008.04.009; Lima EQ, 2007, NEPHROL DIAL TRANSPL, V22, P3322, DOI 10.1093/ndt/gfm431; Lizarraga Karlo J, 2014, J Nephropathol, V3, P57, DOI 10.12860/jnp.2014.13; Macedo E, 2011, KIDNEY INT, V80, P760, DOI 10.1038/ki.2011.150; Mallhi TH, 2015, NEPHROL DIAL TRANSPL, V30; Mehra N, 2012, Indian J Nephrol, V22, P400, DOI 10.4103/0971-4065.103917; Mehra N, 2012, TROP DOCT, V42, P160, DOI 10.1258/td.2012.120023; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nair VR, 2005, INFECT DIS CLIN PRAC, V13, P142, DOI 10.1097/01.idc.0000166956.60011.23; Repizo LP, 2014, REV INST MED TROP SP, V56, P85, DOI 10.1590/S0036-46652014000100014; Schetz M, 2005, CURR OPIN CRIT CARE, V11, P555, DOI 10.1097/01.ccx.0000184300.68383.95; Schiffl H, 2012, CLIN KIDNEY J, V5, P297, DOI 10.1093/ckj/sfs070; Solomon AW, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6761; Udwadia F.E., 2003, INDIAN J CRIT CARE M, V7, P233; Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x; Wiersinga WJ, 2006, CLIN INFECT DIS, V43, P800, DOI 10.1086/507111; Wijesinghe Aruna, 2013, J Med Case Rep, V7, P195, DOI 10.1186/1752-1947-7-195; Wiwanitkit V, 2005, RENAL FAILURE, V27, P647, DOI 10.1080/08860220500200916; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT	41	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138465	10.1371/journal.pone.0138465	http://dx.doi.org/10.1371/journal.pone.0138465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421839	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700039
J	Kodedova, M; Sychrova, H				Kodedova, Marie; Sychrova, Hana			Changes in the Sterol Composition of the Plasma Membrane Affect Membrane Potential, Salt Tolerance and the Activity of Multidrug Resistance Pumps in Saccharomyces cerevisiae	PLOS ONE			English	Article							ERGOSTEROL BIOSYNTHESIS; CANDIDA-ALBICANS; INTRACELLULAR PH; DRUG-RESISTANCE; ERG6 GENE; YEAST; CHOLESTEROL; EPIDEMIOLOGY; ORGANIZATION; TRANSPORTER	We investigated the impact of the deletions of genes from the final steps in the biosynthesis of ergosterol (ERG6, ERG2, ERG3, ERG5, ERG4) on the physiological function of the Saccharomyces cerevisiae plasma membrane by a combination of biological tests and the diSC3(3) fluorescence assay. Most of the erg mutants were more sensitive than the wild type to salt stress or cationic drugs, their susceptibilities were proportional to the hyperpolarization of their plasma membranes. The different sterol composition of the plasma membrane played an important role in the short-term and long-term processes that accompanied the exposure of erg strains to a hyperosmotic stress (effect on cell size, pH homeostasis and survival of yeasts), as well as in the resistance of cells to antifungal drugs. The pleiotropic drug-sensitive phenotypes of erg strains were, to a large extent, a result of the reduced efficiency of the Pdr5 efflux pump, which was shown to be more sensitive to the sterol content of the plasma membrane than Snq2p. In summary, the erg4 Delta and erg6 Delta mutants exhibited the most compromised phenotypes. As Erg6p is not involved in the cholesterol biosynthetic pathway, it may become a target for a new generation of antifungal drugs.	[Kodedova, Marie; Sychrova, Hana] Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Kodedova, M (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic.	Marie.Kodedova@fgu.cas.cz	Sychrova, Hana/B-1350-2012; Kodedova, Marie/B-7559-2012	Sychrova, Hana/0000-0001-5967-5019; Kodedova, Marie/0000-0003-3423-2363	Centre of Biomedical Research [CZ.1.07/2.3.00/30.0025]; European Social Fund; state budget of the Czech Republic; BIOCEV - Biotechnology and Biomedicine Centre of Academy of Sciences; Charles University [CZ.1.05/1.1.00.02.0109]; European Regional Development Fund	Centre of Biomedical Research; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; BIOCEV - Biotechnology and Biomedicine Centre of Academy of Sciences; Charles University; European Regional Development Fund(European Commission)	This work was supported within the project The Centre of Biomedical Research (CZ.1.07/2.3.00/30.0025). This project is co-funded by the European Social Fund and the state budget of the Czech Republic. This work was also supported by BIOCEV - Biotechnology and Biomedicine Centre of Academy of Sciences and Charles University (CZ.1.05/1.1.00.02.0109), the project from European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2010, P NATL ACAD SCI USA, V107, P4170, DOI 10.1073/pnas.0914094107; Anderson JB, 2003, GENETICS, V163, P1287; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Bard M, 2005, DIAGN MICR INFEC DIS, V52, P285, DOI 10.1016/j.diagmicrobio.2005.03.001; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Cadek R, 2004, BBA-BIOMEMBRANES, V1665, P111, DOI 10.1016/j.bbamem.2004.06.020; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; Chung SK, 2000, BIOORGAN MED CHEM, V8, P2475, DOI 10.1016/S0968-0896(00)00177-2; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; Denksteinova B, 1997, FOLIA MICROBIOL, V42, P221, DOI 10.1007/BF02818983; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; Dupont S, 2012, EVOLUTION, V66, P2961, DOI 10.1111/j.1558-5646.2012.01667.x; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; FROMTILING R A, 1988, Clinical Microbiology Reviews, V1, P187; Gaskova D, 1998, YEAST, V14, P1189, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1189::AID-YEA320>3.3.CO;2-B; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hazen KC, 2005, DIAGN MICR INFEC DIS, V52, P35, DOI 10.1016/j.diagmicrobio.2004.12.006; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Hendrych T, 2009, BBA-BIOMEMBRANES, V1788, P717, DOI 10.1016/j.bbamem.2008.12.001; Herman P, 2015, FEBS J, V282, P419, DOI 10.1111/febs.13156; Herrera R, 2014, BBA-BIOMEMBRANES, V1838, P127, DOI 10.1016/j.bbamem.2013.08.022; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Jacquier N, 2012, J STEROID BIOCHEM, V129, P70, DOI 10.1016/j.jsbmb.2010.11.014; Jensen-Pergakes KL, 1998, ANTIMICROB AGENTS CH, V42, P1160, DOI 10.1128/AAC.42.5.1160; KAUFER NF, 1983, NUCLEIC ACIDS RES, V11, P3123; Kaur R, 1999, MICROBIOL-UK, V145, P809, DOI 10.1099/13500872-145-4-809; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141; Kodedova M, 2011, BIOTECHNIQUES, V50, P58, DOI 10.2144/000113568; Kralli A, 1996, J BIOL CHEM, V271, P17152, DOI 10.1074/jbc.271.29.17152; Kristan K, 2012, J STEROID BIOCHEM, V129, P79, DOI 10.1016/j.jsbmb.2011.08.012; LEES ND, 1995, LIPIDS, V30, P221, DOI 10.1007/BF02537824; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Maresova L, 2010, YEAST, V27, P317, DOI 10.1002/yea.1755; MARTY A, 1975, J GEN PHYSIOL, V65, P515, DOI 10.1085/jgp.65.4.515; Merzendorfer H, 2013, BIOL CHEM, V394, P189, DOI 10.1515/hsz-2012-0241; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mollinedo F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00140; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prasad R, 2013, CURR GENET, V59, P243, DOI 10.1007/s00294-013-0402-1; Ren B, 2014, APPL MICROBIOL BIOT, V98, P2609, DOI 10.1007/s00253-013-5425-5; Shalini K, 2011, BEILSTEIN J ORG CHEM, V7, P668, DOI 10.3762/bjoc.7.79; Spanova M, 2012, BBA-MOL CELL BIOL L, V1821, P647, DOI 10.1016/j.bbalip.2012.01.015; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Szopinska A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009589; Tiedje C, 2007, J CELL SCI, V120, P3613, DOI 10.1242/jcs.009860; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; WELIHINDA AA, 1994, BBA-BIOMEMBRANES, V1193, P107, DOI 10.1016/0005-2736(94)90339-5; WISEMAN H, 1993, FEBS LETT, V326, P285, DOI 10.1016/0014-5793(93)81809-E; Xiong QB, 2005, ANTIMICROB AGENTS CH, V49, P518, DOI 10.1128/AAC.49.2.518-524.2005	56	98	101	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139306	10.1371/journal.pone.0139306	http://dx.doi.org/10.1371/journal.pone.0139306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418026	Green Submitted, gold, Green Published			2022-12-27	WOS:000362171400072
J	Raupach, MJ; Barco, A; Steinke, D; Beermann, J; Laakmann, S; Mohrbeck, I; Neumann, H; Kihara, TC; Pointner, K; Radulovici, A; Segelken-Voigt, A; Wesse, C; Knebelsberger, T				Raupach, Michael J.; Barco, Andrea; Steinke, Dirk; Beermann, Jan; Laakmann, Silke; Mohrbeck, Inga; Neumann, Hermann; Kihara, Terue C.; Pointner, Karin; Radulovici, Adriana; Segelken-Voigt, Alexandra; Wesse, Christina; Knebelsberger, Thomas			The Application of DNA Barcodes for the Identification of Marine Crustaceans from the North Sea and Adjacent Regions	PLOS ONE			English	Article							MOLECULAR-SPECIES IDENTIFICATION; CALIGUS-ELONGATUS NORDMANN; OXIDASE SUBUNIT-I; BIOLOGICAL IDENTIFICATIONS; PARASITIC COPEPODS; DIVERSITY; TAXONOMY; POPULATION; PATTERNS; FISH	During the last years DNA barcoding has become a popular method of choice for molecular specimen identification. Here we present a comprehensive DNA barcode library of various crustacean taxa found in the North Sea, one of the most extensively studied marine regions of the world. Our data set includes 1,332 barcodes covering 205 species, including taxa of the Amphipoda, Copepoda, Decapoda, Isopoda, Thecostraca, and others. This dataset represents the most extensive DNA barcode library of the Crustacea in terms of species number to date. By using the Barcode of Life Data Systems (BOLD), unique BINs were identified for 198 (96.6%) of the analyzed species. Six species were characterized by two BINs (2.9%), and three BINs were found for the amphipod species Gammarus salinus Spooner, 1947 (0.4%). Intraspecific distances with values higher than 2.2% were revealed for 13 species (6.3%). Exceptionally high distances of up to 14.87% between two distinct but monophyletic clusters were found for the parasitic copepod Caligus elongatus Nordmann, 1832, supporting the results of previous studies that indicated the existence of an overlooked sea louse species. In contrast to these high distances, haplotype-sharing was observed for two decapod spider crab species, Macropodia parva Van Noort & Adema, 1985 and Macropodia rostrata (Linnaeus, 1761), underlining the need for a taxonomic revision of both species. Summarizing the results, our study confirms the application of DNA barcodes as highly effective identification system for the analyzed marine crustaceans of the North Sea and represents an important milestone for modern biodiversity assessment studies using barcode sequences.	[Raupach, Michael J.; Barco, Andrea; Laakmann, Silke; Mohrbeck, Inga; Kihara, Terue C.; Pointner, Karin; Wesse, Christina; Knebelsberger, Thomas] Senckenberg Meer, German Ctr Marine Biodivers DZMB, Wilhelmshaven, Niedersachsen, Germany; [Steinke, Dirk; Radulovici, Adriana] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Beermann, Jan] Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Biol Anstalt Helgoland, Helgoland, Schleswig Holst, Germany; [Neumann, Hermann] Senckenberg Meer, Dept Marine Res, Niedersachsen, Germany; [Segelken-Voigt, Alexandra] Carl von Ossietzky Univ Oldenburg, Sch Math & Sci 5, Inst Biol & Environm Sci, Anim Biodivers & Evolutionary Biol, D-26111 Oldenburg, Niedersachsen, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); University of Guelph; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Senckenberg Gesellschaft fur Naturforschung (SGN); Carl von Ossietzky Universitat Oldenburg	Raupach, MJ (corresponding author), Senckenberg Meer, German Ctr Marine Biodivers DZMB, Wilhelmshaven, Niedersachsen, Germany.	mraupach@senckenberg.de	Raupach, Michael J./AAF-7566-2020	Raupach, Michael J./0000-0001-8299-6697; Segelken-Voigt, Alexandra/0000-0002-0825-4975; Beermann, Jan/0000-0001-5894-6817; Barco, Andrea/0000-0002-3963-1884; Steinke, Dirk/0000-0002-8992-575X; Laakmann, Silke/0000-0003-3273-7907; Wesse, Christina/0000-0001-7947-6922	Federal Ministry of Education and Research of Germany (Projekttrager Julich) [03F0664A]	Federal Ministry of Education and Research of Germany (Projekttrager Julich)	MJR received funding from Federal Ministry of Education and Research of Germany (Projekttrager Julich); https://www.ptj.de/index.php; grant no. 03F0664A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, DISTRIBUTION ATLAS B; Baeza JA, 2013, MAR ECOL-EVOL PERSP, V34, P381, DOI 10.1111/maec.12038; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barber BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037105; Barber P, 2006, P ROY SOC B-BIOL SCI, V273, P2053, DOI 10.1098/rspb.2006.3540; Beermann J., 2011, MAR BIODIVERS REC, V4, P1, DOI DOI 10.1017/S1755267211000388; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P328, DOI 10.1016/j.ympev.2012.10.020; BIRKY CW, 1983, GENETICS, V103, P513; BISHOP MWH, 1947, NATURE, V159, P501, DOI 10.1038/159501a0; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; BOXSHALL GA, 1974, J MAR BIOL ASSOC UK, V54, P355, DOI 10.1017/S0025315400058598; Brokeland W, 2008, ZOOL J LINN SOC-LOND, V152, P655, DOI 10.1111/j.1096-3642.2008.00362.x; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Brusca RC, 2003, INVERTEBRATES; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Callaway R, 2002, ICES J MAR SCI, V59, P1199, DOI 10.1006/jmsc.2002.1288; Chen YY, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.214.3291; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Costa FO, 2009, SYST BIODIVERS, V7, P365, DOI 10.1017/S1477200009990120; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; CRISP DJ, 1958, J MAR BIOL ASSOC UK, V37, P483, DOI 10.1017/S0025315400023833; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; De Grave S, 2010, J CRUSTACEAN BIOL, V30, P521, DOI 10.1651/10-3278.1; DeWaard Jeremy R., 2008, V410, P275; Doublet V, 2013, J MOL EVOL, V77, P107, DOI 10.1007/s00239-013-9587-7; Doublet V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002938; DYER MF, 1983, J MAR BIOL ASSOC UK, V63, P683, DOI 10.1017/S0025315400070995; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Fischnaller S, 2012, FLY, V6, P284, DOI 10.4161/fly.21535; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; FRANSZ HG, 1991, NETH J SEA RES, V28, P1, DOI 10.1016/0077-7579(91)90003-J; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gruner H-E, 1993, LEHRBUCH SPEZIELLEN, VI; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Harris R., 2000, ICES ZOOPLANKTON MET; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Haye PA, 2012, FOOD CONTROL, V25, P239, DOI 10.1016/j.foodcont.2011.10.034; Hayward PJ, 1990, HDB MARINE FAUNA N W; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEIP C, 1992, ICES J MAR SCI, V49, P13, DOI 10.1093/icesjms/49.1.13; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; Holm ER, 2012, INTEGR COMP BIOL, V52, P348, DOI 10.1093/icb/ics042; HUYS R, 1992, ICES J MAR SCI, V49, P23, DOI 10.1093/icesjms/49.1.23; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kabata Z., 1979, Parasitic Copepoda of British fishes.; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khalaji-Pirbalouty V, 2014, ZOOTAXA, V3826, P230, DOI 10.11646/zootaxa.3826.1.7; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koch W, 2014, J MAR BIOL ASSOC UK, V94, P547, DOI 10.1017/S0025315413001677; Krebes L, 2010, MOL PHYLOGENET EVOL, V54, P372, DOI 10.1016/j.ympev.2009.07.034; Krebes L, 2011, SYST BIODIVERS, V9, P259, DOI 10.1080/14772000.2011.604359; Kroncke I, 2013, ESTUAR COAST SHELF S, V119, P79, DOI 10.1016/j.ecss.2012.12.024; Laakmann S, 2013, MOL ECOL RESOUR, V13, P862, DOI 10.1111/1755-0998.12139; Leache AD, 2014, SYST BIOL, V63, P534, DOI 10.1093/sysbio/syu018; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Lincoln RJ, 1979, BRIT MARINE AMPHIPOD; LUTHER G, 1987, HELGOLANDER MEERESUN, V41, P1, DOI 10.1007/BF02365098; Markert A, 2014, ORG DIVERS EVOL, V14, P369, DOI 10.1007/s13127-014-0176-4; Martin J.W., 2001, UPDATED CLASSIFICATI, VVolume 39, P1; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P1; McClain CR, 2015, PEERJ, V2, DOI 10.7717/peerj.715; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer R, 2013, SYST BIODIVERS, V11, P389, DOI 10.1080/14772000.2013.833143; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Moriniere J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109719; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Negri M, 2014, J CRUSTACEAN BIOL, V34, P848, DOI 10.1163/1937240X-00002277; Neumann H, 2008, HELGOLAND MAR RES, V62, P215, DOI 10.1007/s10152-008-0109-8; Nicole S, 2012, FOOD TECHNOL BIOTECH, V50, P387; Oines O, 2006, J FISH DIS, V29, P167, DOI 10.1111/j.1365-2761.2006.00702.x; Oines O, 2005, J MAR BIOL ASSOC UK, V85, P73, DOI 10.1017/S0025315405010854h; Oines O, 2008, ACTA PARASITOL, V53, P93, DOI 10.2478/s11686-008-0002-2; Ortea I, 2009, J AQUAT FOOD PROD T, V18, P146, DOI 10.1080/10498850802584280; Pante E, 2015, HEREDITY, V114, P450, DOI 10.1038/hdy.2014.105; Rachor E, 2013, ROTE LISTE GEFAHRDET, V2, P81; Radulovici Adriana E., 2010, Diversity, V2, P450; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Riccardi N, 2012, J PLANKTON RES, V34, P484, DOI 10.1093/plankt/fbs022; Riehl T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049354; Rock J, 2007, HEREDITY, V99, P102, DOI 10.1038/sj.hdy.6800971; Rodriguez-Fernandez JI, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2933.1.3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidt S, 2015, MOL ECOL RESOUR, V15, P985, DOI 10.1111/1755-0998.12363; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Sommer U, 2002, ECOL RES, V17, P161, DOI 10.1046/j.1440-1703.2002.00476.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stoeckle MY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02635; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; TAYLOR DJ, 1993, P ROY SOC B-BIOL SCI, V254, P163, DOI 10.1098/rspb.1993.0141; Trautner J, 2014, DISTRIBUTION ATLAS G; Turner JT, 2004, ZOOL STUD, V43, P255; van Noort GJ, 2011, ZOOL MED LEIDEN, V59, P363; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Woodcock TS, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-40; WoRMS Editorial Board, 2015, WORLD REGISTER MARIN; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhou X, 2011, J N AM BENTHOL SOC, V30, P131, DOI 10.1899/10-010.1; Zuna-Kratky T, 2009, VERBREITUNGSATLAS HE	117	97	104	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139421	10.1371/journal.pone.0139421	http://dx.doi.org/10.1371/journal.pone.0139421			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26417993	Green Published, Green Accepted, gold			2022-12-27	WOS:000362171400089
J	Schumann, M; Yli-Peltola, K; Abbiss, CR; Hakkinen, K				Schumann, Moritz; Yli-Peltola, Kaisu; Abbiss, Chris R.; Hakkinen, Keijo			Cardiorespiratory Adaptations during Concurrent Aerobic and Strength Training in Men and Women	PLOS ONE			English	Article							POSTEXERCISE OXYGEN-CONSUMPTION; INVERSE RELATIONSHIP; RESISTANCE EXERCISE; LACTATE THRESHOLD; RUNNING ECONOMY; ENDURANCE; MUSCLE; PERFORMANCE; EFFICIENCY; INCREASES	This study investigated the effects of endurance followed by strength training (ES, men n = 16; women n = 15), the reverse exercise order (SE, men n = 18, women n = 13) and concurrent endurance and strength training performed on alternating days (AD, men n = 21, women n = 18) on cardiorespiratory parameters. Peak oxygen consumption ((V) over dot O-2peak) and oxygen consumption at sub-maximal power outputs ((V) over dot O-2submax) of 50 to 175 Watts in men and 50 to 125 Watts in women were assessed during an incremental cycling test both before and after 24 weeks of training. Increases in (V) over dot O-2peak in both men and women were statistically larger in AD (18 +/- 9% and 25 +/- 11%) compared to ES (7 +/- 9% and 12 +/- 12%, p = 0.002 and 0.009, respectively) and SE (7 +/- 9% and 10 +/- 8%, p = 0.005 and 0.008, respectively). No statistical group interaction was observed for (V) over dot O-2submax in men, but in women (V) over dot O-2submax was statistically lower at week 24 in ES compared to AD at 75W(-2 +/- 6% vs. +3 +/- 6%, p = 0.027) and 125W(-4 +/- 5% vs. +2 +/- 5%, p = 0.010). These findings indicate that endurance and strength training performed on alternating days may optimize the adaptations in (V) over dot O-2peak in both sexes, while performing ES training in women may optimize cardiorespiratory fitness at sub-maximal power outputs.	[Schumann, Moritz; Yli-Peltola, Kaisu; Hakkinen, Keijo] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland; [Abbiss, Chris R.] Edith Cowan Univ, Sch Exercise & Hlth Sci, Ctr Exercise & Sports Sci Res, Perth, WA, Australia	University of Jyvaskyla; Edith Cowan University	Schumann, M (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland.	moritz.schumann@jyu.fi		Abbiss, Chris/0000-0003-3940-5542	Finnish Ministry of Education and Culture; Polar Electro Oy	Finnish Ministry of Education and Culture; Polar Electro Oy	The authors received funding from the following organisations: Finnish Ministry of Education and Culture, http://www.minedu.fi/OPM/?lang=en; Polar Electro Oy, http://www.polar.com/us-en?nogeo. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atkinson G, 2003, MED SCI SPORT EXER, V35, P1242, DOI 10.1249/01.MSS.0000074560.08128.5D; AUNOLA S, 1986, INT J SPORTS MED, V7, P161, DOI 10.1055/s-2008-1025755; Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809; BERGH U, 1991, MED SCI SPORT EXER, V23, P205; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BOND V, 1991, J SPORT MED PHYS FIT, V31, P357; Borsheim E, 2003, SPORTS MED, V33, P1037; Burt D, 2013, EUR J APPL PHYSIOL, V113, P285, DOI 10.1007/s00421-012-2437-2; Cadore EL, 2011, J STRENGTH COND RES, V25, P758, DOI 10.1519/JSC.0b013e318207ed66; Chtara M, 2005, BRIT J SPORT MED, V39, P555, DOI 10.1136/bjsm.2004.015248; Di Blasio A, 2012, J SPORT SCI MED, V11, P393; Doma K, 2014, EUR J SPORT SCI, V14, P107, DOI 10.1080/17461391.2012.726653; Drummond MJ, 2005, J STRENGTH COND RES, V19, P332; Eklund D, 2014, INT J SPORTS MED; Eklund D, 2015, J STRENGTH COND RES; Farrell SW, 2014, MED SCI SPORTS EXERC; Fonda B, 2012, SPORT SCI REV, V19, P187; Goreham C, 1999, AM J PHYSIOL-ENDOC M, V276, pE489; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HECK H, 1985, INT J SPORTS MED, V6, P117, DOI 10.1055/s-2008-1025824; Hickson RC., 1980, INTERFERENCE STRENGT, V45, P255; Hunter GR, 2005, EUR J APPL PHYSIOL, V94, P558, DOI 10.1007/s00421-005-1370-z; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Loveless DJ, 2005, MED SCI SPORT EXER, V37, P1231, DOI 10.1249/01.mss.0000170071.33880.f8; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; MARCINIK EJ, 1991, MED SCI SPORT EXER, V23, P739; Moseley L, 2001, MED SCI SPORT EXER, V33, P621; NELSON AG, 1990, PHYS THER, V70, P287, DOI 10.1093/ptj/70.5.287; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Palmer CD, 2001, J SCI MED SPORT, V4, P447, DOI 10.1016/S1440-2440(01)80053-0; PATE RR, 1992, MED SCI SPORT EXER, V24, P1128; Ratkevicius A, 2006, J SPORT SCI MED, V5, P440; Robineau J, 2014, J STRENGTH COND RES; Ronnestad BR, 2012, J STRENGTH COND RES, V26, P158, DOI 10.1519/JSC.0b013e318218dd94; Ruseski JE, 2011, EUR REV AGING PHYS A, V8, P57, DOI 10.1007/s11556-011-0084-y; SALE DG, 1990, MED SCI SPORT EXER, V22, P348; Schumann M, 2014, MED SCI SPORT EXER, V46, P1758, DOI 10.1249/MSS.0000000000000303; Thompson WR, 2010, ACSMS GUIDELINES EXE, V8th; Welsman JR, 1996, MED SCI SPORT EXER, V28, P259, DOI 10.1097/00005768-199602000-00016; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d; ZHANG YY, 1991, MED SCI SPORT EXER, V23, P625	41	25	26	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139279	10.1371/journal.pone.0139279	http://dx.doi.org/10.1371/journal.pone.0139279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418015	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400071
J	Devapatla, B; Sharma, A; Woo, S				Devapatla, Bharat; Sharma, Ankur; Woo, Sukyung			CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; HUMAN ENDOTHELIAL-CELLS; EPITHELIAL OVARIAN; GROWTH-FACTOR; TUMOR-GROWTH; LUNG-CANCER; ANGIOGENESIS; INTERLEUKIN-8; RESISTANCE; SUNITINIB	Antiangiogenic therapy is important for the treatment of gynecological cancer. However, the therapeutic benefit derived from these treatments is transient, predominantly due to the selective activation of compensatory proangiogenic pathways that lead to rapid development of resistance. We aimed to identify and target potential alternative signaling to antivascular endothelial growth factor (VEGF) therapy, with a view toward developing a combination of antiangiogenic agents to provide extended therapeutic benefits. We developed a preclinical in vivo phenotypic resistance model of ovarian cancer resistant to antiangiogenic therapy. We measured dynamic changes in secreted chemokines and angiogenic signaling in tumors and plasma in response to anti-VEGF treatment, as tumors advanced from the initial responsive phase to progressive disease. In tumors that progressed following sorafenib treatment, gene and protein expression levels of proangiogenic CXC chemokines and their receptors were significantly elevated, compared with responsive tumors. The chemokine (C-X-C motif) ligand 8 (CXCL8), also known as interleukin-8 (IL-8) increase was time-dependent and coincided with the dynamics of tumor progression. We used SB225002, a pharmacological inhibitor of chemokine (C-X-C motif) receptor 2 (CXCR2), to disrupt the CXC chemokine-mediated functions of ovarian cancer cells in in vitro assays of cell growth inhibition, spheroid formation, and cell migration. The combination of CXCR2 inhibitor with sorafenib led to a synergistic inhibition of cell growth in vitro, and further stabilized tumor progression following sorafenib in vivo. Our results suggest that CXCR2-mediated chemokines may represent an important compensatory pathway that promotes resistance to antiangiogenic therapy in ovarian cancer. Thus, simultaneous blockage of this proangiogenic cytokine pathway using CXCR2 inhibitors and the VEGF receptor (VEGFR) pathway could improve the outcomes of antiangiogenic therapy.	[Devapatla, Bharat; Sharma, Ankur; Woo, Sukyung] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Woo, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA.	sukyung-woo@ouhsc.edu			National Institutes of General Medical Sciences of the National Institutes of Health [P20GM103639]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103639] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institutes of General Medical Sciences of the National Institutes of Health under Award Number P20GM103639. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Alvarez AA, 1999, CLIN CANCER RES, V5, P587; Arthur D, 2006, INT J NURS STUD, V43, P107, DOI 10.1016/j.ijnurstu.2005.03.007; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Bento AF, 2008, J LEUKOCYTE BIOL, V84, P1213, DOI 10.1189/jlb.0408231; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brown MR, 2000, BEST PRACT RES CL OB, V14, P901, DOI 10.1053/beog.2000.0134; Chen AA, 2013, P NATL ACAD SCI USA, V110, P16820, DOI 10.1073/pnas.1309392110; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coward JIG, 2015, INT J WOMENS HEALTH, V7, P189, DOI 10.2147/IJWH.S52379; Danso-Abeam D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-79; Davidson BA, 2014, INT J WOMENS HEALTH, V6, P289, DOI 10.2147/IJWH.S49781; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Eskander RN, 2014, GYNECOL ONCOL, V132, P496, DOI 10.1016/j.ygyno.2013.11.029; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Garcia A, 2013, PARASITOLOGY INT; Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088234; Garcia-Areas R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00017; Gimeno-Santos E, 2014, COPD, V11, P190, DOI 10.3109/15412555.2013.831401; Gomez-Raposo C, 2009, CLIN TRANSL ONCOL, V11, P564, DOI 10.1007/s12094-009-0406-y; Griffioen AW, 2012, CLIN CANCER RES, V18, P3961, DOI 10.1158/1078-0432.CCR-12-0002; Grothey A, 2008, J CLIN ONCOL, V26, P5326, DOI 10.1200/JCO.2008.16.3212; Hazelton D, 1999, CLIN CANCER RES, V5, P823; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Huang YX, 2011, J CANCER RES CLIN, V137, P829, DOI 10.1007/s00432-010-0944-2; Hubscher D, 2010, J Stem Cells Regen Med, V6, P47; Ionescu M, 2013, J BACTERIOL, V195, P5273, DOI 10.1128/JB.00713-13; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kossaify A, 2013, BIOMARK INSIGHTS, V8, P115, DOI 10.4137/BMI.S12703; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Martinez L, 2013, ENVIRON TECHNOL, V34, P3137, DOI 10.1080/09593330.2013.808238; Matte I, 2012, AM J CANCER RES, V2, P566; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Quintens R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056719; Ramakrishnan S., 2005, Angiogenesis, V8, P169, DOI 10.1007/s10456-005-9001-1; Rini BI, 2011, CANCER-AM CANCER SOC, V117, P758, DOI 10.1002/cncr.25639; Rodriguez GC, 2001, GYNECOL ONCOL, V80, P245, DOI 10.1006/gyno.2000.6042; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Shaw D, 2013, CURR OPIN ONCOL, V25, P558, DOI 10.1097/CCO.0b013e328363e0da; Shekaran A, 2014, BIOMATERIALS, V35, P5453, DOI 10.1016/j.biomaterials.2014.03.055; Solana AB, 2014, MAGN RESON IMAGING, V32, P684, DOI 10.1016/j.mri.2014.03.008; STRIETER RM, 1995, J LEUKOCYTE BIOL, V57, P752, DOI 10.1002/jlb.57.5.752; Teoh DGK, 2011, CANCER CONTROL, V18, P31, DOI 10.1177/107327481101800105; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Wang Y, 2012, CYTOKINE, V59, P145, DOI 10.1016/j.cyto.2012.04.013; Wang Y, 2011, CYTOKINE, V56, P365, DOI 10.1016/j.cyto.2011.06.005; Xu L, 2000, ONCOL RES, V12, P97, DOI 10.3727/096504001108747567	53	33	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139237	10.1371/journal.pone.0139237	http://dx.doi.org/10.1371/journal.pone.0139237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414070	gold, Green Submitted, Green Published			2022-12-27	WOS:000362170700052
J	Hao, MS; Jensen, AM; Boquist, AS; Liu, YJ; Rasmusson, AG				Hao, Meng-Shu; Jensen, Anna M.; Boquist, Ann-Sofie; Liu, Yun-Jun; Rasmusson, Allan G.			The Ca2+-Regulation of the Mitochondrial External NADPH Dehydrogenase in Plants Is Controlled by Cytosolic pH	PLOS ONE			English	Article							ALTERNATIVE NAD(P)H DEHYDROGENASES; ELECTRON-TRANSPORT CHAIN; REACTIVE OXYGEN; LEAF MITOCHONDRIA; RESPIRATORY-CHAIN; EXOGENOUS NADH; ARABIDOPSIS; METABOLISM; OXIDATION; CA2+	NADPH is a key reductant carrier that maintains internal redox and antioxidant status, and that links biosynthetic, catabolic and signalling pathways. Plants have a mitochondrial external NADPH oxidation pathway, which depends on Ca2+ and pH in vitro, but concentrations of Ca2+ needed are not known. We have determined the K-0.5(Ca2+) of the external NADPH dehydrogenase from Solanum tuberosum mitochondria and membranes of E. coli expressing Arabidopsis thaliana NDB1 over the physiological pH range using O-2 and decylubiquinone as electron acceptors. The K-0.5(Ca2+) of NADPH oxidation was generally higher than for NADH oxidation, and unlike the latter, it depended on pH. At pH 7.5, K-0.5(Ca2+) for NADPH oxidation was high (approximate to 100 mu M), yet 20-fold lower K-0.5(Ca2+) values were determined at pH 6.8. Lower K-0.5(Ca2+) values were observed with decylubiquinone than with O-2 as terminal electron acceptor. NADPH oxidation responded to changes in Ca2+ concentrations more rapidly than NADH oxidation did. Thus, cytosolic acidification is an important activator of external NADPH oxidation, by decreasing the Ca2+-requirements for NDB1. The results are discussed in relation to the present knowledge on how whole cell NADPH redox homeostasis is affected in plants modified for the NDB1 gene.	[Hao, Meng-Shu; Jensen, Anna M.; Boquist, Ann-Sofie; Liu, Yun-Jun; Rasmusson, Allan G.] Lund Univ, Dept Biol, Lund, Sweden; [Jensen, Anna M.] Linnaeus Univ, Dept Forestry & Wood Technol, Vaxjo, Sweden; [Liu, Yun-Jun] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Lund University; Linnaeus University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Rasmusson, AG (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	allan.rasmusson@biol.lu.se		Jensen, Anna Monrad/0000-0001-5113-5624	Carl Trygger Foundation for Scientific Research [10:318, 11:381, 12:397]; Faculty of Science at Lund University	Carl Trygger Foundation for Scientific Research; Faculty of Science at Lund University	This work was supported by The Carl Trygger Foundation for Scientific Research (10:318, 11:381, 12:397; http://www.carltryggersstiftelse.se/); Faculty of Science at Lund University (No grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan WL, 2008, J EXP BOT, V59, P2555, DOI 10.1093/jxb/ern122; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Cardenas L, 2006, PLANT PHYSIOL, V142, P1460, DOI 10.1104/pp.106.087882; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; CORTESE JD, 1992, BIOCHIM BIOPHYS ACTA, V1100, P189; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dell'Orco D, 2012, ANAL CHEM, V84, P2982, DOI 10.1021/ac300213j; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; DOUCE R, 1989, ANNU REV PLANT PHYS, V40, P371, DOI 10.1146/annurev.pp.40.060189.002103; EDMAN K, 1985, BIOCHEM J, V232, P471, DOI 10.1042/bj2320471; Elhafez D, 2006, PLANT CELL PHYSIOL, V47, P43, DOI 10.1093/pcp/pci221; Eschemann A, 2005, J BIOL CHEM, V280, P3138, DOI 10.1074/jbc.M411217200; Escobar MA, 2006, PLANT J, V45, P775, DOI 10.1111/j.1365-313X.2005.02640.x; Felle HH, 2001, PLANT BIOLOGY, V3, P577, DOI 10.1055/s-2001-19372; Feng Y, 2012, NATURE, V491, P478, DOI 10.1038/nature11541; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; FREDLUND KM, 1991, PLANT PHYSIOL, V97, P99, DOI 10.1104/pp.97.1.99; Geisler DA, 2007, J BIOL CHEM, V282, P28455, DOI 10.1074/jbc.M704674200; Gillis TE, 2000, AM J PHYSIOL-REG I, V279, pR1707, DOI 10.1152/ajpregu.2000.279.5.R1707; Gout E, 2011, NEW PHYTOL, V189, P135, DOI 10.1111/j.1469-8137.2010.03449.x; Iwata M, 2012, P NATL ACAD SCI USA, V109, P15247, DOI 10.1073/pnas.1210059109; Johansson FI, 2004, BIOCHEM J, V380, P193, DOI 10.1042/BJ20031969; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; KROMER S, 1995, ANNU REV PLANT PHYS, V46, P45, DOI 10.1146/annurev.pp.46.060195.000401; Liu YJ, 2008, PLANT CELL PHYSIOL, V49, P251, DOI 10.1093/pcp/pcn001; Liu YJ, 2009, PLANT PHYSIOL, V150, P1248, DOI 10.1104/pp.109.136242; Martins Teresa Vaz, 2013, Plants-Basel, V2, P541, DOI 10.3390/plants2040541; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; Melo AMP, 1999, BBA-BIOENERGETICS, V1412, P282, DOI 10.1016/S0005-2728(99)00072-9; Michalecka AM, 2004, PLANT J, V37, P415, DOI 10.1046/j.1365-313X.2003.01970.x; Michalecka AM, 2003, PLANT PHYSIOL, V133, P642, DOI 10.1104/pp.103.024208; Millar AH, 2007, METHOD CELL BIOL, V80, P65, DOI 10.1016/S0091-679X(06)80003-8; Millenaar FF, 2003, PLANT BIOLOGY, V5, P2, DOI 10.1055/s-2003-37974; Moller IM, 1997, PHYSIOL PLANTARUM, V100, P85, DOI 10.1034/j.1399-3054.1997.1000108.x; MOLLER IM, 1981, BIOCHEM J, V194, P487, DOI 10.1042/bj1940487; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; MOORE AL, 1982, BIOCHEM BIOPH RES CO, V109, P513, DOI 10.1016/0006-291X(82)91751-X; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; NASH D, 1983, PLANT PHYSIOL, V71, P627, DOI 10.1104/pp.71.3.627; Noctor G, 2006, PLANT CELL ENVIRON, V29, P409, DOI 10.1111/j.1365-3040.2005.01476.x; Nunes-Nesi A, 2011, PLANT PHYSIOL, V155, P101, DOI 10.1104/pp.110.163816; Pastore D, 2003, PLANT PHYSIOL, V133, P2029, DOI 10.1104/pp.103.028548; Petersen OH, 2005, CELL CALCIUM, V38, P161, DOI 10.1016/j.ceca.2005.06.023; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Pratt J, 2009, PLANT PHYSIOL, V151, P1646, DOI 10.1104/pp.109.144626; Rasmusson AG, 2004, ANNU REV PLANT BIOL, V55, P23, DOI 10.1146/annurev.arplant.55.031903.141720; Rasmusson AG, 2001, PLANT PHYSIOL BIOCH, V39, P1057, DOI 10.1016/S0981-9428(01)01334-1; Rasmusson AG, 1999, PLANT J, V20, P79, DOI 10.1046/j.1365-313X.1999.00576.x; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Rasmusson AG, 2011, ADVAN PL BIO, V1, P357; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; ROBERTS TH, 1995, FEBS LETT, V373, P307, DOI 10.1016/0014-5793(95)01059-N; RUGOLO M, 1991, PLANT PHYSIOL, V95, P157, DOI 10.1104/pp.95.1.157; Sakano K, 2001, INT REV CYTOL, V206, P1; Shishova M, 2004, J PLANT PHYSIOL, V161, P937, DOI 10.1016/j.jplph.2003.12.005; Stael S, 2012, J EXP BOT, V63, P1525, DOI 10.1093/jxb/err394; STRUGLICS A, 1993, PHYSIOL PLANTARUM, V88, P19, DOI 10.1111/j.1399-3054.1993.tb01755.x; Szal B, 2012, PLANT CELL ENVIRON, V35, P1756, DOI 10.1111/j.1365-3040.2012.02559.x; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Wallstrom SV, 2014, PLANT CELL PHYSIOL, V55, P881, DOI 10.1093/pcp/pcu021; Wallstrom SV, 2014, MOL PLANT, V7, P356, DOI 10.1093/mp/sst115; Zhou YB, 2013, METALLOMICS, V5, P29, DOI 10.1039/c2mt20009k	67	13	13	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139224	10.1371/journal.pone.0139224	http://dx.doi.org/10.1371/journal.pone.0139224			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413894	Green Published, Green Submitted, gold			2022-12-27	WOS:000362170700050
J	Mondal, S; Haroun, NAH; Sibanda, P				Mondal, Sabyasachi; Haroun, Nageeb A. H.; Sibanda, Precious			The Effects of Thermal Radiation on an Unsteady MHD Axisymmetric Stagnation-Point Flow over a Shrinking Sheet in Presence of Temperature Dependent Thermal Conductivity with Navier Slip	PLOS ONE			English	Article							HEAT-TRANSFER; STRETCHING SHEET	In this paper, the magnetohydrodynamic (MHD) axisymmetric stagnation-point flow of an unsteady and electrically conducting incompressible viscous fluid in with temperature dependent thermal conductivity, thermal radiation and Navier slip is investigated. The flow is due to a shrinking surface that is shrunk axisymmetrically in its own plane with a linear velocity. The magnetic field is imposed normally to the sheet. The model equations that describe this fluid flow are solved by using the spectral relaxation method. Here, heat transfer processes are discussed for two different types of wall heating; (a) a prescribed surface temperature and (b) a prescribed surface heat flux. We discuss and evaluate how the various parameters affect the fluid flow, heat transfer and the temperature field with the aid of different graphical presentations and tabulated results.	[Mondal, Sabyasachi; Haroun, Nageeb A. H.; Sibanda, Precious] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, ZA-3209 Pietermaritzburg, South Africa	University of Kwazulu Natal	Mondal, S (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.	sabya.mondal.2007@gmail.com	Sibanda, Precious/F-9616-2010; Mondal, Sabyasachi/C-9283-2015; Mondal, Sabyasachi/AAE-2837-2019	Sibanda, Precious/0000-0003-2115-4642; Mondal, Sabyasachi/0000-0003-4666-0568; Mondal, Sabyasachi/0000-0003-4666-0568; Haroun, Nageeb A.H/0000-0003-0044-267X	University of KwaZulu-Natal	University of KwaZulu-Natal	This work is funded by the University of KwaZulu-Natal through SM's postdoctoral fellowship.	ATTIA HA, 2007, TAMKANG J SCI ENG, V1, P11; Bansal JL., 1994, MAGNETOFLUIDDYNAMICS; CARRAGHER P, 1982, Z ANGEW MATH MECH, V62, P564, DOI 10.1002/zamm.19820621009; Chiam TC, 1998, ACTA MECH, V129, P63, DOI 10.1007/BF01379650; CHIAM TC, 1994, J PHYS SOC JPN, V63, P2443, DOI 10.1143/JPSJ.63.2443; Fang TG, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/1/014703; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Homann F, 1936, Z ANGEW MATH MECH, V16, P153, DOI 10.1002/zamm.19360160304; Hussanan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14046-x; Jat RN, 2014, THERMAL ENERGY POWER, V3, P234; Khalid A, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15057-9; Khan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090280; Khan JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107287; Mabood F, 2015, CHEM ENG J, V273, P430, DOI 10.1016/j.cej.2015.03.037; Mabood F, 2015, J MAGN MAGN MATER, V374, P569, DOI 10.1016/j.jmmm.2014.09.013; Mabood F., 2015, FAR E J APPL MATH, V90, P21, DOI DOI 10.17654/FJAMJAN2015_; Mabood F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083581; Mahapatra TR, 2013, J APPL FLUID MECH, V6, P121; Mahapatra TR, 2003, CAN J CHEM ENG, V81, P258; Miklavcic M, 2006, Q APPL MATH, V64, P283, DOI 10.1090/S0033-569X-06-01002-5; Motsa SS, 2014, ADV MATH PHYS, V2014, DOI 10.1155/2014/341964; Motsa SS, 2013, CENT EUR J PHYS, V11, P363, DOI 10.2478/s11534-013-0182-8; Motsa SS, 2013, CHEM ENG COMMUN, V16, P23; Nandy SK, 2014, ALEX ENG J, V53, P929, DOI 10.1016/j.aej.2014.09.001; Pavlov K. B., 1974, MAGN GIDRODIN, V4, P146; Qayyum M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117368; Rahimpour M, 2008, INT J MECH, V2, P1; Rohni AM, 2013, INT COMMUN HEAT MASS, V43, P75, DOI 10.1016/j.icheatmasstransfer.2013.02.001; Samiulhaq, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088766; Shercliff JA., 1965, TXB MAGNETOHYDRODYNA; Wang CY, 2008, INT J NONLIN MECH, V43, P377, DOI 10.1016/j.ijnonlinmec.2007.12.021; WANG CY, 1984, PHYS FLUIDS, V27, P1915, DOI 10.1063/1.864868	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138355	10.1371/journal.pone.0138355	http://dx.doi.org/10.1371/journal.pone.0138355			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414006	Green Published, gold, Green Submitted			2022-12-27	WOS:000362170700015
J	Nascimento-Brito, S; Zukurov, JP; Maricato, JT; Volpini, AC; Salim, ACM; Araujo, FMG; Coimbra, RS; Oliveira, GC; Antoneli, F; Janini, LMR				Nascimento-Brito, Sieberth; Zukurov, Jean Paulo; Maricato, Juliana T.; Volpini, Angela C.; Salim, Anna Christina M.; Araujo, Flavio M. G.; Coimbra, Roney S.; Oliveira, Guilherme C.; Antoneli, Fernando; Janini, Luiz Mario R.			HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA	PLOS ONE			English	Article							CD4(+) T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; APOBEC3G RESTRICTS HIV-1; REVERSE TRANSCRIPTION; ENVELOPE GLYCOPROTEIN; PERIPHERAL-BLOOD; GENE-EXPRESSION; CORECEPTOR USE; INFECTION; PROTEINS	In order to establish new infections HIV-1 particles need to attach to receptors expressed on the cellular surface. HIV-1 particles interact with a cell membrane receptor known as CD4 and subsequently with another cell membrane molecule known as a co-receptor. Two major different co-receptors have been identified: C-C chemokine Receptor type 5 (CCR5) and C-X-C chemokine Receptor type 4 (CXCR4) Previous reports have demonstrated cellular modifications upon HIV-1 binding to its co-receptors including gene expression modulations. Here we investigated the effect of viral binding to either CCR5 or CXCR4 co-receptors on viral diversity after a single round of reverse transcription. CCR5 and CXCR4 pseudotyped viruses were used to infect non-stimulated and stimulated PBMCs and purified CD4 positive cells. We adopted the SOLiD methodology to sequence virtually the entire proviral DNA from all experimental infections. Infections with CCR5 and CXCR4 pseudotyped virus resulted in different patterns of genetic diversification. CCR5 virus infections produced extensive proviral diversity while in CXCR4 infections a more localized substitution process was observed. In addition, we present pioneering results of a recently developed method for the analysis of SOLiD generated sequencing data applicable to the study of viral quasi-species. Our findings demonstrate the feasibility of viral quasi-species evaluation by NGS methodologies. We presented for the first time strong evidence for a host cell driving mechanism acting on the HIV-1 genetic variability under the control of co-receptor stimulation. Additional investigations are needed to further clarify this question, which is relevant to viral diversification process and consequent disease progression.	[Nascimento-Brito, Sieberth] Univ Fed Rural Rio de Janeiro UFRRJ, Dept Microbiol & Imunol Vet, Rio De Janeiro, Brazil; [Nascimento-Brito, Sieberth; Maricato, Juliana T.; Janini, Luiz Mario R.] Univ Fed Sao Paulo UNIFESP, EPM, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Zukurov, Jean Paulo; Janini, Luiz Mario R.] Univ Fed Sao Paulo, EPM, Dept Med, Sao Paulo, Brazil; [Volpini, Angela C.; Salim, Anna Christina M.; Araujo, Flavio M. G.; Oliveira, Guilherme C.] Fundacao Oswaldo Cruz FIOCRUZ, Res Ctr Rene Rachou CPqRR, Genom & Computat Biol Grp, Belo Horizonte, MG, Brazil; [Coimbra, Roney S.] Fiocruz MS, CPqRR, Biosyst Informat Grp, Belo Horizonte, MG, Brazil; [Antoneli, Fernando] Univ Fed Sao Paulo, EPM, Dept Informat Saude, Sao Paulo, Brazil; [Antoneli, Fernando] Univ Fed Sao Paulo, EPM, Lab Biocomplexidade & Genom Evolut, Sao Paulo, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Janini, LMR (corresponding author), Univ Fed Sao Paulo UNIFESP, EPM, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	janini@unifesp.br	Coimbra, Roney/ABA-0586-2022; Coimbra, Roney/B-3102-2013; Junior, Fernando Martins Antoneli/A-5155-2008	Junior, Fernando Martins Antoneli/0000-0001-9179-4632; Janini, Luiz Mario/0000-0002-6186-6284; Coimbra, Roney/0000-0002-9204-0573	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/14543-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [REDE-56/11, RED-00014-14]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309312/2012-4, 306362/2012-0]; Fogarty International Center National Institutes of Health [TW007012]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fogarty International Center National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Support was provided to: LMRJ and SNB by 2009/14543-0 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [www.fapesp.br] (reagents/materials/analysis tools/fellowship); GCO by (REDE-56/11, RED-00014-14) Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [www.fapemig.br], (309312/2012-4, 306362/2012-0) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [www.cnpq.br], (TW007012) Fogarty International Center National Institutes of Health [www.fic.nih.gov]; ACV by (TW007012) Fogarty International Center National Institutes of Health [www.fic.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2009, BBA-BIOMEMBRANES, V1788, P2132, DOI 10.1016/j.bbamem.2009.07.008; Al-Sanabani S, 2005, THESIS UNIFESP; Archer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049602; Arrildt KT, 2012, CURR HIV-AIDS REP, V9, P52, DOI 10.1007/s11904-011-0107-3; Awong G, 2010, CURR OPIN HEMATOL, V17, P327, DOI 10.1097/MOH.0b013e3283395133; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Bohl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069406; Cannavo G, 2001, BLOOD, V97, P1756, DOI 10.1182/blood.V97.6.1756; Card CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045911; Chaipan C, 2013, J VIROL, V87, P444, DOI 10.1128/JVI.00676-12; Chiang KR, 2012, VIRUSES-BASEL, V4, P1390, DOI 10.3390/v4091390; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Choi WT, 2011, EXP BIOL MED, V236, P637, DOI 10.1258/ebm.2011.010389; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Etet PFS, 2012, CELL SIGNAL, V24, P1883, DOI 10.1016/j.cellsig.2012.05.015; Foster JL, 2011, J NEUROIMMUNE PHARM, V6, P230, DOI 10.1007/s11481-011-9262-y; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; Gillick K, 2013, J VIROL, V87, P1508, DOI 10.1128/JVI.02587-12; Gonzalez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029973; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Hill MS, 2007, J HISTOCHEM CYTOCHEM, V55, P63, DOI 10.1369/jhc.6A7054.2006; Holtz CM, 2013, J VIROL, V87, P5296, DOI 10.1128/JVI.03576-12; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jones KL, 2010, J BIOL CHEM, V285, P18603, DOI 10.1074/jbc.M109.090126; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Krueger RL, 2013, J VIROL, V87, P5916, DOI 10.1128/JVI.00398-13; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Loftin LM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S3; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mariani SA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S8; Mariani SA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S2-I19; Medjahed H, 2013, J VIROL, V87, P4103, DOI 10.1128/JVI.03124-12; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Moraes C, 2011, INTEGR BIOL-UK, V3, P959, DOI 10.1039/c1ib00056j; Ng KW, 2011, DIRICHLET RELATED DI, V889; Paiardini M, 2004, IMMUNOL RES, V29, P253, DOI 10.1385/IR:29:1-3:253; Piekna-Przybylska D, 2011, RNA BIOL, V8, P230, DOI 10.4161/rna.8.2.14802; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Ramakrishnan R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-42; Romani B, 2009, ARCH VIROL, V154, P1579, DOI 10.1007/s00705-009-0481-y; SALMINEN MO, 1995, VIROLOGY, V213, P80, DOI 10.1006/viro.1995.1548; Schopman NCT, 2012, VIRUS RES, V169, P438, DOI 10.1016/j.virusres.2012.06.017; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Sirois M, 2008, AIDS RES HUM RETROV, V24, P485, DOI 10.1089/aid.2007.0120; Sloan RD, 2011, RETROVIROLOGY, P8; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; St Gelais C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034521; Suspene R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036246; Verhofstede C, 2012, CURR OPIN HIV AIDS, V7, P432, DOI 10.1097/COH.0b013e328356f6f2; Vermeire J, 2011, CURR HIV RES, V9, P474, DOI 10.2174/157016211798842099; Voronin Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000431; Wicker N, 2008, COMPUT STAT DATA AN, V52, P1315, DOI 10.1016/j.csda.2007.07.011; Wood N, 2009, PLOS PATHOG, P5; Wu L, 2012, RETROVIROLOGY, P9; Yin L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-108; Yuste E, 2000, J VIROL, V74, P9546, DOI 10.1128/JVI.74.20.9546-9552.2000; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046; Zukurov JP, 2014, ARXIV14052044	64	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139037	10.1371/journal.pone.0139037	http://dx.doi.org/10.1371/journal.pone.0139037			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26413773	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700034
J	Nutter, FH; Haylor, JL; Khwaja, A				Nutter, Faith Hannah; Haylor, John L.; Khwaja, Arif			Inhibiting ERK Activation with CI-1040 Leads to Compensatory Upregulation of Alternate MAPKs and Plasminogen Activator Inhibitor-1 following Subtotal Nephrectomy with No Impact on Kidney Fibrosis	PLOS ONE			English	Article							PROTEIN-KINASE ACTIVATION; EPITHELIAL-CELLS; MESENCHYMAL TRANSITION; MEDIATED ACTIVATION; MESANGIAL CELLS; RENAL FIBROSIS; MEK INHIBITOR; C-JUN; GROWTH; P38	Extracellular-signal regulated kinase (ERK) activation by MEK plays a key role in many of the cellular processes that underlie progressive kidney fibrosis including cell proliferation, apoptosis and transforming growth factor beta 1-mediated epithelial to mesenchymal transition. We therefore assessed the therapeutic impact of ERK1/2 inhibition using a MEK inhibitor in the rat 5/6 subtotal nephrectomy (SNx) model of kidney fibrosis. There was a twentyfold upregulation in phospho-ERK1/2 expression in the kidney after SNx in Male Wistar rats. Rats undergoing SNx became hypertensive, proteinuric and developed progressive kidney failure with reduced creatinine clearance. Treatment with the MEK inhibitor, CI-1040 abolished phospho-ERK1/2 expression in kidney tissue and prevented phospho-ERK1/2 expression in peripheral lymphocytes during the entire course of therapy. CI-1040 had no impact on creatinine clearance, proteinuria, glomerular and tubular fibrosis, and a-smooth muscle actin expression. However, inhibition of ERK1/2 activation led to significant compensatory upregulation of the MAP kinases, p38 and JNK in kidney tissue. CI-1040 also increased the expression of plasminogen activator inhibitor-1 (PAI-1), a key inhibitor of plasmin-dependent matrix metalloproteinases. Thus inhibition of ERK1/2 activation has no therapeutic effect on kidney fibrosis in SNx possibly due to increased compensatory activation of the p38 and JNK signalling pathways with subsequent upregulation of PAI-1.	[Nutter, Faith Hannah; Haylor, John L.] Univ Sheffield, Sch Med, Acad Unit Nephrol, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Khwaja, Arif] No Gen Hosp, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England	University of Sheffield; Northern General Hospital	Nutter, FH (corresponding author), Univ Sheffield, Sch Med, Acad Unit Nephrol, Dept Infect & Immun, Sheffield, S Yorkshire, England.	f.nutter@sheffield.ac.uk		Howard, Faith/0000-0001-9899-3079; Khwaja, Arif/0000-0002-4690-3649	Kidney Research UK	Kidney Research UK(Kidney Research UK (KRUK))	Support was provided by Kidney Research UK [www.kidneyresearchuk.org] and Sheffield Kidney Research Fund [http://www.sheffield-kidney-institute.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LF, 2003, SEMIN ONCOL, V30, P105, DOI 10.1053/j.seminoncol.2003.08.012; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Aoudjit L, 2003, AM J PHYSIOL-RENAL, V285, pF765, DOI 10.1152/ajprenal.00100.2003; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bokemeyer D, 1997, J CLIN INVEST, V100, P582, DOI 10.1172/JCI119568; Chen JC, 2012, MOL CELL BIOL, V32, P981, DOI 10.1128/MCB.06410-11; Chetram MA, 2012, J RECEPT SIG TRANSD, V32, P190, DOI 10.3109/10799893.2012.695798; Conway B, 2012, QJM-INT J MED, V105, P611, DOI 10.1093/qjmed/hcr235; D'Abaco GM, 2002, J CELL SCI, V115, P4607, DOI 10.1242/jcs.00161; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Borst MH, 2007, J PATHOL, V213, P219, DOI 10.1002/path.2228; Diaz-Flores E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004125; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Feliers Denis, 2011, J Signal Transduct, V2011, P768512, DOI 10.1155/2011/768512; Fujita H, 2004, AM J PHYSIOL-RENAL, V286, pF120, DOI 10.1152/ajprenal.00351.2002; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Han YJ, 2008, NEPHROLOGY, V13, P411, DOI 10.1111/j.1440-1797.2008.00926.x; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Huang LL, 2012, NEPHRON EXP NEPHROL, V120, pE115, DOI 10.1159/000339500; Ishida T, 1999, DIABETES, V48, P595, DOI 10.2337/diabetes.48.3.595; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; LoRusso PM, 2005, J CLIN ONCOL, V23, P5281, DOI 10.1200/JCO.2005.14.415; Ma FY, 2009, BRAZ J MED BIOL RES, V42, P29, DOI 10.1590/S0100-879X2008005000049; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Ma FY, 2009, LAB INVEST, V89, P470, DOI 10.1038/labinvest.2009.2; Masaki T, 2004, J AM SOC NEPHROL, V15, P1835, DOI 10.1097/01.ASN.0000130623.66271.67; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Ohashi R, 2004, AM J PATHOL, V164, P477, DOI 10.1016/S0002-9440(10)63138-0; Oldroyd SD, 2006, AM J PHYSIOL-RENAL, V290, pF695, DOI 10.1152/ajprenal.00058.2005; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Pippin JW, 2003, J CLIN INVEST, V111, P877, DOI 10.1172/JCI200315645; Reif GA, 2011, AM J PHYSIOL-RENAL, V301, pF1005, DOI 10.1152/ajprenal.00243.2011; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sabbatini M, 2006, AM J PHYSIOL-RENAL, V290, pF1408, DOI 10.1152/ajprenal.00304.2005; Sakai N, 2005, AM J KIDNEY DIS, V45, P54, DOI 10.1053/j.ajkd.2004.08.039; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; Stambe C, 2004, J AM SOC NEPHROL, V15, P370, DOI 10.1097/01.ASN.0000109669.23650.56; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Wada T, 2001, AM J KIDNEY DIS, V38, P1169, DOI 10.1053/ajkd.2001.29206; Wang S, 2008, AM J PHYSIOL-RENAL, V295, pF672, DOI 10.1152/ajprenal.90285.2008; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; WOLF G, 1991, KIDNEY INT, V39, P401, DOI 10.1038/ki.1991.52; Xu T, 2012, MOL BIOL REP, V39, P7743, DOI 10.1007/s11033-012-1611-2; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0137321	10.1371/journal.pone.0137321	http://dx.doi.org/10.1371/journal.pone.0137321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26415098	Green Accepted, Green Published, gold			2022-12-27	WOS:000362170700007
J	Da Boit, M; Mastalurova, I; Brazaite, G; McGovern, N; Thompson, K; Gray, SR				Da Boit, Mariasole; Mastalurova, Ina; Brazaite, Goda; McGovern, Niall; Thompson, Keith; Gray, Stuart Robert			The Effect of Krill Oil Supplementation on Exercise Performance and Markers of Immune Function	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; KILLER-CELL-ACTIVITY; FISH-OIL; EICOSAPENTAENOIC ACID; OXIDATIVE STRESS; INFLAMMATORY PROCESSES; DOCOSAHEXAENOIC ACID; OXYGEN-CONSUMPTION; STRENUOUS EXERCISE; OMEGA-3 INDEX	Background Krill oil is a rich source of the long-chain n-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which may alter immune function after exercise. The aim of the study was to determine the effects of krill oil supplementation on post exercise immune function and performance. Methods Nineteen males and 18 females (age: 25.8 +/- 5.3 years; mean +/- S.D.) were randomly assigned to 2 g/day of krill oil (n = 18) or placebo (n = 19) supplementation for 6 weeks. A maximal incremental exercise test and cycling time trial (time to complete set amount of work) were performed pre-supplementation with the time trial repeated post-supplementation. Blood samples collected pre-and post-supplementation at rest, and immediately, 1 and 3h post-exercise. Plasma IL-6 and thiobarbituric acid reactive substances (TBARS) concentrations and, erythrocyte fatty acid composition were measured. Natural killer (NK) cell cytotoxic activity and peripheral blood mononuclear cell (PBMC) IL-2, IL-4, IL-10, IL-17 and IFN. production were also measured. Results No effects of gender were noted for any variable. PBMC IL-2 and NK cell cytotoxic activity were greater (P < 0.05) 3h post exercise in the krill oil compared to the control group. Plasma IL-6 and TBARS, PBMC IL-4, IL-10, IL-17 and IFN. production, along with performance and physiological measures during exercise, were not different between groups. Conclusion Six weeks of krill oil supplementation can increase PBMC IL-2 production and NK cell cytotoxic activity 3h post-exercise in both healthy young males and females. Krill oil does not modify exercise performance.	[Da Boit, Mariasole; Mastalurova, Ina; Brazaite, Goda; McGovern, Niall; Thompson, Keith; Gray, Stuart Robert] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Aberdeen	Gray, SR (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	Stuart.gray@glasgow.ac.uk	Gray, Stuart R/L-2489-2017	Gray, Stuart R/0000-0001-8969-9636; Thompson, Keith/0000-0002-9167-5147	Aker Biomarine Antarctic AS; BBSRC [BB/J015911/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015911/1] Funding Source: researchfish	Aker Biomarine Antarctic AS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported with funding from Aker Biomarine Antarctic AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade PMM, 2007, PROSTAG LEUKOTR ESS, V77, P139, DOI 10.1016/j.plefa.2007.08.010; Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-36; Buckley JD, 2009, J SCI MED SPORT, V12, P503, DOI 10.1016/j.jsams.2008.01.011; BULL NL, 1983, HUM NUTR-APPL NUTR, V37, P373; Calder PC, 2002, BRIT J NUTR, V87, pS31, DOI 10.1079/BJN2001455; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; (COT) SACoNSaCoT, 2004, ADV FISH CONS BEN RI, DOI [10.1016/j.envres.2014.10.029, DOI 10.1016/J.ENVRES.2014.10.029]; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Gray P, 2014, INT J SPORT NUTR EXE, V24, P206, DOI 10.1123/ijsnem.2013-0081; Gray P, 2012, BRAIN BEHAV IMMUN, V26, P1265, DOI 10.1016/j.bbi.2012.08.002; HALL TJ, 1983, CLIN EXP IMMUNOL, V54, P493; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Kawabata F, 2014, BIOSCI BIOTECH BIOCH, V78, P2081, DOI 10.1080/09168451.2014.946392; Kelley DS, 1999, LIPIDS, V34, P317, DOI 10.1007/s11745-999-0369-5; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; McAnulty SR, 2010, MED SCI SPORT EXER, V42, P1704, DOI 10.1249/MSS.0b013e3181d85bd1; MEYDANI SN, 1988, J NUTR, V118, P1245, DOI 10.1093/jn/118.10.1245; Miles EA, 2006, NUTRITION, V22, P512, DOI 10.1016/j.nut.2005.11.011; Nettleton JA, 2005, J AM DIET ASSOC, V105, P428, DOI 10.1016/j.jada.2004.11.029; Nieman DC, 2009, INT J SPORT NUTR EXE, V19, P536, DOI 10.1123/ijsnem.19.5.536; NIEMAN DC, 1990, J SPORT MED PHYS FIT, V30, P316; Oostenbrug GS, 1997, J APPL PHYSIOL, V83, P746, DOI 10.1152/jappl.1997.83.3.746; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; PEDERSEN BK, 1990, INT J SPORTS MED, V11, P127, DOI 10.1055/s-2007-1024776; Peoples GE, 2010, BRIT J NUTR, V104, P1771, DOI 10.1017/S0007114510002928; Peoples GE, 2008, J CARDIOVASC PHARM, V52, P540, DOI 10.1097/FJC.0b013e3181911913; Perry C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074722; Purasiri P, 1997, IMMUNOLOGY, V92, P166, DOI 10.1046/j.1365-2567.1997.d01-2308.x; Ramprasath VR, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-178; Rodacki CLN, 2012, AM J CLIN NUTR, V95, P428, DOI 10.3945/ajcn.111.021915; Simopoulos Artemis P, 2007, Curr Sports Med Rep, V6, P230, DOI 10.1007/s11932-007-0037-4; Skarpanska-Stejnborn A, 2010, J HUM KINET, V25, P49, DOI 10.2478/v10078-010-0031-4; Thies F, 2001, AM J CLIN NUTR, V73, P539; Toft AD, 2000, J APPL PHYSIOL, V89, P2401, DOI 10.1152/jappl.2000.89.6.2401; Tou JC, 2007, NUTR REV, V65, P63, DOI [10.1111/j.1753-4887.2007.tb00283.x, 10.1301/nr.2007.feb.63-77]; Ulven SM, 2011, LIPIDS, V46, P37, DOI 10.1007/s11745-010-3490-4; von Schacky C, 2014, INT J SPORT NUTR EXE, V24, P559, DOI 10.1123/ijsnem.2014-0041; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; YAMASHITA N, 1986, BIOCHEM BIOPH RES CO, V138, P1058, DOI 10.1016/S0006-291X(86)80389-8; Yaqoob P, 2000, EUR J CLIN INVEST, V30, P260, DOI 10.1046/j.1365-2362.2000.00623.x; Zebrowska A, 2015, EUR J SPORT SCI, V15, P305, DOI 10.1080/17461391.2014.949310	43	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139174	10.1371/journal.pone.0139174	http://dx.doi.org/10.1371/journal.pone.0139174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407095	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000361800700184
J	Gutierrez, L; House, MJ; Vasavda, N; Drasar, E; Marin, IGGY; Kulasekararaj, AG; St Pierre, TG; Thein, SL				Gutierrez, Lucia; House, Michael J.; Vasavda, Nisha; Drasar, Emma; Gonzalez-Gascon y Marin, Isabel; Kulasekararaj, Austin G.; St Pierre, Tim G.; Thein, Swee L.			Tissue Iron Distribution Assessed by MRI in Patients with Iron Loading Anemias	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; BETA-THALASSEMIA MAJOR; BONE-MARROW; MAGNETIC-RESONANCE; SERUM FERRITIN; LIVER-BIOPSY; OVERLOAD; STORES; RELAXOMETRY	Bone marrow, spleen, liver and kidney proton transverse relaxation rates (R2), together with cardiac R2* from patients with sickle cell disease (SCD), paroxysmal nocturnal hemoglobinuria (PNH) and non-transfusion dependent thalassemia (NTDT) have been compared with a control group. Increased liver and bone marrow R2 values for the three groups of patients in comparison with the controls have been found. SCD and PNH patients also present an increased spleen R2 in comparison with the controls. The simultaneous measurement of R2 values for several tissue types by magnetic resonance imaging (MRI) has allowed the identification of iron distribution patterns in diseases associated with iron imbalance. Preferential liver iron loading is found in the highly transfused SCD patients, while the low transfused ones present a preferential iron loading of the spleen. Similar to the highly transfused SCD group, PNH patients preferentially accumulate iron in the liver. A reduced spleen iron accumulation in comparison with the liver and bone marrow loading has been found in NTDT patients, presumably related to the differential increased intestinal iron absorption. The correlation between serum ferritin and tissue R2 is moderate to good for the liver, spleen and bone marrow in SCD and PNH patients. However, serum ferritin does not correlate with NTDT liver R2, spleen R2 or heart R2*. As opposed to serum ferritin measurements, tissue R2 values are a more direct measurement of each tissue's iron loading. This kind of determination will allow a better understanding of the different patterns of tissue iron biodistribution in diseases predisposed to tissue iron accumulation.	[Gutierrez, Lucia] ICMM CSIC, Inst Ciencia Mat Madrid, Madrid, Spain; [Gutierrez, Lucia; House, Michael J.; St Pierre, Tim G.] Univ Western Australia, Sch Phys, Crawley, WA, Australia; [Vasavda, Nisha; Drasar, Emma; Gonzalez-Gascon y Marin, Isabel; Kulasekararaj, Austin G.; Thein, Swee L.] Kings Coll London, Fac Life Sci & Med, Mol Haematol, London WC2R 2LS, England; [Drasar, Emma; Kulasekararaj, Austin G.; Thein, Swee L.] Kings Coll Hosp NHS Fdn Trust, Dept Haematol, London, England; [Gonzalez-Gascon y Marin, Isabel] Hosp Infanta Leonor, Dept Haematol, Madrid, Spain; [Thein, Swee L.] NHLB, NIH, Sickle Cell Branch, Bethesda, MD 20892 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); University of Western Australia; University of London; King's College London; King's College Hospital NHS Foundation Trust; Hospital Universitario Infanta Leonor; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gutierrez, L (corresponding author), ICMM CSIC, Inst Ciencia Mat Madrid, Madrid, Spain.	lucia@icmm.csic.es	Gutierrez, Lucia/A-4305-2008; St Pierre, Timothy G/A-5509-2008; House, Michael J/B-6477-2008	Gutierrez, Lucia/0000-0003-2366-3598; St Pierre, Timothy G/0000-0003-4682-4972; House, Michael J/0000-0002-1752-6274; Gonzalez-Gascon y Marin, Isabel/0000-0001-6329-1704	AXA Research Fund; Medical Research Council (UK) Development grant [G0001249 ID: 62593]	AXA Research Fund(AXA Research Fund); Medical Research Council (UK) Development grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LG is the beneficiary of a postdoctoral grant from the AXA Research Fund. SLT was funded by an Medical Research Council (UK) Development grant (G0001249 ID: 62593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2007, AM J HEMATOL, V82, P1128, DOI 10.1002/ajh.21075; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; ANGELUCCI E, 1995, BRIT J HAEMATOL, V89, P757; Argyropoulou MI, 2007, EUR RADIOL, V17, P3025, DOI 10.1007/s00330-007-0683-1; Brewer CJ, 2009, J MAGN RESON IMAGING, V29, P357, DOI 10.1002/jmri.21666; BRITTENHAM GM, 1993, AM J HEMATOL, V42, P81, DOI 10.1002/ajh.2830420116; Drakonaki EE, 2007, EUR RADIOL, V17, P2079, DOI 10.1007/s00330-006-0504-y; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; GALE E, 1963, J CLIN INVEST, V42, P1076, DOI 10.1172/JCI104793; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Hansbury EN, 2012, PEDIATR BLOOD CANCER, V58, P611, DOI 10.1002/pbc.23304; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HUTT MP, 1961, AM J MED, V31, P736, DOI 10.1016/0002-9343(61)90158-9; KANEKO K, 1993, PEDIATR RADIOL, V23, P435, DOI 10.1007/BF02012442; Kolnagou A, 2006, HEMOGLOBIN, V30, P219, DOI 10.1080/03630260600642542; Kontoyiannis DP, 2007, CANCER-AM CANCER SOC, V110, P1303, DOI 10.1002/cncr.22909; Krishnamurti Lakshmanan, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P6, DOI 10.1016/j.cppeds.2007.10.002; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LEVIN TL, 1995, PEDIATR RADIOL, V25, P614, DOI 10.1007/BF02011829; MAZZA P, 1995, HAEMATOLOGICA, V80, P398; Meloni A, 2010, MAGN RESON MED, V64, P211, DOI 10.1002/mrm.22410; Olivieri NF, 1998, NEW ENGL J MED, V339, P417, DOI 10.1056/NEJM199808133390701; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Papakonstantinou O, 2009, J MAGN RESON IMAGING, V29, P853, DOI 10.1002/jmri.21707; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; RATH CE, 1948, J LAB CLIN MED, V33, P81; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; ROUBIDOUX MA, 1994, ABDOM IMAGING, V19, P168, DOI 10.1007/BF00203497; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Siegelman ES, 1996, RADIOLOGY, V199, P13, DOI 10.1148/radiology.199.1.8633135; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; St Pierre TG, 2004, NMR BIOMED, V17, P446, DOI 10.1002/nbm.905; Taher A, 2008, HAEMATOL-HEMATOL J, V93, P1584, DOI 10.3324/haematol.13098; Taher A, 2006, BLOOD CELL MOL DIS, V37, P12, DOI 10.1016/j.bcmd.2006.04.005; Taher AT, 2011, BRIT J HAEMATOL, V152, P512, DOI 10.1111/j.1365-2141.2010.08486.x; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Vasavda N, 2012, BRIT J HAEMATOL, V157, P599, DOI 10.1111/j.1365-2141.2012.09093.x; Wood JC, 2004, BLOOD, V103, P1934, DOI 10.1182/blood-2003-06-1919	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139220	10.1371/journal.pone.0139220	http://dx.doi.org/10.1371/journal.pone.0139220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406992	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700193
J	Kang, MH; Pengkit, A; Choi, K; Jeon, SS; Choi, HW; Shin, DB; Choi, EH; Uhm, HS; Park, G				Kang, Min Ho; Pengkit, Anchalee; Choi, Kihong; Jeon, Seong Sil; Choi, Hyo Won; Shin, Dong Bum; Choi, Eun Ha; Uhm, Han Sup; Park, Gyungsoon			Differential Inactivation of Fungal Spores in Water and on Seeds by Ozone and Arc Discharge Plasma	PLOS ONE			English	Article							OZONATED WATER; STERILIZATION; RICE; PATHOGENS; BACTERIA; SYSTEM	Seed sterilization is essential for preventing seed borne fungal diseases. Sterilization tools based on physical technologies have recently received much attention. However, available information is very limited in terms of efficiency, safety, and mode of action. In this study, we have examined antifungal activity of ozone and arc discharge plasma, potential tools for seed sterilization. In our results, ozone and arc discharge plasma have shown differential antifungal effects, depending on the environment associated with fungal spores (freely submerged in water or infected seeds). Ozone inactivates Fusarium fujikuroi (fungus causing rice bakanae disease) spores submerged in water more efficiently than arc discharge plasma. However, fungal spores associated with or infecting rice seeds are more effectively deactivated by arc discharge plasma. ROS generated in water by ozone may function as a powerful fungicidal factor. On the other hand, shockwave generated from arc discharge plasma may have greatly contributed to antifungal effects on fungus associated with rice seeds. In support of this notion, addition of ultrasonic wave in ozone generating water has greatly increased the efficiency of seed disinfection.	[Kang, Min Ho; Pengkit, Anchalee; Choi, Kihong; Jeon, Seong Sil; Choi, Eun Ha; Uhm, Han Sup; Park, Gyungsoon] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul 139701, South Korea; [Choi, Hyo Won] Natl Acad Agr Sci, Dept Crop Life Safety, Suwon 441707, South Korea; [Shin, Dong Bum] Natl Inst Crop Sci, Dept Crop Environm, Suwon 441857, South Korea	Kwangwoon University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Uhm, HS (corresponding author), Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul 139701, South Korea.	hsuhm@kw.ac.kr; gyungp@kw.ac.kr	Choi, Eun Ha/AFN-9488-2022	Choi, Eun Ha/0000-0001-5385-1878; Park, Gyungsoon/0000-0003-1592-3847	Rural Development Administration, Republic of Korea [PJ009891]; National Research Foundation of Korea (NRF) [NRF-2010-0027963]; R&D Program of 'Plasma Advanced Technology for Agriculture and Food (Plasma Farming)' through the National Fusion Research Institute of Korea (NFRI) - Government funds	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); R&D Program of 'Plasma Advanced Technology for Agriculture and Food (Plasma Farming)' through the National Fusion Research Institute of Korea (NFRI) - Government funds	This work was supported by the Rural Development Administration, Republic of Korea (PJ009891), the National Research Foundation of Korea (NRF) (NRF-2010-0027963), and R&D Program of 'Plasma Advanced Technology for Agriculture and Food (Plasma Farming)' through the National Fusion Research Institute of Korea (NFRI) funded by the Government funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRIOS GN, 1997, PLANT PATHOLOGY; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bocci V, 2009, MED RES REV, V29, P646, DOI 10.1002/med.20150; Carter LLA, 2008, PHYTOPATHOLOGY, V98, P992, DOI 10.1094/PHYTO-98-9-0992; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fukumoto Y, 2010, HORTIC ENVIRON BIOTE, V51, P21; Gupta AK, 2014, J DERMATOL TREAT, V25, P251, DOI 10.3109/09546634.2012.714456; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Jo YK, 2014, CROP SCI, V54, P796, DOI 10.2135/cropsci2013.05.0331; Kitazaki S, 2014, VACUUM, V110, P217, DOI 10.1016/j.vacuum.2014.06.014; Korachi M, 2010, J ELECTROSTAT, V68, P508, DOI 10.1016/j.elstat.2010.06.014; Korachi M, 2009, J ELECTROSTAT, V67, P678, DOI 10.1016/j.elstat.2009.03.002; Kwack Y, 2014, KOREAN J HORTIC SCI, V32, P901, DOI 10.7235/hort.2014.14129; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Lee HY, 2003, J KOREAN PHYS SOC, V42, pS880; Lee K, 2006, J MICROBIOL, V44, P269; Lerouge S., 2001, PLASMAS POLYM, V6, P175, DOI DOI 10.1023/A:1013196629791; Li Bin, 2006, Zhongguo Shuidao Kexue, V20, P84; Mai-Prochnow A, 2014, INT J ANTIMICROB AG, V43, P508, DOI 10.1016/j.ijantimicag.2014.01.025; Mancini V, 2014, PEST MANAG SCI, V70, P860, DOI 10.1002/ps.3693; Mohan N, 2005, OZONE-SCI ENG, V27, P499, DOI 10.1080/01919510500351875; Munkvold GP, 2009, ANNU REV PHYTOPATHOL, V47, P285, DOI 10.1146/annurev-phyto-080508-081916; Oehmigen K, 2011, PLASMA PROCESS POLYM, V8, P904, DOI 10.1002/ppap.201000099; Ou SH, 1985, RICE DIS; Pak G, 2012, APPL PHYS LETT, V100; Panngom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099300; Pavlovich MJ, 2013, PLASMA PROCESS POLYM, V10, P69, DOI 10.1002/ppap.201200073; Rajkowski KT, 2004, J FOOD PROTECT, V67, P813, DOI 10.4315/0362-028X-67.4.813; Ryu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066231; Selcuk M, 2008, BIORESOURCE TECHNOL, V99, P5104, DOI 10.1016/j.biortech.2007.09.076; Shintani H, 2010, EXP THER MED, V1, P731, DOI 10.3892/etm.2010.136; Thirumdas R, 2015, FOOD BIOPHYS, V10, P1, DOI 10.1007/s11483-014-9382-z; Thobunluepop P, 2008, CHARACTERIZATION BOT; Trinetta V, 2011, INT J FOOD MICROBIOL, V146, P203, DOI 10.1016/j.ijfoodmicro.2011.02.014; Uhm HS, 2009, J HAZARD MATER, V168, P1595, DOI 10.1016/j.jhazmat.2009.03.056	35	40	41	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139263	10.1371/journal.pone.0139263	http://dx.doi.org/10.1371/journal.pone.0139263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406468	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700200
J	Mendis, N; McBride, P; Faucher, SP				Mendis, Nilmini; McBride, Peter; Faucher, Sebastien P.			Short-Term and Long-Term Survival and Virulence of Legionella pneumophila in the Defined Freshwater Medium Fraquil	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; GROWTH TEMPERATURE; PATHOGEN LEGIONELLA; IRON UPTAKE; TAP WATER; EXPRESSION; MODEL; IDENTIFICATION; SYSTEMS; AMEBAS	Legionella pneumophila (Lp) is the etiological agent responsible for Legionnaires' disease, a potentially fatal pulmonary infection. Lp lives and multiplies inside protozoa in a variety of natural and man-made water systems prior to human infection. Fraquil, a defined freshwater medium, was used as a highly reproducible medium to study the behaviour of Lp in water. Adopting a reductionist approach, Fraquil was used to study the impact of temperature, pH and trace metal levels on the survival and subsequent intracellular multiplication of Lp in Acanthamoeba castellanii, a freshwater protozoan and a natural host of Legionella. We show that temperature has a significant impact on the short-and long-term survival of Lp, but that the bacterium retains intracellular multiplication potential for over six months in Fraquil. Moreover, incubation in Fraquil at pH 4.0 resulted in a rapid decline in colony forming units, but was not detrimental to intracellular multiplication. In contrast, variations in trace metal concentrations had no impact on either survival or intracellular multiplication in amoeba. Our data show that Lp is a resilient bacterium in the water environment, remaining infectious to host cells after six months under the nutrient-deprived conditions of Fraquil.	[Mendis, Nilmini; McBride, Peter; Faucher, Sebastien P.] McGill Univ, Fac Agr & Environm Sci, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada	McGill University	Faucher, SP (corresponding author), McGill Univ, Fac Agr & Environm Sci, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada.	sebastien.faucher2@mcgill.ca		Faucher, Sebastien/0000-0002-2721-7715	Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery grant [418289-2012]; John R. Evans Leaders Fund from the Canadian Foundation for Innovation (CFI); Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); NSERC Undergraduate Student Research Award	Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); John R. Evans Leaders Fund from the Canadian Foundation for Innovation (CFI); Fonds de Recherche du Quebec - Nature et Technologies (FRQNT); NSERC Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council (NSERC, nserc-crsng.gc.ca) of Canada Discovery grant 418289-2012 and the John R. Evans Leaders Fund - Funding for research infrastructure from the Canadian Foundation for Innovation (CFI, innovation.ca/) to SPF. NM is supported by a PhD scholarship from Fonds de Recherche du Quebec - Nature et Technologies (FRQNT, frqnt.gouv.qc.ca/accueil). PM was supported by a NSERC Undergraduate Student Research Award (nserc-crsng.gc.ca).	AFNOR, 2010, NF T90 471 QUALITE D; Allard KA, 2006, J BACTERIOL, V188, P1351, DOI 10.1128/JB.188.4.1351-1363.2006; Allombert J, 2014, INFECT IMMUN, V82, P1222, DOI 10.1128/IAI.01077-13; [Anonymous], 1985, CAN MED ASSOC J, V132, P160; Azuma K, 2013, REGUL TOXICOL PHARM, V65, P1, DOI 10.1016/j.yrtph.2012.11.003; Bandyopadhyay P, 2004, INFECT IMMUN, V72, P4541, DOI 10.1128/IAI.72.8.4541-4551.2004; Bargellini A, 2011, WATER RES, V45, P2315, DOI 10.1016/j.watres.2011.01.009; Bartram J, 2007, LEGIONELLA AND THE P; BOPP CA, 1981, J CLIN MICROBIOL, V13, P714, DOI 10.1128/JCM.13.4.714-719.1981; Borella P, 2005, BIOTECHNOL ANN REV, V11, P355, DOI 10.1016/S1387-2656(05)11011-4; Borella P, 2004, EMERG INFECT DIS, V10, P457, DOI 10.3201/eid1003.020707; BUESCHING WJ, 1983, J CLIN MICROBIOL, V17, P1153, DOI 10.1128/JCM.17.6.1153-1155.1983; Cachafeiro SP, 2007, J HOSP INFECT, V67, P209, DOI 10.1016/j.jhin.2007.07.017; Carratala J, 2010, CURR OPIN INFECT DIS, V23, P152, DOI 10.1097/QCO.0b013e328336835b; Cianciotto NP, 2007, BIOMETALS, V20, P323, DOI 10.1007/s10534-006-9057-4; DENNIS PJ, 1984, J APPL BACTERIOL, V56, P349, DOI 10.1111/j.1365-2672.1984.tb01359.x; Diederen BMW, 2008, J INFECTION, V56, P1, DOI 10.1016/j.jinf.2007.09.010; Dufresne SF, 2012, EPIDEMIOL INFECT, V140, P172, DOI 10.1017/S0950268811000355; Edagawa A, 2008, J APPL MICROBIOL, V105, P2104, DOI 10.1111/j.1365-2672.2008.03932.x; EDELSTEIN PH, 1987, INFECT IMMUN, V55, P2701, DOI 10.1128/IAI.55.11.2701-2705.1987; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; GLICK TH, 1978, AM J EPIDEMIOL, V107, P149, DOI 10.1093/oxfordjournals.aje.a112517; Guerrieri E, 2008, CURR MICROBIOL, V57, P532, DOI 10.1007/s00284-008-9237-2; Guillemet TA, 2010, LETT APPL MICROBIOL, V51, P639, DOI 10.1111/j.1472-765X.2010.02947.x; Heuner K, 1999, FEMS MICROBIOL LETT, V175, P69, DOI 10.1016/S0378-1097(99)00160-3; Heuner K, 2003, INT J MED MICROBIOL, V293, P133, DOI 10.1078/1438-4221-00259; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; HUSSONG D, 1987, BIO-TECHNOL, V5, P947, DOI 10.1038/nbt0987-947; KILVINGTON S, 1990, J APPL BACTERIOL, V68, P519, DOI 10.1111/j.1365-2672.1990.tb02904.x; Kuroki T, 2009, JPN J INFECT DIS, V62, P201; Kusnetsov JM, 1996, J APPL BACTERIOL, V81, P341; LANDEEN LK, 1989, APPL ENVIRON MICROB, V55, P3045, DOI 10.1128/AEM.55.12.3045-3050.1989; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Lee G, 2002, APPL GEOCHEM, V17, P569, DOI 10.1016/S0883-2927(01)00125-1; Leoni E, 2005, J APPL MICROBIOL, V98, P373, DOI 10.1111/j.1365-2672.2004.02458.x; Li L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1869-6; Liles MR, 1998, INFECT IMMUN, V66, P1776, DOI 10.1128/IAI.66.4.1776-1782.1998; Loret J. F., 2005, Journal of Water and Health, V3, P423; Manske C, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00125; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; MAUCHLINE WS, 1994, INFECT IMMUN, V62, P2995, DOI 10.1128/IAI.62.7.2995-2997.1994; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; Messi P, 2011, BIOFOULING, V27, P165, DOI 10.1080/08927014.2010.551190; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005; Morel FMM, 1975, TECHNICAL NOTE; Moritz MM, 2010, INT J HYG ENVIR HEAL, V213, P190, DOI 10.1016/j.ijheh.2010.05.003; Mouchtouri VA, 2010, AM J INFECT CONTROL, V38, P50, DOI 10.1016/j.ajic.2009.04.285; Murga R, 2001, MICROBIOL-SGM, V147, P3121, DOI 10.1099/00221287-147-11-3121; Nishimori I, 2014, BIOORGAN MED CHEM, V22, P2939, DOI 10.1016/j.bmc.2014.04.006; PASZKOKOLVA C, 1992, FEMS MICROBIOL ECOL, V102, P45, DOI 10.1111/j.1574-6968.1992.tb05794.x; Pryor M, 2004, WATER SCI TECHNOL, V50, P83, DOI 10.2166/wst.2004.0025; Qin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059018; REEVES MW, 1981, J CLIN MICROBIOL, V13, P688, DOI 10.1128/JCM.13.4.688-695.1981; RISTROPH JD, 1981, J CLIN MICROBIOL, V13, P115, DOI 10.1128/JCM.13.1.115-119.1981; Robey M, 2002, INFECT IMMUN, V70, P5659, DOI 10.1128/IAI.70.10.5659-5669.2002; Roig J, 2003, CURR OPIN INFECT DIS, V16, P145, DOI 10.1097/00001432-200304000-00011; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Serrano-Suarez A, 2013, ENVIRON SCI POLLUT R, V20, P5534, DOI 10.1007/s11356-013-1557-5; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Soderberg MA, 2008, APPL ENVIRON MICROB, V74, P5583, DOI 10.1128/AEM.00067-08; Stewart CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050560; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; Tachibana M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/514395; Taylor M, 2009, MICROB ECOL, V58, P538, DOI 10.1007/s00248-009-9514-z; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Thomas V, 2004, J APPL MICROBIOL, V97, P950, DOI 10.1111/j.1365-2672.2004.02391.x; TISON DL, 1980, APPL ENVIRON MICROB, V39, P456, DOI 10.1128/AEM.39.2.456-459.1980; Trigui H, 2014, APPL ENVIRON MICROBI; Grosso-Becerraa MV, 2014, P NATL ACAD SCI USA, V111, P15562, DOI 10.1073/pnas.1402536111; Viswanathan VK, 2000, INFECT IMMUN, V68, P1069, DOI 10.1128/IAI.68.3.1069-1079.2000; WADOWSKY RM, 1982, APPL ENVIRON MICROB, V43, P1104, DOI 10.1128/AEM.43.5.1104-1110.1982; WADOWSKY RM, 1988, APPL ENVIRON MICROB, V54, P2677, DOI 10.1128/AEM.54.11.2677-2682.1988; WADOWSKY RM, 1985, APPL ENVIRON MICROB, V49, P1197, DOI 10.1128/AEM.49.5.1197-1205.1985; Walczak M, 2013, ANN AGR ENV MED, V20, P649; Walczak M, 2013, ENVIRON SCI-PROC IMP, V15, P2273, DOI 10.1039/c3em00452j; WANG WLL, 1979, ANN INTERN MED, V90, P614, DOI 10.7326/0003-4819-90-4-614; Whiley H, 2011, EMERG INFECT DIS, V17, P579, DOI 10.3201/eid1704.100446; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; YEE RB, 1982, APPL ENVIRON MICROB, V43, P1330, DOI 10.1128/AEM.43.6.1330-1334.1982; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087; Zheng HX, 2013, INFECT IMMUN, V81, P4182, DOI 10.1128/IAI.00858-13	85	22	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139277	10.1371/journal.pone.0139277	http://dx.doi.org/10.1371/journal.pone.0139277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406895	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700202
J	Mimche, PN; Brady, LM; Keeton, S; Fenne, DSJ; King, TP; Quicke, KM; Hudson, LE; Lamb, TJ				Mimche, Patrice N.; Brady, Lauren M.; Keeton, Shirley; Fenne, David S. J.; King, Thayer P.; Quicke, Kendra M.; Hudson, Lauren E.; Lamb, Tracey J.			Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation	PLOS ONE			English	Article							STIMULATES MIGRATION; ADHESION; MOUSE; DIFFERENTIATION; COSTIMULATION; INVOLVEMENT; LYMPHOCYTES; MONOCYTES; RESPONSES; EPHRINB1	The Eph receptor tyrosine kinases interact with their ephrin ligands on adjacent cells to facilitate contact-dependent cell communication. Ephrin B ligands are expressed on T cells and have been suggested to act as co-stimulatory molecules during T cell activation. There are no detailed reports of the expression and modulation of EphB receptors on dendritic cells, the main antigen presenting cells that interact with T cells. Here we show that mouse splenic dendritic cells (DC) and bone-marrow derived DCs (BMDC) express EphB2, a member of the EphB family. EphB2 expression is modulated by ligation of TLR4 and TLR9 and also by interaction with ephrin B ligands. Co-localization of EphB2 with MHC-II is also consistent with a potential role in T cell activation. However, BMDCs derived from EphB2 deficient mice were able to present antigen in the context of MHC-II and produce T cell activating cytokines to the same extent as intact DCs. Collectively our data suggest that EphB2 may contribute to DC responses, but that EphB2 is not required for T cell activation. This result may have arisen because DCs express other members of the EphB receptor family, EphB3, EphB4 and EphB6, all of which can interact with ephrin B ligands, or because EphB2 may be playing a role in another aspect of DC biology such as migration.	[Mimche, Patrice N.; Brady, Lauren M.; King, Thayer P.; Quicke, Kendra M.; Hudson, Lauren E.; Lamb, Tracey J.] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA; [Keeton, Shirley; Fenne, David S. J.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England	Emory University; University of Reading	Lamb, TJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.	tracey.j.lamb@emory.edu	Mimche, Patrice/AHC-8116-2022	Lamb, Tracey/0000-0003-0620-3944	National Institute for Neurological Disorders and Strokes [1R21NS085382-01A1]; Children's Healthcare of Atlanta; Royal Society (UK); Emory Egleston Children's Research Centre; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085382] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Strokes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Children's Healthcare of Atlanta; Royal Society (UK)(Royal Society of London); Emory Egleston Children's Research Centre; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: Funding provided by National Institute for Neurological Disorders and Strokes (1R21NS085382-01A1), Children's Healthcare of Atlanta and the Royal Society (UK) and Emory Egleston Children's Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; Alfaro D, 2007, EUR J IMMUNOL, V37, P2596, DOI 10.1002/eji.200737097; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bedi B, 2012, PARASITE IMMUNOL, V34, P473, DOI 10.1111/j.1365-3024.2012.01382.x; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Braun J, 2011, ARTERIOSCL THROM VAS, V31, P297, DOI 10.1161/ATVBAHA.110.217646; Bush JO, 2012, SEMIN CELL DEV BIOL, V23, P26, DOI 10.1016/j.semcdb.2011.10.018; Dai DD, 2014, BBA-PROTEINS PROTEOM, V1844, P1729, DOI 10.1016/j.bbapap.2014.07.002; de Saint-Vis B, 2003, BLOOD, V102, P4431, DOI 10.1182/blood-2003-02-0500; Fernandes DM, 2000, EUR J IMMUNOL, V30, P2333, DOI 10.1002/1521-4141(2000)30:8<2333::AID-IMMU2333>3.0.CO;2-F; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gurniak CB, 1996, ONCOGENE, V13, P777; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hirai H, SCIENCE, V238, P1717; Holen HL, 2011, SCAND J IMMUNOL, V74, P144, DOI 10.1111/j.1365-3083.2011.02563.x; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; Jellinghaus S, 2013, BBA-MOL CELL RES, V1833, P2201, DOI 10.1016/j.bbamcr.2013.05.017; Luo HY, 2011, J BIOL CHEM, V286, P44976, DOI 10.1074/jbc.M111.316414; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Luo HY, 2002, J CLIN INVEST, V110, P1141, DOI 10.1172/JCI200215883; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Mimche PN, 2015, HEPATOLOGY, V62, P900, DOI 10.1002/hep.27792; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Munthe Else, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-9; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Pfaff D, 2008, J CELL SCI, V121, P3842, DOI 10.1242/jcs.030627; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Rissoan MC, 2002, BLOOD, V100, P3295, DOI 10.1182/blood-2002-02-0638; Sakamoto A, 2011, J INT MED RES, V39, P522, DOI 10.1177/147323001103900220; Shen ZH, 1997, J IMMUNOL, V158, P2723; Wohlfahrt JG, 2004, J IMMUNOL, V172, P843, DOI 10.4049/jimmunol.172.2.843; WYSSCORAY T, 1993, EUR J IMMUNOL, V23, P2175, DOI 10.1002/eji.1830230919; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200; Yu M, 2014, FASEB J, V28, P3609, DOI 10.1096/fj.13-247759	39	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138835	10.1371/journal.pone.0138835	http://dx.doi.org/10.1371/journal.pone.0138835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407069	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000361800700104
J	Patout, M; Lamia, B; Lhuillier, E; Molano, LC; Viacroze, C; Benhamou, D; Muir, JF; Cuvelier, A				Patout, Maxime; Lamia, Bouchra; Lhuillier, Elodie; Molano, Luis-Carlos; Viacroze, Catherine; Benhamou, Daniel; Muir, Jean-Francois; Cuvelier, Antoine			A Randomized Controlled Trial on the Effect of Needle Gauge on the Pain and Anxiety Experienced during Radial Arterial Puncture	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-GAS ANALYSIS; ANESTHESIA	Background Arterial punctures for assessment of arterial blood-gases can be a painful procedure. Lidocaine can be used to reduce pain prior to needle insertion but it is not a widely accepted practice. The purpose of this study was to determine whether a large size needle induces more pain compared to a smaller size needle for radial arterial puncture and to assess the anxiety associated with radial arterial punctures. Methods We conducted a prospective, double-blind, randomized, controlled, monocentric study including all outpatients who had a planned assessment of arterial blood gas analysis. Patients were randomized to have the arterial puncture performed with a 23 or a 25 G needle. The main judgement criteria was pain during arterial puncture. Visual analogue scale for pain (VAS-P) and visual analogue scale for anxiety (VAS-A) were used to assess pain and anxiety during radial arterial puncture. Results Two hundred consecutive patients were randomized. The 25 G needle was as painful as the 23 G needle (6.63 mm [0-19 mm] vs. 5.21 mm [0-18.49 mm], respectively, p = 0.527). Time for arterial puncture was longer with the 25 G needle than with the 23 G needle (42 s [35-55 s] vs. 33 s [24.5-35 s], respectively, p = 0.002). There was a correlation between the level of anxiety prior to the arterial puncture and the pain experienced by the patients (p: 0.369, p<0.0001). There was a correlation between the pain experienced by patients and the anxiety experienced in anticipation of another arterial puncture (p: 0.5124, p<0.0001). Conclusions The use of 23 G needle allows quicker arterial sampling and is not associated with increased pain and symptoms. Anxiety was correlated with the pain experienced by patients during arterial punctures.	[Patout, Maxime; Lamia, Bouchra; Lhuillier, Elodie; Molano, Luis-Carlos; Viacroze, Catherine; Benhamou, Daniel; Muir, Jean-Francois; Cuvelier, Antoine] Rouen Univ Hosp, Resp Dept, Intens Care Unit, Rouen, France; [Patout, Maxime; Lamia, Bouchra; Muir, Jean-Francois; Cuvelier, Antoine] Univ Rouen, Haute Normandie Inst Biomed Res & Innovat, Grp Rech Handicap Ventilatoire, UPRES EA 3830, Rouen, France	CHU de Rouen; Universite de Rouen Normandie	Patout, M (corresponding author), Rouen Univ Hosp, Resp Dept, Intens Care Unit, Rouen, France.	maxime.patout@gstt.nhs.uk	CUVELIER, Antoine/F-5965-2014; Patout, Maxime/AAH-9001-2019	CUVELIER, Antoine/0000-0003-0263-1845; Patout, Maxime/0000-0002-1366-8726				Aaron SD, 2003, RESP MED, V97, P1195, DOI 10.1016/S0954-6111(03)00226-9; [Anonymous], 1998, Arch Bronconeumol, V34, P142; Beesdo K, 2009, J ANXIETY DISORD, V23, P684, DOI 10.1016/j.janxdis.2009.02.007; Bender JJ, 2012, RESP CARE, V57, P1945, DOI 10.4187/respcare.01713; BROWN HI, 1972, ANESTHESIOLOGY, V37, P363, DOI 10.1097/00000542-197209000-00020; Crawford Anne, 2004, Br J Nurs, V13, P529; DAR K, 1995, BRIT MED J, V310, P24, DOI 10.1136/bmj.310.6971.24; Davis MD, 2013, RESP CARE, V58, P1694, DOI 10.4187/respcare.02786; Dev SP, 2011, NEW ENGL J MED, V364, pE7, DOI 10.1056/NEJMvcm0803851; Facco E, 2011, Anesth Prog, V58, P8, DOI 10.2344/0003-3006-58.1.8; Fajac I, 1998, EUR RESPIR J, V11, P712; France JE, 2008, EUR J EMERG MED, V15, P218, DOI 10.1097/MEJ.0b013e3282f4d19b; Giner J, 1997, CHEST, V111, P1474, DOI 10.1378/chest.111.5.1474; Giner J, 1996, CHEST, V110, P1443, DOI 10.1378/chest.110.6.1443; Haynes JM, 2015, RESP CARE, V60, P1, DOI 10.4187/respcare.03312; Marco AVV, 2008, ARCH BRONCONEUMOL, V44, P360; Sanikop Sheetal, 2011, J Oral Sci, V53, P341; SMITH DC, 1992, INVEST RADIOL, V27, P763, DOI 10.1097/00004424-199210000-00001; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Tran NQ, 2002, CHEST, V122, P1357, DOI 10.1378/chest.122.4.1357; TURNER JS, 1990, CRIT CARE MED, V18, P966, DOI 10.1097/00003246-199009000-00012; Vaquer S, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-11; Zavorsky GS, 2007, RESP PHYSIOL NEUROBI, V155, P268, DOI 10.1016/j.resp.2006.07.002	23	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139432	10.1371/journal.pone.0139432	http://dx.doi.org/10.1371/journal.pone.0139432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407017	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700213
J	Richards, JA; Bucsaiova, M; Hesketh, EE; Ventre, C; Henderson, NC; Simpson, K; Bellamy, COC; Howie, SEM; Anderton, SM; Hughes, J; Wigmore, SJ				Richards, James A.; Bucsaiova, Martina; Hesketh, Emily E.; Ventre, Chiara; Henderson, Neil C.; Simpson, Kenneth; Bellamy, Christopher O. C.; Howie, Sarah E. M.; Anderton, Stephen M.; Hughes, Jeremy; Wigmore, Stephen J.			Acute Liver Injury Is Independent of B Cells or Immunoglobulin M	PLOS ONE			English	Article							CD4(+) T-LYMPHOCYTES; NATURAL IGM; REPERFUSION INJURY; IMMUNE-MECHANISMS; APOPTOTIC CELLS; MURINE MODEL; ISCHEMIA; INFLAMMATION; ACTIVATION; MOUSE	Background & Aims Acute liver injury is a clinically important pathology and results in the release of Danger Associated Molecular Patterns, which initiate an immune response. Withdrawal of the injurious agent and curtailing any pathogenic secondary immune response may allow spontaneous resolution of injury. The role B cells and Immunoglobulin M (IgM) play in acute liver injury is largely unknown and it was proposed that B cells and/or IgM would play a significant role in its pathogenesis. Methods Tissue from 3 models of experimental liver injury (ischemia-reperfusion injury, concanavalin A hepatitis and paracetamol-induced liver injury) and patients transplanted following paracetamol overdose were stained for evidence of IgM deposition. Mice deficient in B cells (and IgM) were used to dissect out the role B cells and/or IgM played in the development or resolution of injury. Serum transfer into mice lacking IgM was used to establish the role IgM plays in injury. Results Significant deposition of IgM was seen in the explanted livers of patients transplanted following paracetamol overdose as well as in 3 experimental models of acute liver injury (ischemia-reperfusion injury, concanavalin A hepatitis and paracetamol-induced liver injury). Serum transfer into IgM-deficient mice failed to reconstitute injury (p = 0.66), despite successful engraftment of IgM. Mice deficient in both T and B cells (RAG1-/-) mice (p<0.001), but not B cell deficient (mu MT) mice (p = 0.93), were significantly protected from injury. Further interrogation with T cell deficient (CD3 epsilon KO) mice confirmed that the T cell component is a key mediator of sterile liver injury. Mice deficient in B cells and IgM mice did not have a significant delay in resolution following acute liver injury. Discussion IgM deposition appears to be common feature of both human and murine sterile liver injury. However, neither IgM nor B cells, play a significant role in the development of or resolution from acute liver injury. T cells appear to be key mediators of injury. In conclusion, the therapeutic targeting of IgM or B cells (e.g. with Rituximab) would have limited benefit in protecting patients from acute liver injury.	[Richards, James A.; Bucsaiova, Martina; Hesketh, Emily E.; Ventre, Chiara; Henderson, Neil C.; Howie, Sarah E. M.; Anderton, Stephen M.; Hughes, Jeremy; Wigmore, Stephen J.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Richards, James A.; Wigmore, Stephen J.] Univ Edinburgh, Surg Clin, Edinburgh, Midlothian, Scotland; [Henderson, Neil C.; Simpson, Kenneth] Univ Edinburgh, Sch Clin Sci, Div Hlth Sci, Hepatol, Edinburgh, Midlothian, Scotland; [Bellamy, Christopher O. C.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Bellamy, Christopher O. C.] Royal Infirm Edinburgh NHS Trust, Dept Pathol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Richards, JA (corresponding author), Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	jamesrichards@doctors.net.uk	Wigmore, Stephen/AAF-3562-2019	Wigmore, Stephen/0000-0002-3614-8002; Hughes, Jeremy/0000-0002-3470-0422; Howie, Sarah/0000-0001-7291-3499; Aguiar Bucsai, Martina/0000-0002-9728-3902; Hesketh, Emily/0000-0001-6209-2295; Richards, James/0000-0001-9049-5745	Wellcome Trust [WT 092494/Z/10/Z]; Royal College of Surgeons of Edinburgh; Tenovus Scotland; Dowager Countess Eleanor Peel Trust; MRC [G0801924] Funding Source: UKRI; Kidney Research UK [ST4/2011] Funding Source: researchfish; Medical Research Council [G0801924] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Royal College of Surgeons of Edinburgh; Tenovus Scotland; Dowager Countess Eleanor Peel Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was made possible by the support of (JR): The Wellcome Trust (WT 092494/Z/10/Z), www.wellcome.ac.uk; The Royal College of Surgeons of Edinburgh (Maurice-Wohl Fellowship and Small Research Grant), www.rcsed.ac.uk; Tenovus Scotland, www.tenovus-scotland.org.uk; The Dowager Countess Eleanor Peel Trust, www.peeltrust.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Bower WA, 2007, AM J GASTROENTEROL, V102, P2459, DOI 10.1111/j.1572-0241.2007.01388.x; Burne-Taney MJ, 2003, J IMMUNOL, V171, P3210, DOI 10.4049/jimmunol.171.6.3210; Caldwell CC, 2005, AM J PHYSIOL-GASTR L, V289, pG969, DOI 10.1152/ajpgi.00223.2005; Champe PC., 2005, BIOCHEMISTRY-US; Chen YF, 2009, J IMMUNOL, V182, P6031, DOI 10.4049/jimmunol.0804191; Ciurana CLF, 2004, EUR J IMMUNOL, V34, P2609, DOI 10.1002/eji.200425045; Devey L, 2008, LAB ANIM-UK, V42, P12, DOI 10.1258/la.2007.06009e; Devey LR, 2007, TRANSPLANTATION, V84, P70, DOI 10.1097/01.tp.0000268072.04260.69; Devey LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049647; Eggenhofer E, 2013, J IMMUNOL, V191, P480, DOI 10.4049/jimmunol.1202975; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Feng M, 2012, INT IMMUNOPHARMACOL, V13, P135, DOI 10.1016/j.intimp.2012.03.007; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; Hochegger K, 2007, AM J PHYSIOL-RENAL, V293, pF741, DOI 10.1152/ajprenal.00486.2006; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 2003, BMJ-BRIT MED J, V327, P143, DOI 10.1136/bmj.327.7407.143; Jang HR, 2010, J AM SOC NEPHROL, V21, P654, DOI 10.1681/ASN.2009020182; Khandoga A, 2006, HEPATOLOGY, V43, P306, DOI 10.1002/hep.21017; Kimura K, 2006, AM J PATHOL, V168, P786, DOI 10.2353/ajpath.2006.050314; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kuboki S, 2009, AM J PHYSIOL-GASTR L, V296, pG1054, DOI 10.1152/ajpgi.90464.2008; Lappas CM, 2006, J EXP MED, V203, P2639, DOI 10.1084/jem.20061097; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Lobo PI, 2012, J IMMUNOL, V188, P1675, DOI 10.4049/jimmunol.1101762; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798; Numata K, 2007, J IMMUNOL, V178, P3777, DOI 10.4049/jimmunol.178.6.3777; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Renner B, 2010, J IMMUNOL, V185, P4393, DOI 10.4049/jimmunol.0903239; Savransky V, 2006, KIDNEY INT, V69, P233, DOI 10.1038/sj.ki.5000038; Shen XD, 2009, HEPATOLOGY, V50, P1537, DOI 10.1002/hep.23153; Strey CW, 2011, INT J MOL MED, V27, P447, DOI 10.3892/ijmm.2010.592; Tilney NL, 1997, TRANSPLANTATION, V64, P945, DOI 10.1097/00007890-199710150-00001; Vollmers HP, 2006, HISTOL HISTOPATHOL, V21, P1355, DOI 10.14670/HH-21.1355; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Zhang M, 2006, J IMMUNOL, V177, P4727, DOI 10.4049/jimmunol.177.7.4727; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	45	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138688	10.1371/journal.pone.0138688	http://dx.doi.org/10.1371/journal.pone.0138688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406765	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700071
J	Gideonse, TK				Gideonse, Theodore K.			Survival Tactics and Strategies of Methamphetamine-Using HIV-Positive Men Who Have Sex with Men in San Diego	PLOS ONE			English	Article							ASSERTIVE COMMUNITY TREATMENT; RISK BEHAVIORS; GAY; TRANSMISSION; DEPENDENCE; EFFICACY; ILLNESS; USERS; ABUSE; MODEL	In this article, two ways that HIV-positive drug users survive under the supervision of law enforcement agencies, community health organizations, and social welfare offices are differentiated. First, strategies are long-ranging and often carefully planned, and they involve conscious utilization and manipulation of bureaucratic processes. Second, tactics are short-ranging and often haphazard, and they are used to survive on daily or weekly bases, with entrenched problems and structural solutions avoided or ignored. Data from three years of ethnographic fieldwork with 14 methamphetamine-using HIV-positive men who have sex with men in San Diego, California is used to expand upon these two categories, explaining the different, often ineffectual, ways these men accessed care, services, shelter, drugs, and companionship. This article also examines the policy implications of taking in consideration these different kinds of survival methods, arguing for intensive client-specific interventions when working with long-term addicts with multiple health problems.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Ctr World Hlth,Div Infect Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gideonse, TK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Ctr World Hlth,Div Infect Dis, Los Angeles, CA 90095 USA.	gideonse@ucla.edu	Gideonse, Theodore/P-1204-2016; Gideonse, Theodore/Q-2905-2019	Gideonse, Theodore/0000-0002-1802-5711; Wong, Frank Y./0000-0001-5835-9938	Department of Anthropology at the University of California, San Diego; University of California, Los Angeles Postdoctoral Fellowship Training Program in Global HIV Prevention Research [5T32MH080634]; National Institute on Drug Abuse [R25 DA035692]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA035692] Funding Source: NIH RePORTER	Department of Anthropology at the University of California, San Diego; University of California, Los Angeles Postdoctoral Fellowship Training Program in Global HIV Prevention Research(University of California System); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research that provided the data for this paper was partially funded by the Department of Anthropology at the University of California, San Diego. The writing of this paper was funded by the University of California, Los Angeles Postdoctoral Fellowship Training Program in Global HIV Prevention Research (5T32MH080634). During the writing, TKG was also a scholar with the HIV/AIDS, Substance Abuse, and Trauma Training Program (HA-STTP), at the University of California, Los Angeles supported through an award from the National Institute on Drug Abuse (R25 DA035692). As members of the Department of Anthropology at the University of California, San Diego were on the committee that supervised the dissertation from which this article comes, they had influence of the study design, but the analysis, decision to publish, and preparation of the manuscript are entirely the author's.	Abu-Lugod L, 1986, VEILED SENTIMENTS HO; [Anonymous], 2008, PREV AW HIV INF MEN; Armstrong E. G., 2007, CONT JUSTICE REV, V10, P427, DOI DOI 10.1080/10282580701677519; Associated Press, 1985, LOS ANGELES TIMES, P4; Boddiger D, 2005, LANCET, V365, P1217, DOI 10.1016/S0140-6736(05)74794-2; Bond GR, 2001, DIS MANAG HEALTH OUT, V9, P141, DOI 10.2165/00115677-200109030-00003; Brown B, 2006, FAM SOC, V87, P43, DOI 10.1606/1044-3894.3483; Burke C., 2014, 2013 ADULT ARRESTEE; County of San Diego H and HSA, 2012, HIV AIDS EP REP, P41; Csordas T. J., 1994, EMBODIMENT EXPERIENC, P1; De Certeau M., 2011, PRACTICE EVERYDAY LI; Desjarlais R, 1996, AM ETHNOL, V23, P880, DOI 10.1525/ae.1996.23.4.02a00110; Dillon L, 2014, VOICE OF SAN DIEGO; Engel M, 2008, LOS ANGELES TIMES, pB3; Fernandez J, 1998, HDB METHODS CULTURAL, P89; Fisher Lisa, 2008, ADP LAUNCHES NEW CAM; Garriott William., 2011, POLICING METHAMPHETA; Gideonse TK, 2015, ETHOS, V43, P332, DOI 10.1111/etho.12100; Gideonse TK, 2015, FRAMING S SEE UNPUB; Gideonse TK, STIGMA AGENCY UNPUB; Halkitis PN, 2001, J HOMOSEXUAL, V41, P17, DOI 10.1300/J082v41n02_02; Hallowell Irving, 1955, CULTURE EXPERIENCE; Hollan Douglas, 1997, TRANSCULT PSYCHIATRY, V34, P219, DOI DOI 10.1177/136346159703400203; Holland D, 1998, IDENTITY AGENCY CULT; Jenkins Janis H., 1994, HDB PSYCHOL ANTHR, P97; Lehman AF, 1997, ARCH GEN PSYCHIAT, V54, P1038; Lutz C., 1988, UNNATURAL EMOTIONS E; Mausbach BT, 2007, DRUG ALCOHOL DEPEN, V87, P249, DOI 10.1016/j.drugalcdep.2006.08.026; Methamphetamine Strike Force, 2010, METH REP CARD 2010; MINKLER M, 1980, INT J HEALTH SERV, V10, P311, DOI 10.2190/023K-58E7-6TM8-3RRM; Reback Cathy, 1997, SOCIAL CONSTRUCTION; Reback CJ, 2014, J HOMOSEXUAL, V61, P540, DOI 10.1080/00918369.2014.865459; Reback CJ, 2013, DRUG ALCOHOL DEPEN, V133, P262, DOI 10.1016/j.drugalcdep.2013.06.007; Reding Nick, 2009, METHLAND DEATH LIFE; Roter DL, 2001, PATIENT EDUC COUNS, V44, P79, DOI 10.1016/S0738-3991(01)00108-2; Semple SJ, 2002, J SUBST ABUSE TREAT, V22, P149, DOI 10.1016/S0740-5472(02)00223-4; Shoptaw S, 2002, J ADDICT DIS, V21, P91; Shoptaw S, 2005, DRUG ALCOHOL DEPEN, V78, P125, DOI 10.1016/j.drugalcdep.2004.10.004; SHOPTAW S, 1994, J ADDICT DIS, V13, P129; Warth G, 2011, SAN DIEGO UNION TRIB; Warth Gary, 2007, N COUNTY TIMES  0909	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139239	10.1371/journal.pone.0139239	http://dx.doi.org/10.1371/journal.pone.0139239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26421928	Green Published, gold			2022-12-27	WOS:000362175700082
J	Rodriguez-Marconi, S; De la Iglesia, R; Diez, B; Fonseca, CA; Hajdu, E; Trefault, N				Rodriguez-Marconi, Susana; De la Iglesia, Rodrigo; Diez, Beatriz; Fonseca, Cassio A.; Hajdu, Eduardo; Trefault, Nicole			Characterization of Bacterial, Archaeal and Eukaryote Symbionts from Antarctic Sponges Reveals a High Diversity at a Three-Domain Level and a Particular Signature for This Ecosystem	PLOS ONE			English	Article							MARINE SPONGES; MICROBIAL COMMUNITIES; SOUTHERN-OCEAN; MICROORGANISMS; PORIBACTERIA; EVOLUTION; PROFILES; ECOLOGY; DIATOMS; FUNGAL	Sponge-associated microbial communities include members from the three domains of life. In the case of bacteria, they are diverse, host specific and different from the surrounding seawater. However, little is known about the diversity and specificity of Eukarya and Archaea living in association with marine sponges. This knowledge gap is even greater regarding sponges from regions other than temperate and tropical environments. In Antarctica, marine sponges are abundant and important members of the benthos, structuring the Antarctic marine ecosystem. In this study, we used high throughput ribosomal gene sequencing to investigate the three-domain diversity and community composition from eight different Antarctic sponges. Taxonomic identification reveals that they belong to families Acarnidae, Chalinidae, Hymedesmiidae, Hymeniacidonidae, Leucettidae, Microcionidae, and Myxillidae. Our study indicates that there are different diversity and similarity patterns between bacterial/archaeal and eukaryote microbial symbionts from these Antarctic marine sponges, indicating inherent differences in how organisms from different domains establish symbiotic relationships. In general, when considering diversity indices and number of phyla detected, sponge-associated communities are more diverse than the planktonic communities. We conclude that three-domain microbial communities from Antarctic sponges are different from surrounding planktonic communities, expanding previous observations for Bacteria and including the Antarctic environment. Furthermore, we reveal differences in the composition of the sponge associated bacterial assemblages between Antarctic and tropical-temperate environments and the presence of a highly complex microbial eukaryote community, suggesting a particular signature for Antarctic sponges, different to that reported from other ecosystems.	[Rodriguez-Marconi, Susana; Trefault, Nicole] Univ Mayor, Ctr Genom & Bioinformat, Fac Sci, Camino La Piramide 5750, Santiago, Chile; [De la Iglesia, Rodrigo; Diez, Beatriz] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Santiago, Chile; [Fonseca, Cassio A.; Hajdu, Eduardo] Univ Fed Rio de Janeiro, Museu Nacl, BR-20940040 Rio De Janeiro, Brazil	Universidad Mayor; Pontificia Universidad Catolica de Chile; Universidade Federal do Rio de Janeiro	Trefault, N (corresponding author), Univ Mayor, Ctr Genom & Bioinformat, Fac Sci, Camino La Piramide 5750, Santiago, Chile.	nicole.trefault@umayor.cl	Díez, Beatriz/AAG-2244-2021; Hajdu, Eduardo/C-3863-2009	Díez, Beatriz/0000-0002-9371-8083; Hajdu, Eduardo/0000-0002-8760-9403	CONICYT-FONDECYT [11121554]	CONICYT-FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work has been funded by CONICYT-FONDECYT Initiation into Research Grant # 11121554. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080653; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Bavestrello G, 2000, BIOL BULL, V198, P29, DOI 10.2307/1542801; Bell G, 1997, BIOL J LINN SOC, V60, P21, DOI 10.1111/j.1095-8312.1997.tb01481.x; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cardenas CA, 2014, FEMS MICROBIOL ECOL, V88, P516, DOI 10.1111/1574-6941.12317; Cerrano C, 2004, POLAR BIOL, V27, P231, DOI 10.1007/s00300-003-0581-1; Cleary DFR, 2013, FEMS MICROBIOL ECOL, V85, P465, DOI 10.1111/1574-6941.12135; Doyle J. J., 1987, PHYTOCHEM B, P11; Easson CG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00532; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fan Lu, 2012, Proc Natl Acad Sci U S A, V109, pE1878, DOI 10.1073/pnas.1203287109; Fieseler L, 2004, APPL ENVIRON MICROB, V70, P3724, DOI 10.1128/aem.70.6.3724-3732.2004; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Gilbert SF, 2014, J BIOSCIENCES, V39, P201, DOI 10.1007/s12038-013-9343-6; Giles EC, 2013, FEMS MICROBIOL ECOL, V83, P232, DOI 10.1111/j.1574-6941.2012.01467.x; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Hajdu E, 2011, SER LIVROS MUS NAC, V45, P1; He LM, 2014, MICROB ECOL, V67, P951, DOI 10.1007/s00248-014-0393-6; Henriquez M, 2014, WORLD J MICROB BIOT, V30, P65, DOI 10.1007/s11274-013-1418-x; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hochmuth T, 2010, CHEMBIOCHEM, V11, P2572, DOI 10.1002/cbic.201000510; Hollibaugh JT, 2007, OCEANOGRAPHY, V20, P140, DOI 10.5670/oceanog.2007.59; Jackson SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084438; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Jin LL, 2014, FEMS MICROBIOL ECOL, V90, P935, DOI 10.1111/1574-6941.12446; Kennedy J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091092; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Legendre P., 2012, NUMERICAL ECOLOGY; Li ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep03895; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mangano S, 2011, ATTI ACCAD PELORIT, V89, DOI 10.1478/C1A8901003; Margulis L, 1991, SYMBIOSISOURCE EVO; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; Papaleo MC, 2012, BIOTECHNOL ADV, V30, P272, DOI 10.1016/j.biotechadv.2011.06.011; Pape T, 2006, POLAR BIOL, V29, P662, DOI 10.1007/s00300-005-0103-4; Peck LS, 2005, ANTARCT SCI, V17, P497, DOI 10.1017/S0954102005002920; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Schmitt S, 2011, FEMS MICROBIOL ECOL, V78, P497, DOI 10.1111/j.1574-6941.2011.01179.x; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Vacelet J., 1982, Proceedings of the International Coral Reef Symposium, P713; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; Wilkins D, 2013, ENVIRON MICROBIOL, V15, P1318, DOI 10.1111/1462-2920.12035	57	55	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138837	10.1371/journal.pone.0138837	http://dx.doi.org/10.1371/journal.pone.0138837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421612	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700051
J	Campos, LT; de Almeida, CEV				Campos, Luciana Tourinho; Veloso de Almeida, Carlos Eduardo			Monte Carlo Dosimetry of the Co-60 BEBIG High Dose Rate for Brachytherapy	PLOS ONE			English	Article								Introduction The use of high-dose-rate brachytherapy is currently a widespread practice worldwide. The most common isotope source is Ir-192, but Co-60 is also becoming available for HDR. One of main advantages of Co-60 compared to Ir-192 is the economic and practical benefit because of its longer half-live, which is 5.27 years. Recently, Eckert & Ziegler BEBIG, Germany, introduced a new afterloading brachytherapy machine (MultiSource (R)); it has the option to use either the Co-60 or Ir-192 HDR source. The source for the Monte Carlo calculations is the new Co-60 source (model Co0.A86), which is referred to as the new BEBIG Co-60 HDR source and is a modified version of the Co-60 source (model GK60M21), which is also from BEBIG. Objective and Methods The purpose of this work is to obtain the dosimetry parameters in accordance with the AAPM TG-43U1 formalism with Monte Carlo calculations regarding the BEBIG Co-60 high-dose-rate brachytherapy to investigate the required treatment-planning parameters. The geometric design and material details of the source was provided by the manufacturer and was used to define the Monte Carlo geometry. To validate the source geometry, a few dosimetry parameters had to be calculated according to the AAPM TG-43U1 formalism. The dosimetry studies included the calculation of the air kerma strength Sk, collision kerma in water along the transverse axis with an unbounded phantom, dose rate constant and radial dose function. The Monte Carlo code system that was used was EGSnrc with a new cavity code, which is a part of EGS++ that allows calculating the radial dose function around the source. The spectrum to simulate Co-60 was composed of two photon energies, 1.17 and 1.33 MeV. Only the gamma part of the spectrum was used; the contribution of the electrons to the dose is negligible because of the full absorption by the stainless-steel wall around the metallic Co-60. The XCOM photon cross-section library was used in subsequent simulations, and the photoelectric effect, pair production, Rayleigh scattering and bound Compton scattering were included in the simulation. Variance reduction techniques were used to speed up the calculation and to considerably reduce the computer time. The cut-off energy was 10 keV for electrons and photons. To obtain the dose rate distributions of the source in an unbounded liquid water phantom, the source was immersed at the center of a cube phantom of 100 cm(3). The liquid water density was 0.998 g/cm(3), and photon histories of up to 1010 were used to obtain the results with a standard deviation of less than 0.5% (k = 1). The obtained dose rate constant for the BEBIG Co-60 source was 1.1080.001 cGyh(-1)U(-1), which is consistent with the values in the literature. The radial dose functions were compared with the values of the consensus data set in the literature, and they are consistent with the published data for this energy range.	[Campos, Luciana Tourinho; Veloso de Almeida, Carlos Eduardo] Univ Estado Rio De Janeiro, DBB, LCR, BR-205550 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Campos, LT (corresponding author), Univ Estado Rio De Janeiro, DBB, LCR, Rua Sao Francisco Xavier,524 Maracana, BR-205550 Rio De Janeiro, Brazil.	tc_luciana@yahoo.com.br	Tourinho Campos, Luciana/O-1173-2017	Tourinho Campos, Luciana/0000-0003-4751-129X	Fundacao de Amparo a Pesquisa do Rio de janeiro [E-26/101.013/2011 LTC, E-26/101.016/2011 LTC]	Fundacao de Amparo a Pesquisa do Rio de janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding was provided by Fundacao de Amparo a Pesquisa do Rio de janeiro (http://www.faperj.br/), E-26/101.013/2011 LTC, E-26/101.016/2011 LTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester F, 2005, PHYS MED BIOL, V50, pN309, DOI 10.1088/0031-9155/50/21/N03; DeWerd LA, 2011, MED PHYS, V38, P782, DOI 10.1118/1.3533720; Granero D, 2007, MED PHYS, V34, P3485, DOI 10.1118/1.2759602; Guerrero R, 2014, PHYS MEDICA, V30, P960, DOI 10.1016/j.ejmp.2014.06.039; Kawrakow I., 2006, PIRS877 NRC; Kawrakow I., 2006, PIRS701 NRC; Kawrakow I., 2005, PIRS701 NRC; Medich DC, 2007, MED PHYS, V34, P1999, DOI 10.1118/1.2733809; Medich DC, 2006, MED PHYS, V33, P163, DOI 10.1118/1.2147767; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; Nelson WR, 1985, EGS4 CODE SYSTEM; Palmer A., 2010, FUEL EN ABSTR, V78; Papagiannis P, 2003, MED PHYS, V30, P712, DOI 10.1118/1.1563662; Perez-Calatayud J, 2005, MED PHYS, V32, P28, DOI 10.1118/1.1834835; Perez-Calatayud J, 2012, DOSE CALCULATION PHO; Richter J, 2008, STRAHLENTHER ONKOL, V184, P187, DOI 10.1007/s00066-008-1684-y; Rivard MJ, 2004, MED PHYS, V31, P633, DOI 10.1118/1.1646040; Selvam TP, 2010, MED PHYS, V37, P1365, DOI 10.1118/1.3326948; WILLIAMSON JF, 1995, MED PHYS, V22, P809, DOI 10.1118/1.597483	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139032	10.1371/journal.pone.0139032	http://dx.doi.org/10.1371/journal.pone.0139032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418559	Green Submitted, Green Published, gold			2022-12-27	WOS:000362171400036
J	Deng, YQ; Yang, YQ; Wang, SB; Li, F; Liu, MZ; Hua, QQ; Tao, ZZ				Deng, Yu-Qin; Yang, Ya-Qi; Wang, Shui-Bin; Li, Fen; Liu, Meng-Zhi; Hua, Qing-Quan; Tao, Ze-Zhang			Intranasal Administration of Lentiviral miR-135a Regulates Mast Cell and Allergen-Induced Inflammation by Targeting GATA-3	PLOS ONE			English	Article							IMMUNE-SYSTEM; MICRORNA; EXPRESSION; RHINITIS; DIFFERENTIATION; DISEASE; LUNG	Mast cell (MC) degranulation is the foundation of the acute phase of allergic rhinitis (AR). Previously, downregulation of GATA binding protein 3 (GATA-3) was shown to suppressMC activation in an AR mouse model. Binding of microRNA-135a (miR-135a) to GATA-3 was also observed, and overexpression of this miRNA decreased GATA-3 mRNA and protein expression. However, the effects ofmiR-135a onMCs during AR are currently unknown. In the present study, we utilized a lentiviral (LV) vector to intranasally administer miR-135a to ovalbumin (OVA)-sensitized AR mice. Following miR-135a treatment, the total serumIgE concentration observed during AR was significantly reduced. In the nasal mucosa, the expression of T-box expressed in T cells (T-bet) was higher, whereas that of GATA-3 was lower in the AR mice following miRNA treatment. Notably, during AR, the ratio of type 1 T-helper cells (Th1) to type 2 (Th2) cells in the spleen is unbalanced, favoring Th2. However, administering miR-135a to the ARmice appeared to balance this ratio by increasing and decreasing the percentage of Th1 and Th2 cells, respectively. MiR-135a also appeared to strongly suppress the infiltration of eosinophils and MCs into the nasal mucosa, and it was specifically localized in the MCs, suggesting that its influence is modulated through regulation of GATA-3 in these cells. Additional work identifying the full therapeutic potential of miR-135a in the treatment of AR and diseases involving allergen-induced inflammation is warranted.	[Deng, Yu-Qin; Yang, Ya-Qi; Li, Fen; Liu, Meng-Zhi; Hua, Qing-Quan; Tao, Ze-Zhang] Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan 430072, Hubei, Peoples R China; [Wang, Shui-Bin] Yichang Yiling Hosp, Dept Otolaryngol Head & Neck Surg, Yichang, Hubei, Peoples R China	Wuhan University	Tao, ZZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan 430072, Hubei, Peoples R China.	taozezhang@163.com		Wang, Shui/0000-0002-0307-7658	National Nature Science Foundation of China [81300813]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was suported by the National Nature Science Foundation of China grant 81300813 awarded to YQD.	Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baxter D, 2012, IMMUNOL CELL BIOL, V90, P288, DOI 10.1038/icb.2011.114; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chakir H, 2003, J IMMUNOL METHODS, V278, P157, DOI 10.1016/S0022-1759(03)00200-X; Chen RF, 2010, CLIN EXP ALLERGY, V40, P1482, DOI 10.1111/j.1365-2222.2010.03592.x; Deho' L, 2010, ARCH IMMUNOL THER EX, V58, P279, DOI 10.1007/s00005-010-0086-x; Hellings PW, 2010, CURR ALLERGY ASTHM R, V10, P143, DOI 10.1007/s11882-010-0107-1; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Kanasty RL, 2012, MOL THER, V20, P513, DOI 10.1038/mt.2011.294; Klein Jan A, 2014, J IMMUNOL, V192, P1385, DOI [10.4049/jimmunol.1301888, DOI 10.4049/JIMMUNOL.1301888]; Lampinen M, 1999, CLIN EXP ALLERGY, V29, P314; Lee CC, 2008, MOL THER, V16, P60, DOI 10.1038/sj.mt.6300309; Lilly CM, 1997, J CLIN INVEST, V99, P1767, DOI 10.1172/JCI119341; Loewen N, 2005, ADV BIOCHEM ENG BIOT, V99, P169, DOI 10.1007/10_007; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Luo YY, 2014, EXP THER MED, V8, P1105, DOI 10.3892/etm.2014.1855; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pfeifer Alexander, 2009, V530, P391, DOI 10.1007/978-1-59745-471-1_21; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Shin SH, 2014, BIOL PHARM BULL, V37, P1295, DOI 10.1248/bpb.b14-00102; Suojalehto H, 2014, INT ARCH ALLERGY IMM, V163, P168, DOI 10.1159/000358486; Temkin V, 2001, CYTOKINE, V15, P20, DOI 10.1006/cyto.2001.0890; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tiwari A, 2014, J BIOL CHEM, V289, P32276, DOI 10.1074/jbc.M114.584136; VUKELJA SJ, 1988, CANCER, V62, P1527, DOI 10.1002/1097-0142(19881015)62:8<1527::AID-CNCR2820620813>3.0.CO;2-X; Welker P, 2000, J INVEST DERMATOL, V114, P44, DOI 10.1046/j.1523-1747.2000.00827.x; Winandy S, 2007, NAT IMMUNOL, V8, P796, DOI 10.1038/ni0807-796; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Zhang XH, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0415-3; ZON LI, 1991, J BIOL CHEM, V266, P22948	38	39	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139322	10.1371/journal.pone.0139322	http://dx.doi.org/10.1371/journal.pone.0139322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418311	Green Published, Green Submitted, gold			2022-12-27	WOS:000362171400076
J	Han, F; Zhou, DY; Liu, XX; Cheng, J; Zhang, QW; Shelton, AM				Han, Fei; Zhou, Dingyang; Liu, Xiaoxia; Cheng, Jie; Zhang, Qingwen; Shelton, Anthony M.			Attitudes in China about Crops and Foods Developed by Biotechnology	PLOS ONE			English	Article							GENETICALLY-MODIFIED RICE; EXPERIMENTAL AUCTIONS; CONSUMER ACCEPTANCE; MULTIPLE CROPS; BT COTTON; GM CROPS; WILLINGNESS; ADOPTION; PLANT; SCIENTISTS	Transgenic Bt cotton has been planted in China since 1997 and, in 2009, biosafety certificates for the commercial production of Bt rice and phytase corn were issued by the Chinese government. The public attitude in China toward agricultural biotechnology and genetically modified (GM) crops and foods has received considerable attention worldwide. We investigated the attitudes of consumers, Bt cotton farmers and scientists in China regarding GM crops and foods and the factors influencing their attitudes. Data were collected using interview surveys of consumer households, farmer households and scientists. A discrete choice approach was used to elicit the purchase intentions of the respondents. Two separate probit models were developed to examine the effect of various factors on the choices of the respondents. Bt cotton farmers had a very positive attitude because Bt cotton provided them with significant economic benefits. Chinese consumers from developed regions had a higher acceptance and willingness to pay for GM foods than consumers in other regions. The positive attitude toward GM foods by the scientific community will help to promote biotechnology in China in the future. Our survey emphasized that educational efforts made by government officials, the media and scientists can facilitate the acceptance of GM technology in China. Further educational efforts will be critical for influencing consumer attitudes and decisions of government agencies in the future. More effective educational efforts by government agencies and public media concerning the scientific facts and safety of GM foods would enhance the acceptance of GM crops in China.	[Han, Fei; Liu, Xiaoxia; Zhang, Qingwen] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Zhou, Dingyang] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China; [Han, Fei; Liu, Xiaoxia; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Cheng, Jie] Chinese Acad Social Sci, Inst Populat & Labor Econ, Beijing, Peoples R China	China Agricultural University; Beijing Normal University; Cornell University; Chinese Academy of Social Sciences	Zhang, QW (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	zhangqingwen@263.net; ams5@cornell.edu			National Transgenic Special Program [2014ZX08011002-006]; 973 Project Grant from the Ministry of Science and Technology of China [2006CB102006]; National Key Technologies Research and Development Program of China [2008BADA5B06]	National Transgenic Special Program; 973 Project Grant from the Ministry of Science and Technology of China; National Key Technologies Research and Development Program of China(National Key Technology R&D Program)	This work was supported by National Transgenic Special Program (2014ZX08011002-006), the 973 Project Grant (2006CB102006) from the Ministry of Science and Technology of China and the National Key Technologies Research and Development Program of China (2008BADA5B06).	Amin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086174; Areal FJ, 2011, PLANT BIOTECHNOL J, V9, P945, DOI 10.1111/j.1467-7652.2011.00651.x; Brookes G, 2015, GM CROPS FOOD, V6, P13, DOI 10.1080/21645698.2015.1022310; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; De Steur H, 2010, APPETITE, V54, P118, DOI 10.1016/j.appet.2009.09.017; De Steur H, 2012, FOOD QUAL PREFER, V25, P87, DOI 10.1016/j.foodqual.2012.02.001; Finney D.J., 1971, PROBIT ANAL; Frewer LJ, 1997, SCI TECHNOL HUM VAL, V22, P98, DOI 10.1177/016224399702200105; Govindasamy R, 2008, AGRIBUSINESS, V24, P102, DOI 10.1002/agr.20149; Hall C, 2008, GEOFORUM, V39, P204, DOI 10.1016/j.geoforum.2007.06.003; Hoban TJ, 1997, NAT BIOTECHNOL, V15, P232, DOI 10.1038/nbt0397-232; Huang JK, 2006, APPETITE, V46, P144, DOI 10.1016/j.appet.2005.11.005; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Jia HP, 2010, NAT BIOTECHNOL, V28, P390, DOI 10.1038/nbt0510-390b; Jiang L, 2014, INSECT BIOCHEM MOLEC, V48, P1, DOI 10.1016/j.ibmb.2014.02.003; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041838; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Kouser S, 2011, ECOL ECON, V70, P2105, DOI 10.1016/j.ecolecon.2011.06.008; Lu Changming, 2010, GM Crops, V1, P113, DOI 10.4161/gmcr.1.3.12377; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lusk JL, 2004, EUR REV AGRIC ECON, V31, P179, DOI 10.1093/erae/31.2.179; Macer D, 2000, NAT BIOTECHNOL, V18, P945, DOI 10.1038/79425; McGloughlin MN, 2010, NEW BIOTECHNOL, V27, P494, DOI 10.1016/j.nbt.2010.07.013; Okazaki Y, 2012, PLANT BIOTECHNOL REP, V6, P1, DOI 10.1007/s11816-011-0191-2; Pilcher CD, 2002, J ECON ENTOMOL, V95, P878, DOI 10.1603/0022-0493-95.5.878; Pray C., 2007, AgBioForum, V10, P161; Shelton AM, 2010, CROP PROT, V29, P412, DOI 10.1016/j.cropro.2010.02.016; Stone R, 2008, SCIENCE, V321, P1279, DOI 10.1126/science.321.5894.1279; Stone R, 2011, SCIENCE, V331, P1000, DOI 10.1126/science.331.6020.1000; Wally Owen, 2010, GM Crops, V1, P199, DOI 10.4161/gmcr.1.4.13225; Wang Q, 2015, NATURE, V519, P7, DOI 10.1038/519007a; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zhang XY, 2010, FOOD POLICY, V35, P456, DOI 10.1016/j.foodpol.2010.04.008	36	19	19	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139114	10.1371/journal.pone.0139114	http://dx.doi.org/10.1371/journal.pone.0139114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6EV	26418161	gold, Green Submitted, Green Published			2022-12-27	WOS:000362171400043
J	Wens, I; Dalgas, U; Vandenabeele, F; Grevendonk, L; Verboven, K; Hansen, D; Eijnde, BO				Wens, Inez; Dalgas, Ulrik; Vandenabeele, Frank; Grevendonk, Lotte; Verboven, Kenneth; Hansen, Dominique; Eijnde, Bert O.			High Intensity Exercise in Multiple Sclerosis: Effects on Muscle Contractile Characteristics and Exercise Capacity, a Randomised Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; TRAINING IMPROVES; CHRONOTROPIC INCOMPETENCE; MODERATE EXERCISE; STRENGTH; HEART; IMPACT; DISABILITY; MOBILITY; FITNESS	Introduction Low-to-moderate intensity exercise improves muscle contractile properties and endurance capacity in multiple sclerosis (MS). The impact of high intensity exercise remains unknown. Methods Thirty-four MS patients were randomized into a sedentary control group (SED, n = 11) and 2 exercise groups that performed 12 weeks of a high intensity interval (HITR, n = 12) or high intensity continuous cardiovascular training (HCTR, n = 11), both in combination with resistance training. M. vastus lateralis fiber cross sectional area (CSA) and proportion, kneeflexor/ extensor strength, body composition, maximal endurance capacity and self-reported physical activity levels were assessed before and after 12 weeks. Results Compared to SED, 12 weeks of high intensity exercise increased mean fiber CSA (HITR: + 21 +/- 7%, HCTR: + 23 +/- 5%). Furthermore, fiber type I CSA increased in HCTR (+ 29 +/- 6%), whereas type II (+ 23 +/- 7%) and IIa (+ 23 +/- 6%,) CSA increased in HITR. Muscle strength improved in HITR and HCTR (between + 13 +/- 7% and + 45 +/- 20%) and body fat percentage tended to decrease (HITR: -3.9 +/- 2.0% and HCTR: -2.5 +/- 1.2%). Furthermore, endurance capacity (Wmax + 21 +/- 4%, time to exhaustion + 24 +/- 5%, VO2max + 17 +/- 5%) and lean tissue mass (+ 1.4 +/- 0.5%) only increased in HITR. Finally self-reported physical activity levels increased 73 +/- 19% and 86 +/- 27% in HCTR and HITR, respectively. Conclusion High intensity cardiovascular exercise combined with resistance training was safe, well tolerated and improved muscle contractile characteristics and endurance capacity in MS.	[Wens, Inez; Vandenabeele, Frank; Grevendonk, Lotte; Verboven, Kenneth; Hansen, Dominique; Eijnde, Bert O.] Hasselt Univ, Fac Med & Life Sci, REVAL Rehabil Res Ctr, BIOMED Biomed Res Inst, Diepenbeek, Belgium; [Dalgas, Ulrik] Aarhus Univ, Dept Publ Hlth, Sect Sport Sci, DK-8000 Aarhus C, Denmark	Hasselt University; Aarhus University	Wens, I (corresponding author), Hasselt Univ, Fac Med & Life Sci, REVAL Rehabil Res Ctr, BIOMED Biomed Res Inst, Agoralaan Bldg A, Diepenbeek, Belgium.	inez.wens@uhasselt.be	Hansen, Dominique/AAH-5883-2021; Verboven, Kenneth/AAB-2007-2019; Op 't Eijnde, Bert/AHA-6777-2022; Vandenabeele, Frank/G-9292-2019	Op 't Eijnde, Bert/0000-0002-2262-4661; Vandenabeele, Frank/0000-0001-5556-8937; Cleeren TEST, Hilde/0000-0002-8756-8904; Wens, Inez/0000-0002-8171-5686; Hansen, Dominique/0000-0003-3074-2737; Grevendonk, Lotte/0000-0001-9540-1832; Dalgas, Ulrik/0000-0003-4132-2789	MS Fund, Limburg, Flanders, Belgium; Biogen Idec; Merck Serono; Sanofi Aventis; Biogen	MS Fund, Limburg, Flanders, Belgium; Biogen Idec(Biogen); Merck Serono(Merck & Company); Sanofi Aventis(Sanofi-Aventis); Biogen(Biogen)	This work was supported by MS Fund, Limburg, Flanders, Belgium. Ulrik Dalgas has received research support, travel grants and/or teaching honorary from Biogen Idec, Merck Serono and Sanofi Aventis and further serves as PI for the ongoing Biogen sponsored ACTIMS study. This does not alter our adherence to Plos One policies on sharing data and materials. Furthermore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutcher SH, 2011, J OBES, V2011, DOI 10.1155/2011/868305; Boyne P, 2013, TOP STROKE REHABIL, V20, P317, DOI 10.1310/tsr2004-317; Broekmans T, 2011, MULT SCLER J, V17, P468, DOI 10.1177/1352458510391339; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Brubaker Peter H, 2007, Curr Cardiol Rep, V9, P229, DOI 10.1007/BF02938355; Brubaker PH, 2011, CIRCULATION, V123, P1010, DOI 10.1161/CIRCULATIONAHA.110.940577; Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72; Ciolac EG, 2012, AM J CARDIOVASC DIS, V2, P102; Collett J, 2011, MULT SCLER; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Dalgas U, 2008, MULT SCLER J, V14, P35, DOI 10.1177/1352458507079445; Dalgas U, 2009, Int MS J, V16, P5; Dalgas U, 2009, NEUROLOGY, V73, P1478, DOI 10.1212/WNL.0b013e3181bf98b4; Dalgas U, 2010, MULT SCLER; Dettmers C, 2009, ACTA NEUROL SCAND, V120, P251, DOI 10.1111/j.1600-0404.2008.01152.x; GREEN HJ, 1979, EUR J APPL PHYSIOL O, V41, P109, DOI 10.1007/BF00421658; Guimaraes GV, 2010, HYPERTENS RES, V33, P627, DOI 10.1038/hr.2010.42; Hakkinen K, 1998, J GERONTOL A-BIOL, V53, pB415, DOI 10.1093/gerona/53A.6.B415; Hansen D, 2014, EUR J PHYS REHABIL M; Hansen D, 2013, NEUROREHABILITATION, V33, P139, DOI 10.3233/NRE-130938; Hikida RS, 2000, J GERONTOL A-BIOL, V55, pB347, DOI 10.1093/gerona/55.7.B347; Kemi OJ, 2010, J CARDIOPULM REHABIL, V30, P2, DOI 10.1097/HCR.0b013e3181c56b89; Keteyian SJ, 1999, AM HEART J, V138, P233, DOI 10.1016/S0002-8703(99)70106-7; Kjolhede T, 2012, MULT SCLER J, V18, P1215, DOI 10.1177/1352458512437418; Langeskov-Christensen M, 2014, J NEUROL SCI, V342, P79, DOI 10.1016/j.jns.2014.04.028; LEXELL J, 1989, CLIN PHYSIOL, V9, P333, DOI 10.1111/j.1475-097X.1989.tb00987.x; Miossi R, 2012, ARTHRIT CARE RES, V64, P1159, DOI 10.1002/acr.21678; Mitranun W, 2014, SCAND J MED SCI SPOR, V24, pE69, DOI 10.1111/sms.12112; Morton RD, 2010, J SPORT SCI, V28, P93, DOI 10.1080/02640410903365685; Motl RW, 2008, MULT SCLER J, V14, P129, DOI 10.1177/1352458507080464; Motl RW, 2008, J NERV MENT DIS, V196, P492, DOI 10.1097/NMD.0b013e318177351b; Motl RW, 2012, J NEUROL PHYS THER, V36, P32, DOI 10.1097/NPT.0b013e3182477c92; Petajan JH, 1996, ANN NEUROL, V39, P432, DOI 10.1002/ana.410390405; Raymond MJ, 2013, ARCH PHYS MED REHAB, V94, P1458, DOI 10.1016/j.apmr.2013.02.022; Romberg A, 2004, NEUROLOGY, V63, P2034, DOI 10.1212/01.WNL.0000145761.38400.65; Schulz KH, 2004, J NEUROL SCI, V225, P11, DOI 10.1016/j.jns.2004.06.009; Simoneau JA, 1985, EUR J APPL PHYSL OCC, P250; Sloth M, 2013, SCAND J MED SCI SPOR, V23, pE341, DOI 10.1111/sms.12092; Smith RM, 2006, ARCH PHYS MED REHAB, V87, P723, DOI 10.1016/j.apmr.2006.01.015; Stuifbergen A K, 1997, J Neurosci Nurs, V29, P238; Stuifbergen AK, 2006, ARCH PHYS MED REHAB, V87, P935, DOI 10.1016/j.apmr.2006.04.003; Surakka J, 2004, CLIN REHABIL, V18, P737, DOI 10.1191/0269215504cr780oa; Terzis G, 2008, J STRENGTH COND RES, V22, P1198, DOI 10.1519/JSC.0b013e31816d5c97; Thoumie P, 2005, MULT SCLER J, V11, P485, DOI 10.1191/1352458505ms1176oa; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Washburn RA, 2002, ARCH PHYS MED REHAB, V83, P193, DOI 10.1053/apmr.2002.27467; Wens I, 2012, MULT SCLER J, V18, pS35; Wens I, 2014, AM J PHYS MED REHABI; Wens I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108158	49	53	54	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0133697	10.1371/journal.pone.0133697	http://dx.doi.org/10.1371/journal.pone.0133697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418222	gold, Green Published, Green Submitted			2022-12-27	WOS:000362171400001
J	Zwakenberg, SR; Gundberg, CM; Spijkerman, AMW; van der A, DL; van der Schouw, YT; Beulens, JWJ				Zwakenberg, Sabine R.; Gundberg, Caren M.; Spijkerman, Annemieke M. W.; van der A, Daphne L.; van der Schouw, Yvonne T.; Beulens, Joline W. J.			Osteocalcin Is Not Associated with the Risk of Type 2 Diabetes: Findings from the EPIC-NL Study	PLOS ONE			English	Article							CARBOXYLASE GENE POLYMORPHISM; VITAMIN-K; GAMMA-CARBOXYLATION; OLDER MEN; METABOLISM; LEVEL	Objective To investigate whether total osteocalcin (tOC), uncarboxylated osteocalcin (ucOC) and percentage of uncarboxylated osteocalcin (%ucOC) are associated with the risk of type 2 diabetes. Methods This nested case control study included 1,635 participants, 833 incident diabetes cases and 802 non-diabetic control participants, aged 21-70 years from the EPIC-NL cohort. Baseline concentrations of tOC, ucOC and %ucOC were assessed. During 10 years of follow-up, diabetes cases were self-reported and verified against information from general practitioners or pharmacists. The association between the different forms of osteocalcin and diabetes risk was assessed with logistic regression adjusted for diabetes risk factors (waist circumference, age, sex, cohort, smoking status, family history of diabetes, hypertension, alcohol intake, physical activity and education) and dietary factors (total energy intake and energy adjusted intake of fat, fiber, protein and calcium). Results TOC concentration was not associated with diabetes risk, with an odds ratio (OR) of 0.97 (0.91-1.03) for each ng/ml increment after adjustment for diabetes risk factors and dietary factors. No association between ucOC and % ucOC and the risk of diabetes was observed either. In sex stratified analyses (P interaction = 0.07), higher % ucOC tended to be associated with an increased risk of type 2 diabetes in a multivariable model in women (OR 1.05 for each increment of 5% ucOC (1.00-1.11), P-trend = 0.08), but not in men (OR 0.96 for each increment of 5% ucOC (0.88-1.04)). When waist circumference was replaced by body mass index, none of the osteocalcin forms were associated with the risk of type 2 diabetes in the final model among both women and men. Conclusions Available evidence suggests that tOC, ucOC and %ucOC are each not associated with the risk of type 2 diabetes. However, more large-scale cohort studies are needed to clarify the presence of any association between the different forms of osteocalcin and the risk of type 2 diabetes.	[Zwakenberg, Sabine R.; van der Schouw, Yvonne T.; Beulens, Joline W. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Gundberg, Caren M.] Yale Univ, Sch Med, Dept Orthopaed, New Haven, CT USA; [Spijkerman, Annemieke M. W.; van der A, Daphne L.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Yale University; Netherlands National Institute for Public Health & the Environment	Zwakenberg, SR (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	s.r.zwakenberg-3@umcutrecht.nl	van der Schouw, Yvonne T./F-8327-2014	van der Schouw, Yvonne T./0000-0002-4605-435X; Beulens, Joline/0000-0002-4181-0937	"Europe against Cancer" program of the European Commission; Dutch Ministry of Public Health, Welfare and Sports; Dutch Cancer Society, ZonMW; Netherlands Organization for Health Research and Development; World Cancer Research Fund (WCRF); European Foundation for the Study of Diabetes (EFSD)/Janssen "Rising star" research fellowship; Dutch Heart Foundation [2013T120]	"Europe against Cancer" program of the European Commission; Dutch Ministry of Public Health, Welfare and Sports; Dutch Cancer Society, ZonMW(KWF KankerbestrijdingNetherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); European Foundation for the Study of Diabetes (EFSD)/Janssen "Rising star" research fellowship; Dutch Heart Foundation(Netherlands Heart Foundation)	The EPIC-NL study was funded by "Europe against Cancer" program of the European Commission, the Dutch Ministry of Public Health, Welfare and Sports, the Dutch Cancer Society, ZonMW, the Netherlands Organization for Health Research and Development and the World Cancer Research Fund (WCRF). Analyses of the vitamin K biomarkers were funded by a European Foundation for the Study of Diabetes (EFSD)/Janssen "Rising star" research fellowship (JWJ Beulens). J.W.J. Beulens and S.R. Zwakenberg are supported by the Senior Dr. Dekker grant (2013T120) from the Dutch Heart Foundation.	Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Booth SL, 2009, ANNU REV NUTR, V29, P89, DOI 10.1146/annurev-nutr-080508-141217; Bullo M, 2012, AM J CLIN NUTR, V95, P249, DOI 10.3945/ajcn.111.016642; Choi Hyung Jin, 2011, Diabetes Care, V34, pe147, DOI 10.2337/dc11-0551; Cranenburg ECM, 2007, THROMB HAEMOSTASIS, V98, P120, DOI 10.1160/TH07-04-0266; Diaz-Lopez A, 2013, J CLIN ENDOCR METAB, V98, P4524, DOI 10.1210/jc.2013-2472; Fawzy T, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/876309; Gundberg CM, 2012, ADV NUTR, V3, P149, DOI 10.3945/an.112.001834; Haraikawa M, 2013, ASIA PAC J CLIN NUTR, V22, P646, DOI 10.6133/apjcn.2013.22.4.01; Hwang YC, 2012, DIABETES CARE, V35, P1919, DOI 10.2337/dc11-2471; Kunutsor SK, 2015, EUR J EPIDEMIOL; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Liatis S, 2014, DIABETES METAB, V40, P198, DOI 10.1016/j.diabet.2014.01.001; Ngarmukos C, 2012, CLIN ENDOCRINOL, V77, P42, DOI 10.1111/j.1365-2265.2011.04215.x; Obrant KJ, 1999, J BONE MINER RES, V14, P555, DOI 10.1359/jbmr.1999.14.4.555; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Schurgers LJ, 2001, PATHOPHYSIOL HAEMO T, V30, P298, DOI DOI 10.1159/000054147; Shea MK, 2009, AM J CLIN NUTR, V90, P1230, DOI 10.3945/ajcn.2009.28151; Shearer MJ, 1996, J NUTR, V126, pS1181, DOI 10.1093/jn/126.suppl_4.1181S; Sluijs I, 2010, NETH J MED, V68, P333; Sogabe N, 2007, J NUTR SCI VITAMINOL, V53, P419, DOI 10.3177/jnsv.53.419; Vermeer C., 2012, VITAMIN K EFFECT HLT; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yeap BB, 2014, J CLIN ENDOCR METAB, V99, pE9, DOI 10.1210/jc.2013-3272	26	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0138693	10.1371/journal.pone.0138693	http://dx.doi.org/10.1371/journal.pone.0138693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418005	Green Published, gold			2022-12-27	WOS:000362171400020
J	Davies, JM; Santaolalla, R; von Furstenberg, RJ; Henning, SJ; Abreu, MT				Davies, Julie M.; Santaolalla, Rebeca; von Furstenberg, Richard J.; Henning, Susan J.; Abreu, Maria T.			The Viral Mimetic Polyinosinic: Polycytidylic Acid Alters the Growth Characteristics of Small Intestinal and Colonic Crypt Cultures	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INFLAMMATORY-BOWEL-DISEASE; STEM-CELL ORGANIZATION; TOLL-LIKE RECEPTOR-3; GERM-FREE MICE; EPITHELIAL-CELLS; IN-VITRO; MODEL; TLR3; RECOGNITION	Background & Aims The intestinal epithelium is the first line of defense against enteric pathogens. We investigated the response of small intestinal and colonic crypt cultures to a panel of toll-like receptor ligands to assess the impact of microbial pattern recognition on epithelial growth. Methods Primary murine jejunal enteroids and colonoids were cultured with lipopeptide Pam3CSK4, lipopolysaccharide (LPS) or polyinosinic: polycytidylic acid (Poly I: C) for 4 to 6 days. Surface area, budding and survival were assessed. Proliferation and numbers of lysozyme positive cells were quantified by flow cytometry. Gene expression was assessed by Nanostring and qRT-PCR. Results Exposure to Pam3CSK4 and LPS hadminimal impact on either enteroids or colonoids. In contrast, Poly I: C increased the surface area of enteroids, while colonoids demonstrated decreased budding. Survival was decreased by Poly I: C in enteroids but not in colonoids. Both enteroids and colonoids exhibited upregulated gene expression of chemokines, but these were increased in magnitude in enteroids. Decreases in gene expression associated with epithelial differentiation and lysozyme positive cells weremore apparent in enteroids than in colonoids. Baseline gene expression between enteroids and colonoids differed markedly in levels of stem cell and inflammatorymarkers. The changes inmorphology induced by Poly I: C were mediated by the toll-like receptor adaptor molecule 1 (Ticam1) in enteroids but not in colonoids. Conclusions Poly I: C alters the molecular program of epithelial cells and shifts from absorption and digestion towards defense and inflammation. Diversity of responses to microbial patterns inenteroids and colonoids may underlie differences in susceptibility to infection along the intestinal tract.	[Davies, Julie M.; Santaolalla, Rebeca; Abreu, Maria T.] Univ Miami, Miller Sch Med, Div Gastroenterol, Miami, FL 33136 USA; [von Furstenberg, Richard J.; Henning, Susan J.] Univ N Carolina, Dept Med & Cell Biol & Physiol, Chapel Hill, NC USA	University of Miami; University of North Carolina; University of North Carolina Chapel Hill	Abreu, MT (corresponding author), Univ Miami, Miller Sch Med, Div Gastroenterol, Miami, FL 33136 USA.	mabreu1@med.miami.edu	Davies, Julie/AAU-7129-2021	Davies, Julie/0000-0003-4035-6047; Abreu, Maria T./0000-0002-7294-0574	National Institute of Health, National Cancer Institute [5R01CA137869-05]; National Institute of Diabetes and Digestive and Kidney Diseases [2R01DK099076-06A1]; Crohn's and Colitis Foundation of America Senior Research Award [3786]; Crohn's and Colitis Foundation of America Research Fellowship Award [3591]; Micky AMP; Madeleine Arison Family Foundation Crohn's AMP; Colitis Discovery Laboratory; NATIONAL CANCER INSTITUTE [R01CA137869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099076] Funding Source: NIH RePORTER	National Institute of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America Senior Research Award; Crohn's and Colitis Foundation of America Research Fellowship Award; Micky AMP; Madeleine Arison Family Foundation Crohn's AMP; Colitis Discovery Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was provided by grants to MTA (National Institute of Health, National Cancer Institute 5R01CA137869-05, National Institute of Diabetes and Digestive and Kidney Diseases 2R01DK099076-06A1; and Crohn's and Colitis Foundation of America Senior Research Award #3786), and to RS (Crohn's and Colitis Foundation of America Research Fellowship Award #3591). Additional funding was provided by The Micky & Madeleine Arison Family Foundation Crohn's & Colitis Discovery Laboratory. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; ALAM M, 1994, SCAND J GASTROENTERO, V29, P445, DOI 10.3109/00365529409096836; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Araya RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099236; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Borghan MA, 2007, J GEN VIROL, V88, P2064, DOI 10.1099/vir.0.82618-0; Brown M, 2014, CLIN EXP IMMUNOL, V178, P28, DOI 10.1111/cei.12381; Buske P, 2012, FEBS J, V279, P3475, DOI 10.1111/j.1742-4658.2012.08646.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cramer JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118792; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753; Foulke-Abel J, 2014, EXP BIOL MED, V239, P1124, DOI 10.1177/1535370214529398; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fuller MK, 2013, CELL TISSUE RES, V354, P441, DOI 10.1007/s00441-013-1674-y; Fuller MK, 2012, J SURG RES, V178, P48, DOI 10.1016/j.jss.2012.03.037; Gourbeyre P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12225; Gulati AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032403; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; HEYMAN M, 1987, PEDIATR RES, V22, P72, DOI 10.1203/00006450-198707000-00017; Hsu D, 2010, LAB INVEST, V90, P1295, DOI 10.1038/labinvest.2010.100; Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024; KHOURY KA, 1969, J EXP MED, V130, P659, DOI 10.1084/jem.130.3.659; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; McAllister CS, 2013, J IMMUNOL, V190, P418, DOI 10.4049/jimmunol.1202756; Middendorp S, 2014, STEM CELLS, V32, P1083, DOI 10.1002/stem.1655; Pin C, 2015, INTEGR BIOL-UK, V7, P213, DOI 10.1039/c4ib00236a; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Seya T, 2012, ONCOIMMUNOLOGY, V1, P917, DOI 10.4161/onci.21244; Sommer F, 2015, MUCOSAL IMMUNOL, V8, P372, DOI 10.1038/mi.2014.74; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Takemura N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4492; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Xu J, 2009, INFLAMM RES, V58, P585, DOI 10.1007/s00011-009-0022-x; Zhou Y, 2013, INNATE IMMUN-LONDON, V19, P184, DOI 10.1177/1753425912459975	45	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138531	10.1371/journal.pone.0138531	http://dx.doi.org/10.1371/journal.pone.0138531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414184	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700019
J	Ma, L; Wang, JT; Wu, TL; Siu, LK; Chuang, YC; Lin, JC; Lu, MC; Lu, PL				Ma, Ling; Wang, Jann-Tay; Wu, Tsu-Lan; Siu, L. Kristopher; Chuang, Yin-Ching; Lin, Jung-Chung; Lu, Min-Chi; Lu, Po-Liang			Emergence of OXA-48-Producing Klebsiella pneumoniae in Taiwan	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; BETA-LACTAMASES; PLASMID; CARBAPENEMASES; RESISTANCE; OXA-48; IDENTIFICATION; SURVEILLANCE; CTX-M-15; IMIPENEM	The isolation of OXA-48-producing Enterobacteriaceae has increased dramatically in Mediterranean countries in the past 10 years, and has recently emerged in Asia. Between January 2012 and May 2014, a total of 760 carbapenem non-susceptible Klebsiella pneumoniae (CnSKP) isolates were collected during a Taiwan national surveillance. Carbapenemases were detected in 210 CnSKP isolates (27.6%), including 162 KPC-2 (n = 1), KPC-3, KPC17, and NDM-1 (n = 1 each), OXA-48 (n = 4), IMP-8 (n = 18), and VIM-1 (n = 24). The four blaOXA-48 CnSKP isolates were detected in late 2013. Herein we report the emergence OXA-48-producing K. pneumoniae isolates in Taiwan. PFGE analysis revealed that the four isolates belonged to three different pulsotypes. Three isolates harboured bla(CTX-M) genes and belonged to MLST type ST11. In addition, the plasmids belonged to the incompatibility group, IncA/C. One isolate belonged to ST116 and the plasmid incompatibility group was non-typeable. The sequence upstream of the bla(OXA-48) gene in all four isolates was identical to pKP(OXA)-48N1, a bla(OXA-48)-carrying plasmid. This is the first report of OXA-48-producing Enterobacteriaceae in Taiwan and the second report to identify bla(OXA-48) on an IncA/C plasmid in K. pneumoniae. Given that three isolates belong to the same pandemic clone (ST11) and possess the IncA/ C plasmid and similar plasmid digestion profile that indicated the role of clonal spread or plasmid for dissemination of bla(OXA-48) gene, the emergence of OXA-48-producing K. pneumoniae in Taiwan is of great concern.	[Ma, Ling; Siu, L. Kristopher] Natl Hlth Res Inst, Natl Inst Infect Dis, Miaoli, Taiwan; [Ma, Ling; Siu, L. Kristopher] Natl Hlth Res Inst, Natl Inst Vaccinol, Miaoli, Taiwan; [Wang, Jann-Tay] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, Tsu-Lan] Linkou Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med & Med Res, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Lin, Jung-Chung] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Lu, Min-Chi] Chung Shan Med Univ Hosp, Infect Dis Sect, Dept Med, Taichung 40201, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chi Mei Hospital; Chi Mei Hospital; National Defense Medical Center; Tri-Service General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Lu, MC (corresponding author), Chung Shan Med Univ Hosp, Infect Dis Sect, Dept Med, Taichung 40201, Taiwan.	luminchi@csmu.edu.tw; d830166@cc.kmu.edu.tw	Lu, Po-Liang/D-4499-2009	Lu, Po-Liang/0000-0002-7423-6783; WANG, JANN-TAY/0000-0002-0924-3469	Center for Diseases Control, Taiwan [MOHW103-CDC-C-114-134504]; Kaohsiung Medical University Research Foundation	Center for Diseases Control, Taiwan; Kaohsiung Medical University Research Foundation	This work was supported MOHW103-CDC-C-114-134504 from the Center for Diseases Control, Taiwan and by Kaohsiung Medical University Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2004, ANTIMICROB AGENTS CH, V48, P533, DOI 10.1128/AAC.48.2.533-537.2004; [Anonymous], 2014, M100S24 CLIN LAB STA, P34; Berger S, 2013, ANTIMICROB AGENTS CH, V57, P4064, DOI 10.1128/AAC.02550-12; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Chouchani C, 2012, EUR J CLIN MICROBIOL, V31, P1081, DOI 10.1007/s10096-011-1410-z; Cockerill FR, 2012, METHODS DILUTION ANT; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Hrabak J, 2009, J CLIN MICROBIOL, V47, P3353, DOI 10.1128/JCM.00901-09; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Ko KS, 2010, J MED MICROBIOL, V59, P822, DOI 10.1099/jmm.0.018119-0; Ktari S, 2011, J ANTIMICROB CHEMOTH, V66, P1644, DOI 10.1093/jac/dkr181; Lascols C, 2013, ANTIMICROB AGENTS CH, V57, P130, DOI 10.1128/AAC.01686-12; Lee MY, 2011, INT J ANTIMICROB AG, V38, P160, DOI 10.1016/j.ijantimicag.2011.03.020; Liapis E, 2014, CLIN MICROBIOL INFEC, V20, pO1121, DOI 10.1111/1469-0691.12727; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; Potron A, 2013, J ANTIMICROB CHEMOTH, V68, P476, DOI 10.1093/jac/dks397; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	26	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139152	10.1371/journal.pone.0139152	http://dx.doi.org/10.1371/journal.pone.0139152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414183	Green Submitted, gold, Green Published			2022-12-27	WOS:000362170700045
J	Deacon, NJ; Cavender-Bares, J				Deacon, Nicholas John; Cavender-Bares, Jeannine			Limited Pollen Dispersal Contributes to Population Genetic Structure but Not Local Adaptation in Quercus oleoides Forests of Costa Rica	PLOS ONE			English	Article							TROPICAL DRY FOREST; 2-GENERATION ANALYSIS; BUR OAK; PHENOTYPIC PLASTICITY; SEED DISPERSAL; CHAMAECRISTA-FASCICULATA; ENVIRONMENTAL GRADIENT; DIVERGENT SELECTION; LANDSCAPE GENETICS; PATERNITY ANALYSIS	Background 0pc?>Quercus oleoides Cham. and Schlect., tropical live oak, is a species of conservation importance in its southern range limit of northwestern Costa Rica. It occurs in high-density stands across a fragmented landscape spanning a contrasting elevation and precipitation gradient. We examined genetic diversity and spatial genetic structure in this geographically isolated and genetically distinct population. We characterized population genetic diversity at 11 nuclear microsatellite loci in 260 individuals from 13 sites. We monitored flowering time at 10 sites, and characterized the local environment in order to compare observed spatial genetic structure to hypotheses of isolation-by-distance and isolation-by-environment. Finally, we quantified pollen dispersal distances and tested for local adaptation through a reciprocal transplant experiment in order to experimentally address these hypotheses. Results High genetic diversity ismaintained in the population and the genetic variation is significantly structured among sampled sites. We identified 5 distinct genetic clusters and average pollen dispersal predominately occurred over short distances. Differences among sites in flowering phenology and environmental factors, however, were not strictly associated with genetic differentiation. Growth and survival of upland and lowland progeny in their native and foreign environments was expected to exhibit evidence of local adaptation due to the more extreme dry season in the lowlands. Seedlings planted in the lowland garden experienced much higher mortality than seedlings in the upland garden, but we did not identify evidence for local adaptation. Conclusion Overall, this study indicates that the Costa Rican Q. oleoides population has a rich population genetic history. Despite environmental heterogeneity and habitat fragmentation, isolation-by-distance and isolation-by-environment alone do not explain spatial genetic structure. These results add to studies of genetic structure by examining a common, tropical tree over multiple habitats and provide information for managers of a successional forest in a protected area.	[Deacon, Nicholas John; Cavender-Bares, Jeannine] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Deacon, Nicholas John] Univ Minnesota, Plant Biol Sci Grad Program, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Deacon, NJ (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	deac0004@umn.edu	Deacon, Nicholas/AAA-9150-2020; Cavender-Bares, Jeannine/K-5716-2013; Deacon, Nick/T-6347-2019	Deacon, Nicholas/0000-0002-6180-9888; Cavender-Bares, Jeannine/0000-0003-3375-9630	NSF [IOS-0843665]; University of Minnesota	NSF(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System)	Funding: The study was funded in part by NSF Grant IOS-0843665 to JCB and by The University of Minnesota to NJD including: Dayton-Wilkie Grant, Carolyn Crosby Fellowship, College of Food, Agriculture and Natural Resource Sciences Fellowship, Doctoral Dissertation International Research Grant, the Minnesota Center for Community Genetics, and the Plant Biological Sciences Graduate Program Travel and Summer Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Austerlitz F, 2002, GENETICS, V161, P355; Austerlitz F, 2001, GENET RES, V78, P271, DOI 10.1017/S0016672301005341; Austerlitz F, 2001, GENETICS, V157, P851; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; BECKER M, 1994, ANN SCI FOREST, V51, P477, DOI 10.1051/forest:19940504; Becknell JM, 2012, FOREST ECOL MANAG, V276, P88, DOI 10.1016/j.foreco.2012.03.033; BERG EE, 1995, EVOLUTION, V49, P110, DOI 10.1111/j.1558-5646.1995.tb05963.x; Bischoff A, 2006, BASIC APPL ECOL, V7, P347, DOI 10.1016/j.baae.2005.07.009; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; BOUCHER DH, 1983, COSTA RICAN NATURAL, P319; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Cavender-Bares J, 2011, J BIOGEOGRAPHY; Cavender-Bares J, 2015, J BIOGEOGRAPHY; Cavender-Bares J, 2007, PHOTOSYNTH RES, V94, P437, DOI 10.1007/s11120-007-9215-8; Cavender-Bares J, 2011, J BIOGEOGR, V38, P962, DOI 10.1111/j.1365-2699.2010.02451.x; Cavender-Bares J, 2009, AM J BOT, V96, P1690, DOI 10.3732/ajb.0800315; Chapotin SM, 2003, PLANT CELL ENVIRON, V26, P623, DOI 10.1046/j.1365-3040.2003.00998.x; Clausen J, 1940, EXPT STUDIES NATURE; Craft KJ, 2007, FOREST ECOL MANAG, V239, P13, DOI 10.1016/j.foreco.2006.11.005; Craft KJ, 2006, CAN J FOREST RES, V36, P206, DOI 10.1139/x05-234; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; de Jong G, 2005, NEW PHYTOL, V166, P101, DOI 10.1111/j.1469-8137.2005.01322.x; Deacon NJ, 2010, POPULATION GENETIC S; Derory J, 2010, HEREDITY, V104, P438, DOI 10.1038/hdy.2009.134; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; Dow BD, 1998, NEW FOREST, V15, P161, DOI 10.1023/A:1006557904751; Dow BD, 1996, MOL ECOL, V5, P615, DOI 10.1111/j.1365-294X.1996.tb00357.x; Dutech C, 2005, AM J BOT, V92, P252, DOI 10.3732/ajb.92.2.252; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2004, HEREDITY, V92, P204, DOI 10.1038/sj.hdy.6800397; Epperson BK, 1997, EVOLUTION, V51, P275, DOI 10.1111/j.1558-5646.1997.tb02409.x; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Etterson JR, 2004, EVOLUTION, V58, P1459, DOI 10.1111/j.0014-3820.2004.tb01727.x; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2001, GENETICS AND BIOMETR; Fernandez JF, 2005, J HERED, V96, P635, DOI 10.1093/jhered/esi104; Gailing O, 2008, PLANT BIOLOGY, V10, P624, DOI 10.1111/j.1438-8677.2008.00063.x; Gao H, 2007, GENETICS; Gerber S, 2003, MOL ECOL NOTES, V3, P479, DOI 10.1046/j.1471-8286.2003.00439.x; Geyer CJ, 2007, BIOMETRIKA, V94, P415, DOI 10.1093/biomet/asm030; Gonzalez-Rodriguez A, 2005, BOT J LINN SOC, V147, P427, DOI 10.1111/j.1095-8339.2004.00394.x; Gram WK, 2001, ECOLOGY, V82, P2012, DOI 10.1890/0012-9658(2001)082[2012:ABEAGH]2.0.CO;2; Hall MC, 2006, EVOLUTION, V60, P2466, DOI 10.1554/05-688.1; HALLWACHS W, 1994, CLUMSY DANCE AGOUTIS; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hardy OJ, 2003, GENETICS, V163, P1467; Hendry AP, 2005, MOL ECOL, V14, P901, DOI 10.1111/j.1365-294X.2005.02480.x; Hereford J, 2008, NEW PHYTOL, V178, P888, DOI 10.1111/j.1469-8137.2008.02405.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Herrera W., 1986, CLIMA COSTA RICA, V2; HEYWOOD JS, 1991, ANNU REV ECOL SYST, V22, P335, DOI 10.1146/annurev.es.22.110191.002003; Hirao AS, 2004, HEREDITY, V93, P290, DOI 10.1038/sj.hdy.6800503; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Holt RD, 1997, AM NAT, V149, P563, DOI 10.1086/286005; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; JACKSON MT, 1966, ECOLOGY, V47, P407, DOI 10.2307/1932980; Janzen D.H., 1986, GUANACASTE NATL PARK; JANZEN DH, 1988, ANN MO BOT GARD, V75, P105, DOI 10.2307/2399468; Jump AS, 2009, TRENDS PLANT SCI, V14, P51, DOI 10.1016/j.tplants.2008.10.002; Kampfer S, 1998, HEREDITAS, V129, P183, DOI 10.1111/j.1601-5223.1998.00183.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kissing LB, 2010, J TROP ECOL, V26, P467, DOI 10.1017/S0266467410000131; Klemens J, 2011, SEASONALLY DRY TROPI; Koenig WD, 2005, AM SCI, V93, P340, DOI 10.1511/2005.54.970; Lee CR, 2011, MOL ECOL, V20, P4631, DOI 10.1111/j.1365-294X.2011.05310.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; McClean CJ, 2005, ANN MO BOT GARD, V92, P139; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Nakanishi A, 2005, MOL ECOL, V14, P4469, DOI 10.1111/j.1365-294X.2005.02736.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Ortego J, 2015, PLANT BIOLOGY, V17, P676, DOI 10.1111/plb.12272; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Pritchard JK, 2000, GENETICS, V155, P945; Raabova J, 2007, BIOL CONSERV, V139, P348, DOI 10.1016/j.biocon.2007.07.007; Ramirez-Valiente JA, 2010, EVOL ECOL, V24, P1031, DOI 10.1007/s10682-010-9365-6; Ramirez-Valiente JA, 2009, FOREST ECOL MANAG, V257, P1676, DOI 10.1016/j.foreco.2009.01.024; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; RICE KJ, 1993, OECOLOGIA, V96, P537, DOI 10.1007/BF00320511; Saenz-Romero C, 2006, FOREST ECOL MANAG, V229, P340, DOI 10.1016/j.foreco.2006.04.014; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Shaw RG, 2008, AM NAT, V172, pE35, DOI 10.1086/588063; Slavov GT, 2009, MOL ECOL, V18, P357, DOI 10.1111/j.1365-294X.2008.04016.x; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2004, FOREST ECOL MANAG, V197, P21, DOI 10.1016/j.foreco.2004.05.049; Smouse PE, 2001, EVOLUTION, V55, P260; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sork VL, 2002, MOL ECOL, V11, P1657, DOI 10.1046/j.1365-294X.2002.01574.x; Steinkellner H, 1997, PLANT MOL BIOL, V33, P1093, DOI 10.1023/A:1005736722794; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Temunovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042764; TONSOR SJ, 1985, OECOLOGIA, V67, P442, DOI 10.1007/BF00384953; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Volis S, 2004, AM NAT, V163, P312, DOI 10.1086/381406; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weis AE, 2005, EVOL ECOL RES, V7, P161; Wright S, 1943, GENETICS, V28, P114; Yamagishi H, 2005, ECOL RES, V20, P199, DOI 10.1007/s11284-004-0032-7; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; You FM, 2004, PLANT AN GEN 12 C SA	117	25	26	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138783	10.1371/journal.pone.0138783	http://dx.doi.org/10.1371/journal.pone.0138783			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407244	gold, Green Published, Green Submitted			2022-12-27	WOS:000361800700096
J	Banaszak, M; Dziecielski, M; Nijkamp, P; Ratajczak, W				Banaszak, Michal; Dziecielski, Michal; Nijkamp, Peter; Ratajczak, Waldemar			Self-Organisation in Spatial Systems-From Fractal Chaos to Regular Patterns and Vice Versa	PLOS ONE			English	Article								This study offers a new perspective on the evolutionary patterns of cities or urban agglomerations. Such developments can range from chaotic to fully ordered. We demonstrate that in a dynamic space of interactive human behaviour cities produce a wealth of gravitational attractors whose size and shape depend on the resistance of space emerging inter alia from transport friction costs. This finding offers original insights into the complex evolution of spatial systems and appears to be consistent with the principles of central place theory known from the spatial sciences and geography. Our approach is dynamic in nature and forms a generalisation of hierarchical principles in geographic space.	[Banaszak, Michal; Dziecielski, Michal] Adam Mickiewicz Univ, Fac Phys, PL-61614 Poznan, Poland; [Dziecielski, Michal; Nijkamp, Peter; Ratajczak, Waldemar] Adam Mickiewicz Univ, Fac Geog & Earth Sci, PL-61680 Poznan, Poland; [Nijkamp, Peter] Vrije Univ Amsterdam, Fac Econ & Business Adm, NL-1081 HV Amsterdam, Netherlands	Adam Mickiewicz University; Adam Mickiewicz University; Vrije Universiteit Amsterdam	Nijkamp, P (corresponding author), Adam Mickiewicz Univ, Fac Geog & Earth Sci, Ul Dziegielowa 27, PL-61680 Poznan, Poland.	p.nijkamp@vu.nl	Banaszak, Michal/A-9411-2010	Banaszak, Michal/0000-0003-0106-632X; Nijkamp, Peter/0000-0002-4068-8132; Dziecielski, Michal/0000-0002-7056-5774; kourtit, karima/0000-0002-7171-994X				BEEMAN D, 1976, J COMPUT PHYS, V20, P130, DOI 10.1016/0021-9991(76)90059-0; Benguigui L, 2009, ADV SPAT SCI, P33, DOI 10.1007/978-3-642-01554-0_3; Brakman S., 2009, NEW INTRO GEOGRAPHIC, DOI [10.1017/CBO9780511818745, DOI 10.1017/CBO9780511818745]; Christaller W., 1933, ZENTRALEN ORTE SUDDE; Dieleman F. M., 1971, GEOGRAFISCH TIJDSCHR, VV, P1971; Fingleton B, 2007, NEW HORIZ REG SCI, P168; Fujita M., 1998, SPATIAL EC CITIES RE; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Ikeda K., 2014, BIFURCATION THEORY H; Janowski B., 1908, DISTANCES FACTOR CUL; Kolbl R, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/348; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; Krugman P., 1991, GEOGRAPHY TRADE; Krugman P., 1996, SELF ORG EC; Li J., 2012, ARXIV12070155; Losch A., 1954, EC LOCATION; McCann P, 2005, J ECON GEOGR, V5, P305, DOI 10.1093/jnlecg/lbh050; Nijkamp P., 1992, INTERACTION EVOLUTIO; Nijkamp P., 1998, EX COMPLEX SPATIAL S; Peitgen H. O., 1991, FRACTALS CLASSROOM I; PRIGOGINE Ilya, 1985, ORDER OUT CHAOS MANS; Pumain D., 1982, DYNAMIQUE VILLES; Ravenstein E.G., 1885, J STAT SOC LONDON, V48, P167; Reggiani A., 2014, ENVIRON PLAN B-URBAN, V41, P1; Reggiani A, 2009, ADV SPAT SCI, P275, DOI 10.1007/978-3-642-01554-0_19; REYNAUD J, 1841, ENCY NOUVELLE, VVIII, P670; Rietveld P., 2014, APPL SPATIA IN PRESS; SMITH MW, 1979, PUBLIC HEALTH REP, V94, P248; Stewart JQ, 1948, SOCIOMETRY, V11, P31, DOI 10.2307/2785468; Takayasu H., 1990, FRACTALS PHYS SCI; Tinbergen J., 1961, SCHWEIZERISCHE Z VOL, V97, P412; Wilson A, 2009, ADV SPAT SCI, P11, DOI 10.1007/978-3-642-01554-0_2	32	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0136248	10.1371/journal.pone.0136248	http://dx.doi.org/10.1371/journal.pone.0136248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402913	Green Published, gold, Green Submitted			2022-12-27	WOS:000361798100006
J	Bodega, G; Segura, B; Ciordia, S; Mena, MD; Lopez-Fernandez, LA; Garcia, MI; Trabado, I; Suarez, I				Bodega, Guillermo; Segura, Berta; Ciordia, Sergio; del Carmen Mena, Maria; Andres Lopez-Fernandez, Luis; Isabel Garcia, Maria; Trabado, Isabel; Suarez, Isabel			Ammonia Affects Astroglial Proliferation in Culture	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; HEPATIC-ENCEPHALOPATHY; IN-VITRO; OXIDATIVE-METABOLISM; ENERGY-METABOLISM; DNA-SYNTHESIS; ASTROCYTES; GROWTH; RATS; HYPERAMMONEMIA	Primary cultures of rat astroglial cells were exposed to 1, 3 and 5 mM NH4Cl for up to 10 days. Dose- and time-dependent reductions in cell numbers were seen, plus an increase in the proportion of cells in the S phase. The DNA content was reduced in the treated cells, and BrdU incorporation diminished. However, neither ammonia nor ammonia plus glutamine had any effect on DNA polymerase activity. iTRAQ analysis showed that exposure to ammonia induced a significant reduction in histone and heterochromatin protein 1 expression. A reduction in cell viability was also noted. The ammonia-induced reduction of proliferative activity in these cultured astroglial cells seems to be due to a delay in the completion of the S phase provoked by the inhibition of chromatin protein synthesis.	[Bodega, Guillermo; Suarez, Isabel] Univ Alcala de Henares, Dept Biomed & Biotecnol, Madrid 28871, Spain; [Segura, Berta] UFIEC, Unidad Neurooncol, Inst Salud Carlos III, Madrid 28220, Spain; [Ciordia, Sergio; del Carmen Mena, Maria] CSIC, Ctr Nacl Biotecnol, Prote, Madrid, Spain; [Andres Lopez-Fernandez, Luis; Isabel Garcia, Maria] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Serv Farm, Madrid, Spain; [Trabado, Isabel] Univ Alcala de Henares, Fac Med, Unidad Cult, Madrid 28871, Spain	Universidad de Alcala; Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); General University Gregorio Maranon Hospital; Universidad de Alcala	Bodega, G (corresponding author), Univ Alcala de Henares, Dept Biomed & Biotecnol, Madrid 28871, Spain.	guillermo.bodega@uah.es	Lopez-Fernandez, Luis A/I-9679-2019; Lopez-Fernandez, Luis A/B-7330-2011; Collar, Berta Segura/AAB-1056-2020; Lopez-Fernandez, Luis/AAV-2580-2021	Lopez-Fernandez, Luis A/0000-0003-3964-5837; Lopez-Fernandez, Luis A/0000-0003-3964-5837; Lopez-Fernandez, Luis/0000-0003-3964-5837; Mena, Maria Carmen/0000-0002-6453-2132; Segura, Berta/0000-0001-8507-7434; Ciordia, Sergio/0000-0002-5726-853X	Universidad de Alcala [E02]	Universidad de Alcala	Support was provided by Universidad de Alcala E02. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2005, ROLE GLIA NEUROTOXIC, P329; Bjerring PN, 2013, METAB BRAIN DIS, V28, P179, DOI 10.1007/s11011-012-9346-2; Bodega G, 2006, NEUROCHEM INT, V48, P729, DOI 10.1016/j.neuint.2005.12.014; Bosoi CR, 2009, METAB BRAIN DIS, V24, P95, DOI 10.1007/s11011-008-9112-7; BRUMBACK RA, 1989, ARCH NEUROL-CHICAGO, V46, P845, DOI 10.1001/archneur.1989.00520440027016; BUTTERWORTH RF, 1987, NEUROCHEM PATHOL, V6, P1, DOI 10.1007/BF02833598; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; DIEMER NH, 1977, ACTA NEUROL SCAND, V55, P425, DOI 10.1111/j.1600-0404.1977.tb07623.x; Eguchi S, 1996, HEPATOLOGY, V24, P1452; Franch HA, 2000, J AM SOC NEPHROL, V11, P1631, DOI 10.1681/ASN.V1191631; Gorg B, 2015, GLIA, V63, P37, DOI 10.1002/glia.22731; Haussinger D, 2008, GUT, V57, P1156, DOI 10.1136/gut.2007.122176; Hillmann P, 2008, TOXICOL APPL PHARM, V227, P36, DOI 10.1016/j.taap.2007.10.012; Iversen P, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00353; Kala G, 2005, NEUROCHEM INT, V47, P4, DOI 10.1016/j.neuint.2005.04.001; KNAPP PE, 1992, J HISTOCHEM CYTOCHEM, V40, P1405, DOI 10.1177/40.9.1506676; Leke R, 2013, METAB BRAIN DIS, V28, P187, DOI 10.1007/s11011-012-9347-1; Matsui T, 1997, DIGEST DIS SCI, V42, P1394, DOI 10.1023/A:1018837920769; MATSUI T, 1995, EUR J GASTROEN HEPAT, V7, pS79; Mendez M, 2009, BEHAV BRAIN RES, V198, P346, DOI 10.1016/j.bbr.2008.11.015; Mouille B, 2003, BBA-GEN SUBJECTS, V1624, P88, DOI 10.1016/j.bbagen.2003.09.014; NORENBERG MD, 1972, AM J PATHOL, V67, P403; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; NORENBERG MD, 1987, NEUROCHEM PATHOL, V6, P13, DOI 10.1007/BF02833599; Ott P, 2014, METAB BRAIN DIS, V29, P901, DOI 10.1007/s11011-014-9494-7; RABKIN R, 1993, LAB INVEST, V68, P427; Rao KVR, 2007, METAB BRAIN DIS, V22, P265, DOI 10.1007/s11011-007-9063-4; Rao KVR, 2003, METAB BRAIN DIS, V18, P113, DOI 10.1023/A:1023858902184; Rao KVR, 2001, METAB BRAIN DIS, V16, P67, DOI 10.1023/A:1011666612822; Rattray AMJ, 2012, BIOCHEM SOC T, V40, P880, DOI 10.1042/BST20120065; RENAUPIQUERAS J, 1986, VIRCHOWS ARCH B, V50, P271, DOI 10.1007/BF02889906; Santello M, 2010, NATURE, V463, P169, DOI 10.1038/463169a; Schousboe A, 2014, METAB BRAIN DIS, V29, P913, DOI 10.1007/s11011-014-9513-8; Weissenborn K, 2005, METAB BRAIN DIS, V20, P359, DOI 10.1007/s11011-005-7919-z; Won JH, 1999, UROL RES, V27, P376, DOI 10.1007/s002400050166; ZACHRISSON K, 1994, EUR J GASTROEN HEPAT, V6, P951, DOI 10.1097/00042737-199410000-00019	36	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139619	10.1371/journal.pone.0139619	http://dx.doi.org/10.1371/journal.pone.0139619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26421615	Green Published, gold			2022-12-27	WOS:000362175700135
J	Fernandez-Escamilla, AM; Fernandez-Ballester, G; Morel, B; Casares-Atienza, S; Ramos, JL				Maria Fernandez-Escamilla, Ana; Fernandez-Ballester, Gregorio; Morel, Bertrand; Casares-Atienza, Salvador; Luis Ramos, Juan			Molecular Binding Mechanism of TtgR Repressor to Antibiotics and Antimicrobials	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMPS; GRAM-NEGATIVE BACTERIA; FORCE-FIELD; RESISTANCE; PROTEINS; CRISIS; DOMAIN	A disturbing phenomenon in contemporary medicine is the prevalence of multidrug-resistant pathogenic bacteria. Efflux pumps contribute strongly to this antimicrobial drug resistance, which leads to the subsequent failure of clinical treatments. The TtgR protein of Pseudomonas putida is a HTH-type transcriptional repressor that controls expression of the TtgABC efflux pump, which is the main contributor to resistance against several antimicrobials and toxic compounds in this microbe. One of the main strategies to modulate the bacterial resistance is the rational modification of the ligand binding target site. We report the design and characterization of four mutants-TtgR(S77A), TtgR(E78A), TtgR(N110A) and TtgR(H114A) - at the active ligand binding site. The biophysical characterization of the mutants, in the presence and in the absence of different antimicrobials, revealed that TtgR(N110A) is the variant with highest thermal stability, under any of the experimental conditions tested. EMSA experiments also showed a different dissociation pattern from the operator for TtgR(N110A), in the presence of several antimicrobials, making it a key residue in the TtgR protein repression mechanism of the TtgABC efflux pump. We found that TtgR(E78A) stability is the most affected upon effector binding. We also probe that one mutation at the C-terminal half of helix-alpha 4, TtgR(S77A), provokes a severe protein structure distortion, demonstrating the important role of this residue in the overall protein structure and on the ligand binding site. The data provide new information and deepen the understanding of the TtgR-effector binding mechanism and consequently the TtgABC efflux pump regulation mechanism in Pseudomonas putida.	[Maria Fernandez-Escamilla, Ana; Luis Ramos, Juan] CSIC, EEZ, Environm Protect Dept, E-18008 Granada, Spain; [Fernandez-Ballester, Gregorio] Miguel Hernandez Univ, Inst Mol & Cellular Biol IBMC, E-03202 Alicante, Spain; [Morel, Bertrand; Casares-Atienza, Salvador] Univ Granada, Fac Sci, Phys Chem Dept, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Universidad Miguel Hernandez de Elche; University of Granada	Fernandez-Escamilla, AM (corresponding author), CSIC, EEZ, Environm Protect Dept, C Prof Albareda 1, E-18008 Granada, Spain.	anamfe@eez.csic.es	Casares-Atienza, Salvador/L-6026-2014	Casares-Atienza, Salvador/0000-0001-7257-2196; Morel, Bertrand/0000-0002-2708-8589; Ramos, Juan L./0000-0002-8731-7435; FERNANDEZ-ESCAMILLA, ANA MARIA/0000-0002-6615-4913	Spanish Ministry of Economy and Competitiveness; National programme for Recruitment and Incorporation of Human Resources; Junta de Andalucia [P11-CVI-7391, RYC-2009-04570]; EFDR (European Regional Development Fund)	Spanish Ministry of Economy and Competitiveness(Spanish Government); National programme for Recruitment and Incorporation of Human Resources; Junta de Andalucia(Junta de Andalucia); EFDR (European Regional Development Fund)	This work was supported by Spanish Ministry of Economy and Competitiveness, National programme for Recruitment and Incorporation of Human Resources, Subprogramme: Ramon y Cajal RYC-2009-04570 and grant P11-CVI-7391 from Junta de Andalucia and EFDR (European Regional Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Daniels C, 2010, J BIOL CHEM, V285, P21372, DOI 10.1074/jbc.M110.113282; DiRusso CC, 1998, J BIOL CHEM, V273, P33652, DOI 10.1074/jbc.273.50.33652; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Espinosa-Urgel M, 2015, MOL BIOTECHNOL, V57, P558, DOI 10.1007/s12033-015-9849-2; Franke AA, 2002, J CHROMATOGR B, V777, P45, DOI 10.1016/S1570-0232(02)00216-7; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Gross M, 2013, CURR BIOL, V23, pR1063, DOI 10.1016/j.cub.2013.11.057; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Kieboom J, 2001, MICROBIOL-SGM, V147, P43, DOI 10.1099/00221287-147-1-43; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nikaido H, 2001, J MOL MICROB BIOTECH, V3, P215; Paul SB, 2010, BIOINFORMATION, V4, P473, DOI 10.6026/97320630004473; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Privalov GP, 2000, METHOD ENZYMOL, V323, P31; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Teran W, 2003, ANTIMICROB AGENTS CH, V47, P3067, DOI 10.1128/AAC.47.10.3067-3072.2003; Teran W, 2006, J BIOL CHEM, V281, P7102, DOI 10.1074/jbc.M511095200; The Merck Index, 1989, ENTR 2068; Ughachukwu PO, 2012, ANN MED HEALTH SCI R, V2, P191, DOI 10.4103/2141-9248.105671; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	27	11	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138469	10.1371/journal.pone.0138469	http://dx.doi.org/10.1371/journal.pone.0138469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422008	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700041
J	Rothan, HA; Ambikabothy, J; Abdulrahman, AY; Bahrani, H; Golpich, M; Amini, E; Rahman, NA; Teoh, TC; Mohamed, Z; Yusof, R				Rothan, Hussin A.; Ambikabothy, Jamunaa; Abdulrahman, Ammar Y.; Bahrani, Hirbod; Golpich, Mojtaba; Amini, Elham; Rahman, Noorsaadah A.; Teoh, Teow Chong; Mohamed, Zulqarnain; Yusof, Rohana			Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; MULTIDRUG-RESISTANCE; ESCHERICHIA-COLI; CANCER-THERAPY; LATARCIN 2A; CELL LINES; IN-VITRO; EXPRESSION; PROTEIN; INHIBITION	The production of short anticancer peptides in recombinant form is an alternative method for costly chemical manufacturing. However, the limitations of host toxicity, bioactivity and column purification have impaired production in mass quantities. In this study, short cationic peptides were produced in aggregated inclusion bodies by double fusion with a central protein that has anti-cancer activity. The anticancer peptides Tachiplicin I (TACH) and Latarcin 1 (LATA) were fused with the N-and C-terminus of the MAP30 protein, respectively. We successfully produced the recombinant TACH-MAP30-LATA protein and MAP30 alone in E. coli that represented 59% and 68% of the inclusion bodies. The purified form of the inclusion bodies was prepared by eliminating host cell proteins through multiple washing steps and semi-solubilization in alkaline buffer. The purified active protein was recovered by inclusive solubilization at pH 12.5 in the presence of 2 M urea and refolded in alkaline buffer containing oxides and reduced glutathione. The peptide-fusion protein showed lower CC50 values against cancer cells (HepG2, 0.35 +/- 0.1 mu M and MCF-7, 0.58 +/- 0.1 mu M) compared with normal cells (WRL68, 1.83 +/- 0.2 mu M and ARPE19, 2.5 +/- 0.1 mu M) with outstanding activity compared with its individual components. The presence of the short peptides facilitated the entry of the peptide fusion protein into cancer cells (1.8 to 2.2-fold) compared with MAP30 alone through direct interaction with the cell membrane. The cancer chemotherapy agent doxorubicin showed higher efficiency and selectivity against cancer cells in combination with the peptide-fusion protein. This study provides new data on the mass production of short anticancer peptides as inclusion bodies in E. coli by fusion with a central protein that has similar activity. The product was biologically active against cancer cells compared with normal cells and enhanced the activity and selective delivery of an anticancer chemotherapy agent.	[Rothan, Hussin A.; Ambikabothy, Jamunaa; Abdulrahman, Ammar Y.; Bahrani, Hirbod; Yusof, Rohana] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia; [Golpich, Mojtaba; Amini, Elham] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Med, Kuala Lumpur 56000, Malaysia; [Rahman, Noorsaadah A.] Univ Malaya, Fac Med, Dept Chem, Kuala Lumpur 50603, Malaysia; [Teoh, Teow Chong; Mohamed, Zulqarnain] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Kebangsaan Malaysia; Universiti Malaya; Universiti Malaya	Rothan, HA (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia.	rothan@um.edu.my	MOHAMED, ZULQARNAIN/C-1158-2010; YUSOF, ROHANA/B-9589-2010; Rahman, Noorsaadah Abd./B-9291-2010; Golpich, Mojtaba/K-8061-2014; ROTHAN, HUSSIN/D-5490-2016; TEOH, TEOW CHONG/B-9950-2010; Abdulrahman, Ammar Yasir/AAF-9133-2019	MOHAMED, ZULQARNAIN/0000-0001-7311-0356; YUSOF, ROHANA/0000-0002-6591-3236; Rahman, Noorsaadah Abd./0000-0001-5847-8961; Golpich, Mojtaba/0000-0002-7042-1201; Abdulrahman, Ammar Yasir/0000-0003-4839-6852; ROTHAN, HUSSIN/0000-0002-7300-6388	Ministry of Science, Technology and Innovation-Malaysia, University of Malaya-Malaysia (ERGS) [ER016-2013A, PG081-2014A]	Ministry of Science, Technology and Innovation-Malaysia, University of Malaya-Malaysia (ERGS)	This project was funded by the Ministry of Science, Technology and Innovation-Malaysia, University of Malaya-Malaysia (ERGS grant ER016-2013A and PG081-2014A).	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bommarius B, 2010, PEPTIDES, V31, P1957, DOI 10.1016/j.peptides.2010.08.008; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Brown JM, 1998, CANCER RES, V58, P1408; Chen JG, 2005, CANCER RES, V65, P4614, DOI 10.1158/0008-5472.CAN-04-2253; Chen YX, 2001, CANCER RES, V61, P2434; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Fang EF, 2012, CANCER LETT, V324, P66, DOI 10.1016/j.canlet.2012.05.005; Gaiser RA, 2011, SCI MICROBIAL PATHOG, V11, P992; Garcia M, 2007, GLOBAL CANC FACTS FI; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Kim SK, 2003, PEPTIDES, V24, P945, DOI 10.1016/S0196-9781(03)00194-3; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Lai JR, 2002, BIOCHEMISTRY-US, V41, P12835, DOI 10.1021/bi026127d; Lee-Huang S, 2000, ANTICANCER RES, V20, P653; Martin I, 2010, PHARMACEUTICALS, V3, P1456, DOI 10.3390/ph3051456; Puigbo P, 2008, NUCLEIC ACIDS RES, V36, pD524, DOI 10.1093/nar/gkm831; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Rothan H.A., 2013, OMICS J INTEGR BIOL, V17; Rothan HA, 2014, ANTIVIR RES, V108, P173, DOI 10.1016/j.antiviral.2014.05.019; Rothan HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094561; Rothan HA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-314; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416; SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Suttmann Henrik, 2008, BMC Urol, V8, P5, DOI 10.1186/1471-2490-8-5; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Valdez-Cruz NA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-18; Won A, 2012, BBA-BIOMEMBRANES, V1818, P3072, DOI 10.1016/j.bbamem.2012.07.030; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2015	10	9							e0139248	10.1371/journal.pone.0139248	http://dx.doi.org/10.1371/journal.pone.0139248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EV	26418816	Green Submitted, Green Published, gold			2022-12-27	WOS:000362171400067
J	Haugen, J; Chandyo, RK; Brokstad, KA; Mathisen, M; Ulak, M; Basnet, S; Valentiner-Branth, P; Strand, TA				Haugen, Johanne; Chandyo, Ram K.; Brokstad, Karl A.; Mathisen, Maria; Ulak, Manjeswori; Basnet, Sudha; Valentiner-Branth, Palle; Strand, Tor A.			Cytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; G-CSF; GM-CSF; PEDIATRIC-PATIENTS; GRANULOCYTE; NEUTROPHILS; EXPRESSION; RESPONSES; IL-8; ACTIVATION	Background Children in low and middle-income countries have a high burden of pneumonia. Measuring the cytokine responses may be useful to identify novel markers for diagnosing, monitoring, and treating pneumonia. Objective To describe and compare a wide range of inflammatory mediators in plasma from children with WHO-defined severe and non-severe community acquired pneumonia (CAP), and explore to what extent certain mediators are associated with severity and viral detection. Methods We collected blood samples from 430 children with severe (n = 43) and non-severe (n = 387) CAP. Plasma from these children were analysed for 27 different cytokines, and we measured the association with age, disease severity and viral detection. Results There were generally higher plasma concentrations of several cytokines with both pro-inflammatory and anti-inflammatory effects among children with severe CAP than in children with non-severe CAP. We found significantly higher concentrations of interleukin (IL)-1, IL-4, IL-6, IL-8, IL-9, IL-15, eotaxin, basic fibroblast growth factor (b-FGF), granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-alpha (TNF-alpha) in the group of severe CAP. Most of these associations persisted when adjusting for age in linear regression analyses. The cytokine response was strongly associated with age but to a lesser extent with viral etiology. Conclusion The plasma concentrations of several cytokines, both with pro-inflammatory and anti-inflammatory effects, were higher among children with severe illness. In particular G-CSF and IL6 reflected severity and might provide complementary information on the severity of the infection.	[Haugen, Johanne; Strand, Tor A.] Innlandet Hosp Trust, Dept Med Microbiol, Lillehammer, Norway; [Brokstad, Karl A.] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway; [Haugen, Johanne; Chandyo, Ram K.; Basnet, Sudha; Strand, Tor A.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Mathisen, Maria] Univ Hosp Northern Norway, Tromso, Norway; [Ulak, Manjeswori] Tribhuvan Univ, Inst Med, Dept Child Hlth, Kathmandu, Nepal; [Valentiner-Branth, Palle] Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen, Denmark	Innlandet Hospital Trust; University of Bergen; University of Bergen; UiT The Arctic University of Tromso; University Hospital of North Norway; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Statens Serum Institut	Haugen, J (corresponding author), Innlandet Hosp Trust, Dept Med Microbiol, Lillehammer, Norway.	johanne_haugen@hotmail.com	Brokstad, Karl Albert/AAU-9639-2020; Brokstad, Karl Albert/N-8096-2015; Strand, Tor/D-9836-2016	Brokstad, Karl Albert/0000-0003-0593-2731; Brokstad, Karl Albert/0000-0003-0593-2731; Strand, Tor/0000-0002-4038-151X	South-Eastern Norway Regional Health Authority [2012090]; Innlandet Hosptial Trust [150263]; European Commission (EU-INCO-DC) [INCO-FP6-003740]	South-Eastern Norway Regional Health Authority; Innlandet Hosptial Trust; European Commission (EU-INCO-DC)(European CommissionEuropean Commission Joint Research Centre)	Funding: This work was supported by South-Eastern Norway Regional Health Authority (grant no. 2012090), www.helse-sorost.no, TAS; Innlandet Hosptial Trust projectnr: 150263 www.sykehuset-innlandet.no, JH; and European Commission (EU-INCO-DC contract number INCO-FP6-003740) http://ec.europa.eu/research, TAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2000, EUR RESPIR J, V15, P895, DOI 10.1034/j.1399-3003.2000.15e14.x; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Bordon J, 2013, INT J INFECT DIS, V17, pE76, DOI 10.1016/j.ijid.2012.06.006; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Christ-Crain M, 2010, CRIT CARE, V14, DOI 10.1186/cc8155; Fernandez-Serrano S, 2003, CLIN DIAGN LAB IMMUN, V10, P813, DOI 10.1128/CDLI.10.5.813-820.2003; Fischer JE, 2002, INTENS CARE MED, V28, P1324, DOI 10.1007/s00134-002-1423-2; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Group: WMGRS, 2006, WHO CHILD GROWTH STA; Hoshino M, 2001, J ALLERGY CLIN IMMUN, V107, P295, DOI 10.1067/mai.2001.111928; Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC; Ito Y, 2015, AM J PHYSIOL-LUNG C, V308, pL1178, DOI 10.1152/ajplung.00290.2014; IVAC, 2013, PNEUM DIARRH PROGR R; Kim YH, 2011, PEDIATR PULM, V46, P1233, DOI 10.1002/ppul.21496; Knapp S, 2004, J INFECT DIS, V189, P1506, DOI 10.1086/382962; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Martinez R, 2011, EUR RESPIR J, V37, P393, DOI 10.1183/09031936.00040710; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Matsumoto Y, 2012, MICROBIOL IMMUNOL, V56, P651, DOI 10.1111/j.1348-0421.2012.00489.x; Menendez R, 2012, CHEST, V141, P1537, DOI 10.1378/chest.11-1446; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Meuronen A, 2008, RESPIRATION, V75, P450, DOI 10.1159/000114855; Michelow IC, 2007, PEDIATR PULM, V42, P640, DOI 10.1002/ppul.20633; Paats MS, 2013, EUR RESPIR J, V41, P1378, DOI 10.1183/09031936.00060112; PAUKSEN K, 1994, BRIT J HAEMATOL, V88, P256, DOI 10.1111/j.1365-2141.1994.tb05015.x; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Skevaki Chrysanthi L, 2012, Clin Transl Allergy, V2, P14, DOI 10.1186/2045-7022-2-14; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Valentiner-Branth P, 2010, AM J CLIN NUTR, V91, P1667, DOI 10.3945/ajcn.2009.28907; Verbist KC, 2012, CYTOKINE, V59, P467, DOI 10.1016/j.cyto.2012.05.020; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; World Health Organization, 2002, INT MAN CHILDH ILL N; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105; Ygberg S, 2012, ACTA PAEDIATR, V101, P120, DOI 10.1111/j.1651-2227.2011.02494.x	37	21	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138978	10.1371/journal.pone.0138978	http://dx.doi.org/10.1371/journal.pone.0138978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407163	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700135
J	Ono, M; Yamada, K; Avolio, F; Afzal, V; Bensaddek, D; Lamond, AI				Ono, Motoharu; Yamada, Kayo; Avolio, Fabio; Afzal, Vackar; Bensaddek, Dalila; Lamond, Angus I.			Targeted Knock-Down of miR21 Primary Transcripts Using snoMEN Vectors Induces Apoptosis in Human Cancer Cell Lines	PLOS ONE			English	Article							MESSENGER-RNA SURVEILLANCE; NUCLEOLAR PROTEIN; IN-VIVO; MIRNA; MICRORNAS; REVEALS; SNORNA; GENE; IDENTIFICATION; MIR-21	We have previously reported an antisense technology, 'snoMEN vectors', for targeted knock-down of protein coding mRNAs using human snoRNAs manipulated to contain short regions of sequence complementarity with the mRNA target. Here we characterise the use of snoMEN vectors to target the knock-down of micro RNA primary transcripts. We document the specific knock-down of miR21 in HeLa cells using plasmid vectors expressing miR21-targeted snoMEN RNAs and show this induces apoptosis. Knock-down is dependent on the presence of complementary sequences in the snoMEN vector and the induction of apoptosis can be suppressed by over-expression of miR21. Furthermore, we have also developed lentiviral vectors for delivery of snoMEN RNAs and show this increases the efficiency of vector transduction in many human cell lines that are difficult to transfect with plasmid vectors. Transduction of lentiviral vectors expressing snoMEN targeted to pri-miR21 induces apoptosis in human lung adenocarcinoma cells, which express high levels of miR21, but not in human primary cells. We show that snoMEN-mediated suppression of miRNA expression is prevented by siRNA knock-down of Ago2, but not by knock-down of Ago1 or Upf1. snoMEN RNAs colocalise with Ago2 in cell nuclei and nucleoli and can be co-immunoprecipitated from nuclear extracts by antibodies specific for Ago2.	[Ono, Motoharu; Yamada, Kayo; Avolio, Fabio; Afzal, Vackar; Bensaddek, Dalila; Lamond, Angus I.] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland	University of Dundee	Lamond, AI (corresponding author), Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland.	angus@lifesci.dundee.ac.uk		Avolio, Fabio/0000-0003-2067-5315	Wellcome Trust [073980/Z/03/Z]; MRC [G0801738]; Medical Research Council [G0801738] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this research was provided by a Wellcome Trust Programme Grant to A.I.L. (Ref: 073980/Z/03/Z)(http://www.wellcome.ac.uk/) and by an MRC Milstein Award to A.I.L. (Ref: G0801738) (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranat L, 2008, P NATL ACAD SCI USA, V105, P5028, DOI 10.1073/pnas.0710576105; Ahlenstiel CL, 2012, NUCLEIC ACIDS RES, V40, P1579, DOI 10.1093/nar/gkr891; Ahmad Y., 2012, MOL CELL PROTEOMICS, V11, P1, DOI [10.1074/mcp.M111.013680, DOI 10.1074/mcp.M111.013680]; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bai BY, 2014, FEBS OPEN BIO, V4, P441, DOI 10.1016/j.fob.2014.04.010; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Coffin RS, 1996, GENE THER, V3, P560; De Paula D, 2007, RNA, V13, P431, DOI 10.1261/rna.459807; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Jung EJ, 2010, CANCER CELL, V18, P203, DOI 10.1016/j.ccr.2010.08.015; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Liu J, 2012, NUCLEIC ACIDS RES, V40, P1240, DOI 10.1093/nar/gkr780; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Ono M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062305; Ono M, 2011, NUCLEIC ACIDS RES, V39, P3879, DOI 10.1093/nar/gkq1355; Ono M, 2010, MOL BIOL CELL, V21, P1569, DOI 10.1091/mbc.E10-01-0078; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Scherr M, 2007, CELL CYCLE, V6, P444, DOI 10.4161/cc.6.4.3807; Scott MS, 2012, NUCLEIC ACIDS RES, V40, P3676, DOI 10.1093/nar/gkr1233; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002; Yamada K, 2013, MOL CELL, V49, P922, DOI 10.1016/j.molcel.2012.12.023	53	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138668	10.1371/journal.pone.0138668	http://dx.doi.org/10.1371/journal.pone.0138668			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26405811	gold, Green Submitted, Green Published			2022-12-27	WOS:000361800700067
J	Osathanunkul, M; Suwannapoom, C; Ounjai, S; Rora, JA; Madesis, P; de Boer, H				Osathanunkul, Maslin; Suwannapoom, Chatmongkon; Ounjai, Sarawut; Rora, Jantarika A.; Madesis, Panagiotis; de Boer, Hugo			Refining DNA Barcoding Coupled High Resolution Melting for Discrimination of 12 Closely Related Croton Species	PLOS ONE			English	Article							BAR-HRM ANALYSIS; FORENSIC USES; IDENTIFICATION; PLANTS; MICROSATELLITE; PROFILES; PRODUCTS; CURVES; TOOL	DNA barcoding coupled high resolution melting (Bar-HRM) is an emerging method for species discrimination based on DNA dissociation kinetics. The aim of this work was to evaluate the suitability of different primer sets, derived from selected DNA regions, for Bar-HRM analysis of species in Croton (Euphorbiaceae), one of the largest genera of plants with over 1,200 species. Seven primer pairs were evaluated (matK, rbcL1, rbcL2, rbcL3, rpoC, trnL and ITS1) from four plastid regions, matK, rbcL, rpoC, and trnL, and the nuclear ribosomal marker ITS1. The primer pair derived from the ITS1 region was the single most effective region for the identification of the tested species, whereas the rbcL1 primer pair gave the lowest resolution. It was observed that the ITS1 barcode was the most useful DNA barcoding region overall for species discrimination out of all of the regions and primers assessed. Our Bar-HRM results here also provide further support for the hypothesis that both sequence and base composition affect DNA duplex stability.	[Osathanunkul, Maslin; Ounjai, Sarawut; Rora, Jantarika A.] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50200, Thailand; [Suwannapoom, Chatmongkon] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Suwannapoom, Chatmongkon] Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Anim, Kunming 650223, Peoples R China; [Suwannapoom, Chatmongkon] Chiang Mai Univ, Sci & Technol Res Inst, Chiang Mai 50200, Thailand; [Madesis, Panagiotis] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece; [de Boer, Hugo] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, SE-75236 Uppsala, Sweden; [de Boer, Hugo] Univ Oslo, Nat Hist Museum, NO-0318 Oslo, Norway	Chiang Mai University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chiang Mai University; Centre for Research & Technology Hellas; Uppsala University; University of Oslo	Osathanunkul, M (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50200, Thailand.	omaslin@gmail.com	Madesis, Panagiotis/AAL-5980-2020; de Boer, Hugo Joris/AAS-7585-2020	Madesis, Panagiotis/0000-0003-1447-3514; de Boer, Hugo Joris/0000-0003-1985-7859	National Research Council of Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT))	Funding: This work received funding from the National Research Council of Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 2002, J ETHNOPHARMACOL, V79, P313, DOI 10.1016/S0378-8741(01)00392-0; Berry PE, 2005, AM J BOT, V92, P1520, DOI 10.3732/ajb.92.9.1520; Bosmali I, 2012, FOOD RES INT, V46, P141, DOI 10.1016/j.foodres.2011.12.013; Chayamarit K, 2005, FLORA OF THAILAND 1, V8; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; De Boer HJ, DRUG SAF IN PRESS; de Boer HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084291; DEVOE H, 1962, J MOL BIOL, V4, P500; Dey S, 2015, EXP PARASITOL, V151, P84, DOI 10.1016/j.exppara.2015.01.012; Dumousseau M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-101; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; El-Mekkawy S, 2000, PHYTOCHEMISTRY, V53, P457, DOI 10.1016/S0031-9422(99)00556-7; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Ganopoulos I, 2015, BIOCHEM SYST ECOL, V58, P64, DOI 10.1016/j.bse.2014.11.003; Ganopoulos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060945; Ganopoulos I, 2013, J SCI FOOD AGR, V93, P2281, DOI 10.1002/jsfa.6040; Ganopoulos I, 2012, PLANT MOL BIOL REP, V30, P1322, DOI 10.1007/s11105-012-0453-3; Ganopoulos I, 2012, FOOD CHEM, V133, P505, DOI 10.1016/j.foodchem.2012.01.015; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; GOTOH O, 1981, BIOPOLYMERS, V20, P1033, DOI 10.1002/bip.1981.360200513; Govaerts R, 2000, WORLD CHECKLIST BIBL; GRAY DM, 1970, BIOPOLYMERS, V9, P223, DOI 10.1002/bip.1970.360090207; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Kalivas A, 2014, MOL BIOL REP, V41, P5147, DOI 10.1007/s11033-014-3381-5; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li M, 2011, J SYST EVOL, V49, P271, DOI 10.1111/j.1759-6831.2011.00132.x; Madesis P, 2014, FOOD RES INT, V60, P163, DOI 10.1016/j.foodres.2013.10.042; Madesis P, 2013, FOOD RES INT, V50, P351, DOI 10.1016/j.foodres.2012.10.038; Madesis P, 2012, FOOD CONTROL, V25, P576, DOI 10.1016/j.foodcont.2011.11.034; Minh PTH, 2004, FITOTERAPIA, V75, P552, DOI 10.1016/j.fitote.2004.04.009; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Osathanunkul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128476; Ouarghidi A, 2012, ECON BOT, V66, P370, DOI 10.1007/s12231-012-9215-2; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Rates SMK, 2001, TOXICON, V39, P603, DOI 10.1016/S0041-0101(00)00154-9; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; Rinthong PO, 2011, J NAT MED-TOKYO, V65, P641, DOI 10.1007/s11418-011-0536-8; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schmiderer C, 2010, PLANTA MED, V76, P1934, DOI 10.1055/s-0030-1249908; Skalli S, 2002, B SOC PATHOL EXOT, V95, P284; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; SUGIMOTO N, 1994, FEBS LETT, V354, P74, DOI 10.1016/0014-5793(94)01098-6; Sun L, 2014, NAT PROD RES, V28, P563, DOI 10.1080/14786419.2013.867856; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Thongtan J, 2003, J NAT PROD, V66, P868, DOI 10.1021/np030067a; Turner Douglas H, 2009, NUCLEIC ACIDS RES; Veldman S, 2014, NOVEL PLANT BIORESOURCES: APPLICATIONS IN FOOD, MEDICINE AND COSMETICS, P81; WEBSTER GL, 1993, TAXON, V42, P793, DOI 10.2307/1223265; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853	61	28	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138888	10.1371/journal.pone.0138888	http://dx.doi.org/10.1371/journal.pone.0138888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406615	Green Published, gold, Green Submitted			2022-12-27	WOS:000361800700111
J	Schmidt-Burbach, J; Ronfot, D; Srisangiam, R				Schmidt-Burbach, Jan; Ronfot, Delphine; Srisangiam, Rossukon			Asian Elephant (Elephas maximus), Pig-Tailed Macaque (Macaca nemestrina) and Tiger (Panthera tigris) Populations at Tourism Venues in Thailand and Aspects of Their Welfare	PLOS ONE			English	Article								This study focused on determining the size and welfare aspects of Asian elephant, pig-tailed macaque and tiger populations at facilities open to tourists in Thailand. Data were gathered from 118 venues through direct observations and interviews with staff. A score sheet-based welfare assessment was used to calculate scores between 1 and 10, indicating each venue's welfare situation. Factors such as freedom of movement for the animals, access to veterinary care, environmental noise quality, hygiene standards and work intensity were included in the score sheet. 1688 elephants, 371 macaques and 621 tigers were found at the venues. 89 venues exclusively kept elephants, 9 designated 'Monkey schools' offered macaque shows, 4 venues kept primarily tigers, mostly for petting and photo opportunities, and the remaining venues kept a mix of these animals. A strong imbalance in female to male gender ratios was recorded with about 4: 1 for adult elephants and 1: 4 for adult macaques. Severely inadequate welfare conditions were common, with 75% of macaques and 99% of tigers being kept at venues with scores less than 5. 86% of elephants were kept in inadequate conditions at venues with scores between 3 and 5, but a significant number of venues with scores above 5 were found. 4.6% of elephants were provided commendable conditions, reaching assessment scores of 8 and above. 71% of venues did not offer any sort of education about animals to visitors. This study is the first to assess welfare aspects of captive wild animals at tourism venues across Thailand. It concludes that significant concerns exist about the welfare of wild animals in the tourism sector of Thailand. Urgent attention needs to be given to address these concerns and prevent further suffering. But also to ensure the demand for wild animals doesn't have a negative impact on wild populations.	[Schmidt-Burbach, Jan; Srisangiam, Rossukon] World Anim Protect, Thailand Off, Bangkok, Thailand; [Ronfot, Delphine] Univ Exeter, Exeter, Devon, England	University of Exeter	Schmidt-Burbach, J (corresponding author), World Anim Protect, Thailand Off, Bangkok, Thailand.	janschmidt-burbach@worldanimalprotection.org			Intrepid Foundation	Intrepid Foundation	This study's operational expenses were provided by the Intrepid Foundation (www.theintrepidfoundation.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott B, 2011, ECOL ECON, V70, P721, DOI 10.1016/j.ecolecon.2010.11.006; Agoramoorthy Govindasamy, 2005, J Appl Anim Welf Sci, V8, P141, DOI 10.1207/s15327604jaws0802_6; Ammann K, 2014, NATL GEOGRAPHIC 0415; [Anonymous], 2012, ABC NEWS; ASEAN Centre for Biodiversity, 2013, 2013 ANN REP; Association of Southeast Asian Nations-Wildlife Enforcement Network, 2011, INTR INT WILDL TRAD; Baker S, 2006, WILDLIFE TRADE E SE; Banks D, 2001, THAILANDS TIGER EC; Blokhuis H, WELF QUAL ASS PROT; Botreau IV R, 2007, ANIM WELFARE, V16, P2; Bulte EH, 2005, CONSERV BIOL, V19, P1222, DOI 10.1111/j.1523-1739.2005.00149.x; Care for the Wild, 2008, EXPL THE TIG; Carlstead K, 2000, BIOLOGY OF ANIMAL STRESS, P337, DOI 10.1079/9780851993591.0337; Chatkupt Thomas T., 1999, Journal of Applied Animal Welfare Science, V2, P187, DOI 10.1207/s15327604jaws0203_2; CLUTTONBROCK J, 1992, MAMMAL REV, V22, P79, DOI 10.1111/j.1365-2907.1992.tb00122.x; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Driscolla CA, 2009, PNAS, V106, P1; Eudey Ardith A., 2008, Primate Conservation, V23, P129, DOI 10.1896/052.023.0115; Fernando Prithiviraj, 2011, Gajah, V35, P15; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Godfrey A., 2009, GAJAH, V30, P13; Kleiman D.G., 2010, WILD MAMMALS CAPTIVI, P217; Kontogeorgopoulos N, 2009, J TOURISM, V10; Lair R.C., 1997, GONE ASTRAY CARE MAN; Lincoln GA, 1996, J REPROD FERTIL, V108, P107, DOI 10.1530/jrf.0.1080107; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Nijman V., 2014, ASSESSMENT LIVE ELEP; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; Rees PA, 2009, J APPL ANIM WELF SCI, V12, P44, DOI 10.1080/10888700802536699; RICHARD AF, 1989, INT J PRIMATOL, V10, P569, DOI 10.1007/BF02739365; Roots Clive, 2007, DOMESTICATION; Russell N, 2002, SOC ANIM, V10, P285, DOI 10.1163/156853002320770083; Sakamoto M, 2004, THAI ELEPHANT TRADE; Shepherd C. R., 2008, ELEPHANT IVORY TRADE; Stiles D., 2009, ELEPHANT IVORY TRADE; Sukumar R., 1993, ASIAN ELEPHANT ECOLO; Thailand Department of Tourism, 2011, TOUR ARR THAIL 2011; Thailand Elephant Conservation Center, 2012, THAIL EL; Webster J, 2005, REV SCI TECH OIE, V24, P723, DOI 10.20506/rst.24.2.1602	39	34	34	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139092	10.1371/journal.pone.0139092	http://dx.doi.org/10.1371/journal.pone.0139092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407173	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700165
J	Seo, MY; Jang, W; Rhee, K				Seo, Mi Young; Jang, Wonyul; Rhee, Kunsoo			Integrity of the Pericentriolar Material Is Essential for Maintaining Centriole Association during M Phase	PLOS ONE			English	Article							CENTROSOME REPLICATION; CHROMATID SEPARATION; DUPLICATION; CELLS; CLEAVAGE; CYCLE; DISENGAGEMENT; INHIBITOR; COHESION; NUMBERS	A procentriole is assembled next to the mother centriole during S phase and remains associated until M phase. After functioning as a spindle pole during mitosis, the mother centriole and procentriole are separated at the end of mitosis. A close association of the centriole pair is regarded as an intrinsic block to the centriole reduplication. Therefore, deregulation of this process may cause a problem in the centriole number control, resulting in increased genomic instability. Despite its importance for faithful centriole duplication, the mechanism of centriole separation is not fully understood yet. Here, we report that centriole pairs are prematurely separated in cells whose cell cycle is arrested at M phase by STLC. Dispersal of the pericentriolar material (PCM) was accompanied. This phenomenon was independent of the separase activity but needed the PLK1 activity. Nocodazole effectively inhibited centriole scattering in STLC-treated cells, possibly by reducing the microtubule pulling force around centrosomes. Inhibition of PLK1 also reduced the premature separation of centrioles and the PCM dispersal as well. These results revealed the importance of PCM integrity in centriole association. Therefore, we propose that PCM disassembly is one of the driving forces for centriole separation during mitotic exit.	[Seo, Mi Young; Jang, Wonyul; Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea	Seoul National University (SNU)	Rhee, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	rheek@snu.ac.kr		Seo, Mi Young/0000-0002-6772-8077; Jang, Wonyul/0000-0003-0352-3862	Basic Research Laboratory [NRF-2014R1A4A1005259]; Marine Biotechnology Program [PJT200620]	Basic Research Laboratory; Marine Biotechnology Program	Funding: This study was supported by grants from the Basic Research Laboratory (NRF-2014R1A4A1005259) and Marine Biotechnology Program (PJT200620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Cabral G, 2013, CURR BIOL, V23, P1380, DOI 10.1016/j.cub.2013.06.043; Chang J, 2010, EMBO J, V29, P2395, DOI 10.1038/emboj.2010.118; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Keryer G, 1984, J CELL SCI, V76, P35; Kim K, 2011, J CELL SCI, V124, P338, DOI 10.1242/jcs.078329; Kim K, 2008, EXP CELL RES, V314, P3692, DOI 10.1016/j.yexcr.2008.09.016; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Kuriyama R, 2007, J CELL SCI, V120, P2444, DOI 10.1242/jcs.008938; Lee K, 2012, CELL CYCLE, V11, P2476, DOI 10.4161/cc.20878; Lee S, 2010, CELL CYCLE, V9, P775, DOI 10.4161/cc.9.4.10667; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Maiato H, 2014, NAT CELL BIOL, V16, P386, DOI 10.1038/ncb2958; Mardin BR, 2012, J CELL BIOL, V197, P11, DOI 10.1083/jcb.201108006; Matsuo K, 2012, CURR BIOL, V22, P915, DOI 10.1016/j.cub.2012.03.048; MAZIA D, 1960, J BIOPHYS BIOCHEM CY, V7, P1, DOI 10.1083/jcb.7.1.1; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Oliveira RA, 2013, CURR BIOL, V23, pR601, DOI 10.1016/j.cub.2013.04.003; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Prosser SL, 2012, J CELL SCI, V125, P5353, DOI 10.1242/jcs.106096; Schockel L, 2011, NAT CELL BIOL, V13, P966, DOI 10.1038/ncb2280; SELLITTO C, 1988, J CELL SCI, V89, P57; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sluder G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0455; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Woodruff JB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0459; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	37	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138905	10.1371/journal.pone.0138905	http://dx.doi.org/10.1371/journal.pone.0138905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407333	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700116
J	Wang, AL; Liu, L; Peng, YC; Islam, S; Applebee, M; Appels, R; Yan, YM; Ma, WJ				Wang, Aili; Liu, Li; Peng, Yanchun; Islam, Shahidul; Applebee, Marie; Appels, Rudi; Yan, Yueming; Ma, Wujun			Identification of Low Molecular Weight Glutenin Alleles by Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF-MS) in Common Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							SDS-PAGE; DOUGH PROPERTIES; LMW SUBUNITS; BREAD WHEAT; PAN BREAD; HMW; LANDRACES; GENETICS	Low molecular weight glutenin subunits (LMW-GS) play an important role in determining dough properties and breadmaking quality. However, resolution of the currently used methodologies for analyzing LMW-GS is rather low which prevents an efficient use of genetic variations associated with these alleles in wheat breeding. The aim of the current study is to evaluate and develop a rapid, simple, and accurate method to differentiate LMW-GS alleles using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. A set of standard single LMW-GS allele lines as well as a suite of well documented wheat cultivars were collected from France, CIMMYT, and Canada. Method development and optimization were focused on protein extraction procedures and MALDI-TOF instrument settings to generate reproducible diagnostic spectrum peak profiles for each of the known wheat LMW-GS allele. Results revealed a total of 48 unique allele combinations among the studied genotypes. Characteristic MALDI-TOF peak patterns were obtained for 17 common LMW-GS alleles, including 5 (b, a or c, d, e, f), 7 (a, b, c, d or i, f, g, h) and 5 (a, b, c, d, f) patterns or alleles for the Glu-A3, Glu-B3, and Glu-D3 loci, respectively. In addition, some reproducible MALDI-TOF peak patterns were also obtained that did not match with any known alleles. The results demonstrated a high resolution and throughput nature of MALDI-TOF technology in analyzing LMW-GS alleles, which is suitable for application in wheat breeding programs in processing a large number of wheat lines with high accuracy in limited time. It also suggested that the variation of LMW-GS alleles is more abundant than what has been defined by the current nomenclature system that is mainly based on SDS-PAGE system. The MALDI-TOF technology is useful to differentiate these variations. An international joint effort may be needed to assign allele symbols to these newly identified alleles and determine their effects on end-product quality attributes.	[Wang, Aili; Liu, Li; Peng, Yanchun; Islam, Shahidul; Appels, Rudi; Ma, Wujun] Murdoch Univ, AEGIC, Sch Vet & Life Sci, State Agr Biotechnol Ctr, Perth, WA 6150, Australia; [Wang, Aili; Yan, Yueming] Capital Normal Univ, Coll Life Sci, Key Lab Genet & Biotechnol, Beijing 100037, Peoples R China; [Liu, Li] Chinese Acad Agr Sci, Inst Crop Sci, Natl Wheat Improvement Ctr, Beijing 100081, Peoples R China; [Peng, Yanchun] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Applebee, Marie] South Australian Res & Dev Inst, Urrbrae, SA 5064, Australia	Murdoch University; Capital Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Huazhong Agricultural University; South Australian Research & Development Institute (SARDI)	Ma, WJ (corresponding author), Murdoch Univ, AEGIC, Sch Vet & Life Sci, State Agr Biotechnol Ctr, Perth, WA 6150, Australia.	w.ma@murdoch.edu.au	Ma, Wujun/F-5957-2010	Ma, Wujun/0000-0002-1264-866X; Islam, Shahidul/0000-0001-5994-0521	Australian Grain Research & Development Corporation [UMU00028]	Australian Grain Research & Development Corporation(Grains R&D Corp)	This work is financially funded by Australian Grain Research & Development Corporation project: UMU00028. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbee MJ, 2009, J CEREAL SCI, V49, P254, DOI 10.1016/j.jcs.2008.10.011; BIETZ JA, 1975, CEREAL CHEM, V52, P513; Branlard G, 2003, GENET RESOUR CROP EV, V50, P669, DOI 10.1023/A:1025077005401; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; GUPTA RB, 1990, THEOR APPL GENET, V80, P65, DOI 10.1007/BF00224017; He ZH, 2005, CEREAL CHEM, V82, P345, DOI 10.1094/CC-82-0345; Ikeda TM, 2014, INT GLUT WORKSH 11 P, P96; JACKSON EA, 1983, THEOR APPL GENET, V66, P29, DOI 10.1007/BF00281844; Kussmann M, 1997, J MASS SPECTROM, V32, P593; Lan QX, 2013, GENET RESOUR CROP EV, V60, P799, DOI 10.1007/s10722-012-9877-8; Liu L, 2009, CEREAL RES COMMUN, V37, P57, DOI 10.1556/CRC.37.2009.1.7; Liu L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-124; Liu L, 2009, J CEREAL SCI, V50, P295, DOI 10.1016/j.jcs.2009.05.006; Ma W, 2005, THEOR APPL GENET, V111, P410, DOI 10.1007/s00122-005-2001-0; MARGIOTTA B, 1993, J CEREAL SCI, V17, P221, DOI 10.1006/jcrs.1993.1021; MELAS V, 1994, CEREAL CHEM, V71, P234; Muccilli V, 2005, PROTEOMICS, V5, P719, DOI 10.1002/pmic.200401029; Nagamine T, 2000, J CEREAL SCI, V32, P129, DOI 10.1006/jcrs.2000.0323; NG PKW, 1987, CEREAL CHEM, V64, P324; PAYNE PI, 1984, PHILOS T R SOC B, V304, P359, DOI 10.1098/rstb.1984.0031; SINGH NK, 1991, J CEREAL SCI, V14, P203, DOI 10.1016/S0733-5210(09)80039-8; Skeritt J. H., 1998, AGBIOTECH NEWS INFOR, V10, P247; TATHAM AS, 1991, J CEREAL SCI, V14, P111, DOI 10.1016/S0733-5210(09)80131-8; Wieser H, 1998, CEREAL CHEM, V75, P644, DOI 10.1094/CCHEM.1998.75.5.644; Wrigley C.W., 2006, GLUTEN COMPOSITION W; Zhang XF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-243; Zhang XF, 2011, THEOR APPL GENET, V122, P1503, DOI 10.1007/s00122-011-1550-7; Zheng W, 2011, J CEREAL SCI, V54, P401, DOI 10.1016/j.jcs.2011.08.004	28	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138981	10.1371/journal.pone.0138981	http://dx.doi.org/10.1371/journal.pone.0138981			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26407296	Green Submitted, Green Published, gold			2022-12-27	WOS:000361800700136
J	Zhu, Z; Pan, GX; Zhou, SJ; Dai, JJ; Chen, X; Tang, JH; Chen, SP; Zheng, YL; Song, J; Xu, WB				Zhu, Zhen; Pan, Guixia; Zhou, Shujie; Dai, Jingjing; Chen, Xia; Tang, Jihai; Chen, Shuping; Zheng, Yilun; Song, Jie; Xu, Wenbo			Imported Genotype 2B Rubella Virus Caused the 2012 Outbreak in Anqing City, China	PLOS ONE			English	Article							1E	A rubella outbreak occurred in Anqing city of Anhui province, China, from February to July of 2012, and a total of 241 clinically diagnosed or lab-confirmed patients were reported. The highest number of rubella cases during this outbreak was recorded in teenagers between 10 and 19 years of age who had not previously received the rubella vaccine. Genotyping results indicated that the genotype 2B rubella virus (RV) was responsible for the outbreak. However, a phylogenetic analysis showed that the genotype 2B RVs isolated in Anqing City were not related to 2B RVs found in other cities of Anhui province and in other provinces of China, thus providing evidence for importation. After importation, the transmission of Anqing RVs was interrupted owing to an effective immunization campaign against rubella, suggesting the timeliness and effectiveness of contingency vaccination. Strengthening rubella surveillance, including the integration of epidemiologic information and laboratory data, is a vital strategy for rubella control and elimination. In addition, except for routine immunization, targeted supplementary immunization activities aimed at susceptible groups according to sero-epidemiological surveillance data also play a key role in stopping the continuous transmission of rubella viruses and in preventing further congenital rubella syndrome cases.	[Zhu, Zhen; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Rubella Lab, Minist Hlth, Beijing, Peoples R China; [Zhu, Zhen; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China; [Pan, Guixia; Chen, Shuping; Zheng, Yilun] Anqing Prefecture Ctr Dis Control & Prevent, Anqing, Peoples R China; [Zhou, Shujie; Chen, Xia; Tang, Jihai] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Dai, Jingjing] Anhui Univ Sci & Technol, Sch Med, Huainan, Peoples R China; [Song, Jie] Jilin Univ, Hosp 2, Changchun 130023, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Anhui University of Science & Technology; Jilin University	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Reference Measles Rubella Lab, Minist Hlth, Beijing, Peoples R China.	chenjing_fuchanke@163.com; wenbo_xu1@aliyun.com		dai, jingjing/0000-0001-8337-7281	National Natural Science Foundation of China [81101244]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003, 2012ZX10004215]; National Science and Technology Major Project for Creation of Major New Drugs [2013ZX09304101]; WHO Measles Regional Reference Laboratory [WPCHN1002802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of National Ministry of Science; National Science and Technology Major Project for Creation of Major New Drugs; WHO Measles Regional Reference Laboratory	This work was supported by the National Natural Science Foundation of China (project no. 81101244), Key Technologies R&D Program of National Ministry of Science (2013ZX10004-202, 2012ZX10004201-003, and 2012ZX10004215), National Science and Technology Major Project for Creation of Major New Drugs (2013ZX09304101), and WHO Measles Regional Reference Laboratory funding (WPCHN1002802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy E, 2009, J CLIN MICROBIOL, V47, P182, DOI 10.1128/JCM.01231-08; Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P337; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P126; [Anonymous], 2011, EURO SURVEILL; Chen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-122; D'Agaro P, 2010, J MED VIROL, V82, P1976, DOI 10.1002/jmv.21874; Featherstone DA, 2011, J INFECT DIS, V204, pS491, DOI 10.1093/infdis/jir107; Figueiredo CA, 2012, J MED VIROL, V84, P1666, DOI 10.1002/jmv.23382; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0; Messedi E, 2014, J CLIN VIROL, V61, P248, DOI 10.1016/j.jcv.2014.07.003; Miyoshi M, 2014, JPN J INFECT DIS, V67, P479, DOI 10.7883/yoken.67.479; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tucker JD, 2014, LANCET, V383, P1460, DOI 10.1016/S0140-6736(14)60712-1; Wang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042013; Zhu Z, 2007, J CLIN MICROBIOL, V45, P2847, DOI 10.1128/JCM.00289-07; Zhu Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep07999; Zhu Z, 2014, J MED VIROL, V86, P2114, DOI 10.1002/jmv.23936; Zhu Z, 2012, J CLIN MICROBIOL, V50, P353, DOI 10.1128/JCM.01264-11; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	22	3	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2015	10	9							e0139173	10.1371/journal.pone.0139173	http://dx.doi.org/10.1371/journal.pone.0139173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1BS	26402467	Green Published, Green Submitted, gold			2022-12-27	WOS:000361798100063
J	Xi, JX; Zhao, WZ; Yuan, JE; Kim, J; Si, XH; Xu, XW				Xi, Jinxiang; Zhao, Weizhong; Yuan, Jiayao Eddie; Kim, JongWon; Si, Xiuhua; Xu, Xiaowei			Detecting Lung Diseases from Exhaled Aerosols: Non-Invasive Lung Diagnosis Using Fractal Analysis and SVM Classification	PLOS ONE			English	Article							UPPER TRACHEOBRONCHIAL AIRWAYS; BREATH CONDENSATE; OXIDATIVE STRESS; BRONCHIAL TREE; IMAGE-ANALYSIS; DEPOSITION; CANCER; MODEL; NANOPARTICLE; PARTICLES	Background Each lung structure exhales a unique pattern of aerosols, which can be used to detect and monitor lung diseases non-invasively. The challenges are accurately interpreting the exhaled aerosol fingerprints and quantitatively correlating them to the lung diseases. Objective and Methods In this study, we presented a paradigm of an exhaled aerosol test that addresses the above two challenges and is promising to detect the site and severity of lung diseases. This paradigm consists of two steps: image feature extraction using sub-regional fractal analysis and data classification using a support vector machine (SVM). Numerical experiments were conducted to evaluate the feasibility of the breath test in four asthmatic lung models. A highfidelity image-CFD approach was employed to compute the exhaled aerosol patterns under different disease conditions. Findings By employing the 10-fold cross-validation method, we achieved 100% classification accuracy among four asthmatic models using an ideal 108-sample dataset and 99.1% accuracy using a more realistic 324-sample dataset. The fractal-SVM classifier has been shown to be robust, highly sensitive to structural variations, and inherently suitable for investigating aerosol-disease correlations. Conclusion For the first time, this study quantitatively linked the exhaled aerosol patterns with their underlying diseases and set the stage for the development of a computer-aided diagnostic system for non-invasive detection of obstructive respiratory diseases.	[Xi, Jinxiang; Yuan, Jiayao Eddie] Cent Michigan Univ, Sch Engn & Technol, Mt Pleasant, MI 48859 USA; [Zhao, Weizhong] Xiangtan Univ, Coll Informat Engn, Xiangtan, Hunan, Peoples R China; [Zhao, Weizhong] Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA; [Kim, JongWon] Univ Georgia, Coll Engn, Athens, GA 30602 USA; [Si, Xiuhua] Calif Baptist Univ, Dept Mech Engn, Riverside, CA USA; [Xu, Xiaowei] Univ Arkansas, Dept Informat Sci, Little Rock, AR 72204 USA	Central Michigan University; Xiangtan University; US Food & Drug Administration (FDA); University System of Georgia; University of Georgia; California Baptist University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Xi, JX (corresponding author), Cent Michigan Univ, Sch Engn & Technol, Mt Pleasant, MI 48859 USA.	xi1j@cmich.edu	Xi, Jinxiang/Y-1161-2019		Central Michigan University Early Career Grant [P62242]	Central Michigan University Early Career Grant	Jinxiang Xi was supported by the Central Michigan University Early Career Grant P62242 [https://www.cmich.edu/office_provost/ORSP/Pages/default.aspx]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MD, 1985, AEROSOL SCI TECH, V4, P269, DOI 10.1080/02786828508959055; ANDERSON PJ, 1994, J AEROSOL MED, V7, P77, DOI 10.1089/jam.1994.7.77; Blanchard JD, 1996, J AEROSOL MED, V9, P183, DOI 10.1089/jam.1996.9.183; Boser SR, 2005, AM J RESP CRIT CARE, V172, P817, DOI 10.1164/rccm.200411-1463OC; Canals M, 2000, BIOL RES, V33, P31; Chan HP, 2009, J THORAC ONCOL, V4, P172, DOI 10.1097/JTO.0b013e3181949eb9; Chan HP, 2009, LUNG CANCER, V63, P164, DOI 10.1016/j.lungcan.2008.05.020; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Di Natale C, 2003, BIOSENS BIOELECTRON, V18, P1209, DOI 10.1016/S0956-5663(03)00086-1; Einstein AJ, 1998, J PATHOL, V185, P366; HORSFILED K, 1990, Journal of Applied Physiology, V68, P457; Karperien A, 2013, FRACTAL DIMENSION LA; Kim JW, 2013, INT J NUMER METH BIO, V29, P17, DOI 10.1002/cnm.2490; Kostikas K, 2008, CLIN EXP ALLERGY, V38, P557, DOI 10.1111/j.1365-2222.2008.02940.x; Kostikas K, 2003, CHEST, V124, P1373, DOI 10.1378/chest.124.4.1373; Loukides S, 2011, CURR DRUG TARGETS, V12, P469, DOI 10.2174/138945011794751573; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023; MORSI SA, 1972, J FLUID MECH, V55, P193, DOI 10.1017/S0022112072001806; Mutlu GM, 2001, AM J RESP CRIT CARE, V164, P731, DOI 10.1164/ajrccm.164.5.2101032; Nicoud F, 1999, FLOW TURBUL COMBUST, V62, P183, DOI 10.1023/A:1009995426001; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; SERNETZ M, 1992, PHYSICA A, V191, P13, DOI 10.1016/0378-4371(92)90498-F; Si XHA, 2013, RESP PHYSIOL NEUROBI, V186, P22, DOI 10.1016/j.resp.2012.12.005; Tabesh A, 2007, IEEE T MED IMAGING, V26, P1366, DOI 10.1109/TMI.2007.898536; Vapnik V., 2013, NATURE STAT LAERNING; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; WILSON TA, 1967, NATURE, V213, P668, DOI 10.1038/213668a0; Longest PW, 2007, AEROSOL SCI TECH, V41, P380, DOI 10.1080/02786820701203223; Xi JX, 2008, ANN BIOMED ENG, V36, P1714, DOI 10.1007/s10439-008-9552-6; Xi JX, 2008, J APPL PHYSIOL, V104, P1761, DOI 10.1152/japplphysiol.01233.2007; Xi JX, 2007, ANN BIOMED ENG, V35, P560, DOI 10.1007/s10439-006-9245-y; Xi JX, 2015, THERANOSTICS, V5, P443, DOI 10.7150/thno.11107; Xi JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104682; Xi JX, 2014, INHAL TOXICOL, V26, P492, DOI 10.3109/08958378.2014.925992; Xi JX, 2013, J AEROSOL SCI, V64, P24, DOI 10.1016/j.jaerosci.2013.06.003	37	13	13	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139511	10.1371/journal.pone.0139511	http://dx.doi.org/10.1371/journal.pone.0139511			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422016	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700125
J	Moraes, J; Krawczak, FS; Costa, FB; Soares, JF; Labruna, MB				Moraes-Filho, Jonas; Krawczak, Felipe S.; Costa, Francisco B.; Soares, Joao Fabio; Labruna, Marcelo B.			Comparative Evaluation of the Vector Competence of Four South American Populations of the Rhipicephalus sanguineus Group for the Bacterium Ehrlichia canis, the Agent of Canine Monocytic Ehrlichiosis	PLOS ONE			English	Article							BROWN DOG TICK; POLYMERASE-CHAIN-REACTION; ANAPLASMA-PLATYS; ACARI IXODIDAE; MOLECULAR CHARACTERIZATION; RICKETTSIA-MASSILIAE; GENETIC DIVERSITY; SENSU-LATO; INFECTION; PREVALENCE	This study compared the vector competence of four populations of Rhipicephalus sanguineus group ticks for the bacterium Ehrlichia canis, the agent of canine monocytic ehrlichiosis (CME). Ticks (larvae and nymphs) from the four populations-one from Sao Paulo state, southeastern Brazil (BSP), one from Rio Grande do Sul state, southern Brazil (BRS), one from Argentina (ARG), and one from Uruguay (URU)-were exposed to E. canis infection by feeding on dogs that were experimentally infected with E. canis. Engorged ticks (larvae and nymphs) were allowed to molt to nymphs and adults, respectively, which were tested by molecular analysis (E. canis-specific PCR assay) and used to infest naive dogs. Through infestation of adult ticks on naive dogs, after nymphal acquisition feeding on E. canis-infected dogs, only the BSP population was shown to be competent vectors of E. canis, i.e., only the dogs infested with BSP adult ticks developed clinical illness, seroconverted to E. canis, and yielded E. canis DNA by PCR. This result, demonstrated by two independent replications, is congruent with epidemiological data, since BSP ticks were derived from Sao Paulo state, Brazil, where CME is highly endemic. On the other hand, BRS, ARG, and URU ticks were derived from a geographical region (South America southern cone) where CME has never been properly documented. Molecular analysis of unfed adults at 30 days post molting support these transmission results, since none of the BRS, ARG, and URU ticks were PCR positive, whereas 1% of the BSP nymphs and 31.8% of the BSP adults contained E. canis DNA. We conclude that the absence or scarcity of cases of CME due to E. canis in the South America southern cone is a result of vector incompetence of the R. sanguineus group ticks that prevail on dogs in this part of South America.	[Moraes-Filho, Jonas; Krawczak, Felipe S.; Costa, Francisco B.; Labruna, Marcelo B.] Univ Sao Paulo, Fac Vet Med, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, SP, Brazil; [Soares, Joao Fabio] Univ Cruz Alta UNICRUZ, Cruz Alta, RS, Brazil	Universidade de Sao Paulo; Universidade de Cruz Alta	Labruna, MB (corresponding author), Univ Sao Paulo, Fac Vet Med, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, SP, Brazil.	labruna@usp.br	da Silva Krawczak, Felipe/AAX-9687-2020; Labruna, Marcelo B/B-6241-2013	da Silva Krawczak, Felipe/0000-0002-3817-225X; Labruna, Marcelo B/0000-0002-9675-3132	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/51002-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302832/2007-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [23038.005275/2011-79]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant 2010/51002-5 to JM-F), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Grant 302832/2007-6 to MBL), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Grant 23038.005275/2011-79 to MBL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar DM, 2013, VET MICROBIOL, V164, P315, DOI 10.1016/j.vetmic.2013.02.015; Aguiar DM, 2008, BRAZ J MICROBIOL, V39, P489, DOI [10.1590/S1517-83822008000300014, 10.1590/S1517-838220080003000014]; Aguiar DM, 2007, J MED ENTOMOL, V44, P126, DOI 10.1603/0022-2585(2007)44[126:POECRA]2.0.CO;2; Aguiar Daniel Moura, 2007, Cienc. Rural, V37, P796, DOI 10.1590/S0103-84782007000300030; Bremer WG, 2005, VET PARASITOL, V131, P95, DOI 10.1016/j.vetpar.2005.04.030; Burlini L, 2010, EXP APPL ACAROL, V50, P361, DOI 10.1007/s10493-009-9321-8; Cicuttin GL, 2014, REV CHIL INFECTOL, V31, P563, DOI 10.4067/S0716-10182014000500008; Cicuttin GL, 2014, TICKS TICK-BORNE DIS, V5, P484, DOI 10.1016/j.ttbdis.2014.03.001; Costa LM, 2007, VET J, V174, P673, DOI 10.1016/j.tvjl.2006.11.002; da Costa AP, 2015, REV BRAS PARASITOL V, V24, P28, DOI 10.1590/S1984-29612015008; Vieira RFD, 2011, REV BRAS PARASITOL V, V20, P1, DOI 10.1590/S1984-29612011000100002; Dantas-Torres F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-213; de Castro MB, 2004, VET PARASITOL, V119, P73, DOI 10.1016/j.vetpar.2003.10.012; Diniz PPVDP, 2007, VECTOR-BORNE ZOONOT, V7, P689, DOI 10.1089/vbz.2007.0129; Doyle CK, 2005, J MOL DIAGN, V7, P504, DOI 10.1016/S1525-1578(10)60581-8; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Evans DE, 2000, MEM I OSWALDO CRUZ, V95, P453, DOI 10.1590/S0074-02762000000400003; Eiras DF, 2013, COMP IMMUNOL MICROB, V36, P169, DOI 10.1016/j.cimid.2012.11.008; dos Santos LGF, 2013, REV BRAS PARASITOL V, V22, P114, DOI 10.1590/S1984-29612013005000013; GROVES MG, 1975, AM J VET RES, V36, P937; Harrus S, 2011, VET J, V187, P292, DOI 10.1016/j.tvjl.2010.02.001; Nakaghi ACH, 2008, CIENC RURAL, V38, P766, DOI 10.1590/S0103-84782008000300027; Krawczak FD, 2012, REV BRAS PARASITOL V, V21, P415, DOI 10.1590/S1984-29612012005000001; Labarthe N, 2003, VET THER, V4, P67; Lasta CS, 2013, REV BRAS PARASITOL V, V22, P360, DOI 10.1590/S1984-29612013000300007; Levin ML, 2012, EXP APPL ACAROL, V58, P51, DOI 10.1007/s10493-012-9561-x; LEWIS GE, 1977, AM J VET RES, V38, P1953; Liu GH, 2013, INT J BIOL SCI, V9, P361, DOI 10.7150/ijbs.6081; de Sousa KCM, 2013, REV BRAS PARASITOL V, V22, P525, DOI 10.1590/S1984-29612013000400012; Mathew JS, 1996, AM J VET RES, V57, P1594; McBride JW, 2001, J CLIN MICROBIOL, V39, P315, DOI 10.1128/JCM.39.1.315-322.2001; McClure JC, 2010, ANTIMICROB AGENTS CH, V54, P5012, DOI 10.1128/AAC.01622-09; Melo ALT, 2011, TICKS TICK-BORNE DIS, V2, P213, DOI 10.1016/j.ttbdis.2011.09.007; Moraes J, 2011, ACTA TROP, V117, P51, DOI 10.1016/j.actatropica.2010.09.006; Nava S, 2015, VET PARASITOL, V208, P2, DOI 10.1016/j.vetpar.2014.12.021; Nava S, 2012, VET PARASITOL, V190, P547, DOI 10.1016/j.vetpar.2012.06.032; Neer TM, 2002, J VET INTERN MED, V16, P309, DOI 10.1892/0891-6640(2002)016<0309:CSOEDO>2.3.CO;2; OLIVEIRA PR, 2005, VET PARASITOL, V129, P139, DOI DOI 10.1016/J.VETPAR.2005.01.001; Souza BMPD, 2010, REV BRAS PARASITOL V, V19, P89; Pat-Nah H, 2015, J MED ENTOMOL, V52, P101, DOI 10.1093/jme/tju010; PEGRAM RG, 1987, SYST PARASITOL, V10, P27, DOI 10.1007/BF00009100; Pinter A, 2002, VET PARASITOL, V105, P79, DOI 10.1016/S0304-4017(01)00650-1; Piranda EM, 2011, VECTOR-BORNE ZOONOT, V11, P29, DOI 10.1089/vbz.2009.0250; Ribeiro V. L. S., 1997, Ciencia Rural, V27, P285, DOI 10.1590/S0103-84781997000200019; Romero LE, 2011, RES VET SCI, V91, P95, DOI 10.1016/j.rvsc.2010.07.021; Saito TB, 2008, AM J TROP MED HYG, V79, P102, DOI 10.4269/ajtmh.2008.79.102; Sangioni LA, 2005, EMERG INFECT DIS, V11, P265, DOI 10.3201/eid1102.040656; Santamaria A, 2014, VECTOR-BORNE ZOONOT, V14, P368, DOI 10.1089/vbz.2013.1488; Scott MC, 2012, J MED ENTOMOL, V49, P697, DOI 10.1603/ME11162; Spolidorio MG, 2010, AM J TROP MED HYG, V83, P201, DOI 10.4269/ajtmh.2010.09-0595; Szabo MPJ, 2005, VET PARASITOL, V130, P131, DOI 10.1016/j.vetpar.2005.03.008; Tanikawa A, 2013, RES VET SCI, V94, P474, DOI 10.1016/j.rvsc.2012.10.007; Unver A, 2001, J CLIN MICROBIOL, V39, P2788, DOI 10.1128/JCM.39.8.2788-2793.2001; Vargas-Hernandez G, 2012, VET PARASITOL, V186, P254, DOI 10.1016/j.vetpar.2011.11.011; Venzal J. M., 2007, Parasitologia Latinoamericana, V62, P23; Walker J.B., 2000, TROP ANIM HEALTH PRO	56	83	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0139386	10.1371/journal.pone.0139386	http://dx.doi.org/10.1371/journal.pone.0139386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414283	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700055
J	Shara, N; Yassin, SA; Valaitis, E; Wang, H; Howard, BV; Wang, WY; Lee, ET; Umans, JG				Shara, Nawar; Yassin, Sayf A.; Valaitis, Eduardas; Wang, Hong; Howard, Barbara V.; Wang, Wenyu; Lee, Elisa T.; Umans, Jason G.			Randomly and Non-Randomly Missing Renal Function Data in the Strong Heart Study: A Comparison of Imputation Methods	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; AMERICAN-INDIANS; RISK-FACTORS; CORONARY; CREATININE	Kidney and cardiovascular disease are widespread among populations with high prevalence of diabetes, such as American Indians participating in the Strong Heart Study (SHS). Studying these conditions simultaneously in longitudinal studies is challenging, because the morbidity and mortality associated with these diseases result in missing data, and these data are likely not missing at random. When such data are merely excluded, study findings may be compromised. In this article, a subset of 2264 participants with complete renal function data from Strong Heart Exams 1 (1989-1991), 2 (1993-1995), and 3 (1998-1999) was used to examine the performance of five methods used to impute missing data: listwise deletion, mean of serial measures, adjacent value, multiple imputation, and pattern-mixture. Three missing at random models and one non-missing at random model were used to compare the performance of the imputation techniques on randomly and non-randomly missing data. The pattern-mixture method was found to perform best for imputing renal function data that were not missing at random. Determining whether data are missing at random or not can help in choosing the imputation method that will provide the most accurate results.	[Shara, Nawar; Yassin, Sayf A.; Wang, Hong; Howard, Barbara V.; Umans, Jason G.] MedStar Hlth Res Inst, Hyattsville, MD 20782 USA; [Shara, Nawar; Wang, Hong; Howard, Barbara V.; Umans, Jason G.] Georgetown Howard Univ Ctr Clin & Translat Sci, Washington, DC USA; [Valaitis, Eduardas] Amer Univ, Dept Math & Stat, Washington, DC 20016 USA; [Wang, Wenyu; Lee, Elisa T.] Univ Oklahoma, Coll Publ Hlth, Oklahoma City, OK USA	MedStar Health Research Institute; American University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Shara, N (corresponding author), MedStar Hlth Res Inst, Hyattsville, MD 20782 USA.	Nawar.Shara@MedStar.net		, Sayf H. Abdalhakeem/0000-0001-6288-4970	National Center for Research Resources [UL1RR031975]; National Center for Advancing Translational Sciences, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109319] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Federal funds (Grant # UL1RR031975) from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through the Clinical and Translational Science Awards Program, a trademark of the U.S. Department of Health and Human Services, part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2002, CIRCULATION, V106, P974, DOI 10.1161/01.CIR.0000027560.41358.B3; Anavekar NS, 2004, KIDNEY INT, V66, pS11, DOI 10.1111/j.1523-1755.2004.09203.x; Demirtas H, 2003, STAT MED, V22, P2553, DOI 10.1002/sim.1475; Duncan L, 2001, NEPHROL DIAL TRANSPL, V16, P1042, DOI 10.1093/ndt/16.5.1042; Freeman RV, 2003, J AM COLL CARDIOL, V41, P718, DOI 10.1016/S0735-1097(02)02956-X; Gibson CM, 2003, J AM COLL CARDIOL, V42, P1535, DOI 10.1016/j.jacc.2003.06.001; Gill P.E., 1981, PRACTICAL OPTIMIZATI; Houck P, MACRO FOR LOCF COMP; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; HOWARD BV, 1992, DIABETES, V41, P4, DOI 10.2337/diab.41.2.S4; Januzzi JL, 2002, CIRCULATION, V105, P2361, DOI 10.1161/01.CIR.0000016359.94919.16; Kang T, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S43; Keeley EC, 2003, AM J CARDIOL, V92, P509, DOI 10.1016/S0002-9149(03)00716-1; Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5; Lee Elisa T., 1995, Journal of Investigative Medicine, V43, p510A; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Lee ET, 1998, AM J EPIDEMIOL, V147, P995, DOI 10.1093/oxfordjournals.aje.a009406; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Molenberghs G, 1998, STAT NEERL, V52, P153, DOI 10.1111/1467-9574.00075; Newby LK, 2003, EUR HEART J, V24, P172, DOI 10.1016/S0195-668X(02)00325-1; Resnick HE, 2003, DIABETES CARE, V26, P861, DOI 10.2337/diacare.26.3.861; Troxel AB, 1998, J ROY STAT SOC C-APP, V47, P425, DOI 10.1111/1467-9876.00119; VASQUEZ B, 1984, DIABETOLOGIA, V26, P127, DOI 10.1007/BF00281119	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2015	10	9							e0138923	10.1371/journal.pone.0138923	http://dx.doi.org/10.1371/journal.pone.0138923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6EO	26414328	Green Submitted, Green Published, gold			2022-12-27	WOS:000362170700029
J	Chang, YJ; Burton, T; Ha, L; Huang, Z; Olajubelo, A; Li, C				Chang, Yan-Jung; Burton, Tina; Ha, Lawrence; Huang, Zi; Olajubelo, Adewale; Li, Chris			Modulation of Locomotion and Reproduction by FLP Neuropeptides in the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							FMRFAMIDE-LIKE PEPTIDES; GENE FAMILY; C-ELEGANS; BEHAVIORAL STATES; NERVOUS-SYSTEM; NEURONS; PROTEIN; INSULIN; EXPRESSION; SEROTONIN	Neuropeptides function in animals to modulate most, if not all, complex behaviors. In invertebrates, neuropeptides can function as the primary neurotransmitter of a neuron, but more generally they co-localize with a small molecule neurotransmitter, as is commonly seen in vertebrates. Because a single neuron can express multiple neuropeptides and because neuropeptides can bind to multiple G protein-coupled receptors, neuropeptide actions increase the complexity by which the neural connectome can be activated or inhibited. Humans are estimated to have 90 plus neuropeptide genes; by contrast, nematodes, a relatively simple organism, have a slightly larger complement of neuropeptide genes. For instance, the nematode Caenorhabditis elegans has over 100 neuropeptide-encoding genes, of which at least 31 genes encode peptides of the FMRFamide family. To understand the function of this large FMRFamide peptide family, we isolated knockouts of different FMRFamide-encoding genes and generated transgenic animals in which the peptides are overexpressed. We assayed these animals on two basic behaviors: locomotion and reproduction. Modulating levels of different neuropeptides have strong as well as subtle effects on these behaviors. These data suggest that neuropeptides play critical roles in C. elegans to fine tune neural circuits controlling locomotion and reproduction.	[Chang, Yan-Jung; Burton, Tina; Ha, Lawrence; Huang, Zi; Olajubelo, Adewale; Li, Chris] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Li, Chris] CUNY, Grad Ctr, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Li, C (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	cli@ccny.cuny.edu	LI, chris/HDO-6232-2022	Burton, Tina/0000-0001-9077-9238	National Science Foundation [IOS 0820748]; National Institutes of Health [R01 NS42459]; Research Centers in Minority Institutes grant from National Institute on Minority Health and Health Disparities [5G12MD007603]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042459] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER; Direct For Biological Sciences [0820748] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutes grant from National Institute on Minority Health and Health Disparities; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (IOS 0820748) - CL, National Institutes of Health (R01 NS42459) - CL, and Research Centers in Minority Institutes grant (5G12MD007603) from the National Institute on Minority Health and Health Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeg A, 2011, MOL CELL NEUROSCI, V46, P308, DOI 10.1016/j.mcn.2010.10.001; ALFONSO A, 1994, J NEUROSCI, V14, P2290; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRENNER S, 1974, GENETICS, V77, P71; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; CHALFIE M, 1985, J NEUROSCI, V5, P956; Choi S, 2013, NEURON, V78, P869, DOI 10.1016/j.neuron.2013.04.002; Cohen M, 2009, CELL METAB, V9, P375, DOI 10.1016/j.cmet.2009.02.003; Davis RE, 1996, PARASITOLOGY, V113, pS97, DOI 10.1017/S0031182000077921; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Dimitriadi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001172; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Duret L, 1998, GENOME RES, V8, P348, DOI 10.1101/gr.8.4.348; Glauser DA, 2011, GENETICS, V188, P91, DOI 10.1534/genetics.111.127100; Gregoire FM, 1998, BIOCHEM BIOPH RES CO, V249, P385, DOI 10.1006/bbrc.1998.9164; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hardaker LA, 2001, J NEUROBIOL, V49, P303, DOI 10.1002/neu.10014; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Husson SJ, 2005, BIOCHEM BIOPH RES CO, V335, P76, DOI 10.1016/j.bbrc.2005.07.044; Husson SJ, 2007, FEBS LETT, V581, P4288, DOI 10.1016/j.febslet.2007.08.003; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Husson SJ, 2009, PEPTIDES, V30, P449, DOI 10.1016/j.peptides.2008.07.021; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Keating CD, 2003, CURR BIOL, V13, P1715, DOI 10.1016/j.cub.2003.09.003; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kubiak TM, 2003, J BIOL CHEM, V278, P33724, DOI 10.1074/jbc.M304861200; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Li C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00150; Li C, 2013, LEARN MEMORY, V20, P103, DOI 10.1101/lm.028993.112; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Marks NJ, 1999, BIOCHEM BIOPH RES CO, V254, P222, DOI 10.1006/bbrc.1998.9920; Marks NJ, 1995, BIOCHEM BIOPH RES CO, V217, P845, DOI 10.1006/bbrc.1995.2849; Marks NJ, 1997, BIOCHEM BIOPH RES CO, V231, P591, DOI 10.1006/bbrc.1997.6155; Marks NJ, 2001, BIOCHEM BIOPH RES CO, V286, P1170, DOI 10.1006/bbrc.2001.5524; Marks NJ, 1998, BIOCHEM BIOPH RES CO, V248, P422, DOI 10.1006/bbrc.1998.8982; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nelson LS, 1998, SCIENCE, V281, P1686, DOI 10.1126/science.281.5383.1686; Nelson LS, 1998, MOL BRAIN RES, V58, P103, DOI 10.1016/S0169-328X(98)00106-5; OKKEMA PG, 1993, GENETICS, V135, P385; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; ROSOFF ML, 1992, J NEUROSCI, V12, P2356; ROSOFF ML, 1993, PEPTIDES, V14, P331, DOI 10.1016/0196-9781(93)90049-M; Schafer William R, 2005, WormBook, P1; SCHINKMANN K, 1992, J COMP NEUROL, V316, P251, DOI 10.1002/cne.903160209; Stawicki TM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003472; TRENT C, 1983, GENETICS, V104, P619; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; Waggoner LF, 2000, GENETICS, V154, P1181; Wani KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037831; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	65	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0135164	10.1371/journal.pone.0135164	http://dx.doi.org/10.1371/journal.pone.0135164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406995	Green Published, gold			2022-12-27	WOS:000361800700003
J	Fan, RY; Li, YJ; Li, CF; Zhang, YS				Fan, Rongyan; Li, Yuanjun; Li, Changfu; Zhang, Yansheng			Differential microRNA Analysis of Glandular Trichomes and Young Leaves in Xanthium strumarium L. Reveals Their Putative Roles in Regulating Terpenoid Biosynthesis	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITIES; MEDICINAL-PLANTS; SMALL RNAS; IDENTIFICATION; ARABIDOPSIS; XANTHATIN; GENES; XANTHANOLIDES; GENOMICS; SYNTHASE	The medicinal plant Xanthium strumarium L. (X. strumarium) is covered with glandular trichomes, which are the sites for synthesizing pharmacologically active terpenoids such as xanthatin. MicroRNAs (miRNAs) are a class of 21-24 nucleotide (nt) non-coding RNAs, most of which are identified as regulators of plant growth development. Identification of miRNAs involved in the biosynthesis of plant secondary metabolites remains limited. In this study, high-throughput Illumina sequencing, combined with target gene prediction, was performed to discover novel and conserved miRNAs with potential roles in regulating terpenoid biosynthesis in X. strumarium glandular trichomes. Two small RNA libraries from leaves and glandular trichomes of X. strumarium were established. In total, 1,185 conserved miRNAs and 37 novel miRNAs were identified, with 494 conserved miRNAs and 18 novel miRNAs being differentially expressed between the two tissue sources. Based on the X. strumarium transcriptome data that we recently constructed, 3,307 annotated mRNA transcripts were identified as putative targets of the differentially expressed miRNAs. KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis suggested that some of the differentially expressed miRNAs, including miR6435, miR5021 and miR1134, might be involved in terpenoid biosynthesis in the X. strumarium glandular trichomes. This study provides the first comprehensive analysis of miRNAs in X. strumarium, which forms the basis for further understanding of miRNA-based regulation on terpenoid biosynthesis.	[Fan, Rongyan; Li, Yuanjun; Li, Changfu; Zhang, Yansheng] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan 430074, Peoples R China; [Fan, Rongyan; Li, Yuanjun] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YS (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan 430074, Peoples R China.	zhangys@wbgcas.cn			National Natural Science Foundation of China [31370339]; Grant of One Hundred Talent Program of the CAS [29Y129441R0104444]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grant of One Hundred Talent Program of the CAS	The funding sources are from the National Natural Science Foundation of China (grant number: 31370339) and the Grant of One Hundred Talent Program of the CAS (grant number: 29Y129441R0104444) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDEIMOGIB M, 1991, PHYTOCHEMISTRY, V30, P3461, DOI 10.1016/0031-9422(91)83230-I; AHMED AA, 1990, PHYTOCHEMISTRY, V29, P2211, DOI 10.1016/0031-9422(90)83040-8; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Anjoo Kamboj, 2010, International Journal of Green Pharmacy, V4, P129; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boke H, 2015, PLANT BIOTECHNOL J, V13, P409, DOI 10.1111/pbi.12346; Chandel S, 2012, PARASITOL RES, V110, P1179, DOI 10.1007/s00436-011-2611-1; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076621; Chen MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076120; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen Y, 2014, PLANT PHYSIOL, V166, P2028, DOI 10.1104/pp.114.247486; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; CHOI D, 1992, PLANT CELL, V4, P1333, DOI 10.1105/tpc.4.10.1333; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DUKE SO, 1994, INT J PLANT SCI, V155, P617, DOI 10.1086/297200; Eljounaidi K, 2014, PLANT SCI, V223, P59, DOI 10.1016/j.plantsci.2014.03.007; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Frazier TP, 2011, METHODS MOL BIOL, V678, P13, DOI 10.1007/978-1-60761-682-5_2; Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hammerschmidt DE, 1998, J LAB CLIN MED, V132, P86, DOI 10.1016/S0022-2143(98)90030-0; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; HARADA A, 1985, AGR BIOL CHEM TOKYO, V49, P1887, DOI 10.1080/00021369.1985.10866999; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jung JD, 2003, PLANT CELL REP, V22, P224, DOI 10.1007/s00299-003-0678-6; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KAWAZU K, 1979, EXPERIENTIA, V35, P1294, DOI 10.1007/BF01963966; KUPCHAN SM, 1971, J MED CHEM, V14, P1147, DOI 10.1021/jm00294a001; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Landmann C, 2007, ARCH BIOCHEM BIOPHYS, V465, P417, DOI 10.1016/j.abb.2007.06.011; Lavault M, 2005, FITOTERAPIA, V76, P363, DOI 10.1016/j.fitote.2005.03.019; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DM, 2009, PLANT CELL PHYSIOL, V50, P2146, DOI 10.1093/pcp/pcp149; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Ma YT, 1998, PHYTOCHEMISTRY, V48, P1083, DOI 10.1016/S0031-9422(98)00084-3; Mahmoud AA, 1998, PLANTA MED, V64, P724, DOI 10.1055/s-2006-957566; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Ng DWK, 2011, PLANT CELL, V23, P1729, DOI 10.1105/tpc.111.083915; Nibret E, 2011, PHYTOTHER RES, V25, P1883, DOI 10.1002/ptr.3651; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Prakash P, 2015, GENE, V554, P181, DOI 10.1016/j.gene.2014.10.046; Ramirez-Erosa I, 2007, CAN J PHYSIOL PHARM, V85, P1160, DOI 10.1139/Y07-104; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Robert-Seilaniantz A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P103, DOI 10.1007/978-90-481-3112-9_6; RODRIGUEZ E, 1976, PHYTOCHEMISTRY, V15, P1573, DOI 10.1016/S0031-9422(00)97430-2; ROUSSAKIS C, 1994, PLANTA MED, V60, P473, DOI 10.1055/s-2006-959537; Sato Y, 1997, J PHARM PHARMACOL, V49, P1042, DOI 10.1111/j.2042-7158.1997.tb06038.x; SAXENA VK, 1994, PHYTOCHEMISTRY, V35, P1080, DOI 10.1016/S0031-9422(00)90678-2; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Soo Kim Hyun, 2003, Korean Society for Biotechnology and Bioengineering Journal, V18, P324; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Wang FD, 2013, GENE, V532, P222, DOI 10.1016/j.gene.2013.09.039; Wu B, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034588, 10.1371/journal.pone.0044385]; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Yang TW, 2007, PLANT SCI, V172, P423, DOI 10.1016/j.plantsci.2006.10.009; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin MH, 2005, J ETHNOPHARMACOL, V99, P113, DOI 10.1016/j.jep.2005.02.013; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X	70	34	42	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0139002	10.1371/journal.pone.0139002	http://dx.doi.org/10.1371/journal.pone.0139002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406988	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700143
J	Williams, M; To, A; Bozhilov, K; Talbot, P				Williams, Monique; To, An; Bozhilov, Krassimir; Talbot, Prue			Strategies to Reduce Tin and Other Metals in Electronic Cigarette Aerosol	PLOS ONE			English	Article							IN-VITRO; NICOTINE; SMOKE	Background Metals are present in electronic cigarette (EC) fluid and aerosol and may present health risks to users. Objective The objective of this study was to measure the amounts of tin, copper, zinc, silver, nickel and chromium in the aerosol from four brands of EC and to identify the sources of these metals by examining the elemental composition of the atomizer components. Methods Four brands of popular EC were dissected and the cartomizers were examined microscopically. Elemental composition of cartomizer components was determined using integrated energy dispersive X-ray microanalysis, and the concentrations of the tin, copper, zinc silver, nickel, and chromium in the aerosol were determined for each brand using inductively coupled plasma optical emission spectroscopy. Results All filaments were made of nickel and chromium. Thick wires were copper coated with either tin or silver. Wires were joined to each other by tin solder, brazing, or by brass clamps. High concentrations of tin were detected in the aerosol when tin solder joints were friable. Tin coating on copper wires also contributed to tin in the aerosol. Conclusions Tin concentrations in EC aerosols varied both within and between brands. Tin in aerosol was reduced by coating the thick wire with silver rather than tin, placing stable tin solder joints outside the atomizing chamber, joining wires with brass clamps or by brazing rather than soldering wires. These data demonstrate the feasibility of removing tin and other unwanted metals from EC aerosol by altering designs and using materials of suitable quality.	[Williams, Monique; To, An; Talbot, Prue] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Bozhilov, Krassimir] Univ Calif Riverside, Cent Facil Adv Microscopy & Microanal, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021	To, An/0000-0003-3170-2999	National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: The work was supported by National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Brown CC, 2014, ARCH DIS CHILDHOOD-E, V99, P13, DOI 10.1136/archdischild-2013-304675; Callahan-Lyon P, 2014, TOB CONTROL, V23, P36, DOI 10.1136/tobaccocontrol-2013-051470; Chen IL, 2013, NICOTINE TOB RES, V15, P615, DOI 10.1093/ntr/nts145; Davis B, 2015, NICOTINE TOB RES, V17, P134, DOI 10.1093/ntr/ntu080; Flouris AD, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c311; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Lee N-C, 2009, MAT ADV PACKAGING, P181, DOI DOI 10.1007/978-0-387-78219-5_5; Mansour SA, 2014, PRACTICAL FOOD SAFETY: CONTEMPORARY ISSUES AND FUTURE DIRECTIONS, P213; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; Thota D, 2014, J EMERG MED, V47, P15, DOI 10.1016/j.jemermed.2013.09.034; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Trtchounian A, 2011, TOB CONTROL, V20, P47, DOI 10.1136/tc.2010.037259; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; Williams M, 2015, NICOTINE TOB RES, V17, P201, DOI 10.1093/ntr/ntu118; Williams M, 2011, NICOTINE TOB RES, V13, P1276, DOI 10.1093/ntr/ntr164; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	26	42	45	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138933	10.1371/journal.pone.0138933	http://dx.doi.org/10.1371/journal.pone.0138933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406602	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700121
J	Labree, W; Van de Mheen, D; Rutten, F; Rodenburg, G; Koopmans, G; Foets, M				Labree, Wim; Van de Mheen, Dike; Rutten, Frans; Rodenburg, Gerda; Koopmans, Gerrit; Foets, Marleen			Differences in Overweight and Obesity among Children from Migrant and Native Origin: The Role of Physical Activity, Dietary Intake, and Sleep Duration	PLOS ONE			English	Article							CHILDHOOD OBESITY; VEGETABLE INTAKE; ADOLESCENTS; PREVENTION; WEIGHT; REPRODUCIBILITY; ACCULTURATION; QUESTIONNAIRE; ASSOCIATION; ENVIRONMENT	A cross-sectional survey was performed to examine to what degree differences in overweight and obesity between native Dutch and migrant primary school children could be explained by differences in physical activity, dietary intake, and sleep duration among these children. Subjects (n= 1943) were primary school children around the age of 8-9 years old and their primary caregivers: native Dutch children (n = 1546), Turkish children (n = 93), Moroccan children (n = 66), other non-western children (n = 105), and other western children (n = 133). Multivariate regressions and logistic regressions were used to examine the relationship between migrant status, child's behavior, and BMI or prevalence of overweight, including obesity (logistic). Main explanatory variables were physical activity, dietary intake, and sleep duration. We controlled for age, sex, parental educational level, and parental BMI. Although sleep duration, dietary intake of fruit, and dietary intake of energy-dense snacks were associated with BMI, ethnic differences in sleep duration and dietary intake did not have a large impact on ethnic differences in overweight and obesity among children from migrant and native origin. It is suggested that future preventive strategies to reduce overweight and obesity, in general, consider the role of sleep duration. Also, cross-cultural variation in preparation of food among specific migrant groups, focusing on fat, sugar, and salt, deserves more attention. In order to examine which other variables may clarify ethnic differences in overweight and obesity, future research is needed.	[Labree, Wim; Rutten, Frans; Koopmans, Gerrit; Foets, Marleen] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands; [Van de Mheen, Dike; Rodenburg, Gerda] Res Inst Addict, Rotterdam, Netherlands; [Van de Mheen, Dike; Rodenburg, Gerda] Univ Med Ctr, Erasmus MC, Rotterdam, Netherlands; [Van de Mheen, Dike] Maastricht Univ, Dept Hlth Promot, NL-6200 MD Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Maastricht University	Labree, W (corresponding author), POB 1738, NL-3000 DR Rotterdam, Netherlands.	labree@bmg.eur.nl	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900; Rutten, Gemma/0000-0001-9552-4605	Netherlands Organization for Health Research and Development [115100004]; Institute of Health Policy and Management, a department of the Erasmus University Rotterdam	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Institute of Health Policy and Management, a department of the Erasmus University Rotterdam	This research was made possible by a grant of the Netherlands Organization for Health Research and Development (115100004) and financial support from the Institute of Health Policy and Management, a department of the Erasmus University Rotterdam.	Aranceta J, 2009, NUTR REV, V67, pS83, DOI 10.1111/j.1753-4887.2009.00166.x; Beccuti G, 2011, CURR OPIN CLIN NUTR, V14, P402, DOI 10.1097/MCO.0b013e3283479109; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; Burrows TL, 2013, CLIN NUTR, V32, P613, DOI 10.1016/j.clnu.2012.11.006; Cattaneo A, 2010, OBES REV, V11, P389, DOI 10.1111/j.1467-789X.2009.00639.x; CBS (Statistics Netherlands), 2000, STAND ALL; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; Danielzik S, 2004, INT J OBESITY, V28, P1494, DOI 10.1038/sj.ijo.0802756; de Wilde JA, 2014, ARCH DIS CHILD, V99, P46, DOI 10.1136/archdischild-2013-304222; de Wilde JA, 2009, ARCH DIS CHILD, V94, P795, DOI 10.1136/adc.2009.163709; Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458; GGD (Municipal Health Services), 2009, STANDD BEW MON JEUGD; Gilbert PA, 2008, NUTR REV, V66, P203, DOI 10.1111/j.1753-4887.2008.00025.x; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; Guo XF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-120; Haraldsdottir J, 2005, ANN NUTR METAB, V49, P221, DOI 10.1159/000087276; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; John J, 2010, CURR OPIN CLIN NUTR, V13, P305, DOI 10.1097/MCO.0b013e328337fe18; Knutson KL, 2012, AM J HUM BIOL, V24, P361, DOI 10.1002/ajhb.22219; Labree LJW, 2011, OBES REV, V12, pe535, DOI 10.1111/j.1467-789X.2010.00839.x; Labree LJW, 2014, J PUBLIC HEALTH-HEID, V22, P415, DOI 10.1007/s10389-014-0637-4; Liu JH, 2012, J SPEC PEDIATR NURS, V17, P193, DOI 10.1111/j.1744-6155.2012.00332.x; Lytle LA, 2009, AM J COMMUN PSYCHOL, V44, P338, DOI 10.1007/s10464-009-9269-1; Mejean C, 2009, PUBLIC HEALTH NUTR, V12, P832, DOI 10.1017/S1368980008003285; Meng LP, 2012, BIOMED ENVIRON SCI, V25, P133, DOI 10.3967/0895-3988.2012.02.002; Nicolaou M, 2009, J NUTR EDUC BEHAV, V41, P232, DOI 10.1016/j.jneb.2008.05.011; Rauner A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-19; Renzaho AMN, 2010, PUBLIC HEALTH NUTR, V13, P438, DOI 10.1017/S136898000999111X; SALLIS JF, 1991, J SCHOOL HEALTH, V61, P215, DOI 10.1111/j.1746-1561.1991.tb06017.x; Steinbeck K S, 2001, Obes Rev, V2, P117, DOI 10.1046/j.1467-789x.2001.00033.x; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Toselli S, 2014, ENDOCRINE, V24, pE1; van der Horst K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-142; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788	37	54	54	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0123672	10.1371/journal.pone.0123672	http://dx.doi.org/10.1371/journal.pone.0123672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26406985	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900009
J	Rutten, G; Ensslin, A; Hemp, A; Fischer, M				Rutten, Gemma; Ensslin, Andreas; Hemp, Andreas; Fischer, Markus			Vertical and Horizontal Vegetation Structure across Natural and Modified Habitat Types at Mount Kilimanjaro	PLOS ONE			English	Article							SPECIES-DIVERSITY; TROPICAL FOREST; CLIMATE-CHANGE; LAND-USE; MONTANE FORESTS; TREE DIVERSITY; BIOMASS; CONSERVATION; BIODIVERSITY; GRADIENTS	In most habitats, vegetation provides the main structure of the environment. This complexity can facilitate biodiversity and ecosystem services. Therefore, measures of vegetation structure can serve as indicators in ecosystem management. However, many structural measures are laborious and require expert knowledge. Here, we used consistent and convenient measures to assess vegetation structure over an exceptionally broad elevation gradient of 866-4550m above sea level at Mount Kilimanjaro, Tanzania. Additionally, we compared (human)-modified habitats, including maize fields, traditionally managed home gardens, grasslands, commercial coffee farms and logged and burned forests with natural habitats along this elevation gradient. We distinguished vertical and horizontal vegetation structure to account for habitat complexity and heterogeneity. Vertical vegetation structure (assessed as number, width and density of vegetation layers, maximum canopy height, leaf area index and vegetation cover) displayed a unimodal elevation pattern, peaking at intermediate elevations in montane forests, whereas horizontal structure (assessed as coefficient of variation of number, width and density of vegetation layers, maximum canopy height, leaf area index and vegetation cover) was lowest at intermediate altitudes. Overall, vertical structure was consistently lower in modified than in natural habitat types, whereas horizontal structure was inconsistently different in modified than in natural habitat types, depending on the specific structural measure and habitat type. Our study shows how vertical and horizontal vegetation structure can be assessed efficiently in various habitat types in tropical mountain regions, and we suggest to apply this as a tool for informing future biodiversity and ecosystem service studies.	[Rutten, Gemma; Ensslin, Andreas; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Rutten, Gemma] Bern Univ Appl Sci, Sch Agr Forest & Food Sci, Zollikofen, Switzerland; [Rutten, Gemma; Ensslin, Andreas; Fischer, Markus] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Hemp, Andreas] Univ Bayreuth, Dept Plant Systemat, Bayreuth, Germany; [Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland; [Fischer, Markus] Biodivers & Climate Res Ctr BiK F, Senckenberg Gesell Naturforschung, Frankfurt, Germany	University of Bern; University of Bern; University of Bayreuth; University of Bern; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Rutten, G (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	ggpmrutten@gmail.com	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900; Rutten, Gemma/0000-0001-9552-4605	Swiss National Science Foundation (SNSF) of Research-Unit of the German Research Foundation (DFG) [1246]	Swiss National Science Foundation (SNSF) of Research-Unit of the German Research Foundation (DFG)	Funding: This study was supported by the Swiss National Science Foundation (SNSF) in the context of Research-Unit 1246 of the German Research Foundation (DFG). Prof. Dr. Markus Fischer, Dr. Andreas Hemp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawala S, 2003, DEV CLIMATE CHANGE T; Appelhans T, 2014, MONTHLY ANN CLIMATE; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; BELSKY AJ, 1994, BIOSCIENCE, V44, P77, DOI 10.2307/1312205; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; Dean WRJ, 1999, J ARID ENVIRON, V41, P61, DOI 10.1006/jare.1998.0455; Dickinson MB, 2000, FOREST ECOL MANAG, V134, P137, DOI 10.1016/S0378-1127(99)00252-2; Ensslin A, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00492.1; Garden JG, 2007, AUSTRAL ECOL, V32, P669, DOI 10.1111/j.1442-9993.2007.01750.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; HATLEY CL, 1980, ENVIRON ENTOMOL, V9, P632, DOI 10.1093/ee/9.5.632; Helbig-Bonitz M, 2013, AFRICAN J ECOLOGY; Hemp A, 2005, GLOBAL CHANGE BIOL, V11, P1013, DOI 10.1111/j.1365-2486.2005.00968.x; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Hemp A, 2006, PLANT ECOL, V184, P27, DOI 10.1007/s11258-005-9049-4; Hemp A, 2006, BIODIVERS CONSERV, V15, P1193, DOI 10.1007/s10531-004-8230-8; Herve BD, 2008, BIODIVERS CONSERV, V17, P1821, DOI 10.1007/s10531-007-9276-1; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; JENSEN M, 1993, AGROFOREST SYST, V24, P171, DOI 10.1007/BF00706890; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Kessler M, 2005, BIODIVERS CONSERV, V14, P547, DOI 10.1007/s10531-004-3914-7; KITAYAMA K, 1992, VEGETATIO, V102, P149, DOI 10.1007/BF00044731; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lambrechts C., 2002, AERIAL SURVEY THREAT; Lopez-Gomez AA, 2008, AGR ECOSYST ENVIRON, V124, P160, DOI 10.1016/j.agee.2007.09.008; Lovett JC, 2006, AFR J ECOL, V44, P478, DOI 10.1111/j.1365-2028.2006.00660.x; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Moser G, 2007, ECOSYSTEMS, V10, P924, DOI 10.1007/s10021-007-9063-6; Paletto A, 2009, EUR J FOREST RES, V128, P265, DOI 10.1007/s10342-009-0262-x; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Reich RM, 2010, PLANT ECOL, V210, P67, DOI 10.1007/s11258-010-9738-5; Rhoades CC, 1996, AGROFOREST SYST, V35, P71, DOI 10.1007/BF02345330; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Ruiz-Jaen MC, 2005, FOREST ECOL MANAG, V218, P159, DOI 10.1016/j.foreco.2005.07.008; Rutten G, 2015, FOREST ECOL MANAG, V337, P61, DOI 10.1016/j.foreco.2014.10.036; Schnitzer SA, 2001, ECOLOGY, V82, P913, DOI 10.1890/0012-9658(2001)082[0913:TGATMO]2.0.CO;2; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Stumpf K., 1993, SOC AM FOR NAT CONV; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Van Gemerden BS, 2003, BIODIVERS CONSERV, V12, P1553, DOI 10.1023/A:1023603813163; Williams-Linera G, 2013, PLANT ECOL, P1; Wilson JB, 2011, J VEG SCI, V22, P197, DOI 10.1111/j.1654-1103.2010.01238.x	53	54	54	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138822	10.1371/journal.pone.0138822	http://dx.doi.org/10.1371/journal.pone.0138822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406985	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700103
